PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kinoshita, K; Kuno, S; Ishimine, H; Aoi, N; Mineda, K; Kato, H; Doi, K; Kanayama, K; Feng, J; Mashiko, T; Kurisaki, A; Yoshimura, K				Kinoshita, Kahori; Kuno, Shinichiro; Ishimine, Hisako; Aoi, Noriyuki; Mineda, Kazuhide; Kato, Harunosuke; Doi, Kentaro; Kanayama, Koji; Feng, Jingwei; Mashiko, Takanobu; Kurisaki, Akira; Yoshimura, Kotaro			Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin Ulcers	STEM CELLS TRANSLATIONAL MEDICINE			English	Article							MESENCHYMAL STEM-CELLS; TUMOR-NECROSIS-FACTOR; BONE-MARROW; AUTONOMIC NEUROPATHY; PROGENITOR-CELL; REPAIR; MICE; FIBROBLASTS; POPULATIONS; MEDICINE	Stage-specific embryonic antigen-3 (SSEA-3)-positive multipotent mesenchymal cells (multilineage differentiating stress-enduring [Muse] cells) were isolated from cultured human adipose tissue-derived stem/stromal cells (hASCs) and characterized, and their therapeutic potential for treating diabetic skin ulcers was evaluated. Cultured hASCs were separated using magnetic-activated cell sorting into positive and negative fractions, a SSEA-3(+) cell-enriched fraction (Muse-rich) and the remaining fraction (Muse-poor). Muse-rich hASCs showed upregulated and downregulated pluripotency and cell proliferation genes, respectively, compared with Muse-poor hASCs. These cells also released higher amounts of certain growth factors, particularly under hypoxic conditions, compared with Muse-poor cells. Skin ulcers were generated in severe combined immunodeficiency (SCID) mice with type 1 diabetes, which showed delayed wound healing compared with nondiabetic SCID mice. Treatment with Muse-rich cells significantly accelerated wound healing compared with treatment with Muse-poor Cells. Transplanted cells were integrated into the regenerated dermis as vascular endothelial cells and other cells. However, they were not detected in the surrounding intact regions. Thus, the selected population of ASCs has greater therapeutic effects to accelerate impaired wound healing associated with type 1 diabetes. These cells can be achieved in large amounts with minimal morbidity and could be a practical tool for a variety of stem cell-depleted or ischemic conditions of various organs and tissues.	[Kinoshita, Kahori; Kuno, Shinichiro; Aoi, Noriyuki; Mineda, Kazuhide; Kato, Harunosuke; Doi, Kentaro; Kanayama, Koji; Feng, Jingwei; Mashiko, Takanobu; Yoshimura, Kotaro] Univ Tokyo, Grad Sch Med, Dept Plast Surg, Tokyo 1138655, Japan; [Ishimine, Hisako; Kurisaki, Akira] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Japan	Yoshimura, K (reprint author), Univ Tokyo, Sch Med, Dept Plast Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kotaro-yoshimura@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [B3-24390398, 25670749]	We gratefully acknowledge Drs. Mari Dezawa, Yoshihiro Kushida, and Shohei Wakao (Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine) for technical instructions to isolate and analyze Muse cells in vivo and in vitro. This study was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), contract grants: Grant-in-Aid for Scientific Research B3-24390398 and Grant-in-Aid for Challenging Exploratory Research 25670749.	Acil Y, 2014, J CRANIO MAXILL SURG, V42, P825, DOI 10.1016/j.jcms.2013.11.020; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; SALOMON GD, 1991, ANN SURG, V214, P175, DOI 10.1097/00000658-199108000-00012; Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Bassi EJ, 2012, DIABETES, V61, P2534, DOI 10.2337/db11-0844; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Hausman GJ, 2006, J CLIN INVEST, V116, P3103, DOI 10.1172/JCI30666; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Shinozaki M, 2009, ARCH DERMATOL RES, V301, P531, DOI 10.1007/s00403-009-0969-z; Schmidt RE, 2003, AM J PATHOL, V163, P2077, DOI 10.1016/S0002-9440(10)63565-1; Eto H, 2011, AM J PATHOL, V178, P2322, DOI 10.1016/j.ajpath.2011.01.032; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Kablik J, 2009, DERMATOL SURG, V35, P302, DOI 10.1111/j.1524-4725.2008.01046.x; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Itoi Y, 2010, J PLAST RECONSTR AES, V63, P858, DOI 10.1016/j.bjps.2009.01.069; Eto H, 2013, STEM CELLS DEV, V22, P985, DOI 10.1089/scd.2012.0442; Heneidi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064752; Kono TM, 2014, STEM CELLS, V32, P1831, DOI 10.1002/stem.1676; MOONEY DP, 1990, ANN SURG, V211, P124, DOI 10.1097/00000658-199002000-00002; Schmidt RE, 2008, EXP NEUROL, V209, P161, DOI 10.1016/j.expneurol.2007.09.018; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Tsuchiyama K, 2013, J INVEST DERMATOL, V133, P2425, DOI 10.1038/jid.2013.172; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875; Wakao S, 2014, PATHOL INT, V64, P1; Yang ZC, 2013, CELL REPROGRAM, V15, P195, DOI 10.1089/cell.2012.0080	31	1	1	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	FEB	2015	4	2					146	155		10.5966/sctm.2014-0181		10	Cell & Tissue Engineering	Cell Biology	CA5SK	WOS:000348967900005		
J	Isomura, N; Kataoka, K; Horibuchi, K; Dohmae, K; Oji, H; Cui, YT; Son, JY; Kitazumi, K; Takahashi, N; Kimoto, Y				Isomura, N.; Kataoka, K.; Horibuchi, K.; Dohmae, K.; Oji, H.; Cui, Y. -T.; Son, J. -Y.; Kitazumi, K.; Takahashi, N.; Kimoto, Y.			Thickness and coverage determination of multilayer with an island-like overlayer by hard X-ray photoelectron spectroscopy at multiple photon energies	SURFACE AND INTERFACE ANALYSIS			English	Article						HAXPES; compositional depth profile; nondestructive; photon energy; take-off angle; surface roughness	ANGULAR-DISTRIBUTIONS; PHOTOEMISSION; XPS; COMBINATION; SYSTEM; STATES; GAN	To obtain depth profiles of the elemental composition of materials, we propose the use of hard X-ray photoelectron spectroscopy (HAXPES) over a range of incident photon energies (PEs). Photoelectron intensities are measured as a function of PE and take-off angle (TOA) from a multilayer sample (Au/SiO2/Si). The top layer of the sample (Au) formed an island-like structure, which we modeled as bumps and dips (surface roughness). The PE dependence, measured at angles close to the surface normal, is consistent with the theoretical results, in contrast to the TOA dependence. The Au coverage and layer thicknesses are calculated by curve fitting using experimental and theoretical results. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Isomura, N.; Kataoka, K.; Horibuchi, K.; Dohmae, K.; Kitazumi, K.; Takahashi, N.; Kimoto, Y.] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Oji, H.; Cui, Y. -T.; Son, J. -Y.] Japan Synchrotron Radiat Res Inst JASRI, Sayo, Hyogo 6795198, Japan; [Cui, Y. -T.] Univ Tokyo, Synchrotron Radiat Res Org, Bunkyo Ku, Tokyo 1138656, Japan	Isomura, N (reprint author), Toyota Cent Res & Dev Labs Inc, 41-1 Yokomichi, Nagakute, Aichi 4801192, Japan.	isomura@mosk.tytlabs.co.jp					Kimura K, 2008, SURF INTERFACE ANAL, V40, P423, DOI 10.1002/sia.2628; Kobayashi K, 2003, APPL PHYS LETT, V83, P1005, DOI 10.1063/1.1595714; Olejnik K, 2005, SURF SCI, V595, P212, DOI 10.1016/j.susc.2005.08.014; Tanuma S, 2011, SURF INTERFACE ANAL, V43, P689, DOI 10.1002/sia.3522; Merzlikin SV, 2008, SURF SCI, V602, P755, DOI 10.1016/j.susc.2007.12.005; Fredriksson W, 2012, APPL SURF SCI, V258, P5790, DOI 10.1016/j.apsusc.2012.02.099; Benito N., 2013, J PHYS D, V46; Fadleys CS, 2009, NUCL INSTRUM METH A, V601, P8, DOI 10.1016/j.nima.2008.12.189; Hattori T., 2006, INT J HIGH SPEED ELE, V16, P353, DOI 10.1142/S0129156406003680; Hofmann S., 1983, PRACTICAL SURFACE AN, P141; Isomura N, 2014, J ELECTRON SPECTROSC, V195, P62, DOI 10.1016/j.elspec.2014.05.012; Kikuta D, 2012, PHYS STATUS SOLIDI C, V9, P927, DOI 10.1002/pssc.201100335; Kobata M, 2011, SURF INTERFACE ANAL, V43, P1632, DOI 10.1002/sia.3760; Kobayashi K, 2009, NUCL INSTRUM METH A, V601, P32, DOI 10.1016/j.nima.2008.12.188; Kover L, 2010, J ELECTRON SPECTROSC, V178, P241, DOI 10.1016/j.elspec.2009.12.004; Krassig B, 1995, PHYS REV LETT, V75, P4736, DOI 10.1103/PhysRevLett.75.4736; Narita T, 2011, PHYS STATUS SOLIDI A, V208, P1541, DOI 10.1002/pssa.201000952; Nohira H, 2011, ECS TRANSACTIONS, V41, P137, DOI 10.1149/1.3633293; Nohira H., 2005, ECS T, V1, P87; Oji H, 2014, J PHYS CONF SER, V502, DOI 10.1088/1742-6596/502/1/012006; Rubio-Zuazo J, 2013, J ELECTRON SPECTROSC, V190, P205, DOI 10.1016/j.elspec.2013.04.003; Seah M. P., 1983, PRACTICAL SURFACE AN, P181; SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709; Suga S., 2014, PHOTOELECTRON SPECTR, V176, P219; Tajima S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4850235; Tanuma S, 2013, J ELECTRON SPECTROSC, V190, P127, DOI 10.1016/j.elspec.2013.08.011; Trzhaskovskaya MB, 2006, ATOM DATA NUCL DATA, V92, P245, DOI 10.1016/j.adt.2005.12.002; Weiland C, 2014, SURF INTERFACE ANAL, V46, P407, DOI 10.1002/sia.5517; Yoshikawa H, 2013, J ELECTRON SPECTROSC, V190, P268, DOI 10.1016/j.elspec.2013.08.012	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	FEB	2015	47	2					265	269		10.1002/sia.5701		5	Chemistry, Physical	Chemistry	AZ9GY	WOS:000348523000014		
J	Suzuki, M; Nojima, M; Fujii, M; Seki, T; Matsuo, J				Suzuki, Masato; Nojima, Masashi; Fujii, Makiko; Seki, Toshio; Matsuo, Jiro			Mass analysis by Ar-GCIB-dynamic SIMS for organic materials	SURFACE AND INTERFACE ANALYSIS			English	Article						dynamic SIMS; Ar-GCIB; arginine; glycine; blended polymer; principal component analysis	CLUSTER ION-BEAMS; SPECTROMETRY; POLYMERS; SURFACE; ENERGY	Generally, dynamic secondary ion mass spectrometry (SIMS) has been mainly used as one of the most powerful tools for inorganic mass analysis. On the other hand, an Ar gas cluster ion beam (GCIB) has been developed and spread as a processing tool for surface flattening and also a projectile for time-of-flight (ToF) SIMS. In this study, we newly introduced an Ar-GCIB as a primary ion source to a commercially available dynamic SIMS apparatus, and investigated mass spectra of amino acid films (such as Arginine and Glycine) and polymer films (Polyethylene: PE and Polypropylene: PP) as organic model samples. As a result, each characteristic fragment peak indicating the original molecular organic structure was observed in the acquired mass spectra. In addition, their own molecular ions of the amino acids were also clearly observed. Mass spectra of PE/PP blended-polymer films acquired using Ar-GCIB-dynamic SIMS could be identified between pure PE and PE:PP=1:3 mixture by applying principal component analysis (PCA).	[Suzuki, Masato] Tokyo Univ Sci, Fac Sci & Technol, JP-2788510 Noda, Chiba, Japan; [Nojima, Masashi] Tokyo Univ Sci, RIST, JP-2788510 Noda, Chiba, Japan; [Fujii, Makiko; Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, JP-6110011 Uji, Kyoto, Japan; [Seki, Toshio] Kyoto Univ, Dept Nucl Engn, JP-6110011 Uji, Kyoto, Japan	Suzuki, M (reprint author), Tokyo Univ Sci, Fac Sci & Technol, 2641 Yamazaki, JP-2788510 Noda, Chiba, Japan.	j7213640@ed.tus.ac.jp					Gillen G, 2006, APPL SURF SCI, V252, P6521, DOI 10.1016/j.apsusc.2006.02.234; Miyasaka T, 2008, APPL SURF SCI, V255, P1576, DOI 10.1016/j.apsusc.2008.05.137; Seki T, 2006, NUCL INSTRUM METH B, V242, P179, DOI 10.1016/j.nimb.2005.08.023; Mahoney CM, 2006, APPL SURF SCI, V252, P6502, DOI 10.1016/j.apsusc.2006.02.078; Lee JLS, 2010, ANAL CHEM, V82, P98, DOI 10.1021/ac901045q; Aoyagi S, 2004, APPL SURF SCI, V231, P470, DOI 10.1016/j.apsusc.2004.03.181; DELCORTE A, 1995, NUCL INSTRUM METH B, V100, P213, DOI 10.1016/0168-583X(94)00842-6; Matsuo J, 2012, SURF INTERFACE ANAL, V44, P729, DOI 10.1002/sia.4856; Matsuo J, 2010, SURF INTERFACE ANAL, V42, P1612, DOI 10.1002/sia.3585; Moritani K, 2011, SURF INTERFACE ANAL, V43, P241, DOI 10.1002/sia.3551; Ninomiya S, 2011, SURF INTERFACE ANAL, V43, P221, DOI 10.1002/sia.3656; Ninomiya S, 2008, APPL SURF SCI, V255, P1588, DOI 10.1016/j.apsusc.2008.05.004; vansOoij W. J., 1988, SURF INTERFACE ANAL, V11, P430	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	FEB	2015	47	2					295	297		10.1002/sia.5705		3	Chemistry, Physical	Chemistry	AZ9GY	WOS:000348523000018		
J	Suzuki, M; Nojima, M; Fujii, M; Seki, T; Matsuo, J				Suzuki, Masato; Nojima, Masashi; Fujii, Makiko; Seki, Toshio; Matsuo, Jiro			Mass analysis by Ar-GCIB-dynamic SIMS for organic materials	SURFACE AND INTERFACE ANALYSIS			English	Article						dynamic SIMS; Ar-GCIB; arginine; glycine; blended polymer; principal component analysis	CLUSTER ION-BEAMS; SPECTROMETRY; POLYMERS; SURFACE; ENERGY	Generally, dynamic secondary ion mass spectrometry (SIMS) has been mainly used as one of the most powerful tools for inorganic mass analysis. On the other hand, an Ar gas cluster ion beam (GCIB) has been developed and spread as a processing tool for surface flattening and also a projectile for time-of-flight (ToF) SIMS. In this study, we newly introduced an Ar-GCIB as a primary ion source to a commercially available dynamic SIMS apparatus, and investigated mass spectra of amino acid films (such as Arginine and Glycine) and polymer films (Polyethylene: PE and Polypropylene: PP) as organic model samples. As a result, each characteristic fragment peak indicating the original molecular organic structure was observed in the acquired mass spectra. In addition, their own molecular ions of the amino acids were also clearly observed. Mass spectra of PE/PP blended-polymer films acquired using Ar-GCIB-dynamic SIMS could be identified between pure PE and PE:PP=1:3 mixture by applying principal component analysis (PCA). Copyright (c) 2014 John Wiley & Sons, Ltd.	[Suzuki, Masato] Tokyo Univ Sci, Fac Sci & Technol, JP-2788510 Noda, Chiba, Japan; [Nojima, Masashi] Tokyo Univ Sci, RIST, JP-2788510 Noda, Chiba, Japan; [Fujii, Makiko; Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, JP-6110011 Uji, Kyoto, Japan; [Seki, Toshio] Kyoto Univ, Dept Nucl Engn, JP-6110011 Uji, Kyoto, Japan	Suzuki, M (reprint author), Tokyo Univ Sci, Fac Sci & Technol, 2641 Yamazaki, JP-2788510 Noda, Chiba, Japan.	j7213640@ed.tus.ac.jp					Gillen G, 2006, APPL SURF SCI, V252, P6521, DOI 10.1016/j.apsusc.2006.02.234; Miyasaka T, 2008, APPL SURF SCI, V255, P1576, DOI 10.1016/j.apsusc.2008.05.137; Seki T, 2006, NUCL INSTRUM METH B, V242, P179, DOI 10.1016/j.nimb.2005.08.023; Mahoney CM, 2006, APPL SURF SCI, V252, P6502, DOI 10.1016/j.apsusc.2006.02.078; Lee JLS, 2010, ANAL CHEM, V82, P98, DOI 10.1021/ac901045q; Aoyagi S, 2004, APPL SURF SCI, V231, P470, DOI 10.1016/j.apsusc.2004.03.181; DELCORTE A, 1995, NUCL INSTRUM METH B, V100, P213, DOI 10.1016/0168-583X(94)00842-6; Matsuo J, 2012, SURF INTERFACE ANAL, V44, P729, DOI 10.1002/sia.4856; Matsuo J, 2010, SURF INTERFACE ANAL, V42, P1612, DOI 10.1002/sia.3585; Moritani K, 2011, SURF INTERFACE ANAL, V43, P241, DOI 10.1002/sia.3551; Ninomiya S, 2011, SURF INTERFACE ANAL, V43, P221, DOI 10.1002/sia.3656; Ninomiya S, 2008, APPL SURF SCI, V255, P1588, DOI 10.1016/j.apsusc.2008.05.004; vansOoij W. J., 1988, SURF INTERFACE ANAL, V11, P430	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	FEB	2015	47	2					298	300		10.1002/sia.5707		3	Chemistry, Physical	Chemistry	AZ9GY	WOS:000348523000019		
J	Sasaki, K; Matsuda, M; Ohkura, Y; Kawamura, Y; Inoue, M; Hashimoto, M; Ikeda, K; Kumada, H; Watanabe, G				Sasaki, Kazunari; Matsuda, Masarnichi; Ohkura, Yu; Kawamura, Yusuke; Inoue, Masafumi; Hashimoto, Masaji; Ikeda, Kenji; Kumada, Hiromitsu; Watanabe, Goro			Implication of an extremely high preoperative alpha-fetoprotein value (> 4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma	SURGERY			English	Article							RECURRENCE; PROGNOSIS; RESECTION; CANCER; MANAGEMENT; ABLATION; INVASION; FEATURES; DEATH; JAPAN	Background. The implication of extremely high preoperative alpha-fetoprotein (AFP) values for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma (HCC) remains uncertain. Methods. A total of 762 hepatectomized HCC patients were divided into 3 groups according to preoperative AFP serum concentrations: 578 patients with AFP < 100 ng/mL (low [LAP]), 147 patients with AFP 100-4,000 ng/mL (high [HAP]), and 37 patients with AFP 4,000 ng/mL (extremely high [EAP]). The clinicopathologic features and prognosis of the EAP group were compared with those of the other 2 groups to investigate their characteristics and whether the choice of hepatectomy was valid. Results. The EAP group had a greater proportion of younger patients and those with hepatitis B compared with the other 2 groups. Large tumor size, poor histologic differentiation, and microscopic vascular invasion were also more common in the EAP group. The recurrence-free and overall survival rates of the EAP group were worse than those of the LAP group (both P < .01) but were not greatly different from those of the HAP group (P = .65 and P = .80, respectively). When the analysis was limited to solitary HCC cases, both recurrence-free and overall survival rates of EAP were not significantly different from those of LAP (P = .79 and P = .99, respectively). Conclusion. An extremely high AFP level does not provide additional postoperative prognostic implications beyond those provided by a high AFP level. Hepatectomy should be performed without reservation for cases of HCC associated with an extremely high AFP value.	[Sasaki, Kazunari; Matsuda, Masarnichi; Ohkura, Yu; Hashimoto, Masaji; Watanabe, Goro] Toranomon Gen Hosp, Dept Digest Surg, Hepatopancreatobiliary Surg Unit, Tokyo, Japan; [Kawamura, Yusuke; Ikeda, Kenji; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan; [Inoue, Masafumi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan	Sasaki, K (reprint author), Toranomon Gen Hosp, Dept Digest Surg, Hepatopancreatobiliary Surg Unit, Tokyo, Japan.	sasaki-kz@toranomon.gr.jp					Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Liu C, 2013, WORLD J GASTROENTERO, V19, P1811, DOI 10.3748/wjg.v19.i11.1811; Pawlik TM, 2005, SURGERY, V137, P403, DOI 10.1016/j.surg.2004.12.012; Berry K, 2013, LIVER TRANSPLANT, V19, P634, DOI 10.1002/lt.23652; NOMURA F, 1989, CANCER, V64, P1700, DOI 10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Tateishi R, 2006, HEPATOLOGY, V44, P1518, DOI 10.1002/hep.21408; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649; Chen JG, 2011, DIGEST DIS SCI, V56, P1626, DOI 10.1007/s10620-010-1482-0; Hirohashi S, 2000, WHO CLASSIFICATION T, P157; Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615; Kamiyama T, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-107; Sasaki K, 2014, J HEPATO-BIL-PAN SCI, V21, P142, DOI 10.1002/jhbp.13; Lee YH, 2013, J GASTROINTEST SURG, V17, P730, DOI 10.1007/s11605-012-2081-5; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; Mailey B, 2011, ARCH SURG-CHICAGO, V146, P26, DOI 10.1001/archsurg.2010.295; Toyoda H, 2011, ONCOLOGY-BASEL, V81, P61, DOI 10.1159/000333263; Yamanaka J, 2000, J GASTROEN HEPATOL, V15, P1192, DOI 10.1046/j.1440-1746.2000.02323.x	24	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2015	157	2					223	230		10.1016/j.surg.2014.09.010		8	Surgery	Surgery	CA5TX	WOS:000348971800007		
J	Tomimaru, Y; Eguchi, H; Tatsumi, M; Kim, T; Hama, N; Wada, H; Kawamoto, K; Kobayashi, S; Morii, E; Mori, M; Doki, Y; Nagano, H				Tomimaru, Yoshito; Eguchi, Hidetoshi; Tatsumi, Mitsuaki; Kim, Tonsok; Hama, Naoki; Wada, Hiroshi; Kawamoto, Koichi; Kobayashi, Shogo; Morii, Eiichi; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki			Clinical utility of 2-[F-18] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors	SURGERY			English	Article							FINE-NEEDLE-ASPIRATION; ENDOCRINE TUMORS; PROGNOSTIC STRATIFICATION; CANCER; BEHAVIOR; CLASSIFICATION; BENIGN; NEOPLASMS; DIAGNOSIS; LESIONS	Background. Pancreatic neuroendocrine tumors (PNETs) present various histologic stages, and their clinical behavior ranges from benign, to highly aggressive. World Health Organization (WHO) grading categorizes PNETs into 3 groups (G1, G2, and G3) based on proliferative activity. The aim of this study was to assess the clinical utility of 2-[F-18] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in preoperative differential diagnosis for various histologic grades of PNETs and in predicting postoperative prognosis in PNET patients. Methods. We investigated prospectively 36 patients who underwent preoperative FDG-PET, received surgery for PNETs, and had resected specimens examined via histology. The maximum standardized uptake value (SUVmax) was determined on FDG-PET, and differentiating power between G1/G2 and G3 PNETs was examined using various SUVmax cutoff levels. We also evaluated the prognostic impact of FDG-PET findings using postoperative survival data. Results. SUVmax significantly correlated with WHO grade (Spearman rank correlation 0.584; P = .0018), and the SUVmax of G3 tumors (5.0 +/- 2.5; n = 4) was significantly higher than that of G1/G2 tumors (2.7 +/- 1.6; n = 32; P = .0159). Using 2.5 as a cutoff SUVmax, the sensitivity, specificity, and accuracy of differentiating G3 tumors from G1/G2 tumors were 100.0%, 62.5%, and 66.7%, respectively. Furthermore, the SUVmax of FDG-PET (<2.5 vs >= 2.5) was significantly related to postoperative disease-free survival (P = .0463). Conclusion. These results suggest that FDG-PET may be useful for differentiating G3 PNETs from G1/G2 PNETs and for predicting postoperative prognosis in PNET patients. This preliminary finding is expected to be confirmed by prospective validation with more patients.	[Tomimaru, Yoshito; Eguchi, Hidetoshi; Hama, Naoki; Wada, Hiroshi; Kawamoto, Koichi; Kobayashi, Shogo; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Tatsumi, Mitsuaki; Kim, Tonsok] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan; [Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan	Nagano, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, 2-2 Yamadaoka E-2, Suita, Osaka 5650871, Japan.	hnagano@gesurg.med.osaka-u.ac.jp					Alexiev BA, 2009, CANCER CYTOPATHOL, V117, P40, DOI 10.1002/cncy.20014; Pape UF, 2008, CANCER-AM CANCER SOC, V113, P256, DOI 10.1002/cncr.23549; Adams S, 1998, EUR J NUCL MED, V25, P79; Pasquali C, 1998, WORLD J SURG, V22, P588; Ito T, 2010, J GASTROENTEROL, V45, P234, DOI 10.1007/s00535-009-0194-8; Fletcher JW, 2008, J NUCL MED, V49, P179, DOI 10.2967/jnumed.107.044990; Nakamoto Y, 2000, CANCER-AM CANCER SOC, V89, P2547, DOI 10.1002/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V; Tomimaru Y, 2010, ONCOL REP, V24, P613, DOI 10.3892/or_00000899; Rindi G, 2012, J NATL CANCER I, V104, P764, DOI 10.1093/jnci/djs208; Figueiredo FAF, 2009, GASTROINTEST ENDOSC, V70, P907, DOI 10.1016/j.gie.2009.05.020; Scarpa A, 2010, MODERN PATHOL, V23, P824, DOI 10.1038/modpathol.2010.58; Piani C, 2008, ENDOCR-RELAT CANCER, V15, P175, DOI 10.1677/ERC-07-0126; Yang ZH, 2011, AM J SURG PATHOL, V35, P853, DOI 10.1097/PAS.0b013e31821a0696; Kobayashi S, 2011, J SURG ONCOL, V103, P223, DOI 10.1002/jso.21811; Fesinmeyer MD, 2005, CANCER EPIDEM BIOMAR, V14, P1766, DOI 10.1158/1055-9965.EPI-05-0120; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Goh BKP, 2005, EJSO-EUR J SURG ONC, V31, P282, DOI 10.1016/j.ejso.2004.12.007; Strosberg JR, 2013, J CLIN ONCOL, V31, P420, DOI 10.1200/JCO.2012.44.5924; Chatzipantelis P, 2009, CANCER CYTOPATHOL, V117, P211, DOI 10.1002/cncy.20025; Bosman FT, 2010, WHO CLASSIFICATION T; Chen YK, 2007, J NUCL MED, V48, P8; Frankel WL, 2006, ARCH PATHOL LAB MED, V130, P963; Fukunaga H, 2005, ANN SURG ONCOL, V12, P561, DOI 10.1245/ASO.2005.08.001; Masui T, 2010, ONCOL LETT, V1, P155, DOI 10.3892/ol_00000029; Morin E, 2013, CANCER MED-US, V2, P701, DOI 10.1002/cam4.96; Pais SA, 2010, GASTROINTEST ENDOSC, V71, P1185, DOI 10.1016/j.gie.2009.12.006; Paul AK, 2003, NUCL MED COMMUN, V24, P963, DOI 10.1097/01.mnm.0000090425.24184.e9; Pawlikowski M, 2004, CURR OPIN PHARMACOL, V4, P608, DOI 10.1016/j.coph.2004.06.010; Tatsumi M, 1999, J NUCL MED, V40, P566	29	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2015	157	2					269	276		10.1016/j.surg.2014.09.011		8	Surgery	Surgery	CA5TX	WOS:000348971800012		
J	Tamura, K; Ohtsuka, T; Matsunaga, T; Kimura, H; Watanabe, Y; Ideno, N; Aso, T; Miyazaki, T; Ohuchida, K; Takahata, S; Ito, T; Ushijima, Y; Oda, Y; Mizumoto, K; Tanaka, M				Tamura, Koji; Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Ideno, Noboru; Aso, Teppei; Miyazaki, Tetsuyuki; Ohuchida, Kenoki; Takahata, Shunichi; Ito, Tetsuhide; Ushijima, Yasuhiro; Oda, Yoshinao; Mizumoto, Kazuhiro; Tanaka, Masao			Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis	SURGERY			English	Article							REMNANT PANCREAS; IPMN; CYTOLOGY; SUBTYPE; TUMORS; PROGNOSIS; CARCINOMA; CANCER; CYSTS	Background. Main duct intraductal papillary mucinous neoplasms (MD-IPMNs) may occur in 1 or multiple segments of the pancreatic duct. Unlike multifocal branch duct (BD)-IPMNs, the clonality of multisegmental MD-IPMNs remains unclear. GNAS mutations are common and specific for IPMNs, and mutational assessment might be useful to determine the clonality of IPMNs as well as to detect high-risk IPMN with distinct ductal adenocarcinoma (pancreatic ductal adenocarcinoma [PDAC]). Our aim was to clarifiy clonality using GNAS status in multisegmental MD-IPMNs. Methods. We retrospectively reviewed the medical records of 70 patients with MD-IPMN. Histologic subtypes and KRAS/GNAS mutations were investigated, and the clonal relationships among multisegmental MD-IPMNs were assessed. Mutational analysis was performed using high-resolution melting analysis and subsequent Sanger/pyrosequencing. Results. Thirteen patients had multiple synchronous and/or metachronous lesions. Seven of these 13 patients had multiple MD-IPMNs; 3 had multiple MD-IPMNs and distinct BD-IPMNs; 1 had multiple MD-IPMNs and a distinct PDAC; 1 had a solitary MD-IPMN, BD-IPMN, and PDAC; and 1 had a solitary MD-IPMN and PDAC. KRAS/GNAS mutations were consistent in 10 of 11 multisegmental MD-IPMNs, whereas MD-IPMNs, BD-IPMNs, and PDACs tended to show different mutational patterns. The frequency of malignant IPMNs was significantly higher in the multisegrnent cohort; malignant IPMNs constituted 90% (9/10) of the multiple cohort and 56% (32/57) of the solitary cohort (P = .04). Mutant GNAS was more frequently observed in the intestinal subtype (94%) than the others. Conclusion. MD-IPMNS can be characterized by monoclonal skip progression. Close attention should be paid to the possible presence of skip areas during or after partial pancreatectomy.	[Tamura, Koji; Ohtsuka, Takao; Matsunaga, Taketo; Kimura, Hideyo; Watanabe, Yusuke; Ideno, Noboru; Aso, Teppei; Ohuchida, Kenoki; Takahata, Shunichi; Mizumoto, Kazuhiro; Tanaka, Masao] Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Miyazaki, Tetsuyuki; Oda, Yoshinao] Kyushu Univ, Dept Anat & Pathol, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Ito, Tetsuhide] Kyushu Univ, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Ushijima, Yasuhiro] Kyushu Univ, Dept Clin Radiol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Tanaka, M (reprint author), Kyushu Univ, Dept Surg & Oncol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	masaotan@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [24390318, 24390319, 23390327, 25293285, 25670586, 25670585, 25670584, 25670582, 24592030]	The authors declare no conflicts of interest. This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 24390318, 24390319, 23390327, 25293285, 25670586, 25670585, 25670584, 25670582, and 24592030.	Adsay NV, 2010, WHO CLASSIFICATION T, P304; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Sadakari Y, 2010, SURGERY, V147, P812, DOI 10.1016/j.surg.2009.11.011; Tamura K, 2014, ANN SURG, V259, P360, DOI 10.1097/SLA.0b013e3182a690ff; Shi CJ, 2012, HUM PATHOL, V43, P1, DOI 10.1016/j.humpath.2011.04.003; Distler M, 2013, ANN SURG, V258, P324, DOI 10.1097/SLA.0b013e318287ab73; Eguchi H, 2006, CANCER, V107, P2567, DOI 10.1002/cncr.22301; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Matthaei H, 2012, ANN SURG, V255, P326, DOI 10.1097/SLA.0b013e3182378a18; Zgraggen K, 1997, ANN SURG, V226, P491, DOI 10.1097/00000658-199710000-00010; Izawa T, 2001, CANCER, V92, P1807, DOI 10.1002/1097-0142(20011001)92:7<1807::AID-CNCR1697>3.0.CO;2-0; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Lubezky N, 2011, J GASTROINTEST SURG, V15, P503, DOI 10.1007/s11605-010-1411-8; Hara T, 2013, ANN SURG, V257, P1103, DOI 10.1097/SLA.0b013e318281b824; Nault JC, 2012, J HEPATOL, V56, P184, DOI 10.1016/j.jhep.2011.07.018; Dal Molin M, 2013, ANN SURG ONCOL, V20, P3802, DOI 10.1245/s10434-013-3096-1; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Flejou JF, 2004, GUT, V54, pi6; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Hruban RH, 2007, AFIP ATLAS TUMOR PAT, V6, P75; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Mori Y, 2014, SURGERY, V155, P67, DOI 10.1016/j.surg.2013.06.059; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	24	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2015	157	2					277	284		10.1016/j.surg.2014.09.013		8	Surgery	Surgery	CA5TX	WOS:000348971800013		
J	Murono, K; Kazama, S; Yamaguchi, H; Kawai, K; Ishihara, S; Sunami, E; Kitayama, J; Satoh, Y; Kurihara, M; Yatomi, Y; Watanabe, T				Murono, Koji; Kazama, Shinsuke; Yamaguchi, Hironori; Kawai, Kazushige; Ishihara, Soichiro; Sunami, Eiji; Kitayama, Joji; Satoh, Yumiko; Kurihara, Makiko; Yatomi, Yutaka; Watanabe, Toshiaki			Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer	SURGERY			English	Article							POLYMERASE-CHAIN-REACTION; RAPID GENETIC DIAGNOSIS; QUANTITATIVE RT-PCR; COLORECTAL-CANCER; TUMOR-CELLS; PERIPHERAL-BLOOD; BREAST-CANCER; LYMPH-NODES; ADJUVANT CHEMOTHERAPY; REACTION SYSTEM	Background. Peritoneal dissemination and positive peritoneal lavage cytology are associated with poor prognosis in colorectal cancer. Carcinoembryonic antigen (CEA) messenger RNA (mRNA) is often used as a marker to detect micrometastases. We aimed to evaluate the prognostic significance of CEA mRNA in the peritoneal lavage of colon cancer patients. Methods. Colon cancer patients (n = 201) who underwent curative operative resection between August 2009 and February 2013 were enrolled. CEA mRNA in peritoneal lavage was measured using the transcription-reverse transcription concerted method, a quantitative RNA amplification method. The correlation between CEA mRNA and overall and peritoneal recurrence-free survival was evaluated. Results. Positive CEA mRNA in peritoneal lavage was an independent risk factor for overall recurrence-free survival in colon cancer (1, < .0001). Positive CEA mRNA was a risk factor for poorer overall recurrence in stage II and III patients (P = .04 and P = .02, respectively). Moreover, among stage III patients with positive CEA mRNA, the postoperative chemotherapy group had significantly lower overall and peritoneal recurrence rates than the no postoperative chemotherapy group (P = .001). Conclusion. Positive cm mRNA in peritoneal lavage was associated with high overall recurrence rates in stage II and III colon cancer Further study is necessary to determinate the efficacy of aggressive postoperative chemotherapy for stage II and III colon cancerpatients with positive CEA mRNA.	[Murono, Koji; Kazama, Shinsuke; Yamaguchi, Hironori; Kawai, Kazushige; Ishihara, Soichiro; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Div Surg Oncol, Dept Surg, Tokyo 1138655, Japan; [Satoh, Yumiko; Kurihara, Makiko; Yatomi, Yutaka] Univ Tokyo, Fac Med, Tokyo 1138655, Japan; [Satoh, Yumiko; Kurihara, Makiko; Yatomi, Yutaka] Univ Tokyo, Fac Med, Dept Clin Lab, Tokyo 1138655, Japan	Murono, K (reprint author), Univ Tokyo, Fac Med, Div Surg Oncol, Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	MURONOK-SUR@h.u-tokyo.ac.jp					Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Ishii T, 2004, ANN SURG ONCOL, V11, P778, DOI 10.1245/ASO.2004.12.043; Pestieau SR, 2000, DIS COLON RECTUM, V43, P1341, DOI 10.1007/BF02236627; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P778; Lu CY, 2011, BRIT J CANCER, V104, P1178, DOI 10.1038/bjc.2011.40; Li HH, 2009, J CUTAN PATHOL, V36, P318, DOI 10.1111/j.1600-0560.2008.01020.x; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Soeth E, 1997, CANCER RES, V57, P3106; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Elias D, 2010, J CLIN ONCOL, V28, P63, DOI 10.1200/JCO.2009.23.9285; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Guller U, 2002, ANN SURG, V236, P768, DOI 10.1097/01.SLA.0000036267.30107.B9; Liefers GJ, 1998, NEW ENGL J MED, V339, P223, DOI 10.1056/NEJM199807233390403; Noura S, 2011, ANN SURG ONCOL, V18, P396, DOI 10.1245/s10434-010-1319-2; Sadahiro S, 2001, CANCER, V92, P1251, DOI 10.1002/1097-0142(20010901)92:5<1251::AID-CNCR1445>3.0.CO;2-O; Stillwell AP, 2011, WORLD J SURG, V35, P684, DOI 10.1007/s00268-010-0891-8; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Taniguchi T, 2000, CANCER, V89, P970, DOI 10.1002/1097-0142(20000901)89:5<970::AID-CNCR5>3.0.CO;2-S; Hara M, 2007, CLIN EXP METASTAS, V24, P179, DOI 10.1007/s10585-007-9067-9; [Anonymous], 2010, TNM CLASSIFICATION M; Baskaranathan S, 2004, DIS COLON RECTUM, V47, P2076, DOI 10.1007/s10350-004-0723-8; Egawa K, 1996, BRIT J DERMATOL, V134, P451, DOI 10.1111/j.1365-2133.1996.tb16229.x; Goeminne JC, 1999, BONE MARROW TRANSPL, V24, P769, DOI 10.1038/sj.bmt.1701966; Guadagni F, 1997, INT J CANCER, V72, P949; Guller U, 2002, ANN SURG, V236, P75; Hayama T, 2007, ONCOL REP, V18, P779; Imamura Y, 2010, J SURG ONCOL, V102, P509, DOI 10.1002/jso.21621; Ishiguro T, 2003, ANAL BIOCHEM, V314, P77, DOI 10.1016/S0003-2697(02)00618-8; Ishikawa T, 2007, EJSO-EUR J SURG ONC, V33, P430, DOI 10.1016/j.ejso.2006.09.038; Ishikawa T, 2009, EJSO-EUR J SURG ONC, V35, P895, DOI 10.1016/j.ejso.2008.10.008; Ko Y, 1998, CLIN CANCER RES, V4, P2141; Moon JH, 2012, J SURG ONCOL, V105, P189, DOI 10.1002/jso.22021; MORI M, 1995, CANCER RES, V55, P3417; Mukai M, 2011, ONCOL REP, V26, P737, DOI 10.3892/or.2011.1343; Nishikawa T, 2009, DIS COLON RECTUM, V52, P2016, DOI 10.1007/DCR.0b013e3181b4c46e; Ohashi N, 2007, ANTICANCER RES, V27, P2769; Rosenberg R, 2000, BRIT J CANCER, V83, P1323, DOI 10.1054/bjoc.2000.1442; Sato N, 2012, ANN SURG ONCOL, V19, P2060, DOI 10.1245/s10434-011-1889-7; Satoh Y, 2012, THORAC CARDIOV SURG, V60, P533, DOI 10.1055/s-0031-1298066; Sugarbaker PH, 2000, DIS COLON RECTUM, V43, P7; Sugarbaker Paul H, 2010, World J Gastrointest Oncol, V2, P19, DOI 10.4251/wjgo.v2.i1.19	43	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2015	157	2					322	330		10.1016/j.surg.2014.09.015		9	Surgery	Surgery	CA5TX	WOS:000348971800018		
J	Uemura, M; Yamashita, M; Tomikawa, M; Obata, S; Souzaki, R; Ieiri, S; Ohuchida, K; Matsuoka, N; Katayama, T; Hashizume, M				Uemura, Munenori; Yamashita, Makoto; Tomikawa, Morimasa; Obata, Satoshi; Souzaki, Ryota; Ieiri, Satoshi; Ohuchida, Kenoki; Matsuoka, Noriyuki; Katayama, Tamotsu; Hashizume, Makoto			Objective assessment of the suture ligature method for the laparoscopic intestinal anastomosis model using a new computerized system	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Laparoscopic surgery; Surgical training; Internal pressure; Image analysis; Artificial intestine; Objective assessment	RANDOMIZED CONTROLLED-TRIAL; DIFFERENTIATES EXPERT; SURGERY; SKILLS; ACQUISITION; ENVIRONMENT; SIMULATION; TENSION; FORCE; TIME	Background The purpose of this study was to develop a new objective assessment system for the suture ligature method employed in the laparoscopic intestinal anastomosis model. Suturing skills were evaluated objectively using this system. Methods This study compared 17 expert surgeons, each of whom had performed > 500 laparoscopic procedures, with 36 novice surgeons, each of whom had performed < 15 laparoscopic procedures. Each examinee performed a specific skill assessment task using an artificial model that mimics living tissue, which is linked with the Suture Simulator Instruction Evaluation Unit. The model used internal air pressure measurements and image processing to evaluate suturing skills. Five criteria were used to evaluate the skills of participants. Results The volumes of air pressure leak in the expert and novice groups were 21.13 +/- 6.68 and 8.51 +/- 8.60 kPa, respectively. The numbers of full-thickness sutures in the expert and novice groups were 2.94 +/- 0.24 pairs and 2.47 +/- 0.77 pairs, respectively. Suture tensions in the expert and novice groups were 60.99 +/- 11.81 and 80.90 +/- 16.63 %, respectively. The areas of wound-opening in the expert and novice groups were 1.76 +/- 2.17 and 11.06 +/- 15.37 mm 2, respectively. The performance times in the expert and novice groups were 349 +/- 120 and 750 +/- 269 s, respectively. Significant differences between the expert and novice groups for each criterion were observed. The acceptable range of values for each criterion except for the number of full-thickness sutures was statistically defined by the performance of the expert group. Conclusions Our system is useful for the quantitative assessment of suturing skill in laparoscopic surgery. We believe that this system is a useful tool for training and assessment of laparoscopic surgeons.	[Uemura, Munenori; Ohuchida, Kenoki; Hashizume, Makoto] Kyushu Univ, Ctr Adv Med Innovat, Fukuoka 812, Japan; [Yamashita, Makoto; Tomikawa, Morimasa; Obata, Satoshi; Souzaki, Ryota; Ieiri, Satoshi; Hashizume, Makoto] Kyushu Univ, Dept Adv Med Initiat, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Matsuoka, Noriyuki; Katayama, Tamotsu] Kyoto Kagaku Co Ltd, Kyoto, Japan	Hashizume, M (reprint author), Kyushu Univ, Ctr Adv Med Innovat, Fukuoka 812, Japan.	mhashi@dem.med.kyushu-u.ac.jp					Aggarwal R, 2006, ANN SURG, V244, P310, DOI 10.1097/01.sla.0000218094.92650.44; Lauretta A, 2012, TECH COLOPROCTOL, V16, P477, DOI 10.1007/s10151-012-0918-2; Zimmitti G, 2013, J AM COLL SURGEONS, V217, P1028, DOI 10.1016/j.jamcollsurg.2013.07.392; Verdaasdonk EGG, 2008, SURG ENDOSC, V22, P1636, DOI 10.1007/s00464-007-9672-3; Tanoue K, 2008, SURG ENDOSC, V22, P985, DOI 10.1007/s00464-007-9554-8; Yamaguchi S, 2011, SURG ENDOSC, V25, P771, DOI 10.1007/s00464-010-1251-3; Hofstad EF, 2013, SURG ENDOSC, V27, P854, DOI 10.1007/s00464-012-2524-9; Forestier G, 2012, J BIOMED INFORM, V45, P255, DOI 10.1016/j.jbi.2011.11.002; Bell AK, 2009, SURG ENDOSC, V23, P2356, DOI 10.1007/s00464-009-0346-1; Botden SMBI, 2009, SURG ENDOSC, V23, P2131, DOI 10.1007/s00464-008-0240-2; Cui Y, 2003, J CARDIOVASC SURG, V44, P775; Dehabadi M, 2014, INT J SURG, V12, P258, DOI 10.1016/j.ijsu.2014.01.022; Fumagalli Romario U, 2012, SEMIN THORAC CARDIOV, V24, P213; Hemming K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075132; Horeman T, 2014, J SURG EDUC, V71, P133, DOI [10.1016/j.jsurg.2013.06.021, 10.1016/j.jsurg.2073.06.021]; Ieiri S, 2010, PEDIATR SURG INT, V26, P947, DOI 10.1007/s00383-010-2665-7; Ieiri S, 2013, PEDIATR SURG INT, V29, P501, DOI 10.1007/s00383-013-3276-x; Morse BC, 2013, AM J SURG, V206, P950, DOI 10.1016/j.amjsurg.2013.07.017; Neumuth T, 2009, J AM MED INFORM ASSN, V16, P72, DOI 10.1197/jamia.M2748; Oguma J, 2007, J SURG RES, V140, P129, DOI 10.1016/j.jss.2006.12.008; Uemura M, 2014, J SURG RES, V188, P8, DOI 10.1016/j.jss.2013.12.009; Uemura M, 2014, MINIM INVASIV THER, V23, P165, DOI 10.3109/13645706.2013.867273; WANINGER J, 1992, AM J SURG, V163, P319, DOI 10.1016/0002-9610(92)90013-H; Wilson M, 2010, SURG ENDOSC, V24, P2458, DOI 10.1007/s00464-010-0986-1	24	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	FEB	2015	29	2					444	452		10.1007/s00464-014-3681-9		9	Surgery	Surgery	AZ2HQ	WOS:000348055400018		
J	Hirokawa, F; Hayashi, M; Miyamoto, Y; Asakuma, M; Shimizu, T; Komeda, K; Inoue, Y; Uchiyama, K				Hirokawa, Fumitoshi; Hayashi, Michihiro; Miyamoto, Yoshiharu; Asakuma, Mitsuhiro; Shimizu, Tetsunosuke; Komeda, Koji; Inoue, Yoshihiro; Uchiyama, Kazuhisa			Short- and long-term outcomes of laparoscopic versus open hepatectomy for small malignant liver tumors: a single-center experience	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Laparoscopic hepatectomy; Partial resection; Lateral sectionectomy; Colorectal liver metastases; Hepatocellular carcinoma; Short-term outcome; Long-term outcome	LEFT LATERAL SEGMENTECTOMY; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; POSTEROSUPERIOR SEGMENTS; PULMONARY COMPLICATIONS; HEPATIC RESECTION; CIRRHOSIS; FEASIBILITY; METASTASIS; SURGERY	Background Laparoscopic hepatectomy (Lap-Hx) has been increasingly performed for patients with liver tumors as surgical techniques and devices have progressed. However, the long-term outcomes of Lap-Hx for malignant liver tumors are not oncologically guaranteed. This study compared the short- and long-term outcomes between Lap-Hx and open hepatectomy (Open-Hx) for malignant liver tumors by matched-pair analysis. Methods The indications for Lap-Hx at our department are a tumor size of < 5 cm and fewer than two lesions without macroscopic vascular invasion or the need for biliary reconstruction. In total, 135 patients underwent Lap-Hx for malignant liver tumors through December 2013. We compared the short- and long-term outcomes between Lap-Hx and Open-Hx in patients who met the above-mentioned indications. Results With respect to short- term outcomes, the operation time, blood loss, postoperative hospital stay, white blood cell count, and C-reactive protein level after Lap-Hx were significantly better than those after Open-Hx in both the patients who underwent partial resection and those who underwent lateral sectionectomy. In patients who underwent partial resection, the incidence of postoperative complications after Lap-Hx was significantly lower than that after Open-Hx; in particular, wound infection and respiratory complications were significantly lower. Furthermore, when the tumor was located in the posterosuperior segments, the operation time for Lap-Hx was not shorter than that for Open-Hx. With respect to long-term outcomes of hepatocellular carcinoma, neither overall nor disease-free survival differed between the two groups. With respect to long-term outcomes of colorectal liver metastases, the disease-free survival rate was similar between Lap-Hx and Open-Hx; however, the overall survival rate was significantly better for Lap-Hx than for Open-Hx. Conclusions Lap-Hx is a good option for selected patients with malignant liver tumors. The short- and long-term outcomes of Lap-Hx also are considered to be acceptable.	[Hirokawa, Fumitoshi; Hayashi, Michihiro; Miyamoto, Yoshiharu; Asakuma, Mitsuhiro; Shimizu, Tetsunosuke; Komeda, Koji; Inoue, Yoshihiro; Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka 5698686, Japan	Hirokawa, F (reprint author), Osaka Med Coll, Dept Gen & Gastroenterol Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	sur122@poh.osaka-med.ac.jp					Kaneko H, 2005, AM J SURG, V189, P190, DOI 10.1016/j.amjsurg.2004.09.010; Cho JY, 2008, SURG ENDOSC, V22, P2344, DOI 10.1007/s00464-008-9966-0; Kanazawa A, 2013, SURG ENDOSC, V27, P2592, DOI 10.1007/s00464-013-2795-9; Jiang L, 2013, SURG ENDOSC, V27, P2466, DOI 10.1007/s00464-012-2758-6; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159; Sarpel U, 2009, ANN SURG ONCOL, V16, P1572, DOI 10.1245/s10434-009-0414-8; Ito K, 2009, J GASTROINTEST SURG, V13, P2276, DOI 10.1007/s11605-009-0993-5; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Cha CH, 2003, ANN SURG, V238, P315, DOI 10.1097/01.sla.0000086548.84705.ef; Hirokawa F, 2011, AM SURGEON, V77, P539; Abdalla EK, 2006, ANN SURG ONCOL, V13, P1271, DOI 10.1245/s10434-006-9045-5; Inoue Y, 2013, AM SURGEON, V79, P495; Cheung TT, 2013, ANN SURG, V257, P506, DOI 10.1097/SLA.0b013e31827b947a; Cho JY, 2008, SURGERY, V144, P32, DOI 10.1016/j.surg.2008.03.020; Laurent A, 2003, ARCH SURG-CHICAGO, V138, P763, DOI 10.1001/archsurg.138.7.763; Guerron AD, 2013, SURG ENDOSC, V27, P1138, DOI 10.1007/s00464-012-2563-2; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Kaneko H, 1996, SURGERY, V120, P468, DOI 10.1016/S0039-6060(96)80065-1; Castaing D, 2009, ANN SURG, V250, P849, DOI 10.1097/SLA.0b013e3181bcaf63; Azagra JS, 1996, SURG ENDOSC-ULTRAS, V10, P758, DOI 10.1007/BF00193052; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Chen HY, 2008, ANN SURG ONCOL, V15, P800, DOI 10.1245/s10434-007-9749-1; Fuso L, 2000, RESP MED, V94, P1171, DOI 10.1053/rmed.2000.0946; Gagner MRM, 1992, SURG ENDOSC, V6, P85; Hirokawa F, 2011, SURGERY, V149, P438, DOI 10.1016/j.surg.2009.11.015; Ikeda T, 2013, J HEPATO-BIL-PAN SCI, V20, P145, DOI 10.1007/s00534-012-0558-y; Iwahashi S, 2014, SURG ENDOSC, V28, P80, DOI 10.1007/s00464-013-3165-3; Ker CG, 2000, HEPATO-GASTROENTEROL, V47, P1260; Koffron AJ, 2007, ANN SURG, V246, P385, DOI 10.1097/SLA.0b013e318146996c; Komeda K, 2013, SURG LAPARO ENDO PER, V23, pE103, DOI 10.1097/SLE.0b013e318277d3e9; Shimada M, 2001, SURG ENDOSC-ULTRAS, V15, P541, DOI 10.1007/s004640080099; Smith PR, 2010, RESPIRATION, V80, P269, DOI 10.1159/000253881; Teramoto K, 2005, AM J SURG, V189, P474, DOI 10.1016/j.amjsurg.2004.09.018; Tomimaru Y, 2012, DIGEST DIS SCI, V57, P1942, DOI 10.1007/s10620-012-2114-7; Tsinberg M, 2009, SURG ENDOSC, V23, P847, DOI 10.1007/s00464-008-0262-9	35	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	FEB	2015	29	2					458	465		10.1007/s00464-014-3687-3		8	Surgery	Surgery	AZ2HQ	WOS:000348055400020		
J	Maekawa, S; Nomura, R; Murase, T; Ann, Y; Harada, M				Maekawa, Satoshi; Nomura, Ryosuke; Murase, Takayuki; Ann, Yasuyoshi; Harada, Masaru			Complete closure of artificial gastric ulcer after endoscopic submucosal dissection by combined use of a single over-the-scope clip and through-the-scope clips (with videos)	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Endoscopic submucosal dissection; Complete closure of post-ESD artificial gastric ulcer; Over-the-scope clip; Through-the-scope clips	PERFORATIONS; EFFICACY; CANCER; SYSTEM	Background A 5-7 day hospital stay is usually needed after endoscopic submucosal dissection (ESD) of gastric tumor because of the possibility of delayed perforation or bleeding. The aim of this study was to evaluate the efficacy of combined use of a single over-the-scope clip (OTSC) and through-the-scope clips (TTSCs) to achieve complete closure of artificial gastric ulcer after ESD. Methods We prospectively studied 12 patients with early gastric cancer or gastric adenoma. We performed complete closure of post-ESD artificial gastric ulcer using a combination of a single OTSC and TTSCs. Results Mean size of post-ESD artificial ulcer was 54.6 mm. The mean operating time for the closure procedure was 15.2 min., and the success rate was 91.7 % (11/12). Patients who underwent complete closure of post-ESD artificial gastric ulcer could be discharged the day after ESD and the closing procedure. Conclusions Complete closure of post-ESD artificial gastric ulcer using a combination of a single OTSC and TTSCs is useful for shortening the period of hospitalization and reducing treatment cost.	[Maekawa, Satoshi; Nomura, Ryosuke; Murase, Takayuki; Ann, Yasuyoshi] Japan Labour Hlth & Welf Org Niigata Rosai Hosp, Dept Gastroenterol Med, Niigata 9428502, Japan; [Harada, Masaru] Univ Occupat & Environm Hlth, Dept Internal Med 3, Kitakyushu, Fukuoka 807, Japan	Maekawa, S (reprint author), Japan Labour Hlth & Welf Org Niigata Rosai Hosp, Dept Gastroenterol Med, 1-7-12 Touncho, Niigata 9428502, Japan.	s5083m@niirou.jp					Ono H, 2008, GASTRIC CANCER, V11, P47, DOI 10.1007/s10120-008-0452-0; Schurr MO, 2008, ENDOSCOPY, V40, P584, DOI 10.1055/s-2008-1077354; Raju GS, 2004, GASTROINTEST ENDOSC, V59, P267, DOI 10.1016/S0016-5107(03)02110-2; Kantsevoy SV, 2014, GASTROINTEST ENDOSC, V79, P503, DOI 10.1016/j.gie.2013.10.051; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Chuttani R, 2006, GASTROINTEST ENDOSC, V63, P746, DOI 10.1016/j.gie.2006.02.042; Qadeer MA, 2007, GASTROINTEST ENDOSC, V66, P605, DOI 10.1016/j.gie.2007.03.1028; Goto O, 2010, GASTROINTEST ENDOSC, V71, P241, DOI 10.1016/j.gie.2009.08.030; Kirschniak A, 2007, GASTROINTEST ENDOSC, V66, P162, DOI 10.1016/j.gie.2007.01.034; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Choi KD, 2008, SURG ENDOSC, V22, P1882, DOI 10.1007/s00464-008-9743-0; Lee BI, 2011, GUT LIVER, V5, P454, DOI 10.5009/gnl.2011.5.4.454; Matthes K, 2011, GASTROINTEST ENDOSC, V74, P1369, DOI 10.1016/j.gie.2011.07.057; Naegel A, 2012, GASTROINTEST ENDOSC, V75, P152, DOI 10.1016/j.gie.2011.08.009; Schurr MO, 2008, BIOMED TECH, V53, P45, DOI 10.1515/BMT.2008.011	15	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	FEB	2015	29	2					500	504		10.1007/s00464-014-3725-1		5	Surgery	Surgery	AZ2HQ	WOS:000348055400026		
J	Furukawa, T; Mori, K; Arino, K; Hayashi, K; Shirakawa, N				Furukawa, Takao; Mori, Kaoru; Arino, Kazuma; Hayashi, Kazuhiro; Shirakawa, Nobuyuki			Identifying the evolutionary process of emerging technologies: A chronological network analysis of World Wide Web conference sessions	TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE			English	Article						Emerging technology; Evolutionary process; Trend analysis; Conference session; Chronological network	LITERATURE-BASED DISCOVERY; MEDICAL SUBJECT-HEADINGS; SCIENCE-AND-TECHNOLOGY; PATENT ANALYSIS; COMPLEMENTARY LITERATURES; SCIENTIFIC PUBLICATIONS; DISRUPTIVE TECHNOLOGY; RESEARCH FRONTS; BIBLIOMETRICS; SEARCH	The significance of a computer-based approach in roadmapping processes will increase in accordance with the ever-larger number of scientific publications and enhanced computing technologies. This article proposes a method to analyse chronological changes in research topics as observed from proceedings papers and conference sessions using a text-mining technique, which enables us to detect, identify', and analyse the evolutionary process of emerging technologies in the many rapidly growing research fields. Chronological networks of conference sessions from World Wide Web conferences between 2002 and 2011 are used to visualize the scientific and technical streams formed by the session sequences. The chronological networks demonstrate the evolutionary process of 'Social Networks', 'Monetization' and 'Semantic Analysis' studies. In the evolutionary process of emerging web-based technology, the convergent session nodes that recapitulate past research topics and the divergent session nodes in the networks play significant roles in promoting dynamic interactions among research topics. The proposed method is distinctive in that it is prospective: the session titles reflect future perspectives, including researchers' expectations for pioneering new research fields within a scientific community. This article also discusses the characteristics of a textual method for scientific publication analysis in terms from the aspect coverage, data, links and stability. (C) 2014 Elsevier-Inc. All rights reserved.	[Furukawa, Takao] Kyoritsu Womens Univ, Chiyoda Ku, Tokyo 1018437, Japan; [Mori, Kaoru; Shirakawa, Nobuyuki] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa 2520882, Japan; [Hayashi, Kazuhiro; Shirakawa, Nobuyuki] Natl Inst Sci & Technol Policy, Chiyoda Ku, Tokyo 1000013, Japan; [Shirakawa, Nobuyuki] New Energy & Ind Technol Dev Org, Saiwai Ku, Kawasaki, Kanagawa 2128554, Japan	Furukawa, T (reprint author), Kyoritsu Womens Univ, Chiyoda Ku, 2-2-1 Hitotsubashi, Tokyo 1018437, Japan.	tfurukawa@kyoritsu-wu.ac.jp			JSPS KAKENHI [22500875, 25518017]	This work was supported by JSPS KAKENHI numbers 22500875 and 25518017.	Chen SH, 2012, TECHNOL FORECAST SOC, V79, P1099, DOI 10.1016/j.techfore.2011.12.011; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; Walsh ST, 2004, TECHNOL FORECAST SOC, V71, P161, DOI 10.1016/j.techfore.2003.10.003; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Gmur M, 2003, SCIENTOMETRICS, V57, P27, DOI 10.1023/A:1023619503005; Shibata N, 2008, TECHNOVATION, V28, P758, DOI 10.1016/j.technovation.2008.03.009; Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001; Shibata N, 2011, TECHNOL FORECAST SOC, V78, P274, DOI 10.1016/j.techfore.2010.07.006; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Small H, 1999, J AM SOC INFORM SCI, V50, P799, DOI 10.1002/(SICI)1097-4571(1999)50:9<799::AID-ASI9>3.3.CO;2-7; Lee S, 2009, TECHNOL FORECAST SOC, V76, P769, DOI 10.1016/j.techfore.2009.01.003; Kajikawa Y, 2009, TECHNOL FORECAST SOC, V76, P1115, DOI 10.1016/j.techfore.2009.04.004; Kostoff RN, 2001, TECHNOL FORECAST SOC, V68, P223, DOI 10.1016/S0040-1625(01)00133-0; Kostoff RN, 2013, TECHNOL FORECAST SOC, V80, P1331, DOI 10.1016/j.techfore.2012.12.006; Kajikawa Y, 2008, TECHNOL FORECAST SOC, V75, P1349, DOI 10.1016/j.techfore.2008.04.007; Kim YG, 2008, EXPERT SYST APPL, V34, P1804, DOI 10.1016/j.eswa.2007.01.033; MANSFIELD E, 1991, RES POLICY, V20, P1, DOI 10.1016/0048-7333(91)90080-A; Kajikawa Y, 2008, TECHNOL FORECAST SOC, V75, P771, DOI 10.1016/j.techfore.2007.05.005; Tseng YH, 2007, INFORM PROCESS MANAG, V43, P1216, DOI 10.1016/j.ipm.2006.11.011; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Kostoff RN, 2004, TECHNOL FORECAST SOC, V71, P141, DOI 10.1016/S0040-1625(03)00048-9; Glanzel W, 2011, SCIENTOMETRICS, V88, P297, DOI 10.1007/s11192-011-0347-4; Glanzel W, 2012, SCIENTOMETRICS, V91, P399, DOI 10.1007/s11192-011-0591-7; SWANSON DR, 1987, J AM SOC INFORM SCI, V38, P228, DOI 10.1002/(SICI)1097-4571(198707)38:4<228::AID-ASI2>3.0.CO;2-G; Fleming L, 2004, STRATEGIC MANAGE J, V25, P909, DOI 10.1002/smj.384; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004; Halpern JY, 2011, COMMUN ACM, V54, P36, DOI 10.1145/1978542.1978555; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Behkami NA, 2012, TECHNOL FORECAST SOC, V79, P498, DOI 10.1016/j.techfore.2011.08.015; Blei D. M., 2006, P 23 INT C MACH LEAR, P113, DOI DOI 10.1145/1143844.1143859; Bruza P. D., 2008, LIT BASED DISCOVERY; Chen C., 2006, J AM SOC INF SCI TEC, V57, P357; Chen SH, 2012, TECHNOL FORECAST SOC, V79, P1705, DOI 10.1016/j.techfore.2012.06.005; Coletti MH, 2001, J AM MED INFORM ASSN, V8, P317; Daud A, 2009, LECT NOTES ARTIF INT, V5781, P244; Day G. S., 2004, WHARTON MANAGING EME, P1; Gibbons M., 2000, SCI PUBL POLICY, V27, P159, DOI 10.3152/147154300781782011; Gordon MD, 1998, J AM SOC INFORM SCI, V49, P674; Jo Y, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P370; Kostoff RN, 2006, TECHNOL FORECAST SOC, V73, P923, DOI 10.1016/j.techfore.2005.09.004; Kostoff RN, 2008, TECHNOL FORECAST SOC, V75, P276, DOI 10.1016/j.techfore.2007.11.003; Kostoff RN, 2008, TECHNOL FORECAST SOC, V75, P165, DOI 10.1016/j.techfore.2007.11.004; Kostoff RN, 2008, TECHNOL FORECAST SOC, V75, P186, DOI 10.1016/j.techfore.2007.11.010; Kostoff RN, 2012, TECHNOL FORECAST SOC, V79, P789, DOI 10.1016/j.techfore.2012.02.002; Kostoff RN, 2001, IEEE T ENG MANAGE, V48, P132, DOI 10.1109/17.922473; Kostoff RN, 2001, J AM SOC INF SCI TEC, V52, P1148, DOI 10.1002/asi.1181; Kwakkel J, 2009, PROCEEDINGS OF PICMET 09 - TECHNOLOGY MANAGEMENT IN THE AGE OF FUNDAMENTAL CHANGE, VOLS 1-5, P22, DOI 10.1109/PICMET.2009.5262243; Morchen E., 2008, P 14 ACM SIGKDD INT, P854; Porter A. L., 2003, P PORTL INT C MAN EN, P188, DOI 10.1109/PICMET.2003.1222794; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Smalheiser NR, 2001, TECHNOVATION, V21, P689, DOI 10.1016/S0166-4972(01)00048-7; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Swanson DR, 2001, J AM SOC INF SCI TEC, V52, P797, DOI 10.1002/asi.1135.abs; Swanson DR, 2006, J AM SOC INF SCI TEC, V57, P1427, DOI 10.1002/asi.20438; Vos T., 2009, GATEKEEPING THEORY; Zhang L, 2012, J INFORMETR, V6, P88, DOI 10.1016/j.joi.2011.06.007	57	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0040-1625	1873-5509		TECHNOL FORECAST SOC	Technol. Forecast. Soc. Chang.	FEB	2015	91						280	294		10.1016/j.techfore.2014.03.013		15	Business; Planning & Development	Business & Economics; Public Administration	CA5OY	WOS:000348958900019		
J	Meshesha, DT; Tsunekawa, A; Tsubo, M; Haregeweyn, N; Adgo, E				Meshesha, Derege Tsegaye; Tsunekawa, Atsushi; Tsubo, Mitsuru; Haregeweyn, Nigussie; Adgo, Enyew			Evaluating spatial and temporal variations of rainfall erosivity, case of Central Rift Valley of Ethiopia	THEORETICAL AND APPLIED CLIMATOLOGY			English	Article							GEOGRAPHIC INFORMATION-SYSTEM; SOIL-EROSION; NORTHERN ETHIOPIA; SEDIMENT YIELD; REGION; INTERPOLATION; CONSERVATION; AUSTRALIA; TIGRAY; RUSLE	Land degradation in many Ethiopian highlands occurs mainly due to high rainfall erosivity and poor soil conservation practices. Rainfall erosivity is an indicator of the precipitation energy and ability to cause soil erosion. In Central Rift Valley (CRV) of Ethiopia, where the climate is characterized as arid and semiarid, rainfall is the main driver of soil erosion that in turn causes a serious expansion in land degradation. In order to evaluate the spatial and temporal variability of rainfall erosivity and its impact on soil erosion, long-term rainfall data (1980-2010) was used, and the monthly Fournier index (FI) and the annual modified Fournier index (MFI) were applied. Student's t test analysis was performed particularly to examine statistical significances of differences in average monthly and annual erosivity values. The result indicated that, in a similar spatial pattern with elevation and rainfall amount, average annual erosivity is also found being higher in western highlands of the valley and gradually decreased towards the east. The long-term average annual erosivity (MFI) showed a general decreasing trend in recent 10 years (2000-2010) as compared to previous 20 years (1980-1999). In most of the stations, average erosivity of main rainy months (May, June, July, and August) showed a decreasing trend, whereby some of them (about 33.3 %) are statically significant at 90 and 95 % confidence intervals but with high variation in spatial pattern of changes. The overall result of the study showed that rainfall aggression (erosivity) in the region has a general decreasing trend in the recent decade as compared to previous decades, especially in the western highlands of the valley. Hence, it implies that anthropogenic factors such as land use change being coupled with topography (steep slope) have largely contributed to increased soil erosion rate in the region.	[Meshesha, Derege Tsegaye; Tsunekawa, Atsushi; Haregeweyn, Nigussie; Adgo, Enyew] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan; [Tsubo, Mitsuru] Agr Res Council, Inst Soil Climate & Water, ZA-0083 Pretoria, South Africa; [Haregeweyn, Nigussie] Mekelle Univ, Dept Land Resources Management & Environm Protect, Mekelle, Ethiopia; [Adgo, Enyew] Bahir Dar Univ, Bahir Dar, Ethiopia	Meshesha, DT (reprint author), Tottori Univ, Arid Land Res Ctr, 1390 Hamasaka, Tottori 6800001, Japan.	deremesh@yahoo.com	Tsunekawa, Atsushi/L-8526-2013; Haregeweyn, Nigussie/J-5616-2015	Tsunekawa, Atsushi/0000-0002-7690-0633; Haregeweyn, Nigussie/0000-0003-2920-8094	Global Center of Excellence (COE) Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, Arid Land Research Center (ALRC)	This research was supported by the Global Center of Excellence (COE) Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, Arid Land Research Center (ALRC). We are indebted to the Ethiopian Mapping Authority, the Ethiopian Ministry of Water Resources, and the Ethiopian Ministry of Agriculture and Rural Development for providing the data used in our study.	Ninyerola M, 2007, THEOR APPL CLIMATOL, V89, P195, DOI 10.1007/s00704-006-0264-2; Nyssen J, 2007, SOIL TILL RES, V94, P151, DOI 10.1016/j.still.2006.07.011; Nyssen J, 2005, J HYDROL, V311, P172, DOI 10.1016/j.jhydrol.2004.12.016; Gonzalez-Hidalgo JC, 2007, CATENA, V71, P193, DOI 10.1016/j.catena.2007.03.005; Mekuria W, 2007, J ARID ENVIRON, V69, P270, DOI 10.1016/j.jaridenv.2006.10.009; RENARD KG, 1994, J HYDROL, V157, P287, DOI 10.1016/0022-1694(94)90110-4; Gobin A, 2004, ENVIRON SCI POLICY, V7, P25, DOI 10.1016/j.envsci.2003.09.004; Meshesha DT, 2012, INT J SEDIMENT RES, V27, P84, DOI 10.1016/S1001-6279(12)60018-3; Nyssen J, 2000, LAND DEGRAD DEV, V11, P199, DOI 10.1002/1099-145X(200005/06)11:3<199::AID-LDR376>3.0.CO;2-Y; Ferro V, 1999, HYDROLOG SCI J, V44, P3, DOI 10.1080/02626669909492199; Shi ZH, 2004, CATENA, V55, P33, DOI 10.1016/S0341-8162(03)00088-2; Haregeweyn N, 2012, J SOIL SEDIMENT, V12, P291, DOI 10.1007/s11368-011-0447-z; FRANKE R, 1982, COMPUT MATH APPL, V8, P273, DOI 10.1016/0898-1221(82)90009-8; FERRO V, 1991, HYDROLOG SCI J, V36, P549, DOI 10.1080/02626669109492543; Mutua BM, 2006, LAND DEGRAD DEV, V17, P557, DOI 10.1002/ldr.753; Yu B, 1998, AUST J SOIL RES, V36, P143, DOI 10.1071/S97025; Goovaerts P, 1999, CATENA, V34, P227, DOI 10.1016/S0341-8162(98)00116-7; Arnoldus H. M. J., 1977, FAO SOILS B, V34, P39; Aronica G, 1997, HYDROLOG SCI J, V42, P35, DOI 10.1080/02626669709492004; Bolinne A, 1980, ASSESSMENT EROSION, P111; Borrough PA, 1998, PRINCIPLES GEOGRAPHI; Carolina MA, 2008, GEOJOURNAL, V70, P257; Desta G, 2005, SOIL USE MANAGE, V21, P287, DOI [DOI 10.1111/J.1475-2743.2005.TB00401.X, 10.1111/j.1475-2743.2005.tb00401.x]; Ekanade O, 1997, AGR ECOSYST ENVIRON, V61, P97, DOI 10.1016/S0167-8809(96)01109-7; Greer J, 1971, J SOIL WATER CONSERV, V5, P196; Haregeweyn N, 2011, ENVIRON MANAGE, V50, P1219; Heine G. W., 1986, COGS COMPUTER CONTRI, V3, P60; HUSSEIN MH, 1986, J SOIL WATER CONSERV, V41, P336; Isaaks E.H., 1989, INTRO APPL GEOSTATIS; Jackson R, 1989, CLIMATE WATER AGR TR; Lal R., 1990, SOIL EROSION TROPICS; Lim KJ, 2005, CATENA, V64, P61, DOI 10.1016/j.catena.2005.06.013; Loureiro ND, 2001, J HYDROL, V250, P12; Meshesha DT, 2011, HYDROL SCI IN PRESS; Meshesha DT, 2012, LAND DEGRAD DEV, V23, P130, DOI 10.1002/ldr.1061; Meshesha DT, 2011, J FOOD AGRIC ENVIRON, V9, P784; OduroAfriyie K, 1996, GEODERMA, V74, P161, DOI 10.1016/S0016-7061(96)00054-7; Renard K.G., 1996, HANDBOOK, V703; Rossano C, 2012, AGR ECOSYST ENVIRON, V146, P197; TUNG YK, 1983, J HYDRAUL ENG-ASCE, V109, P1386; Winchell MF, 2008, J SOIL WATER CONSERV, V63, P105, DOI 10.2489/jswc.63.3.105; Wischmeier W. H., 1978, AGR HDB, V537	42	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-798X	1434-4483		THEOR APPL CLIMATOL	Theor. Appl. Climatol.	FEB	2015	119	3-4					515	522		10.1007/s00704-014-1130-2		8	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CA6KC	WOS:000349020900009		
J	Kawanishi, K; Nitta, K; Yamato, M; Okano, T				Kawanishi, Kunio; Nitta, Kosaku; Yamato, Masayuki; Okano, Teruo			Therapeutic Applications of Mesothelial Cell Sheets	THERAPEUTIC APHERESIS AND DIALYSIS			English	Review						Cell sheet; Mesothelial cells; Peritoneal dialysis; Regeneration	PERITONEAL-DIALYSIS; TRANSPLANTATION; REPAIR; INFLAMMATION; ADHESIONS; RABBITS; SURFACE	Mesothelial cells are an integral part of the peritoneum and play an important role in maintaining its structural and functional properties. In recent years a number of studies on mesothelial cells have been performed to evaluate the localization, secretional properties and the ability of regeneration and transdifferentiation of these cells. They are also involved in the repair of the peritoneum damage following surgery or peritonitis. Mesothelial cells produce several cytokines, growth factors and extracellular matrix components, possessing anti-inflammatory and immunomodulatory properties. Based on previous research, cell sheet engineering has made it possible to transplant cells that retain the cells' function, and stacking different cells in layers has also become possible. Arranging blood vessels between the cell layers is a problem when stacking cells in layers. Whether adequate blood flow can be obtained for the cell layers to survive long-term is the difference between success and failure. Mesothelial cell transplantation for peritoneal regeneration needs to be performed under conditions in which the surface area of the visceral peritoneum is large and the mesothelial cell damage area is small. In this article we explain cell sheet engineering as one of the technologies for transplanting cells with a variety of intercellular adhesion and cell membrane molecules maintained intact, and its application to peritoneal regeneration.	[Kawanishi, Kunio; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo 1628666, Japan; [Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan	Nitta, K (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo 1628666, Japan.	knitta@kc.twmu.ac.jp					Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21; Kanzaki M, 2008, EUR J CARDIO-THORAC, V34, P864, DOI 10.1016/j.ejcts.2008.05.048; Takazawa R, 2005, TISSUE ENG, V11, P618, DOI 10.1089/ten.2005.11.618; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Bertram P, 1999, EUR J SURG, V165, P705; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Takagi R, 2012, WORLD J GASTROENTERO, V18, P5145, DOI 10.3748/wjg.v18.i37.5145; Burillon C, 2012, INVEST OPHTH VIS SCI, V53, P1325, DOI 10.1167/iovs.11-7744; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Herrick SE, 2007, INT J ARTIF ORGANS, V30, P527; Hekking LHP, 2005, KIDNEY INT, V68, P2362, DOI 10.1111/j.1523-1755.2005.00698.x; Kanda R, 2014, NEPHROL DIAL TRANSPL, V29, P289, DOI 10.1093/ndt/gft397; Hekking LHR, 2003, PERITON DIALYSIS INT, V23, P323; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Asano T, 2005, BJU INT, V96, P1409, DOI 10.1111/j.1464-410X.2005.05816.x; Brochhausen C, 2011, J BIOMED MATER RES A, V98A, P143, DOI 10.1002/jbm.a.33083; Di Paolo N, 2000, PERITON DIALYSIS INT, V20, P5; DIPAOLO N, 1990, CONTRIB NEPHROL, V84, P10; DIPAOLO N, 1990, CLIN NEPHROL, V34, P179; DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14; Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70; GAUDIO E, 1990, ANAT REC, V228, P145, DOI 10.1002/ar.1092280206; GOTLOIB L, 1984, INT J ARTIF ORGANS, V7, P123; Hekking LHP, 2007, INT J ARTIF ORGANS, V30, P513; Kawanishi Hideki, 2011, Adv Perit Dial, V27, P53; Kawanishi K., 2013, J TISSUE ENG REGEN M, DOI [10.1002/term.1860, DOI 10.1002/TERM.1860]; Lucas PA, 2007, INT J ARTIF ORGANS, V30, P550; Mutsaers S, 2007, INT J ARTIF ORGANS, V30, P557; Mutsaers SE, 2007, INT J ARTIF ORGANS, V30, P484; PFEIFFER CJ, 1987, J SUBMICR CYTOL PATH, V19, P237; vansHinsbergh V W, 1990, BLOOD, V75, P1490; Witkowicz Joanna, 2008, Pol Arch Med Wewn, V118, P307	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					1	7		10.1111/1744-9987.12222		7	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000001		
J	Nakagawa, N; Matsuki, M; Yao, N; Hirayama, T; Ishida, H; Kikuchi, K; Hasebe, N				Nakagawa, Naoki; Matsuki, Motoki; Yao, Naoyuki; Hirayama, Tomoya; Ishida, Hironori; Kikuchi, Kenjiro; Hasebe, Naoyuki			Impact of Metabolic Disturbances and Malnutrition-Inflammation on 6-Year Mortality in Japanese Patients Undergoing Hemodialysis	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						End stage renal disease; Inflammatory cytokine; Malnutrition; Metabolic syndrome	NUTRITIONAL RISK INDEX; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; SIGNIFICANT PREDICTOR; ADIPONECTIN LEVELS; DIALYSIS PATIENTS; ASSOCIATION; STATEMENT; MARKER; COHORT	Metabolic syndrome confers an increased risk of cardiovascular disease (CVD) in the general population. The relationship between adiponectins, and clinical outcomes in patients undergoing hemodialysis remains controversial. We investigated whether adiponectins, biomarkers of inflammation, nutrition status and clinical features predict the mortality of patients undergoing hemodialysis for 6 years. We measured baseline plasma total and high-molecular-weight (HMW) adiponectins, tumor necrosis factor (TNF)-, serum high sensitivity C-reactive protein (hsCRP), and clinical characteristics including visceral fat area (VFA) and the Geriatric Nutritional Risk Index (GNRI) in 133 patients undergoing chronic hemodialysis. Forty-one of the 133 patients died during follow-up. The deceased patients were significantly older, had more prior CVD and diabetes, higher TNF- and hsCRP levels but lower GNRI. VFA, and total and HMW adiponectin did not significantly differ between the two groups. TNF- and hsCRP levels and GNRI score were significant for predicting all-cause and cardiovascular mortality in receiver operating curve analyses. When stratified by a GNRI score of 96, Cox proportional hazards analyses identified TNF- as a significant predictor of all-cause mortality (hazard ratio [HR] 1.23; P=0.038) and hsCRP as a significant predictor of all-cause and cardiovascular mortality (HR, 2.32, P=0.003; HR 2.30, P=0.012, respectively) after adjusting for age, sex, diabetes mellitus, and prior CVD, only in malnourished patients. These results demonstrate that malnutrition and the inflammatory markers TNF- and hsCRP, but not metabolic markers, including VFA and adiponectins have a significant impact on 6-year all-cause and cardiovascular mortality in Japanese patients undergoing hemodialysis.	[Nakagawa, Naoki; Matsuki, Motoki; Kikuchi, Kenjiro; Hasebe, Naoyuki] Asahikawa Med Univ, Div Cardiol Nephrol Pulmonol & Neurol, Dept Internal Med, Asahikawa, Hokkaido, Japan; [Matsuki, Motoki; Yao, Naoyuki; Hirayama, Tomoya; Ishida, Hironori] Kitasaito Hosp, Dept Nephrol, Asahikawa, Hokkaido, Japan; [Matsuki, Motoki; Yao, Naoyuki; Hirayama, Tomoya; Ishida, Hironori] Kitasaito Hosp, Dept Urol, Asahikawa, Hokkaido, Japan; [Yao, Naoyuki] Asahikawa Rehabil Hosp, Dept Internal Med, Asahikawa, Hokkaido, Japan; [Kikuchi, Kenjiro] Hokkaido Junkanki Hosp, Dept Cardiol, Sapporo, Hokkaido, Japan	Nakagawa, N (reprint author), Asahikawa Med Univ, Div Cardiol Nephrol Pulmonol & Neurol, Dept Internal Med, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, Japan.	naka-nao@asahikawa-med.ac.jp			Ministry of Health, Labor and Welfare of Japan	This study was supported, in part, by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan. We thank Kozue Kanzaki and the Kitasaito Hospital staff for help with data collection.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kobayashi I, 2010, NEPHROL DIAL TRANSPL, V25, P3361, DOI 10.1093/ndt/gfq211; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134; Talib A, 2012, HYPERTENS RES, V35, P426, DOI 10.1038/hr.2011.201; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Peake PW, 2005, EUR J ENDOCRINOL, V153, P409, DOI 10.1530/eje.1.01978; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; Yamada K, 2008, AM J CLIN NUTR, V87, P106; Rao M, 2008, NEPHROL DIAL TRANSPL, V23, P2619, DOI 10.1093/ndt/gfn070; Bonet Josep, 2013, Diabetes Metab Syndr Obes, V6, P339, DOI 10.2147/DMSO.S51289; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Lee CC, 2008, ARCH MED RES, V39, P785, DOI 10.1016/j.arcmed.2008.08.005; Nakagawa N, 2011, HYPERTENS RES, V34, P592, DOI 10.1038/hr.2010.282; Park JH, 2012, THER APHER DIAL, V16, P121, DOI 10.1111/j.1744-9987.2011.01046.x; Peralta CA, 2006, CURR OPIN NEPHROL HY, V15, P361, DOI 10.1097/01.mnh.0000232875.27846.7e; Rasic-Milutinovic Z, 2007, INTERNAL MED, V46, P945, DOI 10.2169/internalmedicine.46.0092; Silverberg DS, 2003, CLIN NEPHROL, V60, pS93; Matsuzawa Y, 2002, CIRC J, V66, P987; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Tsai YC, 2007, MEDIAT INFLAMM, DOI 10.1155/2007/19891; Tsangalis G, 2007, INT J ARTIF ORGANS, V30, P118; Tu Shu-Fen, 2012, Glob J Health Sci, V4, P53, DOI 10.5539/gjhs.v4n5p53; Ucar E, 2009, RENAL FAILURE, V31, P221, DOI 10.1080/08860220802669883; Wang AYM, 2008, AM J NEPHROL, V28, P647, DOI 10.1159/000117817; Westerink J, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-13; Yang SY, 2007, BLOOD PURIFICAT, V25, P252, DOI 10.1159/000101698	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					30	39		10.1111/1744-9987.12190		10	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000005		
J	Furuya, F; Shimura, H; Takahashi, K; Akiyama, D; Motosugi, A; Ikegishi, Y; Haraguchi, K; Kobayashi, T				Furuya, Fumihiko; Shimura, Hiroki; Takahashi, Kazuya; Akiyama, Daiichiro; Motosugi, Ai; Ikegishi, Yukinobu; Haraguchi, Kazutaka; Kobayashi, Tetsuro			Skin Autofluorescence Is a Predictor of Cardiovascular Disease in Chronic Kidney Disease Patients	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Coronary artery disease; Diabetes; Hemodialysis	HEMODIALYSIS-PATIENTS; RISK-FACTOR; COMPLICATIONS; GLYCATION; MORTALITY; COLLAGEN; STRESS; PLASMA	Accelerated formation and tissue accumulation of advanced glycation end products (AGEs), reflecting cumulative glycemic and oxidative stress, occurs in age-related and chronic diseases like diabetes mellitus (DM) and renal failure, and contributes to vascular damage. Skin autofluorescence (AFR), a noninvasive measurement method, reflects tissue accumulation of AGEs. AFR has been reported to be an independent predictor of mortality in Caucasian hemodialysis patients. We assessed the relationship between levels of AFR and the prevalence of cardiovascular disease (CVD), and clarified the prognostic usefulness of skin AFR levels in Asian (non-Caucasian) hemodialysis (HD) patients. AFR was measured with an autofluorescence reader in 64 HD patients. Overall and cardiovascular mortality was monitored prospectively during the 3-year follow-up. During follow-up, CVD events occurred in 21 patients. The deaths of 10 HD patients were associated with CVD. Multivariate logistic regression analyses showed that initial AFR was an independent risk factor for de novo CVD in HD patients with or without diabetes. When patients were classified on the basis of AFR tertiles, Cochran-Armitage analysis demonstrated that the highest tertile of AFR level showed an increased odds ratio for the prevalence of CVD. These findings suggest that AFR levels can be used to detect the prevalence of CVD in HD patients with or without diabetes.	[Furuya, Fumihiko; Takahashi, Kazuya; Akiyama, Daiichiro; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo, Yamanashi 4093898, Japan; [Shimura, Hiroki] Fukushima Med Univ, Dept Lab Med, Fukushima, Japan; [Motosugi, Ai; Ikegishi, Yukinobu; Haraguchi, Kazutaka] Haraguchi Internal Med Kidney Clin, Yamanashi, Japan	Furuya, F (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	ffuruya@yamanashi.ac.jp					Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Tanaka K, 2010, THER APHER DIAL, V14, P334, DOI 10.1111/j.1744-9987.2009.00782.x; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Suzuki M, 2012, INT HEART J, V53, P238; Hsu HJ, 2012, EXP GERONTOL, V47, P950, DOI 10.1016/j.exger.2012.08.012; Nakamura K, 2006, CIRC J, V70, P954, DOI 10.1253/circj.70.954; Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/01.hjh.0000042892.24999.92; Hricik DE, 1996, CLIN TRANSPLANT, V10, P568; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1716, DOI 10.1093/ndt/gfg288; MONNIER VM, 1986, NEW ENGL J MED, V314, P403, DOI 10.1056/NEJM198602133140702; Morishita Y, 2011, HYPERTENS RES, V34, P308, DOI 10.1038/hr.2010.238; Takenaka T, 2008, J ATHEROSCLER THROMB, V15, P339; Terawaki H, 2013, CLIN EXP NEPHROL, V17, P549, DOI 10.1007/s10157-012-0742-z	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					40	44		10.1111/1744-9987.12204		5	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000006		
J	Wakasugi, M; Matsuo, K; Kazama, JJ; Narita, I				Wakasugi, Minako; Matsuo, Koji; Kazama, Junichiro James; Narita, Ichiei			Higher Mortality Due to Intracerebral Hemorrhage in Dialysis Patients: A Comparison with the General Population in Japan	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Cerebral infarction; Dialysis; Intracerebral hemorrhage; Mortality; Subarachnoid hemorrhage	STAGE RENAL-DISEASE; MAINTENANCE HEMODIALYSIS; SINGLE-CENTER; RISK-FACTORS; STROKE; PROGNOSIS; COHORT	Cerebrovascular diseases, including intracerebral hemorrhage, cerebral infarction, and subarachnoid hemorrhage, remain prevalent causes of morbidity and mortality among dialysis patients. Their mortality rate for cerebrovascular diseases is roughly three times higher than that in the general population. However, whether mortality rates for all subtypes of cerebrovascular diseases are equally higher has not been evaluated. The aim of this study was to determine the mortality rate for each stroke subtype, comparing dialysis patients and the general population in Japan. We used mortality data reported by the Japanese Society for Dialysis Therapy and national Vital Statistics data between 2008 and 2009. We calculated standardized mortality ratios and compared the mortality rates for stroke subtypes including intracerebral hemorrhage, cerebral infarction, and subarachnoid hemorrhage. During the 2-year study period, 51994 and 933 deaths from intracerebral hemorrhage, 79124 and 511 deaths from cerebral infarction, and 24957 and 147 deaths from subarachnoid hemorrhage were recorded per 252 million person-years and per 546474 dialysis patient-years, respectively. Standardized mortality ratios among dialysis patients relative to the general population were 3.8 (95% confidence interval, 3.6-4.1), 1.3 (1.2-1.4), and 1.3 (1.1-1.6) for intracerebral hemorrhage, cerebral infarction, and subarachnoid hemorrhage, respectively. Intracerebral hemorrhage was the highest cause of mortality in the dialysis population, although cerebral infarction was the highest in the general population. Relative to the general population in Japan, Japanese dialysis patients had higher mortality rates, especially for intracerebral hemorrhage.	[Wakasugi, Minako] Niigata Univ, Ctr Interorgan Commun Res, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Matsuo, Koji; Narita, Ichiei] Niigata Univ, Div Clin Nephrol & Rheumatol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Kazama, Junichiro James] Niigata Univ, Div Blood Purificat Therapy, Med & Dent Hosp, Niigata 9518510, Japan	Wakasugi, M (reprint author), Niigata Univ, Ctr Interorgan Commun Res, Grad Sch Med & Dent Sci, Chuo Ku, Asahimachi 1-757, Niigata 9518510, Japan.	minakowa@med.niigata-u.ac.jp		Wakasugi, Minako/0000-0003-1555-7736			ISEKI K, 1993, KIDNEY INT, V44, P1086, DOI 10.1038/ki.1993.352; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Wakasugi M, 2012, THER APHER DIAL, V16, P226, DOI 10.1111/j.1744-9987.2012.01062.x; Seliger SL, 2003, KIDNEY INT, V64, P603, DOI 10.1046/j.1523-1755.2003.00101.x; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; Power A, 2012, AM J KIDNEY DIS, V59, P249, DOI 10.1053/j.ajkd.2011.07.016; Kaw D, 2006, SEMIN DIALYSIS, V19, P317; Toyoda K, 2005, AM J KIDNEY DIS, V45, P1058, DOI 10.1053/j.ajkd.2005.02.028; Sohal AS, 2006, THROMB RES, V118, P417, DOI 10.1016/j.thromres.2005.03.032; Sozio SM, 2009, AM J KIDNEY DIS, V54, P468, DOI 10.1053/j.ajkd.2009.01.261; Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702; Bureau of Census Ministry of Internal Affairs and Communications, 2010, VOT STAT JAP 2009; Bureau of Census Ministry of Internal Affairs and Communications, 2009, VIT STAT JAP 2008; Esteve J, 1994, STAT METHODS CANC RE, P49; Iseki K, 1996, KIDNEY INT, V50, P1672, DOI 10.1038/ki.1996.484; Kuo CC, 2012, NEPHROLOGY, V17, P243, DOI 10.1111/j.1440-1797.2011.01551.x; Ocak G, 2012, J THROMB HAEMOST, V10, P2484, DOI 10.1111/j.1538-7836.2012.04921.x; ONOYAMA K, 1986, JPN HEART J, V27, P685; Nakai S, 2005, THER APHER DIAL, V9, P431; Shimoyama T, 2013, CEREBROVASC DIS, V36, P47, DOI 10.1159/000351504; Tsubakihara Y, 2009, OVERVIEW REGULAR DIA; Tsubakihara Y, 2010, OVERVIEW REGULAR DIA; Wakasugi M, 2013, THER APHER DIAL, V17, P298, DOI 10.1111/j.1744-9987.2012.01144.x	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					45	49		10.1111/1744-9987.12192		5	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000007		
J	Yamada, S; Tsuruya, K; Tokumoto, M; Yoshida, H; Hasegawa, S; Tanaka, S; Eriguchi, M; Nakano, T; Masutani, K; Ooboshi, H; Kitazono, T				Yamada, Shunsuke; Tsuruya, Kazuhiko; Tokumoto, Masanori; Yoshida, Hisako; Hasegawa, Shoko; Tanaka, Shigeru; Eriguchi, Masahiro; Nakano, Toshiaki; Masutani, Kosuke; Ooboshi, Hiroaki; Kitazono, Takanari			Fibroblast Growth Factor 23, but not Parathyroid Hormone, Is Associated With Urinary Phosphate Regulation in Patients on Peritoneal Dialysis	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Fibroblast growth factor 23; Parathyroid hormone; Peritoneal dialysis; Residual renal function; Urinary phosphate excretion	CHRONIC KIDNEY-DISEASE; RESIDUAL RENAL-FUNCTION; HEMODIALYSIS-PATIENTS; FGF23; TRANSPORT; HYPERPARATHYROIDISM; REABSORPTION; PHOSPHORUS; METABOLISM; MANAGEMENT	Fibroblast growth factor (FGF) 23 plays an important role in regulation of renal phosphate excretion in patients with chronic kidney disease. However, it remains undetermined whether FGF23 is closely linked to renal phosphate handling in patients with low glomerular filtration rate (GFR). The present cross-sectional study included 52 outpatients undergoing peritoneal dialysis with urine volume100mL/day. The primary outcome was level of urinary phosphate excretion, and the secondary outcomes were tubular maximal reabsorption of phosphate normalized to GFR (TmP/GFR), an index of the renal threshold for phosphate excretion, and level of peritoneal phosphate excretion. Variates of interest were serum FGF23 and parathyroid hormone (PTH) levels. The median and interquartile range of serum FGF23 level, TmP/GFR, and total urinary and peritoneal phosphate excretion were 5610 (1493-11430) ng/mL, 1.30 (0.44-1.86) mg/dL, 117 (40-234) mg/day, and 208 (156-250) mg/day, respectively. Multivariate linear regression analysis revealed that serum FGF23 level was significantly (P<0.05) associated with TmP/GFR negatively and significantly (P<0.05) associated with urinary phosphate excretion positively, even after adjusting for confounders. In contrast, none of the three outcome variates was associated with serum PTH level. Neither serum FGF23 nor PTH level was associated with peritoneal phosphate excretion. The present study indicates that FGF23, but not PTH, is involved in urinary phosphate regulation, even in patients on peritoneal dialysis with residual renal function.	[Yamada, Shunsuke; Tsuruya, Kazuhiko; Hasegawa, Shoko; Tanaka, Shigeru; Eriguchi, Masahiro; Nakano, Toshiaki; Masutani, Kosuke; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Tsuruya, Kazuhiko; Yoshida, Hisako] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 8128582, Japan; [Yamada, Shunsuke; Tokumoto, Masanori; Ooboshi, Hiroaki] Fukuoka Dent Coll, Div Internal Med, Fukuoka, Japan	Tsuruya, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, Maidashi3-1-1, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp					Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Rippe B, 2004, PERITON DIALYSIS INT, V24, P10; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; PAYNE RB, 1973, BRIT MED J, V4, P643; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Kaida H, 2005, ANN NUCL MED, V19, P179, DOI 10.1007/BF02984602; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Bacchetta J, 2013, J BONE MINER RES, V28, P46, DOI 10.1002/jbmr.1740; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Koizumi M, 2012, NEPHROL DIAL TRANSPL, V27, P784, DOI 10.1093/ndt/gfr384; Imel EA, 2006, J CLIN ENDOCR METAB, V91, P2055, DOI 10.1012/jc.2005-2105; Gutierrez OM, 2008, KIDNEY INT, V73, P956, DOI 10.1038/ki.2008.4; Tomida K, 2012, BONE, V51, P729, DOI 10.1016/j.bone.2012.06.027; Kuhlmann MK, 2010, BLOOD PURIFICAT, V29, P137, DOI 10.1159/000245640; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Murer H, 2000, PHYSIOL REV, V80, P1373; Penne EL, 2011, CLIN J AM SOC NEPHRO, V6, P281, DOI 10.2215/CJN.04480510; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Pilz S, 2011, AM J KIDNEY DIS, V58, P374, DOI 10.1053/j.ajkd.2011.03.020; Isakova T, 2011, CLIN J AM SOC NEPHRO, V6, P2688, DOI 10.2215/CJN.04290511; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; KRUSE K, 1982, ARCH DIS CHILD, V57, P217; Bernardo AP, 2011, CLIN J AM SOC NEPHRO, V6, P591, DOI 10.2215/CJN.06960810; Graff J, 1996, CLIN PHYSIOL, V16, P31, DOI 10.1111/j.1475-097X.1996.tb00554.x; Kovesdy CP, 2008, KIDNEY INT, V73, P1355, DOI 10.1038/ki.2008.35; Levi M, 2000, AM J KIDNEY DIS, V6, P1276; Messa P, 1998, NEPHROL DIAL TRANSPL, V13, P43, DOI 10.1093/ndt/13.suppl_6.43; Moe OW, 2012, J CLIN INVEST, V122, P2354, DOI 10.1172/JCI64184; Payne RB, 1998, ANN CLIN BIOCHEM, V35, P201; Rufino M, 1998, NEPHROL DIAL TRAN S3, V13, pS65; Sedlacek M, 2000, AM J KIDNEY DIS, V36, P1020, DOI 10.1053/ajkd.2000.19105; Slatopolsky E, 2011, KIDNEY INT, V79, pS3, DOI 10.1038/ki.2011.23; Tonelli M, 2010, NEW ENGL J MED, V362, P1312, DOI 10.1056/NEJMra0912522; Wang AYM, 2004, AM J KIDNEY DIS, V43, P712, DOI 10.1053/j.ajkd.2003.12.032; Wang MJ, 2013, CLIN J AM SOC NEPHRO, V8, P116, DOI 10.2215/CJN.00230112; Weinman EJ, 2012, EXP CELL RES, V318, P1027, DOI 10.1016/j.yexcr.2012.02.037; Working Group Committee for Preparation of Guidelines for Peritoneal Dialysis Japanese Society for Dialysis Therapy; Japanese Society for Dialysis Therapy, 2009, THER APHER DIAL, V14, P489	39	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					73	80		10.1111/1744-9987.12221		8	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000011		
J	Takeshita, K; Matsushita, T; Murohara, T				Takeshita, Kyosuke; Matsushita, Tadashi; Murohara, Toyoaki			Asymptomatic Left Atrial Thrombus in a Dialysis-Dependent Patient Free of Thrombogenic Abnormalities	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter							HEMODIALYSIS-PATIENTS		[Takeshita, Kyosuke; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Takeshita, Kyosuke; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan	Takeshita, K (reprint author), Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	kyousuke@med.nagoya-u.ac.jp	Takeshita, Kyosuke/B-7008-2012; Murohara, Toyoaki/M-4958-2014	Takeshita, Kyosuke/0000-0002-8283-3799; 			Marinigh R, 2011, J AM COLL CARDIOL, V57, P1339, DOI 10.1016/j.jacc.2010.12.013; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Eleftheriadis T, 2008, THER APHER DIAL, V12, P190, DOI 10.1111/j.1744-9987.2008.00569.x; Lo DS, 2006, THROMB RES, V118, P385, DOI 10.1016/j.thromres.2005.03.031	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					93	94		10.1111/1744-9987.12201		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000014		
J	Takanohashi, S; Uyama, S; Togawa, A				Takanohashi, Seiko; Uyama, Satoko; Togawa, Akashi			Three Cases of Emphysematous Cystitis in End-Stage Renal Disease Patients Undergoing Hemodialysis and Continuous Ambulatory Peritoneal Dialysis	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Takanohashi, Seiko; Uyama, Satoko; Togawa, Akashi] Shizuoka Saiseikai Gen Hosp, Dept Nephrol, Shizuoka, Japan	Takanohashi, S (reprint author), Shizuoka Saiseikai Gen Hosp, Dept Nephrol, Shizuoka, Japan.	s152293@siz.saiseikai.or.jp					Lin CJ, 2008, NEPHROLOGY, V13, P178, DOI 10.1111/j.1440-1797.2007.00891.x; Yokoo Takashi, 2007, Clin Exp Nephrol, V11, P247, DOI 10.1007/s10157-007-0478-3	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					94	95		10.1111/1744-9987.12195		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000015		
J	Iwazu, Y; Komori, S; Nagata, D				Iwazu, Yoshitaka; Komori, Satoko; Nagata, Daisuke			Change of Chylous Ascites During Low-Density Lipoprotein Apheresis in a Patient With Idiopathic Nephrotic Syndrome	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Iwazu, Yoshitaka; Komori, Satoko; Nagata, Daisuke] Jichi Med Univ, Dept Internal Med, Div Nephrol, Shimotsuke, Tochigi, Japan	Iwazu, Y (reprint author), Jichi Med Univ, Dept Internal Med, Div Nephrol, Shimotsuke, Tochigi, Japan.	iwazu@jichi.ac.jp					Chen YC, 2005, NEPHROL DIAL TRANSPL, V20, P1501, DOI 10.1093/ndt/gfh791; Iwazu Y, 2012, CLIN EXP NEPHROL, V16, P485, DOI 10.1007/s10157-012-0606-6; Lindenbaum J, 1969, AM J MED, V44, P830; Yokoyama Hitoshi, 2007, Clin Exp Nephrol, V11, P122, DOI 10.1007/s10157-007-0462-y	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	FEB	2015	19	1					97	98		10.1111/1744-9987.12225		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CA7KA	WOS:000349095000017		
J	Arron, JR; Izuhara, K				Arron, Joseph R.; Izuhara, Kenji			Asthma biomarkers: what constitutes a 'gold standard'?	THORAX			English	Editorial Material						Asthma; Eosinophil Biology; Pulmonary eosinophilia	RANDOMIZED CONTROLLED-TRIAL; AIRWAY INFLAMMATION; DOUBLE-BLIND; PERIOSTIN; EXACERBATIONS; LEBRIKIZUMAB; DISEASE; COUNTS		[Arron, Joseph R.] Genentech Res & Early Dev, San Francisco, CA USA; [Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, Saga, Japan	Arron, JR (reprint author), Genentech Inc, MS 231C,1 DNA Way, San Francisco, CA 94080 USA.	arron.joseph@gene.com					Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Arron JR, 2014, EUR RESPIR J, V43, P627, DOI 10.1183/09031936.00117013; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Izuhara K, 2014, ALLERGOL INT, V63, P143, DOI 10.2332/allergolint.13-RAI-0663; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Kim MA, 2014, ANN ALLERG ASTHMA IM, V113, P314, DOI 10.1016/j.anai.2014.06.014; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Zhang XY, 2014, CLIN EXP ALLERGY, V44, P1137, DOI 10.1111/cea.12345; Powell H, 2011, LANCET, V378, P983, DOI 10.1016/S0140-6736(11)60971-9; Arron Joseph R, 2013, Ann Am Thorac Soc, V10 Suppl, pS206, DOI 10.1513/AnnalsATS.201303-047AW; Bossuyt PM, 2003, ANN INTERN MED, V138, P40; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Brightling CE, 2014, AM J RESP CRIT CARE, V189, pA6670; Hanania NA, 2014, J ALLERGY CLIN IMMUN, V133, pAB402; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Kou K, 2014, BRIT J DERMATOL, V171, P283, DOI 10.1111/bjd.12943; McClintock D, 2012, AM J RESP CRIT CARE, V185, pA3959; Nance T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097550; Wagener AH, 2015, THORAX, V70, P115, DOI 10.1136/thoraxjnl-2014-205634; Yamada S, 2014, J DENT RES, V93, P891, DOI 10.1177/0022034514543015	23	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0040-6376	1468-3296		THORAX	Thorax	FEB	2015	70	2					105	107		10.1136/thoraxjnl-2014-206069		3	Respiratory System	Respiratory System	CA2FU	WOS:000348725200003		
J	Ishido, N; Inoue, N; Watanabe, M; Hidaka, Y; Iwatani, Y				Ishido, Naoko; Inoue, Naoya; Watanabe, Mikio; Hidaka, Yoh; Iwatani, Yoshinori			The Relationship Between Skewed X Chromosome Inactivation and the Prognosis of Graves' and Hashimoto's Diseases	THYROID			English	Article							AUTOIMMUNE THYROID-DISEASE; PREMATURE OVARIAN FAILURE; FEMALE PREDISPOSITION; FUNCTIONAL POLYMORPHISMS; WOMEN; ASSOCIATION; PATTERNS; METHYLATION; FREQUENCY; ARTHRITIS	Background: Autoimmune thyroid diseases (AITDs) predominantly develop in females. One of two X chromosomes is randomly inactivated by methylation in each female cell, but it has been reported that skewed X chromosome inactivation (XCI) may be associated with the development of autoimmune diseases. To clarify the significance of skewed XCI in the prognosis and development of AITD, we investigated the proportion of skewed XCI in female patients with AITD. Methods: We analyzed the degree of XCI skewing in 120 female patients with AITD (77 patients with Graves' disease [GD] and 43 patients with Hashimoto's disease [HD]) and 49 female controls in DNA from peripheral blood mononuclear cells (PBMC). We performed XCI analysis by digesting inactive DNA with a methylation-sensitive restriction enzyme (HpaII) followed by a polymerase chain reaction (PCR) assay for the polymorphic CAG repeat of the androgen receptor gene and electrophoresis of the PCR products. Results: The proportion of skewed XCI (>= 65% skewing) was not significantly different between AITD patients and control subjects but was higher in patients with intractable GD (66.7%) than those with GD in remission (25.0%, p=0.0033) and control subjects (32.6%, p=0.0038). When the cutoff value for XCI skewing was relaxed, the proportion of skewed XCI (>= 60% skewing) was higher in patients with severe HD (76.5%) than in those with mild HD (41.2%, p=0.0342). Conclusions: Skewed XCI is related to the prognosis of AITD, particularly the intractability of GD.	[Ishido, Naoko; Inoue, Naoya; Watanabe, Mikio; Iwatani, Yoshinori] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Suita, Osaka 5650871, Japan; [Hidaka, Yoh] Osaka Univ, Grad Sch Med, Dept Lab Med, Suita, Osaka 5650871, Japan	Iwatani, Y (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Biomed Informat, Yamadaoka 1-7, Suita, Osaka 5650871, Japan.	iwatani@sahs.med.osaka-u.ac.jp					Inoue N, 2012, J CLIN IMMUNOL, V32, P1243, DOI 10.1007/s10875-012-9721-0; Simmonds MJ, 2014, J CLIN ENDOCR METAB, V99, pE127, DOI 10.1210/jc.2013-2667; Brix TH, 2005, J CLIN ENDOCR METAB, V90, P5949, DOI 10.1210/jc.2005-1366; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Ozcelik T, 2006, EUR J HUM GENET, V14, P791, DOI 10.1038/sj.ejhg.5201614; Busque L, 1996, BLOOD, V88, P59; Inoue N, 2010, CLIN EXP IMMUNOL, V162, P402, DOI 10.1111/j.1365-2249.2010.04229.x; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Nanba T, 2009, THYROID, V19, P495, DOI 10.1089/thy.2008.0423; Ozbalkan Z, 2005, ARTHRITIS RHEUM, V52, P1564, DOI 10.1002/art.21026; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Yin XM, 2007, ANN NY ACAD SCI, V1110, P193, DOI 10.1196/annals.1423.021; Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P3290, DOI 10.1210/jc.83.9.3290; Selmi C, 2008, BEST PRACT RES CL RH, V22, P913, DOI 10.1016/j.berh.2008.09.002; Medema RH, 2007, CELL, V129, P1253, DOI 10.1016/j.cell.2007.06.008; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Aruna M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017718; Brooks WH, 2010, CLIN REV ALLERG IMMU, V39, P20, DOI 10.1007/s12016-009-8167-5; Brown CJ, 1999, J NATL CANCER I, V91, P304, DOI 10.1093/jnci/91.4.304; Chabchoub G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2759; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; Kim JW, 2004, J KOREAN MED SCI, V19, P258; Manzardo AM, 2012, ALCOHOL CLIN EXP RES, V36, P1325, DOI 10.1111/j.1530-0277.2012.01740.x; Menconi F, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P231, DOI 10.1007/978-1-60327-285-8_44; MONK M, 1990, DEVELOPMENT, P55; Ozcelik T, 2008, CLIN REV ALLERG IMMU, V34, P348, DOI 10.1007/s12016-007-8051-0; Sato K, 2004, AM J MED GENET A, V130A, P240, DOI 10.1002/ajmg.a.30256; Uz E, 2009, ARTHRITIS RHEUM-US, V60, P3410, DOI 10.1002/art.24956; Weetman AP, 2000, THYROID FUNDAMENTAL, P721; Yoon SH, 2008, HUM REPROD, V23, P688, DOI 10.1093/humrep/dem415; Zheng J, 2013, HUM MUTAT, V34, P619, DOI 10.1002/humu.22284	32	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	FEB 1	2015	25	2					256	261		10.1089/thy.2014.0318		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CA6HQ	WOS:000349012300016		
J	Tanaka, T				Tanaka, Toshifumi			On the maximal Thurston-Bennequin number of knots and links in spatial graphs	TOPOLOGY AND ITS APPLICATIONS			English	Article						Knot; Spatial graph; Legendrian link; Legendrian graph	POLYNOMIALS	It is known that there does not exist a Legendrian embedding of K-4 such that all its cycles realize the maximal Thurston-Bennequin numbers that only consist of odd numbers. This paper represents an infinite family of spatial graphs that are Legendrian embeddings of K-4 such that, for each of the Legendrian embeddings, all its cycles but one realize the maximal Thurston Bennequin numbers that consist of odd numbers and its one cycle realizes the maximal Thurston Bennequin number equal to zero. (C) 2014 Elsevier B.V. All rights reserved.	Gifu Univ, Fac Educ, Dept Math Educ, Gifu 5011193, Japan	Tanaka, T (reprint author), Gifu Univ, Fac Educ, Dept Math Educ, Yanagido 1-1, Gifu 5011193, Japan.	tanakat@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture [23740046]	This research was partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (B), 2011-2014 (23740046).	Eliashberg Y, 2009, J SYMPLECT GEOM, V7, P77; Eliashberg Y., 1993, TOPOLOGICAL METHODS; Epstein J., 2003, FIELDS I COMMUN, V35, P103; Fuchs D, 1997, TOPOLOGY, V36, P1025, DOI 10.1016/S0040-9383(96)00035-3; Giroux E., 2002, P INT C MATH, VII, P405; Kalman T, 2008, P AM MATH SOC, V136, P2969, DOI 10.1090/S0002-9939-08-09478-1; KAUFFMAN LH, 1990, T AM MATH SOC, V318, P417, DOI 10.2307/2001315; Kawauchi A., 1996, SURVEY KNOT THEORY; Mohnke K., 2000, CONT MATH, V279; Ng L., 2001, ALGEBR GEOM TOPOL, V1, P427, DOI 10.2140/agt.2001.1.427; Ng L, 2005, ALGEBR GEOM TOPOL, V5, P1637, DOI 10.2140/agt.2005.5.1637; O'Donnol D, 2012, ALGEBR GEOM TOPOL, V12, P1273, DOI 10.2140/agt.2012.12.1273; Swiatkowski J., 1992, ANN GLOB ANAL GEOM, V10, P195; Tabachnikov S, 1997, MATH RES LETT, V4, P143; Tanaka T, 2006, TOPOL APPL, V153, P2476, DOI 10.1016/j.topol.2005.10.001; Tanaka T, 1999, P AM MATH SOC, V127, P3427, DOI 10.1090/S0002-9939-99-04983-7; Yamada S., 1992, KNOTS 90, P447; Yamada S., 1989, J GRAPH THEOR, V13, P531	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-8641	1879-3207		TOPOL APPL	Topology Appl.	FEB 1	2015	180						132	141		10.1016/j.topol.2014.11.011		10	Mathematics, Applied; Mathematics	Mathematics	CA5RO	WOS:000348965700010		
J	Hatakeyama, T; Ichise, A; Yonekura, T; Unno, H; Goda, S; Nakagawa, H				Hatakeyama, Tomomitsu; Ichise, Ayaka; Yonekura, Tomokazu; Unno, Hideaki; Goda, Shuichiro; Nakagawa, Hideyuki			cDNA cloning and characterization of a rhamnose-binding lectin SUL-I from the toxopneustid sea urchin Toxopneustes pileolus venom	TOXICON			English	Article						Sea urchin; Toxopneustes pileolus; cDNA cloning; Rhamnose; Lectin; Carbohydrate-binding	GLOBIFEROUS PEDICELLARIAE; ANIMAL LECTINS; PURIFICATION; GENOME; EGGS; SUBSTANCES; SEQUENCE; DOMAINS; TOXINS	The globiferous pedicellariae of the venomous sea urchin Toxopneustes pileolus contain several biologically active proteins. Among these, a galactose-binding lectin SUL-I isolated from the venom in the large globiferous pedicellariae shows several activities such as mitogenic, chemotactic, and cytotoxic activities through binding to the carbohydrate chains on the cells. We cloned cDNA encoding SUL-I by reverse transcription-PCR using the degenerate primers designed on the basis of the N-terminal amino acid sequence of the protein and expressed the recombinant SUL-I (rSUL-I) in Escherichia coli cells. The SUL-I gene contains an open reading frame of 927 nucleotides corresponding to 308 amino acid residues, including 24 residues of a putative signal sequence. The mature protein with 284 residues is composed of three homologous regions, each showing similarity with the carbohydrate-recognition domains of the rhamnose-binding lectins, which have been mostly found in fish eggs. While rSUL-I exhibited binding activity for several galactose-related sugars, the highest affinity was found for L-rhamnose among carbohydrates tested, confirming that SUL-I is a rhamnose-binding lectin. rSUL-I also showed hemagglutinating activity toward rabbit erythrocytes, indicating the existence of more than one carbohydrate-binding site to cross-link the carbohydrate chains on the cell surface, which may be closely related to its biological activities. (C) 2014 Elsevier Ltd. All rights reserved.	[Hatakeyama, Tomomitsu; Ichise, Ayaka; Yonekura, Tomokazu; Unno, Hideaki; Goda, Shuichiro] Nagasaki Univ, Grad Sch Engn, Biomol Chem Lab, Nagasaki 8528521, Japan; [Nakagawa, Hideyuki] Univ Tokushima, Grad Sch Integrated Arts & Sci, Div Environm Symbiosis, Tokushima 7708502, Japan	Hatakeyama, T (reprint author), Nagasaki Univ, Grad Sch Engn, Biomol Chem Lab, Bunkyo Machi 1-14, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp		Hatakeyama, Tomomitsu/0000-0002-9505-1980	Japan Society for the Promotion of Science (JSPS) [26450128, 10452872, 00346587]	This work was supported by a Grants-in-Aid for Scientific Research (C) to TH (26450128) and Grants-in-Aid for Young Scientists (B) to HU (10452872) and SG (00346587) from the Japan Society for the Promotion of Science (JSPS).	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; NAKAGAWA H, 1991, ARCH BIOCHEM BIOPHYS, V284, P279, DOI 10.1016/0003-9861(91)90296-U; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Nakagawa H, 2003, J TOXICOL-TOXIN REV, V22, P633, DOI 10.1081/TXR-120026918; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Nakagawa H, 1996, ADV EXP MED BIOL, V391, P213; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Edo K, 2012, TOXIN REV, V31, P54, DOI 10.3109/15569543.2012.730090; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Nakagawa H, 1999, J CHEM SOC PAKISTAN, V21, P305; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Igci N, 2012, ARCH TOXICOL, V86, P441, DOI 10.1007/s00204-011-0763-5; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Takei M, 2006, TOXICOL APPL PHARM, V213, P27, DOI 10.1016/j.taap.2005.08.004; Shirai T, 2009, J MOL BIOL, V391, P390, DOI 10.1016/j.jmb.2009.06.027; OZEKI Y, 1991, BIOCHEMISTRY-US, V30, P2391, DOI 10.1021/bi00223a014; Satoh F, 2002, J NAT TOXINS, V11, P297; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Gasteiger E., 2005, PROTEIN IDENTIFICATI; Hatakeyama T, 2012, BIOSCI BIOTECH BIOCH, V76, P1999, DOI 10.1271/bbb.120520; HATAKEYAMA T, 1994, J BIOCHEM-TOKYO, V116, P209; Hosono M, 1999, BBA-GEN SUBJECTS, V1472, P668, DOI 10.1016/S0304-4165(99)00185-3; KIMURA A, 1975, JPN J PHARMACOL, V25, P109, DOI 10.1254/jjp.25.109; Sakai H., 2013, INT AQUAT RES, V5, P1; SASAKI H, 1981, EXP CELL RES, V135, P15, DOI 10.1016/0014-4827(81)90294-9; Shiina N, 2002, FISHERIES SCI, V68, P1352, DOI 10.1046/j.1444-2906.2002.00575.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tateno H, 2010, BIOSCI BIOTECH BIOCH, V74, P1141, DOI 10.1271/bbb.100086; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0041-0101			TOXICON	Toxicon	FEB	2015	94						8	15		10.1016/j.toxicon.2014.11.236		8	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	CA8VG	WOS:000349198400002		
J	Kikuchi, M; Akahoshi, Y; Nakano, H; Ugai, T; Wada, H; Yamasaki, R; Sakamoto, K; Kawamura, K; Ishihara, Y; Sato, M; Ashizawa, M; Terasako-Saito, K; Kimura, S; Yamazaki, R; Kanda, J; Kako, S; Nishida, J; Kanda, Y				Kikuchi, M.; Akahoshi, Y.; Nakano, H.; Ugai, T.; Wada, H.; Yamasaki, R.; Sakamoto, K.; Kawamura, K.; Ishihara, Y.; Sato, M.; Ashizawa, M.; Terasako-Saito, K.; Kimura, S.; Yamazaki, R.; Kanda, J.; Kako, S.; Nishida, J.; Kanda, Y.			Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation	TRANSPLANT INFECTIOUS DISEASE			English	Article						bloodstream infection; allogeneic hematopoietic stem cell transplantation; engraftment	GRAM-NEGATIVE BACTEREMIA; RECIPIENTS; PROPHYLAXIS; BACTERIAL; LEVOFLOXACIN; EPIDEMIOLOGY; MORTALITY; CANCER	BackgroundBloodstream infections (BSI) are frequently observed after allogeneic hematopoietic stem cell transplant (HSCT), and could cause morbidity and mortality. MethodsWe retrospectively evaluated the incidence, characteristics of, and risk factors for BSI at both pre- and post-engraftment in 209 adult HSCT patients at our institute between June 2006 and December 2013. The median age at transplantation was 45years (range, 15-65). A total of 122 patients received bone marrow, 68 received peripheral blood stem cells, and 19 received umbilical cord blood. ResultsThe cumulative incidences of pre- and post-engraftment BSI were 38.9% and 17.2%, respectively. Nine patients had both pre- and post-engraftment BSI. In the pre- and post-engraftment periods, respectively, 67.4% and 84.1% of isolates were gram-positive bacteria (GPB), 28.3% and 11.4% were gram-negative bacteria (GNB), and 4.3% and 4.5% were fungi. Coagulase-negative staphylococci were the most commonly isolated GPB, while Stenotrophomonas maltophilia and Pseudomonas aeruginosa were the most commonly isolated GNB. Pre-engraftment BSI was associated with an increased risk of death. Overall survival at day 180 for patients with or without pre-engraftment BSI was 70.0% and 82.7%, respectively (P=0.02). ConclusionsRisk factors for BSI in the pre-engraftment period were the interval between diagnosis and transplantation (261days or more), engraftment failure, and high-risk disease status at HSCT in a multivariate analysis. No significant risk factor for BSI in the post-engraftment period was identified by a univariate analysis. These findings may be useful for deciding upon empiric antibacterial treatment for HSCT recipients.	[Kikuchi, M.; Akahoshi, Y.; Nakano, H.; Ugai, T.; Wada, H.; Yamasaki, R.; Sakamoto, K.; Kawamura, K.; Ishihara, Y.; Sato, M.; Ashizawa, M.; Terasako-Saito, K.; Kimura, S.; Yamazaki, R.; Kanda, J.; Kako, S.; Nishida, J.; Kanda, Y.] Jichi Med Univ, Div Hematol, Saitama Med Ctr, Saitama 3308503, Japan	Kanda, Y (reprint author), Jichi Med Univ, Div Hematol, Saitama Med Ctr, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	ycanda-tky@umin.ac.jp					Almyroudis NG, 2005, TRANSPL INFECT DIS, V7, P11, DOI 10.1111/j.1399-3062.2005.00088.x; Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024; Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Poutsiaka DD, 2007, BONE MARROW TRANSPL, V40, P63, DOI 10.1038/sj.bmt.1705690; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ortega M, 2005, ANN HEMATOL, V84, P40, DOI 10.1007/s00277-004-0909-0; Busca A, 2012, TRANSPL INFECT DIS, V14, P40, DOI 10.1111/j.1399-3062.2011.00650.x; Cappellano P, 2007, NEW MICROBIOL, V30, P89; Engels EA, 1998, J CLIN ONCOL, V16, P1179; Imataki O, 2004, BONE MARROW TRANSPL, V33, P1173, DOI 10.1038/sj.bmt.1704526; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Liu CY, 2011, BONE MARROW TRANSPL, V46, P1231, DOI 10.1038/bmt.2010.286; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mitchell AE, 2004, BONE MARROW TRANSPL, V33, P303, DOI 10.1038/sj.bmt.1704338; Oliveira AL, 2007, BONE MARROW TRANSPL, V39, P775, DOI 10.1038/sj.bmt.1705677; Poutsiaka DD, 2011, BONE MARROW TRANSPL, V46, P300, DOI 10.1038/bmt.2010.112; Richters A, 2014, BONE MARROW TRANSPL, V49, P264, DOI 10.1038/bmt.2013.172; Saitama Medical Center Jichi Medical University, FREE STAT SOFTW EZR; Yuen KY, 1998, BONE MARROW TRANSPL, V21, P1137, DOI 10.1038/sj.bmt.1701246	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	FEB	2015	17	1					56	65		10.1111/tid.12345		10	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	AZ9KL	WOS:000348532400009		
J	Yagasaki, H; Shichino, H; Shimizu, N; Ohye, T; Kurahashi, H; Yoshikawa, T; Takahashi, S				Yagasaki, H.; Shichino, H.; Shimizu, N.; Ohye, T.; Kurahashi, H.; Yoshikawa, T.; Takahashi, S.			Nine-year follow-up in a child with chromosomal integration of human herpesvirus 6 transmitted from an unrelated donor through the Japan Marrow Donor Program	TRANSPLANT INFECTIOUS DISEASE			English	Letter						human herpesvirus 6; transplantation; chomosomal integration	DNA		[Yagasaki, H.; Shichino, H.; Takahashi, S.] Nihon Univ, Sch Med, Tokyo 1738610, Japan; [Shimizu, N.] Tokyo Med & Dent Univ, Med Res Inst, Dept Virol, Tokyo, Japan; [Ohye, T.; Kurahashi, H.] Fujita Hlth Univ, Div Mol Genet, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Yoshikawa, T.] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan	Yagasaki, H (reprint author), Nihon Univ, Itabashi Ku, 30-1 Ohyaguchi, Tokyo 1738610, Japan.	yagasaki.hiroshi@nihon-u.ac.jp					Endo A, 2014, CLIN INFECT DIS, V59, P545, DOI 10.1093/cid/ciu323; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10; Daibata M, 1999, BLOOD, V94, P1545; desPagter PJ, 2010, BIOL BLOOD MARROW TR, V16, P130; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; Mori T, 2009, TRANSPL INFECT DIS, V11, P503, DOI 10.1111/j.1399-3062.2009.00430.x; Ohye T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04559; Tanaka-Taya K, 2004, J MED VIROL, V73, P465, DOI 10.1002/jmv.20113	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	FEB	2015	17	1					160	161		10.1111/tid.12338		2	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	AZ9KL	WOS:000348532400028		
J	Inoue, K; Kato, Y; Kandori, H				Inoue, Keiichi; Kato, Yoshitaka; Kandori, Hideki			Light-driven ion-translocating rhodopsins in marine bacteria	TRENDS IN MICROBIOLOGY			English	Review						microbial rhodopsin; marine bacteria; retinal; ion pump; transport	PHOTOCHEMICAL-REACTION CYCLE; BACTERIORHODOPSIN PHOTOCYCLE; HALOBACTERIUM-HALOBIUM; PROTON PUMP; SCHIFF-BASE; CHLORIDE PUMP; EXIGUOBACTERIUM-SIBIRICUM; PROTEORHODOPSIN GENES; MICROBIAL RHODOPSINS; IDENTIFICATION	Microbial rhodopsins are the photoreceptive membrane proteins found in diverse microorganisms from within Archaea, Eubacteria, and eukaryotes. They have a heptahelical transmembrane structure that binds to an all-trans retinal chromophore. Since 2000, thousands of proteorhodopsins, genes of light-driven proton pump rhodopsins, have been identified from various species of marine bacteria. This suggests that they are used for the conversion of light into chemical energy, contributing to carbon circulation related to ATP synthesis in the ocean. Furthermore, novel types of rhodopsin (sodium and chloride pumps) have recently been discovered. Here, we review recent progress in our understanding of ion-transporting rhodopsins of marine bacteria, based mainly on biophysical and biochemical research.	[Inoue, Keiichi; Kato, Yoshitaka; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kandori, H (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.	kandori@nitech.ac.jp			KAKENHI grant from the Japanese Ministry of Education, Culture, Sports and Technology (MEXT); KAKENHI grant from Japan Society for the Promotion of Science (JSPS); Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST)	We thank for Dr. Rei Abe-Yoshizumi for invaluable discussion about the manuscript. Our studies were mainly supported by KAKENHI grants from the Japanese Ministry of Education, Culture, Sports and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS), and the Precursory Research for Embryonic Science and Technology (PRE-STO) of the Japan Science and Technology Agency (JST).	Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Brown LS, 2014, BBA-BIOENERGETICS, V1837, P553, DOI 10.1016/j.bbabio.2013.05.006; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Yoshizawa S, 2012, ENVIRON MICROBIOL, V14, P1240, DOI 10.1111/j.1462-2920.2012.02702.x; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Pfleger N, 2008, J BIOMOL NMR, V40, P15, DOI 10.1007/s10858-007-9203-5; Hempelmann F, 2011, J AM CHEM SOC, V133, P4645, DOI 10.1021/ja111116a; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; Koh EY, 2010, APPL ENVIRON MICROB, V76, P5918, DOI 10.1128/AEM.00562-10; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Kuhlbrandt W, 2000, NATURE, V406, P569, DOI 10.1038/35020654; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Stingl U, 2007, APPL ENVIRON MICROB, V73, P2290, DOI 10.1128/AEM.02559-06; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; Finkel OM, 2013, ISME J, V7, P448, DOI 10.1038/ismej.2012.112; Bielawski JP, 2004, P NATL ACAD SCI USA, V101, P14824, DOI 10.1073/pnas.0403999101; DUSCHL A, 1990, J BIOL CHEM, V265, P1261; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Inoue K, 2014, J PHYS CHEM B, V118, P11190, DOI 10.1021/jp507219q; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Ono H, 2014, J PHYS CHEM B, V118, P4784, DOI 10.1021/jp500756f; Varo G, 2003, BIOPHYS J, V84, P1202; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Beja O, 2014, P NATL ACAD SCI USA, V111, P6538, DOI 10.1073/pnas.1405093111; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Lanyi JK, 1997, J BIOL CHEM, V272, P31209, DOI 10.1074/jbc.272.50.31209; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Philosof A, 2013, ENV MICROBIOL REP, V5, P475, DOI 10.1111/1758-2229.12037; Kandori H, 2001, P NATL ACAD SCI USA, V98, P1571, DOI 10.1073/pnas.98.4.1571; Chizhov I, 1996, BIOPHYS J, V71, P2329; SMITH SO, 1983, BIOCHEMISTRY-US, V22, P6141, DOI 10.1021/bi00295a016; Kwon SK, 2013, GENOME BIOL EVOL, V5, P187, DOI 10.1093/gbe/evs134; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Balashov SP, 2012, BIOCHEMISTRY-US, V51, P5748, DOI 10.1021/bi300409m; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Chen DL, 2009, BIOPHYS J, V96, P2779, DOI 10.1016/j.bpj.2008.12.3935; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; Grote M, 2013, J HIST BIOL, V46, P331, DOI 10.1007/s10739-012-9333-9; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; HAZEMOTO N, 1984, BIOPHYS J, V45, P1073; Imasheva ES, 2005, BIOCHEMISTRY-US, V44, P10828, DOI 10.1021/bi050438h; Inoue K., 2013, BIOCHIM BIOPHYS ACTA, V1837, P562; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Kandori H., 2006, CIS TRANS ISOMERIZAT, P53, DOI 10.1002/9783527609338.ch4; Kelemen BR, 2003, BBA-BIOMEMBRANES, V1618, P25, DOI 10.1016/j.bbamem.2003.10.002; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; KOUYAMA T, 1988, BIOCHEMISTRY-US, V27, P5855, DOI 10.1021/bi00416a006; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Lorenz-Fonfria VA, 2009, J AM CHEM SOC, V131, P5891, DOI 10.1021/ja900334c; Ludmann K, 1998, BIOPHYS J, V75, P3110; MAEDA A, 1977, J BIOCHEM-TOKYO, V82, P1599; OESTERHE.D, 1971, NATURE-NEW BIOL, V233, P149; Ozaki Y, 2014, BIOCHEMISTRY-US, V53, P6032, DOI 10.1021/bi500842w; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; PETTEI MJ, 1977, BIOCHEMISTRY-US, V16, P1955, DOI 10.1021/bi00628a031; Rink T, 2000, BIOPHYS J, V78, P1519; Rlyszejko A. L., 2008, J MOL BIOL, V376, P35; Sabehi G, 2007, ISME J, V1, P48, DOI 10.1038/ismej.2007.10; SASAKI J, 1995, BIOPHYS J, V68, P2073; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; TAKAHASHI T, 1985, FEMS MICROBIOL LETT, V28, P161; Tsukamoto T, 2013, FEBS LETT, V587, P322, DOI 10.1016/j.febslet.2012.12.022; VARO G, 1990, BIOCHEMISTRY-US, V29, P6858, DOI 10.1021/bi00481a015; Varo G., 1991, BIOCHEMISTRY-US, V30, P5608; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-34	79	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-842X	1878-4380		TRENDS MICROBIOL	Trends Microbiol.	FEB	2015	23	2					91	98		10.1016/j.tim.2014.10.009		8	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CB3AS	WOS:000349500700007		
J	Yabe, J; Hamambulu, P; Simulundu, E; Ogawa, H; Kajihara, M; Mori-Kajihara, A; Changula-Chitanga, K; Mwase, M; Mweemba-Muwowo, M; Chambaro, HM; Mataa, L; Hang'ombe, B; Namangala, B; Fandamu, P; Sawa, H; Takada, A; Higashi, H; Mweene, AS				Yabe, John; Hamambulu, Pharaoh; Simulundu, Edgar; Ogawa, Hirohito; Kajihara, Masahiro; Mori-Kajihara, Akina; Changula-Chitanga, Katendi; Mwase, Max; Mweemba-Muwowo, Mutinta; Chambaro, Herman Moses; Mataa, Liywalii; Hang'ombe, Bernard; Namangala, Bonniface; Fandamu, Paul; Sawa, Hirofumi; Takada, Ayato; Higashi, Hideaki; Mweene, Aaron Simanyengwe			Pathological and molecular diagnosis of the 2013 African swine fever outbreak in Lusaka, Zambia	TROPICAL ANIMAL HEALTH AND PRODUCTION			English	Article						African swine fever; Pathology; PCR; Zambia	CLINICAL-SAMPLES; PCR ASSAY	African swine fever (ASF) is a highly contagious and fatal hemorrhagic viral disease of domestic pigs. The disease is widespread in sub-Saharan Africa and has repeatedly been introduced into other continents. The current study describes the diagnostic investigations of a hemorrhagic disease that was reported in pigs in Lusaka (October 2013), Zambia. Necropsy, histopathology, and molecular diagnosis using polymerase chain reaction and sequence analysis confirmed the disease to be ASF. The sequences obtained showed high similarity to previously isolated ASF viruses. Consistent surveillance and rapid diagnosis of the disease is recommended to prevent future outbreaks and economic losses as there is currently no vaccine against the disease.	[Yabe, John; Hamambulu, Pharaoh; Simulundu, Edgar; Ogawa, Hirohito; Changula-Chitanga, Katendi; Mwase, Max; Mweemba-Muwowo, Mutinta; Hang'ombe, Bernard; Namangala, Bonniface; Sawa, Hirofumi; Takada, Ayato; Higashi, Hideaki; Mweene, Aaron Simanyengwe] Univ Zambia, Sch Vet Med, Lusaka, Zambia; [Ogawa, Hirohito; Kajihara, Masahiro; Mori-Kajihara, Akina; Sawa, Hirofumi; Takada, Ayato; Higashi, Hideaki] Hokkaido Univ Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Chambaro, Herman Moses; Mataa, Liywalii; Fandamu, Paul] Minist Agr & Livestock, Lusaka, Zambia	Yabe, J (reprint author), Univ Zambia, Sch Vet Med, POB 32379, Lusaka, Zambia.	mjyabe@yahoo.co.uk	Sawa, Hirofumi/F-6954-2012; Higashi, Hideaki/F-6872-2012; Ogawa, Hirohito/F-6918-2012		Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA)	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and Japan Science and Technology Agency (JST)/Japan International Cooperation Agency (JICA) within the framework of the Science and Technology Research Partnership for Sustainable Development (SATREPS).	Aguero M, 2004, VET RES, V35, P551, DOI 10.1051/vetres:2004031; Aguero M, 2003, J CLIN MICROBIOL, V41, P4431, DOI 10.1128/JCM.41.9.4431-4434.2003; Blome S., 2012, VIRUS RES; Costard S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061104; Denis M., 2014, BRIT J VIROLOGY, V1, P42; EFSA Panel, 2014, EFSA J, V12, P3628, DOI DOI 10.2903/J.EFSA.2014.3628; Gomez-Villamandos JC, 2013, VIRUS RES, V173, P140, DOI 10.1016/j.virusres.2013.01.017; Ravaomanana J., 2010, PARASITE VECTOR, V3, P2	8	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-4747	1573-7438		TROP ANIM HEALTH PRO	Trop. Anim. Health Prod.	FEB	2015	47	2					459	463		10.1007/s11250-014-0732-0		5	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CA3FU	WOS:000348792800026		
J	Usui, S; Koketsu, Y				Usui, Shiho; Koketsu, Yuzo			Lifetime reproductive performance and survival of English Berkshire female pigs raised in commercial herds in subtropical Japan	TROPICAL ANIMAL HEALTH AND PRODUCTION			English	Article						Berkshire pigs; Reproductive performance; Survival analysis; Swine	GROWTH	The objective of the present study was to compare lifetime reproductive performance and survival probability of English Berkshire female pigs and crossbred females in a subtropical region of Japan. We analyzed records of 20,417 females entered into the 12 herds in Southern Japan from 2003 to 2007. Generalized linear mixed-effects models were conducted to compare the lifetime reproductive performance of the Berkshire and crossbred females. Multilevel mixed-effects models were conducted to compare the lifetime reproductive performance of the Berkshire and crossbred females. Also, a multilevel proportional hazard model was used to examine the survival probabilities for the two breeds. Berkshire gilts were 39.8 days older at first-mating than crossbred gilts (P=0.05). The pigs born alive (PBA) in Berkshire and crossbred gilts increased from 5.8 to 6.9 pigs and from 10.7 to 11.1 pigs, respectively, as age at first-mating increased from 220 to 310 days old (P<0.05). More Berkshire gilts were culled for reproductive failure than crossbred gilts (7.5 vs. 3.8 %; P<0.05). Also, Berkshire females had 2.7 lower parity at removal, 224.4 days lower reproductive herd-life, and 4.2 pigs fewer average lifetime PBA than crossbred females (P<0.05) and tended to have a lower survival probability (P=0.05). In summary, Berkshire females had later puberty, were more sensitive to age at first-mating for increasing PBA, and had lower fertility and a lower survival probability than crossbred females in commercial herds.	[Usui, Shiho; Koketsu, Yuzo] Meiji Univ, Sch Agr, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Usui, S (reprint author), Meiji Univ, Sch Agr, Tama Ku, Higashi Mita 1-1-1, Kawasaki, Kanagawa 2148571, Japan.	cf30202@meiji.ac.jp					Tummaruk P, 2009, ANIM REPROD SCI, V110, P108, DOI 10.1016/j.anireprosci.2008.01.004; Tomiyama M, 2009, J ANIM SCI, V87, P1613, DOI 10.2527/jas.2008-1214; Sasaki Y, 2011, J SWINE HEALTH PROD, V19, P284; Thomsen H, 2004, J ANIM SCI, V82, P2213; Engblom L, 2007, LIVEST SCI, V106, P76, DOI 10.1016/j.livsci.2006.07.002; Littell RC, 2006, SAS SYSTEM MIXED MOD	6	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-4747	1573-7438		TROP ANIM HEALTH PRO	Trop. Anim. Health Prod.	FEB	2015	47	2					479	482		10.1007/s11250-014-0739-6		4	Agriculture, Dairy & Animal Science; Veterinary Sciences	Agriculture; Veterinary Sciences	CA3FU	WOS:000348792800030		
J	Nakadate, K; Motojima, K; Tanaka-Nakadate, S				Nakadate, Kazuhiko; Motojima, Kento; Tanaka-Nakadate, Sawako			Dilatation of Sinusoidal Capillary and Swelling of Sinusoidal Fenestration in Obesity: An Ultrastructural Study	ULTRASTRUCTURAL PATHOLOGY			English	Article						chronic obesity; nonalcoholic fatty liver disease; sinusoidal endothelium; monosodium glutamate; scanning electron microscopy	TYPE-2 DIABETIC-PATIENTS; FATTY LIVER-DISEASE; RAT-LIVER; DIFFERENTIATED MICRODOMAINS; LUMINAL SURFACE; ELECTRON-MICROSCOPY; METABOLIC SYNDROME; ANIONIC SITES; ENDOTHELIUM; HEPATOCYTES	Obesity, which is one of the causes of the lifestyle-related disease, is a hepatopathic exacerbation factor that causes a chronic hepatic disorder. In this study, we examined the pathological changes in the liver in mice with obesity induced by monosodium glutamate administration. Pathological analysis revealed the deposition of many lipid droplets in hepatocytes and sinusoidal dilatation in obese mice. Scanning electron microscopic analysis revealed the presence of sinusoidal dilatation, and the fenestrations of the sinusoid were significantly swollen in obese mice. These results suggest that a dysfunction of the sinusoidal endothelium occurs in chronic obesity.	[Nakadate, Kazuhiko] Meiji Pharmaceut Univ, Dept Basic Biol, Educ & Res Ctr Pharm, Tokyo 2048588, Japan; [Motojima, Kento] Meiji Pharmaceut Univ, Fac Pharmaceut Sci, Tokyo 2048588, Japan; [Tanaka-Nakadate, Sawako] Dokkyo Med Univ, Sch Med, Dept Pharmacol & Toxicol, Shimotsuga, Tochigi, Japan	Nakadate, K (reprint author), Meiji Pharmaceut Univ, Dept Basic Biol, Educ & Res Ctr Pharm, 2-522-1 Noshio, Tokyo 2048588, Japan.	nakadate@my-pharm.ac.jp					Sarafidis PA, 2006, J HYPERTENS, V24, P621, DOI 10.1097/01.hjh.0000217840.26971.b6; DAN C, 1985, EXP CELL RES, V158, P75, DOI 10.1016/0014-4827(85)90432-X; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Straub AC, 2007, HEPATOLOGY, V45, P205, DOI 10.1002/hep.21444; NAITO M, 1978, CELL TISSUE RES, V190, P371; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Connolly MK, 2010, J IMMUNOL, V185, P2200, DOI 10.4049/jimmunol.1000332; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Mailloux R, 2007, CELL PHYSIOL BIOCHEM, V20, P627, DOI 10.1159/000107546; Caldwell SH, 2006, AM J GASTROENTEROL, V101, P1677, DOI 10.1111/j.1572-0241.2006.00627_8.x; BREWER DB, 1965, J PATHOL BACTERIOL, V90, P437, DOI 10.1002/path.1700900211; DeZanger R, 1982, SINUSOIDAL LIVER CEL, P69; FRASER R, 1978, ATHEROSCLEROSIS, V29, P113, DOI 10.1016/0021-9150(78)90001-1; FRASER R, 1980, BRIT J EXP PATHOL, V61, P222; Fraser R, 1982, CONNECTIVE TISSUE NO, P159; FRASER R, 1980, PATHOLOGY, V12, P371; Frenzel H, 1977, KUPFFER CELLS OTHER, P213; Nakadate K, 2014, YAKUGAKU ZASSHI, V134, P829, DOI 10.1248/yakushi.14-00025; NOPANITAYA W, 1975, EXP MOL PATHOL, V23, P441, DOI 10.1016/0014-4800(75)90036-2; NOPANITAYA W, 1976, BRIT J EXP PATHOL, V57, P604; ORCI L, 1971, J ULTRA MOL STRUCT R, V35, P1, DOI 10.1016/S0022-5320(71)80140-5; PALADE GF, 1981, BIORHEOLOGY, V18, P563; Portincasa Piero, 2005, Rom J Gastroenterol, V14, P43; SIMIONESCU M, 1981, J CELL BIOL, V90, P614, DOI 10.1083/jcb.90.3.614; SIMIONESCU N, 1981, J CELL BIOL, V90, P605, DOI 10.1083/jcb.90.3.605; WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4; WISSE E, 1983, SCAN ELECTRON MICROS, P1441; Wisse E, 1980, COMMUNICATIONS LIVER, P195	33	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0191-3123			ULTRASTRUCT PATHOL	Ultrastruct. Pathol.	FEB	2015	39	1					30	37		10.3109/01913123.2014.947010		8	Microscopy; Pathology	Microscopy; Pathology	CA4ZJ	WOS:000348916000005		
J	Miyauchi, Y; Okazoe, H; Okujyo, M; Inada, F; Kakehi, T; Kikuchi, H; Ichikawa, H; Arakawa, Y; Mori, Y; Kakehi, Y				Miyauchi, Yasuyuki; Okazoe, Homare; Okujyo, Makiko; Inada, Fumi; Kakehi, Takako; Kikuchi, Hiroshi; Ichikawa, Hirohisa; Arakawa, Yukako; Mori, Yoshihiro; Kakehi, Yoshiyuki			Effect of the Continuous Positive Airway Pressure on the Nocturnal Urine Volume or Night-time Frequency in Patients With Obstructive Sleep Apnea Syndrome	UROLOGY			English	Article							SEVERITY; ADULTS	OBJECTIVE To evaluate the effect of continuous positive airway pressure (CPAP) treatment on nocturnal urine volume, night-time urine frequency, and quality of life (QOL) in patients with obstructive sleep apnea syndrome (OSAS). METHODS Ninety-eight participants with suspicious diagnosis of OSAS were prospectively enrolled in this study. Before polysomnography, measurement of the International Prostate Symptom Score-QOL score, the Overactive Bladder Symptom score (OABSS), the International Consultation on Incontinence Modular Questionnaire-Nocturia QOL were carried out to evaluate the lower urinary tract symptoms. During polysomnography, nocturnal urine volume and night-time urine frequency were recorded, and the concentrations of electrolytes in urine were determined. OSAS was confirmed in 92 patients, and 63 patients started to undergo CPAP treatment. Change in lower urinary tract symptoms-related QOL was assessed 1 month after CPAP treatment in 51 patients. Additionally, urine was collected at the time of CPAP titration in 25 patients. RESULTS CPAP treatment significantly improved night-time frequency, which resulted in the improvement of total IPSS and QOL score. The night-time frequency questionnaire in OABSS similarly decreased, although total OABSS scores were not significantly improved. The International Consultation on Incontinence Modular Questionnaire-Nocturia QOL showed no significant changes after CPAP treatment. In addition to the night-time frequency, nocturnal urine volume and urine electrolyte contents significantly decreased after CPAP treatment. CONCLUSION CPAP treatment decreases night-time urine frequency by reducing nocturnal urine volume and improves QOL in OSAS patients. (C) 2015 Elsevier Inc.	KKR Takamatsu Hosp, Dept Urol, Takamatsu, Kagawa, Japan; KKR Takamatsu Hosp, Dept Clin Res, Takamatsu, Kagawa, Japan; KKR Takamatsu Hosp, Dept Internal Med, Takamatsu, Kagawa, Japan; Kagawa Univ, Fac Med, Dept Urol, Takamatsu, Kagawa 760, Japan	Kakehi, Y (reprint author), Kagawa Univ, Fac Med, Dept Urol, 1750-1 Ikenobe,Miki Cho, Miki, Kagawa 7610793, Japan.	kakehi@med.kagawa-u.ac.jp					Flemons WW, 1999, SLEEP, V22, P667; Kaynak H, 2004, J SLEEP RES, V13, P173, DOI 10.1111/j.1365-2869.2004.00400.x; Umlauf MG, 2004, SLEEP, V27, P139; FitzGerald MP, 2006, AM J OBSTET GYNECOL, V194, P1399, DOI 10.1016/j.ajog.2006.01.048; Cruz IAC, 2012, SLEEP BREATH, V16, P361, DOI 10.1007/s11325-011-0502-4; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Kiely JL, 1999, EUR RESPIR J, V13, P1086, DOI 10.1034/j.1399-3003.1999.13e24.x; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Homma Y, 2006, UROLOGY, V68, P560, DOI 10.1016/j.urology.2006.03.035; Gulur DM, 2011, BJU INT, V107, P702, DOI 10.1111/j.1464-410X.2010.09763.x; Oztura I, 2006, SLEEP MED, V7, P362, DOI 10.1016/j.sleep.2005.10.004; Margel D, 2006, UROLOGY, V67, P974, DOI 10.1016/j.urology.2005.11.054; Guilleminault C, 2004, J PSYCHOSOM RES, V56, P511, DOI 10.1016/S0022-3999(04)00021-2; Chasens ER, 2003, GERIATR NURS, V24, P76, DOI 10.1067/mgn.2003.27; Homma Yukio, 2002, Nihon Hinyokika Gakkai Zasshi, V93, P669; Masaki Yoshida, 2010, JPN J UROL SURG, V23, P833; Umlauf M, 1999, Ostomy Wound Manage, V45, P52	17	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	FEB	2015	85	2					333	336		10.1016/j.urology.2014.11.002		4	Urology & Nephrology	Urology & Nephrology	AZ9UN	WOS:000348562200017		
J	Yamamoto, S; Masuda, H; Urakami, S; Fujii, Y; Sakamoto, K; Kozuka, T; Oguchi, M; Fukui, I; Yonese, J				Yamamoto, Shinya; Masuda, Hitoshi; Urakami, Shinji; Fujii, Yasuhisa; Sakamoto, Kimihiko; Kozuka, Takuyo; Oguchi, Masahiko; Fukui, Iwao; Yonese, Junji			Patient-perceived Satisfaction After Definitive Treatment for Men With High-risk Prostate Cancer: Radical Prostatectomy vs Intensity-modulated Radiotherapy With Androgen Deprivation Therapy	UROLOGY			English	Article							QUALITY-OF-LIFE; INDEX COMPOSITE; JAPANESE MEN; STRATIFICATION	OBJECTIVE To assess the change in disease-specific health-related quality of life and to evaluate patient-perceived satisfaction after radical prostatectomy (RP) or intensity-modulated radiotherapy (IMRT) with androgen deprivation therapy (ADT) for patients with high-risk prostate cancer (PCA) that has been defined by the European Association of Urology guideline. METHODS Between 2006 and 2010, 150 patients with high-risk PCA who underwent either RP (n = 97) or IMRT with ADT (n - 53) were enrolled in this prospective health-related quality of life study. Disease-specific health-related quality of life at baseline, 3, 6, 12, and 24 months and patient-perceived satisfaction at 12 and 24 months after these treatments were estimated using the Expanded Prostate Cancer Index Composite. RESULTS Urinary bother and irritation and obstruction scores did not change significantly between both treatment groups throughout the 2-year follow-up. ADT greatly influenced sexual and hormonal functions and bothers in patients who received IMRT with ADT. The patient-perceived satisfaction at 12 months after the treatments was approximately 80% in both treatment groups, and there was no significant difference between the 2 groups. At 12 months after the treatments, urinary function (P = .001) was identified as the most significant predictor of patient-perceived satisfaction, although it was not associated with the treatment type. CONCLUSION The majority of patients with high-risk PCA who received RP or IMRT with ADT reported high patient-perceived satisfaction after the treatments. This study showed that improvement in urinary function might contribute to patient-perceived satisfaction after the treatments. (C) 2015 Elsevier Inc.	Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo 1358550, Japan; Osaka Cent Hosp, Dept Gynecol, Osaka, Japan; Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo 1358550, Japan	Yamamoto, S (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	shinya.yamamoto@jfcr.or.jp					Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Sugimoto M, 2008, INT J UROL, V15, P524, DOI 10.1111/j.1442-2042.2008.02046.x; Arcangeli G, 2009, INT J RADIAT ONCOL, V75, P975, DOI 10.1016/j.ijrobp.2008.12.045; Namiki S, 2011, J SEX MED, V8, P2625, DOI 10.1111/j.1743-6109.2011.02362.x; Fransson P, 2009, LANCET ONCOL, V10, P370, DOI 10.1016/S1470-2045(09)70027-0; Boorjian SA, 2011, CANCER-AM CANCER SOC, V117, P2883, DOI 10.1002/cncr.25900; Yamamoto S, 2012, JPN J CLIN ONCOL, V42, P541, DOI 10.1093/jjco/hys043; [Anonymous], 2014, NCCN CLIN PRACTICE G; Heidenreich A, 2013, EAU GUIDELINES PROST; Kakehi Y, 2007, J UROLOGY, V177, P1856, DOI 10.1016/j.juro.2007.01.066; Kim JH, 2013, PROSTATE CANCER P D, V16, P341, DOI 10.1038/pcan.2013.24; Miwa Sotaro, 2013, Prostate Int, V1, P117, DOI 10.12954/PI.13021; Namiki S, 2010, INT J UROL, V17, P125, DOI 10.1111/j.1442-2042.2009.02437.x; Quon H, 2012, INT J RADIAT ONCOL, V83, P617, DOI 10.1016/j.ijrobp.2011.07.005; Schroeck FR, 2011, EUR UROL, V59, P785; Takizawa I, 2009, ASIAN J ANDROL, V11, P283, DOI 10.1038/aja.2009.10; Yamamoto S, 2014, QUAL LIFE RES, V23, P1641, DOI 10.1007/s11136-013-0603-6	18	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	FEB	2015	85	2					407	413		10.1016/j.urology.2014.09.046		7	Urology & Nephrology	Urology & Nephrology	AZ9UN	WOS:000348562200036		
J	Yamamoto, S				Yamamoto, Shinya			Patient-perceived Satisfaction After Definitive Treatment for Men With High-risk Prostate Cancer: Radical Prostatectomy vs Intensity-modulated Radiotherapy With Androgen Deprivation Therapy COMMENT	UROLOGY			English	Editorial Material									Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan	Yamamoto, S (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan.						Ablin RJ, 2014, THE GREAT PROSTATE H, P262; Basch E, 2014, J CLIN ONCOL, V32, P3436, DOI 10.1200/JCO.2013.54.8404; Bennett CL, 2012, ARCH INTERN MED, V172, P311, DOI 10.1001/archinternmed.2011.2246; Hermanson T, 2014, J CLIN ONCOL, V32, P3591, DOI 10.1200/JCO.2014.57.2404; Hermanson T, 2015, UROLOGY, V85, P407; Namiki S, 2008, J UROLOGY, V179, P245, DOI 10.1016/j.juro.2007.08.164; Nebeker JR, 2005, CANCER, V104, P2289, DOI 10.1002/cncr.21445; Yamamoto S, 2015, UROLOGY, V85, P407, DOI 10.1016/j.urology.2014.09.046	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	FEB	2015	85	2					413	414		10.1016/j.urology.2014.09.051		2	Urology & Nephrology	Urology & Nephrology	AZ9UN	WOS:000348562200037		
J	Hashimoto, K; Mizuno, T; Kitamura, H; Shindo, T; Takahashi, S; Masumori, N				Hashimoto, Kohei; Mizuno, Takahiro; Kitamura, Hiroshi; Shindo, Tetsuya; Takahashi, Satoshi; Masumori, Naoya			The Primary Local Stage at Diagnosis Predicts Regional Symptoms Caused by Local Progression in Patients With Castration-resistant Prostate Cancer	UROLOGY			English	Article							URETERAL OBSTRUCTION; RADICAL PROSTATECTOMY; ANDROGEN DEPRIVATION; RADIATION-THERAPY; MANAGEMENT; STATISTICS; EXPERIENCE; STENTS	OBJECTIVE To identify the characteristics that predict occurrence of local progression-related events (LPREs) in patients with castration-resistant prostate cancer (CRPC) to adjust its management. METHODS We retrospectively reviewed the medical records of 39 patients with CRPC. LPREs were defined as regional symptoms caused by local progression and categorized into urinary events and rectal events. Urinary events were defined as ureteral obstruction, acute urinary retention, or hematuria requiring treatment, and rectal events were rectal obstruction or rectal bleeding caused by tumor invasion. RESULTS The median prostate-specific antigen level at diagnosis was 185 ng/mL. During the median follow-up period of 4.4 years, 10 patients (25.6%) had LPREs. Urinary events were observed in 8 patients (20.5%) and rectal events in 2 (5.1%). The proportion of T4 in patients with LPREs was higher than in those without LPREs (70.0% vs 10.3%; P <. 001). Stage T4 at diagnosis was an independent factor to predict LPREs in multivariate analysis (hazard ratio, 8.62; P =.004). The 5-year cumulative incidence of LPREs in patients with stage T4 was 70.0%, whereas in those with stage <= T3, they were 3.6% (P <. 001). CONCLUSION Patients with stage T4 at diagnosis are more likely to have a risk of LPREs than those with stage <= T3. These results indicate that patients with locally advanced prostate cancer on androgen deprivation therapy need to be closely monitored for early diagnosis of CRPC and treated with the appropriate intervention for LPREs at the appropriate time. (C) 2015 Elsevier Inc.	[Hashimoto, Kohei; Mizuno, Takahiro; Kitamura, Hiroshi; Shindo, Tetsuya; Takahashi, Satoshi; Masumori, Naoya] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608543, Japan	Masumori, N (reprint author), Sapporo Med Univ, Sch Med, Dept Urol, Chuo Ku, S1,W16, Sapporo, Hokkaido 0608543, Japan.	masumori@sapmed.ac.jp					Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Ganatra AM, 2005, J UROLOGY, V174, P2125, DOI 10.1097/01.ju.0000181807.56114.b7; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; CHIOU RK, 1990, J UROLOGY, V143, P957; Chung SY, 2004, J UROLOGY, V172, P592, DOI 10.1097/01.ju.0000130510.28768.f5; STEINBERG GD, 1990, J UROLOGY, V144, P1425; Arai Y, 1996, EUR UROL, V29, P331; Colombel M, 1997, EUR UROL, V31, P21; Crain DS, 2004, J UROLOGY, V171, P668, DOI 10.1097/01.ju.0000104845.24632.92; Din OS, 2009, RADIOTHER ONCOL, V93, P192, DOI 10.1016/j.radonc.2009.04.017; Fine JP, 1999, J AM STAT ASSOC, V94, P456; Fowler JE, 2002, J UROLOGY, V168, P546, DOI 10.1016/S0022-5347(05)64676-9; Furuya Y, 1999, INT J UROL, V6, P187, DOI 10.1046/j.1442-2042.1999.06442.x; Grimm MO, 2002, EUR UROL, V41, P628, DOI 10.1016/S0302-2838(02)00134-3; Hindson B, 2007, AUSTRALAS RADIOL, V51, P584, DOI 10.1111/j.1440-1673.2007.01897.x; Kamiyama Y, 2011, INT J UROL, V18, P379, DOI 10.1111/j.1442-2042.2011.02731.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawakami S, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1681; Oefelein MG, 2004, UROLOGY, V63, P1117, DOI 10.1016/j.urology.2004.01.026; PAUL AB, 1994, BRIT J UROL, V74, P642, DOI 10.1111/j.1464-410X.1994.tb09198.x; Schmeller N, 1997, BRIT J UROL, V79, P226, DOI 10.1046/j.1464-410X.1997.33215.x; Won AC, 2013, BJU INT, V112, P250	25	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	FEB	2015	85	2					430	434		10.1016/j.urology.2014.09.044		5	Urology & Nephrology	Urology & Nephrology	AZ9UN	WOS:000348562200042		
J	Oi, M; Tsuchiya, H; Matsumoto, J; Nogami, S				Oi, Masaaki; Tsuchiya, Hisashi; Matsumoto, Jun; Nogami, Sadao			Dog biting louse (Trichodectes canis) infestation in raccoon dogs (Nyctereutes procyonoides viverrinus) in Japan	VETERINARY DERMATOLOGY			English	Letter									[Oi, Masaaki; Tsuchiya, Hisashi; Matsumoto, Jun; Nogami, Sadao] Nihon Univ, Dept Vet Med, Fujisawa, Kanagawa 2520880, Japan	Oi, M (reprint author), Nihon Univ, Dept Vet Med, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	brma12501@g.nihon-u.ac.jp					Anadon A, 2012, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 2ND EDITION, P604, DOI 10.1016/B978-0-12-385926-6.00050-8; Badr V, 2005, EUR J WILDLIFE RES, V51, P133, DOI 10.1007/s10344-005-0084-1; Gwaltney-Brant SM, 2012, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 2ND EDITION, P609, DOI 10.1016/B978-0-12-385926-6.00051-X; Paterson S, 2008, MANUAL SKIN DIS DOG, P126; SCHWARTZ CC, 1983, J WILDLIFE DIS, V19, P372	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-4493	1365-3164		VET DERMATOL	Vet. Dermatol.	FEB	2015	26	1					70	71		10.1111/vde.12187		2	Dermatology; Veterinary Sciences	Dermatology; Veterinary Sciences	CA4DN	WOS:000348854600017		
J	Moritani, S; Ichihara, S; Yatabe, Y; Hasegawa, M; Iwakoshi, A; Hosoda, W; Narita, M; Nagai, Y; Asai, M; Ujihira, N; Yuba, Y; Jijiwa, M				Moritani, Suzuko; Ichihara, Shu; Yatabe, Yasushi; Hasegawa, Masaki; Iwakoshi, Akari; Hosoda, Waki; Narita, Michihiko; Nagai, Yuichiro; Asai, Masami; Ujihira, Nobuko; Yuba, Yoshiaki; Jijiwa, Mayumi			Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins	VIRCHOWS ARCHIV			English	Article						Adenomyoepithelioma; Myoepithelial cells; Immunohistochemistry; Cytokeratin 5/6; Cytokeratin 14; Paradoxical staining pattern	OF-THE-LITERATURE; MALIGNANT ADENOMYOEPITHELIOMA; PHENOTYPIC ALTERATIONS; PLEOMORPHIC ADENOMA; CELLS; BENIGN; P63; CARCINOMA; LESIONS; TISSUE	To determine which immunohistochemical markers are useful for the identification of neoplastic myoepithelial cells in adenomyoepithelioma of the breast, the expression of seven myoepithelial markers (alpha-smooth muscle actin (alpha-SMA), calponin, p63, CD10, cytokeratin 5/6, cytokeratin 14, and S-100) was examined in 19 lesions from 16 patients. The lesion consisted of seven spindle and 12 clear cell lesions. For normal myoepithelial cells, alpha-SMA, calponin, and p63 were significantly more sensitive than cytokeratin 5/6, cytokeratin 14, and S-100. There was no significant difference in the expression of alpha-SMA, calponin, p63, and CD10 in neoplastic myoepithelial cells of adenomyoepithelioma regardless of spindle or clear cell types. In spindle cell lesions, high-molecular weight cytokeratins (HMWCK; cytokeratin 5/6 and cytokeratin 14) tended to show higher staining scores and S-100 showed lower staining scores than other markers. In clear cell lesions, HMWCK showed significantly lower staining scores than the other five markers. There was no significant difference in staining scores among the other five markers. HMWCK showed a unique paradoxical staining pattern in clear cell lesions, with diffusely positive inner epithelial cells and completely negative outer myoepithelial cells. Although the sensitivity of HMWCK in clear cell lesions is low, with this unique paradoxical staining pattern and relatively high sensitivity in spindle cell lesions, HMWCK could be useful in diagnosing adenomyoepithelioma. In choosing immunohistochemical markers, any of the seven markers are useful, but combining HMWCK and any one of alpha-SMA, calponin, and p63 would be a good panel for the diagnosis of adenomyoepithelioma.	[Moritani, Suzuko; Ichihara, Shu; Hasegawa, Masaki; Iwakoshi, Akari] Nagoya Med Ctr, Div Pathol, Dept Adv Diag, Naka Ku, Nagoya, Aichi 4600001, Japan; [Yatabe, Yasushi; Hosoda, Waki] Aichi Canc Ctr, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan; [Narita, Michihiko] Toyota Kosei Hosp, Dept Pathol, Toyota, Japan; [Nagai, Yuichiro] Chiba Med Ctr, Dept Pathol, Chiba, Japan; [Asai, Masami] Nagoya Kyoritu Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Ujihira, Nobuko] Nagoya Ekisaikai Hosp, Dept Clin Pathol, Nagoya, Aichi, Japan; [Yuba, Yoshiaki] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Pathol, Osaka, Japan; [Jijiwa, Mayumi] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA	Moritani, S (reprint author), Nagoya Med Ctr, Div Pathol, Dept Adv Diag, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan.	MoritaniS@aol.com					Ahmed AA, 2000, ARCH PATHOL LAB MED, V124, P632; Hilson JB, 2009, AM J SURG PATHOL, V33, P227, DOI 10.1097/PAS.0b013e318180431d; Boecker W, 2013, MODERN PATHOL, V26, P1086, DOI 10.1038/modpathol.2013.45; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Clarke CL, 2004, J PATHOL, V204, P147, DOI 10.1002/path.1647; TAVASSOLI FA, 1991, AM J SURG PATHOL, V15, P554, DOI 10.1097/00000478-199106000-00004; Popnikolov NK, 2003, AM J CLIN PATHOL, V120, P161, DOI 10.1039/G6CTR8MDTFUW19XV; Otterbach F, 2000, HISTOPATHOLOGY, V37, P232, DOI 10.1046/j.1365-2559.2000.00882.x; Hungermann D, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-92; Dewar R, 2011, ARCH PATHOL LAB MED, V135, P422, DOI 10.1043/2010-0336-CP.1; LOOSE JH, 1992, AM J SURG PATHOL, V16, P868, DOI 10.1097/00000478-199209000-00005; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Hayes MM, 2011, J CLIN PATHOL, V64, P477, DOI 10.1136/jcp.2010.087718; Reis JS, 2002, ADV ANAT PATHOL, V9, P280, DOI 10.1097/00125480-200209000-00002; Hilson JB, 2010, AM J SURG PATHOL, V34, P896, DOI 10.1097/PAS.0b013e3181dd60d3; CAMERON HM, 1974, J PATHOL, V114, P89, DOI 10.1002/path.1711140206; Catena F, 2008, BREAST CARE, V3, P125, DOI 10.1159/000119727; Choi Jin Sub, 1996, Yonsei Medical Journal, V37, P284; DIAZ NM, 1991, HUM PATHOL, V22, P1206, DOI 10.1016/0046-8177(91)90102-U; Dorpe JV, 1998, VIRCHOWS ARCH, V432, P119; GILLETT CE, 1990, J PATHOL, V160, P19, DOI 10.1002/path.1711600106; Hamperl H, 1970, Curr Top Pathol, V53, P161; HARTZ PH, 1946, AM J CLIN PATHOL, V16, P385; KIAER H, 1984, VIRCHOWS ARCH A, V405, P55, DOI 10.1007/BF00694925; Lakhani SR, 2012, WHO CLASSIFICATION T, P122; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; McLaren BK, 2005, AM J SURG PATHOL, V29, P1294, DOI 10.1097/01.pas.0000164615.38200.86; Moritani S, 2002, MODERN PATHOL, V15, P397, DOI 10.1038/modpathol.3880536; MUKAI K, 1981, AM J SURG PATHOL, V5, P91, DOI 10.1097/00000478-198101000-00013; Nadelman CM, 2006, ARCH PATHOL LAB MED, V130, P1349; NAKAJIMA T, 1982, AM J SURG PATHOL, V6, P715, DOI 10.1097/00000478-198212000-00003; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Rasbridge SA, 1998, VIRCHOWS ARCH, V432, P123, DOI 10.1007/s004280050145; Reis JS, 2003, VIRCHOWS ARCH, V443, P122, DOI 10.1007/s00428-003-0859-2; ROSEN PP, 1987, HUM PATHOL, V18, P1232; Sato K, 2005, PATHOL RES PRACT, V201, P333, DOI 10.1016/j.prp.2005.03.004; Su L, 1996, HUM PATHOL, V27, P800, DOI 10.1016/S0046-8177(96)90452-9; WEIDNER N, 1988, CANCER, V62, P1561, DOI 10.1002/1097-0142(19881015)62:8<1561::AID-CNCR2820620817>3.0.CO;2-Z; ZARBO RJ, 1983, AM J SURG PATHOL, V7, P863, DOI 10.1097/00000478-198307080-00014	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0945-6317	1432-2307		VIRCHOWS ARCH	Virchows Arch.	FEB	2015	466	2					191	198		10.1007/s00428-014-1687-2		8	Pathology	Pathology	CB1HK	WOS:000349377800010		
J	Euanorasetr, J; Intra, B; Mongkol, P; Chankhamhaengdecha, S; Tuchinda, P; Mori, M; Shiomi, K; Nihira, T; Panbangred, W				Euanorasetr, Jirayut; Intra, Bungonsiri; Mongkol, Phayungsak; Chankhamhaengdecha, Surang; Tuchinda, Patoomratana; Mori, Mihoko; Shiomi, Kazuro; Nihira, Takuya; Panbangred, Watanalai			Spirotetronate antibiotics with anti-Clostridium activity from Actinomadura sp 2EPS	WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Actinomadura; Actinomycetes; Clostridium; Secondary metabolites; Spirotetronate antibiotics	BIOLOGICAL-ACTIVITIES; SP MK73-NF4; SP-NOV.; SOIL; FERMENTATION; DIFFICILE; MICROMONOSPORA; DECATROMICINS; BIOSYNTHESIS; EVOLUTION	The rare actinomycetes strain 2EPS was isolated from soil and analysis of cultural, morphological characteristics, diaminopimelic acid content of its cell wall, and 16S rRNA gene sequence indicates that 2EPS belongs to genus Actinomadura. In addition, neighbor-joining phylogenetic tree also confirmed the relationships of this strain to other members of Actinomadura. A butanol extract with antibacterial activity was purified by reversed-phase chromatography to obtain three bioactive compounds, designated as compounds 1, 2 and 3. The structures of these compounds were determined using spectroscopic analysis (H-1-NMR and C-13-NMR) and mass spectrometric analysis (HR-TOF-MS). Compounds 1-3 were identified and found to be the same as those included in the Japanese patent number JP 09227587 for spirotetronate antibiotics and are BE-45722A (1), BE-45722B (2) and BE-45722C (3), respectively. All compounds were active against Gram-positive bacteria (Staphylococcus aureus ATCC 25923, Bacillus cereus ATCC 14579, and B. subtilis ATCC 6633) with low MIC values between 0.08 and 5.0 A mu g/ml. Moreover, both 1 and 3 also exhibited strong activity, with similar MIC values, against Clostridium perfringens S107 at 0.63 A mu g/ml and C. difficile 630 at 0.08 A mu g/ml. These results suggest the identified spirotetronate compounds may have potential in the treatment of Clostridium infections. Overall, this analysis demonstrates that rare actinomycetes are a promising source for discovery of antimicrobial compounds.	[Euanorasetr, Jirayut; Intra, Bungonsiri; Panbangred, Watanalai] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Euanorasetr, Jirayut; Intra, Bungonsiri; Nihira, Takuya; Panbangred, Watanalai] Mahidol Univ, Mahidol Univ Osaka Univ Collaborat Res Ctr Biosci, Fac Sci, Bangkok 10400, Thailand; [Mongkol, Phayungsak; Chankhamhaengdecha, Surang] Mahidol Univ, Dept Biol, Fac Sci, Bangkok 10400, Thailand; [Tuchinda, Patoomratana] Mahidol Univ, Dept Chem, Fac Sci, Bangkok 10400, Thailand; [Mori, Mihoko; Shiomi, Kazuro] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan; [Mori, Mihoko; Shiomi, Kazuro] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo, Japan; [Nihira, Takuya] Osaka Univ, Int Ctr Biotechnol, Osaka, Japan	Panbangred, W (reprint author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	watanalai.pan@mahidol.ac.th			Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [Ph.D/0103/2552]; Japan Student Services Organization (JASSO)	This study was supported by Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. Ph.D/0103/2552) to JE and WP and by the scholarship from the Japan Student Services Organization (JASSO) to JE. We are grateful to Dr. Laran T. Jensen (Department of Biochemistry, Faculty of Science, Mahidol University) for critically proofreading of the manuscript.	Akama S, 1998, Japan Patent JP, Patent No. 10273497; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Momose I, 1999, J ANTIBIOT, V52, P787; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; BECKER B, 1965, APPL MICROBIOL, V13, P236; HAYAKAWA M, 1991, J FERMENT BIOENG, V72, P320, DOI 10.1016/0922-338X(91)90080-Z; Grass JE, 2013, FOODBORNE PATHOG DIS, V10, P131, DOI 10.1089/fpd.2012.1316; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Senesi S, 2010, TOXINS, V2, P1690, DOI 10.3390/toxins2071690; WAITZ JA, 1981, J ANTIBIOT, V34, P1101; Berdy J, 2005, J ANTIBIOT, V58, P1; Tajima K, 2001, INT J SYST EVOL MICR, V51, P1765; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Mathur H, 2013, ANTIMICROB AGENTS CH, V57, P2882, DOI 10.1128/AAC.00261-13; TOMITA F, 1980, J ANTIBIOT, V33, P940; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI 10.1038/ja.2012.27; Bartlett JG, 2010, ANN NY ACAD SCI, V1213, P62, DOI 10.1111/j.1749-6632.2010.05863.x; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Chankhamhaengdecha S, 2013, BIOMED RES INT, V2013, P1; Cook AE, 2005, INT J SYST EVOL MICR, V55, P703, DOI 10.1099/ijs.0.63359-0; Kelly Ciarán P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Lam KS, 1996, J ANTIBIOT, V49, P860; LECHEVALIER H. A., 1970, The Actinomycetales. The Jena International Symposium on Taxonomy, September 1968., P393; LECHEVALIER M P, 1970, International Journal of Systematic Bacteriology, V20, P435; Lee SD, 2012, INT J SYST EVOL MICR, V62, P990, DOI 10.1099/ijs.0.035121-0; Mazzetti C, 2012, J NAT PROD, V75, P1044, DOI 10.1021/np300003n; Miyadoh S, 1993, ACTINOMYCETOLOGICA, V9, P100, DOI DOI 10.3209/SAJ.7_100; Momose I, 1999, J ANTIBIOT, V52, P781; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Sripreechasak P, 2013, J ANTIBIOT, V66, P79, DOI 10.1038/ja.2012.96; Tao WX, 2013, SCI CHINA CHEM, V56, P1364, DOI 10.1007/s11426-013-4921-x; Torigoe K, 1997, Japan Patent, Patent No. [JP 09227587, 09227587]; Trujillo ME, 2012, BERGYS MANUAL SYST B, V5, P1940; Walsh C., 2003, ANTIBIOTICS ACTION O; Zhi X-Y, 2001, INT J SYST EVOL MICR, V51, P373	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0959-3993	1573-0972		WORLD J MICROB BIOT	World J. Microbiol. Biotechnol.	FEB	2015	31	2					391	398		10.1007/s11274-014-1792-z		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CA6HE	WOS:000349010800015		
J	Kaneko, K; Tsuji, S; Kimata, T; Kitao, T; Yamanouchi, S; Kato, S				Kaneko, Kazunari; Tsuji, Shoji; Kimata, Takahisa; Kitao, Tetsuya; Yamanouchi, Sohsaku; Kato, Shogo			Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes	WORLD JOURNAL OF PEDIATRICS			English	Article						angiopoietin-like 4; CD80; cytokine; minimal change nephrotic syndrome; podocyte	MINIMAL-CHANGE DISEASE; NECROSIS-FACTOR-ALPHA; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PROTEINURIC KIDNEY-DISEASE; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; URINARY CD80; ACTIN CYTOSKELETON; HEAVY PROTEINURIA; TH1/TH2 BALANCE	Background: Nephrotic syndrome is the most common cause of kidney disease in children, but its pathogenesis remains unclear. This article reviews the novel aspects of the mechanisms underlying massive proteinuria in minimal-change disease, which is the most common form of childhood nephrotic syndrome. Data sources: This article integrates the findings of a PubMed database search for English language articles published in the past 40 years (from September 1974 to February 2014) using the key words "pathogenesis", "minimal change nephrotic syndrome" or "idiopathic nephrotic syndrome". Results: Unknown humoral factors associated with T-cell dysfunction have been thought to play an important role in the pathogenesis of minimal-change disease. However, recent findings are changing this paradigm, i.e., visceral glomerular epithelial cells (podocytes) may be involved via expression of molecules such as CD80 and angiopoietin-like 4. Conclusions: Recent evidence suggests that minimal-change disease results from interactions between humoral factors and dysfunctional podocytes. In addition to immunosuppressant drugs that target lymphocytes, a biological agent such as an antibody against the abnormal molecule(s) expressed by podocytes may provide novel drug treatment for minimal-change disease.	[Kaneko, Kazunari; Tsuji, Shoji; Kimata, Takahisa; Kitao, Tetsuya; Yamanouchi, Sohsaku; Kato, Shogo] Kansai Med Univ, Dept Pediat, Hirakata, Osaka 5731010, Japan	Kaneko, K (reprint author), Kansai Med Univ, Dept Pediat, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	kanekok@hirakata.kmu.ac.jp			Mami Mizutani Foundation	The study from our institution cited in the text was partly supported by the Mami Mizutani Foundation.	Ahmad H, 2000, NEPHRON, V84, P342, DOI 10.1159/000045609; Alachkar N, 2014, NEW ENGL J MED, V370, P1263, DOI 10.1056/NEJMc1400502#SA2; ALI AA, 1994, TRANSPLANTATION, V58, P849; Alwadhi RK, 2004, J PAEDIATR CHILD H, V40, P28, DOI 10.1111/j.1440-1754.2004.00285.x; MUNDEL P, 1991, J HISTOCHEM CYTOCHEM, V39, P1047; Araya CE, 2006, PEDIATR NEPHROL, V21, P603, DOI 10.1007/s00467-006-0026-5; Liu LL, 2011, CLIN IMMUNOL, V139, P314, DOI 10.1016/j.clim.2011.02.018; Shimada M, 2011, PEDIATR NEPHROL, V26, P645, DOI 10.1007/s00467-010-1676-x; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655; Buscher AK, 2010, CLIN J AM SOC NEPHRO, V5, P2075, DOI 10.2215/CJN.01190210; Cutolo M, 2013, AUTOIMMUN REV, V12, P758, DOI 10.1016/j.autrev.2013.01.001; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Regele HM, 2000, J AM SOC NEPHROL, V11, P403; BUSTOS C, 1994, EUR J CLIN INVEST, V24, P799, DOI 10.1111/j.1365-2362.1994.tb02022.x; Benigni A, 2014, NEW ENGL J MED, V370, P1261, DOI 10.1056/NEJMc1400502#SA1; Raveh D, 2004, PEDIATR NEPHROL, V19, P1281, DOI 10.1007/s00467-004-1573-2; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Ikeuchi Y, 2009, PEDIATR NEPHROL, V24, P489, DOI 10.1007/s00467-008-1003-y; Matsumoto K, 1999, CLIN EXP IMMUNOL, V117, P361, DOI 10.1046/j.1365-2249.1999.00975.x; Ishimoto T, 2013, NEPHROL DIAL TRANSPL, V28, P1439, DOI 10.1093/ndt/gfs543; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; SHALHOUB RJ, 1974, LANCET, V2, P556; Garin EH, 2010, KIDNEY INT, V78, P296, DOI 10.1038/ki.2010.143; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lennon R, 2008, J AM SOC NEPHROL, V19, P2140, DOI 10.1681/ASN.2007080940; Hussain S, 2009, J AM SOC NEPHROL, V20, P1733, DOI 10.1681/ASN.2008111219; KIMATA H, 1995, EUR J IMMUNOL, V25, P1497, DOI 10.1002/eji.1830250604; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; SURANYI MG, 1993, AM J KIDNEY DIS, V21, P251; Sahali D, 2001, J AM SOC NEPHROL, V12, P1648; Jalanko H, 2009, PEDIATR NEPHROL, V24, P2121, DOI 10.1007/s00467-007-0633-9; Araya C, 2009, PEDIATR NEPHROL, V24, P1691, DOI 10.1007/s00467-009-1214-x; Eddy AA, 2003, LANCET, V362, P629, DOI 10.1016/S0140-6736(03)14184-0; Wernerson A, 2003, NEPHROL DIAL TRANSPL, V18, P70, DOI 10.1093/ndt/18.1.70; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Tryggvason K, 2001, CURR OPIN NEPHROL HY, V10, P543, DOI 10.1097/00041552-200107000-00009; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; ADLER S, 1992, AM J PATHOL, V141, P571; Garin EH, 2009, J AM SOC NEPHROL, V20, P260, DOI 10.1681/ASN.2007080836; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572; NEUHAUS TJ, 1995, CLIN EXP IMMUNOL, V100, P475; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Kobayashi T, 2006, CLIN NEPHROL, V65, P423; SAXENA S, 1993, NEPHRON, V65, P56; Assadi F, 2011, PEDIATR NEPHROL, V26, P469, DOI 10.1007/s00467-010-1700-1; Bagga A, 2007, NEW ENGL J MED, V356, P2751, DOI 10.1056/NEJMc063706; Bertelli R, 2010, CLIN EXP IMMUNOL, V161, P151, DOI 10.1111/j.1365-2249.2010.04160.x; Cara-Fuentes G, 2014, PEDIATR NEPHROL, V29, P1363, DOI 10.1007/s00467-013-2679-1; Chin G, 2005, NEPHROL DIAL TRANSPL, V20, P2824, DOI 10.1093/ndt/gfi180; Cho BS, 1999, PEDIATR NEPHROL, V13, P199; Cho MH, 2003, AM J NEPHROL, V23, P260, DOI 10.1159/000072065; Chugh SS, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00023; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Clement LC, 2014, NAT MED, V20, P37, DOI 10.1038/nm.3396; Daniel V, 1997, CLIN NEPHROL, V47, P289; Datta SK, 2009, NAT CLIN PRACT RHEUM, V5, P80, DOI 10.1038/ncprheum0983; Davin JC, 2011, INT J NEPHROL, V2011; Dotsch J, 2008, PEDIATR NEPHROL, V23, P3, DOI 10.1007/s00467-007-0596-x; Fornoni A, 2011, SCI TRANSL MED, V3, pra46; HARDWICKE J, 1959, LANCET, V1, P500; Hingorani SR, 2004, PEDIATR NEPHROL, V19, P300, DOI 10.1007/s00467-003-1346-3; HULTON SA, 1994, PEDIATR NEPHROL, V8, P135; Iharada A, 2009, PEDIATR NEPHROL, V24, P1033, DOI 10.1007/s00467-008-1092-7; Ishimoto T, 2013, PEDIATR NEPHROL, V28, P1803, DOI 10.1007/s00467-013-2498-4; Kanai T, 2010, CLIN EXP NEPHROL, V14, P578, DOI 10.1007/s10157-010-0330-z; Kaneko K., 2009, CURR PEDIAT REV, V5, P56; Kaneko K, 2002, CLIN NEPHROL, V58, P393; Kemper MJ, 2003, CLIN NEPHROL, V60, P242; Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group, 2012, KIDNEY INT S, V2, P163; Kimata T, 2013, AM J NEPHROL, V38, P483, DOI 10.1159/000356439; KOYAMA A, 1991, KIDNEY INT, V40, P453, DOI 10.1038/ki.1991.232; Laflam PF, 2006, PEDIATR NEPHROL, V21, P177, DOI 10.1007/s00467-005-2078-3; Lai KW, 2007, J AM SOC NEPHROL, V18, P1476, DOI 10.1681/ASN.2006070710; Lin Ching-Yuang, 2004, Acta Paediatrica Taiwanica, V45, P77; MANDREOLI M, 1992, CLIN NEPHROL, V37, P177; Matsumoto K, 2001, NEPHRON, V88, P334, DOI 10.1159/000046017; Matsumoto K, 2001, CLIN NEPHROL, V55, P269; MAUER SM, 1979, J PEDIATR-US, V95, P261; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; MEADOW SR, 1981, ARCH DIS CHILD, V56, P517; NEUHAUS TJ, 1994, ARCH DIS CHILD, V71, P522; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; Shimada M, 2012, NEPHROL DIAL TRANSPL, V27, P81, DOI 10.1093/ndt/gfr271; Shimo T, 2013, AM J NEPHROL, V37, P302, DOI 10.1159/000348803; Simic I, 2013, PEDIATR NEPHROL, V28, P2079, DOI 10.1007/s00467-012-2376-5; Spink C, 2013, NEPHROL DIAL TRANSPL, V28, P2800, DOI 10.1093/ndt/gft381; Stachowski J, 2000, PEDIATR NEPHROL, V14, P779; Tojo A, 2012, INT J NEPHROL, V2012, DOI DOI 10.1155/2012/481520.EPUB2012MAY20; van den Berg JG, 2004, CLIN SCI, V107, P125; WARSHAW BL, 1989, AM J CLIN PATHOL, V92, P68; Webb NJA, 1999, KIDNEY INT, V55, P1063, DOI 10.1046/j.1523-1755.1999.0550031063.x; WITTIG HJ, 1970, LANCET, V1, P542; Yap HK, 1999, J AM SOC NEPHROL, V10, P529; YOKOYAMA H, 1985, CLIN EXP IMMUNOL, V61, P601; Zhang SY, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000678	98	1	1	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	CHILDRENS HOSPITAL, 57 ZHUGAN XIANG, HANGZHOU, 310003, PEOPLES R CHINA	1708-8569	1867-0687		WORLD J PEDIATR	World Journal of Pediatrics	FEB	2015	11	1					21	28		10.1007/s12519-015-0003-9		8	Pediatrics	Pediatrics	CA8ON	WOS:000349180600004		
J	Sunagawa, M; Wolf-Johnston, A; Nomiya, M; Sawada, N; Andersson, KE; Hisamitsu, T; Birder, LA				Sunagawa, Masataka; Wolf-Johnston, Amanda; Nomiya, Masanori; Sawada, Norifumi; Andersson, Karl-Erik; Hisamitsu, Tadashi; Birder, Lori A.			Urinary bladder mucosal responses to ischemia	WORLD JOURNAL OF UROLOGY			English	Article						Urothelium; Lamina propria; Sensory; Barrier; Blood flow	TRACT SYMPTOMS; GAP-JUNCTIONS; RABBIT; RAT; OVERACTIVITY; ASSOCIATION; UROTHELIUM; EXPRESSION; CONNEXIN43; STRESS	The objectives of this study were to examine the expression of various cellular proteins within the urothelium (UT) and lamina propria (LP) following chronic bladder ischemia in the rat urinary bladder. Urinary bladders were removed from adult Sprague-Dawley rats 8 weeks after creation of bladder ischemia and from sham controls. Immunocytochemistry was used to examine distribution of LP-vimentin-immunoreactive (IR) cells and connexins (Cx26; Cx43), and western immunoblotting or ELISA for proteins involved in UT barrier and sensory functions. Ischemia was associated with a significant increase in LP-vimentin-IR cells and increased expression of the gap junction proteins Cx26 and Cx43 within the bladder UT as compared to sham control. Ischemia also resulted in an increased (p < 0.05) expression level of the junctional marker (ZO-1) and non-significantly increased expressions of the trophic factor nerve growth factor as well as norepinephrine. Our findings reveal that chronic ischemia alters a number of proteins within the UT and underlying LP. These proteins are involved in barrier function, remodeling, repair as well as intercellular communication. The increased expression of LP-vimentin-IR cells suggests that changes in cell-cell interactions could play a role in ischemia-induced changes in bladder activity.	[Sunagawa, Masataka; Wolf-Johnston, Amanda; Birder, Lori A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Sunagawa, Masataka; Hisamitsu, Tadashi] Showa Univ, Sch Med, Dept Physiol, Tokyo 1428555, Japan; [Nomiya, Masanori; Sawada, Norifumi; Andersson, Karl-Erik] Wake Forest Baptist Med Ctr, Inst Regenerat Med, Winston Salem, NC 27157 USA; [Birder, Lori A.] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Birder, Lori A.] Univ Pittsburgh, Sch Med, Dept Biol Chem, Pittsburgh, PA 15261 USA	Birder, LA (reprint author), Univ Pittsburgh, Sch Med, Dept Med, A 1217 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	lbirder@pitt.edu			NIH [R37 DK54824, R01 DK57284]	This work was supported by NIH grants R37 DK54824 and R01 DK57284 (LAB).	Andersson KE, 2014, NEUROUROL URODYNAM, V33, P9, DOI 10.1002/nau.22465; Ponholzer A, 2006, EUR UROL, V50, P581, DOI 10.1016/j.eururo.2006.01.031; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Gevaert T, 2011, J CELL MOL MED, V15, P2586, DOI 10.1111/j.1582-4934.2011.01262.x; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Ikeda Y, 2007, AM J PHYSIOL-RENAL, V293, pF1018, DOI 10.1152/ajprenal.00183.2007; Gosling JA, 2000, J UROLOGY, V163, P1349, DOI 10.1016/S0022-5347(05)67776-2; Bolt MW, 1997, ANAL BIOCHEM, V247, P185, DOI 10.1006/abio.1997.2061; Birder L, 2013, PHYSIOL REV, V93, P653, DOI 10.1152/physrev.00030.2012; Pinggera GM, 2008, BJU INT, V101, P319, DOI 10.1111/j.1464-410X.2007.07339.x; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; Azadzoi KM, 1999, J UROLOGY, V161, P1626, DOI 10.1016/S0022-5347(05)68995-1; Baskin RS, 1997, J UROLOGY, V157, P2388; Brading AF, 2004, SCAND J UROL NEPHROL, V38, P84, DOI 10.1080/03008880410015336; Cushing P, 2005, J NEUROSCI RES, V82, P788, DOI 10.1002/jnr.20689; HYPOLITE JA, 1993, MOL CELL BIOCHEM, V125, P35, DOI 10.1007/BF00926832; Kim SJ, 2011, UROLOGY, V78, P31; Korosec P, 2000, VIRCHOWS ARCH, V436, P377, DOI 10.1007/s004280050462; Kuroko Y, 2006, NEUROCHEM INT, V49, P448, DOI 10.1016/j.neuint.2006.03.004; Liang CC, 2010, NEUROUROL URODYNAM, V29, P512, DOI 10.1002/nau.20756; LIMAS C, 1993, J PATHOL, V171, P39, DOI 10.1002/path.1711710109; McCloskey DK, 2013, ACTA PHYSL, V207, P7; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P185, DOI 10.1002/nau.21191	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	FEB	2015	33	2					275	280		10.1007/s00345-014-1298-1		6	Urology & Nephrology	Urology & Nephrology	CA5ZR	WOS:000348988300014		
J	Ooi, K; Takamura, N				Ooi, Kazuya; Takamura, Norito			Necessity of Advance Pharmaceutical Education and Research for Upbringing of the Pharmacist Who Can Make a Immediate Decision in Patient's Problems Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Ooi, Kazuya] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Takamura, Norito] Kyushu Univ Hlth & Welf, Sch Pharmaceut Sci, Dept Clin Pharm 2, Nobeoka, Miyazaki 8828508, Japan	Ooi, K (reprint author), Suzuka Univ Med Sci, Fac Pharmaceut Sci, 3500-3 Minamitamagaki Cho, Suzuka, Mie 5138670, Japan.	zooi@suzuka-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					161	161				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400001		
J	Shibata, Y; Kawamoto, M; Kihira, K				Shibata, Yuuka; Kawamoto, Masashi; Kihira, Kenji			The Necessity for Pharmaceutical Education on Perioperative Care-Considering the Activities of Operating Room Pharmacists in Relation to Types of Anesthetic Operations Involved	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						operating room; pharmaceutical education; perioperative care; pharmacist		In an effort better to understand the application of pharmaceutical services in the operating room (OR) we conducted a survey among OR department directors of 526 hospitals throughout Japan. A total of 202 directors responded to the survey. Pharmacists are expected to achieve better outcomes in pharmacotherapy as well as play major roles as members of diverse perioperative care teams. Besides implementing medication safety standards, pharmacists' roles include optimizing drug therapy and other clinical interventions, both in OR and wards. Presently, few pharmacists in Japan participate in perioperative care, which is one of the reasons that the majority of pharmacy schools in Japan have been providing fewer lectures or rotations related to perioperative care. Yet, developing general perioperative management as another crucial role OR pharmacists play and incorporating it into pharmaceutical education would be important. Enriching perioperative care provided by pharmacists can contribute toward improving clinical competence in these professionals.	[Shibata, Yuuka; Kihira, Kenji] Hiroshima Univ Hosp, Dept Pharmaceut Serv, Minami Ku, Hiroshima 7348551, Japan; [Kawamoto, Masashi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Anesthesiol & Clin Care, Minami Ku, Hiroshima 7348551, Japan	Shibata, Y (reprint author), Hiroshima Univ Hosp, Dept Pharmaceut Serv, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	utatti@nifty.com					Shibata Y., 2008, JPN J PHARM HLTH CAR, V34, P181; Shibata Y., 2012, J JPN SOC HOSP PHARM, V48, P1185; Shibata Y., 2012, J JAPANESE ASS OPERA, V33, P381	3	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					163	167				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400002		
J	Katayama, T				Katayama, Toshiya			Practice of Drug Monitoring Based on Comprehensive Pharmaceutical Judgment	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						pharmaceutical service; drug monitoring; comprehensive pharmaceutical judgment	ANTIMICROBIAL THERAPY; SEPTIC SHOCK; PHARMACOKINETICS	With the revisions to the pay for performance of pharmaceutical service of inpatients in April 2012, the ward permanent time of pharmacists grew longer than previously; however, there are as yet few reports on the pharmaceutical outcome of the new medical service. To improve the pharmaceutical service requires that pharmacists collect useful medical information and extract the problems of pharmaceutical care for inpatients. Since many cases of treatment with multidrug regimens are regularly performed, pharmacists cannot contribute to medical treatment only by knowledge of a single disease. Therefore quick and comprehensive judgment of pharmacists is necessary in addition to acquisition of pharmaceutical knowledge. We especially highlight medical emergencies such as severe cases of sepsis and infection to which physicians require rapid judgment. Pharmacists alike require appropriate knowledge of drug administration to avoid medical treatment failure. Moreover, it is necessary for pharmacists to apply advanced drug monitoring in difficult cases. On the other hand, integrated team medical treatment is now advancing, although pharmacists' roles in clinical decision making are increasing, and pharmacists have a greater burden of responsibility than before.	Yokkaichi Social Insurance Hosp, Dept Pharm, Yokaichi, Mie 5100016, Japan	Katayama, T (reprint author), Yokkaichi Social Insurance Hosp, Dept Pharm, 10-8 Hazuyama Cho, Yokaichi, Mie 5100016, Japan.	toshiya@m4.cty-net.ne.jp					Joukhadar C, 2001, CRIT CARE MED, V29, P385, DOI 10.1097/00003246-200102000-00030; Preiswerk B, 2013, INFECTION, V41, P553, DOI 10.1007/s15010-012-0300-3; Gomi H, 2013, J HEPATO-BIL-PAN SCI, V20, P60, DOI 10.1007/s00534-012-0572-0; Tanaka A, 2007, J HEPATO-BILIARY-PAN, V14, P59, DOI 10.1007/s00534-006-1157-6; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1016/j.ccc.2009.08.004; Patel N, 2011, ANTIMICROB AGENTS CH, V55, P1677, DOI 10.1128/AAC.01224-10; Butterfield JM, 2013, ANTIMICROB AGENTS CH, V57, P864, DOI 10.1128/AAC.02000-12; Hidaka S, 2010, YAKUGAKU ZASSHI, V130, P87; Katayama T., 2013, IYAKU J, V49, P53; Tanoue K, 2011, THER APHER DIAL, V15, P327, DOI 10.1111/j.1744-9987.2011.00914.x	10	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					169	174				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400003		
J	Akagawa, S; Morikawa, N; Ikeda, K; Okazaki, T; Takahashi, S				Akagawa, Shinichiro; Morikawa, Norifumi; Ikeda, Kayo; Okazaki, Teruo; Takahashi, Shunsuke			Health Assessment of Local Residents Who Made Full Use of Symptomatology Skills and Test Device	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						words health assessment; self-medication; test device		A strategy named "Japan is back" adopted in June 2013 specifies that pharmacies shall be regarded as community-based places where health-related information is provided, and the public shall be encouraged to use the services of pharmacies and pharmacists who can advise on health and appropriate use of over-the-counter (OTC) drugs, and promote self medication. In Japan there are approximately 55000 pharmacies and 260000 pharmacists, and community residents are recommended to use these resources. As advisors on healthcare in the community, pharmacists are required to make judgments regarding drug use in individuals performing self medication and using OTC drugs in consideration of their symptoms and level of understanding of their health conditions, and recommend that they consult a medical center if necessary. To meet these requirements pharmacists need to have the skills to monitor each individual's lifestyle, behavior, and environment as well as trends in society, and assess their health status. However, education that allows pharmacists to practice such skills remains insufficiently developed. We consider that to be able to detect diseases early among community residents and appropriately support them using pharmacotherapy, it is very important to train pharmacists to do the following at pharmacies: 1) determine individuals who should be treated early using symptomatologic skills; 2) promote public awareness of disease; and 3) perform biochemical examination (blood is collected by fingerprick promptly to obtain biochemical data) in cooperation with the Department of Clinical Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hiroshima University.	[Akagawa, Shinichiro; Okazaki, Teruo; Takahashi, Shunsuke] Drug39 CO LTD, Moji Ku, Kitakyushu, Fukuoka 8010825, Japan; [Morikawa, Norifumi; Ikeda, Kayo] Hiroshima Univ, Sch Pharm, Clin Drug Treatment Lab, Minami Ku, Hiroshima 7348551, Japan	Akagawa, S (reprint author), Drug39 CO LTD, Moji Ku, 3-1-13 Kurogawanishi, Kitakyushu, Fukuoka 8010825, Japan.	s_akagawa@drug39.co.jp					Japan Pharmaceutical Information Center, 2014, JAPIC IRYOUYOU IPP I; Ministry of Economy, UT RES GRAY ZON RES; Ministry of Health Labour and Welfare, BAS DIR COMPR IMPL N; Ministry of Health Labour and Welfare, REQ FUNCT ID SIT PHA; World Health Organization (WHO), 3 WHO CONS GROUP ROL	5	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					175	179				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400004		
J	Ooi, K				Ooi, Kazuya			Key Points in Clinical Pharmaceutical Education and Research, as Seen from Pharmaceutical Consultation Clinics	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						pharmaceutical education; pharmaceutical consultation; second opinion; pharmacist		Pharmaceutical education was expanded to a 6-year system in 2006, in an efforts to enhance clinical pharmaceutical research and education. Since that time, pharmacists have attempted to participate in medical all aspects of medical care, but an environment in which they can master direct pharmaceutical techniques for patients has not yet been sufficiently developed. This is because pharmaceutical education emphasizes the acquisition of knowledge and has not reached the point where it cultivates minds that can adapt to the multitude of situations that are envisaged in medical settings. By incorporating physical assessment in pharmaceutical settings, it is believed that a mind-set of treating patients can be formed in students, leading to the development of pharmacists skilled in the implementation of their area of treatment. We feel that, by shifting to clinical pharmaceutical education and research we will realize an integrated ability in pharmacists to treat patients, which will earn multifaceted appreciation from both patients themselves and medical practitioners. The pharmaceutical consultation clinic established at Mie University offers second opinions by pharmacists, but patients' opinions of pharmacists are tepid and the letter sometimes became the target of acerbic comments. This is a reflection of the current state in which pharmacists have not made their role in medicine clear. Ultimately, efforts must be made to resolve anxiety with respect to the things patients want to hear, without evading this responsibility even when under pressure. Pharmaceutical science should always be cognizant of what the pharmacists' contribution to medicine, should be, and research a means to help that individual acquire the ability to make quick though careful judgments while gathering needed findings.	Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan	Ooi, K (reprint author), Suzuka Univ Med Sci, Fac Pharmaceut Sci, 3500-3 Minamitamagaki Cho, Suzuka, Mie 5138670, Japan.	zooi@suzuka-u.ac.jp					Murata I, 2011, J TRAUMA, V70, P1453, DOI 10.1097/TA.0b013e31820ca00a; Murata I, 2013, J TRAUMA ACUTE CARE, V75, P241, DOI 10.1097/TA.0b013e3182905f11	2	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					181	184				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400005		
J	Takamura, N; Tokunaga, J; Ogata, K; Setoguchi, N				Takamura, Norito; Tokunaga, Jin; Ogata, Kenji; Setoguchi, Nao			Necessity of Research of Pharmaceutical Departments in the Creation of New Pharmaceutical Skills through Technical Education of Physical Assessment	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						physical assessment; pharmaceutical skill; pharmaceutical diagnosis; medical device; Yaku-jutsu	BINDING	Physical assessment skills are now being more widely accepted by pharmacists and pharmaceutical departments than in the past. This is explained by the realization that pharmacists can prevent serious adverse effects and evaluate drug efficacy for their patients through assessment, thus providing effective medical care. However, is that all physical assessment can provide to pharmacists and pharmaceutical students? These students, in turn, should recognize the "need for skill" and the "pleasure to be gained in acquiring that skill" through the physical assessment performed by doctors. They should also recognize the importance of medical devices (e.g., stethoscope, electrocardiograph and endoscope) and take responsibility for creating their own techniques for their use. Here they will consider valuable pharmaceutical skills. "Yaku-jutsu" is a pharmaceutical diagnosis to determine the time required to achieve maximum beneficial effects and effective drug administration based on that diagnosis. Pharmacists cannot gain public trust unless they relieve a patient's pain using Yaku-jutsu which has been made available to them by the research support of a pharmaceutical department.	[Takamura, Norito; Tokunaga, Jin; Ogata, Kenji; Setoguchi, Nao] Kyushu Univ Hlth & Welf, Sch Pharmaceut Sci, Dept Clin Pharm 2, Nobeoka, Miyazaki 8828508, Japan	Takamura, N (reprint author), Kyushu Univ Hlth & Welf, Sch Pharmaceut Sci, Dept Clin Pharm 2, 1714-1 Yoshino Cho, Nobeoka, Miyazaki 8828508, Japan.	noritotaka@phoenix.ac.jp					Setoguchi N, 2013, BIOPHARM DRUG DISPOS, V34, P125, DOI 10.1002/bdd.1829; Takamura N, HIGHLIGHT THIS MONTH; Takamura N, 2007, YAKUGAKU ZASSHI, V127, P1805, DOI 10.1248/yakushi.127.1805; Takamura N, 2013, GANBAROU YAKUZAISHI, P1	4	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					185	188				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400006		
J	Kishikawa, N; Todoroki, K				Kishikawa, Naoya; Todoroki, Kenichiro			The Creation of Useful Analytical Tools to Elucidate Biological Phenomena Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Kishikawa, Naoya] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Todoroki, Kenichiro] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Kishikawa, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kishika@nagasaki-u.ac.jp; todoroki@u-shizuoka-ken.ac.jp	Todoroki, Kenichiro/D-6152-2011					0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					189	190				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400007		
J	Kishikawa, N; Kuroda, N				Kishikawa, Naoya; Kuroda, Naotaka			Chemiluminescence Assay for the Investigation of Reactive Oxygen Species Generator	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						chemiluminescence; reactive oxygen species; quinone; paraquat; high-performance liquid chromatography (HPLC)	QUINONES	Quinones play critical roles in biological systems, but are also regarded as a class of toxins that can cause oxidative stress in living cells, and the involvement of quinone-based reactive oxygen species in oxidative stress has been reported. In biological systems, quinones are reduced to semiquinone radicals by the enzyme NADPH:quinone reductase. Next, semiquinone radicals react with dissolved oxygen to form superoxide anion, which reacts with biological molecules to cause oxidative stress. On the other hand, chemiluminescence reagents such as luminol can emit chemiluminescence after oxidation by reactive oxygen species. Therefore, chemiluminescence reagents have been used widely to investigate reactive oxygen species. We have developed a sensitive and selective assay for quantifying quinones using luminol chemiluminescence. This chemiluminescence assay is based on the generation of reactive oxygen species through the redox reaction between quinone and dithiothreitol, a reductant, followed by detection of the generated reactive oxygen by luminol. Additionally, this assay can be used to quantify the toxic herbicide, paraquat, which produces reactive oxygen species in the same manner as quinones. This review describes the development of a sensitive and selective chemiluminescence assay for investigating quinones and paraquat by utilizing their ability to generate reactive oxygen species.	[Kishikawa, Naoya; Kuroda, Naotaka] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan	Kishikawa, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kishika@nagasaki-u.ac.jp					Yamaguchi S, 2010, ANAL CHIM ACTA, V665, P74, DOI 10.1016/j.aca.2010.03.025; Ahmed S, 2009, TALANTA, V78, P94, DOI 10.1016/j.talanta.2008.10.043; Kishikawa N, 2014, J PHARMACEUT BIOMED, V87, P261, DOI 10.1016/j.jpba.2013.05.035; Lemaire P, 1997, COMP BIOCHEM PHYS C, V117, P131, DOI 10.1016/S0742-8413(97)00060-1; Elgawish MS, 2013, CHEM RES TOXICOL, V26, P1409, DOI 10.1021/tx400253k; Motoyama Y, 2009, J HEALTH SCI, V55, P845; Kishikawa N, 2009, ANAL BIOANAL CHEM, V393, P1337, DOI 10.1007/s00216-008-2541-7; Kishikawa N, 2011, ANAL BIOANAL CHEM, V400, P381, DOI 10.1007/s00216-011-4662-7; Kishikawa N, 2013, FORENSIC TOXICOL, V31, P301, DOI 10.1007/s11419-012-0175-0; Kishikawa N, 2010, CLIN CHIM ACTA, V411, P1111, DOI 10.1016/j.cca.2010.04.005; Kudo K, 2010, FORENSIC TOXICOL, V28, P25, DOI 10.1007/s11419-009-0088-8; Kumagai Y, 2009, J HEALTH SCI, V55, P887; Mikami M, 2011, LUMINESCENCE, V26, P162, DOI 10.1002/bio.1199; Nakashima K, 2000, BUNSEKI KAGAKU, V49, P135, DOI 10.2116/bunsekikagaku.49.135	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					191	196				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400008		
J	Ichibangase, T; Imai, K				Ichibangase, Tomoko; Imai, Kazuhiro			Development and Application of FD-LC-MS/MS Proteomics Analysis Revealing Protein Expression and Biochemical Events in Tissues and Cells	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						proteomics; fluorogenic derivatization; protein; high-performance liquid chromatography (HPLC)	MASS-SPECTROMETRY; INTACT PROTEINS; SEPARATION	It is routine to search for and recognized genetic defects in human disorders to provide knowledge for diagnosis, treatment, and protection against diseases. It is also important to investigate and demonstrate the cause of a disease from the proteomic perspective, because intracellular signaling systems depend on protein dynamics. Demonstrating changes in protein levels enables us to understand biochemical events during the initiation and progression of a disease. To understand changes in protein levels in tissues and cells, we have developed a novel proteomics approach, FD-LC-MS/MS. This consists of fluorogenic derivatization (FD), HPLC separation and detection/quantification of proteins in a biological sample, followed by the isolation and tryptic digestion of target proteins, and then their identification using HPLC and tandem mass spectrometry (MS/MS) with a database-searching algorithm. The method is highly sensitive (femtomole-level detection) through the use of less noisy fluorogenic rather than fluorescence derivatization, and enables precise and comprehensive relative quantitation of protein levels (between-day relative standard deviation of peak heights of ca. 20%) by combining FD with HPLC separation. In this paper, after a simple review of differential profiling using FD-LC-MS/MS, for example the analysis of stimulated vs. unstimulated samples, we introduce the development and application of the FD-LC-MS/MS method for comprehensive differential proteomics of several tissues, including mouse liver, mouse brain, and breast cancer cell lines, to reveal protein levels and biochemical events in tissues and cells.	[Ichibangase, Tomoko; Imai, Kazuhiro] Musashino Univ, Pharmaceut Sci Res Inst, Nishitokyo, Tokyo 2028585, Japan	Ichibangase, T (reprint author), Musashino Univ, Pharmaceut Sci Res Inst, 1-1-20 Shinmachi, Nishitokyo, Tokyo 2028585, Japan.	t_ichiba@musashino-u.ac.jp					Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533; Langley SR, 2013, CARDIOVASC RES, V97, P612, DOI 10.1093/cvr/cvs346; Asamoto H, 2008, J CHROMATOGR A, V1208, P147, DOI 10.1016/j.chroma.2008.08.078; Ichibangase T, 2013, BIOMED CHROMATOGR, V27, P1520, DOI 10.1002/bmc.2952; Ichibangase T, 2007, J PROTEOME RES, V6, P2841, DOI 10.1021/pr070094c; Ichibangase T, 2014, J PHARMACEUT BIOMED, V101, P31, DOI 10.1016/j.jpba.2014.05.036; Ichibangase T, 2014, BIOMED CHROMATOGR, V28, P862, DOI 10.1002/bmc.3172; Ichibangase T, 2012, BIOL PHARM BULL, V35, P1393; Imai K, 2008, BIOMED CHROMATOGR, V22, P1304, DOI 10.1002/bmc.1102; Imai K, 2011, BIOMED CHROMATOGR, V25, P59, DOI 10.1002/bmc.1541; Imai K., 2009, PROTEIN NUCL ACID EN, V54, P754	11	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					197	203				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400009		
J	Hayama, T				Hayama, Tadashi			Highly Selective Analysis of Biogenic-related Compounds Utilizing Fluorous Chemistry	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						perfluoroalkyl-containing compound; fluorous derivatization; biological sample; LC-MS/MS	TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PHASE; DERIVATIZATION; PHOSPHOLIPIDS; BIOANALYSIS; STRATEGY; PLASMA; AMINES	Perfiuoroalkyl-containing compounds are highly fluorous, meaning that they have a remarkable affinity for one another and effectively exclude non-fluorous species. Utilizing this unique property, we have developed a fluorous derivatization with a liquid chromatographic analysis method for highly selective analysis of target analytes. Although most previous methods focused on extremely sensitive detection-oriented derivatization, the fluorous derivatization method involves highly specific separation for analytes. This method includes perfluoroalkylation of analytes with a fluorous reagent, and separation of the derivatives using a perfluoroalkyl-modified stationary phase LC column. The derivatives can be selectively retained on the fluorous-phase LC column, whereas the non-fluorous derivatives are poorly retained under the same separation conditions. The combination of this method with LC-tandem mass spectrometry (MS/MS) is very useful for complex biological sample analysis, because matrix-induced suppression effects, which are a common problem in LC-MS/MS analysis arising from components of a biological endogenous matrix, have not been observed. We have successfully applied this method to precise and accurate LC-MS/MS analysis of some biogenic compounds, such as sialic acids and biogenic amines, in complex biological samples.	Fukuoka Univ, Fac Pharmaceut Sci, Johnan Ku, Fukuoka 8140180, Japan	Hayama, T (reprint author), Fukuoka Univ, Fac Pharmaceut Sci, Johnan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	thayama@fukuoka-u.ac.jp					Hayama T, 2010, RAPID COMMUN MASS SP, V24, P2868, DOI 10.1002/rcm.4710; Sakaguchi Y, 2011, J CHROMATOGR A, V1218, P5581, DOI 10.1016/j.chroma.2011.05.076; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Cametti M, 2012, CHEM SOC REV, V41, P31, DOI 10.1039/c1cs15084g; Marchand DH, 2005, J CHROMATOGR A, V1062, P65, DOI 10.1016/j.chroma.2004.11.014; Cai HL, 2010, ANAL BIOCHEM, V396, P103, DOI 10.1016/j.ab.2009.09.015; Hayama T, 2012, ANAL CHEM, V84, P8407, DOI 10.1021/ac3020092; Pucci V, 2009, J PHARMACEUT BIOMED, V50, P867, DOI 10.1016/j.jpba.2009.05.037; de Jong WHA, 2007, CLIN CHEM, V53, P1684, DOI 10.1373/clinchem.2007.087114; Zhang W, 2006, TETRAHEDRON, V62, P11837, DOI 10.1016/j.tet.2006.08.051; Stokvis E, 2005, RAPID COMMUN MASS SP, V19, P401, DOI 10.1002/rcm.1790; Studer A, 1997, SCIENCE, V275, P823, DOI 10.1126/science.275.5301.823; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Ji CJ, 2008, ANAL CHEM, V80, P9195, DOI 10.1021/ac801339z; Curran DP, 2008, SCIENCE, V321, P1645, DOI 10.1126/science.1158721; Fusstero S., 2012, TOP CURR CHEM, V308, P45; Gladysz J.A., 2004, HDB FLUOROUS CHEM; Hayama T, 2014, J PHARMACEUT BIOMED, V101, P151, DOI 10.1016/j.jpba.2014.04.035; Ismaiel OA, 2007, J CHROMATOGR B, V859, P84, DOI 10.1016/j.jchromb.2007.09.007; Mao HM, 2009, MICROCHEM J, V91, P176, DOI 10.1016/j.microc.2008.10.005; Sakaguchi Y, 2009, ANAL CHEM, V81, P5039, DOI 10.1021/ac9005952; Sakaguchi Y, 2011, J PHARMACEUT BIOMED, V55, P176, DOI 10.1016/j.jpba.2011.01.011; Todoroki K, 2011, J CHROMATOGR B, V879, P1325, DOI 10.1016/j.jchromb.2010.11.038; Uneyama K., 2006, ORGANOFLUORINE CHEM	24	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					205	212				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400010		
J	Todoroki, K				Todoroki, Kenichiro			Development of HPLC Analysis Methods for Therapeutic Monoclonal Antibodies	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						therapeutic monoclonal antibody; high-temperature reversed-phase LC; aggregate	LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; MASS-SPECTROMETRY; HETEROGENEITY; CANCER	Therapeutic monoclonal antibody (mAb) preparations are produced from cultured cells; therefore, detailed and multidimensional analyses of their heterogeneities are required. We analyzed five commercially available mAb preparations by high-temperature reversed-phase LC using a wide-pore core-shell column for pluralistic quality assessment. At a highly elevated column temperature, isopropanol with high eluotropic strength coefficients and a wide-pore core-shell type octyl column showed good peak resolution of the investigated mAbs and their related constituents. We used this method to estimate the residual rate of intact mAbs after a heat aggregation treatment and conducted fragmentation analysis by analyzing their pepsin digests. Each peak component was identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry. All results were compared with those of reversed-phase and size exclusion analyses.	Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Todoroki, K (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	todoroki@u-shizuoka-ken.ac.jp	Todoroki, Kenichiro/D-6152-2011				Chen SL, 2013, J PHARMACEUT BIOMED, V80, P126, DOI 10.1016/j.jpba.2013.02.040; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Beck A, 2012, ANAL CHEM, V84, P4637, DOI 10.1021/ac3002885; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Dillon TM, 2004, J CHROMATOGR A, V1053, P299, DOI 10.1016/j.chroma.2004.08.058; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Fekete S, 2012, J CHROMATOGR A, V1236, P177, DOI 10.1016/j.chroma.2012.03.018; Maeda E, 2012, ANAL CHEM, V84, P2373, DOI 10.1021/ac300234a; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Staub A, 2011, J PHARMACEUT BIOMED, V55, P810, DOI 10.1016/j.jpba.2011.01.031; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Fradkin AH, 2009, J PHARM SCI-US, V98, P3247, DOI 10.1002/jps.21834; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Kumar S, 2011, PHARM RES-DORDR, V28, P949, DOI 10.1007/s11095-011-0414-9; Beck A, 2013, ANAL CHEM, V85, P715, DOI 10.1021/ac3032355; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; Bristol-Myers Squibb, PROD INF ERBITAX; Fradkin H., 2009, J PHARM SCI, V98, P3247; He Yan, 2010, Anal Chem, V82, P3222, DOI 10.1021/ac9028856; Janssen, PROD INF REMICADE; Kuribayashi R, 2012, J PHARMACEUT BIOMED, V67-68, P1, DOI 10.1016/j.jpba.2012.04.005; Roche, PROD INF ACTEMRA	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					213	218				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400011		
J	Uchida, T; Namiki, N				Uchida, Takahiro; Namiki, Noriyuki			Next Generation Type Formulation Developed Using Innovation to Overcome Trade-offs between Patient-oriented Approach and Clinical Effectiveness of Formulation Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Uchida, Takahiro] Mukogawa Womens Univ, Fac Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan; [Namiki, Noriyuki] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Uchida, T (reprint author), Mukogawa Womens Univ, Fac Pharmaceut Sci, 11-68 Koshien 9 Bancho, Nishinomiya, Hyogo 6638179, Japan.	takahiro@mukogawa-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					219	220				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400012		
J	Uchida, T				Uchida, Takahiro			Trade-offs in the Development of Various Dosage Form (Overview)	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						solubility-permeability; orally disintegrating tablet; anticancer drug; total parenteral nutrition; branched-chain amino acid	PERMEABILITY; SOLUBILITY; SYSTEM	In this symposium we focused on trade-offs which might occur in the process of development of many types of formulation and corresponding dissolution methods. Firstly, we focused on a solubility-permeability trade-off in the case of micelle with surfactant or molecular complex with CyD. The micelle would be successful in increasing drug solubility, however it rather decreased permeability of model drug progesterone (Biopharmaceutics Classfication System (BCS) Class II) as an overall flux. Secondly in order to reduce bitterness of branched chain amino acid (BCAA), increasing particle sizes of each amino acid crystals involved in formulation was effective since the release rate of amino acid was restricted efficiently. Thirdly, in the case of injection of paclitaxel (BCS Class II) formulation, the drug was adsorbed to albumin. Thereby the risk of allergy was dramatically decreased compared to the case when non-ionic surfactant was used as an additive. Fourth, anticancer drug was incorporated into the internal (core) phase of an orally disintegrating tablet (ODT), this is also merit to avoid exposure of the drug to a nursing person or individual working person in manufacturing process. Fifth, the convenient syringe type kit pharmaceutical preparation for administration of total parenteral nutrition (TPN) to avoid incompatibility and its risk management effect was briefly discussed. Finally, the risk of an additive such as alcohol for a preterm infant was described.	Mukogawa Womens Univ, Fac Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan	Uchida, T (reprint author), Mukogawa Womens Univ, Fac Pharmaceut Sci, 11-68 Koshien 9 Bancho, Nishinomiya, Hyogo 6638179, Japan.	takahiro@mukogawa-u.ac.jp					Whittaker A, 2009, ARCH DIS CHILD-FETAL, V94, pF236, DOI 10.1136/adc.2008.146035; Miller JM, 2012, MOL PHARMACEUT, V9, P2009, DOI 10.1021/mp300104s; Kawabata Y, 2011, INT J PHARMACEUT, V420, P1, DOI 10.1016/j.ijpharm.2011.08.032; Miller JM, 2011, MOL PHARMACEUT, V8, P1848, DOI 10.1021/mp200181v; Beig A, 2013, EUR J PHARM BIOPHARM, V85, P1293, DOI 10.1016/j.ejpb.2013.05.018; Hazekawa M., 2013, JPN J MED PHARM SCI, V69, P929; Masuda Y., 2006, PHARM TECH JPN, V22, P401; Miyanaga Y, 2004, CHEM PHARM BULL, V52, P490, DOI 10.1248/cpb.52.490; Pharmaceuticals and Medical Devices Agency (PMDA), 2010, MED SAF INF 19; Shibasaki M., 2010, IYAKUHIN KAIHATSU RO, P105; Taiho Pharmaceutical Co. Ltd., 2014, ABR 1 5 INF 100 MG; Uchida T., 2009, J NEW REM CLIN, V58, P854; Yoshida T, 2008, J CONTROL RELEASE, V131, P47, DOI 10.1016/j.jconrel.2008.07.009	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					221	227				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400013		
J	Kondo, H; Sako, K				Kondo, Hiromu; Sako, Kazuhiro			Trade-offs in Oral Drug Product Development	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						trade-off; technology innovation; quality target product profile; oral formulation	SYSTEM	Drug products are developed to meet multiple targets, thereby increasing their value. Pharmaceutical scientists encounter several trade-offs during the development of novel oral formulations. These trade-offs are generated by their desire to supply the highest possible quality products under the prevailing conditions of limited time and cost, and feasible options. When there are two incompatible factors, it is sometimes difficult to dismiss one element. This is because a quality target product profile (QTPP) is critical for each product being developed, and all elements should basically be satisfied with the criteria. Therefore, technological innovation becomes important to overcome the trade-offs. This article introduces examples of such innovations which have been successful in doing this, as well as some encountered in the oral formulation development and in the selection of proper dosage forms. Based on these examples, points to be considered in order to produce the drug product are thoroughly discussed.	[Kondo, Hiromu; Sako, Kazuhiro] Astellas Pharma Inc, Pharmaceut Res & Technol Labs, Yaizu, Shizuoka 4250072, Japan	Sako, K (reprint author), Astellas Pharma Inc, Pharmaceut Res & Technol Labs, 180 Ozumi, Yaizu, Shizuoka 4250072, Japan.	kazuhiro.sako@astellas.com					Sako K, 1996, PHARMACEUT RES, V13, P594, DOI 10.1023/A:1016006423601; Mizumoto T, 2005, INT J PHARM, V306, P83, DOI 10.1016/j.ijpharm.2005.09.009; Maeda A, 2011, INT J PHARMACEUT, V408, P84, DOI 10.1016/j.ijpharm.2011.01.053; Hashimoto T., 2006, THER RES, V27, P1219; Honma Y., 2003, J NEUROGENIC BLADDER, V14, P266; Michel MC, 2005, EUR UROL SUPPL, V4, P15, DOI 10.1016/j.eursup.2004.11.002; Yoshida T, 2008, CHEM PHARM BULL, V56, P1579, DOI 10.1248/cpb.56.1579	7	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					229	235				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400014		
J	Namiki, N				Namiki, Noriyuki			Clinical Functionality Required for Orally Disintegrating Tablets Selected as the Next Generation Type	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						orally disintegrating tablet; patient adherence; clinical functionality; trade-off; innovation		Orally disintegrating tablets. (ODTs) are currently widely used in drug therapy and are clinically attractive, because they are suitable for administration to patients with dysphagia and improve adherence, both of which increase the possibility of achieving the expected therapeutic effect. These properties of ODTs, which increase treatment effectiveness, are termed their "clinical functionality", and ODTs with a high clinical functionality are required to meet the increasing need for these tablets. For example, there is a need for development of a clinically effective ODT with superior disintegrating properties while maintaining high tablet strength, bioequivalence with normal tablets while masking the bitterness with a fine particle coating, and a disintegration mechanism while maintaining moisture resistance and good storage quality. Thus, next-generation ODTs that overcome these conflicting properties, "trade-offs", will be. developed, using innovative formulation research technology. In this symposium, we will discuss a next-generation OD formulation known as PLETAAL OD, a high-dose antiplatelet agent, and will present the results of validation tests performed in our laboratory pertaining to high tablet strength, superior disintegration property, high wicking capacity, and storage stability with high moisture resistance. We will also introduce a second-generation antihistamine ALLELOCK OD and discuss its high clinical functionality achieved by masking the bitterness and obtaining bioequivalence with normal tablets by using granules while maintaining high tablet strength with EXLUB and SOLBLET technology.	Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Namiki, N (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	namiki@u-shizuoka-ken.ac.jp					Kyowa Hakko Kirin Co, 2010, COMM TECHN DOC; Miyamoto Y., 2013, PROG MED, V33, P1013; Namiki N., 2013, PHARM TECH JAPAN, V29, P1971; Namiki N., 2012, PROG MED, V32, P737; Namiki N., 2012, PHARM TECH JAPAN, V28, P519	5	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					237	243				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400015		
J	Kojima, J				Kojima, Jun			Oral Dosage Forms for Children: Acceptability and Palatability	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						pediatric medicine; acceptability; palatability; mini-tablet	FORMULATIONS; MEDICINES	Children generally reject taking medicine which does not have a favorable shape, taste, flavor, etc. However, if a child who needs to take a medicine, rejects taking it, he might never recover from his condition. When a child is unable to take medicine orally, it is intravenously administered, and he and his caregivers then may experience stress. Syrups and suspensions are considered as favorable types of dosage forms in which to orally administer medicine to infants and children. However, they may have disadvantages such as solubility, a bad taste, portability problems or required refrigerator storage. World Health Organization (WHO) currently favors that infants and children be treated with oral solid medicines. New oral solid tablets, such as a mini-tablet, instead of liquid medicines are proposed for this group, however, there are a few reports that mini-tablets are suitable for infants and children. Palatability is one of the main elements of patient acceptability of an oral pediatric medicine. Palatability is defined as the overall appreciation of an oral medicinal product in relation to its smell, taste, aftertaste and feeling in the mouth. Design of the formulation of an oral pediatric medicine should be considered together with its palatability.	[Kojima, Jun] Med & Hlth Resources Res Inst, Toshima Ku, Tokyo 1700013, Japan; [Kojima, Jun] St Lukes Int Hosp, Perioperat Ctr, Chuo Ku, Tokyo 1048560, Japan; [Kojima, Jun] Nihon Univ, Sch Med, Dept Neurol Surg, Itabashi Ku, Oyaguchi, Tokyo 1730032, Japan	Kojima, J (reprint author), Med & Hlth Resources Res Inst, Toshima Ku, 4-38-7 Higashi Ikebukuro, Tokyo 1700013, Japan.	jdw06164@nifty.com					Thomson SA, 2009, PEDIATRICS, V123, pE235, DOI 10.1542/peds.2008-2059; Schirm E, 2003, ACTA PAEDIATR, V92, P1486, DOI 10.1080/08035250310006728; Spomer N, 2012, ARCH DIS CHILD, V97, P283, DOI 10.1136/archdischild-2011-300958; Elaine T., 2003, MED J AUSTRALIA, V179, P195; Kojima J, 2013, YAKKYOKU, V64, P2607; Kojima J, 2013, J JAPAN PEDIAT SOC, V117, P580; Matsumoto T., 2013, YAKKYOKU, V64, P2680; Meltzer EO, 2006, CLIN PEDIATR, V45, P725, DOI 10.1177/0009922806292786; Terashita K., 2014, PHARM TECH JAPAN, V30, P1541; Yoneko Maki, 2012, Yakuzaigaku, V72, P349; Yoneko M, 2013, YAKKYOKU, V64, P2619	11	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					245	247				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400016		
J	Harada, T; Yasuoka, K; Sakurai, M; Murase, T; Owaki, T				Harada, Tsutomu; Yasuoka, Koichi; Sakurai, Maho; Murase, Tsukasa; Owaki, Takayuki			Development of a Novel Oral Jelly Formulation for Elderly Patients	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						trade-off; oral jelly formulation; taste sensor; donepezil hydrochloride; Aricept		Deterioration of the swallowing function in elderly persons and drug refusal among the behavioral abnormalities in Alzheimer's disease (AD) are commonly reported. Therefore, we developed an easy-to-swallow jelly formulation of Donepezil HCl which AD patients can take as a dessert. The development process, however, was full of trade-off problems. (1) Need for evaluating the taste of a drug product vs. Safety of human sensory evaluation of the taste. The trade-off was resolved by using a taste sensor. (2) Speed of development vs. Safety of the manufacturing process. We put priority on the safety rather than speed, and a safer antioxidant agent was found. (3) Usability of the container for AD patients with dysphagia vs. Size of the container. We put priority on its being user-friendly rather than on the size and chose a stable wide-mouth cup. (4) Suitable texture of jelly for swallowing the drug product vs. Residual volume of jelly in the cup. We designed the texture so that the residual volume of jelly in the cup was reduced. (5) Easy peeling properties of aluminum seal vs. High sealing strength for sterilization. The sealing strength was adjusted so that it was adequate to sterilize the drug product. (6) One cup in a heat-sealed aluminum pillow package to prevent overdose vs. Seven cups in a pillow package. A single-dose package was relatively expensive, but it was chosen to assure safety. We faced many difficult trade-off problems in the development of process. However, they were resolved using technical innovations and a people-friendly policy. Finally, we were able to launch a novel oral jelly formulation for elderly patients.	[Harada, Tsutomu] Eisai & Co Ltd, Customer Joy Dept, Planning & Operat Sect, Eisai Japan,Bunkyo Ku, Tokyo 1128088, Japan; [Yasuoka, Koichi; Sakurai, Maho; Murase, Tsukasa] Eisai & Co Ltd, Global Formulat Res, Pharmaceut Sci & Technol CFU, Kakamigahara, Gifu 5016195, Japan; [Owaki, Takayuki] Eisai & Co Ltd, Customer Joy Dept, Technol Ctr, Eisai Japan, Kakamigahara, Gifu 5016195, Japan	Harada, T (reprint author), Eisai & Co Ltd, Customer Joy Dept, Planning & Operat Sect, Eisai Japan,Bunkyo Ku, Koishikawa 5-5-5, Tokyo 1128088, Japan.	tsutomu.harada@biogenidee.com					Asada T, 2013, PREVALENCE DEMENTIA; Du W, 1993, J Geriatr Psychiatry Neurol, V6, P34; FEINBERG MJ, 1992, RADIOLOGY, V183, P811; Harada T., 2011, PHARM TECH JAPAN, V27, P2199; Harada T., 2000, TECHNICAL REPORT IEI, V100, P125; Harada T., 2012, J JAPAN SOC PHARM MA, V21, P557; Harada T., 2001, PHARM TECH JAPAN, V17, P1367; Okada K., 2009, KITAKANTO MED J, V59, P9; Yoshikawa M, 2005, J GERONTOL A-BIOL, V60, P506	9	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					249	254				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400017		
J	Kawasaki, Y; Sendo, T				Kawasaki, Yoichi; Sendo, Toshiaki			Development of Injection Containers for Patient and Medical Staff	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						plastic injection container; trade-off; permeation; photoinitiator; cytotoxicity; endocrine disrupting effect	IN-VITRO; POLYMERIZATION AGENT; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; CYTOTOXICITY; RECEPTOR; GENE; VIVO; ITX; 2-METHYL-4'-(METHYLTHIO)-2-MORPHOLINOPROPIOPHENONE	Recently, there has been a transition from glass to plastic injection containers in Japan. In our previous study, we suggested that plastic containers had less impurity contamination than glass containers. However, the use of some plasticizers has been limited because of their endocrine disrupting effects. Therefore, contamination has been a concern due to chemicals in injection solution packed with plastic containers. Indeed, in our recent study, photoinitiators were detected in an injection solution coming from plastic containers. Photoinitiators mainly exist in ink. We therefore speculated that ink originating from a photoinitiator directly printing on plastic containers had migrated into the injection solutions. In a clinical setting, plastic containers are very tractable because they are lightweight and less breakable. On the other hand, from a safety view point, these containers may be hazardous because of permeation by steam, ambient air or photoinitiators. In the present symposium, we will discuss the risk of photoinitiators leaking into injection solution packed with plastic containers, and countermeasures to avoid this risk.	[Kawasaki, Yoichi; Sendo, Toshiaki] Okayama Univ, Dept Pharm, Kita Ku, Okayama 7008558, Japan	Sendo, T (reprint author), Okayama Univ, Dept Pharm, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	sendou@md.okayama-u.ac.jp					Alanko K, 2001, CONTACT DERMATITIS, V44, P188, DOI 10.1034/j.1600-0536.2001.440308-9.x; Eick JD, 2002, DENT MATER, V18, P413, DOI 10.1016/S0109-5641(01)00071-9; Nedorost ST, 2003, J AM ACAD DERMATOL, V49, pS259, DOI 10.1067/S0190-9622(03)00440-7; Reitsma M, 2013, TOXICOL SCI, V132, P64, DOI 10.1093/toxsci/kfs332; Kawasaki Y, 2012, BIOL PHARM BULL, V35, P256; Ito Y, 2007, J OCCUP HEALTH, V49, P172, DOI 10.1539/joh.49.172; Shimamura M, 2002, TOXICOLOGY, V174, P97, DOI 10.1016/S0300-483X(02)00044-6; Shen DX, 2009, ANAL BIOANAL CHEM, V395, P2359, DOI 10.1007/s00216-009-3115-z; Yamaji K, 2012, BIOL PHARM BULL, V35, P1821; Nalli S, 2006, SCI TOTAL ENVIRON, V366, P286, DOI 10.1016/j.scitotenv.2005.06.020; Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024; Bohonowych JES, 2008, TOXICOL SCI, V102, P278, DOI 10.1093/toxsci/kfn011; DUMANIAN GA, 1995, PLAST RECONSTR SURG, V95, P901, DOI 10.1097/00006534-199595050-00021; Momo F, 2007, BIOPHYS CHEM, V127, P36, DOI 10.1016/j.bpc.2006.12.002; Kostoryz EL, 1999, DENT MATER, V15, P363, DOI 10.1016/S0109-5641(99)00058-5; Morlock G, 2006, ANAL BIOANAL CHEM, V385, P586, DOI 10.1007/s00216-006-0430-5; Anton R., 2005, EFSA J, V293, P1; Chhabra R.S., 2000, TOXIC REP SER, V61, pA1; Chhabra RS, 2000, TOXIC REP SER, V61, P1; Cook N, 2001, Australas J Dermatol, V42, P257, DOI 10.1046/j.1440-0960.2001.00531.x; Hwang DY, 2005, INT J TOXICOL, V24, P157, DOI 10.1080/10915810590948370; Kawasaki Y., 2009, JPN J PHARM HLTH CAR, V35, P286; Kawasaki Y, 2013, BIOL PHARM BULL, V36, P1640; Koinuma M., 2003, J PHARM HLTH CARE SC, V29, P203; Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017; NAGAO M, 1978, BIOCHEM BIOPH RES CO, V83, P373, DOI 10.1016/0006-291X(78)91000-8; Papilloud S, 2002, FOOD ADDIT CONTAM, V19, P168, DOI 10.1080/02652030110084800; Papilloud S, 2002, PROG ORG COAT, V45, P231, DOI 10.1016/S0300-9440(02)00040-1; Pastorelli S., 2007, EUR J FOOD SCI, V227, P1585; Peijnenburg A, 2010, TOXICOL IN VITRO, V24, P1619, DOI 10.1016/j.tiv.2010.06.004; Rhodes MC, 2007, FOOD CHEM TOXICOL, V45, P843, DOI 10.1016/j.fct.2006.11.003; ROBISON SH, 1994, ENVIRON MOL MUTAGEN, V23, P312, DOI 10.1002/em.2850230409; Rothenbacher T, 2007, FOOD ADDIT CONTAM, V24, P438, DOI 10.1080/02652030601182664; Sagratini G, 2006, J AGR FOOD CHEM, V54, P7947, DOI 10.1021/jf0615956; Sanches-Silva A, 2009, J AGR FOOD CHEM, V57, P9516, DOI 10.1021/jf8035758; Sanches Silva A, 2007, Meat Sci, V77, P238, DOI 10.1016/j.meatsci.2007.03.009; Sanches Silva A., 2007, Food Research International, V40, P679, DOI 10.1016/j.foodres.2006.11.012; Sun CL, 2007, J CHROMATOGR A, V1143, P162, DOI 10.1016/j.chroma.2007.01.014; Volk J, 2014, DENT MATER, V30, P215, DOI 10.1016/j.dental.2013.11.008	39	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					255	262				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400018		
J	Kikuchi, M				Kikuchi, Masahiko			The Role of Formulation and Dosage Form in Vaccine	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						vaccine; vaccination; intradermal; device; prefilled syringe		The importance of vaccination has recently been widely recognized among Japanese people with a growing interest in vaccine. On the other hand, because vaccine is administrated to healthy people, it has had a difficult history due to overreaction to adverse events. With the recent rapid increase in the rate of vaccination, however, it is essential to correct the understanding of the public as to the risk and benefit of vaccine. Life spans around the world and infectious diseases are closely related, and vaccine certainly contributes to the control of the latter. Research and Development (R&D) of novel antigens is necessary for creating a next generation vaccine, a high performance device for efficient antigen delivery, and a safe adjuvant for adequate immunological response are also a key to the future. Moreover, various initiatives involving industry, academia, and government cooperation are essential to benefit the people of Japan and appropriate vaccination could actually be viewed as national security.	DAIICHI SANKYO CO LTD, Vaccine Business Strategy Dept, Vaccine Business Intelligence Div, Chuo Ku, Tokyo 1038426, Japan	Kikuchi, M (reprint author), DAIICHI SANKYO CO LTD, Vaccine Business Strategy Dept, Vaccine Business Intelligence Div, Chuo Ku, 3-5-1 Nihonbashi Honcho, Tokyo 1038426, Japan.	kikuchi.masahiko.tw@daiichisankyo.co.jp					Centers for Disease Control and Prevention (CDC), VACC STOR HANDL TOOL	1	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					263	267				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400019		
J	Yamamoto, M; Sugimori, H				Yamamoto, Michiko; Sugimori, Hiroki			What Is Proper Drug Information for Patients to Minimize Risk? - Constructing Drug Guide for Patients - Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Yamamoto, Michiko] Showa Pharmaceut Univ, Machida, Tokyo 1948543, Japan; [Sugimori, Hiroki] Daito Bunka Univ, Grad Sch Sports & Hlth Sci, Dept Prevent Med, Higashi Matsuyama, Saitama 3558501, Japan	Yamamoto, M (reprint author), Showa Pharmaceut Univ, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	m-yamamoto@ac.shoyaku.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					269	270				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400020		
J	Isozaki, M				Isozaki, Makiko			Present State and Future Tasks of "Drug Guide for Patients"	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						"Drug Guide for Patients"; safety information; prescribed drug; risk communication		Safety information on drugs is provided through package inserts, which are the most basic tool offered by pharmaceutical companies, "Emergency Safety Information" and "Pharmaceuticals and Medical Devices Safety Information", etc. issued by the Ministry of Health, Labour and Welfare (MHLW). In addition, the Pharmaceuticals and Medical Devices Agency (PMDA) recently established an information website, and the provision of enhanced information is now being promoted not only for health care professionals but also for patients. "Drug Guide for Patients" is one of the information tools for patients. The "Drug Guide for Patients" is presented so that the patient understands the correct use of the prescribed drug and serious adverse drug reactions can be recognized at an early stage. It is expected to contribute to the prevention of such adverse reactions by early detection and rapid cure. However, the guides have a low profile and are not yet fully exploited. They are currently being prepared without the direct involvement of patients although they are prepared from a patient point of view. These issues need to be resolved by encouraging broad use, a review of the contents and the involvement of patient groups to provide truly useful information. It is hoped that with these steps the guides will aid in further increasing risk communication to patients reading them.	Minist Hlth Labour & Welf, Pharmaceut & Food Safety Bur, Safety Div, Chiyoda Ku, Tokyo 1008916, Japan	Isozaki, M (reprint author), Minist Hlth Labour & Welf, Pharmaceut & Food Safety Bur, Safety Div, Chiyoda Ku, 1-2-2 Kasumigaseki, Tokyo 1008916, Japan.	isozaki-makiko@mhlw.go.jp					Ministry of Health Labour and Welfare, WAK WO UK EN GAID SA; Ministry of Health Labour and Welfare, IY KUH RIS NI TSUIT; Ministry of Health Labour and Welfare, IR AR NI KANS KOND S; Ministry of Health Labour and Welfare, KANJ IYAK GAID SAK U	4	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					271	275				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400021		
J	Yamamoto, M; Doi, H; Furukawa, A				Yamamoto, Michiko; Doi, Hirohisa; Furukawa, Aya			Drug Information for Patients (Package Leaflets), and User Testing in EU	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						Drug Guide for Patients; user testing; patient information leaflet; package leaflet (PL); drug information for patient; risk communication		Patients and consumers have desired high quality drug information in their pharmacotherapy, and are entitled to receive it. It is desirable that the information should be aimed at shared decision-making between patients and healthcare professionals about medications. The quality of drug information available to patients should also be assured. With an aim to improve the quality of "Drug Guide for Patients", we investigated Patient Information Leaflets (PILs) which are approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) with regard to the criteria of development and user testing for assuring the quality of the PILs. In the European Union (EU), these are called Package Leaflets (PLs). PILs have been a legal requirement in the UK since 1999 for all medications. The user testing of PILs has been implemented as evidence since 2005 so that people can rely on the information provided in the leaflet. Execution of PILs which follow the guidance of the user testing, according to the guidance of this user testing, would reflect the views of patients. Here, we introduce the development process and implementation of user testing of PILs. In terms of readability, accessibility and understandability of drug information for patients, we need to discuss involving the public in decisions on how its quality should be assured and how it can be made easily be comprehensible for patients, in order to make effective use of "Drug Guide for Patients" in the future in Japan.	[Yamamoto, Michiko; Doi, Hirohisa] Showa Pharmaceut Univ, Machida, Tokyo 1948543, Japan; [Furukawa, Aya] TAMA Univ, Med Risk Management Ctr, Tama Ku, Tokyo 2060022, Japan	Yamamoto, M (reprint author), Showa Pharmaceut Univ, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	m-yamamoto@ac.shoyaku.ac.jp					[Anonymous], 2008, KANJ IYAK GUID SAK T; Raynor DK, 2013, RES SOC ADMIN PHARM, V9, P640, DOI 10.1016/j.sapharm.2013.02.007; Committee on Safety of Medicines Working Group on Patient Information Medicines and Healthcare Products Regulatory Agency (MHRA), 2005, ALW READ LEAFL GETT; European Commission, 1998, GUID READ LAB PACK L; European Medicines Agency, 2013, QUAL REV DOC HUM PRO; Grant Research, 2014, REPORT FISCAL YEAR H, V25, P7; Knapp Peter, 2010, Int J Pharm Pract, V18, P362, DOI 10.1111/j.2042-7174.2010.00060.x; Medicines and Healthcare Products Regulatory Agency (MHRA), 2005, GUID US TEST PAT INF; Medicines and Healthcare Products Regulatory Agency (MHRA), 2007, FURTH GUID DES PAT I; Medicines and Healthcare Products Regulatory Agency (MHRA), QUAL CRIT PILS; Medicines and Healthcare Products Regulatory Agency (MHRA), BEST PRACT GUID PAT; Medicines and Healthcare Products Regulatory Agency (MHRA), PAT INF QUAL UN PIQU; Raynor D. K., 2013, BMJ OPEN, V18; Raynor DK, 2011, PATIENT EDUC COUNS, V83, P404, DOI 10.1016/j.pec.2011.03.016; Sless D, 1997, WRITING MED PEOPLE U; Sless D., 2006, WRITNG MED PEOPLE US; Yamamoto M., 2013, JPN J SOC PHARM, V32, P8; Yamamoto M., 2013, REPORT FISCAL YEAR H, V24, P48; Yamamoto M., 2014, REPORT FISCAL YEAR H, V25, P36; Yamamoto M., 2012, REPORT FISCAL YEAR H, V23, P34	20	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					277	284				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400022		
J	Orii, T				Orii, Takao			Review of Drug Information Provided to Patients from the Viewpoint of Hospital Pharmacists	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						patient; consumer; hospital pharmacist; drug information; communication tool		Risks for patients and consumers can be minimized depending on how they are provided appropriate drug information. Therefore, from the viewpoint of hospital pharmacists, I would like to report on how information should be provided in order to minimize patient risk. For example, there is an ongoing opinion that the provision of easy-to-understand drug information to patients and consumers "does not appear necessary". The reasons for this include the following: Because the level of understanding varies greatly among patients, it is difficult to define what "easy-to-understand" information entails; rather, it may cause misunderstanding. These problems occur repeatedly if they are resolved by individual institutions. Therefore, it is essential to standardize the drug information provided to patients, that is, to establish a system to transmit drug information to patients and consumers. Regardless of whether the development of a hospital information system is in progress or not, it can be said that the development of such information systems is gradually spreading outside of hospitals and the situation is changing. From the viewpoint of patients, medical services are not limited to those from hospitals. Patient-centered collaboration between hospitals/clinics and pharmacies (but not the collaboration between hospital pharmacists and community pharmacists (why not?)) can provide good medical services only if patient information is shared. It is essential to establish a system for providing a drug guide for patients, in order to have patients understand drug information. The preparation of Drug Information for Patients would provide health care specialists a communication tool that helps minimize patient risk.	NTT Med Ctr Tokyo, Dept Pharm, Shinagawa Ku, Tokyo 1418625, Japan	Orii, T (reprint author), NTT Med Ctr Tokyo, Dept Pharm, Shinagawa Ku, 5-9-22 Higashi Gotanda, Tokyo 1418625, Japan.	orii-tky@umin.ac.jp					Lenchus J. D., 2011, LEGAL BACKGROUNDER, V26, P1; Yamamoto M., 2013, MED DRUG J, V49, P643	2	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					285	289				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400023		
J	Asada, K				Asada, Kazuhiro			Findings from a Questionnaire Survey on New Guidelines for Preparing Drug Guide for Patients and a Perspective from a Pharmaceutical Company as the Information Provider	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						Drug Guide for Patients; draft guideline; questionnaire survey		Draft versions of two products of based on a "Drug Guide for Patients" have been prepared the guidelines proposed in "Research on risk communication between patients and healthcare professionals regarding information on safety measures for drugs, etc." by Health and Labour Sciences Research Grants. We conducted a questionnaire survey on the draft to identify issues regarding the contents and their preparation from the viewpoint of pharmaceutical companies as authors. The questionnaire results indicated that, the segments of the contents of the "Drug Guide for Patients" based on the new guidelines are generally acceptable. In this paper, the author offers proposals to address issues regarding the preparation of easy-to-read contents for patients and strategies to promote the overall understanding recognition of Drug Guide for Patients. Drug Guide for Patients are expected to be utilized as materials providing information to be used for routine risk minimization activities of the Risk Management Plan in the future.	JPMA, Drug Evaluat Comm, Post Mkt Surveillance Expert Comm, Chuo Ku, Tokyo 1030023, Japan	Asada, K (reprint author), JPMA, Drug Evaluat Comm, Post Mkt Surveillance Expert Comm, Chuo Ku, 3-4-1 Nihonbashi Honcho, Tokyo 1030023, Japan.	kazuhiro.asada@torii.co.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					291	295				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400024		
J	Sato, T				Sato, Tsugumichi			What Is a Medication Guide Suits Patients' Needs?	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						Drug Guide for Patients; drug information; patients' needs; patient-centered care; risk communication		In order for a patient to read a medication guide and develop appropriate behavior regarding use of the medication, the guide should suit patients' needs. In medical care, the primary needs of patients are preventing/curing disease and/or relieving symptoms. Certainly, patients would like knowledge about what can be expected after taking a medication. However, current "Drug Guides for Patients" are based on drug labeling, which is essentially a medically sophisticated instruction manual for medical professionals who have existing knowledge about the medical treatment of the disease. Thus, there seems to be a gap in patients' needs and the contents of existing drug guides. Consequently, this disconnect may be part of the reason Drug Guides for Patients have been underused. If a patient treatment guide, which gives an overview of the disease and possible treatment strategies, is provided in conjunction with a drug guide, this combination may be useful for satisfying patients' needs. In addition, patients generally prefer detailed drug information. Consistently, surveys have revealed that many patients would like to get more information about prescribed medicine than what is frequently provided in medical practice. Furthermore, one survey reported that detailed information about possible side effects resulted in improved compliance. The need to provide patients with drug information can be considered from three points of view: patients' rights, best decision-making by the patient, and minimizing risks. Although in daily practice doctors and pharmacists may have some difficulty providing detailed medication information that includes all possible risks, more effective ways to communicate this information to patients have been suggested.	Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Pharm, Noda, Chiba 2788510, Japan	Sato, T (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Pharm, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	tsugusato@rs.tus.ac.jp					Asai R., 2000, FARUMASHIA, V36, P976; Beppu H., 1995, GEKKAN YAKUJI, V37, P1277; Committee on Quality of Health Care in America. Institute of Medicine, 2001, CROSSING QUALITY CHA; Fujimoto Pharmaceutical Corporation, TERMS NI TSUI; Herxheimer A., 2014, HAND S IYAK ANZ KANS, P17; Hirokawa R., 1992, AIDS KARANO KOKUHATS; Igarashi T., 2013, FARUMASHIA, V48, P1163; Ikeda Y., 2002, J JPN SOC HOSP PHARM, V38, P197; Ishizuka R., 1998, JPN J HOSP PHARM, V34, P1033; Kawana T., 2012, PHARM MED DEVICE REG, V43, P110; Kobayashi E., 2011, PHARM MED DEVICE REG, V42, P723; Matsuyama K., 1998, JPN J HOSP PHARM, V24, P243; Ministry of Health Labour and Welfare, JUT FUK SHIKK BETS T; Ministry of Health Labour and Welfare, IYAK RIS KANR KEIK S; Ministry of Health Labour and Welfare, 2014, KANJ IYAK GAID SAK Y; Murohara M., 1992, JPN J HOSP PHARM, V18, P236; National Institute of Public Health, MHLW GRANTS SYST; Ninomiya E., 1990, JPN J CLIN PHARM THE, V21, P341; Pecorino P. A., MED ETHICS PATIENTS; Pharmaceuticals and Medical Devices Agency, KANJ IYAK GAID; Suka M., 2011, J JAPAN SOC HEALTHCA, V48, P235; Tensho M., 2011, GEKKAN YAKUJI, V53, P349; Tsuchiya F., 1997, JUDAINA FUKUSAYO KAI, P1; World Medical Association (WMA), WMA DECL LISB RIGHTS; Yamamoto H., 2011, GEKKAN YAKUJI, V53, P343; Yamamoto M., 2013, JPN J SOC PHARM, V32, P8; Yamamoto M., 2013, YAKUGAI FUKUSAYO GAK, P30; Yamazaki S., 1996, GEKKAN YAKUJI, V38, P353	28	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					297	306				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400025		
J	Ogra, Y				Ogra, Yasumitsu			Development of Metallomics Research on Environmental Toxicology	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						metallomics; speciation; hyphenated technique; inductively coupled argon plasma mass spectrometry; selenium; metallothionein	TANDEM MASS-SPECTROMETRY; SELENIUM METABOLITES; ICP-MS; L-SELENOMETHIONINE; ALLIUM-SATIVUM; HUMAN URINE; SPECIATION; IDENTIFICATION; TELLURIUM; SELENOMETABOLITES	Metallomics is newly coined terms and defined as a comprehensive analysis of the entirety of metal and metalloid species within a cell or tissue type. Then, metallome is defined as the entire category of metalloproteins and any other metal-containing biomolecules. Metallomics and research on metallome require analytical techniques that can provide information on the identification and quantification of metal/metalloid-containing biomolecules. This concept has been called speciation, and the acquisition of data according to the concept is performed using hyphenated techniques involving both separation and detection methods. In this review, the author intends to present several applications of complementary use of HPLC-inductively coupled plasma mass spectrometry (ICP-MS) and HPLC-electrospray ionization tandem mass spectrometry for identification of unknown selenium-containing metabolites, and also to present a newly developed technique, capillary LC-ICP-MS to be used for the analysis of metal-binding proteins.	Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, Machida, Tokyo 1948543, Japan	Ogra, Y (reprint author), Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	ogra@ac.shoyaku.ac.jp		Ogra, Yasumitsu/0000-0002-8268-1828			Anan Y, 2013, METALLOMICS, V5, P1215, DOI 10.1039/c3mt00108c; Ogra Y, 2007, J ANAL ATOM SPECTROM, V22, P1390, DOI 10.1039/b707348h; Ogra Y, 2013, METALLOMICS, V5, P429, DOI 10.1039/c2mt20187a; Haraguchi H, 2004, J ANAL ATOM SPECTROM, V19, P5, DOI 10.1039/b308213j; Ogra Y, 2008, ANAL BIOANAL CHEM, V390, P1685, DOI 10.1007/s00216-007-1796-8; Miyayama T, 2007, J ANAL ATOM SPECTROM, V22, P179, DOI 10.1039/b613662c; Ogra Y, 2002, J CHROMATOGR B, V767, P301, DOI 10.1016/S1570-0232(01)00581-5; Lobinski R, 2010, PURE APPL CHEM, V82, P493, DOI 10.1351/PAC-REP-09-03-04; Kuehnelt D, 2007, TOXICOL APPL PHARM, V220, P211, DOI 10.1016/j.taap.2007.01.005; Ogra Y, 2008, J INORG BIOCHEM, V102, P1507, DOI 10.1016/j.jinorgbio.2008.01.012; Francesconi KA, 2004, CLIN CHEM, V50, P2240, DOI 10.1373/clinchem.2004.039875; Anan Y, 2011, J ANAL ATOM SPECTROM, V26, P80, DOI 10.1039/c0ja00031k; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Ogra Y, 2009, J ANAL ATOM SPECTROM, V24, P1477, DOI 10.1039/b910235c; Ogra Y, 2005, J CHROMATOGR A, V1093, P118, DOI 10.1016/j.chroma.2005.07.081; Templeton DM, 2000, PURE APPL CHEM, V72, P1453, DOI 10.1351/pac200072081453; BYARD JL, 1969, ARCH BIOCHEM BIOPHYS, V130, P556, DOI 10.1016/0003-9861(69)90070-8; Yamashita Y, 2010, J BIOL CHEM, V285, P18134, DOI 10.1074/jbc.C110.106377; Suzuki KT, 2002, FOOD ADDIT CONTAM, V19, P974, DOI 10.1080/02652030210153578; Gammelgaard B, 2004, J ANAL ATOM SPECTROM, V19, P135, DOI 10.1039/b307539g; Bettmer J, 2009, J PROTEOMICS, V72, P989, DOI 10.1016/j.jprot.2009.05.003; Kuehnelt D, 2005, ANAL BIOANAL CHEM, V383, P235, DOI 10.1007/s00216-005-0007-8; Bock A, 2007, BIOL CHEM, V388, P985, DOI 10.1515/BC.2007.148; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Kobayashi Y, 2002, P NATL ACAD SCI USA, V99, P15932, DOI 10.1073/pnas.252610699; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Miyayama T, 2011, METALLOMICS, V3, P693, DOI 10.1039/c1mt00016k; Ogra Y, 2009, METALLOMICS, V1, P78, DOI 10.1039/b813118j; Ogra Y, 2004, ANAL BIOANAL CHEM, V379, P861, DOI 10.1007/s00216-004-2670-6; Ogra Y, 2007, J ANAL ATOM SPECTROM, V22, P153, DOI 10.1039/b613835g; Ogra Y, 2010, METALLOMICS, V2, P328, DOI 10.1039/c000088d; Ogra Y, 2008, ANAL BIOANAL CHEM, V390, P45, DOI 10.1007/s00216-007-1546-y; Szpunar J, 2003, APPL SPECTROSC, V57, p102A	33	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					307	314				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400026		
J	Murata, I; Otsuka, A; Hara, C; Motohashi, R; Kouno, S; Inoue, Y; Kanamoto, I				Murata, Isamu; Otsuka, Akio; Hara, Chihiro; Motohashi, Risa; Kouno, Shiho; Inoue, Yutaka; Kanamoto, Ikuo			Pharmacokinetics Characteristics of Dexamethasone in Crush Syndrome Model Rats	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						crush syndrome; dexamethasone; pharmacokinetic parameter; HPLC-UV	SHOCK; REPERFUSION; MANAGEMENT; MICROSOMES; RECEPTOR; INJURY	Crush syndrome (CS) is characterized by ischemia/reperfusion-induced rhabdomyolysis and subsequent systemic inflammation and has a high mortality rate, even when treated with conventional therapy. In previous studies, we demonstrated that treatment of rats with acute lethal CS using dexamethasone (DEX) had therapeutic effects in laboratory findings and improved the clinical course of CS. However, because the application of DEX in CS therapy is unknown, evaluation of the pharmacokinetic parameters of DEX was considered essential to support its clinical use. Here, we investigated the pharmacokinetic characteristics of DEX in a rat model of CS. Anesthetized rats were subjected to bilateral hind limb compression using rubber tourniquets for 5 h, followed by reperfusion for 0 to 24 h. Rats were divided randomly into 4 groups: saline-treated sham (S) and CS groups and 5.0 mg/kg DEX-treated S (S-DEX) and CS (CS-DEX) groups. Blood and tissue samples were collected for HPLC analysis. In the CS-DEX group, the pharmacokinetic parameters of the area under the concentration-time curve, mean residence time, and distribution volume levels increased significantly compared to the S-DEX group, whereas total body clearance, elimination rate constant, and renal clearance levels decreased significantly. Moreover, decrease of muscle tissue DEX concentration and of CYP3A activity were observed in the CS-DEX group. These results show the pharmacokinetic characteristics of DEX in the rat CS model and support the potential use of DEX in disaster medical care.	[Murata, Isamu; Otsuka, Akio; Hara, Chihiro; Motohashi, Risa; Kouno, Shiho; Inoue, Yutaka; Kanamoto, Ikuo] Josai Univ, Fac Pharmaceut Sci, Lab Drug Safety Managemen, Sakado, Saitama 3500295, Japan	Murata, I (reprint author), Josai Univ, Fac Pharmaceut Sci, Lab Drug Safety Managemen, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	ismurata@josai.ac.jp					Pascussi JM, 2000, MOL PHARMACOL, V58, P361; Oda J, 1997, J TRAUMA, V42, P470, DOI 10.1097/00005373-199703000-00015; Murata I, 2011, J TRAUMA, V70, P1453, DOI 10.1097/TA.0b013e31820ca00a; Otagiri M, 2009, YAKUGAKU ZASSHI, V129, P413; BETTER OS, 1990, NEW ENGL J MED, V322, P825; Baltes MRH, 1998, J CHROMATOGR B, V706, P201, DOI 10.1016/S0378-4347(97)00565-3; Cuzzocrea S, 1997, J IMMUNOL, V159, P5089; DIETZMAN R H, 1969, Angiology, V20, P691, DOI 10.1177/000331976902001108; Gonzalez Dario, 2005, Crit Care Med, V33, pS34, DOI 10.1097/01.CCM.0000151065.13564.6F; Greaves I, 2003, J R Army Med Corps, V149, P255; Inoue Y., 2013, JAPANESE J REANIMATO, V32, P23; Iqbal MS, 2006, CHROMATOGRAPHIA, V64, P219, DOI 10.1365/s10337-006-0019-3; MIDDLETO.ES, 1969, ANN SURG, V170, P174, DOI 10.1097/00000658-196908000-00003; Murata I, 2013, J TRAUMA ACUTE CARE, V75, P241, DOI 10.1097/TA.0b013e3182905f11; Nakajou K, 2005, J BIOCHEM, V137, P607, DOI 10.1093/jb/mvi071; NOMURA A, 1995, YAKUGAKU ZASSHI, V115, P633; SAMBHI MP, 1965, CIRCULATION, V31, P523; SCHUMER W, 1970, ARCH SURG-CHICAGO, V100, P405; Sever MS, 2006, NEW ENGL J MED, V354, P1052, DOI 10.1056/NEJMra054329; Shi Ying-kang, 2010, Chin J Traumatol, V13, P131; TOPFER F, 1995, INT J PARASITOL, V25, P1259, DOI 10.1016/0020-7519(95)00052-4; Yokota J., 2005, JMAJ, V48, P341	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					315	322				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400027		
J	Taniuchi, N; Niidome, T; Sugimoto, H				Taniuchi, Nobuhiko; Niidome, Tetsuhiro; Sugimoto, Hachiro			Fundamental Study of Memory Impairment and Non-cognitive Behavioral Alterations in APPswe/PS1dE9 Mice	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						APPswe/PS1dE9 mouse; spatial memory; locomotor activity	FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; EXPLORATORY ACTIVITY; MOUSE MODEL; IN-VIVO; HIPPOCAMPAL; DEPOSITION; SYMPTOMS; DEFICITS	In addition to cognitive decline, Alzheimer's disease patients also exhibit non-cognitive symptoms commonly referred to as behavioral and psychological symptoms of dementia, or BPSD. These symptoms have a serious impact on the quality of life of these patients, as well as that of their caregivers, but there are currently no effective therapies. The amyloid beta-peptide (A beta) is suspected to play a central role in the cascade leading to Alzheimer's disease, but the precise mechanisms are still incompletely known. To assess the influence of A beta pathology on cognitive and non-cognitive behaviors, we examined locomotor activity, motor coordination, and spatial memory in male and female APPswePS1dE9 mice (Alzheimer's disease model, double transgenic mice expressing an amyloid precursor protein with Swedish mutation and a presenilin-1 with deletion of exon 9) at 5 months of age, when the mice had subtle A beta deposits, and again at 9 months of age, when the mice had numerous A beta deposits. Compared to wild-type mice, the male and female APPswe/PS1dE9 mice showed normal motor coordination in the rotarod test at both 5 and 9 months. In the Morris water maze test, male and female APPswe/PS1dE9 mice showed impaired spatial memory at 9 months; however, no such deficits were found at 5 months. In a locomotor activity test, male APPswe/PS1dE9 mice exhibited locomotor hyperactivity at 9 months, while females exhibited locomotor hyperactivity at both 5 and 9 months compared to the control mice. Together, these results indicate that APPswe/PS1dE9 mice developed spatial memory impairment and BPSD-like behavioral alterations resulting from A beta accumulation.	[Taniuchi, Nobuhiko; Niidome, Tetsuhiro; Sugimoto, Hachiro] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Neurosci Drug Discovery, Sakyo Ku, Kyoto 6068501, Japan	Sugimoto, H (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Neurosci Drug Discovery, Sakyo Ku, Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	hsugimot@mail.doshisha.ac.jp					Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Taniuchi N, 2007, NEUROREPORT, V18, P1801; Heneka MT, 2006, J NEUROSCI, V26, P1343, DOI 10.1523/JNEUROSCI.4236-05.2006; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Corder EH, 2004, ANN NY ACAD SCI, V1019, P24, DOI 10.1196/annals.1297.005; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Goddyn H, 2006, BEHAV BRAIN RES, V173, P138, DOI 10.1016/j.bbr.2006.06.016; Lanari A, 2006, MECH AGEING DEV, V127, P158, DOI 10.1016/j.mad.2005.09.016; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Amtul Z, 2010, NEUROSCIENCE, V169, P781, DOI 10.1016/j.neuroscience.2010.05.031; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; BACHMAN DL, 1992, NEUROLOGY, V42, P115; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; COHEN CA, 1993, GERONTOLOGIST, V33, P714; Coutureau E, 2000, EXP BRAIN RES, V131, P381, DOI 10.1007/s002219900301; Edwards SR, 2014, CLIN EXP PHARMACOL P, V41, P798, DOI 10.1111/1440-1681.12277; Fargo K., 2014, ALZHEIMERS DEMENT, V10, pe47; Finkel SI, 2003, CLIN GERIATR MED, V19, P799, DOI 10.1016/S0749-0690(03)00046-6; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goto Y, 2008, EUR J PHARMACOL, V583, P84, DOI 10.1016/j.ejphar.2008.01.030; Jansen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063643; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li LX, 2009, BRAIN RES BULL, V78, P145, DOI 10.1016/j.brainresbull.2008.09.019; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Rosario ER, 2010, BRAIN RES, V1359, P281, DOI 10.1016/j.brainres.2010.08.068; Suo ZM, 2004, J NEUROSCI, V24, P3444, DOI 10.1523/JNEUROSCI.4856-03.2004	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	FEB	2015	135	2					323	329				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA1RY	WOS:000348690400028		
J	Ashida, F; Sakata, S; Ohtsuka, T				Ashida, Fumihiro; Sakata, Sei-ichiro; Ohtsuka, Tatsuya			Analysis of complicated one-dimensional stress oscillation behaviour in a functionally graded material plate	ZAMM-ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND MECHANIK			English	Article						Complicated stress oscillation; one-dimensional elastodynamic problem; exact analytical solution; functionally graded material plate; mechanical impedance	THICK HOLLOW CYLINDERS; SPHERICALLY SYMMETRIC PROBLEMS; WAVE-PROPAGATION; THERMOELASTIC WAVES; DYNAMIC LOADINGS; ELASTICITY; SPHERE	A one-dimensional elastodynamic problem in a functionally graded material (FGM) plate subjected to an impact pressure is analyzed in this paper. Applying techniques of the space-variable transformation and Laplace transform, exact analytical solutions are derived for two cases of variations in material properties when nonhomogeneous material properties are expressed as exponential functions of the space-variable. Numerical calculations for time histories of stresses have been carried out. Analytical and numerical results reveal that the stress oscillation obtained from one analytical solution is complicated and quasi-periodic when the mechanical impedance depends on the space-variable, whereas it derived from the other analytical solution is monotonic and periodic when the impedance is independent of the space-variable. The factor which causes the different behaviours is also investigated based on the analytical and numerical results. This effect could be a key to controlling a complicated stress oscillation in an FGM plate. (C) 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Ashida, Fumihiro] Shimane Univ, Dept Mech Elect & Elect Engn, Matsue, Shimane 6908504, Japan; [Sakata, Sei-ichiro] Kinki Univ, Dept Mech Engn, Higashiosaka, Osaka 5778502, Japan; [Ohtsuka, Tatsuya] Daio Paper Cooperat, Shikokuchuo, Ehime 7990492, Japan		ashida@ecs.shimane-u.ac.jp					Abu-Alshaikh I, 2006, J ENG MATH, V54, P17, DOI 10.1007/s10665-005-7718-x; Akbari A, 2010, CMES-COMP MODEL ENG, V65, P27; Hosseini SM, 2009, MATER DESIGN, V30, P2011, DOI 10.1016/j.matdes.2008.08.048; Safari-Kahnaki A, 2011, INT J MECH MATER DES, V7, P167, DOI 10.1007/s10999-011-9157-3; Sun D, 2011, COMPOS PART B-ENG, V42, P657, DOI 10.1016/j.compositesb.2011.02.020; Sun D, 2011, COMPOS STRUCT, V93, P1474, DOI 10.1016/j.compstruct.2010.12.002; Berezovski A, 2003, EUR J MECH A-SOLID, V22, P257, DOI 10.1016/S0997-7538(03)00029-9; Babaei MH, 2010, P R SOC A, V466, P1077, DOI 10.1098/rspa.2009.0543; Chiu TC, 1999, J SOUND VIB, V222, P453, DOI 10.1006/jsvi.1998.2065; Asgari M, 2009, ACTA MECH, V208, P163, DOI 10.1007/s00707-008-0133-4; Bagri A, 2008, COMPOS STRUCT, V83, P168, DOI 10.1016/j.compstruct.2007.04.024; Aksoy HG, 2009, FINITE ELEM ANAL DES, V45, P876, DOI 10.1016/j.finel.2009.06.025; Asemi K, 2010, INT J MECH MATER DES, V6, P367, DOI 10.1007/s10999-010-9144-0; Bagri A, 2007, J THERM STRESSES, V30, P1175, DOI 10.1080/01495730701519508; Ding HJ, 2003, INT J MECH SCI, V45, P1029, DOI 10.1016/j.ijmecsci.2003.09.005; Gradshteyn I. S., 1980, TABLES INTEGRALS SER, P971; Javanbakht M, 2012, APPL MATH MODEL, V36, P5320, DOI 10.1016/j.apm.2011.12.022; Kanoria M, 2010, J THERM STRESSES, V33, P459, DOI 10.1080/01495731003738440; Ma CC, 2012, CMC-COMPUT MATER CON, V31, P37; Nikkhah M, 2011, APPL MATH MECH-ENGL, V32, P189, DOI 10.1007/s10483-011-1405-9; Nikkhah M, 2010, INT J MECH MATER DES, V6, P239, DOI 10.1007/s10999-010-9133-3; Shariyat M, 2011, INT J PRES VES PIP, V88, P75, DOI 10.1016/j.ijpvp.2011.01.005; Banks-Sills L, 2002, COMPOS PART B-ENG, V33, P7, DOI 10.1016/S1359-8368(01)00057-9; Sumi N, 1997, J THERM STRESSES, V20, P281, DOI 10.1080/01495739708956103; Sun D, 2012, APPL MATH MODEL, V36, P444, DOI 10.1016/j.apm.2011.07.023	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0044-2267	1521-4001		ZAMM-Z ANGEW MATH ME	ZAMM-Z. Angew. Math. Mech.	FEB	2015	95	2					184	192		10.1002/zamm.201300082		9	Mathematics, Applied; Mechanics	Mathematics; Mechanics	CA2CW	WOS:000348717500006		
J	Noguchi, M; Yoshioka, K; Hikono, H; Iwagami, G; Suzuki, C; Kikuchi, K				Noguchi, Michiko; Yoshioka, Koji; Hikono, Hirokazu; Iwagami, Gentaro; Suzuki, Chie; Kikuchi, Kazuhiro			Centrifugation on Percoll density gradient enhances motility, membrane integrity and in vitro fertilizing ability of frozen-thawed boar sperm	ZYGOTE			English	Article						Acrosomal membrane; In vitro fertilization; Plasma membrane; Sperm motility	BOVINE EMBRYO PRODUCTION; PORCINE OOCYTES; IVF SYSTEMS; PIG OOCYTES; SEMEN; SPERMATOZOA; CRYOPRESERVATION; MATURATION; COINCUBATION; PENETRATION	The effects of Percoll density gradient centrifugation on sperm quality, in vitro fertilizability and developmental capacity of frozen-thawed boar sperm were evaluated. Two-step density gradient centrifugation by Percoll enhanced significantly the motility parameters of sperm compared with a simple centrifugation procedure. Percentages of motile sperm and sperm with intact plasma and acrosome membranes after Percoll separation were significantly greater than those after simple centrifugation. The rates of penetration, cleavage and blastocyst formation after in vitro fertilization were significantly improved by Percoll separation compared with simple centrifugation and were influenced positively by the intactness of sperm head membranes, but not any sperm motility parameters. However, insemination with increased concentrations of sperm prepared by Percoll gradient centrifugation did not improve the success of fertilization and embryo development in vitro. Our results indicate that the integrity of sperm head membranes after Percoll separation is important for successful embryo development in vitro, more so than sperm motility.	[Yoshioka, Koji] Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; Hokkaido Res Org, Shintoku, Hokkaido, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Yoshioka, K (reprint author), Natl Inst Anim Hlth, Kannondai 3-1-5, Tsukuba, Ibaraki 3050856, Japan.	kojiyos@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [21011]	This research was supported by a grant for research and development projects for application in promoting new policy of agriculture, forestry and fisheries (No. 21011) from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Bailey JL, 2000, J ANDROL, V21, P1; Jeong BS, 2001, MOL REPROD DEV, V59, P330, DOI 10.1002/mrd.1038; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Matas C, 2011, ANIM REPROD SCI, V127, P62, DOI 10.1016/j.anireprosci.2011.06.009; Pena FJ, 2003, THERIOGENOLOGY, V60, P677, DOI 10.1016/S0093-691X(03)00081-5; GRANT SA, 1994, J REPROD FERTIL, V100, P477; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Carvajal G, 2004, J ANDROL, V25, P389; Maxwell WMC, 1997, MOL REPROD DEV, V46, P408, DOI 10.1002/(SICI)1098-2795(199703)46:3<408::AID-MRD21>3.0.CO;2-T; Flores E, 2008, THERIOGENOLOGY, V70, P936, DOI 10.1016/j.theriogenology.2008.05.056; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Ward F, 2003, THERIOGENOLOGY, V59, P1575, DOI 10.1016/S0093-691X(02)01202-5; Funahashi H, 2003, REPROD FERT DEVELOP, V15, P167, DOI 10.1071/RD02076; Ikeda H, 2002, THERIOGENOLOGY, V57, P1309, DOI 10.1016/S0093-691X(02)00630-1; Rath D, 1997, THERIOGENOLOGY, V47, P785, DOI 10.1016/S0093-691X(97)00034-4; Donnelly ET, 1998, FERTIL STERIL, V70, P305, DOI 10.1016/S0015-0282(98)00146-0; Gil MA, 2007, THERIOGENOLOGY, V67, P620, DOI 10.1016/j.theriogenology.2006.09.022; Brito LFC, 2003, THERIOGENOLOGY, V60, P1539, DOI 10.1016/S0093-691X(03)00174-2; Curry MR, 2000, REV REPROD, V5, P46, DOI 10.1530/ror.0.0050046; Machado GM, 2009, THERIOGENOLOGY, V71, P1289, DOI 10.1016/j.theriogenology.2009.01.002; Ward F, 2002, THERIOGENOLOGY, V57, P2105, DOI 10.1016/S0093-691X(02)00696-9; Gil MA, 2008, THERIOGENOLOGY, V70, P1260, DOI 10.1016/j.theriogenology.2008.06.004; Suzuki K, 2003, THERIOGENOLOGY, V60, P1481, DOI 10.1016/S0093-691X(03)00115-8; Suzuki C, 2005, THERIOGENOLOGY, V64, P1287, DOI 10.1016/j.theriogenology.2005.03.009; Cesari A, 2006, THERIOGENOLOGY, V66, P1185, DOI 10.1016/j.theriogenology.2006.03.029; DROBNIS EZ, 1991, J ANDROL, V12, P201; Gadea J, 2005, THERIOGENOLOGY, V63, P431, DOI 10.1016/j.theriogenology.2004.09.023; Gil MA, 2005, THERIOGENOLOGY, V64, P305, DOI 10.1016/j.theriogenology.2004.11.024; Martecikova S, 2010, VET MED-CZECH, V55, P429; Mercado E., 2009, ANIM REPROD SCI, V115, P149; Mito T, 2009, THERIOGENOLOGY, V72, P841, DOI 10.1016/j.theriogenology.2009.06.004; Oliveira L.Z., 2011, ANDROLOGIA, V44, P9; Popwell JM, 2004, ANIM REPROD SCI, V81, P97, DOI 10.1016/j.anireprosci.2003.08.007; Salumets A, 2002, FERTIL STERIL, V78, P1082, DOI 10.1016/S0015-0282(02)04215-2; SONE M, 1992, Japanese Journal of Swine Science, V29, P41; Suzuki K, 2003, ANIM REPROD SCI, V77, P157, DOI 10.1016/S0378-4320(03)00035-6; Tartaglione CM, 2004, THERIOGENOLOGY, V62, P1245, DOI 10.1016/j.theriogenology.2004.01.012; Valcarcel A, 1996, ANIM REPROD SCI, V41, P215, DOI 10.1016/0378-4320(95)01453-5; WANG WH, 1991, J REPROD FERTIL, V93, P491; Xu X, 1996, THERIOGENOLOGY, V46, P1325, DOI 10.1016/S0093-691X(96)00313-5; Xu X, 1996, THERIOGENOLOGY, V45, P745, DOI 10.1016/0093-691X(96)00004-0	41	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0967-1994	1469-8730		ZYGOTE	Zygote	FEB	2015	23	1					68	75		10.1017/S0967199413000208		8	Cell Biology; Developmental Biology; Reproductive Biology	Cell Biology; Developmental Biology; Reproductive Biology	CA1WG	WOS:000348699000008		
J	Yoon, JH; Lee, JM; Lee, ES; Baek, J; Lee, S; Iwadate, Y; Han, JK; Choi, BI				Yoon, Jeong Hee; Lee, Jeong Min; Lee, Eun Sun; Baek, Jeehyun; Lee, Sangwoo; Iwadate, Yuji; Han, Joon Koo; Choi, Byung Ihn			Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity	ABDOMINAL IMAGING			English	Article						Magnetic resonance imaging; Hepatobiliary phase; Respiratory-gated imaging; Gd-EOB-DTPA; Gadoxetic acid	MULTIDETECTOR-ROW CT; HEPATOCELLULAR CARCINOMAS; OBSERVER PERFORMANCE; HEPATOBILIARY-PHASE; HEPATOCYTE PHASE; FLIP ANGLE; EOB-DTPA; 3.0 T; MRI; METASTASES	Purpose: To determine whether a navigator-gated three-dimensional T1-weighted gradient-echo sequence (T1W-GRE, navigated LAVA) can improve diagnostic performance for the detection of focal liver lesions (FLLs) compared to standard breath-hold (BH) T1W-GRE breath-hold LAVA (BH-LAVA) during the hepatobiliary phase (HBP) of gadoxetic acid liver magnetic resonance imaging (MRI) in patients with limited breath-holding capacity. Materials and methods: This retrospective study was approved by our institutional review board and the requirement for informed consent was waived. We included 372 patients who underwent liver MRI including both navigated LAVA and BH-LAVA sequences. Overall image quality of the two HBP image sets was compared. In patients with limited breath-holding capacity, diagnostic performances in detecting FLLs on the two HBP images were compared using jackknife-alternative free-response receiver-operating characteristic (JAFROC) analysis by two reviewers. Results: There were 13 cases (13/372; 3.5%) of image acquisition failure using the navigated LAVA sequence due to severe irregular breathing, and 50 of 359 patients had limited breath-holding capacity. In these patients, overall image quality of navigated LAVA (2.78 +/- 0.95) was significantly better than that of BH-LAVA (2.42 +/- 0.81, P < 0.005), and both readers showed significantly higher JAFROC figure-of-merit values with navigated LAVA compared to BH-LAVA (0.94 and 0.86 in reviewer 1, respectively; 0.89 and 0.83 in reviewer 2, respectively, P < 0.005). Overall image quality of navigated LAVA was also better than that of BH-LAVA in patients with sufficient breath-holding capacity (n = 309, 3.96 +/- 0.88, 3.81 +/- 0.66, respectively, P < 0.001). Conclusion: The navigated LAVA sequence could provide better image quality and diagnostic performance in detecting FLLs than BH-LAVA in patients with limited breath-holding capacity during HBP of gadoxetic acid MRI.	[Yoon, Jeong Hee; Lee, Jeong Min; Han, Joon Koo; Choi, Byung Ihn] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Lee, Jeong Min; Han, Joon Koo; Choi, Byung Ihn] Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul 110744, South Korea; [Lee, Eun Sun] Natl Canc Ctr, Dept Radiol, Goyang Si, Gyeonggi Do, South Korea; [Baek, Jeehyun] Human Med Imaging & Intervent Ctr, Seoul, South Korea; [Lee, Sangwoo] GE Healthcare, Global Appl Sci Lab, Seoul, South Korea; [Iwadate, Yuji] GE Healthcare, Global Appl Sci Lab, Tokyo, Japan	Lee, JM (reprint author), Seoul Natl Univ Hosp, Dept Radiol, 101 Daehak Ro, Seoul 110744, South Korea.	JMSH@SNU.AC.KR					Kitao A, 2011, EUR RADIOL, V21, P2056, DOI 10.1007/s00330-011-2165-8; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Lee KH, 2013, KOREAN J RADIOL, V14, P894, DOI 10.3348/kjr.2013.14.6.894; Ba-Ssalamah A, 2009, EUR RADIOL, V19, P342, DOI 10.1007/s00330-008-1172-x; Sun HY, 2010, INVEST RADIOL, V45, P96, DOI 10.1097/RLI.0b013e3181c5faf7; Becker-Weidman DJS, 2011, RADIOLOGY, V261, P824, DOI 10.1148/radiol.11110157; Nagle SK, 2012, J MAGN RESON IMAGING, V36, P890, DOI 10.1002/jmri.23713; Ayuso C, 2012, ABDOM IMAGING, V37, P215, DOI 10.1007/s00261-011-9794-x; Wile GE, 2010, MAGN RESON IMAGING C, V18, P525, DOI 10.1016/j.mric.2010.07.010; Golfieri R, 2011, EUR RADIOL, V21, P1233, DOI 10.1007/s00330-010-2030-1; Reiner CS, 2013, EUR RADIOL, V23, P3087, DOI 10.1007/s00330-013-2910-2; Lee JM, 2011, KOREAN J RADIOL, V12, P403, DOI 10.3348/kjr.2011.12.4.403; Young PM, 2010, AM J ROENTGENOL, V195, P687, DOI 10.2214/AJR.09.3892; Horton KM, 1999, RADIOGRAPHICS, V19, P431; Zheng B, 2005, MED PHYS, V32, P1031, DOI 10.1118/1.1884766; Mainenti PP, 2010, ABDOM IMAGING, V35, P511, DOI 10.1007/s00261-009-9555-2; Berger-Kulemann V, 2012, EJSO-EUR J SURG ONC, V38, P670, DOI 10.1016/j.ejso.2012.05.004; Bashir MR, 2011, EUR RADIOL, V21, P291, DOI 10.1007/s00330-010-1917-1; Yun EJ, 1999, ABDOM IMAGING, V24, P262, DOI 10.1007/s002619900492; Vasanawala SS, 2010, PEDIATR RADIOL, V40, P340, DOI 10.1007/s00247-009-1502-4; Yoon JH, 2014, ABDOM IMAGING, V39, P711, DOI 10.1007/s00261-014-0099-8; Motosugi U, 2011, RADIOLOGY, V260, P446, DOI 10.1148/radiol.11103548; Gore RM, 2012, CANCER IMAGING, V12, P373, DOI 10.1102/1470-7330.2012.9028; Bashir MR, 2012, J MAGN RESON IMAGING, V35, P611, DOI 10.1002/jmri.22850; Asbach P, 2008, INVEST RADIOL, V43, P809, DOI 10.1097/RLI.0b013e318186242b; Ahn SJ, 2011, J MAGN RESON IMAGING, V34, P310, DOI 10.1002/jmri.22658; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; Chakraborty DP, 2006, ACAD RADIOL, V13, P1187, DOI 10.1016/j.acra.2006.06.016; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Yu MH, 2013, J MAGN RESON IMAGING, V38, P1020, DOI 10.1002/jmri.24088; Golfieri R, 2012, J MAGN RESON IMAGING, V36, P648, DOI 10.1002/jmri.23685; Iwadate Y, 2013, MAGN RESON MED, V72, P172; Knowles B, 2012, HPB, V14, P298, DOI 10.1111/j.1477-2574.2012.00447.x; Maniam Santhi, 2010, World J Radiol, V2, P309, DOI 10.4329/wjr.v2.i8.309; Martin DA, 2005, LITERARY REV, V48, P116; Ringe KI, 2011, EUR J RADIOL, V79, P201, DOI 10.1016/j.ejrad.2010.03.008; Tran PVP, 2013, J MAGN RESON IMAGING, V37, P700, DOI 10.1002/jmri.23864; Yoon MA, 2009, INVEST RADIOL, V44, P641, DOI 10.1097/RLI.0b013e3181ab6e57	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	FEB	2015	40	2					278	288		10.1007/s00261-014-0214-x		11	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	AZ6AC	WOS:000348298800008		
J	Taheri, A; Tatsuoka, F				Taheri, Abbas; Tatsuoka, Fumio			Small- and large-strain behaviour of a cement-treated soil during various loading histories and testing conditions	ACTA GEOTECHNICA			English	Article						Cement-treated soil; Large strain; Loading history; Small strain; Stiffness	TRIAXIAL COMPRESSION TESTS; MIXED GRAVELLY SOIL; DEFORMATION CHARACTERISTICS; STIFFNESS; STRENGTH; SAND	The effects of loading histories on small-strain and large-strain stiffness of a compacted cement-mixed well-graded gravelly soil were evaluated by consolidated drained triaxial compression (TC) tests. Various cyclic loading histories were applied during otherwise continuous monotonic loading at different confining pressures, sigma(h)s, and multiple-step loading with stepwise increase or decrease of sigma(h). To evaluate small-strain stiffness, minute unload/reload cycles were applied during TC loading. The value of peak-to-peak secant modulus from a minute unload/reload cycle was defined as the equivalent Young's modulus, E-eq. The average of E-eq values measured during continuous monotonic loading at low deviator stresses was rather close to the elastic modulus, E-e. As the E-e increased with an increase in the axial stress, the E-eq value increased first and then decreased due to an increase in creep strains. The stress-strain behaviour after the start of a large-scale yielding and the peak shear strength is not noticeably affected by the previous cyclic loading with relatively large stress amplitude. However, the large-strain stiffness during reloading is significantly affected by the following factors controlled by pre-cyclic loading history; (a) strain hardening; (b) strain nonlinearity; (c) hysteresis effect; (d) viscous effect; and (e) damage to bonding by immediately preceding large unloading. The tangent stiffness, E-tan, at a given stress level during reloading becoming larger with an increase in the effects of factor (a) and smaller by the effects of factors (b), (c), (d) and (e). In addition, increase of sigma(h) has a negative effect on stiffness of primary loading curves and a positive effect on stiffness of reloading curves. The effect of loading history on the small-strain stiffness in terms of equivalent Young's modulus, E-eq, was found to be significant. This effect depends on various factors. Four factors-axial stress level, strain-hardening effect, creep effect by the viscous properties and damage due to a loading history-were identified to be responsible for equivalent Young's modulus, E-eq variations. Axial stress increase and strain-hardening effect both increase E-eq, making E-eq closer to the E-e. However, creep strains by the viscous properties and damage due to a loading history both decrease E-eq.	[Taheri, Abbas] Univ Adelaide, Sch Civil Environm & Min Engn, Adelaide, SA 5005, Australia; [Tatsuoka, Fumio] Tokyo Univ Sci, Dept Civil Engn, Tokyo 162, Japan	Taheri, A (reprint author), Univ Adelaide, Sch Civil Environm & Min Engn, Adelaide, SA 5005, Australia.	abbas.taheri@adelaide.edu.au			Japan Society for the Promotion of Science [P08392]	The first author is grateful to the Japan Society for the Promotion of Science for the fellowship (ID No. P08392) supporting this research.	Tatsuoka F, 2009, GEOSYNTH INT, V16, P301, DOI 10.1680/gein.2009.16.4.301; ATKINSON JH, 1990, GEOTECHNIQUE, V40, P531; Aoki H, 2003, GEOSYNTHETICS ENG J, V18, P237; Chang WF, 1988, DEMONSTRATION PROJEC; de Magistris FS, 1999, GEOTECH TEST J, V22, P44; Fortuna S, 2006, SOIL STRESS STRAIN B; Goto S., 1991, SOILS FOUND, V31, P169; Hansen KD, 1990, ROLLER COMPACTED CON; Hayano K, 1997, GEOTECHNIQUE, V47, P439; JGS, 2001, 25332001 JGS; Jovicic V, 1997, GEOTECHNIQUE, V47, P357; Kongsukprasert L, 2007, SOILS FOUND, V47, P375, DOI 10.3208/sandf.47.375; Kongsukprasert L, 2003, P 3 INT C PREF DEF C, V1, P569; Kongsukprasert L, 2005, SOILS FOUND, V45, P55; Kongsukprasert L, 2005, SOILS FOUND, V45, P107; Lohani TN, 2004, SOILS FOUND, V44, P95; Schrader EK, 1996, ACI SPECIAL PUBLICAT, P77; Taheri A, 2012, SOILS FOUND, V52, P151; Tatsuoka F, 1999, P 14 IC SMFE HAMB SE, V4, P2129; Tatsuoka F., 1999, P WORKSH MOD ADV TES, P17; Tatsuoka F, 1993, MEASURING SMALL STRA; Tatsuoka F, 2003, J GEOTECH GEOENVIRON, V129, P450, DOI 10.1061/(ASCE)1090-0241(2003)129:6(450); Tatsuoka F., 1995, P INT S PREF DEF GEO, V2, P947; Tatsuoka F, 2004, SOILS FOUND, V44, P83; Tatsuoka F, 1997, GROUND IMPROVEMENT, V1, P37; Tatsuoka F, 2003, P CHAR ENG PROP NAT, P1461; Wang Y, 2005, CAN GEOTECH J, V42, P1200, DOI 10.1139/T05-009; Watanabe K, 2003, P 3 INT C PREF DEF C, V1, P683; Watanabe O, 2003, P 58 ANN C JSCE TOK, V3, P1091	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-1125	1861-1133		ACTA GEOTECH	Acta Geotech.	FEB	2015	10	1					131	155		10.1007/s11440-014-0339-7		25	Engineering, Geological	Engineering	AZ6AJ	WOS:000348299900008		
J	Thal, DR; Walter, J; Saido, TC; Fandrich, M				Thal, Dietmar Rudolf; Walter, Jochen; Saido, Takaomi C.; Faendrich, Marcus			Neuropathology and biochemistry of A beta and its aggregates in Alzheimer's disease	ACTA NEUROPATHOLOGICA			English	Review						Amyloid; Oligomers; Fibrils; Plaques; Alzheimer; Peptide modification; Preclinical AD	AMYLOID PRECURSOR PROTEIN; APP TRANSGENIC MICE; SENILE PLAQUES; HUMAN BRAIN; NATIONAL INSTITUTE; PEPTIDE AGGREGATION; COGNITIVE DECLINE; DIFFUSE PLAQUES; ASSOCIATION GUIDELINES; DIAGNOSTIC GUIDELINES	Alzheimer's disease (AD) is characterized by beta-amyloid plaques and intraneuronal tau aggregation usually associated with cerebral amyloid angiopathy (CAA). Both beta-amyloid plaques and CAA deposits contain fibrillar aggregates of the amyloid beta-peptide (A beta). A beta plaques and CAA develop first in neocortical areas of preclinical AD patients and, then, expand in a characteristic sequence into further brain regions with end-stage pathology in symptomatic AD patients. A beta aggregates are not restricted to amyloid plaques and CAA. Soluble and several types of insoluble non-plaque- and non-CAA-associated A beta aggregates have been described. Amyloid fibrils are products of a complex self-assembly process that involves different types of transient intermediates. Amongst these intermediate species are protofibrils and oligomers. Different variants of A beta peptides may result from alternative processing or from mutations that lead to rare forms of familial AD. These variants can exhibit different self-assembly and aggregation properties. In addition, several post-translational modifications of A beta have been described that result, for example, in the production of N-terminal truncated A beta with pyroglutamate modification at position 3 (A beta(N3pE)) or of A beta phosphorylated at serine 8 (pSer8A beta). Both A beta(N3pE) and pSer8A beta show enhanced aggregation into oligomers and fibrils. However, the earliest detectable soluble and insoluble A beta aggregates in the human brain exhibit non-modified A beta, whereas A beta(N3pE) and pSer8A beta are detected in later stages. This finding indicates the existence of different biochemical stages of A beta aggregate maturation with pSer8A beta being related mainly to cases with symptomatic AD. The conversion from preclinical to symptomatic AD could thereby be related to combined effects of increased A beta concentration, maturation of aggregates and spread of deposits into additional brain regions. Thus, the inhibition of A beta aggregation and maturation before entering the symptomatic stage of the disease as indicated by the accumulation of pSer8A beta may represent an attractive treatment strategy for preventing disease progression.	[Thal, Dietmar Rudolf] Univ Ulm, Inst Pathol, Ctr Biomed Res, Neuropathol Lab, D-89081 Ulm, Germany; [Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Faendrich, Marcus] Univ Ulm, Inst Pharmaceut Biotechnol, Ctr Biomed Res, D-89081 Ulm, Germany	Thal, DR (reprint author), Univ Ulm, Inst Pathol, Ctr Biomed Res, Neuropathol Lab, Helmholtzstr 8-1, D-89081 Ulm, Germany.	dietmar.thal@uni-ulm.de; jochen.walter@ukb.uni-bonn.de; marcus.faendrich@uni-ulm.de			DFG [TH624/6-1, WA1477/6, FA456/12-1]; Alzheimer Forschung Initiative [10810, 13803]	The authors thank Bill Close (Institute for Pharmaceutical Biotechnology, Center for Biomedical Research, University of Ulm, Germany) for reading the manuscript. This study was supported by DFG-Grants TH624/6-1 (DRT), WA1477/6 (JW), FA456/12-1 (MF) and Alzheimer Forschung Initiative Grants #10810, 13803 (DRT).	Akiyama H, 1996, NEUROSCI LETT, V206, P169, DOI 10.1016/S0304-3940(96)12474-5; Alzheimer A, 1907, ALLG Z PSYCHIAT, V64, P146; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Gandy S, 2013, NEURON, V78, P575, DOI 10.1016/j.neuron.2013.05.007; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; MORI H, 1992, J BIOL CHEM, V267, P17082; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681; Kumar S, 2014, J BIOL CHEM, V289, P20318, DOI 10.1074/jbc.M114.554725; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Upadhaya AR, 2012, NEUROBIOL AGING, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; MIRRA SS, 1991, NEUROLOGY, V41, P479; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Weekman EM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-127; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Funato H, 1998, AM J PATHOL, V152, P983; Bayer TA, 2014, ACTA NEUROPATHOL, V127, P787, DOI 10.1007/s00401-014-1287-x; Domert J, 2014, NEUROBIOL DIS, V65, P82, DOI 10.1016/j.nbd.2013.12.019; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; DICKSON DW, 1988, AM J PATHOL, V132, P86; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Benseny-Cases N, 2007, BIOCHEM BIOPH RES CO, V361, P916, DOI 10.1016/j.bbrc.2007.07.082; Kumar S, 2013, ACTA NEUROPATHOL, V125, P699, DOI 10.1007/s00401-013-1107-8; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Terry RD, 2000, J NEUROPATH EXP NEUR, V59, P1118; Yamaguchi H, 1998, ACTA NEUROPATHOL, V95, P217; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Fandrich M, 2009, PRION, V3, P89; Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Thal DR, 2002, NEUROLOGY, V58, P1791; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Thal DR, 2014, J ALZHEIMERS DIS, V42, pS421, DOI 10.3233/JAD-141461; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Morgado I, 2011, CURR OPIN COLLOID IN, V16, P508, DOI 10.1016/j.cocis.2011.06.016; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Rolyan H, 2011, J NEURAL TRANSM, V118, P699, DOI 10.1007/s00702-010-0572-7; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Kane MD, 2000, J NEUROSCI, V20, P3606; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Thal DR, 2013, EUR ARCH PSY CLIN N, V263, pS137, DOI 10.1007/s00406-013-0449-5; Sachse C, 2010, ANGEW CHEM INT EDIT, V49, P1321, DOI 10.1002/anie.200904781; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Thal DR, 2000, J NEUROPATH EXP NEUR, V59, P733; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Bittner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015477; BOOSS J, 1991, ACTA NEUROPATHOL, V82, P172; Capetillo-Zarate E, 2011, AM J PATHOL, V179, P2551, DOI 10.1016/j.ajpath.2011.07.045; Elobeid A, 2014, ALZHEIMERS DEMENT, V10, P522, DOI 10.1016/j.jalz.2012.12.009; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; JENSEN MB, 1994, EXP BRAIN RES, V98, P245; KALARIA RN, 1993, NEUROREPORT, V4, P211, DOI 10.1097/00001756-199302000-00025; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Milton NGN, 2001, NEUROREPORT, V12, P3839, DOI 10.1097/00001756-200112040-00047; Phinney AL, 1999, J NEUROSCI, V19, P8552; Prokop Stefan, 2013, Acta Neuropathol, V126, P461; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rijal Upadhaya A, 2013, ACTA NEUROPATHOL COM, V1, P77, DOI [DOI 10.1186/2051-5960-1-77, 10.1186/2051-5960-1-77]; Sachse C, 2006, J MOL BIOL, V362, P347, DOI 10.1016/j.jmb.2006.07.011; Schulze PC, 1998, NEUROPATHOLOGY, V18, P55, DOI 10.1111/j.1440-1789.1998.tb00078.x; SHAPIRA R, 1988, J NEUROCHEM, V50, P69, DOI 10.1111/j.1471-4159.1988.tb13231.x; Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350; Thal DR, 1997, ACTA NEUROPATHOL, V94, P255; Thal DR, 1998, NEUROBIOL AGING, V19, P517, DOI 10.1016/S0197-4580(98)00090-6; Thal DR, 1998, J BRAIN RES, V39, P175; Upadhaya AR, 2012, J CELL MOL MED, V16, P287, DOI 10.1111/j.1582-4934.2011.01306.x; Vitalis A, 2010, J MOL BIOL, V403, P148, DOI 10.1016/j.jmb.2010.08.003; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; WANG D, 1995, J NEUROPATH EXP NEUR, V54, P548, DOI 10.1097/00005072-199507000-00009; Wisniewski HM, 1973, PROGR NEUROPATHOLOGY, V2, P1	153	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	FEB	2015	129	2					167	182		10.1007/s00401-014-1375-y		16	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AZ7ZS	WOS:000348435100002		
J	Chae, JJ; Ambrose, WM; Espinoza, FA; Mulreany, DG; Ng, S; Takezawa, T; Trexler, MM; Schein, OD; Chuck, RS; Elisseeff, JH				Chae, J. Jeremy; Ambrose, Winnette McIntosh; Espinoza, Freddy A.; Mulreany, Daniel G.; Ng, Shengyong; Takezawa, Toshiaki; Trexler, Morgana M.; Schein, Oliver D.; Chuck, Roy S.; Elisseeff, Jennifer H.			Regeneration of corneal epithelium utilizing a collagen vitrigel membrane in rabbit models for corneal stromal wound and limbal stem cell deficiency	ACTA OPHTHALMOLOGICA			English	Article						cell transplantation; collagen vitrigel; corneal epithelium; corneal wound; fibrin glue; limbal stem cell deficiency	OCULAR SURFACE RECONSTRUCTION; IN-SITU KERATOMILEUSIS; AMNIOTIC MEMBRANE; FIBRIN GLUE; BIOLOGICAL RESPONSE; GENE-EXPRESSION; TRANSPLANTATION; INGROWTH; TISSUE; VITRO	Purpose: This study was performed to evaluate the potential of a collagen-based membrane, collagen vitrigel (CV), for reconstructing corneal epithelium in the stromal wound and limbal stem cell deficiency (LSCD) models. Methods: Three groups of rabbits were used in the stromal wound model: CV affixed using fibrin glue (CV + FG group, n = 9), fibrin glue only (FG group, n = 3) and an untreated control group (n = 3). In the LSCD model, one group received CV containing human limbal epithelial cells (CV + hLEC group, n = 2) and the other was an untreated control (n = 1). Gross observation, including fluorescent staining, pathological examination, immunohistochemistry and electron microscopy, was used to evaluate the effect of CV on the corneal epithelium. Results: In the stromal wound model, fluorescent staining showed that epithelial reconstruction occurred as rapidly in the CV + FG group as it did in the control group. The pathological examination proved that the CV supported a healthy corneal epithelium in the CV + FG group, whereas FG led to hypertrophy and inappropriate differentiation of corneal epithelium in the FG group. In the LSCD model, the corneas in the CV + hLEC group showed sustained tissue transparency with good epithelialization, low inflammatory response and reduced neovascularization. However, the control cornea was translucent and showed high amounts of inflammation and neovascularization. Conclusion: We have demonstrated that CV supports corneal epithelial differentiation and prevents epithelial hypertrophy, in addition to serving as a scaffold for hLEC transplantation, without complications.	[Chae, J. Jeremy; Ambrose, Winnette McIntosh; Espinoza, Freddy A.; Mulreany, Daniel G.; Ng, Shengyong; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA; [Chae, J. Jeremy; Ambrose, Winnette McIntosh; Espinoza, Freddy A.; Mulreany, Daniel G.; Ng, Shengyong; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21231 USA; [Takezawa, Toshiaki] Natl Inst Agrobiol Sci, Div Anim Sci, Tsukuba, Ibaraki, Japan; [Trexler, Morgana M.] Johns Hopkins Univ, Appl Phys Lab, Res & Exploratory Dev Dept, Laurel, MD USA; [Schein, Oliver D.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21231 USA; [Chuck, Roy S.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10467 USA	Chae, JJ (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Smith Bldg Rm 5033 400 N Broadway, Baltimore, MD 21231 USA.	jhe@jhu.edu			Congressionally Directed Medical Research Program under U.S. Army Medical Research and Materiel Command [W81XWH-09-2-0173]; Research to Prevent Blindness (RPB) Foundation; RPB; National Science Foundation Graduate Research Fellowship; UNCF-Merck Graduate Dissertation fellowship; Mokam Scientific Foundation	This study was funded by the Congressionally Directed Medical Research Program under the U.S. Army Medical Research and Materiel Command (Contract No W81XWH-09-2-0173, Program Manager Dr. Charmaine Richman), the Jules Stein Chair from the Research to Prevent Blindness (RPB) Foundation, and an unrestricted core grant from RPB to the Albert Einstein College of Medicine. This study was also funded by a National Science Foundation Graduate Research Fellowship and a UNCF-Merck Graduate Dissertation fellowship to Winnette McIntosh Ambrose, and by the Mokam Scientific Foundation scholarship to J. Jeremy Chae. The authors sincerely thank Dr. Tae Kyun Kim (Joint Reconstruction Center, Department of Orthopedic Surgery, Seoul National University Bundang Hospital) for helpful discussion and review.	Adds PJ, 2001, BRIT J OPHTHALMOL, V85, P905, DOI 10.1136/bjo.85.8.905; Anderson NJ, 2003, J CATARACT REFR SURG, V29, P1425, DOI 10.1016/S0886-3350(02)01989-2; Lee SH, 1997, AM J OPHTHALMOL, V123, P303; Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5; Takezawa T, 2007, CELLS TISSUES ORGANS, V185, P237, DOI 10.1159/000101325; Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013; Li F, 2005, BIOMATERIALS, V26, P3093, DOI 10.1016/j.biomaterials.2004.07.063; Maycock NJR, 2014, ACTA OPHTHALMOL, V92, pE170, DOI 10.1111/aos.12227; Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399; KIM JC, 1995, CORNEA, V14, P473; Wilson SE, 1999, EXP EYE RES, V68, P377, DOI 10.1006/exer.1998.0603; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Gomaa A, 2010, CLIN EXP OPHTHALMOL, V38, P211, DOI 10.1111/j.1442-9071.2010.02231.x; Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Echevarria TJ, 2011, STEM CELL REV REP, V7, P256, DOI 10.1007/s12015-010-9199-1; Grande JP, 1997, J LAB CLIN MED, V130, P476, DOI 10.1016/S0022-2143(97)90124-4; Wang MY, 2000, AM J OPHTHALMOL, V129, P746, DOI 10.1016/S0002-9394(00)00357-3; Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Calderon-Colon X, 2012, BIOMATERIALS, V33, P8286, DOI 10.1016/j.biomaterials.2012.07.062; Griffith M, 2002, CORNEA, V21, pS54, DOI 10.1097/01.ICO.0000028326.06702.9C; Takezawa T, 2007, J BIOTECHNOL, V131, P76, DOI 10.1016/j.jbiotec.2007.05.033; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Ang LPK, 2010, INVEST OPHTH VIS SCI, V51, P758, DOI 10.1167/iovs.09-3379; Lu L, 2001, EXP BIOL MED, V226, P653; Choi JS, 2013, OCUL SURF, V11, P16, DOI 10.1016/j.jtos.2012.08.006; Takezawa T, 2004, CELL TRANSPLANT, V13, P463, DOI 10.3727/000000004783983882; Ordonez P, 2012, STEM CELLS, V30, P100, DOI 10.1002/stem.794; Hicks CR, 2003, EYE, V17, P385, DOI 10.1038/sj.eye.6700333; Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904; Fagerholm P, 2000, J CATARACT REFR SURG, V26, P432, DOI 10.1016/S0886-3350(99)00436-8; Higa K, 2008, CORNEA, V27, pS41, DOI 10.1097/ICO.0b013e31817f358e; Ma Joseph J. K., 2005, International Ophthalmology Clinics, V45, P49, DOI 10.1097/01.iio.0000176365.71016.28; Krachmer JH, 2005, CORNEA; LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419; Ambrose WM, 2009, J BIOMED MATER RES B, V90B, P818, DOI 10.1002/jbm.b.31351; Miyashita H, 2006, J BIOMED MATER RES B, V76B, P56, DOI 10.1002/jbm.b.30332; Rapuano CJ, 2010, CORNEA, V29, P307, DOI 10.1097/ICO.0b013e3181b7f3c5; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Sweeney DF, 2003, INVEST OPHTH VIS SCI, V44, P3301, DOI 10.1167/iovs.02-0561; Szurman P, 2006, CORNEA, V25, P460, DOI 10.1097/01.ico.0000183493.00884.8f; TrinkausRandall V, 1997, ARTIF ORGANS, V21, P1185; WATANABE K, 1987, INVEST OPHTH VIS SCI, V28, P205; Wilson SE, 2003, EXP EYE RES, V76, P193, DOI 10.1016/S0014-4835(02)00277-4; Woo HM, 2001, BRIT J OPHTHALMOL, V85, P345, DOI 10.1136/bjo.85.3.345; Yeh DL, 2006, AM J OPHTHALMOL, V141, P960, DOI 10.1016/j.ajo.2005.12.001	51	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	FEB	2015	93	1					E57	E66		10.1111/aos.12503		10	Ophthalmology	Ophthalmology	AZ8ZL	WOS:000348500500009		
J	Araki, S; Imai, S; Ishigaki, H; Mimura, T; Nishizawa, K; Ueba, H; Kumagai, K; Kubo, M; Mori, K; Ogasawara, K; Matsusue, Y				Araki, Susumu; Imai, Shinji; Ishigaki, Hirohito; Mimura, Tomohiro; Nishizawa, Kazuya; Ueba, Hiroaki; Kumagai, Kousuke; Kubo, Mitsuhiko; Mori, Kanji; Ogasawara, Kazumasa; Matsusue, Yoshitaka			Improved quality of cartilage repair by bone marrow mesenchymal stem cells for treatment of an osteochondral defect in a cynomolgus macaque model	ACTA ORTHOPAEDICA			English	Article							AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; FOLLOW-UP; KNEE; TRANSPLANTATION; SCAFFOLD; MICROFRACTURE; REGENERATION; RABBITS	Background and purpose - Integration of repaired cartilage with surrounding native cartilage is a major challenge for successful tissue-engineering strategies of cartilage repair. We investigated whether incorporation of mesenchymal stem cells (MSCs) into the collagen scaffold improves integration and repair of cartilage defects in a cynomolgus macaque model. Methods - Cynomolgus macaque bone marrow-derived MSCs were isolated and incorporated into type-I collagen gel. Full-thickness osteochondral defects (3 mm in diameter, 5 mm in depth) were created in the patellar groove of 36 knees of 18 macaques and were either left untreated (null group, n = 12), had collagen gel alone inserted (gel group, n = 12), or had collagen gel incorporating MSCs inserted (MSC group, n = 12). After 6, 12, and 24 weeks, the cartilage integration and tissue response were evaluated macroscopically and histologically (4 null, 4 gel, and 4 MSC knees at each time point). Results - The gel group showed most cartilage-rich reparative tissue covering the defect, owing to formation of excessive cartilage extruding though the insufficient subchondral bone. Despite the fact that a lower amount of new cartilage was produced, the MSC group had better-quality cartilage with regular surface, seamless integration with neighboring naive cartilage, and reconstruction of trabecular subchondral bone. Interpretation - Even with intensive investigation, MSC-based cell therapy has not yet been established in experimental cartilage repair. Our model using cynomolgus macaques had optimized conditions, and the method using MSCs is superior to other experimental settings, allowing the possibility that the procedure might be introduced to future clinical practice.	[Araki, Susumu; Imai, Shinji; Mimura, Tomohiro; Nishizawa, Kazuya; Ueba, Hiroaki; Kumagai, Kousuke; Kubo, Mitsuhiko; Mori, Kanji; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 52021, Japan; [Ishigaki, Hirohito; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Mol Med Biochem, Otsu, Shiga 52021, Japan	Araki, S (reprint author), Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 52021, Japan.	arakisu@belle.shiga-med.ac.jp			Japanese Ministry of Science and Education [22500457]	We are very grateful to Mrs Yoko Uratani for her skillful technical assistance and to Professor Yoshitaka Murakami, Toho University, for help with statistics. This work was supported by a grant-in-aid from the Japanese Ministry of Science and Education (22500457).	Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M; Gross AE, 2008, CLIN ORTHOP RELAT R, V466, P1863, DOI 10.1007/s11999-008-0282-8; Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532; Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455; Lane JG, 2004, AM J SPORT MED, V32, P1440, DOI 10.1177/0363546504263945; Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037; MATSUSUE Y, 1993, ARTHROSCOPY, V9, P318, DOI 10.1016/S0749-8063(05)80428-1; Henderson I, 2006, ARTHROSCOPY, V22, P1318, DOI 10.1016/j.arthro.2006.07.057; Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414; FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Redman SN, 2004, OSTEOARTHR CARTILAGE, V12, P106, DOI 10.1016/j.joca.2002.12.001; Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382; Nakamura A, 2010, BONE, V46, P418, DOI 10.1016/j.bone.2009.08.048; Loken S, 2008, KNEE SURG SPORT TR A, V16, P896, DOI 10.1007/s00167-008-0566-2; Caplan AI, 1997, CLIN ORTHOP RELAT R, P254; Dashtdar H, 2011, J ORTHOP RES, V29, P1336, DOI 10.1002/jor.21413; Guo XM, 2004, TISSUE ENG, V10, P1818, DOI 10.1089/ten.2004.10.1818; Kubo M, 2007, ACTA ORTHOP, V78, P845, DOI 10.1080/17453670710014653; Labbe B, 2011, METHODS MOL BIOL, V702, P429, DOI 10.1007/978-1-61737-960-4_31; Mimura T, 2008, OSTEOARTHR CARTILAGE, V16, P1083, DOI 10.1016/j.joca.2008.02.003; Nishizawa K, 2010, CELL TISSUE RES, V341, P371, DOI 10.1007/s00441-010-1020-6	25	1	1	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1745-3674	1745-3682		ACTA ORTHOP	Acta Orthop.	FEB	2015	86	1					119	126		10.3109/17453674.2014.958807		8	Orthopedics	Orthopedics	AZ6ZD	WOS:000348367000019		
J	Wakuda, K; Kenmotsu, H; Naito, T; Akamatsu, H; Ono, A; Shukuya, T; Nakamura, Y; Tsuya, A; Murakami, H; Takahashi, T; Endo, M; Nakajima, T; Yamamoto, N				Wakuda, Kazushige; Kenmotsu, Hirotsugu; Naito, Tateaki; Akamatsu, Hiroaki; Ono, Akira; Shukuya, Takehito; Nakamura, Yukiko; Tsuya, Asuka; Murakami, Haruyasu; Takahashi, Toshiaki; Endo, Masahiro; Nakajima, Takashi; Yamamoto, Nobuyuki			Efficacy of Rechallenge Chemotherapy in Patients With Sensitive Relapsed Small Cell Lung Cancer	AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS			English	Article						small cell lung cancer; rechallenge chemotherapy; second-line; sensitive relapse; amrubicin	PHASE-II TRIAL; 2ND-LINE CHEMOTHERAPY; TOPOTECAN; AMRUBICIN	Objectives: To evaluate the efficacy of rechallenge with current induction regimens for sensitive-relapse small cell lung cancer (SCLC) patients. Methods: We defined sensitive relapse as treatment-free interval (TFI >= 90 d). Sensitive-relapse SCLC patients who received second-line chemotherapy were separated into those treated with rechallenge chemotherapy (rechallenge group) and those treated with other regimens (other group). The endpoints were overall survival (OS), progression-free survival, and toxicity. Results: Sixty-five patients (19 rechallenge group and 46 other group) were assessable for efficacy and safety evaluation. No significant differences in age, sex, ECOG performance status at relapse, disease extent at diagnosis, or response to first-line treatment were found between the 2 groups, but TFI was significantly longer in the rechallenge group. Twenty-one patients of the other group received amrubicin. There was no significant difference in OS between the 2 groups (median survival time [MST]: rechallenge group, 14.4 mo; other group, 13.1 mo; P = 0.51). In the patients treated with amrubicin, MST was 12.6 months. Comparing the rechallenge group with the patients treated with amrubicin, there was also no significant difference in OS (P = 0.38). Both the rechallenge and other group included 11 patients with ex-sensitive relapse (TFI >= 180 d). There was no significant difference in OS between the 2 groups (MST 15.7 vs. 26.9 mo, P = 0.46). Conclusions: Rechallenge chemotherapy did not prove superior to other chemotherapies, suggesting that monotherapy, such as amrubicin, might be reasonable as second-line chemotherapy for sensitive-relapse SCLC patients.	[Wakuda, Kazushige; Kenmotsu, Hirotsugu; Naito, Tateaki; Akamatsu, Hiroaki; Ono, Akira; Shukuya, Takehito; Nakamura, Yukiko; Tsuya, Asuka; Murakami, Haruyasu; Takahashi, Toshiaki; Yamamoto, Nobuyuki] Shizuoka Canc Ctr Hosp, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Endo, Masahiro] Shizuoka Canc Ctr Hosp, Div Diagnost Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Nakajima, Takashi] Shizuoka Canc Ctr Hosp, Div Pathol, Nagaizumi, Shizuoka 4118777, Japan	Kenmotsu, H (reprint author), Shizuoka Canc Ctr Hosp, Div Thorac Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	h.kenmotsu@scchr.jp			National Cancer Center Research and Development Fund [24-013, 24-008]	Supported by the National Cancer Center Research and Development Fund 24-013 (N.Y.) and 24-008 (N.Y.).	Tiseo M, 2007, J THORAC ONCOL, V2, P764, DOI 10.1097/JTO.0b013e3180986262; Ebi N, 1997, JPN J CLIN ONCOL, V27, P166, DOI 10.1093/jjco/27.3.166; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Rosti G, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj910; Jotte R, 2011, J CLIN ONCOL, V29, P287, DOI 10.1200/JCO.2010.29.8851; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; GIACCONE G, 1988, J CLIN ONCOL, V6, P1264; Garassino MC, 2011, LUNG CANCER, V72, P378, DOI 10.1016/j.lungcan.2010.09.009; Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; POSTMUS PE, 1987, EUR J CANCER CLIN ON, V23, P1409, DOI 10.1016/0277-5379(87)90128-3; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; GIACCONE G, 1987, EUR J CANCER CLIN ON, V23, P1697, DOI 10.1016/0277-5379(87)90452-4; von Pawel J, 1999, J CLIN ONCOL, V17, P658; Stupp R, 2004, LUNG CANCER-J IASLC, V45, P105, DOI 10.1016/j.lungcan.2003.12.006; Onoda S, 2006, J CLIN ONCOL, V24, P5448, DOI 10.1200/JCO.2006.08.4145; Jotte R, 2011, ASCO M ABSTR S, V29, P7000; Kato T, 2006, ASCO M, V24, P7061	19	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3732	1537-453X		AM J CLIN ONCOL-CANC	Am. J. Clin. Oncol.-Cancer Clin. Trials	FEB	2015	38	1					28	32		10.1097/COC.0b013e318286907b		5	Oncology	Oncology	AZ5WK	WOS:000348288900006		
J	Morishima, Y; Kamisato, C				Morishima, Yoshiyuki; Kamisato, Chikako			Laboratory Measurements of the Oral Direct Factor Xa Inhibitor Edoxaban Comparison of Prothrombin Time, Activated Partial Thromboplastin Time, and Thrombin Generation Assay	AMERICAN JOURNAL OF CLINICAL PATHOLOGY			English	Article						Activated partial thromboplastin time; Coagulation assay; Direct factor Xa inhibitor; Monitoring; Prothrombin time; Thrombin generation assay	SYMPTOMATIC VENOUS THROMBOEMBOLISM; ATRIAL-FIBRILLATION; STROKE PREVENTION; IN-VITRO; WARFARIN; ANTICOAGULANTS; SAFETY; RIVAROXABAN	Objectives: Edoxaban, an oral direct factor Xa inhibitor, does not require routine monitoring. However, assessment of the anticoagulant effects may be required in certain situations. Methods: We investigated the effects of edoxaban on prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin generation using human platelet-poor plasma (PPP) or platelet-rich plasma (PRP). Results: Edoxaban concentration-dependently prolonged PT and aPTT. There was a considerable variation in the magnitude of PT prolongation among the reagents used The variability in aPTT prolongation among the reagents was smaller than that of PT Edoxaban concentration-dependently inhibited thrombin generation, with a more potent effect seen in PPP than in PRP. Thrombin generation assay was three times more sensitive to edoxaban than PT and aPTT. Conclusions: PT had disadvantages of a large variability among different PT reagents. aPTT could be used as a conventional and convenient test with a smaller variation among reagents. Thrombin generation was the most sensitive assay.	[Morishima, Yoshiyuki; Kamisato, Chikako] Daiichi Sankyo, R&D Div, Biol Res Labs, Tokyo 1408710, Japan	Morishima, Y (reprint author), Daiichi Sankyo, R&D Div, Biol Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	morishima.yoshiyuki.t4@daiichisankyo.co.jp			Daiichi Sankyo	The authors thank Yoko Shiozaki for technical assistance and Yuko Honda for editorial assistance. Additional editorial support was provided by AlphaBioCom, LLC, King of Prussia, PA, and funded by Daiichi Sankyo.	Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741; Gerotziafas GT, 2007, J THROMB HAEMOST, V5, P955, DOI 10.1111/j.1538-7836.2007.02477.x; Samama MM, 2007, J THROMB HAEMOST, V5, P2554, DOI 10.1111/j.1538-7836.2007.02753.x; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Francart SJ, 2014, THROMB HAEMOSTASIS, V111, P1133, DOI 10.1160/TH13-10-0871; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Samama MM, 2012, THROMB RES, V129, pE77, DOI 10.1016/j.thromres.2011.07.026; Gouin-Thibault I, 2014, THROMB HAEMOSTASIS, V111, P240, DOI 10.1160/TH13-06-0470; Barrett YC, 2010, THROMB HAEMOSTASIS, V104, P1263, DOI 10.1160/TH10-05-0328; Samama MM, 2012, THROMB HAEMOSTASIS, V107, P379, DOI 10.1160/TH11-06-0391; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Hankey GJ, 2014, THROMB HAEMOSTASIS, V111, P808, DOI 10.1160/TH13-09-0741; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Fuji T., 2010, ASH ANN M, V116, P3320; Fuji T, 2011, ASH ANN M, V118, P208; Fujita S, 2010, PATHOPHYSIOL HAEMO T, V37, P366; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; HIRSH J, 1995, AM J CARDIOL, V75, pB39, DOI 10.1016/0002-9149(95)80009-H; Samama MM, 2010, THROMB RES, V126, pE286, DOI 10.1016/j.thromres.2010.07.015; Ten Cate Hugo, 2013, Thromb J, V11, P8, DOI 10.1186/1477-9560-11-8	24	4	4	AMER SOC CLINICAL PATHOLOGY	CHICAGO	2100 W HARRISON ST, CHICAGO, IL 60612 USA	0002-9173	1943-7722		AM J CLIN PATHOL	Am. J. Clin. Pathol.	FEB	2015	143	2					241	247		10.1309/AJCPQ2NJD3PXFTUG		7	Pathology	Pathology	AZ5OO	WOS:000348270200011		
J	Hayashi, K; Ogawa, S; Manabe, S; Yoshimura, K				Hayashi, Ken; Ogawa, Soichiro; Manabe, Shin-ichi; Yoshimura, Koichi			Binocular Visual Function of Modified Pseudophakic Monovision	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							MULTIFOCAL INTRAOCULAR LENSES; PATIENT SATISFACTION; CATARACT-SURGERY; PERFORMANCE	PURPOSE: To compare binocular visual function of pseudophakic patients having modified monovision (0.75 diopter [D] anisometropia) with that of patients having conventional monovision (1.75 D anisometropia). DESIGN: Prospective observational study. METHODS: Eighty-two patients that underwent bilateral implantation of a monofocal intraocular lens were recruited at 3 months postoperatively. Modified monovision was simulated by adding a +0.75 D spherical lens to the nondominant eye, while conventional monovision was simulated by adding a +1.75 D spherical lens. Binocular corrected visual acuity (VA) at various distances, binocular contrast VA (contrast VA) and that with glare (glare VA), and stereoacuity were evaluated. RESULTS: With modified monovision, mean binocular corrected intermediate VA at 1.0 m was 20/19 and near VA at 0.3 m was 20/51, and stereoacuity was 125 +/- 100 seconds of arc. Mean binocular intermediate VA at 1.0 m was significantly better with modified monovision than with conventional monovision (P = .0001), while near VA and intermediate VA at 0.5 m were significantly worse (P < .0001). Mean binocular photopic and mesopic contrast VA and glare VA tended to be better with modified monovision than with conventional monovision, but the difference was not significant. Mean stereoacuity was significantly better with modified monovision than with conventional monovision (P = .0020). CONCLUSIONS: Modified pseudophakic monovision provided excellent binocular VA from far to intermediate distances, although near VA was worse than that with conventional monovision. Contrast VA with and without glare tended to be better and stereoacuity was significantly better with modified monovision, suggesting that this method is useful for correcting presbyopia without marked impairment of binocular function. (C) 2015 by Elsevier Inc. All rights reserved.	[Hayashi, Ken; Ogawa, Soichiro; Manabe, Shin-ichi; Yoshimura, Koichi] Hayashi Eye Hosp, Hakata Ku, Fukuoka 8120011, Japan	Hayashi, K (reprint author), Hayashi Eye Hosp, Hakata Ku, 4-23-35 Hakataekimae, Fukuoka 8120011, Japan.	hayashi-ken@hayashi.or.jp		HAYASHI, KEN/0000-0002-7297-1477	Alcon Japan Ltd; Santen Pharmaceutical Inc; Senjyu Pharmaceutical Ltd; HOYA Corp; Pfizer Japan Inc; Novartis Pharma K.K.; Wakamoto Pharmaceutical Ltd; Nitten Pharmaceutical Ltd; Japan Association of Health Service; EBMs Ltd.	ALL AUTHORS HAVE COMPLETED AND SUBMITTED THE ICMJE FORM FOR DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST and none were reported for the submitted work. Outside the submitted work, the Hayashi Eye Hospital (K.H., SO., S.-I.M., K.Y.) has received a research grant for clinical trials of materials sponsored by Alcon Japan Ltd; Santen Pharmaceutical Inc; Senjyu Pharmaceutical Ltd; HOYA Corp; Pfizer Japan Inc; Novartis Pharma K.K.; Wakamoto Pharmaceutical Ltd; Nitten Pharmaceutical Ltd; Japan Association of Health Service; and EBMs Ltd. Dr Hayashi has received lecture fees with or without travel expenses for materials outside the submitted work from Santen Pharmaceutical Inc; Alcon Japan Ltd; and Pfizer Japan Inc. The authors received no government or nongovernment financial support for this study. Contributions of authors: designed the study (K.H.); conducted the study (K.H.); data analysis and interpretation (K.H).; wrote the article (K.H.); critically revised the article (SO., S.-I.M., K.Y.); final approval of the article (K.H., SO., S.-I.M., K.Y.); data collection (S.O., S.-I.M., K.Y.); provided materials, patients, or resources (K.H.); statistical expertise (K.H.); literature search (K.H.); and administrative, technical, or logistic support (K.H.).	Finkelman YM, 2009, J CATARACT REFR SURG, V35, P998, DOI 10.1016/j.jcrs.2009.01.035; Zhang FX, 2011, J CATARACT REFR SURG, V37, P446, DOI 10.1016/j.jcrs.2010.10.045; Ito M, 2012, J CATARACT REFR SURG, V38, P1440, DOI 10.1016/j.jcrs.2012.03.031; Greenbaum S, 2002, J CATARACT REFR SURG, V28, P1439, DOI 10.1016/S0886-3350(02)01218-X; Zhang FX, 2011, J CATARACT REFR SURG, V37, P853, DOI 10.1016/j.jcrs.2010.12.041; Handa T, 2004, J CATARACT REFR SURG, V30, P769, DOI 10.1016/j.jcrs.2003.07.013; PARDHAN S, 1990, OPHTHAL PHYSL OPT, V10, P33, DOI 10.1111/j.1475-1313.1990.tb01103.x; Hayashi K, 2014, J CATARACT REFR SURG, V40, P87, DOI 10.1016/j.jcrs.2013.07.037; Hayashi K, 2011, J REFRACT SURG, V27, P332, DOI 10.3928/1081597X-20100817-01; Hayashi K, 2013, J CATARACT REFR SURG, V39, P851, DOI 10.1016/j.jcrs.2013.01.030; ISOMURA Y, 1980, Nippon Ganka Gakkai Zasshi, V84, P1619; Ito M, 2009, J CATARACT REFR SURG, V35, P710, DOI 10.1016/j.jcrs.2008.12.019; Ito M, 2009, J CATARACT REFR SURG, V35, P1501, DOI 10.1016/j.jcrs.2009.03.051; Learning DV, 2004, J CATARACT REFR SURG, V30, P892; Lubiński Wojciech, 2013, Klin Oczna, V115, P189; Marques FF, 2009, ARQ BRAS OFTALMOL, V72, P164, DOI 10.1590/S0004-27492009000200006; Pick ZS, 2008, CLIN EXP OPHTHALMOL, V36, P604, DOI 10.1111/j.1442-9071.2008.01869.x; Willkins MR, 2013, OPHTHALMOLOGY, V120, P2449; Xiao Jianhe, 2011, Indian J Ophthalmol, V59, P481, DOI 10.4103/0301-4738.86318	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	FEB	2015	159	2					232	240		10.1016/j.ajo.2014.10.023		9	Ophthalmology	Ophthalmology	CA0WM	WOS:000348634300004		
J	Noda, Y; Ogawa, A; Toyama, T; Ueta, T				Noda, Yasuo; Ogawa, Asako; Toyama, Taku; Ueta, Takashi			Long-Term Increase in Subfoveal Choroidal Thickness After Surgery for Senile Cataracts REPLY	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Letter									[Noda, Yasuo; Ogawa, Asako; Toyama, Taku; Ueta, Takashi] No Org, Tokyo, Japan							Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	FEB	2015	159	2					407	407				1	Ophthalmology	Ophthalmology	CA0WM	WOS:000348634300029		
J	Nilsson, P; Sekiguchi, M; Akagi, T; Izumi, S; Komor, T; Hui, K; Sorgjerd, K; Tanaka, M; Saito, T; Iwata, N; Saido, TC				Nilsson, Per; Sekiguchi, Misaki; Akagi, Takumi; Izumi, Shinichi; Komor, Toshihisa; Hui, Kelvin; Soergjerd, Karin; Tanaka, Motomasa; Saito, Takashi; Iwata, Nobuhisa; Saido, Takaomi C.			Autophagy-Related Protein 7 Deficiency in Amyloid beta (A beta) Precursor Protein Transgenic Mice Decreases A beta in the Multivesicular Bodies and Induces A beta Accumulation in the Golgi	AMERICAN JOURNAL OF PATHOLOGY			English	Article							ALZHEIMERS-DISEASE; UNCONVENTIONAL SECRETION; PATHOLOGY; EXPRESSION; PEPTIDE; NEURODEGENERATION; MACROAUTOPHAGY; DEGRADATION; IMPAIRMENT; CLEARANCE	Alzheimer disease (AD) is biochemically characterized by increased levels of amyloid beta (A beta) peptide, which aggregates into extracellular A beta plagues in AD brains. Before plague formation, A beta accumulates intracellularly in both AD brains and in the brains of AD model mice, which may contribute to disease progression. Autophagy, which is impaired in AD, clears cellular protein aggregates and participates in A beta metabolism. In addition to a degradative role of autophagy in All metabolism we recently showed that A beta secretion is inhibited in mice Lacking autophagy-related gene 7 (Atg7) in excitatory neurons in the mouse forebrain. This inhibition of A beta secretion Leads to intracellular accumulation of A beta. Here, we used fluorescence and immunoelectron microscopy to elucidate the subcellular Localization of the intracellular A beta accumulation which accumulates in All precursor protein mice lacking Atg7. Autophagy deficiency causes accumulation of p62(+) aggregates, but these aggregates do not contain A beta. However, knockdown of Atg7 induced A13 accumulation in the Golgi and a concomitant reduction of A beta in the multivesicular bodies. This indicates that Atg7 influences the transport of All possibly derived from Golgi to multivesicular bodies.	[Nilsson, Per; Sekiguchi, Misaki; Soergjerd, Karin; Saito, Takashi; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Akagi, Takumi] RIKEN, Inst Sci, Support Unit Anim Resources Dev, Wako, Saitama 3510198, Japan; [Hui, Kelvin; Tanaka, Motomasa] RIKEN, Inst Sci, Lab Prot Conformat Dis, Wako, Saitama 3510198, Japan; [Nilsson, Per] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Izumi, Shinichi; Komor, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki 852, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Nagasaki 852, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Biotechnol, Nagasaki 852, Japan	Nilsson, P (reprint author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	per-nilsson@brain.riken.jp	Saito, Takashi/G-2563-2015		Swedish Research Council, RIKEN Brain Science Institute; Japanese Ministry of Education, Sports, Science and Technology; Japanese Ministry of Health, Labour and Welfare	Supported by research grants from the Swedish Research Council, RIKEN Brain Science Institute, the Japanese Ministry of Education, Sports, Science and Technology, and the Japanese Ministry of Health, Labour and Welfare (P.N., M.S., K.H., M.T., KS., T.S., and T.C.S.).	Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Boland B, 2010, J BIOL CHEM, V285, P37415, DOI 10.1074/jbc.M110.186411; SAIDO TC, 1994, J BIOL CHEM, V269, P15253; Nilsson P, 2014, BIOESSAYS, V36, P570, DOI 10.1002/bies.201400002; Abramowski D, 2012, J NEUROSCI, V32, P1273, DOI 10.1523/JNEUROSCI.4586-11.2012; Goto S, 2009, FREE RADICAL BIO MED, V46, P1392, DOI 10.1016/j.freeradbiomed.2009.02.025; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee MJ, 2013, PROG NEUROBIOL, V105, P49, DOI 10.1016/j.pneurobio.2013.03.001; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Gendreau Kerry L, 2013, Front Neurol, V4, P160, DOI 10.3389/fneur.2013.00160; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721; Inoue K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-48; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Vardarajan BN, 2012, NEUROBIOL AGING, V33; Zhao W, 2013, HUM MOL GENET, V23, P1365	42	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	FEB	2015	185	2					305	313		10.1016/j.ajpath.2014.10.011		9	Pathology	Pathology	AZ8UH	WOS:000348489400004		
J	Valverde-Franco, G; Hum, D; Matsuo, K; Lussier, B; Pelletier, JP; Fahmi, H; Kapoor, M; Martel-Pelletier, J				Valverde-Franco, Gladys; Hum, David; Matsuo, Koichi; Lussier, Bertrand; Pelletier, Jean-Pierre; Fahmi, Hassan; Kapoor, Mohit; Martel-Pelletier, Johanne			The in Vivo Effect of Prophylactic Subchondral Bone Protection of Osteoarthritic Synovial Membrane in Bone-Specific Ephb4-Overexpressing Mice	AMERICAN JOURNAL OF PATHOLOGY			English	Article							GROWTH-FACTOR-BETA; TELOPEPTIDE LYSYL HYDROXYLASE; MURINE KNEE-JOINT; OSTEOPHYTE FORMATION; SYSTEMIC-SCLEROSIS; GENE-EXPRESSION; SCLERODERMA FIBROBLASTS; CARTILAGE DEGENERATION; RHEUMATOID-ARTHRITIS; TRANSIENT FIBROSIS	Osteoarthritis (OA) is characterized by progressive joint destruction, including synovial membrane alteration. EphB4 and its Ligand ephrin-B2 were found in vitro to positively affect OA subchondral bone and cartilage. In vivo in an experimental mouse model overexpressing bone-specific Ephb4 (TgEphB4), a protective effect was found on both the subchondraL bone and cartilage during OA. We investigated in the TgEphB4 mouse model the in vivo effect on synoviaL membrane during OA. Knee OA was surgically induced by destabilization of the medial meniscus (DMM). Synovial membrane was evaluated using histology, histomorphometry, IHC, and real-time PCR. Compared to DMM-wild-type (WT) mice, DMM-TgEphB4 mice had a significant decrease in synovial membrane thickness, vascular endothelial growth factor, and the profibrotic markers fibrin, type 1 procollagen, type 3 collagen, connective tissue growth factor, smooth muscle actin-alpha, cartilage oligomeric matrix protein, and procoLlagen-Lysine, and 2-oxoglutarate 5-dioxygenase 2. Moreover, factors known to modulate transforming growth factor-beta signaling, transforming growth factor receptor 1/ALK1, phosphorylated Smad-1, and heat shock protein 9013 were significantly decreased in DMM-TgEphB4 compared with DMM-WT mice. Ephb4 overexpression also exhibited a protective effect on synovial membrane thickness of aged (24-month-old) mice. Overexpression of bone-specific Ephb4 clearly demonstrated prevention of the development and/or progression of fibrosis in OA synovial membrane, reinforcing the hypothesis that protecting the subchondral bone prophylactically and during OA reduces the pathologic changes in other articular tissues.	[Valverde-Franco, Gladys; Hum, David; Pelletier, Jean-Pierre; Fahmi, Hassan; Kapoor, Mohit; Martel-Pelletier, Johanne] Univ Montreal Hosp Res Ctr CRCHUM, Osteoarthritis Res Unit, Montreal, PQ, Canada; [Matsuo, Koichi] Keio Univ, Sch Med, Lab Cell & Tissue Biol, Tokyo, Japan; [Lussier, Bertrand] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Martel-Pelletier, J (reprint author), Univ Montreal Hosp, Res Ctr, Osteoarthritis Res Unit, 900 Saint Denis,,Pavilion R R11-412B, Montreal, PQ H2X 0A9, Canada.	jm@martelpelletier.ca			Chair in Osteoarthritis of the University of Montreal, Montreal, QC, Canada	Supported by a grant from the Chair in Osteoarthritis of the University of Montreal, Montreal, QC, Canada.	Valverde-Franco G, 2012, ARTHRITIS RHEUM-US, V64, P3614, DOI 10.1002/art.34638; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; WILHELMI G, 1976, PHARMACOLOGY, V14, P289, DOI 10.1159/000136607; VATER CA, 1979, BIOCHEM J, V181, P639; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Davidson ENB, 2006, ARTHRITIS RHEUM, V54, P1653, DOI 10.1002/art.21795; Matsui Y, 2004, J MOL CELL CARDIOL, V37, P477, DOI 10.1016/j.yjmcc.2004.05.012; van den Bosch MH, 2014, CELL SIGNAL, V26, P951, DOI 10.1016/j.cellsig.2014.01.021; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Remst DFG, 2014, ARTHRITIS RHEUMATOL, V66, P647, DOI 10.1002/art.38266; Munoz-Felix JM, 2013, CYTOKINE GROWTH F R, V24, P523, DOI 10.1016/j.cytogfr.2013.08.002; Tat SK, 2008, ARTHRITIS RHEUM-US, V58, P3820, DOI 10.1002/art.24029; Morko J, 2005, ARTHRITIS RHEUM, V52, P3713, DOI 10.1002/art.21423; Trojanowska M, 2009, CURR OPIN RHEUMATOL, V21, P623, DOI 10.1097/BOR.0b013e32833038ce; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Attur M, 2010, BEST PRACT RES CL RH, V24, P71, DOI 10.1016/j.berh.2009.08.011; Wu LH, 2012, CURR PHARM DESIGN, V18, P3293; Pannu J, 2008, ARTHRITIS RHEUM, V58, P2528, DOI 10.1002/art.23698; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI [10.1359/jbmr.080209, 10.1359/JBMR.080209]; Morris E, 2011, J CELL PHYSIOL, V226, P3340, DOI 10.1002/jcp.22690; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Asano Y, 2005, J IMMUNOL, V175, P7708; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Farina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850; Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; Couchourel D, 2009, ARTHRITIS RHEUM, V60, P1438, DOI 10.1002/art.24489; Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426; Doss F, 2007, SCAND J RHEUMATOL, V36, P136, DOI 10.1080/03009740701250785; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Asano Y, 2006, J INVEST DERMATOL, V126, P1761, DOI 10.1038/sj.jid.5700331; Glasson SS, 2007, CURR DRUG TARGETS, V8, P367, DOI 10.2174/138945007779940061; Recklies AD, 1998, ARTHRITIS RHEUM, V41, P997, DOI 10.1002/1529-0131(199806)41:6<997::AID-ART6>3.0.CO;2-G; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; van der Kraan PM, 2012, CELL TISSUE RES, V347, P257, DOI 10.1007/s00441-011-1194-6; Tomcik M, 2014, ANN RHEUM DIS, V73, P1215, DOI 10.1136/annrheumdis-2012-203095; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P979, DOI 10.1016/j.joca.2005.03.008; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Munoz-Felix JM, 2014, KIDNEY INT, V85, P319, DOI 10.1038/ki.2013.292; Schlaak JF, 1996, CLIN EXP RHEUMATOL, V14, P155; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; Arthur A, 2013, J BONE MINER RES, V28, P926, DOI 10.1002/jbmr.1821; Bancroft JD, 2008, THEORY PRACTICE HIST, P150; Barley RDC, 2010, VIRCHOWS ARCH, V456, P561, DOI 10.1007/s00428-010-0890-z; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; Bastiaansen-Jenniskens YM, 2013, ARTHRITIS RHEUM-US, V65, P2070, DOI 10.1002/art.37996; Bonniaud P, 2003, AM J RESP CRIT CARE, V168, P770, DOI 10.1164/rccm.200210-1254OC; Carleton HM, 1967, CARLETONS HISTOLOGIC; FAVA R, 1989, J EXP MED, V169, P291, DOI 10.1084/jem.169.1.291; Fernandes JC, 1998, J RHEUMATOL, V25, P951; Furuzawa-Carballeda J, 2008, CLIN EXP RHEUMATOL, V26, P554; Hopwood B, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2301; Tat SK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2782; Li J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3887; Martel-Pelletier J, 2010, EKLEM HAST CERRAHISI, V21, P2; Massicotte F, 2002, OSTEOARTHR CARTILAGE, V10, P491, DOI 10.1053/joca.2002.0528; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Mimura Y, 2005, AM J PATHOL, V166, P1451, DOI 10.1016/S0002-9440(10)62362-0; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Scharstuhl A, 2003, ARTHRITIS RHEUM, V48, P3442, DOI 10.1002/art.11328; Schumacher JA, 2007, PROTEOMICS, V7, P2603, DOI 10.1002/pmic.200700108; Tardif G, 2004, ARTHRITIS RHEUM, V50, P2521, DOI 10.1002/art.20441; Tsuchida AI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4107; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; van der Kraan PM, 2001, OSTEOARTHR CARTILAGE, V9, P92, DOI 10.1053/joca.2000.0364; van Meurs JBJ, 1999, ARTHRITIS RHEUM, V42, P1128, DOI 10.1002/1529-0131(199906)42:6<1128::AID-ANR9>3.0.CO;2-2; Vasheghani F, 2013, AM J PATHOL, V182, P1099, DOI 10.1016/j.ajpath.2012.12.012; Wenham Claire Y J, 2010, Ther Adv Musculoskelet Dis, V2, P349, DOI 10.1177/1759720X10378373; Wrightont KH, 2008, P NATL ACAD SCI USA, V105, P9244, DOI 10.1073/pnas.0800163105	73	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	FEB	2015	185	2					335	346		10.1016/j.ajpath.2014.10.004		12	Pathology	Pathology	AZ8UH	WOS:000348489400007		
J	Yuge, R; Kitadai, Y; Shinagawa, K; Onoyama, M; Tanaka, S; Yasui, W; Chayama, K				Yuge, Ryo; Kitadai, Yasuhiko; Shinagawa, Kei; Onoyama, Mieko; Tanaka, Shinji; Yasui, Wataru; Chayama, Kazuaki			mTOR and PDGF Pathway Blockade Inhibits Liver Metastasis of Colorectal Cancer by Modulating the Tumor Microenvironment	AMERICAN JOURNAL OF PATHOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN PANCREATIC-CARCINOMA; MESENCHYMAL STEM-CELLS; HUMAN-COLON-CARCINOMA; NUDE-MOUSE MODEL; RAD001 EVEROLIMUS; PROLONGS SURVIVAL; ENDOTHELIAL-CELLS; OVARIAN-CANCER; STROMAL CELLS	Tumor growth and metastasis are not determined by cancer cells alone but also by a variety of stromat cells, and platelet-derived growth factor receptors (PDGF-Rs) are overexpressed by various stromal cell populations. Activation of PI3K-AKT-mTOR signaling is frequently observed in many cancer types. We investigated whether the mTOR inhibitor everolimus, alone or in combination with the PDGF-R tyrosine kinase inhibitor nilotinib, can inhibit growth and metastasis of human colon cancer. The effects of nilotinib and everolimus on tumor growth and metastasis were examined in an orthotopic mouse model of human colon cancer and a model of Liver metastasis. After treatment with nilotinib (versus distilled water), the stromal reaction of xenografts growing in the cecal wall and liver was significantly decreased. After treatment with everolimus, the stromal reaction did not decrease, but tumor cell proliferation and microvessel density decreased. With the two drugs in combination, both stromal reaction and tumor cell proliferation decreased and apoptosis of tumor cells increased, resulting in remarkable inhibition of tumor growth at both the orthotopic and the metastatic site. Concurrent inhibition of tumor cells and activated stromaL cells by a PDGF-R tyrosine kinase inhibitor and an mTOR inhibitor used in combination may represent a novel therapeutic approach for colorectal cancer.	[Yuge, Ryo; Kitadai, Yasuhiko; Onoyama, Mieko; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Shinagawa, Kei; Tanaka, Shinji] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima 7348551, Japan; [Yasui, Wataru] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan	Kitadai, Y (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kitadai@hiroshima-u.ac.jp			Ministry of Education, Culture, Science, Sports and Technology of Japan	Supported in part by grants-in-aid for cancer research from the Ministry of Education, Culture, Science, Sports and Technology of Japan.	Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; MORIKAWA K, 1988, CANCER RES, V48, P6863; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Manegold PC, 2008, CLIN CANCER RES, V14, P892, DOI 10.1158/1078-0432.CCR-07-0955; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Mabuchi S, 2007, CLIN CANCER RES, V13, P4261, DOI 10.1158/1078-0432.CCR-06-2770; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Pietras K, 2005, J CLIN ONCOL, V23, P939; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Pietras K, 2001, CANCER RES, V61, P2929; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Pietras K, 2004, SEMIN ONCOL, V31, P18, DOI 10.1053/j.seminoncol.2004.03.036; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Shinagawa K, 2013, INT J CANCER, V132, P813, DOI 10.1002/ijc.27735; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Kitadai Y, 2006, INT J CANCER, V119, P2567, DOI 10.1002/ijc.22229; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Philp AJ, 2001, CANCER RES, V61, P7426; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Guba M, 2005, BLOOD, V105, P4463, DOI 10.1182/blood-2004-09-3540; Lane HA, 2009, CLIN CANCER RES, V15, P1612, DOI 10.1158/1078-0432.CCR-08-2057; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Kitadai Y, 2006, AM J PATHOL, V169, P2054, DOI 10.2353/ajpath.2006.060653; Deininger MW, 2008, CLIN CANCER RES, V14, P4027, DOI 10.1158/1078-0432.CCR-07-5015; Erber Ralf, 2004, FASEB Journal, V18, P338; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Hwang RF, 2003, CLIN CANCER RES, V9, P6534; Kim SJ, 2003, CLIN CANCER RES, V9, P1200; Onoyama M, 2013, NEOPLASIA, V15, P1391, DOI 10.1593/neo.131668; Sumida T, 2011, INT J CANCER, V128, P2050, DOI 10.1002/ijc.25812; Yokoi K, 2005, CANCER RES, V65, P10371, DOI 10.1158/0008-5472.CAN-05-1698	38	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	FEB	2015	185	2					399	408		10.1016/j.ajpath.2014.10.014		10	Pathology	Pathology	AZ8UH	WOS:000348489400012		
J	Ohama, H; Asai, A; Ito, I; Suzuki, S; Kobayashi, M; Higuchi, K; Suzuki, F				Ohama, Hideko; Asai, Akira; Ito, Ichiaki; Suzuki, Sumihiro; Kobayashi, Makiko; Higuchi, Kazuhide; Suzuki, Fujio			M2b Macrophage Elimination and Improved Resistance of Mice with Chronic Alcohol Consumption to Opportunistic Infections	AMERICAN JOURNAL OF PATHOLOGY			English	Article							BLOOD MONONUCLEAR-CELLS; LIVER-DISEASE; IMMUNE-RESPONSES; BACTERIAL TRANSLOCATION; STAPHYLOCOCCUS-AUREUS; APOPTOTIC CELLS; INNATE IMMUNITY; KUPFFER CELLS; HOST-DEFENSE; NOD MICE	Alcohol abuse was found to predispose persons to opportunistic infections. In this study, we tried to improve the host antibacterial resistance of chronic alcohol-consuming (CAC) mice to opportunistic infections. Bactericidal macrophages with functions to produce IL-12 and to express mRNAs for CXCL9 and inducible nitric oxide synthase (M1 macrophages) were characterized as the main effector cells in host antibacterial innate immunities against infections with opportunistic pathogens. However, CAC mice were found to be carriers of M2b macrophages [macrophages with functions to produce IL-10 and to express mRNAs for CD163, chemokine ligand (CCL)1, and LIGHT (homologous to Lymphotoxin, exhibits inducible expression, competes with herpes simplex virus glycoprotein D for high-voltage electron microscopy on T cells)], which were inhibitory on macrophage conversion from resident macrophages to M1 macrophages. Under treatment with CCL1 antisense oligodeoxynucleotides, a specific inhibitor of M2b macrophages, CAC mouse macrophages reverted to resident macrophages, and M1 macrophages were induced by a bacterial antigen from macrophages of CAC mice that were previously treated with the oligodeoxynucleotides. Opportunistic infections (enterococcal translocation and Klebsiella pneumonia) in CAC mice were completely controlled by CCL1 antisense oligodeoxynucleotides. These results indicate that certain opportunistic infections in alcoholics are controllable through the modulation of M2b macrophages.	[Ohama, Hideko; Asai, Akira; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 569, Japan; [Ito, Ichiaki; Kobayashi, Makiko; Suzuki, Fujio] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Suzuki, Sumihiro] Univ N Texas, Hlth Sci Ctr, Dept Biostat & Epidemiol, Ft Worth, TX USA	Suzuki, F (reprint author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	fsuzuki@utmb.edu			University of Texas Medical Branch account Education, Research and Development	Supported by The University of Texas Medical Branch account Education, Research and Development (F.S.).	Katakura T, 2005, CLIN EXP IMMUNOL, V142, P419, DOI 10.1111/j.1365-2249.2005.02944.x; Maree AFM, 2008, J APPL PHYSIOL, V104, P157, DOI 10.1152/japplphysiol.00514.2007; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453; Asai A, 2012, J LEUKOCYTE BIOL, V92, P859, DOI 10.1189/jlb.0212107; PENNER E, 1978, CLIN EXP IMMUNOL, V34, P28; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Shellito JE, 2001, ALCOHOL CLIN EXP RES, V25, P872, DOI 10.1111/j.1530-0277.2001.tb02293.x; MORLAND H, 1988, ALCOHOL CLIN EXP RES, V12, P755, DOI 10.1111/j.1530-0277.1988.tb01340.x; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Zisman DA, 1998, ALCOHOL CLIN EXP RES, V22, P621, DOI 10.1111/j.1530-0277.1998.tb04303.x; Starkenburg S, 2001, ALCOHOL CLIN EXP RES, V25, P1221, DOI 10.1111/j.1530-0277.2001.tb02339.x; Boe DM, 2010, ALCOHOL CLIN EXP RES, V34, P1723, DOI 10.1111/j.1530-0277.2010.01259.x; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bode C, 2003, BEST PRACT RES CL GA, V17, P575, DOI 10.1053/ybega.2003.392; Kobayashi M, 2012, J IMMUNOL, V189, P296, DOI 10.4049/jimmunol.1200350; Tsuda Y, 2008, J IMMUNOL, V180, P4133; Laso FJ, 1997, ALCOHOL CLIN EXP RES, V21, P1226, DOI 10.1097/00000374-199710000-00011; FERNANDEZSOLA J, 1995, ARCH INTERN MED, V155, P1649, DOI 10.1001/archinte.155.15.1649; Lippai D, 2013, J LEUKOCYTE BIOL, V94, P171, DOI 10.1189/jlb.1212659; Pascual M, 2011, IMMUNOL CELL BIOL, V89, P716, DOI 10.1038/icb.2010.163; Bagby GJ, 1998, ALCOHOL CLIN EXP RES, V22, P1740, DOI 10.1097/00000374-199811000-00017; Bhatty M, 2011, ALCOHOL, V45, P523, DOI 10.1016/j.alcohol.2011.02.305; Latif O, 2002, FRONT BIOSCI, V7, pA135, DOI 10.2741/latif; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Curtis BJ, 2013, ALCOHOL RES-CURR REV, V35, P97; Tabata T, 2002, J GASTROENTEROL, V37, P726, DOI 10.1007/s005350200118; Sester DP, 1999, J LEUKOCYTE BIOL, V66, P542; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Moss M, 2005, CLIN INFECT DIS, V41, pS490, DOI 10.1086/432003; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Pan HN, 2006, ALCOHOL CLIN EXP RES, V30, P1615, DOI 10.1111/j.1530-0277.2006.00194.x; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Laso FJ, 2007, ALCOHOL CLIN EXP RES, V31, P846, DOI 10.1111/j.1530-0277.2007.00377.x; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; THOMAS HC, 1978, CLIN EXP IMMUNOL, V31, P150; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; Liu W, 2011, EXP MOL PATHOL, V91, P761, DOI 10.1016/j.yexmp.2011.08.003; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296; Bautista AP, 2002, FRONT BIOSCI, V7, pA117; Siggins RW, 2011, J IMMUNOL, V186, P4306, DOI 10.4049/jimmunol.1002885; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Wang QS, 2010, CELL RES, V20, P701, DOI 10.1038/cr.2010.52; BAGASRA O, 1988, IMMUNOLOGY, V65, P405; Dominguez-Santalla MJ, 2001, ALCOHOL CLIN EXP RES, V25, P1198, DOI 10.1111/j.1530-0277.2001.tb02336.x; Engelich G, 2001, CLIN INFECT DIS, V33, P2040, DOI 10.1086/324502; Ferrante CJL, 2012, ADV WOUND CARE, V1, P10, DOI [10.1089/wound.2011.0307, DOI 10.1089/WOUND.2011.0307]; Katakura T, 2004, J IMMUNOL, V172, P1407; Shigematsu K, 2009, J LEUKOCYTE BIOL, V86, P999, DOI 10.1189/jlb.0409235; Tanaka H, 2004, J SURG RES, V118, P114, DOI 10.1016/S0022-4804(03)00355-X; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Weisfelt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009102; Zhang Ping, 2008, Curr Drug Abuse Rev, V1, P56	60	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	FEB	2015	185	2					420	431		10.1016/j.ajpath.2014.09.022		12	Pathology	Pathology	AZ8UH	WOS:000348489400014		
J	Suzuki, H; Hirata, Y; Suzuki, N; Ihara, S; Sakitani, K; Kobayashi, Y; Kinoshita, H; Hayakawa, Y; Yamada, A; Watabe, H; Tateishi, K; Ikenoue, T; Yamaji, Y; Koike, K				Suzuki, Hirobumi; Hirata, Yoshihiro; Suzuki, Nobumi; Ihara, Sozaburo; Sakitani, Kosuke; Kobayashi, Yuka; Kinoshita, Hiroto; Hayakawa, Yoku; Yamada, Atsuo; Watabe, Hirotsugu; Tateishi, Keisuke; Ikenoue, Tsuneo; Yamaji, Yutaka; Koike, Kazuhiko			Characterization of a New Small Bowel Adenocarcinoma Cell Line and Screening of Anti-Cancer Drug against Small Bowel Adenocarcinoma	AMERICAN JOURNAL OF PATHOLOGY			English	Article							ISLAND METHYLATOR PHENOTYPE; SMALL-INTESTINAL ADENOCARCINOMAS; PROTEASOME INHIBITOR BORTEZOMIB; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; COLON-CANCER; UNITED-STATES; BETA-CATENIN; APC GENES; IN-VITRO	Small bowel adenocarcinoma (SBA) is a rare, aggressive malignancy with a poor prognosis, and the mechanisms of carcinogenesis in SBA remain unclear. Our aims were to investigate the molecular mechanisms underlying SBA and to identify treatments by establishing and characterizing an SBA cell line and performing anti-cancer drug screening. SIAC1 cells, established from jejunal SBA, showed epithelial characteristics and formed organoids in 3D culture. SIAC1 cells had a heterozygous beta-catenin deletion mutation, resulting in a stable beta-catenin protein with enhanced Wnt/beta-catenin activity. SIAC1 cells lacked MLH1 and MSH6 expression, and target genes such as TGFBR2 and ACVR2 showed frameshift mutations. Among 10 clinical SBA samples, 2 (20%) had interstitial deletions in beta-catenin, expression of mismatch repair protein was aberrant in 4 (40%), and heterozygous frameshift mutations of three target genes were found in all 10 samples. On screening assay using 140 compounds, eribulin significantly inhibited SIAC1 cell growth both in vitro and in vivo by inhibition of the Wnt/beta-catenin pathway via enhanced degradation of beta-catenin. In conclusion, we established an SBA cell line with molecular characteristics similar to those of clinical SBA samples, including beta-catenin deletion and mismatch repair protein deficiency, that will be useful for SBA research. Eribulin might be a candidate for SBA treatment due to its inhibitory effect on Wnt/beta-catenin signaling.	[Suzuki, Hirobumi; Hirata, Yoshihiro; Suzuki, Nobumi; Ihara, Sozaburo; Sakitani, Kosuke; Kobayashi, Yuka; Kinoshita, Hiroto; Hayakawa, Yoku; Yamada, Atsuo; Watabe, Hirotsugu; Tateishi, Keisuke; Ikenoue, Tsuneo; Yamaji, Yutaka; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan	Hirata, Y (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	suzuhiro817@yahoo.co.jp; hiratay-int@h.u-tokyo.ac.jp			 [24590931]	Supported by Grant-in-Aid for Scientific Research 24590931 (A.Y. and Y.Hi.).	Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Zaanan A, 2010, ANN ONCOL, V21, P1786, DOI 10.1093/annonc/mdq038; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Fleisher AS, 2001, ONCOGENE, V20, P329, DOI 10.1038/sj.onc.1204104; Dietmaier W, 1997, CANCER RES, V57, P4749; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Li YJ, 2005, WORLD J GASTROENTERO, V11, P2117; Aparicio T, 2013, BRIT J CANCER, V109, P3057, DOI 10.1038/bjc.2013.677; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Herman JG, 1999, SEMIN CANCER BIOL, V9, P359, DOI 10.1006/scbi.1999.0138; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Benson AB, 2013, J NATL COMPR CANC NE, V11, P141; Rim SH, 2009, CANCER, V115, P1967, DOI 10.1002/cncr.24216; Laforest A, 2014, EUR J CANCER, V50, P1740, DOI 10.1016/j.ejca.2014.04.007; SELLNER F, 1990, CANCER, V66, P702, DOI 10.1002/1097-0142(19900815)66:4<702::AID-CNCR2820660419>3.0.CO;2-Z; Williams S, 2003, MOL CANCER THER, V2, P835; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; O'Connell JB, 2004, J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Bilimoria KY, 2009, ANN SURG, V249, P63, DOI [10.1097/SLA.0b013e31818e4641, 10.1097/SLA.0b013e31818c4641]; Overman MJ, 2010, BRIT J CANCER, V102, P144, DOI 10.1038/sj.bjc.6605449; Arai M, 1997, INT J CANCER, V70, P390, DOI 10.1002/(SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.0.CO;2-R; Blaker H, 2004, PATHOL RES PRACT, V200, P1, DOI 10.1016/jprp.2003.12.001; Boland CR, 2008, GASTROINTEST ENDOSC, V18; Breuhahn K, 2008, J PATHOL, V215, P300, DOI 10.1002/path.2362; Coyne GO, 2012, EXPERT OPIN DRUG SAF, V11, P643, DOI 10.1517/14740338.2012.698608; Delaunoit T, 2005, AM J GASTROENTEROL, V100, P703, DOI 10.1111/j.1572-0241.2005.40605.x; Duldulao MP, 2012, J SURG RES, V174, P1, DOI 10.1016/j.jss.2011.06.016; Fomier M, 2012, BREAST J, V18, P41; HIBI K, 1995, JPN J CANCER RES, V86, P357; Konishi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027889; Michel S, 2010, MOL CARCINOGEN, V49, P175, DOI 10.1002/mc.20587; Nakata W, 2011, INT J ONCOL, V39, P1529, DOI 10.3892/ijo.2011.1141; Newman S, 2007, CURR OPIN INVEST DR, V8, P1057; Olschwang S, 1999, EUR J CANCER PREV, V8, pS33; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Painuly Utkarsh, 2013, Clin Med Insights Oncol, V7, P53, DOI 10.4137/CMO.S7764; Pinheiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-587; Sakitani K, 2012, INFECT IMMUN, V80, P3795, DOI 10.1128/IAI.00637-12; Suzuki H., 2012, DIAGN THER ENDOSC, V2012; Talamonti MS, 2002, ARCH SURG-CHICAGO, V137, P564, DOI 10.1001/archsurg.137.5.564; Talamonti M. S., 2002, ARCH SURG-CHICAGO, V137, P570, DOI DOI 10.1001/ARCH-SURG.137.5.564; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Vlaykova T, 2011, J BUON, V16, P265; Warth A, 2011, MODERN PATHOL, V24, P564, DOI 10.1038/modpathol.2010.223; Wheeler JMD, 2002, GUT, V50, P218, DOI 10.1136/gut.50.2.218; Wu AH, 1997, INT J CANCER, V70, P512, DOI 10.1002/(SICI)1097-0215(19970304)70:5<512::AID-IJC4>3.0.CO;2-0; Yamaguchi Hirohito, 2012, Front Oncol, V2, P15, DOI 10.3389/fonc.2012.00015	53	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	FEB	2015	185	2					550	562		10.1016/j.ajpath.2014.10.006		13	Pathology	Pathology	AZ8UH	WOS:000348489400024		
J	Akiyama, K; Maishi, N; Ohga, N; Hida, Y; Ohba, Y; Alam, MT; Kawamoto, T; Ohmura, H; Yamada, K; Torii, C; Shindoh, M; Hida, K				Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Hida, Yasuhiro; Ohba, Yusuke; Alam, Mohammad Towfik; Kawamoto, Taisuke; Ohmura, Hitomi; Yamada, Kenji; Torii, Chisaho; Shindoh, Masanobu; Hida, Kyoko			Inhibition of Multidrug Transporter in Tumor Endothelial Cells Enhances Antiangiogenic Effects of Low-Dose Metronomic Paclitaxel	AMERICAN JOURNAL OF PATHOLOGY			English	Article							METASTATIC BREAST-CANCER; PHASE-II TRIAL; RECURRENT MALIGNANT GLIOMA; ORAL CYCLOPHOSPHAMIDE; ANTITUMOR-ACTIVITY; DRUG-RESISTANCE; GROWTH-FACTOR; ANGIOGENESIS; CHEMOTHERAPY; MELANOMA	Tumor angiogenesis plays an important role in tumor progression and metastasis. Tumor endothelial cells (TECs) are a therapeutic target of antiangiogenic chemotherapy that was recently developed and is currently being investigated in the clinic with promising results. Low-dose chemotherapy, which is the Long-term administration of relatively Low doses of chemotherapeutic agents, has been proposed for targeting tumor angiogenesis in various types of cancers. ALthough the efficacy of low-dose chemotherapy has been confirmed in several clinical models, some studies show insufficienttherapeutic effect for malignant cancers. As a possible mechanism of the treatment failure, it has been considered that tumor cells may acquire resistance to this therapy. However, drug resistance by TECs may also be due to another mechanism for resistance of tumor cells to low-dose chemotherapy. We reported elsewhere that TECs were resistant to the anticancer drug paclitaxel, which is a mitotic inhibitor, concomitant with P-glycoprotein up-regulation. Verapamil, a P-glycoprotein inhibitor, abrogated TEC resistance in vitro. Herein, we demonstrated that verapamil coadministration enhanced the effects of Low-dose paclitaxel concomitant with inhibiting tumor angiogenesis in a preclinical in vivo mouse melanoma xenograft model. Furthermore, verapamil coadministration reduced lung metastasis. These results suggest that inhibiting P-gLycoprotein in TECs may be a novel strategy for low-dose chemotherapy targeting TECs.	[Akiyama, Kosuke; Maishi, Nako; Yamada, Kenji; Torii, Chisaho; Hida, Kyoko] Hokkaido Univ, Inst Med Genet, Div Vasc Biol, Sapporo, Hokkaido 0600815, Japan; [Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Alam, Mohammad Towfik; Kawamoto, Taisuke; Ohmura, Hitomi; Yamada, Kenji; Torii, Chisaho; Hida, Kyoko] Hokkaido Univ, Dept Vasc Biol, Grad Sch Dent Med, Sapporo, Hokkaido 0600815, Japan; [Alam, Mohammad Towfik; Shindoh, Masanobu] Hokkaido Univ, Dept Oral Pathol & Biol, Grad Sch Dent Med, Sapporo, Hokkaido 0600815, Japan; [Hida, Yasuhiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido 0600815, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Sapporo, Hokkaido 0600815, Japan	Hida, K (reprint author), Hokkaido Univ, Inst Med Genet, Div Vasc Biol, Kita Ku, N15 W7, Sapporo, Hokkaido 0600815, Japan.	khida@igm.hokudai.ac.jp	Hida, Kyoko/A-8444-2012; Shindoh, Masanobu/A-4799-2012; Hida, Yasuhiro/A-7761-2012	Shindoh, Masanobu/0000-0002-7782-5823; Hida, Yasuhiro/0000-0003-1759-4215	Scientific Research from the Ministry of Education, Science, and Culture of Japan [23112501]; Naito Foundation	Supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (grant 23112501 to K.H.) and The Naito Foundation (K.H.).	Bocci G, 2003, P NATL ACAD SCI USA, V100, P12917, DOI 10.1073/pnas.2135406100; Browder T, 2000, CANCER RES, V60, P1878; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Osawa T, 2012, CANCER SCI, V103, P1038, DOI 10.1111/j.1349-7006.2012.02261.x; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Perez-Sayans M, 2010, CANCER LETT, V295, P135, DOI 10.1016/j.canlet.2010.03.019; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Colleoni M, 2006, ANN ONCOL, V17, P232, DOI 10.1093/annonc/mdj066; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Perry JR, 2008, CANCER, V113, P2152, DOI 10.1002/cncr.23813; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Kong DS, 2006, ONCOL REP, V16, P1117; Ohga N, 2009, CANCER SCI, V100, P1963, DOI 10.1111/j.1349-7006.2009.01255.x; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; Xiong YQ, 2009, CLIN CANCER RES, V15, P4838, DOI 10.1158/1078-0432.CCR-08-2780; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Bottini A, 2006, J CLIN ONCOL, V24, P3623, DOI 10.1200/JCO.2005.04.5773; Colleoni M, 2002, ANN ONCOL, V13, P73, DOI 10.1093/annonc/mdf013; Fontana A, 2009, CLIN CANCER RES, V15, P4954, DOI 10.1158/1078-0432.CCR-08-3317; Grange C, 2006, ONCOL REP, V15, P381; Reardon DA, 2009, BRIT J CANCER, V101, P1986, DOI 10.1038/sj.bjc.6605412; Walker L, 2005, MELANOMA RES, V15, P453, DOI 10.1097/00008390-200510000-00015; Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Bhatt RS, 2010, CANCER-AM CANCER SOC, V116, P1751, DOI 10.1002/cncr.24902; Eikesdal HP, 2009, SEMIN CANCER BIOL, V19, P310, DOI 10.1016/j.semcancer.2009.05.006; Fidler U, 2007, J CELL BIOCHEM, V101, P927; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Hida K, 2008, CANCER SCI, V99, P459, DOI 10.1111/j.1349-7006.2007.00704.x; Inuzuka T, 2009, BIOCHEM BIOPH RES CO, V379, P510, DOI 10.1016/j.bbrc.2008.12.101; Jurado JM, 2008, CLIN TRANSL ONCOL, V18, P583; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; Kesari S, 2007, NEURO-ONCOLOGY, V9, P354, DOI 10.1215/15228517-2007-006; Krzyzanowska MK, 2007, CANCER CHEMOTH PHARM, V60, P135, DOI 10.1007/s00280-006-0347-x; Lasagna N, 2006, CANCER RES, V66, P2673, DOI 10.1158/008-5472.CAN-05-2290; Miyoshi Hiroyuki, 2004, Methods Mol Biol, V246, P429; Orlando L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-225	38	2	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	FEB	2015	185	2					572	580		10.1016/j.ajpath.2014.10.017		9	Pathology	Pathology	AZ8UH	WOS:000348489400026		
J	Tsutaya, T; Shimomi, A; Nagaoka, T; Sawada, J; Hirata, K; Yoneda, M				Tsutaya, Takumi; Shimomi, Akina; Nagaoka, Tomohito; Sawada, Junmei; Hirata, Kazuaki; Yoneda, Minoru			Infant Feeding Practice in Medieval Japan: Stable Carbon and Nitrogen Isotope Analysis of Human Skeletons From Yuigahama-Minami	AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY			English	Article						breastfeeding; fertility; Kamakura; subadult health; weaning	EARLY-CHILDHOOD DIET; BONE-COLLAGEN; RATIO ANALYSIS; WEANING PRACTICES; HUNTER-GATHERERS; WHARRAM-PERCY; AMINO-ACIDS; DENTIN; JOMON; POPULATION	A longer breastfeeding duration provides various positive effects in subadult health because of abundant immunological factors and nutrients in human breast milk, and decreases the natural fertility of a population through lactational amenorrhea. In this study, we measured stable carbon and nitrogen isotope ratios in the bone collagen of three adults and 45 subadults from the Yuigahama-minami site (from 12th to 14th century) in Kamakura, the early medieval capital of Japan. Marine foods, C-3-based terrestrial foods, and freshwater fish are the primarily protein sources for adults. The changes in the nitrogen isotope ratios of subadults suggest that the relative dietary protein contribution from breast milk started to decrease from 1.1 years of age and ended at 3.8 years. The age at the end of weaning in the Yuigahama-minami population was greater than that in the typical non-industrial populations, a premodern population in the Edo period Japan, and medieval populations in the UK. Skeletons of townspeople from medieval Kamakura indicate severe nutritional stress (e.g., enamel hypoplasia and cribra orbitalia), yet this longer duration of breastfeeding did not compensate adverse effects for nutritional deficiency. The longer breastfeeding period may have been a consequence of complementary food shortage and bad health of subadults. Kamakura experienced urbanization and population increase in the early medieval period. The younger age-at-death distribution and high nutritional stresses in the Yuigahama-minami population and later weaning, which is closely associated with longer inter-birth interval for mothers, suggests that Kamakura developed and increased its population by immigration during urbanization. Am J Phys Anthropol 156:241-251, 2015. (c) 2014 Wiley Periodicals, Inc.	[Tsutaya, Takumi; Shimomi, Akina; Yoneda, Minoru] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Nagaoka, Tomohito; Sawada, Junmei; Hirata, Kazuaki] St Marianna Univ, Dept Anat, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Yoneda, Minoru] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	Tsutaya, T (reprint author), Univ Tokyo, Univ Museum, Lab Radiocarbon Dating, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	127309@ib.k.u-tokyo.ac.jp			Japan Society for the Promotion of Science [17107006, 18500769, 20370095, 20255007, 24-785]	Grant sponsor: Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research); Grant numbers: 17107006, 18500769, 20370095, 20255007, 24-785.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Amino Y, 1989, YOMIGAERU CHUSEI 3 B; Eerkens JW, 2011, J ARCHAEOL SCI, V38, P3101, DOI 10.1016/j.jas.2011.07.010; ELLISON PT, 1994, ANNU REV ANTHROPOL, V23, P255, DOI 10.1146/annurev.anthro.23.1.255; Valeggia C, 2009, AM J HUM BIOL, V21, P559, DOI 10.1002/ajhb.20907; Wright LE, 1999, J ARCHAEOL SCI, V26, P1159, DOI 10.1006/jasc.1998.0351; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Sellen DW, 2001, J NUTR, V131, P2707; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Nagaoka T, 2006, AM J PHYS ANTHROPOL, V131, P1, DOI 10.1002/ajpa.20402; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Katzenberg MA, 1999, INT J OSTEOARCHAEOL, V9, P316, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<316::AID-OA500>3.0.CO;2-D; BocquetAppel JP, 1996, AM J PHYS ANTHROPOL, V99, P571, DOI 10.1002/(SICI)1096-8644(199604)99:4<571::AID-AJPA4>3.0.CO;2-X; Naito YI, 2013, J ARCHAEOL SCI, V40, P2913, DOI 10.1016/j.jas.2013.03.012; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Kramer MS, 2004, ADV EXP MED BIOL, V554, P63; Olsen KC, 2014, AM J PHYS ANTHROPOL, V153, P598, DOI 10.1002/ajpa.22459; Howcroft R, 2012, AM J PHYS ANTHROPOL, V149, P217, DOI 10.1002/ajpa.22113; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Beaumont J, 2013, ARCHAEOMETRY, V55, P277, DOI 10.1111/j.1475-4754.2012.00682.x; Beaumont J, 2013, AM J PHYS ANTHROPOL, V150, P87, DOI 10.1002/ajpa.22179; Prowse TL, 2008, AM J PHYS ANTHROPOL, V137, P294, DOI 10.1002/ajpa.20870; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Burt NM, 2013, J ARCHAEOL SCI, V40, P3854, DOI 10.1016/j.jas.2013.05.022; KEYFITZ N, 1980, GEOGR ANAL, V12, P142; Romek KM, 2013, AMINO ACIDS, V45, P1365, DOI 10.1007/s00726-013-1597-7; BARRY H, 1971, ETHNOLOGY, V10, P466; Henderson RC, 2014, AM J PHYS ANTHROPOL, V154, P585, DOI 10.1002/ajpa.22554; Chamberlain A, 2009, HUM BIOL, V81, P275, DOI 10.3378/027.081.0309; Lee-Thorp JA, 2008, ARCHAEOMETRY, V50, P925, DOI 10.1111/j.1475-4754.2008.00441.x; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 1983, FERTILITY BIOL BEHAV; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; Burt NM, 2013, AM J PHYS ANTHROPOL, V152, P407, DOI 10.1002/ajpa.22370; Burt NM, 2014, ARCH ORAL BIOL, V59, P1226, DOI 10.1016/j.archoralbio.2014.07.014; Choy K, 2010, AM J PHYS ANTHROPOL, V142, P74, DOI 10.1002/ajpa.21202; CORNELL LL, 1986, J FAM HIST, V11, P311, DOI 10.1177/036319908601100401; Cunningham AS., 1995, BREASTFEEDING BIOCUL, P243; de Luca A, 2012, PEDIATR RES, V71, P598, DOI 10.1038/pr.2012.3; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; Eerkens JW, 2013, AM J PHYS ANTHROPOL, V152, P471, DOI 10.1002/ajpa.22384; Ehara A, 2009, NIHON SHOKU SEIKATSU; Ellison PT, 1995, BREASTFEEDING BIOCUL, P305; Fagre T., 1993, PREHISTORIC HUMAN BO, P121; Farris William Wayne, 2006, JAPANS MEDIEVAL POPU; Ferembach D, 1980, J HUM EVOL, V9, P517; FLECKER H., 1942, AMER JOUR ROENTGENOL AND RADIUM THERAP, V47, P97; Fogel ML, 1989, ANN REPORT DIRECTOR, V88, P111; Ford CS, 1964, COMP STUDY HUMAN REP; Fuller BT, 2003, J ARCHAEOL SCI, V30, P1673, DOI 10.1016/S0305-4403(03)00073-6; Gomi F, 2004, CHUSEI TOSHI KAMAKUR; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Hayami A, 1999, HIST HUMANITY SCI CU, V5, P344; Hirata K, 2002, YUIGAHAMA MINAMI SIT, V2, P1; Hirata K, 2011, KOKOGAKU WO KAGAKU S, P208; HOUGHTON P, 1974, AM J PHYS ANTHROPOL, V41, P381, DOI 10.1002/ajpa.1330410305; Howcroft R, 2014, J ANTHROPOL ARCHAEOL, V34, P42, DOI 10.1016/j.jaa.2014.01.001; Ip S., 2007, BREASTFEEDING MATERN; Kajitani S, 2008, TEIKYO J LANG STUD, V1, P71; Kajitani S, 2007, TEIKYO J COMP CULT, V20, P65; Katzenberg MA, 1996, YEARB PHYS ANTHROPOL, V39, P177; KATZENBERG MA, 1993, AM J PHYS ANTHROPOL, V90, P267, DOI 10.1002/ajpa.1330900302; Kawano S, 1995, CHUSEI TOSHI KAMAKUR; Kito H, 2000, JINKO KARA YOMU NIHO; Kobayashi K., 1967, J FS U TOKYO ANTHR, V3, P107; Kusaka S, 2008, ANTHROPOL SCI, V116, P171, DOI 10.1537/asc.070703; Kusaka S, 2010, J ARCHAEOL SCI, V37, P1968, DOI 10.1016/j.jas.2010.03.002; Lewis ME, 2007, CAM S BIO EVOL ANTHR, V50, P1; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Michaelsen KF, 2000, EUROPEAN SERIES, V87; Millard AD, 2000, PERSPECTIVES AMINO A, P51; Minagawa M., 2001, B NATL MUSEUM JAPANE, V86, P333; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Minami M, 2011, KOKOGAKU WO KAGAKU S, P233; Minami M, 2007, P INT S RADIOM DATIN, V18, P134; Moriyama S, 2002, NIHON KODOMO SHI; Muramatsu A., 2009, BUNKAZAIGAKU ZASSHI, V5, P75; Nagaoka T, 2013, ANTHROPOL SCI, V121, P203, DOI 10.1537/ase.131010; Nitsch EK, 2011, AM J PHYS ANTHROPOL, V146, P619, DOI 10.1002/ajpa.21623; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; R Core Team, 2014, R LANG ENV STAT COMP; Saiki H, 2002, YUIGAHAMA MINAMI ISE; Saito O, 2002, EDO TO OSAKA KINDAI; Sawada J, 2007, ANTHROPOL SCI, V115, P257; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schurr MR, 2005, AM J PHYS ANTHROPOL, V126, P278, DOI 10.1002/ajpa.20034; Schwarcz HP, 2000, BIOGEOCHEMICAL APPRO, P189; SHARLIN A, 1978, PAST PRESENT, P126; SMITH TC, 1973, PAST PRESENT, P127; Sone M, 2011, B YOKOHAMA WOMEN JUN, V26, P1; Suzuki K, 1983, J JAPANESE HIST, V247, P32; Suzuki K, 2013, CHUSEI KAMAKURA NO T; Suzuki K., 1982, J JAPANESE HIST, V242, P15; Tsutaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072327; Tsutaya T, 2014, AM J PHYS ANTHROPOL, V153, P559, DOI 10.1002/ajpa.22454; Ubelaker D.H., 1999, HUMAN SKELETAL REMAI; vansKlinken G. J., 1999, J ARCHAEOL SCI, V26, P687; WAKEBE T, 1990, Nagasaki Igakkai Zasshi, V65, P805; Waters-Rist AL, 2011, AM J PHYS ANTHROPOL, V146, P225, DOI 10.1002/ajpa.21568; WEBB PAO, 1985, AM J PHYS ANTHROPOL, V68, P457, DOI 10.1002/ajpa.1330680402; WHO, 1998, COMPL FEED YOUNG CHI; Wood J., 1988, NATURAL HUMAN FERTIL, P39; Wood JW., 1994, DYNAMICS HUMAN REPRO; Woods R, 2003, POPUL DEV REV, V29, P29, DOI 10.1111/j.1728-4457.2003.00029.x; World Health Organization (WHO), 2009, INF YOUNG CHILD FEED; YAMAMOTO M, 1988, J ANTHROPOL SOC NIP, V96, P417; Yamamura K, 1990, CAMBRIDGE HIST JAPAN, V3; Yamazumi M, 1976, KOSODATE NO SHO; Yoneda M, 2004, J ARCHAEOL SCI, V31, P97, DOI 10.1016/S0305-4403(03)00103-1; Yoneda M, 2011, NIHON RETTO NO KANKY, V6, P85	115	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-9483	1096-8644		AM J PHYS ANTHROPOL	Am. J. Phys. Anthropol.	FEB	2015	156	2					241	251		10.1002/ajpa.22643		11	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	AZ8BS	WOS:000348440300006		
J	Terui, Y; Sakamoto, A; Yoshida, T; Kasahara, T; Tomitori, H; Higashi, K; Igarashi, K; Kashiwagi, K				Terui, Yusuke; Sakamoto, Akihiko; Yoshida, Taketo; Kasahara, Takuma; Tomitori, Hideyuki; Higashi, Kyohei; Igarashi, Kazuei; Kashiwagi, Keiko			Polyamine stimulation of eEF1A synthesis based on the unusual position of a complementary sequence to 18S rRNA in eEF1A mRNA	AMINO ACIDS			English	Article						Polyamines; Protein synthesis; mRNA; 5 '-UTR; CR sequence	OLIGOPEPTIDE-BINDING PROTEIN; SHINE-DALGARNO SEQUENCE; ESCHERICHIA-COLI; TRANSLATION INITIATION; BOVINE LYMPHOCYTES; STRUCTURAL-CHANGE; SPERMIDINE; SITE; PREDICTION; MECHANISM	It is thought that Shine-Dalgarno-like sequences, which exhibit complementarity to the nucleotide sequences at the 3'-end of 18S rRNA, are not present in eukaryotic mRNAs. However, complementary sequences consisting of more than 5 nucleotides to the 3'-end of 18S rRNA, i.e., a CR sequence, are present at -17 to -32 upstream from the initiation codon AUG in 18 mRNAs involved in protein synthesis except eEF1A mRNA. Thus, effects of the CR sequence in mRNAs and polyamines on protein synthesis were examined using control and polyamine-reduced FM3A and NIH3T3 cells. Polyamines did not stimulate protein synthesis encoded by 18 mRNAs possessing a normal CR sequence. When the CR sequence was deleted, protein synthetic activities decreased to less than 70 % of intact mRNAs. In eEF1A mRNA, the CR sequence was located at -33 to -39 upstream from the initiation codon AUG, and polyamines stimulated eEF1A synthesis about threefold. When the CR sequence was shifted to -22 to -28 upstream from the AUG, eEF1A synthesis increased in polyamine-reduced cells and the degree of polyamine stimulation decreased greatly. The results indicate that the CR sequence exists in many eukaryotic mRNAs, and the location of a CR sequence in mRNAs influences polyamine stimulation of protein synthesis.	[Terui, Yusuke; Sakamoto, Akihiko; Yoshida, Taketo; Kasahara, Takuma; Tomitori, Hideyuki; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Choshi, Chiba 2880025, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Igarashi, Kazuei] Innovat Plaza Chiba Univ, Amine Pharma Res Inst, Chiba, Japan	Kashiwagi, K (reprint author), Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2880025, Japan.	kkashiwagi@cis.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Drs. A. J. Michael and K. Williams for their help in preparing the manuscript. We also thank Dr. R. G. Mirmira for his kind gift of antibody against hypusinated eIF5A. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Yoshida M, 1999, J BIOL CHEM, V274, P22723, DOI 10.1074/jbc.274.32.22723; Nishimura K, 2005, BIOCHEM J, V385, P779; Meng Z, 2010, J CELL BIOCHEM, V110, P531, DOI 10.1002/jcb.22569; Nishimura K, 2009, INT J BIOCHEM CELL B, V41, P2251, DOI 10.1016/j.biocel.2009.04.021; Yueh A, 1996, GENE DEV, V10, P1557, DOI 10.1101/gad.10.12.1557; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; IGARASHI K, 1979, EUR J BIOCHEM, V93, P345, DOI 10.1111/j.1432-1033.1979.tb12829.x; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; Uemura T, 2009, INT J BIOCHEM CELL B, V41, P2538, DOI 10.1016/j.biocel.2009.08.010; Sakamoto A, 2012, INT J BIOCHEM CELL B, V44, P1877, DOI 10.1016/j.biocel.2012.07.010; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; ECHANDI G, 1975, BIOCHEM BIOPH RES CO, V67, P1185, DOI 10.1016/0006-291X(75)90798-6; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; HOLMBERG L, 1994, NUCLEIC ACIDS RES, V22, P1374, DOI 10.1093/nar/22.8.1374; Igarashi Kazuei, 2010, Int J Biochem Cell Biol, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1984, CANCER RES, V44, P5332; IGARASHI K, 1979, BIOCHEM BIOPH RES CO, V91, P440, DOI 10.1016/0006-291X(79)91541-9; Igarashi K, 1997, J BIOL CHEM, V272, P4058; JAKUS J, 1993, J BIOL CHEM, V268, P13151; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Nishiki Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-421; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164; Sambrook J, 2001, MOL CLONING LAB MANU; SCHEPER GC, 1994, FEBS LETT, V352, P271, DOI 10.1016/0014-5793(94)00975-9; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342	40	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	FEB	2015	47	2					345	356		10.1007/s00726-014-1867-z		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ6AK	WOS:000348300000011		
J	Sahoo, BR; Dikhit, MR; Bhoi, GK; Maharana, J; Lenka, SK; Dubey, PK; Tiwari, DK				Sahoo, Bikash Ranjan; Dikhit, Manas Ranjan; Bhoi, Gopal Krushna; Maharana, Jitendra; Lenka, Santosh Kumar; Dubey, Praveen Kumar; Tiwari, Dharmendra Kumar			Understanding the distinguishable structural and functional features in zebrafish TLR3 and TLR22, and their binding modes with fish dsRNA viruses: an exploratory structural model analysis	AMINO ACIDS			English	Article						TLR3; TLR22; Molecular docking; Molecular dynamics simulation; MM/PBSA; RNA	TOLL-LIKE RECEPTOR-3; CARP CTENOPHARYNGODON-IDELLA; DOUBLE-STRANDED-RNA; LIGAND-BINDING; MOLECULAR-DYNAMICS; LABEO-ROHITA; NUCLEOTIDE-BINDING; PROTEIN STRUCTURES; INNATE IMMUNITY; HIGH-THROUGHPUT	Viral infections are one of the major challenges in aquaculture production, and considered as the potential threat for fish farming. Toll-like receptor (TLR) 3 and TLR22 are highly specialized innate immune receptors that recognize double-stranded (ds)-RNA of viruses resulting in the induction of innate immunity. The existence of TLR3 and TLR22 only in aquatic animals indicates their distinctive characteristics in viral infection; however, the studies in exploring their structural features and dsRNA binding mechanism are still elusive. Here, we studied the structural and functional differentiations of TLR3 and TLR22 in zebrafish by employing comparative modeling and molecular dynamics simulation. Comparative structural analysis revealed a distinct spatial arrangement of TLR22 ectodomain with a flattened horseshoe-shape conformation as compared to other TLRs. Essential dynamics studies showed that unlike TLR3, TLR22 possessed a prominent motion, elasticity and twisting at both terminus separated by a distance equivalent to the length of a short-sized dsRNA. Interaction analysis of polyinosinic:polycytidylic acid (poly I:C) and dsRNA depicted leucine-rich-repeats (LRR)2-3 and LRR18-19 (in TLR3) and LRRNT-LRR3 and LRR22-24 (in TLR22) as the potential binding sites. The short-sized dsRNA binds tightly across its full-length with TLR22-monomer, and suggested that TLR22 dimer may sense long-sized dsRNA. Binding energy (BE) calculation using MM/PBSA method from the TLR3- and TLR22-ligand complexes revealed an adequate binding affinity between TLR22-monomer and dsRNA as like as TLR3-dimer-dsRNA complex. Mutagenesis and BE computation of key residues suggested their involvement in dsRNA recognition. These findings can be helpful for therapeutic applications against viral diseases in fish.	[Sahoo, Bikash Ranjan; Bhoi, Gopal Krushna; Maharana, Jitendra; Lenka, Santosh Kumar] Orissa Univ Agr & Technol, Dept Bioinformat, Bhubaneswar 751001, Orissa, India; [Sahoo, Bikash Ranjan] Osaka Univ, Suita, Osaka 5650871, Japan; [Dikhit, Manas Ranjan] Rajendra Mem Res Inst Med Sci, Biomed Informat Ctr, Patna 800007, Bihar, India; [Dubey, Praveen Kumar] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Tiwari, Dharmendra Kumar] Osaka Univ, Inst Sci & Ind Res, Dept Biomol Sci & Engn, Suita, Osaka 5650871, Japan	Sahoo, BR (reprint author), Osaka Univ, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	bikash.bioinformatics@gmail.com		Maharana, Jitendra/0000-0003-4628-5956			C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Amini K, 2014, ANAL METHODS-UK, V6, P3322, DOI 10.1039/c4ay00369a; Su JG, 2012, DEV COMP IMMUNOL, V36, P450, DOI 10.1016/j.dci.2011.08.015; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Samanta M, 2014, APPL BIOCHEM BIOTECH, V174, P309, DOI 10.1007/s12010-014-1058-0; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Kim H, 2014, NATURE, V506, P334, DOI 10.1038/nature13039; Pietretti D, 2014, DEV COMP IMMUNOL, V43, P205, DOI 10.1016/j.dci.2013.08.010; Sahoo BR, 2012, INT J BIOL MACROMOL, V51, P531, DOI 10.1016/j.ijbiomac.2012.06.005; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Samanta M, 2013, MOL BIOL REP, V40, P225, DOI 10.1007/s11033-012-2053-6; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Luo JQ, 2012, J MOL BIOL, V421, P112, DOI 10.1016/j.jmb.2012.05.006; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics./btl.448; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Sahoo BR, 2013, APPL BIOCHEM BIOTECH, V170, P1282, DOI 10.1007/s12010-013-0263-6; Chen LJ, 2013, FISH SHELLFISH IMMUN, V34, P909, DOI 10.1016/j.fsi.2013.01.003; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Matsuo A, 2008, J IMMUNOL, V181, P3474; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bhattacharya D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069648; Brown SP, 2006, J CHEM INF MODEL, V46, P999, DOI 10.1021/ci050488t; Buchan DW, 2013, NUCLEIC ACIDS RES, V41, P349; COLOVOS C, 1993, PROTEIN SCI, V2, P1511; Eswar N., 2007, CURR PROTOC PROTEIN, V50, P291, DOI DOI 10.1002/0471140864.PS0209S50; Ferre F., 2005, NUCLEIC ACIDS RES, V33, P230; Finn R. D., 2010, NUCLEIC ACIDS RES, V38, P211, DOI DOI 10.1093/NAR/GKP985; Gupta R., 2002, PAC S BIOCOMPUT, V7, P310, DOI DOI 10.1142/9789812799623_; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Joosten R.P., 2011, NUCLEIC ACIDS RES, V39, P411, DOI DOI 10.1093/NAR/GKQ1105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I., 2012, NUCLEIC ACIDS RES, V40, P302, DOI DOI 10.1093/NAR/GKR931); Li YG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-114; Maharana J, 2014, J MOL RECOGNIT, V27, P260, DOI 10.1002/jmr.2357; Maharana J, 2013, FISH PHYSIOL BIOCHEM, V39, P1007, DOI 10.1007/s10695-012-9758-2; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V37, P225; Maynard CM, 2010, J MOL BIOL, V397, P260, DOI 10.1016/j.jmb.2009.12.051; Naumann K, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/283649; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Sahoo BR, 2013, BIOMED RES INT, DOI 10.1155/2013/185282; Sahoo BR, 2014, MOL BIOSYST, V10, P1104, DOI 10.1039/c3mb70600a; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang Y, 2010, J BIOL CHEM, V285, P36836, DOI 10.1074/jbc.M110.167973; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, P407, DOI DOI 10.1093/NAR/GKM290; Zhao Y, 2006, BIOPOLYMERS, V81, P256, DOI 10.1002/bip.20408	74	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	FEB	2015	47	2					381	400		10.1007/s00726-014-1872-2		20	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ6AK	WOS:000348300000014		
J	Eid, N; Ito, Y; Otsuki, Y				Eid, N.; Ito, Y.; Otsuki, Y.			Ethanol-induced damage in rat testis: oxidative stress-mediated germ cell apoptosis and vacuolization in Sertoli cells	ANDROLOGIA			English	Letter							TREATED RATS; INVOLVEMENT		[Eid, N.; Ito, Y.; Otsuki, Y.] Osaka Med Coll, Div Life Sci, Dept Anat & Cell Biol, Takatsuki, Osaka, Japan	Eid, N (reprint author), Osaka Med Coll, Div Life Sci, Dept Anat & Cell Biol, Takatsuki, Osaka, Japan.	nabil@art.osaka-med.ac.jp					Eid N, 2012, J MOL HISTOL, V43, P71, DOI 10.1007/s10735-011-9372-0; Eid NAS, 2002, INT J ANDROL, V25, P159, DOI 10.1046/j.1365-2605.2002.00341.x; Eid N, 2013, J HEPATOL, V59, P398, DOI 10.1016/j.jhep.2013.03.038; Eid N, 2011, J MENS HEALTH, V8, pS36; Otsuki Yoshinori, 2004, Medical Electron Microscopy, V37, P163; Uygur R, 2014, ANDROLOGIA, V46, P356, DOI 10.1111/and.12085	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-4569	1439-0272		ANDROLOGIA	Andrologia	FEB	2015	47	1					3	3		10.1111/and.12385		1	Andrology	Endocrinology & Metabolism	AZ2JN	WOS:000348060100002		
J	Hiwatashi, N; Hirano, S; Mizuta, M; Tateya, I; Kanemaru, S; Nakamura, T; Ito, J; Kawai, K; Suzuki, S				Hiwatashi, Nao; Hirano, Shigeru; Mizuta, Masanobu; Tateya, Ichiro; Kanemaru, Shin-ichi; Nakamura, Tatsuo; Ito, Juichi; Kawai, Katsuya; Suzuki, Shigehiko			Biocompatibility and Efficacy of Collagen/Gelatin Sponge Scaffold With Sustained Release of Basic Fibroblast Growth Factor on Vocal Fold Fibroblasts in 3-Dimensional Culture	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						basic fibroblast growth factor; collagen scaffold; gene expression; sustained release; vocal fold	CELL-CULTURE; HISTOLOGIC CHARACTERIZATION; EXTRACELLULAR-MATRIX; DIABETIC MICE; RABBIT MODEL; CANINE; HYALURONAN; SCAR; ACCELERATION; BIOLOGY	Objective: Treatment of vocal fold scarring remains challenging. We have previously reported the therapeutic effects of local injection of basic fibroblast growth factor (bFGF) in animal models and humans. A novel collagen/gelatin sponge (CGS) is capable of sustained release of bFGF, which compensates for its quick absorption in vivo, avoiding multiple injections. This study aimed to evaluate the biocompatibility and efficacy of the CGS in rat vocal fold fibroblasts prior to human trials. Methods: Fibroblasts extracted from Sprague-Dawley rat vocal folds were seeded onto a CGS and then cultivated with bFGF at concentrations of 0, 10, and 100 ng/mL. Vocal fold fibroblast morphology, adhesion, proliferation, and gene expression were measured under these 3-dimensional conditions. Results: Cells adhered to the CGS from day 1. Although no significant differences in cell morphology were detected, cell proliferation was accelerated by bFGF administration. Expression of endogenous bFGF and hepatocyte growth factor was significantly up-regulated at 10 ng/mL bFGF. The expression of procollagen I and procollagen III was significantly suppressed, whereas HAS-1 and HAS-2 were up-regulated at 10 and 100 ng/mL bFGF. Conclusion: The collagen/gelatin sponge is biocompatible with vocal fold fibroblasts and may be useful as a bFGF drug delivery system for the treatment of scarred vocal folds.	[Hiwatashi, Nao; Hirano, Shigeru; Mizuta, Masanobu; Tateya, Ichiro; Kanemaru, Shin-ichi; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan; [Kanemaru, Shin-ichi] Tazuke Kofukai Med Res Inst, Kitano Hosp, Dept Otolaryngol Head & Neck Surg, Osaka, Japan; [Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto 6068507, Japan; [Kawai, Katsuya; Suzuki, Shigehiko] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto 6068507, Japan	Hirano, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan.	hirano@ent.kuhp.kyoto-u.ac.jp			Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation.	Hirano S, 2004, LARYNGOSCOPE, V114, P2161, DOI 10.1097/01.mlg.0000149450.37640.db; SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6; MCGEE GS, 1988, J SURG RES, V45, P145, DOI 10.1016/0022-4804(88)90034-0; Matsumoto K, 1997, BIOCHEM BIOPH RES CO, V239, P639, DOI 10.1006/bbrc.1997.7517; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Ayvazyan A, 2011, J SURG RES, V171, pE247, DOI 10.1016/j.jss.2011.06.059; Chen X, 2010, ACTA BIOMATER, V6, P2940, DOI 10.1016/j.actbio.2010.01.032; Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215; Suehiro A, 2010, ANN OTO RHINOL LARYN, V119, P690; Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; HIRANO M, 1974, FOLIA PHONIATR, V26, P89; Hirano S, 2009, J VOICE, V23, P399, DOI 10.1016/j.jvoice.2007.12.002; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127; Allen J, 2010, CURR OPIN OTOLARYNGO, V18, P475, DOI 10.1097/MOO.0b013e32833fecd1; Tanaka E, 1996, BIOL PHARM BULL, V19, P1141; Hirano S, 2013, LARYNGOSCOPE, V123, P2749, DOI 10.1002/lary.24092; Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150; Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P617; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95; Suehiro A, 2010, ACTA OTO-LARYNGOL, V130, P844, DOI 10.3109/00016480903426618; Okumura M, 1996, BIOL PHARM BULL, V19, P530; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hirano S, 2003, LARYNGOSCOPE, V113, P144, DOI 10.1097/00005537-200301000-00027; Hirano Shigeru, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P143, DOI 10.1097/01.moo.0000162261.49739.b7; Isogai N, 2005, J BIOMED MATER RES A, V74A, P408, DOI 10.1002/jbm.a.30343; Stephens P, 2002, J Wound Care, V11, P253; Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183; Thibeault SL, 2011, J VOICE, V25, P249, DOI 10.1016/j.jvoice.2009.10.003; Whalen G F, 1989, Growth Factors, V1, P157, DOI 10.3109/08977198909029125	35	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	FEB	2015	124	2					116	125		10.1177/0003489414546396		10	Otorhinolaryngology	Otorhinolaryngology	AZ6ZJ	WOS:000348367600006		
J	Okumura, Y; Hidaka, H; Seiji, K; Nomura, K; Takata, Y; Suzuki, T; Katori, Y				Okumura, Yuri; Hidaka, Hiroshi; Seiji, Kazumasa; Nomura, Kazuhiro; Takata, Yusuke; Suzuki, Takahiro; Katori, Yukio			Unique Migration of a Dental Needle Into the Parapharyngeal Space: Successful Removal by an Intraoral Approach and Simulation for Tracking Visibility in X-ray Fluoroscopy	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						compensating filter; needle migration; parapharyngeal space; surgical microscope; X-ray fluoroscopy	FOREIGN-BODY; C-ARM; MANAGEMENT; ABSCESSES; BREAKAGE; DRAINAGE; NERVE	Objectives: The first objective was to describe a novel case of migration of a broken dental needle into the parapharyngeal space. The second was to address the importance of simulation elucidating visualization of such a thin needle under X-ray fluoroscopy. Methods: Clinical case records (including computed tomography [CT] and surgical approaches) were reviewed, and a simulation experiment using a head phantom was conducted using the same settings applied intraoperatively. Results: A 36-year-old man was referred after failure to locate a broken 31-G dental needle. Computed tomography revealed migration of the needle into the parapharyngeal space. Intraoperative X-ray fluoroscopy failed to identify the needle, so a steel wire was applied as a reference during X-ray to locate the foreign body. The needle was successfully removed using an intraoral approach with tonsillectomy under surgical microscopy. The simulation showed that the dental needle was able to be identified only after applying an appropriate compensating filter, contrasting with the steel wire. Conclusion: Meticulous preoperative simulation regarding visual identification of dental needle foreign bodies is mandatory. Intraoperative radiography and an intraoral approach with tonsillectomy under surgical microscopy offer benefits for accessing the parapharyngeal space, specifically for cases medial to the great vessels.	[Okumura, Yuri; Hidaka, Hiroshi; Nomura, Kazuhiro; Takata, Yusuke; Suzuki, Takahiro; Katori, Yukio] Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Seiji, Kazumasa] Tohoku Univ, Dept Diagnost Radiol, Grad Sch Med, Sendai, Miyagi 9808575, Japan	Hidaka, H (reprint author), Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808575, Japan.	ZAY00015@nifty.com					Amar YG, 2004, OTOLARYNG HEAD NECK, V130, P676, DOI 10.1016/j.otohns.2003.11.016; Choi SS, 1997, ARCH OTOLARYNGOL, V123, P1271; Balaji S M, 2013, Ann Maxillofac Surg, V3, P93, DOI 10.4103/2231-0746.110076; BLUMSTEIN H, 1993, NEW ENGL J MED, V328, P1426, DOI 10.1056/NEJM199305133281916; Brucoli M, 2012, J CRANIOFAC SURG, V23, P1583, DOI 10.1097/SCS.0b013e3182505527; Burduk PK, 2006, EUR ARCH OTO-RHINO-L, V263, P772, DOI 10.1007/s00405-006-0068-0; Ethunandan M, 2007, BRIT DENT J, V202, P395, DOI 10.1038/bdj.2007.272; Hajiioannou J, 2011, INT J OTOLARYNGOL, V2011, DOI 10.1155/2011/274102; Ho AS, 2011, AURIS NASUS LARYNX, V38, P747, DOI 10.1016/j.anl.2011.01.003; HO KH, 1988, AUST DENT J, V33, P308; Joshi AA, 2003, AM J OTOLARYNG, V24, P89, DOI 10.1053/ajot.2003.20; Kim GH, 2011, ENT-EAR NOSE THROAT, V90, pE13; Nezafati Saeed, 2008, J Oral Sci, V50, P351, DOI 10.2334/josnusd.50.351; Oda K, 2013, ACTA OTO-LARYNGOL, V133, P509, DOI 10.3109/00016489.2012.754997; Ogadako Rhiyoma Monique, 2011, Dent Update, V38, P631; Osinubi OA, 1996, J LARYNGOL OTOL, V110, P793; Park SS, 2012, J CRANIO MAXILL SURG, V40, P572, DOI 10.1016/j.jcms.2011.10.013; Rahman Naomi, 2013, J Ir Dent Assoc, V59, P241; Takemura A, 2008, J DIGIT IMAGING, V21, P99, DOI 10.1007/s10278-007-9016-9; Thompson M, 2003, INT J ORAL MAXILLOF, V32, P279; Thumfart WF, 1999, SURG APPROACHES OTOR, P113; Zhao YF, 2011, INT J ORAL MAX SURG, V40, P209, DOI 10.1016/j.ijom.2010.07.009	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	FEB	2015	124	2					162	167		10.1177/0003489414547106		6	Otorhinolaryngology	Otorhinolaryngology	AZ6ZJ	WOS:000348367600014		
J	Yoon, J; Adachi, K; Kasai, H				Yoon, Jaewoo; Adachi, Kyoko; Kasai, Hiroaki			Isolation and classification of a novel marine Bacteroidetes as Frondibacter aureus gen. nov., sp nov.	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Bacteroidetes; Flavobacteriaceae; Frondibacter aureus gen. nov., sp nov.; 16S rRNA gene; Polyphasic taxonomy	PERFORMANCE LIQUID-CHROMATOGRAPHY; FAMILY FLAVOBACTERIACEAE; DEOXYRIBONUCLEIC-ACID; MEMBER; WATER; SEA; BACTERIUM	A facultatively anaerobic, Gram-stain negative, golden-yellow pigmented, non-motile and rod-shaped bacterium, designated strain A5Q-67(T) was isolated from leaf litter collected at the mangrove estuary of Nakama River, Japan. Phylogenetic analysis based on the 16S rRNA gene sequence revealed the novel isolate was affiliated with the family Flavobacteriaceae of the phylum Bacteroidetes and that it showed highest sequence similarity (94.2 %) to Imtechella halotolerans K1(T). The strain could be differentiated phenotypically from recognized members of the family Flavobacteriaceae. The major fatty acids of strain A5Q-67(T) were identified as iso-C17:0 3-OH, summed feature 1 (iso-C15:1 H and/or C13:0 3-OH) and iso-C15:0 as defined by the MIDI system. The DNA G+C content was determined to be 36.7 mol%, the major respiratory quinone was identified as menaquinone 6 (MK-6) and a polar lipid profile was present consisting of phosphatidylethanolamine, two unidentified aminolipids and an unidentified lipid. From the distinct phylogenetic position and combination of genotypic and phenotypic characteristics, the strain is considered to represent a novel genus for which the name Frondibacter aureus gen. nov., sp. nov. is proposed. The type strain of F. aureus is A5Q-67(T) (=KCTC 32991(T) = NBRC 110021(T)).	[Yoon, Jaewoo] Keimyung Univ, Coll Pharm, Taegu 704701, South Korea; [Adachi, Kyoko] Marine Biotechnol Inst, Kamaishi, Iwate 0260001, Japan; [Kasai, Hiroaki] Kitasato Univ, Marine Biosci Kamaishi Res Lab, Ofunato, Iwate 0220101, Japan	Yoon, J (reprint author), Keimyung Univ, Coll Pharm, 1095 Dalgubeoldaero, Taegu 704701, South Korea.	jwyoon@kmu.ac.kr			Dongil Culture & Scholarship Foundation	This study was supported by Dongil Culture & Scholarship Foundation for the grant in 2014.	FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Zeng YX, 2013, ANTON LEEUW INT J G, V103, P1309, DOI 10.1007/s10482-013-9912-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; O'Sullivan LA, 2006, INT J SYST EVOL MICR, V56, P169, DOI 10.1099/ijs.0.63941-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; MARMUR J, 1961, J MOL BIOL, V3, P208; Brettar I, 2004, INT J SYST EVOL MICR, V54, P2335, DOI 10.1099/ijs.0.63255-0; McCammon SA, 1998, INT J SYST BACTERIOL, V48, P1405; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0; DITTMER JC, 1964, J LIPID RES, V5, P126; COLLINS MD, 1981, J APPL BACTERIOL, V51, P129, DOI 10.1111/j.1365-2672.1981.tb00916.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697; PERRY LB, 1973, J APPL BACTERIOL, V36, P227, DOI 10.1111/j.1365-2672.1973.tb04095.x; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Collins C. H., 1984, MICROBIOLOGICAL METH; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, P119; HANSEN GH, 1991, J MICROBIOL METH, V13, P231; Kimura M., 1983, NEUTRAL THEORY MOL E; Liu ZP, 2006, INT J SYST EVOL MICR, V56, P2825, DOI 10.1099/ojs.0.64587-0; Ludwig W, 2001, BERGEYS MANUAL SYSTE, V1, P49; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Quan ZX, 2008, INT J SYST EVOL MICR, V58, P1388, DOI 10.1099/ijs.0.65611-0; Reichenbach H, 1989, BERGEYS MANUAL SYSTE, V3, P2015; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasser M., 1990, 101 MIDI; Surendra V, 2012, INT J SYST EVOL MICR, V62, P2624, DOI 10.1099/ijs.0.038356-0; Wang GH, 2013, INT J SYST EVOL MICR, V63, P3056, DOI 10.1099/ijs.0.048413-0; Worliczek HL, 2007, SYST APPL MICROBIOL, V30, P355, DOI 10.1016/j.syapm.2007.03.004	34	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	FEB	2015	107	2					321	328		10.1007/s10482-014-0330-1		8	Microbiology	Microbiology	AZ6WF	WOS:000348358000002		
J	Uzuhashi, S; Okada, G; Ohkuma, M				Uzuhashi, Shihomi; Okada, Gen; Ohkuma, Moriya			Four new Pythium species from aquatic environments in Japan	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Diversity; Molecular phylogeny; Morphology; Oomycete; Taxonomy; Water	RED ROT DISEASE; FILAMENTOUS SPORANGIA; MOLECULAR PHYLOGENY; GENUS PYTHIUM; REGION; PYTHIACEAE; TAXONOMY	Four new species of Pythium s.str., namely Pythium utonaiense, Pythium brachiatum, Pythium biforme and Pythium junctum, were described based on their morphology and molecular phylogeny. These species were isolated from freshwater samples collected from aquatic environments (pond and lake) in Japan. They were identified as belonging to the genus Pythium s.str. by their morphology, such as filamentous hyphal inflated structures, and molecular phylogenetic analyses based on the internal transcribed spacer region of the ribosomal RNA gene and mitochondrial cytochrome c oxidase subunit 1 gene. The new species are compared to closely related Pythium species regarding their phylogenetic positions and morphological features.	[Uzuhashi, Shihomi; Okada, Gen; Ohkuma, Moriya] RIKEN BioResource Ctr, Microbe Div, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan	Uzuhashi, S (reprint author), RIKEN BioResource Ctr, Microbe Div, Japan Collect Microorganisms, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	shihomi.uzu84@gmail.com	Ohkuma, Moriya/A-8100-2011				ALISHTAYEH MS, 1985, BOT J LINN SOC, V91, P297, DOI 10.1111/j.1095-8339.1985.tb01152.x; Bala K, 2010, PERSOONIA, V25, P22, DOI 10.3767/003158510X524754; DECOCK AWAM, 1986, MYCOTAXON, V25, P101; Uzuhashi S, 2010, MYCOSCIENCE, V51, P337, DOI 10.1007/s10267-010-0046-7; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Senda M, 2009, MYCOLOGIA, V101, P439, DOI 10.3852/08-104; Levesque CA, 2004, MYCOL RES, V108, P1363, DOI 10.1017/S0953756204001431; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Perneel M, 2006, MYCOL RES, V110, P583, DOI 10.1016/j.mycres.2005.12.002; Kawamura Y, 2005, PLANT DIS, V89, P1041, DOI 10.1094/PD-89-1041; Belbahri L, 2008, FEMS MICROBIOL LETT, V284, P17, DOI 10.1111/j.1574-6968.2008.01168.x; Edson HA, 1915, J AGRIC RES, V4, P279; Fischer A., 1892, RABENHORST KRYPTOGAM, V1, P505; Kageyama K, 2007, MYCOL RES, V111, P416, DOI 10.1016/j.mycres.2007.01.019; Kurokawa K, 2010, MYCOSCIENCE, V51, P321, DOI 10.1007/s10267-010-0041-z; Long YanYan, 2010, Mycosystema, V29, P795; Long YY, 2014, MYCOL PROG, V13, P145, DOI 10.1007/s11557-013-0901-y; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Park CS, 2000, FISHERIES SCI, V66, P261, DOI 10.1046/j.1444-2906.2000.00043.x; PAUL B, 1987, T BRIT MYCOL SOC, V89, P195; Paul B, 2001, FEMS MICROBIOL LETT, V199, P55, DOI 10.1111/j.1574-6968.2001.tb10650.x; Pringsheim N., 1858, JB WISS BOT, V1, P284; Schroter J, 1893, ENGLER PRANTL NAT PF, V1, P104; Uzuhashi S, 2008, MYCOSCIENCE, V49, P276, DOI 10.1007/s10267-008-0416-6; Uzuhashi S, 2009, MYCOSCIENCE, V50, P281, DOI 10.1007/s10267-009-0486-0; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; WATANABE T, 1981, Annals of the Phytopathological Society of Japan, V47, P449; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	28	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	FEB	2015	107	2					375	391		10.1007/s10482-014-0336-8		17	Microbiology	Microbiology	AZ6WF	WOS:000348358000008		
J	Togashi, T; Kitahara, H; Takano, K; Hangyo, M; Mita, M; Young, JC; Suzuki, T				Togashi, Takahisa; Kitahara, Hideaki; Takano, Keisuke; Hangyo, Masanori; Mita, Mamoru; Young, John C.; Suzuki, Takehito			Terahertz path-length lens composed of oblique metal slit array	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							INDEX LENS; METAMATERIAL	Need for high-performance and sophisticated optical devices in the terahertz wave band is growing rapidly with terahertz technological progress. This paper presents a lens in the terahertz wave band based on phase control using an oblique metal slit array. A convex oblique slit array can produce a focusing effect. This focusing effect is confirmed by full-wave analysis for the designed terahertz path-length lens. The effective refractive index computed from the full-wave analysis is consistent with analytical expressions and changes from 1.00 to 1.56 with the angle of the metal slit array. Full-wave analysis also confirms that the lamination errors of the path-length lens have limited influence on the focusing effects. The robustness of the lens design is essential for its industrial applications to terahertz optical devices.	[Togashi, Takahisa; Suzuki, Takehito] Ibaraki Univ, Dept Elect & Elect Engn, Hitachi, Ibaraki 3168511, Japan; [Kitahara, Hideaki; Takano, Keisuke; Hangyo, Masanori] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Mita, Mamoru] Ibaraki Univ, M&M Res Lab, Hitachi, Ibaraki 3168511, Japan; [Young, John C.] Univ Kentucky, Lexington, KY 40506 USA	Suzuki, T (reprint author), Ibaraki Univ, Dept Elect & Elect Engn, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 3168511, Japan.	takehito@mx.ibaraki.ac.jp	Takano, Keisuke/L-4372-2015		Ministry of Internal Affairs and Communications [122103011]; Japan Society for the Promotion of Science (JSPS) [26706017, 26600108]	This research has been partially commissioned by a Strategic Information and Communications R&D Promotion Programme (SCOPE) (No. 122103011) from the Ministry of Internal Affairs and Communications, and supported by a Grant- in-Aid for Young Scientists (A) (No. 26706017) from Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Challenging Exploratory Research (No. 26600108) from Japan Society for the Promotion of Science (JSPS).	Alu A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.123902; Huang XR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.243901; Tao H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.241103; Takebayashi Y, 2014, APPL PHYS A-MATER, V115, P501, DOI 10.1007/s00339-013-8074-8; Paul O, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3453758; KOCK WE, 1948, AT&T TECH J, V27, P58; Siemion A, 2012, OPT LETT, V37, P4320, DOI 10.1364/OL.37.004320; Shin J, 2006, IEEE J SEL TOP QUANT, V12, P1116, DOI 10.1109/JSTQE.2006.879577; Torres V, 2013, OPT EXPRESS, V21, P9156, DOI 10.1364/OE.21.009156; Chen HT, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.073901; Landy NI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125104; Choi M, 2011, NATURE, V470, P369, DOI 10.1038/nature09776; KOCK WE, 1946, P IRE, V34, P828, DOI 10.1109/JRPROC.1946.232264; Kan T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4809533; Neu J, 2010, OPT EXPRESS, V18, P27748, DOI 10.1364/OE.18.027748; Tao H, 2008, OPT EXPRESS, V16, P7181, DOI 10.1364/OE.16.007181; Landy NI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.207402; Brown J., 1955, Proceedings of the Institution of Electrical Engineers. B. Radio and Electronic Engineering, V102; BROWN J, 1950, P I ELECTR ENG, V97, P45; COHN SB, 1953, P IRE, V41, P1177, DOI 10.1109/JRPROC.1953.274454; Fan RH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803467; JONES SSD, 1949, NATURE, V163, P324, DOI 10.1038/163324a0; Kishi Y., 2013, IRMMW THZ 2013 TH7 3; Kitahara H., 2012, INT S FRONT THZ TECH; KOCK WE, 1949, P IRE, V37, P852, DOI 10.1109/JRPROC.1949.229682; Konno T, 2012, APPL PHYS A-MATER, V109, P1103, DOI 10.1007/s00339-012-7394-4; Pimenov A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.193102	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	FEB	2015	118	2					397	402		10.1007/s00339-014-8918-x		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ6AL	WOS:000348300100002		
J	Otsuka, S; Hamada, Y; Shimizu, T; Shingubara, S				Otsuka, Shintaro; Hamada, Yoshifumi; Shimizu, Tomohiro; Shingubara, Shoso			Ferromagnetic nano-conductive filament formed in Ni/TiO2/Pt resistive-switching memory	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							METAL-OXIDES; MAGNETOTRANSPORT; NANOFILAMENTS	There is a question whether the conductive filament (CF) formed in the oxide layer of a resistive-switching random access memory is made of oxygen vacancies or metallic atoms. We investigated the CF of Ni/TiO2/Pt device using temperature coefficient of resistance (TCR), anisotropic magnetoresistance (AMR), and cross-sectional transmission electron microscopy with energy dispersive X-ray analysis (TEM-EDX). The low resistance state (LRS) of the device showed metallic property by TCR measurement. Furthermore, the device in the LRS showed AMR, which was a direct evidence of the formation of ferromagnetic CF. The cross-sectional TEM-EDX observation revealed that a nano-sized Ni precipitation existed in the area nearby a conductive spot. It is intensively suggested that Ni atoms migrated from the adjacent Ni electrode to TiO2 layer to form the nano-sized ferromagnetic CF.	[Otsuka, Shintaro; Hamada, Yoshifumi; Shimizu, Tomohiro; Shingubara, Shoso] Kansai Univ, Grad Sch Sci & Technol, Suita, Osaka 5648680, Japan	Otsuka, S (reprint author), Kansai Univ, Grad Sch Sci & Technol, Suita, Osaka 5648680, Japan.	k788955@kansai-u.ac.jp; shingu@kansai-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	This work is supported by a Research Fellowship from the Japan Society for the Promotion of Science (JSPS). This work is partially supported by the Strategic Project to Support the Formation of Research Bases at Private Universities: the Matching Fund Subsidy from Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Akinaga H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.100001; Sun J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790837; Akinaga H, 2010, P IEEE, V98, P2237, DOI 10.1109/JPROC.2010.2070830; Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6; SMIT J, 1951, PHYSICA, V17, P612, DOI 10.1016/0031-8914(51)90117-6; Yang JJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215201; [Anonymous], 1972, AM I PHYS HDB, P9; Yakushiji K, 2005, NAT MATER, V4, P57, DOI 10.1038/nmat1278; Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160; Wu X, 2013, J APPL PHYS, V113, DOI 10.1063/1.4794519; Liu T, 2012, ECS SOLID STATE LETT, V1, pQ11, DOI 10.1149/2.012201ssl; Choi BJ, 2005, J APPL PHYS, V98, DOI 10.1063/1.2001146; MCGUIRE TR, 1975, IEEE T MAGN, V11, P1018, DOI 10.1109/TMAG.1975.1058782; Wang XL, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4834795; Tsunoda K, 2007, INT EL DEVICES MEET, P767, DOI 10.1109/IEDM.2007.4419060; Kondo H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.081101; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Bae YC, 2011, APPL PHYS A-MATER, V102, P1009, DOI 10.1007/s00339-011-6289-0; Baek IG, 2004, IEEE INTERNATIONAL ELECTRON DEVICES MEETING 2004, TECHNICAL DIGEST, P587, DOI 10.1109/IEDM.2004.1419228; Hosoi Y., 2006, IEDM, P793; Kwon DH, 2010, NAT NANOTECHNOL, V5, P148, DOI [10.1038/nnano.2009.456, 10.1038/NNANO.2009.456]; Martin JI, 2002, J MAGN MAGN MATER, V240, P14, DOI 10.1016/S0304-8853(01)00711-9; Okamoto K., 2011, IEDM; Rheem Y, 2007, PHYS STATUS SOLIDI A, V204, P4004, DOI 10.1002/pssa.200777135; Rheem Y, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/12/125204; Shimizu T., 2004, T MAGN SOC JPN, V4, P231; Shingubara S, 2004, J MAGN MAGN MATER, V272, P1598, DOI 10.1016/j.jmmm.2003.12.320; Son JY, 2010, ACS NANO, V4, P3288, DOI 10.1021/nn100323x	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	FEB	2015	118	2					613	619		10.1007/s00339-014-8769-5		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ6AL	WOS:000348300100031		
J	Momose, Y; Suzuki, D; Sakurai, T; Nakayama, K				Momose, Yoshihiro; Suzuki, Daisuke; Sakurai, Takao; Nakayama, Keiji			Photoemission from real iron surfaces and its relationship to light penetration of the overlayer	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							PHOTOELECTRIC-EMISSION; OPTICAL-PROPERTIES; SINGLE-CRYSTAL; OXIDATION; SILICON; WATER	We report the photoemission from real iron surfaces at elevated temperatures, called thermally assisted photoemission (TAPE), and its relationship to the X-ray photoelectron spectroscopy (XPS) results. TAPE measurements were carried out using a Geiger counter under a gaseous atmosphere of He containing 1 % isobutane vapor at normal atmospheric pressure. A sample was initially heated to temperatures ranging from 25 to 353 A degrees C under light irradiation at a certain wavelength of 200, 210, 220, and 230 nm, and then, wavelength was scanned from 300 to 170 nm at the final temperature. The values of a constant related to electron photoemission probability, alpha A, where A is identical with the Richardson constant, and photothreshold (photoelectric work function), I center dot, were obtained from a plot of the square root of the electron photoemission intensity against the photon energy; the alpha A values increased with temperature, and the I center dot values also increased with temperature. From the Arrhenius plot, the alpha A was found to have an activation energy Delta E (alpha A) = 0.096 eV. The activation energies of the surface oxygen component ratio Z = O2-/(OH + O2-) and the surface elemental composition ratio X = Fe/(O + N + C + Fe) obtained from the XPS data were also determined from their Arrhenius plots: Delta E (Z) = 0.113 eV and Delta E (X) = 0.039 eV, respectively. From a close resemblance between the latter activation energies and those of the Delta E (alpha A) and the Delta E (a) = 0.112-0.040 eV for the quantum yields (Momose et al. in Appl Phys A. doi:10.1007/s00339-014-8589-7, 2014), it was found that the increase in the intensity of the TAPE with temperature was strongly associated with the increase in the values of Z and X with temperature. It was therefore concluded that the ability of the surface overlayer to pass the incident light became a rate-determining step to start the photoemission, which was decisively controlled by the temperature-dependent surface oxygen components and surface compositions. The intensity of the TAPE was found to be more predominately influenced by the temperature dependence of the alpha A than that of the phi.	[Momose, Yoshihiro; Suzuki, Daisuke] Ibaraki Univ, Dept Mat Sci, Hitachi, Ibaraki 3168511, Japan; [Sakurai, Takao] Ashikaga Inst Technol, Ashikaga 3268558, Japan; [Nakayama, Keiji] Inst Mesotechnol, Kashiwa, Chiba 2770085, Japan	Momose, Y (reprint author), Ibaraki Univ, Dept Mat Sci, Hitachi, Ibaraki 3168511, Japan.	y.momose@cpost.plala.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	The authors would like to thank the grant-in-aid through Ministry of Education, Culture, Sports, Science, and Technology of Japan for supporting this work. One of the authors (YM) also would like to express his grateful acknowledgment to a reviewer of JVSTA for many helpful comments made on this work.	AMES I, 1963, IBM J RES DEV, V7, P34; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; Grosvenor AP, 2004, SURF SCI, V572, P217, DOI 10.1016/j.susc.2004.08.035; DuBridge LA, 1932, PHYS REV, V39, P108, DOI 10.1103/PhysRev.39.108; MICHAELSON HB, 1977, J APPL PHYS, V48, P4729, DOI 10.1063/1.323539; LEIBBRANDT GWR, 1993, SURF SCI, V287, P250, DOI 10.1016/0039-6028(93)90780-N; CHEN CT, 1981, J OPT SOC AM, V71, P932, DOI 10.1364/JOSA.71.000932; CONDER K, ELECT IONIC CONDUCTI, P1; DEKKER AJ, 1957, SOLID STATE PHYS, P223; DUBRIDGE LA, 1935, NEW THEORIES PHOTOEL; GOBELI GW, 1962, PHYS REV, V127, P141, DOI 10.1103/PhysRev.127.141; KUBODERA H, 1966, TETSU TO HAGANE, V52, P1171; LIDE DR, 1999, CRC HDB CHEM PHYS; Momose Y, 2014, APPL PHYS A-MATER, V117, P1525, DOI 10.1007/s00339-014-8589-7; Momose Y, 2008, SURF INTERFACE ANAL, V40, P620, DOI 10.1002/sia.2670; Nienhaus H., 2002, SURF SCI REP, V45, P1, DOI 10.1016/S0167-5729(01)00019-X; OBATA H, 2000, 10 FUK IND TECHN CTR, P12; QUICKENDEN TI, 1980, J CHEM PHYS, V72, P4416, DOI 10.1063/1.439733; Roosendaal SJ, 2000, PHYS REV LETT, V84, P3366, DOI 10.1103/PhysRevLett.84.3366; SATO K, MAT SCI 951 KATSUAKI; SCHLEGEL A, 1979, J PHYS C SOLID STATE, V12, P1157, DOI 10.1088/0022-3719/12/6/027; SPICER WE, 1977, CHEM PHYS SOLID SURF, P235	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	FEB	2015	118	2					637	647		10.1007/s00339-014-8773-9		11	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ6AL	WOS:000348300100034		
J	Suzuki, D; Esaka, F; Miyamoto, Y; Magara, M				Suzuki, Daisuke; Esaka, Fumitaka; Miyamoto, Yutaka; Magara, Masaaki			Direct isotope ratio analysis of individual uranium-plutonium mixed particles with various U/Pu ratios by thermal ionization mass spectrometry	APPLIED RADIATION AND ISOTOPES			English	Article						U-Pu mixed particle; U/Pu ratios; Isotope ratio analysis; TIMS	SAFEGUARDS	Uranium and plutonium isotope ratios in individual uranium-plutonium (U-Pu) mixed particles with various U/Pu atomic ratios were analyzed without prior chemical separation by thermal ionization mass' spectrometry (TIMS). Prior to measurement, micron-sized particles with U/Pu ratios of 1, 5, 10, 18, and 70 were produced from uranium and plutonium certified reference materials. In the TIMS analysis, the peaks of americium, plutonium, and uranium ion signals were successfully separated by continuously increasing the evaporation filament current. Consequently, the uranium and plutonium isotope ratios, except the Pu-238/Pu-239 ratio, were successfully determined for the particles at all U/Pu ratios. This indicates that TIMS direct analysis allows for the measurement of individual U-Pu mixed particles without prior chemical separation. (C) 2014 Elsevier Ltd. All rights reserved.	[Suzuki, Daisuke; Esaka, Fumitaka; Miyamoto, Yutaka; Magara, Masaaki] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Res Grp Analyt Chem, Naka, Ibaraki 3191195, Japan	Suzuki, D (reprint author), Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Res Grp Analyt Chem, Naka, Ibaraki 3191195, Japan.	suzuki.daisuke@jaea.go.jp			Nuclear Regulation Authority, Japan	This work was financially supported by the Nuclear Regulation Authority, Japan. The authors would like to thank Mr. N. Kohno and Mr. T. Watanabe for particle production, Mr. T. Onodera for sample preparation and Mr. K. Kanazawa for TIMS measurement.	Mayer K, 2005, ANALYST, V130, P433, DOI 10.1039/b412922a; Esaka F, 2010, TALANTA, V83, P569, DOI 10.1016/j.talanta.2010.10.009; HONIG RE, 1969, RCA REV, V30, P285; Aggarwal SK, 2007, J RADIOANAL NUCL CH, V273, P775, DOI 10.1007/s10967-007-0947-x; Esaka F, 2007, TALANTA, V71, P1011, DOI 10.1016/j.talanta.2006.05.091; Suzuki D, 2012, CHEM LETT, V41, P90, DOI 10.1246/cl.2012.90; Raptis K, 2013, J RADIOANAL NUCL CH, V296, P585, DOI 10.1007/s10967-012-2081-7; Donohue DL, 1998, J ALLOY COMPD, V271, P11, DOI 10.1016/S0925-8388(98)00015-2; Esaka F., 2011, MASS SPECTROM LETT, V2, P80; Karande AP, 2010, J RADIOANAL NUCL CH, V284, P451, DOI 10.1007/s10967-010-0497-5; Lee CG, 2012, INT J MASS SPECTROM, V314, P57, DOI 10.1016/j.ijms.2012.02.006; Miyamoto Y, 2013, RADIOCHIM ACTA, V101, P745, DOI 10.1524/ract.2013.2079; Ranebo Y, 2010, ANAL CHEM, V82, P4055, DOI 10.1021/ac9029295; Shinonaga T, 2009, SPECTROCHIM ACTA B, V64, P95, DOI 10.1016/j.sab.2008.10.044; Wallenius M, 2007, J ALLOY COMPD, V444, P57, DOI 10.1016/j.jallcom.2006.10.161	15	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0969-8043			APPL RADIAT ISOTOPES	Appl. Radiat. Isot.	FEB	2015	96						52	56		10.1016/j.apradiso.2014.11.012		5	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	CA2PD	WOS:000348749100008		
J	Wang, QY; Liang, ZQ; Wang, XB; Zhao, WX; Wu, YB; Zhou, TF				Wang, Qiuyan; Liang, Zhiqiang; Wang, Xibin; Zhao, Wenxiang; Wu, Yongbo; Zhou, Tianfeng			Fractal analysis of surface topography in ground monocrystal sapphire	APPLIED SURFACE SCIENCE			English	Article						Monocrystal sapphire; Box counting method; Fractal dimension; Material removal mode	DIMENSION; CERAMICS; GEOMETRY; MODELS	The surface characterization of ground monocrystal sapphire is investigated by fractal analysis method. A serial of ground sapphire surfaces in ductile removal and brittle removal mode are obtained by grinding experiments, and their three dimensional (3D) and two dimensional (2D) fractal dimensions are calculated and analyzed by box-counting methods. The 3D surface fractal dimension D-s shows a negative correlation with the surface roughness parameter Ra and is sensitive to the ground surface defects. For the ground surface with larger fractal dimension D-s, its micro-topography is more exquisite with minor defects. Once the fractal dimension Ds become smaller, deep cracks and pronounced defects are exhibited in ground surface. Moreover, the material removal mode can be implied from the distribution of 2D cross-sectional profile fractal dimension D-L. The workpiece surface generated in ductile removal mode has high surface quality with high 2D and 3D fractal dimensions. This study indicates that the box-counting fractal analysis is an effective method to evaluate ground sapphire surface comprehensively. (C) 2014 Elsevier B.V. All rights reserved.	[Wang, Qiuyan; Liang, Zhiqiang; Wang, Xibin; Zhao, Wenxiang; Zhou, Tianfeng] Beijing Inst Technol, Key Lab Fundamental Sci Adv Machining, Beijing 100081, Peoples R China; [Wu, Yongbo] Akita Prefectural Univ, Dept Machine Intelligence & Syst Engn, Yurihonjo, Akita 0150055, Japan	Liang, ZQ (reprint author), Beijing Inst Technol, Key Lab Fundamental Sci Adv Machining, Beijing 100081, Peoples R China.	wangqy1019@126.com; liangzhiqiang@bit.edu.cn; cutting0@bit.edu.cn; zhaowx@bit.edu.cn; wuyb@akita-pu.ac.jp; zhoutf@bit.edu.cn			National Natural Science Foundation of China [51205024]; Beijing Institute of Technology (BIT) Foundation for Fundamental Research [20130342024]	This experimental work was carried out at Akita Prefectural University (APU), Japan. The authors would like to express deep appreciation to APU for providing the experimental facilities. This work was also supported by National Natural Science Foundation of China (No. 51205024) and Beijing Institute of Technology (BIT) Foundation for Fundamental Research (No. 20130342024).	SAYLES RS, 1978, NATURE, V271, P431, DOI 10.1038/271431a0; Liang ZQ, 2010, INT J MACH TOOL MANU, V50, P728, DOI 10.1016/j.ijmachtools.2010.04.005; LOPEZ J, 1995, INT J MACH TOOL MANU, V35, P211, DOI 10.1016/0890-6955(94)P2375-P; Vilchis-Granados J, 2013, APPL SURF SCI, V279, P97, DOI 10.1016/j.apsusc.2013.04.042; Ghosh D, 2008, ACTA MATER, V56, P3011, DOI 10.1016/j.actamat.2008.02.038; Chen MJ, 2008, INT J MACH TOOL MANU, V48, P905, DOI 10.1016/j.ijmachtools.2007.11.002; Park H, 2002, THIN SOLID FILMS, V422, P135, DOI 10.1016/S0040-6090(02)00985-9; Liang XH, 2012, APPL SURF SCI, V258, P6406, DOI 10.1016/j.apsusc.2012.03.050; MANDELBROT BB, 1975, P NATL ACAD SCI USA, V72, P3825, DOI 10.1073/pnas.72.10.3825; Liang ZQ, 2013, INT J MACH TOOL MANU, V71, P41, DOI 10.1016/j.ijmachtools.2013.04.004; Zahouani H, 1998, MATH COMPUT MODEL, V28, P517, DOI 10.1016/S0895-7177(98)00139-3; Kulesza S, 2014, APPL SURF SCI, V293, P196, DOI 10.1016/j.apsusc.2013.12.132; Kong YL, 2014, APPL SURF SCI, V301, P363, DOI 10.1016/j.apsusc.2014.02.081; DUBUC B, 1989, PHYS REV A, V39, P1500, DOI 10.1103/PhysRevA.39.1500; Asgharifar M., 2014, MANUF LETT, V2, P26; Blackmore D, 1998, INT J MACH TOOL MANU, V38, P551, DOI 10.1016/S0890-6955(97)00101-6; Chuang TJ, 2003, J EUR CERAM SOC, V23, P1723, DOI 10.1016/S0955-2219(02)00409-0; Dolgaev SI, 1996, APPL SURF SCI, V96-8, P491, DOI 10.1016/0169-4332(95)00501-3; Jiang ZD, 2001, INT J MACH TOOL MANU, V41, P2179, DOI 10.1016/S0890-6955(01)00085-2; Kim JH, 1999, JPN J APPL PHYS 1, V38, P2721, DOI 10.1143/JJAP.38.2721; Komanduri R., 1994, ADV INTELLIGENCE PRO; Laheurte R, 2012, OPT EXPRESS, V20, P13551, DOI 10.1364/OE.20.013551; Lawrence KD, 2013, APPL SURF SCI, V280, P332, DOI 10.1016/j.apsusc.2013.04.157; Mandelbrot B. B., 1983, FRACTAL GEOMETRY NAT; Marinescu ID, 2007, HDB MACHINING GRINDI; Pinkas M, 2010, MATER CHEM PHYS, V124, P323, DOI 10.1016/j.matchemphys.2010.06.041; Prabhu S., 2011, J BRAZ SOC MECH SCI, V4, P459; Rosen BG, 1998, INT J MACH TOOL MANU, V38, P519, DOI 10.1016/S0890-6955(97)00097-7; Russ J.C., 1994, FRACTAL SURFACES; Tang H.L., 2013, ADV TOP CRYST GROWTH, P307; Thomas T., 1999, ROUGH SURFACES; Thomas TR, 1999, WEAR, V232, P41, DOI 10.1016/S0043-1648(99)00128-3; Zhang GM, 1996, INT J MACH TOOL MANU, V36, P1137, DOI 10.1016/0890-6955(95)00085-2; Zhang Y, 2001, INT J MACH TOOL MANU, V41, P2045, DOI 10.1016/S0890-6955(01)00070-0; Zmeskal O., 2001, HARFA HARMONIC FRACT, P3	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	FEB 1	2015	327						182	189		10.1016/j.apsusc.2014.11.093		8	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AZ8GQ	WOS:000348453800025		
J	Wang, J; Matsuda, N; Shinozaki, N; Miyoshi, N; Shiraishi, T				Wang, Jin; Matsuda, Nozomu; Shinozaki, Nobuya; Miyoshi, Noriko; Shiraishi, Takanobu			Effect of SUS316L stainless steel surface conditions on the wetting of molten multi-component oxides ceramic	APPLIED SURFACE SCIENCE			English	Article						Wetting behavior; SUS316L stainless steel; Multi-component oxides ceramic	SEALING TREATMENT; CORROSION-RESISTANCE; WEAR-RESISTANCE; COATINGS; PLASMA; OXIDATION; WETTABILITY; ALUMINA; SYSTEM	A study on the effect of SUS316L stainless steel surface conditions on the wetting behavior of molten multi-component oxides ceramic was performed and aimed to contribute to the further understanding of the application of oxides ceramic in penetration treatment of stainless steel coatings and the deposition of stainless steel cermet coatings. The results show that at 1273 K, different surface pre-treatments (polishing and heating) had an important effect on the wetting behavior. The molten multi-component oxides showed good wettability on both stainless steel substrates, however, the wetting process on the polished substrate was significantly slower than that on the heated substrates. The mechanism of the interfacial reactions was discussed based on the microscopic and thermodynamic analysis, the substrates reacted with oxygen generated from the decomposition of the molten multi-component oxides and oxygen contained in the argon atmosphere, and the oxide film caused the molten multi-component oxides ceramic to spread on the substrates surfaces. For the polished substrate, more time was required for the surface oxidation to reach the surface composition of Heated-S, which resulted in relatively slow spreading and wetting rates. Moreover, the variance of the surface roughness drove the final contact angles to slightly different values following the sequence Polished-S > Heated-S. (C) 2014 Elsevier B.V. All rights reserved.	[Wang, Jin; Shinozaki, Nobuya] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Fukuoka 8080196, Japan; [Matsuda, Nozomu] Nippon Steel & Sumitomo Met Corp, Bar & Wire Prod Unit, Fukuoka 8028686, Japan; [Miyoshi, Noriko] Kyushu Inst Technol, Ctr Instrumental Anal, Fukuoka 8048550, Japan; [Shiraishi, Takanobu] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528588, Japan	Wang, J (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Fukuoka 8080196, Japan.	wangjinustb@gmail.com					MARASCO AL, 1991, OXID MET, V36, P157, DOI 10.1007/BF00938460; Bonn D, 2009, REV MOD PHYS, V81, P739, DOI 10.1103/RevModPhys.81.739; Troczynski T, 1999, J THERM SPRAY TECHN, V8, P229, DOI 10.1361/105996399770350458; Vesel A, 2008, APPL SURF SCI, V255, P1759, DOI 10.1016/j.apsusc.2008.06.017; Knuuttila J, 1999, J THERM SPRAY TECHN, V8, P249, DOI 10.1007/s11666-999-0002-2; Ctibor P, 2007, WEAR, V262, P1274, DOI 10.1016/j.wear.2007.01.005; Jung IH, 2006, SOLID STATE IONICS, V177, P765, DOI 10.1016/j.ssi.2006.01.012; Wolansky G, 1999, COLLOID SURFACE A, V156, P381, DOI 10.1016/S0927-7757(99)00098-9; Zhang JJ, 2011, J THERM SPRAY TECHN, V20, P508, DOI 10.1007/s11666-010-9528-6; Barin I., 1993, THERMOCHEMICAL DATA; Ctibor P, 2009, MATER SCI-MEDZG, V15, P108; Erwin P.K., 2008, THESIS SWISS FEDERAL, P84; Froumin N, 2000, ACTA MATER, V48, P1435, DOI 10.1016/S1359-6454(99)00452-8; Hosokawa H, 2012, INT J REFRACT MET H, V33, P1, DOI 10.1016/j.ijrmhm.2012.01.005; Jian P, 2006, J POWER SOURCES, V158, P354, DOI 10.1016/j.jpowsour.2005.09.056; King AH, 2010, SCRIPTA MATER, V62, P889, DOI 10.1016/j.scriptamat.2010.02.020; Li HY, 2013, CORROS ENG SCI TECHN, V48, P65, DOI 10.1179/1743278212Y.0000000040; Li SJ, 2013, ADV MATER RES-SWITZ, V602-604, P1591, DOI 10.4028/www.scientific.net/AMR.602-604.1591; Liscano S, 2004, SURF COAT TECH, V188, P135, DOI 10.1016/j.surfcoat.2004.08.009; Naidich YV, 2008, J EUR CERAM SOC, V28, P717, DOI 10.1016/j.jeurceramsoc.2007.07.021; Nogi K, 2010, SCRIPTA MATER, V62, P945, DOI 10.1016/j.scriptamat.2010.03.007; Ohmori A., 1995, HIGH TEMP SOC JPN, P549; Rado C, 2000, MAT SCI ENG A-STRUCT, V276, P195, DOI 10.1016/S0921-5093(99)00274-9; Shinozaki N., 2004, REFRACTORIES, V56, P595; Song EP, 2006, MAT SCI ENG A-STRUCT, V429, P189, DOI 10.1016/j.msea.2006.05.087; Wanger C. D., 1979, HDB XRAY PHOTOELECTR; Yang GJ, 2013, J THERM SPRAY TECHN, V22, P36, DOI 10.1007/s11666-012-9831-5	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	FEB 1	2015	327						470	477		10.1016/j.apsusc.2014.10.182		8	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AZ8GQ	WOS:000348453800064		
J	Yoo, IY; Lee, TJ; Lee, CK				Yoo, In Young; Lee, Timothy Jeonglyeol; Lee, Choong-Ki			Effect of Health and Wellness Values on Festival Visit Motivation	Asia Pacific Journal of Tourism Research			English	Article						push and pull framework; Australia; health and wellness tourism; food festival	TOURISM MOTIVATION; CULINARY TOURISM; FOOD FESTIVALS; EVENTS; WINE	Understanding the motivation to visit particular tourist destinations and festivals is important for building effective tourism marketing strategies. This paper explores the effect of existing health and wellness values on the motivation to visit a festival using a field survey at the Goomeri Pumpkin Festival, a typical Australian festival which uses the natural environment, traditions and local produce to provide 21 events during the festival. The study focused on establishing the relationship between health and wellness values and festival attendees' motivation. Qualitative research with random sampling was selected to collect the data. The results revealed high levels of health and wellness values among the participants as well as social interaction, family togetherness, cultural exploration, novelty, natural environment, relaxation, previous food festival experience and food as motivations. Findings of this paper can contribute to festival tourism marketing especially to demonstrate that health-related interests can be significant catalysts for attracting festival attendees.	[Yoo, In Young] Univ Queensland, Sch Tourism, Brisbane, Qld 4072, Australia; [Lee, Timothy Jeonglyeol] Ritsumeikan Asia Pacific Univ APU, Dept Tourism & Hosp Management, Beppu, Oita 8748577, Japan; [Lee, Timothy Jeonglyeol; Lee, Choong-Ki] Kyung Hee Univ, Coll Hotel & Tourism Management, Seoul 130701, South Korea	Yoo, IY (reprint author), Univ Queensland, Sch Tourism, Brisbane, Qld 4072, Australia.	timlee7@apu.ac.jp					Park KS, 2008, J TRAVEL TOUR MARK, V25, P161, DOI 10.1080/10548400802402883; ISOAHOLA SE, 1982, ANN TOURISM RES, V9, P256, DOI 10.1016/0160-7383(82)90049-4; Crompton JL, 1997, ANN TOURISM RES, V24, P425, DOI 10.1016/S0160-7383(97)80010-2; McCabe S, 2013, ANN TOURISM RES, V41, P42, DOI 10.1016/j.annals.2012.12.001; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037//0003-066X.55.1.68; Toates F, 1998, NEUROSCI BIOBEHAV R, V22, P59; Kim H, 2006, TOURISM MANAGE, V27, P957, DOI 10.1016/j.tourman.2005.09.007; Kim SS, 2002, ANN TOURISM RES, V29, P257, DOI 10.1016/S0160-7383(01)00043-3; Getz D, 2008, TOURISM MANAGE, V29, P403, DOI 10.1016/j.tourman.2007.07.017; Mason MC, 2012, TOURISM MANAGE, V33, P1329, DOI 10.1016/j.tourman.2011.12.016; Henderson JC, 2009, BRIT FOOD J, V111, P317, DOI 10.1108/00070700910951470; Tikkanen I, 2007, BRIT FOOD J, V109, P721, DOI 10.1108/00070700710780698; Arcodia C., 2006, J CONVENTION EVENT T, V8, P1, DOI DOI 10.1300/J452V08N02_01; Ardell D. B., 1986, HIGH LEVEL WELLNESS; Baloglu S., 1996, International Journal of Contemporary Hospitality Management, V8, P32, DOI 10.1108/09596119610115989; Bennett M., 2004, Journal of Vacation Marketing, V10, P122, DOI 10.1177/135676670401000203; Berlin H.A, 2011, NEUROPSYCHOANALYSIS, V13, P5, DOI DOI 10.1080/15294145.2011.10773654; Brown G. P., 2006, Journal of Travel & Tourism Marketing, V21, P31; Chen J. S., 2008, Anatolia, V19, P103; Cooper M., 2009, HLTH WELLNESS TOURIS; Corbin J., 2008, BASICS QUALITATIVE R; Dann G. M. S., 1977, ANN TOURISM RES, V4, P184, DOI DOI 10.1016/0160-7383(77)90037-8; Delbosc A. R., 2008, Visitor Studies, V11, P3, DOI 10.1080/10645570801938368; Getz D., 2012, Event Management, V16, P171, DOI 10.3727/152599512X13343565268456; Greenberg JS, 1978, HLTH ED, V9, P20; Hall C. M., 2001, SPECIAL INTEREST TOU; Hall C. M., 2008, FOOD WINE FESTIVALS; Han J. S., 2012, KOREAN J TOURISM RES, V27, P587; Heckhausen J., 2008, MOTIVATION ACTION; Hegarty J. A., 2001, International Journal of Hospitality Management, V20, P3, DOI 10.1016/S0278-4319(00)00028-1; Hjalager A. M., 2002, TOURISM GASTRONOMY, P21; Hjalager A. M., 2000, International Journal of Tourism Research, V2, P281; Horng JS, 2012, ASIA PAC J TOUR RES, V17, P277, DOI 10.1080/10941665.2011.625432; Iso-Ahola S., 1980, SOCIAL PSYCHOL LEISU; Jennings G., 2001, TOURISM RES; Judith A. W., 1985, AORN J, V41, P1; Kim YG, 2010, INT J HOSP MANAG, V29, P216, DOI 10.1016/j.ijhm.2009.10.015; Kim YG, 2009, INT J HOSP MANAG, V28, P423, DOI 10.1016/j.ijhm.2008.11.005; Kivela J, 2006, J HOSPITALITY TOURIS, V3, P354, DOI DOI 10.1177/1096348006286797; Laesser C., 2011, Tourism Review, V66, P83, DOI 10.1108/16605371111127251; Lee I, 2011, INT J TOUR RES, V13, P355, DOI 10.1002/jtr.852; Lin CH, 2013, ASIA PAC J TOUR RES, V18, P183, DOI 10.1080/10941665.2011.640698; Lincoln Y. S., 1985, NATURALISTIC INQUIRY; Long LM, 2004, CULINARY TOURISM; Uysal M., 1993, Festival Management & Event Tourism, V1, P5; Mason M. C., 2009, Journal of Foodservice Business Research, V12, P364; Mueller H., 2001, Journal of Vacation Marketing, V7, P5, DOI 10.1177/135676670100700101; Nicholson R. E., 2001, Journal of Travel Research, V39, P449; Oh MinJung, 2012, Event Management, V16, P1, DOI 10.3727/152599512X13264729827479; Selwood J, 2003, FOOD TOURISM WORLD D, P178, DOI 10.1016/B978-0-7506-5503-3.50013-0; Smith M., 2009, HLTH WELLNESS TOURIS; Stace R., 2007, Asia Pacific Journal of Tourism Research, V12, P203, DOI 10.1080/10941660701416770; Turvey M. T., 1997, PERCEIVING ACTING KN, P211; Yolal M., 2009, Journal of Convention & Event Tourism, V10, P276, DOI 10.1080/15470140903372020; Voigt C., 2011, Tourism Review, V66, P16, DOI 10.1108/16605371111127206; Wan YKP, 2013, INT J TOUR RES, V15, P226, DOI 10.1002/jtr.1863; YUAN J., 2005, J VACATION MARKETING, V11, P41, DOI 10.1177/1356766705050842	57	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1094-1665	1741-6507		ASIA PAC J TOUR RES	Asia Pac. J. Tour. Res.	FEB 1	2015	20	2					152	170		10.1080/10941665.2013.866970		19	Hospitality, Leisure, Sport & Tourism	Social Sciences - Other Topics	CA5CV	WOS:000348926500002		
J	Muraki, K; Hatano, N; Suzuki, H; Muraki, Y; Iwajima, Y; Maeda, Y; Ono, H				Muraki, Katsuhiko; Hatano, Noriyuki; Suzuki, Hiroka; Muraki, Yukiko; Iwajima, Yui; Maeda, Yasuhiro; Ono, Hideki			Oseltamivir Blocks Human Neuronal Nicotinic Acetylcholine Receptor-Mediated Currents	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY			English	Article							VIRUS NEURAMINIDASE INHIBITOR; RANDOMIZED CONTROLLED-TRIAL; ACUTE INFLUENZA; PRODRUG; MICE; HYPOTHERMIA; ACTIVATION; SUBUNITS; CHILDREN; EFFICACY	The effects of oseltamivir, a neuraminidase inhibitor, were tested on the function of neuronal nicotinic acetylcholine receptors (nAChRs) in a neuroblastoma cell line IMR32 derived from human peripheral neurons and on recombinant human 34 nAChRs expressed in HEK cells. IMR32 cells predominately express 34 nAChRs. Nicotine (nic, 30m)-evoked currents recorded at -90mV in IMR32 cells using the whole-cell patch clamp technique were reversibly blocked by oseltamivir in a concentration-dependent manner. In contrast, an active metabolite of oseltamivir, oseltamivir carboxylate (OC) at 30m had little effect on the nic-evoked currents. Oseltamivir also blocked nic-evoked currents derived from HEK cells with recombinant 34 nAChRs. This blockade was voltage-dependent with 10, 30 and 100 m oseltamivir inhibiting similar to 50% at -100, -60 and -40mV, respectively. Non-inactivating currents in IMR32 cells and in HEK cells with 34 nAChRs, which were evoked by an endogenous nicotinic agonist, ACh (5m), were reversibly blocked by oseltamivir. These data demonstrate that oseltamivir blocks nAChRs, presumably via binding to a site in the channel pore.	[Muraki, Katsuhiko; Hatano, Noriyuki; Suzuki, Hiroka; Muraki, Yukiko] Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Iwajima, Yui; Ono, Hideki] Nagoya City Univ, Lab CNS Pharmacol, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Maeda, Yasuhiro] Nagoya City Univ, Lab Hosp Pharm, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Ono, Hideki] Musashino Univ, Lab Clin Pharm & Pharmacol, Fac Pharm, Tokyo, Japan	Muraki, K (reprint author), Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	kmuraki@dpc.agu.ac.jp			Japanese Society of Promotion and Science (JSPS); Institute of Pharmaceutical Life Sciences, Aichi Gakuin University	This work was supported by Grants-in-Aid for Scientific Research to KM and NH from the Japanese Society of Promotion and Science (JSPS). This study was also supported by a research grant in 2013 from Institute of Pharmaceutical Life Sciences, Aichi Gakuin University to HS. We thank Dr. J. Dempster (University of Strathclyde, UK) for developing the electrophysiology software (WinWCP and WinEDR).	Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Li WX, 1998, ANTIMICROB AGENTS CH, V42, P647; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; Nelson ME, 2001, J GEN PHYSIOL, V118, P563, DOI 10.1085/jgp.118.5.563; Shi DS, 2006, J PHARMACOL EXP THER, V319, P1477, DOI 10.1124/jpet.106.111807; Jefferson T, 2009, LANCET, V374, P1312, DOI 10.1016/S0140-6736(09)61804-3; Sun M, 2007, J PHYSIOL-LONDON, V578, P751, DOI 10.1113/jphysiol.2006.120147; Chung S, 2010, PSYCHIAT INVEST, V7, P302, DOI 10.4306/pi.2010.7.4.302; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nelson ME, 1999, J PHYSIOL-LONDON, V516, P657, DOI 10.1111/j.1469-7793.1999.0657u.x; Slemmer JE, 2000, J PHARMACOL EXP THER, V295, P321; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Hiasa M, 2013, BRIT J PHARMACOL, V169, P115, DOI 10.1111/bph.12102; Hatano N, 2012, J BIOL CHEM, V287, P31962, DOI 10.1074/jbc.M112.361139; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Dutkowski R, 2010, J ANTIMICROB CHEM S2, V65, pii11, DOI DOI 10.1093/JAC/DKQ012; Francis MM, 2000, MOL PHARMACOL, V58, P109; Freichel C, 2012, BASIC CLIN PHARMACOL, V111, P50, DOI 10.1111/j.1742-7843.2012.00861.x; Kadowaki T, 2011, PARKINSONISM RELAT D, V17, P133, DOI 10.1016/j.parkreldis.2010.10.013; Kitching A, 2009, EUROSURVEILLANCE, V14, P2; Lindemann L, 2010, EUR J PHARMACOL, V628, P6, DOI 10.1016/j.ejphar.2009.11.020; Ono H, 2008, BIOL PHARM BULL, V31, P638, DOI 10.1248/bpb.31.638; Ono H, 2013, BASIC CLIN PHARMACOL, V113, P25, DOI 10.1111/bcpt.12058; Puttfarcken PS, 1997, J NEUROCHEM, V69, P930; Sidwell RW, 1998, ANTIVIR RES, V37, P107, DOI 10.1016/S0166-3542(97)00065-X; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Zhang J, 1999, MOL PHARMACOL, V55, P970	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-7835	1742-7843		BASIC CLIN PHARMACOL	Basic Clin. Pharmacol. Toxicol.	FEB	2015	116	2					87	95		10.1111/bcpt.12290		9	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AZ8YN	WOS:000348497700002		
J	Morton, J; Akita, F; Nakajima, Y; Shen, JR; Krausz, E				Morton, Jennifer; Akita, Fusamichi; Nakajima, Yoshild; Shen, Jian-Ren; Krausz, Elmars			Optical identification of the long-wavelength (700-1700 nm) electronic excitations of the native reaction centre, Mn4CaO5 cluster and cytochromes of photosystem II in plants and cyanobacteria	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						Photosystem II; Reaction centre; Oxygen evolving centre; Charge-transfer; Circular dichroism; Magnetic circular dichroism	OXYGEN-EVOLVING COMPLEX; CIRCULAR-DICHROISM SPECTROSCOPY; PHOTOSYNTHETIC REACTION CENTERS; CORE COMPLEXES; PARAMAGNETIC-RESONANCE; MANGANESE CLUSTER; MODEL COMPLEXES; NONHEME IRON; PS II; STATE	Visible/UV absorption in PS II core complexes is dominated by the chl-a absorptions, which extend to similar to 700 nm. A broad 700-730 nm PS II core complex absorption in spinach has been assigned [1] to a charge transfer excitation between Chl(D1) and Chl(D2). Emission from this state, which peaks at 780 nm, has been seen [2] for both plant and cyanobacterial samples. We show that Thermosynechococcus vulcanus PS II core complexes have parallel absorbance in the 700-730 nm region and similar photochemical behaviour to that seen in spinach. This establishes the low energy charge transfer state as intrinsic to the native PS II reaction centre. High-sensitivity MCD measurements made in the 700-1700 nm region reveal additional electronic excitations at similar to 770 nm and similar to 1550 nm. The temperature and field dependence of MCD spectra establish that the system peaking near 1550 nm is a heme-to-Fe(III) charge transfer excitation. These transitions have not previously been observed for cyt b(559) or cyt C-550. The distinctive characteristics of the MCD signals seen at 770 nm allow us to assign absorption in this region to a d(z)(2) -> d(x2) (-) (y2) transition of Mn(III) in the Ca-Mn4O5 cluster of the oxygen evolving centre. Current measurements were performed in the S-1 state. Detailed analyses of this spectral region, especially in higher S states, promise to provide a new window on models of water oxidation. (C) 2014 Elsevier B.V. All rights reserved.	[Morton, Jennifer; Krausz, Elmars] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Akita, Fusamichi; Nakajima, Yoshild; Shen, Jian-Ren] Okayama Univ, Fac Sci, Photosynth Res Ctr, Grad Sch Nat Sci & Technol,Dept Biol, Okayama, Japan	Krausz, E (reprint author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.	elmars.krausz@anu.edu.au	Akita, Fusamichi/C-2034-2015; Shen, Jian-Ren/B-2558-2011; Krausz, Elmars/I-2885-2014	Akita, Fusamichi/0000-0003-0537-6157; 	Australian Research Council [DP1 10104565]; MEXT/JSPS of Japan [24000018]	We would like to dedicate this paper to our late colleague Warwick Hillier whose untimely death was a shock to his friends and colleagues. He was involved in the early stages of this project. The tireless technical support of Keith Jackman was critical in many aspects of this demanding project. Paul Smith prepared the spinach PS II core complexes used in this work. We would like to acknowledge the continuing help and encouragement of Bill Rutherford and Nick Cox. We recognise the support of the Australian Research Council through grant DP1 10104565 (E.K.) and MEXT/JSPS of Japan through a Grant-in-Aid for Specially Promoted Research No. 24000018 (J.R.S.).	Schlodder E, 2014, J AM CHEM SOC, V136, P3904, DOI 10.1021/ja412375j; Krausz E, 2013, PHOTOSYNTH RES, V116, P411, DOI 10.1007/s11120-013-9881-7; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Morton J, 2014, BBA-BIOENERGETICS, V1837, P167, DOI 10.1016/j.bbabio.2013.09.008; Boussac A, 2005, PLANT CELL PHYSIOL, V46, P837, DOI 10.1093/pcp/pci088; SOLOMON EI, 1995, COORDIN CHEM REV, V144, P369, DOI 10.1016/0010-8545(95)01150-N; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; PIEPHO SB, 1978, J AM CHEM SOC, V100, P2996, DOI 10.1021/ja00478a011; SCHATZ PN, 1978, MOL PHYS, V35, P1537, DOI 10.1080/00268977800101151; MATHIS P, 1981, ISRAEL J CHEM, V21, P316; Stranger R, 1996, INORG CHEM, V35, P4218, DOI 10.1021/ic951581+; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; GAMELIN DR, 1994, J AM CHEM SOC, V116, P2392, DOI 10.1021/ja00085a019; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Wu AJ, 2004, CHEM REV, V104, P903, DOI 10.1021/cr020627v; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Hughes JL, 2004, J PHYS CHEM B, V108, P10428, DOI 10.1021/jp0492523; Geiger RA, 2011, INORG CHEM, V50, P10190, DOI 10.1021/ic201168j; Baxter R, 1999, J AM CHEM SOC, V121, P9451, DOI 10.1021/ja9838662; Boussac A, 1996, BIOCHEMISTRY-US, V35, P6984, DOI 10.1021/bi960636w; Brunold TC, 2000, J AM CHEM SOC, V122, P8511, DOI 10.1021/ja000264l; Brunold TC, 1998, J AM CHEM SOC, V120, P8724, DOI 10.1021/ja981394l; BUTLER WL, 1971, BIOCHIM BIOPHYS ACTA, V245, P237, DOI 10.1016/0005-2728(71)90028-4; CHEESMAN MR, 1991, ADV INORG CHEM RAD, V36, P201; Cox N, 2009, BIOPHYS J, V97, P2024, DOI 10.1016/j.bpj.2009.06.033; Cua A, 2000, J AM CHEM SOC, V122, P2069, DOI 10.1021/ja9932885; DEXHEIMER SL, 1992, J AM CHEM SOC, V114, P2821, DOI 10.1021/ja00034a010; DISMUKES GC, 1984, FEBS LETT, V178, P51, DOI 10.1016/0014-5793(84)81238-7; Houssier C., 1970, J AM CHEM SOC, V92, P779, DOI 10.1021/ja00707a007; Hughes JL, 2007, J LUMIN, V127, P239, DOI 10.1016/j.jlumin.2007.02.030; Hughes JL, 2007, J LUMIN, V122, P284, DOI 10.1016/j.jlumin.2006.01.142; Hughes JL, 2010, BBA-BIOENERGETICS, V1797, P11, DOI 10.1016/j.bbabio.2009.07.007; Hughes J.L, 2007, APPL PHYS METHODS IN; Hughes JL, 2006, J LUMIN, V119, P298, DOI 10.1016/j.jlumin.2006.01.012; Hughes JL, 2006, BBA-BIOENERGETICS, V1757, P841, DOI 10.1016/j.bbabio.2006.05.035; Krausz E, 2005, PHOTOCH PHOTOBIO SCI, V4, P744, DOI 10.1039/b417905f; Krausz E, 2008, PHOTOSYNTH RES, V98, P207, DOI 10.1007/s11120-008-9328-8; KRAUSZ E, 1993, AUST J CHEM, V46, P1041; Matsuoka H, 2006, J PHYS CHEM B, V110, P13242, DOI 10.1021/jp055008f; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; PARSON WW, 1987, J AM CHEM SOC, V109, P6152, DOI 10.1021/ja00254a040; Piepho S. B., 1983, GROUP THEORY SPECTRO; SCHEJTER A, 1984, BIOCHEMISTRY-US, V23, P1081, DOI 10.1021/bi00301a007; Schlodder E, 2011, BBA-BIOENERGETICS, V1807, P1423, DOI 10.1016/j.bbabio.2011.06.018; Smith PJ, 2002, BIOCHEMISTRY-US, V41, P1981, DOI 10.1021/bi0111202; Solomon EI, 2003, P NATL ACAD SCI USA, V100, P3589, DOI 10.1073/pnas.0336792100; Steffen R., 2008, MEAS SCI TECHNOL, V19; THOMSON AJ, 1982, BIOCHEM J, V207, P167; VELTHUYS BR, 1988, BIOCHIM BIOPHYS ACTA, V933, P249, DOI 10.1016/0005-2728(88)90032-1; WARSHEL A, 1987, J AM CHEM SOC, V109, P6143, DOI 10.1021/ja00254a039; Yamauchi T, 1997, BIOCHEMISTRY-US, V36, P7520, DOI 10.1021/bi962791g	52	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	FEB	2015	1847	2					153	161		10.1016/j.bbabio.2014.11.003		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ6NY	WOS:000348337400002		
J	Sigfridsson, KGV; Leidel, N; Sanganas, O; Chemev, P; Lenz, O; Yoon, KS; Nishihara, H; Parkin, A; Armstrong, FA; Dementin, S; Rousset, M; De Lacey, AL; Haumann, M				Sigfridsson, Kajsa G. V.; Leidel, Nils; Sanganas, Oliver; Chemev, Petko; Lenz, Oliver; Yoon, Ki-Seok; Nishihara, Hirofumi; Parkin, Alison; Armstrong, Fraser A.; Dementin, Sebastien; Rousset, Marc; De lacey, Antonio L.; Haumann, Michael			Structural differences of oxidized iron-sulfur and nickel-iron cofactors in O-2-tolerant and O-2-sensitive hydrogenases studied by X-ray absorption spectroscopy	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						[NiFe]-hydrogenase; O-2-tolerance; FeS cluster; [NiFe] active site; X-ray absorption spectroscopy	MEMBRANE-BOUND HYDROGENASE; DESULFOVIBRIO-GIGAS HYDROGENASE; RALSTONIA-EUTROPHA H16; VULGARIS MIYAZAKI-F; NIFE HYDROGENASE; ACTIVE-SITE; ESCHERICHIA-COLI; CARBON-MONOXIDE; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS	The class of [NiFe]-hydrogenases comprises oxygen-sensitive periplasmic (PH) and oxygen-tolerant membrane-bound (MBH) enzymes. For three PHs and four MBHs from six bacterial species, structural features of the nickel-iron active site of hydrogen turnover and of the iron-sulfur clusters functioning in electron transfer were determined using X-ray absorption spectroscopy (XAS). Fe-XAS indicated surplus oxidized iron and a lower number of similar to 2.7 angstrom Fe-Fe distances plus additional shorter and longer distances in the oxidized MBHs compared to the oxidized PHs. This supported a double-oxidized and modified proximal FeS cluster in all MBHs with an apparent trimer-plus-monomer arrangement of its four iron atoms, in agreement with crystal data showing a [4Fe3S] cluster instead of a [4Fe4S] cubane as in the PHs. Ni-XAS indicated coordination of the nickel by the thiol group sulfurs of four conserved cysteines and at least one iron-oxygen bond in both MBH and PH proteins. Structural differences of the oxidized inactive [NiFe] cofactor of MBHs in the Ni-B state compared to PHs in the Ni-A state included a similar to 0.05 angstrom longer Ni-O bond, a two times larger spread of the Ni-S bond lengths, and a similar to 0.1 angstrom shorter Ni-Fe distance. The modified proximal [4Fe3S] cluster, weaker binding of the Ni-Fe bridging oxygen species, and an altered localization of reduced oxygen species at the active site may each contribute to O-2 tolerance. (C) 2014 Elsevier B.V. All rights reserved.	[Sigfridsson, Kajsa G. V.; Leidel, Nils; Sanganas, Oliver; Chemev, Petko; Haumann, Michael] Free Univ Berlin, Inst Experimentalphys, D-14195 Berlin, Germany; [Sanganas, Oliver] Humboldt Univ, D-10115 Berlin, Germany; [Yoon, Ki-Seok; Nishihara, Hirofumi] Ibaraki Univ, Dept Bioresource Sci, Ibaraki 3000393, Japan; [Parkin, Alison; Armstrong, Fraser A.] Univ Oxford, Dept Inorgan Chem, Oxford OX1 3QR, England; [Dementin, Sebastien; Rousset, Marc] CNRS Marseille, Unite Bioenerget & Ingn Prot, F-13402 Marseille, France; [De lacey, Antonio L.] CSIC, Inst Catalisis, Madrid 28049, Spain	Haumann, M (reprint author), Free Univ Berlin, FB Phys, Arnimallee 14, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	De Lacey, Antonio/H-3311-2015	De Lacey, Antonio/0000-0002-9347-0452	Deutsche Forschungsgemeinschaft (DFG); DFG [Ha3265/3-1, Ha3265/6-1]; Bundesministerium fur Bildung und Wissenschaft [05K14KE1]; MINECO [CTQ2012-32448]	M.H. thanks the Deutsche Forschungsgemeinschaft (DFG) for a Heisenberg Fellowship and the DFG (grants Ha3265/3-1 and Ha3265/6-1) and the Bundesministerium fur Bildung und Wissenschaft (grant 05K14KE1 within the Rontgen-Angstrom Cluster) for the financial support. A.L.D.L thanks MINECO (project CTQ2012-32448) for the financial support. F.A.A. is a Royal Society Wolfson Research Merit Award holder. We thank the beamline scientists F. Schafers (BESSY at HZB, Berlin), W. Meyer-Klaucke (EMBL at DESY, Hamburg), B. Bilsborough (SRS at Daresbury, UK), and S. Mangold (ANKA at KIT, Karlsruhe) for the technical assistance and H. Dau (FU-Berlin) for providing access to XAS equipment at BESSY. We thank J. Fritsch (Humboldt Universitat zu Berlin) for the preparation of the Re MBH samples and P. Infossi and M.-T. Giudici-Orticoni (CNRS Marseille) for generously providing the A. aeolicus protein.	ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; Trofanchuk O, 2000, J BIOL INORG CHEM, V5, P36, DOI 10.1007/PL00010654; Parkin A, 2008, J AM CHEM SOC, V130, P13410, DOI 10.1021/ja803657d; Roessler MM, 2012, J AM CHEM SOC, V134, P15581, DOI 10.1021/ja307117y; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Saggu M, 2010, CHEMPHYSCHEM, V11, P1215, DOI 10.1002/cphc.200900988; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Saggu M, 2010, PHYS CHEM CHEM PHYS, V12, P2139, DOI 10.1039/b922236g; Rudiger O, 2005, J AM CHEM SOC, V127, P16008, DOI 10.1021/ja0554312; [Anonymous], 2007, CHEM REV, V107; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Abou Hamdan A, 2013, NAT CHEM BIOL, V9, P15, DOI [10.1038/nchembio.1110, 10.1038/NCHEMBIO.1110]; Liebgott PP, 2011, J AM CHEM SOC, V133, P986, DOI 10.1021/ja108787s; Gu WW, 2003, J INORG BIOCHEM, V93, P41, DOI 10.1016/S0162-0134(02)00494-4; Dau H, 2004, PHYS CHEM CHEM PHYS, V6, P4781, DOI 10.1039/b408146c; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Pandelia ME, 2010, J AM CHEM SOC, V132, P6991, DOI 10.1021/ja910838d; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Rehr JJ, 2010, PHYS CHEM CHEM PHYS, V12, P5503, DOI 10.1039/b926434e; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Fritsch J, 2011, BIOCHEMISTRY-US, V50, P5858, DOI 10.1021/bi200367u; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Pandelia ME, 2010, BIOCHEMISTRY-US, V49, P8873, DOI 10.1021/bi1006546; Carepo M, 2002, J AM CHEM SOC, V124, P281, DOI 10.1021/ja010204v; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Evans RM, 2013, J AM CHEM SOC, V135, P2694, DOI 10.1021/ja311055d; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Pandelia ME, 2012, BBA-BIOENERGETICS, V1817, P1565, DOI 10.1016/j.bbabio.2012.04.012; Frielingsdorf S, 2014, NAT CHEM BIOL, V10, P378, DOI 10.1038/nchembio.1500; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Higuchi Y, 1999, STRUCT FOLD DES, V7, P549, DOI 10.1016/S0969-2126(99)80071-9; Shafaat HS, 2013, BBA-BIOENERGETICS, V1827, P986, DOI 10.1016/j.bbabio.2013.01.015; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Lambertz C, 2014, CHEM SCI, V5, P1187, DOI 10.1039/c3sc52703d; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; Cammack R., 1997, HYDROGEN FUEL LEARNI; Davidson G, 2000, BIOCHEMISTRY-US, V39, P7468, DOI 10.1021/bi000300t; De Lacey AL, 2004, J BIOL INORG CHEM, V9, P636, DOI 10.1007/s00775-004-0559-7; DerVartanian ME, 1996, BIOCHEM BIOPH RES CO, V227, P211, DOI 10.1006/bbrc.1996.1491; Gu ZJ, 1996, J AM CHEM SOC, V118, P11155, DOI 10.1021/ja962429p; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Loscher S, 2006, BIOCHEMISTRY-US, V45, P11658, DOI 10.1021/bi061068f; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Schafer C., 2014, APPL ENVIRON MICROB, V79, P5137; VANDERZWAAN JW, 1990, BIOCHIM BIOPHYS ACTA, V1041, P101, DOI 10.1016/0167-4838(90)90051-G; Volbeda A, 2013, STRUCTURE, V21, P184, DOI 10.1016/j.str.2012.11.010; Yoon KS, 2009, FEMS MICROBIOL LETT, V290, P114, DOI 10.1111/j.1574-6968.2008.01417.x	66	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	FEB	2015	1847	2					162	170		10.1016/j.bbabio.2014.06.011		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ6NY	WOS:000348337400003		
J	Sugiura, M; Nakamura, M; Koyama, K; Boussac, A				Sugiura, Miwa; Nakamura, Makoto; Koyama, Kazumi; Boussac, Alain			Assembly of oxygen-evolving Photosystem II efficiently occurs with the apo-Cytb(559) but the holo-Cytb(559) accelerates the recovery of a functional enzyme upon photoinhibition	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						Photosystem II; Cytb(559); Haem axial ligands; Photoinhibition	CYANOBACTERIUM THERMOSYNECHOCOCCUS-ELONGATUS; SITE-DIRECTED MUTAGENESIS; PCC 6803 MUTANTS; CYTOCHROME B(559); CHLAMYDOMONAS-REINHARDTII; ELECTRON-TRANSFER; REDOX PROPERTIES; WATER OXIDATION; ALPHA-SUBUNIT; AXIAL-LIGANDS	Cytb(559) in Photosystem II is a heterodimeric b-type cytochrome. The subunits, PsbE and PsbF, consist each in a membrane alpha-helix. Roles for Cytb559 remain elusive. In Thermosynechococcus elongatus, taking advantage of the robustness of the PSII variant with PsbA3 as the D1 subunit (WT*3), 4 mutants were designed hoping to get mutants nevertheless the obligatory phototrophy of this cyanobacterium. In two of them, an axial histidine ligand of the haem-iron was substituted for either a methionine, PsbE/H23M, which could be potentially a ligand or for an alanine, PsbE/H23A, which cannot. In the other mutants, PsbE/Y19F and PsbE/T26P, the environment around PsbE/H23 was expected to be modified. From EPR, MALDI-TOF and O-2 evolution activity measurements, the following results were obtained: Whereas the PsbE/H23M and PsbE/H23A mutants assemble only an apo-Cytb(559) the steady-state level of active PSII was comparable to that in WT*3. The lack of the haem or, in PsbE/T26P, conversion of the high-potential into a lower potential form, slowed-down the recovery rate of the O-2 activity after high-light illumination but did not affect the photoinhibition rate. This resulted in the following order for the steady-state level of active PSII centers under high-light conditions: PsbE/H23M approximate to PsbE/H23A << PsbE/Y19F <= PsbE/T26P <= WT*3. These data show i) that the haem has no structural role provided that PsbE and PsbF are present, ii) a lack of correlation between the rate of photoinhibition and the E-m of the haem and iii) that the holo-Cytb(559) favors the recovery of a functional enzyme upon photoinhibition. (C) 2014 Elsevier B.V. All rights reserved.	[Sugiura, Miwa; Koyama, Kazumi] Ehime Univ, Proteo Sci Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa; Nakamura, Makoto] Ehime Univ, Grad Sch Sci & Technol, Dept Chem, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Boussac, Alain] CEA Saclay, CNRS, UMR 8221, iBiTec S, F-91191 Gif Sur Yvette, France	Sugiura, M (reprint author), Ehime Univ, Proteo Sci Res Ctr, Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	miwa.sugiura@chime-u.ac.jp; alain.boussac@cea.fr			JST-PRESTO program [4018]; Ministry of Education, Science, Sports, Culture and Technology [21612007]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; CEA/DSV "Bioenergie" program	We thank to Chizuko Azami, Yui Ozaki and Masato Nakamura (Ehime University) for technical assistance. This study was supported by JST-PRESTO program (4018 for M.S.) and Grant-in-Aid for scientific research from the Ministry of Education, Science, Sports, Culture and Technology (21612007 for M.S.). AB was supported in part by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01 and the CEA/DSV "Bioenergie" program.	Andrews H, 2005, BIOCHEMISTRY-US, V44, P6092, DOI 10.1021/bi0500473; Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; Pospisil P, 2006, BIOCHEM J, V397, P321, DOI 10.1042/BJ20060068; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; Nagao R, 2010, J BIOL CHEM, V285, P29191, DOI 10.1074/jbc.M110.146092; Blomberg MRA, 2014, CHEM REV, V114, P3601, DOI 10.1021/cr400388t; Roncel M, 2001, EUR J BIOCHEM, V268, P4961, DOI 10.1046/j.0014-2956.2001.02427.x; Shinopoulos KE, 2012, BBA-BIOENERGETICS, V1817, P66, DOI 10.1016/j.bbabio.2011.08.002; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; BERTHOMIEU C, 1992, BIOCHEMISTRY-US, V31, P11460, DOI 10.1021/bi00161a026; Bondarava N, 2010, PHYSIOL PLANTARUM, V138, P463, DOI 10.1111/j.1399-3054.2009.01312.x; Chiu YF, 2013, BBA-BIOENERGETICS, V1827, P507, DOI 10.1016/j.bbabio.2013.01.016; Chiu YF, 2009, BBA-BIOENERGETICS, V1787, P1179, DOI 10.1016/j.bbabio.2009.05.007; Enami I, 2003, PLANT CELL PHYSIOL, V44, P820, DOI 10.1093/pcp/pcg106; Fufezan C, 2005, BIOCHEMISTRY-US, V44, P12780, DOI 10.1021/bi051000k; Guerrero F, 2014, BBA-BIOENERGETICS, V1837, P908, DOI [10.1016/j.bbabio.2014.02.024, 10.1016/j.bbabio2014.02.024]; Hamilton ML, 2014, PLANT CELL PHYSIOL, V55, P1276, DOI 10.1093/pcp/pcu070; Hung CH, 2007, BBA-BIOENERGETICS, V1767, P686, DOI 10.1016/j.bbabio.2007.02.016; Hung CH, 2010, J BIOL CHEM, V285, P5653, DOI 10.1074/jbc.M109.044719; IKEUCHI M, 1988, PLANT CELL PHYSIOL, V29, P1233; Ishikita H, 2005, FEBS LETT, V579, P3190, DOI 10.1016/j.febslet.2005.05.004; Isobe H, 2014, PHYS CHEM CHEM PHYS, V16, P11911, DOI 10.1039/c4cp00282b; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; Kaminskaya OP, 2013, BBA-BIOENERGETICS, V1827, P471, DOI 10.1016/j.bbabio.2013.01.007; Kerfeld CA, 2003, PLANT CELL PHYSIOL, V44, P697, DOI 10.1093/pcp/pcg084; Koua F.H.M., 2013, P NATL ACAD SCI USA, V110, P3389; Ma JJ, 2007, J INTEGR PLANT BIOL, V49, P1054, DOI 10.1111/j.1672-9072.2007.00486.x; Ma JJ, 2007, CHINESE SCI BULL, V52, P896, DOI 10.1007/s11434-007-0147-7; Morais F, 2001, J BIOL CHEM, V276, P31986, DOI 10.1074/jbc.M103935200; Muh F, 2012, BBA-BIOENERGETICS, V1817, P44, DOI 10.1016/j.bbabio.2011.05.021; PAKRASI HB, 1991, EMBO J, V10, P1619; Roncel M, 2012, BBA-BIOENERGETICS, V1817, P1152, DOI 10.1016/j.bbabio.2012.01.008; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1922, DOI 10.1016/j.bbabio.2014.08.008; Sugiura M, 2010, J BIOL CHEM, V285, P30008, DOI 10.1074/jbc.M110.136945; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P139, DOI 10.1016/j.bbabio.2013.09.009; Wohlleben W., 1993, BIOTECHNIQUES, V15, P831; Yatsunyk A.L, 2006, INORG CHEM, V45, P5417	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	FEB	2015	1847	2					276	285		10.1016/j.bbabio.2014.11.009		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ6NY	WOS:000348337400014		
J	Najafpour, MM; Ghobadi, MZ; Haghighi, B; Tomo, T; Shen, JR; Allakhverdiey, SI				Najafpour, Mohammad Mandi; Ghobadi, Mohadeseh Zarei; Haghighi, Behzad; Tomo, Tatsuya; Shen, Jian-Ren; Allakhverdiey, Suleyman I.			Comparison of nano-sized Mn oxides with the Mn cluster of photosystem II as catalysts for water oxidation	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Review						Model complex; Nano-sized manganese oxides; Photosystem II; Water oxidation; Water-oxidizing complex	OXYGEN-EVOLVING COMPLEX; PROMISING STRUCTURAL MODEL; COUPLED ELECTRON-TRANSFER; RAY-ABSORPTION SPECTROSCOPY; LAYERED MANGANESE OXIDE; UV-INDUCED PHOTODAMAGE; SCHIFF-BASE COMPLEXES; O BOND FORMATION; OXIDIZING COMPLEX; ARTIFICIAL PHOTOSYNTHESIS	"Back to Nature" is a promising way to solve the problems that we face today, such as air pollution and shortage of energy supply based on conventional fossil fuels. A Mn cluster inside photosystem II catalyzes light-induced water-splitting leading to the generation of protons, electrons and oxygen in photosynthetic organisms, and has been considered as a good model for the synthesis of new artificial water-oxidizing catalysts. Herein, we surveyed the structural and functional details of this cluster and its surrounding environment. Then, we review the mechanistic findings concerning the cluster and compare this biological catalyst with nano-sized Mn oxides, which are among the best artificial Mn-based water-oxidizing catalysts. (C) 2014 Elsevier B.V. All rights reserved.	[Najafpour, Mohammad Mandi; Ghobadi, Mohadeseh Zarei; Haghighi, Behzad] IASBS, Dept Chem, Zanjan 4513766731, Iran; [Najafpour, Mohammad Mandi; Haghighi, Behzad] IASBS, Ctr Climate Change & Global Warming, Zanjan 4513766731, Iran; [Tomo, Tatsuya] Tokyo Univ Sci, Fac Sci, Dept Biol, Shinjuku Ku, Tokyo 1628601, Japan; [Tomo, Tatsuya] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Shen, Jian-Ren] Okayama Univ, Fac Sci, Photosynth Res Ctr, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Allakhverdiey, Suleyman I.] Russian Acad Sci, Inst Plant Physiol, Controlled Photo Biosynth Lab, Moscow 127276, Russia; [Allakhverdiey, Suleyman I.] Russian Acad Sci, Inst Basic Biol Problems, Pushchino 142290, Moscow Region, Russia; [Allakhverdiey, Suleyman I.] Moscow MV Lomonosov State Univ, Fac Biology, Dept Plant Physiol, Moscow 119991, Russia	Najafpour, MM (reprint author), IASBS, Dept Chem, Zanjan 4513766731, Iran.	mmnajafpour@iasbs.ac.ir; suleyman.allakhverdiev@gmail.com	Shen, Jian-Ren/B-2558-2011		Institute for Advanced Studies in Basic Sciences; National Elite Foundation; JSPS, MEXT, Japan [24370025, 26220801, 24000018]; Russian Science Foundation [14-14-00039]	MMN and MZG are grateful to the Institute for Advanced Studies in Basic Sciences and the National Elite Foundation for financial support. TT was supported by Grants-in-Aid for Scientific Reserch (24370025, 26220801), JRS was supported by a grant-in-aid for Specially Promoted Research No. 24000018 from JSPS, MEXT, Japan, and SIA was supported by grant from the Russian Science Foundation (No: 14-14-00039).	Allakhverdiev S.I., P NATL ACAD SCI US, V107; Shimazaki Y, 2004, ANGEW CHEM INT EDIT, V43, P98, DOI 10.1002/anie.200352564; Nakagawa T, 2009, J PHYS CHEM C, V113, P12958, DOI 10.1021/jp9060076; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; De Las Rivas J, 2004, PHOTOSYNTH RES, V81, P329, DOI 10.1023/B:PRES.0000036889.44048.e4; YACHANDRA VK, 1993, SCIENCE, V260, P675, DOI 10.1126/science.8480177; Allakhverdiev SI, 2011, P NATL ACAD SCI USA, V108, P8054, DOI 10.1073/pnas.1100173108; Gorlin Y, 2010, J AM CHEM SOC, V132, P13612, DOI 10.1021/ja104587v; Najafpour MM, 2014, RSC ADV, V4, P39077, DOI 10.1039/c4ra04719b; FORBUSH B, 1971, PHOTOCHEM PHOTOBIOL, V14, P307, DOI 10.1111/j.1751-1097.1971.tb06175.x; Najafpour MM, 2012, BBA-BIOENERGETICS, V1817, P1110, DOI 10.1016/j.bbabio.2012.04.002; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Kent CA, 2013, J AM CHEM SOC, V135, P8432, DOI 10.1021/ja400616a; Navrotsky A, 2010, SCIENCE, V330, P199, DOI 10.1126/science.1195875; KIRBY JA, 1981, J AM CHEM SOC, V103, P5529, DOI 10.1021/ja00408a042; Najafpour MM, 2014, BIOCHEMISTRY-MOSCOW+, V79, P324, DOI 10.1134/S0006297914040026; Najafpour MM, 2014, RSC ADV, V4, P6375, DOI 10.1039/c3ra46925e; Tomo T, 2012, BBA-BIOENERGETICS, V1817, P1299, DOI 10.1016/j.bbabio.2012.02.018; Najafpour MM, 2012, J R SOC INTERFACE, V9, P2383, DOI 10.1098/rsif.2012.0412; Najafpour MM, 2011, DALTON T, V40, P9374, DOI 10.1039/c1dt11048a; Najafpour MM, 2013, CHEM COMMUN, V49, P8824, DOI 10.1039/c3cc44399j; Najafpour MM, 2013, PHOTOSYNTH RES, V117, P413, DOI 10.1007/s11120-013-9814-5; Hammarstrom L, 2011, ENERG ENVIRON SCI, V4, P2379, DOI 10.1039/c1ee01348c; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Geletii YV, 2009, J AM CHEM SOC, V131, P7522, DOI 10.1021/ja901373m; Morris ND, 2011, J PHYS CHEM A, V115, P547, DOI 10.1021/jp1110955; Ruettinger W, 2000, J AM CHEM SOC, V122, P10353, DOI 10.1021/ja0005587; Parent AR, 2014, CHEMSUSCHEM, V7, P2070, DOI 10.1002/cssc.201402322; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Najafpour MM, 2010, ANGEW CHEM INT EDIT, V49, P2233, DOI 10.1002/anie.200906745; Najafpour MM, 2012, RSC ADV, V2, P11253, DOI 10.1039/c2ra21251j; JAKLEVIC J, 1977, SOLID STATE COMMUN, V23, P679, DOI 10.1016/0038-1098(77)90548-8; Haumann M, 1999, BIOCHEMISTRY-US, V38, P1258, DOI 10.1021/bi981557i; Duan LL, 2012, NAT CHEM, V4, P418, DOI [10.1038/nchem.1301, 10.1038/NCHEM.1301]; Lohmiller T, 2012, J BIOL CHEM, V287, P24721, DOI 10.1074/jbc.M112.365288; Wiechen M, 2012, CHEM SCI, V3, P2330, DOI 10.1039/c2sc20226c; Najafpour MM, 2014, J AM CHEM SOC, V136, P7245, DOI 10.1021/ja5028716; Pecoraro VL, 1998, PURE APPL CHEM, V70, P925, DOI 10.1351/pac199870040925; Zaharieva I, 2011, ENERG ENVIRON SCI, V4, P2400, DOI 10.1039/c0ee00815j; Zhao YX, 2011, J PHYS CHEM LETT, V2, P402, DOI 10.1021/jz200051c; Hocking RK, 2011, NAT CHEM, V3, P461, DOI [10.1038/nchem.1049, 10.1038/NCHEM.1049]; Najafpour MM, 2012, DALTON T, V41, P10292, DOI 10.1039/c2dt30965c; Najafpour MM, 2014, DALTON T, V43, P13122, DOI 10.1039/c4dt01367k; Vinyard DJ, 2013, ANNU REV BIOCHEM, V82, P577, DOI 10.1146/annurev-biochem-070511-100425; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; HARRIMAN A, 1988, J CHEM SOC FARAD T 1, V84, P2795, DOI 10.1039/f19888402795; Russell MJ, 2003, SCIENCE, V302, P580, DOI 10.1126/science.1091765; Boppana VBR, 2011, CHEM COMMUN, V47, P8973, DOI 10.1039/c1cc12258d; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Limburg J, 1997, J AM CHEM SOC, V119, P2761, DOI 10.1021/ja963899m; Kanady JS, 2013, J AM CHEM SOC, V135, P1073, DOI 10.1021/ja310022p; Limburg J, 1999, SCIENCE, V283, P1524, DOI 10.1126/science.283.5407.1524; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Maneiro M, 2003, P NATL ACAD SCI USA, V100, P3707, DOI 10.1073/pnas.0637229100; Kusunoki M, 2007, BBA-BIOENERGETICS, V1767, P484, DOI 10.1016/j.bbabio.2007.03.012; Dau H, 2001, BBA-BIOENERGETICS, V1503, P24, DOI 10.1016/S0005-2728(00)00230-9; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Parent AR, 2013, CHEM SOC REV, V42, P2247, DOI 10.1039/c2cs35225g; MORITA M, 1977, ELECTROCHIM ACTA, V22, P325, DOI 10.1016/0013-4686(77)85081-0; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589; Shevela D, 2011, CHEM-EUR J, V17, P5415, DOI 10.1002/chem.201002548; Wei Z, 2011, J PHOTOCH PHOTOBIO B, V104, P118, DOI 10.1016/j.jphotobiol.2011.01.017; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Yagi M, 2004, J AM CHEM SOC, V126, P8084, DOI 10.1021/ja039780c; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Gao Y, 2009, J AM CHEM SOC, V131, P8726, DOI 10.1021/ja901139r; Hays AMA, 1998, BIOCHEMISTRY-US, V37, P11352, DOI 10.1021/bi980510u; Zhang M, 2014, NAT CHEM, V6, P362, DOI [10.1038/nchem.1874, 10.1038/NCHEM.1874]; Maier J, 2002, SOLID STATE IONICS, V154, P291, DOI 10.1016/S0167-2738(02)00499-X; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Jiao F, 2010, CHEM COMMUN, V46, P2920, DOI 10.1039/b921820c; Wang D, 2013, P NATL ACAD SCI USA, V110, P15579, DOI 10.1073/pnas.1315383110; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Surendranath Y, 2009, J AM CHEM SOC, V131, P2615, DOI 10.1021/ja807769r; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Hocking RK, 2014, CHEMCATCHEM, V6, P2028, DOI 10.1002/cctc.201400066; Limburg J, 1999, J CHEM SOC DALTON, P1353, DOI 10.1039/a807583b; HARRIMAN A, 1987, J CHEM SOC FARAD T 1, V83, P3001, DOI 10.1039/f19878303001; Ruttinger W, 1997, CHEM REV, V97, P1, DOI 10.1021/cr950201z; ASHMAWY FM, 1985, J CHEM SOC DALTON, P1391, DOI 10.1039/dt9850001391; Najafpour MM, 2014, J PHOTOCH PHOTOBIO B, V141, P247, DOI 10.1016/j.jphotobiol.2014.10.016; Najafpour MM, 2012, DALTON T, V41, P3906, DOI 10.1039/c2dt11672c; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; Moore GF, 2008, J AM CHEM SOC, V130, P10466, DOI 10.1021/ja803015m; Najafpour MM, 2011, DALTON T, V40, P9076, DOI 10.1039/c1dt10746a; ASHMAWY FM, 1984, J CHEM SOC CHEM COMM, P14, DOI 10.1039/c39840000014; BARBATO R, 1995, EUR J BIOCHEM, V227, P723, DOI 10.1111/j.1432-1033.1995.tb20194.x; BOUCHER LJ, 1975, INORG CHEM, V14, P1289, DOI 10.1021/ic50148a017; CALVIN M, 1974, SCIENCE, V184, P375, DOI 10.1126/science.184.4134.375; DEROSE VJ, 1994, J AM CHEM SOC, V116, P5239, DOI 10.1021/ja00091a031; Dismukes GC, 2005, ADV PHOTO RESPIRAT, V22, P683; FUJIWARA M, 1985, POLYHEDRON, V4, P1895, DOI 10.1016/S0277-5387(00)86708-X; Karlsson E. A., 2011, ANGEW CHEM, V123, P11919; KIRBY JA, 1981, J AM CHEM SOC, V103, P5537, DOI 10.1021/ja00408a043; Kirin S.I., 2006, CONCEPTS MODELS BIOI, P159; Lachaud Fabien, 2005, Angew Chem Int Ed Engl, V44, P1536, DOI 10.1002/anie.200461948; Lee S.Y., CHEMSUSCHEM; Mamedov F, 1998, BIOCHEMISTRY-US, V37, P14245, DOI 10.1021/bi980194j; Najafpour M.M., 2014, COORD CHEM IN PRESS; Najafpour M.M., 2013, SOAJ NANOPHOTOBIOSCI, V1, P79; Najafpour MM, 2013, DALTON T, V42, P879, DOI 10.1039/c2dt32236f; Najafpour MM, 2014, NEW J CHEM, V38, P852, DOI 10.1039/c3nj01393f; Najafpour MM, 2013, DALTON T, V42, P4772, DOI 10.1039/c3dt50280e; Najafpour MM, 2014, PLANT PHYSIOL BIOCH, V81, P3, DOI 10.1016/j.plaphy.2014.01.020; ONO TA, 1983, FEBS LETT, V164, P255, DOI 10.1016/0014-5793(83)80297-X; Pirson A., 1937, Z BOT, V31, P193; Popelkova H, 2011, PHOTOSYNTH RES, V110, P111, DOI 10.1007/s11120-011-9703-8; RAMARAJ R, 1986, ANGEW CHEM INT EDIT, V25, P825, DOI 10.1002/anie.198608252; SETLIK I, 1990, PHOTOSYNTH RES, V23, P39, DOI 10.1007/BF00030061; Shafirovich V.Y., 1979, KINET CATAL, V20; Shcheglova I.S., 1968, KINET KATAL, V9, P461; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837	115	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	FEB	2015	1847	2					294	306		10.1016/j.bbabio.2014.11.006		13	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ6NY	WOS:000348337400016		
J	Sakamoto, S; Uto, T; Shoyama, Y				Sakamoto, Seiichi; Uto, Takuhiro; Shoyama, Yukihiro			Effect of glycyrrhetinic acid on lipid raft model at the air/water interface	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Glycyrrhetinic acid (GA); Glycyrrhizin (GC); Langmuir monolayer; Lipid raft; Membrane-disrupting activity	ATOMIC-FORCE MICROSCOPY; GLYCYRRHIZA-GLABRA; LANGMUIR MONOLAYER; PHASE-EQUILIBRIA; LICORICE EXTRACT; CELL-MEMBRANES; CANCER CELLS; CHOLESTEROL; DOMAINS; FLUORESCENCE	To investigate an interfacial behavior of the aglycon of glycyrrhizin (GC), glycyrrhetinic acid (GA), with a lipid raft model consisting of equimolar ternary mixtures of N-palmitoyl sphingomyelin (PSM), dioleoylphosphatidylcholine (DOPC), and cholesterol (CHOL), Langmuir monolayer techniques were systematically conducted. Surface pressure (pi)-molecular area (A) and surface potential (Delta V)-A isotherms showed that the adsorbed GA at the air/water interface was desorbed into the bulk upon compression of the lipid monolayer. In situ morphological analysis by Brewster angle microscopy and fluorescence microscopy revealed that the raft domains became smaller as the concentrations of GA in the subphase (C-GA) increased, suggesting that GA promotes the formation of fluid networks related to various cellular processes via lipid rafts. In addition, ex situ morphological analysis by atomic force microscopy revealed that GA interacts with lipid raft by lying down at the surface. Interestingly, the distinctive striped regions were formed at C-GA = 5.0 mu M. This phenomenon was observed to be induced by the interaction of CHOL with adsorbed GA and is involved in the membrane-disrupting activity of saponin and its aglycon. A quantitative comparison of GA with GC (Sakamoto et al., 2013) revealed that GA interacts more strongly with the raft model than GC in the monolayer state. Various biological activities of GA are known to be stronger than those of GC. This fact allows us to hypothesize that differences in the interactions of GA/GC with the model monolayer correlate to their degree of exertion for numerous activities. (C) 2014 Elsevier B.V. All rights reserved.	[Sakamoto, Seiichi] Kyushu Univ, Dept Pharmacognosy, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Uto, Takuhiro; Shoyama, Yukihiro] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharmacognosy, Nagasaki 8593298, Japan	Sakamoto, S (reprint author), Kyushu Univ, Dept Pharmacognosy, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	s.sakamoto@phar.kyushu-u.ac.jp			Japan Food Chemical Research Foundation; Japan Society for the Promotion of Science (JSPS) [25750167]	The research in this paper was supported by The Japan Food Chemical Research Foundation. This work was also funded by a Grant-in-Aid for Young Scientists (B) [25750167] of the Japan Society for the Promotion of Science (JSPS). Finally, I thank O. Shibata for the discussion and H. Nakahara for the help with experiments, analyses, and comments on the manuscript.	AMAGAYA S, 1984, J PHARMACOBIO-DYNAM, V7, P923; Bottger S, 2012, BIOORGAN MED CHEM, V20, P2822, DOI 10.1016/j.bmc.2012.03.032; Rossi T, 2003, ANTICANCER RES, V23, P3813; Yuan CB, 2002, BIOPHYS J, V82, P2526; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Holthuis JCM, 2003, MOL MEMBR BIOL, V20, P231, DOI 10.1080/0988768031000100768; Smart EJ, 1996, J BIOL CHEM, V271, P29427; STEWART PM, 1987, LANCET, V2, P821; Ikeda T, 2005, BIOL PHARM BULL, V28, P1779, DOI 10.1248/bpb.28.1779; Fedida-Metula S, 2008, CARCINOGENESIS, V29, P1546, DOI 10.1093/carcin/bgn146; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Lee JR, 2009, EVID-BASED COMPL ALT, V6, P195, DOI 10.1093/ecam/nem078; Lawrence JC, 2003, BIOPHYS J, V84, P1827; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Fukai T, 2002, LIFE SCI, V71, P1449, DOI 10.1016/S0024-3205(02)01864-7; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; VOGEL V, 1988, J COLLOID INTERF SCI, V126, P408, DOI 10.1016/0021-9797(88)90140-3; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Satomi Y, 2005, ANTICANCER RES, V25, P4043; Krausse R, 2004, J ANTIMICROB CHEMOTH, V54, P243, DOI 10.1093/jac/dkh287; YAMAMURA Y, 1995, BIOL PHARM BULL, V18, P337; Kim JK, 2006, BIOCHEM BIOPH RES CO, V345, P1215, DOI 10.1016/j.bbrc.2006.05.035; YANO S, 1989, CHEM PHARM BULL, V37, P2500; Prenner E, 2007, CHEM PHYS LIPIDS, V145, P106, DOI 10.1016/j.chemphyslip.2006.11.002; Sakamoto S, 2013, BBA-BIOMEMBRANES, V1828, P1271, DOI 10.1016/j.bbamem.2013.01.006; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; Hayashi H, 2009, PLANT BIOTECHNOL, V26, P101, DOI 10.5511/plantbiotechnology.26.101; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; Mukherjee M, 2010, INDIAN J EXP BIOL, V48, P269; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Sharma G, 2012, J CELL PHYSIOL, V227, P1923, DOI 10.1002/jcp.22920; Hac-Wydro K, 2011, COLLOID SURFACE B, V88, P635, DOI 10.1016/j.colsurfb.2011.07.055; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Zajchowski LD, 2002, EUR J BIOCHEM, V269, P737, DOI 10.1046/j.0014-2956.2001.02715.x; Gupta VK, 2008, J ETHNOPHARMACOL, V116, P377, DOI 10.1016/j.jep.2007.11.037; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Shibata S, 2000, YAKUGAKU ZASSHI, V120, P849; HATTORI M, 1983, PLANTA MED, V48, P38, DOI 10.1055/s-2007-969875; Chandrasekaran CV, 2011, PHYTOMEDICINE, V18, P278, DOI 10.1016/j.phymed.2010.08.001; Brown DA, 2001, P NATL ACAD SCI USA, V98, P10517, DOI 10.1073/pnas.191386898; Davies J.T., 1963, INTERFACIAL PHENOMEN, P265; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; Dhingra D, 2004, J ETHNOPHARMACOL, V91, P361, DOI 10.1016/j.jep.2004.01.016; Friis-Moller A, 2002, PLANTA MED, V68, P416, DOI 10.1055/s-2002-32087; Hardy ME, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-96; Hawthorne S, 2008, J PHARM PHARMACOL, V60, P661, DOI 10.1211/jpp.60.5.0013; Juhasz J, 2009, BBA-BIOMEMBRANES, V1788, P2541, DOI 10.1016/j.bbamem.2009.10.006; KRAUS SD, 1960, J PHARM PHARMACOL, V12, P300; Kroes BH, 1997, IMMUNOLOGY, V90, P115, DOI 10.1046/j.1365-2567.1997.00131.x; Li W, 1998, PLANTA MED, V64, P746, DOI 10.1055/s-2006-957571; LOGEMANN W, 1960, NATURE, V187, P607, DOI 10.1038/187607a0; Loosen H., 1955, MEDIZINISCHE, V43, P1520; NOSE M, 1994, PLANTA MED, V60, P136, DOI 10.1055/s-2006-959435; Periasamy N, 2009, BBA-BIOMEMBRANES, V1788, P390, DOI 10.1016/j.bbamem.2008.09.017; Radhakrishnan A, 1999, J AM CHEM SOC, V121, P486, DOI 10.1021/ja9835537; RECKTENWALD DJ, 1981, BIOCHEMISTRY-US, V20, P4505, DOI 10.1021/bi00518a042; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Shi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044921; Stockl MT, 2010, BBA-BIOMEMBRANES, V1798, P1444, DOI 10.1016/j.bbamem.2009.12.015; Wheeler G, 2011, BBA-BIOMEMBRANES, V1808, P634, DOI 10.1016/j.bbamem.2010.11.017; Yamaguchi H, 2011, J BIOL CHEM, V286, P36888, DOI 10.1074/jbc.M111.265900	62	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	FEB	2015	1848	2					434	443		10.1016/j.bbamem.2014.11.014		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CA1QT	WOS:000348687500007		
J	Tsuchiya, R; Tanaka, T; Hozumi, Y; Nakano, T; Okada, M; Topham, MK; Iino, M; Goto, K				Tsuchiya, Rieko; Tanaka, Toshiaki; Hozumi, Yasukazu; Nakano, Tomoyuki; Okada, Masashi; Topham, Matthew K.; Iino, Mitsuyoshi; Goto, Kaoru			Downregulation of diacylglycerol kinase zeta enhances activation of cytokine-induced NF-kappa B signaling pathway	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Diacylglycerol kinase zeta; Inflammation; TNF-alpha; NF-kappa B; Nuclear translocation; CBP	TOXOPLASMA-GONDII INFECTION; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; DGK-ZETA; NUCLEAR-LOCALIZATION; TRANSCRIPTIONAL ACTIVATION; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; DENDRITIC CELLS; P65 SUBUNIT	The transcription factor NF-kappa B family serves as a key component of many pathophysiological events such as innate and adaptive immune response, inflammation, apoptosis, and oncogenesis. Various cell signals trigger activation of the regulatory mechanisms of NF-kappa B, resulting in its nuclear translocation and transcriptional initiation. The diacylglycerol kinase (DGK) family, a lipid second messenger-metabolizing enzyme in phosphoinositide signaling, is shown to regulate widely various cellular processes. Results of recent studies suggest that one family member, DGK zeta, is closely involved in immune and inflammatory responses. Nevertheless, little is known about the regulatory mechanism of DGK zeta on NF-kappa B pathway in cytokine-induced inflammatory signaling. This study shows that siRNA-mediated DGK zeta knockdown in HeLa cells facilitates degradation of I kappa B, followed by nuclear translocation of NF-kappa B p65 subunit. In addition, DGK zeta-deficient MEFs show upregulation of p65 subunit phosphoiylation at Serine 468 and 536 and its interaction with CBP transcriptional coactivator upon TNF-alpha stimulation. These modifications of p65 subunit might engender enhanced NF-kappa B transcriptional reporter assay of DGK zeta knockdown cells. These findings provide further insight into the regulatory mechanisms of cytokine-induced NF-kappa B activation. (C) 2014 Elsevier B.V. All rights reserved.	[Tsuchiya, Rieko; Tanaka, Toshiaki; Hozumi, Yasukazu; Nakano, Tomoyuki; Okada, Masashi; Goto, Kaoru] Yamagata Univ, Sch Med, Dept Anat & Cell Biol, Yamagata 9909585, Japan; [Tsuchiya, Rieko; Iino, Mitsuyoshi] Yamagata Univ, Sch Med, Dept Dent Oral & Maxillofacial Plast & Reconstruc, Yamagata 9909585, Japan; [Topham, Matthew K.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Goto, K (reprint author), Yamagata Univ, Sch Med, Dept Anat & Cell Biol, Iida Nishi 2-2-2, Yamagata 9909585, Japan.	kgoto@med.id.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (K.G.).	Ali H, 2004, NEUROSCI LETT, V372, P190, DOI 10.1016/j.neulet.2004.09.052; Hasegawa H, 2008, J CELL BIOCHEM, V105, P756, DOI 10.1002/jcb.21873; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Pasparakis M, 2006, CELL DEATH DIFFER, V13, P861, DOI 10.1038/sj.cdd.4401870; Goto K, 2007, INT REV CYTOL, V264, P25, DOI 10.1016/S0074-7696(07)64002-9; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Tanaka T, 2013, J CELL SCI, V126, P2785, DOI 10.1242/jcs.118711; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355; Scanga CA, 2002, J IMMUNOL, V168, P5997; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Ninomiya-Tsuji J, 1999, NATURE, V398, P252; Kai M, 2009, FEBS LETT, V583, P3265, DOI 10.1016/j.febslet.2009.09.017; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Topham MK, 1998, NATURE, V394, P697; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Matsui H, 2014, BBA-MOL CELL BIOL L, V1841, P1440, DOI 10.1016/j.bbalip.2014.07.007; Chan HM, 2001, J CELL SCI, V114, P2363; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Hozumi Y, 2003, EUR J NEUROSCI, V18, P1448, DOI 10.1046/j.1460-9568.2003.02871.x; GOTO K, 1992, MOL BRAIN RES, V16, P75, DOI 10.1016/0169-328X(92)90196-I; Shikama N, 1997, TRENDS CELL BIOL, V7, P230; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Baldi L, 1996, J BIOL CHEM, V271, P376; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Roff M, 1996, J BIOL CHEM, V271, P7844; Olenchock BA, 2006, J EXP MED, V203, P1471, DOI 10.1084/jem.20052424; Yanagisawa K, 2007, BBA-MOL CELL BIOL L, V1771, P462, DOI 10.1016/j.bbalip.2006.12.008; LIMATOLA C, 1994, BIOCHEM J, V304, P1001; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066; Bunting M, 1996, J BIOL CHEM, V271, P10230; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cipres A, 2003, J BIOL CHEM, V278, P35629, DOI 10.1074/jbc.M305635200; Evangelisti C, 2010, CELL CYCLE, V9, P384; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; Goto Kaoru, 2014, Adv Biol Regul, V54, P242; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Lieberman Linda A, 2002, Int Rev Immunol, V21, P373, DOI 10.1080/08830180213281; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Nakano T, 2012, J HISTOCHEM CYTOCHEM, V60, P130, DOI 10.1369/0022155411429154; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Okada M, 2011, EXP CELL RES, V317, P2853, DOI 10.1016/j.yexcr.2011.09.014; Okada M, 2012, CELL SIGNAL, V24, P1573, DOI 10.1016/j.cellsig.2012.03.021; Okada M, 2012, BIOCHEM BIOPH RES CO, V420, P479, DOI 10.1016/j.bbrc.2012.03.057; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Ravi R, 1998, CANCER RES, V58, P4531; Saino-Saito S, 2011, NEUROSCI LETT, V494, P185, DOI 10.1016/j.neulet.2011.02.062; Shirai Y, 2000, J BIOL CHEM, V275, P24760, DOI 10.1074/jbc.M003151200; Suzuki Y, 2012, HISTOCHEM CELL BIOL, V137, P499, DOI 10.1007/s00418-011-0907-y; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411	80	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	FEB	2015	1853	2					361	369		10.1016/j.bbamcr.2014.11.011		9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AZ9SD	WOS:000348554600010		
J	Guan, L; Shiiya, A; Hisatomi, S; Fujii, K; Nonaka, M; Harada, N				Guan, Ling; Shiiya, Ayaka; Hisatomi, Shihoko; Fujii, Kunihiko; Nonaka, Masanori; Harada, Naoki			Sulfate-reducing bacteria mediate thionation of diphenylarsinic acid under anaerobic conditions	BIODEGRADATION			English	Article						Anaerobic transformation; Desulfotomaculum acetoxidans; Diphenylarsinic acid; Diphenylthioarsinic acid; Sulfate-reducing bacteria; Thionation	CHEMICAL WARFARE AGENTS; DESULFOTOMACULUM-ACETOXIDANS; SOIL; TRANSFORMATION; DESULFOVIBRIO; SPECIATION; WATER; NOV.	Diphenylarsinic acid (DPAA) is often found as a toxic intermediate metabolite of diphenylchloroarsine or diphenylcyanoarsine that were produced as chemical warfare agents and were buried in soil after the World Wars. In our previous study Guan et al. (J Hazard Mater 241-242:355-362, 2012), after application of sulfate and carbon sources, anaerobic transformation of DPAA in soil was enhanced with the production of diphenylthioarsinic acid (DPTAA) as a main metabolite. This study aimed to isolate and characterize anaerobic soil microorganisms responsible for the metabolism of DPAA. First, we obtained four microbial consortia capable of transforming DPAA to DPTAA at a high transformation rate of more than 80 % after 4 weeks of incubation. Sequencing for the bacterial 16S rRNA gene clone libraries constructed from the consortia revealed that all the positive consortia contained Desulfotomaculum acetoxidans species. In contrast, the absence of dissimilatory sulfite reductase gene (dsrAB) which is unique to sulfate-reducing bacteria was confirmed in the negative consortia showing no DPAA reduction. Finally, strain DEA14 showing transformation of DPAA to DPTAA was isolated from one of the positive consortia. The isolate was assigned to D. acetoxidans based on the partial 16S rDNA sequence analysis. Thionation of DPAA was also carried out in a pure culture of a known sulfate-reducing bacterial strain, Desulfovibrio aerotolerans JCM 12613(T). These facts indicate that sulfate-reducing bacteria are microorganisms responsible for the transformation of DPAA to DPTAA under anaerobic conditions.	[Guan, Ling] Niigata Univ, Ctr Fostering Innovat Leadership, Nishi Ku, Niigata 9502181, Japan; [Guan, Ling; Shiiya, Ayaka; Hisatomi, Shihoko] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Guan, Ling; Nonaka, Masanori; Harada, Naoki] Niigata Univ, Inst Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Fujii, Kunihiko] Niigata Univ, Off Environm & Safety, Nishi Ku, Niigata 9502181, Japan	Harada, N (reprint author), Niigata Univ, Inst Sci & Technol, Nishi Ku, 2-8050 Ikarashi, Niigata 9502181, Japan.	naharada@agr.niigata-u.ac.jp			Japan Society for the Promotion of Science [22510083, 25340084]; Iijima Memorial Foundation for the Promotion of Food Science and Technology	This research was financed in part by the Grants-in-Aid for Scientific Research (No. 22510083 and 25340084) from the Japan Society for the Promotion of Science and the Iijima Memorial Foundation for the Promotion of Food Science and Technology. We thank the Field Center for Sustainable Agriculture and Forestry, Faculty of Agriculture, Niigata University, for providing soil samples.	Wada T, 2006, APPL ORGANOMET CHEM, V20, P573, DOI 10.1002/aoc.1109; Guan L, 2012, J HAZARD MATER, V241, P355, DOI 10.1016/j.jhazmat.2012.09.054; Harada N, 2010, BIODEGRADATION, V21, P491, DOI 10.1007/s10532-009-9318-3; Kohler M, 2001, CHEMOSPHERE, V42, P425, DOI 10.1016/S0045-6535(00)00060-6; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Newman DK, 1997, APPL ENVIRON MICROB, V63, P2022; Spring S, 2009, STAND GENOMIC SCI, V1, P242, DOI 10.4056/sigs.39508; Ishii K, 2004, ANN NEUROL, V56, P741, DOI 10.1002/ana.20290; Li YR, 2011, J HAZARD MATER, V188, P140, DOI 10.1016/j.jhazmat.2011.01.093; Song JH, 2008, J MICROBIOL BIOTECHN, V18, P1408; Hanaoka S, 2005, APPL ORGANOMET CHEM, V19, P265, DOI 10.1002/aoc.790; Groudev S, 2008, HYDROMETALLURGY, V94, P93, DOI 10.1016/j.hydromet.2008.05.023; Daus B, 2010, ENVIRON POLLUT, V158, P3439, DOI 10.1016/j.envpol.2010.06.029; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P1134; Ishizaki M, 2005, J HEALTH SCI, V51, P130, DOI 10.1248/jhs.51.130; WIDDEL F, 1977, ARCH MICROBIOL, V112, P119, DOI 10.1007/BF00446665; Arao T, 2009, ENVIRON SCI TECHNOL, V43, P1097, DOI 10.1021/es8023397; Baba K, 2008, ANAL CHEM, V80, P5768, DOI 10.1021/ac8002984; Bausinger T, 2005, B ENVIRON CONTAM TOX, V74, P1045, DOI 10.1007/s00128-005-0686-z; Buddhawong S, 2005, ENG LIFE SCI, V5, P247, DOI 10.1002/elsc.200520076; Duncan WFA, 2004, 5 INT S WAST PROC RE, P469; Garnaga G, 2006, ENVIRON POLLUT, V144, P855, DOI 10.1016/j.envpol.2006.02.013; Haas R, 1998, FRESEN J ANAL CHEM, V361, P313, DOI 10.1007/s002160050892; Hisatomi S, 2013, J HAZARD MATER, V262, P25, DOI 10.1016/j.jhazmat.2013.08.020; Maejima Y, 2011, J ENVIRON QUAL, V40, P76, DOI 10.2134/jeq2009.0496; Mogensen GL, 2005, ANAEROBE, V11, P339, DOI 10.1016/j.anaerobe.2005.04.002; Scholten JCM, 2000, MICROBIAL ECOL, V40, P292; Sierra-Alvarez R, 2006, J AGR FOOD CHEM, V54, P3959, DOI 10.1021/jf053223n; Singhakant C, 2009, J ENVIRON SCI HEAL A, V44, P163, DOI 10.1080/10934520802539780; TAYLOR BF, 1979, CURR MICROBIOL, V3, P101, DOI 10.1007/BF02602440; Wanger M, 1998, J BACTERIOL, V180, P2975; WIDDEL F, 1981, ARCH MICROBIOL, V129, P401, DOI 10.1007/BF00406471; WOOLSON EA, 1975, ADV CHEM SER, P97; Yamazaki K, 2008, FEMS MICROBIOL LETT, V286, P171, DOI 10.1111/j.1574-6968.2008.01271.x	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0923-9820	1572-9729		BIODEGRADATION	Biodegradation	FEB	2015	26	1					29	38		10.1007/s10532-014-9713-2		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AZ8DL	WOS:000348444900003		
J	Gan, KJ; Morihara, T; Silverman, MA				Gan, Kathlyn J.; Morihara, Takashi; Silverman, Michael A.			Atlas stumbled: Kinesin light chain-1 variant E triggers a vicious cycle of axonal transport disruption and amyloid-beta generation in Alzheimer's disease	BIOESSAYS			English	Article						alternative splicing; Alzheimer's disease; amyloid-beta; amyloid precursor protein; axonal transport; kinesin; kinesin light chain	GLYCOGEN-SYNTHASE KINASE-3; CULTURED HIPPOCAMPAL-NEURONS; PRECURSOR PROTEIN; ENDOPLASMIC-RETICULUM; NEURODEGENERATIVE DISEASES; SCAFFOLDING PROTEINS; SYNAPTIC PLASTICITY; SECRETORY GRANULES; TRANSFECTED CELLS; TRANSGENIC MICE	Substantial evidence implicates fast axonal transport (FAT) defects in neurodegeneration. In Alzheimer's disease (AD), it is controversial whether transport defects cause or arise from amyloid-beta (A beta)-induced toxicity. Using a novel, unbiased genetic screen, Morihara et al. identified kinesin light chain-1 splice variant E (KLC1vE) as a modifier of A beta accumulation. Here, we propose three mechanisms to explain this causal role. First, KLC1vE reduces APP transport, leading to A beta accumulation. Second, reduced transport of APP by KLC1vE triggers an ER stress response that activates the amyloidogenic pathway. Third, KLC1vE impairs transport of other KLC1 cargos that regulate amyloidogenesis, promoting Ab retention within the secretory pathway. Collectively, KLC1vE perpetuates a vicious cycle of A beta generation, kinase dysregulation, and global FAT impairment that inevitably leads to cellular toxicity. These concepts implicate alternative splicing of KLC1 in AD and suggest that the reciprocal influence of transport mechanisms on disease states contributes to neurodegeneration.	[Gan, Kathlyn J.; Silverman, Michael A.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Morihara, Takashi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Silverman, Michael A.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Silverman, Michael A.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	Morihara, T (reprint author), Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan.	morihara@psy.med.osaka-u.ac.jp; masilver@sfu.ca		Silverman, Michael A./0000-0001-6967-4917	C.D. Nelson Memorial Graduate Scholarship from Simon Fraser University; NSERC Postgraduate Scholarship; Japanese Society for Promotion of Science Long-Term Invitation Fellowship [L11710]	We thank V. Muresan, N. Kimura, and T.D. Williams for their critical reading of this manuscript, and M. Leroux and J. Provisor for assistance with the figures. K.J.G. is funded by a C.D. Nelson Memorial Graduate Scholarship from Simon Fraser University and an NSERC Postgraduate Scholarship. For initiating this work, M.A.S. thanks the Japanese Society for Promotion of Science Long-Term Invitation Fellowship (#L11710), and to Professor M. Takeda for his support.	Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; Lee S, 2011, CYTOSKELETON, V68, P8, DOI 10.1002/cm.20488; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Aplin AE, 1996, J NEUROCHEM, V67, P699; Gallagher JJ, 2012, NEUROIMAGE, V60, P1856, DOI 10.1016/j.neuroimage.2012.01.132; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Twomey C, 2006, FEBS LETT, V580, P4015, DOI 10.1016/j.febslet.2006.06.035; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Dumanchin C, 1998, HUM MOL GENET, V7, P1825, DOI 10.1093/hmg/7.11.1825; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Inoue T, 2011, REV NEUROSCIENCE, V22, P675, DOI 10.1515/RNS.2011.048; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Ari C, 2014, NEUROBIOL AGING, V35, P1839, DOI 10.1016/j.neurobiolaging.2014.02.006; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Ramser EM, 2013, MOL BIOL CELL, V24, P2494, DOI 10.1091/mbc.E12-12-0858; Maeder CI, 2014, CURR OPIN NEUROBIOL, V27, P165, DOI 10.1016/j.conb.2014.03.015; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x; Morihara T, 2014, P NATL ACAD SCI USA, V111, P2638, DOI 10.1073/pnas.1307345111; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Walter J, 1996, MOL MED, V2, P673; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Placido AI, 2014, BBA-MOL BASIS DIS, V1842, P1444, DOI 10.1016/j.bbadis.2014.05.003; McCart AE, 2003, TRAFFIC, V4, P576, DOI 10.1034/j.1600-0854.2003.00113.x; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Medina M, 2014, EXPERT OPIN THER TAR, V18, P69, DOI 10.1517/14728222.2013.843670; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Dikeakos JD, 2009, P NATL ACAD SCI USA, V106, P7408, DOI 10.1073/pnas.0809576106; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Weaver C, 2013, TRAFFIC, V14, P295, DOI 10.1111/tra.12037; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Pigino G, 2003, J NEUROSCI, V23, P4499; Fang C, 2014, NEUROBIOL DIS, V68, P78, DOI 10.1016/j.nbd.2014.04.013; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Perez DI, 2011, MED RES REV, V31, P924, DOI 10.1002/med.20207; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Borysov SI, 2011, CELL CYCLE, V10, P1397, DOI 10.4161/cc.10.9.15478; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Pernigo S, 2013, SCIENCE, V340, P356, DOI 10.1126/science.1234264; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Hinckelmann MV, 2013, TRENDS CELL BIOL, V23, P634, DOI 10.1016/j.tcb.2013.08.007; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Aplin AE, 1997, NEUROREPORT, V8, P639, DOI 10.1097/00001756-199702100-00012; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Fu MM, 2014, TRENDS CELL BIOL, V24, P564, DOI 10.1016/j.tcb.2014.05.002; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Goldstein LSB, 2012, PROG NEUROBIOL, V99, P186, DOI 10.1016/j.pneurobio.2012.03.006; Gyoeva FK, 2004, BIOCHEMISTRY-US, V43, P13525, DOI 10.1021/bi0492881; Handley MTW, 2007, J CELL SCI, V120, P973, DOI 10.1242/jcs.03406; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Hwang EM, 2006, BIOCHEM BIOPH RES CO, V349, P654, DOI 10.1016/j.bbrc.2006.08.077; Jiang ST, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-6; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kanai Y, 2000, J NEUROSCI, V20, P6374; Kavanagh T, 2013, J MOL NEUROSCI, V51, P28, DOI 10.1007/s12031-012-9940-0; Khodjakov A, 1998, MOL BIOL CELL, V9, P333; Killian RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029755; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; KULIAWAT R, 1994, J CELL BIOL, V126, P77, DOI 10.1083/jcb.126.1.77; Li JQ, 2015, MOL NEUROBIOL, V51, P383, DOI 10.1007/s12035-014-8695-8; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Minoshima S, 2008, EUR J NUCL MED MOL I, V35, pS89, DOI 10.1007/s00259-007-0707-8; Muresan V, 2012, NEURODEGENER DIS, V10, P60, DOI 10.1159/000332815; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; Pagani L., 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/925050; Pimenova AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087014; Reifert J, 2011, J BIOL CHEM, V286, P20797, DOI 10.1074/jbc.M111.234674; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Shaw JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003792; Stenoien DL, 1997, MOL BIOL CELL, V8, P675; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Tanahashi H, 2001, NEUROSCI LETT, V307, P9, DOI 10.1016/S0304-3940(01)01912-7; Terry RD, 1998, J NEURAL TRANSM-SUPP, P141; Wong YL, 2010, P NATL ACAD SCI USA, V107, P11781, DOI 10.1073/pnas.1005854107; Zhang Shuting, 2013, Transl Neurodegener, V2, P15, DOI 10.1186/2047-9158-2-15; Zhu HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033943	118	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	FEB	2015	37	2					131	141		10.1002/bies.201400131		11	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	AZ9AQ	WOS:000348504100006		
J	Himoto, T; Nomura, T; Tani, J; Miyoshi, H; Morishita, A; Yoneyama, H; Haba, R; Masugata, H; Masaki, T				Himoto, Takashi; Nomura, Takako; Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Haba, Reiji; Masugata, Hisashi; Masaki, Tsutomu			Exacerbation of Insulin Resistance and Hepatic Steatosis Deriving from Zinc Deficiency in Patients with HCV-Related Chronic Liver Disease	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						Hepatic steatosis; Hepatitis C virus; Insulin resistance; Iron overload; Lipid peroxidation; Zinc	ACTIVATED RECEPTOR-ALPHA; C VIRUS-INFECTION; LIPID-PEROXIDATION; IRON OVERLOAD; ANTIOXIDANT STATUS; VIRAL GENOTYPES; SUPPLEMENTATION; GLUTATHIONE; RIBAVIRIN; TISSUES	The role of zinc (Zn) in hepatic steatosis of patients with HCV-related chronic liver disease (CLD-C) remains uncertain, although persistent HCV infection often evokes hepatic steatosis. The primary purpose of this study was to elucidate the contribution of Zn deficiency to hepatic steatosis in patients with CLD-C. Fifty nondiabetic patients with CLD-C were enrolled. Hepatic 4-hydroxy-2-nonenal (4-HNE) expression was examined using an immunohistochemical procedure as a marker for lipid peroxidation. Serum ferritin levels were assessed for iron overload. Insulin resistance was evaluated using the values of the homeostasis model for assessment of insulin resistance (HOMA-IR). The severity of hepatic steatosis was graded on the classification system proposed by Brunt and colleagues. Serum Zn levels were inversely correlated with serum ferritin levels in the patients with CLD-C (r = -0.382, p = 0.0062). Serum ferritin levels were strongly associated with the HOMA-IR values (r = 0.476, p = 0.0005). Therefore, Zn deficiency resulted in insulin resistance through iron overload. Moreover, serum Zn levels were significantly decreased in proportion to the level of hepatic 4-HNE expression, which was enhanced as hepatic steatosis developed. Then, Zn deficiency eventually seemed to exacerbate hepatic steatosis by way of an increase in lipid peroxidation. However, the serum Zn levels were not associated with either loads of HCV-RNA or HCV genotypes. These data suggest that, in patients with CLD-C, Zn deficiency promotes insulin resistance by exacerbating iron overload in the liver and induces hepatic steatosis by facilitating lipid peroxidation.	[Himoto, Takashi] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa 7610123, Japan; [Nomura, Takako; Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Masaki, Tsutomu] Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan; [Haba, Reiji] Kagawa Univ, Sch Med, Dept Diag Pathol, Takamatsu, Kagawa 760, Japan; [Masugata, Hisashi] Kagawa Univ, Sch Med, Dept Integrated Med, Takamatsu, Kagawa 760, Japan	Himoto, T (reprint author), Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, 281-1 Mure Cho, Takamatsu, Kagawa 7610123, Japan.	himoto@chs.pref.kagawa.jp					FARINATI F, 1995, J HEPATOL, V22, P449, DOI 10.1016/0168-8278(95)80108-1; Reiterer G, 2004, J NUTR, V134, P1711; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Kassab-Chekir A, 2003, CLIN CHIM ACTA, V338, P79, DOI 10.1016/j.cccn.2003.07.010; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Macdonald GA, 2001, J GASTROEN HEPATOL, V16, P599, DOI 10.1046/j.1440-1746.2001.02445.x; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; MCCLAIN CJ, 1985, PROG FOOD NUTR SCI, V9, P185; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Hughes S, 2006, J AM COLL NUTR, V25, P285; Fartoux L, 2005, GUT, V54, P1003, DOI 10.1136/gut.2004.050302; Himoto T, 2010, EXP THER MED, V1, P707, DOI 10.3892/etm_00000109; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Ozturk A, 2003, BIOL TRACE ELEM RES, V94, P157, DOI 10.1385/BTER:94:2:157; Baltaci AK, 2012, BRATISL MED J, V113, P400, DOI 10.4149/BLL_2012_090; Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836; BODE JC, 1988, HEPATOLOGY, V8, P1605, DOI 10.1002/hep.1840080622; Dehshal MH, 2007, MED SCI MONITOR, V13, pCR235; Delima R, 2007, LIVER INT, V27, P4, DOI 10.1111/j.1478-3231.2006.01428.x; DiSilvestro RA, 2000, J NUTR, V130, p1509S; FLETCHER LM, 1989, GASTROENTEROLOGY, V97, P1011; GIMENEZ A, 1994, J HEPATOL, V21, P292, DOI 10.1016/S0168-8278(05)80304-6; Himoto T, 2011, NUTR RES, V31, P829, DOI 10.1016/j.nutres.2011.09.021; Himoto T, 2011, BIOL TRACE ELEM RES, V144, P133, DOI 10.1007/s12011-011-9049-2; Himoto T, 2013, NUTR RES, V33, P27, DOI 10.1016/j.nutres.2012.11.007; Himoto T, 2007, SCAND J GASTROENTERO, V42, P1078, DOI 10.1080/00365520701272409; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Kohgo Y, 2007, WORLD J GASTROENTERO, V13, P4699; Koike K, 2005, HEPATOL RES, V33, P145, DOI 10.1016/j.hepres.2005.09.023; Lange CM, 2012, HEPATOLOGY, V55, P1038, DOI 10.1002/hep.24787; LAU JYN, 1993, LANCET, V341, P1501, DOI 10.1016/0140-6736(93)90635-T; LIFSCHIT.MD, 1971, J APPL PHYSIOL, V31, P88; MCNALL AD, 1995, J NUTR, V125, P874; Mikhail T H, 1996, Boll Chim Farm, V135, P591; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; Moriyama M, 2006, DIGEST DIS SCI, V51, P1967, DOI 10.1007/s10620-005-9051-7; Sandres-Saune K, 2007, J MED VIROL, V79, P1821, DOI 10.1002/jmv.21003; Sebastiani G, 2006, J VIRAL HEPATITIS, V13, P199, DOI 10.1111/j.1365-2893.2005.00662.x; SHAHEEN AA, 1995, INT J BIOCHEM CELL B, V27, P89, DOI 10.1016/1357-2725(94)00053-0; Zhong W, 2013, PLOS ONE, V8, P1	47	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	FEB	2015	163	1-2					81	88		10.1007/s12011-014-0177-3		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AZ3EC	WOS:000348109500011		
J	Arai, S; Arora, M; Wang, T; Spellman, SR; He, W; Courie, DR; Urbano-Ispizua, A; Cutler, CS; Bacigalupo, AA; Battiwallaw, M; Flowers, ME; Juckett, MB; Lee, SJ; Loren, AW; Klumpp, TR; Prockup, SE; Ringden, OETH; Savani, BN; Socie, G; Schultz, KR; Spitzer, T; Teshima, T; Bredeson, CN; Jacobsohn, DA; Hayashi, RJ; Drobyski, WR; Frangoul, HA; Akpek, G; Ho, VT; Lewis, VA; Gale, RP; Koreth, J; Chao, NJ; Aljurf, MD; Cooper, BW; Laughlin, MJ; Hsu, JW; Hematti, P; Verdonck, LF; Solh, MM; Norkin, M; Reddy, V; Perez-Simon, JA; Khera, N; Lewis, ID; Atsuta, Y; Olsson, RF; Saber, W; Waller, EK; Blaise, D; Pidala, JA; Martin, PJ; Satwani, P; Bornhauser, M; Inamoto, Y; Weisdorf, DJ; Horowitz, MM; Pavletic, SZ				Arai, Sally; Arora, Mukta; Wang, Tao; Spellman, Stephen R.; He, Wensheng; Courie, Daniel R.; Urbano-Ispizua, Alvaro; Cutler, Corey S.; Bacigalupo, Andrea A.; Battiwallaw, Minoo; Flowers, Mary E.; Juckett, Mark B.; Lee, Stephanie J.; Loren, Alison W.; Klumpp, Thomas R.; Prockup, Susan E.; Ringden, Olle E. T. H.; Savani, Bipin N.; Socie, Gerard; Schultz, Kirk R.; Spitzer, Thomas; Teshima, Takanori; Bredeson, Christopher N.; Jacobsohn, David A.; Hayashi, Robert J.; Drobyski, William R.; Frangoul, Haydar A.; Akpek, Gorgiin; Ho, Vincent T.; Lewis, Victor A.; Gale, Robert Peter; Koreth, John; Chao, Nelson J.; Aljurf, Mahmoud D.; Cooper, Brenda W.; Laughlin, Mary J.; Hsu, Jack W.; Hematti, Peiman; Verdonck, Leo F.; Solh, Melhelm M.; Norkin, Maxim; Reddy, Vijay; Perez-Simon, Jose A.; Khera, Nandita; Lewis, Ian D.; Atsuta, Yoshiko; Olsson, Richard F.; Saber, Wael; Waller, Edmund K.; Blaise, Didier; Pidala, Joseph A.; Martin, Paul J.; Satwani, Prakash; Bornhauser, Martin; Inamoto, Yoshihiro; Weisdorf, Daniel J.; Horowitz, Mary M.; Pavletic, Steven Z.		Graft-Vs-Host Dis Working Comm CIB	Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Incidence; cGVHD; Allogeneic transplant; Nonrelapse mortality	HEMATOPOIETIC-CELL TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; BONE-MARROW; UNRELATED DONORS; STEM-CELL; REDUCED-INTENSITY; CLINICAL-TRIALS; COMPETING RISKS; SINGLE-CENTER	Although transplant practices have changed over the last decades, no information is available on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) over time. This study used the central database of the Center for International Blood and Marrow Transplant Research (CIBMTR) to describe time trends for cGVHD incidence, nonrelapse mortality, and risk factors for cGVHD. The 12-year period was divided into 3 intervals, 1995 to 1999, 2000 to 2003, and 2004 to 2007, and included 26,563 patients with acute leukemia, chronic myeloid leukemia, and myelodysplastic syndrome. Multivariate analysis showed an increased incidence of cGVHD in more recent years (odds ratio = 1.19, P <.0001), and this trend was still seen when adjusting for donor type, graft type, or conditioning intensity. In patients with cGVHD, nonrelapse mortality has decreased over time, but at 5 years there were no significant differences among different time periods. Risk factors for cGVHD were in line with previous studies. This is the first comprehensive characterization of the trends in cGVHD incidence and underscores the mounting need for addressing this major late complication of transplantation in future research. (C) 2015 American Society for Blood and Marrow Transplantation.	[Arai, Sally; Arora, Mukta; Wang, Tao] Stanford Univ, Med Ctr, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Arora, Mukta] Univ Minnesota, Med Ctr, Div Hematol Oncol & Transplant, Minneapolis, MN 55455 USA; [Wang, Tao] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Dept Med, Milwaukee, WI 53226 USA; [Wang, Tao] Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA; [Spellman, Stephen R.] Ctr Int Blood & Marrow Transplant Res, Natl Marrow Donor Program, Minneapolis, MN USA; [He, Wensheng; Loren, Alison W.] Univ Michigan, Div Hematol Oncol, Ann Arbor, MI USA; [Loren, Alison W.; Spitzer, Thomas] Hosp Clin Barcelona, Div Hematol Oncol, Barcelona, Spain; [Socie, Gerard; Bredeson, Christopher N.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Teshima, Takanori; Waller, Edmund K.] IRCCS AOU San Martino IST, Dept Hematol, Genoa, Italy; [Loren, Alison W.; Hematti, Peiman; Satwani, Prakash] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [Koreth, John; Norkin, Maxim] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Koreth, John; Perez-Simon, Jose A.] Univ Washington, Seattle, WA 98195 USA; [Aljurf, Mahmoud D.; Cooper, Brenda W.; Laughlin, Mary J.] Univ Wisconsin, Hosp & Clin, Dept Med, Div Hematol Oncol Bone Marrow Transplantat, Madison, WI 53792 USA; [Hematti, Peiman; Verdonck, Leo F.; Solh, Melhelm M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Hematti, Peiman; Solh, Melhelm M.; Norkin, Maxim] Univ Penn, Med Ctr, Abramson Canc Ctr, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Reddy, Vijay; Perez-Simon, Jose A.; Khera, Nandita] Temple Bone Marrow Transplant Program, Div Bone Marrow Transplantat, Philadelphia, PA USA; [Lewis, Ian D.; Atsuta, Yoshiko; Olsson, Richard F.] Mem Sloan Kettering Canc Ctr, Dept Pediat, Div Bone Marrow Transplant, New York, NY 10021 USA; [Saber, Wael; Waller, Edmund K.; Blaise, Didier] Karolinska Univ Hosp, Div Clin Immunol, Stockholm, Sweden; [Saber, Wael; Waller, Edmund K.; Blaise, Didier] Karolinska Univ Hosp, Ctr Allogene Stem Cell Transplantat, Stockholm, Sweden; [Pidala, Joseph A.; Martin, Paul J.; Satwani, Prakash] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37235 USA; [Martin, Paul J.] Hop St Louis, Div Hematol, Paris, France; [Satwani, Prakash; Bornhauser, Martin] Univ British Columbia, British Columbias Childrens Hosp, Dept Pediat Hematol Oncol BMT, Vancouver, BC V5Z 1M9, Canada; [Bornhauser, Martin; Inamoto, Yoshihiro] Massachusetts Gen Hosp, Dept Bone Marrow Transplant Oncol, Boston, MA 02114 USA; [Inamoto, Yoshihiro; Weisdorf, Daniel J.] Kyushu Univ Hosp, Fukuoka 812, Japan; [Horowitz, Mary M.] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [Horowitz, Mary M.; Pavletic, Steven Z.] Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Div Blood & Marrow Transplantat, Washington, DC USA; [Pavletic, Steven Z.; Graft-Vs-Host Dis Working Comm CIB] Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO USA	Pavletic, SZ (reprint author), NCI, Ctr Canc Res, Expt Transplantat & Immunol Branch, NIH, 9000 Rockville Pike,Bldg 10 CRC,Room 3E-3330, Bethesda, MD 20892 USA.	pavletis@mail.nih.gov		Olsson, Richard/0000-0001-5970-2128	National Cancer Institute (NCI) [U24-CA76518]; National Heart, Lung, and Blood Institute (NHLBI) [U24-CA76518]; National Institute of Allergy and Infectious Diseases (NIAID) [U24-CA76518]; NHLBI [5U01HL069294]; NCI; Health Resources and Services Administration [HHSH234200637015C]; Office of Naval Research [N00014-06-1-0704, N00014-08-1-0058]; Allos, Inc.; Amgen, Inc.; Angioblast; Anonymous donation to the Medical College of Wisconsin; Ariad; Be The Match Foundation; Blue Cross and Blue Shield Association; Buchanan Family Foundation; CaridianBCT; Celgene Corporation; CellGenix, GmbH; Fresenius-Biotech North America, Inc.; Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; Genzyme Corporation; GlaxoSmithKline; HistoGenetics, Inc.; Kiadis Pharma; Medical College of Wisconsin; Merck 82 Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; RemedyMD; Sanofi; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; Tarix Pharmaceuticals; Teva Neuroscience, Inc.; Therakos; WellPoint The views expressed in this article do not reflect the official policy or position of the NIH; Department of the Navy; Department of Defense, or any other agency of the U.S. Government	The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute (NCI), the National Heart, Lung, and Blood Institute (NHLBI) (U24-CA76518), and the National Institute of Allergy and Infectious Diseases (NIAID) (U24-CA76518); Grant/Cooperative Agreement 5U01HL069294 from the NHLBI and NCI; contract HHSH234200637015C with Health Resources and Services Administration; 2 grants (N00014-06-1-0704 and N00014-08-1-0058) from the Office of Naval Research; and grants from Allos, Inc.; Amgen, Inc.; Angioblast; Anonymous donation to the Medical College of Wisconsin; Ariad; Be The Match Foundation; Blue Cross and Blue Shield Association; Buchanan Family Foundation; CaridianBCT; Celgene Corporation; CellGenix, GmbH; Fresenius-Biotech North America, Inc.; Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc.; Genzyme Corporation; GlaxoSmithKline; HistoGenetics, Inc.; Kiadis Pharma; The Medical College of Wisconsin; Merck 82 Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; RemedyMD; Sanofi; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; Tarix Pharmaceuticals; Teva Neuroscience, Inc.; Therakos; and WellPoint The views expressed in this article do not reflect the official policy or position of the NIH, the Department of the Navy, the Department of Defense, or any other agency of the U.S. Government.	Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Hahn T, 2013, J CLIN ONCOL, V31, P2437, DOI 10.1200/JCO.2012.46.6193; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; Arora M, 2009, BONE MARROW TRANSPL, V43, P149, DOI 10.1038/bmt.2008.305; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Couriel DR, 2004, BIOL BLOOD MARROW TR, V10, P178, DOI 10.1016/j.bbmt.2003.10.006; Weisdorf D, 2012, BIOL BLOOD MARROW TR, V18, P1727, DOI 10.1016/j.bbmt.2012.06.014; Cutler C, 2001, J CLIN ONCOL, V19, P3685; Devine SM, 2011, BIOL BLOOD MARROW TR, V17, P1343, DOI 10.1016/j.bbmt.2011.02.002; Bar M, 2013, BIOL BLOOD MARROW TR, V19, P949, DOI 10.1016/j.bbmt.2013.03.001; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P215, DOI 10.1053/bbmt.2003.50026; Klein JP, 2005, BIOMETRICS, V61, P223, DOI 10.1111/j.0006-341X.2005.031209.x; Remberger M, 2011, BIOL BLOOD MARROW TR, V17, P1688, DOI 10.1016/j.bbmt.2011.05.001; Martin PJ, 2006, BIOL BLOOD MARROW TR, V12, P491, DOI 10.1016/j.bbmt.2006.03.004; Remberger M, 2005, BLOOD, V105, P548, DOI 10.1182/blood-2004-03-1000; Lee SJ, 2002, BLOOD, V100, P406, DOI 10.1182/blood.V100.2.406; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; Arora M, 2011, BLOOD, V117, P6714, DOI 10.1182/blood-2010-12-323824; Weisdorf D, 2008, BIOL BLOOD MARROW TR, V14, P748, DOI 10.1016/j.bbmt.2008.04.003; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Ringden O, 2002, J CLIN ONCOL, V20, P4655, DOI 10.1200/JCO.2002.12.049; Carlens S, 1998, BONE MARROW TRANSPL, V22, P755, DOI 10.1038/sj.bmt.1701423; Aoudjhane M, 2005, LEUKEMIA, V19, P2304, DOI 10.1038/sj.leu.2403967; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Luger S, 2002, BONE MARROW TRANSPL, V30, P199, DOI 10.1038/sj.bmt.1703610; Malladi RK, 2009, BONE MARROW TRANSPL, V43, P709, DOI 10.1038/bmt.2008.375; RINGDEN O, 1985, EXP HEMATOL, V13, P1062; Subramaniam DS, 2007, LEUKEMIA, V21, P853, DOI 10.1038/sj.leu.2404642	32	6	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2					266	274		10.1016/j.bbmt.2014.10.021		9	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UW	WOS:000348632700009		
J	Kanda, J; Ichinohe, T; Fuji, S; Maeda, Y; Ohashi, K; Fukuda, T; Miyamura, K; Iwato, K; Eto, T; Nakamae, H; Kobayashi, N; Mori, T; Mori, SI; Morishima, Y; Atsuta, Y; Kanda, Y				Kanda, Junya; Ichinohe, Tatsuo; Fuji, Shigeo; Maeda, Yoshinobu; Ohashi, Kazuteru; Fukuda, Takahiro; Miyamura, Koichi; Iwato, Koji; Eto, Tetsuya; Nakamae, Hirohisa; Kobayashi, Naoki; Mori, Takehiko; Mori, Shin-ichiro; Morishima, Yasuo; Atsuta, Yoshiko; Kanda, Yoshinobu		HLA Working Grp Japan Soc Hematopo	Impact of HLA Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the Japan Society for Hematopoietic Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						Donor selection; HLA mismatch; GVHD; Overall survival; Graft-versus-host direction; Host-versus-graft direction	VERSUS-HOST-DISEASE; CORD BLOOD TRANSPLANTATION; ALLELE MISMATCH; HIGH-RISK; IDENTICAL SIBLINGS; DONORS; LEUKEMIA; SURVIVAL; COMPATIBILITY; COMBINATIONS	The relative desirability of an unrelated donor with a bidirectional 1-locus mismatch (1MM-Bi), a 1-locus mismatch only in the graft-versus-host direction (1MM-GVH), or a 1-locus mismatch only in the host-versus-graft direction (1MM-HVG) is not yet clear. We analyzed adult patients with leukemia or myelodys-plastic syndrome who received a first allogeneic stem cell transplant from an HLA-A, -B, -C, and -DRB1 matched or 1-allele mismatched unrelated donor in Japan. The effects of 1MM-Bi (n = 1020), 1MM-GVH (n = 83), and 1MM-HVG (n = 83) compared with a zero mismatch (0MM) (n = 2570) were analyzed after adjusting for other significant variables. The risk of grades III to IV acute graft-versus-host disease (GVHD) was higher with marginal significance in the 1MM-GVH group than in the 0MM group (hazard ratio, 1.85; P = .014). However, there was no significant difference in overall or nonrelapse mortality between the 1MM-GVH and 0MM groups. There was no significant difference in acute GVHD or overall or nonrelapse mortality between the 1MM-HVG and 0MM groups. The risks of acute GVHD and overall mortality were significantly higher in the 1MM-Bi group than in the 0MM group. These findings indicate that unrelated donors with 1MM-GVH and 1MM-HVG are both good candidates for patients without an HLA-matched unrelated donor in a Japanese cohort. (C) 2015 American Society for Blood and Marrow Transplantation.	[Kanda, Junya; Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama 3308503, Japan; [Ichinohe, Tatsuo] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan; [Fuji, Shigeo; Fukuda, Takahiro] Natl Canc Ctr, Stem Cell Transplantat Div, Tokyo, Japan; [Maeda, Yoshinobu] Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Hematol & Oncol, Okayama, Japan; [Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Iwato, Koji] Hiroshima Red Cross & Atom Bomb Survivors Hosp, Dept Blood Transfus, Hiroshima, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Nakamae, Hirohisa] Osaka City Univ, Grad Sch Med, Dept Hematol, Osaka 558, Japan; [Kobayashi, Naoki] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan; [Mori, Takehiko] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Mori, Shin-ichiro] St Lukes Int Hosp, Dept Hematol Oncol, Tokyo, Japan; [Morishima, Yasuo] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Kanda, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	ycanda-tky@umin.ac.jp			Japan Leukemia Research Fund	Financial disclosure: This work was supported in part by the Japan Leukemia Research Fund (to J.K.).	ANASETTI C, 1989, NEW ENGL J MED, V320, P197, DOI 10.1056/NEJM198901263200401; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Kanda Y, 2003, BLOOD, V102, P1541, DOI 10.1182/blood-2003-02-0430; Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Schetelig J, 2008, J CLIN ONCOL, V26, P5183, DOI 10.1200/JCO.2007.15.5184; Hahn T, 2013, J CLIN ONCOL, V31, P2437, DOI 10.1200/JCO.2012.46.6193; Kanda Y, 2013, BRIT J HAEMATOL, V161, P566, DOI 10.1111/bjh.12279; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; ANASETTI C, 1990, HUM IMMUNOL, V29, P79, DOI 10.1016/0198-8859(90)90071-V; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Oh H, 2005, BLOOD, V105, P1408, DOI 10.1182/blood-2004-06-2385; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Hurley CK, 2013, BLOOD, V121, P4800, DOI 10.1182/blood-2013-01-480343; Ciurea SO, 2009, TRANSPLANTATION, V88, P1019, DOI 10.1097/TP.0b013e3181b9d710; Takanashi M, 2010, BLOOD, V116, P2839, DOI 10.1182/blood-2009-10-249219; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Yoshihara S, 2012, BONE MARROW TRANSPL, V47, P508, DOI 10.1038/bmt.2011.131; Morishima Y, 2002, BLOOD, V99, P4200, DOI 10.1182/blood.V99.11.4200; Yakoub-Agha I, 2006, J CLIN ONCOL, V24, P5695, DOI 10.1200/JCO.2006.08.0952; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Fine JP, 1999, J AM STAT ASSOC, V94, P456; Inamoto Y, 2007, INT J HEMATOL, V85, P163, DOI 10.1532/IJH97.06183; Kanda J, 2013, INT J HEMATOL, V98, P300, DOI 10.1007/s12185-013-1405-x; Kanda J, 2013, BIOL BLOOD MARROW TR, V19, P247, DOI 10.1016/j.bbmt.2012.09.017; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kanda Y, 2014, BIOL BLOOD MARROW TR, V20, P526, DOI 10.1016/j.bbmt.2014.01.003; Kuwatsuka Y, 2014, BIOL BLOOD MARROW TR, V20, P662, DOI 10.1016/j.bbmt.2014.01.020; Morishima Y, 2007, BIOL BLOOD MARROW TR, V13, P315, DOI 10.1016/j.bbmt.2006.10.027; Morishima Y, 2013, BIOL BLOOD MARROW TR, V19, P1197, DOI 10.1016/j.bbmt.2013.05.020; Stevens CE, 2011, BLOOD, V118, P3969, DOI 10.1182/blood-2010-11-317271	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2					305	311		10.1016/j.bbmt.2014.10.015		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UW	WOS:000348632700015		
J	Kawashima, N; Ito, Y; Sekiya, Y; Narita, A; Okuno, Y; Muramatsu, H; Irie, M; Hama, A; Takahashi, Y; Kojima, S				Kawashima, Nozomu; Ito, Yoshinori; Sekiya, Yuko; Narita, Atsushi; Okuno, Yusuke; Muramatsu, Hideki; Irie, Masahiro; Hama, Asahito; Takahashi, Yoshiyuki; Kojima, Seiji			Choreito Formula for BK Virus-associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION			English	Article						BK virus; Hemorrhagic cystitis; Pediatric; Choreito; Kampo medicine	BONE-MARROW-TRANSPLANTATION; HYPERBARIC-OXYGEN THERAPY; CLINICAL EFFECTIVENESS; PEDIATRIC-PATIENTS; CHILDREN; MANAGEMENT; POLYOMAVIRUS; RECIPIENTS; INFECTION; CIDOFOVIR	Therapy for BK virus (BKV) associated hemorrhagic cystitis (BKV-HC) is limited after hematopoietic stem cell transplantation (HSCT). We examined whether choreito, a formula from Japanese traditional Kampo medicine, is effective for treating BKV-HC. Among children who underwent allogeneic HSCT between October 2006 and March 2014, 14 were diagnosed with BKV-HC (median, 36 days; range, 14 to 330 days) after HSCT, and 6 consecutive children received pharmaceutical-grade choreito extract granules. The hematuria grade before treatment was significantly higher in the choreito group than in the nonchoreito group (P = .018). The duration from therapy to complete resolution was significantly shorter in the choreito group (median, 9 days; range, 4 to 17 days) than in the nonchoreito group (median, 17 days; range, 15 to 66 days; P = .037). In 11 children with macroscopic hematuria, the duration from treatment to resolution of macroscopic hematuria was significantly shorter in the choreito group than in the nonchoreito group (median, 2 days versus 11 days; P = .0043). The BIN load in urine was significantly decreased 1 month after choreito administration. No adverse effects related to choreito administration were observed. Choreito may be a safe and considerably promising therapy for the hemostasis of BKV-HC after HSCT. (C) 2015 American Society for Blood and Marrow Transplantation.	[Kawashima, Nozomu; Ito, Yoshinori; Sekiya, Yuko; Narita, Atsushi; Okuno, Yusuke; Muramatsu, Hideki; Irie, Masahiro; Hama, Asahito; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4668550, Japan	Kojima, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kojimas@med.nagoya-u.ac.jp	Muramatsu, Hideki/I-3763-2012		Sanofi K.K	Financial disclosure: Dr. Seiji Kojima received a research grant from Sanofi K.K. The other authors have no conflicts of interest to disclose.	Oshrine B, 2013, BIOL BLOOD MARROW TR, V19, P1702, DOI 10.1016/j.bbmt.2013.09.007; Drew RJ, 2013, TRANSPL INFECT DIS, V15, P276, DOI 10.1111/tid.12066; Zhao YY, 2011, J PHARM PHARMACOL, V63, P1581, DOI 10.1111/j.2042-7158.2011.01361.x; Cesaro S, 2008, BONE MARROW TRANSPL, V41, P363, DOI 10.1038/sj.bmt.1705909; Gorczynska E, 2005, BIOL BLOOD MARROW TR, V11, P797, DOI 10.1016/j.bbmt.2005.06.007; Kwon HJ, 2013, TRANSPL INFECT DIS, V15, P569, DOI 10.1111/tid.12136; Gilis L, 2014, BONE MARROW TRANSPL, V49, P664, DOI 10.1038/bmt.2013.235; Hale GA, 2003, BIOL BLOOD MARROW TR, V9, P698, DOI 10.1016/S1083-8791(03)00269-6; Cesaro S, 2009, CLIN INFECT DIS, V49, P233, DOI 10.1086/599829; Decker DB, 2009, J PEDIATR UROL, V5, P254, DOI 10.1016/j.jpurol.2009.02.199; DROLLER MJ, 1982, J UROLOGY, V128, P1385; Funahashi Y, 2010, J CLIN MICROBIOL, V48, P825, DOI 10.1128/JCM.01699-09; Haines HL, 2011, BIOL BLOOD MARROW TR, V17, P1512, DOI 10.1016/j.bbmt.2011.02.012; Harkensee C, 2008, BRIT J HAEMATOL, V142, P717, DOI 10.1111/j.1365-2141.2008.07254.x; Hassan Z, 2011, PEDIATR TRANSPLANT, V15, P348, DOI 10.1111/j.1399-3046.2011.01505.x; Horii A, 1988, Hinyokika Kiyo, V34, P2237; Kawashima N, 2012, PHYTOMEDICINE, V19, P1143, DOI 10.1016/j.phymed.2012.06.012; Kloos RQH, 2013, BIOL BLOOD MARROW TR, V19, P1263, DOI 10.1016/j.bbmt.2013.05.014; Laskin BL, 2013, BIOL BLOOD MARROW TR, V19, P1175, DOI 10.1016/j.bbmt.2013.05.002; Lee YJ, 2014, BIOL BLOOD MARROW TR, V20, P1204, DOI 10.1016/j.bbmt.2014.04.017; Li RM, 2013, VIROLOGY, V440, P41, DOI 10.1016/j.virol.2013.01.024; Megged O, 2011, J PEDIAT HEMATOL ONC, V33, P190, DOI 10.1097/MPH.0b013e3181fce388; Savva-Bordalo J, 2012, BONE MARROW TRANSPL, V47, P1095, DOI 10.1038/bmt.2011.228; Wada S, 2001, JPN J ENDOUROL ESWL, V14, P155; Zama D, 2013, PEDIATR TRANSPLANT, V17, P86, DOI 10.1111/petr.12031; Zaman RA, 2014, TRANSPLANTATION, V97, P1166, DOI 10.1097/01.TP.0000441825.72639.4f	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1083-8791	1523-6536		BIOL BLOOD MARROW TR	Biol. Blood Marrow Transplant.	FEB	2015	21	2					319	325		10.1016/j.bbmt.2014.10.018		7	Hematology; Immunology; Transplantation	Hematology; Immunology; Transplantation	CA0UW	WOS:000348632700017		
J	Yoshida, T				Yoshida, Toshiaki			4-Methoxymethyl-2,3,5,6-tetrafluorobenzyl alcohol as a urinary biomarker for monitoring of metofluthrin, a fluorine-containing pyrethroid, in exposed rats	BIOMARKERS			English	Article						Biomonitoring; metabolism; mosquito repellent; toxicokinetics; urine	GAS CHROMATOGRAPHY/MASS SPECTROMETRY; EXCRETION KINETICS; SPATIAL REPELLENCY; AGRICULTURAL AREA; URBAN-POPULATION; NORTHERN POLAND; PREGNANT-WOMEN; AEDES-AEGYPTI; LIVER-TUMORS; METABOLITES	Context: A fluorine-containing pyrethroid metofluthrin is widely used recently in mosquito repellents. Objective: The urinary excretion kinetics of its metabolites was evaluated in rats to establish an optimal biomarker for monitoring metofluthrin exposure of the general population. Methods and results: After metofluthrin had been administered intraperitoneally to rats, the urinary excretion kinetics of the major metofluthrin metabolites was evaluated by moment analysis. The urinary excretion amounts of 4-methoxymethyl-2,3,5,6-tetrafluorobenzyl alcohol were estimated to be proportional to the absorption amounts over a wide exposure range. Conclusion: Urinary 4-methoxymethyl-2,3,5,6-tetrafluorobenzyl alcohol was considered to be an optimal biomarker for metofluthrin exposure.	Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 5370025, Japan	Yoshida, T (reprint author), Osaka Prefectural Inst Publ Hlth, Higashinari Ku, 1-3-69 Nakamichi, Osaka 5370025, Japan.	tsyosida@iph.pref.osaka.jp			Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [26460820]	This work was conducted in part with research funds (Grant No. 26460820) from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government.	Achee N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-300; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; Ujihara K, 2004, BIOSCI BIOTECH BIOCH, V68, P170, DOI 10.1271/bbb.68.170; Barr DB, 2010, ENVIRON HEALTH PERSP, V118, P742, DOI 10.1289/ehp.0901275; Dewailly E, 2014, ENVIRON INT, V63, P201, DOI 10.1016/j.envint.2013.11.014; Couture C, 2009, J OCCUP ENVIRON HYG, V6, P341, DOI 10.1080/15459620902850907; Kaneko H, 2011, J AGR FOOD CHEM, V59, P2786, DOI 10.1021/jf102567z; Fortin MC, 2008, ENVIRON RES, V107, P343, DOI 10.1016/j.envres.2008.03.002; Deguchi Y, 2009, TOXICOL SCI, V108, P69, DOI 10.1093/toxsci/kfp006; Qi XJ, 2012, INT J HYG ENVIR HEAL, V215, P487, DOI 10.1016/j.ijheh.2011.12.003; Wielgomas B, 2013, INT J HYG ENVIR HEAL, V216, P295, DOI 10.1016/j.ijheh.2012.09.001; Wielgomas B, 2013, CHEMOSPHERE, V93, P2547, DOI 10.1016/j.chemosphere.2013.09.070; California Environmental Protection Agency (EPA) Department of Pesticide Regulation Medical Toxicology Branch, 2006, SUMM TOX DAT MET CHE; Heudorf U, 2001, ENVIRON HEALTH PERSP, V109, P213, DOI 10.2307/3434687; Hirose Y, 2009, TOXICOLOGY, V258, P64, DOI 10.1016/j.tox.2009.01.007; Kawada H, 2006, AM J TROP MED HYG, V75, P1153; Matsuo N, 2005, SUMITOMO KAGAKU, V2005-II, P4; Sarikaya R, 2013, CHEMOSPHERE, V93, P238, DOI 10.1016/j.chemosphere.2013.04.072; Tomigahara Y, 2005, 30 ANN M PEST SCI SO, P95; Wu CH, 2013, CHEMOSPHERE, V90, P2705, DOI 10.1016/j.chemosphere.2012.11.050; Yamada T, 2009, TOXICOL SCI, V108, P59, DOI 10.1093/toxsci/kfp007; Yoshida T, 2009, J CHROMATOGR A, V1216, P5069, DOI 10.1016/j.chroma.2009.04.087; Yoshida T, 2014, ENVIRON TOXICOL PHAR, V37, P1123, DOI 10.1016/j.etap.2014.03.019; Yoshida T, 2012, TOXICOL ENVIRON CHEM, V94, P1789, DOI 10.1080/02772248.2012.729838; Yoshida T, 2014, ENVIRON TOXICOL PHAR, V37, P103, DOI 10.1016/j.etap.2013.11.011; Yoshida T, 2013, J CHROMATOGR B, V913, P77, DOI 10.1016/j.jchromb.2012.11.025	26	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-750X	1366-5804		BIOMARKERS	Biomarkers	FEB	2015	20	1					71	76		10.3109/1354750X.2014.992814		6	Biotechnology & Applied Microbiology; Toxicology	Biotechnology & Applied Microbiology; Toxicology	AZ7AC	WOS:000348369500011		
J	Kamiya, K; Shimizu, K; Kobashi, H; Igarashi, A; Komatsu, M; Nakamura, A; Kojima, T; Nakamura, T				Kamiya, Kazutaka; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito; Komatsu, Mari; Nakamura, Akio; Kojima, Takashi; Nakamura, Tomoaki			Three-year follow-up of posterior chamber toric phakic intraocular lens implantation for the correction of high myopic astigmatism in eyes with keratoconus	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							COLLAGEN CROSS-LINKING; ICL IMPLANTATION; COLLAMER LENS; REFRACTIVE SURGERY; IRIS-CLAW; REASONS; ERRORS	Aim To assess the clinical outcomes following the use of toric implantable collamer lenses (toric ICL, STAAR Surgical) for the correction of high myopic astigmatism with keratoconus. Methods This retrospective study evaluated 21 eyes of 11 patients with spherical equivalents of -9.70 +/- 2.33 D (mean +/- SD) and astigmatism of -3.21 +/- 1.56 D who underwent toric ICL implantation for keratoconus. Preoperatively, and at 1, 3 and 6 months and 1, 2 and 3 years postoperatively, we assessed the safety, efficacy, predictability, stability and adverse events of the surgery. Results The logarithm of the minimum angle of resolution (logMAR) uncorrected distance visual acuity (UDVA) and the logMAR corrected distance visual acuity (CDVA) were -0.06 +/- 0.11 and -0.12 +/- 0.09, respectively, at 3 years postoperatively. At 3 years, 67% and 86% of the eyes were within +/- 0.5 and +/- 1.0 D, respectively, of the targeted correction. Manifest refraction changes of 0.04 +/- 0.33 D occurred from 1 month to 3 years postoperatively. No significant change in manifest refraction (analysis of variance, p=0.989) or keratometry (p=0.951), or visionthreatening complications occurred during the observation period. Conclusions Toric ICL implantation is beneficial according to measures of safety, efficacy, predictability and stability for the correction of refractive errors for keratoconus during a 3-year observation period. The disease did not progress even in the late-postoperative period, suggesting the viability of this procedure as a surgical option for the treatment of such eyes.	[Kamiya, Kazutaka; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito] Kitasato Univ, Dept Ophthalmol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Komatsu, Mari] Sanno Hosp, Tokyo, Japan; [Nakamura, Akio] Nakamura Eye Clin, Ibaraki, Japan; [Kojima, Takashi; Nakamura, Tomoaki] Nagoya Eye Clin, Nagoya, Aichi, Japan	Kamiya, K (reprint author), Kitasato Univ, Dept Ophthalmol, Sch Med, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	kamiyak-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24592642]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24592642).	Alfonso JF, 2010, J CATARACT REFR SURG, V36, P906, DOI 10.1016/j.jcrs.2009.11.032; Alfonso JF, 2008, J REFRACT SURG, V24, P867; Ali M, 2014, CORNEA, V33, P470, DOI 10.1097/ICO.0000000000000088; Alio JL, 2014, J CATARACT REFR SURG, V40, P383, DOI 10.1016/j.jcrs.2013.07.052; Park S, 2013, BIOMED CHROMATOGR, V27, P27, DOI 10.1002/bmc.2743; Pinero DP, 2010, INVEST OPHTH VIS SCI, V51, P1948, DOI 10.1167/iovs.09-4177; Guell JL, 2012, J CATARACT REFR SURG, V38, P475, DOI 10.1016/j.jcrs.2011.10.031; Kirwan C, 2008, OPHTHALMOLOGICA, V222, P334, DOI 10.1159/000145333; Izquierdo L, 2011, J REFRACT SURG, V27, P482, DOI 10.3928/1081597X-20101223-02; Fadlallah A, 2013, J REFRACT SURG, V29, P84, DOI 10.3928/1081597X-20130117-01; Coskunseven E, 2007, AM J OPHTHALMOL, V144, P387, DOI 10.1016/j.ajo.2007.05.035; Ortiz D, 2007, J CATARACT REFR SURG, V33, P1371, DOI 10.1016/j.jcrs.2007.04.021; Budo C, 2005, J REFRACT SURG, V21, P218; Dirani A, 2014, EUR J OPHTHALMOL, V24, P338, DOI 10.5301/ejo.5000384; Hashemian SJ, 2013, CLIN EXP OPTOM, V96, P225, DOI 10.1111/j.1444-0938.2012.00800.x; Hori-Komai Y, 2002, J CATARACT REFR SURG, V28, P795, DOI 10.1016/S0886-3350(01)01321-9; Jarade E, 2013, J REFRACT SURG, V29, P444, DOI 10.3928/1081597X-20130617-01; Kamiya K, 2011, GRAEF ARCH CLIN EXP, V249, P1073, DOI 10.1007/s00417-010-1540-5; Kamiya K, 2008, J REFRACT SURG, V24, P840; Kato N, 2011, OPHTHALMOLOGY, V118, P605, DOI 10.1016/j.ophtha.2010.08.043; Kymionis George D, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe22, DOI 10.3928/15428877-20110210-05; Leccisotti A, 2003, J CATARACT REFR SURG, V29, P1530, DOI 10.1016/S0886-3350(03)00346-8; Moshirfar M, 2006, J CATARACT REFR SURG, V32, P1227, DOI 10.1016/j.jcrs.2006.02.017; Rodriguez-Ausin P, 2011, CORNEA, V30, P1051, DOI 10.1097/ICO.0b013e3182096789; Sedaghat M, 2011, J REFRACT SURG, V27, P489, DOI 10.3928/1081597X-20110203-01; Sharma N, 2005, J REFRACT SURG, V21, P496	26	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	FEB	2015	99	2					177	183		10.1136/bjophthalmol-2014-305612		7	Ophthalmology	Ophthalmology	AZ5UG	WOS:000348285500008		
J	Shimura, M; Yasuda, K				Shimura, Masahiko; Yasuda, Kanako			Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							MACULAR EDEMA SECONDARY; GRID LASER TREATMENT; TRIAMCINOLONE; RANIBIZUMAB; INJECTION; TRIAL; DEGENERATION; INSTILLATION; THERAPY; AVASTIN	Background/aims To evaluate the effectiveness of topical bromfenac during treatment with intravitreal injections of bevacizumab (IVB) in eyes with macular oedema (ME) secondary to branch retinal vein occlusion (BRVO). Methods Prospective interventional case-control study. 48 eyes of 44 patients with ME-BRVO who received 1.25 mg/0.05 mL of IVB showed temporary regression of ME. Additional IVB were given when ME recurred. 24 eyes received topical bromfenac, and the other 24 eyes received topical saline as control, four times a day during the clinical course of 48 weeks. The clinical course of foveal thickness (FT) as measured by optical coherence tomography, logarithm of the minimum angle of resolution visual acuity (VA), was monitored. The number of IVB was also recorded. Results There were no significant differences in FT, VA between the bromfenac-treated eyes and the control eyes at the initial and final examinations. The number of injections in bromfenac-treated eyes of 3.8 +/- 1.1 times was significantly less than in the control eyes of 4.8 +/- 1.2 times. Conclusions Although topical bromfenac during IVB therapy in eyes with ME secondary to BRVO did not affect the visual prognosis, it had the advantage of reducing the number of injections.	[Shimura, Masahiko; Yasuda, Kanako] NTT East Japan Tohoku Hosp, Dept Ophthalmol, Sendai, Miyagi, Japan	Shimura, M (reprint author), Tokyo Med Univ, Dept Ophthalmol, Hachioji Med Ctr, 1163 Tate Machi, Hachioji, Tokyo 1930998, Japan.	masahiko@v101.vaio.ne.jp			NTT (Nippon Telegraph and Telephone Corporation) East Japan Tohoku Hospital	This study was supported by 2009-2011 scientific grants in aid for clinical research by NTT (Nippon Telegraph and Telephone Corporation) East Japan Tohoku Hospital.	Kreutzer TC, 2008, BRIT J OPHTHALMOL, V92, P351, DOI 10.1136/bjo.2007.123513; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P209, DOI 10.1016/j.ophtha.2013.08.038; Sampat KM, 2010, CURR OPIN OPHTHALMOL, V21, P178, DOI 10.1097/ICU.0b013e328338679a; Parodi MB, 1999, GRAEF ARCH CLIN EXP, V237, P1024; Tanito M, 2011, INVEST OPHTH VIS SCI, V52, P7944, DOI 10.1167/iovs.11-8178; Yoshinaga N, 2011, LAB INVEST, V91, P1277, DOI 10.1038/labinvest.2011.101; Gomi F, 2012, RETINA-J RET VIT DIS, V32, P1804, DOI 10.1097/IAE.0b013e31825be87f; Smiddy WE, 2011, OPHTHALMOLOGY, V118, P1827, DOI 10.1016/j.ophtha.2010.12.034; Parodi MB, 1999, DOC OPHTHALMOL, V97, P427; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Flaxel C, 2012, RETINA-J RET VIT DIS, V32, P417, DOI 10.1097/IAE.0b013e318229b0af; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; Funk M, 2009, INVEST OPHTH VIS SCI, V50, P1025, DOI 10.1167/iovs.08-2510; Ehlers JP, 2011, SURV OPHTHALMOL, V56, P281, DOI 10.1016/j.survophthal.2010.11.006; Cekic O, 2005, RETINA-J RET VIT DIS, V25, P851; Warren KA, 2010, RETINA-J RET VIT DIS, V30, P260, DOI 10.1097/IAE.0b013e3181b8628e; Kondo M, 2009, RETINA-J RET VIT DIS, V29, P1242, DOI 10.1097/IAE.0b013e3181aa8e20; Kriechbaum K, 2008, BRIT J OPHTHALMOL, V92, P518, DOI 10.1136/bjo.2007.127282; Scott IU, 2009, ARCH OPHTHALMOL-CHIC, V127, P1115, DOI 10.1001/archophthalmol.2009.233; Asai T, 2006, CORNEA, V25, P224, DOI 10.1097/01.ico.0000177835.93130.d4; Baklayan GA, 2008, J OCUL PHARMACOL TH, V24, P392, DOI 10.1089/jop.2007.0082; Branch Vein Occlusion Study Group, 1984, AM J OPHTHALMOL, V98, P271; Gunther JB, 2009, SURV OPHTHALMOL, V54, P372, DOI 10.1016/j.survophthal.2009.02.004; GUTMAN FA, 1974, T AM ACAD OPHTHALMOL, V78, pO178; Radwan AE, 2013, GRAEF ARCH CLIN EXP, V251, P1801, DOI 10.1007/s00417-013-2309-4; Ramezani Alireza, 2011, J Ophthalmic Vis Res, V6, P101	26	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	FEB	2015	99	2					215	219		10.1136/bjophthalmol-2013-304720		5	Ophthalmology	Ophthalmology	AZ5UG	WOS:000348285500015		
J	Tsukitome, H; Hatsukawa, Y; Morimitsu, T; Yagasaki, T; Kondo, M				Tsukitome, Hideyuki; Hatsukawa, Yoshikazu; Morimitsu, Tomoko; Yagasaki, Teiji; Kondo, Mineo			Changes in angle of optic nerve and angle of ocular orbit with increasing age in Japanese children	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							CRANIOFACIAL SURGERY; OPHTHALMIC FINDINGS; STRABISMUS; POSITION; GROWTH; VOLUME; APERT	Purpose To study changes in the opening angle of the optic nerve and the angle of the ocular orbit with increasing age in normal Japanese children. Methods We studied 147 normal children (aged 6 months to 18 years) who had undergone CT as a diagnostic procedure. Measurements were performed on axial CT images that included the entire optic nerve of both eyes. The opening angle of the optic nerve was defined as the angle formed by the intersection of a line running through the left optic nerve and a vertical line passing through the centre of the nose. The opening angle of the orbit was defined as the angle formed by the intersection of a line running tangentially along the deep lateral wall of the left orbit and a vertical line passing through the centre of the nose. The relationship between age and these opening angles was analysed by regression analysis. Results The correlation between age and opening angle of the optic nerve was not significant. In contrast, the opening angle of the orbit decreased relatively rapidly until about 2-3 years of age, and then it stabilised. The decrease in the opening angle of the orbit with increasing age was significant (p<0.001). The relationship between these two parameters was best fitted by a logarithmic regression curve. Conclusions Because the opening angle of the orbit decreased significantly with increasing age, this factor must be considered when diagnosing and treating strabismus in children.	[Tsukitome, Hideyuki; Kondo, Mineo] Mie Univ, Dept Ophthalmol, Grad Sch Med, Tsu, Mie 5148507, Japan; [Hatsukawa, Yoshikazu; Morimitsu, Tomoko] Osaka Med Ctr, Dept Ophthalmol, Osaka, Japan; [Hatsukawa, Yoshikazu; Morimitsu, Tomoko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Yagasaki, Teiji] Yagasaki Eye Clin, Ichinomiya, Japan	Kondo, M (reprint author), Mie Univ, Dept Ophthalmol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	mineo@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20592603]	Grant support: Grant-in-Aid for Scientific Research C (No 20592603) from the Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/).	Furuta M, 2001, JPN J OPHTHALMOL, V45, P600, DOI 10.1016/S0021-5155(01)00419-1; Bentley RP, 2002, J NEUROSURG, V96, P742, DOI 10.3171/jns.2002.96.4.0742; Khong JJ, 2006, OPHTHALMOLOGY, V113, P347, DOI 10.1016/j.ophtha.2005.10.011; Chau A, 2004, OPHTHAL PHYSL OPT, V24, P436, DOI 10.1111/j.1475-1313.2004.00217.x; Escaravage GK, 2013, OPHTHAL PLAST RECONS, V29, P150, DOI 10.1097/IOP.0b013e3182859716; Khong JJ, 2006, AM J OPHTHALMOL, V142, P328, DOI 10.1016/j.ajo.2006.02.046; Kreiborg S, 2010, J CRANIOFAC SURG, V21, P1354, DOI 10.1097/SCS.0b013e3181ef2b53; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P315, DOI 10.1597/1545-1569(1992)029<0315:GPITOR>2.3.CO;2; Chia A, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.116905; ARCHER SM, 1989, OPHTHALMOLOGY, V96, P133; Duke- Elder S, 1963, SYSTEM OPHTHALMOLOGY, P304; LEMKE B. N., 2012, SMITH NESIS OPHTHALM, P3; MORAX S, 1984, J MAXILLOFAC SURG, V12, P47, DOI 10.1016/S0301-0503(84)80211-8; Rosenberg JB, 2013, J PEDIAT OPHTH STRAB, V50, P141, DOI 10.3928/01913913-20121113-02; Yagasaki T, 2012, 2 WORLD C PED OPHTH; Yang GJ, 2012, AM J OPHTHALMOL, V154, P601, DOI 10.1016/j.ajo.2012.03.025; Zimmermann AA, 1934, ANAT REC, V59, P109, DOI 10.1002/ar.1090590110	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	FEB	2015	99	2					263	266		10.1136/bjophthalmol-2014-305236		4	Ophthalmology	Ophthalmology	AZ5UG	WOS:000348285500025		
J	Masuoka, T; Nakamura, T; Kudo, M; Yoshida, J; Takaoka, Y; Kato, N; Ishibashi, T; Imaizumi, N; Nishio, M				Masuoka, T.; Nakamura, T.; Kudo, M.; Yoshida, J.; Takaoka, Y.; Kato, N.; Ishibashi, T.; Imaizumi, N.; Nishio, M.			Biphasic modulation by mGlu(5) receptors of TRPV1-mediated intracellular calcium elevation in sensory neurons contributes to heat sensitivity	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; INFLAMMATORY HYPERALGESIA; CONCISE GUIDE; DORSAL-HORN; THERMAL HYPERALGESIA; SYMPATHETIC NEURONS; CAPSAICIN RECEPTOR; ARRIVE GUIDELINES; SIGNALING CASCADE; UP-REGULATION	Background and PurposeElevation of glutamate, an excitatory amino acid, during inflammation and injury plays a crucial role in the reception and transmission of sensory information via ionotropic and metabotropic receptors. This study aimed to investigate the mechanisms underlying the biphasic effects of metabotropic glutamate mGlu(5) receptor activation on responses to noxious heat. Experimental ApproachWe assessed the effects of intraplantar quisqualate, a non-selective glutamate receptor agonist, on heat and mechanical pain behaviours in mice. In addition, the effects of quisqualate on the intracellular calcium response and on membrane currents mediated by TRPV1 channels, were examined in cultured dorsal root ganglion neurons from mice. Key ResultsActivation of mGlu(5) receptors in hind paw transiently increased, then decreased, the response to noxious heat. In sensory neurons, activation of mGlu(5) receptors potentiated TRPV1-mediated intracellular calcium elevation, while terminating activation of mGlu(5) receptors depressed it. TRPV1-induced currents were potentiated by activation of mGlu(5) receptors under voltage clamp conditions and these disappeared after washout. However, voltage-gated calcium currents were inhibited by the mGlu(5) receptor agonist, even after washout. Conclusions and ImplicationsThese results suggest that, in sensory neurons, mGlu(5) receptors biphasically modulate TRPV1-mediated intracellular calcium response via transient potentiation of TRPV1 channel-induced currents and persistent inhibition of voltage-gated calcium currents, contributing to heat hyper- and hypoalgesia.	[Masuoka, T.; Nakamura, T.; Kudo, M.; Yoshida, J.; Takaoka, Y.; Ishibashi, T.; Imaizumi, N.; Nishio, M.] Kanazawa Med Univ, Sch Med, Dept Pharmacol, Uchinada, Ishikawa 9200293, Japan; [Kato, N.] Kanazawa Med Univ, Sch Med, Dept Physiol 1, Uchinada, Ishikawa 9200293, Japan; [Ishibashi, T.] Kanazawa Med Univ, Sch Nursing, Dept Pharmacol, Uchinada, Ishikawa 9200293, Japan	Masuoka, T (reprint author), Kanazawa Med Univ, Sch Med, Dept Pharmacol, Uchinada, Ishikawa 9200293, Japan.	masuoka@kanazawa-med.ac.jp			Kanazawa Medical University [K2012-11, S2013-9, C2013-3]; JSPS KAKENHI [25870852, 26460348, 26670129]	We thank Dr Ryo Yamamoto at the Department of Physiology I, Kanazawa Medical University, for continuous encouragement during the course of this study. We also thank Ms Yasuko Shinzawa for her secretarial assistance. This work was supported by a grant for Assist KAKEN (K2012-11), a grant for Promoted Research (S2013-9), and a grant for Collaborative Research (C2013-3) all from Kanazawa Medical University; and JSPS KAKENHI grants (numbers 25870852, 26460348 and 26670129).	Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Walker K, 2001, NEUROPHARMACOLOGY, V40, P10; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Stawski P, 2010, BIOORGAN MED CHEM, V18, P7759, DOI 10.1016/j.bmc.2010.09.012; Hu HJ, 2002, J NEUROSCI, V22, P7444; Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; ABE T, 1992, J BIOL CHEM, V267, P13361; Mitchell K, 2014, PAIN, V155, P733, DOI 10.1016/j.pain.2014.01.007; Guo W, 2004, J NEUROSCI, V24, P9161, DOI 10.1523/JNEUROSCI.3422-04.2004; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Hudson LJ, 2002, J NEUROSCI, V22, P2660; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; Chiechio S, 2012, CURR OPIN PHARMACOL, V12, P28, DOI 10.1016/j.coph.2011.10.010; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Lawand NB, 2000, PAIN, V86, P69, DOI 10.1016/S0304-3959(99)00311-5; Kumar V, 2012, J BIOL CHEM, V287, P5412, DOI 10.1074/jbc.M111.301366; Caterina MJ, 1997, NATURE, V389, P816; Geffeney SL, 2012, NEURON, V74, P609, DOI 10.1016/j.neuron.2012.04.023; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; Won YJ, 2009, J NEUROSCI, V29, P13603, DOI 10.1523/JNEUROSCI.2244-09.2009; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1582, DOI 10.1111/bph.12446; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Crawford JH, 2000, NEUROPHARMACOLOGY, V39, P621, DOI 10.1016/S0028-3908(99)00167-7; Han P, 2013, J MOL NEUROSCI, V50, P23, DOI 10.1007/s12031-012-9849-7; Jung SS, 2011, NEUROSCI LETT, V500, P197, DOI 10.1016/j.neulet.2011.06.035; Li JQ, 2010, J NEUROCHEM, V112, P162, DOI 10.1111/j.1471-4159.2009.06437.x; Liu LW, 2004, EUR BIOPHYS J BIOPHY, V33, P255, DOI 10.1007/s00249-003-0387-7; Liu MG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-258; Liu XJ, 2010, EUR J NEUROSCI, V32, P278, DOI 10.1111/j.1460-9568.2010.07351.x; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; SAHARA Y, 1993, J NEUROSCI, V13, P3041; SAYER RJ, 1992, J NEUROPHYSIOL, V68, P833; Yan LH, 2009, PHARMACOL RES, V59, P290, DOI 10.1016/j.phrs.2009.01.012; Yoshida J, 2005, EUR J PHARMACOL, V510, P217, DOI 10.1016/j.ejphar.2005.01.029	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	FEB	2015	172	4					1020	1033		10.1111/bph.12962		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ9CB	WOS:000348507700005		
J	Maehara, T; Matsumoto, K; Horiguchi, K; Kondo, M; Iino, S; Horie, S; Murata, T; Tsubone, H; Shimada, S; Ozaki, H; Hori, M				Maehara, Toko; Matsumoto, Kenjiro; Horiguchi, Kazuhide; Kondo, Makoto; Iino, Satoshi; Horie, Shunji; Murata, Takahisa; Tsubone, Hirokazu; Shimada, Shoichi; Ozaki, Hiroshi; Hori, Masatoshi			Therapeutic action of 5-HT3 receptor antagonists targeting peritoneal macrophages in post-operative ileus	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; NITRIC-OXIDE SYNTHASE; EMETOGENIC CHEMOTHERAPY; ARRIVE GUIDELINES; INDUCED COLITIS; CONCISE GUIDE; SEROTONIN; CELLS; PHARMACOLOGY; INFLAMMATION	Background and PurposePost-operative ileus (POI) is induced by intestinal inflammation. Here, we aimed to clarify the effects of 5-HT3 receptor antagonists against POI. Experimental ApproachWe administered three 5-HT3 receptor antagonists, ondansetron, tropisetron and palonosetron, to a mouse model of POI induced by surgical intestinal manipulation (IM). Immunohistochemistry, intestinal transit, inflammatory mediator mRNA expression and 5-HT content were measured. In some experiments, 5-HT(3)A receptor null mice were used. Key ResultsThree 5-HT3 receptor antagonists reduced IM-induced infiltration of inflammatory CD68-positive macrophages and myeloperoxidase-stained neutrophils. Ondansetron exhibited no anti-inflammatory actions in 5-HT(3)A receptor null mice. Ondansetron inhibited expression of the chemokine CCL2, IL-1, IL-6, TNF- and iNOS mRNAs up-regulated by IM, and also ameliorated the delayed gastrointestinal transit. Peritoneal macrophages, but not most infiltrating monocyte-derived macrophages, expressed 5-HT3 receptors. IM stimulation increased the 5-HT content of peritoneal lavage fluid, which up-regulated mRNA expression of proinflammatory cytokines in peritoneal macrophages. Immunohistochemical localization of 5-HT3 receptors suggests that ondansetron suppressed expression of these mRNAs in activated peritoneal macrophages, adhering to the serosal region of the inflamed intestinal wall. Conclusion and Implications5-HT3 receptor antagonists were anti-inflammatory, mainly targeting peritoneal macrophages expressing these receptors. They also restored the delayed gastrointestinal transit by IM. 5-HT3 receptor antagonists should be therapeutically useful agents against POI.	[Maehara, Toko; Ozaki, Hiroshi; Hori, Masatoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Tokyo 1138657, Japan; [Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo 1138657, Japan; [Tsubone, Hirokazu] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo 1138657, Japan; [Matsumoto, Kenjiro; Horie, Shunji] Josai Int Univ, Fac Pharmaceut Sci, Lab Pharmacol, Chiba 2838555, Japan; [Horiguchi, Kazuhide; Iino, Satoshi] Univ Fukui, Fac Med Sci, Dept Morphol & Physiol Sci, Div Anat & Neurosci, Fukui 9101193, Japan; [Kondo, Makoto; Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, Suita, Osaka 5650871, Japan	Hori, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, Tokyo 1138657, Japan.	ahori@mail.ecc.u-tokyo.ac.jp			Japanese Ministry of Education [24248050, 25660224, 25252055]	This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education (to M. H., no. 24248050 and no. 25660224 and to H. O., no. 25252055).	Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Engel DR, 2010, NAT MED, V16, P1407, DOI 10.1038/nm.2255; Schwarz NT, 2001, GASTROENTEROLOGY, V121, P1354, DOI 10.1053/gast.2001.29605; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Heimes K, 2009, EUR J PHARMACOL, V624, P58, DOI 10.1016/j.ejphar.2009.09.049; Kim DY, 2000, AM J GASTROENTEROL, V95, P2698, DOI 10.1016/S0002-9270(00)01970-5; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1449, DOI 10.1111/bph.12444; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Tajima T, 2012, AM J PHYSIOL-GASTR L, V302, pG524, DOI 10.1152/ajpgi.00264.2011; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Shi CJ, 2013, J MOL MODEL, V19, P871, DOI 10.1007/s00894-012-1618-6; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Linden DR, 2003, AM J PHYSIOL-GASTR L, V285, pG207, DOI 10.1152/ajpgi.00488.2002; Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P9, DOI 10.1080/03009740410006952; Tsuchida Y, 2011, GUT, V60, P638, DOI 10.1136/gut.2010.227546; Bauer AJ, 2004, NEUROGASTROENT MOTIL, V16, P54, DOI 10.1111/j.1743-3150.2004.00558.x; Miura S, 2013, SUPPORT CARE CANCER, V21, P2575, DOI 10.1007/s00520-013-1835-2; Turler A, 2006, ANN SURG, V244, P220, DOI 10.1097/01.sla.0000229963.37544.59; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; El-Salhy M, 1997, J INTERN MED, V242, P413, DOI 10.1046/j.1365-2796.1997.00237.x; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1582, DOI 10.1111/bph.12446; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Candiotti KA, 2007, ANESTH ANALG, V104, P1370, DOI 10.1213/01.ane.0000261474.85547.8b; Celio L, 2012, TUMORI, V98, P279, DOI 10.1700/1125.12393; Costa R, 2012, NEUROPHARMACOLOGY, V63, P798, DOI 10.1016/j.neuropharm.2012.06.004; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; GERSHON MD, 1965, SCIENCE, V149, P197, DOI 10.1126/science.149.3680.197; JACKSON MB, 1995, ANNU REV PHYSIOL, V57, P447; Jensen BM, 2006, CURR PROTOC IMMUNOL, V74; Kim K, 2012, BIOMOL THER, V20, P506, DOI 10.4062/biomolther.2012.20.6.506; Kiyosue M, 2006, NEUROGASTROENT MOTIL, V18, P1019, DOI 10.1111/j.1365-2982.2006.00841.x; KLIMETZEK V, 1980, CELL IMMUNOL, V53, P257, DOI 10.1016/0008-8749(80)90327-5; Liu FC, 2011, RESUSCITATION, V82, P335, DOI 10.1016/j.resuscitation.2010.11.007; Maleki-Dizaji N, 2010, INT IMMUNOPHARMACOL, V10, P1010, DOI 10.1016/j.intimp.2010.05.013; Mattei P, 2006, WORLD J SURG, V30, P1382, DOI 10.1007/s00268-005-0613-9; Nagakura Y, 1996, EUR J PHARMACOL, V311, P67, DOI 10.1016/0014-2999(96)00403-7; Oshima S, 1999, HISTOCHEM CELL BIOL, V112, P257, DOI 10.1007/s004180050445; Panteleev S S, 2013, Ross Fiziol Zh Im I M Sechenova, V99, P471; Prasad M, 1999, GASTROENTEROLOGY, V117, P489, DOI 10.1053/gast.1999.0029900489; Sallam HS, 2007, AM J PHYSIOL-REG I, V292, pR253, DOI 10.1152/ajpregu.00100.2006; Spiller Robin C, 2004, Br Med Bull, V72, P15; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069424; Vega Lde L, 2005, BIOCHEM PHARMACOL, V70, P369; Yasuda M, 2013, BRIT J PHARMACOL, V168, P1388, DOI 10.1111/bph.12019	53	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	FEB	2015	172	4					1136	1147		10.1111/bph.13006		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ9CB	WOS:000348507700014		
J	Torok, S; Vegvari, A; Rezeli, M; Fehniger, TE; Tovari, J; Paku, S; Laszlo, V; Hegedus, B; Rozsas, A; Dome, B; Marko-Varga, G				Torok, S.; Vegvari, A.; Rezeli, M.; Fehniger, T. E.; Tovari, J.; Paku, S.; Laszlo, V.; Hegedus, B.; Rozsas, A.; Dome, B.; Marko-Varga, G.			Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							TANDEM MASS-SPECTROMETRY; GASTROINTESTINAL STROMAL TUMOR; TYROSINE KINASE INHIBITOR; RENAL-CELL CARCINOMA; ANTITUMOR-ACTIVITY; ANTIANGIOGENIC THERAPY; ACTIVE METABOLITE; ARRIVE GUIDELINES; CONCISE GUIDE; GROWTH-FACTOR	Background and PurposeThe clinical effects of anti-angiogenic agents remain controversial. Therefore, elucidating the pharmacological properties of these compounds is a pivotal issue. Experimental ApproachThe effects of treatment with sunitinib on tumour and normal tissues of mice bearing C-26 adenocarcinoma cells were analysed by matrix-assisted laser desorption ionization MS imaging (MALDI-MSI). Expression of the key targets of sunitinib - angiogenic receptors - was studied by immunofluorescent labelling. Key ResultsMALDI-MS assays showed that sunitinib and its fragment ions were present throughout tumour and normal tissues. Major metabolites were identified in blood and solid tissues, while minor drug metabolites were detectable only in blood. Tumour growth and intratumour VEGF receptor-2 expressions were significantly reduced in sunitinib-treated mice, while the expression of the other targeted receptors, PDGF receptor - or - and fibroblast growth factor receptor-1, remained unaffected. Within tumour tissue, the close proximity of sunitinib metabolites to the precursor ion suggested in situ metabolism of the administered drug. There were intratumour areas where the signal intensity of sunitinib correlated with expression of VEGF receptor-2. Conclusions and ImplicationsThis is the first study that demonstrates MALDI-MSI is a versatile platform to study the intratumour localization of an unlabelled anti-angiogenic drug. The combination of MALDI-MSI and immunofluorescence analysis can provide further insights into the molecular interaction of drug compounds and their targets within tumour tissue.	[Torok, S.; Rozsas, A.; Dome, B.] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary; [Torok, S.; Laszlo, V.; Hegedus, B.; Dome, B.] Med Univ Vienna, Div Thorac Surg, Dept Surg, Ctr Comprehens Canc, A-1090 Vienna, Austria; [Torok, S.; Vegvari, A.; Rezeli, M.; Fehniger, T. E.; Marko-Varga, G.] Lund Univ, Dept Biomed Engn, Biomed Ctr, SE-22184 Lund, Sweden; [Vegvari, A.] Lund Univ, CREATE Hlth, SE-22184 Lund, Sweden; [Fehniger, T. E.; Marko-Varga, G.] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, SE-22184 Lund, Sweden; [Tovari, J.] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Paku, S.] Semmelweis Univ, Inst Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Paku, S.; Hegedus, B.] Semmelweis Univ, Hungarian Acad Sci, Tumor Progress Res Grp, H-1085 Budapest, Hungary; [Rozsas, A.; Dome, B.] Semmelweis Univ, Dept Thorac Surg, H-1085 Budapest, Hungary; [Rozsas, A.; Dome, B.] Natl Inst Oncol, Budapest, Hungary; [Dome, B.] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Mol & Gender Imaging, A-1090 Vienna, Austria; [Marko-Varga, G.] Tokyo Med Univ, Dept Surg 1, Tokyo 1608402, Japan	Dome, B (reprint author), Med Univ Vienna, Dept Thorac Surg, Translat Thorac Oncol Lab, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	balazs.dome@meduniwien.ac.at; gyorgy.marko-varga@bme.lth.se	Vegvari, Akos/A-4941-2011; Hegedus, Balazs/B-6076-2008; 	Vegvari, Akos/0000-0002-1287-0906; Hegedus, Balazs/0000-0002-4341-4153; Dome, Balazs/0000-0001-8799-8624	Kutatasi es Technologiai Innovacios Alap (Research and Technology Innovation Fund) [AIK 12-1-2013-0041]; Orszagos Kutatasi Tudomanyos Alapprogramok (Hungarian Scientific Research Fund) [K109626, K108465, MOB80325, K84173]; ONB Jubilaumsfondsprojekt [14043]; Vienna Fund for Innovative Interdisciplinary Cancer Research; EACR Travel Fellowship; Hungarian Pulmonology Foundation Research Fellowship; Mrs. Berta Kamprad Foundation; Ingabritt & Arne Lundbergs forskningsstiftelse; Crafoord Foundation;  [EUREKA_HU_12-1-2012-0057]	The authors were supported by Kutatasi es Technologiai Innovacios Alap (Research and Technology Innovation Fund) AIK 12-1-2013-0041 (B. D., V. L., S. P.); Orszagos Kutatasi Tudomanyos Alapprogramok (Hungarian Scientific Research Fund) K109626, K108465 (B. D., B. H.), MOB80325 (B. H.), and K84173 (J. T.); EUREKA_HU_12-1-2012-0057 (B. D.); ONB Jubilaumsfondsprojekt No. 14043 (B. D., V. L.); and the Vienna Fund for Innovative Interdisciplinary Cancer Research (B. D., V. L.). S. T. was recipient of an EACR Travel Fellowship and a Hungarian Pulmonology Foundation Research Fellowship. A. V. is grateful for the Innovative Support 2011-039226 for CREATE Health. This work was also supported by grants from the Mrs. Berta Kamprad Foundation, Ingabritt & Arne Lundbergs forskningsstiftelse and the Crafoord Foundation.	Abe H, 2013, INT J UROL, V20, P944, DOI 10.1111/iju.12187; Amir E, 2009, EXPERT OPIN INV DRUG, V18, P1667, DOI 10.1517/13543780903336050; Strupat K, 2009, J AM SOC MASS SPECTR, V20, P1451, DOI 10.1016/j.jasms.2009.04.013; Fehniger TE, 2011, ANAL CHEM, V83, P8329, DOI 10.1021/ac2014349; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Jayson GC, 2012, NAT REV CLIN ONCOL, V9, P297, DOI 10.1038/nrclinonc.2012.8; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Xiao YY, 2013, EUR J CLIN PHARMACOL, V69, P151, DOI 10.1007/s00228-012-1333-3; Solon EG, 2010, AAPS J, V12, P11, DOI 10.1208/s12248-009-9158-4; Lankheet NAG, 2011, J ANAL TOXICOL, V35, P558; Solon EG, 2012, CHEM RES TOXICOL, V25, P543, DOI 10.1021/tx200509f; Groseclose MR, 2007, J MASS SPECTROM, V42, P254, DOI 10.1002/jms.1177; Choueiri TK, 2013, J NATL COMPR CANC NE, V11, P694; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1676, DOI 10.1111/bph.12449; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbre.2007.02.156; Wong H, 2012, CLIN CANCER RES, V18, P3846, DOI 10.1158/1078-0432.CCR-12-0738; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Waldner MJ, 2012, EXPERT OPIN THER TAR, V16, P5, DOI 10.1517/14728222.2011.641951; Rodamer M, 2011, J CHROMATOGR B, V879, P695, DOI 10.1016/j.jchromb.2011.02.006; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Garcia VM, 2012, CLIN CANCER RES, V18, P3750, DOI 10.1158/1078-0432.CCR-11-1275; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Rock EP, 2007, ONCOLOGIST, V12, P107, DOI 10.1634/theoncologist.12-1-107; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Casadonte R, 2011, NAT PROTOC, V6, P1695, DOI 10.1038/nprot.2011.388; Baratte S, 2004, J CHROMATOGR A, V1024, P87, DOI 10.1016/j.chroma.2003.10.085; Cananzi FCM, 2013, EJSO-EUR J SURG ONC, V39, P1171, DOI 10.1016/j.ejso.2013.08.030; CHUNG WG, 1995, XENOBIOTICA, V25, P929; de Bruijn P, 2010, J PHARMACEUT BIOMED, V51, P934, DOI 10.1016/j.jpba.2009.10.020; DING A, 1995, DRUG METAB DISPOS, V23, P369; Dome B, 2002, J PATHOL, V197, P355, DOI 10.1002/path.1124; Domingues I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025668; Etienne-Grimaldi MC, 2009, J CHROMATOGR B, V877, P3757, DOI 10.1016/j.jchromb.2009.09.011; Glassman Patrick M., 2014, Cancer Biology Medicine, V11, P20, DOI 10.7497/j.issn.2095-3941.2014.01.002; Gusev AI, 1996, RAPID COMMUN MASS SP, V10, P1215; Gustafsson OJR, 2013, RAPID COMMUN MASS SP, V27, P655, DOI 10.1002/rcm.6488; HOOKER AD, 1995, BIOTECHNOL BIOENG, V48, P639, DOI 10.1002/bit.260480612; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; Manea M, 2011, BIOCONJUGATE CHEM, V22, P1320, DOI 10.1021/bc100547p; Marko-Varga György, 2012, Clin Transl Med, V1, P8, DOI 10.1186/2001-1326-1-8; Paku S, 2011, AM J PATHOL, V179, P1573, DOI 10.1016/j.ajpath.2011.05.033; Peng L, 2013, CURR MOL MED, V13, P333; Qiu F, 2013, BIOMED CHROMATOGR, V27, P615, DOI 10.1002/bmc.2836; Rais R, 2012, BIOMED CHROMATOGR, V26, P1315, DOI 10.1002/bmc.2697; Speed B, 2012, DRUG METAB DISPOS, V40, P539, DOI 10.1124/dmd.111.042853; Zhou QY, 2010, J PHARMACEUT BIOMED, V51, P958, DOI 10.1016/j.jpba.2009.10.006	52	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	FEB	2015	172	4					1148	1163		10.1111/bph.12990		16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ9CB	WOS:000348507700015		
J	Makihara, K; Azuma, S; Kawato, N; Ueno, H; Nakata, I				Makihara, Katsuya; Azuma, Sayaka; Kawato, Nobuyuki; Ueno, Hiroyuki; Nakata, Izumi			Pre-treatment serum total bilirubin level as an indicator of optimal CPT-11 dosage	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Irinotecan; Total bilirubin; Toxicity; Solid tumor; Neutropenia; Diarrhea	METASTATIC COLORECTAL-CANCER; SEVERE NEUTROPENIA; UGT1A1-ASTERISK-6 AND-ASTERISK-28; UGT1A1 POLYMORPHISM; IRINOTECAN; TOXICITY; JAPANESE; PREDICT; EFFICACY; DIARRHEA	Irinotecan (CPT-11), a highly effective chemotherapeutic agent, can cause severe neutropenia and diarrhea. The area under the curve of plasma levels over time of SN-38, an active metabolite of CPT-11, was previously reported to correlate with the pre-treatment serum total bilirubin level (PTB). However, there are no established criteria for selecting CPT-11 dose on the basis of PTB. Therefore, we evaluated PTB as an indicator for the optimal CPT-11 dose. Retrospective analyses were conducted in patients administered CPT-11 as a single agent at the Osaka National Hospital from June 2006 to July 2013. Data obtained during the first 28 days following CPT-11 administration were analyzed to compare PTB between patients with and without grade 3-4 neutropenia and grade 3-4 diarrhea. Receiver operating characteristics (ROC) curve analysis was performed to determine the optimal PTB cutoff value for PTB-associated toxicity. Subgroup analysis was performed comparing the incidence of toxicity in patients with PTB values below or above the cutoff value. Although PTB incidence was significantly higher in patients who developed grade 3-4 neutropenia than in those who did not, PTB was not associated with grade 3-4 diarrhea. The PTB cutoff value for association with grade 3-4 neutropenia occurrence was set at 0.8 mg/dL. The incidence of febrile neutropenia (FN) significantly elevated to 21 % in patients with PTB a parts per thousand yen0.8 mg/dL, whereas that of patients with PTB < 0.8 mg/dL was 4 %. In the subgroup analysis, no difference was found in the neutropenia incidence between patients treated with a dose below 80 mg/m(2) and those treated on a weekly schedule. PTB can be used as a predictive marker of CPT-11-induced severe neutropenia and FN. In patients with PTB a parts per thousand yen0.8 mg/dL, the CPT-11 dose should be reduced to less than 80 mg/m(2) with weekly dosing.	[Makihara, Katsuya; Azuma, Sayaka; Kawato, Nobuyuki; Ueno, Hiroyuki; Nakata, Izumi] Osaka Natl Hosp, Natl Hosp Org, Dept Pharm, Chuo Ku, Osaka, Japan	Makihara, K (reprint author), Osaka Natl Hosp, Natl Hosp Org, Dept Pharm, Chuo Ku, 2-1-14 Hoenzaka, Osaka, Japan.	katsuya@onh.go.jp					Minami H, 2007, PHARMACOGENET GENOM, V17, P497, DOI 10.1097/FPC.0b013e328014341f; Schaaf LJ, 2006, CLIN CANCER RES, V12, P3782, DOI 10.1158/1078-0432.CCR-05-2152; Glimelius B, 2011, PHARMACOGENOMICS J, V11, P61, DOI 10.1038/tpj.2010.10; Toffoli G, 2006, J CLIN ONCOL, V24, P3061, DOI 10.1200/JCO.2005.05.5400; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Cote JF, 2007, CLIN CANCER RES, V13, P3269, DOI 10.1158/1078-0432.CCR-06-2290; Rouits E, 2004, CLIN CANCER RES, V10, P5151, DOI 10.1158/1078-0432.CCR-03-0548; Onoue M, 2009, INT J CLIN ONCOL, V14, P136, DOI 10.1007/s10147-008-0821-z; Schulz C, 2009, WORLD J GASTROENTERO, V15, P5058, DOI 10.3748/wjg.15.5058; Sai K, 2004, CLIN PHARMACOL THER, V75, P501, DOI 10.1016/j.clpt.2004.01.010; Hoskins JM, 2007, J NATL CANCER I, V99, P1290, DOI 10.1093/jnci/djm115; de Jong FA, 2007, CLIN PHARMACOL THER, V81, P42, DOI 10.1038/sj.clpt.6100019; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; Freyer G, 2000, BRIT J CANCER, V83, P431, DOI 10.1054/bjoc.2000.1303; Carlini LE, 2005, CLIN CANCER RES, V11, P1226; Sai K, 2008, YAKUGAKU ZASSHI, V128, P575, DOI 10.1248/yakushi.128.575; Iyer L., 2002, Pharmacogenomics Journal, V2, P43, DOI 10.1038/sj.tpj.6500072; Font A, 2003, INVEST NEW DRUG, V21, P435, DOI 10.1023/A:1026251202137; Gao J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0604-x; Hasegawa Y, 2006, EXPERT REV MOL DIAGN, V6, P527, DOI 10.1586/14737159.6.4.527; Meyerhardt JA, 2004, J CLIN ONCOL, V22, P1439, DOI 10.1200/JCO.2004.10.043; Ramchandani RP, 2007, J CLIN PHARMACOL, V47, P78, DOI 10.1177/0091270006295060; Ratain MJ, 2010, CLIN CANCER RES, V16, P371, DOI 10.1158/1078-0432.CCR-09-2936; Ruggiero A, 2009, J CHEMOTHERAPY, V21, P693; Shimoyama Shouji, 2010, World J Gastrointest Surg, V2, P14, DOI 10.4240/wjgs.v2.i1.14; Tanaka Hiroyuki, 2009, Gan To Kagaku Ryoho, V36, P1505	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	FEB	2015	75	2					273	279		10.1007/s00280-014-2633-3		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AZ8DT	WOS:000348445700006		
J	Kanai, M; Hatano, E; Kobayashi, S; Fujiwara, Y; Marubashi, S; Miyamoto, A; Shiomi, H; Kubo, S; Ikuta, S; Yanagimoto, H; Terajima, H; Ikoma, H; Sakai, D; Kodama, Y; Seo, S; Morita, S; Ajiki, T; Nagano, H; Ioka, T				Kanai, Masashi; Hatano, Etsuro; Kobayashi, Shogo; Fujiwara, Yutaka; Marubashi, Shigeru; Miyamoto, Atsushi; Shiomi, Hisanori; Kubo, Shoji; Ikuta, Shinichi; Yanagimoto, Hiroaki; Terajima, Hiroaki; Ikoma, Hisashi; Sakai, Daisuke; Kodama, Yuzo; Seo, Satoru; Morita, Satoshi; Ajiki, Tetsuo; Nagano, Hiroaki; Ioka, Tatsuya			A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Biliary; Gemcitabine; Cisplatin; S-1; Chemotherapy	S-1 PLUS CISPLATIN; CELL LUNG-CANCER; 1ST-LINE TREATMENT; GEMCITABINE; TRIAL; OXALIPLATIN; MULTICENTER; JAPAN	Gemcitabine/cisplatin combination therapy has been the standard palliative chemotherapy for patients with advanced biliary tract cancer (BTC). We aimed to evaluate the efficacy and safety of adding S-1 to gemcitabine/cisplatin combination therapy for patients with advanced BTC. Patients with histologically or cytologically confirmed unresectable or recurrent BTC were eligible for inclusion. The primary end point was overall survival. Based on the results of our preceding phase I study, gemcitabine and cisplatin were administered intravenously at doses of 1,000 or 25 mg/m(2), respectively, on day 1, and oral S-1 was administered daily at a dose of 80 mg/m(2) on days 1-7 every 2 weeks. This study was registered with ClinicalTrials.gov (NCT01284413) and the UMIN Clinical Trials Registry (ID 000004468). Fifty patients enrolled between October 2011 and August 2012 were evaluated. After a median follow-up of 15.1 months (range 2.4-24.4 months), the median overall survival time was 16.2 months [95 % confidence interval (CI) 10.2-22.2 months], and the one-year overall survival rate was 59.9 % (95 % CI 46.2-73.5 %). The grade 3-4 hematological toxicities were as follows: neutropenia (32 %), anemia (32 %), thrombocytopenia (10 %), and febrile neutropenia (4 %). The common grade 3-4 non-hematological toxicities were biliary tract infection (14 %), anorexia/nausea (10 %), and fatigue (8 %). Gemcitabine/cisplatin/S-1 combination chemotherapy offered a promising survival benefit with manageable toxicity in patients with advanced BTC. A randomized phase III trial to investigate the efficacy of this regimen compared to gemcitabine/cisplatin combination therapy in patients with advanced BTC is now underway (UMIN000014371/NCT02182778).	[Kanai, Masashi] Kyoto Univ, Grad Sch Med, Dept Clin Oncol & Pharmacogen, Sakyo Ku, Kyoto 6068507, Japan; [Hatano, Etsuro; Seo, Satoru] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068507, Japan; [Kobayashi, Shogo; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; [Fujiwara, Yutaka] Natl Canc Ctr, Dept Expt Therapeut, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan; [Marubashi, Shigeru] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Miyamoto, Atsushi] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan; [Shiomi, Hisanori] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga, Japan; [Kubo, Shoji] Osaka City Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Osaka 558, Japan; [Ikuta, Shinichi] Meiwa Gen Hosp, Dept Surg, Kobe, Hyogo, Japan; [Yanagimoto, Hiroaki] Kansai Med Univ, Dept Surg, Osaka, Japan; [Terajima, Hiroaki] Kitano Hosp, Dept Gastroenterol Surg & Oncol, Osaka, Japan; [Ikoma, Hisashi] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 602, Japan; [Sakai, Daisuke] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Osaka, Japan; [Kodama, Yuzo] Kyoto Univ Hosp, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto 606, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto 6068507, Japan; [Ajiki, Tetsuo] Kobe Univ Hosp, Grad Sch Med, Dept Surg, Kobe, Hyogo, Japan; [Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan	Kanai, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Clin Oncol & Pharmacogen, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kanai@kuhp.kyoto-u.ac.jp			Tatsuya Ioka; Taiho Pharmaceutical	Honoraria Tatsuya Ioka, Eli Lilly, Taiho Pharmaceutical. Research Funding Tatsuya Ioka, Taiho Pharmaceutical.	Ichinose Y, 2004, CLIN CANCER RES, V10, P7860, DOI 10.1158/1078-0432.CCR-04-1200; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Glimelius B, 1996, ANN ONCOL, V7, P593; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Sasaki T, 2010, CANCER CHEMOTH PHARM, V65, P1101, DOI 10.1007/s00280-009-1115-5; Furuse J, 2008, CANCER CHEMOTH PHARM, V62, P849, DOI 10.1007/s00280-007-0673-7; Eckel F, 2007, BRIT J CANCER, V96, P896, DOI 10.1038/sj.bjc.6603648; Leonard GD, 2005, EXPERT OPIN PHARMACO, V6, P211, DOI 10.1515/14656566.6.2.211; Knox JJ, 2005, J CLIN ONCOL, V23, P2332, DOI 10.1200/JCO.2005.51.008; Morizane C, 2013, CANCER SCI, V104, P1211, DOI 10.1111/cas.12218; Muro K, 2010, LANCET ONCOL, V11, P853, DOI 10.1016/S1470-2045(10)70181-9; Andre T, 2004, ANN ONCOL, V15, P1339, DOI 10.1093/annonc/mdh351; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Choi ER, 2011, J GASTROEN HEPATOL, V26, P1804, DOI 10.1111/j.1440-1746.2011.06804.x; Gruenberger B, 2010, LANCET ONCOL, V11, P1142, DOI [10.1016/S1470-2045(10)70247-3, 10.1016/S1470.2045(10)70247.3]; Ikezawa K, 2014, J HEPATO-BIL-PAN SCI, V21, P98, DOI 10.1002/jhbp.2; Kanai M, 2012, CANCER CHEMOTH PHARM, V69, P1181, DOI 10.1007/s00280-011-1818-2; Kanai M, 2010, CANCER CHEMOTH PHARM, V67, P1429, DOI 10.1007/s00280-010-1443-5; Komiyama K, 2012, BRIT J CANCER, V107, P1474, DOI 10.1038/bjc.2012.437; Lan BY, 2012, AM J SURG, V204, P232, DOI 10.1016/j.amjsurg.2011.07.025; Sasaki T, 2012, INVEST NEW DRUG, V30, P708, DOI 10.1007/s10637-010-9553-9; Tamada Kiichi, 2011, World J Clin Oncol, V2, P203, DOI 10.5306/wjco.v2.i5.203; Ueno H, 2004, BRIT J CANCER, V91, P1769, DOI 10.1038/sj.bjc.6602208; Yamashita Y, 2010, JPN J CLIN ONCOL, V40, P24, DOI 10.1093/jjco/hyp119	25	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	FEB	2015	75	2					293	300		10.1007/s00280-014-2648-9		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AZ8DT	WOS:000348445700008		
J	Suzuki, K; Ozono, S; Yamaguchi, A; Koike, H; Matsui, H; Nagata, M; Takubo, T; Miyashita, K; Matsushima, T; Akaza, H				Suzuki, Kazuhiro; Ozono, Seiichiro; Yamaguchi, Akito; Koike, Hidekazu; Matsui, Hiroshi; Nagata, Masao; Takubo, Takatoshi; Miyashita, Kana; Matsushima, Takafumi; Akaza, Hideyuki			A phase 1 multiple-dose study of orteronel in Japanese patients with castration-resistant prostate cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Orteronel; Castration-resistant prostate cancer; 17,20-Lyase inhibitor; Phase 1	17,20-LYASE INHIBITOR; ABIRATERONE; CYP17; TAK-700; THERAPY	Orteronel (TAK-700) is a non-steroidal, selective, reversible inhibitor of 17,20-lyase. We evaluated the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor effect of orteronel with or without prednisolone in Japanese patients with castration-resistant prostate cancer (CRPC). We conducted a phase 1 study in men with progressive and chemotherapy-na < ve CRPC. Patients received orteronel orally at doses of 200-400 mg twice daily (BID) with or without oral prednisolone (5 mg BID). Dose-limiting toxicity (DLT) was assessed during Cycle 1 (28 days). Patients could continue study treatment until any of criteria for treatment discontinuation were met. Gonadotropin-releasing hormone therapy was continued in patients without prior orchidectomy. Fifteen patients were enrolled and administered at least one dose of orteronel. No DLTs were reported during Cycle 1 in this study. Adverse events (AEs) were reported in all 15 patients. Most common AEs (> 30 %) were hyperlipasemia (47 %), hyperamylasemia (40 %), and constipation (33 %). Acute pancreatitis (Grades 2 and 3) and pancreatitis (Grade 1) were complicated in three patients during the study. Dose-dependent increase in plasma orteronel concentrations was indicated over the 200-400 mg BID dose range. Prednisolone coadministered did not alter PK of orteronel. Serum testosterone was rapidly suppressed below the lower limit of quantification across all doses. Of 15 subjects, 13 achieved at least a 50 % reduction from baseline in prostate-specific antigen. Orteronel at doses up to 400 mg BID was tolerable in Japanese CRPC patients. The present results support further evaluation of orteronel with or without prednisolone.	[Suzuki, Kazuhiro; Koike, Hidekazu; Matsui, Hiroshi] Gunma Univ, Grad Sch Med, Dept Urol, Gunma, Japan; [Ozono, Seiichiro; Nagata, Masao] Hamamatsu Univ, Sch Med, Dept Urol, Shizuoka, Japan; [Yamaguchi, Akito] Harasanshin Hosp, Fukuoka, Japan; [Takubo, Takatoshi; Miyashita, Kana; Matsushima, Takafumi] Takeda Pharmaceut Co Ltd, Osaka, Japan; [Akaza, Hideyuki] Univ Tokyo, Dept Strateg Invest Comprehens Canc Network, Res Ctr Adv Sci & Technol, Tokyo, Japan	Suzuki, K (reprint author), Gunma Univ, Grad Sch Med, Dept Urol, Gunma, Japan.	kazu@gunma-u.ac.jp			Takeda Pharmaceutical Company Limited	The authors would like to thank all patients and their families as well as all investigators and site staff involved in the study. Takeda Bio Development Center Ltd. (currently Takeda Pharmaceutical Company Limited) sponsored this study, provided the study design, and performed statistical analyses. Yutaka Takahashi, SunFlare Co., Ltd., Tokyo, Japan, provided writing and editorial support, funded by Takeda Pharmaceutical Company Limited.	Minami H, 2008, CANCER SCI, V99, P1492, DOI 10.1111/j.1349-7006.2008.00837.x; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Vasaitis TS, 2011, J STEROID BIOCHEM, V125, P23, DOI 10.1016/j.jsbmb.2010.11.005; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Ang J, 2009, BRIT J CANCER, V100, P671, DOI 10.1038/sj.bjc.6604904; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Hotte SJ, 2010, CURR ONCOL, V17, pS72; Kaku T, 2011, BIOORGAN MED CHEM, V19, P6383, DOI 10.1016/j.bmc.2011.08.066; Schweizer Michael T, 2012, Ther Adv Urol, V4, P167, DOI 10.1177/1756287212452196; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	FEB	2015	75	2					373	380		10.1007/s00280-014-2654-y		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AZ8DT	WOS:000348445700017		
J	Yamamoto, N; Yokoyama, S; Ieda, J; Mitani, Y; Yamaguchi, S; Takifuji, K; Hotta, T; Matsuda, K; Watanabe, T; Shively, JE; Yamaue, H				Yamamoto, Naoyuki; Yokoyama, Shozo; Ieda, Junji; Mitani, Yasuyuki; Yamaguchi, Shunsuke; Takifuji, Katsunari; Hotta, Tsukasa; Matsuda, Kenji; Watanabe, Takashi; Shively, John E.; Yamaue, Hiroki			CEACAM1 and hollow spheroid formation modulate the chemosensitivity of colorectal cancer to 5-fluorouracil	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						CEACAM1; Hollow spheroid; Colorectal cancer; Chemoresistance; 5FU	CELL-ADHESION MOLECULE; INDEPENDENT PROGNOSTIC-SIGNIFICANCE; POLARIZED EPITHELIAL-CELLS; ANTIGEN GENE FAMILY; BILIARY GLYCOPROTEIN; CARCINOEMBRYONIC ANTIGEN; CYTOPLASMIC DOMAIN; INTERFERON-GAMMA; CARCINOMA CELLS; CD66A BGP	Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) re-expressed and promoted hollow spheroid (HS) formation beyond the invasion front of colorectal cancer. The aim of the present study was to clarify whether CEACAM1 cytoplasmic domain isoform balance and HS are associated with resistance to 5-fluorouracil (5FU). Two-dimensional (D) or 3D culture systems were employed to evaluate the effects of CEACAM1 cytoplasmic isoform balance and HS formation on the chemosensitivity of colorectal cancer cells to 5FU. The risk factors for postoperative recurrence were calculated based on the presence of HS and various clinicopathological characteristics in 82 patients with Stage III colorectal cancer who had undergone curative surgery followed by 5FU-based chemotherapy. CEACAM1-4L-transfected HT29 and CEACAM1-4L and 4S expressing parental LS174T cells had significantly higher resistance to 5FU in comparison with CEACAM1-4S- or vector control-transfected cells. In 3D culture, HS formation induced by CEACAM1-4L induced chemoresistance to 5FU, whereas the solid spheres formed in response to CEACAM1-4S were destroyed by 5FU treatment. HS was identified as an independent factor for recurrence of Stage III colorectal cancer after curative resection followed by 5FU-based chemotherapy. Kaplan-Meier survival curves demonstrated that patients with HS had lower recurrence-free survival rate. CEACAM1 long cytoplasmic domain isoform dominance and HS formation are phenotypes associated with chemoresistance to 5FU.	[Yamamoto, Naoyuki; Yokoyama, Shozo; Ieda, Junji; Mitani, Yasuyuki; Yamaguchi, Shunsuke; Takifuji, Katsunari; Hotta, Tsukasa; Matsuda, Kenji; Watanabe, Takashi; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan; [Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA	Yokoyama, S (reprint author), Wakayama Med Univ, Sch Med, Dept Surg 2, 811-1 Kimiidera, Wakayama 6418510, Japan.	yokoyama@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23591904]; Takeda Science Foundation, Japan	This study was supported by a Grant-in-Aid 23591904 from Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Takeda Science Foundation, Japan.	THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Nollau P, 1997, CANCER RES, V57, P2354; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Bamberger AM, 1998, AM J PATHOL, V152, P1401; Turbide C, 1997, CANCER RES, V57, P2781; Yokoyama S, 2007, ONCOGENE, V26, P7637, DOI 10.1038/sj.onc.1210577; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; Ieda J, 2011, INT J CANCER, V129, P1351, DOI 10.1002/ijc.26072; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Luo WP, 1999, CANCER GENE THER, V6, P313, DOI 10.1038/sj.cgt.7700055; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273; Kang WY, 2007, INT J COLORECTAL DIS, V22, P869, DOI 10.1007/s00384-006-0247-x; Ho DH, 1998, CLIN CANCER RES, V4, P2085; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Riethdorf L, 1997, J HISTOCHEM CYTOCHEM, V45, P957; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; BRUMMER J, 1995, ONCOGENE, V11, P1649; Chen CJ, 1996, J BIOL CHEM, V271, P28181; CHEN CJ, 1995, CANCER RES, V55, P3873; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Ozeki M, 2008, J LEUKOCYTE BIOL, V84, P769, DOI 10.1189/jlb.1207817; Sundberg U, 2004, J CELL SCI, V117, P1091, DOI 10.1242/jcs.00944; Sundberg U, 2002, J CELL SCI, V115, P1273; TAKAHASHI H, 1993, CANCER RES, V53, P1612; Tamura K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000179; Thies A, 2002, J CLIN ONCOL, V20, P2530, DOI 10.1200/JCO.2002.05.033; Wattanatorn W, 1997, PHARMACOTHERAPY, V17, P881	29	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	FEB	2015	75	2					421	430		10.1007/s00280-014-2662-y		10	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AZ8DT	WOS:000348445700022		
J	Teirstein, PS; Meredith, IT; Feldman, RL; Rabinowitz, AC; Cannon, LA; Lee, TC; Dens, J; Dubois, CL; Mooney, MR; Pompili, VJ; Saito, S; Allocco, DJ; Dawkins, KD; Stone, GW				Teirstein, Paul S.; Meredith, Ian T.; Feldman, Robert L.; Rabinowitz, A. Charles; Cannon, Louis A.; Lee, Tommy C.; Dens, Joseph; Dubois, Christophe L.; Mooney, Michael R.; Pompili, Vincent J.; Saito, Shigeru; Allocco, Dominic J.; Dawkins, Keith D.; Stone, Gregg W.			Two-Year Safety and Effectiveness of the Platinum Chromium Everolimus-Eluting Stent for the Treatment of Small Vessels and Longer Lesions	CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS			English	Article						coronary stenosis; everolimus; randomized controlled trial; stents; drug-eluting	CORONARY-ARTERY-DISEASE; BIODEGRADABLE POLYMER; RANDOMIZED-TRIALS; TAXUS LIBERTE; FOLLOW-UP; IMPLANTATION; THROMBOSIS; REVASCULARIZATION; OUTCOMES; METAANALYSIS	ObjectivesTo report 1- and 2-year clinical outcomes of patients receiving platinum chromium everolimus-eluting stents (PtCr-EES) in the prospective, single-arm PLATINUM small vessel (SV) and long lesion (LL) studies. BackgroundSmall vessel diameter and long lesion length are independently associated with increased risk of adverse cardiac events after drug-eluting stent implantation. MethodsThe PLATINUM SV study enrolled 94 patients with coronary artery lesions in vessels 2.25 mm to <2.50 mm in diameter and 28 mm in length. The PLATINUM LL study enrolled 102 patients with lesions >24 to 34 mm long in vessels 2.50 to 4.25 mm in diameter. The primary endpoint for both studies was target lesion failure (TLF) at 1 year compared to a prespecified performance goal based on outcomes with the TAXUS Express paclitaxel-eluting stent in small vessels and long lesions. ResultsOne-year TLF rates with the PtCr-EES were significantly (P<0.001) lower than the predetermined performance goals: 2.4% versus 21.1% in the SV cohort and 3.2% versus 19.4% in the LL cohort. Cumulative rates of TLF to 2 years were 4.7% in the SV cohort and 8.8% in the LL cohort. No myocardial infarction or ARC definite/probable stent thromboses occurred in either cohort through 2-year follow-up. ConclusionsThe clinical efficacy and safety outcomes observed in these small vessel and long lesion cohorts support the use of the PtCr-EES in the treatment of small diameter vessels and long lesions. (c) 2014 Wiley Periodicals, Inc.	[Teirstein, Paul S.] Scripps Clin, Div Cardiovasc Dis, La Jolla, CA 92037 USA; [Meredith, Ian T.] Monash Med Ctr, Southern Hlth, MonashHEART, Clayton, Vic 3168, Australia; [Feldman, Robert L.] Munroe Reg Med Ctr, Ocala, FL USA; [Rabinowitz, A. Charles] TexSan Heart Hosp, San Antonio, TX USA; [Cannon, Louis A.] McLaren Northern Michigan, Cardiac & Vasc Res Ctr, Petoskey, MI USA; [Lee, Tommy C.] Bakersfield Mem Hosp, Bakersfield, CA USA; [Dens, Joseph] Ziekenhuis Oost Limburg, Genk, Belgium; [Dubois, Christophe L.] Univ Hosp Leuven, Dept Cardiovasc Dis, Leuven, Belgium; [Dubois, Christophe L.] Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium; [Mooney, Michael R.] Minneapolis Heart Inst Fdn, Minneapolis, MN USA; [Pompili, Vincent J.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Saito, Shigeru] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan; [Allocco, Dominic J.; Dawkins, Keith D.] Boston Sci Corp, Marlborough, MA USA; [Stone, Gregg W.] Columbia Univ, New York Presbyterian Hosp, Med Ctr, New York, NY USA; Cardiovasc Res Fdn, New York, NY USA	Teirstein, PS (reprint author), Scripps Clin, 10666 North Torrey Pines Rd, La Jolla, CA 92037 USA.	Teirstein.Paul@scrippshealth.org			Boston Scientific Corporation, Natick, MA	Contract grant sponsor: Boston Scientific Corporation, Natick, MA.	Akiyama T, 1998, J AM COLL CARDIOL, V32, P1610, DOI 10.1016/S0735-1097(98)00444-6; Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; Turco MA, 2008, JACC-CARDIOVASC INTE, V1, P699, DOI 10.1016/j.jcin.2008.09.007; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396; Mamas MA, 2012, EUROINTERVENTION, V8, P196, DOI 10.4244/EIJV8I2A33; O'Brien BJ, 2010, BIOMATERIALS, V31, P3755, DOI 10.1016/j.biomaterials.2010.01.146; Marzocchi A, 2007, CIRCULATION, V115, P3181, DOI 10.1161/CIRCULATIONAHA.106.667592; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Kastrati A, 2006, CIRCULATION, V113, P2293, DOI 10.1161/CIRCULATIONAHA.105.601823; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Palmerini T, 2012, CIRC-CARDIOVASC INTE, V5, P357, DOI 10.1161/CIRCINTERVENTIONS.111.967083; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Stone GW, 2011, J AM COLL CARDIOL, V57, P1700, DOI 10.1016/j.jacc.2011.02.016; Cannon LA, 2011, EUROINTERVENTION, V6, P920, DOI 10.4244/EIJV6I8A161; Kereiakes DJ, 2012, EUROINTERVENTION, V8, P187, DOI 10.4244/EIJV8I2A32; Bartorelli AL, 2010, CATHETER CARDIO INTE, V76, P60, DOI 10.1002/ccd.22452; Hernandez JMD, 2011, J AM COLL CARDIOL, V58, pB68; Farb A, 2002, CIRCULATION, V106, P2379, DOI 10.1161/01.CIR.0000033973.06059.04; Kereiakes Dean J, 2004, Rev Cardiovasc Med, V5 Suppl 2, pS34; Menown IBA, 2010, ADV THER, V27, P129, DOI 10.1007/s12325-010-0022-9; Meredith I, 2011, EUROINTERVENTION SM, V7, pM157; Mutoh M, 2007, CIRC J, V71, P1328, DOI 10.1253/circj.71.1328; Sarno G, 2013, INT J CARDIOL, V167, P148; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Turco MA, 2012, J INTERV CARDIOL, V25, P353, DOI 10.1111/j.1540-8183.2012.00737.x; Wykrzykowska JJ, 2009, EUROINTERVENTION, V5, P310, DOI 10.4244/V5I3A49; Wykrzykowska JJ, 2009, JACC-CARDIOVASC INTE, V2, P861, DOI 10.1016/j.jcin.2009.05.024	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1522-1946	1522-726X		CATHETER CARDIO INTE	Catheter. Cardiovasc. Interv.	FEB 1	2015	85	2					207	215		10.1002/ccd.25565		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AZ9BA	WOS:000348505000008		
J	Symss, NP; Oi, S				Symss, Nigel Peter; Oi, Shizuo			Is there an ideal shunt? A panoramic view of 110 years in CSF diversions and shunt systems used for the treatment of hydrocephalus: from historical events to current trends	CHILDS NERVOUS SYSTEM			English	Review						Hydrocephalus; Shunts; CSF diversion; Complications	NORMAL-PRESSURE HYDROCEPHALUS; VENTRICULO-ATRIAL SHUNTS; ADJUSTABLE VALVE SOPHY; CEREBROSPINAL-FLUID; TECHNICAL NOTE; SINUS SHUNT; BLOOD-FLOW; ENDOSCOPIC AQUEDUCTOPLASTY; INFANTILE HYDROCEPHALUS; LUMBOPERITONEAL SHUNTS	The goal of this study is to evaluate whether an "ideal shunt" exists. This is a retrospective analysis based on original papers in the field of Hydrocephalus and Shunts. Patients of all age groups, who had hydrocephalus, and underwent some form of CSF diversion were included. The study has been divided into four stages: from 1900 to 1949, 1950 to 1974, 1975 to 1999, and from 2000 to 2010. In stage 1 (historical era): Saphenous vein grafts, rubber conduits, and other materials were used in CSF diversions. In 1949, the first implantable shunt tube was developed by Nulsen. In stage 2 (experimental stage): the Holter valve was developed. Newer innovations were developed in relation to the ventriculo-atrial shunt, which was the preferred CSF diversion. In stage 3 (developmental stage), a large number of different design shunt systems were developed, with the aim of reducing complications. The ventriculo-peritoneal shunt had become the preferred CSF diversion. Also, the programmable valve was born. In stage 4 (era of programmable valve, there is a preference for the use of programmable shunt systems. However, shunt failure rate at 1 year being around 25 to 40 %, and shunt survival at 1 and 2 years are 50-70 and 47-53 % in most series. Every shunt is an ideal shunt provided the choice of the shunt used should be made by the matching performance of the shunt system to the altered profile of CSF dynamics of a given patient. The most important factor being the opening pressure.	[Symss, Nigel Peter] Global Neurosci, Div Pediat Neurosurg, Madras 600100, Tamil Nadu, India; [Oi, Shizuo] Laureate Int Univ Hlth Sci Asia, St Thomas Univ, Amagasaki, Hyogo, Japan	Symss, NP (reprint author), Global Neurosci, Div Pediat Neurosurg, Sholinganallur Rd, Madras 600100, Tamil Nadu, India.	nigelpetersymss@gmail.com					Ahn ES, 2007, CHILD NERV SYST, V23, P297, DOI 10.1007/s00381-006-0236-y; Ames CD, 2001, J UROLOGY, V165, P1169, DOI 10.1016/S0022-5347(05)66458-0; AMES RH, 1967, J NEUROSURG, V27, P525, DOI 10.3171/jns.1967.27.6.0525; AMMAR A, 1995, CHILD NERV SYST, V11, P421, DOI 10.1007/BF00717410; KEUCHER TR, 1979, J NEUROSURG, V50, P179, DOI 10.3171/jns.1979.50.2.0179; Pandey A, 2009, PEDIATR NEUROSURG, V45, P6, DOI 10.1159/000202618; SAINTEROSE C, 1987, J NEUROSURG, V66, P213, DOI 10.3171/jns.1987.66.2.0213; Albright AL, 2001, NEUROSURGERY, V48, P764, DOI 10.1097/00006123-200104000-00013; ELSHAFEI IL, 1987, CHILD NERV SYST, V3, P342, DOI 10.1007/BF00270704; DIROCCO C, 1994, CHILD NERV SYST, V10, P321; El-Shafei IL, 2001, CHILD NERV SYST, V17, P457, DOI 10.1007/s003810100456; Enger PO, 2003, ACTA NEUROCHIR, V145, P243, DOI 10.1007/s00701-002-1068-5; Jea A, 2007, J NEUROSURG, V106, P421, DOI 10.3171/ped.2007.106.6.421; GOWER DJ, 1984, J NEUROSURG, V61, P1079, DOI 10.3171/jns.1984.61.6.1079; OI S, 1986, CHILD NERV SYST, V2, P282, DOI 10.1007/BF00271938; Czosnyka Z, 1998, NEUROSURGERY, V42, P327, DOI 10.1097/00006123-199802000-00069; El Shafei IL, 2005, PEDIATR NEUROSURG, V41, P305, DOI 10.1159/000088733; ELSHAFEI IL, 1985, CHILD NERV SYST, V1, P200, DOI 10.1007/BF00270762; Sagan LM, 2006, J NEUROSURG, V105, P275, DOI 10.3171/ped.2006.105.4.275; MATSON DD, 1951, J NEUROSURG, V8, P398, DOI 10.3171/jns.1951.8.4.0398; Ersahin Y, 2007, CHILD NERV SYST, V23, P143, DOI 10.1007/s00381-006-0227-z; Drake JM, 1998, NEUROSURGERY, V43, P294, DOI 10.1097/00006123-199808000-00068; SCARFF JE, 1963, J NEUROL NEUROSUR PS, V26, P1, DOI 10.1136/jnnp.26.1.1; Czosnyka Z, 1998, ACT NEUR S, V71, P334; Cinalli G, 2006, J NEUROSURG, V104, P21, DOI 10.3171/ped.2006.104.1.21; Anthogalidis EI, 1999, CLIN NEUROL NEUROSUR, V101, P203, DOI 10.1016/S0303-8467(99)00036-0; Arnell K, 2006, EUR J PEDIATR SURG, V16, P1, DOI 10.1055/s-2006-923904; BECKER DP, 1968, J NEUROSURG, V28, P215, DOI 10.3171/jns.1968.28.3.0215; Belliard H, 1996, NEUROCHIRURGIE, V42, P139; Bhasin RR, 2007, CHILD NERV SYST, V23, P483, DOI 10.1007/s00381-006-0292-3; BIDDLE A, 1966, J NEUROSURG, V24, P760, DOI 10.3171/jns.1966.24.4.0760; BLACK PM, 1994, NEUROSURGERY, V34, P1110; Borgbjerg BM, 1998, ACTA NEUROCHIR, V140, P459, DOI 10.1007/s007010050125; BRIHAYE J, 1954, Acta Neurochir (Wien), V4, P1, DOI 10.1007/BF01413613; Britz GW, 1998, PEDIATR NEUROSURG, V29, P161, DOI 10.1159/000028713; Chang C C, 1999, Neurosurg Focus, V7, pe8; Cheng JYS, 2007, ACTA NEUROCHIR, V149, P1269, DOI 10.1007/s00701-007-1413-9; CHIDIAC A, 1992, NEUROCHIRURGIE, V38, P291; CHOUX M, 1992, J NEUROSURG, V77, P875, DOI 10.3171/jns.1992.77.6.0875; CHUMAS PD, 1993, NEUROSURGERY, V32, P376; Constantini S, 2001, CHILD NERV SYST, V17, P466, DOI 10.1007/s003810100474; Dandy W, 1920, SURG GYNECOL OBSTET, V31, P340; Davis SE, 2000, PEDIATR NEUROSURG, V33, P58, DOI 10.1159/000028988; Drake JM, 1995, THE SHUNT BOOK, P121; EISENBER.HM, 1971, J NEUROSURG, V35, P427, DOI 10.3171/jns.1971.35.4.0427; ELSHAFEI IL, 1975, CHILD BRAIN, V1, P311; Eymann R, 2007, J NEUROSURG S, V106, P179; Fein J M, 1973, Surg Neurol, V1, P205; Ferguson AH, 1898, NY MED J, V67, P902; FISCHER EG, 1969, J NEUROSURG, V31, P441, DOI 10.3171/jns.1969.31.4.0441; Frazier JL, 2002, NEUROSURGERY, V51, P819, DOI 10.1227/01.NEU.0000024284.80115.29; Frim DM, 2001, PEDIATR NEUROSURG, V34, P73, DOI 10.1159/000055998; George E, 1953, PEDIATRICS, V12, P326; Gupta PK, 2000, NEUROL INDIA, V48, P89; Gutierrez Lara F, 1975, J NEUROSURG, V42, P104; Hahn Y S, 1976, Yonsei Med J, V17, P157; Hakim C, 1985, THESIS MIT CAMBRIDGE; HAKIM S, 1973, DEV MED CHILD NEUROL, V15, P646; HAMMON WM, 1971, J NEUROSURG, V34, P792, DOI 10.3171/jns.1971.34.6.0792; Hanlo PW, 2003, J NEUROSURG, V99, P52, DOI 10.3171/jns.2003.99.1.0052; Hansasuta Ake, 2007, Journal of the Medical Association of Thailand, V90, P473; HARSH GR, 1954, J NEUROSURG, V11, P284, DOI 10.3171/jns.1954.11.3.0284; Hebb AO, 2001, NEUROSURGERY, V49, P1166, DOI 10.1097/00006123-200111000-00028; Heile B, 1925, ZBL CHIR, V52, P2229; Heile B, 1908, DTSCH MED WCHNSCHR, V24, P1468; HOFFMAN HJ, 1976, J NEUROSURG, V44, P258, DOI 10.3171/jns.1976.44.2.0258; HOOPER R, 1969, J NEUROSURG, V30, P93, DOI 10.3171/jns.1969.30.1.0093; Kanai Makoto, 1999, Osaka City Medical Journal, V45, P123; Kausch W, 1908, ARCH KLIN CHIR, V87, P709; Keifer M, 2006, ACTA NEUROCHIR S, V96, P343; Kestle JRW, 2005, J NEUROSURG, V102, P141, DOI 10.3171/jns.2005.102.2.0141; Khorasani L, 2004, PEDIATR NEUROSURG, V40, P270, DOI 10.1159/000083739; KIRSCH WM, 1970, J NEUROSURG, V32, P258, DOI 10.3171/jns.1970.32.2.0258; Kondageski C, 2007, J NEUROSURG, V106, P95, DOI 10.3171/ped.2007.106.2.95; Lam CH, 1997, BRIT J NEUROSURG, V11, P43; LAMESCH AJ, 1972, J PEDIATR SURG, V7, P55, DOI 10.1016/0022-3468(72)90404-6; LEE JH, 1992, NEUROSURGERY, V30, P249; LUMENTA CB, 1990, CHILD NERV SYST, V6, P270, DOI 10.1007/BF00307663; Martin JE, 2003, PEDIATR NEUROSURG, V38, P94, DOI 10.1159/000068052; MATSON DD, 1953, PEDIATRICS, V12, P326; Matushita H, 2008, CHILD NERV SYST, V24, P949, DOI 10.1007/s00381-008-0591-y; Mauer UM, 2007, J NEUROSURG, V107, P788, DOI 10.3171/JNS-07/10/0788; McCullough DC, 1990, HYDROCEPHALUS, V3, P1; MCIVOR J, 1988, J PEDIATR ORTHOPED, V8, P687; Meier U, 2006, ACT NEUR S, V96, P368; MILHORAT TH, 1975, J NEUROSURG, V42, P605, DOI 10.3171/jns.1975.42.5.0605; Mohanty A, 2006, J NEUROSURG, V105, P348, DOI 10.3171/ped.2006.105.5.348; MOZINGO JR, 1974, SURG NEUROL, V2, P195; Nakajima M, 2009, J NEUROSURG, V111, P618, DOI 10.3171/2009.1.JNS08204; Nishimoto SH, 1970, J NEUROSURG, V33, P602; Novelli PM, 1997, PEDIATR NEUROSURG, V26, P197, DOI 10.1159/000121191; NUGENT GR, 1966, J NEUROSURG, V24, P34, DOI 10.3171/jns.1966.24.1.0034; Nulsen FE, 1952, SURG FORUM, V2, P399; OI S, 1985, CHILD NERV SYST, V1, P189, DOI 10.1007/BF00270760; OI S, 1989, CHILD NERV SYST, V5, P76, DOI 10.1007/BF00571114; Oi S, 1986, J PEDIAT NEUROSCI, V2, P125; OI S, 1991, J NEUROSURG, V74, P371, DOI 10.3171/jns.1991.74.3.0371; OI S, 1985, NEUROSURGERY, V17, P891; Oi S, 1991, CURR TR HYD, V1, P39; OVERTON MC, 1966, J NEUROSURG, V25, P164, DOI 10.3171/jns.1966.25.2.0164; OVERTON MC, 1965, J NEUROSURG, V23, P517, DOI 10.3171/jns.1965.23.5.0517; Rohde V, 2009, J NEUROS-PEDIATR, V3, P90, DOI 10.3171/2008.11.PEDS08154; SAINTE-ROSE C, 1991, Pediatric Neurosurgery, V17, P2, DOI 10.1159/000120557; Samadani U, 2003, NEUROSURGERY, V53, P778, DOI 10.1227/01.NEU.0000080071.17465.2A; SAMUELSO.S, 1972, J NEUROSURG, V37, P548, DOI 10.3171/jns.1972.37.5.0548; Schulder M, 1999, SURG NEUROL, V51, P27, DOI 10.1016/S0090-3019(97)00433-3; Sciubba DM, 2007, CHILD NERV SYST, V23, P867, DOI 10.1007/s00381-007-0334-5; SMITH JA, 1980, J UROLOGY, V123, P224; Sood S, 1999, CHILD NERV SYST, V15, P246, DOI 10.1007/s003810050383; Spitz EB, 1952, PEDIATR CLIN N AM, V6, P1215; Spoerri O, 1969, J Neurosurg, V30, P752, DOI 10.3171/jns.1969.30.6.0752; Sprung C, 1996, CHILD NERV SYST, V12, P573; STEINBOK P, 1994, CHILD NERV SYST, V10, P536, DOI 10.1007/BF00335079; Surfield GA, 2006, J PEDIATR SURG, V41, P1933, DOI 10.1016/j.jpedsurg.2006.07.017; Takahashi Y, 2001, CHILD NERV SYST, V17, P472, DOI 10.1007/s003810000424; Takeda N, 2002, CHILD NERV SYST, V18, P238, DOI 10.1007/s00381-002-0559-2	116	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2015	31	2					191	202		10.1007/s00381-014-2608-z		12	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AZ8ED	WOS:000348446700004		
J	Yamashita, M; Akai, T; Kishibe, M; Shimada, K				Yamashita, Masanobu; Akai, Takuya; Kishibe, Miyuki; Shimada, Kenichi			One-piece bone flap osteotomy using thread wire saw for fronto-orbital advancement with distraction osteogenesis in craniosynostosis	CHILDS NERVOUS SYSTEM			English	Article						Craniosynostosis; Fronto-orbital advancement; Distraction osteogenesis; Thread wire saw; T-saw	CRANIOFACIAL SYNOSTOSIS; GRADUAL DISTRACTION	The objectives of this study are to describe our new technique of one-piece bone flap osteotomy for fronto-orbital advancement with distraction osteogenesis in craniosynostosis using a thin, flexible, and safe thread wire saw (the T-saw) and to compare the results with those of classic osteotomy using an osteotome. Initial osteotomy is performed between two pterion burr holes using a craniotome with a guarded footplate. The outer sphenoid wing and lateral orbital rim are separated using a reciprocating saw. Limited dura dissection from inner cortex between burr holes in the pterion and nasion is performed. The T-saw is inserted through the epidural space behind the superior orbital wall between the lateral orbital rim and nasion burr hole; the osteotomy is performed with gentle reciprocating strokes. Dura protection with a malleable retractor is not absolutely necessary. Five patients underwent one-piece fronto-orbital bone flap osteotomies using a T-saw in 2009-2014. The median age was 26 months (7-132 months), median operation time was 275 min (183-303 min), and median estimated blood loss was 65 mL (20-250 mL). These values did not differ from those of control cases. No complications, including incomplete osteotomy, occurred. The T-saw creates an osteotomy as a "one-stroke sketch," so incomplete osteotomy never occurs. The osteotomy can be performed safely without protecting the dura. Osteotomy with T-saw does not negate the advantages of fronto-orbital advancement with distraction osteogenesis, including shorter operative time, less intraoperative bleeding, and fewer complications.	[Yamashita, Masanobu; Kishibe, Miyuki; Shimada, Kenichi] Kanazawa Med Univ, Dept Plast & Reconstruct Surg, Uchinada, Ishikawa 9200293, Japan; [Akai, Takuya] Kanazawa Med Univ, Dept Neurosurg, Uchinada, Ishikawa 9200293, Japan	Yamashita, M (reprint author), Kanazawa Med Univ, Dept Plast & Reconstruct Surg, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	m-y@kanazawa-med.ac.jp					Sugawara Y, 1998, ANN PLAS SURG, V40, P554, DOI 10.1097/00000637-199805000-00021; MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1; Akai T, 2006, PEDIATR NEUROSURG, V42, P288, DOI 10.1159/000094064; Angelini A, 2013, SPINE, V38, pE185, DOI 10.1097/BRS.0b013e31827db1ba; Hirabayashi S, 1998, J NEUROSURG, V89, P1058, DOI 10.3171/jns.1998.89.6.1058; Kawahara N, 1999, SPINE, V24, P1363, DOI 10.1097/00007632-199907010-00015; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; MARCHAC D, 1978, PLAST RECONSTR SURG, V61, P823, DOI 10.1097/00006534-197861060-00001; Shimizu S, 2011, SKULL BASE-INTERD AP, V21, P322, DOI 10.1055/s-0031-1284214; Tomita K, 1996, J BONE JOINT SURG AM, V78A, P1915; Yonehara Y, 2003, J CRANIOFAC SURG, V14, P526, DOI 10.1097/00001665-200307000-00025	11	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2015	31	2					279	283		10.1007/s00381-014-2554-9		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AZ8ED	WOS:000348446700014		
J	Hayakawa, H; Samura, T; Kamijo, TC; Sakai, Y; Aihara, T				Hayakawa, Hirofumi; Samura, Toshikazu; Kamijo, Tadanobu Chuyo; Sakai, Yutaka; Aihara, Takeshi			Spatial information enhanced by non-spatial information in hippocampal granule cells	COGNITIVE NEURODYNAMICS			English	Article						Dentate gyrus; Granule cell model; Temporal pattern discrimination; Spatial and non-spatial information	THETA PHASE PRECESSION; ENTORHINAL CORTEX; DORSAL HIPPOCAMPUS; DECLARATIVE MEMORY; FASCIA DENTATA; RAT; SEQUENCES; OSCILLATIONS; CONNECTIONS; CORTICES	The hippocampus organizes sequential memory composed of non-spatial information (such as objects and odors) and spatial information (places). The dentate gyrus (DG) in the hippocampus receives two types of information from the lateral and medial entorhinal cortices. Non-spatial and spatial information is delivered respectively to distal and medial dendrites (MDs) of granule cells (GCs) within the molecular layer in the DG. To investigate the role of the association of those two inputs, we measured the response characteristics of distal and MDs of a GC in a rat hippocampal slice and developed a multi-compartment GC model with dynamic synapses; this model reproduces the response characteristics of the dendrites. Upon applying random inputs or input sequences generated by a Markov process to the computational model, it was found that a high-frequency random pulse input to distal dendrites (DDs) and, separately, regular burst inputs to MDs were effective for inducing GC activation. Furthermore, when the random and theta burst inputs were simultaneously applied to the respective dendrites, the pattern discrimination for theta burst input to MDs that caused slight GC activation was enhanced in the presence of random input to DDs. These results suggest that the temporal pattern discrimination of spatial information is originally involved in a synaptic characteristic in GCs and is enhanced by non-spatial information input to DDs. Consequently, the co-activation of two separate inputs may play a crucial role in the information processing on dendrites of GCs by usefully combing each temporal sequence.	[Hayakawa, Hirofumi; Sakai, Yutaka; Aihara, Takeshi] Tamagawa Univ, Grad Sch Brain Sci, Machida, Tokyo 1948610, Japan; [Samura, Toshikazu] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Kamijo, Tadanobu Chuyo] NIPS, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi, Japan	Aihara, T (reprint author), Tamagawa Univ, Grad Sch Brain Sci, 6-1-1 Tamagawagakuen, Machida, Tokyo 1948610, Japan.	aihara@eng.tamagawa.ac.jp			Global COE Program at Tamagawa University; MEXT KAKENHI [21120006, 23500186]	We thank Dr. Satoshi Fujii of Yamagata Univ., Dr Hatsuo Hayashi of Kyushu Institute of Technology, Drs. Kyonsoo Hong and Makoto Nishiyama of New York University, and Dr. Hideaki Shimazaki of RIKEN BSI for valuable discussion and advice. We also thank Drs. Yasuhiro Fukushima, for technical assistance. This work was supported by the Global COE Program at Tamagawa University and MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2009-2013): MEXT KAKENHI Grant Number 21120006, 23500186.	Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Pignatelli M, 2012, J PHYSIOL-PARIS, V106, P81, DOI 10.1016/j.jphysparis.2011.09.007; Young BJ, 1997, J NEUROSCI, V17, P5183; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Yamaguchi Y, 2003, BIOL CYBERN, V89, P1, DOI 10.1007/s00422-003-0415-9; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Xu W, 2012, NEUROSCIENCE, V223, P12, DOI 10.1016/j.neuroscience.2012.07.067; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Bi GQ, 1998, J NEUROSCI, V18, P10464; ALONSO A, 1987, EXP BRAIN RES, V67, P502, DOI 10.1007/BF00247283; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Yoganarasimha D, 2011, HIPPOCAMPUS, V21, P1363, DOI 10.1002/hipo.20839; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Ferrante M, 2009, P NATL ACAD SCI USA, V106, P18004, DOI 10.1073/pnas.0904784106; Hampson RE, 1999, NATURE, V402, P610; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Hayashi H, 2011, NEURAL NETWORKS, V24, P233, DOI 10.1016/j.neunet.2010.12.004; HJORTHSI.A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; HJORTHSI.A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; Igarashi J, 2007, COGN NEURODYNAMICS, V1, P169, DOI 10.1007/s11571-006-9003-8; Ishizuka S, 2004, BRAIN INSP IT 1 1 M; Sullivan D, 2014, J NEUROSCI, V34, P662, DOI 10.1523/JNEUROSCI.0552-13.2014; Wagatsuma H, 2007, COGN NEURODYNAMICS, V1, P119, DOI 10.1007/s11571-006-9013-6	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics	FEB	2015	9	1					1	12		10.1007/s11571-014-9309-x		12	Neurosciences	Neurosciences & Neurology	AZ7BR	WOS:000348373800001		
J	Pelucchi, M; Somers, KP; Yasunaga, K; Burke, U; Frassoldati, A; Ranzi, E; Curran, HJ; Faravelli, T				Pelucchi, Matteo; Somers, Kieran P.; Yasunaga, Kenji; Burke, Ultan; Frassoldati, Alessio; Ranzi, Eliseo; Curran, Henry J.; Faravelli, Tiziano			An experimental and kinetic modeling study of the pyrolysis and oxidation of n-C-3-C-5 aldehydes in shock tubes	COMBUSTION AND FLAME			English	Article						Aldehydes; Shock tube; Kinetic modeling; Ignition delay time; Pyrolysis	JET-STIRRED REACTOR; TEMPERATURE-COEFFICIENT REGIME; HEAVY-DUTY VEHICLES; THERMAL-DECOMPOSITION; ACETALDEHYDE OXIDATION; PROPANAL OXIDATION; ORGANIC-COMPOUNDS; OXYGENATED FUELS; COMBUSTION BOMB; DIESEL-ENGINE	Due to the increasing interest in the use of biofuels for energy production, it is of great importance to better understand the combustion and thermal decomposition characteristics of species such as aldehydes. These are known to be key intermediate products of transport fossil and bio-fuels combustion and are also dangerous pollutants emitted from combustion in internal combustion engines and from gasification of biomasses. In this study, an experimental and kinetic modeling investigation of propanal, n-butanal and n-pentanal pyrolysis and oxidation in two shock tube facilities was carried out. Experiments were performed in a single pulse shock tube to determine the speciation profiles of the fuels and intermediate species under pyrolysis conditions for mixture of pure propanal/n-butanal/n-pentanal (3%)-Ar (97%), at averaged reflected pressure of 1.9 atm and at reflected shock temperatures of 972-1372 K. Additionally, ignition delay times for mixtures of pure propanal/n-butanal/n-pentanal (1%)-O-2/Ar were measured in the temperature range 1136-1847 K, at pressures of 1 and 3 atm, and at equivalence ratios of 0.5, 1.0 and 2.0. A comprehensive sub-mechanism for the high temperature kinetics of the three aldehydes was developed. This scheme was then coupled with NUIG (National University of Ireland, Galway) and POLIMI (Politecnico di Milano) C-0-C-4 kinetic schemes. The inclusion of the aldehydes sub-mechanism in two different kinetic environments, required modifications for the H-abstraction reactions, due to different rate rules in use in the two kinetic environments, and due to differences in the C-0-C-4 kinetic schemes. Both of the models were validated and showed good agreement with the new experimental data. The mechanisms are also satisfactorily compared with ignition delay times, speciation profiles and laminar burning velocities previously published in literature. Reaction pathways and sensitivity analyses were also performed to highlight the important reaction steps involved in the pyrolysis and oxidation processes. The major differences between the models and the experiments have to be attributed to the chemistry of the smaller species, more than to aldehyde specific reactions. This work further highlights the relevant role of the C-0-C-4 sub-mechanism, mainly in terms of a unification process that needs to start from the smaller species chemistry in order to obtain an unambiguous description of any fuel investigated. (C) 2014 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Pelucchi, Matteo; Frassoldati, Alessio; Ranzi, Eliseo; Faravelli, Tiziano] Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-20133 Milan, Italy; [Somers, Kieran P.; Burke, Ultan; Curran, Henry J.] Natl Univ Ireland, Combust Chem Ctr, Galway, Ireland; [Yasunaga, Kenji] Natl Def Acad, Dept Appl Chem, Yokosuka, Kanagawa 2398686, Japan	Pelucchi, M (reprint author), Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.	matteo.pelucchi@polimi.it		Somers, Kieran Patrick/0000-0001-7007-4492; Frassoldati, Alessio/0000-0003-0264-438X; Faravelli, Tiziano/0000-0001-8382-7342			Abrantes R. d., 2005, REV SAUDE PUBL, V39, P479; Akih-Kumgeh B, 2011, COMBUST FLAME, V158, P1877, DOI 10.1016/j.combustflame.2011.02.015; RITTER ER, 1991, INT J CHEM KINET, V23, P767, DOI 10.1002/kin.550230903; Yasunaga K, 2012, COMBUST FLAME, V159, P2009, DOI 10.1016/j.combustflame.2012.02.008; RANZI E, 1994, COMBUST FLAME, V99, P201, DOI 10.1016/0010-2180(94)90123-6; Heufer KA, 2012, ENERG FUEL, V26, P6678, DOI 10.1021/ef3012596; HIDAKA Y, 1993, COMBUST FLAME, V92, P365, DOI 10.1016/0010-2180(93)90149-W; He BQ, 2003, ATMOS ENVIRON, V37, P4965, DOI 10.1016/j.atmosenv.2003.08.029; Ranzi E, 2001, PROG ENERG COMBUST, V27, P99, DOI 10.1016/S0360-1285(00)00013-7; Zador J, 2009, PHYS CHEM CHEM PHYS, V11, P11040, DOI 10.1039/b915707g; Chang AY, 2000, Z PHYS CHEM, V214, P1533, DOI 10.1524/zpch.2000.214.11.1533; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Vasu SS, 2013, ENERG FUEL, V27, P7072, DOI 10.1021/ef401406z; Simmie JM, 2012, J PHYS CHEM A, V116, P4528, DOI 10.1021/jp301870w; LIFSHITZ A, 1990, J PHYS CHEM-US, V94, P2966, DOI 10.1021/j100370a043; Healy D, 2010, ENERG FUEL, V24, P1521, DOI 10.1021/ef9011005; Kasper T, 2009, P COMBUST INST, V32, P1285, DOI 10.1016/j.proci.2008.06.040; Buzzi-Ferraris G, 2012, COMPUT-AIDED CHEM EN, V30, P1312; Grana R, 2010, COMBUST FLAME, V157, P2137, DOI 10.1016/j.combustflame.2010.05.009; DEAN AM, 1980, COMBUST FLAME, V37, P41, DOI 10.1016/0010-2180(80)90070-X; Schauer JJ, 2002, ENVIRON SCI TECHNOL, V36, P1169, DOI 10.1021/es0108077; Oehlschlaeger MA, 2005, P COMBUST INST, V30, P1119, DOI 10.1016/j.proci.2004.07.032; Frassoldati A, 2012, COMBUST FLAME, V159, P2295, DOI 10.1016/j.combustflame.2012.03.002; Mendes J, 2013, J PHYS CHEM A, V117, P4515, DOI 10.1021/jp4000413; Roman-Leshkov Y, 2007, NATURE, V447, P982, DOI 10.1038/nature05923; Zhang JX, 2013, COMBUST FLAME, V160, P1541, DOI 10.1016/j.combustflame.2013.04.002; Curran HJ, 2006, INT J CHEM KINET, V38, P250, DOI 10.1002/kin.20153; Dooley S, 2008, COMBUST FLAME, V153, P2, DOI 10.1016/j.combustflame.2008.01.005; Ranzi E, 2012, PROG ENERG COMBUST, V38, P468, DOI 10.1016/j.pecs.2012.03.004; Sarathy SM, 2013, COMBUST FLAME, V160, P2712, DOI 10.1016/j.combustflame.2013.06.022; Eiteneer B, 1998, J PHYS CHEM A, V102, P5196, DOI 10.1021/jp981184v; He PJ, 2012, J AIR WASTE MANAGE, V62, P461, DOI 10.1080/10962247.2012.658954; Ballesteros R, 2012, FUEL, V95, P136, DOI 10.1016/j.fuel.2011.09.012; BENSON SW, 1958, J CHEM PHYS, V29, P546, DOI 10.1063/1.1744539; Smith JM, 2005, INT J CHEM KINET, V37, P728, DOI 10.1002/kin.20120; Black G, 2010, COMBUST FLAME, V157, P363, DOI 10.1016/j.combustflame.2009.07.007; Frassoldati A, 2010, COMBUST FLAME, V157, P2, DOI 10.1016/j.combustflame.2009.09.002; Sarathy SM, 2009, COMBUST FLAME, V156, P852, DOI 10.1016/j.combustflame.2008.11.019; Matheu DM, 2003, INT J CHEM KINET, V35, P95, DOI 10.1002/kin.10106; Keromnes A, 2013, COMBUST FLAME, V160, P995, DOI 10.1016/j.combustflame.2013.01.001; Glarborg P, 2003, COMBUST FLAME, V132, P629, DOI 10.1016/S0010-2180(02)00535-7; Sarathy SM, 2012, COMBUST FLAME, V159, P2028, DOI 10.1016/j.combustflame.2011.12.017; da Silva G, 2006, J PHYS CHEM A, V110, P13058, DOI 10.1021/jp063772b; Curran HJ, 1998, COMBUST FLAME, V114, P149, DOI 10.1016/S0010-2180(97)00282-4; Ranzi E, 2014, CHEM ENG SCI, V110, P2, DOI 10.1016/j.ces.2013.08.014; Zhou CW, 2011, PHYS CHEM CHEM PHYS, V13, P11175, DOI 10.1039/c0cp02754e; Davidson DF, 2010, J PROPUL POWER, V26, P280, DOI 10.2514/1.44034; Healy D, 2010, COMBUST FLAME, V157, P1526, DOI 10.1016/j.combustflame.2010.01.016; Barker JR, 2009, INT J CHEM KINET, V41, P748, DOI 10.1002/kin.20447; Veloo PS, 2013, COMBUST FLAME, V160, P1609, DOI 10.1016/j.combustflame.2013.03.018; Manca D, 2001, COMBUST THEOR MODEL, V5, P185, DOI 10.1088/1364-7830/5/2/304; GROSJEAN D, 1982, ENVIRON SCI TECHNOL, V16, P254, DOI 10.1021/es00099a005; Barker JR, 2001, INT J CHEM KINET, V33, P232, DOI 10.1002/kin.1017; Correa SM, 2008, ATMOS ENVIRON, V42, P769, DOI 10.1016/j.atmosenv.2007.09.073; HIDAKA Y, 1993, INT J CHEM KINET, V25, P305, DOI 10.1002/kin.550250409; Poulopoulos SG, 2001, ATMOS ENVIRON, V35, P4399, DOI 10.1016/S1352-2310(01)00248-5; HIDAKA Y, 1989, INT J CHEM KINET, V21, P643, DOI 10.1002/kin.550210805; Togbe C, 2011, P COMBUST INST, V33, P367, DOI 10.1016/j.proci.2010.05.003; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Burcat A., 2005, CHEMISTRY; Burke S.M., 2013, THESIS NATL U IRELAN; Cahill TM, 2012, ENVIRON SCI TECHNOL, V46, P8382, DOI 10.1021/es301659u; CAVANAGH J, 1990, COMBUST FLAME, V82, P15, DOI 10.1016/0010-2180(90)90075-3; Cuoci A., 2011, 34 M IT SECT COMB I; Dagaut P, 1995, COMBUST SCI TECHNOL, V107, P301, DOI 10.1080/00102209508907809; DEAN AM, 1985, J PHYS CHEM-US, V89, P4600, DOI 10.1021/j100267a038; Dente M., 2007, ADV CHEM ENG, V32, P51; DIMAIO FP, 1993, COMBUST SCI TECHNOL, V91, P119; Friedrichs G, 2002, INT J CHEM KINET, V34, P374, DOI 10.1002/kin.10059; Galmiche B, 2011, ENERG FUEL, V25, P2013, DOI 10.1021/ef2003552; GRAY P, 1981, P ROY SOC LOND A MAT, V374, P313, DOI 10.1098/rspa.1981.0025; Grosjean D, 2001, ENVIRON SCI TECHNOL, V35, P45, DOI 10.1021/es001326a; HALSTEAD MP, 1971, PROC R SOC LON SER-A, V322, P377, DOI 10.1098/rspa.1971.0074; Hanson R., 2014, PROGR ENERGY COMBUST; Healy D, 2010, ENERG FUEL, V24, P1617, DOI 10.1021/ef901292j; Hidaka Y, 2005, Shock Waves, Vols 1 and 2, Proceedings, P603, DOI 10.1007/978-3-540-27009-6_90; Hidaka Y, 1996, COMBUST FLAME, V106, P155, DOI 10.1016/0010-2180(95)00252-9; HIDAKA Y, 1985, INT J CHEM KINET, V17, P441, DOI 10.1002/kin.550170410; Hidaka Y, 1996, COMBUST FLAME, V107, P401, DOI 10.1016/S0010-2180(96)00094-6; HOCHGREB S, 1992, COMBUST FLAME, V91, P257, DOI 10.1016/0010-2180(92)90058-W; Huynh L.K., 2007, 2007 ANN M 2007; KAISER EW, 1986, INT J CHEM KINET, V18, P655, DOI 10.1002/kin.550180606; KAISER EW, 1987, INT J CHEM KINET, V19, P457, DOI 10.1002/kin.550190506; Karavalakis G, 2012, FUEL, V102, P85, DOI 10.1016/j.fuel.2012.05.030; Kassel LS, 1928, J PHYS CHEM-US, V32, P225, DOI 10.1021/j150284a007; Kee R.J., 2005, CHEM REACTING FLOW T, P496; Kee R.J., 1989, SANDIA NATL LAB; Li J, 2007, INT J CHEM KINET, V39, P109, DOI 10.1002/kin.20218; Lide D. R., 2004, CRC HDB CHEM PHYS, P1; Man XJ, 2014, COMBUST FLAME, V161, P644, DOI 10.1016/j.combustflame.2013.08.003; Metcalfe WK, 2013, INT J CHEM KINET, V45, P638, DOI 10.1002/kin.20802; Naik C.V., 2012, J ENG GAS TURB POWER, V134; Oehlschlaeger MA, 2004, J PHYS CHEM A, V108, P4247, DOI 10.1021/jp0313627; Orme JP, 2006, J PHYS CHEM A, V110, P114, DOI 10.1021/jp0543678; Ranzi E., 1993, COMBUST SCI TECHNOL, V95, P1; Roy MM, 2008, ENERG CONVERS MANAGE, V49, P1111, DOI 10.1016/j.enconman.2007.09.014; Serinyel Z, 2010, J PHYS CHEM A, V114, P12176, DOI 10.1021/jp107167f; Togbe C, 2011, ENERG FUEL, V25, P676, DOI 10.1021/ef101485q; Veloo PS, 2013, P COMBUST INST, V34, P599, DOI 10.1016/j.proci.2012.06.138; Wang SK, 2015, P COMBUST INST, V35, P473, DOI 10.1016/j.proci.2014.06.112; Yasunaga K, 2008, INT J CHEM KINET, V40, P73, DOI 10.1002/kin.20294; Zervas E, 2008, FUEL, V87, P1141, DOI 10.1016/j.fuel.2007.06.010; Zhang JX, 2013, ENERG FUEL, V27, P2804, DOI 10.1021/ef302164n; Zhang P, 2013, J PHYS CHEM A, V117, P1890, DOI 10.1021/jp400155z	104	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	FEB	2015	162	2					265	286		10.1016/j.combustflame.2014.07.027		22	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	AZ7QB	WOS:000348411900001		
J	Shi, BL; Hu, J; Ishizuka, S				Shi, Baolu; Hu, Jie; Ishizuka, Satoru			Carbon dioxide diluted methane/oxygen combustion in a rapidly mixed tubular flame burner	COMBUSTION AND FLAME			English	Article						CO2 diluted methane/oxygen combustion; Tubular flame; Mixing; Fuel-dilution; Damkohler number	NON-PREMIXED FLAMES; BURNING VELOCITY; AIR; CH4/CO2; STRETCH	An inherently safe technique of rapidly mixed tubular flame combustion, in which fuel and oxidizer are separately injected from their own slits, has been extended to CO2 diluted methane/oxygen combustion. Two different cases are investigated. When CO2 is added only to the oxidizer slit, a stable tubular flame is obtained for a wide range of equivalence ratios with the oxidizers of oxygen mole fraction between 0.21 and 0.50. However, once the oxygen mole fraction exceeds 0.60, the stable flame is obtained within a small equivalence ratio range near the lean extinction limit, and the stable range becomes narrower and narrower with increasing the oxygen mole fraction. When CO2 is added also to the fuel slit so as to maintain the oxidizer/fuel injection velocity ratio near unity, and the flow rates of fuel and oxidizer are increased, the stable range is dramatically widened and a stable flame at stoichiometry can be obtained up to the oxygen mole fraction of 0.86, which yields adiabatic flame temperature around 2950 K. The Damkohler number, defined as the mixing to reaction time ratio, is examined to discuss the criterion for the establishment of stable tubular flame. It is found that when CO2 is added only to the oxidizer slit, stable flame can be obtained for D-a < 1, whereas not for D-a > 1 due to formation of diffusion flames near the fuel slits. When CO2 is added also to the fuel slit, however, stable flame can be established even for D-a >= 1 as well as. D-a < 1. Detailed observations indicate that when D-a is adequately smaller than unity, the flame is uniform in luminosity, whereas the flame is non-uniform when D-a is near or larger than unity. It is considered that the diffusion flame formation at the fuel slits is prohibited due to the high injection velocities, which gives a chance of fuel/oxidizer mixing, however, the tubular flame obtained is of non-uniform structure due to insufficient mixing time when D-a >= 1. (C) 2014 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Shi, Baolu; Hu, Jie; Ishizuka, Satoru] Hiroshima Univ, Grad Sch Engn, Dept Mech Sci & Engn, Higashihiroshima 7398527, Japan	Shi, BL (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Mech Sci & Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	smashingsky@hotmail.com					Wall TF, 2007, P COMBUST INST, V31, P31, DOI 10.1016/j.proci.2006.08.123; Ishizuka S, 2007, P COMBUST INST, V31, P1085, DOI 10.1016/j.proci.2006.07.128; Kee RJ, 2008, COMBUST FLAME, V152, P114, DOI 10.1016/j.combustflame.2007.07.019; Kutne P, 2011, P COMBUST INST, V33, P3383, DOI 10.1016/j.proci.2010.07.008; Maruta K, 2007, P COMBUST INST, V31, P1223, DOI 10.1016/j.proci.2006.08.013; Toftegaard MB, 2010, PROG ENERG COMBUST, V36, P581, DOI 10.1016/j.pecs.2010.02.001; Liu CY, 2012, APPL ENERG, V89, P387, DOI 10.1016/j.apenergy.2011.08.004; Ditaranto M, 2006, COMBUST FLAME, V146, P493, DOI 10.1016/j.combustflame.2006.04.015; Liu FS, 2003, COMBUST FLAME, V133, P495, DOI 10.1016/S0010-2180(03)00019-1; Amato A, 2011, P COMBUST INST, V33, P3399, DOI 10.1016/j.proci.2010.07.015; Li X, 2014, COMBUST FLAME, V161, P1526, DOI 10.1016/j.combusflame.2013.12.004; MILLER JA, 1989, PROG ENERG COMBUST, V15, P287, DOI 10.1016/0360-1285(89)90017-8; ISHIZUKA S, 1993, PROG ENERG COMBUST, V19, P187, DOI 10.1016/0360-1285(93)90015-7; Baukal C. E., 1998, OXYGEN ENHANCED COMB; DU J, 1995, COMBUST FLAME, V100, P367, DOI 10.1016/0010-2180(94)00136-G; Fujimori T, 2013, P COMBUST INST, V34, P2111, DOI 10.1016/j.proci.2012.10.004; Ishizuka S., 2013, TUBULAR COMBUSTION; Jahn G., 1934, THESIS OLDENBOURG; Kee R. J., 1985, 858240 SAND SAND NAT; Kee R.J., 1986, SAND868246 SAND NAT; Poinsot T., 2001, THEORETICAL NUMERICA, P57; Shi BL, 2014, COMBUST FLAME, V161, P1310, DOI 10.1016/j.combustflame.2013.11.001; Shi BL, 2013, P COMBUST INST, V34, P3369, DOI 10.1016/j.proci.2012.06.133; Smith GP, 1999, GRI MECH OPTIMIZED D; Taniguchi M, 2011, P COMBUST INST, V33, P3391, DOI 10.1016/j.proci.2010.07.020; SCHOLTE TG, 1959, COMBUST FLAME, V3, P495, DOI 10.1016/0010-2180(59)90055-0; Yamaoka I., 1985, 20 S INT COMB COMB I; Zhang YY, 2007, P COMBUST INST, V31, P1101, DOI 10.1016/j.proci.2006.07.030; Zhang YY, 2009, P COMBUST INST, V32, P1149, DOI 10.1016/j.proci.2008.06.066; Zhu D.L., 1988, 22 S INT COMB COMB I, P1537	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	FEB	2015	162	2					420	430		10.1016/j.combustflame.2014.07.022		11	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	AZ7QB	WOS:000348411900011		
J	Yotsukura, S; Mamitsuka, H				Yotsukura, Sohiya; Mamitsuka, Hiroshi			Evaluation of serum-based cancer biomarkers: A brief review from a clinical and computational viewpoint	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY			English	Review						Serum biomarkers; Quantitative assessment; Computational evaluation; Predictive values; Likelihood ratios; Receiver operating characteristic curve; Diagnostic odds ratio	EPITHELIAL OVARIAN-CANCER; PROSTATE-SPECIFIC ANTIGEN; POSITIVE PREDICTIVE-VALUE; CIRCULATING TUMOR-CELLS; DIAGNOSTIC-ODDS RATIO; BREAST-CANCER; METABOLIC SYNDROME; LUNG-CANCER; CARCINOEMBRYONIC ANTIGEN; HEPATOCELLULAR-CARCINOMA	Biomarkers are vital to detect diseases in various clinical stages. A variety of cancer serum biomarkers are already known, while for more accurate cancer-type detection, there required more rigorous evaluation manners, especially computational evaluation measures, for biomarkers. In this review, we first show three typical pitfalls in finding biomarkers and their examples, after briefly presenting standard five clinical biomarker screening phases by National Cancer Institute. We then introduce current computational biomarker evaluation measures, including current, standard methods with their intrinsic features. We further show an up-to-date list of existing cancer serum biomarkers, pointing out several issues, being caused by the limitations of current biomarker evaluation approaches. Finally we discuss the current attempts to develop new, statistically robust, computational serum-based biomarker measures in terms of specificity to each of various cancer types. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yotsukura, Sohiya; Mamitsuka, Hiroshi] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto 6110011, Japan	Yotsukura, S (reprint author), Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto 6110011, Japan.	yotsus@kuicr.kyoto-u.ac.jp			JSPS KAKENHI [2430054, 26-381]	This work was partially supported by JSPS KAKENHI #2430054 and #26-381. S.Y. is supported by Grant-in-Aid for JSPS Fellows.	Abraham J., 2010, COMMUNITY ONCOL, V7, P249; Mainous AG, 2013, J AM GERIATR SOC, V61, P132, DOI 10.1111/jgs.12044; Jiang W, 2007, J NATL CANCER I, V99, P1036, DOI 10.1093/jnci/djm022; Walter RB, 2012, BLOOD, V119, P6198, DOI 10.1182/blood-2011-11-325050; Palmqvist R, 2003, DIS COLON RECTUM, V46, P1538, DOI 10.1097/01.DCR.0000089121.59268.D2; Sekijima Y, 2011, HUM PATHOL, V42, P1785, DOI 10.1016/j.humpath.2011.03.004; Li Y, 2010, LUNG CANCER, V70, P14, DOI 10.1016/j.lungcan.2010.01.005; Tan H, 2007, CELL STRESS CHAPERON, V12, P230, DOI 10.1379/CSC-266.1; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; Gui JC, 2014, CLIN EXP MED, V14, P225, DOI 10.1007/s10238-013-0234-9; Gilligan T, 2009, CLEV CLIN J MED, V76, P446, DOI 10.3949/ccjm.76a.09079; Lempiainen A, 2012, CLIN CHEM, V58, P1123, DOI 10.1373/clinchem.2012.183723; Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d; Shabaik A, 2011, DIAGN CYTOPATHOL, V39, P328, DOI 10.1002/dc.21389; Luftner D, 2000, ANTICANCER RES, V20, P5077; Baudin E, 2003, J CLIN ENDOCR METAB, V88, P1107, DOI 10.1210/jc.2002-021365; Baker DL, 2002, JAMA-J AM MED ASSOC, V287, P3081, DOI 10.1001/jama.287.23.3081; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Passerini R, 2012, AM J CLIN PATHOL, V138, P281, DOI 10.1309/AJCPOPNPLLCYR07H; Deandrea S, 2008, CANCER EPIDEM BIOMAR, V17, P2025, DOI 10.1158/1055-9965.EPI-08-0157; Badoux XC, 2011, BLOOD, V118, P2085, DOI 10.1182/blood-2011-03-341032; Douillard JY, 2014, BRIT J CANCER, V110, P55, DOI 10.1038/bjc.2013.721; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Huang HJ, 2005, J CLIN PATHOL, V58, P611, DOI 10.1136/jcp.2004.022772; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; Joseph B, 2013, WORLD J SURG, V37, P525, DOI 10.1007/s00268-012-1871-y; Medeiros LR, 2009, EUR J OBSTET GYN R B, V142, P99, DOI 10.1016/j.ejogrb.2008.08.011; Warnock DG, 2010, NAT BIOTECHNOL, V28, P444, DOI 10.1038/nbt0510-444; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Nakagawa T, 2007, CLIN CANCER RES, V13, P4105, DOI 10.1158/1078-0432.CCR-07-0419; Kim TW, 2004, CLIN CANCER RES, V10, P3076, DOI 10.1158/1078-0432.CCR-03-0581; Lazzeri M, 2013, BJU INT, V112, P313, DOI 10.1111/bju.12217; Ueland FR, 2011, OBSTET GYNECOL, V117, P1289, DOI 10.1097/AOG.0b013e31821b5118; Leman ES, 2007, UROLOGY, V69, P714, DOI 10.1016/j.urology.2007.01.097; Sterling RK, 2007, AM J GASTROENTEROL, V102, P2196, DOI 10.1111/j.1572-0241.2007.01405.x; Kern SE, 2012, CANCER RES, V72, P6097, DOI 10.1158/0008-5472.CAN-12-3232; MCGUIRE WL, 1992, NEW ENGL J MED, V326, P1756; Bozkurt M, 2013, EUR J GYNAECOL ONCOL, V34, P540; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Cho HY, 2013, MED SCI MONITOR, V19, P230, DOI 10.12659/MSM.883865; King KL, 2000, CANCER, V88, P2464, DOI 10.1002/1097-0142(20000601)88:11<2464::AID-CNCR6>3.0.CO;2-W; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Partheen K, 2011, J GYNECOL ONCOL, V22, P244, DOI 10.3802/jgo.2011.22.4.244; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Attia J, 2003, AUST PRESCR, V26, P111; Auewarakul CU, 2006, ANN HEMATOL, V85, P108, DOI 10.1007/s00277-005-0039-3; Ballehaninna Umashankar K, 2011, Indian J Surg Oncol, V2, P88, DOI 10.1007/s13193-011-0042-1; BARILLARI P, 1992, DIS COLON RECTUM, V35, P471, DOI 10.1007/BF02049405; Barroso-Sousa R, 2013, CLINICS, V68, P1134, DOI 10.6061/clinics/2013(08)12; Bohning D, 2011, STAT METHODS MED RES, V20, P541, DOI 10.1177/0962280210374532; Buckler AJ, 2013, J DIGIT IMAGING, V26, P614, DOI 10.1007/s10278-013-9598-3; Chen L, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-161; Chudeka-Glaz AC-PA, 2013, J MOL BIOMARK DIAGN, pS4; Daga H, 2012, ANN ONCOL, V23, P492; Drucker Elisabeth, 2013, EPMA J, V4, P7, DOI 10.1186/1878-5085-4-7; Drunker EKK, 2013, EPMA J, V4, P4; EP D, 2010, CLIN CHEM, V56, P542; EP D, 2010, J NATL CANC I, V102, P1462; EP D, 2012, BMC MED; Füzéry Anna K, 2013, Clin Proteomics, V10, P13, DOI 10.1186/1559-0275-10-13; GABRIELLI S, 1992, ULTRASOUND OBST GYN, V2, P110, DOI 10.1046/j.1469-0705.1992.02020110.x; Gann PH, 2002, J UROLOGY, V167, P2427, DOI 10.1016/S0022-5347(05)64998-1; Gonzalez-Santiago AE, 2011, J CLIN LAB ANAL, V25, P238, DOI 10.1002/jcla.20465; HANLEY JA, 1982, J RADIOL, V143, P29; HB G, 2010, J UROL, V183, P11; Jin T., 2013, BIOMED REP, V1, P731; Kammerer S, 2005, P NATL ACAD SCI USA, V102, P2004, DOI 10.1073/pnas.0409806102; Kumar MSS, 2009, CURR TRENDS SCI, V40, P3; Kyrgidis Athanassios, 2010, J Carcinog, V9, P3, DOI 10.4103/1477-3163.62141; Laudisio A, 2013, J AM GERIATR SOC, V61, P963, DOI 10.1111/jgs.12256; Lewington S, 2012, CLIN CHEM, V58, P1192, DOI 10.1373/clinchem.2012.184226; Lotrakul MSS, 1998, BMC PSYCHIATRY, V8, P46; Magder LS, 2003, J CLIN EPIDEMIOL, V56, P956, DOI 10.1016/S0895-4356(03)00153-7; Mahdavi A, 2006, FERTIL STERIL, V85, P819, DOI 10.1016/j.fertnstert.2005.08.061; March S, 2004, J HEPATOL, V40, P40; Margel DP-FM, 2011, EUR J UROL, V93, P103; McWilliams RRPG, 2010, CANCER, V116, P230; Meigs JB, 2004, DIABETES CARE, V27, P1417, DOI 10.2337/diacare.27.6.1417; Montagnana M, 2011, CLIN CHEM LAB MED, V49, P521, DOI 10.1515/CCLM.2011.075; Mose F, 2013, INT J STD AIDS, V24, P537, DOI 10.1177/0956462412473892; Msaouel P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-336; Murakami Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048366; Okamoto TOT, 1995, BREAST CANC, V2, P127, DOI 10.1007/BF02966951; Pepe MSFZ, 2007, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Pepe MSJH, 2004, AM J EPIDEMIOL, V159, P82; Roy S, 2013, INT BRAZ J UROL, V39, P631, DOI 10.1590/S1677-5538.IBJU.2013.05.04; Saad AARS, 2007, J CLIN ONCOL S, V25, P10533; Schroder FH, 2008, EUR UROL, V53, P468, DOI 10.1016/j.eururo.2007.10.047; Seliger VI, 2013, J CYST FIBROS, V12, P706, DOI 10.1016/j.jcf.2013.03.004; Shibata T, 2009, DIGEST DIS SCI, V54, P70, DOI 10.1007/s10620-008-0313-z; Slattery ML, 2011, CANCER EPIDEM BIOMAR, V20, P57, DOI 10.1158/1055-9965.EPI-10-0843; Sonego P, 2008, BRIEF BIOINFORM, V9, P198, DOI 10.1093/bib/bbm064; Soto MEBN, 2013, RESULTS IMMUNOL; Soyluk O, 2011, THYROID, V21, P1301, DOI 10.1089/thy.2011.0122; Stieber P, 2006, J CLIN ONCOL S, V24, P10554; Takahashi Y, 2006, ONCOL REP, V15, P323; Tang LH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-314; Ulivi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057401; Uozaki H, 2000, PATHOL RES PRACT, V196, P665; Xu EP, 2013, CARCINOGENESIS, V34, P2521, DOI 10.1093/carcin/bgt230; Yang ZJ, 2013, ONCOL LETT, V6, P28, DOI 10.3892/ol.2013.1339; Yesil ABG, 2013, GASTROENT RES PRACT, V2013; Yuen MF, 2003, ANN ONCOL, V14, P1463, DOI 10.1093/annonc/mdg400; Zhang JX, 2012, HUM REPROD, V27, P2484, DOI 10.1093/humrep/des191; Zheng YCT, 2005, BIOMETRICS, V62, P279; Zinkin NTGF, 2008, CLIN CANC RES	107	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1040-8428	1879-0461		CRIT REV ONCOL HEMAT	Crit. Rev. Oncol./Hematol.	FEB	2015	93	2					103	115		10.1016/j.critrevonc.2014.10.002		13	Oncology; Hematology	Oncology; Hematology	CA5ND	WOS:000348954200003		
J	Takahashi, M; Koide, K; Mizuhashi, F				Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi			Variation in mouthguard thickness due to different heating conditions during fabrication: Part 2	DENTAL TRAUMATOLOGY			English	Article						mouthguard; thickness; heating conditions; polyolefin-polystyrene co-polymer sheet; olefin co-polymer sheet	VACUUM-FORMING PROCESS; GUARDS; FIT	The purpose of this study was to determine changes in the thickness of mouthguard sheets under different heating conditions during fabrication. Mouthguards were fabricated with polyolefin-polystyrene co-polymer (OS) and olefin co-polymer (OL) sheets (4.0-mm thick) utilizing a vacuum-forming machine under the following three conditions: (A) the sheet was moulded when it sagged 15mm below the sheet frame (i.e. the normally used position); (B) the sheet frame was lowered to and heated at 30mm below the top of the post and moulded when it sagged by 15mm; and (C) the sheet frame was lowered to and heated at 50mm below the top of the post and moulded when it sagged by 15mm. The working model was trimmed to a height of 20mm at the incisor and 15mm at the first molar. Post-moulding thickness was determined for the incisal portion (incisal edge and labial surface) and molar portion (cusp, central groove and buccal surface). Dimensions were measured, and differences in the change in thickness due to heating condition were analysed using the Kruskal-Wallis test. Under condition C, OS and OL decreased in thickness from 0.36-0.54mm to 0.26-0.30mm, respectively, at the incisal portion and from 0.34-0.66mm to 0.17-0.47mm, respectively, at the molar portion. It may be clinically useful when moulding a mouthguard to maintain the thickness of the incisal and molar portions by adjusting the height of the sheet frame.	[Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi] Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, Niigata 9518580, Japan	Takahashi, M (reprint author), Nippon Dent Univ, Sch Life Dent Niigata, Dept Removable Prosthodont, 1-8 Hamaura Cho, Niigata 9518580, Japan.	mutsumit@ngt.ndu.ac.jp					Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; GOING RE, 1974, J AM DENT ASSOC, V89, P132; Takahashi M, 2013, J PROSTHODONT RES, V57, P169, DOI 10.1016/j.jpor.2013.01.004; BISHOP BM, 1985, J PROSTHET DENT, V53, P256, DOI 10.1016/0022-3913(85)90123-4; Bemelmanns P, 2001, INT J SPORTS MED, V22, P149, DOI 10.1055/s-2001-11342; DELSROSSI G, 2008, DENT TRAUMTOL, V24, P197; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; JOHNSEN D C, 1991, Dental Clinics of North America, V35, P657; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; MCNUTT T, 1989, Pediatric Dentistry, V11, P209; Mizuhashi F, 2012, DENT TRAUMATOL, V28, P291, DOI 10.1111/j.1600-9657.2011.01091.x; Mizuhashi F, 2013, DENT TRAUMATOL, V29, P307, DOI 10.1111/edt.12004; Padilla R, 1996, J Calif Dent Assoc, V24, P30; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; RANALLI D N, 1991, Dental Clinics of North America, V35, P627; Takahashi F, 2008, J SPORTS DENT, V11, P64; Takahashi F, 2004, J SPORTS DENT, V7, P12; Takahashi M, 2011, ANN JPN PROTHODONT S, V3, P135; Takahashi M, 2013, J PROSTHODONT RES, V57, P179, DOI 10.1016/j.jpor.2013.04.002; Takahashi M, 2012, ANN JPN PROTHODONT S, V4, P286; Takeuchi M, 2006, EFFECTIVELY THERMOFO, p[24, 54]; Westerman B, 1995, AUST DENT J, V40, P389; Yonehata Y, 2003, J PROSTHET DENT, V89, P23, DOI 10.1067/mpr.2003.62	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2015	31	1					18	23		10.1111/edt.12122		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2UM	WOS:000348763400003		
J	Tuna, EB; Arai, K; Tekkesin, MS; Seymen, F; Gencay, K; Kuboyama, N; Maeda, T				Tuna, Elif Bahar; Arai, Kiyoshi; Tekkesin, Merva Soluk; Seymen, Figen; Gencay, Koray; Kuboyama, Noboru; Maeda, Takahide			Effect of fibroblast growth factor and enamel matrix derivative treatment on root resorption after delayed replantation	DENTAL TRAUMATOLOGY			English	Article						Dog; Enamel Matrix Derivative; Fibroblast Growth Factor-basic; Tooth Replantation; Periodontal Ligament	PERIODONTAL-LIGAMENT CELLS; PERMANENT INCISORS; REPLACEMENT RESORPTION; HEALING-PROCESS; AVULSED TEETH; EMDOGAIN GEL; DOG TEETH; MONKEYS; PROTEINS; STORAGE	BackgroundPeriodontal ligament (PDL) healing and long term prognosis of replanted avulsed teeth should rely on several factors including length of extra-oral dry time and type of the storage medium. The status of periodontal ligament is critical for the healing of replanted teeth. Different substances have been used for root surface treatment to promote formation of PDL and increase the survival of avulsed teeth submitted to replantation. AimThe purpose of this study was to assess the effect of recombinant basic fibroblast growth factor 2 (bFGF) and enamel matrix derivative (EMD) on root resorption after delayed replantation. Design18 freshly extracted single-rooted incisor and premolar teeth were extracted from the beagle dogs and immersed in whole bovine milk for 45 and 60min (n=3 each). Following storage period, sockets washed and teeth were treated with bFGF and EMD and replanted into the sockets. After 8weeks, dogs were sacrificed, specimens processed to 4-m thick serial sections for histopathologic examination and morphometric assessments. Thus, the proportions of the roots that exhibited signs of surface resorption, inflammatory resorption, and replacement resorption, that is, ankylosis and normal PDL were noted. ResultsThe percentage of root resorption was in the following order: EMD>milk>bFGF for 45 min and milk>EMD>bFGF for 60min. For all groups, teeth stored 60min showed significantly higher incidence of PDL resorption than those stored for 45min (P<0.01). The highest incidence of replacement resorption was observed in teeth treated with EMD for 60min. After 8weeks, the least resorption was found in bFGF-treated group (P<0.01). ConclusionsThe findings of this study suggest that use of bFGF favored the formation of new periodontal ligament; prevent ankylosis and resorption process following delayed replantation of teeth while EMD shows replacement resorption, which may turn to ankylosis.	[Tuna, Elif Bahar; Arai, Kiyoshi; Maeda, Takahide] Nihon Univ, Sch Dent Matsudo, Dept Pediat Dent, Chiba, Japan; [Tuna, Elif Bahar; Seymen, Figen; Gencay, Koray] Istanbul Univ, Fac Dent, Dept Pedodont, TR-34093 Istanbul, Turkey; [Tekkesin, Merva Soluk] Istanbul Univ, Dept Tumor Pathol, Inst Oncol, TR-34093 Istanbul, Turkey; [Kuboyama, Noboru] Nihon Univ, Sch Dent Matsudo, Dept Pharmacol, Chiba, Japan	Tuna, EB (reprint author), Istanbul Univ, Fac Dent, Dept Pedodont, TR-34093 Istanbul, Turkey.	ebtuna@istanbul.edu.tr			Scientific and Technological Research Council of Turkey (TUBITAK) [BIDEB 2219]	This work has been supported by research grant given to Elif Bahar Tuna by the Scientific and Technological Research Council of Turkey (TUBITAK, BIDEB 2219).	Andersson L, 2006, DENT TRAUMATOL, V22, P57, DOI 10.1111/j.1600-9657.2006.00338.x; ANDREASEN JO, 1981, INT J ORAL MAXILLOF, V10, P43, DOI 10.1016/S0300-9785(81)80007-5; ANDREASEN JO, 1975, ACTA ODONTOL SCAND, V33, P313, DOI 10.3109/00016357509004636; ANDREASEN JO, 1981, ACTA ODONTOL SCAND, V39, P15; Andreasen JO, 2007, TXB COLOR ATLAS TRAU, P444; Takayama S, 1997, J PERIODONTAL RES, V32, P667, DOI 10.1111/j.1600-0765.1997.tb00577.x; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Kaida H, 2008, J ENDODONT, V34, P26, DOI 10.1016/j.joen.2007.09.011; Takayama S, 2001, J DENT RES, V80, P2075; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P76; Ito M, 2002, BONE, V31, P351, DOI 10.1016/S8756-3282(02)00830-X; Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x; Marino TG, 2000, J ENDODONT, V26, P699, DOI 10.1097/00004770-200012000-00005; Sae-Lim V, 2004, J PERIODONTOL, V75, P1570, DOI 10.1902/jop.2004.75.12.1570; Schjott M, 2005, DENT TRAUMATOL, V21, P46, DOI 10.1111/j.1600-9657.2004.00295.x; Van der Pauw MT, 2000, J PERIODONTOL, V71, P31, DOI 10.1902/jop.2000.71.1.31; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x; Araujo M, 2003, J CLIN PERIODONTOL, V30, P855, DOI 10.1034/j.1600-051X.2003.00400.x; Araujo MG, 1998, J CLIN PERIODONTOL, V25, P524, DOI 10.1111/j.1600-051X.1998.tb02482.x; Bryson EC, 2002, DENT TRAUMATOL, V18, P316, DOI 10.1034/j.1600-9657.2002.00142.x; Casaroto AR, 2010, DENT TRAUMATOL, V26, P323, DOI 10.1111/j.1600-9657.2010.00879.x; Coccia C T, 1980, J Endod, V6, P413, DOI 10.1016/S0099-2399(80)80217-2; Filippi A, 2001, DENT TRAUMATOL, V17, P134, DOI 10.1034/j.1600-9657.2001.017003134.x; GIBRAN NS, 1994, J SURG RES, V56, P226, DOI 10.1006/jsre.1994.1036; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Iqbal MK, 2001, DENT TRAUMATOL, V17, P36, DOI 10.1034/j.1600-9657.2001.170107.x; Ivanovski S, 2001, ARCH ORAL BIOL, V46, P679, DOI 10.1016/S0003-9969(01)00036-X; Kasaj Adrian, 2008, J Oral Sci, V50, P279, DOI 10.2334/josnusd.50.279; Khademi AA, 2008, DENT TRAUMATOL, V24, P510, DOI [10.1111/j.1600-9657.2008.00648.x, 10.1111/j.1600-9657.2008.00648]; Lam K, 2004, ORAL SURG ORAL MED O, V97, P100, DOI 10.1016/S1079-2104(03)00318-4; Ledoux Dominique, 1992, Progress in Growth Factor Research, V4, P107, DOI 10.1016/0955-2235(92)90026-E; LINDSKOG S, 1983, SCAND J DENT RES, V91, P465; Lustosa-Pereira A, 2006, DENT TRAUMATOL, V22, P30, DOI 10.1111/j.1600-9657.2006.00417.x; Panzarini SR., 2003, REV ASS PAUL CIR DEN, V57, P27; Poi WR, 2007, DENT TRAUMATOL, V23, P35, DOI 10.1111/j.1600-9657.2006.00481.x; Seshima F, 2010, ORAL SURG ORAL MED O, V109, P142, DOI 10.1016/j.tripleo.2009.07.055; Thong YL, 2009, DENT TRAUMATOL, V25, P386, DOI 10.1111/j.1600-9657.2008.00631.x; Trope M, 2002, DENT TRAUMATOL, V18, P1, DOI 10.1046/j.1600-4469.2001.00001.x; Trowbridge HO, 1997, INFLAMATION REV PROC, P153; YU W, 1994, LASER SURG MED, V15, P281, DOI 10.1002/lsm.1900150308	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2015	31	1					49	56		10.1111/edt.12141		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2UM	WOS:000348763400008		
J	Nogami, S; Yamauchi, K; Yamashita, T; Kataoka, Y; Hirayama, B; Tanaka, K; Takahashi, T				Nogami, Shinnosuke; Yamauchi, Kensuke; Yamashita, Toshio; Kataoka, Yoshihiro; Hirayama, Bunichi; Tanaka, Kenko; Takahashi, Tetsu			Elderly patients with maxillofacial trauma: study of mandibular condyle fractures	DENTAL TRAUMATOLOGY			English	Article						mandibular condyle fractures; elderly; maxillofacial trauma	FACIAL FRACTURES; MANAGEMENT; ANGLE	Background/AimThe aim of this study was to investigate the trends and characteristic features of mandibular condyle fractures in elderly patients in terms of etiology, patterns, and treatment modalities. Patients and methodsRecords of 201 patients aged 65years and older, who were treated for maxillofacial fractures at the Department of Oral and Maxillofacial Surgery, Kyushu Dental University, and Tohoku University from January 2002 to December 2013, were retrospectively analyzed. Patient records and radiographs were examined, with the following information: relevant medical history, cause of fracture, the presence and state of premolars and molars in the maxilla and mandible, number and location of mandible fracture, and method of treatment. As for the state of premolars and molars, premolars or molars in the mandible in contact with the maxilla were regarded as contacted. ResultsA fall was responsible for the majority of the fractures (173/201). With condyle fractures, there was a significant difference between the contacted and non-contacted group in regard to incidence. Furthermore, there was a significantly greater number of cases with symphysis and condyle combination fractures in the non-contacted group (70.9%) than in the contacted group (51.9%). As for the method of treatment, arthrocentesis was the most commonly employed. ConclusionsThe present findings suggest that contacted molars in the maxilla and mandible have an influence on condyle fractures in elderly individuals.	[Nogami, Shinnosuke; Yamauchi, Kensuke; Hirayama, Bunichi; Tanaka, Kenko; Takahashi, Tetsu] Tohoku Univ, Grad Sch Dent, Div Oral & Maxillofacial Surg, Dept Oral Med & Surg, Sendai, Miyagi 9808575, Japan; [Yamashita, Toshio] Fukuoka Dent Coll, Dept Oral & Maxillofacial Surg, Fukuoka, Japan; [Kataoka, Yoshihiro] Kyushu Dent Univ, Dept Oral & Maxillofacial Surg, Kitakyushu, Fukuoka, Japan	Nogami, S (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral & Maxillofacial Surg, Dept Oral Med & Surg,Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	s-nogami@dent.tohoku.ac.jp					Iida S, 2004, J TRAUMA, V57, P613, DOI 10.1097/01.TA.0000096647.36992.83; KELLY DE, 1975, J ORAL SURG, V33, P146; Duan DH, 2008, INT J ORAL MAX SURG, V37, P25, DOI 10.1016/j.ijom.2007.07.010; Yamamoto K, 2011, J ORAL MAXIL SURG, V69, P2204, DOI 10.1016/j.joms.2011.02.115; Yamamoto K, 2010, J ORAL MAXIL SURG, V68, P1602, DOI 10.1016/j.joms.2009.09.029; Banks P., 1991, KILLEYS FRACTURES MA; Chrcanovic Bruno Ramos, 2004, Braz Oral Res, V18, P322, DOI 10.1590/S1806-83242004000400009; Chrcanovic BR, 2010, J TRAUMA, V69, pE73, DOI 10.1097/TA.0b013e3181cc847b; Gerbino G, 1999, J ORAL MAXIL SURG, V57, P777, DOI 10.1016/S0278-2391(99)90812-1; GOLDSCHMIDT MJ, 1995, J ORAL MAXIL SURG, V53, P1145, DOI 10.1016/0278-2391(95)90620-7; HUSSAIN K, 1994, J TRAUMA, V36, P34, DOI 10.1097/00005373-199401000-00006; Jung Yun-Hoa, 2013, Imaging Sci Dent, V43, P219, DOI 10.5624/isd.2013.43.4.219; Kober C, 2001, Mund Kiefer Gesichtschir, V5, P114, DOI 10.1007/s100060000262; Marciani RD, 1999, ORAL SURG ORAL MED O, V87, P272, DOI 10.1016/S1079-2104(99)70208-8; Nogami S, 2013, J ORAL MAXIL SURG, V71, P1050, DOI 10.1016/j.joms.2013.01.021; Nogami S, 2014, J ORAL REHABIL, V41, P141, DOI 10.1111/joor.12124; SANTORA TA, 1994, SURG CLIN N AM, V74, P163; Sidal Tarkan, 2006, Spec Care Dentist, V26, P145, DOI 10.1111/j.1754-4505.2006.tb01715.x; Thangavelu A, 2010, INT J ORAL MAX SURG, V39, P136, DOI 10.1016/j.ijom.2009.12.005; Wade CV, 2004, BRIT J ORAL MAX SURG, V42, P138, DOI 10.1016/S0266-4356(03)00256-0; Zhu SJ, 2005, INT J ORAL MAX SURG, V34, P382, DOI 10.1016/j.ijmo.2004.10.002	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2015	31	1					73	76		10.1111/edt.12129		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2UM	WOS:000348763400012		
J	Maruoka, D; Arai, M; Tanaka, T; Okimoto, K; Oyamada, A; Minemura, S; Tsuboi, M; Matsumura, T; Nakagawa, T; Kanda, T; Katsuno, T; Imazeki, F; Yokosuka, O				Maruoka, Daisuke; Arai, Makoto; Tanaka, Takeshi; Okimoto, Kenichiro; Oyamada, Arata; Minemura, Shoko; Tsuboi, Masaru; Matsumura, Tomoaki; Nakagawa, Tomoo; Kanda, Tatsuo; Katsuno, Tatsuro; Imazeki, Fumio; Yokosuka, Osamu			Mosapride Citrate Increases Postprandial Glucagon-Like Peptide-1, Insulin, and Gene Expression of Sweet Taste Receptors	DIGESTIVE DISEASES AND SCIENCES			English	Article						Mosapride; Glucagon-like peptide-1; Incretins; L cells; Taste receptors, type 1	II DIABETES-MELLITUS; GLYCEMIC CONTROL; GASTROINTESTINAL-TRACT; GASTROKINETIC AGENT; ORAL GLUCOSE; IN-VIVO; CELLS; GLP-1; SECRETION; GUT	Mosapride citrate-a prokinetic agent-improves hemoglobin A1c levels in diabetic patients; however, the underlying mechanism is unclear. We aimed to clarify this mechanism. Preprandial and postprandial (90 min after a meal) blood was obtained from 12 healthy men, and serum insulin and plasma active glucagon-like peptide-1 concentrations were measured. Measurements were also taken after the administration of 5 mg of mosapride citrate three times per day after every meal for 14 days. In addition, C57BL/6 mice were permitted free access to water containing 0.04 % domperidone (D group) or 0.02 % mosapride citrate (M group) for 2 weeks (four mice per group). T1r2 (taste receptor, type 1, member 2), T1r3, and Gnat3 (guanine nucleotide-binding protein, alpha transducing 3) mRNA expression levels of the stomach, duodenum, and proximal and mid-jejunum were evaluated. In human subjects, postprandial plasma active glucagon-like peptide-1 and serum insulin concentrations after administration of mosapride citrate were significantly higher than those pre-administration (4.8 +/- A 2.2 pmol/L, 45.6 +/- A 41.6 mu IU/mL, and 3.7 +/- A 1.2 pmol/L, 34.1 +/- A 28.4 mu IU/mL, respectively). The mouse expression levels of T1r2 and Gnat3 in the proximal jejunum and mid-jejunum in the M group (4.1 +/- A 1.8-fold, 3.1 +/- A 1.6-fold, and 4.6 +/- A 0.8-fold, 3.1 +/- A 0.9-fold increases, respectively), were significantly higher than those of the control group. The administration of mosapride citrate for 2 weeks enhanced postprandial plasma active glucagon-like peptide-1 and serum insulin concentration and increased the expression of sweet taste receptors in the upper intestine.	[Maruoka, Daisuke; Arai, Makoto; Okimoto, Kenichiro; Oyamada, Arata; Minemura, Shoko; Tsuboi, Masaru; Matsumura, Tomoaki; Nakagawa, Tomoo; Kanda, Tatsuo; Katsuno, Tatsuro; Imazeki, Fumio; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608670, Japan; [Tanaka, Takeshi] Chiba Univ, Grad Sch Med, Dept Environm Biochem, Chiba 2608670, Japan	Arai, M (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	d-maruoka@biscuit.ocn.ne.jp; araim-cib@umin.ac.jp; take64@faculty.chiba-u.jp; kenrunaway@yahoo.co.jp; a-oyamada@live.jp; koshoramunemi@yahoo.co.jp; gotama81@hotmail.com; matsumura919@yahoo.co.jp; tom20852@yahoo.co.jp; kanda2t@yahoo.co.jp; katsuno@faculty.chiba-u.jp; imazekif@faculty.chiba-u.jp; yokosukao@faculty.chiba-u.jp					Ueno N, 2002, DIABETOLOGIA, V45, P792, DOI 10.1007/s00125-002-0835-4; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932; Gerspach AC, 2011, AM J PHYSIOL-ENDOC M, V301, pE317, DOI 10.1152/ajpendo.00077.2011; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Mine Y, 1997, J PHARMACOL EXP THER, V283, P1000; Ueno N, 2010, DIABETES RES CLIN PR, V87, P27, DOI 10.1016/j.diabres.2009.09.024; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Dyer J, 2005, BIOCHEM SOC T, V33, P302; Schirra J, 1996, J CLIN INVEST, V97, P92, DOI 10.1172/JCI118411; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; GOKE B, 1995, DIGESTION, V56, P493; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; CREUTZFELDT W, 1979, DIABETOLOGIA, V16, P75, DOI 10.1007/BF01225454; Nam JS, 2010, DIABETES RES CLIN PR, V87, P329, DOI 10.1016/j.diabres.2009.12.021; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Hongo M, 2012, J GASTROEN HEPATOL, V27, P62, DOI 10.1111/j.1440-1746.2011.06949.x; Brown RJ, 2009, DIABETES CARE, V32, P2184, DOI 10.2337/dc09-1185; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; Hass N, 2010, CELL TISSUE RES, V339, P493, DOI 10.1007/s00441-009-0907-6; Hosaka H, 2012, ALIMENT PHARM THER, V36, P895, DOI 10.1111/apt.12050; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Aoki K, 2013, ENDOCR J, V60, P493; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Lee A, 2002, DIABETES OBES METAB, V4, P329, DOI 10.1046/j.1463-1326.2002.00219.x; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Farup CE, 1998, DIABETES CARE, V21, P1699, DOI 10.2337/diacare.21.10.1699; Gebhard B, 2001, DIGEST DIS SCI, V46, P1915, DOI 10.1023/A:1010635131228; Hansen L, 2004, AM J PHYSIOL-ENDOC M, V287, pE939, DOI 10.1152/ajpendo.00197.2004; Koch KL, 1999, DIGEST DIS SCI, V44, P1061, DOI 10.1023/A:1026647417465; Koshiyama H, 2000, DIABETES CARE, V23, P1198, DOI 10.2337/diacare.23.8.1198; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Mannucci E, 2001, DIABETES CARE, V24, P489, DOI 10.2337/diacare.24.3.489; MICHIELS M, 1981, European Journal of Drug Metabolism and Pharmacokinetics, V6, P37; Migoya E, 2010, DIABETES, V59, pA156; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nauck MA, 1996, Z GASTROENTEROL, V34, P159; Patterson D, 1999, AM J GASTROENTEROL, V94, P1230; Quigley EMM, 1997, GASTROENTEROLOGY, V113, P1790, DOI 10.1053/gast.1997.v113.agast971131790; Romero F, 2012, SURG ENDOSC, V26, P2231, DOI 10.1007/s00464-012-2166-y; Rossler P, 1998, EUR J CELL BIOL, V77, P253; SAKASHITA M, 1993, ARZNEIMITTEL-FORSCH, V43-2, P867; Ueno N, 2000, DIABETOLOGIA, V43, P411, DOI 10.1007/s001250051323; Wu TZ, 2013, DIABETES CARE, V36, pE202, DOI 10.2337/dc13-0958; YOSHIDA N, 1991, J PHARMACOL EXP THER, V257, P781	49	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	FEB	2015	60	2					345	353		10.1007/s10620-014-3271-7		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ7SP	WOS:000348418400011		
J	Kishimoto, M; Fukui, T; Suzuki, R; Takahashi, Y; Sumimoto, K; Okazaki, T; Sakao, M; Sakaguchi, Y; Yoshida, K; Uchida, K; Nishio, A; Matsuzaki, K; Okazaki, K				Kishimoto, Masanobu; Fukui, Toshiro; Suzuki, Ryo; Takahashi, Yu; Sumimoto, Kimi; Okazaki, Takashi; Sakao, Masayuki; Sakaguchi, Yutaku; Yoshida, Katsunori; Uchida, Kazushige; Nishio, Akiyoshi; Matsuzaki, Koichi; Okazaki, Kazuichi			Phosphorylation of Smad2/3 at Specific Linker Threonine Indicates Slow-Cycling Intestinal Stem-Like Cells Before Reentry to Cell Cycle	DIGESTIVE DISEASES AND SCIENCES			English	Article						Smad2/3; Phosphorylation; Linker threonine residue; Intestinal stem cell; Regeneration	TGF-BETA SIGNAL; DEPENDENT KINASES; COLORECTAL-CANCER; TUMOR SUPPRESSION; EXPRESSION MARKS; SELF-RENEWAL; IN-VITRO; LGR5; IDENTIFICATION; ONCOGENESIS	Quiescent (slow-cycling) and active (rapid-cycling) stem cells are demonstrated in small intestines. We have identified significant expression of Smad2/3, phosphorylated at specific linker threonine residues (pSmad2/3L-Thr), in murine stomach, and suggested these cells are epithelial stem cells. Here, we explore whether pSmad2/3L-Thr could serve as a biomarker for small intestine and colon stem cells. We examined small intestines and colons from C57BL/6 mice and colons with dextran sulfate sodium (DSS)-induced colitis. We performed double-immunofluorescent staining of pSmad2/3L-Thr with Ki67, cytokeratin 8, chromogranin A, CDK4, DCAMKL1, and Musashi-1. Small intestines and colons from Lgr5-EGFP knock-in mice were examined by pSmad2/3L-Thr immunofluorescent staining. To examine BrdU label retention of pSmad2/3L-Thr immunostaining-positive cells, we collected specimens after BrdU administration and observed double-immunofluorescent staining of pSmad2/3L-Thr with BrdU. In small intestines and colons, pSmad2/3L-Thr immunostaining-strongly positive cells were detected around crypt bases. Immunohistochemical co-localization of pSmad2/3L-Thr with Ki67 was not observed. pSmad2/3L-Thr immunostaining-strongly positive cells showed co-localization with cytokeratin 8, CDK4, and Musashi-1 and different localization from chromogranin A and DCAMKL1 immunostaining-positive cells. Under a light microscope, pSmad2/3L-Thr immunostaining-strongly positive cells were morphologically undifferentiated. In Lgr5-EGFP knock-in mice, some but not all pSmad2/3L-Thr immunostaining-strongly positive cells showed co-localization with Lgr5. pSmad2/3L-Thr immunostaining-strongly positive cells showed co-localization with BrdU at 5, 10, and 15 days after administration. In DSS-induced colitis, pSmad2/3L-Thr and Ki67 immunostaining-positive cells increased in the regeneration phase and decreased in the injury phase. In murine small intestines and colons, we suggest pSmad2/3L-Thr immunostaining-strongly positive cells are epithelial stem-like cells just before reentry to the cell cycle.	[Kishimoto, Masanobu; Fukui, Toshiro; Suzuki, Ryo; Takahashi, Yu; Sumimoto, Kimi; Okazaki, Takashi; Sakao, Masayuki; Sakaguchi, Yutaku; Yoshida, Katsunori; Uchida, Kazushige; Nishio, Akiyoshi; Matsuzaki, Koichi; Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Hirakata, Osaka 5731010, Japan	Fukui, T (reprint author), Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	kishimom@hirakata.kmu.ac.jp; fukuitos@hirakata.kmu.ac.jp; suzukryo@hirakata.kmu.ac.jp; takahyu@hirakata.kmu.ac.jp; sumimotk@hirakata.kmu.ac.jp; okazakta@hirakata.kmu.ac.jp; sakaoma@hirakata.kmu.ac.jp; sakagucy@hirakata.kmu.ac.jp; yoshidka@hirakata.kmu.ac.jp; uchidak@hirakata.kmu.ac.jp; nishioa@takii.kmu.ac.jp; matsuzak@takii.kmu.ac.jp; okazaki@hirakata.kmu.ac.jp			Japan Society for the Promotion of Science [22790676]; Health and Labour Sciences Research Grant for Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; CREST Japan Science and Technology Agency; Grant-aided Program for the Strategic Research Foundation for Private Universities; NEXT - Ministry of Education, Culture, Sports, Science and Technology in Japan	This study was supported by the Grant-in-Aid for Young Scientists (B) (22790676) from the Japan Society for the Promotion of Science, by the Health and Labour Sciences Research Grant for Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan, and by the Grant-in-Aid from CREST Japan Science and Technology Agency, by the Grant-aided Program for the Strategic Research Foundation for Private Universities, by the NEXT-Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Susaki E, 2007, MOL CELL BIOL, V27, P4626, DOI 10.1128/MCB.00862-06; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Potten CS, 2002, J CELL SCI, V115, P2381; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Lin SA, 2011, J GASTROENTEROL, V46, P1039, DOI 10.1007/s00535-011-0424-8; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; WEIDNER N, 1994, HUM PATHOL, V25, P337, DOI 10.1016/0046-8177(94)90140-6; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Chen S, 2008, BRIT J DERMATOL, V159, P952, DOI 10.1111/j.1365-2133.2008.08731.x; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Fujimoto K, 2002, GASTROENTEROLOGY, V123, P1941, DOI 10.1053/gast.2002.37065; Fukui T, 2011, J GASTROENTEROL, V46, P456, DOI 10.1007/s00535-010-0364-8; Furukawa Y, 2000, BRIT J HAEMATOL, V110, P663, DOI 10.1046/j.1365-2141.2000.02253.x; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2180; Karam Sherif M., 1999, Frontiers in Bioscience, V4, pD286, DOI 10.2741/Karam; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Matsuzaki K, 2006, HISTOL HISTOPATHOL, V21, P645; Montgomery RK, 2009, GASTROENTEROLOGY, V136, P2051, DOI 10.1053/j.gastro.2009.04.021; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nakanishi Y, 2012, NAT GENET, V45, P98, DOI DOI 10.1038/NG.2481; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Snippert HJ, 2009, GASTROENTEROLOGY, V136; VISSER JWM, 1990, EXP HEMATOL, V18, P248; Watt FM, 1998, PHILOS T ROY SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Wrana JL, 2000, SCI STKE, V2000, P1	65	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	FEB	2015	60	2					362	374		10.1007/s10620-014-3348-3		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ7SP	WOS:000348418400013		
J	Tadokoro, Y; Kasai, S; Ichiki, A				Tadokoro, Yukihiro; Kasai, Seiya; Ichiki, Akihisa			Concept, analysis, and demonstration of a novel delay network exhibiting stochastic resonance induced by external noise	DIGITAL SIGNAL PROCESSING			English	Article						Stochastic resonance; Sub-threshold signal; External noise; Arrayed system; In-out correlation	NON-GAUSSIAN NOISE; SIGNAL-DETECTION; ENHANCED DETECTION; SUBTHRESHOLD SIGNALS; THRESHOLD DEVICES; SYSTEMS; DETECTORS; AMPLIFICATION; INFORMATION; QUANTIZERS	Stochastic resonance offers the possibility of signal amplification by the addition of noise. This curious, interesting phenomenon has received considerable attention since the 1990s. Since such effect has the potential to improve the signal processing performance, intensive works have been done about this topic. One of the most effective implementations of stochastic resonance is in the Collins network, which can provide outstanding performance in that the network output consists of an amplified version of a weak, sub-threshold signal. In practical situations, the sub-threshold signal is easily buried in external noise from the environment. The present paper focuses on the discrete-time system (plus continuous-time system) and analyzes this situation to clarify the performance degradation of the amplification effect. As a countermeasure, we herein propose a novel delay network. The present analysis indicates that the proposed scheme produces an amplification effect in the presence of external noise. The results of the analysis are used to determine the condition for which the delay network is effective, and the results of an experimental evaluation verifies the validity of the analysis. (C) 2014 Elsevier Inc. All rights reserved.	[Tadokoro, Yukihiro] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Kasai, Seiya] Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0608628, Japan; [Ichiki, Akihisa] Nagoya Univ, Green Mobil Collaborat Res Ctr, Nagoya, Aichi 4648603, Japan	Tadokoro, Y (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	tadokoro@mosk.tytlabs.co.jp	Kasai, Seiya/A-1947-2012	Kasai, Seiya/0000-0003-1291-2587			Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Oya T, 2012, IEEE T NANOTECHNOL, V11, P134, DOI 10.1109/TNANO.2011.2159989; Duan FB, 2013, DIGIT SIGNAL PROCESS, V23, P1585, DOI 10.1016/j.dsp.2013.05.009; Dylov DV, 2010, NAT PHOTONICS, V4, P323, DOI 10.1038/NPHOTON.2010.31; Bayram S, 2011, IEEE T SIGNAL PROCES, V59, P1292, DOI 10.1109/TSP.2010.2097257; Chapeau-Blondeau F, 2008, DIGIT SIGNAL PROCESS, V18, P434, DOI 10.1016/j.dsp.2007.04.012; Chapeau-Blondeau F, 1999, DIGIT SIGNAL PROCESS, V9, P162, DOI 10.1006/dspr.1999.0341; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Chen H, 2009, IEEE T INFORM THEORY, V55, P499, DOI 10.1109/TIT/2008.2009813; Mitaim S, 1998, P IEEE, V86, P2152, DOI 10.1109/5.726785; ChapeauBlondeau F, 1997, PHYS REV E, V55, P1478, DOI 10.1103/PhysRevE.55.1478; Bayram S, 2012, DIGIT SIGNAL PROCESS, V22, P391, DOI 10.1016/j.dsp.2012.02.003; Patel A, 2009, IEEE T SIGNAL PROCES, V57, P1655, DOI 10.1109/TSP.2009.2012893; Kay S, 2000, IEEE SIGNAL PROC LET, V7, P8, DOI 10.1109/97.809511; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5074, DOI 10.1109/TSP.2008.929508; DYKMAN MI, 1994, PHYS REV E, V49, P1935, DOI 10.1103/PhysRevE.49.1935; Rousseau D, 2006, SIGNAL PROCESS, V86, P3456, DOI 10.1016/j.sigpro.2006.03.008; Chapeau-Blondeau F, 2004, IEEE T SIGNAL PROCES, V52, P1327, DOI 10.1109/TSP.2004.826176; Mori T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.218101; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Saha AA, 2003, SIGNAL PROCESS, V83, P1193, DOI 10.1016/S0165-1684(03)00039-2; Rousseau D, 2005, DIGIT SIGNAL PROCESS, V15, P19, DOI 10.1016/j.dsp.2004.09.006; Kay S, 2008, IEEE SIGNAL PROC LET, V15, P709, DOI 10.1109/LSP.2008.2001568; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Patel A, 2008, IEEE T NEURAL NETWOR, V19, P1993, DOI 10.1109/TNN.2008.2005610; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5031, DOI 10.1109/TSP.2008.928509; He QB, 2012, DIGIT SIGNAL PROCESS, V22, P614, DOI 10.1016/j.dsp.2012.02.008; Bayram S, 2014, DIGIT SIGNAL PROCESS, V25, P17, DOI 10.1016/j.dsp.2013.10.014; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Chapeau-Blondeau F, 2005, ELECTRON LETT, V41, P618, DOI 10.1049/el:20051065; Chapeau-Blondeau F, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01003; Chapeau-Blondeau F, 2002, FLUCT NOISE LETT, V2, pL221, DOI 10.1142/S0219477502000798; Chen HO, 2007, IEEE T SIGNAL PROCES, V55, P3172, DOI 10.1109/TSP.2007.893757; Gailey PC, 1997, PHYS REV LETT, V79, P4701, DOI 10.1103/PhysRevLett.79.4701; Ham H, 2009, IEICE T FUND ELECTR, VE92A, P1012, DOI 10.1587/transfun.E92.A.1012; Ichiki A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012124; Ichiki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.031106; Kasai S, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.083001; Kosko B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031911; Lee I, 2006, IEEE T NANOTECHNOL, V5, P613, DOI 10.1109/TNANO.2006.883476; McDonnell MD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061105; Rousseau D, 2005, SIGNAL PROCESS, V85, P571, DOI 10.1016/j.sigpro.2004.11.002; Sugiura S, 2012, IEEE SIGNAL PROC LET, V19, P655, DOI 10.1109/LSP.2012.2210873; Tadokoro Y., 2012, P 2012 INT WORKSH NO, P52; Tadokoro Y., 2013, P NAN PER IT, P56; Utagawa A, 2009, IEICE T FUND ELECTR, VE92A, P2508, DOI 10.1587/transfun.E92.A.2508; Wang YG, 2007, DIGIT SIGNAL PROCESS, V17, P76, DOI 10.1016/j.dsp.2006.05.007	48	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1051-2004	1095-4333		DIGIT SIGNAL PROCESS	Digit. Signal Prog.	FEB	2015	37						1	12		10.1016/j.dsp.2014.10.008		12	Engineering, Electrical & Electronic	Engineering	AZ9UF	WOS:000348559800001		
J	Ogawa, T; Miyajima, M; Wakiyama, N; Terada, K				Ogawa, Toru; Miyajima, Makoto; Wakiyama, Naoki; Terada, Katsuhide			Aluminum elution and precipitation in glass vials: effect of pH and buffer species	DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY			English	Article						Acetate buffer; aluminum; borosilicate glass; citrate buffer; extractables; histidine buffer; phosphate buffer	ATTACK; DRUG	Inorganic extractables from glass vials may cause particle formation in the drug solution. In this study, the ability of eluting Al ion from borosilicate glass vials, and tendencies of precipitation containing Al were investigated using various pHs of phosphate, citrate, acetate and histidine buffer. Through heating, all of the buffers showed that Si and Al were eluted from glass vials in ratios almost the same as the composition of borosilicate glass, and the amounts of Al and Si from various buffer solutions at pH 7 were in the following order: citrate>phosphate>acetate>histidine. In addition, during storage after heating, the Al concentration at certain pHs of phosphate and acetate buffer solution decreased, suggesting the formation of particles containing Al. In citrate buffer, Al did not decrease in spite of the high elution amount. Considering that the solubility profile of aluminum oxide and the Al eluting profile of borosilicate glass were different, it is speculated that Al ion may be forced to leach into the buffer solution according to Si elution on the surface of glass vials. When Al ions were added to the buffer solutions, phosphate, acetate and histidine buffer showed a decrease of Al concentration during storage at a neutral range of pHs, indicating the formation of particles containing Al. In conclusion, it is suggested that phosphate buffer solution has higher possibility of forming particles containing Al than other buffer solutions.	[Ogawa, Toru; Miyajima, Makoto; Wakiyama, Naoki] Daiichi Sankyo Co Ltd, Formulat Technol Res Labs, Hiratsuka, Kanagawa 2540014, Japan; [Terada, Katsuhide] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 274, Japan	Ogawa, T (reprint author), Daiichi Sankyo Co Ltd, Formulat Technol Res Labs, 1-12-1 Shinomiya, Hiratsuka, Kanagawa 2540014, Japan.	ogawa.toru.ir@daiichisankyo.co.jp					Abernethy S, 1986, J PARENTER SCI TECHN, V40, pS1; Adams P B, 1977, Bull Parenter Drug Assoc, V31, P213; Sacha GA, 2010, PHARM DEV TECHNOL, V15, P6, DOI 10.3109/10837450903511178; BORCHERT SJ, 1989, J PARENT SCI TECHN, V43, P67; Ennis RD, 2001, PHARM DEV TECHNOL, V6, P393, DOI 10.1081/PDT-100002248; Iacocca RG, 2010, AAPS PHARMSCITECH, V11, P1340, DOI 10.1208/s12249-010-9506-9; Newton DW, 2008, AM J HEALTH-SYST PH, V65, P73, DOI 10.2146/ajhp070138; BACON FR, 1959, J AM CERAM SOC, V42, P199, DOI 10.1111/j.1151-2916.1959.tb12947.x; BODDAPATI S, 1980, J PHARM SCI, V69, P608, DOI 10.1002/jps.2600690540; Brown JB, 1937, J AM CERAM SOC, V20, P245, DOI 10.1111/j.1151-2916.1937.tb19897.x; Dimbleby V., 1952, J PHARM PHARMACOL, V5, P969; ERNSBERGER FM, 1959, J AM CERAM SOC, V42, P373, DOI 10.1111/j.1151-2916.1959.tb13595.x; Guadagnino Emanuel, 2012, PDA J Pharm Sci Technol, V66, P116, DOI 10.5731/pdajpst.2012.00853; Newton DW, 2009, AM J HEALTH-SYST PH, V66, P348, DOI 10.2146/ajhp080059; Ogawa T, 2013, CHEM PHARM BULL, V61, P539; Wang YJ, 1983, 5 PAR DRUG ASS INC; White Frank, 2008, PDA J Pharm Sci Technol, V62, P157	17	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0363-9045	1520-5762		DRUG DEV IND PHARM	Drug Dev. Ind. Pharm.	FEB	2015	41	2					315	321		10.3109/03639045.2013.859154		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA5BT	WOS:000348923200019		
J	Ching, PKG; de los Reyes, VC; Sucaldito, MN; Tayag, E; Columna-Vingno, AB; Malbas, FF; Bolo, GC; Sejvar, JJ; Eagles, D; Playford, G; Dueger, E; Kaku, Y; Morikawa, S; Kuroda, M; Marsh, GA; McCullough, S; Foxwell, AR				Ching, Paola Katrina G.; Carr de los Reyes, Vikki; Nemia Sucaldito, Maria; Tayag, Enrique; Baby Columna-Vingno, Alah; Malbas, Fedelino F., Jr.; Bolo, Gilbert C., Jr.; Sejvar, James J.; Eagles, Debbie; Playford, Geoffrey; Dueger, Erica; Kaku, Yoshihiro; Morikawa, Shigeru; Kuroda, Makoto; Marsh, Glenn A.; McCullough, Sam; Foxwell, A. Ruth			Outbreak of Henipavirus Infection, Philippines, 2014	EMERGING INFECTIOUS DISEASES			English	Article							NIPAH VIRUS; EMERGING PARAMYXOVIRUSES; HENDRA VIRUS; ENCEPHALITIS; BANGLADESH; BATS	During 2014, henipavirus infection caused severe illness among humans and horses in southern Philippines; fatality rates among humans were high. Horse-to-human and human-to-human transmission occurred. The most likely source of horse infection was fruit bats. Ongoing surveillance is needed for rapid diagnosis, risk factor investigation, control measure implementation, and further virus characterization.	[Ching, Paola Katrina G.; Carr de los Reyes, Vikki; Nemia Sucaldito, Maria; Tayag, Enrique; Malbas, Fedelino F., Jr.] Dept Hlth, Manila, Philippines; [Baby Columna-Vingno, Alah] Ctr Hlth Dev Reg XII, Gen Santos, Philippines; [Bolo, Gilbert C., Jr.] Dept Agr, Manila, Philippines; [Sejvar, James J.; Eagles, Debbie; Playford, Geoffrey; Dueger, Erica; Foxwell, A. Ruth] WHO, Manila, Philippines; [Sejvar, James J.; Dueger, Erica] Ctr Dis Control & Prevent, Atlanta, GA USA; [Eagles, Debbie; Marsh, Glenn A.; McCullough, Sam] Australian Anim Hlth Lab, Geelong, Vic, Australia; [Playford, Geoffrey] Univ Queensland, Brisbane, Qld, Australia; [Kaku, Yoshihiro; Morikawa, Shigeru; Kuroda, Makoto] Natl Inst Infect Dis, Tokyo, Japan; [Foxwell, A. Ruth] Australian Natl Univ, Canberra, ACT, Australia	Foxwell, AR (reprint author), 40 Endeavour St, Red Hill, ACT 2603, Australia.	ruth.foxwell@grnail.com	McCullough, Sam/H-7987-2013				Rahman MA, 2012, VECTOR-BORNE ZOONOT, V12, P65, DOI 10.1089/vbz.2011.0656; Field HE, 2007, CURR TOP MICROBIOL, V315, P133; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Chadha MS, 2006, EMERG INFECT DIS, V12, P235; Aljofan M, 2013, VIRUS RES, V177, P119, DOI 10.1016/j.virusres.2013.08.002; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Kaku Y, 2012, J VIROL METHODS, V179, P226, DOI 10.1016/j.jviromet.2011.11.003; Field HE, 2009, ZOONOSES PUBLIC HLTH, V56, P278, DOI 10.1111/j.1863-2378.2008.01218.x; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Bellini WJ, 2005, J NEUROVIROL, V11, P481, DOI 10.1080/13550280500187435; Ksiazek TG, 2011, VIRUS RES, V162, P173, DOI 10.1016/j.virusres.2011.09.026; Mahalingam S, 2012, LANCET INFECT DIS, V12, P799, DOI 10.1016/S1473-3099(12)70158-5; Sahani M, 2001, INT J EPIDEMIOL, V30, P1017, DOI 10.1093/ije/30.5.1017	15	3	3	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	FEB	2015	21	2					328	331		10.3201/eid2102.141433		4	Immunology; Infectious Diseases	Immunology; Infectious Diseases	AZ8WC	WOS:000348491400021		
J	Kim, HG; Lee, DK; Park, C; Kil, S; Son, Y; Park, JH				Kim, Ho Gul; Lee, Dong Kun; Park, Chan; Kil, Sungho; Son, Yonghoon; Park, Jin Han			Evaluating landslide hazards using RCP 4.5 and 8.5 scenarios	ENVIRONMENTAL EARTH SCIENCES			English	Article						Climate change scenario; Maximum entropy model; Landslide susceptibility map; Gangwondo	LOGISTIC-REGRESSION; SUSCEPTIBILITY; GIS; AREA	Recently, extreme meteorological events have occurred frequently owing to climate change and its influence. Impacts of concentrated precipitation events include the damage caused by landslides. Many areas in Gangwondo (Korea) are located at high elevation and have large elevation differences; these areas are thus at high risk of landslides. The purpose of this study was to evaluate the landslide hazard of the province using representative concentration pathways (RCP) scenarios 4.5 and 8.5 and to compare results. This study produced an optimal landslide model for the province through analysis of variables and points of landslide origin. Estimates indicate that the landslide hazard area will increase to 154 km(2). The RCP 8.5 scenario showed a larger (by about 59 km 2) landslide hazard area than the RCP 4.5 scenario. The uncertainty of climate change scenarios was also explored using statistical values of each scenario period. An overlay analysis (overlay of landslide hazard areas and land cover map) showed that 40.6 % of farmlands would be susceptible to landslides in 2070-2099 (RCP 8.5). Additionally, damage to the alpine agriculture due to landslides was also identified as a critical area. In the RCP 8.5 scenario, the land-use types that occupy more than 20 % of the landslide hazard area are transportation, recreational facilities, and vinyl house for farming. This suggests that casualties from landslides will increase in future. It also highlights a lack of policies to manage development. Therefore, the local government of Gangwondo should consider landslide hazard areas when planning future land uses.	[Kim, Ho Gul; Lee, Dong Kun; Park, Jin Han] Seoul Natl Univ, Interdisciplinary Program Landscape Architecture, Seoul, South Korea; [Lee, Dong Kun] Seoul Natl Univ, Res Inst Agr Life Sci, Seoul, South Korea; [Lee, Dong Kun] Seoul Natl Univ, CALS, Dept Landscape Architecture & Rural Syst Engn, Seoul, South Korea; [Park, Chan] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Kil, Sungho] Texas A&M Univ, Coll Architecture, Dept Landscape Architecture & Urban Planning, College Stn, TX 77843 USA; [Son, Yonghoon] Seoul Natl Univ, Grad Sch Environm Studies, Seoul, South Korea	Lee, DK (reprint author), Seoul Natl Univ, CALS, Dept Landscape Architecture & Rural Syst Engn, Seoul, South Korea.	khgghk@snu.ac.kr; dklee7@snu.ac.kr			BK 21 Plus Project (Seoul National University Interdisciplinary Program in Landscape Architecture, Global leadership program towards innovative green infrastructure); Development of Economic Assessment Technique for Climate Change Impact and Adaptation Considering Uncertainties (Korea Ministry of Environment) [2014001310010]; Development of climate change adaptation and management technique, and supportive system (Korea Ministry of Environment) [416-111-014]	This work was supported by the BK 21 Plus Project in 2014 (Seoul National University Interdisciplinary Program in Landscape Architecture, Global leadership program towards innovative green infrastructure), The Development of Economic Assessment Technique for Climate Change Impact and Adaptation Considering Uncertainties (Korea Ministry of Environment, Project number: 2014001310010), and Development of climate change adaptation and management technique, and supportive system (Korea Ministry of Environment, Project number: 416-111-014).	Yilmaz I, 2009, COMPUT GEOSCI-UK, V35, P1125, DOI 10.1016/j.cageo.2008.08.007; Guzzetti F, 2007, METEOROL ATMOS PHYS, V98, P239, DOI 10.1007/s00703-007-0262-7; Guzzetti F, 2008, LANDSLIDES, V5, P3, DOI 10.1007/s10346-007-0112-1; Rozos D, 2011, ENVIRON EARTH SCI, V63, P49, DOI 10.1007/s12665-010-0687-z; Hansson SL, 2005, BRIT J PSYCHIAT, V187, P262, DOI 10.1192/bjp.187.3.262; Bathrellos GD, 2013, STOCH ENV RES RISK A, V27, P573, DOI 10.1007/s00477-012-0602-0; Vorpahl P, 2012, ECOL MODEL, V239, P27, DOI 10.1016/j.ecolmodel.2011.12.007; Lee S, 2006, ENVIRON GEOL, V50, P847, DOI 10.1007/s00254-006-0256-7; Bathrellos GD, 2012, ENVIRON EARTH SCI, V66, P537, DOI 10.1007/s12665-011-1263-x; Yao X, 2008, GEOMORPHOLOGY, V101, P572, DOI 10.1016/j.geomorph.2008.02.011; Rozos D, 2013, ENVIRON EARTH SCI, V70, P3255, DOI 10.1007/s12665-013-2390-3; Al-shalabi M, 2013, ENVIRON EARTH SCI, V70, P425, DOI 10.1007/s12665-012-2137-6; Yesilnacar E, 2005, ENG GEOL, V79, P251, DOI 10.1016/j.enggeo.2005.02.002; Pradhan B, 2010, ENVIRON EARTH SCI, V60, P1037, DOI 10.1007/s12665-009-0245-8; Saha AK, 2005, LANDSLIDES, V2, P61, DOI 10.1007/s10346-004-0039-8; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ayalew L, 2005, GEOMORPHOLOGY, V65, P15, DOI 10.1016/j.geomorph.2004.06.010; Felicisimo A, 2013, LANDSLIDES, V10, P175, DOI 10.1007/s10346-012-0320-1; Ermini L, 2005, GEOMORPHOLOGY, V66, P327, DOI 10.1016/j.geomorph.2004.09.025; Choi JH, 2011, J ENG GEOL, V21, P281; Jyaness ET, 1957, PHYS REV, V106, P620; Keller EA, 2006, NATURAL HAZARDS EART; Kim Koo, 2011, Journal of Pharmacopuncture, V14, P33; Kim WY, 2009, J ENG GEOL, V19, P331; Knutti R., 2012, CLIMATE CHANGE, V3, P369, DOI [10.1038/nclimate1716, DOI 10.1038/NCLIMATE1716]; Papadopoulou-Vrynioti K, 2013, ENG GEOL, V158, P77, DOI 10.1016/j.enggeo.2013.02.009; Yoo Nam-Jae, 2012, [JOURNAL of THE KOREAN GEOENVIRONMENTAL SOCIETY, 한국지반환경공학회 논문집], V13, P75	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	FEB	2015	73	3					1385	1400		10.1007/s12665-014-3775-7		16	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	AZ6PI	WOS:000348340900038		
J	Demura, S; Murakami, H; Shirai, T; Kato, S; Yoshioka, K; Ota, T; Ishii, T; Igarashi, T; Tsuchiya, H				Demura, S.; Murakami, H.; Shirai, T.; Kato, S.; Yoshioka, K.; Ota, T.; Ishii, T.; Igarashi, T.; Tsuchiya, H.			Surgical treatment for pyogenic vertebral osteomyelitis using iodine-supported spinal instruments: initial case series of 14 patients	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							PIN TRACT INFECTION; EXTERNAL FIXATION; TUBERCULOSIS; PREVENTION; MANAGEMENT; CAGES	Reports have detailed the increasing use of spinal instrumentation in the treatment of pyogenic vertebral osteomyelitis, with the aims of achieving a lower pseudoarthrosis rate and restoring spinal alignment. However, controversy remains over the use of instrumentation in the presence of active infection because of concerns about increased bacterial adherence and biofilm formation on the metallic implant surface. Fourteen consecutive patients were followed who were diagnosed as having pyogenic vertebral osteomyelitis and underwent surgery with spinal instrumentation with iodine-containing surfaces that could be directly supported to existing titanium implants. Bone-cage interfaces and implant-related complications after surgery were evaluated. The white blood cell (WBC) count and C-reactive protein (CRP) level were analyzed during the follow-up period. To confirm the influence of iodine release from the implant, thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) were also examined. The infection subsided in all 14 patients. Both WBC counts and CRP levels returned to normal ranges by the final follow-up. One patient showed a lucent area around the screw and two patients showed lucencies inside the cage. However, no cage dislocations, cage migrations, or screw pull-outs were noted, and all patients' FT3, FT4, and TSH levels were within normal ranges during the follow-up period. We demonstrated the efficacy of iodine-supported titanium implants in the management of pyogenic vertebral osteomyelitis. No cytotoxicity or adverse effects were noted in this series.	[Demura, S.; Murakami, H.; Shirai, T.; Kato, S.; Yoshioka, K.; Ota, T.; Ishii, T.; Igarashi, T.; Tsuchiya, H.] Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan	Demura, S (reprint author), Kanazawa Univ, Sch Med, Dept Orthopaed Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	demudon@med.kanazawa-u.ac.jp					Hardes J, 2010, J SURG ONCOL, V101, P389, DOI 10.1002/jso.21498; Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036; EISMONT FJ, 1983, J BONE JOINT SURG AM, V65, P19; SAPICO FL, 1979, REV INFECT DIS, V1, P754; Jensen AG, 1997, J INFECTION, V34, P113, DOI 10.1016/S0163-4453(97)92395-1; Ha KY, 2005, SPINE, V30, P38; Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3; Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D; Yilmaz C, 1999, J BONE JOINT SURG AM, V81A, P1261; Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008; Shirai T, 2014, J ORTHOP SCI, V19, P598, DOI 10.1007/s00776-014-0561-z; Grammatico L, 2008, EPIDEMIOL INFECT, V136, P653, DOI 10.1017/S095026SS07008850; [Anonymous], 2015, EUR J CLIN MICROBIOL, V34, P261; Liljenqvist U, 2003, EUR SPINE J, V12, P606, DOI 10.1007/s00586-003-0614-z; Shirai T, 2009, J BIOMED MATER RES B, V91B, P373, DOI 10.1002/jbm.b.31412; Hadjipavlou AG, 2000, SPINE, V25, P1668, DOI 10.1097/00007632-200007010-00010; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; OSENBACH RK, 1990, SURG NEUROL, V33, P266, DOI 10.1016/0090-3019(90)90047-S; OGA M, 1993, SPINE, V18, P1890, DOI 10.1097/00007632-199310000-00028; Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3; Chen WH, 2011, SPINE, V36, P103, DOI 10.1097/BRS.0b013e3181cb46ba; Cheung WY, 2012, INT ORTHOP, V36, P397, DOI 10.1007/s00264-011-1384-6; Hashimoto K, 1999, INORG MATER, V6, P457; Hee HT, 2002, J SPINAL DISORD TECH, V15, P149; Jevtic V, 2004, EUR RADIOL, V14, pE43, DOI 10.1007/s00330-003-2046-x; Korovessis Panagiotis, 2008, Spine (Phila Pa 1976), V33, pE759, DOI 10.1097/BRS.0b013e318187875e; Rezai AR, 1999, NEUROSURGERY, V44, P1018, DOI 10.1097/00006123-199905000-00047	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	FEB	2015	34	2					261	266		10.1007/s10096-014-2226-4		6	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	AZ7ES	WOS:000348382400008		
J	Kawada, T				Kawada, Tomoyuki			Dietary glycemic load and cognitive performance in elderly subjects	EUROPEAN JOURNAL OF NUTRITION			English	Letter							REGRESSION; EVENTS		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI 10.1056/NEJMoa1215740; Power SE, EUR J NUTR, DOI [10.1007/s00394-014-0737-5, DOI 10.1007/S00394-014-0737-5]	4	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-6207	1436-6215		EUR J NUTR	Eur. J. Nutr.	FEB	2015	54	1					157	158		10.1007/s00394-014-0791-z		2	Nutrition & Dietetics	Nutrition & Dietetics	AZ8BT	WOS:000348440400015		
J	Ozeki, N; Kawai, R; Hase, N; Hiyama, T; Yamaguchi, H; Kondo, A; Nakata, K; Mogi, M				Ozeki, Nobuaki; Kawai, Rie; Hase, Naoko; Hiyama, Taiki; Yamaguchi, Hideyuki; Kondo, Ayami; Nakata, Kazuhiko; Mogi, Makio			alpha 2 Integrin, extracellular matrix metalloproteinase inducer, and matrix metalloproteinase-3 act sequentially to induce differentiation of mouse embryonic stem cells into odontoblast-like cells	EXPERIMENTAL CELL RESEARCH			English	Article						alpha 2 integrin; Embryonic stem cells; Extracellular matrix metalloproteinase inducer; Matrix metalloproteinase-3	OSTEOBLASTIC DIFFERENTIATION; CONDITIONED MEDIUM; TNF-ALPHA; EMMPRIN; ACTIVATION; TUMOR; EXPRESSION; CD147; RAT; PROLIFERATION	We previously reported that interleukin 113 acts via matrix metalloproteinase (MMP)-3 to regulate cell proliferation and suppress apoptosis in alpha 2 integrin-positive odontoblast-like cells differentiated from mouse embryonic stem (ES) cells. Here we characterize the signal cascade underpinning odontoblastic differentiation in mouse ES cells. The expression of alpha 2 integrin, extracellular matrix metalloproteinase inducer (Emmprin), and MMP-3 mRNA and protein were all potently increased during odontoblastic differentiation. Small interfering RNA (siRNA) disruption of the expression of these effectors potently suppressed the expression of the odontoblastic biomarkers dentin sialophosphoprotein, dentin matrix protein-1 and alkaline phosphatase, and blocked odontoblast calcification. Our siRNA, western blot and blocking antibody analyses revealed a unique sequential cascade involving alpha 2 integrin, Emmprin and MMP-3 that drives ES cell differentiation into odontoblasts. This cascade requires the interaction between alpha 2 integrin and Emmprin and is potentiated by exogenous MMP-3. Finally, although odontoblast-like cells potently express alpha 2, alpha 6, alpha V, beta 1, and beta 3, integrins, we confirmed that beta 1 integrin acts as the trigger for ES cell differentiation, apparently in complex with alpha 2 integrin. These results demonstrate a unique and unanticipated role for an alpha 2 integrin-, Emmprin-, and MMP-3-mediated signaling cascade in driving mouse ES cell differentiation into odontoblast-like cells. (C) 2014 Elsevier Inc. All rights reserved.	[Ozeki, Nobuaki; Kawai, Rie; Hase, Naoko; Hiyama, Taiki; Yamaguchi, Hideyuki; Nakata, Kazuhiko] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 4648651, Japan; [Kondo, Ayami; Mogi, Makio] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Nagoya, Aichi 4648650, Japan	Mogi, M (reprint author), Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	makio@dpc.agu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25253101, 26462903, 26861614, 26462904]	This work was supported by a Grant-in-Aid-for Scientific Research (A) (No. 25253101; to NO), a Grant-in-Aid-for Scientific Research (C) (No. 26462903; to TM), a Grant-in-Aid-for Young Scientists (B) (No. 26861614; to RK) and a Grant-in-Aid-for Scientific Research (C) (No. 26462904; to NO) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We also thank Dr. Randall H. Kramer (UCSF, CA, USA) for donation of experimental reagents and for helpful discussion.	Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Dani C, 1997, J CELL SCI, V110, P1279; Huet E, 2008, FASEB J, V22, P1144, DOI 10.1096/fj.07-8748com; KATAOKA H, 1993, CANCER RES, V53, P3154; Reddy VS, 2010, AM J PHYSIOL-HEART C, V299, pH1242, DOI 10.1152/ajpheart.00451.2010; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102; Ozeki N, 2014, ORAL DIS, V20, P505, DOI 10.1111/odi.12165; Caudroy S, 2002, CLIN EXP METASTAS, V19, P697, DOI 10.1023/A:1021350718226; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; Yamaguchi H, 2014, J ENDODONT, V40, P89, DOI 10.1016/j.joen.2013.09.029; Guo HM, 1997, J BIOL CHEM, V272, P24; Choi EY, 2002, EXP MOL MED, V34, P391; Haseneen NA, 2003, AM J PHYSIOL-LUNG C, V284, pL541, DOI 10.1152/ajplung.00290.2002; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981; BISWAS C, 1995, CANCER RES, V55, P434; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Koyama Y, 2008, BIOCHEM BIOPH RES CO, V371, P659, DOI 10.1016/j.bbrc.2008.04.064; Yu JH, 2006, TISSUE ENG, V12, P3097, DOI 10.1089/ten.2006.12.3097; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Tian J, 2013, RHEUMATOL INT, V33, P1829, DOI 10.1007/s00296-012-2657-0; Huang CYC, 2009, REGEN MED, V4, P809, DOI [10.2217/rme.09.55, 10.2217/RME.09.55]; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje; Xu JP, 2009, STEM CELLS DEV, V18, P487, DOI 10.1089/scd.2008.0113; Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; Sun JX, 2001, CANCER RES, V61, P2276; Azuma Y, 2007, EUR J PHARMACOL, V568, P260, DOI 10.1016/j.ejphar.2007.05.001; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066391; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; Emingil G., 2013, J PERIODONTOL; Hiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083563; Huo N, 2010, STEM CELLS DEV, V19, P93, DOI 10.1089/scd.2009.0048; Kawai R, 2014, ORAL DIS, V20, P395, DOI 10.1111/odi.12134; Khunkaewla P, 2008, MOL IMMUNOL, V45, P1703, DOI 10.1016/j.molimm.2007.09.032; Koch C, 1999, INT IMMUNOL, V11, P777, DOI 10.1093/intimm/11.5.777; Liu H, 2013, INT J CARDIOL, V168, P3248, DOI 10.1016/j.ijcard.2013.04.141; MEDVINSKII L A, 1981, Byulleten' Eksperimental'noi Biologii i Meditsiny, V91, P379; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Ozeki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080026; Ozeki N., 2013, ORAL DIS; Ozeki N, 2006, EXP CELL RES, V312, P4162, DOI 10.1016/j.yexcr.2006.09.017; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Sato T, 2009, GYNECOL ONCOL, V114, P337, DOI 10.1016/j.ygyno.2009.04.004; Siwik DA, 2008, J MOL CELL CARDIOL, V44, P210, DOI 10.1016/j.yjmcc.2007.07.054; Suzuki S, 2004, EXP CELL RES, V293, P259, DOI 10.1016/j.yexer.2003.10.010; Tseng WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063963; Wang CH, 2011, J CELL MOL MED, V15, P850, DOI 10.1111/j.1582-4934.2010.01084.x; Wei M, 2012, J KOREAN MED SCI, V27, P291, DOI 10.3346/jkms.2012.27.3.291; Yao CC, 1996, J BIOL CHEM, V271, P25598	56	1	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	FEB 1	2015	331	1					21	37		10.1016/j.yexcr.2014.08.004		17	Oncology; Cell Biology	Oncology; Cell Biology	CA0UK	WOS:000348631600003		
J	Ozeki, N; Hase, N; Kawai, R; Yamaguchi, H; Hiyama, T; Kondo, A; Nakata, K; Mogi, M				Ozeki, Nobuaki; Hase, Naoko; Kawai, Rie; Yamaguchi, Hideyuki; Hiyama, Taiki; Kondo, Ayami; Nakata, Kazuhiko; Mogi, Makio			Unique proliferation response in odontoblastic cells derived from human skeletal muscle stem cells by cytokine-induced matrix metalloproteinase-3	EXPERIMENTAL CELL RESEARCH			English	Article						MMP-3; Cytokine; Inflammation; Human stem cells; Odontoblast	NECROSIS-FACTOR-ALPHA; DENTAL-PULP CELLS; PROINFLAMMATORY CYTOKINES; DIFFERENTIAL EXPRESSION; PERIAPICAL LESIONS; NITRIC-OXIDE; TISSUE; INHIBITORS; DEATH; DEGRADATION	A pro-inflammatory cytokine mixture (CM: interleukin (IL-1 beta), tumor necrosis factor-alpha and interferon-gamma) and IL-1 beta-induced matrix metalloproteinase (MMP)-3 activity have been shown to increase the proliferation of rat dental pulp cells and murine stem cell-derived odontoblast-like cells. This suggests that MMP-3 may regulate wound healing and regeneration in the odontoblast-rich dental pulp. Here, we determined whether these results can be extrapolated to human dental pulp by investigating the effects of CM-induced MMP-3 up-regulation on the proliferation and apoptosis of purified odontoblast-like cells derived from human skeletal muscle stem cells. We used siRNA to specifically reduce MMP-3 expression. We found that CM treatment increased MMP-3 mRNA and protein levels as well as MMP-3 activity. Cell proliferation was also markedly increased, with no changes in apoptosis, upon treatment with CM and following the application of exogenous MMP-3. Endogenous tissue inhibitors of metalloproteinases were constitutively expressed during all experiments and unaffected by MMP-3. Although treatment with MMP-3 siRNA suppressed cell proliferation, it also unexpectedly increased apoptosis. This siRNA-mediated increase in apoptosis could be reversed by exogenous MMP-3. These results demonstrate that cytokine-induced MMP-3 activity regulates cell proliferation and suppresses apoptosis in human odontoblast-like cells. (C) 2014 Elsevier Inc. All rights reserved.	[Ozeki, Nobuaki; Hase, Naoko; Kawai, Rie; Yamaguchi, Hideyuki; Hiyama, Taiki; Nakata, Kazuhiko] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 4648651, Japan; [Kondo, Ayami; Mogi, Makio] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Mogi, M (reprint author), Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	makio@dpc.agu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25253101, 26462903, 26861614, 26462904]	This work was supported by a Grant-in-Aid-for Scientific Research (A) (No. 25253101; to NO), a Grant-in-Aid-for Scientific Research (C) (No. 26462903; to TM), a Grant-in-Aid-for Young Scientists (B) (No. 26861614; to RK) and a Grant-in-Aid-for Scientific Research (C) (No. 26462904; to NO) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank Dr. Randall H. Kramer for the donation of experimental reagents and for helpful discussions.	Zhong S, 2012, J ENDODONT, V38, P746, DOI 10.1016/j.joen.2012.02.020; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Ozeki N, 2002, ARCH ORAL BIOL, V47, P511, DOI 10.1016/S0003-9969(02)00035-3; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Abd-Elmeguid A, 2012, J ENDODONT, V38, P75, DOI 10.1016/j.joen.2011.10.005; Westermarck J, 1999, FASEB J, V13, P781; Wahlgren J, 2002, INT ENDOD J, V35, P897, DOI 10.1046/j.1365-2591.2002.00587.x; Paula-Silva FWG, 2010, J ENDODONT, V36, P231, DOI 10.1016/j.joen.2009.10.030; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Ozeki N, 2014, ORAL DIS, V20, P505, DOI 10.1111/odi.12165; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; Kim RH, 2013, J ENDODONT, V39, P57, DOI 10.1016/j.joen.2012.09.006; Yamaguchi H, 2014, J ENDODONT, V40, P89, DOI 10.1016/j.joen.2013.09.029; Ozeki N, 2014, EXP CELL RES, V323, P165, DOI 10.1016/j.yexcr.2014.02.018; WOESSNER JF, 1991, FASEB J, V5, P2145; Herrera I, 2013, J BIOL CHEM, V288, P25964, DOI 10.1074/jbc.M113.459784; Song Z, 2012, J ENDODONT, V38, P1592, DOI 10.1016/j.joen.2012.09.023; TANIISHII N, 1995, ORAL MICROBIOL IMMUN, V10, P213, DOI 10.1111/j.1399-302X.1995.tb00145.x; Shin SJ, 2002, J ENDODONT, V28, P313, DOI 10.1097/00004770-200204000-00013; Goda S, 2008, J DENT RES, V87, P782; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Damoulis PD, 1997, J BONE MINER RES, V12, P412, DOI 10.1359/jbmr.1997.12.3.412; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; Gusman H, 2002, EUR J ORAL SCI, V110, P353, DOI 10.1034/j.1600-0722.2002.21347.x; Kawai R, 2014, ORAL DIS, V20, P395, DOI 10.1111/odi.12134; Koyama N., 2009, J MED INVESTIG S, V56, pS247; Mogi M, 1999, BIOCHEM PHARMACOL, V58, P649, DOI 10.1016/S0006-2952(99)00131-8; Ozeki N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080026; Ozeki N, 2014, J BIOL CHEM, V289, P14380, DOI 10.1074/jbc.M113.526772; Ozeki N., ORAL DIS IN PRESS; Ozeki N, 2006, EXP CELL RES, V312, P4162, DOI 10.1016/j.yexcr.2006.09.017; Ozeld N., EXP CELL RE IN PRESS; Palosaari H, 2003, EUR J ORAL SCI, V111, P117, DOI 10.1034/j.1600-0722.2003.00026.x; Tseng WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063963; Zhang J, 2014, Eur J Histochem, V58, P2262, DOI 10.4081/ejh.2014.2262	39	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	FEB 1	2015	331	1					105	114		10.1016/j.yexcr.2014.09.015		10	Oncology; Cell Biology	Oncology; Cell Biology	CA0UK	WOS:000348631600010		
J	Rajapakshe, AR; Podyma-Inoue, KA; Terasawa, K; Hasegawa, K; Namba, T; Kumei, Y; Yanagishita, M; Hara-Yokoyama, M				Rajapakshe, Anupama R.; Podyma-Inoue, Katarzyna A.; Terasawa, Kazue; Hasegawa, Katsuya; Namba, Toshimitsu; Kumei, Yasuhiro; Yanagishita, Masaki; Hara-Yokoyama, Miki			Lysosome-associated membrane proteins (LAMPs) regulate intracellular positioning of mitochondria in MC3T3-E1 cells	EXPERIMENTAL CELL RESEARCH			English	Article						Lysosome-associated membrane proteins (LAMPs); Lysosomes; Mitochondria; Intracellular positioning	BIDIRECTIONAL TRANSPORT; CAENORHABDITIS-ELEGANS; CULTURED-CELLS; MOTORS; GLYCOPROTEINS; MICROTUBULES; DYNEIN; MICE; TRAFFICKING; OSTEOBLASTS	The intracellular positioning of both lysosomes and mitochondria meets the requirements of degradation and energy supply, which are respectively the two major functions for cellular maintenance. The positioning of both lysosomes and mitochondria is apparently affected by the nutrient status of the cells. However, the mechanism coordinating the positioning of the organelles has not been sufficiently elucidated. Lysosome-associated membrane proteins-1 and -2 (LAMP-I and LAMP-2) are highly glycosylated proteins that are abundant in lysosomal membranes. In the present study, we demonstrated that the siRNA-mediated downregulation of LAMP-I, LAMP-2 or their combination enhanced the perinuclear localization of mitochondria, in the pre-osteoblastic cell line MC3T3-E1. On the other hand, in the osteocytic cell line MLO-Y4, in which both the lysosomes and mitochondria originally accumulate in the perinuclear region and mitochondria also fill dendrites, the effect of siRNA of LAMP-1 or LAMP-2 was barely observed. LAMPs are not directly associated with mitochondria, and there do not seem to be any accessory molecules commonly required to recruit the motor proteins to lysosomes and mitochondria. Our results suggest that LAMPs may regulate the positioning of lysosomes and mitochondria. A possible mechanism involving the indirect and context-dependent action of LAMPs is discussed. (C) 2014 Elsevier Inc. All rights reserved.	[Rajapakshe, Anupama R.; Podyma-Inoue, Katarzyna A.; Terasawa, Kazue; Namba, Toshimitsu; Kumei, Yasuhiro; Yanagishita, Masaki; Hara-Yokoyama, Miki] TMDU, Grad Sch Med & Dent Sci, Biochem Sect, Dept Hard Tissue Engn,Bunkyo Ku, Tokyo 1138549, Japan; [Hasegawa, Katsuya] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan	Hara-Yokoyama, M (reprint author), TMDU, Grad Sch Med & Dent Sci, Biochem Sect, Dept Hard Tissue Engn,Bunkyo Ku, I-5-45 Yushima, Tokyo 1138549, Japan.	m.yokoyama.bch@tmd.ac.jp			 [22592060];  [25463072];  [23650319];  [26463087]	We thank Prof. Lynda F. Bonewald (Department of Oral Biology, University of Missouri-Kansas City) for providing the mouse osteocyte-like cell line (MLO-Y4). This work was supported by Grants-in-Aid for Scientific Research 22592060 and 25463072 (to M.H.) and 23650319 and 26463087 (to K.A.I.).	AKISAKA T, 1987, CELL TISSUE RES, V247, P469, DOI 10.1007/BF00215738; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Beertsen W, 2008, J IMMUNOL, V180, P475; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; An JH, 2010, BONE, V47, P140, DOI 10.1016/j.bone.2010.04.593; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Tanaka Y, 2000, NATURE, V406, P902; Kariya Y, 2009, J BONE MINER RES, V24, P1741, DOI [10.1359/jbmr.090409, 10.1359/JBMR.090409]; Sasaki A, 2013, MOL BIOL CELL, V24, P1584, DOI 10.1091/mbc.E12-08-0628; CHEN JW, 1988, J BIOL CHEM, V263, P8754; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013; Zhao HB, 2012, TRAFFIC, V13, P1307, DOI 10.1111/j.1600-0854.2012.01395.x; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Birsa N, 2013, BIOCHEM SOC T, V41, P1525, DOI 10.1042/BST20130234; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; da Silva AF, 2014, CELL MOL LIFE SCI, V71, P2313, DOI 10.1007/s00018-014-1557-8; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Bryantseva SA, 2012, CELL BIOL INT, V36, P1, DOI 10.1042/CBI20110413; Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; Guo DY, 2010, PROTEOMICS, V10, P3688, DOI 10.1002/pmic.201000306; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; LIN SXH, 1992, J CELL SCI, V101, P125; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; Nakae I, 2010, MOL BIOL CELL, V21, P2434, DOI 10.1091/mbc.E09-12-1010; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Taniguchi T, 2010, FEBS LETT, V584, P3969, DOI 10.1016/j.febslet.2010.07.055; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wilke S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-62	44	2	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	FEB 1	2015	331	1					211	222		10.1016/j.yexcr.2014.09.014		12	Oncology; Cell Biology	Oncology; Cell Biology	CA0UK	WOS:000348631600019		
J	Shimazawa, R; Ikeda, M				Shimazawa, Rumiko; Ikeda, Masayuki			International differences in companion diagnostic approvals: how are we able to manage the differences?	EXPERT REVIEW OF MOLECULAR DIAGNOSTICS			English	Editorial Material						biomarkers; diagnostic test approval; drug approval; individualized medicine; pharmacogenetics; US FDA	PERSONALIZED MEDICINE; COLORECTAL-CANCER; JAPAN; CHALLENGES; BIOMARKERS; USA; EU	One would expect regulations for drugs and diagnostics not to differ significantly between countries, given that regulatory authorities evaluate the same scientific data generated in an increasingly globally harmonized context. However, studies of our own and others have provided compelling evidence of differences in regulations for drugs and in vitro companion diagnostics in personalized medicine. Differing regulatory processes create hurdles for both pharmaceutical and companion diagnostics companies with different platforms that employ different technologies. The rising cost of healthcare caused by improvements in technology is another issue that faces all advanced countries. To address these issues and to facilitate access to personalized medicine, regulatory authorities, academia and the pharmaceutical industry should increase dialogue on the differences on an international platform.	[Shimazawa, Rumiko] Osaka Univ, Grad Sch Med, Osaka, Japan; [Ikeda, Masayuki] Kagawa Univ Hosp, Dept Med Informat, Ikenobe, Kagawa 7610793, Japan	Ikeda, M (reprint author), Kagawa Univ Hosp, Dept Med Informat, Miki Cho, Ikenobe, Kagawa 7610793, Japan.	massie.ikeda@gmail.com					Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Cohen J, 2013, PHARMACOGENOMICS J, V13, P378, DOI 10.1038/tpj.2011.63; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Meckley LM, 2010, HEALTH POLICY, V94, P91, DOI 10.1016/j.healthpol.2009.09.006; Ong FS, 2012, EXPERT REV MOL DIAGN, V12, P593, DOI [10.1586/erm.12.59, 10.1586/ERM.12.59]; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Chalkidou K, 2011, DRUG DISCOV TODAY, V16, P873, DOI 10.1016/j.drudis.2011.08.015; Miller I, 2011, PERS MED, V8, P137, DOI 10.2217/PME.11.2; Folino-Gallo P, 2001, EUR J CLIN PHARMACOL, V57, P441; Fujiwara Y, 2011, NEW ENGL J MED, V365, P2339, DOI 10.1056/NEJMc1112018; Garfield S, ADV ACCESS PERSONALI; Jorgensen JT, 2011, DRUG DISCOV TODAY, V16, P891, DOI 10.1016/j.drudis.2011.09.010; Shimazawa R, 2013, PHARMACOEPIDEM DR S, V22, P306, DOI 10.1002/pds.3408; Shimazawa R, 2013, J CLIN PHARM THER, V38, P468, DOI 10.1111/jcpt.12089; Shimazawa R, 2013, BRIT J CLIN PHARMACO, V75, P1365, DOI 10.1111/j.1365-2125.2012.04462.x; Shimazawa R, 2014, J CLIN PHARM THER, V39, P210, DOI 10.1111/jcpt.12129; US FDA, TABL PHARM BIOM DRUG	17	1	1	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1473-7159	1744-8352		EXPERT REV MOL DIAGN	Expert Rev. Mol. Diagn.	FEB	2015	15	2			SI		157	159		10.1586/14737159.2015.969243		3	Pathology	Pathology	AZ7EA	WOS:000348380400002		
J	Badruzzaman, M; Imamura, S; Takeuchi, Y; Ikegami, T; Takemura, A				Badruzzaman, Muhammad; Imamura, Satoshi; Takeuchi, Yuki; Ikegami, Taro; Takemura, Akihiro			Effects of neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment on ovarian development of the sapphire devil, Chrysiptera cyanea	FISH PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Damselfish; Dopamine; MPTP; Ovary; Reproduction; Tyrosine hydroxylase; Vitellogenesis	GONADOTROPIN-RELEASING-HORMONE; GAD67 MESSENGER-RNA; TROPICAL DAMSELFISH; GOLDFISH BRAIN; DOPAMINERGIC INHIBITION; REPRODUCTIVE ACTIVITY; CLARIAS-GARIEPINUS; RECEPTOR SUBTYPES; GENE-EXPRESSION; FEMALE GOLDFISH	In the neuroendocrine system controlling fish reproduction, dopamine (DA) acts as a gonadotropin inhibitory factor and plays a role in regulating gonadal development of certain species. The present study examined the effects of chemical destruction of dopaminergic neurons in the brain on DA production and ovarian development in the sapphire devil Chrysiptera cyanea, a reef-associated damselfish. The avidin-biotin-peroxidase complex method using an antibody against tyrosine hydroxylase (TH), a critical enzyme in the DA synthesis pathway, identified a population of dopaminergic neurons with somata in the anteroventral preoptic nucleus of the diencephalon and fibers terminating in the proximal pars distalis of the pituitary. Maintaining fish in seawater containing 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at 0.02 and 0.2 A mu g/mL for 2 days resulted in decreases in DA, 3,4-dihydroxyphenylacetic acid (DOPAC; DA metabolite), and DA metabolic rate in the whole brain. The number of TH-positive neurons in the diencephalon decreased after 0.02 A mu g/mL MPTP treatment for 2 days. These results suggest that MPTP treatment destroys TH-positive neurons in the diencephalon, thereby decreasing the synthesis and release of DA from the brain. This treatment rescued ovarian development in fish with artificially retracted ovaries during the spawning season. The gonadosomatic index of MPTP-treated fish 5 and 7 days after treatment was significantly higher than that of control fish. Oocytes in the vitellogenic stages were observed in the ovaries of MPTP-treated fish, but not in control fish. These results suggest that DA in the brain drives ovarian development in the sapphire devil.	[Badruzzaman, Muhammad; Imamura, Satoshi; Takeuchi, Yuki; Ikegami, Taro; Takemura, Akihiro] Univ Ryukyus, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan	Takemura, A (reprint author), Univ Ryukyus, Dept Chem Biol & Marine Sci, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	takemura@sci.u-ryukyu.ac.jp			Japan Society for the Promotion of Science (JSPS) [23248033, 25660170]	We thank the staff of Sesoko Station, Tropical Biosphere Research Center, University of the Ryukyus, for their technical assistance. This study was supported in part by a Grant-in-Aid for Scientific Research (A) (JSPS KAKENHI Grant Number: 23248033) and for Challenging Exploratory Research (JSPS KAKENHI Grant Number: 25660170) from the Japan Society for the Promotion of Science (JSPS) to AT.	CHANG JP, 1990, NEUROENDOCRINOLOGY, V51, P664, DOI 10.1159/000125408; KAH O, 1987, NEUROENDOCRINOLOGY, V45, P451, DOI 10.1159/000124774; Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0; Levavi-Sivan B, 2004, BIOL REPROD, V70, P1545, DOI 10.1095/biolreprod.103.021998; Hoque MM, 1999, J FISH BIOL, V55, P1213, DOI 10.1006/jfbi.1999.1124; Dufour S, 2010, J FISH BIOL, V76, P129, DOI 10.1111/j.1095-8649.2009.02499.x; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; Kumakura N, 2003, GEN COMP ENDOCR, V131, P264, DOI 10.1016/S0016-6480(03)00012-1; CHANG JP, 1983, NEUROENDOCRINOLOGY, V36, P351, DOI 10.1159/000123480; YU KL, 1991, GEN COMP ENDOCR, V81, P256, DOI 10.1016/0016-6480(91)90010-4; Fontaine R, 2013, ENDOCRINOLOGY, V154, P807, DOI 10.1210/en.2012-1759; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Aizen J, 2005, GEN COMP ENDOCR, V142, P212, DOI 10.1016/j.ygcen.2005.01.002; Dufour S, 2005, ANN NY ACAD SCI, V1040, P9, DOI 10.1196/annals.1327.002; NAGAHAMA Y, 1994, INT J DEV BIOL, V38, P217; Vidal B, 2004, BIOL REPROD, V71, P1491, DOI 10.1095/biolreprod.104.030627; PENG C, 1994, ENDOCRINOLOGY, V134, P1095, DOI 10.1210/en.134.3.1095; Rahman MS, 2000, COMP BIOCHEM PHYS B, V127, P113, DOI 10.1016/S0305-0491(00)00240-6; Petzinger GM, 2006, J NEUROSCI RES, V83, P332, DOI 10.1002/jnr.20730; GROVES DJ, 1986, GEN COMP ENDOCR, V62, P315, DOI 10.1016/0016-6480(86)90122-X; Weltzien FA, 2006, ENDOCRINOLOGY, V147, P2964, DOI 10.1210/en.2005-1477; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; POLI A, 1990, BRAIN RES, V534, P45, DOI 10.1016/0006-8993(90)90110-W; DUFOUR S, 1988, GEN COMP ENDOCR, V70, P20, DOI 10.1016/0016-6480(88)90090-1; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017; Badruzzaman M, 2014, THESIS U RYUKYUS; Badruzzaman M, 2013, GEN COMP ENDOCR, V194, P240, DOI 10.1016/j.ygcen.2013.09.012; Bapary MA, 2012, MAR BIOL RES, V8, P154, DOI 10.1080/17451000.2011.605146; Bapary MAJ, 2009, MAR BIOL RES, V5, P462, DOI 10.1080/17451000802644722; Bapary MAJ, 2011, AQUACULTURE, V314, P188, DOI 10.1016/j.aquaculture.2011.02.006; DELEEUW R, 1988, GEN COMP ENDOCR, V72, P408, DOI 10.1016/0016-6480(88)90163-3; DELEEUW R, 1986, GEN COMP ENDOCR, V63, P171, DOI 10.1016/0016-6480(86)90153-X; GOPING G, 1995, BRAIN RES, V687, P35, DOI 10.1016/0006-8993(95)00391-3; Hibbert B, 2004, MOL BRAIN RES, V128, P121, DOI 10.1016/j.molbraines.2004.06.008; Hibbert B, 2005, GEN COMP ENDOCR, V140, P176, DOI 10.1016/j.ygcen.2004.11.008; Levavi-Sivan B, 2006, BIOL REPROD, V75, P642, DOI 10.1095/biolreprod.106.051540; Lucchi R, 1998, BRAIN RES, V782, P105, DOI 10.1016/S0006-8993(97)01272-9; Masuda H., 1984, FISHES JAPANESE ARCH; Matsui H, 2009, NEUROSCI RES, V65, P263, DOI 10.1016/j.neures.2009.07.010; Mok EYM, 1998, PHYSIOL BEHAV, V64, P227, DOI 10.1016/S0031-9384(98)00038-9; PETER RE, 1986, RECENT PROG HORM RES, V42, P513; Pham HQ, 2013, FISH PHYSIOL BIOCHEM, V39, P403, DOI 10.1007/s10695-012-9708-z; Podhorec P, 2012, GEN COMP ENDOCR, V175, P34, DOI 10.1016/j.ygcen.2011.10.013; POLLARD HB, 1992, FASEB J, V6, P3108; Saligaut C, 1998, GEN COMP ENDOCR, V109, P302, DOI 10.1006/gcen.1997.7033; Takemura A, 2010, GEN COMP ENDOCR, V166, P513, DOI 10.1016/j.ygcen.2010.01.001	47	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-1742	1573-5168		FISH PHYSIOL BIOCHEM	Fish Physiol. Biochem.	FEB	2015	41	1					61	71		10.1007/s10695-014-0006-9		11	Biochemistry & Molecular Biology; Fisheries; Physiology	Biochemistry & Molecular Biology; Fisheries; Physiology	AZ8EM	WOS:000348447700006		
J	Sonmez, AY; Bilen, S; Alak, G; Hisar, O; Yanik, T; Biswas, G				Sonmez, Adem Yavuz; Bilen, Soner; Alak, Gonca; Hisar, Olcay; Yanik, Talat; Biswas, Gouranga			Growth performance and antioxidant enzyme activities in rainbow trout (Oncorhynchus mykiss) juveniles fed diets supplemented with sage, mint and thyme oils	FISH PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Fish; Oxidative stress biomarkers; Plant oils; Feed supplement; Growth	GLUTATHIONE S-TRANSFERASES; CYTOCHROME-C-OXIDASE; OXIDATIVE STRESS; MEDICINAL-PLANTS; LIPID-PEROXIDATION; FISH; SALVIA; LIVER; BIOMARKERS; EXTRACTS	This study evaluated effects of dietary supplementation of sage (Salvia officinalis), mint (Mentha spicata) and thyme (Thymus vulgaris) oils on growth performance, lipid peroxidation level (melondialdehyde, MDA) and liver antioxidant enzyme activities (superoxide dismutase, SOD; catalase, CAT; glucose-6-phosphate dehydrogenase, G6PD; glutathione reductase, GR; glutathione-S-transferase, GST and glutathione peroxidase, GPx) in rainbow trout (Oncorhynchus mykiss) juveniles. For this purpose, triplicate groups of rainbow trout were fed daily ad libitum with diets containing sage, mint and thyme oils at 500, 1,000 and 1,500 mg kg(-1) for 60 days. While weight gain percentage of fish fed the diets containing sage and thyme oils was significantly higher than the control group, that of fish fed mint oil was the lowest. Similarly, specific growth rate was found to be the highest in all groups of the sage and thyme oil feeding and the lowest in the mint groups. Moreover, feed conversion ratio was significantly higher in the mint oil administered groups. Survival rate was also significantly reduced in the fish fed the diet containing mint oil. It was observed that SOD, G6PD and GPx activities were significantly increased in liver tissues of all the treated fish groups compared to that of control diet-fed group. However, CAT, GST and GR activities were significantly decreased in experimental diet-fed fish groups at the end of the experiment. On the other hand, a significant reduction was found in MDA levels in the fish fed the diets with sage and thyme oils compared to control and mint diets on the 30th and 60th days of experiment. Overall, dietary inclusion of sage and thyme oils is effective in enhancing rainbow trout growth, reduction in MDA and least changing antioxidant enzyme activities at a low level of 500 mg kg(-1) diet, and they can be used as important feed supplements for rainbow trout production.	[Sonmez, Adem Yavuz; Bilen, Soner] Kastamonu Univ, Fac Fisheries & Aquaculture, Dept Basic Sci, Kastamonu, Turkey; [Alak, Gonca] Ataturk Univ, Fac Agr, Dept Anim Biotechnol, Erzurum, Turkey; [Hisar, Olcay] Canakkale Onsekiz Mart Univ, Marine Sci & Technol Fac, Dept Aquaculture, Canakkale, Turkey; [Yanik, Talat] Ataturk Univ, Fac Fisheries & Aquaculture, Dept Aquaculture, Erzurum, Turkey; [Biswas, Gouranga] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki, Japan	Bilen, S (reprint author), Kastamonu Univ, Fac Fisheries & Aquaculture, Dept Basic Sci, Kuzeykent Yerleskesi, Kastamonu, Turkey.	sbilen@kastamonu.edu.tr			Scientific Research Project Coordination of Ataturk University, Turkey	This study was supported by Scientific Research Project Coordination of Ataturk University, Turkey.	Ugulu I, 2009, J MED PLANTS RES, V3, P345; John S, 2001, J NUTR BIOCHEM, V12, P500, DOI 10.1016/S0955-2863(01)00160-7; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Javanmardi J, 2002, J AGR FOOD CHEM, V50, P5878, DOI 10.1021/jf020487q; Blanchette B, 2007, MAR BIOTECHNOL, V9, P513, DOI 10.1007/s10126-007-9034-0; Hudson JB, 2000, PHARM BIOL, V38, P171, DOI 10.1076/1388-0209(200007)3831-SFT171; Holmblad T, 1999, AQUACULTURE, V172, P111, DOI 10.1016/S0044-8486(98)00446-3; Harley RM, 2004, FA GE VAS P, V7, P167; Iscan G, 2002, J AGR FOOD CHEM, V50, P3943, DOI 10.1021/jf011476k; Giri U, 1996, CARCINOGENESIS, V17, P2023, DOI 10.1093/carcin/17.9.2023; Perry NSL, 2003, PHARMACOL BIOCHEM BE, V75, P651, DOI 10.1016/S0091-3057(03)00108-4; Giao MS, 2010, J MED FOOD, V13, P131, DOI 10.1089/jmf.2008.0323; Uner N, 2006, ENVIRON TOXICOL PHAR, V21, P241, DOI 10.1016/j.etap.2005.08.007; Pandey S, 2008, CHEM-BIOL INTERACT, V174, P183, DOI 10.1016/j.cbi.2008.05.014; Haznedaroglu MZ, 2001, FITOTERAPIA, V72, P829, DOI 10.1016/S0367-326X(01)00335-5; Castex M, 2010, FISH SHELLFISH IMMUN, V28, P622, DOI 10.1016/j.fsi.2009.12.024; HARMAN D, 1972, J AM GERIATR SOC, V20, P145; Zhang X, 2008, AQUAT TOXICOL, V86, P4, DOI 10.1016/j.aquatox.2007.07.002; Lin J, 1999, J ETHNOPHARMACOL, V68, P267, DOI 10.1016/S0378-8741(99)00130-0; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Otto DME, 1996, FISH PHYSIOL BIOCHEM, V15, P349, DOI 10.1007/BF02112362; Gaetani GF, 1996, BLOOD, V87, P1595; Knorzer OC, 1996, PHYSIOL PLANTARUM, V97, P388, DOI 10.1034/j.1399-3054.1996.970225.x; Pandey S, 2003, SCI TOTAL ENVIRON, V309, P105, DOI 10.1016/S0048-9697(03)00006-8; Kostaki M, 2009, FOOD MICROBIOL, V26, P475, DOI 10.1016/j.fm.2009.02.008; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Baranauskiene R, 2003, J AGR FOOD CHEM, V51, P7751, DOI 10.1021/jf0303316; Kelen M, 2008, BIORESOURCE TECHNOL, V99, P4096, DOI 10.1016/j.biortech.2007.09.002; Barroso JB, 1999, AQUACULTURE, V179, P375, DOI 10.1016/S0044-8486(99)00172-6; BASTROP R, 1991, COMP BIOCHEM PHYS A, V98, P143, DOI 10.1016/0300-9629(91)90592-Z; BAYTOP T., 1999, THERAPY MED PLANTS T; Beutler E, 1984, RED CELL METABOLISM; BUNKER VW, 1992, MED LAB SCI, V49, P299; CAO J, 1992, J BIOL CHEM, V267, P24273; Claiborne A., 1985, CRC HDB METHODS OXYG, V559, P283; Davis P.H., 1988, FLORA TURKEY E AEGEA, V10; DEQUIROGA GB, 1991, BIOCHEM J, V277, P289; Fasseas M. K., 2007, FOOD CHEM, V106, P1188, DOI DOI 10.1016/J.F00DCHEM.2007.07.060; Guner A, 2000, FLORA TURKEY, V11, P656; Hisar O, 2009, ASIAN J CHEM, V21, P3133; Hisar O, 2012, AQUACULT NUTR, V18, P211, DOI 10.1111/j.1365-2095.2011.00890.x; Li ZH, 2009, AQUAC RES, V40, P526, DOI 10.1111/j.1365-2109.2008.02123.x; Monteiro DA, 2006, COMP BIOCHEM PHYS C, V143, P141, DOI 10.1016/j.cbpe.2006.01.004; Moreno L, 2002, PHYTOTHER RES, V16, pS10, DOI 10.1002/ptr.744; NEWALL C.A., 1996, HERBAL MED GUIDE HLT; Peragon J, 1998, CAN J FISH AQUAT SCI, V55, P649, DOI 10.1139/cjfas-55-3-649; Reynolds JEF, 1996, EXTRA PHARMACOPEIA, V31, P1379; SOCCI DJ, 1995, BRAIN RES, V693, P88, DOI 10.1016/0006-8993(95)00707-W; Speers-Roesch B, 2005, COMP BIOCHEM PHYS A, V140, P487, DOI 10.1016/j.cbpb.2005.02.014; TUIK, 2013, FISH STAT; Uehleke B., 2002, MMW Fortschritte der Medizin, V144, P695; Yasin N. M. N., 2007, WORLD J DAIRY FOOD S, V2, P01; Youdim KA, 2000, BRIT J NUTR, V83, P87	53	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-1742	1573-5168		FISH PHYSIOL BIOCHEM	Fish Physiol. Biochem.	FEB	2015	41	1					165	175		10.1007/s10695-014-0014-9		11	Biochemistry & Molecular Biology; Fisheries; Physiology	Biochemistry & Molecular Biology; Fisheries; Physiology	AZ8EM	WOS:000348447700014		
J	Saito, S; Iwade, Y; Tokuoka, E; Nishio, T; Otomo, Y; Araki, E; Konuma, H; Nakagawa, H; Tanaka, H; Sugiyama, K; Hasegawa, A; Sugita-Konishi, Y; Hara-Kudo, Y				Saito, Shioko; Iwade, Yoshito; Tokuoka, Eisuke; Nishio, Tomohiro; Otomo, Yoshimitsu; Araki, Emiko; Konuma, Hirotaka; Nakagawa, Hiroshi; Tanaka, Hiroyuki; Sugiyama, Kanji; Hasegawa, Akio; Sugita-Konishi, Yoshiko; Hara-Kudo, Yukiko			Epidemiological Evidence of Lesser Role of Thermostable Direct Hemolysin (TDH)-Related Hemolysin (TRH) Than TDH on Vibrio parahaemolyticus Pathogenicity	Foodborne Pathogens and Disease			English	Article							SOUTHERN THAILAND; COASTAL ENVIRONMENT; CLINICAL ISOLATE; GENE TRH; STRAINS; SEAFOOD; ASSOCIATION; INFECTIONS; CONTAMINATION; PURIFICATION	Vibrio parahaemolyticus carrying the tdh gene, encoding the thermostable direct hemolysin (TDH), or the trh gene, encoding the TDH-related hemolysin (TRH), are both considered virulent strains. There are, however, disproportionally fewer reports of infections caused by seafood contaminated with trh-positive strains than by seafood contaminated with tdh-positive strains. Bivalves such as clams and oysters are the major seafood varieties associated with the infections. In this study, the prevalence of strains possessing the tdh and trh genes was investigated in Japan in 74 samples collected in 2007-2008 and in 177 samples collected in 2010 of domestic bivalves, bloody clams, hen clams, short-neck clams, and rock oysters. The tdh-positive and trh-negative, tdh-negative and trh-positive, and tdh-positive and trh-positive samples represented 5.4%, 12.2%, and 4.1% of all samples collected in 2007-2008, and 5.1%, 18.6%, and 5.6% of all samples collected in 2010, respectively. As determined by polymerase chain reaction, the prevalence of tdh negative and trh positive in all samples was two to four times higher than that of tdh positive and trh negative. In the samples collected in 2010, the tdh-negative and trh-positive V. parahaemolyticus (20 samples) was more often isolated than tdh-positive and trh-negative V. parahaemolyticus (7 samples). The most common serotype of tdh-positive isolates (22 of 24 strains) was pandemic O3:K6. The trh-positive isolates (61 strains) were various serotypes including OUT:KUT. In 330 V. parahaemolyticus outbreaks and sporadic infections in Japan, most outbreaks and sporadic infections were caused by tdh-positive and trh-negative strains (89.4%). The frequencies of infections caused by tdh-negative and trh-positive, and both tdh- and trh-positive strains were 1.2% and 3.0%, respectively. This finding suggests that the virulence of trh might be less than that of tdh, although trh-positive V. parahaemolyticus frequently contaminated bivalves.	[Saito, Shioko] Akita Res Ctr Publ Hlth & Environm, Akita, Japan; [Iwade, Yoshito] Mie Prefecture Hlth & Environm Res Inst, Yokaichi, Japan; [Tokuoka, Eisuke] Kumamoto Prefectural Inst Publ Hlth & Environm Sc, Udo, Japan; [Nishio, Tomohiro; Sugiyama, Kanji] Shizuoka Inst Environm & Hyg, Shizuoka, Japan; [Otomo, Yoshimitsu] Hirosaki Univ, Hirosaki, Aomori, Japan; [Araki, Emiko; Konuma, Hirotaka] Tokai Univ, Sch Marine Sci & Technol, Dept Fisheries, Shizuoka, Japan; [Nakagawa, Hiroshi] BML Food Sci Solut, Tokyo, Japan; [Tanaka, Hiroyuki] Japan Food Res Labs, Tokyo, Japan; [Hasegawa, Akio; Sugita-Konishi, Yoshiko; Hara-Kudo, Yukiko] Univ Tokyo, Tokyo, Japan; [Sugita-Konishi, Yoshiko; Hara-Kudo, Yukiko] Natl Inst Hlth Sci, Div Microbiol, Tokyo 1588501, Japan	Hara-Kudo, Y (reprint author), Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	ykudo@nihs.go.jp			Ministry of Health, Labour, and Welfare, Japan	We are thankful to Fumio Gondaira for providing anti-K6 immunomagnetic beads. This research was supported by a grant from the Ministry of Health, Labour, and Welfare, Japan. We appreciate the following governments of prefectures Okinawa, Kagoshima, Kumamoto, Oita, Fukuoka, Hiroshima, Tokyo Metropolitan, Saitama, and Hokkaido, as well as the cities of Nagasaki, Fukuoka, and Kitakyusyu for their cooperation in responding to the questionnaire on V. parahaemolyticus outbreaks.	Robert-Pillot A, 2004, INT J FOOD MICROBIOL, V91, P319, DOI 10.1016/j.ijfoodmicro.2003.07.006; Hara-Kudo Y, 2012, INT J FOOD MICROBIOL, V157, P95, DOI 10.1016/j.ijfoodmicro.2012.04.019; Thongjun Junthip, 2013, Trop Med Health, V41, P151, DOI 10.2149/tmh.2013-06; Johnson CN, 2010, APPL ENVIRON MICROB, V76, P7076, DOI 10.1128/AEM.00697-10; Kim YB, 1999, J CLIN MICROBIOL, V37, P1173; HONDA T, 1988, INFECT IMMUN, V56, P961; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578; Hara-Kudo Y, 2003, APPL ENVIRON MICROB, V69, P3883, DOI 10.1128/AEM.69.7.3883-3891.2003; Nakaguchi Yoshitsugu, 2013, Trop Med Health, V41, P95, DOI 10.2149/tmh.2011-06; Parsons MB, 2007, FOODBORNE PATHOG DIS, V4, P285, DOI 10.1089/fpd.2007.0089; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; DePaola A, 2004, BACTERIOLOGICAL ANAL; Hara-Kudo Y, 2001, Kansenshogaku Zasshi, V75, P955; HONDA T, 1989, FEMS MICROBIOL LETT, V57, P241, DOI 10.1016/0378-1097(89)90307-8; Honda T, 1990, JPN J INFECT DIS, V64, P767; Ikeda Y., 1997, Annual Report of Fukuoka City Institute for Hygiene and Environment, V22, P119; NISHIBUCHI M, 1989, INFECT IMMUN, V57, P2691; Obata H, 1996, J JPN ASS INFECT DIS, V70, P815; Ottaviani D, 2013, ENVIRON MICROBIOL, V15, P1377, DOI 10.1111/j.1462-2920.2012.02839.x; SHIRAI H, 1990, INFECT IMMUN, V58, P3568; Suzuki N, 1997, J JPN ASS INFECT DIS, V71, P417; Suzuki N, 1994, J JPN ASS INFECT DIS, V68, P1068; TADA J, 1992, MOL CELL PROBE, V6, P477, DOI 10.1016/0890-8508(92)90044-X; Takahashi A, 2000, INFECT IMMUN, V68, P5435, DOI 10.1128/IAI.68.9.5435-5438.2000; Vuddhakul V, 2006, J FOOD PROTECT, V69, P2615; Wootipoom N, 2007, J MED MICROBIOL, V56, P1630, DOI 10.1099/jmm.0.47439-0; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594	27	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1535-3141	1556-7125		FOODBORNE PATHOG DIS	Foodborne Pathog. Dis.	FEB 1	2015	12	2					131	138		10.1089/fpd.2014.1810		8	Food Science & Technology	Food Science & Technology	CA6GI	WOS:000349008100006		
J	Deditius, AP; Smith, FN; Utsunomiya, S; Ewing, RC				Deditius, Artur P.; Smith, Frances N. (Skomurski); Utsunomiya, Satoshi; Ewing, Rodney C.			Role of vein-phases in nanoscale sequestration of U, Nb, Ti, and Pb during the alteration of pyrochlore	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							NUCLEAR-WASTE GLASSES; GROUP MINERALS; HYDROTHERMAL ALTERATION; GEOCHEMICAL ALTERATION; RADIATION-DAMAGE; HETEROGENEOUS REDUCTION; CRYSTALLINE PYROCHLORE; GRENVILLE PROVINCE; AQUEOUS ALTERATION; DOPED ZIRCONOLITE	Grains of pyrochlore and secondary phases from tailings of Silver Crater Mine in Bancroft, Ontario (Canada) have been studied to understand the alteration processes, redox conditions, and retention of pyrochlore-derived species (U, Ti, Nb, Pb, Ta, REE) in near-field environments. Alteration processes are documented by the formation of two types of co-existing secondary veins associated with primary apatite and calcite: (i) amorphous Fe-rich veins, 46-75 wt.% of FeO, and similar to 500 ppm of UO2, and (ii) crystalline calcite-rich veins, found in fractures and penetrating the pyrochlore. Based on electron microprobe analysis (EMPA), the chemical composition of the pyrochlore is: (Ca(0.84)U(0.35)Fe(0.20)Na(0.09)Pb(0.04)Ln(0.04)Mn(0.03)Sr(0.01)Th(0.01) Mg-0.01)(1.62)(Nb1.00Ti0.87Ta0.10Si0.02)(2.0)O6.5F0.14. Elemental mapping revealed that migration of liberated U, Pb, Nb, Ta, Ti, and REE, is confined to the secondary veins of Fe-rich and calcite-rich compositions. Transmission electron microscopy (TEM), high-angle annular dark-field scanning TEM (HAADF-STEM), energy dispersive spectroscopy (EDS), and electron energy loss spectroscopy (EELS) results showed that pyrochlore contains nanoparticulate inclusions of uraninite, galena, and magnetite, while secondary veins host betafite, magnetite, Pb-0, cerusite, and 10 angstrom mica nanoparticles (NPs). Randomly oriented uraninite NPs, 15 nm in size, concentrate around pores, 50-100 nm in size, in the pyrochlore. In the Fe-rich veins, HAADF-STEM images revealed that U, Pb, Nb, and Ti were sequestered in the form of spherical betafite NPs, <800 nm in size, with composition: (Ca1.1Fe0.35Pb0.28U0.09)(1.83)(Ti1.56Nb0.44)(2.0)O-6.1. The association of betafite NPs, magnetite, and Pb-0 NPs in Fe-rich and calcite-rich veins indicates reducing conditions during alteration of pyrochlore and immobilization of pyrochlore derived elements. This observation combined with identification of nanoscale galena and magnetite in pyrochlore, and the association of Pb-0 and Fe3O4 in veins, indicate relatively low fS(2) and fO(2) conditions during pyrochlore alteration. In spite of prolonged exposure (>= 20 years) to atmospheric conditions, pyrochlore and betafite NPs retained <25 wt.% and <6 wt.% of UO2, respectively; and no secondary uranyl phases were observed. The alteration of pyrochlore most likely began with metamictization, followed by volume swelling, fracturing and surface interactions with fluids that caused mobilization of major and minor elements. The occurrence of amorphous Fe-rich material on the surface of the pyrochlore suggests that amorphous gels could form in Fe-rich environments as an alteration product of crystalline waste forms. The nano-geochemical complexity of the samples investigated here suggests that there is a significant nano-scale component to the sequestration of actinides during the alteration of natural and likely synthetic materials. (C) 2014 Elsevier Ltd. All rights reserved.	[Deditius, Artur P.] Murdoch Univ, Sch Engn & Informat Technol, Murdoch, WA 6150, Australia; [Deditius, Artur P.] Graz Univ Technol, Inst Appl Geosci, A-8010 Graz, Austria; [Smith, Frances N. (Skomurski)] Pacific NW Natl Lab, Nucl Chem & Engn Grp, Richland, WA 99352 USA; [Utsunomiya, Satoshi] Kyushu Univ, Dept Chem, Higashi Ku, Fukuoka 8128581, Japan; [Ewing, Rodney C.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA	Deditius, AP (reprint author), Murdoch Univ, Sch Engn & Informat Technol, Murdoch, WA 6150, Australia.	A.Deditius@murdoch.edu.au; frances.smith@pnnl.gov; utsunomiya.satoshi.998@m.kyushu-u.ac.jp; rewing1@stanford.edu			U.S. Department of Energy Office of Science, Office of Basic Energy Sciences Energy Frontier Research Centers program [DE-SC0001089]; JSPS [24540516, 20840035, 24340132]; EMPA analyses [EAR-9911352]	The authors are indebted to three anonymous reviewers and Associate Editor Chris Kim for their insightful comments that greatly improved the manuscript. R.C.E. was supported by the U.S. Department of Energy Office of Science, Office of Basic Energy Sciences Energy Frontier Research Centers program under Award Number DE-SC0001089. S.U. is thankful to JSPS KAKENHI Grant Numbers 24540516, 20840035 and 24340132; the EMPA analyses were supported by #EAR-9911352. The authors are grateful to Carl Henderson for help with EMPA analyses conducted at the Electron Microbeam Analysis Laboratory (EMAL) at the University of Michigan.	Alexander R. L., 1986, URANIUM DEPOSITS CAN, V33, P62; Nasraoui M, 2000, J ASIAN EARTH SCI, V18, P237, DOI 10.1016/S1367-9120(99)00056-5; Lian J, 2001, J NUCL MATER, V297, P89, DOI 10.1016/S0022-3115(01)00585-2; Sickafus KE, 2000, SCIENCE, V289, P748, DOI 10.1126/science.289.5480.748; Moyes LN, 2000, ENVIRON SCI TECHNOL, V34, P1062, DOI 10.1021/es990703k; Ferriss EDA, 2009, J NUCL MATER, V384, P130, DOI 10.1016/j.jnucmat.2008.11.007; de Combarieu G, 2011, APPL GEOCHEM, V26, P65, DOI 10.1016/j.apgeochem.2010.11.004; Tooth B, 2011, GEOCHIM COSMOCHIM AC, V75, P5423, DOI 10.1016/j.gca.2011.07.020; HOGARTH DD, 1977, AM MINERAL, V62, P403; Lorand JP, 2013, LITHOS, V164, P2, DOI 10.1016/j.lithos.2012.08.017; Dodge CJ, 2002, ENVIRON SCI TECHNOL, V36, P3504, DOI 10.1021/es011450+; Atencio D, 2010, CAN MINERAL, V48, P673, DOI 10.3749/canmin.48.3.673; Poinssot C, 2012, J NUCL MATER, V420, P182, DOI 10.1016/j.jnucmat.2011.09.012; Strachan DM, 2005, J NUCL MATER, V345, P109, DOI 10.1016/j.jnucmat.2005.04.064; Ewing RC, 2000, REV MINERAL GEOCHEM, V39, P319; Grambow B, 2006, ELEMENTS, V2, P357, DOI 10.2113/gselements.2.6.357; KAMIZONO H, 1991, J AM CERAM SOC, V74, P863, DOI 10.1111/j.1151-2916.1991.tb06942.x; Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405; Geisler T, 2005, J NUCL MATER, V344, P17, DOI 10.1016/j.jnucmat.2005.04.009; Pelegrin E, 2010, J NON-CRYST SOLIDS, V356, P2497, DOI 10.1016/j.jnoncrysol.2010.02.022; Roberts SK, 2000, RADIOCHIM ACTA, V88, P539, DOI 10.1524/ract.2000.88.9-11.539; Scott TB, 2005, GEOCHIM COSMOCHIM AC, V69, P5639, DOI 10.1016/j.gca.2005.07.003; HAYAKAWA I, 1993, J MATER SCI, V28, P513, DOI 10.1007/BF00357832; Rolland S, 2013, J NUCL MATER, V433, P382, DOI 10.1016/j.jnucmat.2012.10.001; Weber WJ, 2000, SCIENCE, V289, P2051, DOI 10.1126/science.289.5487.2051; Lumpkin GR, 2001, J NUCL MATER, V289, P136, DOI 10.1016/S0022-3115(00)00693-0; Lumpkin GR, 2006, ELEMENTS, V2, P365, DOI 10.2113/gselements.2.6.365; JANECZEK J, 1992, J NUCL MATER, V190, P128, DOI 10.1016/0022-3115(92)90082-V; MEZGER K, 1993, CONTRIB MINERAL PETR, V114, P13, DOI 10.1007/BF00307862; Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101; Deditius AP, 2007, GEOCHIM COSMOCHIM AC, V71, P4954, DOI [10.1016/j.gca.2007.08.008, 10.1016/i.gca.2007.08.008]; Skomurski FN, 2011, GEOCHIM COSMOCHIM AC, V75, P7277, DOI 10.1016/j.gca.2011.08.006; Singer DM, 2009, GEOCHIM COSMOCHIM AC, V73, P5989, DOI 10.1016/j.gca.2009.07.002; Begg BD, 2001, J NUCL MATER, V289, P188, DOI 10.1016/S0022-3115(00)00696-6; Burger E, 2013, APPL GEOCHEM, V31, P159, DOI 10.1016/j.apgeochem.2012.12.016; Geckeis H, 2013, CHEM REV, V113, P1016, DOI 10.1021/cr300370h; LUMPKIN GR, 1992, AM MINERAL, V77, P179; Wang SX, 1999, J MATER RES, V14, P4470, DOI 10.1557/JMR.1999.0606; Moecher DP, 1997, CAN J EARTH SCI, V34, P1185, DOI 10.1139/e17-095; Ewing RC, 2005, EARTH PLANET SC LETT, V229, P165, DOI 10.1016/j.epsl.2004.11.017; Wang SX, 1999, NUCL INSTRUM METH B, V148, P704, DOI 10.1016/S0168-583X(98)00847-7; Jollivet P, 2012, J NUCL MATER, V420, P508, DOI 10.1016/j.jnucmat.2011.10.026; Ilton ES, 2004, GEOCHIM COSMOCHIM AC, V68, P2417, DOI 10.1016/j.gca.2003.08.010; Feron D, 2008, J NUCL MATER, V379, P16, DOI 10.1016/j.jnucmat.2008.06.023; Putnis A, 2009, REV MINERAL GEOCHEM, V70, P87, DOI 10.2138/rmg.2009.70.3; Poml P, 2011, J NUCL MATER, V410, P10, DOI 10.1016/j.jnucmat.2010.12.218; Lumpkin GR, 1996, AM MINERAL, V81, P1237; Leturcq G, 2005, APPL GEOCHEM, V20, P899, DOI 10.1016/j.apgeochem.2004.10.006; Bambi ACJM, 2012, MINERAL MAG, V76, P377, DOI 10.1180/minmag.2012.076.2.07; Bonazzi P, 2006, AM MINERAL, V91, P794, DOI 10.2138/am.2006.1777; Chakhmouradian AR, 2002, EUR J MINERAL, V14, P821, DOI 10.1127/0935-1221/2002/0014-0821; EWING RC, 1974, SCIENCE, V184, P561, DOI 10.1126/science.184.4136.561; Finch R, 1999, REV MINERAL <D>, V38, P91; Forbes TZ, 2011, GEOCHIM COSMOCHIM AC, V75, P7893, DOI 10.1016/j.gca.2011.09.034; Geisler T, 2005, AM MINERAL, V90, P1683, DOI 10.2138/am.2005.1970; Geisler T, 2004, MINERAL MAG, V68, P905, DOI 10.1180/0026461046860230; Giere R., 2002, MAT RES SOC S P, V713, P24; Hazen R. M., 2008, AM MINERAL, V94, P1293; Icenhower J. P., 2003, PNNL14252; Kamiishi E, 2013, CHEM GEOL, V340, P121, DOI 10.1016/j.chemgeo.2012.12.019; Lentz D, 1996, ORE GEOL REV, V11, P197, DOI 10.1016/0169-1368(95)00034-8; Lettermoser B. G., 1988, MINER PETROL, V38, P37; Lian J, 2009, J NUCL MATER, V393, P481, DOI 10.1016/j.jnucmat.2009.07.005; LITTLE HW, 1969, ECON GEOL, V64, P691; Lumpkin G. R., 1988, PHYS CHEM MINER, V2, P2; LUMPKIN GR, 1995, AM MINERAL, V80, P732; Lumpkin GR, 2000, MATER RES SOC SYMP P, V663, P921; Okamoto H., 1986, BINARY ALLOY PHASE D, V1, P312; Poml P, 2007, GEOCHIM COSMOCHIM AC, V71, P3311, DOI 10.1016/j.gca.2007.03.031; POUCHOU JL, 1984, RECH AEROSPATIALE, P167; Savary V, 1997, GEOCHIM COSMOCHIM AC, V61, P4479, DOI 10.1016/S0016-7037(97)00261-5; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Szenknect S, 2013, INORG CHEM, V52, P6957, DOI [10.1021/ic400272s, 10.1021/ic4002725]; Utsunomiya S, 2005, EARTH PLANET SC LETT, V240, P521, DOI 10.1016/j.epsl.2005.09.034; Wall F, 1996, MINERAL MAG, V60, P731, DOI 10.1180/minmag.1996.060.402.03; Xu HF, 2004, ENVIRON SCI TECHNOL, V38, P1480, DOI 10.1021/es030582y; YOKOI H, 1995, MATER RES SOC SYMP P, V353, P783; ZHANG Y, 2001, MATER RES SOC S P, V663, P325; Zhu S, 2002, APPL PHYS LETT, V80, P4327, DOI 10.1063/1.1482784	79	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037	1872-9533		GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	FEB 1	2015	150						226	252		10.1016/j.gca.2014.11.024		27	Geochemistry & Geophysics	Geochemistry & Geophysics	AZ9DH	WOS:000348511300014		
J	Okada, T; Matsuzawa, T; Umino, N; Yoshida, K; Hasegawa, A; Takahashi, H; Yamada, T; Kosuga, M; Takeda, T; Kato, A; Igarashi, T; Obara, K; Sakai, S; Saiga, A; Iidaka, T; Iwasaki, T; Hirata, N; Tsumura, N; Yamanaka, Y; Terakawa, T; Nakamichi, H; Okuda, T; Horikawa, S; Katao, H; Miura, T; Kubo, A; Matsushima, T; Goto, K; Miyamachi, H				Okada, T.; Matsuzawa, T.; Umino, N.; Yoshida, K.; Hasegawa, A.; Takahashi, H.; Yamada, T.; Kosuga, M.; Takeda, T.; Kato, A.; Igarashi, T.; Obara, K.; Sakai, S.; Saiga, A.; Iidaka, T.; Iwasaki, T.; Hirata, N.; Tsumura, N.; Yamanaka, Y.; Terakawa, T.; Nakamichi, H.; Okuda, T.; Horikawa, S.; Katao, H.; Miura, T.; Kubo, A.; Matsushima, T.; Goto, K.; Miyamachi, H.			Hypocenter migration and crustal seismic velocity distribution observed for the inland earthquake swarms induced by the 2011 Tohoku-Oki earthquake in NE Japan: implications for crustal fluid distribution and crustal permeability	GEOFLUIDS			English	Article						crustal fluid; crustal permeability; hypocenter migration; induced earthquake; seismic low-velocity area; the 2011 Tohoku-Oki earthquake	M-W 9.0; PACIFIC COAST; NORTHEASTERN JAPAN; HAYWARD FAULT; STRESS; CALIFORNIA; PRESSURE; DRIVEN; AFTERSHOCKS; TOMOGRAPHY	After the occurrence of the 2011 magnitude 9 Tohoku earthquake, the seismicity in the overriding plate changed. The seismicity appears to form distinct belts. From the spatiotemporal distribution of hypocenters, we can quantify the evolution of seismicity after the 2011 Tohoku earthquake. In some earthquake swarms near Sendai (Nagamachi-Rifu fault), Moriyoshi-zan volcano, Senya fault, and the Yamagata-Fukushima border (Aizu-Kitakata area, west of Azuma volcano), we can observe temporal expansion of the focal area. This temporal expansion is attributed to fluid diffusion. Observed diffusivity would correspond to the permeability of about 10(-15) (m(2)). We can detect the area from which fluid migrates as a seismic low-velocity area. In the lower crust, we found seismic low-velocity areas, which appear to be elongated along N-S or NE-SW, the strike of the island arc. These seismic low-velocity areas are located not only beneath the volcanic front but also beneath the fore-arc region. Seismic activity in the upper crust tends to be high above these low-velocity areas in the lower crust. Most of the shallow earthquakes after the 2011 Tohoku earthquake are located above the seismic low-velocity areas. We thus suggest fluid pressure changes are responsible for the belts of seismicity.	[Okada, T.; Matsuzawa, T.; Umino, N.; Yoshida, K.; Hasegawa, A.] Tohoku Univ, Grad Sch Sci, Res Ctr Predict Earthquakes & Volcan Erupt, Sendai, Miyagi 9808578, Japan; [Takahashi, H.; Yamada, T.] Hokkaido Univ, Grad Sch Sci, Inst Seismol & Volcanol, Sapporo, Hokkaido, Japan; [Kosuga, M.] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori, Japan; [Takeda, T.] Tetsuya Takeda, Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki, Japan; [Kato, A.; Igarashi, T.; Obara, K.; Sakai, S.; Iidaka, T.; Iwasaki, T.; Hirata, N.] Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; [Saiga, A.] Assoc Dev Earthquake Predict, Tono Res Inst Earthquake Sci, Mizunami, Japan; [Tsumura, N.] Chiba Univ, Fac Sci, Chiba, Japan; [Yamanaka, Y.; Terakawa, T.; Okuda, T.; Horikawa, S.] Nagoya Univ, Grad Sch Environm Studies, Earthquake & Volcano Res Ctr, Nagoya, Aichi 4648601, Japan; [Nakamichi, H.; Katao, H.; Miura, T.] Kyoto Univ, Disaster Prevent Res Inst, Kagoshima, Japan; [Kubo, A.] Kochi Univ, Fac Sci, Kochi Earthquake Observ, Kochi 780, Japan; [Matsushima, T.] Kyushu Univ, Fac Sci, Inst Seismol & Volcanol, Shimabara, Japan; [Goto, K.; Miyamachi, H.] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 890, Japan	Okada, T (reprint author), Tohoku Univ, Grad Sch Sci, Res Ctr Predict Earthquakes & Volcan Erupt, Sendai, Miyagi 9808578, Japan.	okada@aob.gp.tohoku.ac.jp		Yamada, Takuji/0000-0001-6630-3686	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT, Japan [23900002]; Tokyo Institute of Technology [21109002]	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, under its Observation and Research Program for Prediction of Earthquakes and Volcanic Eruptions. This work was conducted with the support of a Grant-in-Aid for Special Purposes (23900002), MEXT, Japan. This work was partly conducted with the support of the Scientific Research Program on Innovative Areas, 'Geofluids: Nature and Dynamics of Fluids in Subduction Zones,' at the Tokyo Institute of Technology (21109002). This study is a part of the 'multidisciplinary research project for high strain rate zone' promoted by MEXT. We used data from the Japan Meteorological Agency (JMA), Hi-net/NIED, University of Tokyo, Hirosaki University, and the Association for the Development of Earthquake Prediction (ADEP). Some of the temporary stations are operated cooperatively with the Japan Nuclear Energy Safety Organization (JNES). The authors have declared no conflicts of interest. We thank Sadato Ueki, Satoshi Miura, Shinji Toda, Dapeng Zhao, Takeyoshi Yoshida, Yasuo Yabe, Junichi Nakajima, Naoki Uchida, Yusaku Ohta, Mako Ohzono, Masa'aki Ichiki, Ryota Takagi, Shin'ya Sakanaka, Jun Muto, Bun'ichiro Shibazaki, and Richard Sibson for their valuable comments. We acknowledge the efforts toward seismic observation by all the members of the Group for the aftershock observations of the 2011 off the Pacific coast of Tohoku Earthquake, and Shuichiro Hori, Toshio Kono, Satoshi Hirahara, Takashi Nakayama, Toshiya Sato, Kenji Tachibana, Syuichi Suzuki, Tomotsugu Demachi, and Toshiki Kaida. The comments by Prof. C. Manning, Prof. T. Gleeson, Prof. S. Ingebritsen and two anonymous reviewers improved the manuscript well.	Zhang HJ, 2003, B SEISMOL SOC AM, V93, P1875, DOI 10.1785/0120020190; Chen X, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008973; Hasegawa A, 2012, EARTH PLANET SC LETT, V355, P231, DOI 10.1016/j.epsl.2012.08.042; Hasegawa A, 2011, EARTH PLANETS SPACE, V63, P703, DOI 10.5047/eps.2011.06.007; Shapiro SA, 1997, GEOPHYS J INT, V131, pF15, DOI 10.1111/j.1365-246X.1997.tb01215.x; Umino N, 2002, B SEISMOL SOC AM, V92, P2465, DOI 10.1785/0120010140; Miller SA, 2004, NATURE, V427, P724, DOI 10.1038/nature02251; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Hirose F, 2011, EARTH PLANETS SPACE, V63, P513, DOI 10.5047/eps.2011.05.019; Okada T, 2012, EARTH PLANETS SPACE, V64, P717, DOI 10.5047/eps.2012.03.005; Sibson RH, 2013, TECTONOPHYSICS, V600, P142, DOI 10.1016/j.tecto.2013.02.035; Ingebritsen SE, 2010, GEOFLUIDS, V10, P193, DOI 10.1111/j.1468-8123.2010.00278.x; HASEGAWA A, 1978, TECTONOPHYSICS, V47, P43, DOI 10.1016/0040-1951(78)90150-6; Hasegawa A, 2009, GONDWANA RES, V16, P370, DOI 10.1016/j.gr.2009.03.007; Cattin R, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002167; Hill DP, 2005, J VOLCANOL GEOTH RES, V146, P257, DOI 10.1016/j.jvolgeores.2005.03.002; Sibson RH, 2003, GEOPHYS J INT, V154, P584, DOI 10.1046/j.1365-246X.2003.01965.x; Kato A, 2013, GEOPHYS RES LETT, V40, P273, DOI [10.1002/GRL.50104, 10.1002/grl.50104]; Geological Survey of Japan, 2013, VOLC OF JAP; Hardebeck JL, 2012, B SEISMOL SOC AM, V102, P377, DOI 10.1785/0120110169; Hori S., 1991, Zisin. Journal of the Seismological Society of Japan, V44; KOSUGA M., 2012, J SEISMOLOGICAL SOC, V65, P69; Miyazawa M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049795; NAKAGAWA M., 1983, J JAP ASS MINERAL PE, V78, P197; Nakazato H, 1996, J JPN ASS MINER PETR, V91, P1, DOI 10.2465/ganko.91.1; Ohzono M, 2012, EARTH PLANETS SPACE, V64, P1231, DOI 10.5047/eps.2012.05.015; Okada T, 2003, EARTH PLANETS SPACE, V55, P741; Okada T, 2011, EARTH PLANETS SPACE, V63, P749, DOI 10.5047/eps.2011.06.027; Rice J., 1992, INT GEOPHYS, V51, P475, DOI DOI 10.1016/S0074-6142(08)62835-1; Sangawa A., 1987, Zisin. Journal of the Seismological Society of Japan, V40; Sato H., 2004, J JPN ASS PETROL TEC, V69, P145; Sato H, 2002, TECTONOPHYSICS, V355, P41, DOI 10.1016/S0040-1951(02)00133-6; Terakawa T, 2013, EARTH PLANET SC LETT, V365, P17, DOI 10.1016/j.epsl.2013.01.017; The Headquarters for Earthquake Research Promotion, 2008, EV AIZ BONCH TOEN SE; Toda S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047834; Tong P, 2012, SOLID EARTH, V3, P43, DOI 10.5194/se-3-43-2012; Yoshida K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049729; Yukutake Y, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008036; Zoback MD, 1997, J GEOPHYS RES-SOL EA, V102, P18477, DOI 10.1029/96JB02814	39	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1468-8115	1468-8123		GEOFLUIDS	Geofluids	FEB	2015	15	1-2			SI		293	309		10.1111/gfl.12112		17	Geochemistry & Geophysics; Geology	Geochemistry & Geophysics; Geology	AZ9BC	WOS:000348505200018		
J	Burstall, F; Hertrich-Jeromin, U; Rossman, W; Santos, S				Burstall, F.; Hertrich-Jeromin, U.; Rossman, W.; Santos, S.			Discrete special isothermic surfaces	GEOMETRIAE DEDICATA			English	Article						Isothermic surface; Darboux transformation; Lawson correspondence; Backlund transformation; Polynomial conserved quantity; Constant mean curvature		We discuss special isothermic nets of type , a new class of discrete isothermic nets, generalizing isothermic nets with constant mean curvature in spaceforms. In the case these are the discrete analogues of Bianchi's special isothermic surfaces that can be regarded as the origin of the rich transformation theory of isothermic surfaces. Accordingly, special isothermic nets come with Backlund transformations and a Lawson correspondence. The notion of complementary nets naturally occurs and sheds further light on the relation between geometry and integrability.	[Burstall, F.] Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England; [Hertrich-Jeromin, U.] Vienna Univ Technol, A-1040 Vienna, Austria; [Rossman, W.] Kobe Univ, Dept Math, Kobe, Hyogo 6578501, Japan; [Santos, S.] Univ Lisbon, Dept Matemat, CMAF, P-1749016 Lisbon, Portugal	Hertrich-Jeromin, U (reprint author), Vienna Univ Technol, Wiedner Hauptstr 8-10-104, A-1040 Vienna, Austria.	f.e.burstall@bath.ac.uk; udo.hertrich-jeromin@tuwien.ac.at; wayne@math.kobe-u.ac.jp; susantos@ptmat.fc.ul.pt			Vienna University of Technology	The third author expresses his gratitude to Vienna University of Technology for financial support and their hospitality during the preparation of this paper. The figures in this text were created using Mathematica.	Bobenko AI, 1999, OXF LEC S MATH APPL, V16, P3; Bernstein H, 2001, T AM MATH SOC, V353, P2245, DOI 10.1090/S0002-9947-00-02691-X; Bianchi L., 1904, ANN MAT, V11, P93; Bobenko A., 2014, DISCRET COMPUT GEOM; Bobenko A. I., 2008, GRAD STUD MATH, V98; Burstall F., 2014, ARXIV14061293; Burstall F., 2014, RIMS KOKYUROKU, V1880, P133; Burstall FE, 2012, J LOND MATH SOC, V85, P571, DOI 10.1112/jlms/jdr050; EISENHART LP, 1923, TRANSFORMATIONS SURF; Hertrich-Jeromin U., 2003, LONDON MATH SOC LECT, V300; Hertrich-Jeromin U, 1999, OXF LEC S MATH APPL, V16, P59	11	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	FEB	2015	174	1					1	11		10.1007/s10711-014-0001-4		11	Mathematics	Mathematics	AZ7TX	WOS:000348421600001		
J	Shioya, T				Shioya, Takashi			Estimate of isodiametric constant for closed surfaces	GEOMETRIAE DEDICATA			English	Article						A. D. Alexandrov's conjecture; Isodiametric inequality; Area; Diameter; Curvature	MANIFOLDS; THEOREM	We give an explicit estimate of the area of a closed surface by the diameter and a lower bound of curvature. This is better than Calabi-Cao's (J Differ Geom 36(3): 517-549, 1992) estimate for a nonnegatively curved two-sphere.	Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan	Shioya, T (reprint author), Tohoku Univ, Math Inst, Sendai, Miyagi 9808578, Japan.	shioya@math.tohoku.ac.jp			Japan Society for the Promotion of Science	The author is partially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Alexandrow A.D., 1955, INNERE GEOMETRIE KON; GROMOLL D, 1987, ANN SCI ECOLE NORM S, V20, P227; CALABI E, 1992, J DIFFER GEOM, V36, P517; Cheeger J., 2008, COMP THEOREMS RIEMAN; Fiala F., 1941, COMMENT MATH HELV, V13, P293; Freitas P., ARXIV14060811V1; GROVE K, 1977, ANN MATH, V106, P201, DOI 10.2307/1971164; GROVE K, 1991, J DIFFER GEOM, V33, P379; HARTMAN P, 1964, AM J MATH, V86, P705, DOI 10.2307/2373154; HERSCH J, 1970, CR ACAD SCI A MATH, V270, P1645; Krysiak J., 2004, ALEXANDROVS CONJECTU; SAKAI T., 1989, GEOMETRY MANIFOLDS P, V8, P303; Shiohama K., 2003, CAMBRIDGE TRACTS MAT, V159; SHIOYA T., 1993, ADV STUDIES PURE MAT, V22, P309; Zalgaller VA, 2009, SIBERIAN MATH J+, V50, P846; ZHONG JQ, 1984, SCI SIN A-MATH P A T, V27, P1265	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	FEB	2015	174	1					279	285		10.1007/s10711-014-0017-9		7	Mathematics	Mathematics	AZ7TX	WOS:000348421600017		
J	Sasaki, D				Sasaki, Dounnu			An intersection functional on the space of subset currents on a free group	GEOMETRIAE DEDICATA			English	Article						Free group; Subset current; Geodesic current; Strengthened Hanna Neumann Conjecture; Reduced rank	COMPLEX; GRAPHS	Kapovich and Nagnibeda introduced the space of subset currents on a free group of rank , which can be thought of as a measure-theoretic completion of the set of all conjugacy classes of finitely generated subgroups of . We define a product of two finitely generated subgroups and of by the sum of the reduced rank over all double cosets , and extend the product to a continuous symmetric -bilinear functional . We also give an answer to a question presented by Kapovich and Nagnibeda. The definition of originates in the Strengthened Hanna Neumann Conjecture, which has been proven independently by Friedman and Mineyev, and can be stated as follows: for any finitely generated subgroups and of the inequality holds. As a corollary to our theorem, this inequality is generalized to the inequality for subset currents.	Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Sasaki, D (reprint author), Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Okubo 3-4-1, Tokyo 1698555, Japan.	dounnu-daigaku@moegi.waseda.jp					BONAHON F, 1988, INVENT MATH, V92, P139, DOI 10.1007/BF01393996; Kapovich I, 2005, INT J ALGEBR COMPUT, V15, P939, DOI 10.1142/S0218196705002700; Kapovich I, 2009, GEOM TOPOL, V13, P1805, DOI 10.2140/gt.2009.13.1805; Bestvina M, 2014, ADV MATH, V256, P104, DOI 10.1016/j.aim.2014.02.001; Kapovich I, 2007, GEOM FUNCT ANAL, V17, P1201, DOI 10.1007/s00039-007-0621-z; Kapovich I, 2006, CONTEMP MATH, V394, P149; Bestvina M., 2012, ARXIV12113608; BONAHON F, 1991, MATH SCI R, V19, P143; BONAHON F, 1986, ANN MATH, V124, P71, DOI 10.2307/1971388; CULLER M, 1986, INVENT MATH, V84, P91, DOI 10.1007/BF01388734; Friedman J., 2011, ARXIV11050129; Hamenstadt U., 2012, ARXIV12111630; Horbez C., 2014, ARXIV14057938; Kapovich I, 2013, GEOMETRIAE DEDICATA, V166, P307, DOI 10.1007/s10711-012-9797-y; Kapovich I., 2013, ARXIV12115836; Kechris A. S., 1995, GRADUATE TEXTS MATH; Martin R., 1995, MR2693216 UCLA, P87; Mineyev I, 2012, ANN MATH, V175, P393, DOI 10.4007/annals.2012.175.1.11; NEUMANN WD, 1990, LECT NOTES MATH, V1456, P161; STALLINGS JR, 1983, INVENT MATH, V71, P551, DOI 10.1007/BF02095993	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	FEB	2015	174	1					311	338		10.1007/s10711-014-0019-7		28	Mathematics	Mathematics	AZ7TX	WOS:000348421600019		
J	Moghadam, HS; Khedr, MZ; Arai, S; Stern, RJ; Ghorbani, G; Tamura, A; Ottley, CJ				Moghadam, Hadi Shafaii; Khedr, Mohamed Zaki; Arai, Shoji; Stern, Robert J.; Ghorbani, Ghasem; Tamura, Akihiro; Ottley, Chris J.			Arc-related harzburgite-dunite-chromitite complexes in the mantle section of the Sabzevar ophiolite, Iran: A model for formation of podiform chromitites	GONDWANA RESEARCH			English	Article						Podiform chromitite; Geochemistry; Melt-mantle interaction; Sabzevar ophiolite	NORTHERN OMAN OPHIOLITE; SW TURKEY IMPLICATIONS; MELT-ROCK INTERACTION; MOHO TRANSITION ZONE; OCEANIC UPPER-MANTLE; IZU-BONIN-MARIANA; ABYSSAL PERIDOTITES; SPINEL-PERIDOTITES; SUBDUCTION INITIATION; TECTONIC EVOLUTION	Podiform chromitites are common within the mantle section of the Late Cretaceous Sabzevar ophiolite in NE Iran. We studied chromitite pods and related ultramafic rocks from three Sabzevar massifs: Baghjar-Kuh Siah, Gaft Chromitite Mine and Forumad peridotite-chromitite. These represent an upper mantle sequence just below the Sabzevar Moho. The Baghjar-Kuh Siah mantle sequence contains plagioclase Iherzolites, enriched in bulk REEs, with low Cr# spinels and MORB-like clinopyroxenes. These lherzolites formed due to the impregnation of MORB-like melts. The Gaft and Forumad harzburgites are depleted in trace and rare earth elements and thus are residues after high degree of partial melting (more than exhaustion of Cpx). The Galt Chromitite Mine includes two types of podiform chromitites, high Cr# and low Cr#. The melt precipitating high Cr# spinel was boninitic whereas the melt forming the low Cr# chromitites was tholeiitic. Most Forumad massif chromitites have high Cr# spinels, although those rich in silicate inclusions are aluminous. Trace and REE element patterns of Forumad harzburgite clinopyroxene are similar to those in supra-subduction zone (SSZ) peridotites while those of Baghjar-Kuh Siah lherzolites are similar to MOR peridotite clinopyroxenes. These mineral data are also consistent with bulk rock trace and rare earth elements composition of their host peridotites. Field observations indicate that early tholeiitic magmas were followed by late boninites, as revealed in chromitite compositions as well as mantle rocks and dikes. We suggest a time-integrated model for the evolution of the Sabzevar mantle sequence during an early stage of subduction initiation associated with formation of an incipient arc. In this scenario, MORB-like melts (forearc basalts) formed first, causing low Cr# chromitites and plagioclase-clinopyroxene impregnations. Subsequent arc-like or boninitic melts with increasing contribution of slab-derived fluids were responsible for the formation of replacive dunites and high Cr# chromitites. (C) 2013 International Association for Gondwana Research. Published by Elsevier B.V. All rights reserved.	[Moghadam, Hadi Shafaii; Ghorbani, Ghasem] Damghan Univ, Sch Earth Sci, Damghan, Iran; [Khedr, Mohamed Zaki; Arai, Shoji; Tamura, Akihiro] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; [Khedr, Mohamed Zaki] Kafrelsheikh Univ, Fac Sci, Dept Geol, Kafr El Shaikh, Kafr El Sheikh, Egypt; [Stern, Robert J.] Univ Texas Dallas, Dept Geosci, Richardson, TX 75083 USA; [Ottley, Chris J.] Univ Durham, Northern Ctr Isotop & Elemental Tracing, Dept Earth Sci, Durham DH1 3LE, England	Moghadam, HS (reprint author), Damghan Univ, Sch Earth Sci, Damghan, Iran.	hadishafaii@du.ac.ir			Kanazawa University (Japan); Damghan University (Iran)	This research was funded by Kanazawa University (Japan) to the first author (HSM). Partial support from Damghan University (Iran) is acknowledged. We thank Paul Robinson for inviting us to join this scientific discussion on the origin and significance of ophiolitic peridotite and chromitite. We are very grateful to Yildirim Dilek and Ercan Aldanmaz for their constructive reviews of the manuscript. Editorial suggestions by Prof. Santosh are highly appreciated.	Ahmed AH, 2012, J ASIAN EARTH SCI, V56, P118, DOI 10.1016/j.jseaes.2012.05.002; Ahmed AH, 2002, CONTRIB MINERAL PETR, V143, P263, DOI 10.1007/s00410-002-0347-8; Akizawa N, 2012, CONTRIB MINERAL PETR, V164, P601, DOI 10.1007/s00410-012-0762-4; ALAVI M, 1991, GEOL SOC AM BULL, V103, P983, DOI 10.1130/0016-7606(1991)103<0983:SASCOT>2.3.CO;2; Aldanmaz E, 2012, CHEM GEOL, V294, P152, DOI 10.1016/j.chemgeo.2011.11.027; TAKAHASHI E, 1980, GEOCHIM COSMOCHIM AC, V44, P1643, DOI 10.1016/0016-7037(80)90217-3; Hellebrand E, 2005, CONTRIB MINERAL PETR, V150, P486, DOI 10.1007/s00410-005-0036-5; SOBOLEV AV, 1993, NATURE, V363, P151, DOI 10.1038/363151a0; STERN RJ, 1992, GEOL SOC AM BULL, V104, P1621, DOI 10.1130/0016-7606(1992)104<1621:SZIEFT>2.3.CO;2; Zhou MF, 1998, GEOCHIM COSMOCHIM AC, V62, P677, DOI 10.1016/S0016-7037(97)00382-7; Zhou MF, 2005, J PETROL, V46, P615, DOI 10.1093/petrology/egh091; ARAI S, 1980, J PETROL, V21, P141; Ishizuka O, 2011, EARTH PLANET SC LETT, V306, P229, DOI 10.1016/j.epsl.2011.04.006; Arai S, 1997, J ASIAN EARTH SCI, V15, P303; Kelemen PB, 1997, PHILOS T R SOC A, V355, P283; ARAI S, 1994, ECON GEOL BULL SOC, V89, P1279; Morishita T, 2011, LITHOS, V124, P215, DOI 10.1016/j.lithos.2010.10.003; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; Arai S, 2011, ISL ARC, V20, P125, DOI 10.1111/j.1440-1738.2010.00747.x; Hellebrand E, 2001, NATURE, V410, P677, DOI 10.1038/35070546; Rossetti F, 2010, TECTONICS, V29, DOI 10.1029/2009TC002487; Zhou MF, 1997, ECON GEOL BULL SOC, V92, P259; Rollinson H, 2013, LITHOS, V177, P314, DOI 10.1016/j.lithos.2013.07.004; Aldanmaz E, 2009, LITHOS, V113, P691, DOI 10.1016/j.lithos.2009.03.010; Seyler M, 1997, EARTH PLANET SC LETT, V146, P273, DOI 10.1016/S0012-821X(96)00220-8; Zhou MF, 2001, J ASIAN EARTH SCI, V19, P517, DOI 10.1016/S1367-9120(00)00048-1; Robinson AC, 2004, GEOL SOC AM BULL, V116, P953, DOI 10.1130/B25375.1; KELEMEN PB, 1992, NATURE, V358, P635, DOI 10.1038/358635a0; Yang JS, 2007, J METAMORPH GEOL, V25, P187, DOI 10.1111/j.1525-1314.2006.00688.x; Loucks RR, 1996, CONTRIB MINERAL PETR, V125, P140, DOI 10.1007/s004100050211; Bizimis M, 2000, CHEM GEOL, V165, P67, DOI 10.1016/S0009-2541(99)00164-3; Tamura A, 2006, LITHOS, V90, P43, DOI 10.1016/j.lithos.2005.12.012; Matveev S, 2002, EARTH PLANET SC LETT, V203, P235, DOI 10.1016/S0012-821X(02)00860-9; Stern RJ, 2004, EARTH PLANET SC LETT, V226, P275, DOI 10.1016/j.epsl.2004.08.007; Zhou MF, 1996, J PETROL, V37, P3, DOI 10.1093/petrology/37.1.3; Falloon TJ, 2008, J PETROL, V49, P591, DOI 10.1093/petrology/egn009; Arai S, 2006, J GEOL SOC LONDON, V163, P869, DOI 10.1144/0016-76492005-057; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; Ghiorso MS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000217; Parkinson IJ, 1998, J PETROL, V39, P1577; Dijkstra AH, 2001, J PETROL, V42, P5, DOI 10.1093/petrology/42.1.5; Piccardo GB, 2007, LITHOS, V94, P181, DOI 10.1016/j.lithos.2006.07.002; HART SR, 1993, CONTRIB MINERAL PETR, V113, P1, DOI 10.1007/BF00320827; Niu YL, 1997, EARTH PLANET SC LETT, V152, P251, DOI 10.1016/S0012-821X(97)00119-2; [Anonymous], 1993, GEOL SOC SPEC PUBL; OBATA M, 1974, B SOC FR MINERAL CR, V97, P101; Pearce JA, 2000, CONTRIB MINERAL PETR, V139, P36, DOI 10.1007/s004100050572; Arai S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029198; ARAI S, 1994, MINER DEPOSITA, V29, P434, DOI 10.1007/BF01886963; ARAI S, 1994, J VOLCANOL GEOTH RES, V59, P279, DOI 10.1016/0377-0273(94)90083-3; Arai S., 1995, ISL ARC, V4, P104, DOI 10.1111/j.1440-1738.1995.tb00135.x; Arai S, 1997, RESOUR GEOL, V47, P177; Arai S, 1997, GEOCHIM COSMOCHIM AC, V61, P671, DOI 10.1016/S0016-7037(96)00389-4; Arai S, 2004, J PETROL, V45, P369, DOI 10.1093/petrology/egg100; Arai S., 2010, GEOCHIMICA COSMOCHIM, V74, P2231; Arai S, 1992, J MINERAL PETROL ECO, V87, P351; Baroz F., 1984, OFIOLITI, V9, P3; BENN K, 1988, TECTONOPHYSICS, V151, P75, DOI 10.1016/0040-1951(88)90241-7; BERBERIAN M, 1981, CAN J EARTH SCI, V18, P210, DOI 10.1139/e81-019; Bloomer S.H., 1983, GEOPHYS MONOGR SER, V27, P94; CASSARD D, 1981, ECON GEOL, V76, P805; Dick H.J.B., 1989, GEOL SOC LOND SPEC P, V42, P71, DOI DOI 10.1144/GSL.SP.1989.042.01.06; ELTHON D, 1992, J GEOPHYS RES-SOL EA, V97, P9015, DOI 10.1029/92JB00723; Gaetani GA, 1994, P ODP SCI RESULTS, V135, P557; Hellebrand E, 2002, CHEM GEOL, V182, P227, DOI 10.1016/S0009-2541(01)00291-1; HOCK M, 1986, MINER DEPOSITA, V21, P190; JOHNSON KTM, 1992, J GEOPHYS RES-SOL EA, V97, P9219, DOI 10.1029/92JB00701; Kamenetsky VS, 2001, J PETROL, V42, P655, DOI 10.1093/petrology/42.4.655; Koepke J, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002488; Koga K.T., 2001, GEOCHEMISTRY GEOPHYS, V2; Leblanc M, 1992, LITHOS, V27, P231; LEBLANC M, 1983, ECON GEOL, V78, P293; Lensch G., 1980, P INT OPH S MIN AGR, P398; Maleki L, 2013, THESIS DAMGHAN U; MAUREL C, 1982, CR ACAD SCI II, V295, P209; Merlini A, 2011, ORE GEOL REV, V41, P22, DOI 10.1016/j.oregeorev.2011.06.002; Miura M, 2012, J ASIAN EARTH SCI, V59, P52, DOI 10.1016/j.jseaes.2012.05.008; Morishita T, 2005, GEOCHEM J, V39, P327, DOI 10.2343/geochemj.39.327; NICOLAS A, 1989, STRUCTURE OPHIOLITES; Noghreyan M.K., 1982, THESIS U NANCY FRANC; Ottley C.J., 2003, SPECIAL PUBLICATION, V291, P221; Paktunc D., 1990, ORE GEOL REV, V5, P211; Potts P.J., 1992, GEOCHEMICAL REFERENC; ROEDER PL, 1991, J PETROL, V32, P909; Rollinson H., 2013, GONDWANA RES, V27, P543; ROSS K, 1993, NATURE, V365, P826, DOI 10.1038/365826a0; Sano S, 2007, J PETROL, V48, P113, DOI 10.1093/petrology/egl056; Sengor A.M.C., 1990, GEOL SOC LOND SPEC P, V49, P797, DOI DOI 10.1144/GSL.SP.1992.049.01.49; Shafaii Moghadam H, 2009, THESIS S BEHESHTI U; Shi RD, 2012, GONDWANA RES, V21, P194, DOI 10.1016/j.gr.2011.05.011; Shojaat B, 2003, J ASIAN EARTH SCI, V21, P1053, DOI 10.1016/S1367-9120(02)00143-8; Stern RJ, 2011, GEOL SOC SPEC PUBL, V338, P7, DOI 10.1144/SP338.2; ISHII T, 1992, P OC DRILL PROGR SCI, V0125; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Takahashi E., 1987, TECHNICAL REPORTS A, P1; Tamura A, 2008, CONTRIB MINERAL PETR, V155, P491, DOI 10.1007/s00410-007-0254-0; Uesugi J., 2003, J GEOGR, V112, P750; Uysal E., 2012, LITHOS, V132-133, P50; Whattam SA, 2011, CONTRIB MINERAL PETR, V162, P1031, DOI 10.1007/s00410-011-0638-z; Yamamoto J, 2009, EARTH PLANET SC LETT, V280, P167, DOI 10.1016/j.epsl.2009.01.029; Zaki Khedr M., 2013, GONDWANA RES, V25, P1242; Zhou MF, 1994, INT GEOL REV, V36, P678	104	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1342-937X	1878-0571		GONDWANA RES	Gondwana Res.	FEB	2015	27	2			SI		575	593		10.1016/j.gr.2013.09.007		19	Geosciences, Multidisciplinary	Geology	CA0PU	WOS:000348620100008		
J	Uysal, I; Ersoy, EY; Dilek, Y; Escayola, M; Sarifakioglu, E; Saka, S; Hirata, T				Uysal, Ibrahim; Ersoy, E. Yalcin; Dilek, Yildirim; Escayola, Monica; Sarifakioglu, Ender; Saka, Samet; Hirata, Takafumi			Depletion and refertilization of the Tethyan oceanic upper mantle as revealed by the early Jurassic Refahiye ophiolite, NE Anatolia-Turkey	GONDWANA RESEARCH			English	Article						Neotetyhan ophiolite; HSE and Re-Os isotope geochemistry; U-Pb zircon dating; Mantle refertilization; Partial melting of upper mantle	PLATINUM-GROUP ELEMENTS; PLASMA-MASS SPECTROMETRY; FORE-ARC ACCRETION; DILUTION-ICP-MS; U-PB AGE; TRACE-ELEMENT; ABYSSAL PERIDOTITES; GEOCHEMICAL EVIDENCE; SUPRA-SUBDUCTION; MIDOCEAN RIDGE	We present new whole-rock major and trace element, Re-Os isotope and mineral chemistry data for the upper mantle peridotites and mafic rocks in the Rehafiye ophiolite in NE Anatolia (Turkey), and discuss their significance for the mantle evolution in Neotethys. The Refahiye peridotites include clinopyroxene (cpx)-rich and cpx-poor harzburgites. Assuming an initial fertile mantle composition, the cpx-rich harzburgites have a limited range of Cr-spl Cr# (33-38), implying 14-18% melt extraction. However, TiO2 contents of the Cr-spl in these rocks are too high (up to 0.24 wt.%) to explain their Ti concentrations with a simple melt extraction model in a mid-ocean ridge (MOR) setting, and suggest re-crystallization from an impregnating fertile melt. The interstitial phases of cpx in these samples have high TiO2 (up to 0.40 wt.%) and Na2O (up to 025 wt.%) contents. They also contain interstitial pargasitic amphibole with TiO2 contents varying between 0.69 and 0.88 wt.%. These textures and the mineral chemistry data indicate refertilization of the previously depleted, MOR-type peridotites by percolating hydrous melts. The whole-rock REE partial melting modeling is consistent with slightly lower degrees of mantle melting (similar to 12-14%) compared to the melt extraction degrees obtained from the Cr-spl compositions (similar to 15%). Chromian spinet (Cr-spl) phases in the cpx-poor harzburgites show a wider variation of Cr#, ranging between 57 and 75, and reflect 30-40% of partial melting. In contrast, the whole-rock geochemistry of these rocks represents slightly lower degrees of partial melting, varying between 30 and 35%. The enrichment of TiO2 contents of the Cr-spl (up to 020 wt.%) in some of the cpx-poor harzburgites can be explained by their interaction with Ti-rich hydrous melt formed at supra-subduction (SSZ) tectonic setting. Highly unradiogenic Os isotope composition (0.11956) of a cpx-poor harzburgite sample suggests an ancient melt depletion event experienced by these rocks, whereas its high Re content is a manifestation of subduction enrichment. The mafic units of the Refahiye ophiolite show MORB-like to island arc tholeiite (IAT) geochemical signatures typical of SSZ oceanic crust. A U-Pb zircon age of 183 +/- 1 Ma obtained from an isotropic gabbro sample suggests that the crystallization of the SSZ-type mafic units in the Refahiye ophiolite is as old as the early Jurassic. (C) 2013 International Association for Gondwana Research. Published by Elsevier B.V. All rights reserved.	[Uysal, Ibrahim; Saka, Samet] Karadeniz Tech Univ, Dept Geol Engn, TR-61080 Trabzon, Turkey; [Ersoy, E. Yalcin] Dokuz Eylul Univ, Dept Geol Engn, TR-35160 Izmir, Turkey; [Dilek, Yildirim] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Escayola, Monica] Univ Nacl Salta, RA-4400 Salta, Buenos Aires, Argentina; [Sarifakioglu, Ender] Geol Res Dept, Gen Directorate MTA, TR-06520 Ankara, Turkey; [Hirata, Takafumi] Kyoto Univ, Grad Sch Sci, Dept Geol & Mineral, Sakyo Ku, Kyoto 6068502, Japan	Uysal, I (reprint author), Karadeniz Tech Univ, Dept Geol Engn, TR-61080 Trabzon, Turkey.	uysal.ibrahim@gmail.com	Ersoy, Yalcin/C-7084-2012	Ersoy, Yalcin/0000-0002-8563-9561	TUBITAK (Turkey); NSF (USA); NATO Science Programme; Miami University	Our work in the Tethyan ophiolites in Anatolia and beyond has been supported by research grants from the TUBITAK (Turkey), NSF (USA), NATO Science Programme, and Miami University that we gratefully acknowledge. A Dokuz and F. Aydin are thanked for their help during the field studies and microscopic investigations, respectively. We also thank M. Kaliwoda, KT. Fehr, R. Hochleitner and D. Muller for their great help with the electron microprobe measurements. S. Arai and T. Morishita provided insightful comments on an earlier version of this manuscript that helped us greatly with our interpretations. We thank A. Polat and the anonymous referee for their constructive and thorough reviews for the Journal that helped us improved the paper.	AKTIMUR HT, 1995, 9792 MTA; ALLEGRE CJ, 1980, EARTH PLANET SC LETT, V48, P148, DOI 10.1016/0012-821X(80)90177-6; Dilek Y, 1999, GEOL SOC AM BULL, V111, P1192, DOI 10.1130/0016-7606(1999)111<1192:SAPOTO>2.3.CO;2; Dilek Y, 2003, GEOL SOC SPEC PUBL, V218, P43, DOI 10.1144/GSL.SP.2003.218.01.04; Leake BE, 1997, EUR J MINERAL, V9, P623; Meisel T, 2001, ANALYST, V126, P322, DOI 10.1039/b007575m; Arai S, 2008, J PETROL, V49, P665, DOI 10.1093/petrology/egm069; Shirey SB, 1998, ANNU REV EARTH PL SC, V26, P423, DOI 10.1146/annurev.earth.26.1.423; Dilek Y, 2009, LITHOS, V113, P1, DOI 10.1016/j.lithos.2009.04.022; ARAI S, 1994, CHEM GEOL, V113, P191, DOI 10.1016/0009-2541(94)90066-3; Ishizuka O, 2011, EARTH PLANET SC LETT, V306, P229, DOI 10.1016/j.epsl.2011.04.006; Meisel T, 2003, J ANAL ATOM SPECTROM, V18, P720, DOI 10.1039/b301754k; Morishita T, 2011, LITHOS, V124, P215, DOI 10.1016/j.lithos.2010.10.003; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; Smoliar MI, 1996, SCIENCE, V271, P1099, DOI 10.1126/science.271.5252.1099; Pearce JA, 2008, LITHOS, V100, P14, DOI 10.1016/j.lithos.2007.06.016; Bockrath C, 2004, CHEM GEOL, V208, P265, DOI 10.1016/j.chemgeo.2004.04.016; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Iizuka T, 2004, GEOCHEM J, V38, P229; DILEK Y, 1992, J GEOL, V100, P305; Borghini G, 2007, LITHOS, V94, P210, DOI 10.1016/j.lithos.2006.06.014; Saccani E, 2004, LITHOS, V73, P229, DOI 10.1016/j.lithos.2003.12.002; HIRATA T, 1995, GEOCHIM COSMOCHIM AC, V59, P2491, DOI 10.1016/0016-7037(95)00144-1; Zheng L, 2009, CHEM GEOL, V268, P1, DOI 10.1016/j.chemgeo.2009.06.021; Dilek Y, 2009, LITHOS, V113, P68, DOI 10.1016/j.lithos.2009.05.044; KINZLER RJ, 1992, J GEOPHYS RES-SOL EA, V97, P6885, DOI 10.1029/91JB02840; Coltorti M, 2007, LITHOS, V99, P68, DOI 10.1016/j.lithos.2007.05.009; Dilek Y, 2011, GEOL SOC AM BULL, V123, P387, DOI 10.1130/B30446.1; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; Brenan JM, 2003, EARTH PLANET SC LETT, V212, P135, DOI 10.1016/S0012-821X(03)00234-6; Rice SP, 2006, GEOL SOC SPEC PUBL, V260, P413, DOI 10.1144/GSL.SP.2006.260.01.17; Ishimaru S, 2007, J PETROL, V48, P395, DOI 10.1093/petrology/egl065; Saccani E, 2011, LITHOS, V124, P227, DOI 10.1016/j.lithos.2010.10.009; Parkinson IJ, 1998, J PETROL, V39, P1577; Pearce JA, 2010, GONDWANA RES, V18, P60, DOI 10.1016/j.gr.2009.12.003; Eiler JM, 2000, J PETROL, V41, P229, DOI 10.1093/petrology/41.2.229; Niu YL, 2004, J PETROL, V45, P2423, DOI 10.1093/petrology/egh068; Uysal I, 2012, LITHOS, V132, P50, DOI 10.1016/j.lithos.2011.11.009; Gaetani GA, 2004, CONTRIB MINERAL PETR, V147, P511, DOI 10.1007/s00410-004-0575-1; Yokoyama TD, 2011, ANAL CHEM, V83, P8892, DOI 10.1021/ac2012448; Dijkstra AH, 2001, J PETROL, V42, P5, DOI 10.1093/petrology/42.1.5; OZAWA K, 1995, J GEOPHYS RES-SOL EA, V100, P22315, DOI 10.1029/95JB01967; Adam J, 2006, CONTRIB MINERAL PETR, V152, P1, DOI 10.1007/s00410-006-0085-4; Liu CZ, 2010, LITHOS, V114, P413, DOI 10.1016/j.lithos.2009.10.008; Dinter DA, 1998, GEOL SOC AM BULL, V110, P1208, DOI 10.1130/0016-7606(1998)110<1208:LCEOTA>2.3.CO;2; Piccardo GB, 2007, LITHOS, V94, P181, DOI 10.1016/j.lithos.2006.07.002; Garuti G, 1997, TECTONOPHYSICS, V276, P181, DOI 10.1016/S0040-1951(97)00050-4; Ulrich M, 2010, LITHOS, V115, P223, DOI 10.1016/j.lithos.2009.12.011; Dilek Y, 2006, GEOL S AM S, V409, P1, DOI 10.1130/2006.2409(01); Polat A, 2002, CHEM GEOL, V184, P231, DOI 10.1016/S0009-2541(01)00363-1; Pearce JA, 2000, CONTRIB MINERAL PETR, V139, P36, DOI 10.1007/s004100050572; Luguet A, 2007, GEOCHIM COSMOCHIM AC, V71, P3082, DOI 10.1016/j.gca.2007.04.011; Okay AI, 2002, LITHOS, V64, P155, DOI 10.1016/S0024-4937(02)00200-1; Choi SH, 2008, CONTRIB MINERAL PETR, V156, P551, DOI 10.1007/s00410-008-0300-6; Zou HB, 1998, GEOCHIM COSMOCHIM AC, V62, P1937, DOI 10.1016/S0016-7037(98)00115-X; ARAI S, 1992, MINERAL MAG, V56, P173, DOI 10.1180/minmag.1992.056.383.04; Barth M, 2009, CONTRIB MINERAL PETR, V157, P23, DOI 10.1007/s00410-008-0318-9; Batanova VG, 2008, CHEM GEOL, V248, P195, DOI 10.1016/j.chemgeo.2007.09.002; Bedard E, 2009, LITHOS, V113, P48, DOI 10.1016/j.lithos.2009.01.011; Delavari M, 2009, Journal of Applied Sciences, V9, DOI 10.3923/jas.2009.2671.2687; Dilek Y, 2009, ISL ARC, V18, P551, DOI 10.1111/j.1440-1738.2009.00692.x; Dilek Y, 2003, GEOL SOC SPEC PUBL, V218, P1, DOI 10.1144/GSL.SP.2003.218.01.01; ELLER JM, 2007, GEOCHEM GEOPHY GEOSY, V8; Elliott T, 1997, J GEOPHYS RES-SOL EA, V102, P14991, DOI 10.1029/97JB00788; FABRIES J, 1989, J PETROL, V30, P199; Flower MFJ, 2003, GEOL SOC SPEC PUBL, V218, P21, DOI 10.1144/GSL.SP.2003.218.01.03; Fumes H., 2012, GEOLOGICAL SOC AM B, V124, P1027; Hauri EH, 2002, PHILOS T ROY SOC A, V360, P2371, DOI 10.1098/rsta.2002.1073; HEBERT R, 1983, EARTH PLANET SC LETT, V65, P107, DOI 10.1016/0012-821X(83)90193-0; Hebert R, 1990, P ODP SCI RESULTS, V106/109, P103; Hellebrand E, 2002, CHEM GEOL, V182, P227, DOI 10.1016/S0009-2541(01)00291-1; IWANO H, 2012, J GEOL SOC JPN, V118, P365, DOI DOI 10.5575/geosoc.2012.0006; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; Kinzler RJ, 1997, J GEOPHYS RES-SOL EA, V102, P853, DOI 10.1029/96JB00988; Langmuir C.H., 1992, AM GEOPHYS UNION GEO, V71, P183; MCKENZIE D, 1991, J PETROL, V32, P1021; Niu YL, 1997, J PETROL, V38, P1047, DOI 10.1093/petrology/38.8.1047; O'Neill C, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002799; OKAY AI, 1984, KET S GEOL SOC TURK, P83; Ottley C.J., 2003, SPECIAL PUBLICATION, V291, P221; OZEN H, 2008, 11055 GEN DIR MIN RE; Ozgul N., 1981, 6995 MTA; Paliulionyte V, 2006, GEOSTAND GEOANAL RES, V30, P87, DOI 10.1111/j.1751-908X.2006.tb00915.x; Palme H, 2004, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B0-08-043751-6/02177-0; PARKINSON IJ, 1992, P OCEAN DRILLING PRO, V0125; Pouchou J.L., 1984, RECH AEROSPATIALE, V3, P13; Rampone E, 2008, CONTRIB MINERAL PETR, V156, P453, DOI 10.1007/s00410-008-0296-y; Rampone E, 1997, GEOCHIM COSMOCHIM AC, V61, P4557, DOI 10.1016/S0016-7037(97)00260-3; RICOU LE, 1980, GEOLOGICAL SOC TURKE, V23, P101; ROUX VL, 2007, EARTH PLANET SC LETT, V259, P599; SARIFAKIOGLU E, 2013, SOLID EARTH IN PRESS; Sarifakioglu E, 2009, TURK J EARTH SCI, V18, P187, DOI 10.3906/yer-0702-4; SAUNDERS AD, 1991, PHILOS T ROY SOC A, V335, P377, DOI 10.1098/rsta.1991.0053; Seyler M, 2007, CONTRIB MINERAL PETR, V153, P303, DOI 10.1007/s00410-006-0148-6; Seyler M, 2001, GEOLOGY, V29, P155, DOI 10.1130/0091-7613(2001)029<0155:CMRIEM>2.0.CO;2; SHERVAIS JW, 1982, EARTH PLANET SC LETT, V59, P101, DOI 10.1016/0012-821X(82)90120-0; ISHII T, 1992, P OC DRILL PROGR SCI, V0125; Suhr G, 1999, J PETROL, V40, P575, DOI 10.1093/petrology/40.4.575; UYSAL I, 2013, MINERALOGY PETROLOGY; Uysal I, 2007, CAN MINERAL, V45, P1471, DOI 10.3749/canmin.45.6.1471; WALKER RJ, 1989, SCIENCE, V243, P519, DOI 10.1126/science.243.4890.519; WITTEICKSCHEN G, 1994, CHEM GEOL, V117, P235, DOI 10.1016/0009-2541(94)90130-9; YILMAZ A, 1985, GEOLOGICAL SOC TURKE, V28, P79; YILMAZ A, 1990, MIDDLE E TECHNICAL U, V21, P221	106	5	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1342-937X	1878-0571		GONDWANA RES	Gondwana Res.	FEB	2015	27	2			SI		594	611		10.1016/j.gr.2013.09.008		18	Geosciences, Multidisciplinary	Geology	CA0PU	WOS:000348620100009		
J	Han, TS; Hur, K; Xu, GR; Choi, B; Okugawa, Y; Toiyama, Y; Oshima, H; Oshima, M; Lee, HJ; Kim, VN; Chang, AN; Goel, A; Yang, HK				Han, Tae-Su; Hur, Keun; Xu, Guorong; Choi, Boram; Okugawa, Yoshinaga; Toiyama, Yuji; Oshima, Hiroko; Oshima, Masanobu; Lee, Hyuk-Joon; Kim, V. Narry; Chang, Aaron N.; Goel, Ajay; Yang, Han-Kwang			MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1	GUT			English	Article							ACTIVATED MACROPHAGES; CANCER; EXPRESSION; TRANSCRIPTOME; METASTASIS; MARKERS; ALPHA; CELLS	Objective Gastric cancer (GC) remains difficult to cure due to heterogeneity in a clinical challenge and the molecular mechanisms underlying this disease are complex and not completely understood. Accumulating evidence suggests that microRNAs (miRNAs) play an important role in GC, but the role of specific miRNAs involved in this disease remains elusive. We performed next generation sequencing (NGS)-based whole-transcriptome profiling to discover GC-specific miRNAs, followed by functional validation of results. Design NGS-based miRNA profiles were generated in matched pairs of GCs and adjacent normal mucosa (NM). Quantitative RT-PCR validation of miR-29c expression was performed in 274 gastric tissues, which included two cohorts of matched GC and NM specimens. Functional validation of miR-29c and its gene targets was undertaken in cell lines, as well as K19-C2mE and K19-Wnt1/C2mE transgenic mice. Results NGS analysis revealed four GC-specific miRNAs. Among these, miR-29c expression was significantly decreased in GC versus NM tissues (p<0.001). Ectopic expression of miR-29c mimics in GC cell lines resulted in reduced proliferation, adhesion, invasion and migration. High miR-29c expression suppressed xenograft tumour growth in nude mice. Direct interaction between miR-29c and its newly discovered target, ITGB1, was identified in cell lines and transgenic mice. MiR-29c expression demonstrated a stepwise decrease in wild type hyperplasia-dysplasia cascade in transgenic mice models of GC. Conclusions MiR-29c acts as a tumour suppressor in GC by directly targeting ITGB1. Loss of miR-29c expression is an early event in the initiation of gastric carcinogenesis and may serve as a diagnostic and therapeutic biomarker for patients with GC.	[Han, Tae-Su; Choi, Boram; Lee, Hyuk-Joon; Yang, Han-Kwang] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea; [Han, Tae-Su; Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 920, Japan; [Hur, Keun; Okugawa, Yoshinaga; Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Baylor Res Inst, Dallas, TX 75246 USA; [Hur, Keun; Okugawa, Yoshinaga; Goel, Ajay] Baylor Univ, Med Ctr, Sammons Canc Ctr, Dallas, TX 75246 USA; [Hur, Keun] Korea Res Inst Biosci & Biotechnol, Biomed Genom Res Ctr, Taejon, South Korea; [Xu, Guorong; Chang, Aaron N.] Baylor Univ, Med Ctr, Baylor Inst Immunol Res, Dallas, TX 75246 USA; [Xu, Guorong; Chang, Aaron N.] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX 75246 USA; [Okugawa, Yoshinaga; Toiyama, Yuji] Mie Univ, Grad Sch Med, Inst Life Sci, Div Reparat Med,Dept Gastrointestinal & Pediat Su, Tsu, Mie, Japan; [Lee, Hyuk-Joon; Yang, Han-Kwang] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110744, South Korea; [Kim, V. Narry] Seoul Natl Univ, Dept Biol Sci, Seoul 110744, South Korea	Goel, A (reprint author), Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, 3500 Gaston Ave,Suite H-250, Dallas, TX 75246 USA.	ajay.goel@baylorhealth.edu; hkyang@snu.ac.kr	Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004	A3 Foresight programme from National Research Foundation of Korea	This study was supported by A3 Foresight programme from National Research Foundation of Korea.	Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Thiel A, 2012, HELICOBACTER, V17, P26, DOI 10.1111/j.1523-5378.2012.00979.x; Xu ZY, 2010, BIOMED PHARMACOTHER, V64, P133, DOI 10.1016/j.biopha.2009.06.021; Kim YH, 2012, CANCER RES, V72, P2512, DOI 10.1158/0008-5472.CAN-11-3870; Hur K, 2012, J PATHOL, V228, P88, DOI 10.1002/path.4055; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Liang H, 2013, CANCER LETT, V340, P241, DOI 10.1016/j.canlet.2012.11.029; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Bae HJ, 2013, ONCOGENE; Foubert Philippe, 2012, Methods Mol Biol, V757, P471, DOI 10.1007/978-1-61779-166-6_27; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Matsuo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-15; Ribeiro-dos-Santos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013205; Tseng CW, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-99; Zhao ZS, 2011, J SURG ONCOL, V104, P525, DOI 10.1002/jso.21984	35	12	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	FEB	2015	64	2					203	U30		10.1136/gutjnl-2013-306640		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ8FG	WOS:000348449800006		
J	Kuba, K; Inoue, H; Hayashi, T; Matsumura, S; Minami, K; Takajo, H; Morita, K; Nakahira, M; Sugasawa, M				Kuba, Kiyomi; Inoue, Hitoshi; Hayashi, Takahiro; Matsumura, Satoko; Minami, Kazuhiko; Takajo, Humihiko; Morita, Kei; Nakahira, Mitsuhiko; Sugasawa, Masashi			Laryngeal osteosarcoma: Case report and literature review	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						laryngeal osteosarcoma; hoarseness; odynophagia; thyroid cartilage; head and neck	NECK OSTEOSARCOMA; OSTEO-SARCOMA; SOFT-TISSUE; HEAD; CHEMOTHERAPY	BackgroundSarcomas of the larynx are uncommon tumors, and osteosarcoma is the rarest. Only 24 cases of osteosarcoma of the larynx have been reported. The only case reported in Asia was from Thailand in 1981. MethodsA 55-year-old male patient was referred to our hospital because of an 8-month history of odynophagia and a gradually enlarging left neck mass. A neck CT scan was performed. A literature review was also performed for this report. ResultsThe CT scan revealed extensive calcification with enlargement of the thyroid cartilage. The patient was diagnosed with osteosarcoma and was successfully treated by surgery alone. ConclusionAdequate surgical resection is required for successful treatment of laryngeal sarcomas. Adjuvant therapy is not contraindicated, but chemotherapy may improve the prognosis in patients with high-grade tumors or metastatic disease. (c) 2014 Wiley Periodicals, Inc. Head Neck37: E26-E29, 2015	[Kuba, Kiyomi; Inoue, Hitoshi; Hayashi, Takahiro; Matsumura, Satoko; Minami, Kazuhiko; Takajo, Humihiko; Morita, Kei; Nakahira, Mitsuhiko; Sugasawa, Masashi] Saitama Med Univ Int Med Ctr, Dept Head & Neck Surg & Otolaryngol, Saitama 3501298, Japan	Kuba, K (reprint author), Saitama Med Univ Int Med Ctr, Dept Head & Neck Surg & Otolaryngol, 1397-1 Yamane, Saitama 3501298, Japan.	kiyokuba@saitama-med.ac.jp					Ferrari S, 1999, TUMORI, V85, P458; Smith RB, 2003, CANCER, V98, P1670, DOI 10.1002/cncr.11716; Arslan M, 2008, J BUON, V13, P437; Athre RS, 2005, LARYNGOSCOPE, V115, P74, DOI 10.1097/01.mlg.0000150672.45484.5c; Berge JK, 1998, ARCH OTOLARYNGOL, V124, P207; CLERF LH, 1946, ARCH OTOLARYNGOL, V44, P517; DAHM LJ, 1978, CANCER, V42, P2343, DOI 10.1002/1097-0142(197811)42:5<2343::AID-CNCR2820420535>3.0.CO;2-0; GORENSTEIN A, 1980, ARCH OTOLARYNGOL, V106, P8; HAAR JG, 1978, ARCH OTOLARYNGOL, V104, P477; Laskar S, 2008, HEAD NECK-J SCI SPEC, V30, P1020, DOI 10.1002/hed.20820; LEVINE HL, 1986, OTOLARYNG CLIN N AM, V19, P475; Madrigal Fernando Martinez, 2002, Ann Diagn Pathol, V6, P1, DOI 10.1053/adpa.2002.30604; Mendenhall WM, 2011, AM J OTOLARYNG, V32, P597, DOI 10.1016/j.amjoto.2010.09.002; MORLEY A R, 1973, Journal of Laryngology and Otology, V87, P997, DOI 10.1017/S0022215100077914; Mottola Giampiero, 2008, Cases J, V1, P365, DOI 10.1186/1757-1626-1-365; Myssiorek D, 1998, ANN OTO RHINOL LARYN, V107, P70; Oda D, 1997, HEAD NECK-J SCI SPEC, V19, P513, DOI 10.1002/(SICI)1097-0347(199709)19:6<513::AID-HED9>3.0.CO;2-1; PINSOLLE J, 1990, OTOLARYNG HEAD NECK, V102, P276; REMAGEN W, 1983, HNO, V31, P366; Rossi RM, 1998, OTOLARYNG HEAD NECK, V118, P385, DOI 10.1016/S0194-5998(98)70321-3; Rydzewski Bogdan, 2005, Otolaryngol Pol, V59, P285; Sanaat Z, 2009, ARCH IRAN MED, V12, P499; Sheen TS, 1997, HEAD NECK-J SCI SPEC, V19, P57, DOI 10.1002/(SICI)1097-0347(199701)19:1<57::AID-HED11>3.0.CO;2-O; Smeele LE, 1997, J CLIN ONCOL, V15, P363; SPRINKLE PM, 1966, LARYNGOSCOPE, V76, P325, DOI 10.1288/00005537-196602000-00011; SUCHATLAMPONG V, 1981, J MED ASSOC THAILAND, V64, P301; Topaloglu I, 2004, OTOLARYNG HEAD NECK, V131, P789, DOI 10.1016/j.otohns.2004.01.016; vansLaer CG, 1989, ANN OTO RHINOL LARYN, V98, P971	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	FEB	2015	37	2					E26	E29		10.1002/hed.23767		4	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	AZ9QH	WOS:000348548700005		
J	Takeuchi, H; Taki, Y; Nouchi, R; Hashizume, H; Sekiguchi, A; Kotozaki, Y; Nakagawa, S; Miyauchi, CM; Sassa, Y; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Nouchi, Rui; Hashizume, Hiroshi; Sekiguchi, Atsushi; Kotozaki, Yuka; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Sassa, Yuko; Kawashima, Ryuta			The Structure of the Amygdala Associates With Human Sexual Permissiveness: Evidence From Voxel-Based Morphometry	HUMAN BRAIN MAPPING			English	Article						sexual permissiveness; voxel-based morphometry; gray matter; white matter; amygdala; hypothalamus	WHITE-MATTER STRUCTURES; REGIONAL GRAY; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; ATTITUDES; BEHAVIOR; INTELLIGENCE; STIMULATION; ACTIVATION; CREATIVITY	Sexual behavior is a critical function of human procreation. Despite previous studies that investigated the neural mechanisms of basic human physiological sexual functions, the neural mechanisms that underlie individual differences in human sexual permissiveness remain unknown. We used voxel-based morphometry and a questionnaire (scale for sexual attitudes) to measure sexual permissiveness to investigate the gray matter and white matter structural correlates of sexual permissiveness. Sexual permissiveness was negatively correlated with regional gray matter density of the structures involving the right amygdala and surrounding areas, and positively correlated with regional white matter density of the white matter area that spread around the left amygdala to the hypothalamus area. There were no gender-specific relationships in the neural correlates of our findings. These findings suggest that structural variations in regions that play key roles in the basic physiological aspects of human sexuality underlie individual complex sexual attitudes in social life. Hum Brain Mapp 36:440-448, 2015. (c) 2014 The Authors. Human Brain Mapping Published by Wiley Periodicals, Inc.	[Takeuchi, Hikaru; Taki, Yasuyuki; Sassa, Yuko; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki; Sekiguchi, Atsushi] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimaging Anal, Sendai, Miyagi 9808575, Japan; [Taki, Yasuyuki] Tohoku Univ, Dept Radiol & Nucl Med, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Human & Social Response Res Div, Sendai, Miyagi 9808575, Japan; [Hashizume, Hiroshi] Kyoto Univ, Res Adm Off, Kyoto, Japan; [Sekiguchi, Atsushi; Nakagawa, Seishu; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 9808575, Japan; [Kotozaki, Yuka] Fukushima Med Univ, Japan Div Clin Res, Med Ind Translat Res Ctr, Sch Med, Fukushima, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Dept Gen Syst Studies, Grad Sch Arts, Tokyo, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Grad Sch Sci, Dept Gen Syst Studies, Tokyo 113, Japan; [Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Dept Adv Brain Sci, Sendai, Miyagi 9808575, Japan	Takeuchi, H (reprint author), Tohoku Univ, Smart Ageing Int Res Ctr, IDAC, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	takehi@idac.tohoku.ac.jp			JST/RISTEX; JST/CREST; KAKENHI (Ministry of Education, Culture, Sports, Science, and Technology) [23700306, 25700012]	Contract grant sponsors: JST/RISTEX and JST/CREST; Contract grant sponsor: KAKENHI (Young Scientists (B), Young Scientists (A), Ministry of Education, Culture, Sports, Science, and Technology); Contract grant numbers: 23700306 and 25700012	Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Takeuchi H, 2013, CORTEX, V49, P1148, DOI 10.1016/j.cortex.2013.01.014; Takeuchi H, 2014, BRAIN STRUCT FUNCT, V219, P71, DOI 10.1007/s00429-012-0485-3; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Takeuchi H, 2013, HUM BRAIN MAPP, V34, P1025, DOI 10.1002/hbm.21492; Mechelli A, 2005, CURR MED IMAGING REV, V1, P105, DOI 10.2174/1573405054038726; Lemaire JJ, 2011, BRAIN RES, V1371, P43, DOI 10.1016/j.brainres.2010.11.072; Bramen JE, 2011, CEREB CORTEX, V21, P636, DOI 10.1093/cercor/bhq137; Hendrick C, 2006, J SEX RES, V43, P76; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; Takeuchi H, 2011, NEUROPSYCHOLOGIA, V49, P3466, DOI 10.1016/j.neuropsychologia.2011.08.022; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; MILLER BC, 1988, J YOUTH ADOLESCENCE, V17, P521, DOI 10.1007/BF01537829; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Okamoto M, 2004, NEUROIMAGE, V21, P1275, DOI 10.1016/j.neuroimage.2003.12.003; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Takeuchi H, 2012, NEUROIMAGE, V63, P1119, DOI 10.1016/j.neuroimage.2012.08.037; Baird AD, 2007, J NEUROL NEUROSUR PS, V78, P1042, DOI 10.1136/jnnp.2006.107193; Buss D. M., 2000, DANGEROUS PASSION WH; CAGGIULA AR, 1970, J COMP PHYSIOL PSYCH, V70, P399, DOI 10.1037/h0028706; Focke Niels K, 2014, Front Psychiatry, V5, P39, DOI 10.3389/fpsyt.2014.00039; Gloor P, 1986, LIMBIC SYSTEM FUNCTI; Greenstein B., 2000, COLOR ATLAS NEUROSCI; HALPERN CT, 1994, J BIOSOC SCI, V26, P217; HENDRICK S, 1985, J PERS SOC PSYCHOL, V48, P1630; Hendrick S., 1987, J SEX RES, V23, P502, DOI [10.1080/00224498709551387, DOI 10.1080/00224498709551387]; Kaplan HS, 1980, NEW SEX THERAPY; Meisel RL, 1994, PHYSL REPRODUCTION, P3; Ogawa S, 2013, EMAGRES, V2, P1; OLIVER MB, 1992, SOC PSYCHOL QUART, V55, P321, DOI 10.2307/2786800; PERACHIO AA, 1979, BRAIN RES, V177, P127, DOI 10.1016/0006-8993(79)90923-5; Raven J., 1998, MANUAL RAVENS PROGR; Silver M., 2010, NEUROIMAGE, V54, P992, DOI DOI 10.1016/J.NEUR0IMAGE.2010.08.049; Sprecher S., 1993, SEXUALITY; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025532; Takeuchi H., 2010, HUM BRAIN MAPP, V32, P1497, DOI [10.1002/hbm.21122, DOI 10.1002/HBM.21122]; Takeuchi H., 2014, BRAIN STRUCT FUNCT; Takeuchi H, 2014, HUM BRAIN MAPP, V35, P185, DOI 10.1002/hbm.22167; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Taki Y., 2011, NEUROIMAGE, V59, P1023, DOI DOI 10.1016/J.NEUR0IMAGE.2011.08.092; Wada M, 1992, SHAKAISHINRIGAKU KEN, V7, P54; Wada M, 1991, B TOKYO GAKUGEI U, V42, P197	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	FEB	2015	36	2					440	448		10.1002/hbm.22638		9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AZ7DN	WOS:000348378800003		
J	Liu, Z; Cheung, G; Chakareski, J; Ji, YS				Liu, Zhi; Cheung, Gene; Chakareski, Jacob; Ji, Yusheng			Multiple Description Coding and Recovery of Free Viewpoint Video for Wireless Multi-Path Streaming	IEEE JOURNAL OF SELECTED TOPICS IN SIGNAL PROCESSING			English	Article						Free-viewpoints video; multiple description coding; wireless multi-path streaming; depth-image-based rendering	INTERPOLATION; MOTION; CHANNELS	By transmitting texture and depth videos captured from two nearby camera viewpoints, a client can synthesize via depth-image-based rendering (DIBR) any freely chosen intermediate virtual view of the 3D scene, enhancing the user's perception of depth. During wireless network transmission, burst packet losses can corrupt the transmitted texture and depth videos and degrade the synthesized view quality at the client. In this paper, we propose a multiple description coding system for multi-path transmission of free-viewpoint video, with joint interview and temporal description recovery capability. In particular, we encode separately the even frames of the left view and the odd frames of the right view, and transmit them as one description on one path. The second description comprises the remaining frames in the two views and is transmitted over a second path. If the receiver receives only one description due to burst loss in the other path, the missing frames in the other description are partially reconstructed using our frame recovery procedure. First, we construct two recovery candidates for each lost pixel in a frame. The first candidate is generated via temporal super-resolution from its predecessor and successor frames in the same view. The second candidate is generated via DIBR from the received frame of the same time instance in the other view. Next, we select the best pixel candidates one patch at a time, where an image patch corresponds to a neighborhood of pixels with similar depth values in the 3D scene. Near-optimal source and channel coding rates for each description are selected using a branch-and-bound method, for given transmission bandwidth on each path. Experimental results show that our system can outperform a traditional single-description/single-path transmission scheme by up to 5.5 dB in Peak Signal-to-Noise Ratio (PSNR) of the synthesized intermediate view at the client.	[Liu, Zhi; Cheung, Gene; Ji, Yusheng] Grad Univ Adv Studies, Natl Inst Informat, Tokyo 1018430, Japan; [Chakareski, Jacob] Univ Alabama, Dept Elect & Comp Engn, Tuscaloosa, AL 35487 USA	Liu, Z (reprint author), Grad Univ Adv Studies, Natl Inst Informat, Tokyo 1018430, Japan.	liuzhi@nii.ac.jp; cheung@nii.ac.jp; jakov@jakov.org; kei@nii.ac.jp			JSPS [23240011]; JSPS Research Fellowships for Young Scientists; JSPS KAKENHI [23700136]	This work was supported in part by JSPS Grant-in-Aid for Scientific Research A (23240011) and JSPS Research Fellowships for Young Scientists and in part by JSPS KAKENHI under Grant 23700136. The associate editor coordinating the review of this manuscript and approving it for publication was Prof. Beatrice Pesquet-Popescu.	Ahn I., 2012, P IEEE INT C MULT EX, P109; Xiu XY, 2012, IEEE T MULTIMEDIA, V14, P1109, DOI 10.1109/TMM.2012.2191267; Zhai JF, 2005, IEEE INT SYMP CIRC S, P4927; Wiegand T, 2003, IEEE T CIRC SYST VID, V13, P560, DOI 10.1109/TCSVT.2003.815165; Golubchik L, 2002, PERFORM EVALUATION, V49, P429, DOI 10.1016/S0166-5316(02)00125-6; Wang C, 2010, IEEE T CIRC SYST VID, V20, P886, DOI 10.1109/TCSVT.2010.2046057; Merkle P, 2007, IEEE T CIRC SYST VID, V17, P1461, DOI 10.1109/TCSVT.2007.903665; Choi BD, 2007, IEEE T CIRC SYST VID, V17, P407, DOI 10.1109/TCSVT.2007.893835; GILBERT EN, 1960, AT&T TECH J, V39, P1253; Kurutepe E, 2007, IEEE T CIRC SYST VID, V17, P1558, DOI 10.1109/TCSVT.2007.903664; Flierl M, 2007, IEEE T CIRC SYST VID, V17, P1474, DOI 10.1109/TCSVT.2007.903780; Min DB, 2012, IEEE T IMAGE PROCESS, V21, P1176, DOI 10.1109/TIP.2011.2163164; Cheung G, 2011, IEEE T IMAGE PROCESS, V20, P3179, DOI 10.1109/TIP.2011.2158230; Apostolopoulos J., 1999, P INT WORKSH VER LOW, P168; Areia JD, 2007, 2007 IEEE NINTH WORKSHOP ON MULTIMEDIA SIGNAL PROCESSING, P453, DOI 10.1109/MMSP.2007.4412914; Chakareski J, 2014, IEEE T IMAGE PROCESS, V23, P931, DOI 10.1109/TIP.2013.2293419; Chakareski J., 2003, P 11 ACM INT C MULT, P422; Chakareski J, 2005, MULTIMEDIA SYST, V10, P275, DOI 10.1007/s00530-004-0162-3; Cheung G, 2007, IEEE J-STSP, V1, P319, DOI 10.1109/JSTSP.2007.902069; Cheung G, 2007, IEEE T CIRC SYST VID, V17, P649, DOI 10.1109/TCSVT.2007.896620; Cheung G., 2011, P 2011 IEEE INT WORK, P1; Daribo I., 2010, P IEEE WORKSH MULT S, P167; Daribo I., 2012, P PICT COD S; Ding Y, 2011, IEEE INFOCOM SER, P2051; FUJII T, 2006, P IEEE INT C MULT EX, P437; Gautier J., 2012, P PICT COD S KRAK PO; GERSHO A., 1992, VECTOR QUANTIZATION; Gokturk S., 2004, C COMP VIS PATT REC; Hou I. H., 2010, P IEEE INFOCOM, P1; Hu W., 2012, P IEEE INT C IM PROC; Kang Y.-S., 2008, P 3DTV C IST TURK MA; Kim J, 2000, IEEE T CIRC SYST VID, V10, P1164, DOI 10.1109/76.875520; Liu Z., 2012, P IEEE GLOB COMM C A; Macchiavello B, 2012, IEEE IMAGE PROC, P1653, DOI 10.1109/ICIP.2012.6467194; Macchiavello B., 2012, P IS T SPIE VISUAL I; Macchiavello B., 2013, IEEE T MULT IN PRESS; Merkle P., P IEEE INT C IM PROC; Ouaret M., 2007, P EUR C SIGN PROC EU; Petrazzuoli G., 2013, EURASIP J ADV SIG PR, V2013, P154; Podolsky M., 1998, UCBCSD981024; Reel S., 2013, P APSIPA ASC; Reichelt S., 2010, P SPIE 3 DIMENSIONAL; Shen G., 2010, PICT COD S PCS 2010, P566; Shum Heung-Yeung, 2007, IMAGE BASED RENDERIN; Singh V., 2013, P ACM MULT SYST; Sorensen J., 2010, P IEEE GLOBECOM, P1; Sun D., 2010, P IEEE CVPR; Sun J., 2008, P IEEE COMP SOC C VI; Tanimoto M, 2011, IEEE SIGNAL PROC MAG, V28, P67, DOI 10.1109/MSP.2010.939077; Tanimoto M., 2007, ISOIECJTC1SC29WG11; Tian D., 2009, P SPIE APPL DIGIAL I, V7443; Tomasi C., 1998, P 6 INT C COMP VIS W; Wenger S., 1997, P AVSPN 97 AB UK; Wenger S, 1998, IEEE T CIRC SYST VID, V8, P867, DOI 10.1109/76.735382; Xia PY, 2011, IEEE T MULTIMEDIA, V13, P366, DOI 10.1109/TMM.2010.2098021; Zhang C., 2009, P IEEE MMSP RIO DE J, P1; Zhu C, 2009, IEEE T CIRC SYST VID, V19, P511, DOI 10.1109/TCSVT.2009.2013521	57	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-4553	1941-0484		IEEE J-STSP	IEEE J. Sel. Top. Signal Process.	FEB	2015	9	1								10.1109/JSTSP.2014.2330332		14	Engineering, Electrical & Electronic	Engineering	AZ6ZH	WOS:000348367400013		
J	Kojima, A				Kojima, Akira			H-infinity Controller Design for Preview and Delayed Systems	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						Delayed system; H-infinity control; operator Riccati equation; preview control; state-space approach	HANKEL-NORM APPROXIMATION; QUADRATIC CONTROL-PROBLEM; DIMENSIONAL SYSTEMS; TIME; INPUT	The H-infinity control problem of general preview/delayed systems is solved using analytic solutions of the corresponding operator Riccati equations. The solution to the problem can be applied to a broad range of input/output delayed systems and enables the handling of preview/delayed control problems. The solvability condition is characterized by the roots of the transcendental equations and the control law for the general problem is given based on a predictive compensation with an integro-differential observer. Some interpretations of typical control problems are presented based on the solvability condition and the resulting control law.	Tokyo Metropolitan Univ, Grad Sch Syst Design, Tokyo 1910065, Japan	Kojima, A (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, Tokyo 1910065, Japan.	akojima@sd.tmu.ac.jp			JST CREST; JSPS [26420423]	This work was supported by JST CREST and JSPS under Grant-in-Aid for Scientific Research (C) 26420423. Recommended by Associate Editor L. Mirkin.	Kristalny M, 2011, 2011 50TH IEEE CONFERENCE ON DECISION AND CONTROL AND EUROPEAN CONTROL CONFERENCE (CDC-ECC), P3464, DOI 10.1109/CDC.2011.6161332; KHARGONEKAR PP, 1991, SIAM J CONTROL OPTIM, V29, P1373, DOI 10.1137/0329070; Kojima A, 2003, AUTOMATICA, V39, P693, DOI 10.1016/S0005-1098(02)00286-8; Ball J. A., 2006, SIAM J CONTROL OPTIM, V44, P531; BHAT KPM, 1976, IEEE T AUTOMAT CONTR, V21, P266, DOI 10.1109/TAC.1976.1101180; Foias C., 1996, ROBUST CONTROL INFIN; FUJINAKA T, 1987, AUTOMATICA, V23, P763, DOI 10.1016/0005-1098(87)90034-3; Gu GX, 1996, IEEE DECIS CONTR P, P4046, DOI 10.1109/CDC.1996.577371; Ito K, 1998, SIAM J CONTROL OPTIM, V36, P82, DOI 10.1137/S0363012994274422; Kashima K, 2008, IEEE T AUTOMAT CONTR, V53, P881, DOI 10.1109/TAC.2008.920230; Kojima A, 2006, IEEE T AUTOMAT CONTR, V51, P1920, DOI 10.1109/TAC.2006.886485; Kojima A, 2004, INT J ROBUST NONLIN, V14, P627, DOI 10.1002/rnc.897; Kojima A, 2005, IEEE DECIS CONTR P, P5770; Kristalny M., 2010, THESIS TECHNION IIT; Kristalny M, 2013, IEEE T CONTR SYST T, V21, P1191, DOI 10.1109/TCST.2013.2261070; Meinsma G, 2005, IEEE T AUTOMAT CONTR, V50, P199, DOI 10.1109/TAC.2004.841936; Meinsma G, 2000, IEEE T AUTOMAT CONTR, V45, P272, DOI 10.1109/9.839949; Mirkin L, 2003, AUTOMATICA, V39, P1495, DOI 10.1016/S0005-1098(03)00141-9; Nagpal KM, 1997, SIAM J CONTROL OPTIM, V35, P1217, DOI 10.1137/S0363012994277499; Pritchard AJ, 1985, IMA J MATH CONTROL I, V2, P335, DOI 10.1093/imamci/2.4.335; PRITCHARD AJ, 1987, SIAM J CONTROL OPTIM, V25, P121, DOI 10.1137/0325009; Sasane AJ, 2002, INTEGR EQUAT OPER TH, V43, P356, DOI 10.1007/BF01255569; Sasane AJ, 2001, INTEGR EQUAT OPER TH, V39, P98, DOI 10.1007/BF01192150; Tadmor G, 2005, IEEE T AUTOMAT CONTR, V50, P19, DOI 10.1109/TAC.2004.840460; Tadmor G, 2000, IEEE T AUTOMAT CONTR, V45, P382, DOI 10.1109/9.847719; van Keulen B., 1993, H CONTROL DISTRIBUTE; ZHOU K, 1987, SYST CONTROL LETT, V8, P307, DOI 10.1016/0167-6911(87)90096-X; Zhou K., 1996, ROBUST OPTIMAL CONTR	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9286	1558-2523		IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	FEB	2015	60	2					404	419		10.1109/TAC.2014.2354911		16	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AZ7DP	WOS:000348379000009		
J	Tomida, N; Tanaka, T; Ono, S; Yamagishi, M; Higashi, H				Tomida, Naoki; Tanaka, Toshihisa; Ono, Shunsuke; Yamagishi, Masao; Higashi, Hiroshi			Active Data Selection for Motor Imagery EEG Classification	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Brain-machine interfaces; electroencephalography (EEG); l(1)-norm; motor imagery; sparsity-aware signal processing	BRAIN-COMPUTER INTERFACE; SINGLE-TRIAL EEG; SPATIAL-PATTERNS; FILTERS; MOVEMENT; SIGNAL; COMMUNICATION	Rejecting or selecting data from multiple trials of electroencephalography (EEG) recordings is crucial. We propose a sparsity-aware method to data selection from a set of multiple EEG recordings during motor-imagery tasks, aiming at brain machine interfaces (BMIs). Instead of empirical averaging over sample co-variance matrices for multiple trials including low-quality data, which can lead to poor performance in BMI classification, we introduce weighted averaging with weight coefficients that can reject such trials. The weight coefficients are determined by the l(1)-minimization problem that lead to sparse weights such that almost zero-values are allocated to low-quality trials. The proposed method was successfully applied for estimating co-variance matrices for the so-called common spatial pattern (CSP) method, which is widely used for feature extraction from EEG in the two-class classification. Classification of EEG signals during motor imagery was examined to support the proposed method. It should be noted that the proposed data selection method can be applied to a number of variants of the original CSP method.	[Tomida, Naoki; Ono, Shunsuke; Yamagishi, Masao] Tokyo Inst Technol, Dept Commu & Comp Engn, Tokyo 1528550, Japan; [Tanaka, Toshihisa] Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Tokyo 1848588, Japan; [Tanaka, Toshihisa; Higashi, Hiroshi] RIKEN, Brain Sci Inst, Saitama 3510198, Japan; [Higashi, Hiroshi] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi 4418580, Japan	Tanaka, T (reprint author), Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Tokyo 1848588, Japan.	tomida@sp.ce.titech.ac.jp; tanakat@cc.tuat.ac.jp; ono@sp.ce.titech.ac.jp; myamagi@sp.ce.titech.ac.jp; higashi@tut.jp			JSPS KAKENHI [24360146]	This work was supported in part by JSPS KAKENHI Grant 24360146. Asterisk indicates corresponding author.	Ang K. K., 2013, J COMPUTING SCI ENG, V7, P139, DOI DOI 10.5626/JCSE.2013.7.2.139; Yuan H, 2014, IEEE T BIO-MED ENG, V61, P1425, DOI 10.1109/TBME.2014.2312397; Tomioka R, 2010, NEUROIMAGE, V49, P415, DOI 10.1016/j.neuroimage.2009.07.045; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Higashi H, 2013, IEEE T BIO-MED ENG, V60, P1100, DOI 10.1109/TBME.2012.2215960; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI [10.1109/MSP.2008.4408441, 10.1109/MSP.200790.900,9]; McFarland DJ, 2008, COMPUTER, V41, P52, DOI 10.1109/MC.2008.409; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Ang KK, 2010, IEEE ENG MED BIO, P5549; Wang HX, 2012, IEEE T BIO-MED ENG, V59, P653, DOI 10.1109/TBME.2011.2177523; McFarland DJ, 2011, COMMUN ACM, V54, P60, DOI 10.1145/1941487.1941506; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Wu W, 2008, IEEE T BIO-MED ENG, V55, P1733, DOI 10.1109/TBME.2008.919125; Ang KK, 2008, IEEE IJCNN, P2390; BARTZ D, 2013, P ADV NEURAL INFORM, V26, P1869; Bauschke HH, 2011, CMS BOOKS MATH, P1, DOI 10.1007/978-1-4419-9467-7; Bishop C. M., 2006, PATTERN RECOGNITION; Boyd S., 2011, FDN TRENDS MACH LEAR, V3, P1, DOI DOI 10.1561/2200000016; DINI DH, 2013, P 10 INT S WIR COMM, P1; Dornhege G., 2007, BRAIN COMPUTER INTER; Duchi J. C., 2008, INT C MACH LERANING, V307, P272; ECKSTEIN J, 1992, MATH PROGRAM, V55, P293, DOI 10.1007/BF01581204; GABAY D, 1976, COMPUT MATH APPL, V2, P19; He B., 2013, NEURAL ENG, P87; Higashi H, 2013, COMPUT INTEL NEUROSC, DOI 10.1155/2013/537218; Liu Y, 2014, J NEUROSCI METH, V222, P238, DOI 10.1016/j.jneumeth.2013.11.009; Maronna R. A., 2006, WILEY SERIES PROBABI; Park C, 2014, IEEE T NEUR SYS REH, V22, P1, DOI 10.1109/TNSRE.2013.2294903; Prasad G., 2009, P 4 IEEE EMB C NEUR, P258; Samek W., 2013, IEEE REV BIOMED ENG, V7, P50; Sanei S, 2013, ADAPTIVE PROCESSING OF BRAIN SIGNALS, P1, DOI 10.1002/9781118622162; Tomida N, 2013, INT CONF ACOUST SPEE, P983, DOI 10.1109/ICASSP.2013.6637796; TOMIDA N, 2014, P IEEE 36 ANN INT C, P668; Tomioka R, 2006, SPECTRALLY WEIGHTED; Yong XY, 2008, IEEE ENG MED BIO, P2087; Zhang C., 2012, P 2012 INT JOINT C N, P1; Ziehe A., 2004, J MACH LEARN RES, V5, P801	43	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	FEB	2015	62	2					458	467		10.1109/TBME.2014.2358536		10	Engineering, Biomedical	Engineering	AZ5ZK	WOS:000348297000008		
J	Shenai, K; Bakowski, M; Ohtani, N				Shenai, Krishna; Bakowski, Mietek; Ohtani, Noboru			Special Issue on Wide Bandgap Power Switching Devices for Energy Efficiency and Renewable Energy Integration Foreword	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Editorial Material									[Shenai, Krishna] Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL USA; [Shenai, Krishna] Amer Phys Soc, College Pk, MD USA; [Shenai, Krishna] Amer Assoc Advancement Sci, Washington, DC USA; [Bakowski, Mietek] ABB Corp Res Ctr, Vasteras, Sweden; [Bakowski, Mietek] Acreo Swedish ICT AB, Kista, Sweden; [Ohtani, Noboru] Nippon Steel Corp Ltd, Adv Technol Res Labs, Tokyo, Japan; [Ohtani, Noboru] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan	Shenai, K (reprint author), Lopel Corp, Naperville, IL 60540 USA.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					245	247		10.1109/TED.2014.2383351		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100001		
J	Tanimoto, S; Matsui, K				Tanimoto, Satoshi; Matsui, Kohei			High Junction Temperature and Low Parasitic Inductance Power Module Technology for Compact Power Conversion Systems	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Electronics packaging; GaN; inverters; power module; semiconductor power devices; SiC	ELECTRONICS; RANGE; RELIABILITY; DEVICES; PERFORMANCE; INVERTER; WIRE	Advanced power module technology capable of taking advantage of the superior features of next-generation power devices, such as those fabricated with SiC and GaN, must be developed to create much more compact and cost-effective power conversion systems. New power modules based on such technology are especially required to allow fast switching of power devices in the extended junction temperature range. This paper describes the major technical challenges involved in sufficiently improving the thermal stress reliability of the critical package systems in SiC power modules and in markedly reducing internal parasitic inductance. Thermal stress reliabilities of the die attachment system, wire bonding system, and encapsulant system are successfully improved, all of which are shown to be able to achieve common life targets: 1) 3000 h for a storage test at 250 degrees C and 2) 3000 cycles for thermal cycling between -40 degrees C and 250 degrees C. A novel phase-leg power module capable of substantially reducing the loop inductance along the principal current tracks is proposed and fabricated by applying SiC-JFETs, SiC-Schottky barrier diodes, and the abovementioned reliable thermal stress package systems. Double pulse switching testing of the module reveals smaller drain-source voltage spikes and ringing even in turn-ON and turn-OFF transients at very high slew rates of current and voltage. Finally, a 0.34 L forced-air-cooled dc 600 V input ac 50 Hz 400 V 25 kW output three-phase SiC inverter is fabricated using three-phase leg modules and its operation is demonstrated at high-power levels.	[Tanimoto, Satoshi] Nissan Motor Co Ltd, Nissan Res Ctr, Elect Vehicle Syst Lab, Yokosuka, Kanagawa 2208686, Japan; [Tanimoto, Satoshi] Shibaura Inst Technol, Green Innovat Res Ctr, Koto 1358548, Japan; [Matsui, Kohei] Fuji Elect Co Ltd, Corp Res & Dept, Shinagawa 1410032, Japan	Tanimoto, S (reprint author), Nissan Motor Co Ltd, Nissan Res Ctr, Elect Vehicle Syst Lab, Yokosuka, Kanagawa 2208686, Japan.	s-tanimoto@mail.nissan.co.jp; matsui-kouhei@fujielectric.co.jp			Green IT Project through the New Energy and Industrial Technology Development Organization, Kawasaki, Japan; Research and Department Partnership through the Future Power Electronics Technology, Minato, Japan	This work was supported in part by the Green IT Project through the New Energy and Industrial Technology Development Organization, Kawasaki, Japan, and in part by the Research and Department Partnership through the Future Power Electronics Technology, Minato, Japan. The review of this paper was arranged by Editor M. Bakowski.	Agyakwa PA, 2011, MICROELECTRON RELIAB, V51, P406, DOI 10.1016/j.microrel.2010.08.018; Chen Z, 2014, IEEE T POWER ELECTR, V29, P2307, DOI 10.1109/TPEL.2013.2283245; Neudeck PG, 2002, P IEEE, V90, P1065, DOI 10.1109/JPROC.2002.1021571; [Anonymous], 6074922 IEC; Kelley R, 2010, APPL POWER ELECT CO, P1838, DOI 10.1109/APEC.2010.5433483; [Anonymous], SIL CARB ENH MOD JUN, P1; Katsis DC, 2008, IEEE POWER ELECTRON, P290, DOI 10.1109/PESC.2008.4591943; [Anonymous], 6074919 IEC; Bayerer R., 2011, U.S. Patent, Patent No. [0 216 561, 0216561]; Bayerer R., 1990, EP Patent, Patent No. [0 427 143, 0427143]; Bayerer R, 2014, PROC INT SYMP POWER, P438, DOI 10.1109/ISPSD.2014.6856070; Beckedahl P., 2014, P 8 INT C INT POW SY, P1; Black AG, 2007, IEEE POWER ELECTRON, P981, DOI 10.1109/PESC.2007.4342122; Castellazzi A., 2010, P INT POW EL C SAPP, P528; CHEN Z, 2010, P INT POW EL C IPEC, P164; Clavel E., 2009, P EL SEM DEV, P317, DOI 10.1002/9780470611494.ch6; Friedrichs P, 2006, MICROELECTRON ENG, V83, P181, DOI 10.1016/j.mee.2005.10.049; Gobrecht J., 1988, U.S. Patent, Patent No. [4 766 481, 4766481]; Hamada K, 2008, PHYS STATUS SOLIDI B, V245, P1223, DOI 10.1002/pssb.200844079; Hashino S., 2010, P 14 INT POW EL MOT, pT9; Hoene E., 2013, P POW CONV INT MOT P, P1; Hornberger J, 2004, AEROSP CONF PROC, P2538; Izumi T, 2013, MATER SCI FORUM, V740-742, P669, DOI 10.4028/www.scientific.net/MSF.740-742.669; Kurosu T., 2010, POW EL C IPEC SAPP J, P2115; Liang Z., 2008, P IEEE MIL COMM C MI, P1; Lutz J, 2011, SEMICONDUCTOR POWER DEVICES: PHYSICS, CHARACTERISTICS, RELIABILITY, P343, DOI 10.1007/978-3-642-11125-9_11; Matsui K., 2013, P IEEJ GEN TECH M NA, V4, P252; Matsui K, 2012, MATER SCI FORUM, V717-720, P1233, DOI 10.4028/www.scientific.net/MSF.717-720.1233; McCluskey FP, 2006, MICROELECTRON RELIAB, V46, P1910, DOI 10.1016/j.microrel.2006.07.090; Morozumi A, 2013, PROC INT SYMP POWER, P109, DOI 10.1109/ISPSD.2013.6694408; PALMER DW, 1978, IEEE T COMPON HYBR, V1, P333, DOI 10.1109/TCHMT.1978.1135312; Reinhardt KC, 1996, PROC IECEC, P127, DOI 10.1109/IECEC.1996.552858; Ritenour A, 2010, MATER SCI FORUM, V645-648, P937, DOI 10.4028/www.scientific.net/MSF.645-648.937; Sato S, 2011, MATER SCI FORUM, V679-680, P738, DOI 10.4028/www.scientific.net/MSF.679-680.738; Scofield J. D., 2010, P IMAPS INT C HIGH T, P289; Shen YQ, 2006, P IEEE S IND EL, V2, P847; Stockmeier T., 1200, P PCIM HONG KONG OCT, P1; Tanimoto S., 2010, P IMAPS INT C EXH HI, P32; Tanimoto S, 2013, MATER SCI FORUM, V740-742, P1040, DOI 10.4028/www.scientific.net/MSF.740-742.1040; Tanimoto S., 2012, P 18 S MICR ASS TECH, P107; Tanimoto S, 2013, ECS TRANSACTIONS, V58, P33, DOI 10.1149/05804.0033ecst; Tanimoto Satoshi, 2013, Journal of Microelectronics and Electronic Packaging, V10, DOI 10.4071/imaps.373; Tanisawa H., SANKEN TECH REP, V45, P9; Tanisawa S., 2013, J SMART PROCESS, V2, P152; Vogel K., 2012, P POW CONV INT MOT P, P238; Xiao Y, 2004, APPL POWER ELECT CO, P516; Xu F, 2011, 2011 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P2405; Yamada Y, 2007, MICROELECTRON RELIAB, V47, P2147, DOI 10.1016/j.microrel.2007.07.102; Yao YY, 2012, IEEE T COMP PACK MAN, V2, P539, DOI 10.1109/TCPMT.2011.2173344	49	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					258	269		10.1109/TED.2014.2359978		12	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100003		
J	Hamada, K; Nagao, M; Ajioka, M; Kawai, F				Hamada, Kimimori; Nagao, Masaru; Ajioka, Masaki; Kawai, Fumiaki			SiC-Emerging Power Device Technology for Next-Generation Electrically Powered Environmentally Friendly Vehicles	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Electric vehicles (EVs); hybrid vehicles (HVs); junction barrier Schottky (JBS) diode; MOSFETs; power electronics circuit; power semiconductor devices; semiconductor growth; silicon carbide (SiC)	BANDGAP SEMICONDUCTOR-DEVICES; FUTURE-PROSPECTS; SINGLE-CRYSTALS; LEAKAGE CURRENT; JBS DIODES; EXPECTATIONS; ELECTRONICS; VOLTAGE; IMPACT	The automotive industry is developing a range of electrically powered environmentally friendly vehicles such as hybrid vehicles (HVs), plug-in hybrid vehicles, full electric vehicles, and fuel cell vehicles to help reduce tailpipe CO2 emissions and achieve energy diversification. HVs are regarded as one of the most practical types of environmentally friendly vehicle and have already been widely accepted in the market. Toyota Motor Corporation has positioned HV systems as a core technology that can be applied to all next-generation electrically powered environmentally friendly vehicles and is currently working to enhance the performance of HV system components. Because of its low loss and high-temperature operation properties, silicon carbide (SiC) is regarded as a highly promising material for power semiconductor devices to help reduce the size and weight of the power control unit, one of the key components of a HV system. Wide-ranging activities are under way to meet the challenges of adopting SiC in an automotive environment, such as the development of crystal growth technologies, device structures, process technologies, defect analysis, and application to on-board systems. This paper describes the current situation and future prospects for on-board SiC power devices and the development of SiC-based technologies.	[Hamada, Kimimori; Nagao, Masaru; Ajioka, Masaki; Kawai, Fumiaki] Toyota Motor Co Ltd, Toyota 4700309, Japan	Hamada, K (reprint author), Toyota Motor Co Ltd, Toyota 4700309, Japan.	kimimori_hamada@mail.toyota.co.jp; masaru_nagao@mail.toyota.co.jp; masaki_ajioka@mail.toyota.co.jp; fumiaki_kawai@mail.toyota.co.jp					Fujiwara H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4718527; [Anonymous], 2014, TOYOTA GLOBAL NEWSRO; Nakamura D, 2004, NATURE, V430, P1009, DOI 10.1038/nature02810; Hatakeyama T, 2002, MATER SCI FORUM, V389-3, P1169; Banzhaf C. T., 2012, MATER SCI FORUM, V740-742, P691; Brosselard P, 2009, MATER SCI FORUM, V600-603, P935, DOI 10.4028/www.scientific.net/MSF.600-603.935; Dolny GM, 2009, MATER SCI FORUM, V615-617, P667; Fujibayashi H., 2013, INT C SIL CARB REL M, P108; Fujiwara H, 2012, MATER SCI FORUM, V717-720, P911, DOI 10.4028/www.scientific.net/MSF.717-720.911; Fujiwara H., 2012, APPL PHYS LETT, V101; Hamada K, 2009, MATER SCI FORUM, V600-603, P889, DOI 10.4028/www.scientific.net/MSF.600-603.889; Hamada K, 2008, PHYS STATUS SOLIDI B, V245, P1223, DOI 10.1002/pssb.200844079; Hirokazu F., 2011, MATER SCI FORUM, V679-680, P694; Ishikawa T., 2011, P INT S ECOTOPIA SCI, P306; Ito M., 2013, 15 INT C SIL CARB RE, P302; Kagawa Y., 2013, MATER SCI FORUM, V778-780, P919; Katsuno T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597413; Nakamura D, 2007, J CRYST GROWTH, V304, P57, DOI 10.1016/j.jcrysgro.2007.02.002; Nakamura T., 2011, IEDM, P599; Takaya H, 2013, PROC INT SYMP POWER, P43, DOI 10.1109/ISPSD.2013.6694394; Urakami Y, 2012, MATER SCI FORUM, V717-720, P9, DOI 10.4028/www.scientific.net/MSF.717-720.9; Wada K, 2014, PROC INT SYMP POWER, P225, DOI 10.1109/ISPSD.2014.6856017; Yamamoto T, 2009, MATER SCI FORUM, V600-603, P939, DOI 10.4028/www.scientific.net/MSF.600-603.939	23	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					278	285		10.1109/TED.2014.2359240		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100005		
J	Nakazawa, S; Okuda, T; Suda, J; Nakamura, T; Kimoto, T				Nakazawa, Seiya; Okuda, Takafumi; Suda, Jun; Nakamura, Takashi; Kimoto, Tsunenobu			Interface Properties of 4H-SiC (11(2)over-bar0) and (1(1)over-bar00) MOS Structures Annealed in NO	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Channel mobility; fast interface states; interface state density; nonpolar face; silicon carbide	INVERSION CHANNEL MOBILITY; SIC/SIO2 INTERFACE; ELECTRON-TRANSPORT; EPITAXIAL-GROWTH; CONDUCTION-BAND; NITRIC-OXIDE; MOSFETS; FACE; DENSITY; DEVICES	Interface properties of 4H-SiC (11 (2) over bar0) and (1 (1) over bar 00) metal-oxide-semiconductor (MOS) structures annealed in nitric oxide are characterized by conductance, high-low, and C-psi s methods. Compared with 4H-SiC (0001) MOS structures, generation of very fast interface states by nitridation is much smaller in 4H-SiC (11 (2) over bar0) and (1 (1) over bar 00). The effective mobility of planar MOSFETs fabricated on Al+-implanted p-body doped to 1x10(17) cm(-3) is 103 cm(2)/Vs on (1 (1) over bar 00), 92 cm(2)/Vs on (11 (2) over bar0), and 20 cm(2)/Vs on (0001). The mobility-limiting factors are discussed on the basis of experimental results. The high channel mobilities for (11 (2) over bar0) and (1 (1) over bar 00) MOSFETs can be correlated with the lower density of fast interface states generated by nitridation.	[Nakazawa, Seiya; Okuda, Takafumi; Suda, Jun; Kimoto, Tsunenobu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan; [Nakamura, Takashi] ROHM Co Ltd, Power Elect Res & Dev Div, Kyoto 6158585, Japan	Nakazawa, S (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan.	nakazawa@semicon.kuee.kyoto-u.ac.jp; okuda@semicon.kuee.kyoto-u.ac.jp; suda@kuee.kyoto-u.ac.jp; takashi.nakamura@dsn.rohm.co.jp; kimoto@kuee.kyoto-u.ac.jp			Super Cluster Program through the Japan Science and Technology Agency	This work was supported by the Super Cluster Program through the Japan Science and Technology Agency. The review of this paper was arranged by Editor M. Bakowski.	Afanas'ev VV, 1997, PHYS STATUS SOLIDI A, V162, P321, DOI 10.1002/1521-396X(199707)162:1<321::AID-PSSA321>3.0.CO;2-F; Penumatcha AV, 2013, IEEE T ELECTRON DEV, V60, P923, DOI 10.1109/TED.2013.2237777; Lelis AJ, 2008, IEEE T ELECTRON DEV, V55, P1835, DOI 10.1109/TED.2008.926672; Noborio M, 2009, PHYS STATUS SOLIDI A, V206, P2374, DOI 10.1002/pssa.200925247; Tan J, 1998, IEEE ELECTR DEVICE L, V19, P487, DOI 10.1109/55.735755; Tilak V, 2009, PHYS STATUS SOLIDI A, V206, P2391, DOI 10.1002/pssa.200925164; Endo T, 2009, MATER SCI FORUM, V600-603, P691, DOI 10.4028/www.scientific.net/MSF.600-603.691; Chung GY, 2001, IEEE ELECTR DEVICE L, V22, P176, DOI 10.1109/55.915604; Noborio M, 2009, IEEE T ELECTRON DEV, V56, P1953, DOI 10.1109/TED.2009.2025909; Cooper JA, 2002, IEEE T ELECTRON DEV, V49, P658, DOI 10.1109/16.992876; Cooper JA, 1997, PHYS STATUS SOLIDI A, V162, P305, DOI 10.1002/1521-396X(199707)162:1<305::AID-PSSA305>3.0.CO;2-7; BHATNAGAR M, 1993, IEEE T ELECTRON DEV, V40, P645, DOI 10.1109/16.199372; Yano H, 1999, IEEE ELECTR DEVICE L, V20, P611, DOI 10.1109/55.806101; Kimoto T, 2005, JPN J APPL PHYS 1, V44, P1213, DOI 10.1143/JJAP.44.1213; Chow TP, 2009, PHYS STATUS SOLIDI A, V206, P2478, DOI 10.1002/pssa.200925125; Dhar S, 2004, APPL PHYS LETT, V84, P1498, DOI 10.1063/1.1651325; Negoro Y, 2004, J APPL PHYS, V96, P224, DOI 10.1063/1.1756213; Dimitrijev S, 1997, IEEE ELECTR DEVICE L, V18, P175, DOI 10.1109/55.568752; Das MK, 2000, MATER SCI FORUM, V338-3, P1069; Saks NS, 2004, ADV TEXTS PHYS, P387; Kimoto T, 2010, S VLSI TECH, P9, DOI 10.1109/VLSIT.2010.5556137; Kimoto T, 1997, PHYS STATUS SOLIDI B, V202, P247, DOI 10.1002/1521-3951(199707)202:1<247::AID-PSSB247>3.0.CO;2-Q; Chen X. D., 2008, J APPL PHYS, V103; Dhar S., 2010, J APPL PHYS, V108; Kimoto T, 2000, MATER SCI FORUM, V338-3, P189; Kimoto T., 2014, FUNDAMENTALS OF SILI; Nakamura T., 2011, P IEDM DEC; Nicollian E. H., 1982, MOS PHYSICS AND TECH; Ouisse T, 1997, PHYS STATUS SOLIDI A, V162, P339, DOI 10.1002/1521-396X(199707)162:1<339::AID-PSSA339>3.0.CO;2-G; Senzaki J, 2002, IEEE ELECTR DEVICE L, V23, P13, DOI 10.1109/55.974797; Yano H., 2007, APPL PHYS LETT, V90; Yoshioka H., 2014, APPL PHYS LETT, V104; Yoshioka H., 2012, J APPL PHYS, V112; Yoshioka H., 2012, J APPL PHYS, V111	34	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					309	315		10.1109/TED.2014.2352117		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100009		
J	Yano, H; Kanafuji, N; Osawa, A; Hatayama, T; Fuyuki, T				Yano, Hiroshi; Kanafuji, Natsuko; Osawa, Ai; Hatayama, Tomoaki; Fuyuki, Takashi			Threshold Voltage Instability in 4H-SiC MOSFETs With Phosphorus-Doped and Nitrided Gate Oxides	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						4H-SiC MOSFETs; bias-temperature stress; near-interface trap (NIT); NO annealing; oxide trap; phosphorus-doped oxide; POCl3 annealing; threshold voltage instability	DEFECT CENTERS; FILMS; RELIABILITY; INTERFACE; TEMPERATURE; ELECTRON; MOBILITY; SIO2; DEPENDENCE; SILICON	Threshold voltage instability was investigated for 4H-SiC MOSFETs with phosphorus-doped (POCl3-annealed) and nitrided (NO-annealed) gate oxides. Threshold voltage shift observed in the bidirectional drain current-gate voltage characteristics was evaluated using various gate voltage sweeps at room and elevated temperatures up to 200 degrees C. The threshold voltage shift was also studied after applying positive and negative bias-temperature stress. Two types of MOSFETs showed different instability characteristics, depending on gate biases and temperatures. These features were found to originate from the difference in trap density and trap location at/near the oxide/SiC interface and in the oxide. It is apparent that the oxide traps in phosphorus-doped oxides and near-interface traps in nitrided oxides are the main origin of the threshold voltage instability via capture and emission (in the case of oxide traps, only capture) of both electrons and holes.	[Yano, Hiroshi; Kanafuji, Natsuko; Osawa, Ai; Hatayama, Tomoaki; Fuyuki, Takashi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan	Yano, H (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	yano.hiroshi.fn@u.tsukuba.ac.jp; k-natsuko@ms.naist.jp; o-ai@ms.naist.jp; hatayama@ms.naist.jp; fuyuki@ms.naist.jp			Japan Society for the Promotion of Sciences through the Funding Program (FIRST Program) for World-Leading Innovation Research and Development on Science and Technology;  [23760283]	This work was supported in part by the Japan Society for the Promotion of Sciences through the Funding Program (FIRST Program) for World-Leading Innovation Research and Development on Science and Technology and in part by a Grant-in-Aid for Young Scientists (B) under Grant 23760283. The review of this paper was arranged by Editor M. Bakowski.	Agarwal AK, 1997, IEEE ELECTR DEVICE L, V18, P592, DOI 10.1109/55.644081; Akagi T., 2012, MATER SCI FORUM, V740-742, P695; Andreev V. V., 1997, Russian Microelectronics, V26; Afanas'ev VV, 1997, PHYS STATUS SOLIDI A, V162, P321, DOI 10.1002/1521-396X(199707)162:1<321::AID-PSSA321>3.0.CO;2-F; Sharma YK, 2013, IEEE ELECTR DEVICE L, V34, P175, DOI 10.1109/LED.2012.2232900; Lelis AJ, 2008, IEEE T ELECTRON DEV, V55, P1835, DOI 10.1109/TED.2008.926672; Lipkin LA, 2002, MATER SCI FORUM, V389-3, P985; Okamoto D, 2012, MATER SCI FORUM, V717-720, P733, DOI 10.4028/www.scientific.net/MSF.717-720.733; Rozen J, 2011, IEEE T ELECTRON DEV, V58, P3808, DOI 10.1109/TED.2011.2164800; Das MK, 2012, MATER SCI FORUM, V717-720, P1073, DOI 10.4028/www.scientific.net/MSF.717-720.1073; Chung GY, 2001, IEEE ELECTR DEVICE L, V22, P176, DOI 10.1109/55.915604; Green R, 2012, MATER SCI FORUM, V717-720, P1085, DOI 10.4028/www.scientific.net/MSF.717-720.1085; Yano H, 2013, MATER SCI FORUM, V740-742, P727, DOI 10.4028/www.scientific.net/MSF.740-742.727; Lu CY, 2003, IEEE T ELECTRON DEV, V50, P1582, DOI 10.1109/TED.2003.814974; GRISCOM DL, 1983, J APPL PHYS, V54, P3743, DOI 10.1063/1.332591; Yano H, 2012, ECS TRANSACTIONS, V50, P257, DOI 10.1149/05003.0257ecst; Negoro Y, 2004, J APPL PHYS, V96, P224, DOI 10.1063/1.1756213; Dimitrijev S, 1997, IEEE ELECTR DEVICE L, V18, P175, DOI 10.1109/55.568752; Okamoto D, 2010, IEEE ELECTR DEVICE L, V31, P710, DOI 10.1109/LED.2010.2047239; Bondarenko G. G., 1999, Russian Physics Journal, V42, DOI 10.1007/BF02508221; Fujihira K, 2004, IEEE ELECTR DEVICE L, V25, P734, DOI [10.1109/LED.2004.837533, 10.1109/led.2004.837533]; Lenahan PM, 1997, IEEE T NUCL SCI, V44, P1834, DOI 10.1109/23.658950; Li HF, 1998, IEEE ELECTR DEVICE L, V19, P279; Morishita R, 2012, MATER SCI FORUM, V717-720, P739, DOI 10.4028/www.scientific.net/MSF.717-720.739; Okamoto D., 2010, APPL PHYS LETT, V96; SNOW EH, 1965, J APPL PHYS, V36, P1664, DOI 10.1063/1.1703105; SNOW EH, 1966, J ELECTROCHEM SOC, V113, P263, DOI 10.1149/1.2423929; Spitz J, 1998, IEEE ELECTR DEVICE L, V19, P100, DOI 10.1109/55.663527; Warren WL, 1995, IEEE T NUCL SCI, V42, P1731, DOI 10.1109/23.488772; WARREN WL, 1995, APPL PHYS LETT, V67, P995, DOI 10.1063/1.114970; Yano H, 2011, MATER SCI FORUM, V679-680, P603, DOI 10.4028/www.scientific.net/MSF.679-680.603	31	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					324	332		10.1109/TED.2014.2358260		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100011		
J	Kaji, N; Niwa, H; Suda, J; Kimoto, T				Kaji, Naoki; Niwa, Hiroki; Suda, Jun; Kimoto, Tsunenobu			Ultrahigh- Voltage SiC p-i-n Diodes With Improved Forward Characteristics	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Carrier lifetime; junction termination extension (JTE); on-resistance; p-i-n diode; silicon carbide (SiC)	JUNCTION TERMINATION EXTENSION; 4H-SIC PIN DIODES; CARRIER LIFETIME; KV; RECTIFIERS; 4H; DEVICES	Silicon carbide (SiC) p-i-n diodes having five different n(-)-layer (i-layer) thicknesses from 48 to 268 mu m are fabricated. The forward characteristics of SiC p-i-n diodes are significantly improved by carrier-lifetime enhancement. After this improvement, the differential on-resistance is inversely proportional to the square root of current density for all the diodes with different thicknesses of n(-)-layer. As a result, the forward current density-voltage characteristics can be approximately expressed by a parabolic function, as in the case of Si p-i-n diodes. Using a 268-mu m-thick n(-)-layer, the lifetime enhancement, and an improved space-modulated junction termination extension structure, a very high blocking voltage over 26.9 kV and low differential on-resistance of 9.7 m Omega.cm(2) are achieved.	[Kaji, Naoki; Niwa, Hiroki; Suda, Jun; Kimoto, Tsunenobu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan	Kaji, N (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan.	kaji@semicon.kuee.kyoto-u.ac.jp; niwa@semicon.kuee.kyoto-u.ac.jp; suda@kuee.kyoto-u.ac.jp; kimoto@kuee.kyoto-u.ac.jp			FIRST Program through the Japan Society for the Promotion of Science, Japan	This work was supported by the FIRST Program through the Japan Society for the Promotion of Science, Japan. The review of this paper was arranged by Editor M. Bakowski.	Sung WJ, 2011, IEEE ELECTR DEVICE L, V32, P880, DOI 10.1109/LED.2011.2144561; Lipkin LA, 2002, MATER SCI FORUM, V389-3, P985; Hiyoshi T, 2008, IEEE T ELECTRON DEV, V55, P1841, DOI 10.1109/TED.2008.926643; Son NT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.187603; Miyake H, 2012, IEEE ELECTR DEVICE L, V33, P1598, DOI 10.1109/LED.2012.2215004; Feng G, 2012, IEEE T ELECTRON DEV, V59, P414, DOI 10.1109/TED.2011.2175486; Konstantinov AO, 1997, APPL PHYS LETT, V71, P90, DOI 10.1063/1.119478; Ryu SH, 2012, MATER SCI FORUM, V717-720, P1135, DOI 10.4028/www.scientific.net/MSF.717-720.1135; Nakayama K, 2012, IEEE T ELECTRON DEV, V59, P895, DOI 10.1109/TED.2011.2181516; Ivanov PA, 2006, SOLID STATE ELECTRON, V50, P1368, DOI 10.1016/j.sse.2006.06.018; Cooper JA, 2002, IEEE T ELECTRON DEV, V49, P658, DOI 10.1109/16.992876; BHATNAGAR M, 1993, IEEE T ELECTRON DEV, V40, P645, DOI 10.1109/16.199372; Sundaresan S, 2012, MATER SCI FORUM, V717-720, P949, DOI 10.4028/www.scientific.net/MSF.717-720.949; Galeckas A, 1997, APPL PHYS LETT, V71, P3269, DOI 10.1063/1.120309; Zhang QJ, 2012, MATER SCI FORUM, V717-720, P1151, DOI 10.4028/www.scientific.net/MSF.717-720.1151; Danno K., 2007, APPL PHYS LETT, V90; Fedison JB, 2001, IEEE ELECTR DEVICE L, V22, P130, DOI 10.1109/55.910619; Ghandhi S. K., 1977, SEMICONDUCTOR POWER; Hiyoshi T., 2009, APPL PHYS EXP, V2; Kaji N., 2013, JPN J APPL PHYS, V52; Kawahara K., 2009, J APPL PHYS, V106; Kawahara K., 2012, J APPL PHYS, V111; Kimoto T., 2014, FUNDAMENTALS SILICON; Koizumi A., 2009, J APPL PHYS, V106; Landsberg P. T., 1991, RECOMBINATION SEMICO; Lee HS, 2008, IEEE T ELECTRON DEV, V55, P1894, DOI 10.1109/TED.2008.926645; Luts J., 2011, SEMICONDUCTOR POWER; Niwa H., 2012, APPL PHYS EXP, V5; Persson C, 1999, J APPL PHYS, V86, P4419, DOI 10.1063/1.371380; Ryu SH, 2006, INT SYM POW SEMICOND, P265; SCHAFFER WJ, 1994, MATER RES SOC SYMP P, V339, P595; SCHLANGE.H, 1969, SOLID STATE ELECTRON, V12, P267, DOI 10.1016/0038-1101(69)90008-2; Singh R, 2002, IEEE T ELECTRON DEV, V49, P2308, DOI 10.1109/TED.2002.805576; Storasta L., 2007, APPL PHYS LETT, V90; Sugawara Y., 2001, Proceedings of the 13th International Symposium on Power Semiconductor Devices & ICs. IPSD '01 (IEEE Cat. No.01CH37216), DOI 10.1109/ISPSD.2001.934552; Sugawara Y., 2004, Proceedings of the 16th International Symposium on Power Semiconductor Devices & IC's; Wang J, 2009, IEE IND ELECTRON M, V3, P16, DOI 10.1109/MIE.2009.932583	37	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					374	381		10.1109/TED.2014.2352279		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100018		
J	Mikamura, Y; Hiratsuka, K; Tsuno, T; Michikoshi, H; Tanaka, S; Masuda, T; Wada, K; Horii, T; Genba, J; Hiyoshi, T; Sekiguchi, T				Mikamura, Yasuki; Hiratsuka, Kenji; Tsuno, Takashi; Michikoshi, Hisato; Tanaka, So; Masuda, Takeyoshi; Wada, Keiji; Horii, Taku; Genba, Jun; Hiyoshi, Toru; Sekiguchi, Takeshi			Novel Designed SiC Devices for High Power and High Efficiency Systems	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						(0-33-8) face; 4H-silicon carbide (SiC); buried p(+) region; channel mobility; field-limiting ring (FLR); junction FET (JFET); junction termination extension (JTE); MOSFET; V-groove trench	CHEMICAL-VAPOR-DEPOSITION; 4H-SIC MOSFETS; CHANNEL MOBILITY; FACE; TERMINATION; INTERFACE; VOLTAGE; GROWTH; DIODES	Two types of 4H-silicon carbide (SiC) MOSFETs are proposed in this paper. One is the novel designed V-groove trench MOSFET that utilizes the 4H-SiC (0-33-8) face for the channel region. The MOS interface using this face shows the extremely low interface state density (D-it) of 3 x 10(11)cm(-2) eV(-1), which causes the high channel mobility of 80 cm(2) V-1 s(-1) results in very low channel resistance. The buried p(+) regions located close to the trench bottom can effectively alleviate the electric field crowding without the significant sacrifice of the increase of the resistance. The low specific ON-state resistance of 3.5 m.cm(2) with sufficiently high blocking voltage of 1700 V is obtained. The other is the double implanted MOSFET with the carefully designed junction termination extension and field-limiting rings for the edge termination region, and the additional doping into the junction FET region. With a high-quality and high-uniformity epitaxial layer, 6 mm x 6 mm devices are fabricated. The well balanced specific ON-state resistance of 14.2 m.cm(2) and the blocking voltage of 3850 V are obtained for 3300 V application.	[Mikamura, Yasuki; Hiratsuka, Kenji; Tsuno, Takashi; Michikoshi, Hisato; Tanaka, So; Masuda, Takeyoshi; Wada, Keiji; Horii, Taku; Genba, Jun; Hiyoshi, Toru; Sekiguchi, Takeshi] Sumitomo Elect Ind Ltd, Power Device Div, Osaka 5410041, Japan	Mikamura, Y (reprint author), Sumitomo Elect Ind Ltd, Power Device Div, Osaka 5410041, Japan.	mikamura-yasuki@sei.co.jp; hir@sei.co.jp; tsuno-t@sei.co.jp; michikoshi-hisato@sei.co.jp; tanaka-so@sei.co.jp; takeyoshi@sei.co.jp; wada-keiji@sei.co.jp; horii-taku@sei.co.jp; genba@sei.co.jp; hiyoshi-tooru@sei.co.jp; sekiguchi-takeshi@sei.co.jp					Fukuda K, 2004, APPL PHYS LETT, V84, P2088, DOI 10.1063/1.1682680; Lipkin LA, 2002, MATER SCI FORUM, V389-3, P985; Hiyoshi T, 2008, IEEE T ELECTRON DEV, V55, P1841, DOI 10.1109/TED.2008.926643; Danno K, 2004, JPN J APPL PHYS 2, V43, pL969, DOI 10.1143/JJAP.43.L969; Chung GY, 2000, APPL PHYS LETT, V76, P1713, DOI 10.1063/1.126167; BHATNAGAR M, 1993, IEEE T ELECTRON DEV, V40, P645, DOI 10.1109/16.199372; Yano H, 1999, IEEE ELECTR DEVICE L, V20, P611, DOI 10.1109/55.806101; Niwa H, 2012, PROC INT SYMP POWER, P381, DOI 10.1109/ISPSD.2012.6229101; Niwa H, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.064001; Hori T, 2007, J CRYST GROWTH, V306, P297, DOI 10.1016/j.jcrysgro.2007.05.009; Okamoto D, 2010, IEEE ELECTR DEVICE L, V31, P710, DOI 10.1109/LED.2010.2047239; Fujisawa H., 2007, INT C SIL CARB REL M, pWe209; Hirao T, 2002, MATER SCI FORUM, V389-3, P1065; Hiyoshi T, 2013, MATER SCI FORUM, V740-742, P506, DOI 10.4028/www.scientific.net/MSF.740-742.506; Koketsu H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.051201; Masuda T, 2014, MATER SCI FORUM, V778-780, P907, DOI 10.4028/www.scientific.net/MSF.778-780.907; Onose H., 2000, P INT S POW SEM DEV, P245; Saitoh Y, 2014, MATER SCI FORUM, V778-780, P931, DOI 10.4028/www.scientific.net/MSF.778-780.931; Sheridan DC, 2000, SOLID STATE ELECTRON, V44, P1367, DOI 10.1016/S0038-1101(00)00081-2; Wada K, 2014, MATER SCI FORUM, V778-780, P915, DOI 10.4028/www.scientific.net/MSF.778-780.915	20	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					382	389		10.1109/TED.2014.2362537		8	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100019		
J	Imaizumi, M; Miura, N				Imaizumi, Masayuki; Miura, Naruhisa			Characteristics of 600, 1200, and 3300 V Planar SiC-MOSFETs for Energy Conversion Applications	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Body diode; planar MOSFET; power module; reverse bias safe operating area (RBSOA); silicon carbide (SiC); switching loss; threshold voltage	THRESHOLD VOLTAGE; KV	SiC-MOSFETs provide superior performance for next generation power electronics systems. High threshold voltage 600 V SiC-MOSFETs were realized utilizing a reoxidation process, which drastically improves a tradeoff between an ON-resistance and a threshold voltage. Low-loss SiC-MOSFETs with a 1200 V/100-A rating have been developed. Using the developed SiC-MOSFETs, 1200 V/800-A high-power full SiC module with an ON-resistance as low as 2.9 m Omega at 150 degrees C was successfully fabricated. The high-power module markedly reduces power loss especially at high carrier frequency. Large-area 3300 V SiC-MOSFETs with an ON-resistance of 52 m Omega at 175 degrees C exhibit an adequate reverse bias safe operating area and 3300 V SiC-MOSFETs screened by applying a body diode current stress show stable characteristics under a continuous current through their body diode for 1000 h.	[Imaizumi, Masayuki] Mitsubishi Electr Corp, Power Device Works, Fukuoka 8190192, Japan; [Miura, Naruhisa] Mitsubishi Electr Corp, Adv Technol Res & Dev Ctr, Amagasaki, Hyogo 6618661, Japan; [Miura, Naruhisa] Future Power Elect Technol, Minato 1050012, Japan	Imaizumi, M (reprint author), Mitsubishi Electr Corp, Power Device Works, Fukuoka 8190192, Japan.	imaizumi.masayuki@ah.mitsubishielectric.co.jp; miura.naruhisa@db.mitsubishielectric.co.jp			Ministry of Economy, Trade and Industry; New Energy and Industrial Technology Development Organization through the Project entitled Novel Semiconductor Power Electronics Project Realizing Low Carbon Emission Society through the	This work was supported in part by the Ministry of Economy, Trade and Industry, and in part by the New Energy and Industrial Technology Development Organization through the Project entitled Novel Semiconductor Power Electronics Project Realizing Low Carbon Emission Society through the Research and Development Partnership for Future Power Electronics Technology, Minato, Japan. The review of this paper was arranged by Editor M. Bakowski.	[Anonymous], 2011, MITSUBISHI ELECT LAU; [Anonymous], 2012, MITSUBISHI ELECT LAU; [Anonymous], 2011, CREE RELEASES SILICO; Tarui Y, 2006, MATER SCI FORUM, V527-529, P1285; Wood RA, 2011, IEEE T POWER ELECTR, V26, P2504, DOI 10.1109/TPEL.2011.2108670; [Anonymous], 2010, WORLDS 1 LOW ON RESI; Bolotnikov A, 2012, PROC INT SYMP POWER, P389, DOI 10.1109/ISPSD.2012.6229103; Furuhashi M, 2013, PROC INT SYMP POWER, P55, DOI 10.1109/ISPSD.2013.6694397; Furukawa A, 2011, PROC INT SYMP POWER, P288, DOI 10.1109/ISPSD.2011.5890847; Hamada K., 2013, JPN J APPL PHYS, V52; Imaizumi M, 2006, MATER SCI FORUM, V527-529, P1289; Imaizumi M., 2013, P IEEE IEDM DEC; Kimoto T, 2013, PROC EUR S-STATE DEV, P22, DOI 10.1109/ESSDERC.2013.6818812; Kono Hiroshi, 2014, Materials Science Forum, V778-780, DOI 10.4028/www.scientific.net/MSF.778-780.935; Miura N., 2006, P INT S POW SEM DEV, P1; Nakata S, 2009, MATER SCI FORUM, V615-617, P903, DOI 10.4028/www.scientific.net/MSF.615-617.903; Palmour JW, 2014, PROC INT SYMP POWER, P79, DOI 10.1109/ISPSD.2014.6855980; Senzaki J, 2014, MATER SCI FORUM, V778-780, P521, DOI 10.4028/www.scientific.net/MSF.778-780.521; Wada K, 2014, MATER SCI FORUM, V778-780, P915, DOI 10.4028/www.scientific.net/MSF.778-780.915; Yamamoto S, 2014, MATER SCI FORUM, V778-780, P951, DOI 10.4028/www.scientific.net/MSF.778-780.951	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					390	395		10.1109/TED.2014.2358581		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100020		
J	Fukuda, K; Okamoto, D; Okamoto, M; Deguchi, T; Mizushima, T; Takenaka, K; Fujisawa, H; Harada, S; Tanaka, Y; Yonezawa, Y; Kato, T; Katakami, S; Arai, M; Takei, M; Matsunaga, S; Takao, K; Shinohe, T; Izumi, T; Hayashi, T; Ogata, S; Asano, K; Okumura, H; Kimoto, T				Fukuda, Kenji; Okamoto, Dai; Okamoto, Mitsuo; Deguchi, Tadayoshi; Mizushima, Tomonori; Takenaka, Kensuke; Fujisawa, Hiroyuki; Harada, Shinsuke; Tanaka, Yasunori; Yonezawa, Yoshiyuki; Kato, Tomohisa; Katakami, Shuji; Arai, Manabu; Takei, Manabu; Matsunaga, Shinichiro; Takao, Kazuto; Shinohe, Takashi; Izumi, Toru; Hayashi, Toshihiko; Ogata, Syuuji; Asano, Katsunori; Okumura, Hajime; Kimoto, Tsunenobu			Development of Ultrahigh-Voltage SiC Devices	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						n-type insulated-gate bipolar transistors (IGBTs); p-i-n; p-type IGBTs; package technology; silicon carbide (SiC); switching test; ultrahigh voltage	4H-SIC PIN DIODES; HIGH-TEMPERATURE; IGBTS	Ultrahigh-voltage silicon carbide (SiC) devices [p-i-n diodes and insulated-gate bipolar transistors (IGBTs)] and switching test have been investigated. As a result, we have succeeded in developing a 13-kV p-i-n diode, 15-kV p-channel IGBT, and 16-kV flip-type n-channel implantation and epitaxial IGBT with a low differential specific on-resistance (R-diff,R-on). It was revealed that a power module fabricated using a nanotech resin, Si3N4 ceramic substrate, and W base plate was suitable for ultrahigh voltage and high temperature. A switching test was carried out using a clamped inductive load circuit, which indicated that the energy loss of a circuit with ultrahigh-voltage SiC devices is lower than that of Si devices.	[Fukuda, Kenji; Okamoto, Dai; Okamoto, Mitsuo; Deguchi, Tadayoshi; Mizushima, Tomonori; Takenaka, Kensuke; Fujisawa, Hiroyuki; Harada, Shinsuke; Tanaka, Yasunori; Yonezawa, Yoshiyuki; Kato, Tomohisa; Okumura, Hajime] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Katakami, Shuji; Arai, Manabu] New Japan Radio Co Ltd, Fujimino 3568510, Japan; [Takei, Manabu; Matsunaga, Shinichiro] Fuji Elect Co Ltd, Corp Res & Dev, Tokyo 1918502, Japan; [Takao, Kazuto; Shinohe, Takashi] Toshiba Co Ltd, Corp Res & Dev Ctr, Kawasaki, Kanagawa 2128582, Japan; [Izumi, Toru; Hayashi, Toshihiko; Ogata, Syuuji; Asano, Katsunori] Kansai Elect Power Co Inc, Power Engn Res & Dev Ctr, Amagasaki, Hyogo 6610974, Japan; [Kimoto, Tsunenobu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6068501, Japan	Fukuda, K (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	k-fukuda@aist.go.jp; dai.okamoto@aist.go.jp; mitsuo-okamoto@aist.go.jp; t-deguchi@aist.go.jp; mizushima-tomonori@aist.go.jp; takenaka-kensuke@aist.go.jp; h-fujisawa@aist.go.jp; s-harada@aist.go.jp; yasunori-tanaka@aist.go.jp; yoshiyuki-yonezawa@aist.go.jp; t-kato@aist.go.jp; s-katakami@aist.go.jp; marai@njr.co.jp; takei-manabu@fujielectric.co.jp; matsunaga-shinichiro@aist.go.jp; kazuto.takao@toshiba.co.jp; takashi.shinohe@toshiba.co.jp; izumi.toru@d5.kepco.co.jp; hayashi.toshihiko@b4.kepco.co.jp; ogata.shuuji@c4.kepco.co.jp; asano.katsunori@c2.kepco.co.jp; h-okumura@aist.go.jp; kimoto@kuee.kyoto-u.ac.jp			Japan Society for the Promotion of Science through the First Program entitled Funding Program for World-Leading Innovative Research and Development on Science and Technology; Joint Research Project, Tsukuba Power Electronics Constellations, Tsukuba, Japan	This work was supported by the Japan Society for the Promotion of Science through the First Program entitled Funding Program for World-Leading Innovative Research and Development on Science and Technology and in part by the Joint Research Project, Tsukuba Power Electronics Constellations, Tsukuba, Japan. The review of this paper was arranged by Editor M. Bakowski.	Sung WJ, 2011, IEEE ELECTR DEVICE L, V32, P880, DOI 10.1109/LED.2011.2144561; Katakami S, 2013, MATER SCI FORUM, V740-742, P958, DOI 10.4028/www.scientific.net/MSF.740-742.958; Wang XK, 2010, IEEE T ELECTRON DEV, V57, P511, DOI 10.1109/TED.2009.2037379; Cheng L, 2014, MATER SCI FORUM, V778-780, P1089, DOI 10.4028/www.scientific.net/MSF.778-780.1089; Sundaresan S, 2012, MATER SCI FORUM, V717-720, P949, DOI 10.4028/www.scientific.net/MSF.717-720.949; Deguchi Tadayoshi, 2014, Materials Science Forum, V778-780, DOI 10.4028/www.scientific.net/MSF.778-780.1038; Harada S., 2006, P IEEE IEDM, P903; Hayashi T, 2013, MATER SCI FORUM, V740-742, P1036, DOI 10.4028/www.scientific.net/MSF.740-742.1036; Izumi T, 2013, MATER SCI FORUM, V740-742, P669, DOI 10.4028/www.scientific.net/MSF.740-742.669; Kadavelugu A., 2014, P INT POW EL C HIR J, P3726; Niwa H., 2012, APPL PHYS EXP, V5; Okamoto D, 2013, MATER SCI FORUM, V740-742, P907, DOI 10.4028/www.scientific.net/MSF.740-742.907; Okamoto D, 2014, MATER SCI FORUM, V778-780, P855, DOI 10.4028/www.scientific.net/MSF.778-780.855; Ryu S, 2013, MATER SCI FORUM, V740-742, P954, DOI 10.4028/www.scientific.net/MSF.740-742.954; Sugawara Y., 2001, Proceedings of the 13th International Symposium on Power Semiconductor Devices & ICs. IPSD '01 (IEEE Cat. No.01CH37216), DOI 10.1109/ISPSD.2001.934552; Yonczawa Y., 2013, P INT EL DEV M WASH, P661	16	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					396	404		10.1109/TED.2014.2357812		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100021		
J	Kuzuhara, M; Tokuda, H				Kuzuhara, Masaaki; Tokuda, Hirokuni			Low-Loss and High-Voltage III-Nitride Transistors for Power Switching Applications	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Breakdown voltage; current collapse; field plate (FP); GaN; gate leakage; high-electron mobility transistor (HEMT); ON-resistance	HIGH BREAKDOWN VOLTAGE; FIELD-EFFECT TRANSISTORS; ELECTRON-MOBILITY TRANSISTORS; MOLECULAR-BEAM EPITAXY; ALGAN/GAN HETEROSTRUCTURES; CURRENT-COLLAPSE; CONTACT-RESISTANCE; MODULATING PLATE; SUPER-JUNCTION; OHMIC CONTACTS	This paper describes recent technological advances on III-nitride-based transistors for power switching applications. Focuses are placed on the progress toward enhancing the breakdown voltage, lowering the ON-resistance, suppressing current collapse, and reducing the leakage current in AlGaN/GaN high-electron mobility transistors (HEMTs). Recent publications revealed that the tradeoff relation between ON-resistance and breakdown voltage in AlGaN/GaN HEMTs exceeded the SiC limit and was getting close to the GaN limit; however, the breakdown voltage achieved was still lower than the theoretical impact ionization limit. A novel process featuring strain-controlled annealing with a metal stack, including Al gave rise to significant reduction in the sheet resistance in AlGaN/GaN heterostructures, suggesting the possibility of dramatic reduction in ON-resistance of GaN-based power devices. Some of the interesting approaches to suppress current collapse indicated that surface trapping effects must be controlled by the optimization of surface processing as well as by the reduction of bulk traps in the epitaxial layers. Close correlation between the local gate leakage current and point defects exposed on the free-standing GaN substrate demonstrated that further reduction of defects on bulk GaN substrates is truly required as future challenges.	[Kuzuhara, Masaaki; Tokuda, Hirokuni] Univ Fukui, Dept Elect & Elect Engn, Fukui 9108507, Japan	Kuzuhara, M (reprint author), Univ Fukui, Dept Elect & Elect Engn, Fukui 9108507, Japan.	kuzuhara@fuee.u-fukui.ac.jp; htokuda@u-fukui.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [25420328, 24560399]	This work was supported by a Grant-in-Aid of Basic Research (C) under Grant 25420328 and Grant 24560399 through the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The review of this paper was arranged by Editor M. Bakowski.	Ando Y, 2005, INT EL DEVICES MEET, P585; Chung JW, 2010, IEEE ELECTR DEVICE L, V31, P195, DOI 10.1109/LED.2009.2038935; Morita T, 2011, APPL POWER ELECT CO, P481, DOI 10.1109/APEC.2011.5744640; Suda J, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.101003; Redwing JM, 1996, APPL PHYS LETT, V69, P963, DOI 10.1063/1.117096; Dora Y, 2006, IEEE ELECTR DEVICE L, V27, P713, DOI 10.1109/LED.2006.881020; Van Hove M, 2012, IEEE ELECTR DEVICE L, V33, P667, DOI 10.1109/LED.2012.2188016; Faqir M, 2008, IEEE T DEVICE MAT RE, V8, P240, DOI 10.1109/TDMR.2008.922017; Tipirneni N, 2006, IEEE ELECTR DEVICE L, V27, P716, DOI 10.1109/LED.2006.881084; Im KS, 2010, IEEE ELECTR DEVICE L, V31, P192, DOI 10.1109/LED.2009.2039024; KHAN MA, 1993, APPL PHYS LETT, V63, P1214; Hsu L, 1997, PHYS REV B, V56, P1520, DOI 10.1103/PhysRevB.56.1520; Ishida H, 2008, IEEE ELECTR DEVICE L, V29, P1087, DOI 10.1109/LED.2008.2002753; Park BR, 2013, IEEE ELECTR DEVICE L, V34, P354, DOI 10.1109/LED.2012.2236678; Zhou Q, 2013, IEEE T ELECTRON DEV, V60, P1075, DOI 10.1109/TED.2013.2241439; Imade M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.075501; Lu B, 2010, IEEE ELECTR DEVICE L, V31, P951, DOI 10.1109/LED.2010.2052587; Okamoto Y, 2004, IEEE T MICROW THEORY, V52, P2536, DOI 10.1109/TMTT.2004.837159; Bisi D, 2013, IEEE T ELECTRON DEV, V60, P3166, DOI 10.1109/TED.2013.2279021; Wu YF, 2004, IEEE ELECTR DEVICE L, V25, P117, DOI 10.1109/LED.2003.822667; Kizilyalli IC, 2013, IEEE T ELECTRON DEV, V60, P3067, DOI 10.1109/TED.2013.2266664; Ando Y, 2003, IEEE ELECTR DEVICE L, V24, P289, DOI 10.1109/LED.2003.812532; Qiao D, 2002, APPL PHYS LETT, V80, P992, DOI 10.1063/1.1447591; Ikeda N, 2007, PHYS STATUS SOLIDI A, V204, P2028, DOI 10.1002/pssa.200674822; Choi W, 2014, IEEE ELECTR DEVICE L, V35, P175, DOI 10.1109/LED.2013.2293579; Kim H, 2003, IEEE ELECTR DEVICE L, V24, P421, DOI 10.1109/LED.2003.813375; Bahat-Treidel E, 2010, IEEE T ELECTRON DEV, V57, P3050, DOI 10.1109/TED.2010.2069566; Liu ZH, 2010, IEEE ELECTR DEVICE L, V31, P96, DOI 10.1109/LED.2009.2036135; Wang MJ, 2014, IEEE T ELECTRON DEV, V61, P2035, DOI 10.1109/TED.2014.2315994; Ibbetson JP, 2000, APPL PHYS LETT, V77, P250, DOI 10.1063/1.126940; Lee HS, 2011, IEEE ELECTR DEVICE L, V32, P623, DOI 10.1109/LED.2011.2114322; Vetury R, 2001, IEEE T ELECTRON DEV, V48, P560, DOI 10.1109/16.906451; Srivastava P, 2011, IEEE ELECTR DEVICE L, V32, P30, DOI 10.1109/LED.2010.2089493; Smorchkova IP, 1999, J APPL PHYS, V86, P4520, DOI 10.1063/1.371396; Gaska R, 1998, APPL PHYS LETT, V72, P707, DOI 10.1063/1.120852; Liu ZH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573794; Manfra MJ, 2004, APPL PHYS LETT, V85, P5394, DOI 10.1063/1.1824176; Sun M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.074202; Xing HL, 2004, IEEE ELECTR DEVICE L, V25, P161, DOI 10.1109/LED.2004.824845; Nanjo T, 2013, IEEE T ELECTRON DEV, V60, P1046, DOI 10.1109/TED.2012.2233742; Lee HS, 2012, IEEE ELECTR DEVICE L, V33, P982, DOI 10.1109/LED.2012.2196673; Ren F, 1998, APPL PHYS LETT, V73, P3893, DOI 10.1063/1.122927; Khan MA, 2000, IEEE ELECTR DEVICE L, V21, P63, DOI 10.1109/55.821668; Hasan MT, 2013, IEEE ELECTR DEVICE L, V34, P1379, DOI 10.1109/LED.2013.2280712; Azize M., 2010, J APPL PHYS, V108; Boutros K. S., 2009, IEDM, P161; Bright AN, 2001, J APPL PHYS, V89, P3143, DOI 10.1063/1.1347003; Chang CY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3168648; Choi YC, 2006, J VAC SCI TECHNOL B, V24, P2601, DOI 10.1116/1.2366542; Christy D, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026501; Dang XZ, 1999, APPL PHYS LETT, V74, P3890, DOI 10.1063/1.124214; Dasgupta S., 2011, IEEE ELECTR DEVICE L, V32, P33; Deguchi T., 2011, P TWHM, P67; Fehlberg TB, 2011, IEEE T ELECTRON DEV, V58, P2589, DOI 10.1109/TED.2011.2154333; Hasegawa R., 2011, P INT C SOL STAT DEV, P620; Hatano M, 2012, IEICE T ELECTRON, VE95C, P1332, DOI 10.1587/transele.E95.C.1332; Hatano M, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.044101; Higashiwaki M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079798; Jiang QM, 2013, IEEE ELECTR DEVICE L, V34, P357, DOI 10.1109/LED.2012.2236637; Kawaguchi G., 2014, ISCS MONTP FRANC MAY; Kawamura F, 2006, JPN J APPL PHYS 1, V45, P2528, DOI [10.1143/JJAP.45.2528, 10.1143/JJAP.45.25281]; Kojima T, 2013, PHYS STATUS SOLIDI C, V10, P1405, DOI 10.1002/pssc.201300221; Lee JG, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.066502; Lee KB, 2011, PRINCIPLES OF MICROELECTROMECHANICAL SYSTEMS, P32; Liu XK, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CF06; Liu XK, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.066501; Medjdoub F, 2010, IEEE ELECTR DEVICE L, V31, P111, DOI 10.1109/LED.2009.2037719; Mohammed FM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149968; Nakayama T, 2004, APPL PHYS LETT, V85, P3775, DOI 10.1063/1.1810210; Nassif-Khalil SG, 2003, IEEE T ELECTRON DEV, V50, P1385, DOI 10.1109/TED.2003.813460; Ochiai M, 2003, JPN J APPL PHYS 1, V42, P2278, DOI 10.1143/JJAP.42.2278; Ota K., 2009, IEDM, P153; Rai S, 2006, JPN J APPL PHYS 1, V45, P4985, DOI 10.1143/JJAP.45.4985; Russo S, 2007, IEEE T ELECTRON DEV, V54, P1071, DOI 10.1109/TED.2007.894614; Sakaida Y., 2014, CSMANTECH DENV CO US, P197; Shi JX, 2011, IEEE ELECTR DEVICE L, V32, P312, DOI 10.1109/LED.2010.2098839; Tang ZK, 2013, IEEE ELECTR DEVICE L, V34, P366, DOI 10.1109/LED.2012.2236638; Tokuda H, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.041001; Tokuda H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.121003; Tokuda H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4773511; Tokuda H., 2012, APPL PHYS LETT, V101; Vertiatchikh A, 2006, SOLID STATE ELECTRON, V50, P1425, DOI 10.1016/j.sse.2006.07.003; Visalli D, 2009, PHYS STATUS SOLIDI C, V6, pS988, DOI 10.1002/pssc.200880835; Visalli D, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C101; Yafune N, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.100202	85	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	FEB	2015	62	2					405	413		10.1109/TED.2014.2359055		9	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AZ7FZ	WOS:000348386100022		
J	Watanabe, S; Oohama, Y				Watanabe, Shun; Oohama, Yasutada			The Optimal Use of Rate-Limited Randomness in Broadcast Channels With Confidential Messages	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Broadcast channel; confidential messages; randomness constraint; stochastic encoder; superposition coding; wire-tap channel	INFORMATION; CAPACITY; RESOLVABILITY; COMMON	In coding schemes for the wire-tap channel or for broadcast channels with confidential messages, it is well-known that the sender needs to use stochastic encoding to avoid information about the transmitted confidential message from being leaked to an eavesdropper. In this paper, we investigate the tradeoff between the rate of random numbers needed to realize the stochastic encoding and the rates of common, private, and confidential messages. For the direct theorem, we use the superposition coding scheme for the wire-tap channel, recently proposed by Chia and El Gamal, and its strong security is proved. The matching converse theorem is also established. Our result clarifies that a combination of ordinary stochastic encoding and channel prefixing by channel simulation is suboptimal.	[Watanabe, Shun] Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima 7700855, Japan; [Oohama, Yasutada] Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan	Watanabe, S (reprint author), Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima 7700855, Japan.	shun-wata@is.tokushima-u.ac.jp; oohama@uec.ac.jp	Watanabe, Shun/G-3384-2015		 [2376033700];  [2336017202];  [2324607101]	This work was supported in part by the Grant-in-Aid for Young Scientists under Grant (B):2376033700, in part by the Grant-in-Aid for Scientific Research under Grant (B): 2336017202, and in part by the Grant-in-Aid for Scientific Research under Grant (A):2324607101. This paper was presented at the 2012 IEEE International Symposium on Information Theory.	Hayashi M, 2006, IEEE T INFORM THEORY, V52, P1562, DOI 10.1109/TIT.2006.871040; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Chia YK, 2012, IEEE T INFORM THEORY, V58, P2748, DOI 10.1109/TIT.2012.2184668; Marandi A, 2012, OPT EXPRESS, V20, P19322, DOI 10.1364/OE.20.019322; KORNER J, 1977, IEEE T INFORM THEORY, V23, P60, DOI 10.1109/TIT.1977.1055655; Devetak I, 2005, IEEE T INFORM THEORY, V51, P44, DOI 10.1109/TIT.2004.839515; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; Bloch MR, 2013, IEEE T INFORM THEORY, V59, P8077, DOI 10.1109/TIT.2013.2283722; WYNER AD, 1975, IEEE T INFORM THEORY, V21, P163, DOI 10.1109/TIT.1975.1055346; Hayashi M, 2011, IEEE T INFORM THEORY, V57, P3989, DOI 10.1109/TIT.2011.2110950; STEINBERG Y, 1994, IEEE T INFORM THEORY, V40, P634, DOI 10.1109/18.335877; WYNER AD, 1975, AT&T TECH J, V54, P1355; Bloch M. R., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283039; Cai N., 2004, Problems of Information Transmission, V40, DOI 10.1007/s11122-005-0002-x; Chou R. A., 2014, POLAR CODING BROADCA; Cover T. M., 2006, ELEMENTS INFORM THEO; Csiszar I., 1996, Problems of Information Transmission, V32; Gamal A. E., 2011, NETWORK INFORM THEOR; Han T.S., 2003, INFORM SPECTRUM METH; Hayashi M., 2012, QUANTUM WIRETAP CHAN; Hayashi M., 2012, SECURE MULTIPLEX COD; Kobayashi D., 2005, P IEEE INF THEOR WOR, P13; Korner J., 2011, INFORM THEORY CODING; Liang Y., 2009, INFORM THEORETIC SEC; MAURER UM, 1994, KLUW COMMUN, V276, P271; Nair C, 2010, IEEE T INFORM THEORY, V56, P4207, DOI 10.1109/TIT.2010.2054310; Oohama Y., 2009, CAPACITY RESULTS REA; Oohama Y., 2003, P IEEE INT S INF THE, P226; Ozel O., 2011, P IEEE INT S INF THE, P627	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	FEB	2015	61	2					983	995		10.1109/TIT.2014.2382096		13	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	AZ5ZY	WOS:000348298400021		
J	Noda, T				Noda, Taku			Application of Frequency-Partitioning Fitting to the Phase-Domain Frequency-Dependent Modeling of Overhead Transmission Lines	IEEE TRANSACTIONS ON POWER DELIVERY			English	Article						Electromagnetic transient analysis; frequency response; identification; power system modeling; power system simulation; power transmission lines	ELECTROMAGNETIC TRANSIENT SIMULATIONS; MULTIPHASE NETWORK EQUIVALENT; IDENTIFICATION; CABLES	This paper shows that a previously proposed linear-system identification method based on frequency partitioning and adaptive weighting can be successfully applied to the phase-domain frequency-dependent modeling of overhead transmission lines for electromagnetic transient simulations. As the framework of the phase-domain modeling, the universal line model is used, and the frequency responses of the characteristic admittance and propagation function matrices are realized by linear equivalents obtained by the identification method mentioned before, instead of the well-known Vector Fitting method. In this paper, numerical techniques to enhance the identification method for this phase-domain line modeling application are also presented. For validation, the proposed approach is applied to modeling an existing 500-kV double-circuit transmission line. The effectiveness of the numerical techniques for enhancements are shown through the modeling process, and transient waveforms obtained by the proposed approach are compared with those by the rigorous Laplace transform method and with a field-test result.	Cent Res Inst Elect Power Ind, Elect Power Engn Res Lab, Yokosuka, Kanagawa 2400196, Japan	Noda, T (reprint author), Cent Res Inst Elect Power Ind, Elect Power Engn Res Lab, Yokosuka, Kanagawa 2400196, Japan.	takunoda@ieee.org					AMETANI A, 1976, IEEE T POWER AP SYST, V95, P1545, DOI 10.1109/T-PAS.1976.32253; AMETANI A, 1973, INT J ELEC ENG EDUC, V10, P277; GUSTAVSEN B, 1995, IEEE T POWER DELIVER, V10, P1076, DOI 10.1109/61.400879; Gustavsen B, 2001, IEEE T POWER SYST, V16, P97, DOI 10.1109/59.910786; Noda T, 2005, IEEE T POWER DELIVER, V20, P1134, DOI 10.1109/TPWRD.2004.834347; MARTI JR, 1982, IEEE T POWER AP SYST, V101, P147, DOI 10.1109/TPAS.1982.317332; Morched A, 1999, IEEE T POWER DELIVER, V14, P1032, DOI 10.1109/61.772350; Noda T, 1997, IEEE T POWER DELIVER, V12, P1327, DOI 10.1109/61.637011; Noda T, 1996, IEEE T POWER DELIVER, V11, P401, DOI 10.1109/61.484040; ANGELIDIS G, 1995, IEEE T POWER DELIVER, V10, P941, DOI 10.1109/61.400835; Gustavsen B, 1999, IEEE T POWER DELIVER, V14, P1052, DOI 10.1109/61.772353; Noda T, 2007, IEEE T POWER DELIVER, V22, P1257, DOI 10.1109/TPWRD.2007.893382; WEDEPOHL LM, 1969, P I ELECTR ENG, V116, P1553; SEMLYEN A, 1975, IEEE T POWER AP SYST, VPA94, P561, DOI 10.1109/T-PAS.1975.31884; HAUER JF, 1981, IEEE T POWER AP SYST, V100, P4918, DOI 10.1109/TPAS.1981.316457; MartinezVelasco JA, 2010, POWER SYSTEM TRANSIENTS: PARAMETER DETERMINATION, P1; MEYER WS, 1974, IEEE T POWER AP SYST, VPA93, P1401, DOI 10.1109/TPAS.1974.293870; Nguyen HV, 1997, IEEE T POWER DELIVER, V12, P1335, DOI 10.1109/61.637012; Noda T, 2008, IEEJ T ELECTR ELECTR, V3, P549, DOI 10.1002/tee.20312; Noda T, 2009, IEEE T POWER DELIVER, V24, P390, DOI 10.1109/TPWRD.2008.923397; Noda T, 2003, IEEE T POWER DELIVER, V18, P1478, DOI 10.1109/TPWRD.2003.817802; Ono T., 1985, 121 CRIEPI; Wedepohl L.M., 1963, Proceedings of the Institution of Electrical Engineers, V110	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8977	1937-4208		IEEE T POWER DELIVER	IEEE Trans. Power Deliv.	FEB	2015	30	1					174	183		10.1109/TPWRD.2014.2329532		10	Engineering, Electrical & Electronic	Engineering	AZ7CE	WOS:000348375100020		
J	Janssen, ALJ; Dufournet, D; Ito, H; Shperling, B				Janssen, Anton L. J.; Dufournet, Denis; Ito, Hiroki; Shperling, Ben			Investigations on Requirements for UHV/EHV AC Switchgear by CIGRE Study Committee A3	IEEE TRANSACTIONS ON POWER DELIVERY			English	Article						High-speed ground or earthing switches (HSES); induced current switching; initial transient recovery voltage (ITRV); long-line faults (LLFs); switchgear; transformer-limited faults (TLFs); transient recovery voltage (TRV); ultra-high voltage (UHV) ac; unloaded line switching	SPEED GROUNDING SWITCHES	On request of IEC Technical Subcommittee 17A, CIGRE Study Committee A3 "High Voltage Equipment" investigated the requirements for ultra-high voltage ac switchgear, especially for parameters which cannot be extrapolated linearly from the corresponding equipment characteristics with lower-rated voltage, namely 800 kV. For circuit breakers, such aspects are the first pole-to-clear factor, the amplitude factor, the time to peak to define the transient recovery voltage envelope, the surge impedance of overhead lines, the damping and refraction of traveling waves, long-line faults, transformer-limited faults, initial transient recovery voltage, and the influence of shunt and series compensation. Disconnectors utilized for interrupting the bus transfer currents, bus charging currents and very fast transients, ground switches used for interrupting induced line currents, and high-speed ground or earthing switches have been studied as well. Based on these system and substation studies and simulations, recommendations have been provided to IEC SC 17A.	[Janssen, Anton L. J.] Liander, NL-6812 AH Arnhem, Netherlands; [Dufournet, Denis] Alstom Grid, F-69611 Villeurbanne, France; [Ito, Hiroki] Mitsubishi Electr Corp, Tokyo 1008310, Japan; [Shperling, Ben] New York Power Author, New York, NY 10601 USA	Janssen, ALJ (reprint author), Liander, NL-6812 AH Arnhem, Netherlands.	anton.janssen@alliander.com; denis.dufournet@alstom.com; ito.hiroki@aj.MitsubishiElectric.co.jp; ben.shperling@nypa.gov					[Anonymous], 2011, IEEE APPL GUID TRV A; [Anonymous], 2012, 6227110120 IEC; HASIBAR RM, 1981, IEEE T POWER AP SYST, V100, P1512, DOI 10.1109/TPAS.1981.316499; [Anonymous], 2013, 62271102 IEC; [Anonymous], 2012, 62271100 IEC; [Anonymous], 2011, 456 CIGRE WORK GROUP; [Anonymous], 2014, 570 CIGRE WORK GROUP; [Anonymous], 2013, 542 CIGRE WORK GROUP; [Anonymous], 2008, 362 CIGRE WORK GROUP; [Anonymous], 2010, 408 CIGRE WORK GROUP; [Anonymous], 2012, 519 CIGRE WORK GROUP; [Anonymous], 2013, 62271112 IEC; [Anonymous], 2011, 622711 IEC; [Anonymous], 2007, 336 CIGRE WORK GROUP; Han B., 2010, IEEE INT C POW SYST; Janssen A., 2014, CIGRE SC A3 SESS 201, pA3; Janssen A. L. J., 2010, CIGRE SC A3 SESS 201, pA3; Mizoguchi H, 1998, IEEE T POWER DELIVER, V13, P495, DOI 10.1109/61.660920; SHPERLING BR, 1978, IEEE T POWER AP SYST, V97, P1421; Steurer M, 2004, IEEE T POWER DELIVER, V19, P168, DOI 10.1109/TPWRD.2003.820219; Yamagata Y., 2012, CIGRE SC A3 SESS 201, pA3	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8977	1937-4208		IEEE T POWER DELIVER	IEEE Trans. Power Deliv.	FEB	2015	30	1					377	384		10.1109/TPWRD.2014.2331853		8	Engineering, Electrical & Electronic	Engineering	AZ7CE	WOS:000348375100043		
J	Jayatilleke, A; Jayatilleke, A; Jimba, M; Yasuoka, J				Jayatilleke, Achini; Jayatilleke, Achala; Jimba, Masamine; Yasuoka, Junko			Informal social control and intimate partner violence	INJURY PREVENTION			English	Letter									[Jayatilleke, Achini; Jimba, Masamine; Yasuoka, Junko] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo 1130033, Japan; [Jayatilleke, Achala] Univ Colombo, Postgrad Inst Med, Colombo, Sri Lanka	Yasuoka, J (reprint author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo 1130033, Japan.	jyasuoka@post.harvard.edu					Xu X, 2005, AM J PUBLIC HEALTH, V95, P78, DOI 10.2105/AJPH.2003.023978; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Emery CR, 2014, INJURY PREV, DOI [10.1136/injuryprev-2013-041117, DOI 10.1136/INJURYPREV-2013-041117]; Geberth VJ., 2006, PRACTICAL HOMICIDE I, P999	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	FEB	2015	21	1					70	70		10.1136/injuryprev-2014-041421		1	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AZ5SQ	WOS:000348280400018		
J	Saijo, Y; Chiba, S; Yoshioka, E; Nakagi, Y; Ito, T; Kitaoka-Higashiguchi, K; Yoshida, T				Saijo, Yasuaki; Chiba, Shigeru; Yoshioka, Eiji; Nakagi, Yoshihiko; Ito, Toshihiro; Kitaoka-Higashiguchi, Kazuyo; Yoshida, Takahiko			Synergistic interaction between job control and social support at work on depression, burnout, and insomnia among Japanese civil servants	INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH			English	Article						Job control; Social support; Job demands; Depression; Burnout; Insomnia; Synergy index	SOCIOECONOMIC-STATUS; RISK-FACTORS; HEALTH; STRESS; ASSOCIATION; SYMPTOMS; VALIDITY; STRAIN; LIFE; QUESTIONNAIRE	To elucidate whether low job control and low social support at work have synergistic interaction on mental health. The synergistic interaction was also analyzed after stratification by high and low job demands. Participants were 2,121 local government employees in Asahikawa city, Japan. The Brief Job Stress Questionnaire was used to assess job demands, job control, and social support. Depression was assessed using the Patient Health Questionnaire-9. The Maslach Burnout Inventory-General Survey was used to assess burnout. Insomnia was assessed using the Athens Insomnia Scale. Possible confounder-adjusted logistic regression analyses were performed to obtain odds ratios for depression, burnout, and insomnia, and synergy indices between job control and social support at work were assessed. The synergy indices among men and women, respectively, were 2.08 (80 % confidence interval: 1.01, 4.27) and 1.98 (0.67, 5.89) for depression, 1.79 (1.28, 2.51) and 2.62 (1.07, 6.40) for burnout, and 1.92 (1.22, 3.02) and 2.77 (0.43, 18.01) for insomnia. Men with high job demands had higher synergistic interaction on depression and burnout, compared to men with low job demands, and women with low job demands had higher synergistic interaction between job control and social support at work on burnout and insomnia, compared to women with high job demands. There were more-than-additive interactions of job control and social support at work on depression, burnout, and insomnia. After stratification by job demands, the synergistic interaction may be different between men and women. To assess job stress, it is necessary to consider the interactive effect of not only job demands and job control but also job control and social support at work.	[Saijo, Yasuaki; Yoshioka, Eiji; Nakagi, Yoshihiko; Ito, Toshihiro; Yoshida, Takahiko] Asahikawa Med Univ, Dept Hlth Sci, Asahikawa, Hokkaido 0788510, Japan; [Chiba, Shigeru] Asahikawa Med Univ, Dept Psychiat & Neurol, Asahikawa, Hokkaido 0788510, Japan; [Kitaoka-Higashiguchi, Kazuyo] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Saijo, Y (reprint author), Asahikawa Med Univ, Dept Hlth Sci, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	y-saijo@asahikawa-med.ac.jp			Japan Society for the Promotion of Science [21590549]	This work was supported by Grants-in-Aid for Scientific Research (No. 21590549) from the Japan Society for the Promotion of Science.	Ahola K, 2014, J OCCUP HEALTH, V55, P450; Hakanen JJ, 2012, J AFFECT DISORDERS, V141, P415, DOI 10.1016/j.jad.2012.02.043; Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Ota A, 2009, SLEEP MED, V10, P1112, DOI 10.1016/j.sleep.2009.03.005; Ota A, 2005, SLEEP MED, V6, P353, DOI 10.1016/j.sleep.2004.12.008; Sanne B, 2005, OCCUP MED-OXFORD, V55, P463, DOI 10.1093/occmed/kqi071; Sinokki M, 2010, J OCCUP ENVIRON MED, V52, P54, DOI 10.1097/JOM.0b013e3181c5c373; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Santavirta N, 2007, BRIT J EDUC PSYCHOL, V77, P213, DOI 10.1348/000709905X92045; Benca RM, 2008, SLEEP MED, V9, pS3, DOI 10.1016/S1389-9457(08)70010-8; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Ahola K, 2008, J PSYCHOSOM RES, V64, P185, DOI 10.1016/j.jpsychores.2007.06.022; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Kim BS, 2012, SOC PSYCH PSYCH EPID, V47, P2019, DOI 10.1007/s00127-012-0502-0; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Brenninkmeijer V, 2003, OCCUP ENVIRON MED, V60, P16; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/PRO.101.3.952-960; ARONSSON G, 1989, INT J HEALTH SERV, V19, P459, DOI 10.2190/N6KQ-HWA0-H7CJ-KUPQ; Bender Ash, 2008, Curr Psychiatry Rep, V10, P73, DOI 10.1007/s11920-008-0013-6; Choi B, 2011, INT ARCH OCC ENV HEA, V84, P77, DOI 10.1007/s00420-010-0554-y; Choi BK, 2008, SCAND J WORK ENV HEA, P22; Fransson EI, 2012, AM J EPIDEMIOL, V176, P1078, DOI 10.1093/aje/kws336; GARDELL B, 1982, INT J HEALTH SERV, V12, P31, DOI 10.2190/K3DH-0AXW-7DCP-GPFM; GREENLAND S, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431660; JOHNSON JV, 1989, INT J HEALTH SERV, V19, P469, DOI 10.2190/H1D1-AB94-JM7X-DDM4; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kawada T, 2011, WORK, V40, P393, DOI 10.3233/WOR-2011-1251; Kitaoka-Higashiguchi K, 2009, J OCCUP HEALTH, V51, P123; Kitaoka-Higashiguchi K, 2004, JAPANESE J PSYCHOL, V75, P415; Kitaoka-Higashiguchi K, 2004, STRESS HEALTH, V20, P255, DOI 10.1002/smi.1030; Kucharczyk Erica R, 2012, Sleep Med Rev, V16, P547, DOI 10.1016/j.smrv.2012.01.005; Marshall Stephen W, 2007, Epidemiol Perspect Innov, V4, P4, DOI 10.1186/1742-5573-4-4; Maslach C., 1996, MASLACH BURNOUT INVE; Nishi N, 2004, SOC SCI MED, V58, P1159, DOI 10.1016/S0277-9536(03)00287-9; Rothman Kenneth J., 1986, MODERN EPIDEMIOLOGY; Roy T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-123; Saijo Y, 2008, SOC SCI MED, V67, P971, DOI 10.1016/j.socscimed.2008.06.014; Shimomitsu T, 2000, REPORTS STUDY JOB ST; Suwazono Y, 2008, RISK ANAL, V28, P1689, DOI 10.1111/j.1539-6924.2008.01107.x; Umehara K, 2007, J OCCUP HEALTH, V49, P467, DOI 10.1539/joh.49.467	46	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-0131	1432-1246		INT ARCH OCC ENV HEA	Int. Arch. Occup. Environ. Health	FEB	2015	88	2					143	152		10.1007/s00420-014-0945-6		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AZ8CA	WOS:000348441100002		
J	Yin, S; Nishi, T; Grossmann, IE				Yin, Sisi; Nishi, Tatsushi; Grossmann, Ignacio E.			Optimal quantity discount coordination for supply chain optimization with one manufacturer and multiple suppliers under demand uncertainty	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Supply chain coordination; Quantity discounts; Game theoretical model; Stackelberg game; Demand uncertainty	PRICE-SENSITIVE DEMAND; GAME-THEORY APPROACH; INVENTORY CONTROL; DECISIONS; COMPANIES	In this paper, a coordination strategy is developed to integrate business decisions and manufacturing planning in supply chain management. We consider one manufacturer and multiple suppliers to determine production, prices, and inventory simultaneously with uncertain demands. This paper aims at providing an optimal discount policy derived from Stackelberg equilibrium to coordinate a manufacturer and multiple suppliers. The optimal discount coordination mechanism helps the manufacturer to select suppliers in order to maintain long-term relationship with the contracted suppliers under demand uncertainty. Noncooperative game is applied in order to resolve decision-making in order to determine quantities of components, price, production, and selection of suppliers simultaneously. Computational experiments are conducted to demonstrate the effectiveness and efficiency of the proposed approach.	[Yin, Sisi; Nishi, Tatsushi] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 560, Japan; [Grossmann, Ignacio E.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA	Nishi, T (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Toyonaka, Osaka 560, Japan.	nishi@sys.es.osaka-u.ac.jp					Alaei S, 2014, INT J ADV MANUF TECH, V74, P101, DOI 10.1007/s00170-014-5922-4; Kim B, 2002, IIE TRANS, V34, P663, DOI 10.1080/07408170208928903; Esmaeili M, 2009, EUR J OPER RES, V195, P442, DOI 10.1016/j.ejor.2008.02.026; Yu YG, 2009, COMPUT IND ENG, V57, P368, DOI 10.1016/j.cie.2008.12.003; Xiao TJ, 2010, COMPUT IND ENG, V59, P840, DOI 10.1016/j.cie.2010.08.011; Zhang GQ, 2009, INT J PROD RES, V47, P2409, DOI 10.1080/00207540701678944; Sarmah SP, 2006, EUR J OPER RES, V175, P1, DOI 10.1016/j.ejor.2005.08.006; Xiao TJ, 2010, INT J PROD ECON, V124, P171, DOI 10.1016/j.ijpe.2009.10.021; Hennet JC, 2008, ENG APPL ARTIF INTEL, V21, P399, DOI 10.1016/j.engappai.2007.10.003; Nishi T, 2008, IEEE T AUTOM SCI ENG, V5, P259, DOI 10.1109/TASE.2007.894727; Viswanathan S, 2003, EUR J OPER RES, V149, P571, DOI 10.1016/S0377-2217(02)00469-1; Chopra S., 2012, SUPPLY CHAIN MANAGEM; Constantine EP, 2006, J COMP INT MGMT, V9, P3; Huang Y, 2010, TRANSPORT RES B-LOG, V47, P115; Hussain AHA, 2010, P INT MULTICONF ENG, P978; Kalvelagen E, 2004, NEW SPECIAL FUNCTION; Kokhlesian M, 2014, INT J ADV MANUF TECH, V71, P1975; Kuzdrall P. J., 1982, Decision Sciences, V13, DOI 10.1111/j.1540-5915.1982.tb00133.x; Leng MM, 2010, EUR J OPER RES, V204, P96, DOI 10.1016/j.ejor.2009.10.011; Li SX, 1996, INT J PROD ECON, V43, P37, DOI 10.1016/0925-5273(95)00183-2; Pezeshki Y, 2013, INT J ADV MANUF TECH, V64, P961, DOI 10.1007/s00170-012-4046-y; Qin YY, 2007, INT J PROD ECON, V105, P43, DOI 10.1016/j.ijpe.2006.02.005; Tominaga H, 2008, INT J INNOV COMPUT I, V4, P513; Yang DQ, 2011, AUTOMATICA, V47, P1317, DOI 10.1016/j.automatica.2011.02.005; Yin S, 2014, INT J SYST SCI, V14, P2354; Yin S, 2012, PROC CIRP, V3, P251, DOI 10.1016/j.procir.2012.07.044	26	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	FEB	2015	76	5-8					1173	1184		10.1007/s00170-014-6298-1		12	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	AZ6DA	WOS:000348307500034		
J	Kanayama, A; Kobayashi, I; Shibuya, K				Kanayama, Akiko; Kobayashi, Intetsu; Shibuya, Kazutoshi			Distribution and antimicrobial susceptibility profile of extended-spectrum beta-lactamase-producing Proteus mirabilis strains recently isolated in Japan	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Proteus mirabilis; CTX-M-type beta-lactamase; Extended-spectrum beta-lactamase; Antimicrobial susceptibility	URINARY-TRACT-INFECTIONS; ESCHERICHIA-COLI; RISK-FACTORS; RESISTANCE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; EMERGENCE; PATHOGENS; OUTBREAK; GENES	Here we report on the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Proteus mirabilis from a nationwide antimicrobial resistance survey in different geographical regions of Japan. A total of 799 P. mirabilis isolates recovered between July 2009 and June 2010 from 314 healthcare facilities were characterised according to ESBL production, source, location and antimicrobial susceptibility pattern. ESBL production was found in 364 (45.6%) of the isolates, among which 354 (97.3%) produced CTX-M-2 group beta-lactamases. Of the 349 ESBL-producing isolates in which the inpatient or outpatient status of the source was known, 324 (92.8%) were from inpatients and 25 (7.2%) were from outpatients (P < 0.05). Results of pulsed-field gel electrophoresis (PFGE) analysis performed on 66 of the ESBL-producers generated a distribution of PFGE patterns into 21 groups. Genetic relatedness was seen among isolates within a region, which is consistent with horizontal transmission. With respect to the frequency of ESBL-producersby specimen source, 12/14 (85.7%) central venous catheter specimens yielded ESBL-producing P. mirabilis compared with 159/405 (39.3%), 119/209 (56.9%), 42/77 (54.5%) and 20/49 (40.8%), respectively, for isolates from urine, sputum, decubitus ulcer and wound specimens. Among the ESBL-producers, non susceptibility to ciprofloxacin was found in 74.2% of the ESBL-producing isolates compared with 17.7% of the ESBL-non-producing isolates. These results show that approximately one-half of the P. mirabilis isolates from clinical specimens in Japan are ESBL-producers and that the potential for concomitant fluoroquinolone resistance must also be considered. (C) 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.	[Kanayama, Akiko; Shibuya, Kazutoshi] Toho Univ, Grad Sch Med, Dept Surg Pathol, Ota Ku, Tokyo 1438541, Japan; [Kanayama, Akiko; Kobayashi, Intetsu] Toho Univ, Fac Nursing, Dept Infect Control & Prevent, Ota Ku, Tokyo 1410015, Japan	Kanayama, A (reprint author), Toho Univ, Fac Nursing, Dept Infect Control & Prevent, Ota Ku, 4-16-20 Omori Nishi, Tokyo 1410015, Japan.	akiki@med.toho-u.ac.jp					Abbott SL, 2011, MANUAL CLIN MICROBIO, P639; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Tinelli M, 2012, J ANTIMICROB CHEMOTH, V67, P2982, DOI 10.1093/jac/dks300; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Ishii Y, 2005, J CLIN MICROBIOL, V43, P1072, DOI 10.1128/JCM.43.3.1072-1075.2005; Endimiani A, 2005, ANTIMICROB AGENTS CH, V49, P2598, DOI 10.1128/AAC.49.7.2598-2605.2005; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Nagano N, 2003, J CLIN MICROBIOL, V41, P5530, DOI 10.1128/JCM.41.12.5530-5536.2003; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Chong Y, 2011, EUR J CLIN MICROBIOL, V30, P83, DOI 10.1007/s10096-010-1057-1; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Empel J, 2008, ANTIMICROB AGENTS CH, V52, P2449, DOI 10.1128/AAC.00043-08; Nakamura T, 2012, AM J CLIN PATHOL, V137, P620, DOI 10.1309/AJCP48PDVKWQOXEZ; Karlowsky JA, 2011, ANTIMICROB AGENTS CH, V55, P3169, DOI 10.1128/AAC.00066-11; Anunnatsiri S, 2012, SE ASIAN J TROP MED, V43, P1169; Canton R, 2012, FRONT MICROBIOL, V3, P1, DOI DOI 10.3389/FMICB.2012.00110; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI S; Clinical and Laboratory Standards Institute, 2012, M07A9 CLSI; Doernberg SB, 2012, AM J INFECT CONTROL, V40, P123, DOI 10.1016/j.ajic.2011.04.001; Hu YY, 2012, ANTIMICROB AGENTS CH, V56, P2278, DOI 10.1128/AAC.05519-11; Jones CH, 2009, ANTIMICROB AGENTS CH, V53, P465, DOI 10.1128/AAC.00883-08; Kanayama A, 2010, INT J ANTIMICROB AG, V36, P340, DOI 10.1016/j.ijantimicag.2010.06.002; Kaneko A, 2000, J ANTIMICROB CHEMOTH, V45, P771, DOI 10.1093/jac/45.6.771; Nakano R, 2012, J MED MICROBIOL, V61, P1727, DOI 10.1099/jmm.0.049726-0; Sardelic S, 2010, CHEMOTHERAPY, V56, P208, DOI 10.1159/000316332; Tanaka M, 1998, SEX TRANSM INFECT, V74, P59; Tibbetts R, 2008, J CLIN MICROBIOL, V46, P3080, DOI 10.1128/JCM.00979-08	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	FEB	2015	45	2					113	118		10.1016/j.ijantimicag.2014.06.005		6	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AZ5WP	WOS:000348289500004		
J	Kawai, T; Shin, M; Nishizawa, Y; Horise, Y; Nishikawa, A; Nakamura, T				Kawai, Toshikazu; Shin, Myongyu; Nishizawa, Yuji; Horise, Yuki; Nishikawa, Atsushi; Nakamura, Tatsuo			Mobile locally operated detachable end-effector manipulator for endoscopic surgery	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Local operation; Endoscopic surgery; Mobile surgical robot; Third arm; Disassembled mechanism	ROBOTIC SYSTEM; NEUROSURGERY	Local surgery is safer than remote surgery because emergencies can be more easily addressed. Although many locally operated surgical robots and devices have been developed, none can safely grasp organs and provide traction. A new manipulator with a detachable commercial forceps was developed that can act as a third arm for a surgeon situated in a sterile area near the patient. This mechanism can be disassembled into compact parts that enable mobile use. A mobile locally operated detachable end-effector manipulator (LODEM) was developed and tested. This device uses crank-slider and cable-rod mechanisms to achieve 5 degrees of freedom and an acting force of more than 5 N. The total mass is less than 15 kg. The positional accuracy and speed of the prototype device were evaluated while performing simulated in vivo surgery. The accuracy of the mobile LODEM was 0.4 mm, sufficient for handling organs. The manipulator could be assembled and disassembled in 8 min, making it highly mobile. The manipulator could successfully handle the target organs with the required level of dexterity during an in vivo laparoscopic surgical procedure. A mobile LODEM was designed that allows minimally invasive robotically assisted endoscopic surgery by a surgeon working near the patient. This device is highly promising for robotic surgery applications.	[Kawai, Toshikazu; Shin, Myongyu] Osaka Inst Technol, Grad Sch Engn, Asahi Ward, Osaka 5358585, Japan; [Nishizawa, Yuji] East Hosp, Natl Canc Ctr, Dept Colon Surg, Kashiwa, Chiba 2778577, Japan; [Horise, Yuki] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Toyonaka, Osaka 5600043, Japan; [Nishikawa, Atsushi] Shinshu Univ, Ueda, Nagano 3868567, Japan; [Nakamura, Tatsuo] Kyoto Univ, Sakyo Ku, Kyoto 6068507, Japan	Kawai, T (reprint author), Osaka Inst Technol, Grad Sch Engn, Asahi Ward, 5-16-1 Omiya, Osaka 5358585, Japan.	kawai@bme.oit.ac.jp			JSPS KAKENHI [23560306]	The work was supported in part by JSPS KAKENHI Grant Number 23560306 (2011-2014). We are grateful to the surgeons of National Cancer Center Hospital East who assisted with our research.	Anna MD, 1998, AM J SURG, V175, P482, DOI [10.1016/S0002-9610(98)00080-4, DOI 10.1016/S0002-9610(98)00080-4]; Taylor RH, 2003, IEEE T ROBOTIC AUTOM, V19, P765, DOI 10.1109/TRA.2003.817058; Arata J, 2008, INT J COMPUT ASS RAD, V3, P371, DOI 10.1007/s11548-008-0228-3; Allaf ME, 1998, SURG ENDOSC-ULTRAS, V12, P1415, DOI 10.1007/s004649900871; Ida Y, 2012, INT J COMPUT ASS RAD, V7, P27, DOI 10.1007/s11548-011-0602-4; Marescaux J, 2001, NATURE, V413, P379, DOI 10.1038/35096636; Arata J, 2011, INT J COMPUT ASS RAD, V6, P375, DOI 10.1007/s11548-010-0514-8; Goto T, 2013, NEUROSURGERY, V72, pA39, DOI 10.1227/NEU.0b013e318271ee66; GREEN PS, 1995, IEEE ENG MED BIOL, V14, P324, DOI 10.1109/51.391769; Guthart GS, 2000, P IEEE INT C ROB AUT, DOI 10.1109/ROBOT.2000.844121; Heijnsdijk EAM, 2004, SURG ENDOSC, V18, P1766, DOI 10.1007/s00464-004-9000-0; Hongo K, 2003, INT CONGR SER, V1256, P509, DOI 10.1016/S0531-5131(03)00247-4; Kawai T, 2013, INT J CARS S1, V8, pS384; Kawai T, 2013, P IEEE EMBS, P4953, DOI [10.1109/EMBC.2013.6610659, DOI 10.1109/EMBC.2013.6610659]; Kawai T, 2012, J JSCAS, V14, P5; Kawai T, 2005, IEEE ENG MED BIOL, V24, P57, DOI 10.1109/MEMB.2005.1463397; Kobayashi E, 1999, Comput Aided Surg, V4, P182, DOI 10.3109/10929089909148172; Nguyen NT, 2009, J GASTROINTEST SURG, V13, P1125, DOI 10.1007/s11605-008-0642-4; Nishizawa Y, 2013, P SAGES; Okamoto J, 2011, INT J CARS S1, V6, pS83; Pott Peter P, 2005, Comput Aided Surg, V10, P101, DOI 10.3109/10929080500228753; Shin M, 2012, INT J CARS S1, V7, pS390; Torres BJR, 2009, SURG ENDOSC, V23, P1624, DOI [10.1007/s00464-008-9992-y, DOI 10.1007/S00464-008-9992-Y]; Uecker D. R., 1994, P 1 INT S MED ROB CO, P176; Wang Y, 2000, J ROBOTICS SOC JAPAN, V18, P45, DOI 10.7210/jrsj.18.45	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	FEB	2015	10	2					161	169		10.1007/s11548-014-1062-4		9	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AZ7FB	WOS:000348383400005		
J	Tanaka, Y; Fukuda, T; Fujiwara, M; Sano, A				Tanaka, Yoshihiro; Fukuda, Tomohiro; Fujiwara, Michitaka; Sano, Akihito			Tactile sensor using acoustic reflection for lump detection in laparoscopic surgery	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Tactile sensor; Acoustic reflection; Surgical assistance system; Tumor detection	MINIMALLY INVASIVE SURGERY; FORCE FEEDBACK; TISSUE	Laparoscopic surgery limits a surgeon's tactile sense. A tactile sensor could allow real-time tumor detection in laparoscopic surgery through lump inspection. This study was aimed at developing a simple and biocompatible tactile sensor for laparoscopic surgery. The proposed tactile sensor has a forceps-like shape, has no electrical elements in the tissue contact area, and can be sterilized and cleaned. We developed a tactile sensor using acoustic reflection. It is composed of a handle with a speaker and a microphone, an aluminum tube, and a sensor tip with a deformable elastic cavity. The acoustic wave in the tube is the superposition of the input wave and two waves reflected at the closed edge and the projection generated by deformation due to contact with an object. By measuring the acoustic wave in the tube, information of the deformation is derived. The sensor is modeled, and the output is analyzed to determine design parameters of the sensor. Then, a prototype of the sensor is assembled. Fundamental experiments show that the sensor output increases with increasing normal deformation. Moreover, experiments using a phantom of the stomach wall with a 0-IIc type tumor (most common early stage gastric cancer) show that large sensor output is obtained for the lump when the sensor is moved across the back surface of the tumor. The theoretical and experimental results show that the sensor is sensitive to the deformation due to contact with an object and has the potential to detect a lump in laparoscopic surgery.	[Tanaka, Yoshihiro; Sano, Akihito] Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Showa Ku, Nagoya, Aichi 4668555, Japan; [Fukuda, Tomohiro] Nagoya Inst Technol, Dept Mech Engn, Fac Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; [Fujiwara, Michitaka] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Showa Ku, Nagoya, Aichi 4668550, Japan	Tanaka, Y (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Engn Phys Elect & Mech, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	tanaka.yoshihiro@nitech.ac.jp			JSPS [25289060]	This research was funded in part by the JSPS Grant-in-Aid for Scientific Research (B) (No. 25289060).	Phipps S, 2005, UROLOGY, V66, P447, DOI 10.1016/j.urology.2005.03.017; Puangmali P, 2008, IEEE SENS J, V8, P371, DOI 10.1109/JSEN.2008.917481; Beccani M, 2014, IEEE T BIO-MED ENG, V61, P353, DOI 10.1109/TBME.2013.2279337; Peirs J, 2004, SENSOR ACTUAT A-PHYS, V115, P447, DOI 10.1016/j.sna.2004.04.057; Sokhanvar S, 2007, SMART MATER STRUCT, V16, P989, DOI 10.1088/0964-1726/16/4/006; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260; Yoneyama T, 2013, INT J COMPUT ASS RAD, V8, P819, DOI 10.1007/s11548-012-0807-1; Hoyt K, 2008, CANCER BIOMARK, V4, P213; Kaim L, 2011, IEEE T HAPTICS, V4, P242, DOI [10.1109/TOH.2011.19, 10.1109/ToH.2011.19]; Kandel E R, 2000, PRINCIPLES NEURAL SC; Kaneko M, 2004, IEEE INT CONF ROBOT, P1562, DOI 10.1109/ROBOT.2004.1308046; Lindahl O. A., 2009, Journal of Medical Engineering & Technology, V33, P263, DOI 10.1080/03091900802491188; MORGAN ES, 1978, NDT INT, V11, P179, DOI 10.1016/0308-9126(78)90052-4; Nielsen RO, 2009, 2009 IEEE CONFERENCE ON TECHNOLOGIES FOR HOMELAND SECURITY, P101, DOI 10.1109/THS.2009.5168021; Shinoda H, 1997, IEEE INT CONF ROBOT, P3087; Takaki T, 2010, IEEE INT CONF ROBOT, P3648, DOI 10.1109/ROBOT.2010.5509708; Takashima K, 2007, Complex Medical Engineering, P13, DOI 10.1007/978-4-431-30962-8_2; Tanaka M, 2007, J MATER PROCESS TECH, V181, P286, DOI 10.1016/j.jmatprotec.2006.03.059; Tanaka Y, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P145, DOI 10.1109/WHC.2013.6548399; Tanaka Y, 2010, INT J COMPUT ASS RAD, V5, P359, DOI 10.1007/s11548-010-0426-7; Tanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093363; Teramoto K, 2002, P 41 SICE ANN C, V1, P121, DOI 10.1109/SICE.2002.1195196	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	FEB	2015	10	2					183	193		10.1007/s11548-014-1067-z		11	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AZ7FB	WOS:000348383400007		
J	Fukuda, S; Baba, S; Akasaka, T				Fukuda, S.; Baba, S.; Akasaka, T.			Psychological stress has the potential to cause a decline in the epidermal permeability barrier function of the horny layer	INTERNATIONAL JOURNAL OF COSMETIC SCIENCE			English	Article						amylase; chromogranin A; epidermal permeability barrier function; psychological stress; transepidermal water loss	SALIVARY ALPHA-AMYLASE; ATOPIC-DERMATITIS; CHROMOGRANIN-A; ADRENERGIC ACTIVITY; PSORIASIS; EXACERBATION; HOMEOSTASIS; MECHANISMS; RESPONSES; PROTEIN	Synopsis ObjectivePsychological stress is known to have a negative effect on a large number of skin diseases. However, there is little research on the relationship between psychological stress and the epidermal permeability barrier function (EPBF) of healthy individuals. We hypothesize that psychological stress deteriorates EPBF and aimed to investigate this relationship. MethodsPsychological stress was assessed using salivary alpha-amylase (sAmy; KIU L-1), and chromogranin A level corrected with total protein (CgAP; pmol mg(-1) protein) as psychological stress biomarkers. Measurements were obtained from 16 healthy female students during two periods of presumed higher stress (final examinations and returning from a long vacation), and a period considered as a control. The EPBF level was evaluated by measuring transepidermal water loss (TEWL; gm(-2)h(-1)). The TEWL was measured three times: just before (TEWL [Intact]), immediately after (TEWL [Str]) and 4h after (TEWL [4h]) barrier disruption by tape stripping. The rate of barrier disruption was evaluated by comparing the difference between the TEWL [Intact] and the TEWL [Str] (delta-BD: gm(-2)h(-1)). The recovery was assessed by comparing the difference between the TEWL [Intact] and TEWL [4h] (delta-RE: gm(-2)h(-1)). ResultsThe subjects demonstrated a significant increase in the sAmy value after the long vacation compared with the control. There was no change in the CgAP value between the groups. Meanwhile, the EPBF level showed significant deterioration during both higher stress periods. There was a significant increase in delta-BD and delta-RE after the long vacation. ConclusionsThe results indicate the possibility that psychological stress causes a decline in EPBF and deterioration in barrier disruption and recovery. Furthermore, it implies a relationship between psychological stress and the exacerbation or protracted healing of skin disease.	[Fukuda, S.; Baba, S.; Akasaka, T.] Iwate Med Univ, Dept Dermatol, Fac Med, Morioka, Iwate 0208505, Japan	Fukuda, S (reprint author), Iwate Med Univ, Dept Dermatol, Fac Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	toyofuji-730@mbr.nifty.com					Saruta J, 2005, CELLS TISSUES ORGANS, V180, P237, DOI 10.1159/000088939; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; Buske-Kirschbaum A, 2002, J NEUROIMMUNOL, V129, P161, DOI 10.1016/S0165-5728(02)00168-6; Seiffert K, 2005, DERMATOLOGY, V210, P286, DOI 10.1159/000084752; Altemus M, 2001, J INVEST DERMATOL, V117, P309, DOI 10.1046/j.1523-1747.2001.01373.x; Kimata H, 2003, PHYSIOL BEHAV, V80, P395, DOI 10.1016/j.physbeh.2003.09.004; Kodama A, 1999, J ALLERGY CLIN IMMUN, V104, P173, DOI 10.1016/S0091-6749(99)70130-2; Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Padgett DA, 1998, BRAIN BEHAV IMMUN, V12, P64, DOI 10.1006/brbi.1997.0512; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Kimata H, 2007, INDIAN PEDIATR, V44, P281; Filaire E, 2009, EUR J APPL PHYSIOL, V106, P71, DOI 10.1007/s00421-009-0991-z; ALABADIE MS, 1994, BRIT J DERMATOL, V130, P199, DOI 10.1111/j.1365-2133.1994.tb02900.x; Miller TR, 2012, CRISIS, V33, P169, DOI 10.1027/0227-5910/a000126; Kanno T, 1999, EXP PHYSIOL, V84, P1073; Garg A, 2001, ARCH DERMATOL, V137, P53; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Busch L, 2006, CELLS TISSUES ORGANS, V182, P117, DOI 10.1159/000093962; Den R, 2007, BIOMED RES-TOKYO, V28, P57, DOI 10.2220/biomedres.28.57; Denda M, 2003, J INVEST DERMATOL, V121, P142, DOI 10.1046/j.1523-1747.2003.12310.x; GOODALL M, 1962, J CLIN INVEST, V41, P197, DOI 10.1172/JCI104471; GROVE GL, 1983, J GERONTOL, V38, P137; HAVLIK RJ, 1992, PLAST RECONSTR SURG, V90, P57, DOI 10.1097/00006534-199207000-00008; Heller M M, 2011, Skin Therapy Lett, V16, P1; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; Kawaguchi Y, 1997, CLIN EXP IMMUNOL, V109, P397, DOI 10.1046/j.1365-2249.1997.4111309.x; Lonne-Rahm S, 2004, J AM ACAD DERMATOL, V51, P899, DOI 10.1016/j.jaad.2004.05.035; Lonne-Rahm SB, 2008, J EUR ACAD DERMATOL, V22, P11, DOI 10.1111/j.1468-3083.2007.02202.x; Malhotra SK, 2008, INDIAN J DERMATOL VE, V74, P594; Orion D., 2012, CLIN DERMATOL, V30, P280; Schmitt J, 2007, GEN HOSP PSYCHIAT, V29, P134, DOI 10.1016/j.genhosppsych.2006.12.004; Tartaro J, 2005, J HEALTH PSYCHOL, V10, P753, DOI 10.1177/1359105305057311; The Ministry of Health Labour and Welfare Japan, 2005, STAT DAT SUIC DEATH	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-5463	1468-2494		INT J COSMETIC SCI	Int. J. Cosmetic Sci.	FEB	2015	37	1					63	69		10.1111/ics.12169		7	Chemistry, Applied; Dermatology	Chemistry; Dermatology	AZ2IZ	WOS:000348058700006		
J	Onoda, H; Matsukura, A				Onoda, H.; Matsukura, A.			Temperature dependence and P/Ti ratio in phosphoric acid treatment of titanium dioxide and powder properties	INTERNATIONAL JOURNAL OF COSMETIC SCIENCE			English	Article						chemical synthesis; skin barrier; spectroscopy	IN-VITRO; PHOSPHATES; SKIN; BLUE	Synopsis ObjectiveTitanium dioxide has photocatalytic activity and is used as a white pigment for cosmetics. A certain degree of sebum on the skin is decomposed by the ultraviolet radiation in sunlight. In this work, titanium dioxide was shaken with phosphoric acid to synthesize a white pigment for cosmetics. MethodsTitanium dioxide was treated with 0.1mol/L of phosphoric acid at various P/Ti molar ratios, and then shaken in hot water for 1h. The chemical composition, powder properties, photocatalytic activity, colour phase, and smoothness of the obtained powder were studied. ResultsThe obtained materials indicated XRD peaks of titanium dioxide, however the peaks diminished subsequent to phosphoric acid treatment. The samples included small particles with sub-micrometer size. The photocatalytic activity of the obtained powders decreased, decomposing less sebum on the skin. Samples prepared at high P/Ti ratio with high shaking temperature indicated low whiteness in in L*a*b* colour space. The shaking and heating temperature and P/Ti ratio had influence on the smoothness of the obtained materials. ConclusionPhosphoric acid treatment of titanium dioxide is an effective method to inhibit photocatalytic activity for a white pigment.	[Onoda, H.; Matsukura, A.] Kyoto Prefectural Univ, Dept Informat & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Onoda, H (reprint author), Kyoto Prefectural Univ, Dept Informat & Environm Sci, Sakyo Ku, 1-5 Shimogamo Nakaragi Cyo, Kyoto 6068522, Japan.	onoda@kpu.ac.jp					Ramaswamy V, 2008, MATER RES BULL, V43, P1145, DOI 10.1016/j.materresbull.2007.06.003; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Cheng SY, 2009, FIBER POLYM, V10, P132, DOI 10.1007/s12221-009-0132-7; Senzui M, 2010, J TOXICOL SCI, V35, P107; Gamer AO, 2006, TOXICOL IN VITRO, V20, P301, DOI 10.1016/j.tiv.2005.08.008; Jones DJ, 2000, J MATER CHEM, V10, P1957, DOI 10.1039/b002474k; Bhaumik A, 2001, J AM CHEM SOC, V123, P691, DOI 10.1021/ja002481s; Du P, 2008, J CATAL, V260, P75, DOI 10.1016/j.jcat.2008.09.005; Onoda H, 2012, INT J COSMETIC SCI, V34, P86, DOI 10.1111/j.1468-2494.2011.00685.x; Onoda H, 2012, J MATER CHEM, V22, P19826, DOI 10.1039/c2jm33952h; Onoda Hiroaki, 2014, Journal of Advanced Ceramics, V3, DOI 10.1007/s40145-014-0103-3	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-5463	1468-2494		INT J COSMETIC SCI	Int. J. Cosmetic Sci.	FEB	2015	37	1					123	128		10.1111/ics.12179		6	Chemistry, Applied; Dermatology	Chemistry; Dermatology	AZ2IZ	WOS:000348058700014		
J	Uchiyama, M; Oguri, M; Mojumdar, EH; Gooris, GS; Bouwstra, JA				Uchiyama, Masayuki; Oguri, Masashi; Mojumdar, Enamul H.; Gooris, Gert S.; Bouwstra, Joke A.			Variation in fatty acid chain length distribution affects permeability barrier function of stratum corneum lipid model membranes	INTERNATIONAL JOURNAL OF COSMETIC SCIENCE			English	Meeting Abstract						Stratum corneum; skin lipid organization; permeation; barrier function			[Uchiyama, Masayuki; Oguri, Masashi] Kao Corp, Beauty Res Ctr, Sumida Ku, Tokyo, Japan; [Uchiyama, Masayuki; Oguri, Masashi; Mojumdar, Enamul H.; Gooris, Gert S.; Bouwstra, Joke A.] Leiden Univ, Leiden Acad Ctr Drug Res, Dept Drug Delivery Technol, Leiden, Netherlands							Groen D., BIOCH BIOPHYS ACTA, V1808, P1529	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-5463	1468-2494		INT J COSMETIC SCI	Int. J. Cosmetic Sci.	FEB	2015	37	1				PO19	158	158				1	Chemistry, Applied; Dermatology	Chemistry; Dermatology	AZ2IZ	WOS:000348058700061		
J	Gahlan, HA; Arai, S; Almadani, SA				Gahlan, Hisham A.; Arai, Shoji; Almadani, Sattam A.			Petrogenesis of carbonated meta-ultramafic lenses from the Neoproterozoic Heiani ophiolite, South Eastern Desert, Egypt: A natural analogue to CO2 sequestration	JOURNAL OF AFRICAN EARTH SCIENCES			English	Article						Meta-ultramafic; Carbonate-orthopyroxenite; Low-P/high-T regional metamorphism; CO2-metasomatism; Heiani ophiolite	ARABIAN-NUBIAN SHIELD; HIGHLY DEPLETED PERIDOTITE; CHROMIAN SPINEL; SYSTEM MGO-AL2O3-SIO2; BRITISH-COLUMBIA; TRACE-ELEMENTS; ORTHO-PYROXENE; WESTERN JAPAN; ICP-MS; SUTURE	Among a set of peculiar meta-ultramafics, carbonate-orthopyroxenites are observed for the first time in the Heiani ophiolite belt, South Eastern Desert, Egypt. They form massive lensoidal masses up to 50 m long and 20 m wide. The lenses show a marked structural concordance with their neighboring country rocks. The typical country rocks are represented by the following high-grade metamorphic rocks: kyanite-muscovite schists, amphibolites, kyanite-bearing biotite gneisses, migmatites, granite gneisses and mobilizates. The studied carbonate-orthopyroxenites consist mainly of metamorphic orthopyroxene + magnesite, among other metamorphic, relict primary and retrograde secondary minerals. According to primary chromian spinel (Cr#, 0.7-0.84) chemistry and morphology, absence of clinopyroxene and presence of primary mantle olivine (Fo(89-91)) as relicts in the metamorphic orthopyroxene, the Heiani carbonate-orthopyroxenites seem to have formed from a highly depleted mantle peridotite precursor. At a late collisional stage during the Pan-Africa terrane accretion and the E-W crustal shortening (ca. 650-620 Ma), high-grade (upper amphibolite facies) low-P/high-T regional metamorphism (ca. 660 Ma) accompanied by CO2-metasomatism resulted in formation of the Heiani carbonate-orthopyroxenites. Mostly the carbonate-bearing shelf sediments beneath and/or in juxtaposition with the Heiani ophiolite are considered to be the proven source of the CO2-rich fluids. Although, a mixed sedimentary-mantle C source is not unlikely. A mineral paragenetic correlation with experimental data for the system MgO-SiO2-H2O-CO2 suggests metamorphic conditions consistent with those of the high-grade country rocks; i.e. 630-650 degrees C, 6-7 kbar (20-23 km depth) and high-X-CO2 (0.6-0.7). The CO2-bearing fluids discharging along faults gave rise to regionally widespread carbonate-bearing assemblages. Accordingly, the Heiani carbonate-orthopyroxenites are considered the by-products of natural carbon sequestration by an ultramafic rock. (C) 2014 Elsevier Ltd. All rights reserved.	[Gahlan, Hisham A.; Almadani, Sattam A.] King Saud Univ, Dept Geol & Geophys, Riyadh 11451, Saudi Arabia; [Arai, Shoji] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan	Gahlan, HA (reprint author), King Saud Univ, Dept Geol & Geophys, Riyadh 11451, Saudi Arabia.	hjhlan@yahoo.com			King Saud University, Deanship of Scientific Research, College of Science, Research Center	H.A.G. and S.A.A. owe the debt of gratitude to King Saud University, Deanship of Scientific Research, College of Science, Research Center, for supporting the current research. The sincere appreciation has been expressed to T. Morishita for his support in the microprobe and LA-ICP-MS analyses. H.A.G. is indebted to A. Kroner for useful discussions about the Arabian Nubian Shield terranes. Also, the sincere thanks are extended to A. Khudeir for his assistance in mapping the region around G. Heiani area. We are grateful to two anonymous reviewers for their highly constructive comments that improved the manuscript. Special thanks are paid to Read Mapeo for his editorial handling.	Abdeen MM, 2011, PRECAMBRIAN RES, V185, P95, DOI 10.1016/j.precamres.2010.12.006; Ali KA, 2010, GONDWANA RES, V18, P583, DOI 10.1016/j.gr.2010.03.002; HALLS C, 1995, MINER DEPOSITA, V30, P303, DOI 10.1007/BF00196366; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; [Anonymous], 1972, GEOTIMES, V17, P24; BONATTI E, 1989, EARTH PLANET SC LETT, V91, P297, DOI 10.1016/0012-821X(89)90005-8; SEIFRITZ W, 1990, NATURE, V345, P486, DOI 10.1038/345486b0; EVANS BW, 1974, AM J SCI, V274, P274; ARAI S, 1980, J PETROL, V21, P141; STERN RJ, 1989, J GEOL SOC LONDON, V146, P1017, DOI 10.1144/gsjgs.146.6.1017; GASPARIK T, 1984, CONTRIB MINERAL PETR, V85, P186, DOI 10.1007/BF00371708; LONEY RA, 1971, J PETROL, V12, P245; Kelemen PB, 2011, ANNU REV EARTH PL SC, V39, P545, DOI 10.1146/annurev-earth-092010-152509; Hellebrand E, 2001, NATURE, V410, P677, DOI 10.1038/35070546; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Akbulut M, 2006, GEOL J, V41, P557, DOI 10.1002/gj.1058; RUDNICK RL, 1993, EARTH PLANET SC LETT, V114, P463, DOI 10.1016/0012-821X(93)90076-L; Barnes SJ, 2000, J PETROL, V41, P387, DOI 10.1093/petrology/41.3.387; STERN RJ, 1990, GEOLOGY, V18, P1103, DOI 10.1130/0091-7613(1990)018<1103:OOLPSI>2.3.CO;2; Ucurum A, 2000, OFIOLITI, V25, P15; KRONER A, 1992, PRECAMBRIAN RES, V59, P15, DOI 10.1016/0301-9268(92)90049-T; Kubo K, 2002, J PETROL, V43, P423, DOI 10.1093/petrology/43.3.423; ARAI S, 1975, CONTRIB MINERAL PETR, V52, P1, DOI 10.1007/BF00377998; Abdelsalam MG, 2003, PRECAMBRIAN RES, V124, P87, DOI 10.1016/S0301-9268(03)00080-9; Bedini RM, 1999, GEOCHIM COSMOCHIM AC, V63, P3883, DOI 10.1016/S0016-7037(99)00154-4; FROST BR, 1975, J PETROL, V16, P272; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; GREILING RO, 1994, GEOL RUNDSCH, V83, P484, DOI 10.1007/BF01083222; Abdelsalam MG, 1996, J AFR EARTH SCI, V23, P289, DOI 10.1016/S0899-5362(97)00003-1; Ishimaru S, 2007, J PETROL, V48, P395, DOI 10.1093/petrology/egl065; LUTH WC, 1964, J GEOPHYS RES, V69, P759, DOI 10.1029/JZ069i004p00759; Moussa EMM, 2008, PRECAMBRIAN RES, V160, P341, DOI 10.1016/j.precamres.2007.08.006; Grove TL, 2006, EARTH PLANET SC LETT, V249, P74, DOI 10.1016/j.epsl.2006.06.043; Matsumoto I, 2001, MINER PETROL, V73, P305, DOI 10.1007/s007100170004; Gahlan HA, 2009, J AFR EARTH SCI, V53, P70, DOI 10.1016/j.jafrearsci.2008.09.005; Ishiwatari A, 2003, GEOL SOC SPEC PUBL, V218, P597, DOI 10.1144/GSL.SP.2003.218.01.30; Trommsdorff V, 1998, CONTRIB MINERAL PETR, V132, P139, DOI 10.1007/s004100050412; Beinlich A, 2012, TERRA NOVA, V24, P446, DOI 10.1111/j.1365-3121.2012.01083.x; MATSUI Y, 1974, B SOC FR MINERAL CR, V97, P122; Adam J, 1997, EUR J MINERAL, V9, P569; Ramadan TM, 2001, PHOTOGRAMM ENG REM S, V67, P491; ARAI S, 1992, MINERAL MAG, V56, P173, DOI 10.1180/minmag.1992.056.383.04; ARAI S, 1994, J VOLCANOL GEOTH RES, V59, P279, DOI 10.1016/0377-0273(94)90083-3; AUCLAIR M, 1993, ECON GEOL BULL SOC, V88, P123; BAKER J, 1994, CONTRIB MINERAL PETR, V116, P130, DOI 10.1007/BF00310695; Barth T.F.W., 1926, NORSK GEOLOGISK TIDS, V9, P271; DANCKWERTH PA, 1978, CONTRIB MINERAL PETR, V66, P189, DOI 10.1007/BF00372158; de Wall H, 2001, PRECAMBRIAN RES, V107, P179, DOI 10.1016/S0301-9268(00)00141-8; Droop G.T.R., 1989, GEOLOGICAL SOC SPECI, V43, P469, DOI 10.1144/GSL.SP.1989.043.01.43; El-Gaby S, 1988, PAN AFRICAN BELT NE, P17; ENGLAND RN, 1973, EARTH PLANET SC LETT, V17, P416, DOI 10.1016/0012-821X(73)90210-0; Gahlan H.A., 2006, THESIS KANAZAWA U; Gahlan H.A., 2006, 6 INT C GEOL MIDDL E, pA; Guo H., 2013, J PALAEOGEOGR, V2, P209; Hansen LD, 2005, CAN MINERAL, V43, P225, DOI 10.2113/gscanmin.43.1.225; Irvine T.N., 1965, CAN J EARTH SCI, V2, P648, DOI DOI 10.1139/E65-046; Ishida Y, 2004, SCI REPORTS KANAZAWA, V48, P31; Jedrysek M.O., 1990, TERRA NOVA, V2, P154, DOI DOI 10.1111/J.1365-3121.1990.TB00057.X; Johannes W., 1970, NEUES JB MINER ABH, V113, P274; JOHANNES W, 1969, AM J SCI, V267, P1083; Kamenetsky VS, 2001, J PETROL, V42, P655, DOI 10.1093/petrology/42.4.655; Katzir Y, 1999, J METAMORPH GEOL, V17, P301; Kralik M., 1989, MONOGRAPH SERIES MIN, V28, P197; Kroner A., 1987, GEODYNAMICS SERIES I, V17, P235; Kroner A., 2004, ENCY GEOLOGY, V1, P1; LIIPO J, 1995, LITHOS, V36, P15, DOI 10.1016/0024-4937(95)00002-W; Morishita T, 2005, GEOSTAND GEOANAL RES, V29, P107, DOI 10.1111/j.1751-908X.2005.tb00659.x; Nozaka T, 2011, J METAMORPH GEOL, V29, P385, DOI 10.1111/j.1525-1314.2010.00921.x; Pearce J. A., 1984, SPEC PUBL GEOL SOC L, V16, P77, DOI DOI 10.1144/GSL.SP.1984.016.01.06; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; Peters T., 1968, CONTRIB MINERAL PETR, V18, P65, DOI 10.1007/BF00371986; Pettersen K., 1883, TROMSO MUS ARSHEFTER, V6, P81; PINSENT RH, 1977, J PETROL, V18, P567; Pitcairn I., 2013, GEOPH RES ABSTR, V15; QUICK JE, 1990, GEOL SOC AM BULL, V102, P1007, DOI 10.1130/0016-7606(1990)102<1007:GAOOTL>2.3.CO;2; Randall B., 1960, 21 INT GEOL C NORD, P443; Raymond L.A., 2002, STUDY IGNEOUS SEDIME, P720; Reitan P., 1958, NORGES GEOLOGISKE UN, V205, P111; Ren DW, 2006, J AFR EARTH SCI, V44, P181, DOI 10.1016/j.jafrearsci.2005.10.010; RICHARDS.SW, 1969, AM J SCI, V267, P259; Rosenbusch H., 1884, NEUES JB MINERALOGIE, V1, P195; Schreyer W., 1972, LITHOS, V5, P345, DOI 10.1016/0024-4937(72)90089-8; STERN RJ, 1990, PRECAMBRIAN RES, V46, P259, DOI 10.1016/0301-9268(90)90005-B; Takahashi E., 1986, B VOLCANOLOGICAL SOC, V30, pS17; Trommsdorff V., 1974, SCHWEIZ MINER PETROG, V54, P333; Vakanjak B., 1984, INT GEOL REV, V26, P673; VANCE JA, 1977, GEOL SOC AM BULL, V88, P1497, DOI 10.1130/0016-7606(1977)88<1497:FOPBDI>2.0.CO;2; VEIZER J, 1989, GEOCHIM COSMOCHIM AC, V53, P845, DOI 10.1016/0016-7037(89)90030-6; White R. W., 1966, CONTRIB MINERAL PETR, V12, P245, DOI 10.1007/BF00518082; Zoheir BA, 2007, GONDWANA RES, V12, P289, DOI 10.1016/j.gr.2006.10.005	90	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1464-343X	1879-1956		J AFR EARTH SCI	J. Afr. Earth Sci.	FEB	2015	102						102	115		10.1016/j.jafrearsci.2014.11.002		14	Geosciences, Multidisciplinary	Geology	CA0QJ	WOS:000348621500009		
J	Neh, AV; Ako, AA; Ayuk, AR; Hosono, T				Neh, Akenji Victorine; Ako, Andrew Ako; Ayuk, Akoachere Richard, II; Hosono, Takahiro			DRASTIC-GIS model for assessing vulnerability to pollution of the phreatic aquiferous formations in Douala-Cameroon	JOURNAL OF AFRICAN EARTH SCIENCES			English	Article						DRASTIC-GIS model; Aquifer vulnerability; Pollution; Douala-Cameroon	ASSESSING GROUNDWATER VULNERABILITY; BASIN; AREA	The pollution potentials of the aquiferous formations in Douala was obtained by evaluating the aquifer vulnerability. Aquifer vulnerability is an intrinsic property of groundwater which gives the possibility of percolation and diffusion of contaminants from the ground surface into the subsurface. Aquifer vulnerability to pollution was evaluated for the phreatic aquifer in Douala using the DRASTIC method. DRASTIC is a groundwater quality model representing; Depth to Water, Net Recharge, Aquifer Media, Soil Media, Topography, Impact of vadose Zones, and Hydraulic Conductivity. From data, five thematic maps were generated and an intrinsic vulnerability map was developed based upon calculations of DRASTIC Indices (D.I). The D.I for the different inhabited quarters were; Bonamoussadi (BS) = 145, Bali (BA) = 138, Bonapriso (BP) = 140, Airport(AP) = 129, Ndogbong(ND) = 120, Bepanda(BE) = 130, Vallee Besengue (VB) = 134, New Bell (NB) = 125, Bonassama BM) = 128 and Rail(RA) = 167. ArcGIS quantile classification subdivided the area into four groups; very low, low, moderate and high ground water vulnerability risk zones covering about 30%, 30%, 20% and 20% of the study area respectively. An in-depth study is recommended to give a detailed perspective to the evolution and nature of actual pollution in the area. (C) 2014 Elsevier Ltd. All rights reserved.	[Neh, Akenji Victorine] Univ Buea, Dept Environm Sci, Buea, Cameroon; [Ako, Andrew Ako] Hydrol Res Ctr Yaounde, Yaounde, Cameroon; [Ayuk, Akoachere Richard, II] Univ Buea, Dept Geol, Buea, Cameroon; [Hosono, Takahiro] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8608555, Japan	Ako, AA (reprint author), Hydrol Res Ctr Yaounde, P Box 4110, Yaounde, Cameroon.	akenjivictorine@yahoo.com; akoandrewako@yahoo.com; rakoachere@gmail.com; hosono@kumamoto-u.ac.jp					ALAYAMANI M.S., 1993, GROUND WATER, V31, P551; Alter L., 1987, NWWA EPA SERIES; Yin LH, 2013, ENVIRON EARTH SCI, V69, P171, DOI 10.1007/s12665-012-1945-z; Babiker IS, 2005, SCI TOTAL ENVIRON, V345, P127, DOI 10.1016/j.scitotenv.2004.11.005; EVANS BM, 1990, J SOIL WATER CONSERV, V45, P242; Kim YJ, 1999, HYDROGEOL J, V7, P227, DOI 10.1007/s100400050195; Leone A, 2009, J ENVIRON MANAGE, V90, P2969, DOI 10.1016/j.jenvman.2007.08.009; Thapinta A, 2003, ENVIRON INT, V29, P87, DOI 10.1016/S0160-4120(02)00149-6; Napolitano P, 1996, IAHS-AISH P, P559; Rahman A, 2008, APPL GEOGR, V28, P32, DOI 10.1016/j.apgeog.2007.07.008; Bai LP, 2012, WATER ENVIRON J, V26, P381, DOI 10.1111/j.1747-6593.2011.00298.x; Neshat A, 2014, RESOUR CONSERV RECY, V86, P74, DOI 10.1016/j.resconrec.2014.02.008; Fritch TG, 2000, ENVIRON MANAGE, V25, P337, DOI 10.1007/s002679910026; Al-Adamat RAN, 2003, APPL GEOGR, V23, P303, DOI 10.1016/j.apgeog.2003.08.007; Anwar P., 2003, HYDROLOGY WATERSHED, P399; Avery B.W., 1980, SOIL SURVEY TECHNICA, V14; Barbash J.E., 1996, PESTICIDES GROUNDWAT; Barber C., 1993, J AUST GEOL GEOPHYS, V14, P1147; Chitsazan M, 2009, WATER RESOUR MANAG, V23, P1137, DOI 10.1007/s11269-008-9319-8; Djuikom E., 2011, Journal of Applied Biosciences, V37, P2434; Eneke GT, 2011, INT J ENVIRON RES, V5, P475; Feumba R., 2011, Journal of Water Resource and Protection, V3, P607, DOI 10.4236/jwarp.2011.38070; Fraga CM, 2013, REM-REV ESC MINAS, V66, P49, DOI 10.1590/S0370-44672013000100007; Gee G.W., 2004, CHLORIDE MASS BALANC; Hallaq A.A., 2011, NAJAH U J RES NAT SC, V25; Hamza MH, 2007, J ENVIRON MANAGE, V84, P12, DOI 10.1016/j.jenvman.2006.04.004; Insaf S., 2005, SCI TOTAL ENVIRON, V345, P127; Jawed I., 2012, ASIAN J WATER ENV PO, V9, P105; Katte V.Y., 2003, AFR WATER J, P43; Knox R, 1993, SUBSURFACE TRANSPORT; Lobo EA, 2004, VIE MILIEU, V54, P105; Lodwick W. A., 1990, International Journal of Geographical Information Systems, V4, DOI 10.1080/02693799008941556; Mafany G.T., 1999, THESIS BUEA U CAMERO; Margat J, 1968, 68SGC198HYD BRGM; MERCHANT JW, 1994, PHOTOGRAMM ENG REM S, V60, P1117; Ndjama J., 2008, AFR J ENV SCI TECHNO, V2, P422; Osborn N.I., 1998, 985 OKL WAT RES BOAR; Prior J.C., 2003, IOWA GEOLOGICAL SURV, V6; Rosen L, 1994, 37 C INT ASS GREAT L, P166; Saatsaz Masoud, 2011, International Journal of Water, V6, DOI 10.1504/IJW.2011.043313; Samake M., 2010, J SUSTAIN DEV, V3, P2; Tamfu S., 1995, NATL HYDROCARBON J C, V3, P6; Tesoriero AJ, 1998, P SOURC WAT ASS PROT, P157; Tilahun K, 2010, ENVIRON EARTH SCI, V59, P1485, DOI 10.1007/s12665-009-0134-1; Voudouris K., 2004, HYDROTECHNIKA J HELE, V14, P17; Voudouris K, 2010, EUR WATER, V30, P13; Worrall F, 2005, J HYDROL, V303, P92, DOI 10.1016/j.jhydrol.2004.08.019	47	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1464-343X	1879-1956		J AFR EARTH SCI	J. Afr. Earth Sci.	FEB	2015	102						180	190		10.1016/j.jafrearsci.2014.11.001		11	Geosciences, Multidisciplinary	Geology	CA0QJ	WOS:000348621500014		
J	Nanatani, K; Shijuku, T; Takano, Y; Zulkifli, L; Yamazaki, T; Tominaga, A; Souma, S; Onai, K; Morishita, M; Ishiura, M; Hagemann, M; Suzuki, I; Maruyama, H; Arai, F; Uozumi, N				Nanatani, Kei; Shijuku, Toshiaki; Takano, Yousuke; Zulkifli, Lalu; Yamazaki, Tomoko; Tominaga, Akira; Souma, Satoshi; Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro; Hagemann, Martin; Suzuki, Iwane; Maruyama, Hisataka; Arai, Fumihito; Uozumi, Nobuyuki			Comparative Analysis of kdp and ktr Mutants Reveals Distinct Roles of the Potassium Transporters in the Model Cyanobacterium Synechocystis sp Strain PCC 6803	JOURNAL OF BACTERIOLOGY			English	Article							NITROGEN-FIXING CYANOBACTERIUM; DEPENDENT K+ UPTAKE; ESCHERICHIA-COLI; TRANSMEMBRANE TOPOLOGY; CIRCADIAN REGULATION; ANABAENA-TORULOSA; BACILLUS-SUBTILIS; OSMOTIC-STRESS; HIGH-AFFINITY; SP PCC-6803	Photoautotrophic bacteria have developed mechanisms to maintain K+ homeostasis under conditions of changing ionic concentrations in the environment. Synechocystis sp. strain PCC 6803 contains genes encoding a well-characterized Ktr-type K+ uptake transporter (Ktr) and a putative ATP-dependent transporter specific for K+ (Kdp). The contributions of each of these K+ transport systems to cellular K+ homeostasis have not yet been defined conclusively. To verify the functionality of Kdp, kdp genes were expressed in Escherichia coli, where Kdp conferred K+ uptake, albeit with lower rates than were conferred by Ktr. An on-chip microfluidic device enabled monitoring of the biphasic initial volume recovery of single Synechocystis cells after hyperosmotic shock. Here, Ktr functioned as the primary K+ uptake system during the first recovery phase, whereas Kdp did not contribute significantly. The expression of the kdp operon in Synechocystis was induced by extracellular K+ depletion. Correspondingly, Kdp-mediated K+ uptake supported Synechocystis cell growth with trace amounts of external potassium. This induction of kdp expression depended on two adjacent genes, hik20 and rre19, encoding a putative two-component system. The circadian expression of kdp and ktr peaked at subjective dawn, which may support the acquisition of K+ required for the regular diurnal photosynthetic metabolism. These results indicate that Kdp contributes to the maintenance of a basal intracellular K+ concentration under conditions of limited K+ in natural environments, whereas Ktr mediates fast potassium movements in the presence of greater K+ availability. Through their distinct activities, both Ktr and Kdp coordinate the responses of Synechocystis to changes in K+ levels under fluctuating environmental conditions.	[Nanatani, Kei; Shijuku, Toshiaki; Takano, Yousuke; Zulkifli, Lalu; Tominaga, Akira; Souma, Satoshi; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi, Japan; [Yamazaki, Tomoko] Nagoya Univ, Sch Agr Sci, Nagoya, Aichi 4648601, Japan; [Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan; [Hagemann, Martin] Univ Rostock, Dept Plant Physiol, D-18055 Rostock, Germany; [Suzuki, Iwane] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Maruyama, Hisataka; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Dept Micronano Syst Engn, Nagoya, Aichi 4648601, Japan	Uozumi, N (reprint author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi, Japan.	uozumi@biophy.che.tohoku.ac.jp			Japan Society for the Promotion of Science [24246045, 24580100, 24658090, 25292055]	This work was supported by the Japan Society for the Promotion of Science (grants 24246045, 24580100, 24658090, and 25292055).	Alahari A, 2001, J BACTERIOL, V183, P5778, DOI 10.1128/JB.183.19.5778-5781.2001; ALTENDORF K, 1992, ANN NY ACAD SCI, V671, P228, DOI 10.1111/j.1749-6632.1992.tb43799.x; Altendorf K, 1998, ACTA PHYSIOL SCAND, V163, P137; Wakamoto Y, 2005, ANALYST, V130, P311, DOI 10.1039/b409860a; Akai M, 2012, J BACTERIOL, V194, P6828, DOI 10.1128/JB.01665-12; Durell SR, 1999, BIOPHYS J, V77, P775; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; Alahari A, 1998, MICROBIOL-UK, V144, P1557; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; Chen ZH, 2012, PLANT PHYSIOL, V159, P1235, DOI 10.1104/pp.112.197350; RHOADS DB, 1976, J GEN PHYSIOL, V67, P325, DOI 10.1085/jgp.67.3.325; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Durell SR, 1999, BIOPHYS J, V77, P789; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Yang AHJ, 2009, NATURE, V457, P71, DOI 10.1038/nature07593; Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113; Peng CC, 2013, LAB CHIP, V13, P3239, DOI 10.1039/c3lc50388g; Gassel M, 1999, J BIOL CHEM, V274, P37901; AOKI S, 1995, J BACTERIOL, V177, P5606; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; Kato N, 2007, CHANNELS, V1, P161; Checchetto V, 2012, P NATL ACAD SCI USA, V109, P11043, DOI 10.1073/pnas.1205960109; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678; Ballal A, 2002, ARCH MICROBIOL, V178, P141, DOI 10.1007/s00203-002-0435-1; Ballal A, 2005, APPL ENVIRON MICROB, V71, P5297, DOI 10.1128/AEM.71.9.5297-5303.2005; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Durell SR, 2000, BIOPHYS J, V78, P188; Escassi L, 2002, PLANTA, V214, P759, DOI 10.1007/s004250100669; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Grundling A, 2013, MBIO, V4, DOI 10.1128/mBio.00784-13; Haupt M, 2005, J MOL MICROB BIOTECH, V10, P120, DOI 10.1159/000091559; Itri JN, 2010, J NEUROPHYSIOL, V103, P632, DOI 10.1152/jn.00670.2009; Kim MJ, 2011, LAB CHIP, V11, P104, DOI 10.1039/c0lc00110d; Kimura S, 2009, MICROBIOL-SGM, V155, P2256, DOI 10.1099/mic.0.028514-0; KONDO T, 1983, PLANT CELL PHYSIOL, V24, P659; Kucho K, 2005, GENES GENET SYST, V80, P19, DOI 10.1266/ggs.80.19; Los Dmitry A., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P221; Marin K, 2006, MICROBIOL-SGM, V152, P2023, DOI 10.1099/mic.0.28771-0; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Miller J. H., 1972, EXPT MOL GENETICS; Moshelion M, 2002, PLANT PHYSIOL, V128, P634, DOI [10.1104/pp.010549, 10.1104/pp.128.2.634]; Nanatani K, 2013, CHANNELS, V7, P238, DOI 10.4161/chan.25350; Price-Whelan A, 2013, MBIO, V4, DOI 10.1128/mBio.00407-13; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; REED RH, 1985, FEMS MICROBIOL LETT, V28, P225, DOI 10.1111/j.1574-6968.1985.tb00796.x; Sato Y, 2014, J BIOCHEM, V155, P315, DOI 10.1093/jb/mvu007; SIEBERS A, 1989, J BIOL CHEM, V264, P5831; Simonetta SH, 2008, J COMP PHYSIOL A, V194, P821, DOI 10.1007/s00359-008-0353-z; SNAITH PJ, 1986, J EXP BOT, V37, P188, DOI 10.1093/jxb/37.2.188; SWEENEY BM, 1974, PLANT PHYSIOL, V53, P337, DOI 10.1104/pp.53.3.337; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; Zanetti M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010118; Zulkifli L, 2006, J BACTERIOL, V188, P7985, DOI 10.1128/JB.00886-06; Zulkifli L, 2010, J BACTERIOL, V192, P5063, DOI 10.1128/JB.00569-10	65	3	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	FEB	2015	197	4					676	687		10.1128/JB.02276-14		12	Microbiology	Microbiology	AZ5RN	WOS:000348277600003		
J	Passmore, IJ; Nishikawa, K; Lilley, KS; Bowden, SD; Chung, JCS; Welch, M				Passmore, Ian J.; Nishikawa, Kahoko; Lilley, Kathryn S.; Bowden, Steven D.; Chung, Jade C. S.; Welch, Martin			Mep72, a Metzincin Protease That Is Preferentially Secreted by Biofilms of Pseudomonas aeruginosa	JOURNAL OF BACTERIOLOGY			English	Article							EXTRACELLULAR-MATRIX; BACTERIAL BIOFILMS; CYSTIC-FIBROSIS; ANTIBIOTIC SUSCEPTIBILITY; PERSISTENT INFECTIONS; GENE-EXPRESSION; III SECRETION; EXOENZYME S; IDENTIFICATION; PROTEINS	In this work, we compared the profile of proteins secreted by planktonic and biofilm cultures of Pseudomonas aeruginosa using two-dimensional difference gel electrophoresis (2D-DiGE). This revealed that a novel metzincin protease, Mep72, was secreted during biofilm growth. Subsequent Western blotting and reverse transcription-PCR (RT-PCR) analyses demonstrated that Mep72 was expressed only during biofilm growth. Mep72 has a tridomain structure comprised of a metzincin protease-like domain and two tandem carbohydrate-binding domains. Unlike the only other metzincin (alkaline protease; AprA) in P. aeruginosa, Mep72 is secreted through the type II pathway and undergoes processing during export. During this processing, the metzincin domain is liberated from the carbohydrate-binding domains. This processing may be self-catalyzed, since purified Mep72 autodegraded in vitro. This autodegradation was retarded in the presence of alginate (an extracellular matrix component of many P. aeruginosa biofilms). The expression of full-length mep72 in Escherichia coli was toxic. However, this toxicity could be alleviated by coexpression of mep72 with the adjacent gene, bamI. Mep72 and BamI were found to form a protein-protein complex in vitro. 2D-DiGE revealed that the electrophoretic mobility of several discrete protein spots was altered in the biofilm secretome of an mep72 mutant, including type III secretion proteins (PopD, PcrV, and ExoS) and a flagellum-associated protein (FliD). Mep72 was found to bind directly to ExoS and PcrV and to affect the processing of these proteins in the biofilm secretome. We conclude that Mep72 is a secreted biofilm-specific regulator that affects the processing of a very specific subset of virulence factors.	[Passmore, Ian J.; Nishikawa, Kahoko; Lilley, Kathryn S.; Bowden, Steven D.; Chung, Jade C. S.; Welch, Martin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Nishikawa, Kahoko] Natl Def Med Coll, Dept Traumatol & Crit Care Med, Saitama, Japan	Welch, M (reprint author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mw240@cam.ac.uk			BBSRC; Isaac Newton Trust (Cambridge); Japanese Society for Acute Infection	This study was funded by the BBSRC, the Isaac Newton Trust (Cambridge), and a grant from the Japanese Society for Acute Infection to K.N.	GILKES NR, 1991, MICROBIOL REV, V55, P303; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1623, DOI 10.1128/AAC.50.5.1623-1627.2006; Purschke FG, 2012, MOL CELL PROTEOMICS, V11, P1652, DOI 10.1074/mcp.M112.017673; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Sarkisova S, 2005, J BACTERIOL, V187, P4327, DOI 10.1128/JB.187.13.4327-4337.2005; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Bardoel BW, 2012, J MOL BIOL, V415, P573, DOI 10.1016/j.jmb.2011.11.039; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6579.2005; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; LAM J, 1980, INFECT IMMUN, V28, P546; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1615, DOI 10.1128/AAC.50.5.1615-1622.2006; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Govan JRW, 1996, MICROBIOL REV, V60, P539; Yahr TL, 1997, J BACTERIOL, V179, P7165; Patell S, 2010, ENV MICROBIOL REP, V2, P440, DOI 10.1111/j.1758-2229.2010.00158.x; Schaber JA, 2007, INFECT IMMUN, V75, P3715, DOI 10.1128/IAI.00586-07; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; Braun P, 1998, J BACTERIOL, V180, P3467; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; Van Delden C, 1998, EMERG INFECT DIS, V4, P551; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Hege T, 2001, J BIOL CHEM, V276, P35087, DOI 10.1074/jbc.M104020200; Arevalo-Ferro C, 2003, ENVIRON MICROBIOL, V5, P1350, DOI 10.1046/j.1462-2920.2003.00532.x; Ball G, 1999, J BACTERIOL, V181, P382; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bode W, 1996, ADV EXP MED BIOL, V389, P1; Caballero AR, 2001, ANAL BIOCHEM, V290, P330, DOI 10.1006/abio.2001.4999; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Feltzer RE, 2000, J BIOL CHEM, V275, P21002, DOI 10.1074/jbc.M002088200; Hentzer M., 2005, BIOFILMS, V2, P37, DOI 10.1017/S1479050505001699; Horsman SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046826; Kim EJ, 2005, MICROBIOL-SGM, V151, P1127, DOI 10.1099/mic.0.27566-0; Kwon DH, 2007, ANTIMICROB AGENTS CH, V51, P2070, DOI 10.1128/AAC.01472-06; Mikkelsen H, 2009, MICROBIOL-SGM, V155, P687, DOI 10.1099/mic.0.025551-0; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	54	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0021-9193	1098-5530		J BACTERIOL	J. Bacteriol.	FEB	2015	197	4					762	773		10.1128/JB.02404-14		12	Microbiology	Microbiology	AZ5RN	WOS:000348277600011		
J	Washio, A; Nakagawa, A; Nishihara, T; Maeda, H; Kitamura, C				Washio, Ayako; Nakagawa, Aika; Nishihara, Tatsuji; Maeda, Hidefumi; Kitamura, Chiaki			Physicochemical properties of newly developed bioactive glass cement and its effects on various cells	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						bioactive glass; biocompatibility; hydroxyapatite; pulp capping; endodontic treatment	MINERAL TRIOXIDE AGGREGATE; PORTLAND-CEMENT; DENTIN; WHITE; CYTOTOXICITY; BIOGLASS(R); SURFACE; MTA	Biomaterials used in dental treatments are expected to have favorable properties such as biocompatibility and an ability to induce tissue formation in dental pulp and periapical tissue, as well as sealing to block external stimuli. Bioactive glasses have been applied in bone engineering, but rarely applied in the field of dentistry. In the present study, bioactive glass cement for dental treatment was developed, and then its physicochemical properties and effects on cell responses were analyzed. To clarify the physicochemical attributes of the cement, field emission scanning electron microscopy, X-ray diffraction, and pH measurement were carried out. Cell attachment, morphology, and viability to the cement were also examined to clarify the effects of the cement on odontoblast-like cells (KN-3 cells), osteoblastic cells (MC3T3-E1 cells), human periodontal ligament stem/progenitor cells and neuro-differentiative cells (PC-12 cells). Hydroxyapatite-like precipitation was formed on the surface of the hardened cement and the pH level changed from pH10 to pH9, then stabilized in simulate body fluid. The cement had no cytotxic effects on these cells, and particulary induced process elongation of PC-12 cells. Our results suggest that the newly developed bioactive glass cement have capability of the application in dental procedures as bioactive cement. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 373-380, 2015.	[Washio, Ayako; Nakagawa, Aika; Kitamura, Chiaki] Kyushu Dent Univ, Div Endodont & Restorat Dent, Dept Sci Oral Funct, Kitakyushu, Fukuoka, Japan; [Nishihara, Tatsuji] Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan; [Maeda, Hidefumi] Kyushu Univ, Dept Endodontol & Operat Dent, Div Oral Rehabil, Fukuoka 812, Japan	Kitamura, C (reprint author), Kyushu Dent Univ, Div Endodont & Restorat Dent, Dept Sci Oral Funct, Kitakyushu, Fukuoka, Japan.	chi-aki-k@kyu-dent.ac.jp			Ministry of Education, Science, and Culture of Japan	This research was supported by Grants-in-Aid for Scientific Research (Kitamura, Washio) from the Ministry of Education, Science, and Culture of Japan.	Al-Daafas A, 2007, ORAL SURG ORAL MED O, V103, P92; Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011; Yuan ZL, 2010, J ENDODONT, V36, P1145, DOI 10.1016/j.joen.2010.03.025; Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9; Dammaschke T, 2005, DENT MATER, V21, P731, DOI 10.1016/j.dental.2005.01.019; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Paranjpe A, 2010, J ENDODONT, V36, P1042, DOI 10.1016/j.joen.2010.02.013; Kuo TC, 2007, J ENDODONT, V33, P451, DOI 10.1016/j.joen.2006.12.014; Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3; Bakry AS, 2011, J DENT RES, V90, P246, DOI 10.1177/0022034510387793; Bakry AS, 2009, IADR GEN SESS MIAM F; Bakry AS, 2011, J DENT, V39, P9599; Bramante CM, 2008, ORAL SURG ORAL MED O, V106, P909, DOI 10.1016/j.tripleo.2008.07.018; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Lutz-Christian G, 2010, MATERIALS, V3, P3867; Makkawy HAM, 1998, J ENDODONT, V24, P477, DOI 10.1016/S0099-2399(98)80050-2; Nomiyama K, 2007, J ENDODONT, V33, P118; OGUNTEBI B, 1993, J DENT RES, V72, P484, DOI 10.1177/00220345930720020301; Okiji T, 2009, INT J DENT, V2009, DOI 10.1155/2009/464280; Torabinejad M, 1999, J ENDODONT, V25, P97; Zhao DS, 2008, ACTA BIOMATER, V4, P1118, DOI 10.1016/j.actbio.2008.02.012	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	FEB	2015	103	2					373	380		10.1002/jbm.b.33209		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AZ7TD	WOS:000348419700014		
J	Kawajiri, H; Mizuno, T; Moriwaki, T; Ishibashi-Ueda, H; Yamanami, M; Kanda, K; Yaku, H; Nakayama, Y				Kawajiri, Hidetake; Mizuno, Takeshi; Moriwaki, Takeshi; Ishibashi-Ueda, Hatsue; Yamanami, Masashi; Kanda, Keiichi; Yaku, Hitoshi; Nakayama, Yasuhide			Development of tissue-engineered self-expandable aortic stent grafts (Bio stent grafts) using in-body tissue architecture technology in beagles	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						endovascular aortic repair (EVAR); covered stents; connective tissue; in vivo tissue engineering; stent graft	ANEURYSM REPAIR; AORTOENTERIC FISTULA; CLINICAL-TRIALS; MODEL; VALVE	In this study, we aimed to describe the development of tissue-engineered self-expandable aortic stent grafts (Bio stent graft) using in-body tissue architecture technology in beagles and to determine its mechanical and histological properties. The preparation mold was assembled by insertion of an acryl rod (outer diameter, 8.6 mm; length, 40 mm) into a self-expanding nitinol stent (internal diameter, 9.0 mm; length, 35 mm). The molds (n=6) were embedded into the subcutaneous pouches of three beagles for 4 weeks. After harvesting and removing each rod, the excessive fragile tissue connected around the molds was trimmed, and thus tubular autologous connective tissues with the stent were obtained for use as Bio stent grafts (outer diameter, approximately 9.3 mm in all molds). The stent strut was completely surrounded by the dense collagenous membrane (thickness, approximate to 150 mu m). The Bio stent graft luminal surface was extremely flat and smooth. The graft wall of the Bio stent graft possessed an elastic modulus that was almost two times higher than that of the native beagle abdominal aorta. This Bio stent graft is expected to exhibit excellent biocompatibility after being implanted in the aorta, which may reduce the risk of type 1 endoleaks or migration. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 381-386, 2015.	[Kawajiri, Hidetake; Mizuno, Takeshi; Moriwaki, Takeshi; Yamanami, Masashi; Nakayama, Yasuhide] Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, Osaka, Japan; [Kawajiri, Hidetake; Yamanami, Masashi; Kanda, Keiichi; Yaku, Hitoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Surg, Kyoto, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Pathol, Osaka, Japan	Nakayama, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Div Med Engn & Mat, Osaka, Japan.	ny@ncvc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [B23360374, B25293299]	Contract grant sponsor: Grant-in-Aid for Scientific Research; contract grant number: B23360374, B25293299, from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Chenu C, 2009, EUR J VASC ENDOVASC, V37, P401, DOI 10.1016/j.ejvs.2008.11.037; Danneels MIL, 2006, EUR J VASC ENDOVASC, V32, P27, DOI 10.1016/j.ejvs.2005.11.031; Fatima J, 2013, J VASC SURG, V58, P371, DOI 10.1016/j.jvs.2013.01.047; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; Torsello G, 2011, J VASC SURG, V54, P300, DOI 10.1016/j.jvs.2010.12.062; Yamanami M, 2010, CIRCULATION, V122, pS100, DOI 10.1161/CIRCULATIONAHA.109.922211; DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Hayashida K, 2007, J THORAC CARDIOV SUR, V134, P152, DOI 10.1016/j.jtcvs.2007.01.087; Hoshina K, 2011, INT ANGIOL, V30, P467; Brinster CJ, 2011, J VASC SURG, V54, P42, DOI 10.1016/j.jvs.2010.12.042; D'Elia P, 2009, J CARDIOVASC SURG, V50, P165; Garcia-Toca M, 2010, J VASC SURG, V52, p22S, DOI 10.1016/j.jvs.2010.06.140; Knepper J, 2010, SEMIN VASC SURG, V23, P170, DOI 10.1053/j.semvascsurg.2010.05.005; Kubota Suguru, 2013, Gen Thorac Cardiovasc Surg, V61, P560, DOI 10.1007/s11748-013-0280-y; Nakayama Y, 2007, J ARTIF ORGANS, V10, P171, DOI 10.1007/s10047-007-0376-1; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Prinssen M, 2004, EUR J VASC ENDOVASC, V27, P121, DOI 10.1016/j.ejvs.2003.11.006; Sayeed S, 2006, J CARDIOVASC SURG, V47, P251; Takewa Y, 2012, J ARTIF ORGANS, V16, P176; Watanabe T, 2005, ARTIF ORGANS, V29, P733	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	FEB	2015	103	2					381	386		10.1002/jbm.b.33218		6	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AZ7TD	WOS:000348419700015		
J	Kitamura, T; Takegata, M; Haruna, M; Yoshida, K; Yamashita, H; Murakami, M; Goto, Y				Kitamura, Toshinori; Takegata, Mizuki; Haruna, Megumi; Yoshida, Keiko; Yamashita, Hiroshi; Murakami, Mikihiko; Goto, Yoshitaka			The Mother-Infant Bonding Scale: Factor Structure and Psychosocial Correlates of Parental Bonding Disorders in Japan	JOURNAL OF CHILD AND FAMILY STUDIES			English	Article						Child; Parental bonding disorder; Mother-Infant Bonding Scale; Attachment; Gender difference	HOSPITAL ANXIETY; DEPRESSION SCALE; POSTNATAL-PERIOD; MATERNAL MOOD; POSTPARTUM; QUESTIONNAIRES; VALIDATION; ATTACHMENT; VALIDITY; VERSION	Bonding disorders towards their child has been recognized as a serious problem, which might lead to give adverse effects on the relationship with child or maltreatment towards their child. The aim of this study was to identify the factor structure of the Mother-Infant Bonding Scale (MIBS) as well as the determinants of parental bonding disorders in Japan. In this cross-sectional observational study, the MIBS and other psychosocial questionnaires were distributed to 396 fathers and 733 mothers of children aged between 0 and 10, at 20 clinics of Kumamoto prefecture, in Japan. An exploratory factor analysis of the MIBS revealed a two-factor structure: lack of affection (LA) and anger and rejection (AR). A confirmatory factor analysis demonstrated its cross-validity, with no statistical differences between fathers and mothers. A multi-group analysis using structural equation modelling demonstrated that LA and AR were predicted by parental dysphoric mood while only AR was predicted by parental anger. To be concluded, the current study suggests that the MIBS has two subscales that can be predicted by intrapersonal and interpersonal variables, and may provide information applicable to the design of therapeutic or preventive approaches to parents with bonding disorders.	[Kitamura, Toshinori; Takegata, Mizuki] Kitamura Inst Mental Hlth Tokyo, Minato Ku, Tokyo 1070052, Japan; [Haruna, Megumi] Univ Tokyo, Grad Sch Med, Dept Midwifery & Womens Hlth, Div Hlth Sci & Nursing, Tokyo, Japan; [Yoshida, Keiko; Yamashita, Hiroshi] Kyushu Univ Hosp, Dept Child Psychiat, Fukuoka 812, Japan; [Murakami, Mikihiko; Goto, Yoshitaka] Kumamoto Paediat Assoc, Kumamoto, Japan	Kitamura, T (reprint author), Kitamura Inst Mental Hlth Tokyo, Minato Ku, 101 Akasaka 8-5-13, Tokyo 1070052, Japan.	kitamura@institute-of-mental-health.jp					Kokubu M, 2012, ARCH WOMEN MENT HLTH, V15, P211, DOI 10.1007/s00737-012-0279-x; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Taylor A, 2005, ARCH WOMEN MENT HLTH, V8, P45, DOI 10.1007/s00737-005-0074-z; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P233, DOI 10.1007/s00737-006-0132-1; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037//0022-3514.61.2.226; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Arbuckle J. L., 1955, AMOS 4 0 USERS GUIDE; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Bienfait M, 2011, EARLY HUM DEV, V87, P281, DOI 10.1016/j.earlhumdev.2011.01.031; Bland J. M., 1997, BRIT MED J, V314, P314, DOI DOI 10.1136/BMJ.314.7080.572; Bowby J., 1969, ATTACHMENT LOSS ATTA, V1; Brockington I, 1996, MOTHERHOOD MENTAL HL; Brockington I, 2011, PSYCHOPATHOLOGY, V44, P329, DOI 10.1159/000325058; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P243, DOI 10.1007/s00737-006-0133-0; Caughy MO, 2009, J CHILD FAM STUD, V18, P10, DOI 10.1007/s10826-008-9201-6; Edhborg M, 2011, ARCH WOMEN MENT HLTH, V14, P307, DOI 10.1007/s00737-011-0221-7; Griffin D., 1994, ADV PERSONAL RELATIO, V5, P17; Kitamura T., 1993, ARCH PSYCHIAT DIAGNO, V4, P371; Kitamura Toshinori, 2004, World Psychiatry, V3, P100; Kumar RC, 1997, BRIT J PSYCHIAT, V171, P175, DOI 10.1192/bjp.171.2.175; Lengua LJ, 2005, J APPL DEV PSYCHOL, V26, P21, DOI 10.1016/j.appdev.2004.10.001; Lu X., 2008, OPEN FAMILY STUDIES, V1, P17, DOI 10.2174/1874922400801010017; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; Matsuoka N, 2006, HLTH ARCH WOMENS MEN, V9, P23; Moehler E, 2006, ARCH WOMEN MENT HLTH, V9, P273, DOI 10.1007/s00737-006-0149-5; Nagata M, 2003, PSYCHOPATHOLOGY, V36, P142, DOI 10.1159/000071259; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23; Sedlar G, 2001, J FAM VIOLENCE, V16, P361, DOI 10.1023/A:1012220809344; Spielberger C. D, 1988, MANUAL STATE TRAIT A; Suzuki T., 1994, JAPANESE J HLTH PSYC, V7, P1; van Bussel JCH, 2010, ARCH WOMEN MENT HLTH, V13, P373, DOI 10.1007/s00737-009-0140-z; Wittkowski A, 2007, ARCH WOMEN MENT HLTH, V10, P171, DOI 10.1007/s00737-007-0191-y; Yalcin SS, 2010, PAEDIATR PERINAT EP, V24, P584, DOI 10.1111/j.1365-3016.2010.01150.x; Yoshida K, 2012, ARCH WOMEN MENT HLTH, V15, P343, DOI 10.1007/s00737-012-0291-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1062-1024	1573-2843		J CHILD FAM STUD	J. Child Fam. Stud.	FEB	2015	24	2					393	401		10.1007/s10826-013-9849-4		9	Family Studies; Psychology, Developmental; Psychiatry	Family Studies; Psychology; Psychiatry	AZ7KJ	WOS:000348397700016		
J	Tsuji, K; Shibuya, Y; Akashi, M; Furudoi, S; Yakushijin, K; Kawamoto, S; Okamura, A; Matsuoka, H; Komori, T				Tsuji, K.; Shibuya, Y.; Akashi, M.; Furudoi, S.; Yakushijin, K.; Kawamoto, S.; Okamura, A.; Matsuoka, H.; Komori, T.			Prospective Study of Dental Intervention for Hematopoietic Malignancy	JOURNAL OF DENTAL RESEARCH			English	Article						chemotherapy; myelosuppressive grade; inflammation; dental treatment protocol; odontogenic infection; oral hygiene	STEM-CELL TRANSPLANTATION; C-REACTIVE PROTEIN; HEMATOLOGIC MALIGNANCIES; CANCER-PATIENTS; CHEMOTHERAPY; MANAGEMENT; SEPTICEMIA; RECIPIENTS; PERIODONTITIS; INFECTION	Various chemotherapeutic agents used in patients with hematopoietic malignancy cause serious side effects, including myelosuppression and immunosuppression. Immunosuppression makes patients more susceptible to infection, resulting in an increased risk of infectious complications, including the development of severe septicemia that may be life-threatening. It is necessary for dental staff to be familiar with an appropriate protocol in such cases and to share information about the chemotherapy with a hematologist. To verify the effectiveness of our dental intervention protocol, we conducted a prospective study on the incidence of complications for each myelosuppressive grade of chemotherapy in patients with hematopoietic malignancy. We compared the incidence of complications between treatment P (patients who finished all the dental treatments according to the protocol) and treatment Q (patients who did not) per grade (A, B, C, D) and incidence of systemic or oral findings. We also compared the incidence of oral complication related to the residual teeth between first chemo (patients who were undergoing chemotherapy for the first time) and prior chemo (not the first time). There were significant differences in inflammatory complications between treatment P and treatment Q. We found that both systemic and oral inflammatory complications increased with higher-grade myelosuppressive chemotherapy. Additionally, there was a significant difference between the incidence of oral complications related to the residual teeth between first chemo and prior chemo. Complete implementation of the dental intervention protocol was associated with fewer oral and systemic infectious and inflammatory complications in patients with hematopoietic malignancies undergoing chemotherapy. The incidence of oral and systemic complications also increased with grade of chemotherapy. These results support the validity of our dental intervention protocol. We should pay close attention to the oral state of de novo hematopoietic malignancy patients.	[Tsuji, K.; Akashi, M.; Furudoi, S.; Komori, T.] Kobe Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med, Chuo Ku, Kobe, Hyogo 657, Japan; [Shibuya, Y.] Nagoya City Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Yakushijin, K.; Kawamoto, S.; Okamura, A.; Matsuoka, H.] Kobe Univ, Div Med Oncol Hematol, Dept Med, Grad Sch Med,Chuo Ku, Kobe, Hyogo 657, Japan	Shibuya, Y (reprint author), Nagoya City Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	shibuya@med.nagoya-cu.ac.jp					Akashi M, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-41; Akintoye SO, 2002, ORAL SURG ORAL MED O, V94, P581, DOI 10.1067/moe.2002.128960; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Yamagata K, 2011, ORAL SURG ORAL MED O, V111, P146, DOI 10.1016/j.tripleo.2010.09.006; Raber-Durlacher JE, 2013, SUPPORT CARE CANCER, V21, P1621, DOI 10.1007/s00520-012-1706-2; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Yamagata K, 2006, BONE MARROW TRANSPL, V38, P237, DOI 10.1038/sj.bmt.1705429; Toljanic JA, 1999, CANCER, V85, P1843, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1843::AID-CNCR26>3.0.CO;2-R; Raber-Durlacher JE, 2002, SUPPORT CARE CANCER, V10, P466, DOI 10.1007/s00520-002-0346-3; Appelbaum FR, 1996, CA-CANCER J CLIN, V46, P142, DOI 10.3322/canjclin.46.3.142; Barker GJ, 1999, SUPPORT CARE CANCER, V7, P17, DOI 10.1007/s005200050217; BERGMANN OJ, 1988, J CLIN MICROBIOL, V26, P2105; Boku H, 1984, Nihon Shishubyo Gakkai Kaishi, V26, P329; Chopra Rahul, 2012, J Indian Soc Periodontol, V16, P28, DOI 10.4103/0972-124X.94600; Elad S, 2003, SUPPORT CARE CANCER, V11, P674, DOI 10.1007/s00520-003-0499-8; Fernandes MJ, 2009, BRIT DENT J, V207, DOI 10.1038/sj.bdj.2009.804; Ishikawa A, 2008, J DENT RES, V87, P594; Iwamoto Y, 2003, J PERIODONTOL, V74, P1231, DOI 10.1902/jop.2003.74.8.1231; Melkos A B, 2003, Clin Oral Investig, V7, P113, DOI 10.1007/s00784-003-0209-4; Miller P D Jr, 1985, Int J Periodontics Restorative Dent, V5, P8; TAI CCE, 1994, ORAL SURG ORAL MED O, V78, P151, DOI 10.1016/0030-4220(94)90138-4; Tomblyn M, 2009, BONE MARROW TRANSPL, V44, P453, DOI 10.1038/bmt.2009.254	22	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	FEB	2015	94	2					289	296		10.1177/0022034514561768		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA1BO	WOS:000348647900007		
J	Asakawa-Tanne, Y; Su, S; Kunimatsu, R; Hirose, N; Mitsuyoshi, T; Okamoto, Y; Tanaka, E; Tanne, K; Tanimoto, K				Asakawa-Tanne, Y.; Su, S.; Kunimatsu, R.; Hirose, N.; Mitsuyoshi, T.; Okamoto, Y.; Tanaka, E.; Tanne, K.; Tanimoto, K.			Effects of Enzymatic Degradation after Loading in Temporomandibular Joint	JOURNAL OF DENTAL RESEARCH			English	Article						lubrication; cyclic loading; hyaluronan; superficial zone protein; osteoarthritis; matrix metalloproteases	SUPERFICIAL ZONE PROTEIN; SYNOVIAL-FLUID; ARTICULAR-CARTILAGE; LUBRICATING ABILITY; MATRIX METALLOPROTEINASES; MOLECULAR-WEIGHT; HYALURONIC-ACID; OSTEOARTHRITIS; DISORDERS; FRICTION	Synovial fluid of the joint decreases friction between the cartilage surfaces and reduces cartilage wear during articulation. Characteristic changes of synovial fluid have been shown in patients with osteoarthritis (OA) in the temporomandibular joint (TMJ). OA is generally considered to be induced by excessive mechanical stress. However, whether the changes in synovial fluid precede the mechanical overloading or vice versa remains unclear. In the present study, our purpose was to examine if the breakdown of joint lubrication affects the frictional properties of mandibular condylar cartilage and leads to subsequent degenerative changes in TMJ. We measured the frictional coefficient in porcine TMJ by a pendulum device after digestion with hyaluronidase (HAase) or trypsin. Gene expressions of interleukin-1 (IL-1), cyclooxygenase-2 (COX-2), matrix metalloproteinases (MMPs), type II collagen, and histology were examined after prolonged cyclic loading by an active pendulum system. The results showed that the frictional coefficient increased significantly after HAase (35%) or trypsin (74%) treatment. Gene expression of IL-1, COX-2, and MMPs-1, -3, and -9 increased significantly in enzyme-treated TMJs after cyclic loading. The increase in the trypsin-treated group was greater than that in the HAase-treated group. Type II collagen expression was reduced in both enzyme-treated groups. Histology revealed surface fibrillation and increased MMP-1 in the trypsin-treated group, as well as increased IL-1 in both enzyme-treated groups after cyclic loading. The findings demonstrated that the compromised lubrication in TMJ is associated with altered frictional properties and surface wear of condylar cartilage, accompanied by release of pro-inflammatory and matrix degradation mediators under mechanical loading.	[Asakawa-Tanne, Y.; Su, S.; Kunimatsu, R.; Hirose, N.; Mitsuyoshi, T.; Okamoto, Y.; Tanne, K.; Tanimoto, K.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthodont, Minami Ku, Hiroshima 7348553, Japan; [Tanaka, E.] Univ Tokushima, Grad Sch, Dept Orthodont & Dentofacial Orthoped, Inst Hlth Biosci, Kuramoto, Tokushima, Japan	Tanimoto, K (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthodont, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	tkotaro@hiroshima-u.ac.jp	Tanaka, Eiji/E-7105-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [23792429]	This research was supported by a Grant-in-Aid (No. 23792429) for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Rahamim E, 2001, J ORAL MAXIL SURG, V59, P1326, DOI 10.1053/joms.2001.27530; Tanaka E, 2004, J DENT RES, V83, P404; Drewniak EI, 2012, ARTHRITIS RHEUM-US, V64, P465, DOI 10.1002/art.33337; Wei LL, 2010, J ORAL MAXIL SURG, V68, P2478, DOI 10.1016/j.joms.2010.01.018; Yoshida K, 2006, ORAL SURG ORAL MED O, V102, P22, DOI 10.1016/j.tripleo.2005.07.013; Chan SMT, 2010, OSTEOARTHR CARTILAGE, V18, P956, DOI 10.1016/j.joca.2010.03.012; Alstergren P, 2000, J ORAL MAXIL SURG, V58, P180, DOI 10.1016/S0278-2391(00)90335-5; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104; Takahashi T, 2004, J ORAL PATHOL MED, V33, P224, DOI 10.1111/j.0904-2512.2004.00024.x; Tanaka E, 2008, ANN BIOMED ENG, V36, P14, DOI 10.1007/s10439-007-9401-z; Wang P, 2013, FASEB J, V27, P4664, DOI 10.1096/fj.13-234542; Koolstra JH, 2012, OSTEOARTHR CARTILAGE, V20, P43, DOI 10.1016/j.joca.2011.10.009; Chan SMT, 2011, J BIOMECH, V44, P1340, DOI 10.1016/j.jbiomech.2011.01.003; Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1; Kwiecinski JJ, 2011, OSTEOARTHR CARTILAGE, V19, P1356, DOI 10.1016/j.joca.2011.07.019; Tanaka E, 2006, J ORAL MAXIL SURG, V64, P1221, DOI 10.1016/j.joms.2006.04.017; Poole AR, 2002, ANN RHEUM DIS, V61, P78; Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02; Nitzan DW, 2001, J ORAL MAXIL SURG, V59, P36, DOI 10.1053/joms.2001.19278; Benz M, 2004, J BIOMED MATER RES A, V71A, P6, DOI 10.1002/jbm.a.30123; Fujisawa T, 2003, J DENT RES, V82, P731; GROOTVELD M, 1991, BIOCHEM J, V273, P459; HASKIN CL, 1995, CRIT REV ORAL BIOL M, V6, P248; Hill A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106497; Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373; Jay GD, 2004, J RHEUMATOL, V31, P557; Kawai N, 2004, J BIOMED MATER RES A, V70A, P149, DOI 10.1002/jbm.a.30078; Kim YK, 2012, J CRANIO MAXILL SURG, V40, pE337, DOI 10.1016/j.jcms.2012.02.002; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Teeple E, 2007, OSTEOARTHR CARTILAGE, V15, P309, DOI 10.1016/j.joca.2006.08.011; Yanagida-Suekawa T, 2013, EUR J ORAL SCI, V121, P566, DOI 10.1111/eos.12082	32	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	FEB	2015	94	2					337	343		10.1177/0022034514560588		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA1BO	WOS:000348647900013		
J	Robinson, MA; Vanrenterghem, J; Pataky, TC				Robinson, Mark A.; Vanrenterghem, Jos; Pataky, Todd C.			Statistical Parametric Mapping (SPM) for alpha-based statistical analyses of multi-muscle EMG time-series	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Biomechanics; Multivariate statistics; Vector-field analysis; Random field theory; Experimental error	ELECTROMYOGRAPHY; PATTERNS; MUSCLES; MOVEMENT; SHOULDER; BEHAVIOR; SIGNALS; GAIT; SEMG	Multi-muscle EMG time-series are highly correlated and time dependent yet traditional statistical analysis of scalars from an EMG time-series fails to account for such dependencies. This paper promotes the use of SPM vector-field analysis for the generalised analysis of EMG time-series. We reanalysed a publicly available dataset of Young versus Adult EMG gait data to contrast scalar and SPM vector-field analysis. Independent scalar analyses of EMG data between 35% and 45% stance phase showed no statistical differences between the Young and Adult groups. SPM vector-field analysis did however identify statistical differences within this time period. As scalar analysis failed to consider the multi-muscle and time dependence of the EMG time-series it exhibited Type II error. SPM vector-field analysis on the other hand accounts for both dependencies whilst tightly controlling for Type I and Type II error making it highly applicable to EMG data analysis. Additionally SPM vector-field analysis is generalizable to linear and non-linear parametric and non-parametric statistical models, allowing its use under constraints that are common to electromyography and kinesiology. (C) 2014 Elsevier Ltd. All rights reserved.	[Robinson, Mark A.; Vanrenterghem, Jos] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Pataky, Todd C.] Shinshu Univ, Dept Bioengn, Matsumoto, Nagano, Japan	Robinson, MA (reprint author), Tom Reilly Bldg,Byrom St Campus, Liverpool L3 3AF, Merseyside, England.	m.a.robinson@ljmu.ac.uk		Vanrenterghem, Jos/0000-0002-1682-8430			Bovi G, 2011, GAIT POSTURE, V33, P6, DOI 10.1016/j.gaitpost.2010.08.009; Brandon SCE, 2013, J ELECTROMYOGR KINES, V23, P1304, DOI 10.1016/j.jelekin.2013.09.010; Disselhorst-Klug C, 2009, CLIN BIOMECH, V24, P225, DOI 10.1016/j.clinbiomech.2008.08.003; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Houck J, 2003, J ELECTROMYOGR KINES, V13, P545, DOI 10.1016/S1050-6411(03)00056-7; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Frigo C, 2009, CLIN BIOMECH, V24, P236, DOI 10.1016/j.clinbiomech.2008.07.012; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0921-884X(96)95190-5; Cao J, 1999, ANN STAT, V27, P925; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gribble PL, 1998, EXP BRAIN RES, V123, P355, DOI 10.1007/s002210050580; Gribble PL, 1999, J NEUROPHYSIOL, V82, P2310; Koshland GF, 2005, EXP BRAIN RES, V164, P133, DOI 10.1007/s00221-005-2218-9; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Taylor J., 2007, RANDOM FIELDS GEOMET; Trevithick BA, 2007, J ELECTROMYOGR KINES, V17, P74, DOI 10.1016/j.jelekin.2005.11.012; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; Wren TAL, 2006, J BIOMECH, V39, P2714, DOI 10.1016/j.jbiotech.2005.09.006	23	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	FEB	2015	25	1					14	19		10.1016/j.jelekin.2014.10.018		6	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	AZ5WN	WOS:000348289200003		
J	Takasaki, H; Delbridge, BM; Johnston, V				Takasaki, Hiroshi; Delbridge, Blane Michael; Johnston, Venerina			Taping across the upper trapezius muscle reduces activity during a standardized typing task - An assessor-blinded randomized cross-over study	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Electromyography; Computers; Neck muscle; Orthotic tape	SURFACE ELECTROMYOGRAM RECORDINGS; NECK PAIN; RISK-FACTORS; DISORDERS; WORK; PERFORMANCE; WORKPLACE; SURGEONS; FATIGUE; SIZE	Clinically, taping is believed to alter muscle activity. The purpose of this study was to investigate: (1) whether taping across the upper trapezius (UT) muscle influenced the level of UT and lower trapezius (LT) muscle activity and the ratio of these activities (UT/LT ratio) during a static typing task; and (2) if the activity of these muscles varied with the application of tensioned taping. Forty-two healthy participants performed a 15-min typing task on three separate occasions under one of three conditions: taping applied perpendicular to the UT fibers with tension; taping without tension; and no taping. Activity of the UT and LT muscles was assessed using surface electromyography. Between conditions, significant differences were found in the change of the normalized amplitude in the UT activity (p = .027) and UT/LT ratio (p = .024) but not in the LT activity (p = .93). Compared with the no taping condition, the UT activity was less in both the tensioned taping (p = .009) and the non-tensioned taping (p = .004). There was no difference between the two taping conditions in the change of the UT (p = .91) activity and the UT/LT ratio (p = .92). In conclusion, both tensioned and non-tensioned taping across the UT muscle reduces its activity during a typing task. (C) 2014 Elsevier Ltd. All rights reserved.	[Takasaki, Hiroshi; Delbridge, Blane Michael; Johnston, Venerina] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld, Australia; [Takasaki, Hiroshi] Saitama Prefectural Univ, Div Phys Therapy, Kosigaya, Saitama 3438540, Japan	Takasaki, H (reprint author), Saitama Prefectural Univ, Div Phys Therapy, Sannomiya 820, Kosigaya, Saitama 3438540, Japan.	physical.therapy.takasaki@gmail.com					Smith M, 2009, PHYS THER SPORT, V10, P45, DOI 10.1016/j.ptsp.2008.12.002; Falla D, 2007, EXP BRAIN RES, V178, P385, DOI 10.1007/s00221-006-0746-6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Johnston V, 2008, APPL ERGON, V39, P171, DOI 10.1016/j.apergo.2007.05.011; Ekstrom RA, 2005, J ELECTROMYOGR KINES, V15, P418, DOI 10.1016/j.jelekin.2004.09.006; Neziri AY, 2013, REGION ANESTH PAIN M, V38, P308, DOI 10.1097/AAP.0b013e318295a3ea; Farina D, 2002, EUR J APPL PHYSIOL, V86, P469, DOI 10.1007/s00421-001-0574-0; JENSEN C, 1993, EUR J APPL PHYSIOL O, V67, P266, DOI 10.1007/BF00864227; Huang TS, 2012, ERGONOMICS, V55, P1404, DOI 10.1080/00140139.2012.709543; Levanon Y, 2012, ERGONOMICS, V55, P1571, DOI 10.1080/00140139.2012.726654; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Selkowitz DM, 2007, J ORTHOP SPORT PHYS, V37, P694; Stone AM, 2013, MANUAL THER, V18, P111, DOI 10.1016/j.math.2012.07.009; Karatas N, 2012, TURK NEUROSURG, V22, P83, DOI 10.5137/1019-5149.JTN.5377-11.1; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Griffiths KL, 2012, WORK, V42, P533, DOI 10.3233/WOR-2012-1396; Marta SMA, 2013, INT SPORTMED J, V14, P11; Moeller CR, 2014, J ATHL TRAINING, V49, P345, DOI 10.4085/1062-6050-49.3.10; Morin GE, 1997, J SPORT REHABIL, V6, P309; Morrissey D, 2000, J BODYWORK MOVEMENT, V4, P189, DOI DOI 10.1054/JBMT.2000.0156; Morrissey D., 2010, POCKETBOOK TAPING TE, P141; Paulus I, 2008, J REHABIL MED, V40, P426, DOI 10.2340/16501977-0189; Persson UM, 2010, POCKETBOOK TAPING TE, P31, DOI 10.1016/B978-0-7020-3027-7.00004-2; Sandvik L, 1996, STAT MED, V15, P1587, DOI 10.1002/(SICI)1097-0258(19960730)15:14<1587::AID-SIM279>3.0.CO;2-F; Straker LM, 2008, J ELECTROMYOGR KINES, V18, P606, DOI 10.1016/j.jelekin.2006.09.015; Szeto GPY, 2010, SURG ENDOSC, V24, P1712, DOI 10.1007/s00464-009-0834-3; Takasaki H, 2014, AM J PHYS MED REHAB, V93, P665, DOI 10.1097/PHM.0000000000000087; Tobin S, 2000, PHYSIOTHERAPY, V86, P173, DOI 10.1016/S0031-9406(05)60960-1; Voerman GE, 2007, J OCCUP REHABIL, V17, P137, DOI 10.1007/s10926-007-9066-3	30	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	FEB	2015	25	1					115	120		10.1016/j.jelekin.2014.10.004		6	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	AZ5WN	WOS:000348289200017		
J	Miyamoto, T; Fukuda, K; Watanabe, K; Hidaka, M; Moritani, T				Miyamoto, Toshiaki; Fukuda, Kazuhito; Watanabe, Kohei; Hidaka, Masami; Moritani, Toshio			Gender difference in metabolic responses to surface electrical muscle stimulation in type 2 diabetes	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Surface electrical muscle stimulation; Gender difference; Type 2 diabetes; Glucose metabolism; Exercise	HEPATIC GLUCOSE-PRODUCTION; EXERCISE; WOMEN; HYPERGLYCEMIA; OXIDATION; MELLITUS; KINETICS; FEMALES; HUMANS; MALES	Objective: The aim of this study was to examine whether or not there is a gender difference in metabolic responses to surface electrical muscle stimulation (sEMS) in type 2 diabetes (T2DM). Methods: Ten men and eight women with T2DM participated in two sessions; in both sessions the subjects were investigated after a breakfast and that in one occasion they underwent 30-min sEMS while in the other they were followed while resting. Blood and gas exchange data were compared between genders as to the extent of blood glucose and non-esterified fatty acids responses to sEMS. Results: The time course change of blood glucose concentration after sEMS did not statistically differ between genders while sEMS could attenuate postprandial blood glucose level regardless of gender (p < 0.05). Women had a lower respiratory quotient and lactate concentration during sEMS when compared with men (p < 0.05). Conclusions: This study indicated that sEMS might have resulted in lower anaerobic glycolysis in women as compared to men with T2DM. sEMS is expected to be a new exercise method in T2DM. Determining the possible gender differences and precise mechanisms might further shed some light for the efficacy of sEMS use for clinical practice. (C) 2014 Elsevier Ltd. All rights reserved.	[Miyamoto, Toshiaki; Hidaka, Masami] Hyogo Univ Hlth Sci, Grad Sch Hlth Sci, Kobe, Hyogo 6508530, Japan; [Fukuda, Kazuhito] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Watanabe, Kohei] Chukyo Univ, Sch Int Liberal Studies, Nagoya, Aichi, Japan; [Moritani, Toshio] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Miyamoto, T (reprint author), Hyogo Univ Hlth Sci, Grad Sch Hlth Sci, Dept Rehabil, Kobe, Hyogo 6508530, Japan.	t-miyamoto@huhs.ac.jp			Japan Society for the Promotion of Science	This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Yki-Jarvinen H, 1998, DIABETES METAB REV, V14, pS45; Larsen JJS, 1997, DIABETOLOGIA, V40, P447, DOI 10.1007/s001250050699; Miyamoto T, 2012, DIABETES RES CLIN PR, V96, P306, DOI 10.1016/j.diabres.2012.01.006; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360; KOMI PV, 1978, ACTA PHYSIOL SCAND, V103, P210, DOI 10.1111/j.1748-1716.1978.tb06208.x; MARKER JC, 1991, AM J PHYSIOL, V260, pE705; Hamada T, 2003, J APPL PHYSIOL, V94, P2107, DOI 10.1152/japplphysiol.00486.2002; Hamada T, 2004, J APPL PHYSIOL, V96, P911, DOI 10.1152/japplphysiol.00664.2003; SINACORE DR, 1990, PHYS THER, V70, P416; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435; BRAUN JEA, 1992, CAN MED ASSOC J, V147, P1192; Derave W, 2007, OBESITY, V15, P704, DOI 10.1038/oby.2007.548; Borch-Johnsen K, 1999, LANCET, V354, P617; Horton TJ, 2006, J APPL PHYSIOL, V100, P1883, DOI 10.1152/japplphysiol.01431.2005; KENDRICK ZV, 1987, J APPL PHYSIOL, V63, P492; Kimura T, 2010, INT J SPORT HLTH SCI, V8, P1, DOI DOI 10.5432/IJSHS.20090033; KJAER M, 1993, AM J PHYSIOL, V265, pE275; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; Moritani TOS, 1991, J SPORTS MED SCI, V5, P13; NYGAARD E, 1981, ACTA PHYSIOL SCAND, V112, P299, DOI 10.1111/j.1748-1716.1981.tb06820.x; Ruby BC, 2002, J APPL PHYSIOL, V92, P1125, DOI 10.1152/japplphysiol.00296.2001; Steffensen CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE634; Tarnopolsky MA, 2000, CAN J APPL PHYSIOL, V25, P312; The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]; Zinman B, 1997, DIABETES CARE, V20, P1908	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	FEB	2015	25	1					136	142		10.1016/j.jelekin.2014.06.013		7	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	AZ5WN	WOS:000348289200020		
J	Kamio, M; Furukawa, D; Wakabayashi, K; Hiei, K; Yano, H; Sato, H; Yoshie-Stark, Y; Akiba, T; Tanaka, Y				Kamio, Michiya; Furukawa, Dai; Wakabayashi, Kaori; Hiei, Kaori; Yano, Hirona; Sato, Hiroshi; Yoshie-Stark, Yumiko; Akiba, Tatsuro; Tanaka, Yuji			Grooming behavior by elongated third maxillipeds of phyllosoma larvae of the smooth fan lobster riding on jellyfishes	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						Antifouling; Chemoreception; Glycine; Plankton; Programmed behavior; Quantitative NMR; Scyphozoa	AURELIA-AURITA; DECAPODA SCYLLARIDAE; JASUS-VERREAUXI; CHEMOSENSORY ACTIVATION; IBACUS-NOVEMDENTATUS; ASYMMETRIC SETAE; PANULIRUS-ARGUS; SPINY LOBSTER; JELLY-FISH; CRAB	Animals groom their body surface to prevent or remove parasites and non-biological fouling that can negatively impact their mobility, appearance, and health. The jellyfish riders, phyllosoma larvae of the smooth fan lobster lbacus novemdentatus Gibbes which spend their planktonic larval period riding on and eating live jellyfish, have a characteristic body shape, a leaf-like flat body without gills and a pair of elongated third maxillipeds. Although the third maxillipeds lack exopods and are very long compared with that of other types of decapod crustacean adults and larvae, their function is not known. In the present study, we hypothesized that the elongated third maxillipeds of I. novemdentatus.phyllosoma larvae constitute a grooming organ specialized to remove fouling from their body surface and/or an organ to manipulate their food, and tested the hypothesis through morphological and behavioral experiments. Our morphological observations show that the third maxillipeds are longer than the larva's body and that the tip of the maxillipeds has a comb-like structure. Our behavioral experiments show that the larvae spent about 50% of their time grooming with their third maxillipeds but did not use these maxillipeds to manipulate jellyfish for eating. The maxillipeds removed an experimentallyapplied foulant from most of their body parts, suggesting that this artificial foulant stimulated grooming on that location. Thus, the grooming has characteristics of both programmed and stimulus-driven behaviors. Inhibition of this behavior enhanced growth of microbes on the body surface of that phyllosoma fed with jellyfish. Glycine was identified as major free amino acid in jellyfish tissue using amino acid analysis and as a major metabolite by nuclear magnetic resonance (NMR) spectroscopy. Glycine induced appetitive and grooming behaviors in the larvae. Thus, we conclude that the phyllosoma larvae use the elongated third maxillipeds for cleaning their entire body surface and that the maxillipeds are functionally specialized for this cleaning behavior. This frequent whole body cleaning behavior with specialized appendages might be adaptive to their lifestyle of riding on jellyfish, where they are exposed to large amounts of mucus released from the jellyfish which could otherwise cause growth of microbes on their body surface. (C) 2014 Elsevier B.V. All rights reserved.	[Kamio, Michiya; Furukawa, Dai; Wakabayashi, Kaori; Yano, Hirona; Sato, Hiroshi; Tanaka, Yuji] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci, Tokyo, Japan; [Hiei, Kaori] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Tokyo, Japan; [Yoshie-Stark, Yumiko] Univ Tokyo, Fac Life Sci, Tokyo 1138654, Japan; [Akiba, Tatsuro] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	Kamio, M (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci, Tokyo, Japan.	mkamio@kaiyodai.ac.jp	Kamio, Michiya/O-1923-2014	Kamio, Michiya/0000-0003-3505-1978	Mikimoto Fund for Marine Ecology;  [25.10983]	We thank Dr. Charles Derby at Georgia State University for reading our manuscript, correcting the English language and valuable discussions. We thank several professors at Tokyo University of Marine Science and Technology for their assistance: Dr. Haruto Ishii for valuable discussion on the biology of jellyfish; Dr. Katsuyuki Hamasaki for valuable discussions on decapod larvae; Dr. Hidekazu Suzuki for identification of microbial fouling on the phyllosoma; and Dr. Hiroshi Nagai for allowing us to use facilities to prepare samples for NMR projects and valuable discussion on jellyfish venomous tentacles. We also thank Dr. Koichi Konishi of the National Research Institute of Fisheries Science for valuable discussions on decapod-larvae biology; Dr. Anders Garm at University of Copenhagen for discussion on nomenclature of setae; and Dr. Erin Wittke at Tokyo University of Marine Science and Technology for providing the hair of wild grizzly bear from Invermere, British Columbia, Canada. Collection of moon jellyfish was made possible by support from the research and training vessels Hiyodori and Shinyomaru of Tokyo University of Marine Science and Technology. The present study was supported by grants-in-aid for JSPS fellows (no. 25.10983) and Mikimoto Fund for Marine Ecology to KW., the Program for Promotion of Basic and Applied Researches for Innovations in Biooriented Industry to Y.T., and Research Promotion for Marine Science and Technology in Tokyo University of Marine Science and Technology to Y.T. M.K. was supported by internal grant from Tokyo University of Marine Science and Technology, Narishige Zoological Science Award, the Sumitomo Foundation for Basic Science Research grant number 120594, and JSPS KAKENHI grant number 23780212.[SS]	Mikami S, 1997, J CRUSTACEAN BIOL, V17, P289, DOI 10.2307/1549280; Eckstein RA, 2000, APPL ANIM BEHAV SCI, V68, P141, DOI 10.1016/S0168-1591(00)00095-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Garm A, 2004, J MORPHOL, V260, P85, DOI 10.1002/jmor.10213; HERRNKIND W, 1976, B MAR SCI, V26, P110; Mooring MS, 1996, PHYSIOL BEHAV, V59, P965, DOI 10.1016/0031-9384(95)02186-8; Becker K, 1996, J EXP MAR BIOL ECOL, V203, P245, DOI 10.1016/0022-0981(96)02575-0; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Wakabayashi K, 2012, BIOL BULL-US, V222, P1; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; SCHOLTZ G, 1995, ZOOL J LINN SOC-LOND, V113, P289, DOI 10.1006/zjls.1995.0011; Webber WR, 2001, NEW ZEAL J MAR FRESH, V35, P1025; Garm A, 2004, ZOOL J LINN SOC-LOND, V142, P233, DOI 10.1111/j.1096-3642.2004.00132.x; Wakabayashi K, 2012, AQUACULTURE, V330, P162, DOI 10.1016/j.aquaculture.2011.12.005; Uye S, 2005, J PLANKTON RES, V27, P237, DOI 10.1093/plankt/fbh172; Nicholson JK, 1999, XENOBIOTICA, V29, P1181; MARINOVIC B, 1994, J CRUSTACEAN BIOL, V14, P80, DOI 10.2307/1549057; ABARZUA S, 1995, MAR ECOL PROG SER, V123, P301, DOI 10.3354/meps123301; Waite JL, 2012, INT J PARASITOL, V42, P463, DOI 10.1016/j.ijpara.2012.03.005; Mooring MS, 2004, BIOL J LINN SOC, V81, P17, DOI 10.1111/j.1095-8312.2004.00273.x; Schmidt M, 2005, J EXP BIOL, V208, P233, DOI 10.1242/jeb.01357; Wakabayashi Kaori, 2012, Taxa, V33, P5; SHANKS AL, 1988, MAR ECOL PROG SER, V45, P81, DOI 10.3354/meps045081; Kittaka J, 1997, B MAR SCI, V61, P57; THOMAS LR, 1963, NATURE, V198, P208, DOI 10.1038/198208a0; Ishii H, 2001, HYDROBIOLOGIA, V451, P311, DOI 10.1023/A:1011814525325; Barbato JC, 1997, BIOL BULL, V193, P107, DOI 10.2307/1542756; Barber R.T., 2000, 50 YEARS OCEAN DISCO, P11; BAUER R T, 1989, P49; Bauer R.T., 2013, FUNCTIONAL MORPHOLOG, V1, P337; Cericola VJ, 2010, J CRUSTACEAN BIOL, V30, P557, DOI 10.1651/09-3204.1; Cox SL, 2003, J MAR BIOL ASSOC UK, V83, P465, DOI 10.1017/S0025315403007355h; Cox SL, 2003, J EXP MAR BIOL ECOL, V296, P35, DOI 10.1016/S0022-0981(03)00303-4; Daniel PC, 2001, MAR FRESHWATER RES, V52, P1333, DOI 10.1071/MF01013; GLYNN P W, 1970, Journal of Experimental Marine Biology and Ecology, V5, P88, DOI 10.1016/0022-0981(70)90031-6; Gurney R., 1941, LARVAE DECAPOD CRUST; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; Haond C, 2001, CELL TISSUE RES, V305, P445; Kamio M, 2000, ZOOL SCI, V17, P731, DOI 10.2108/zsj.17.731; Kamio M, 2002, MAR ECOL PROG SER, V234, P183, DOI 10.3354/meps234183; Kamio M, 2014, J EXP BIOL, V217, P1286, DOI 10.1242/jeb.099051; Kays I, 2014, NAT PROTOC, V9, P1, DOI 10.1038/nprot.2013.157; Kittaka Jiro, 2005, Bulletin of Plankton Society of Japan, V52, P91; LESSER J H R, 1974, Crustaceana (Leiden), V27, P259, DOI 10.1163/156854074X00794; Matsuda H., 2007, B FISHERIES RES AGEN, V20, P77; Miyazaki H, 2012, PATHOL RES PRACT, V208, P503, DOI 10.1016/j.prp.2012.05.006; Mooring MS, 1998, ANIM BEHAV, V56, P1561, DOI 10.1006/anbe.1998.0915; Nagai H., 2012, HDB MARINE NATURAL P, P1388; Niggl W, 2010, J EXP MAR BIOL ECOL, V384, P99, DOI 10.1016/j.jembe.2010.01.011; Orton JH, 1922, NATURE, V110, P178, DOI 10.1038/110178a0; Palero F, 2011, J MAR BIOL ASSOC UK, V91, P485, DOI 10.1017/S0025315410000287; ROBERTSO.PB, 1968, B MAR SCI, V18, P294; Schmidt M., 2012, SOC NEUR ABSTR, V174, P21; Sekiguchi H., 2007, BIOL FISHERIES SLIPP, P69; Shojima Y., 1963, Bulletin of the Japanese Society of Scientific Fisheries, V29, P349; Shojima Y., 1973, B SEIKAI REG FISH RE, V43, P105; SOUTHWARD AJ, 1955, J MAR BIOL ASSOC UK, V34, P201; Tanaka Y., 2014, COPEPODS DIVERSITY H, P145; TARDENT P, 1995, BIOESSAYS, V17, P351, DOI 10.1002/bies.950170411	59	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981	1879-1697		J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	FEB	2015	463						115	124		10.1016/j.jembe.2014.11.008		10	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CA0TD	WOS:000348628400015		
J	Hamabata, T; Hikida, T; Okamoto, K; Watanabe, S; Kamezaki, N				Hamabata, Tomoko; Hikida, Tsutomu; Okamoto, Kei; Watanabe, Saya; Kamezaki, Naoki			Ontogenetic habitat shifts of green turtles (Chelonia mydas) suggested by the size modality in foraging aggregations along the coasts of the western Japanese main islands	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						Size distribution; Foraging ground; Ontogenetic habitat shift; Green turtle; Developmental change	GENETIC-STRUCTURE; SEA-TURTLES; POPULATION-GENETICS; YAEYAMA ISLANDS; CENTRAL FLORIDA; MARINE TURTLES; MTDNA EVIDENCE; PACIFIC; CONSERVATION; ROOKERIES	To understand the life histories and ontogenetic habitat utilization of green turtles along the coasts of the western Japanese main islands, we collected size frequency and genetic data of green turtles captured by pound nets in three foraging grounds (FG): Nomaike (n = 38), Muroto (n = 93), and Kumano-nada (n = 31), and compared their natal origins among different size classes. Population genetic analyses based on an 820-bp fragment of mitochondrial DNA showed that the three FG were part of a single multiple-coast FG. Although turtles from all size classes originated mainly from rookeries in the Ogasawara Group, the size distributions clearly exhibited bimodality, with low occurrences of turtles in the 50-70-cm straight carapace length (SCL) range. The bimodal size distributions could not be attributed to demographic shifts in rookeries, because the number of female green turtles in Ogasawara has exhibited an increasing trend since 1979. We also examined whether factors such as seasonality and predation risk could have caused the size bimodality. There were, however, no strong relationships between sea-surface temperatures when turtles were captured and the sizes of the turtles (r(2) < 0.2), and it appeared that predation risk could not result in the size modality observed in the FG. Our results strongly suggest that after switching from a pelagic to a neritic lifestyle, the green turtles in the neritic FG along the western Japanese main islands undergo another ontogenetic habitat shift upon reaching similar to 50-cm SCL. Here, we explore the possibility that developmental growth might stimulate a habitat shift, resulting in habitat differentiations by size and growth phase in the long-lived green turtle. (C) 2014 Elsevier B.V. All rights reserved.	[Hamabata, Tomoko; Hikida, Tsutomu] Kyoto Univ, Grad Sch Sci, Sakyo, Kyoto 6068502, Japan; [Watanabe, Saya] Sea Turtle Assoc Japan, Hirakata, Osaka 5730163, Japan; [Kamezaki, Naoki] Suma Aqualife Pk Kobe, Kobe, Hyogo 6540049, Japan; [Kamezaki, Naoki] Okayama Univ Sci, Fac Biosphere Geosphere Sci, Okayama, Okayama 7000005, Japan	Hamabata, T (reprint author), Kyoto Univ, Grad Sch Sci, Kitashirakawa Oiwakecho, Sakyo, Kyoto 6068502, Japan.	hamabata@zoo.zool.kyoto-u.ac.jp			Kuroshio Biological Research Foundation; Japan Science Society	We thank Takaoka, Shiina, Mitsu, Shirose, and Haida pound net fishery associations, Shimakatsu pound net association Co., Ltd., S. Yamashita, N. Yamashita, and K. Miyauchi for their cooperation in collecting green turtles. We thank Dr. Nishizawa for his help in the MSA of this study. We also thank Dr. Jensen to help us to confirm new haplotypes and assign the standardized names of longer haplotypes. We wish to acknowledge use of the Maptool program of SEATURTLE.ORG for maps in this paper. This research was financially supported in part by grants for Excellent Graduate Schools, MEXT, Japan, from the Kuroshio Biological Research Foundation, and the Sasagawa Scientific Research Grant from The Japan Science Society. [SS]	ABREU-GROBOIS F. A., 2006, 26 ANN S SEA TURTL B, P179; Amorocho DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031486; Sterling EJ, 2013, CHELONIAN CONSERV BI, V12, P2, DOI 10.2744/CCB-1014.1; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; Schmid JR, 2003, J WILDLIFE MANAGE, V67, P196, DOI 10.2307/3803075; Cheng IJ, 1997, BIOL CONSERV, V82, P235, DOI 10.1016/S0006-3207(97)00027-X; Chassin-Noria O, 2004, GENETICA, V121, P195, DOI 10.1023/B:GENE.0000040394.47843.e4; Zug GR, 2002, FISH B-NOAA, V100, P117; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Dethmers KEM, 2010, MAR FRESHWATER RES, V61, P1376, DOI 10.1071/MF10084; Pella J, 2001, FISH B-NOAA, V99, P151; Dutton Peter H., 2008, Endangered Species Research, V5, P37, DOI 10.3354/esr00101; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.2307/2410454; Hatase H, 2006, OECOLOGIA, V149, P52, DOI 10.1007/s00442-006-0431-2; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Bass AL, 2000, HERPETOLOGICA, V56, P357; Burkholder DA, 2011, MAR ECOL PROG SER, V439, P277, DOI 10.3354/meps09313; Bolten AB, 2003, CRC MAR BIOL SER, P243; Parker DM, 2011, PAC SCI, V65, P419, DOI 10.2984/65.4.419; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Nishizawa H, 2010, ZOOL SCI, V27, P14, DOI 10.2108/zsj.27.14; Cheng IJ, 2008, J ZOOL, V276, P375, DOI 10.1111/j.1469-7998.2008.00501.x; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Bresette Michael J., 2010, Endangered Species Research, V9, P105, DOI 10.3354/esr00245; Carman VG, 2012, J EXP MAR BIOL ECOL, V429, P64, DOI 10.1016/j.jembe.2012.06.007; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Luke K, 2004, MAR BIOL, V144, P799, DOI 10.1007/s00227-003-1241-2; Nishizawa H, 2013, MAR BIOL, V160, P2671, DOI 10.1007/s00227-013-2261-1; Cardona L, 2009, MAR BIOL, V156, P1487, DOI 10.1007/s00227-009-1188-z; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Balazs G.H., 1980, H7924C NAT OC ATM AD; Godley BJ, 2003, MAR ECOL PROG SER, V253, P279, DOI 10.3354/meps253279; Hamabata T, 2014, MAR BIOL, V161, P495, DOI 10.1007/s00227-013-2352-z; Hamabata Tomoko, 2009, Bulletin of the Graduate School of Social and Cultural Studies Kyushu University, V15, P35; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; Jensen M. P., 2010, THESIS U CANBERRA AU; Kameda K, 2009, UMIGAME NEWSL, V81, P17; Kamezaki N., 2007, B HERPETOL SOC JAPAN, V1, P78; Limpus CJ, 2005, MONITORING GREEN TUR; Lohman K, 2013, BIOL SEA TURTLES, V3, P135; Lopez-Mendilaharsu M, 2005, AQUAT CONSERV, V15, P259, DOI 10.1002/aqc.676; Maison K.A., 2010, NMFSFSPO110 NOAA; Meylan PA, 2011, B AM MUSEUM NATURAL; Naro-Maciel E, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0888; Ng CKY, 2014, PAC SCI, V68, P231, DOI 10.2984/68.2.5; Nishizawa Hideaki, 2014, Endangered Species Research, V24, P171, DOI 10.3354/esr00592; Nishizawa Hideaki, 2011, Endangered Species Research, V14, P141, DOI 10.3354/esr00355; Okamoto K, 2011, UMIGAME NEWSL, V88, P13; Okamoto Kei, 2014, Current Herpetology, V33, P46, DOI 10.5358/hsj.33.46; Shimada T., 2009, UMIGAME NEWS LETT, P7; Tachikawa H, 1991, UMIGAME NEWSL, V8, P7; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Yamaguchi M, 2005, UMIGAME NEWSL, V66, P2	59	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981	1879-1697		J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	FEB	2015	463						181	188		10.1016/j.jembe.2014.12.007		8	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CA0TD	WOS:000348628400023		
J	Kobayashi, K; Hayakawa, A; Hohashi, N				Kobayashi, Kyoko; Hayakawa, Akira; Hohashi, Naohiro			Interrelations Between Siblings and Parents in Families Living With Children With Cancer	JOURNAL OF FAMILY NURSING			English	Article						siblings; sibling-parent relationship; family functioning; interrelations; childhood cancer; quality of life; Japan	QUALITY-OF-LIFE; CHILDHOOD-CANCER; PEDIATRIC CANCER; CIRCUMPLEX MODEL; HEALTH; EXPERIENCES; ADJUSTMENT; DIAGNOSIS; SUPPORT; RESEARCHERS	Having a child diagnosed with cancer is a stressful event for the family. This exploratory multimethod study utilized both quantitative and qualitative multiinformant methodologies to investigate the relationships between parental family functioning and siblings' health-related quality of life (HRQOL) and to describe interrelations between the experiences of parents and siblings of children with childhood cancer. A total of 14 Japanese families participated in the quantitative study, and 4 families of the 14 participated in the qualitative study. In-depth, semistructured interviews revealed three family-unit stages during the time course of the ill child's treatment that included particular parent-sibling interrelations. We also found strong correlation between parental family functioning and siblings' HRQOL in the quantitative study. The results suggest the importance of family nursing interventions directed to individual family members and the family unit that focus on strengthening the parent-sibling relationship and supporting families who are experiencing childhood cancer.	[Kobayashi, Kyoko] St Lukes Int Univ, Dept Child & Family Nursing, Sch Nursing, Tokyo 1040044, Japan; [Hayakawa, Akira] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 657, Japan; [Hohashi, Naohiro] Kobe Univ, Dept Nursing, Grad Sch Hlth Sci, Div Family Hlth Care Nursing, Kobe, Hyogo 657, Japan	Kobayashi, K (reprint author), St Lukes Int Univ, Dept Child & Family Nursing, Sch Nursing, Chuo Ku, 10-1 Akashicho, Tokyo 1040044, Japan.	kyoko-kobayashi@slcn.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [22792228]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded in part by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology in Japan (#22792228).	Alderfer M. A., 2006, COMPREHENSIVE HDB CH, P53; Alderfer MA, 2010, SCH MENT HEALTH, V2, P72, DOI DOI 10.1007/S12310-010-9027-4; COHEN DS, 1994, J CLIN PSYCHOL, V50, P303; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Woodgate RL, 2006, CANCER NURS, V29, P406, DOI 10.1097/00002820-200609000-00010; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303255359; Sloper P, 2000, HEALTH SOC CARE COMM, V8, P298, DOI 10.1046/j.1365-2524.2000.00254.x; Alderfer MA, 2010, PSYCHO-ONCOLOGY, V19, P789, DOI 10.1002/pon.1638; Feltbower RG, 2009, EUR J CANCER, V45, P420, DOI 10.1016/j.ejca.2008.09.020; Houtzager BA, 1999, SUPPORT CARE CANCER, V7, P302, DOI 10.1007/s005200050268; Houtzager BA, 2005, CHILD CARE HLTH DEV, V31, P75; Kaplan LM, 2013, FAM SYST HEALTH, V31, P205, DOI 10.1037/a0032550; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; ROBERTS CS, 1982, NURS RES, V31, P231; Houtzager BA, 2004, PSYCHO-ONCOL, V13, P499, DOI 10.1002/pon.759; BARRERA M, 1981, AM J COMMUN PSYCHOL, V9, P435, DOI 10.1007/BF00918174; Nolbris M, 2007, EUR J ONCOL NURS, V11, P106, DOI 10.1016/j.ejon.2006.10.002; Patterson JM, 2004, PSYCHO-ONCOL, V13, P390, DOI 10.1002/pon.761; Buchbinder D, 2011, PSYCHO-ONCOLOGY, V20, P1259, DOI 10.1002/pon.1848; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066X.32.7.513; Lahteenmaki PM, 2004, ARCH DIS CHILD, V89, P1008, DOI 10.1136/adc.2002.012088; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Baba S, 2010, CANCER SCI, V101, P787, DOI 10.1111/j.1349-7006.2009.01443.x; Bally JMG, 2014, J FAM NURS, V20, P287, DOI 10.1177/1074840714532716; Brown C, 2008, QUAL HEALTH RES, V18, P19, DOI 10.1177/1049732307309221; CANCER DMJ, 1996, MEDICAL AND PEDIATRI, V27, P98, DOI DOI 10.1002/(SICI)1096-911X(199608)27:2<LESSTHAN>98::AID-MPO6<GREATERTHAN>3.0.CO;2-O; Clarke-Steffen L, 1993, Cancer Pract, V1, P285; Clarke-Steffen L, 1997, J Pediatr Nurs, V12, P278, DOI 10.1016/S0882-5963(97)80045-0; Cohen J., 1988, STATISTICAL POWER AN; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; CRESWELL JW, 2006, DESIGNING AND CONDUC; CROMWELL RE, 1975, POWER IN FAMILIES; Deatrick Janet A, 2006, J Pediatr Oncol Nurs, V23, P19; DEHAAN R, 1993, STROKE, V24, P320; Dowrick C, 1995, FAM PRACT, V12, P461, DOI 10.1093/fampra/12.4.461; FISHER L, 1985, FAM PROCESS, V24, P213, DOI 10.1111/j.1545-5300.1985.00213.x; Franco OH, 2012, EUR J EPIDEMIOL, V27, P255, DOI 10.1007/s10654-012-9664-z; Fujita N, 2011, LEUKEMIA LYMPHOMA, V52, P223, DOI 10.3109/10428194.2010.537794; Harding R, 1996, Prof Nurse, V11, P588; Hohashi N, 2000, JAPANESE J RES FAMIL, V6, P2; HOHASHI N, 2008, METHOD ASSESSMENT FA; HOHASHI N, 2008, JAPANESE JOURNAL OF, V50, P18; Kobayashi K, 2011, QUAL LIFE RES, V20, P1091, DOI 10.1007/s11136-010-9834-y; Kobayashi K, 2011, NURS HEALTH SCI, V13, P170, DOI 10.1111/j.1442-2018.2011.00595.x; KOBAYASHI K, 2013, JOURNAL OF JAPANESE, V22, P129; Kobayashi K, 2010, PEDIATR INT, V52, P80, DOI 10.1111/j.1442-200X.2009.02889.x; Larson R., 2004, HDB ADOLESCENT PSYCH, P299; LAVERA LL, 2008, PRESENTED AT THE ACA; Manzi C, 2006, J MARRIAGE FAM, V68, P673, DOI 10.1111/j.1741-3737.2006.00282.x; Mason Jennifer, 2002, QUALITATIVE RESEARCH; McGrath P., 2001, CHILD FAMILY SOCIAL, V6, P229, DOI [10.1046/j.1365-2206.2001.00200.x, DOI 10.1046/J.1365-2206.2001.00200.X]; MORIARTY HJ, 1990, ADV NURS SCI, V12, P1; OLSON DH, 1991, FAM PROCESS, V30, P74, DOI 10.1111/j.1545-5300.1991.00074.x; OLSON DH, 1989, CIRCUMPLEX MODEL SYS, P7; Patton M. Q., 1990, QUALITATIVE EVALUATI; SHIMADA Y, 1998, STUDIES ON PSYCHOLOG, P120; *STAT INF DEP, 2014, VITAL STATISTICS OF; Svavarsdottir Erla Kolbrun, 2013, Oncol Nurs Forum, V40, pE346, DOI 10.1188/13.ONF.E346-E357; Svavarsdottir EK, 2014, J FAM NURS, V20, P13, DOI 10.1177/1074840713520345; TACHIGI S, 1999, THEORETICAL AND EMPI; Woodgate RL, 2004, J ADV NURS, V46, P358, DOI 10.1111/j.1365-2648.2004.03002.x	66	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-8407	1552-549X		J FAM NURS	J. Fam. Nurs.	FEB	2015	21	1					119	148		10.1177/1074840714564061		30	Family Studies; Nursing	Family Studies; Nursing	AZ9JA	WOS:000348528400006		
J	Oshima, T; Yoshikawa, H; Ohtani, M; Mimasaka, S				Oshima, Toru; Yoshikawa, Hiroshi; Ohtani, Maki; Mimasaka, Sohtaro			Examination of postmortem retinal folds: A non-invasive study	Journal of Forensic and Legal Medicine			English	Article						Retinal fold; Child abuse; Postmortem; Ophthalmology; Ultrasound imaging; Non-invasive	TEARS; ENDOSCOPY; PRESSURE; ADHESION; FUNDUS; EYE	The postmortem retinal fold has been previously documented, but its mechanism of formation is not known. All previous studies of the fold involved invasive techniques and the postmortem ocular fundus has yet to be non-invasively examined. Our study used the non-invasive techniques of monocular indirect ophthalmoscopy and ocular echography to examine 79 postmortem eyes of 42 bodies. We examined whether the postmortem retinal fold was associated with postmortem time, position, and/or age. Age was significantly associated with postmortem retinal fold formation (Mann-Whitney U test, P = 0.013), which led us to examine the effect of posterior vitreous detachment (PVD) on retinal folds. The absence of a PVD was statistically associated with the presence of a retinal fold (Fisher's exact test, P < 0.0001). Interestingly, the presence of a PVD was also significantly correlated with retinal fold height (Mann-Whitney U test, P < 0.0001). Therefore, we hypothesized that retinal folds result from postmortem vitreoretinal traction caused by eyeball flaccidity. We also believe that the loss of retinochoroidal hydrostatic pressure plays a role. It is important that forensic pathologists not confuse a postmortem retinal fold with traumatic retinal detachment or perimacular retinal folds caused by child abuse. When child abuse is suspected, forensic pathologists should perform enucleation and a subsequent histological examination for confirmation. (C) 2014 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Oshima, Toru; Ohtani, Maki; Mimasaka, Sohtaro] Akita Univ, Grad Sch Med, Dept Forens Sci, Akita 0108543, Japan; [Yoshikawa, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Higashi Ku, Fukuoka 8128582, Japan	Oshima, T (reprint author), Akita Univ, Grad Sch Med, Dept Forens Sci, 1-1-1 Hondo, Akita 0108543, Japan.	tooshima@med.akita-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25860485]	This research was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (Grant # 25860485).	Alappatt JJ, 1998, RETINA-J RET VIT DIS, V18, P506; GAYNON MW, 1988, AM J OPHTHALMOL, V106, P423; [Anonymous], 2014, ULTR B SCANN UD 8000; Kivlin JD, 2008, ARCH OPHTHALMOL-CHIC, V126, P800, DOI 10.1001/archopht.126.6.800; [Anonymous], ABUSIVE HEAD TRAUMA; Amberg R, 2001, FORENSIC SCI INT, V124, P157, DOI 10.1016/S0379-0738(01)00582-5; Balci Y, 2010, AM J FOREN MED PATH, V31, P151, DOI 10.1097/PAF.0b013e3181dd7933; Davis NL, 2006, AM J FOREN MED PATH, V27, P1, DOI 10.1097/01.paf.0000201102.03778.65; Dutton JJ, 2010, RETINAL DETACHMENT R, P350; Green WR, 1996, OPHTHALMIC PATHOLOGY, P780; Green WR, 1996, OPHTHALMIC PATHOLOGY, P961; JALKH AE, 1983, RETINA-J RET VIT DIS, V3, P154, DOI 10.1097/00006982-198300330-00002; KAIN HL, 1984, ARCH OPHTHALMOL-CHIC, V102, P608; Kevorkian J, 1961, J FORENSIC SCI, P261; Kinyoun JL, 1977, RETINA, V4, P9; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; MAURICE DM, 1971, EXP EYE RES, V12, P212, DOI 10.1016/0014-4835(71)90093-5; SEBAG J, 1991, ARCH OPHTHALMOL-CHIC, V109, P966; Shunmugam M, 2014, SURV OPHTHALMOL, V59, P192, DOI 10.1016/j.survophthal.2013.03.006; Spencer WH, 1996, OPHTHALMIC PATHOLOGY, P630; Spencer WH, 1996, OPHTHALMIC PATHOLOGY, P623; SUSAL AL, 1983, OPHTHALMOLOGY, V90, P266; Suto Shin, 2014, Nippon Ganka Gakkai Zasshi, V118, P7; Tsujinaka M, 2003, USEFULNESS POSTMORTE, V5, P288; Vij K, 2014, CHANGES EYES TXB FOR, P79; Wurdemann HV, 1920, AM J OPHTHALMOL, P321; Yoshioka N, 2002, NIHON HOIGAKU ZASSHI, V56, P319	27	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	FEB	2015	30						16	20		10.1016/j.jflm.2014.12.011		5	Medicine, Legal	Legal Medicine	AZ8HN	WOS:000348456400005		
J	Tokuoka, Y; Hashigoe, K				Tokuoka, Yoshinori; Hashigoe, Kiyokazu			Effects of stone-walled terracing and historical forest disturbances on revegetation processes after the abandonment of mountain slope uses on the Yura Peninsula, southwestern Japan	JOURNAL OF FOREST RESEARCH			English	Article						Agricultural legacy; Field boundary; Forest succession; Novel ecosystem; Species diversity	CONSERVATION; GROWTH	Abandonment of traditional land uses has become an ecosystem management concern in many agricultural landscapes. In this study, we investigated the reforested vegetation about half a century after the abandonment of mountain slopes used for terraced fields and wood production on the Yura Peninsula, Ehime Prefecture, southwestern Japan. Multivariate analyses of species composition indicated that, although many endozoochorous evergreen trees were common on the mountain slopes, fern species adapted to inhabiting the stone-wall structures (e.g., Cyrtomium falcatum, Microlepia strigosa, and Asplenium incisum) and common weed species of arable land occurred significantly more frequently in former stone-walled terraced fields than in former unwalled terraced fields and secondary forests. Tree layer composition was influenced by the forest area around the abandoned terraced fields. Moreover, historically less disturbed forests in the southwestern part of the peninsula were core habitats for regionally rare species, such as Jasminanthes mucronata, Firmiana simplex, and Ardisia sieboldii, and some of those species became established within neighboring abandoned terraced fields. These results indicate that land-use legacies, especially stone-walled terracing and historical forest disturbances, influence the revegetation processes of abandoned mountain slopes in warm-temperate coastal areas.	[Tokuoka, Yoshinori] Natl Inst Agroenvironm Sci, Biodivers Div, Tsukuba, Ibaraki 3058604, Japan	Tokuoka, Y (reprint author), Natl Inst Agroenvironm Sci, Biodivers Div, 3-1-3 Kannondai, Tsukuba, Ibaraki 3058604, Japan.	tokuoka@affrc.go.jp			Seto Inland Sea culture from the Fukutake Foundation; Japan Society for the Promotion of Science KAKENHI Grant [26870835]	We thank all the villagers who consented to being interviewed, Mr. Shota Ninomiya for his assistance in the field survey, and Mr. Shozo Fujita and Mr. Hirofumi Oda for their help in gathering historical information. This study was supported by a grant for research on the Seto Inland Sea culture from the Fukutake Foundation and a Japan Society for the Promotion of Science KAKENHI Grant (26870835).	Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Tokuoka Y, 2011, PLANT ECOL, V212, P923, DOI 10.1007/s11258-010-9868-9; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Foster DR, 1996, TRENDS ECOL EVOL, V11, P419, DOI 10.1016/0169-5347(96)10047-1; Lawson D, 1999, PLANT ECOL, V145, P267, DOI 10.1023/A:1009873127360; ARITA H, 2007, T JPN SOC IRRIG DRAI, V249, P255; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE; Chibaken-Shiryou-Kenkyuzaidan, 2003, CHIB NO SHIZ; Collier MJ, 2013, LANDSCAPE RES, V38, P141, DOI 10.1080/01426397.2012.682567; Daniel Herve, 2004, Urban Forestry & Urban Greening, V3, P19, DOI 10.1016/j.ufug.2004.04.001; Harada M, 1994, YURA HANTOU; Hattori T, 2004, JPN J ECOL, V51, P11; Hattori Tamotsu, 2012, Humans and Nature, V23, P1; Hobbs RJ, 2007, OLD FIELDS DYNAMICS, P17; Iwatsuki K, 1999, FERNS FERN ALLIES JA; Kuroda A, 2008, LANDSC RES JPN, V71, P581; Kuroda A., 2009, Japanese Journal of Conservation Ecology, V14, P55; Legendre P., 1998, NUMERICAL ECOLOGY; Matsumoto S, 2003, ANN TSUKUBA BOT GARD, V22, P1; Meiners SJ, 2002, AM J BOT, V89, P446; Miyamoto H, 2006, DANBATA KARA NO KOTO; Miyawaki A, 1994, HDB JAPANESE VEGETAT; Osawa K, 1953, UCHIUMI SONSHI JYOKA, V1; R Development Core Team, 2013, R LANG ENV STAT COMP; Sato T., 2008, Journal of the Japanese Forest Society, V90, P364, DOI 10.4005/jjfs.90.364; Tarolli P., 2014, ANTHROPOCENE, V6, P10, DOI [DOI 10.1016/J.ANCENE.2014.03.002, 10.1016/j.ancene.2014.03.002]; Uchiumi-sonshi-hensan-iinkai, 2004, SHINT UCH SONSH; Uehara K, 1961, ILLUSTRATED ENCY TRE, VII; Wakamori T, 1961, UWA CHITAI NO MINZOK; Yamada K, 1952, JPN J HUM GEOGR, V5, P392; Yamagawa Hiromi, 2013, Japanese Journal of Ecology (Otsu), V63, P219; Yamagawa H, 2007, JPN J FOR ENV, V49, P111; Yamanaka T, 1971, KOCHI DAIGAKU GAKUJY, V19, P17	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					24	34		10.1007/s10310-014-0471-0		11	Forestry	Forestry	AZ7KZ	WOS:000348399200004		
J	Hoang, HTN; Hoshino, S; Hashimoto, S				Hai Thi Nguyen Hoang; Hoshino, Satoshi; Hashimoto, Shizuka			Forest stewardship council certificate for a group of planters in Vietnam: SWOT analysis and implications	JOURNAL OF FOREST RESEARCH			English	Article						Certification; Forest management; FSC; Sustainable development	ENTERPRISES; MANAGEMENT	A group of smallholders in Vietnam has obtained Forest Stewardship Council certification (FSC) for their Acacia plantation forest. Although the certification aims to improve livelihoods via economic, social, and environmental benefits, there are concerns amongst smallholders regarding the outcomes from their certification decision as well as difficulties in maintaining the certification. This article assesses the benefits and challenges of forest management certification from the perspective of small household groups who have achieved FSC certification. The FSC has brought new opportunities for farmers, such as increased selling price and extended trade networks, but is also associated with significant obstacles such as high initial and annual surveillance audit fees, difficult paper work, and complicated procedures for selling wood. Additionally, the small size of the plantations and low expertise in forest management make it more difficult and costly for farmers to achieve certification. There is a heavy dependency on donors for financial and technical support. Because subsidies from organizations like the World Wide Fund for Nature Vietnam are unlikely to continue indefinitely, the benefit of certification for smallholders is uncertain. Feasible actions to increase the sustainability of the group are suggested, including increasing the responsibility of the group members, enhancing the awareness and capacity of the local people, and searching for additional support from other organizations and wood processing companies. From the macro level, a national forest stewardship council should be established so that the audit cost for certification would be reduced.	[Hai Thi Nguyen Hoang; Hoshino, Satoshi; Hashimoto, Shizuka] Kyoto Univ, Grad Sch Global Environm Studies, Lab Sustainable Rural Dev, Sakyo Ward, Kyoto 6068501, Japan	Hoang, HTN (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Lab Sustainable Rural Dev, Sakyo Ward, Yoshidahonmachi, Kyoto 6068501, Japan.	hai.htn@gmail.com					Hain H, 2007, INT FOREST REV, V9, P759, DOI 10.1505/ifor.9.3.759; Araujo M, 2009, FOREST POLICY ECON, V11, P579, DOI 10.1016/j.forpol.2009.07.008; Cubbage F, 2010, FOREST POLICY ECON, V12, P497, DOI 10.1016/j.forpol.2010.06.004; Auer MR, 2012, HUM ECOL, V40, P5, DOI 10.1007/s10745-011-9451-6; Bray DB, 2002, RISE COMMUNITY FORES; Cashore B, 2012, FOREST POLICY ECON, V18, P13, DOI [10.1016/j.forpol.2011.12.005, 10.1016/j.forpol.2012.03.001]; Helms Marilyn M, 2010, Journal of Strategy and Management, V3, DOI 10.1108/17554251011064837; Humphries SS, 2006, FOREST ECOL MANAG, V235, P30, DOI 10.1016/j.foreco.2006.07.027; Kollert W, 2007, FOREST POLICY ECON, V9, P862, DOI 10.1016/j.forpol.2006.03.005; Kotler P., 1988, MARKETING MANAGEMENT; Nguyen TQ, 2007, 14 FOR POL I; NUSSBAUM R., 2005, FOREST CERTIFICATION; Sugiura K., 2012, Journal of Forestry Research, V23, P165, DOI 10.1007/s11676-012-0249-1; Tacconi L., 2004, LEARNING LESSONS PRO; Weihrich H., 1999, EUROPEAN BUSINESS RE, V99, P9, DOI DOI 10.1108/09555349910251822; Zhao JZ, 2011, ENVIRON MANAGE, V48, P1086, DOI 10.1007/s00267-011-9620-9	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					35	42		10.1007/s10310-014-0472-z		8	Forestry	Forestry	AZ7KZ	WOS:000348399200005		
J	Komatsu, H; Kume, T				Komatsu, Hikaru; Kume, Tomonori			Changes in the sapwood area of Japanese cedar and cypress plantations after thinning	JOURNAL OF FOREST RESEARCH			English	Article						Japanese cedar; Japanese cypress; Sapwood area; Thinning; Transpiration	CRYPTOMERIA-JAPONICA; CHAMAECYPARIS-OBTUSA; FORESTED CATCHMENT; STAND AGE; TRANSPIRATION; MANAGEMENT; CLIMATE; YIELD	Previous studies have revealed that the sapwood area at stand scale (A) is an important factor determining changes in transpiration by canopy trees (E). This study examined changes in A for four to six years after thinning of two Japanese cedar and two cypress plantation sites, each having three or four plots with different thinning intensities and one control plot. We focused on whether there was a difference in A (delta A) between a thinned plot and a control plot during the experimental period. We observed increased radial stem growth for plots with low stem density (N) due to intensive thinning. However, delta A did not decrease to zero during the experimental period for any plot. The increased radial stem growth was not large enough to cancel the effect of low N due to thinning. These results imply that a lower E for thinned plantations as compared to non-thinned plantationsis remains for several years (more than 10 years, according to our results) after thinning and that thinning could be an effective method of reducing water consumption by canopy trees.	[Komatsu, Hikaru] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068302, Japan; [Komatsu, Hikaru] Kyoto Univ, Fac Agr, Kyoto 6068502, Japan; [Kume, Tomonori] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 106, Taiwan	Komatsu, H (reprint author), Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068302, Japan.	kmthkr@gmail.com			CREST project	We acknowledge Dr. Kenji Tsuruta (Kyoto University, Japan) for providing data of the sapwood area at tree scale. Thanks are also due to two anonymous reviewers for their useful comments. This research was supported by a CREST project (Development of Innovative Technologies for Increasing in Watershed Runoff and Improving River Environment by the Management Practice of Devastated Forest Plantation).	Alsheimer M, 1998, ANN SCI FOREST, V55, P103, DOI 10.1051/forest:19980107; Vertessy RA, 2001, FOREST ECOL MANAG, V143, P13, DOI 10.1016/S0378-1127(00)00501-6; Kumagai T, 2005, FOREST ECOL MANAG, V206, P191, DOI 10.1016/j.foreco.2004.10.066; Morikawa Y, 1986, TREE PHYSIOL, V2, P105; Licata JA, 2011, ECOHYDROLOGY, V4, P83, DOI 10.1002/eco.125; Kume T, 2010, TREE PHYSIOL, V30, P129, DOI 10.1093/treephys/tpp074; Ford CR, 2011, ECOL APPL, V21, P2049, DOI 10.1890/10-2246.1; Trisurat Y, 2010, ENVIRON MANAGE, V45, P626, DOI 10.1007/s00267-010-9438-x; BREDA N, 1995, TREE PHYSIOL, V15, P295; Dung BX, 2011, ECOHYDROLOGY, V4, P367, DOI 10.1002/eco.135; Onda Y, 2010, HYDROL PROCESS, V24, P527, DOI 10.1002/hyp.7548; Forestry and Forest Products Research Institute, 2010, POINTS INT THINN OP; Fujimori T, 2000, LIVING WITH FORESTS; Fukada H, 2009, B KOCHI PREF FOR TEC, V34, P56; Hayashi S., 1972, Journal of the Japanese Forestry Society, V54, P218; Imawaka S, 2008, B KYUSHU U FOREST, V89, P75; Japan Forestry Agency, 2013, WHIT PAP FOR FOR; Kawahara T, 1989, B FFPRI, V356, P47; KIYONO Y, 1988, Journal of the Japanese Forestry Society, V70, P455; Komatsu H., 2013, HYDROL RES LETT, V7, P60, DOI DOI 10.3178/HRL.7.60; Komatsu H, 2010, J ENVIRON MANAGE, V91, P814, DOI 10.1016/j.jenvman.2009.10.011; Komatsu H, 2010, SUIRI KAGAKU, V314, P1; Komatsu H., 2009, Journal of the Japanese Forest Society, V91, P94, DOI 10.4005/jjfs.91.94; Komatsu H, 2008, FOREST ECOL MANAG, V255, P880, DOI 10.1016/j.foreco.2007.10.010; Kunisaki T, 2001, JPN J FOR PLANN, V35, P31; Kuraji K, 2003, EFFECTS FORESTS STAB; Lagergren F, 2008, FOREST ECOL MANAG, V255, P2312, DOI 10.1016/j.foreco.2007.12.047; Macfarlane C, 2010, FOREST ECOL MANAG, V260, P96, DOI 10.1016/j.foreco.2010.04.005; Miyamoto K, 2009, JPN J FOR ENV, V51, P21; Moore GW, 2010, TREES-STRUCT FUNCT, V24, P165, DOI 10.1007/s00468-009-0390-4; Morotomi T, 2012, FISCAL SCI WATER FOR; Murakami S, 2000, J HYDROL, V227, P114, DOI 10.1016/S0022-1694(99)00175-4; Sawano S, 2005, J JPN SOC HYDROL WAT, V18, P435, DOI 10.3178/jjshwr.18.435; Takeuchi I, 1975, B GOV FOR EXP STA, V272, P141; Tamai S., 1983, Journal of the Japanese Forestry Society, V65, P372; Tsukamoto Y., 1998, CONSERVATION FOREST; Tsuruta Kenji, 2011, Journal of Japan Society of Hydrology and Water Resources, V24, DOI 10.3178/jjshwr.24.261; Yashiro Y, 2010, J PLANT RES, V123, P463, DOI 10.1007/s10265-010-0323-8	38	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					43	51		10.1007/s10310-014-0468-8		9	Forestry	Forestry	AZ7KZ	WOS:000348399200006		
J	Ueyama, M; Kudo, S; Iwama, C; Nagano, H; Kobayashi, H; Harazono, Y; Yoshikawa, K				Ueyama, Masahito; Kudo, Shinya; Iwama, Chie; Nagano, Hirohiko; Kobayashi, Hideki; Harazono, Yoshinobu; Yoshikawa, Kenji			Does summer warming reduce black spruce productivity in interior Alaska?	JOURNAL OF FOREST RESEARCH			English	Article						Alaska; Black spruce; Boreal forest; Drought; Renewed response; Tree ring	WHITE SPRUCE; FOREST; GROWTH; TEMPERATURE; SENSITIVITY; ECOSYSTEMS; LANDSCAPE; TREELINE	High-latitude warming has had a discernible effect on the productivity of boreal forests. Here, we report a change in the growth responses of a major biome of boreal North America, black spruce, to climatic warming, based on tree rings sampled at 11 sites in interior Alaska. Tree ring growth was negatively correlated with growing season air temperature, but positively correlated with annual precipitation. The magnitude of the negative correlation increased with increasing growing season temperature until the 1980s, suggesting that warming-induced drought restricted the productivity. However, after the mid-1990s, the negative correlation diminished, and tree ring growth responded positively to air temperature, suggesting that the productivity of the high-latitude forest, and potentially its carbon uptake, will increase under expected warming. The future trajectories of high-latitude forests in interior Alaska and associated carbon cycle feedback will depend on the duration and strength of this renewed response under future climatic warming.	[Ueyama, Masahito; Kudo, Shinya; Iwama, Chie; Harazono, Yoshinobu] Osaka Prefecture Univ, Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Nagano, Hirohiko; Harazono, Yoshinobu] Univ Alaska Fairbanks, Int Arctic Res Ctr, Fairbanks, AK 99775 USA; [Kobayashi, Hideki] Japan Agcy Marine Earth Sci & Technol, Dept Environm Geochem Cycle Res, Kanazawa Ku, Yokosuka, Kanagawa 2360001, Japan; [Yoshikawa, Kenji] Univ Alaska Fairbanks, Water & Environm Res Ctr, Fairbanks, AK 99775 USA	Ueyama, M (reprint author), Osaka Prefecture Univ, Sch Life & Environm Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	miyabi-flux@muh.biglobe.ne.jp	Kobayashi, Hideki/A-9616-2010; Nagano, Hirohiko/K-8145-2012	Nagano, Hirohiko/0000-0002-3090-7709	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [RF1-1201]; JSPS KAKENHI [23310009]	This study was supported in part by the Environment Research and Technology Development Fund (RF1-1201) of the Ministry of the Environment, Japan, and by JSPS KAKENHI Grant Number 23310009. We thank Dr. T. Nakai of Nagoya University and Dr. H. Iwata of Kyoto University for help with tree ring sampling, and two anonymous reviewers for beneficial comments.	Iwata H, 2011, SOLA, V7, P105, DOI 10.2151/sola.2011-027; Ueyama M, 2014, GLOBAL CHANGE BIOL, V20, P1161, DOI 10.1111/gcb.12434; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1192666; Ueyama M, 2009, AGR FOREST METEOROL, V149, P582, DOI 10.1016/j.agrformet.2008.10.011; Wilmking M, 2005, GLOBAL PLANET CHANGE, V47, P282, DOI 10.1016/j.gloplacha.2004.10.017; Nakai T, 2013, POLAR SCI, V7, P136, DOI 10.1016/j.polar.2013.03.003; Hayes DJ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003813; Euskirchen ES, 2006, GLOBAL CHANGE BIOL, V12, P731, DOI 10.1111/j.1365-2486.2006.01113.x; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Rocha AV, 2006, GLOBAL CHANGE BIOL, V12, P1378, DOI 10.1111/j.1365-2486.2006.01179.x; Beck PSA, 2011, ECOL LETT, V14, P373, DOI 10.1111/j.1461-0248.2011.01598.x; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Girardin MP, 2012, BIOGEOSCIENCES, V9, P2523, DOI 10.5194/bg-9-2523-2012; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wilmking M, 2008, DENDROCHRONOLOGIA, V25, P167, DOI 10.1016/j.dendro.2007.04.003; Cook E, 1992, METHODS DENDROCHRONO, P104; Goetz AJ, 2006, P NATL ACAD SCI USA, V102, P13521; Grissino- Mayer HD, 1992, INT TREE RING DATA B, P104; Hastings D. A., 1999, GLOBAL LAND ONE KILO; Hinzman LD, 2003, J GEOPHYS RES, V108, DOI [10.1029/2001JD000415.2003, DOI 10.1029/2001JD000415.2003]; Iwata H, 2013, POLAR SCI, V7, P113, DOI 10.1016/j.polar.2013.03.004; Krishnan P, 2008, J GEOPHYS RES, P113, DOI [10.1029/2007/JDF008965, DOI 10.1029/2007/JDF008965]; Liu HP, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000483; Shulski M., 2007, CLIMATE ALASKA, P216; Speer JH, 2010, FUNDAMENTALS TREE RI, P333; Ueyama M, 2013, J GEOPHYS RES-BIOGEO, V118, P1266, DOI 10.1002/jgrg.20095; Wilmking M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023331	29	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					52	59		10.1007/s10310-014-0448-z		8	Forestry	Forestry	AZ7KZ	WOS:000348399200007		
J	Osono, T				Osono, Takashi			Diversity, resource utilization, and phenology of fruiting bodies of litter-decomposing macrofungi in subtropical, temperate, and subalpine forests	JOURNAL OF FOREST RESEARCH			English	Article						Climate; Decomposition; Mycena; Radiocarbon; Seasonal changes	LEAF-LITTER; CONIFEROUS FOREST; SPECIES RICHNESS; NEEDLE LITTER; FUNGI; REGIONS; OLD; ECTOMYCORRHIZAL; DEGRADATION; COMMUNITIES	The diversity, vegetative and reproductive characteristics, and phenology of litter decomposing macrofungi (LDM) were compared between humus forms and climatic regions. Fruiting bodies of LDM were examined for the forest floor of subtropical (ST), cool temperate (CT), and subalpine (SA) forests in Japan. Field surveys during one growing season yielded 35, 32, and 18 species in ST, CT, and SA, respectively. Species richness was generally higher in mull than in moder humus and in a warmer than in a cooler climate. A total of ten fungal families were observed, and species in the Mycenaceae dominated in the LDM assemblages at all study sites. A larger number of species fruited on deeper F layers of the forest floor in SA than in ST, where 74 % of species fruited directly on leaf litter. This observation was consistent with the analysis of radiocarbon content in fruiting bodies, implying that LDM tended to utilize older carbon accumulated at deeper layers of the forest floor in cooler climates. Seasonal changes in the fruiting frequency over a growing season exhibited similar two-peak patterns for all the study sites, coinciding with the periods of rainfall and increasing and decreasing air temperatures in early summer and autumn, respectively, but the fruiting period extended longer in a warmer than in a cooler climate.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Osono, T (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	tosono@ecology.kyoto-u.ac.jp	Osono, Takashi/N-9580-2014	Osono, Takashi/0000-0001-8552-7490	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [19780114]; Sumitomo Foundation; Nissan Global Foundation; Nippon Life Inst. Foundation; Grants for Excellent Graduate Schools, MEXT, Japan [12-01]	I thank Dr. D. Hirose and Dr. T. Miyamoto for help with the identification of macrofungi; Dr. F. Hyodo for useful discussion of radiocarbon analysis; Dr. A. Takashima and staff at the Yona Experimental Forest, University of the Ryukyus for help with field work at ST; Dr. Y. Fukasawa and staff at Ashiu Experimental Forest, Kyoto University for help with fieldwork at CT; and Dr. Elizabeth Nakajima for critical reading of the manuscript. This study received partial financial support from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (No. 19780114), The Sumitomo Foundation, Nissan Global Foundation, Nippon Life Inst. Foundation, and the Grants for Excellent Graduate Schools, MEXT, Japan (12-01) to Kyoto University.	Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Gomez-Hernandez M, 2012, BIODIVERS CONSERV, V21, P2247, DOI 10.1007/s10531-011-0180-3; Osono T, 2003, SOIL BIOL BIOCHEM, V35, P1423, DOI 10.1016/S0038-0717(03)00236-0; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; Yamashita S, 2004, J FOREST RES-JPN, V9, P165, DOI 10.1007/s10310-003-0072-9; Osono T, 2011, FUNGAL ECOL, V4, P375, DOI 10.1016/j.funeco.2011.02.004; Hirose Dai, 2006, Mycoscience, V47, P242, DOI 10.1007/s10267-006-0299-3; Richard F, 2004, CAN J BOT, V82, P1711, DOI 10.1139/B04-128; Schmit JP, 1999, CAN J BOT, V77, P1014, DOI 10.1139/cjb-77-7-1014; Ikeda A, 2014, POPUL ECOL, V56, P289, DOI 10.1007/s10144-013-0412-3; Steffen KT, 2007, RES MICROBIOL, V158, P447, DOI 10.1016/j.resmic.2007.04.002; Osono T, 2011, FUNGAL ECOL, V4, P210, DOI 10.1016/j.funeco.2010.11.003; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; Straatsma G, 2001, MYCOL RES, V105, P515, DOI 10.1017/S0953756201004154; SASTAD SM, 1995, CAN J BOT, V73, P807; Mueller GM, 2007, BIODIVERS CONSERV, V16, P37, DOI 10.1007/s10531-006-9108-8; Berg B, 1986, SCAND J FOREST RES, V1, P359, DOI 10.1080/02827588609382428; VILLENEUVE N, 1989, CAN J BOT, V67, P2616; Osono T, 2002, SOIL BIOL BIOCHEM, V34, P1537, DOI 10.1016/S0038-0717(02)00123-2; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; O'Hanlon R, 2012, FUNGAL ECOL, V5, P499, DOI 10.1016/j.funeco.2011.12.008; Bagci E, 1996, FLAVOUR FRAG J, V11, P251, DOI 10.1002/(SICI)1099-1026(199607)11:4<251::AID-FFJ577>3.0.CO;2-K; BRUNNER I, 1992, CAN J BOT, V70, P1247; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Gates GM, 2011, FUNGAL ECOL, V4, P68, DOI 10.1016/j.funeco.2010.08.001; HANSEN P A, 1992, Cryptogamic Botany, V2, P355; HINTIKKA V, 1988, Acta Botanica Fennica, V136, P89; Hongo T, 1994, FUNGI; Hyodo F, 2006, FUNCT ECOL, V20, P385, DOI 10.1111/j.1365-2435.2006.01081.x; Imazeki R, 1987, COLORED ILLUSTRATION; Imazeki R., 1989, COLORED ILLUSTRATION, VII; Imazeki R, 1988, FUNGI JAPAN; Lange M, 1993, OPERA BOT, V120, P1; Levin I, 1997, RADIOCARBON, V39, P205; Lopez-Quintero CA, 2012, BIODIVERS CONSERV, V21, P2221, DOI 10.1007/s10531-012-0280-8; Miyamoto Toshizumi, 2000, Mycoscience, V41, P105, DOI 10.1007/BF02464317; Mori A, 2004, TREE PHYSIOL, V24, P661; Murakami Y, 1989, T MYCOLOGICAL SOC JA, V30, P89; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Okabe H, 1986, THESIS KYOTO U KYOTO; Okabe H, 1983, B KYOTO U FOR, V53, P20; Oksanen J., 2013, MULTIVARIATE ANAL EC; Osono T, 2011, EUR J SOIL BIOL, V47, P114, DOI 10.1016/j.ejsobi.2010.12.002; Osono T, 2014, J FOR RES IN PRESS; Outerbridge RAM, 2002, THESIS U VICTORIA; Peterson SW, 2000, INTEGRATION MODERN T, P163; R Development Core Team, 2009, R LANG ENV STAT COMP; RASTIN N, 1990, SOIL BIOL BIOCHEM, V22, P1039, DOI 10.1016/0038-0717(90)90029-Y; Takeda H, 1988, B KYOTO U FOREST, V60, P33; Tian XJ, 1997, ECOL RES, V12, P289, DOI 10.1007/BF02529458; Tsukamoto J, 1996, ECOL RES, V11, P35, DOI 10.1007/BF02347818; TYLER G, 1985, FOREST ECOL MANAG, V10, P13, DOI 10.1016/0378-1127(85)90011-8; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Xu X, 1998, SCI B FAC AGR U RYUK, V45, P185; Xu X, 1998, SCI B FAC AGR U RYUK, V45, P195	56	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					60	68		10.1007/s10310-014-0459-9		9	Forestry	Forestry	AZ7KZ	WOS:000348399200008		
J	Osono, T				Osono, Takashi			Hyphal length in the forest floor and soil of subtropical, temperate, and subalpine forests	JOURNAL OF FOREST RESEARCH			English	Article						Climate; Fungal biomass; Fungi; Mycelia; Seasonal change	LEAF-LITTER DECOMPOSITION; FUNGAL COLONIZATION; CONIFEROUS FOREST; DECIDUOUS FOREST; NEEDLE LITTER; SUCCESSION; DYNAMICS; LEAVES; JAPAN; COMMUNITIES	Fungi are a major component of soil biota in terrestrial ecosystems of various climatic regions, but few studies have compared the effects of soil layer and season on their abundance between sites with different humus forms and climatic conditions. In the present study, the hyphal length in the forest floor and soil was investigated in subtropical (ST), cool temperate (CT), and subalpine (SA) forests in Japan with an agar film method. The primary aim was to describe the seasonal variations in hyphal length in different layers of mull and moder humus forms in forests of these three climatic regions. The total hyphal length was generally higher in CT than in ST and SA and decreased with the soil depth. Seasonal changes in total hyphal length were observed in ST and in the lower slope of CT where mull humus developed. The length of darkly pigmented hyphae and the proportion of them relative to the total hyphal length were higher at the upper slope of the CT forest (moder humus) than at the other sites, and decreased in the order F > L > A layers. Clamp-bearing hyphal length in Basidiomycota accounted for as much as 19 % of the total hyphal length and decreased with the depth of the forest floor and soil in all study sites. Seasonal changes of hyphal length and the layer x month interaction were significant on mull but not on moder humus, suggesting that hyphal length was more sensitive to season in mull than in moder humus.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Osono, T (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	tosono@ecology.kyoto-u.ac.jp	Osono, Takashi/N-9580-2014	Osono, Takashi/0000-0001-8552-7490	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [19780114]; Sumitomo Foundation; Nissan Global Foundation; Nippon Life Inst. Foundation; Grants for Excellent Graduate Schools, MEXT, Japan [12-01]	I thank Dr. A. Takashima and staff at the Yona Experimental Forest, University of the Ryukyus, for help with fieldwork at ST; the staff at Ashiu Experimental Forest, Kyoto University, for help with fieldwork at CT; and Dr. Elizabeth Nakajima for her critical reading of the manuscript. This study received partial financial support from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (No. 19780114), The Sumitomo Foundation, Nissan Global Foundation, Nippon Life Inst. Foundation, and Grants for Excellent Graduate Schools, MEXT, Japan (12-01) to Kyoto University.	Osono T, 2006, SOIL BIOL BIOCHEM, V38, P2743, DOI 10.1016/j.soilbio.2006.04.028; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Osono T, 2007, CAN J MICROBIOL, V53, P1, DOI 10.1139/W06-092; Mori A, 2004, FOREST ECOL MANAG, V196, P287, DOI 10.1016/j.foreco.2004.03.027; Osono T, 2003, SOIL BIOL BIOCHEM, V35, P1423, DOI 10.1016/S0038-0717(03)00236-0; Holden SR, 2013, ECOSYSTEMS, V16, P34, DOI 10.1007/s10021-012-9594-3; Osono T, 2009, FUNGAL DIVERS, V36, P101; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Osono T, 2011, FUNGAL ECOL, V4, P375, DOI 10.1016/j.funeco.2011.02.004; Fioretto A, 1998, SOIL BIOL BIOCHEM, V30, P721, DOI 10.1016/S0038-0717(97)00182-X; BERG B, 1979, SOIL BIOL BIOCHEM, V11, P339, DOI 10.1016/0038-0717(79)90045-2; WIDDEN P, 1979, CAN J BOT, V57, P2408; Osono T, 2005, MYCOLOGIA, V97, P589, DOI 10.3852/mycologia.97.3.589; JONES PCT, 1948, J GEN MICROBIOL, V2, P54; Osono T, 2008, ECOL RES, V23, P909, DOI 10.1007/s11284-007-0455-z; Hobara S, 2014, BIOGEOCHEMISTRY, V118, P471, DOI 10.1007/s10533-013-9912-7; Osono T, 2002, SOIL BIOL BIOCHEM, V34, P1537, DOI 10.1016/S0038-0717(02)00123-2; Osono T, 2001, ECOL RES, V16, P649, DOI 10.1046/j.1440-1703.2001.00426.x; Koide K, 2005, ECOL RES, V20, P599, DOI 10.1007/s11284-005-0077-2; Baath E, 1977, SWED CONIFER FOR PRO, V13, P1; Dix NJ, 1995, FUNGAL ECOLOGY; Enoki T, 2003, ECOL RES, V18, P103, DOI 10.1046/j.1440-1703.2003.00549.x; Frankland JC, 1982, BIOMASS NUTR CYCLING, P241; HUNT GA, 1983, SOIL BIOL BIOCHEM, V15, P641, DOI 10.1016/0038-0717(83)90027-5; KJOLLER A, 1982, Oikos, V39, P391, DOI 10.2307/3544690; Newell S.Y., 1992, FUNGAL COMMUNITY ITS, P521; OLSON F. C. W., 1950, TRANS AMER MICROSC SOC, V69, P272, DOI 10.2307/3223098; Osono T, 2008, ECOL RES, V23, P51, DOI 10.1007/s11284-007-0336-5; Osono T, 2014, POLAR SCI, V8, P207, DOI 10.1016/j.polar.2013.10.004; Osono T, 2011, EUR J SOIL BIOL, V47, P114, DOI 10.1016/j.ejsobi.2010.12.002; Osono T, 2012, POLAR SCI, V6, P121, DOI 10.1016/j.polar.2011.12.001; Osono T, 2014, J FOR RES IN PRESS; Robinson CH, 1996, POLAR BIOL, V16, P71, DOI 10.1007/BF02388737; RUSCOE QW, 1971, NEW ZEAL J SCI, V14, P554; Boddy L, 2008, BR MYCOL SY, V28, P1; Takeda H, 1988, B KYOTO U FOREST, V60, P33; Tateno R, 2003, ECOL RES, V18, P559, DOI 10.1046/j.1440-1703.2003.00578.x; Tian XJ, 1997, ECOL RES, V12, P289, DOI 10.1007/BF02529458; Tokumasu Seiji, 1998, Mycoscience, V39, P417, DOI 10.1007/BF02460902; Tsukamoto J, 1996, ECOL RES, V11, P35, DOI 10.1007/BF02347818; van der Wal A, 2009, SOIL BIOL BIOCHEM, V41, P417, DOI 10.1016/j.soilbio.2008.10.031; WEST AW, 1988, BIOL FERT SOILS, V7, P88	42	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					69	76		10.1007/s10310-014-0461-2		8	Forestry	Forestry	AZ7KZ	WOS:000348399200009		
J	Osono, T				Osono, Takashi			Effects of litter type, origin of isolate, and temperature on decomposition of leaf litter by macrofungi	JOURNAL OF FOREST RESEARCH			English	Article						Acid-unhydrolyzable residue; Leaves; Litter-decomposing macrofungi; Selective delignification; Temperature	NITROGEN DYNAMICS; CLIMATE-CHANGE; DIVERSE FUNGI; FOREST; MODEL; JAPAN; OAK; DEGRADATION; QUALITY; NEEDLE	The dependence of hyphal growth and litter decomposition on litter type and incubation temperature used as substratum were compared for litter-decomposing macrofungi originating from subtropical (ST), cool temperate (CT), and subalpine forests (SA) in Japan. In the first series of pure culture decomposition tests using a total of 39 litter types as substrata inoculated with six fungal isolates from the three climatic regions, the fungal decomposition of litter was negatively affected by the content of acid-unhydrolyzable residues (AUR) or extractives and positively by N content in the litter. Secondly, cross-inoculation tests were performed to examine the mass loss of leaf litter of broad-leaved trees from ST, CT, and SA, each inoculated with three Mycena species from the three climates and incubated at seven temperatures between 5 and 35 A degrees C. Fungal isolate, litter type, incubation temperature, and their interactions significantly affected the mass loss of litter during the incubation. The greatest values of mass loss were found at 20 or 25 A degrees C, and were generally consistent with the optimum temperatures of colony diameter growth rate of these isolates. Isolates from cooler regions were more sensitive to higher temperature than isolates from warmer regions. The decomposition of recalcitrant compounds (as acid-unhydrolyzable residues, AUR) by Mycena sp. from ST was also affected by litter type and incubation temperature, but the degree of selective decomposition of AUR relative to other components, such as cellulose, was insensitive to the range of temperature tested.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Osono, T (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	tosono@ecology.kyoto-u.ac.jp	Osono, Takashi/N-9580-2014	Osono, Takashi/0000-0001-8552-7490	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [19780114]; Sumitomo Foundation; Nissan Global Foundation; Nippon Life Inst. Foundation; Grants for Excellent Graduate Schools, MEXT, Japan [12-01]	I thank Mr. Y. Hagiwara for help with chemical analyses and Dr. Elizabeth Nakajima for critical reading of the manuscript. This study received partial financial support from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (No. 19780114), The Sumitomo Foundation, Nissan Global Foundation, Nippon Life Inst. Foundation, and the Grants for Excellent Graduate Schools, MEXT, Japan (12-01) to Kyoto University.	ADASKAVEG JE, 1995, APPL ENVIRON MICROB, V61, P138; Russell GL, 1995, ATMOS OCEAN, V33, P683; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Osono T, 2009, MYCOSCIENCE, V50, P52, DOI 10.1007/s10267-008-0442-4; Osono T, 2011, MYCOSCIENCE, V52, P327, DOI 10.1007/s10267-011-0112-9; Osono T, 2014, PLANT SOIL, V376, P411, DOI 10.1007/s11104-013-1993-5; Lindahl B, 2008, BR MYCOL SY, V28, P183; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2011, FUNGAL ECOL, V4, P375, DOI 10.1016/j.funeco.2011.02.004; Steffen KT, 2007, RES MICROBIOL, V158, P447, DOI 10.1016/j.resmic.2007.04.002; Osono T, 2011, FUNGAL ECOL, V4, P210, DOI 10.1016/j.funeco.2010.11.003; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Hagiwara Y, 2012, J FOREST RES-JPN, V17, P51, DOI 10.1007/s10310-011-0265-6; MANABE S, 1991, J CLIMATE, V4, P785, DOI 10.1175/1520-0442(1991)004<0785:TROACO>2.0.CO;2; Murphy KL, 1998, ECOL APPL, V8, P1061; Matsui T, 2004, J VEG SCI, V15, P605, DOI 10.1658/1100-9233(2004)015[0605:PDVASI]2.0.CO;2; Hughes KA, 2007, SCI TOTAL ENVIRON, V372, P539, DOI 10.1016/j.scitotenv.2006.09.016; BOER GJ, 1992, J CLIMATE, V5, P1045, DOI 10.1175/1520-0442(1992)005<1045:GGCCSW>2.0.CO;2; GENG XY, 1993, CAN J BOT, V71, P693; Hosoya T, 2010, MYCOSCIENCE, V51, P116, DOI 10.1007/s10267-009-0020-4; Iwamoto Susumu, 2001, Mycoscience, V42, P273, DOI 10.1007/BF02463919; KING HGC, 1967, PEDOBIOLOGIA, V7, P192; LINDEBERG G., 1946, ARKIV BOT, V33A, P1; Mikola P, 1956, COMMUN I FOREST FENN, V48, P4; Miyamoto Toshizumi, 2000, Mycoscience, V41, P105, DOI 10.1007/BF02464317; Osono T, 2014, J FOR RES UNPUB; Osono T, 2003, MYCOLOGIA, V95, P820, DOI 10.2307/3762010; Osono T, 2005, ECOL RES, V20, P41, DOI 10.1007/s11284-004-0002-0; Osono T, 2011, EUR J SOIL BIOL, V47, P114, DOI 10.1016/j.ejsobi.2010.12.002; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Osono T, 2014, J FOR RES IN PRESS; STUMP LM, 1993, CAN J FOREST RES, V23, P492, DOI 10.1139/x93-067; Tokumasu Seiji, 2001, Mycoscience, V42, P575, DOI 10.1007/BF02460957; TSUKADA M, 1983, QUATERNARY RES, V19, P212, DOI 10.1016/0033-5894(83)90006-6; Zifcakova L, 2011, FUNGAL ECOL, V4, P427	37	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					77	84		10.1007/s10310-014-0462-1		8	Forestry	Forestry	AZ7KZ	WOS:000348399200010		
J	Nakajima, H				Nakajima, Haruki			Estimating sound seedfall density of Fagus crenata using a visual survey	JOURNAL OF FOREST RESEARCH			English	Article						Forest regeneration; Seedfall density; Seeding; Visual survey; Wildlife conservation	NORTHERN JAPAN; BLACK BEARS; ACORN PRODUCTION; MAST PRODUCTION; IMAGE-ANALYSIS; WEATHER; PREDATION; DISPERSAL; BEHAVIOR; FOREST	Estimating forest tree seeding before seedfall is important because annual fluctuations in seeding affect forest regeneration and wildlife behavior. Visual surveys for estimating tree seeding can be conducted easily, but cannot distinguish sound and unsound seeds, and cannot directly measure sound seedfall density, which closely correlates to seedling density and the food availability for wildlife. To establish an effective model for estimating sound seedfall density of Fagus crenata from a visual survey, seeding intensity at the tree level was visually rated into five classes in four stands for 7 years. Seedfall density of the visually surveyed trees was also measured by seed traps. Seeding intensity was strongly correlated with sound seedfall density at the tree level, and sound seedfall density differed among the five classes. However, a model that used only seeding intensity as an explanatory variable was not as effective at estimating sound seedfall density as more complex models that used the stand-level seeding index, calculated from the composition ratio of seeding intensity, in the current and previous years. More complex models improved the estimates because the proportion of sound-to-total seeds at the tree level depended on stand-level total seed production resulting from pollination efficiency and insect predator satiation. This method should be useful for forest management and wildlife conservation because it is rapid, easy, and highly accurate.	Toyama Prefectural Agr Forestry & Fisheries Res C, Forest Res Inst, Tateyama, Toyama 9301362, Japan	Nakajima, H (reprint author), Toyama Prefectural Agr Forestry & Fisheries Res C, Forest Res Inst, 3 Yoshimine, Tateyama, Toyama 9301362, Japan.	nakajima@fes.pref.toyama.jp			Toyama Prefecture, Japan	I thank the anonymous referees and editor for their valuable comments. I am grateful to Toyama District Forest Office and Nanto City for permission to use the stands, to my colleagues at Toyama Prefectural Government for their helpful support, and to Yukimi Kayamori and Natsuko Aoki for their assistance with counting seeds in the laboratory. This study was funded by Toyama Prefecture, Japan.	Kon H, 2005, J ECOL, V93, P1148, DOI 10.1111/j.1365-2745.2005.01040.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; KOENIG WD, 1994, CAN J FOREST RES, V24, P2105, DOI 10.1139/x94-270; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Masaka K, 2002, CAN J FOREST RES, V32, P9, DOI 10.1139/x01-159; Yasaka M, 2003, FOREST ECOL MANAG, V184, P277, DOI 10.1016/S0378-1127(03)00157-9; Oka T, 2004, J WILDLIFE MANAGE, V68, P979, DOI 10.2193/0022-541X(2004)068[0979:RBCIBP]2.0.CO;2; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Bates D., 2012, LME4 LINEAR MIXED EF; Cecich RA, 1999, CAN J FOREST RES, V29, P1817, DOI 10.1139/cjfr-29-12-1817; Garrison Barrett A., 1998, Western Journal of Applied Forestry, V13, P27; GARSHELIS DL, 1981, J WILDLIFE MANAGE, V45, P912, DOI 10.2307/3808099; Greenberg CH, 2007, J WILDLIFE MANAGE, V71, P1654, DOI 10.2193/2006-295; Hashizume H, 1984, B FAC AGR TOTTORI U, V36, P35; Hashizume H., 1978, Journal of the Japanese Forestry Society, V60, P163; Hashizume H., 1974, Journal of the Japanese Forestry Society, V56, P393; Hashizume H., 1974, Journal of the Japanese Forestry Society, V56, P165; HIROKI S, 1995, ECOL RES, V10, P161, DOI 10.1007/BF02347938; Hirota J., 1993, Journal of the Japanese Forestry Society, V75, P313; Igarashi Y, 1997, J APPL ENTOMOL, V121, P65; Kamitani T., 1986, Journal of the Japanese Forestry Society, V68, P447; KIKUCHI S, 1968, Bulletin of the Yamagata University (Agricultural Science), V5, P221; Koike S, 2012, MAMM STUDY, V37, P21, DOI 10.3106/041.037.0103; Kon H, 2005, CAN J BOT, V83, P1402, DOI 10.1139/b05-120; Koyama H, 2007, JPN J FOR ENV SOC, V49, P35; Koyama H., 2000, Journal of the Japanese Forestry Society, V82, P39; Kozakai C, 2011, J WILDLIFE MANAGE, V75, P867, DOI 10.1002/jwmg.122; Masaki T, 2008, POPUL ECOL, V50, P357, DOI 10.1007/s10144-008-0104-6; MCDONALD PM, 1992, CAN J FOREST RES, V22, P832, DOI 10.1139/x92-112; Miguchi H., 1984, Journal of the Japanese Forestry Society, V66, P320; Mizoue N, 2003, ENVIRON MONIT ASSESS, V89, P179, DOI 10.1023/A:1026044701939; Mizui N., 1991, Journal of the Japanese Forestry Society, V73, P258; Mizutani M., 2013, Journal of the Japanese Forest Society, V95, P76, DOI 10.4005/jjfs.95.76; Myers R. H., 1990, CLASSICAL MODERN REG; Nakajima H., 2013, Journal of the Japanese Forest Society, V95, P71, DOI 10.4005/jjfs.95.71; Nakajima H., 2013, Journal of the Japanese Forest Society, V95, P51, DOI 10.4005/jjfs.95.51; Nakajima H, 2011, ANN FOREST SCI, V68, P1333, DOI 10.1007/s13595-011-0132-9; Nakajima H, 2009, B TOYAMA FOR RES I, V1, P16; Perry Roger W., 1999, Southern Journal of Applied Forestry, V23, P164; R Core Team, 2012, R LANG ENV STAT COMP; SAITO H, 1991, ECOL RES, V6, P277, DOI 10.1007/BF02347128; Sawada H., 2008, Journal of the Japanese Forest Society, V90, P129, DOI 10.4005/jjfs.90.129; Sugita H., 2009, Journal of the Japanese Forest Society, V91, P382, DOI 10.4005/jjfs.91.382; Suzuki W, 2005, FOREST ECOL MANAG, V205, P105, DOI 10.1016/j.foreco.2004.10.050; Takeda H., 1992, Journal of the Japanese Forestry Society, V74, P55; Terazawa K., 1995, Journal of the Japanese Forestry Society, V77, P137; Yasaka M., 2001, Journal of the Japanese Forestry Society, V83, P322	47	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					94	103		10.1007/s10310-014-0440-7		10	Forestry	Forestry	AZ7KZ	WOS:000348399200012		
J	Pinkantayong, P; Kubo, M; Terada, T; Fujii, M; Kamoda, S; Muramoto, K; Kamata, N				Pinkantayong, Panisara; Kubo, Mamoru; Terada, Tamami; Fujii, Masanori; Kamoda, Shigehiro; Muramoto, Ken-ichiro; Kamata, Naoto			The effect of successive years of defoliation by the larch sawfly (Pristiphora erichsonii (Hartig)) on the foliage properties of the Japanese larch (Larix kaempferi (Lamb.) Carr.), with particular reference to the CN balance hypothesis	JOURNAL OF FOREST RESEARCH			English	Article						Carbon/nutrient balance; Foliar chemistry; Insect defoliation; Induced plant response; Larch plantation	SPRUCE BUDWORM; PHYTOPHAGOUS INSECTS; NUTRITIONAL ECOLOGY; CONDENSED TANNINS; GROWTH; HERBIVORY; PHENOLICS; OUTBREAKS; PINE; HYMENOPTERA	The carbon/nutrient balance hypothesis (CNBH) attempts to explain the mechanism of induced changes in plant properties. The responses of the Japanese larch (Larix kaempferi) to defoliation by the larch sawfly (Pristiphora erichsonii) were examined from the perspective of the CNBH. This study was conducted in seven Japanese larch plantations in central Hokkaido, Japan. The defoliation intensity was determined from canopy photos taken from 2009 to 2012. The chemical and physical properties of the foliage were determined from 2010 to 2012. Severe insect defoliation was found at two sites in 2009 and at all seven sites in 2010 and 2011. A decrease in foliar nitrogen and increases in phenolics, tannins, and the CN ratio were found in the years following severe defoliation and were significantly influenced by the 2009 defoliation intensity. The influence of defoliation in 2010 and 2011 was weaker. These results indicated that the past defoliation history additively affected the foliage properties in the 2 years following insect defoliation. In addition to the 2009 defoliation effects, site effects were found on phenolics, sugars, and the CN ratio. Relative to the other sites, the CN ratio was high at both sites where severe defoliation was found in 2009. Phenolics and sugars did not increase linearly with the CN ratio, indicating that limitations affected their synthesis. These results suggest that the induced changes in L. kaempferi properties are partially up-regulated under nitrogen limitation, but that secondary compound synthesis was, most likely, influenced by external site-dependent factors other than nitrogen limitation.	[Pinkantayong, Panisara] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Forests, Educ & Res Ctr, Tokyo, Japan; [Kubo, Mamoru] Kanazawa Univ, Grad Sch Nat Sci & Technol, Fac Elect & Comp Engn, Kanazawa, Ishikawa 9201192, Japan; [Terada, Tamami] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan; [Fujii, Masanori; Kamata, Naoto] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Chichibu Forest, Chichibu, Saitama, Japan; [Kamoda, Shigehiro] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Forests, Arboricultural Res Inst, Minami Izu, Japan; [Muramoto, Ken-ichiro] Ishikawa Natl Coll Technol, Tsubata, Japan	Pinkantayong, P (reprint author), Univ Phayao, Sch Agr & Nat Resources, Div Agr Sci, Phayao 56000, Thailand.	magibao225@hotmail.com	Kubo, Mamoru/C-3786-2015		JSPS [20254001, 12934444]	We wish to express our sincere thanks to the present and former staff of the UTHF: D. Sakaue, S. Ogasawara, K. Okamura, T. Okahira, M. Suzuki, N. Kimura, I. Murakawa, M. Matsui, Y. Nakagawa, and H. Ogawa, for their kind support of our field work. We also thank Y. Watano and M. Murakami, Chiba University, for their help in preparing powdered needle samples. Y. Matsumoto, the University of Tokyo, kindly allowed us to use facilities in his laboratory and gave useful advice on chemical analysis. S. Toda helped with the laboratory experiments. T. Hirao gave us useful comments on the statistical analyses. We would also like to express our sincere gratitude to all of them. This study was supported by Grants-in-aid for Scientific Research from JSPS awarded to K. Muramoto (20254001) and to M. Murakami (12934444).	KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331; Jarzomski CM, 2000, OIKOS, V88, P371, DOI 10.1034/j.1600-0706.2000.880216.x; Chow PS, 2004, TREE PHYSIOL, V24, P1129; LOWMAN MD, 1983, AUST J ECOL, V8, P17, DOI 10.1111/j.1442-9993.1983.tb01515.x; Schofield P, 2001, ANIM FEED SCI TECH, V91, P21, DOI 10.1016/S0377-8401(01)00228-0; FEENY PP, 1968, J INSECT PHYSIOL, V14, P805, DOI 10.1016/0022-1910(68)90191-1; Roitto M, 2009, TREE PHYSIOL, V29, P207, DOI 10.1093/treephys/tpn017; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; HAUKIOJA E, 1985, OECOLOGIA, V65, P214, DOI 10.1007/BF00379220; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; BALTENSWEILER W, 1977, ANNU REV ENTOMOL, V22, P79, DOI 10.1146/annurev.en.22.010177.000455; Girardin MP, 2001, ECOSCIENCE, V8, P127; ROSSITER M, 1988, ECOLOGY, V69, P267, DOI 10.2307/1943182; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; BERENBAUM MR, 1983, ENTOMOL EXP APPL, V34, P245; BRYANT JP, 1991, AM NAT, V137, P50, DOI 10.1086/285145; Bryant JP, 1983, OIKOS, V40, P14; Buckner CH, 1956, P 10 INT C ENT GOV C, V4, P353; Chapman L, 2007, AGR FOREST METEOROL, V143, P151, DOI 10.1016/j.agrformet.2006.12.006; CLANCY KM, 1992, ECOL ENTOMOL, V17, P189, DOI 10.1111/j.1365-2311.1992.tb01047.x; CLANCY KM, 1988, CAN J FOREST RES, V18, P530, DOI 10.1139/x88-077; Clancy KM, 2003, P INT S IUFRO KAN 20, P37; Clancy KM, 2004, CAN J FOREST RES, V34, P939, DOI 10.1139/X03-264; CORK SJ, 1991, J CHEM ECOL, V17, P123, DOI 10.1007/BF00994426; DAHLSTEN DL, 1967, ECOLOGY, V48, P275, DOI 10.2307/1933111; David RS, 1993, SAWFLY LIFE HIST ADA, P3; Drooz AT, 1960, TECHNICAL B, V1212, P52; Geri C, 1993, SAWFLY LIFE HIST ADA, P211; Haukioja E, 2005, ANN ZOOL FENN, V42, P313; Haukioja E, 2003, P INT S IUFRO KAN 20, P26; Higashiura Y, 1990, HOPPO RINGYO, V42, P42; Hochuli DF, 1996, OIKOS, V75, P133, DOI 10.2307/3546331; Howe Gregg A., 2008, P7, DOI 10.1007/978-1-4020-8182-8_1; HUNTER AF, 1992, OECOLOGIA, V89, P316; IVES WGH, 1976, CAN ENTOMOL, V108, P701; Japan Meteorological Agency, 2013, WEATH CLIM EARTHQ IN; Kamata N, 1996, J FOR RES, V1, P1, DOI 10.1007/BF02348331; Kamata N, 2002, B ENTOMOL RES, V92, P109, DOI 10.1070/BER2002159; Karban R., 1997, INDUCED RESPONSES HE; LE JEUNE R. R., 1947, CANADIAN ENT, V79, P130; Lynch Ann M., 2012, P126; MATTSON WJ, 1991, FOREST ECOL MANAG, V39, P183, DOI 10.1016/0378-1127(91)90176-V; MULDREW J. A., 1955, CANADIAN ENT, V87, P117; Ozaki K, 2004, FOREST ECOL MANAG, V187, P75, DOI 10.1016/S0378-1127(03)00308-6; Pinheiro J., 2013, PACKAGE NLME LINEAR, P1; PROP N., 1960, ARCH NEERLAND ZOOL, V13, P380; R Development Core Team, 2012, R LANG ENV STAT COMP; SMIRNOFF WA, 1968, J INVERTEBR PATHOL, V10, P417, DOI 10.1016/0022-2011(68)90100-6; Takata K, 2005, J FOR RES, V8-2, P111; TURNOCK W. J., 1960, CANADIAN ENT, V92, P500; WAGNER MR, 1985, OECOLOGIA, V67, P235, DOI 10.1007/BF00384291	51	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					104	113		10.1007/s10310-014-0442-5		10	Forestry	Forestry	AZ7KZ	WOS:000348399200013		
J	Itioka, T; Takano, KT; Kishimoto-Yamada, K; Tzuchiya, T; Ohshima, Y; Katsuyama, R; Yago, M; Yata, O; Nakagawa, M; Nakashizuka, T				Itioka, Takao; Takano, Kohei Takenaka; Kishimoto-Yamada, Keiko; Tzuchiya, Taizo; Ohshima, Yasuhiro; Katsuyama, Rai-ichiro; Yago, Masaya; Yata, Osamu; Nakagawa, Michiko; Nakashizuka, Tohru			Chronosequential changes in species richness of forest-edge-dwelling butterflies during forest restoration after swidden cultivation in a humid tropical rainforest region in Borneo	JOURNAL OF FOREST RESEARCH			English	Article						Assessment of insect species richness; Butterfly assemblage; Deforestation; Southeast Asian tropics; Swidden cultivation	PLANTATION FORESTS; EAST KALIMANTAN; DIVERSITY; CONSERVATION; BIODIVERSITY; DISTURBANCE; IMPACT; ASSEMBLAGES; SECONDARY; INDICATORS	In contrast to the large number of studies addressing the effects of deforestation on insect diversity, few studies have focused on the recovery of diversity during forest restoration. In this study, we investigated the recovery, or chronosequential change, of butterfly species richness during forest restoration after cessation of swidden cultivation in a humid tropical rainforest region in Borneo. Through conducting censuses on butterflies at 21 study plots, placed at open habitats adjoining edges of forest stands that differed in elapsed years after cessation (< 3, 5-13, and 20-60 year-old fallows, and isolated and large-area primary forests), we obtained presence or absence data on 132 butterfly species. The cumulative number of observed species was significantly higher at two types of primary forests than at three types of fallows; significantly higher at two older fallows than the youngest fallows; and not significantly different between the two older fallows. The species number in the older fallows was less than half that of either type of primary forest. The numbers of species at the oldest fallows and isolated primary forests significantly decreased with distance from the large-area primary forests, and the majority of butterflies observed in the fallows were also observed in the primary forests. These results suggest that although the species richness of forest-edge-dwelling butterflies recovers in the initial 20 years of forest restoration, the recovery pace decreases thereafter and depends on the presence of large-area primary forest in the vicinity. It is suggested that forest fragmentation also decreases butterfly diversity.	[Itioka, Takao; Kishimoto-Yamada, Keiko; Tzuchiya, Taizo] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Takano, Kohei Takenaka; Kishimoto-Yamada, Keiko; Nakagawa, Michiko; Nakashizuka, Tohru] Natl Inst Humanities, Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan; [Takano, Kohei Takenaka; Nakashizuka, Tohru] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kishimoto-Yamada, Keiko] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Ohshima, Yasuhiro; Katsuyama, Rai-ichiro; Yata, Osamu] Kyushu Univ, Grad Sch Social & Cultural Studies, Fukuoka 8190395, Japan; [Ohshima, Yasuhiro] Mie Prefectural Museum, Tsu, Mie 5140006, Japan; [Katsuyama, Rai-ichiro] Res Inst Evolutionary Biol, Setagaya Ku, Tokyo 1580098, Japan; [Katsuyama, Rai-ichiro; Yago, Masaya] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Yata, Osamu] Kyushu Univ Museum, Fukuoka 8128581, Japan; [Nakagawa, Michiko] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Itioka, T (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsucho, Kyoto 6068501, Japan.	ichioka.takao.5m@kyoto-u.ac.jp	Takano, Kohei/D-8077-2013	Takano, Kohei/0000-0001-8803-0252	Research Institute for Humanity and Nature [P2-5, D-04]; JSPS KAKENHI [23570111]	Our study was conducted in accordance with the Memorandum of Understanding signed between the Sarawak Forestry Corporation and the Japan Research Consortium for Tropical Forests in Sarawak in November 2005. We thank Ms L. Chong and Mr H. Kaliang for help with the approval procedure to gain permission to conduct the study. We also thank Dr K. Momose, Dr S. Sakai, and Prof N. Yamamura for their extensive support of our study, Dr T. Matsumoto, Dr H. O. Tanaka, Mr D. Matsumoto and Mr T. Okubo for their assistance work, and Dr M. Yamashita for providing the map information of our plots. This study was financially supported by the Research Institute for Humanity and Nature (project number P2-5 and D-04) and JSPS KAKENHI (23570111 to MY).	Dumbrell AJ, 2005, BIOL CONSERV, V125, P123, DOI 10.1016/j.biocon.2005.02.016; Ghazoul J, 2002, BIODIVERS CONSERV, V11, P521, DOI 10.1023/A:1014812701423; Edwards DP, 2012, ECOL APPL, V22, P561, DOI 10.1890/11-1362.1; Willott SJ, 2000, CONSERV BIOL, V14, P1055, DOI 10.1046/j.1523-1739.2000.98427.x; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bonebrake TC, 2010, BIOL CONSERV, V143, P1831, DOI 10.1016/j.biocon.2010.04.044; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Bobo KS, 2006, J INSECT CONSERV, V10, P29, DOI 10.1007/s10841-005-8564-x; Lewis OT, 2001, CONSERV BIOL, V15, P389, DOI 10.1046/j.1523-1739.2001.015002389.x; Cleary DFR, 2004, J ECON ENTOMOL, V97, P429, DOI 10.1603/0022-0493-97.2.429; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Beck J, 2002, J TROP ECOL, V18, P33, DOI 10.1017/S026646740200202X; KREMEN C, 1992, ECOL APPL, V2, P203, DOI 10.2307/1941776; Nakagawa M, 2006, FOREST ECOL MANAG, V231, P55, DOI 10.1016/j.foreco.2006.05.006; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Spitzer K, 1997, BIOL CONSERV, V80, P9, DOI 10.1016/S0006-3207(96)00079-1; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Sodhi NS, 2009, BIOTROPICA, V41, P103, DOI 10.1111/j.1744-7429.2008.00460.x; Hill JK, 2001, OECOLOGIA, V128, P294, DOI 10.1007/s004420100651; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Kumagai T, 2005, AGR FOREST METEOROL, V128, P81, DOI 10.1016/j.agrformet.2004.08.006; Hamer KC, 2005, J TROP ECOL, V21, P417, DOI 10.1017/S026646705002361; Basset Y, 1998, J APPL ECOL, V35, P461, DOI 10.1046/j.1365-2664.1998.00311.x; Basset Y, 2001, J APPL ECOL, V38, P1045, DOI 10.1046/j.1365-2664.2001.00660.x; Cleary DFR, 2009, BASIC APPL ECOL, V10, P237, DOI 10.1016/j.baae.2008.03.004; Cleary DFR, 2005, J APPL ENTOMOL, V129, P52, DOI 10.1111/j.1439-0418.2005.00916.x; Cleary DFR, 2006, DIVERS DISTRIB, V12, P409, DOI 10.1111/j.1366-9516.2006.00256.x; Corlett R. T., 2011, TROPICAL RAIN FOREST; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Fleishman E, 2009, CONSERV BIOL, V23, P1109, DOI 10.1111/j.1523-1739.2009.01246.x; Florens FBV, 2010, BIODIVERS CONSERV, V19, P3835, DOI 10.1007/s10531-010-9930-x; Hawes J, 2009, J TROP ECOL, V25, P281, DOI 10.1017/S0266467409006038; Hayes L, 2009, INSECT CONSERV DIVER, V2, P194, DOI 10.1111/j.1752-4598.2009.00058.x; Hazebroek HP, 2000, NATL PARKS SARAWAK; Hill JK, 1995, J APPL ECOL, V32, P754, DOI 10.2307/2404815; Hirowatari T, 2007, ENTOMOL SCI, V10, P113, DOI 10.1111/j.1479-8298.2007.00205.x; Ichikawa M, 2002, THESIS KYOTO U KYOTO; Ichikawa M, 2003, POLITICAL ECOLOGY TR, P177; Itioka Takao, 2009, Contributions from the Biological Laboratory Kyoto University, V30, P25; Koh LP, 2007, J APPL ECOL, V44, P703, DOI 10.1111/j.1365-2664.2007.01324.x; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; MacArthur RH, 1967, THEORY ISLAND BIOGEO; Maeto K, 2009, J INSECT CONSERV, V13, P245, DOI 10.1007/s10841-008-9164-3; Ohsaki N, 1999, NAT INSECTS, V34, P24; Oksanen J., 2010, MULTIVARIATE ANAL EC; Safian S, 2011, J INSECT CONSERV, V15, P351, DOI 10.1007/s10841-010-9343-x; SAS Institute Inc, 2012, JMP 10 MOD MULT METH; Shahabuddin M, 2005, BIODIVERS CONSERV, V14, P863; Stork NE, 2003, BIODIVERS CONSERV, V12, P387, DOI 10.1023/A:1022470308591; Tanaka Hiroshi O., 2007, Asian Myrmecology, V1, P31; Vasconcelos HL, 2000, J APPL ECOL, V37, P508, DOI 10.1046/j.1365-2664.2000.00512.x; Veddeler D, 2005, BIODIVERS CONSERV, V14, P3577, DOI 10.1007/s10531-004-0829-2; Willott SJ, 1999, PHILOS T ROY SOC B, V354, P1783, DOI 10.1098/rstb.1999.0520; Woodcock P, 2011, PHILOS T R SOC B, V366, P3256, DOI 10.1098/rstb.2011.0031; Yumoto T, 2005, POLLINATION ECOLOGY, P13	60	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					125	134		10.1007/s10310-014-0444-3		10	Forestry	Forestry	AZ7KZ	WOS:000348399200015		
J	Abe, T; Yasui, T; Yokoya, M; Knapp, M				Abe, Tetsuto; Yasui, Takaya; Yokoya, Midori; Knapp, Marcel			Regaining habitats from invasive weeds by planting limited-recruitment endemic trees on an oceanic island: successes and failures 11 years later	JOURNAL OF FOREST RESEARCH			English	Article						Endemic tree plantation; Forest restoration; Species composition; Technical transfer; Weed control	DRY FOREST RESTORATION; CONSERVATION PRIORITIES; ECOLOGICAL RESTORATION; BIOLOGICAL INVASION; ECOSYSTEM SERVICES; OGASAWARA ISLANDS; MYRICA-FAYA; COSTA-RICA; BIODIVERSITY; RECOVERY	The degradation of biodiversity caused by anthropic habitat destruction is a global issue. The recovery of natural habitats from invasive alien weeds in order to conserve endemic ecosystems is especially important on small oceanic islands. Planting of endemic trees may be an effective measure, but a complete restoration process within the island is essential to avoid accidental introduction of invasive aliens. To test planting techniques, we planted two endemic tree species whose regeneration was hindered by alien species on degraded lands on Chichi-jima (Ogasawara Islands) and monitored vegetation changes. During an 11-year period, about half of the Elaeocarpus photiniifolius seedlings survived in gap areas, but all Morus boninensis failed. The E. photiniifolius trees reached a height of 4.7 +/- A 2.4 m. The restored canopy created a dark environment that greatly reduced the volume of the predominant invasive weeds. These results suggest that E. photiniifolius is suitable for restoration of forests on degraded land and for the suppression of weeds on the island. Low species diversity in the restored forests, however, was a remaining issue to be addressed. Herein we discuss potential improvement measures to facilitate the recovery of species diversity, including other native tree candidates.	[Abe, Tetsuto] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Chuo Ku, Kumamoto 8600862, Japan; [Yasui, Takaya; Yokoya, Midori; Knapp, Marcel] Ogasawara Wildlife Res Soc, Tokyo 1002101, Japan	Abe, T (reprint author), Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Chuo Ku, 4-11-16 Kurokami, Kumamoto 8600862, Japan.	tetsuabe@ffpri.affrc.go.jp			Kashima Foundation; Ministry of the Environment	We thank the Governmental Office of Ogasawara National Forests and Ministry of the Environment for permitting our research. Koichi Kamo and Nobuyuki Tanaka provided useful insight. This work was funded in part by the Kashima Foundation and the Ministry of the Environment.	Abe T, 2008, PLANT ECOL, V198, P169, DOI 10.1007/s11258-007-9393-7; Ackerman JD, 2007, LANKESTERIANA, V7, P19; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Holl KD, 2000, RESTOR ECOL, V8, P339, DOI 10.1046/j.1526-100x.2000.80049.x; Campbell DJ, 2002, BIOL CONSERV, V107, P19, DOI 10.1016/S0006-3207(02)00039-3; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Cabin RJ, 2002, ECOL APPL, V12, P1595, DOI 10.1890/1051-0761(2002)012[1595:EOLAGA]2.0.CO;2; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Brown KA, 2004, P NATL ACAD SCI USA, V101, P6045, DOI 10.1073/pnas.0401456101; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kueffer C, 2010, BIOL CONSERV, V143, P1792, DOI 10.1016/j.biocon.2010.04.031; Meyer JY, 1996, J BIOGEOGR, V23, P775, DOI 10.1111/j.1365-2699.1996.tb00038.x; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Cordell Susan, 2008, Pacific Conservation Biology, V14, P279; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; Cabin RJ, 2000, CONSERV BIOL, V14, P439, DOI 10.1046/j.1523-1739.2000.99006.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Cusack D, 2004, FOREST ECOL MANAG, V188, P1, DOI 10.1016/S0378-1127(03)00302-5; Abe T, 2011, J FOREST RES-JPN, V16, P484, DOI 10.1007/s10310-010-0239-0; Lugo AE, 2004, FRONT ECOL ENVIRON, V2, P265, DOI 10.2307/3868267; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Goldstein JH, 2008, CONSERV LETT, V1, P236, DOI 10.1111/j.1755-263X.2008.00031.x; Zahawi RA, 2013, J APPL ECOL, V50, P88, DOI 10.1111/1365-2664.12014; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Carnevale NJ, 2002, FOREST ECOL MANAG, V163, P217, DOI 10.1016/S0378-1127(01)00581-3; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Baider C, 2011, BIOL INVASIONS, V13, P2641, DOI 10.1007/s10530-011-9980-3; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Thaxton JM, 2012, RESTOR ECOL, V20, P475, DOI 10.1111/j.1526-100X.2011.00793.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Manson RH, 2001, ECOLOGY, V82, P3320, DOI 10.1890/0012-9658(2001)082[3320:LTEORH]2.0.CO;2; Bremer B, 2009, BOT J LINN SOC, V161, P105; du Toit JT, 2004, TRENDS ECOL EVOL, V19, P12, DOI 10.1016/j.tree.2003.09.018; Florens FBV, 2013, RESTOR ECOL, V21, P1, DOI 10.1111/j.1526-100X.2012.00920.x; Forsyth SA, 2003, OECOLOGIA, V136, P551, DOI 10.1007/s00442-003-1295-3; GAGNE WC, 1988, BIOSCIENCE, V38, P264, DOI 10.2307/1310850; Harris CJ, 2012, RESTOR ECOL, V20, P584, DOI 10.1111/j.1526-100X.2011.00823.x; Hata K, 2004, OGASAWARA KENKYU NEN, V27, P75; Hata K, 2007, TROPICS, V16, P283, DOI 10.3759/tropics.16.283; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Kobayashi S, 1987, OGASAWARA RES, V13, pI; Kobayashi S, 1987, OGASAWARA RES, V13, P1; Liu H, 2010, BOTANY, V88, P290, DOI 10.1139/B10-017; Ministry of the Environment, 2012, RED LIST; Mueller-Dombois D., 2008, Pacific Science, V62, P303, DOI 10.2984/1534-6188(2008)62[303:PIFSIA]2.0.CO;2; Ogasawara Branch Office of the Tokyo Metropolitan Government, 1914, BRIEF TOP FOR OG ISL; Ogden JAE, 2005, BIOL CONSERV, V125, P427, DOI 10.1016/j.biocon.2005.03.025; Ono M, 1985, ENDEMIC PLANT SPECIE; R Development Core Team, 2009, R LANG ENV STAT COMP; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Samways MJ, 2010, BIODIVERS CONSERV, V19, P425, DOI 10.1007/s10531-008-9524-z; SANDERS RW, 1982, TAXON, V31, P284, DOI 10.2307/1219993; Shimizu Yoshikazu, 2003, Global Environmental Research, V7, P3; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P65; Tani N, 2003, CONSERV GENET, V4, P605, DOI 10.1023/A:1025655331429; Toyoda T, 2003, FLORA BONIN ISLANDS; Toyoshima H, 1938, B IMP FOR EXP STATIO, V36, P1; Yamakata H, 1906, TOPOGRAPHY OGASAWARA; Yamashita N, 2003, J VEG SCI, V14, P15, DOI 10.1658/1100-9233(2003)014[0015:SASDOI]2.0.CO;2; Yoshida Keiichiro, 2000, Japanese Journal of Ecology (Otsu), V50, P111	72	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					135	142		10.1007/s10310-014-0469-7		8	Forestry	Forestry	AZ7KZ	WOS:000348399200016		
J	Sakamoto, SH; Suzuki, SN; Koshimoto, C; Okubo, Y; Eto, T; Suzuki, RO				Sakamoto, Shinsuke H.; Suzuki, Satoshi N.; Koshimoto, Chihiro; Okubo, Yoshinobu; Eto, Takeshi; Suzuki, Ryo O.			Trap distance affects the efficiency and robustness in monitoring the abundance and composition of forest-floor rodents	JOURNAL OF FOREST RESEARCH			English	Article						Apodemus argenteus; Apodemus speciosus; Arboreal; Community ecology; Terrestrial	SMALL-MAMMAL COMMUNITIES; APODEMUS-SPECIOSUS; WOOD MOUSE; ACORNS; POPULATIONS; CONSUMPTION; ARGENTEUS; NORTHERN; WINBUGS; DENSITY	Intensive monitoring of multiple taxonomic groups is essential to understand ecosystem structure and function. In such studies, plant ecologists desire to monitor animal communities as efficiently as possible. We examined the efficiency of two trapping methods with different trap distances and total trapping areas for monitoring forest-floor rodent communities. We especially targeted two endemic, terrestrial, and semi-arboreal species dominating in forests throughout Japan. The long-distance (25 m) and the short-distance (10 m) methods assumed less than and more than one trap per female territory, respectively. Irrespective of species, capture efficiency tended to be higher in the long-distance than in the short-distance method. Recapture probabilities of two species were more similar in the short-distance than in the long-distance method in 2013. Observed densities for both species in the short-distance method were relatively similar to the estimated densities based on the long-distance method in 2011. In contrast, observed densities were lower than the estimated densities in the short-distance method in 2013. Observed densities of semi-arboreal species tended to be underestimated when only terrestrial traps were used. From these results, we propose that the short-distance method can efficiently estimate densities and community composition when researchers plan a small-effort study for a short time with a small area. In contrast, the long-distance method will allow researchers to estimate population densities robustly, when taking a large effort of a 3- to 4-day session with a large area. Our results also suggest that using both terrestrial and arboreal traps will improve the estimation.	[Sakamoto, Shinsuke H.; Koshimoto, Chihiro] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioresources, Miyazaki 8891692, Japan; [Suzuki, Satoshi N.] Univ Tokyo, Grad Sch Agr & Life Sci, Univ Tokyo Chichibu Forest, Chichibu, Saitama 3680034, Japan; [Okubo, Yoshinobu; Eto, Takeshi] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki 8892192, Japan; [Suzuki, Ryo O.] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano 3862204, Japan	Sakamoto, SH (reprint author), Miyazaki Univ, Frontier Sci Res Ctr, Div Bioresources, Kiyotake 5200, Miyazaki 8891692, Japan.	aposhin1@med.miyazaki-u.ac.jp			JSPS [24657018, 23650236]; University of Miyazaki	We acknowledge the Sugadaira Montane Research Center, University of Tsukuba, for permission to conduct research within the site. We also thank Takahiro Ogai, Shigekazu Tomizuka, Kouji Nagaoka, and Mariko Katsuyama for their research assistance and a member of SMRC for valuable advice on the field research. This work was supported by Grant-in-Aid for Challenging Exploratory Research from JSPS (Grant Numbers 24657018 to Shinsuke H. Sakamoto; 23650236 to Chihiro Koshimoto), and by grants from the University of Miyazaki (Support Program for Integrated Research Project for Human and Veterinary Medicine).	Abe M, 2008, ECOL RES, V23, P681, DOI 10.1007/s11284-007-0428-2; Fontaine JB, 2012, ECOL APPL, V22, P1547; Lambert TD, 2005, J MAMMAL, V86, P982, DOI 10.1644/1545-1542(2005)86[982:VISMSR]2.0.CO;2; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Takahashi A, 2008, ECOL RES, V23, P1033, DOI 10.1007/s11284-008-0473-5; DUESER RD, 1978, ECOLOGY, V59, P89, DOI 10.2307/1936634; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; STEELE BB, 1984, BIOL CONSERV, V30, P157, DOI 10.1016/0006-3207(84)90064-8; Baxter R, 2001, MAMMAL REV, V31, P47, DOI 10.1046/j.1365-2907.2001.00078.x; Weltzin JF, 1997, ECOLOGY, V78, P751; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Sturtz S, 2005, J STAT SOFTW, V12, P1; Biodiversity Center of Japan Ministry of the Environment, 2012, MON SIT 1000 PROJ; CRIDDLE STUART, 1930, JOUR MAMMALOGY, V11, P265, DOI 10.2307/1374147; DOI T, 1982, RES POPUL ECOL, V24, P110, DOI 10.1007/BF02515593; Dyer LA, 2010, ECOLOGY, V91, P3707, DOI 10.1890/08-1634.1; Focardi S, 2000, J ZOOL, V250, P329, DOI 10.1017/S095283690000306X; Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; HAMILTON W. J., 1941, JOUR MAMMAL, V22, P250, DOI 10.2307/1374950; Hobbie JE, 2003, BIOSCIENCE, V53, P21, DOI 10.1641/0006-3568(2003)053[0021:TULTER]2.0.CO;2; Holloway GL, 2007, J MAMMAL, V88, P226, DOI 10.1644/05-MAMM-A-368R2.1; LAURANCE WF, 1994, BIOL CONSERV, V69, P23, DOI 10.1016/0006-3207(94)90325-5; Lincoln FC, 1930, US DEP AGRIC CIRCULA, V118, P1; Mizuki I, 2009, J FOREST RES-JPN, V14, P95, DOI 10.1007/s10310-008-0106-4; Murakami O., 1974, Japanese Journal of Ecology, V24, P194; Nakata T, 2009, WILD MAMMALS JAPAN, P169; OFARRELL MJ, 1994, J MAMMAL, V75, P692, DOI 10.2307/1382517; OKA T, 1992, ECOL RES, V7, P163, DOI 10.1007/BF02348495; OSTFELD RS, 1993, ECOLOGY, V74, P1792, DOI 10.2307/1939937; Pearson DE, 2003, WILDLIFE SOC B, V31, P454; Petersen C.G.J., 1896, REPORT DANISH BIOL S, V6, P1; R Development Core Team, 2010, R LANG ENV STAT COMP; Sakamoto SH, 2012, MAMM STUDY, V37, P261, DOI 10.3106/041.037.0401; Sekijima Tsuneo, 2004, Mammal Study, V29, P97, DOI 10.3106/mammalstudy.29.97; Sekijima Tsuneo, 1997, Japanese Journal of Ecology (Tokyo), V47, P151; Shimada T, 2001, ECOL RES, V16, P127, DOI 10.1046/j.1440-1703.2001.00378.x; Sone K., 1999, J FOREST RES, V4, P167, DOI 10.1007/BF02762243; Tamura N, 2008, ECOL RES, V23, P607, DOI 10.1007/s11284-007-0414-8; US Long Term Ecological Research Network, 2012, LTER NETW HIST; Vander Wall SB, 1990, FOOD HOARDING ANIMAL; Weihong Ji, 1999, New Zealand Journal of Ecology, V23, P45; WIENER JG, 1972, J MAMMAL, V53, P868, DOI 10.2307/1379222; WILLIAMS DF, 1983, J WILDLIFE MANAGE, V47, P841, DOI 10.2307/3808622	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					151	159		10.1007/s10310-014-0447-0		9	Forestry	Forestry	AZ7KZ	WOS:000348399200018		
J	Kanazashi, A; Nagamitsu, T; Suzuki, W				Kanazashi, Ayako; Nagamitsu, Teruyoshi; Suzuki, Wajiro			Seed dormancy and germination characteristics in relation to the regeneration of Acer pycnanthum, a vulnerable tree species in Japan	JOURNAL OF FOREST RESEARCH			English	Article						Acer pycnanthum; Regeneration strategy; Seed dormancy; Seed germination	RED MAPLE; DECIDUOUS FOREST; NORTH-AMERICA; SEEDLINGS; SURVIVAL; RUBRUM; GROWTH; RAIN	Seed dormancy and germination characteristics of the vulnerable tree species Acer pycnanthum were investigated to understand its regeneration strategy. Seeds of A. pycnanthum mature 1 month after pollination and are dispersed in late spring. All dispersed seeds were in dormancy upon collection from which they were released by cold (5 A degrees C) stratification over a period of at least 12 weeks. Germination percentages were higher under low temperature conditions (10-20 A degrees C) and when the temperature was alternated in diurnal cycles. Light effects on germination were not observed. Seed viability was not lost even though seeds had experienced room temperature conditions (20-30 A degrees C, 35-70 % humidity) after dispersal for 5-10 months. Seeds of A. pycnanthum can endure summer heat and survive until the following spring, allowing their seedlings to germinate promptly. In the case of light intensity-independent dormancy release, regeneration can occur under canopy conditions where shade-intolerant seedlings are at a disadvantage. To verify this conclusion, the shade tolerance of A. pycnanthum requires further investigation.	[Kanazashi, Ayako] Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Tsukuba, Ibaraki 3058687, Japan; [Nagamitsu, Teruyoshi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Suzuki, Wajiro] Tadami Beech Ctr, Fukushima 9680421, Japan	Kanazashi, A (reprint author), Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Matsunosato 1, Tsukuba, Ibaraki 3058687, Japan.	ayakoka@ffpri.affrc.go.jp			Ministry of Environment of Japan	We thank Takashi Masaki and Satoshi Kikuchi of the Forestry and Forest Products Research Institute for their valuable suggestions and manuscript critiques. We also thank Asako Kitazawa, Japanese Red Maple Conservation Group, for supporting seed collection in Iida City, and Mamoru Okamoto and Atsushi Suzuki, formerly with the Forestry and Forest Products Research Institute, for assistance with seed collection. This study was supported by grants from the Ministry of Environment of Japan.	Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Tift BD, 1999, CAN J FOREST RES, V29, P157, DOI 10.1139/cjfr-29-2-157; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; Seiwa K, 1998, J ECOL, V86, P219, DOI 10.1046/j.1365-2745.1998.00245.x; Seiwa K, 1996, VEGETATIO, V123, P51, DOI 10.1007/BF00044887; Seiwa K, 1997, SEED SCI RES, V7, P195; Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; Bourgoin A, 2004, CAN J FOREST RES, V34, P2181, DOI 10.1139/X04-092; HOULE G, 1991, HOLARCTIC ECOL, V14, P142; Connor KF, 2001, TREES-STRUCT FUNCT, V15, P131, DOI 10.1007/s004680100092; ABRAMS MD, 1992, BIOSCIENCE, V42, P346, DOI 10.2307/1311781; ALVAREZBUYLLA ER, 1990, OECOLOGIA, V84, P314; FREAS KE, 1983, J ECOL, V71, P211, DOI 10.2307/2259973; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Barnes VB, 2004, ENVIRON REV, V12, P163; Baskin C.C., 2001, SEEDS ECOLOGY BIOGEO; De Jong PC, 1994, MAPLES WORLD, P69; Dennis Frank G. Jr., 1996, P47; Environment Agency of Japan, 2000, THREAT WILD LIF JAP, V8, P660; Farmer R. E., 1997, SEED ECOPHYSIOLOGY T; FARMER RE, 1981, FOREST SCI, V27, P446; FARMER RE, 1984, FOREST SCI, V30, P670; Gabriel WJ, 1990, AGR HDB, V2, P70; GARWOOD N.C., 1989, ECOLOGY SOIL SEED BA, P149; Goto T, 2002, ECOLOGY SATOYAMA, P97; Grime J. P., 2001, PLANT STRATEGIES VEG; Hirabayashi K, 1969, B BOT SOC NAGANO, V2, P1; HOSNER JOHN F., 1960, FOREST SCI, V6, P246; HOULE G, 1994, J ECOL, V82, P39, DOI 10.2307/2261384; Japanese Red Maple Conservation Group, 2003, REP JAP RED MAPL GRO, P188; Lambers Janneke Hille Ris, 2005, Canadian Journal of Forest Research, V35, P806, DOI 10.1139/x05-017; LOUCKS WL, 1973, J FOREST, V71, P496; Mizui N, 1993, B HOKKAIDO FOR RES I, V30, P1; Nakagoshi N., 1985, POPULATION STRUCTURE, P551; Nikolaeva M. G., 2001, Botanicheskii Zhurnal (St. Petersburg), V86, P1; Nomiya H, 2010, J FOREST RES-JPN, V15, P123, DOI 10.1007/s10310-009-0165-1; OGATA K., 1965, B TOKYO U FOR, V60, P1; R Development Core Team, 2011, R LANG ENV STAT COMP; Saeki I, 2005, FOREST ECOL MANAG, V216, P283, DOI 10.1016/j.foreco.2005.05.040; Saeki I, 2005, LANDSC ECOL ENG, V1, P135, DOI DOI 10.1007/S11355-005-0015-Z; Seiwa K, 2009, SHUSEIBUTSUGAKU KENK, V32, P153; Silvertown J, 1987, INTRO PLANT POPULATI; Suszka B., 1971, Arboretum Kornickie, Poznan, V16, P157; Suzuki Wajiro, 2011, Bulletin of the Forestry and Forest Products Research Institute, V10, P73; Suzuki W, 2000, J FOR RES, V. 5, P181, DOI 10.1007/BF02762399; Tanaka H, 1995, J VEG SCI, V6, P887, DOI 10.2307/3236403; Thompson K, 1992, SEEDS ECOLOGY REGENE, P231; Tremblay MF, 1996, FOREST SCI, V42, P154; Walters RS, 1990, AGR HDB, V2, P60; WASHITANI I, 1987, Ecological Research, V2, P191, DOI 10.1007/BF02349773; Washitani I., 1986, ECOL RES, V1, P71, DOI 10.1007/BF02361206	51	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					160	166		10.1007/s10310-014-0451-4		7	Forestry	Forestry	AZ7KZ	WOS:000348399200019		
J	Yoshii, C; Yamaura, Y; Soga, M; Shibuya, M; Nakamura, F				Yoshii, Chiaki; Yamaura, Yuichi; Soga, Masashi; Shibuya, Masato; Nakamura, Futoshi			Comparable benefits of land sparing and sharing indicated by bird responses to stand-level plantation intensity in Hokkaido, northern Japan	JOURNAL OF FOREST RESEARCH			English	Article						Broad-leaved trees; Conifer plantations; Land-use intensity; Planted forest; Response diversity	BIODIVERSITY CONSERVATION; FORESTS; LANDSCAPE; DIVERSITY; ABUNDANCE; TRAITS; MODELS; SITES; SCALE	We examined potentially contrasting conservation benefits of land sparing (land-use specialization) and land sharing (multiple-use forestry) strategies in forested landscapes by investigating relationships between bird functional group densities and basal areas of coniferous trees (an index of plantation intensity) in Sakhalin fir (Abies sachalinensis) and Sakhalin spruce (Picea glehnii) plantations. Densities of most bird functional groups increased with decreasing plantation intensity in both plantation types. In many cases, linear models were best for descriptors of bird density-plantation intensity relationships, but statistical support of linear and nonlinear (quadratic) models was similar. This outcome indicates that ecological benefits of land sparing and land sharing are potentially comparable in the plantations we studied. In real landscapes, land-use decision making depends on a variety of factors other than biodiversity conservation (e.g., social and biophysical factors). Furthermore, niche theory also predicts that population densities could linearly respond to environmental gradients. When density-intensity relationships are linear, as in this study, land-sparing and land-sharing strategies provide similar benefits in terms of biodiversity conservation, and contrasting land-use strategies could be flexibly chosen to enhance the accommodation of biodiversity conservation to resource production.	[Yoshii, Chiaki; Yamaura, Yuichi; Soga, Masashi; Shibuya, Masato; Nakamura, Futoshi] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Yamaura, Yuichi] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 3058687, Japan	Yamaura, Y (reprint author), Forestry & Forest Prod Res Inst, Dept Forest Vegetat, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	yamaura@ffpri.affrc.go.jp	Yamaura, Yuichi/A-3638-2012; Nakamura, Futoshi/A-6696-2012	Yamaura, Yuichi/0000-0001-9355-4413; 	JSPS KAKENHIs [23780153, 24310029]; Asahi Glass Foundation (Kondo Jiro Grant)	The forest management office of the Ishikari General Subprefectural Bureau provided assistance in our field survey. We greatly thank the members of the Department of Forest Science and the members of the Forest Ecosystem Management Group of Hokkaido University for their field assistance and helpful discussions during the study. This study was partially supported by JSPS KAKENHIs Grant Nos. 23780153 and 24310029 and the Asahi Glass Foundation (Kondo Jiro Grant of 2012).	Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Vance MD, 2003, ECOLOGY, V84, P2643, DOI 10.1890/02-0159; Yamaura Y, 2013, ORNITHOL SCI, V12, P73; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P3107, DOI 10.1007/s10531-012-0357-4; Mastrangelo ME, 2012, CONSERV BIOL, V26, P1040, DOI 10.1111/j.1523-1739.2012.01904.x; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Lindenmayer DB, 2002, ECOL MONOGR, V72, P1, DOI 10.1890/0012-9615(2002)072[0001:EOFFOB]2.0.CO;2; Hodgson JA, 2010, ECOL LETT, V13, P1358, DOI 10.1111/j.1461-0248.2010.01528.x; Edwards DP, 2014, GLOBAL CHANGE BIOL, V20, P183, DOI 10.1111/gcb.12353; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Hartley MJ, 2002, FOREST ECOL MANAG, V155, P81, DOI 10.1016/S0378-1127(01)00549-7; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Dullinger S, 2013, P NATL ACAD SCI USA, V110, P7342, DOI 10.1073/pnas.1216303110; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; Bibby CJ, 2000, BIRD CENSUS TECHNIQU; Chey VK, 1998, B ENTOMOL RES, V88, P15; Fischer Joern, 2008, Frontiers in Ecology and the Environment, V6, P380, DOI 10.1890/070019; Food and Agriculture Organization [FAO], 2010, GLOB FOR RES ASS 201; Fujimaki Y, 2012, BIRDS HOKKAIDO; Hausner VH, 2003, ECOL APPL, V13, P999, DOI 10.1890/1051-0761(2003)13[999:SITFML]2.0.CO;2; Kikuchi K, 2013, J FOREST RES-JPN, V18, P389, DOI 10.1007/s10310-012-0358-x; Moore Susan E., 1999, P400, DOI 10.1017/CBO9780511613029.014; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1998, POPULATION LIMITATIO; R Development Core Team, 2012, R LANG ENV STAT COMP; Ralph CJ, 1993, USDA FOREST SERVICE; Sedjo RA, 1997, ENVIRONMENT, V39, P14; Toyoshima Y, 2013, FOREST ECOL MANAG, V307, P54, DOI 10.1016/j.foreco.2013.07.006; Van Horne B, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P63; Wiens J, 2007, CONSERV BIOL, V21, P1371, DOI 10.1111/j.1523-1739.2007.00695.x; Yamaura Y, 2008, ECOL RES, V23, P317, DOI 10.1007/s11284-007-0380-1; Yamaura Y, 2009, BIOL CONSERV, V142, P2155, DOI 10.1016/j.biocon.2009.04.015; Yamaura Y, 2008, CAN J FOREST RES, V38, P1223, DOI 10.1139/X07-226	39	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					167	174		10.1007/s10310-014-0453-2		8	Forestry	Forestry	AZ7KZ	WOS:000348399200020		
J	Miyamoto, N; Ono, M; Watanabe, A				Miyamoto, Naoko; Ono, Masako; Watanabe, Atsushi			Construction of a core collection and evaluation of genetic resources for Cryptomeria japonica (Japanese cedar)	JOURNAL OF FOREST RESEARCH			English	Article						Core collection; Cryptomeria japonica; Genetic markers; Genetic resources; GIS	MORPHOLOGICAL DESCRIPTORS; MICROSATELLITE MARKERS; GERMPLASM COLLECTION; CONSERVATION; SELECTION; TRAITS	In order to improve the accessibility of genetic resources, a core collection needs to be constructed and appropriately evaluated. For Cryptomeria japonica, the most important forestry species in Japan, we constructed a core collection derived from 3,203 plus trees. First, genetic redundancy was removed based on SSR genotypes from the plus tree population. One diploid accession from each of the 539 groups that were identified using information on the original growing location was then selected considering the conservation conditions. We defined this population composed of 539 individuals as a core collection for C. japonica, and then evaluated the collection status of this core collection from multiple viewpoints. This core collection proved to contain on average one entry selected per 10 km radius (314 km(2)) from 10 x 10 km grid squares with an area of more than 40 % covered with C. japonica, and covered more than 85 % retention of all 12 environmental factors affecting plus trees, while maintaining almost the same genetic diversity as the complete set of plus trees. These methods of evaluation from multiple viewpoints, using a geographic information system and genetic markers, were efficient in determining whether the collection of resources was complete, and, if not, where additional efforts for balancing a deficit should be devoted.	[Miyamoto, Naoko; Ono, Masako] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki 3191301, Japan; [Watanabe, Atsushi] Kyushu Univ, Fac Agr, Fukuoka, Higashi 8128581, Japan	Watanabe, A (reprint author), Kyushu Univ, Fac Agr, Hakozaki 6-10-1, Fukuoka, Higashi 8128581, Japan.	nabeatsu@agr.kyushu-u.ac.jp			Forest Tree Breeding Center	We thank the Tohoku, Kansai, and Kyusyu Regional Breeding Offices for providing genetic resources. We are also grateful to K. Tanaka, H. Hatakeyama, T. Kaminaga, and M. Shibata for their helpful assistance in DNA analysis. We would like to thank the anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper. Financial support was provided by the Forest Tree Breeding Center.	[Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Oliveira MF, 2010, FIELD CROP RES, V119, P277, DOI 10.1016/j.fcr.2010.07.021; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Reddy LJ, 2005, GENET RESOUR CROP EV, V52, P1049, DOI 10.1007/s10722-004-6152-7; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Santesteban LG, 2009, SPAN J AGRIC RES, V7, P572; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Upadhyaya HD, 2003, GENET RESOUR CROP EV, V50, P139, DOI 10.1023/A:1022945715628; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Kang CW, 2006, BREEDING SCI, V56, P85, DOI 10.1270/jsbbs.56.85; Volk GM, 2005, J AM SOC HORTIC SCI, V130, P203; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Dwivedi SL, 2008, CROP SCI, V48, P625, DOI 10.2135/cropsci2007.04.0240; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; [Anonymous], 2009, COLL CONS MAN SEEDS; Gepts P, 2006, CROP SCI, V46, P2278, DOI 10.2135/cropsci2006.03.0169gas; Tani N, 2004, ANN FOREST SCI, V61, P569, DOI 10.1051/forest:2004052; Moriguchi Y, 2003, THEOR APPL GENET, V106, P751, DOI [10.1007/s00122-002-1149-0, 10.1007/s00122-003-1310-4]; Bhattacharjee R, 2007, EUPHYTICA, V155, P35, DOI 10.1007/s10681-006-9298-x; Brown A. H. D., 1989, The use of plant genetic resources., P136; Brown AHD, 1991, GENETICS CONSERVATIO; El Bakkali A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061265; Environmental Agency, 1999, REP VEG SURV 5 NAT S; Escribano P, 2008, ANN APPL BIOL, V153, P25, DOI 10.1111/j.1744-7348.2008.00232.x; Forest and Forestry Products Research Institute Forest Tree Breeding Center, 2013, EX COND STAT FOR TRE; Forestry Agency, 2010, ANN REP FOR FOR JAP; Forestry Agency, 2007, STAT DAT 2007; Forestry Agency Guidance Department, 1994, NOT REL FOR TREE BRE; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Hayashi Y., 1960, TAXONOMICAL PHYTOGEO; Hintum van TJL, 2000, IPGRI TECHNICAL B, V3; Japan Forest Tree Breeding Association, 2004, PROJ FOR TREE BREED; Kaga Akito, 2012, Breed Sci, V61, P566, DOI 10.1270/jsbbs.61.566; Kira T, 1977, VEGETATION SCI ENV P, P21; Mahalakshmi V, 2007, GENET RESOUR CROP EV, V54, P1817, DOI 10.1007/s10722-006-9203-4; McKeand S, 1998, J FOREST, V96, P12; Meteorological Agency, 1996, CLIM NORM JAP; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; Miyamoto N, 2008, FOR FORESTRY PROD RE, V2008, P76; Mousadik EA, 1996, THEOR APPL GENET, V92, P832; Nijensohn SE, 2005, CAN J FOREST RES, V35, P1041, DOI 10.1139/X05-029; Ohba K, 1978, KYUSHU J FOR RES, V31, P67; Pearson R.G., 2007, SPECIES DISTRIBUTION; R Core Team, 2013, R LANG ENV STAT COMP; Rao V. Ramanatha, 2002, Plant Cell Tissue and Organ Culture, V68, P1, DOI 10.1023/A:1013359015812; Rodino AP, 2003, EUPHYTICA, V131, P165, DOI 10.1023/A:1023973309788; Shehzad T, 2009, GENET RESOUR CROP EV, V56, P809, DOI 10.1007/s10722-008-9403-1; Shiraishi S., 1995, Journal of the Japanese Forestry Society, V77, P429; Soto-Cerda BJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-78; Suzuki T, 1971, JPN J ECOL, V20, P252; Tomaru N, 1994, MEMOIRS I AGR FOREST, V6, P1; Tsumura Y, 2006, HDB REVEGETATION BIO, P59; Uchiyama K, 2014, TREE GENET IN PRESS; Xiurong Z, 2000, GENET RESOUR CROP EV, V47, P273, DOI DOI 10.1023/A:1008767307675; Zenkoku Ringyo Kairyo Fukyu Kyokai, 1969, ALL CRYPT JAP; Zenkoku Ringyo Kairyo Fukyu Kyokai, 1983, ALL CRYPT JAP	58	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					186	196		10.1007/s10310-014-0460-3		11	Forestry	Forestry	AZ7KZ	WOS:000348399200022		
J	Kenzo, T; Furutani, R; Hattori, D; Tanaka, S; Sakurai, K; Ninomiya, I; Kendawang, JJ				Kenzo, Tanaka; Furutani, Ryo; Hattori, Daisuke; Tanaka, Sota; Sakurai, Katsutoshi; Ninomiya, Ikuo; Kendawang, Joseph Jawa			Aboveground and belowground biomass in logged-over tropical rain forests under different soil conditions in Borneo	JOURNAL OF FOREST RESEARCH			English	Article						Carbon stock; Dipterocarp; Fine root; REDD; Tropical heath forest	MIXED DIPTEROCARP FORESTS; MULU-NATIONAL-PARK; PRIMARY PRODUCTIVITY; ROOT BIOMASS; HEATH FOREST; SARAWAK; DYNAMICS; MALAYSIA; ECOSYSTEMS; LANDSCAPE	Although an estimation of forest biomass is essential for the development of a carbon storage baseline in the "Reducing Emissions from Deforestation and Degradation in Developing Countries" scheme, few have been conducted in logged-over rain forests of Southeast Asia. We measured the aboveground and belowground biomass in logged-over mixed dipterocarp forests growing on an infertile soil with bleached white sand (Sabal) and on a clay and nutrient-rich soil (Balai Ringin) in Sarawak, Malaysia. We established four 0.5-ha plots on each site and calculated the biomass. Basal area and stand density of large trees (diameter at breast height, DBH a parts per thousand yen 10 cm) were relatively similar in Sabal (27.0 m(2), 720 tree ha(-1)) and Balai Ringin (28.9 m(2), 586 tree ha(-1)). However, the corresponding measurements for small trees (1 a parts per thousand currency sign DBH < 10 cm) were twice as large in Sabal than in Balai Ringin. Aboveground biomass (AGB) in the forests was less than half of the value recorded for undisturbed forests in Borneo, even 20 years after logging. Although total AGB was 20 % smaller in Sabal (205 Mg ha(-1)) than in Balai Ringin (242 Mg ha(-1)), the total belowground biomass (TBGB) was 20 % greater in Sabal (59.6 Mg ha(-1)) than in Balai Ringin (44.6 Mg ha(-1)). The larger TBGB in Sabal was due to the larger amounts of small roots (diameter < 5 mm) in Sabal (26.8 Mg ha(-1)) compared to Balai Ringin (5.8 Mg ha(-1)). This accumulation of small roots at Sabal may have contributed to rapid nutrient absorption from infertile soil.	[Kenzo, Tanaka] Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Furutani, Ryo; Ninomiya, Ikuo] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Hattori, Daisuke] Shikoku Univ, Fac Human Life Sci, Tokushima 7711192, Japan; [Tanaka, Sota] Koch Univ, Grad Sch Kuroshio Sci, Nanko Ku, Kochi 7838502, Japan; [Sakurai, Katsutoshi] Koch Univ, Fac Agr, Nanko Ku, Kochi 7838502, Japan; [Kendawang, Joseph Jawa] Wisma Sumber Alam, Sarawak Planted Forest, Kuching 93660, Sarawak, Malaysia	Kenzo, T (reprint author), Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan.	mona@affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [13575038]; Global Environment Research Account for National Institutes, Ministry of the Environment, Japan	The authors thank to the Sarawak Forestry Cooperation, the Sarawak Forest Department, and to Dr. K. O. Irino and Mr. A. Jee for their kind support of this study. This research was partly supported by Grant-in-Aid for scientific research (No. 13575038) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by the Global Environment Research Account for National Institutes, Ministry of the Environment, Japan.	Angelsen A, 2009, REALISING REDD NATL, P362; Kenzo T, 2009, J FOREST RES-JPN, V14, P365, DOI 10.1007/s10310-009-0149-1; Vogt KA, 1996, PLANT SOIL, V187, P159; Clark DB, 2008, ECOL LETT, V11, P163, DOI 10.1111/j.1461-0248.2007.01134.x; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Miyamoto K, 2007, BIOTROPICA, V39, P35, DOI 10.1111/j.1744-7429.2006.00231.x; Ngo KM, 2013, FOREST ECOL MANAG, V296, P81, DOI 10.1016/j.foreco.2013.02.004; Kenzo T, 2009, J TROP ECOL, V25, P371, DOI 10.1017/S0266467409006129; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Kenzo T, 2010, FOREST ECOL MANAG, V260, P875, DOI 10.1016/j.foreco.2010.06.006; YAMAKURA T, 1986, VEGETATIO, V68, P71; Sist P, 2003, ENVIRON CONSERV, V30, P364, DOI 10.1017/S0376892903000389; Tangki H, 2008, FOREST ECOL MANAG, V256, P1960, DOI 10.1016/j.foreco.2008.07.018; Ziegler AD, 2012, GLOBAL CHANGE BIOL, V18, P3087, DOI 10.1111/j.1365-2486.2012.02747.x; Paoli GD, 2008, OECOLOGIA, V155, P287, DOI 10.1007/s00442-007-0906-9; CANNON CH, 1994, FOREST ECOL MANAG, V67, P49, DOI 10.1016/0378-1127(94)90007-8; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Morel AC, 2011, FOREST ECOL MANAG, V262, P1786, DOI 10.1016/j.foreco.2011.07.008; ASHTON PS, 1992, J ECOL, V80, P459, DOI 10.2307/2260691; Niiyama K, 2010, J TROP ECOL, V26, P271, DOI 10.1017/S0266467410000040; Pinard MA, 2000, J APPL ECOL, V37, P267, DOI 10.1046/j.1365-2664.2000.00488.x; ANDERSON JM, 1983, J ECOL, V71, P503, DOI 10.2307/2259731; Ashton PS, 1964, ECOLOGICAL STUDIES M, P75; BONGERS F, 1985, VEGETATIO, V63, P13, DOI 10.1007/BF00032183; Brunig EF, 1974, ECOLOGICAL STUDIES K, P237; Brunig EF, 1983, TROPICAL RAIN FOREST, V14 A, P49; Brunig EF, 1996, CONSERVATION MANAGEM; Brunig EF, 1976, GARDENS B SINGAP, V24, P81; Davies Stuart J., 1996, Journal of Tropical Forest Science, V8, P542; Fredericksen T. S., 2000, Journal of Sustainable Forestry, V11, P113, DOI 10.1300/J091v11n03_07; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Kartawinata K, 1989, ECOSYSTEMS WORLD B, V14B, P591; Katagiri S, 1991, SE ASIAN STUD, V29, P35; Kendawang JJ, 2007, TROPICS, V16, P309, DOI 10.3759/tropics.16.309; Kendawang JJ, 2004, SOIL SCI PLANT NUTR, V50, P677; Kingsbury N, 1997, J TROP ECOL, V13, P475; KLINGE H, 1978, Tropical Ecology, V19, P93; Kuusipalo J, 1996, FOREST ECOL MANAG, V81, P85, DOI 10.1016/0378-1127(95)03654-7; Lasco RD, 2006, J TROP FOR SCI, V18, P166; Lee H. S., 2002, Journal of Tropical Forest Science, V14, P379; MacKinnon K., 1996, ECOLOGY KALIMANTAN; MANOKARAN N, 1990, Journal of Tropical Forest Science, V3, P14; Murach D., 1998, Soils of tropical forest ecosystems: characteristics, ecology and management., P186; Nakagawa M, 2013, BIODIVERS CONSERV, V22, P127, DOI 10.1007/s10531-012-0405-0; NEWBERY DM, 1991, VEGETATIO, V96, P43, DOI 10.1007/BF00031653; Noguchi H, 2014, JARQ-JPN AGR RES Q, V48, P231; Pinard MA, 1996, BIOTROPICA, V28, P278, DOI 10.2307/2389193; Powers JS, 2013, BIOTROPICA, V45, P1, DOI 10.1111/j.1744-7429.2012.00881.x; Priatna D, 2006, REINWARDTIA, V12, P237; PROCTOR J, 1983, J ECOL, V71, P237, DOI 10.2307/2259975; Saner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029642; Sanford RL, 1996, TROPICAL FOREST PLAN, P269; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; STARK NM, 1978, ECOLOGY, V59, P434, DOI 10.2307/1936571; Whitmore TC, 1984, TROPICAL RAIN FOREST; Yamada T, 2013, FOREST ECOL MANAG, V310, P531, DOI 10.1016/j.foreco.2013.08.057; YAMAKURA T, 1990, J TROP ECOL, V6, P371	57	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					197	205		10.1007/s10310-014-0465-y		9	Forestry	Forestry	AZ7KZ	WOS:000348399200023		
J	Fujimoto, T; Chiyoda, K; Yamaguchi, K; Isoda, K				Fujimoto, Takaaki; Chiyoda, Keisuke; Yamaguchi, Kazuho; Isoda, Keiya			Heritability estimates for wood stiffness and its related near-infrared spectral bands in sugi (Cryptomeria japonica) clones	JOURNAL OF FOREST RESEARCH			English	Article						Cryptomeria japonica; Dynamic modulus of elasticity; Genetic control; Rapid screening; Variable selection	LEAST-SQUARES REGRESSION; PLUS-TREE CLONES; MECHANICAL-PROPERTIES; GENETIC-VARIATIONS; VARIABLE SELECTION; TEST STANDS; SPECTROSCOPY; COMPONENTS; ELASTICITY; LUMBER	Rapid and cost-effective methods of evaluating the properties of wood are required for forest-tree breeding programs. In this work, we first attempted to develop a calibration model for predicting the stiffness of wood using near-infrared (NIR) spectroscopy. Wood samples were collected from three stands of sugi (Cryptomeria japonica) plus-tree clones aged from 34 to 36 years old. Two to three sample trees were harvested from each clone, yielding a total of 129 sample trees. Partial least-squares analysis was performed to predict the dynamic modulus of elasticity (E (fr)). A reasonable calibration model that allowed E (fr) to be predicted with a correlation coefficient of 0.69 and a root mean square error of prediction of 0.82 GPa was obtained. Second, in a novel approach, we tried to select the NIR spectral bands that were the most strongly related to wood stiffness, and we examined the degree to which these bands were genetically controlled. The heritability estimates (h (2)) for the NIR absorbance values at 7,320 and 6,281 cm(-1), which were found to be the most important bands for predicting E (fr), were 0.48 and 0.57, respectively. Although the genetic control of the NIR spectral bands was weaker than the genetic control associated with the actual measurement of E (fr) (h (2) = 0.74), the results imply that the NIR spectral bands are under moderate genetic control. Assuming that the NIR spectral bands are the dissected components of the target trait (E (fr)), the results should provide useful information when attempting to perform genomics-based breeding.	[Fujimoto, Takaaki; Chiyoda, Keisuke] Tottori Univ, Fac Agr, Tottori 6808553, Japan; [Yamaguchi, Kazuho; Isoda, Keiya] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Kansai Reg Breeding Off, Okayama 7094335, Japan	Fujimoto, T (reprint author), Tottori Univ, Fac Agr, Tottori 6808553, Japan.	tafujimoto@muses.tottori-u.ac.jp; bkxpt912@yahoo.co.jp; kazuyama@affrc.go.jp; keiso@affrc.go.jp					Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Schimleck LR, 2003, J AGR FOOD CHEM, V51, P2433, DOI 10.1021/jf020981u; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Fujimoto T, 2008, J NEAR INFRARED SPEC, V16, P529, DOI [10.1255/jnirs.813, 10.1255/jnirs.818]; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Neale DB, 2007, CURR OPIN GENET DEV, V17, P539, DOI 10.1016/j.gde.2007.10.002; Schwanninger M, 2011, J NEAR INFRARED SPEC, V19, P287, DOI 10.1255/jnirs.955; Tsuchikawa S, 2007, APPL SPECTROSC REV, V42, P43, DOI 10.1080/05704920601036707; Kelley SS, 2004, WOOD SCI TECHNOL, V38, P257, DOI 10.1007/s00226-003-0213-5; Arima T, 1993, J SOC MAT SCI JPN, V42, P141; Bishop C. M., 2006, PATTERN RECOGNITION; Efron B., 1993, INTRO BOOTSTRAP; Forestry Agency, 2013, ANN REP TRENDS FOR F; Fujimoto T, 2010, APPL SPECTROSC, V64, P92; FUJISAWA Y, 1993, MOKUZAI GAKKAISHI, V39, P875; FUJISAWA Y, 1994, MOKUZAI GAKKAISHI, V40, P457; FUJISAWA Y, 1995, MOKUZAI GAKKAISHI, V41, P249; FUJISAWA Y, 1992, MOKUZAI GAKKAISHI, V38, P638; Hastie T., 2013, LARS LEAST ANGLE REG; Kramer R., 1998, CHEMOMETRIC TECHNIQU; Lestander TA, 2008, CAN J FOREST RES, V38, P2052, DOI 10.1139/X08-047; Mackay T. F. C., 1996, INTRO QUANTITATIVE G; Mevik B.-H., 2013, PLS PARTIAL LEAST SQ; Pinheiro J., 2013, NLME LINEAR NONLINEA, P1; Tsuchikawa S, 2005, APPL SPECTROSC, V59, P86, DOI 10.1366/0003702052940413; Tsuchikawa S, 2011, APPL SPECTROSC REV, V48, P560, DOI DOI 10.1080/05704928.2011.621079; Wehrens R, 2011, USE R, P1, DOI 10.1007/978-3-642-17841-2; Zou H, 2013, ELASTICNET ELASTIC N	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					206	212		10.1007/s10310-014-0464-z		7	Forestry	Forestry	AZ7KZ	WOS:000348399200024		
J	Ayabe, Y; Minoura, T; Hijii, N				Ayabe, Yoshiko; Minoura, Tetsuaki; Hijii, Naoki			Plasticity in resource use by the leafminer moth Phyllocnistis sp in response to variations in host plant resources over space and time	JOURNAL OF FOREST RESEARCH			English	Article						Lammas shoot; Leafminer; Microhabitat use; Resource availability	HERBIVOROUS INSECTS; LEAF EXPANSION; OVIPOSITION; GRACILLARIIDAE; LEPIDOPTERA; PERFORMANCE; CITRELLA	We examined how sedentary herbivorous insects cope with changes in resource availability with host plant phenology by studying the multivoltine lepidopteran leafminer Phyllocnistis sp. on the Japanese privet (Ligustrum japonicum). The privet offers three resources: primary shoots in the spring, lammas shoots later in the season, and older leaves. We examined the seasonal abundance of these resources and the density of mines in each to assess competition between leafminers at the tree, shoot, and leaf scale. The leafminer initially used leaves of primary shoots, then shifted to young leaves of lammas shoots, but never used old leaves. The relative scarcity of lammas shoots increased the density of mines, so the leafminers maximized their use of the intra-leaf microhabitat: they commonly preferred the lower surface of leaves, but came to use both surfaces. Thus the leafminer compensated for the lower availability of lammas shoots by maximizing microhabitat use.	[Ayabe, Yoshiko; Minoura, Tetsuaki; Hijii, Naoki] Nagoya Univ, Grad Sch Bioagr Sci, Lab Forest Protect, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Ayabe, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Forest Protect, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ayabe@agr.nagoya-u.ac.jp					Nakamura M, 2003, FUNCT ECOL, V17, P851, DOI 10.1111/j.1365-2435.2003.00786.x; Eber S, 2004, J ANIM ECOL, V73, P948, DOI 10.1111/j.0021-8790.2004.00867.x; Martinsen GD, 2000, OECOLOGIA, V123, P82, DOI 10.1007/s004420050992; Konno K, 1997, J INSECT PHYSIOL, V43, P217, DOI 10.1016/S0022-1910(96)00099-6; Connor EF, 1997, OIKOS, V79, P6, DOI 10.2307/3546085; HESPENHEIDE HA, 1991, ANNU REV ENTOMOL, V36, P535; DANELL K, 1985, OIKOS, V44, P75, DOI 10.2307/3544046; Groenteman R, 2006, ECOL ENTOMOL, V31, P155, DOI 10.1111/j.0307-6946.2006.00772.x; POTTER DA, 1989, OECOLOGIA, V78, P322, DOI 10.1007/BF00379105; AUERBACH M, 1984, ECOL ENTOMOL, V9, P361, DOI 10.1111/j.1365-2311.1984.tb00831.x; Auerbach Michael J., 1995, P83, DOI 10.1016/B978-012159270-7/50006-3; Ayabe Y, 2008, INSECT SCI, V15, P343, DOI 10.1111/j.1744-7917.2008.00219.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; England JR, 2011, TREES-STRUCT FUNCT, V25, P987, DOI 10.1007/s00468-011-0573-7; Feath SH, 1991, ENVIRON ENTOMOL, V20, P196; Gratani L, 2009, PHOTOSYNTHETICA, V47, P323, DOI 10.1007/s11099-009-0052-1; Jesus CR, 2008, BRAZ J BIOL, V68, P205, DOI 10.1590/S1519-69842008000100030; Knapp JL, 1995, CITRUS LEAFMINER PHY, P26; Morrison A, 2009, ECOL ENTOMOL, V34, P287, DOI 10.1111/j.1365-2311.2008.01076.x; Pena JE, 1997, J ECON ENTOMOL, V90, P458; PRICE PW, 1994, RES POPUL ECOL, V36, P3, DOI 10.1007/BF02515079; R Development Core Team, 2011, R LANG ENV STAT COMP; REAVEY D, 1991, OIKOS, V61, P19, DOI 10.2307/3545403; Roberts M., 2000, ADV BIOL; Varone L, 2009, TREES-STRUCT FUNCT, V23, P1255, DOI 10.1007/s00468-009-0365-5; Vercher R, 2008, AGR FOREST ENTOMOL, V10, P45; WARD SA, 1992, OIKOS, V63, P506, DOI 10.2307/3544978	27	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					213	221		10.1007/s10310-014-0467-9		9	Forestry	Forestry	AZ7KZ	WOS:000348399200025		
J	Okada, Y; Kurokawa, U				Okada, Yasuhiko; Kurokawa, Ushio			Examining effects of tree roots on shearing resistance in shallow landslides triggered by heavy rainfall in Shobara in 2010	JOURNAL OF FOREST RESEARCH			English	Article						Shallow landslides; Shearing resistance; Tree root effect		The long-term accumulation of precipitation was accompanied by a seasonal rain front (known as the Baiu front) covering wide areas of western and central Japan during the period 11-16 July 2010. In Shobara city, Hiroshima prefecture, more than a thousand shallow landslides occurred within a very limited area (9 km(2) = 3 x 3 km) during the afternoon of 16 July 2010, claiming one fatality. In the source areas on steep slopes, meanwhile, volcanoclastic soil slid due to the heavy rainfall, then fluidised to flow over long distances. Landslides appeared to occur on all slopes; not only young forests but also mature forests. A field investigation revealed a case where slides occurred in young Japanese cypress (Chamaecyparis obtusa) forests, but surface water only flowed over the ground in mature Japanese cypress forest sandwiched by the young forests, while the side ends of the slides reached the edge of the mature forest. To examine the differences between both forests, simplified cone penetration tests, tests on tree root distribution in trenches, tree root pull out tests, soil samples, and geotechnical soil tests were all conducted. Although the number of lateral roots found in the trenches differed little, the root diameters in the mature forest exceeded those in the young forest. The thicker and stronger root in the mature forest would, thus, help prevent shallow landslides.	[Okada, Yasuhiko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Kurokawa, Ushio] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto 8600862, Japan	Okada, Y (reprint author), Forestry & Forest Prod Res Inst, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	okada10@ffpri.affrc.go.jp; ushio@ffpri.affrc.go.jp					Abe K, 1997, B FOR FOR PROD RES I, V373, P105; ABE K, 1991, CAN J FOREST RES, V21, P1012, DOI 10.1139/x91-139; Cruden DM, 1996, LANDSLIDES INVESTIGA, P501; Kaibori M, 2010, J JPN SOC EROS CONTR, V63, P30; Kitahara H, 2010, WATER SCI, V53, P11; Osanai N, 2007, FDN ENG EQUIP MON, V35, P19; Tsukamoto Y, 1987, B EXP FOR TOKYO U AG, V23, P65	7	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					230	235		10.1007/s10310-014-0470-1		6	Forestry	Forestry	AZ7KZ	WOS:000348399200027		
J	Yamagawa, H; Ito, S; Hosaka, T; Yoshida, S; Nakao, T; Shimizu, O				Yamagawa, Hiromi; Ito, Satoshi; Hosaka, Takenori; Yoshida, Shigejiro; Nakao, Toshio; Shimizu, Osamu			Effect of pre-logging stand type and harvesting roads on the densities of advanced-regenerated and postharvest-germinated tree seedlings after clear-cutting of hinoki cypress (Chamaecyparis obtusa) in Yoshinogari, Kyushu, Japan	JOURNAL OF FOREST RESEARCH			English	Article						Buried seeds; Natural forest recovery; Pioneer species; Soil erosion; Soil physical properties	NATURAL FOREST RECOVERY; CONIFER PLANTATION; MANAGEMENT; EROSION	To clarify the effects of pre-logging forest type (hinoki plantation or lucidophyllous forest) and harvesting roads on tree regeneration, we examined the density of regenerated trees, physical properties of soil, and soil erosion 2 years after clear-cutting in northern Kyushu, Japan. The results showed that the density of regenerated individuals was affected by the forest type before logging and by road construction. In a clear-cut lucidophyllous forest, most of the recovering vegetation consisted of lucidophyllous species originating from advanced regeneration and seedlings of pioneer species. Conversely, since few individuals originated from advanced regeneration in the clear-cut hinoki plantation sites, recovery to climax stand conditions at these sites is likely to be delayed compared to areas of clear-cut lucidophyllous forest. Few regenerated individuals were observed on harvesting road surfaces. Similarly, vegetation recovery was limited on harvesting road surfaces and along the side-cast slopes adjacent to roads. The number of germinated seedlings of pioneer species was positively correlated with litter cover and thickness of the A horizon, and negatively correlated with the rate of apparent soil erosion. These findings indicated that the establishment of seedlings of pioneer species originating from buried seeds is affected by the thickness of the A horizon of the soil. Since the recovered vegetation and the leaf litter derived therefrom will inhibit soil erosion, we propose that advanced regeneration and soil physical properties immediately after clear-cutting are important for the rapid recovery of climax forest conditions and for the prevention of soil erosion after clear-cutting.	[Yamagawa, Hiromi] Forestry & Forest Prod Res Inst, Kyusyu Res Ctr, Kumamoto 8600862, Japan; [Ito, Satoshi; Nakao, Toshio; Shimizu, Osamu] Miyazaki Univ, Fac Agr, Miyazaki 8892192, Japan; [Hosaka, Takenori; Yoshida, Shigejiro] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8218581, Japan	Yamagawa, H (reprint author), Forestry & Forest Prod Res Inst, Kyusyu Res Ctr, 4-11-16 Kurokami, Kumamoto 8600862, Japan.	yamaghy@affrc.go.jp			Agriculture, Forestry and Fisheries Research Council Secretariat (AFFRC) of Japan [1614]; Japan Society for the Promotion of Science (JSPS) [20-4420, 18658065, 20380090]	We would like to thank the building office at Gokayama Dam in Fukuoka Prefecture for their cooperation and for permitting us to access the study site. Part of the work presented in this manuscript was conducted as part of the Research Project for Utilizing Advanced Technologies in Agriculture, Forestry and Fisheries from the Agriculture, Forestry and Fisheries Research Council Secretariat (AFFRC) of Japan (No. 1614) and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (Nos. 20-4420, 18658065, and 20380090).	Sakai A, 2005, J FOR RES-JPN, V10, P295, DOI 10.1007/s10310-004-0138-3; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019; Wemple BC, 2001, EARTH SURF PROC LAND, V26, P191, DOI 10.1002/1096-9837(200102)26:2<191::AID-ESP175>3.3.CO;2-L; Forsyth AR, 2006, FOREST ECOL MANAG, V221, P194, DOI 10.1016/j.foreco.2005.09.018; Merino A, 1998, FOREST ECOL MANAG, V103, P235, DOI 10.1016/S0378-1127(97)00229-6; Edeso JM, 1999, LAND DEGRAD DEV, V10, P79; Hasegawa S, 1984, J JPN I LANDSC ARCHI, V47, P85; Hattori S, 1992, B FOR FOR PROD RES I, V362, P1; Japan Meteorological Agency, 2002, MESH CLIM DAT JAP; Kitamura S, 1971, COLORED ILLUSTRATION, VI; Miura S, 2003, J FOREST RES, V8, P27, DOI DOI 10.1007/S103100300003; Miyawaki A, 1981, VEGETATION JAPAN KYU; Mogi T, 2000, WOODY PLANTS JAPAN; Murata G, 1979, COLORED ILLUSTRATION, VII; Nagashima K, 2009, J FOREST RES-JPN, V14, P135, DOI 10.1007/s10310-009-0118-8; Okuda S, 1997, WILD PLANTS JAPAN; R Development Core Team, 2010, R LANG ENV STAT COMP; Sakai A, 2006, J FOREST RES-JPN, V11, P253, DOI 10.1007/s10310-005-0182-7; Sakai M, 2003, SOCIALIZATION FOREST; Sato H., 2006, Journal of the Japanese Forest Society, V88, P50, DOI 10.4005/jjfs.88.50; Smith D.M., 1986, PRACTICE SILVICULTUR; Tsukamoto J., 1989, Journal of the Japanese Forestry Society, V71, P469; Yamagawa H, 2006, J FOREST RES-JPN, V11, P455, DOI 10.1007/s10310-006-0229-4; Yamagawa H, 2006, J FOREST RES-JPN, V11, P99, DOI 10.1007/s10310-005-0192-5; Yamagawa H, 2007, JPN J FOR ENV, V49, P111; Yamagawa H, 2010, LANDSC ECOL ENG, V6, P109, DOI 10.1007/s11355-009-0088-1	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					236	243		10.1007/s10310-014-0452-3		8	Forestry	Forestry	AZ7KZ	WOS:000348399200028		
J	Kurokochi, H; Tan, EK; Asakawa, S; Lian, CL				Kurokochi, Hiroyuki; Tan, Engkong; Asakawa, Shuichi; Lian, Chunlan			Development of 18 microsatellite markers in Pieris japonica, a poisonous tree insulated from the browsing pressure of herbivores, using a next-generation sequencer	JOURNAL OF FOREST RESEARCH			English	Article						Herbivorous animal; Ion PGM sequencer; Poisonous tree; SSR; Tree expansion	CENTRAL JAPAN; VEGETATION; FORESTS	Pieris japonica is a poisonous tree species that is rarely eaten by herbivorous animals, which could allow it to expand its distribution and change ecosystems. Using a next-generation sequencer, 18 microsatellite markers were isolated from P. japonica and characterized. The number of alleles at each locus ranged from 2 to 11. The observed and expected heterozygosities ranged from 0.13 to 1.00 and 0.32 to 0.88, respectively. These markers will be useful for genetic studies of P. japonica, which will be essential for conservation of its surrounding environment.	[Kurokochi, Hiroyuki; Lian, Chunlan] Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo 1880002, Japan; [Tan, Engkong; Asakawa, Shuichi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Kurokochi, H (reprint author), Univ Tokyo, Asian Nat Environm Sci Ctr, 1-1-8 Midori Cho, Tokyo 1880002, Japan.	kurokochi@es.a.u-tokyo.ac.jp			University of Tokyo Chichibu Forest; SUNTRY	We thank the Tokyo University Forest of Chichibu, Japan for allowing us to sample our target species. This study was supported in part by Grant in aid from the joint project between the University of Tokyo Chichibu Forest and SUNTRY to H.K.	Kurokochi H, 2014, CONSERV GENET RESOUR, V6, P593, DOI 10.1007/s12686-014-0148-1; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Kurokochi H, 2013, BOTANY, V91, P148, DOI 10.1139/cjb-2012-0159; Suzuki M, 2008, ECOL RES, V23, P151, DOI 10.1007/s11284-007-0348-1; Kurokochi Hiroyuki, 2014, Journal of Ecology and Environment, V37, P21, DOI 10.5141/ecoenv.2014.003; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Fujiki D, 2010, J FOREST RES-JPN, V15, P140, DOI 10.1007/s10310-009-0172-2; Hester AJ, 2000, FORESTRY, V73, P382; Iwai N, 2012, J FOREST RES-JPN, V17, P446, DOI 10.1007/s10310-011-0310-5; Kurata S, 1964, ILLUSTRATED IMPORTAN, V3; Maesako Y, 2007, VEG SCI, V24, P103; Nomiya H, 2003, PLANT ECOL, V164, P263, DOI 10.1023/A:1021294021438; RAYMOND M, 1995, J HERED, V86, P248; Sato M, 2014, CONSERV GENET RESOUR, V6, P685, DOI 10.1007/s12686-014-0182-z; Uehara K., 1959, ILLUSTRATIONS TREES; Vazwuez DP, 2002, BIOL INVASIONS, V4, P175; Yokoyama S, 1998, FOREST ECOL MANAG, V103, P49, DOI 10.1016/S0378-1127(97)00175-8	17	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					244	247		10.1007/s10310-014-0456-z		4	Forestry	Forestry	AZ7KZ	WOS:000348399200029		
J	Itou, T; Hayama, K; Sakai, A; Tanouchi, H; Okuda, S; Kushima, H; Kajimoto, T				Itou, Takeharu; Hayama, Kayo; Sakai, Atsushi; Tanouchi, Hiroyuki; Okuda, Shiro; Kushima, Hiromichi; Kajimoto, Takuya			Developing an effective glyphosate application technique to control Bischofia javanica Blume, an invasive alien tree species in the Ogasawara Islands	JOURNAL OF FOREST RESEARCH			English	Article						Bischofia javanica; Glyphosate; Herbicide; Invasive species; Ogasawara (Bonin) Islands		Bischofia javanica is a non-native tree species in Japan's Ogasawara Islands, where it threatens native tree species due to its rapid propagation and growth. An effective method is needed to limit the expansion of B. javanica populations and to conserve the natural forest ecosystem of the islands. For this purpose, we examined the effectiveness of a new application technique for the herbicide glyphosate on B. javanica. In this method, glyphosate solution is directly injected into holes drilled in the stem, and each hole is then plugged with a cork stopper to prevent loss of the solution, namely the drill-and-plug method. We also developed an allometric regression model linking stem diameter with total aboveground biomass (AGB) to estimate the necessary herbicide dosage. Our results suggest that between 0.1 and 0.5 g kg(-1) (active ingredient per unit AGB) is required to control most B. javanica trees. Verification of the drill-and-plug method using the minimum dosage (0.1 g kg(-1)) showed that most of the herbicide-treated trees were killed. These results suggest that the drill-and-plug method can help control the B. javanica invasion of the Ogasawara Islands.	[Itou, Takeharu; Sakai, Atsushi; Tanouchi, Hiroyuki] Forestry & Forest Prod Res Inst, Shikoku Res Ctr, Kochi 7808077, Japan; [Hayama, Kayo] Motochi Hahajima Ogasawara, Ogasawara Environm Planning Lab, Tokyo 1002211, Japan; [Okuda, Shiro] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Fushimi Ku, Kyoto 6120855, Japan; [Kushima, Hiromichi] Forestry & Forest Prod Res Inst, Hachioji, Tokyo 1930843, Japan; [Kajimoto, Takuya] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Itou, T (reprint author), Forestry & Forest Prod Res Inst, Shikoku Res Ctr, 2-915 Asakura Nishimachi, Kochi 7808077, Japan.	takeharu@affrc.go.jp			Japan Forest Technology Association; Japan Ministry of the Environment	We are grateful to H. Utsugi, H. Sakai, K. Miyamoto, T. Otani, M. Noguchi, and other members of the Forestry and Forest Products Research Institute for their helpful comments on an early version of the manuscript. We thank T. Yasui and the members of the Ogasawara Wildlife Research Society for their assistance with our field measurements of tree biomass; Y. Hoshi and H. Umeno, residents of the Ogasawara Islands, for their help with the verification tests; and N. Yamashita, S. Makino, and I. Okochi, as well as other members of Forestry and Forest Products Research Institute, for their support during the study. We also thank the members of the Kanto Regional Forest Office at Ogasawara for maintaining the Coffee-yama test site. The authors would like to thank the coordinating editor and two anonymous reviewers for their valuable comments and suggestions to improve the manuscript. The verification experiment was carried out as a part of a research project funded by the Japan Forest Technology Association and the Japan Ministry of the Environment.	Cantoni E, 2001, J AM STAT ASSOC, V96, P1022, DOI 10.1198/016214501753209004; LOOPE LL, 1988, BIOSCIENCE, V38, P272, DOI 10.2307/1310851; Buckley HL, 2010, J ECOL, V98, P645, DOI 10.1111/j.1365-2745.2010.01650.x; Richardson DM, 1998, CONSERV BIOL, V12, P18, DOI 10.1046/j.1523-1739.1998.96392.x; Asai M, 2001, METHODS WEED SCI, P267; Au RCF, 2012, EFFICACY BIOL CHEM H, P1; Ferrel J, 2006, SSAGR260 U FLOR I FO; FRANZ J. E., 1997, GLYPHOSATE UNIQUE GL; Harrington TB, 2005, WEED TECHNOL, V19, P47, DOI 10.1614/WT-03-220R2; Itou T., 2005, Journal of Weed Science and Technology, V50, P18; Kawakami K, 2010, RESTORING THE OCEANIC ISLAND ECOSYSTEM: IMPACT AND MANAGEMENT OF INVASIVE ALIEN SPECIES IN THE BONIN ISLANDS, P1, DOI 10.1007/978-4-431-53859-2; Papritz A, 2009, ENVIRON POLLUT, V157, P2019, DOI 10.1016/j.envpol.2009.02.032; R Development Core Team, 2012, R LANG ENV STAT COMP; Ripley BD, 2002, MODERN APPL STAT S; Shimizu Y, 1988, I APPL GEOGR KOMAZAW, V1, P31; Shimizu Yoshikazu, 2003, Global Environmental Research, V7, P3; Sunarno B, 1995, BISCHOFIA BLUME INTE; Tanimoto T, 1995, B FOR FOR PROD RES I, V369, P1; Yamashita N, 2002, ANN BOT-LONDON, V90, P599, DOI 10.1093/aob/mcf231; Yamashita N, 2003, J VEG SCI, V14, P14	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	FEB	2015	20	1					248	253		10.1007/s10310-014-0457-y		6	Forestry	Forestry	AZ7KZ	WOS:000348399200030		
J	Hasegawa, T; Kubo, N; Ohira, M; Sakurai, K; Toyokawa, T; Yamashita, Y; Yamazoe, S; Kimura, K; Nagahara, H; Amano, R; Shibutani, M; Tanaka, H; Muguruma, K; Ohtani, H; Yashiro, M; Maeda, K; Hirakawa, K				Hasegawa, Tsuyoshi; Kubo, Naoshi; Ohira, Masaichi; Sakurai, Katsunobu; Toyokawa, Takahiro; Yamashita, Yoshito; Yamazoe, Sadaaki; Kimura, Kenjiro; Nagahara, Hisashi; Amano, Ryosuke; Shibutani, Masatsune; Tanaka, Hiroaki; Muguruma, Kazuya; Ohtani, Hiroshi; Yashiro, Masakazu; Maeda, Kiyoshi; Hirakawa, Kosei			Impact of Body Mass Index on Surgical Outcomes after Esophagectomy for Patients with Esophageal Squamous Cell Carcinoma	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Squamous cell carcinoma; Esophagus; Anastomotic leakage; Overweight	COMPUTED-TOMOGRAPHY; ANASTOMOTIC LEAK; SHORT-TERM; CANCER; OBESITY; METAANALYSIS; RESECTION; COMPLICATIONS; SURGERY; SURVIVAL	Patients with overweight reportedly have more comorbidities, including diabetes mellitus and cardiovascular disease, and longer operating times as well as more blood loss during surgery compared with those with normal weight. However, the impact of overweight on the short-term outcome after transthoracic esophagectomy for patients with esophageal squamous cell carcinoma (ESCC) remains unclear. We hypothesized that overweight has a negative impact on short-term surgical outcomes after esophagectomy for patients with ESCC. A total of 304 patients who underwent transthoracic esophagectomy for ESCC were included in this study. Body mass index (BMI) was classified into three categories, < 18.49, 18.50-24.99, and > 25.00 (kg/m(2)), defined as low, normal, and high BMI, respectively, according to the World Health Organization criteria. We investigated the association of BMI status with patient demographics and surgical outcomes after esophagectomy for patients with ESCC. In addition, overall survival and relapse-free survival stratified by BMI were compared. Fifty-nine (19.4 %) and 41 (13.4 %) patients were classified to low BMI and high BMI, respectively. The high-BMI group had significantly higher comorbidity rates of diabetes mellitus (p < 0.01) and anastomotic leakage (p = 0.011) than the normal-BMI group. There were no significant association between high BMI and another various complications except for an anastomotic leakage, severe complications defined by Clavien-Dindo classification and in-hospital mortality. In multivariate analysis, high BMI was a significant risk factor for anastomotic leakage (p = 0.030, hazard ratio; 3.423, 95%CI; 1.128-10.38). On the other hand, no significant association was observed between low BMI and short surgical outcomes. There were no significant differences in overall and relapse-free survival among the three BMI groups in univariate and multivariate analysis (p = 0.128 and p = 0.584, respectively). The surgical treatment should not be denied for patients with ESCC due to overweight and underweight. However, intraoperative prevention and postoperative careful monitoring for anastomotic leakage might be required after esophagectomy for overweight patients with ESCC.	[Hasegawa, Tsuyoshi; Kubo, Naoshi; Ohira, Masaichi; Sakurai, Katsunobu; Toyokawa, Takahiro; Yamashita, Yoshito; Yamazoe, Sadaaki; Kimura, Kenjiro; Nagahara, Hisashi; Amano, Ryosuke; Shibutani, Masatsune; Tanaka, Hiroaki; Muguruma, Kazuya; Ohtani, Hiroshi; Yashiro, Masakazu; Maeda, Kiyoshi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan; [Yamashita, Yoshito] Osaka City Gen Hosp, Dept Surg Gastroenterol, Osaka, Japan	Kubo, N (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	k-naoshi@med.osaka-cu.ac.jp					BONE RC, 1992, CRIT CARE MED, V20, P864; Watanabe M, 2013, ANN SURG ONCOL, V20, P3984, DOI 10.1245/s10434-013-3073-8; Yasunaga H, 2013, BRIT J SURG, V100, P1335, DOI 10.1002/bjs.9221; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Kayani B, 2012, WORLD J SURG, V36, P1785, DOI 10.1007/s00268-012-1582-4; Dai JG, 2011, SURGERY, V149, P404, DOI 10.1016/j.surg.2010.08.005; Kubo N, 2014, ANTICANCER RES, V34, P2399; Yoon HH, 2011, J CLIN ONCOL, V29, P4561, DOI 10.1200/JCO.2011.37.1260; Dindo D, 2003, LANCET, V361, P2032, DOI 10.1016/S0140-6736(03)13640-9; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Blom R, 2012, ANN SURG ONCOL, V19, P766, DOI 10.1245/s10434-011-2103-7; Schaible A, 2014, SURG ENDOSC, V28, P2078, DOI 10.1007/s00464-014-3435-8; Ye T, 2013, ANN THORAC SURG, V96, P1933, DOI 10.1016/j.athoracsur.2013.06.050; Ashrafian H, 2011, HEART, V97, P171, DOI 10.1136/hrt.2010.207092; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Lantos JE, 2013, J THORAC IMAG, V28, P121, DOI 10.1097/RTI.0b013e31826ff062; [Anonymous], 2000, WHO TECH REP SER, V894, P1; Adams JP, 2000, BRIT J ANAESTH, V85, P91, DOI 10.1093/bja/85.1.91; Zhang SS, 2013, BRIT J CANCER, V109, P2894, DOI 10.1038/bjc.2013.666; Tang H, 2012, J GASTROINTEST SURG, V16, P722, DOI 10.1007/s11605-011-1788-z; Strauss C, 2010, ANN SURG, V251, P647, DOI 10.1097/SLA.0b013e3181c1aeb8; Kassis ES, 2013, ANN THORAC SURG, V96, P1919, DOI 10.1016/j.athoracsur.2013.07.119; Hampel H, 2005, ANN INTERN MED, V143, P199; Scarpa M, 2013, J GASTROINTEST SURG, V17, P218, DOI 10.1007/s11605-012-2023-2; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Mathur AK, 2010, J GASTROINTEST SURG, V14, P1285, DOI 10.1007/s11605-010-1232-9; Grotenhuis BA, 2010, WORLD J SURG, V34, P2621, DOI 10.1007/s00268-010-0697-8; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Kubo N, 2014, SURG LAPARO ENDO PER, V24, P158, DOI 10.1097/SLE.0b013e31828fa6d7; Nobuoka D, 2011, SURG TODAY, V41, P928, DOI 10.1007/s00595-010-4397-7; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Scipione CN, 2007, ANN THORAC SURG, V84, P376, DOI 10.1016/j.athoracsur.2006.11.070; Takeuchi H, 2014, ANN SURG IN PRESS, DOI [10.1097/SLA.0000000000000644, DOI 10.1097/SLA.0000000000000644)]; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	FEB	2015	19	2					226	233		10.1007/s11605-014-2686-y		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ7LF	WOS:000348399800003		
J	Tanaka, E; Kim, M; Lim, JS; Choi, YY; Saklani, A; Noh, SH; Hyung, WJ				Tanaka, Eiji; Kim, Minjhi; Lim, Joon Seok; Choi, Yoon Young; Saklani, Avanish; Noh, Sung Hoon; Hyung, Woo Jin			Usefulness of Laparoscopic Side-to-Side Duodenojejunostomy for Gastrointestinal Stromal Tumors Located at the Duodenojejunal Junction	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						GIST; Duodenojejunal junction; Laparoscopy; Resection	MESENTERIC-ARTERY SYNDROME; SURGICAL-TREATMENT; RESECTION; DUODENUM	Surgery for gastrointestinal stromal tumor (GIST) at the duodenojejunal junction is a technically challenging and difficult procedure because of the anatomical complexity. When it comes to laparoscopic surgery, it is more challenging than open surgery. This study aimed to introduce our laparoscopic procedure and to evaluate its clinical implication by comparing with open procedures. Between 2003 and 2013, 19 patients underwent segmental resection for a GIST at the duodenojejunal junction: laparoscopic segmental resection with side-to-side duodenojejunostomy (n = 8) and open surgery (n = 11). Clinicopathological findings, operation details, and postoperative outcomes were compared. Both groups were comparable in demographics and clinicopathological characteristics. Postoperative hospital stay of the laparoscopic group (6.3 days) was significantly shorter than the open group (15.7 days, P = 0.008) while no significant differences were observed regarding estimated blood loss, operation time, and morbidity. All patients in both groups underwent curative resection without operative mortality. Two patients experienced recurrence after open surgery whereas none of the patients after laparoscopic duodenojejunostomy had recurrence with a median follow-up period of 36 months. Laparoscopic segmental resection with side-to-side duodenojejunostomy for a GIST at the duodenojejunal junction is a safe, feasible, and effective alternative to open approach, providing benefits of minimally invasive surgery.	[Tanaka, Eiji; Kim, Minjhi; Choi, Yoon Young; Saklani, Avanish; Noh, Sung Hoon; Hyung, Woo Jin] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea; [Tanaka, Eiji] Kyoto Univ, Dept Surg, Kyoto, Japan; [Lim, Joon Seok] Yonsei Univ, Coll Med, Dept Radiol, Seoul 120752, South Korea; [Lim, Joon Seok; Noh, Sung Hoon; Hyung, Woo Jin] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Gastr Canc Ctr, Seoul, South Korea; [Saklani, Avanish] Tata Mem Canc Ctr, Bombay, Maharashtra, India	Hyung, WJ (reprint author), Yonsei Univ, Coll Med, Dept Surg, 50-1 Yonsei Ro, Seoul 120752, South Korea.	wjhyung@yuhs.ac			Ministry of Health, Welfare, & Family Affairs, Republic of Korea [1320270]	This work was supported by a grant of the Korea Healthcare technology R&D project, Ministry of Health, Welfare, & Family Affairs, Republic of Korea (1320270).	Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Sexton JA, 2008, SURG ENDOSC, V22, P2583, DOI 10.1007/s00464-008-9807-1; Goh BKP, 2008, J SURG ONCOL, V97, P388, DOI 10.1002/jso.20954; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Novitsky YW, 2006, ANN SURG, V243, P738, DOI 10.1097/01.sla.0000219739.11758.27; Chung JC, 2011, J KOREAN SURG SOC, V80, pS12, DOI 10.4174/jkss.2011.80.Suppl1.S12; Connolly EM, 2003, BRIT J SURG, V90, P1178, DOI 10.1002/bjs.4352; Ihn Kyong, 2012, J Gastric Cancer, V12, P243, DOI 10.5230/jgc.2012.12.4.243; Jo JB, 2008, SURG LAPARO ENDO PER, V18, P213, DOI 10.1097/SLE.0b013e3181661b36; Kim IY, 2003, YONSEI MED J, V44, P526; Kim SK, 2008, ABDOM IMAGING, V33, P395, DOI 10.1007/s00261-007-9284-3; Kim Yoo-Min, 2010, J Gastric Cancer, V10, P188, DOI 10.5230/jgc.2010.10.4.188; Lewis J J, 1996, Curr Probl Surg, V33, P817; Munene G, 2010, AM SURGEON, V76, P321; Pandey Richa, 2012, J Gastrointest Cancer, V43, P547, DOI 10.1007/s12029-012-9423-0; Sakamoto Y, 2003, JPN J CLIN ONCOL, V33, P364, DOI 10.1093/jjco/hyg063; Wu TJ, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-29	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	FEB	2015	19	2					313	318		10.1007/s11605-014-2699-6		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ7LF	WOS:000348399800014		
J	Nakata, H; Wakayama, T; Takai, Y; Iseki, S				Nakata, Hiroki; Wakayama, Tomohiko; Takai, Yoshimi; Iseki, Shoichi			Quantitative Analysis of the Cellular Composition in Seminiferous Tubules in Normal and Genetically Modified Infertile Mice	JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY			English	Article						spermatogenesis; stage; fluorescence; lectin; immunohistochemistry; cell adhesion molecule	MOUSE; CYCLE; SPERMATOGENESIS; EPITHELIUM; ADHESION; SPERMATOGONIA; EPIDIDYMIS; JUNCTIONS; RENEWAL; BINDING	The aim of this study was to establish a quantitative standard for the cellular composition in seminiferous tubules at each stage of spermatogenesis in the mouse testis, and thereby evaluate abnormalities in the infertile mouse testis. We applied a combination of lectin histochemistry for acrosomes and immunohistochemistry for various specific cell markers, both of which were visualized with fluorescence, on paraffin sections of the testis. We first examined seminiferous tubules from normal mice and counted the number of each cell type at each stage of spermatogenesis. We then examined seminiferous tubules from genetically modified mice deficient (-/-) for one of the cell adhesion molecules, nectin-2 or nectin-3, and compared the number of each cell type at each stage of spermatogenesis with the corresponding value in normal mice. In both nectin-2(-/-) and nectin-3(-/-) mice, which are infertile despite the apparently normal morphology of the seminiferous epithelia, we measured a progressive loss in the later-step spermatids, with significantly lower numbers of step 11-16 spermatids in nectin-3(-/-) mice and step 15-16 spermatids in nectin-2(-/-) mice as compared with that in normal control mice. The present study demonstrated that a quantitative analysis of cellular compositions at different stages in seminiferous tubules was useful for evaluating abnormalities in spermatogenesis.	[Nakata, Hiroki; Wakayama, Tomohiko; Iseki, Shoichi] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa 9208640, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan	Iseki, S (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	siseki@med.kanazawa-u.ac.jp			Ministry of Education, Culture, Science, Sports and Technology of Japan [25460241]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported in part by a Grant-in-Aid for scientific research from the Ministry of Education, Culture, Science, Sports and Technology of Japan to TW (#25460241).	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; De Rooij DG, 2000, J ANDROL, V21, P776; Inagaki M, 2006, GENES CELLS, V11, P1125, DOI 10.1111/j.1365-2443.2006.01006.x; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; LEE MC, 1984, DIFFERENTIATION, V27, P74, DOI 10.1111/j.1432-0436.1984.tb01410.x; ARYA M, 1986, AM J ANAT, V175, P449, DOI 10.1002/aja.1001750405; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Imai T, 2004, MOL CELL ENDOCRINOL, V214, P107, DOI 10.1016/j.mce.2003.10.065; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; Lipshultz L.I., 2009, INFERTILITY MALE; Meistrich Marvin L, 2013, Methods Mol Biol, V927, P299; Muciaccia B, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111682; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Russell L.D., 1990, HISTOLOGICAL HISTOPA	26	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0022-1554	1551-5044		J HISTOCHEM CYTOCHEM	J. Histochem. Cytochem.	FEB	2015	63	2					99	113		10.1369/0022155414562045		15	Cell Biology	Cell Biology	AZ9JP	WOS:000348529900003		
J	Gordon, EA; Bischof, J; Daske, H; Munter, P; Saka, C; Smith, KJ; Venter, ER				Gordon, Elizabeth A.; Bischof, Jannis; Daske, Holger; Munter, Paul; Saka, Chika; Smith, Kimberly J.; Venter, Elmar R.			The IASB's Discussion Paper on the Conceptual Framework for Financial Reporting: A Commentary and Research Review	Journal of International Financial Management & Accounting			English	Review							PRICES FULLY REFLECT; PRO FORMA EARNINGS; SFAS NO. 106; VALUE-RELEVANCE; FAIR-VALUE; COMPREHENSIVE INCOME; CASH FLOWS; FIRM PERFORMANCE; INFORMATION ASYMMETRY; ACCOUNTING EARNINGS	Consistent with the mission of the International Association for Accounting Education and Research (IAAER) to promote global excellence in accounting education and research, and to maximize accounting academics' contribution to the development and maintenance of high-quality, globally recognized standards of accounting practice, this paper provides a commentary and research review by an ad hoc committee of the IAAER on the IASB's Discussion Paper DP/2013/1A Review of the Conceptual Framework for Financial Reporting. The comments focus on four main areas about which prior academic research can inform standard setters in their consideration of the revised Conceptual Framework: (1) recognition and derecognition, (2) measurement, (3) presentation and disclosure, and (4) other comprehensive income. The views expressed here by the ad hoc committee are those of the authors and do not necessarily reflect a consensus view of the IAAER membership or its Executive Committee. The paper supports the IASB's general objective of developing one set of globally acceptable accounting standards based on a cohesive and complete Conceptual Framework.	[Gordon, Elizabeth A.] Temple Univ, Fox Sch Business & Management, Philadelphia, PA 19122 USA; [Bischof, Jannis] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Daske, Holger] Univ Mannheim, D-68161 Mannheim, Germany; [Munter, Paul] KPMG LLP, Dept Profess Practice, New York, NY USA; [Saka, Chika] Kwansei Gakuin Univ, Sch Business Adm, Nishinomiya, Hyogo 6628501, Japan; [Smith, Kimberly J.] Coll William & Mary, Mason Sch Business, Williamsburg, VA 23188 USA; [Venter, Elmar R.] Univ Pretoria, Dept Taxat, ZA-0001 Pretoria, Gauteng, South Africa	Gordon, EA (reprint author), Temple Univ, Fox Sch Business & Management, 1801 Liacouras Walk, Philadelphia, PA 19122 USA.	egordon@temple.edu; jannis.bischof@chicagobooth.edu; daske@bwl.uni-mannheim.de; pmunter@kpmg.com; chika@kwansei.ac.jp; kim.smith@mason.wm.edu; elmar.venter@up.ac.za					Barth ME, 2014, ACCOUNT HORIZ, V28, P331, DOI 10.2308/acch-50689; Basu S, 1997, J ACCOUNT ECON, V24, P3, DOI 10.1016/S0165-4101(97)00014-1; Kanagaretnam K, 2009, J ACCOUNT PUBLIC POL, V28, P349, DOI 10.1016/j.jaccpubpol.2009.06.004; DRTINA RE, 1985, ACCOUNT REV, V60, P314; Fairfield PM, 1996, ACCOUNT REV, V71, P337; Nelson KK, 1996, ACCOUNT REV, V71, P161; Hodder LD, 2006, ACCOUNT REV, V81, P337, DOI 10.2308/accr.2006.81.2.337; Dichev ID, 2008, ACCOUNT HORIZ, V22, P453, DOI 10.2308/acch.2008.22.4.453; Rees LL, 2012, ACCOUNT HORIZ, V26, P789, DOI 10.2308/acch-50237; Francis J, 2004, ACCOUNT REV, V79, P967, DOI 10.2308/accr.2004.79.4.967; Bromwich M, 2010, ABACUS, V46, P348, DOI 10.1111/j.1467-6281.2010.00322.x; Altamuro J, 2013, REV ACCOUNT STUD, V18, P833, DOI 10.1007/s11142-013-9234-y; Barth ME, 2010, EUR ACCOUNT REV, V19, P399, DOI 10.1080/09638180.2010.498619; DECHOW PM, 1994, J ACCOUNT ECON, V18, P3, DOI 10.1016/0165-4101(94)90016-7; Lee YJ, 2006, CONTEMP ACCOUNT RES, V23, P655, DOI 10.1506/5QB8-PBQY-Y86L-DRYL; Huizinga H, 2012, J FINANC ECON, V106, P614, DOI 10.1016/j.jfineco.2012.06.008; Song CJ, 2010, ACCOUNT REV, V85, P1375, DOI 10.2308/accr.2010.85.4.1375; Barth ME, 2001, J ACCOUNT ECON, V31, P77, DOI 10.1016/S0165-4101(01)00019-2; Tarca A, 2008, J INT FIN MANAG ACC, V19, P184, DOI 10.1111/j.1467-646X.2008.01021.x; Jones DA, 2011, ACCOUNT REV, V86, P2047, DOI 10.2308/accr-10133; Healy PM, 2001, J ACCOUNT ECON, V31, P405, DOI 10.1016/S0165-4101(01)00018-0; Chambers D, 2007, REV ACCOUNT STUD, V12, P557, DOI 10.1007/s11142-007-9043-2; Hirshleifer D, 2003, J ACCOUNT ECON, V36, P337, DOI 10.1016/j.jacceco.2003.10.002; Choudhary P, 2011, J ACCOUNT ECON, V51, P77, DOI 10.1016/j.jacceco.2010.09.004; Aboody D, 1999, J ACCOUNT ECON, V26, P149, DOI 10.1016/S0165-4101(98)00040-8; Bradshaw MT, 2002, J ACCOUNTING RES, V40, P41, DOI 10.1111/1475-679X.00038; Ahmed AS, 2006, ACCOUNT REV, V81, P567, DOI 10.2308/accr.2006.81.3.567; Brown LD, 2003, REV ACC STUD, V8, P561, DOI 10.1023/A:1027328418571; Koonce L, 2011, ACCOUNT REV, V86, P2075, DOI 10.2308/accr-10134; Dhaliwal D, 1999, J ACCOUNT ECON, V26, P43, DOI 10.1016/S0165-4101(98)00033-0; Dechow PM, 2006, REV ACCOUNT STUD, V11, P253, DOI 10.1007/s11142-006-9004-1; Dichev ID, 2008, ACCOUNT REV, V83, P1425, DOI 10.2308/accr.2008.83.6.1425; Hunton JE, 2006, ACCOUNT REV, V81, P135, DOI 10.2308/accr.2006.81.1.135; EASTON PD, 1993, J ACCOUNTING RES, V31, P1, DOI 10.2307/2491161; Kothari SP, 2010, J ACCOUNT ECON, V50, P246, DOI 10.1016/j.jacceco.2010.09.003; Barton J, 2010, ACCOUNT REV, V85, P753, DOI 10.2308/accr.2010.85.3.753; Glaum M, 2013, ACCOUNT BUS RES, V43, P163, DOI 10.1080/00014788.2012.711131; Laux C, 2009, ACCOUNT ORG SOC, V34, P826, DOI 10.1016/j.aos.2009.04.003; Collins DW, 1997, J ACCOUNT ECON, V24, P39, DOI 10.1016/S0165-4101(97)00015-3; Bhattacharya N, 2003, J ACCOUNT ECON, V36, P285, DOI 10.1016/j.jacceco.2003.06.001; Bratten B, 2013, ACCOUNT REV, V88, P1179, DOI 10.2308/accr-50421; Blankespoor E, 2013, ACCOUNT REV, V88, P1143, DOI 10.2308/accr-50419; Burgstahler D, 2002, J ACCOUNTING RES, V40, P585, DOI 10.1111/1475-679X.00063; Barth ME, 2003, J ACCOUNTING RES, V41, P581, DOI 10.1111/1475-679X.00117; Bamber LS, 2010, ACCOUNT REV, V85, P97, DOI 10.2308/accr.2010.85.1.97; Yu K, 2013, ACCOUNT REV, V88, P1095, DOI 10.2308/accr-50381; Muller KA, 2002, J ACCOUNTING RES, V40, P865, DOI 10.1111/1475-679X.00074; Davis-Friday PY, 1999, ACCOUNT REV, V74, P403, DOI 10.2308/accr.1999.74.4.403; Austin L. M., 1995, ACCOUNT FINANC, V35, P73; Badertscher BA, 2014, ACCOUNT REV, V89, P811, DOI 10.2308/accr-50685; Barker R., 2004, ACCOUNT HORIZ, V18, P157, DOI 10.2308/acch.2004.18.2.157; Barth M. E., 1998, J ACCOUNT RES, V36, P99; Barth M. E., 1995, ACCOUNT HORIZ, V9, P97; Barth ME, 1996, ACCOUNT REV, V71, P513; Barth ME, 2007, ACCOUNT BUS RES, P7; BARTH ME, 1994, ACCOUNT REV, V69, P1; Bhattacharya N, 2007, ACCOUNT REV, V82, P581, DOI 10.2308/accr.2007.82.3.581; Bischof J., 2014, WORKING PAPER; Bischof J, 2014, J BUS FINAN ACCOUNT, V41, P363, DOI 10.1111/jbfa.12063; Brown P, 2014, J BUS FINAN ACCOUNT, V41, P1, DOI 10.1111/jbfa.12066; Cahan S. F., 2000, J BUSINESS FINANCE A, V27, P1273; Cantrell BW, 2014, ACCOUNT REV, V89, P147, DOI 10.2308/accr-50593; Chen S., 2004, INT J ACCOUNTING, V39, P339, DOI 10.1016/j.intacc.2004.06.012; Cheng CSA, 1996, J ACCOUNTING RES, V34, P173, DOI 10.2307/2491338; Chuk EC, 2013, ACCOUNT REV, V88, P395, DOI 10.2308/accr-50320; Cready W, 2010, ACCOUNT REV, V85, P1577, DOI 10.2308/accr.2010.85.5.1577; Davis-Friday PY, 2004, CONTEMP ACCOUNT RES, V21, P399, DOI 10.1506/T0VC-Q15Y-W5QV-4UKQ; Easton P., 2000, REV ACC STUD, V5, P281, DOI 10.1023/A:1026589405910; Eccher A., 1996, J ACCOUNT ECON, V22, P79; Entwistle G. M., 2010, J ACCOUNTING AUDITIN, V25, P261; Financial Accounting Standards Board (FASB), 2010, CONC FRAM FIN REP; Gassen J, 2010, EUR ACCOUNT REV, V19, P495, DOI 10.1080/09638180.2010.496548; Gebhardt G, 2012, ACCOUNT BUS RES, V42, P267, DOI 10.1080/00014788.2012.681859; Gebhardt G, 2014, ABACUS, V50, P107, DOI 10.1111/abac.12024; Glaum M., 2003, J INT FIN MANAG ACC, V14, P64, DOI 10.1111/1467-646X.00090; Gordon EA, 2001, J ACCOUNTING RES, V39, P177, DOI 10.1111/1475-679X.00008; Hales J, 2013, ACCOUNT HORIZ, V27, P539, DOI 10.2308/acch-50498; Hirst DE, 1998, J ACCOUNTING RES, V36, P47, DOI 10.2307/2491306; Hodder L, 2008, ACCOUNT REV, V83, P915, DOI 10.2308/accr.2008.83.4.915; Huefner R. J., 1989, ACCOUNTING HORIZONS, V3, P66; IASB, 2010, CONC FRAM FIN REP 20; IASB, 2009, IASB FASB M JUL 2009; IASB, 2013, DP20131 IASB; International Accounting Standards Board (IASB), 2008, PREL VIEWS FIN STAT; Khurana I.K., 2003, J ACCOUNTING PUBLIC, V22, P19, DOI 10.1016/S0278-4254(02)00084-4; Kolev K, 2008, ACCOUNT REV, V83, P157, DOI 10.2308/accr.2008.83.1.157; Krishnan G. V., 2000, J BUSINESS FINANCE A, V27, P215, DOI DOI 10.1111/1468-5957.00311; Lambert R, 2010, J ACCOUNT ECON, V50, P287, DOI 10.1016/j.jacceco.2010.09.006; Landsman WR, 2007, ACCOUNT BUS RES, P19; Laux C, 2010, J ECON PERSPECT, V24, P93, DOI 10.1257/jep.24.1.93; Libby R, 2013, ACCOUNT REV, V88, P641, DOI 10.2308/accr-50332; LIPE RC, 1986, J ACCOUNTING RES, V24, P37, DOI 10.2307/2490728; Michels J., 2013, WORKING PAPER; Nikolaev VV, 2010, J ACCOUNT RES, V48, P137, DOI 10.1111/j.1475-679X.2009.00359.x; Ohlson J., 1992, J ACCOUNTING AUDITIN, V4, P553; Ohlson J. A., 1999, REV ACCOUNT STUD, V4, P145; Ohlson JA, 2006, ACCOUNT REV, V81, P271, DOI 10.2308/accr.2006.81.1.271; Parkvall M, 1999, J PIDGIN CREOLE LANG, V14, P347, DOI 10.1075/jpcl.14.2.07par; Schipper K, 2007, ACCOUNT REV, V82, P301, DOI 10.2308/accr.2007.82.2.301; Sloan RG, 1996, ACCOUNT REV, V71, P289; VansCauwenberge P., 2007, ABACUS, V43, P1; Venter E. R., 2013, INT J ACCOUNTING, V48, P26; Venter ER, 2014, ABACUS, V50, P1, DOI 10.1111/abac.12020; Vincent L., 2003, ACCOUNTING HORIZON S, V17, P97, DOI DOI 10.2308/ACCH.2003.17.S-1.97; Watts R., 2003, ACCOUNT HORIZ, V17, P287, DOI DOI 10.2308/ACCH.2003.17.4.287	105	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0954-1314	1467-646X		J INT FIN MANAG ACC	J. Int. Financ. Manag. Account.	FEB	2015	26	1					72	110		10.1111/jifm.12024		39	Business, Finance	Business & Economics	CA2BI	WOS:000348713600003		
J	Lv, SY; Li, J; Feng, W; Liu, HR; Du, J; Sun, J; Cui, J; Sun, B; Han, XC; Oda, K; Amizuka, N; Xu, X; Li, MQ				Lv, Shengyu; Li, Juan; Feng, Wei; Liu, Hongrui; Du, Juan; Sun, Jing; Cui, Jian; Sun, Bao; Han, Xiuchun; Oda, Kimimitsu; Amizuka, Norio; Xu, Xin; Li, Minqi			Expression of HMGB1 in the periodontal tissue subjected to orthodontic force application by Waldo's method in mice	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						HMGB1; Orthodontic tooth movement; Periodontal tissue; Waldo's method	MOBILITY-GROUP BOX-1; NECROSIS-FACTOR-ALPHA; TOOTH MOVEMENT; ROOT RESORPTION; CELLS; RELEASE; OSTEOBLAST; CYTOKINE; RUNX2; DIFFERENTIATION	Recent studies indicate that high mobility group box protein 1 (HMGB1) originating from periodontal ligament (PDL) cells can be a potential regulator in the process of orthodontic tooth movement and periodontal tissue remodeling. The aim of this study is to investigate HMGB1 expression in periodontal tissue during orthodontic tooth movement in mice according to Waldo's method. Six 7-week-old C57BL6 mice were used in these experiments. The elastic band was inserted into the teeth space between the right first and second maxillary molars. After 3 days of mechanical loading, mice were fixed with transcardial perfusion of 4 % paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), and the maxillary was extracted for histochemical analyses. The histological examination revealed local PDL tear at the tension side and the formation of extensive cell-free hyaline zones at the compression side. The immunolocalization of HMGB1 was significantly presented at tension side of PDL, apical area and dental pulp, whereas at the compression side of PDL, the labeling of HMGB1 was almost undetectable as the presence of hyaline zone. Taken together, we concluded that the orthodontic tooth movement by Waldo's method leads to histological changes and HMGB1 expression pattern that differ from those of coil spring method, including PDL tear and extensive hyaline zone which may severely destroy periodontal tissue and in turn impede tooth movement.	[Lv, Shengyu; Li, Juan; Feng, Wei; Liu, Hongrui; Du, Juan; Sun, Jing; Cui, Jian; Sun, Bao; Han, Xiuchun; Xu, Xin; Li, Minqi] Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Jinan 250012, Peoples R China; [Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Biochem, Niigata, Japan; [Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Sapporo, Hokkaido, Japan	Li, MQ (reprint author), Shandong Univ, Sch Stomatol, Dept Bone Metab, Shandong Prov Key Lab Oral Biomed, Wenhua West Rd 44-1, Jinan 250012, Peoples R China.	liminqi@sdu.edu.cn			National Nature Science Foundation of China [81271965, 81470719, 81311140173]; Specialized Research Fund for the Doctoral Program of Higher Education [20120131110073]	This study was partially supported by the National Nature Science Foundation of China (Nos. 81271965; 81470719; 81311140173) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120131110073) to Li M.	Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Dumitriu IE, 2005, J IMMUNOL, V174, P7506; MOSTAFA YA, 1991, AM J ORTHOD DENTOFAC, V99, P30, DOI 10.1016/S0889-5406(05)81677-4; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Feghali K, 2009, ORAL MICROBIOL IMMUN, V24, P292, DOI 10.1111/j.1399-302X.2009.00508.x; Sano Y, 2002, EUR J ORTHODONT, V24, P159, DOI 10.1093/ejo/24.2.159; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Zhang Y, 2011, J BONE MINER RES, V26, P604, DOI 10.1002/jbmr.225; Taspinar F, 2003, J INT MED RES, V31, P197; Lv SY, 2014, J MOL HISTOL, V45, P303, DOI 10.1007/s10735-013-9548-x; Kim YS, 2010, J CELL BIOCHEM, V111, P1310, DOI 10.1002/jcb.22858; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Yang H, 2002, J ENDOTOXIN RES, V8, P469, DOI 10.1179/096805102125001091; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Ong CKL, 2000, ANGLE ORTHOD, V70, P118; Chang HW, 2012, CLIN ORAL INVEST, V16, P679, DOI 10.1007/s00784-011-0552-9; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Zhang XF, 2014, BIOCHEM BIOPH RES CO, V450, P1547, DOI 10.1016/j.bbrc.2014.07.027; Franzen TJ, 2013, EUR J ORTHODONT, V35, P152, DOI 10.1093/ejo/cjr127; Charoonpatrapong K, 2006, J CELL PHYSIOL, V207, P480, DOI 10.1002/jcp.20577; HAMERSKY PA, 1980, AM J ORTHOD DENTOFAC, V77, P368, DOI 10.1016/0002-9416(80)90103-7; Hoeppner LH, 2009, J CELL PHYSIOL, V221, P480, DOI 10.1002/jcp.21879; Kohno T, 2002, J Orthod, V29, P129, DOI 10.1093/ortho/29.2.129; Kurol J, 1998, ANGLE ORTHOD, V68, P161; Morimoto Y, 2008, J PERIODONTAL RES, V43, P76, DOI 10.1111/j.1600-0765.2007.00996.x; Rana MW, 2001, AM J ORTHOD DENTOFAC, V119, P516, DOI 10.1067/mod.2001.113654; Sugars R, 2007, CELL TISSUE RES, V327, P511, DOI 10.1007/s00441-006-0293-2; WALDO CM, 1954, J DENT RES, V33, P481, DOI 10.1177/00220345540330040701; Wolf M, 2014, EUR J ORTHODONT, V36, P624, DOI 10.1093/ejo/cjt037; Yang JP, 2008, J CELL PHYSIOL, V214, P730, DOI 10.1002/jcp.21268; Zhang DL, 2003, J PERIODONTAL RES, V38, P324	32	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	FEB	2015	46	1					107	114		10.1007/s10735-014-9606-z		8	Cell Biology	Cell Biology	AZ7WI	WOS:000348425400010		
J	Uesu, K; Shimizu, K; SenGupta, A				Uesu, Kagumi; Shimizu, Kunio; SenGupta, Ashis			A possibly asymmetric multivariate generalization of the Mobius distribution for directional data	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						Hyperbolic space; Mobius transformation; Spherically symmetric beta distribution; Stereographic projection	SYMMETRIC DISTRIBUTIONS; FAMILY	A family of possibly asymmetric distributions on the unit hyper-disc with center at the origin is proposed. The paper presents a non-trivial multivariate generalization of the Mobius distribution on the unit disc. The family is obtained by applying a conformal mapping to the spherically symmetric beta distribution. The density functions of the family are unimodal, monotonic or uniantimodal. The conditional distribution of direction cosine given the length is a t-distribution on the sphere. The conditional distribution of the length given the direction cosine has a simple closed form expression, though not of any standard known distribution. Modality, skewness and direction parameters are globally orthogonal in the sense that the Fisher information matrix is diagonal. The proposed model on the hyper-disc, introducing this probability distribution for the very first time, is applied to an emerging area of astrophysics for a dataset on gamma-ray bursts and to a challenging area of geoinformatics for a dataset on worldwide earthquakes with magnitude greater than or equal to 7.0 M-W. (C) 2014 Elsevier Inc. All rights reserved.	[Uesu, Kagumi] Univ Tokyo, Tokyo, Japan; [Shimizu, Kunio] Keio Univ, Yokohama, Kanagawa 223, Japan; [SenGupta, Ashis] Indian Stat Inst, Kolkata, India; [SenGupta, Ashis] Univ Calif Riverside, Riverside, CA 92521 USA	Shimizu, K (reprint author), Inst Stat Math, Tokyo, Japan.	uesu@rice.ocn.ne.jp; k-shmz@ism.ac.jp; amsseng@gmail.com					Abramowitz M., 1972, HDB MATH FUNCTIONS F; Amari S., 1985, LECT NOTES STAT, V28; Shimizu K, 2002, COMMUN STAT-THEOR M, V31, P513, DOI 10.1081/STA-120003131; Shieh GS, 2011, BIOINFORMATICS, V27, P912, DOI 10.1093/bioinformatics/btr049; Dortet-Bernadet JL, 2008, BIOSTATISTICS, V9, P66, DOI 10.1093/biostatistics/kxm012; Shieh GS, 2005, ANN I STAT MATH, V57, P789, DOI 10.1007/BF02915439; Fang K.T., 1990, SYMMETRIC MULTIVARIA; Gradshteyn I S, 2007, TABLE INTEGRALS SERI; Huckemann SF, 2010, ANN STAT, V38, P2465, DOI 10.1214/09-AOS783; Jammalamadaka S. R., 2001, TOPICS CIRCULAR STAT; Johnson N. L., 1995, CONTINUOUS UNIVARIAT, V2; Jones MC, 2005, J AM STAT ASSOC, V100, P1422, DOI 10.1198/016214505000000286; Jones MC, 2002, J MULTIVARIATE ANAL, V81, P85, DOI 10.1006/jmva.2001.1993; Jones MC, 2004, ANN I STAT MATH, V56, P733, DOI 10.1007/BF02506486; Kato S, 2009, BERNOULLI, V15, P898, DOI 10.3150/08-BEJ178; KUMARASWAMY P, 1980, J HYDROL, V46, P79, DOI 10.1016/0022-1694(80)90036-0; Mardia K. V., 2000, DIRECTIONAL STAT; MCCULLAGH P, 1989, J AM STAT ASSOC, V84, P125, DOI 10.2307/2289855; MCDONALD JB, 1984, ECONOMETRICA, V52, P647, DOI 10.2307/1913469; Minh D. L. P., 2003, COMMUNICATIONS STAT, V32, P1, DOI 10.1081/STA-120017796; Ratcliffe J.G., 2006, FDN HYPERBOLIC MANIF; SenGupta A., 2014, ENV ECOL STAT; SenGupta A., 2004, B CALCUTTA MATH SOC, V96, P139; SenGupta A., 2010, LECT NOTE IMS; SenGupta A, 2013, J MULTIVARIATE ANAL, V119, P200, DOI 10.1016/j.jmva.2013.04.011; Sengupta A, 2011, COMMUN STAT-THEOR M, V40, P457, DOI 10.1080/03610920903377807; SESHADRI V, 1991, STAT PROBABIL LETT, V12, P373, DOI 10.1016/0167-7152(91)90025-M; Terras A., 1985, HARMONIC ANAL SYMMET, V1; Watson G. S., 1983, STAT SPHERES	29	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	FEB	2015	134						146	162		10.1016/j.jmva.2014.11.004		17	Statistics & Probability	Mathematics	AZ8TF	WOS:000348486700011		
J	Kawasoe, T; Takeshima, H; Yamashita, S; Mizuguchi, S; Fukushima, T; Yokogami, K; Yamasaki, K				Kawasoe, Takuma; Takeshima, Hideo; Yamashita, Shinji; Mizuguchi, Sohei; Fukushima, Tsuyoshi; Yokogami, Kiyotaka; Yamasaki, Kouji			Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme	JOURNAL OF NEUROSURGERY			English	Article						glioblastoma; mesenchymal transition; p53; microvascular proliferation; laser microdissection; oncology	NEWLY-DIAGNOSED GLIOBLASTOMA; STEM-LIKE CELLS; ANTIANGIOGENIC THERAPY; BRAIN-TUMORS; ANGIOGENESIS; BEVACIZUMAB; METASTASIS; GLIOMAS; IDH1	OBJECT Glioblastoma multiforme (GBM), one of the most aggressive tumors in humans, is highly angiogenic. However, treatment with the angiogenesis inhibitor bevacizumab has not significaritly prolonged overall patient survival times. GBM resistance to angiogenesis inhibitors is attributed to multiple interacting mechanisms. Although mesenchymal transition via glioma stem-like cells has attracted attention, it is considered a poor biomarker. There is no simple method for differentiating tumor-derived and reactive vascular cells from normal cells. The authors attempted to detect the mesenchymal transition of tumor cells by means of p53 and isocitrate dehydrogenase 1 (IDH1) immunohistochemistry. METHODS Using antibody against p53 and IDH1 R132H, the authors immunohistochemically analyzed GBM tissue from patients who had undergone surgery at the University of Miyazaki Hospital during August 2005 December 2011. They focused on microvascular proliferation with a p53-positive ratio exceeding 50%. They compared TP53 mutations in original tumor tissues and in p53-positive and p53-negative microvascular proliferation cells collected by laser microdissection. RESULTS Among 61 enrolled GBM patients, the first screening step (immunostaining) identified 46 GBMs as p53 positive, 3 of which manifested areas of prominent p53-positive microvascular proliferation (> 50%). Histologically, areas of p53-positive microvascular proliferation tended to be clustered, and they coexisted with areas of p53-negative microvascular proliferation. Both types of microvascular proliferation cells were clearly separated from original tumor cells by glial fibrillary acidic protein, epidermal growth factor receptor, and low-/high-molecular-weight cytokeratin. DNA sequencing analysis disclosed that p53-positive microvascular proliferation cells exhibited TP53 mutations identical to those observed in the original tumor; p53-negative microvascular proliferation cells contained a normal allele. Although immunostaining indicated that 3 (2 primary and 1 secondary) of the 61 GBMs were positive for IDH1, no tumors contained microvascular proliferation cells positive for IDH1 R132H. CONCLUSIONS Some microvascular proliferation clusters in GBM result from mesenchymal transition. The identification of useful markers might reveal this phenomenon as an infrequent event in GBMs.	[Kawasoe, Takuma; Takeshima, Hideo; Yamashita, Shinji; Mizuguchi, Sohei; Yokogami, Kiyotaka; Yamasaki, Kouji] Miyazaki Univ, Fac Med, Div Clin Neurosci, Dept Neurosurg, Kiyotake, Miyazaki 8891692, Japan; [Fukushima, Tsuyoshi] Miyazaki Univ, Fac Med, Div Pathol, Dept Oncopathol & Regenerat Biol, Kiyotake, Miyazaki 8891692, Japan	Kawasoe, T (reprint author), Miyazaki Univ, Fac Med, Div Clin Neurosci, Dept Neurosurg, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	tkawasoe@email.jp					Gerstner ER, 2012, CANCER J, V18, P45, DOI 10.1097/PPO.0b013e3182431c6f; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Kulla A, 2003, ACTA NEUROPATHOL, V105, P328, DOI 10.1007/s00401-003-0681-6; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Schutze K, 1998, NAT BIOTECHNOL, V16, P737, DOI 10.1038/nbt0898-737; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Machein MR, 2000, J NEURO-ONCOL, V50, P109, DOI 10.1023/A:1006416003964; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Brat DJ, 2001, AM J PATHOL, V158, P789, DOI 10.1016/S0002-9440(10)64025-4; de Groot JF, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0380-6; Levidou G, 2010, J NEUROONCOL, V100, P373; Levidou G, 2010, J NEURO-ONCOL, V100, P363, DOI 10.1007/s11060-010-0204-y; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Zariwala M, 1994, INT J CANCER, V56, P807	27	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2015	122	2					317	323		10.3171/2014.10.JNS132159		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AZ7OQ	WOS:000348408400012		
J	Morisako, H; Goto, T; Ohata, K				Morisako, Hiroki; Goto, Takeo; Ohata, Kenji			Petroclival meningiomas resected via a combined transpetrosal approach: surgical outcomes in 60 cases and a new scoring system for clinical evaluation	JOURNAL OF NEUROSURGERY			English	Article						petroclival meningioma; combined transpetrosal approach; surgical management; outcome; new scoring system; skull base	PETROUS APICECTOMY APPROACH; GAMMA-KNIFE RADIOSURGERY; SKULL BASE MENINGIOMA; TRANSCOCHLEAR APPROACH; FOLLOW-UP; EXPERIENCE; MANAGEMENT; LESIONS; SURGERY; CLIVUS	OBJECT Petroclival meningiomas are among the most challenging intracranial tumors to treat surgically. Many skull base approaches have been described to improve resection and decrease patient morbidity. The authors undertook this study to evaluate the results of their treatment of petroclival meningiomas using objective measurements of tumor volume and a new impairment scoring system to assess neurological symptoms that severely affect the patient's quality of life, such as impairment of swallowing and speaking, motor function, and consciousness and communication. METHODS Between January 1990 and December 2009, the authors used a combined transpetrosal approach to treat 60 patients with benign (WHO Grade I) petroclival meningiomas. In this retrospective study, all 60 cases were analyzed in detail with regard to tumor volume, extent of resection (EOR), long-term tumor control, neurological outcome, and the patient condition. In addition, patients were divided into 2 groups according to the period during which the surgery was performed: the early group, from 1990 to 1999, and the late group, from 2000 to 2009. A new scoring system, the petroclival meningioma impairment scale (PCMIS), was created for quantitative assessment of 8 categories of neurological functions, with scores assigned in each category according to the level of disability and its impact on the patient. The PCMIS was used preoperatively, at 3 months after surgery, and at the time of the last follow-up examination, and the, results for the 2 groups were compared. RESULTS There were 24 cases in the early group (1990-1999), and the mean duration of follow-up was 149.3 months. The mean EOR was 96.1%, and good long-term tumor control was obtained in 22 patients (91.7%). One of patients died because of a postoperative complication in the perioperative period. The PCMIS improved in 3 patients (12.5%), remained stable in 1 (4.2%), and worsened in 20 (83.3%). There were 36 cases in the late group (2000-2009), and the mean duration of follow-up was 77.9 months. The mean EOR was 92.7%, and good long-term tumor control was obtained in 34 patients (94.4%). the PCMIS score improved in 23 patients (63.9%), remained stable in 5 (13.9%), and worsened in 8 (22.2%). CONCLUSIONS The combined transpetrosal approach has provided satisfactory functional improvements and excellent tumor controlfor patients with petroclival meningiomas. The PCMIS provides a specific tool for quantitative assessment of the patient's state.	[Morisako, Hiroki; Goto, Takeo; Ohata, Kenji] Osaka City Univ, Grad Sch Med, Dept Neurosurg, Osaka 5458585, Japan	Morisako, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Neurosurg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	hmorisako@med.osaka-cu.ac.jp					Mathiesen T, 2007, NEUROSURGERY, V60, P982, DOI 10.1227/01.NEU.0000255476.06247.F1; HAKUBA A, 1988, SURG NEUROL, V30, P108, DOI 10.1016/0090-3019(88)90095-X; Kollova A, 2007, J NEUROSURG, V107, P325, DOI 10.3171/JNS-07/08/0325; ALMEFTY O, 1988, NEUROSURGERY, V22, P510; Subach BR, 1998, NEUROSURGERY, V42, P437, DOI 10.1097/00006123-199803000-00001; Natarajan SK, 2007, NEUROSURGERY, V60, P965, DOI 10.1227/01.NEU.0000255472.52882.D6; Little KM, 2005, NEUROSURGERY, V56, P546, DOI 10.1227/01.NEU.0000153906.12640.62; Roche PH, 2003, ACTA NEUROCHIR, V145, P883, DOI 10.1007/s00701-003-0123-1; Almefty R, 2014, J NEUROSURG, V120, P40, DOI 10.3171/2013.8.JNS13535; Ichinose T, 2010, J NEUROSURG, V113, P1072, DOI 10.3171/2010.2.JNS091118; SPETZLER RF, 1992, J NEUROSURG, V76, P588, DOI 10.3171/jns.1992.76.4.0588; Bambakidis NC, 2008, NEUROSURGERY, V62, P1182, DOI [10.1227/01.neu.0000333784.04435.65, 10.1227/01.NEU.0000280119.36270.BA]; HOUSE WF, 1976, ARCH OTOLARYNGOL, V102, P334; BRICOLO AP, 1992, NEUROSURGERY, V31, P813; GOEL A, 1995, ACTA NEUROCHIR, V135, P78, DOI 10.1007/BF02307418; Couldwell WT, 1996, J NEUROSURG, V84, P20, DOI 10.3171/jns.1996.84.1.0020; Flannery TJ, 2010, J NEUROSURG, V112, P957, DOI 10.3171/2009.8.JNS09695; Kondziolka D, 2008, NEUROSURGERY, V62, P53, DOI [10.1227/01.NEU.0000311061.72626.0D, 10.1227/01.NEU.0000296986.77158.4C]; Jung HW, 2000, NEUROSURGERY, V46, P567, DOI 10.1097/00006123-200003000-00008; Iwai Y, 2008, J NEUROSURG, V109, P804, DOI 10.3171/JNS/2008/109/11/0804; SEKHAR LN, 1990, NEUROSURGERY, V27, P764; SAMII M, 1989, NEUROSURGERY, V24, P12; GARDNER G, 1988, ANN OTO RHINOL LARYN, V97, P55; KAWASE T, 1994, ACTA NEUROCHIR, V129, P113, DOI 10.1007/BF01406489; Chanda A, 2002, NEUROSURGERY, V51, P147, DOI 10.1227/01.NEU.0000017464.15355.C9; Cho CW, 2002, NEUROSURGERY, V51, P708, DOI 10.1227/01.NEU.0000023603.90705.6B; Gudjonsson O, 2001, ACTA U UPSALIENSIS C, V1041, P27; House WF, 1985, OTOLARYNGOL HEAD NEC, V93, P184; Park CK, 2006, SURG NEUROL, V66, P160, DOI 10.1016/j.surneu.2005.12.024; Quiniones-Hinojosa A, 2006, NEUROSURGERY, V58, P208, DOI 10.1227/01.NEU.0000192714.15356.08; SANNA M, 1994, J LARYNGOL OTOL, V108, P1036; SEKHAR LN, 1994, J NEUROSURG, V81, P860, DOI 10.3171/jns.1994.81.6.0860; Sekhar LN, 1999, NEUROSURGERY, V44, P537, DOI 10.1097/00006123-199903000-00060; Van Havenbergh T, 2003, NEUROSURGERY, V52, P55, DOI 10.1227/01.NEU.0000038932.18712.EE; Zachenhofer I, 2006, NEUROSURGERY, V58, P28, DOI 10.1227/01.NEU.0000190654.82265.A3	35	2	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2015	122	2					373	380		10.3171/2014.8.JNS132406		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AZ7OQ	WOS:000348408400018		
J	Funaki, T; Takahashi, JC; Takagi, Y; Kikuchi, T; Yoshida, K; Mitsuhara, T; Kataoka, H; Okada, T; Fushimi, Y; Miyamoto, S				Funaki, Takeshi; Takahashi, Jun C.; Takagi, Yasushi; Kikuchi, Takayuki; Yoshida, Kazumichi; Mitsuhara, Takafumi; Kataoka, Hiroharu; Okada, Tomohisa; Fushimi, Yasutaka; Miyamoto, Susumu			Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications	JOURNAL OF NEUROSURGERY			English	Article						moyamoya disease; rapid progression; cerebral revascularization; intraoperative complication; vascular disorders	SURGICAL-TREATMENT; PROGRESSION; REVASCULARIZATION; HYPERPERFUSION; INVOLVEMENT; OUTCOMES; ANGINA	OBJECT Unstable moyamoya disease, reasonably defined as cases exhibiting either rapid disease progression or repeated ischemic stroke, represents a challenge in the treatment of moyamoya disease. Despite its overall efficacy, direct bypass for such unstable disease remains controversial in terms of safety. This study aims to reveal factors associated with unstable disease and to assess its impact on postoperative silent or symptomatic ischemic lesions. METHODS This retrospective cohort study included both pediatric and adult patients with moyamoya disease who had undergone 140 consecutive direct bypass procedures at Kyoto University Hospital. "Unstable moyamoya disease" was defined as either the rapid progression of a steno-occlusive lesion or repeat ischemic stroke, either occurring within 6 months of surgery. The extent of progression was determined through a comparison of the findings between 2 different MR angiography sessions performed before surgery. The clinical variables of the stable and unstable disease groups. were compared, and the association between unstable disease and postoperative diffusion-weighted imaging (DWI) detected lesion was assessed through univariate and multivariate analyses with generalized estimating equations. RESULTS Of 134 direct bypass procedures performed after patients had undergone at least 2 sessions of MR angiography, 24 (17.9%) were classified as cases of unstable disease. Age younger than 3 years (p = 0.029), underlying disease causing moyamoya syndrome (p = 0.049), and radiographic evidence of infarction (p = 0.030) were identified as factors associated with unstable disease. Postoperative DWI-defined lesions were detected after 13 of 140 procedures (9.3%), although only 4 lesions (2.9%) could be classified as a permanent complication. The incidence of postoperative DWI-detected lesions in the unstable group was notable at 33.3% (8 of 24). Univariate analysis revealed that unstable disease (p < 0.001), underlying disease (p = 0.028), and recent stroke (p = 0.012) were factors associated with DWI-detected lesions. Unstable disease remained statistically significant after adjustment for covariates in both the primary and sensitivity analyses (primary analysis: OR 6.62 [95% CI 1.79-24.5]; sensitivity analysis: OR 5.36 [95% CI 1.47-19.6]). CONCLUSIONS Unstable moyamoya disease, more prevalent in younger patients and those with underlying disease, is a possible risk factor for perioperative ischemic complications. Recognition of unstable moyamoya disease may contribute to an improved surgical result through focused perioperative management based on appropriate surgical risk stratification.	[Funaki, Takeshi; Takahashi, Jun C.; Takagi, Yasushi; Kikuchi, Takayuki; Yoshida, Kazumichi; Mitsuhara, Takafumi; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Okada, Tomohisa; Fushimi, Yasutaka] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Kataoka, Hiroharu] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Osaka, Japan	Funaki, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	tfunaki@kuhp.kyoto-u.ac.jp					Kim SK, 2004, NEUROSURGERY, V54, P840, DOI 10.1227/01.NEU.0000114140.41509.14; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; Guzman R, 2009, J NEUROSURG, V111, P927, DOI 10.3171/2009.4.JNS081649; Yeon JY, 2011, STROKE, V42, P2973, DOI 10.1161/STROKEAHA.111.622522; Fujimura M, 2012, CEREBROVASC DIS, V33, P436, DOI 10.1159/000336765; Kim TW, 2011, J KOREAN NEUROSURG S, V49, P65, DOI 10.3340/jkns.2011.49.1.65; [Anonymous], 2012, NEUROL MED CHIR TOKY, V52, P245; Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99; Kelly ME, 2006, CEREBROVASC DIS, V22, P109, DOI 10.1159/000093238; Austen W G, 1975, Circulation, V51, P5; Diggle P. J., 2002, ANAL LONGITUDINAL DA; Fujiwara F, 1997, NEUROL SURG TOKYO, V25, P79; Funaki T, 2013, J NEUROSURG-PEDIATR, V12, P626, DOI 10.3171/2013.9.PEDS13111; Hayashi T, 2010, J NEUROSURG-PEDIATR, V6, P73, DOI 10.3171/2010.4.PEDS09478; Hyun SJ, 2010, ACTA NEUROCHIR, V152, P1181, DOI 10.1007/s00701-010-0638-1; Ishikawa T, 1997, STROKE, V28, P1170; Jung YJ, 2011, J KOREAN NEUROSURG S, V50, P492, DOI 10.3340/jkns.2011.50.6.492; KARASAWA J, 1977, Neurologia Medico-Chirurgica, V17, P29, DOI 10.2176/nmc.17pt1.29; KARASAWA J, 1978, J NEUROSURG, V49, P679, DOI 10.3171/jns.1978.49.5.0679; Khan N, 2012, NEUROSURGERY, V71, P587, DOI 10.1227/NEU.0b013e3182600b3c; Kim SH, 2005, J NEUROSURG, V103, P433; Lee SC, 2014, ACTA NEUROCHIR, V156, P103, DOI 10.1007/s00701-013-1921-8; Lin N, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.10.FOCUS11228; Mallory GW, 2013, NEUROSURGERY, V73, P984, DOI 10.1227/NEU.0000000000000162; MOISE A, 1983, NEW ENGL J MED, V309, P685, DOI 10.1056/NEJM198309223091201; Sato K, 1997, CHILD NERV SYST, V13, P68, DOI 10.1007/s003810050044; Smith ER, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/2/E17; Yeghiazarians Y, 2000, NEW ENGL J MED, V342, P101, DOI 10.1056/NEJM200001133420207	28	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2015	122	2					400	407		10.3171/2014.10.JNS14231		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AZ7OQ	WOS:000348408400023		
J	Matsumae, M				Matsumae, Mitsunori			Regarding Bering's hypothesis on choroid plexus pulsatility Response	JOURNAL OF NEUROSURGERY			English	Letter							CEREBROSPINAL FLUID		Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan	Matsumae, M (reprint author), Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan.						BERING EA, 1955, ARCH NEURO PSYCHIATR, V73, P165; BERING EA, 1962, J NEUROSURG, V19, P405, DOI 10.3171/jns.1962.19.5.0405; Dandy WE, 1919, ANN SURG, V70, P129, DOI 10.1097/00000658-191908000-00001	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2015	122	2					480	481		10.3171/2014.6.JNS141331		2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AZ7OQ	WOS:000348408400042		
J	Wang, HY; Guo, XY; Liu, Z; Gao, HW				Wang Haiyan; Guo Xinyu; Liu Zhe; Gao Huiwang			A comparative study of CART and PTM for modelling water age	JOURNAL OF OCEAN UNIVERSITY OF CHINA			English	Article						CART; PTM; pseudo displacement; water age	TRANSPORT TIME SCALES; RESIDENCE TIME; ESTUARY	CART (Constituent-oriented age and residence time theory) and PTM (Particle-tracking method) are two widely used numerical methods to calculate water age. These two methods are essentially equivalent in theory but their results may be different in practice. The difference of the two methods was evaluated by applying them to calculate water age in an idealized one-dimensional domain. The model results by the two methods are consistent with each other in the case with either spatially uniform flow field or spatially uniform diffusion coefficient. If we allow the spatial variation in horizontal diffusion, a term called pseudo displacement arising from the spatial variation of diffusion coefficient likely plays an important role for the PTM to obtain accurate water age. In particular, if the water particle is released at a place where the diffusion is not the weakest, the water age calculated by the PTM without pseudo displacement is much larger than that by the CART. This suggests that the pseudo displacement cannot be neglected in the PTM to calculate water age in a realistic ocean. As an example, we present its potential importance in the Bohai Sea where the diffusion coefficient varies spatially and greatly.	[Wang Haiyan; Liu Zhe; Gao Huiwang] Ocean Univ China, Key Lab Marine Environm & Ecol, Minist Educ, Qingdao 266100, Peoples R China; [Guo Xinyu] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan	Liu, Z (reprint author), Ocean Univ China, Key Lab Marine Environm & Ecol, Minist Educ, Qingdao 266100, Peoples R China.	zliu@ouc.edu.cn		Liu, Zhe/0000-0001-6782-8249	National Natural Science Foundation of China [41176007, 40706007]; China Scholarship Council (CSC)	This work was funded by the National Natural Science Foundation of China (Nos. 41176007 and 40706007). It was carried out while H. Wang was visiting the Center for Marine Environmental Studies at Ehime University, Japan. She thanks the China Scholarship Council (CSC) for supporting her stay in Japan.	de Brye B, 2013, J MARINE SYST, V128, P3, DOI 10.1016/j.jmarsys.2012.03.002; Wang Y, 2010, J MARINE SYST, V82, P154, DOI 10.1016/j.jmarsys.2010.04.012; Monsen NE, 2002, LIMNOL OCEANOGR, V47, P1545; Deleersnijder E, 2001, J MARINE SYST, V28, P229, DOI 10.1016/S0924-7963(01)00026-4; BOLIN B, 1973, TELLUS, V25, P58; Liu WC, 2011, COMPUT GEOSCI-UK, V37, P1148, DOI 10.1016/j.cageo.2010.07.007; Visser AW, 1997, MAR ECOL PROG SER, V158, P275, DOI 10.3354/meps158275; TAKEOKA H, 1984, CONT SHELF RES, V3, P311, DOI 10.1016/0278-4343(84)90014-1; Blumberg A. F., 2002, PRIMER ECOMSED USER, P29; Chen XJ, 2007, ESTUAR COAST SHELF S, V75, P358, DOI 10.1016/j.ecss.2007.04.020; Delhez EJM, 2004, ESTUAR COAST SHELF S, V61, P691, DOI 10.1016/j.ecss.2004.07.013; Hilton ABC, 1998, J WATERW PORT C-ASCE, V124, P82, DOI 10.1061/(ASCE)0733-950X(1998)124:2(82); Liu Z, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008263; Wang Q, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004555; Zhang X. Y., 1995, THESIS MIT CAMBRIDGE, P84; Zimmerman J. T. F., 1976, NETHERLANDS J SEA RE, V10, P149, DOI DOI 10.1016/0077-7579(76)90013-2	16	0	0	OCEAN UNIV CHINA	QINGDAO	5 YUSHAN RD, QINGDAO, 266003, PEOPLES R CHINA	1672-5182	1993-5021		J OCEAN U CHINA	J. OCEAN UNIV.	FEB	2015	14	1					47	58		10.1007/s11802-015-2393-7		12	Oceanography	Oceanography	AZ6RE	WOS:000348345700006		
J	Maeda, H				Maeda, Hayato			Nutraceutical Effects of Fucoxanthin for Obesity and Diabetes Therapy: A Review	Journal of Oleo Science			English	Review						fucoxanthin; obesity; diabetes; carotenoid; UCP1 (uncoupling protein 1)	DIABETIC/OBESE KK-A(Y) MICE; BROWN-ALGAE FUCOXANTHIN; WHITE ADIPOSE-TISSUE; UNCOUPLING PROTEINS; CANCER CELLS; EXPRESSION; ANTIOBESITY; WEIGHT; LIVER; FAT	Obesity, which results from an imbalance between energy intake and energy expenditure, has become a major health risk factor worldwide, causing numerous and various diseases such as diabetes, hypertension, and cardiovascular diseases. Fucoxanthin, a specific carotenoid in brown algae, has garnered much attention for its anti-obesity and anti-diabetic effects attributable to a unique mechanism. Fucoxanthin induces uncoupling protein 1 (UCP1) expression in white adipose tissue (WAT). That inner membrane mitochondrial protein, UCP1, can dissipate energy through oxidation of fatty acids and heat production. Furthermore, fucoxanthin improves insulin resistance and ameliorates blood glucose levels through down-regulation of adipocytokines related to insulin resistance in WAT and up-regulation of glucose transporter 4 (GLUT4) in skeletal muscle. Algae fucoxanthin is a beneficial compound for the prevention of the metabolic syndrome.	Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan	Maeda, H (reprint author), Hirosaki Univ, Fac Agr & Life Sci, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	hayatosp@cc.hirosaki-u.ac.jp	Maeda, Hayato/E-8335-2013	Maeda, Hayato/0000-0002-8546-6250			O'Neill ME, 2001, BRIT J NUTR, V85, P499, DOI 10.1079/BJN2000284; Kotake-Nara E, 2005, CANCER LETT, V220, P75, DOI 10.1016/j.canlet.2004.07.048; Woo MN, 2009, MOL NUTR FOOD RES, V53, P1603, DOI 10.1002/mnfr.200900079; Asai A, 2008, BRIT J NUTR, V100, P273, DOI 10.1017/S0007114507895468; Maeda H, 2009, MOL MED REP, V2, P897, DOI 10.3892/mmr_00000189; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; Beppu F, 2009, J TOXICOL SCI, V34, P501; Yim MJ, 2011, J AGR FOOD CHEM, V59, P1646, DOI 10.1021/jf103290f; Sachindra NM, 2007, J AGR FOOD CHEM, V55, P8516, DOI 10.1021/jf071848a; Sugawara T, 2006, J AGR FOOD CHEM, V54, P9805, DOI 10.1021/jf062204q; Sugawara T, 2002, J NUTR, V132, P946; Maeda H, 2007, J AGR FOOD CHEM, V55, P7701, DOI 10.1021/jf071569n; Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x; Okada T, 2011, J FOOD SCI, V76, pH2, DOI 10.1111/j.1750-3841.2010.01878.x; Ricquier D, 2000, J PHYSIOL-LONDON, V529, P3, DOI 10.1111/j.1469-7793.2000.00003.x; Hosokawa M, 2004, BBA-GEN SUBJECTS, V1675, P113, DOI 10.1016/j.bbagen.2004.08.012; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Kim KN, 2010, EUR J PHARMACOL, V649, P369, DOI 10.1016/j.ejphar.2010.09.032; Matsuno T, 2001, FISHERIES SCI, V67, P771, DOI 10.1046/j.1444-2906.2001.00323.x; Tsukui T, 2007, J AGR FOOD CHEM, V55, P5025, DOI 10.1021/jf070110q; Hosokawa M, 2010, ARCH BIOCHEM BIOPHYS, V504, P17, DOI 10.1016/j.abb.2010.05.031; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Maeda H, 2006, INT J MOL MED, V18, P147; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; Beppu F, 2009, J TOXICOL SCI, V34, P693; Das SK, 2010, J AGR FOOD CHEM, V58, P6090, DOI 10.1021/jf100303k; Drevon CA, 2005, BBA-MOL BASIS DIS, V1740, P287, DOI 10.1016/j.bbadis.2004.11.019; Harris WS, 2006, CURR OPIN LIPIDOL, V17, P387, DOI 10.1097/01.mol.0000236363.63840.16; Hashimoto T, 2009, BRIT J NUTR, V102, P242, DOI 10.1017/S0007114508199007; KAHN BB, 1993, ENDOCRINOLOGY, V132, P13, DOI 10.1210/en.132.1.13; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Maeda Hayato, 2007, J Oleo Sci, V56, P615; Maeda H., 2013, ISRN INFLAMMATION, V2013, DOI 10.1155/2013/76375824049664; Nishikawa S, 2012, PHYTOMEDICINE, V19, P389, DOI 10.1016/j.phymed.2011.11.001; Okada T, 2008, J OLEO SCI, V57, P345, DOI 10.5650/jos.57.345; Olefsky J M, 1985, Adv Exp Med Biol, V189, P176	37	2	2	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	FEB	2015	64	2					125	132		10.5650/jos.ess14226		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CA1SM	WOS:000348691800001		
J	Morita, T; Fukuoka, T; Imura, T; Kitamoto, D				Morita, Tomotake; Fukuoka, Tokuma; Imura, Tomohiro; Kitamoto, Dai			Mannosylerythritol Lipids: Production and Applications	Journal of Oleo Science			English	Review						glycolipid; biosurfactant; mannosylerythritol lipid; yeast; sugarcane; cosmetics	PARANTARCTICA JCM 11752(T); SURFACE-ACTIVE PROPERTIES; SCITAMINEA NBRC 32730; CELL LINE HL60; GLYCOLIPID BIOSURFACTANTS; CANDIDA-ANTARCTICA; PSEUDOZYMA-APHIDIS; HUMAN SKIN; INTERFACIAL PROPERTIES; BASIDIOMYCETOUS YEAST	Mannosylerythritol lipids (MELs) are a glycolipid class of biosurfactants produced by a variety yeast and fungal strains that exhibit excellent interfacial and biochemical properties. MEL-producing fungi were identified using an efficient screening method for the glycolipid production and taxonomical classification on the basis of ribosomal RNA sequences. MEL production is limited primarily to the genus Pseudozyma, with significant variability among the MEL structures produced by each species. Outside of Pseudozyma, one recently isolated strain, Ustilago scitaminea, has been shown to exhibit abundant MEL-B production from sugarcane juice. Structural analyses of these compounds suggest a role for MELs in numerous cosmetic applications. MELs act as effective topical moisturizers and can repair damaged hair. Furthermore, these compounds have been shown to exhibit both protective and healing activities, to activate fibroblasts and papilla cells, and to act as natural antioxidants. In this review, we provide a brief summary of MEL research over the past few decades, focusing on the identification of MEL-producing fungi, the structural characterization of MELs, the use of alternative compounds as a primary carbon source, and the use of these compounds in cosmetic applications.	[Morita, Tomotake; Fukuoka, Tokuma; Imura, Tomohiro; Kitamoto, Dai] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan	Morita, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba Cent 5-2,Higashi 1-1-1, Tsukuba, Ibaraki 3058565, Japan.	morita-tomotake@aist.go.jp					Morita T, 2011, J BIOSCI BIOENG, V112, P137, DOI 10.1016/j.jbiosc.2011.04.008; Fukuoka T, 2008, CARBOHYD RES, V343, P555, DOI 10.1016/j.carres.2007.11.023; Morita T, 2007, APPL MICROBIOL BIOT, V74, P307, DOI 10.1007/s00253-006-0672-3; Morita T, 2011, BIOSCI BIOTECH BIOCH, V75, P1371, DOI 10.1271/bbb.110221; Kitamoto D, 2001, BIOTECHNOL LETT, V23, P1709, DOI 10.1023/A:1012464717259; Zhao XX, 1999, CANCER RES, V59, P482; Morita T, 2009, APPL MICROBIOL BIOT, V83, P1017, DOI 10.1007/s00253-009-1945-4; Isoda H, 1997, BIOSCI BIOTECH BIOCH, V61, P609; Morita T, 2010, J OLEO SCI, V59, P267, DOI 10.5650/jos.59.267; Morita T, 2009, J OLEO SCI, V58, P639, DOI 10.5650/jos.58.639; Yamamoto S, 2012, J OLEO SCI, V61, P407, DOI 10.5650/jos.61.407; Fukuoka T, 2007, APPL MICROBIOL BIOT, V76, P801, DOI 10.1007/s00253-007-1051-4; Morita T, 2012, APPL MICROBIOL BIOT, V96, P931, DOI 10.1007/s00253-012-4230-x; Morita T, 2006, APPL MICROBIOL BIOT, V73, P305, DOI 10.1007/s00253-006-0466-7; Fukuoka T, 2007, BIOTECHNOL LETT, V29, P1111, DOI 10.1007/s10529-007-9363-0; KITAMOTO D, 1993, J BIOTECHNOL, V29, P91, DOI 10.1016/0168-1656(93)90042-L; Fukuoka T, 2011, CARBOHYD RES, V346, P266, DOI 10.1016/j.carres.2010.11.025; Fukuoka Tokuma, 2007, J Oleo Sci, V56, P435; Fukuoka T, 2008, CARBOHYD RES, V343, P2947, DOI 10.1016/j.carres.2008.08.034; IMOKAWA G, 1989, ARCH DERMATOL RES, V281, P45, DOI 10.1007/BF00424272; Inoh Y, 2010, INT J PHARMACEUT, V398, P225, DOI 10.1016/j.ijpharm.2010.07.042; Isoda H, 1997, LIPIDS, V32, P263, DOI 10.1007/s11745-997-0033-0; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P37; KITAMOTO D, 1992, BIOTECHNOL LETT, V14, P305, DOI 10.1007/BF01022329; Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187; Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009; Konishi M, 2008, APPL MICROBIOL BIOT, V78, P37, DOI 10.1007/s00253-007-1292-2; Konishi M, 2014, BIOSCI BIOTECH BIOCH, V78, P516, DOI 10.1080/09168451.2014.882754; LEVEQUE JL, 1993, SKIN PHARMACOL, V6, P111; Morita T, 2010, APPL MICROBIOL BIOT, V88, P679, DOI 10.1007/s00253-010-2762-5; Morita T, 2008, J BIOSCI BIOENG, V105, P493, DOI 10.1263/jbb.105.493; Morita T, 2010, J OLEO SCI, V59, P451, DOI 10.5650/jos.59.451; Morita T, 2008, J OLEO SCI, V57, P123, DOI 10.5650/jos.57.123; Morita T, 2009, BIOSCI BIOTECH BIOCH, V73, P2352, DOI 10.1271/bbb.90439; Morita T, 2009, BIOTECHNOL APPL BIOC, V53, P39, DOI 10.1042/BA20090033; Morita T, 2008, J OLEO SCI, V57, P549, DOI 10.5650/jos.57.549; Morita T, 2013, APPL MICROBIOL BIOT, V97, P4691, DOI 10.1007/s00253-013-4858-1; Morita T, 2009, BIOSCI BIOTECH BIOCH, V73, P788, DOI 10.1271/bbb.80901; Morita T, 2007, FEMS YEAST RES, V7, P286, DOI 10.1111/j.1567-1364.2006.00154.x; Morita T, 2008, J OLEO SCI, V57, P557, DOI 10.5650/jos.57.557; Morita Y, 2011, BBA-GEN SUBJECTS, V1810, P1302, DOI 10.1016/j.bbagen.2011.07.002; Rau U, 2005, APPL MICROBIOL BIOT, V66, P551, DOI 10.1007/s00253-004-1672-9; Rau U, 2005, APPL MICROBIOL BIOT, V68, P607, DOI 10.1007/s00253-005-1906-5; Spoeckner S, 1999, APPL MICROBIOL BIOT, V51, P33, DOI 10.1007/s002530051359; Sugibayashi Kenji, 2004, Drug Metab Pharmacokinet, V19, P352, DOI 10.2133/dmpk.19.352; Takahashi M, 2012, J OLEO SCI, V61, P457, DOI 10.5650/jos.61.457; Ueno Y, 2007, J CONTROL RELEASE, V123, P247, DOI 10.1016/j.jconrel.2007.08.012; Wakamatsu Y, 2001, EUR J BIOCHEM, V268, P374, DOI 10.1046/j.1432-1327.2001.01887.x; Yamamoto S, 2013, J OLEO SCI, V62, P381, DOI 10.5650/jos.62.381; Zhao XX, 2001, J BIOL CHEM, V276, P39903, DOI 10.1074/jbc.M010281200	50	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	FEB	2015	64	2					133	141		10.5650/jos.ess14185		9	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CA1SM	WOS:000348691800002		
J	Kawase, T; Okada, K; Oida, T				Kawase, Tokuzo; Okada, Kazuyuki; Oida, Tatsuo			Novel Fluorinated Gemini Surfactants with gamma-Butyrolactone Segments	Journal of Oleo Science			English	Article						Gemini surfactant; semifluoroalkyl; gamma-butyrolactone; surface tension; recovery	SEMIFLUOROALKYL GROUP; HYDROPHOBIC GROUP; MOLECULES; ACIDS	In this work, novel gamma-butyrolactone-type monomeric and dimeric (gemini) surfactants with a semifluoroalkyl group [Rf-(CH2)(3)-; Rf = C4F9, C6F13, C8F17] as the hydrophobic group were successfully synthesized. Dimethyl malonate was dimerized or connected using Br(CH2)(s)Br (s = 0, 1, 2, 3) to give tetraesters, and they were bis-allylated. Radical addition of fluoroalkyl using Rf-I and an initiator, i.e., 2,2'-azobisisobutyronitrile for C4F9 or di-t-butyl peroxide for C6F13 and C8F17, was perform at high temperature, with prolonged heating, to obtain bis(semifluoroalkyl)-dilactone diesters. These dilactone diesters were hydrolyzed using KOH/EtOH followed by decarboxylation in AcOH to afford gamma-butyrolactonetype gemini surfactants. Common 1 + 1 semifluoroalkyl lactone surfactants were synthesized using the same method. Their surfactant properties [critical micelle concentration (CMC), gamma(CMC), pC(20), Gamma(CMC), and A(G)] were investigated by measuring the surface tension of the gamma-hydroxybutyrate form prepared in aqueous tetrabutylammonium hydroxide solution. As expected, the CMC values of the gemini surfactants were more than one order of magnitude smaller than those of the corresponding 1 + 1 surfactants. Other properties also showed the excellent ability of the gemini structure to reduce the surface tension. These surfactants were easily and quantitatively recovered by acidification. The monomeric surfactant was recovered in the gamma-hydroxybutyric acid form, and the gemini surfactant as a mixture of gamma-butyrolactone and gamma-hydroxybutyric acid forms.	[Kawase, Tokuzo; Okada, Kazuyuki; Oida, Tatsuo] Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Kyoto 6068585, Japan	Kawase, T (reprint author), Kyoto Inst Technol, Dept Chem & Mat Technol, Sakyo Ku, Hashigamicho 1, Kyoto 6068585, Japan.	kawase@kit.ac.jp					Lehmler HJ, 2005, CHEMOSPHERE, V58, P1471, DOI 10.1016/j.chemosphere.2004.11.078; Kawase T, 2012, TENSIDE SURFACT DET, V49, P498; MENGER FM, 1993, J AM CHEM SOC, V115, P10083, DOI 10.1021/ja00075a025; Hori H, 2008, ENVIRON SCI TECHNOL, V42, P7438, DOI 10.1021/es800832p; Kawase T, 2009, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 6, P173; NEWKOME GR, 1990, J AM CHEM SOC, V112, P8458, DOI 10.1021/ja00179a034; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Kawase T, 2010, J OLEO SCI, V59, P483, DOI 10.5650/jos.59.483; BRACE NO, 1962, J ORG CHEM, V27, P4491, DOI 10.1021/jo01059a090; MENGER FM, 1991, J AM CHEM SOC, V113, P1451, DOI 10.1021/ja00004a077; Brace NO, 2003, J FLUORINE CHEM, V123, P237, DOI 10.1016/S0022-1139(03)00160-X; Kissa E., 2001, SURFACTANT SCI SERIE, V97; Li YF, 2009, SYNTHESIS-STUTTGART, P3383, DOI 10.1055/s-0029-1216981; Menger F. M., 2000, ANGEW CHEM INT EDIT, V39, P1906, DOI DOI 10.1002/1521-3773; More environmentally friendly alternatives to PFOS-compounds and PFOA, 2005, MOR ENV FRIENDL ALT; Rosen M. J., 2004, SURFACTANTS INTERFAC; Salager J-L., SURFACTANTS TYPES US, P44; Zana R, 2002, J COLLOID INTERF SCI, V248, P203, DOI 10.1006/jcis.2001.8104; Zana R, 2002, ADV COLLOID INTERFAC, V97, P203	20	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	FEB	2015	64	2					169	182		10.5650/jos.ess14193		14	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CA1SM	WOS:000348691800006		
J	Imura, T; Nakayama, M; Taira, T; Sakai, H; Abe, M; Kitamoto, D				Imura, Tomohiro; Nakayama, Mio; Taira, Toshiaki; Sakai, Hideki; Abe, Masahiko; Kitamoto, Dai			Interfacial and Emulsifying Properties of Soybean Peptides with Different Degrees of Hydrolysis	Journal of Oleo Science			English	Article						soybean peptide; surface tension; association; emulsification; liquid paraffin; silicon oil	FUNCTIONAL-PROPERTIES; PROTEIN; SOLUBILIZATION; SURFACTANT; CASEIN	In this study, the effects of the degree of hydrolysis on the interfacial and emulsifying properties of soybean peptides were evaluated based on surface and interfacial tension, dynamic light scattering (DLS), and freeze-fracture transmission electron microscopy (FF-TEM) analyses. Of the five evaluated soybean peptides (SP95, SP87, SP75, SP49, and SP23), those with higher degrees of hydrolysis (SP95 and SP87) did not exhibit noticeable surface-active properties in water, whereas those with relatively low degrees of hydrolysis (SP75, SP49, and SP23) exhibited remarkable surface tension-lowering activity. The latter set (SP75, SP49, and SP23) also formed giant associates with average sizes ranging from 64.5 nm to 82.6 nm above their critical association concentration (CAC). Moreover, SP23 with the lowest degree of hydrolysis exhibited excellent emulsifying activity for soybean oil, and FF-TEM analysis demonstrated that the emulsions were stabilized by a lamella-like multilayer peptide structure on the oil droplets that prevented coagulation. The peptide with the lowest degree of hydrolysis (SP23) was effective not only for soybean oil emulsification, but also for the emulsification of liquid paraffin and silicon oil that are generally difficult to emulsify.	[Imura, Tomohiro; Taira, Toshiaki; Kitamoto, Dai] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan; [Nakayama, Mio; Sakai, Hideki; Abe, Masahiko] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan	Imura, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba Cent 5-2,1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	t-imura@aist.go.jp					Imura T, 2013, J OLEO SCI, V62, P499, DOI 10.5650/jos.62.499; Dehsorkhi A, 2014, J PEPT SCI, V20, P453, DOI 10.1002/psc.2633; HOYLE NT, 1994, J FOOD SCI, V59, P76, DOI 10.1111/j.1365-2621.1994.tb06901.x; van der Ven C, 2001, J AGR FOOD CHEM, V49, P5005, DOI 10.1021/jf01014cc; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Pencer J, 2003, LANGMUIR, V19, P7488, DOI 10.1021/la0345439; Francis MF, 2003, J CONTROL RELEASE, V93, P59, DOI 10.1016/j.jconrel.2003.08.001; Kondo Y, 2002, J AM CHEM SOC, V124, P6516, DOI 10.1021/ja0178564; Mandal D, 2014, ORG BIOMOL CHEM, V12, P3544, DOI 10.1039/c4ob00447g; Nagarajan R, 1996, CURR OPIN COLLOID IN, V1, P391; Chan WM, 1999, FOOD RES INT, V32, P119, DOI 10.1016/S0963-9969(99)00064-2; Cho H-Y., 2002, J KOREAN FISH SOC, V35, P97; Choi YJ, 2009, J FOOD SCI, V74, pC17, DOI 10.1111/j.1750-3841.2008.00988.x; Dziuba J, 2003, POLIMERY-W, V48, P50; Imura T, 2014, LANGMUIR, V30, P4752, DOI 10.1021/la500267b; Joye IJ, 2014, J AGR FOOD CHEM, V62, P2623, DOI 10.1021/jf5001343; Jung S, 2005, J FOOD SCI, V70, pC180; Pal Singh B., 2014, PEPTIDES, V63, P171; Panyam D, 2004, J FOOD SCI, V69, pC154; Pepe-Mooney BJ, 2009, CURR OPIN STRUC BIOL, V19, P483, DOI 10.1016/j.sbi.2009.07.001; SUZUKI T, 1989, J COLLOID INTERF SCI, V129, P491, DOI 10.1016/0021-9797(89)90463-3; Taira T, 2014, J OLEO SCI, V63, P407, DOI 10.5650/jos.ess13138; TAJIMA K, 1970, B CHEM SOC JPN, V43, P1991, DOI 10.1246/bcsj.43.1991	23	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	FEB	2015	64	2					183	189		10.5650/jos.ess14167		7	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CA1SM	WOS:000348691800007		
J	Hashimoto, N; Kawaguchi, K; Yoshioka, K				Hashimoto, Naoya; Kawaguchi, Koji; Yoshioka, Kotaro			Dispersion Granulation Method Leveraging pH Responsiveness of Monoalkyl Sulfosuccinate	Journal of Oleo Science			English	Article						monoalkyl sulfosuccinate; pH responsiveness; ionization state; dispersion granulation method		Monoalkyl sulfosuccinate is an anionic surfactant having two types of hydrophilic groups in one molecule, carboxylic acid group and sulfonic acid group, resulting in three ionization states depending on its pH. In state I, both carboxylic acid and sulfonic acid groups are not ionized; in state II, only sulfonic acid group is ionized; and in state III, both carboxylic acid and sulfonic acid groups are ionized. The ionization state affects the hydrophile-lipophile balance (HLB) of the surfactant, an index of the distribution coefficient of water/oil ratio of the surfactant. The decrease in HLB promotes the adsorption of the surfactant to the oil/water interface and improves the interface activity. State II has high emulsifying property for high interface activity but low water solubility. In contrast, state III has low emulsifying property for low interface activity but high water solubility. We applied the pH responsiveness of mono alkyl sulfosuccinate to the dispersion granulation method to change the state from II to III in a mild range of pH (weak acidity and weak alkalinity). Consequently, we successfully developed a novel dispersion granulation method that decreased the amount of surfactant needed for emulsifying resin solution by employing state II for its high emulsifying property, and we also reduced the amount of surfactant remaining on resin particles after the washing process by employing state III for its high water solubility.	[Hashimoto, Naoya; Kawaguchi, Koji] Sanyo Chem Ind Ltd, Surfactants Res Dept, Higashiyama Ku, Kyoto 6050995, Japan; [Yoshioka, Kotaro] Sanyo Chem Ind Ltd, PEB Res Dept, Higashiyama Ku, Kyoto 6050995, Japan	Kawaguchi, K (reprint author), Sanyo Chem Ind Ltd, Surfactants Res Dept, Higashiyama Ku, 11-1 Ikkyo Nomoto Cho, Kyoto 6050995, Japan.	k.kawaguchi@sanyo-chemical.com					ANDERSEN DL, 1957, J AM OIL CHEM SOC, V34, P188, DOI 10.1007/BF02670950; [Anonymous], 1993, CHEM HDB CHEM SOC JA, P10; [Anonymous], 2013, SAN CHEM PROD OUTL; [Anonymous], 2005, INT SURF, P34; [Anonymous], 2002, Applied Surface and Colloid Chemistry, V1, P289, Patent No. 04275339; [Anonymous], 1995, NEW DEV RES PART; Derjaguin B., 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L; Fujimoto T, 2007, INTRO SURFACTANTS, P90; Hirayama C., 1992, Jap. Pat. Pub., Patent No. [H04-246434, 6325664]; Long T. A., 1937, J AM CHEM SOC, V59, P2197; Noda H., 2012, KINKA KINKI CHEM SOC, V64, P14; Nonomura Y., 2004, HYOMEN, V42, P12; Oda R., 1957, SYNTHESIS APPL SURFA, P501; Onodera S., 1992, Jap. Pat. Pub., Patent No. [H04-275339, 04246434]; Satta K., 1986, APPL SURFACE COLLOID, Patent No. S63-25664; Verwey E. J. W., 1948, THEORY STABILITY LYO; Xu Q., 2005, FRAGRANCE J SPECAIL, V19, P39	17	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	FEB	2015	64	2					191	196		10.5650/jos.ess14113		6	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CA1SM	WOS:000348691800008		
J	Ide, T; Azechi, A; Kitade, S; Kunimatsu, Y; Suzuki, N; Nakajima, C; Ogata, N				Ide, Takashi; Azechi, Ayana; Kitade, Sayaka; Kunimatsu, Yoko; Suzuki, Natsuko; Nakajima, Chihiro; Ogata, Naoki			Comparative Effects of Sesame Seeds Differing in Lignan Contents and Composition on Fatty Acid Oxidation in Rat Liver	Journal of Oleo Science			English	Article						sesame lignans; hepatic fatty acid oxidation; hepatic lipogenesis; serum lipids; rat	GENE-EXPRESSION; MALIC ENZYME; FISH-OIL; MICE; METABOLISM; STRESS; TRIGLYCERIDE; GLUCOSIDES; EPISESAMIN; ACTIVATION	We compared the physiological activities of sesame seeds rich in lignans from three varieties (Gomazou, Maruhime and Maruemon), and those from a conventional cultivar (Masekin) in rats. The sum of the values of fat-soluble lignans (sesamin and sesamolin) in seeds of Gomazou, Maruhime and Maruemon varieties was approximately double the value in Masekin. Seeds from Maruemon contained fat-soluble lignan most exclusively as sesamin while other varieties contained sesamin and sesamolin at about a 2:1 ratio. After a 16 d experiment, sesame seeds, added at 200 g/kg to the experimental diets, increased the activity and mRNA levels of fatty acid oxidation enzymes. Increases were stronger with seeds rich in lignans than with seeds from Masekin. In contrast, sesame seeds lowered the activity and mRNA levels of lipogenic enzymes. However, sesame seeds from all the varieties were comparable in affecting these parameters. Serum triacylglycerol concentrations were lower in rats fed diets containing sesame seeds rich in lignans than in those fed a diet free of sesame seeds or a diet containing seeds from the Masekin variety. Serum malondialdehyde (a marker of lipid peroxidation) was lower in rats fed diets containing sesame seeds rich in lignans than in those fed a sesame seed-free diet or Masekin diet. It is apparent that sesame seeds rich in lignans, irrespective of lignan composition, more profoundly affect hepatic fatty acid oxidation and serum triacylglycerol levels and possibly attenuate oxidative stress. Therefore, consumption of sesame seeds rich in lignans hopefully results in physiological activity to promote health.	[Ide, Takashi; Azechi, Ayana; Kitade, Sayaka; Kunimatsu, Yoko; Suzuki, Natsuko; Nakajima, Chihiro] Jumonji Univ, Fac Human Life, Dept Food & Nutr, Niiza, Saitama 3528510, Japan; [Ogata, Naoki] Natl Agr & Food Res Org NARO, Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan	Ide, T (reprint author), Jumonji Univ, Fac Human Life, Dept Food & Nutr, 2-1-28 Sugasawa, Niiza, Saitama 3528510, Japan.	t-ide@jumonji-u.ac.jp			Japan Society for the Promotion of Science [25450177]	This study was supported by a grant-in-aid for scientific research (Scientific Research C, no. 25450177) from the Japan Society for the Promotion of Science.	AKIMOTO K, 1993, ANN NUTR METAB, V37, P218, DOI 10.1159/000177771; American Institute of Nutrition, 1977, J NUTR, V107, P1340; Ma JQ, 2014, FOOD CHEM TOXICOL, V64, P41, DOI 10.1016/j.fct.2013.11.017; Nakano D, 2006, J PHARMACOL EXP THER, V318, P328, DOI 10.1124/jpet.105.100149; Kang MH, 1998, J NUTR, V128, P1018; Ide T, 2009, J NUTR SCI VITAMINOL, V55, P31, DOI 10.3177/jnsv.55.31; Visavadiya NP, 2008, FOOD CHEM TOXICOL, V46, P1889, DOI 10.1016/j.fct.2008.01.012; Sirato-Yasumoto S, 2001, J AGR FOOD CHEM, V49, P2647, DOI 10.1021/jf001362t; Ide T, 2001, BBA-MOL CELL BIOL L, V1534, P1, DOI 10.1016/S1388-1981(01)00167-6; Ide T, 2009, FORUM NUTR, V61, P10, DOI 10.1159/000212735; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; NOGUCHI T, 1992, P SOC EXP BIOL MED, V200, P206; CASTELEIN H, 1994, J BIOL CHEM, V269, P26754; Hirata F, 1996, ATHEROSCLEROSIS, V122, P135, DOI 10.1016/0021-9150(95)05769-2; Lim JS, 2007, BRIT J NUTR, V97, P85, DOI 10.1017/S0007114507252699; IDE T, 1978, J NUTR, V108, P601; Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961; HIROSE N, 1991, J LIPID RES, V32, P629; Alipoor B, 2012, INT J FOOD SCI NUTR, V63, P674, DOI 10.3109/09637486.2011.652077; Ashakumary L, 1999, METABOLISM, V48, P1303, DOI 10.1016/S0026-0495(99)90272-X; HIROSE N, 1992, ANTICANCER RES, V12, P1259; Ide T, 2004, J NUTR BIOCHEM, V15, P169, DOI 10.1016/j.jnutbio.2003.11.001; Ide T, 2005, DIABETES, V54, P412; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Ferre P., 2001, Biochemical Society Transactions, V29, P547, DOI 10.1042/BST0290547; FUKUDA Y, 1986, J AM OIL CHEM SOC, V63, P1027, DOI 10.1007/BF02673792; Ide T, 2004, BBA-MOL CELL BIOL L, V1682, P80, DOI 10.1016/S1388-1981(04)00036-8; IDE T, 1982, METABOLISM, V31, P1065, DOI 10.1016/0026-0495(82)90153-6; Ide T, 2012, BRIT J NUTR, V108, P1980, DOI 10.1017/S0007114512000141; IDE T, 1981, J BIOL CHEM, V256, P247; Ide T, 2013, EUR J NUTR, V52, P1015, DOI 10.1007/s00394-012-0408-3; Kang MH, 1999, J NUTR, V129, P1885; KATSUZAKI H, 1994, PHYTOCHEMISTRY, V35, P773, DOI 10.1016/S0031-9422(00)90603-4; Khoschsorur GA, 2000, CHROMATOGRAPHIA, V52, P181, DOI 10.1007/BF02490453; Kushiro M, 2002, J NUTR BIOCHEM, V13, P289, DOI 10.1016/S0955-2863(01)00224-8; LOEBER G, 1991, J BIOL CHEM, V266, P3016; Moazzami AA, 2006, J AGR FOOD CHEM, V54, P633, DOI 10.1021/jf051541g; Nakano D, 2003, BIOL PHARM BULL, V26, P1701, DOI 10.1248/bpb.26.1701; Ogata N., 2013, B NARO I CROP SCI, V14, P57; Pearson D. J., 1969, METHOD ENZYMOL, V14, P612; The Council for Science and Technology Ministry of Education Culture Sports Science and Technology of Japan, 2005, STAND TABL FOOD COMP, P91; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; Wichitsranoi J, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-82; WINDMUEL.HG, 1967, ARCH BIOCHEM BIOPHYS, V122, P362, DOI 10.1016/0003-9861(67)90206-8; YAMASHITA K, 1992, J NUTR, V122, P2440; Yamazaki T, 2007, HEPATOLOGY, V46, P1779, DOI 10.1002/hep.21934; Yasumoto S., 2003, B NATL I CROP SCI, V4, P45	50	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	FEB	2015	64	2					211	222		10.5650/jos.ess14182		12	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CA1SM	WOS:000348691800011		
J	Aoki, A; Akaboshi, H; Ogura, T; Aikawa, T; Kondo, T; Tobori, N; Yuasa, M				Aoki, Asami; Akaboshi, Hikaru; Ogura, Taku; Aikawa, Tatsuo; Kondo, Takeshi; Tobori, Norio; Yuasa, Makoto			Preparation of pH-sensitive Anionic Liposomes Designed for Drug Delivery System (DDS) Application	Journal of Oleo Science			English	Article						pH-sensitive anionic liposome; anionic bilayer membrane-component; acidic pH-sensitivity; drug delivery system (DDS)	SMALL-ANGLE SCATTERING; CANCER-THERAPY; PHOSPHATIDYLETHANOLAMINE; LAMELLAR; PARTICLES; MEMBRANES; MIXTURES; LIPIDS; PHASE	We prepared pH-sensitive anionic liposomes composed solely of anionic bilayer membrane components that were designed to promote efficient release of entrapped agents in response to acidic pH. The pH-sensitive anionic liposomes showed high dispersion stability at neutral pH, but the fluidity of the bilayer membrane was enhanced in an acidic environment. These liposomes were rather simple and were composed of dimyristoylphosphatidylcholine (DMPC), an anionic bilayer membrane component, and polyoxyethylene sorbitan monostearate (Tween 80). In particular, the present pH-sensitive anionic liposomes showed higher temporal stability than those of conventional DMPC/DPPC liposomes. We found that pH-sensitive properties strongly depended on the molecular structure, pK(a) value, and amount of an incorporated anionic bilayer membrane component, such as sodium oleate (SO), dimyristoylphosphatidylserine (DMPS), or sodium beta-sitosterol sulfate (SS). These results provide an opportunity to manipulate liposomal stability in a pH-dependent manner, which could lead to the formulation of a high performance drug delivery system (DDS).	[Aoki, Asami; Ogura, Taku; Tobori, Norio] Lion Corp, R&D, Funct Mat Sci Res Labs, Edogawa Ku, Tokyo 1320035, Japan; [Akaboshi, Hikaru; Aikawa, Tatsuo; Kondo, Takeshi; Yuasa, Makoto] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Aikawa, Tatsuo; Kondo, Takeshi; Yuasa, Makoto] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Yuasa, M (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	yuasa@rs.noda.tus.ac.jp					WEBB MS, 1993, BIOCHIM BIOPHYS ACTA, V1145, P93, DOI 10.1016/0005-2736(93)90385-D; BANGHAM AD, 1964, J MOL BIOL, V8, P660; Drummond DC, 2000, PROG LIPID RES, V39, P409, DOI 10.1016/S0163-7827(00)00011-4; Hope MJ, 1998, MOL MEMBR BIOL, V15, P1, DOI 10.3109/09687689809027512; MONCELLI MR, 1994, BIOPHYS J, V66, P1969; Shi GF, 2002, J CONTROL RELEASE, V80, P309, DOI 10.1016/S0168-3659(02)00017-2; GLATTER O, 1980, J APPL CRYSTALLOGR, V13, P577, DOI 10.1107/S0021889880012794; Henry DC, 1931, P R SOC LOND A-CONTA, V133, P106, DOI 10.1098/rspa.1931.0133; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; GLATTER O, 1981, J APPL CRYSTALLOGR, V14, P101, DOI 10.1107/S002188988100887X; Hafez IM, 2000, BIOPHYS J, V79, P1438; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; CONNOR J, 1984, P NATL ACAD SCI-BIOL, V81, P1715, DOI 10.1073/pnas.81.6.1715; Fruhwirth T, 2004, J APPL CRYSTALLOGR, V37, P703, DOI 10.1107/S0021889804012956; Hiraka K, 2008, COLLOID SURFACE B, V67, P54, DOI 10.1016/j.colsurfb.2008.07.014; Karanth H, 2007, J PHARM PHARMACOL, V59, P469, DOI 10.1211/jpp.59.4.0001; Kawakami H, 2007, POLYM ADVAN TECHNOL, V18, P82, DOI 10.1002/pat.855; LAI MZ, 1985, BIOCHEMISTRY-US, V24, P1654, DOI 10.1021/bi00328a013; Maeda T., 2001, J CONTROL RELEASE, V74, P47; NAYAR R, 1988, BIOCHIM BIOPHYS ACTA, V937, P31, DOI 10.1016/0005-2736(88)90224-6; Nojima S., 1988, LIPOSOME; Op den Kamp J. A., 1969, BIOCHIM BIOPHYS ACTA, V176, P298; Paliwal SR, 2012, MOL PHARMACEUT, V9, P176, DOI 10.1021/mp200439z; Papahajopoulos D., 1967, BIOCHIM BIOPHYS ACTA, V183, P417; Sato T, 2009, J PHYS CHEM B, V113, P8418, DOI 10.1021/jp9002142; Sumida Y, 2001, LANGMUIR, V17, P609, DOI 10.1021/la0008939; Terada H., 1992, LIPOSOME LIFE SCI EX; Yuasa M., 2004, MOL PHARM, V1, P387	28	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	FEB	2015	64	2					233	242		10.5650/jos.ess14157		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CA1SM	WOS:000348691800013		
J	Okada, S; Irie, T; Tanaka, J; Yasuhara, R; Yamamoto, G; Isobe, T; Hokazono, C; Tachikawa, T; Kohno, Y; Mishima, K				Okada, Seiji; Irie, Tarou; Tanaka, Junichi; Yasuhara, Rika; Yamamoto, Gou; Isobe, Tomohide; Hokazono, Chie; Tachikawa, Tetsuhiko; Kohno, Yohko; Mishima, Kenji			Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						carcinogenesis; differentiation; epithelial precursor lesion; hematopoietic pre-B-cell leukemia transcription factor-interacting protein; oral squamous cell carcinoma	HUMAN EPIDERMAL-KERATINOCYTES; POOR-PROGNOSIS; HOX GENES; DIFFERENTIAL REGULATION; TUMOR-CELLS; KINASE-C; EXPRESSION; PROLIFERATION; CARCINOMA; CANCER	BackgroundHematopoietic pre-B-cell leukemia transcription factor-interacting protein (HPIP) is a corepressor of pre-B-cell leukemia homeobox (PBX) 1 and is known to play a role in hematopoiesis. Recently, HPIP was demonstrated to promote breast cancer cell proliferation and hepatocellular carcinoma growth. Moreover, it has been revealed that homeobox and PBX proteins, the expression of which is regulated by HPIP, play key roles in cancer of various organs, including oral squamous cell carcinoma (OSCC). Nevertheless, there has not been any study regarding the role of HPIP in OSCC. This study investigated the expression of HPIP in normal oral mucosa, epithelial precursor lesion (OEPL), and OSCC, and the functional roles of HPIP in OSCC cells and normal keratinocytes. Materials and methodsImmunohistochemical analysis of HPIP, Ki-67, and involucrin was performed in OSCC specimens, and the change in involucrin expression following RNA interference treatment against HPIP was examined by quantitative RT-PCR and Western blot analysis in SCC9 and NHEK cells undergoing extracellular calcium-induced differentiation. Matrigel transwell and cell proliferation assays for both cell lines transfected with HPIP siRNA were also conducted. ResultsHPIP expression increased in OEPL and OSCC specimens. In vitro analysis revealed that HPIP suppressed differentiation and proliferation of SCC9 cells and transwell migration of NHEK cells, while HPIP promoted invasion of SCC9 and proliferation of NHEK cells. However, HPIP has no significant effect on NHEK cell differentiation. ConclusionHPIP may play a critical role in oral carcinogenesis and is thus a potential target for anticancer therapy, with particular emphasis on its involvement in differentiation and migration/metastasis.	[Okada, Seiji; Irie, Tarou; Tanaka, Junichi; Yasuhara, Rika; Yamamoto, Gou; Isobe, Tomohide; Hokazono, Chie; Tachikawa, Tetsuhiko; Kohno, Yohko; Mishima, Kenji] Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Pathol,Shinagawa Ku, Tokyo 1428555, Japan	Irie, T (reprint author), Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Pathol,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	tarou@dent.showa-u.ac.jp			Project to Establish a Strategic Research Center for Innovative Dentistry from Ministry of Education, Culture, Sport, Science, and Technology, Japan	This work was supported by the Project to Establish a Strategic Research Center for Innovative Dentistry from the Ministry of Education, Culture, Sport, Science, and Technology, Japan.	Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Wang XH, 2008, BBA-MOL CELL RES, V1783, P1220, DOI 10.1016/j.bbamcr.2008.01.026; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Tseng YH, 2007, ORAL ONCOL, V43, P670, DOI 10.1016/j.oraloncology.2006.08.003; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Yamatoji M, 2010, ONCOL REP, V23, P61, DOI 10.3892/or_00000606; Xu XJ, 2013, IUBMB LIFE, V65, P873, DOI 10.1002/iub.1202; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; GEHRING WJ, 1990, TRENDS GENET, V6, P323; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Tseng YH, 2011, J ORAL PATHOL MED, V40, P160, DOI 10.1111/j.1600-0714.2010.00978.x; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Abramovich C, 2000, J BIOL CHEM, V275, P26172, DOI 10.1074/jbc.M001323200; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Nishi K, 2009, J CELL BIOCHEM, V106, P63, DOI 10.1002/jcb.21978; Rubio CA, 2008, ANTICANCER RES, V28, P2417; Destro MFDS, 2010, INT J ONCOL, V36, P141, DOI 10.3892/ijo_00000485; Morgan R, 2012, BREAST CANCER RES TR, V136, P389, DOI 10.1007/s10549-012-2259-2; Hassan NMM, 2006, ONCOL RES, V16, P217; Abramovich C, 2002, ONCOGENE, V21, P6766, DOI 10.1038/sj.onc.1205784; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Bitu CC, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-146; Cui XP, 2014, DIGEST DIS SCI, V59, P1442, DOI 10.1007/s10620-014-3033-6; Denning MF, 1998, EXP CELL RES, V239, P50, DOI 10.1006/excr.1997.3890; Gale N, 2005, WHO CLASSIFICATION T, P177; IMAI K, 1995, HEAD NECK-J SCI SPEC, V17, P204, DOI 10.1002/hed.2880170307; Kaur J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067361; Li B, 2009, INT J GYNECOL CANCER, V19, P1347, DOI 10.1111/IGC.0b013e3181a83f1d; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; Mikami T, 2011, ORAL ONCOL, V47, P497, DOI 10.1016/j.oraloncology.2011.03.015; Patel H, 2013, J ORAL PATHOL MED, V42, P250, DOI 10.1111/j.1600-0714.2012.01196.x; Qiu Y, 2010, INT J ONCOL, V36, P651, DOI 10.3892/ijo_00000541; Ramberg H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-50; RUBIN AL, 1986, CANCER RES, V46, P2356; Rubio CA, 2007, J GASTROEN HEPATOL, V22, P1877, DOI 10.1111/j.1440-1746.2007.04839.x; Umegaki N, 2007, J INVEST DERMATOL, V127, P1456, DOI 10.1038/sj.jid.5700716; Watanabe Shinya, 2009, Bull Tokyo Dent Coll, V50, P125; Wu HT, 2009, J ORAL PATHOL MED, V38, P206, DOI 10.1111/j.1600-0714.2008.00659.x	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	FEB	2015	44	2					115	125		10.1111/jop.12210		11	Dentistry, Oral Surgery & Medicine; Pathology	Dentistry, Oral Surgery & Medicine; Pathology	AZ8YP	WOS:000348497900006		
J	Tanaka, J; Irie, T; Yamamoto, G; Yasuhara, R; Isobe, T; Hokazono, C; Tachikawa, T; Kohno, Y; Mishima, K				Tanaka, Junichi; Irie, Tarou; Yamamoto, Gou; Yasuhara, Rika; Isobe, Tomohide; Hokazono, Chie; Tachikawa, Tetsuhiko; Kohno, Yohko; Mishima, Kenji			ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						angiopoietin-like protein 4; cancer therapy; invasion; lymph node metastasis; oral squamous cell carcinoma	ANGIOPOIETIN-LIKE 4; PROMOTES VENOUS INVASION; PROGNOSTIC-SIGNIFICANCE; E-CADHERIN; CANCER; EXPRESSION; NECK; HEAD; PROTEIN; ANGIOGENESIS	Lymph node metastasis is a major factor for poor prognosis in oral squamous cell carcinoma (OSCC). However, the molecular mechanisms of lymph node metastasis are unclear. We determined that angiopoietin-like protein 4 (ANGPTL4) mRNA and protein expression were increased in OSCC cells established from the primary site in metastatic cases. In addition, ANGPTL4 expression in biopsy specimens was correlated with the presence of lymph node metastasis. Therefore, our initial findings suggest that OSCC cells expressing ANGPTL4 may possess metastatic ability. Furthermore, cell culture supernatants from OSCC cells that metastasized to the lymph node contain ANGPTL4 and promote invasive ability. These findings suggest that secreted ANGPTL4 may affect the invasive ability of OSCC. Moreover, the rates of positive ANGPTL4 expression at the primary site were significantly higher in the lymph node metastasis group. These results demonstrate that ANGPTL4 contributes to OSCC metastasis by stimulating cell invasion. Therefore, ANGPTL4 is a potential therapeutic target for preventing cancer metastasis.	[Tanaka, Junichi; Irie, Tarou; Yamamoto, Gou; Yasuhara, Rika; Isobe, Tomohide; Hokazono, Chie; Tachikawa, Tetsuhiko; Kohno, Yohko; Mishima, Kenji] Showa Univ, Sch Dent, Div Pathol, Dept Oral Diagnost Sci,Shinagawa Ku, Tokyo 1428555, Japan	Mishima, K (reprint author), Showa Univ, Sch Dent, Div Pathol, Dept Oral Diagnost Sci,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	mishima-k@dent.showa-u.ac.jp			Project to Establish Strategic Research Center for Innovative Dentistry from Ministry of Education, Culture, Sport, Science, and Technology, Japan	This work was supported by the Project to Establish Strategic Research Center for Innovative Dentistry from Ministry of Education, Culture, Sport, Science, and Technology, Japan (to T.I).	Karatzanis AD, 2010, J SURG ONCOL, V101, P131, DOI 10.1002/jso.21449; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Ito Y, 2003, CANCER RES, V63, P6651; Okura M, 2009, ORAL ONCOL, V45, P908, DOI 10.1016/j.oraloncology.2009.03.013; Bosch FX, 2005, INT J CANCER, V114, P779, DOI 10.1002/ijc.20782; Huang XF, 2012, ONCOL REP, V27, P1541, DOI 10.3892/or.2012.1672; Lea J, 2010, HEAD NECK-J SCI SPEC, V32, P184, DOI 10.1002/hed.21163; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Nakayama T, 2011, ONCOL REP, V25, P929, DOI 10.3892/or.2011.1176; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Mishima K, 2002, ORAL ONCOL, V38, P468, DOI 10.1016/S1368-8375(01)00104-X; Yao M, 2007, ORAL ONCOL, V43, P213, DOI 10.1016/j.oraloncology.2006.04.013; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Takes RP, 2004, ORAL ONCOL, V40, P656, DOI 10.1016/j.oraloncology.2003.11.001; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Fan S, 2011, INT J ORAL SCI, V3, P180, DOI 10.4248/IJOS11068; Izraely S, 2012, INT J CANCER, V131, P1071, DOI 10.1002/ijc.27324; Kurtz KA, 2006, OTOLARYNG HEAD NECK, V134, P142, DOI 10.1016/j.otohns.2005.08.026; Yotsumoto F, 2013, MOL CANCER RES, V11, P506, DOI 10.1158/1541-7786.MCR-12-0428; Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Girroir EE, 2008, TOXICOLOGY, V243, P236, DOI 10.1016/j.tox.2007.10.023; Nakayama T, 2010, ONCOL REP, V24, P599, DOI 10.3892/or_00000897; BECK T, 1994, GYNECOL ONCOL, V53, P220, DOI 10.1006/gyno.1994.1119; Casiglia Jeffrey, 2001, General Dentistry, V49, P72; Chui X, 1996, BRIT J CANCER, V73, P1233, DOI 10.1038/bjc.1996.236; GRANDI C, 1985, HEAD NECK SURG, V8, P67, DOI 10.1002/hed.2890080202; Hayashi S, 2013, EXP CELL RES, V319, P1220, DOI 10.1016/j.yexcr.2013.03.004; Ifon ET, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-19; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Katoh Y, 2006, INT J MOL MED, V17, P1145; Kyzas PA, 2006, AM J SURG PATHOL, V30, P185, DOI 10.1097/01.pas.0000178090.54147.f8; lesJan S, 2003, AM J PATHOL, V162, P1521; Li KQ, 2004, CHINESE MED J-PEKING, V117, P1364; Mamedova LK, 2010, J ANIM SCI, V88, P124, DOI 10.2527/jas.2009-2258; Mishima K, 1998, MODERN PATHOL, V11, P886; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200	47	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	FEB	2015	44	2					126	133		10.1111/jop.12212		8	Dentistry, Oral Surgery & Medicine; Pathology	Dentistry, Oral Surgery & Medicine; Pathology	AZ8YP	WOS:000348497900007		
J	Mizuki, H; Kawamura, T; Nagasawa, D				Mizuki, Harumi; Kawamura, Takafumi; Nagasawa, Dai			In situ immunohistochemical detection of intracellular Mycoplasma salivarium in the epithelial cells of oral leukoplakia	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						immunohistochemistry; intracellular location; Mycoplasma; oral leukoplakia	MALIGNANT-TRANSFORMATION; HOST-CELLS; HELA-CELLS; CLASSIFICATION; LOCATION; SURVIVAL; ANTIBODY; MUCOSA; RISK	BackgroundMycoplasmas are the smallest free-living organisms; Mycoplasma salivarium and Mycoplasma orale are the most common species isolated from the oropharynx. Oral leukoplakia is the most prevalent potentially malignant disorder of the oral mucosa; its etiology has not been defined. Our previous study with DNA-binding fluorescent dye suggested the presence of mycoplasmas in the epithelial cells of leukoplakia tissue. ObjectiveOur aim was to detect M.salivarium in the epithelial cells of leukoplakia by immunohistochemistry. DesignWe produced a polyclonal antibody (PAb) reactive to Mycoplasma by injecting a rabbit with M.salivarium cells (ATCC 23064) mixed with complete Freund's adjuvant and a monoclonal antibody specific to M.salivarium by injecting M.salivarium cells (ATCC 23557) mixed with complete Freund's adjuvant into the footpads of a rat. Then, we attempted to detect M.salivarium in the epithelium of leukoplakia tissues by immunohistochemistry. ResultsWe obtained an antimycoplasma rabbit PAb reactive to all seven Mycoplasma species used in this study. Three hybridoma clones producing monoclonal antibodies specific to M.salivarium were obtained, and an M.salivarium-specific monoclonal antibody, designated 7-6H, was established. Immunohistochemistry with these antibodies revealed M.salivarium in the epithelial cells of leukoplakia with hyperplasia and hyperkeratosis on histology. PCR and sequencing verified the presence of M.salivarium DNA in the epithelial cells of leukoplakia. ConclusionIntracellular M.salivarium was identified in the epithelial cells of leukoplakia.	[Mizuki, Harumi; Kawamura, Takafumi; Nagasawa, Dai] Iwate Med Univ, Sch Dent, Dept Oral & Maxillofacial Reconstruct Surg, Div Oral & Maxillofacial Surg, Morioka, Iwate 0208505, Japan	Mizuki, H (reprint author), Iwate Med Univ, Sch Dent, Dept Oral & Maxillofacial Reconstruct Surg, Div Oral & Maxillofacial Surg, 1-3-27 Chuo Dori, Morioka, Iwate 0208505, Japan.	hmizuki@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank Prof. Koujiro Tohyama and Mr. Kinji Ishida of the Center for Electron Microscopy and Bio-Imaging Research, Central Research Laboratories for their help with immunoelectron microscopy by ultracryotomy-immunolabeling methods. This work was supported in part by Grants-in Aid for High-Tech Research Project (2005-2009) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akagi T, 2006, J NEUROSCI METH, V153, P276, DOI 10.1016/j.jneumeth.2005.11.007; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; JENSEN JS, 1994, INT J EXP PATHOL, V75, P91; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P127, DOI 10.1111/j.1600-0714.2007.00584.x; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Mizuki H, 2001, ORAL ONCOL, V37, P521, DOI 10.1016/S1368-8375(01)00016-1; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094; Brailo V, 2006, ORAL ONCOL, V42, P370, DOI 10.1016/j.oraloncology.2005.09.001; BANOCZY J, 1980, J ORAL PATHOL MED, V9, P41, DOI 10.1111/j.1600-0714.1980.tb01386.x; Blanchard A, 2002, MOL BIOL PATHOGENICI, P45, DOI 10.1007/0-306-47606-1_3; BLAZEK R, 1990, J IMMUNOL METHODS, V131, P203, DOI 10.1016/0022-1759(90)90191-W; Diaz-Garcia FJ, 2006, HUM REPROD, V21, P1591, DOI 10.1093/humrep/de1032; ENGEL L D, 1970, Journal of Periodontal Research, V5, P163; HASHIMOT.K, 1968, ORAL SURG ORAL MED O, V25, P901, DOI 10.1016/0030-4220(68)90169-2; KANNAN S, 1993, PATHOL RES PRACT, V189, P1169; KUMAGAI K, 1971, J INFECT DIS, V123, P16; Kunze E, 2008, APPL IMMUNOHISTO M M, V16, P76; Lo SC, 1993, CLIN INFECT DIS    S, V17, P259; Mao L, 1997, MOL MED TODAY, V3, P442, DOI 10.1016/S1357-4310(97)01111-8; Rottem S, 1998, TRENDS MICROBIOL, V6, P436, DOI 10.1016/S0966-842X(98)01358-4; Saghravanian N, 2011, ACTA ODONTOL SCAND, V69, P406, DOI 10.3109/00016357.2011.572560; Sanno A, 1998, ENDOCR PATHOL, V9, P195; Sharma P, 2011, INT J ORAL MED SCI, V10, P140; Tarshis M, 2004, CURR MICROBIOL, V49, P136, DOI 10.1007/s00284-004-4298-3; UCHIDA A, 1981, Bulletin of Tokyo Medical and Dental University, V28, P117; WATANABE T, 1986, J CLIN MICROBIOL, V23, P1034; Yavlovich A, 2004, FEMS MICROBIOL LETT, V233, P241, DOI 10.1016/j.femsle.2004.02.016; Yavlovich A, 2004, INFECT IMMUN, V72, P5004, DOI 10.1128/IAI.72.9.5004-5011.2004; Zhang BX, 1997, P SOC EXP BIOL MED, V214, P359	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	FEB	2015	44	2					134	144		10.1111/jop.12215		11	Dentistry, Oral Surgery & Medicine; Pathology	Dentistry, Oral Surgery & Medicine; Pathology	AZ8YP	WOS:000348497900008		
J	Tsukada, Y; Nakamura, N; Ohde, S; Akahane, K; Sekiguchi, K; Terahara, A				Tsukada, Yoichiro; Nakamura, Naoki; Ohde, Sachiko; Akahane, Keiko; Sekiguchi, Kenji; Terahara, Atsuro			Factors that Delay Treatment of Symptomatic Metastatic Extradural Spinal Cord Compression	JOURNAL OF PALLIATIVE MEDICINE			English	Article							CLINICAL-PRACTICE; MANAGEMENT; MORTALITY; WEEKEND; CANCER; ADMISSION; ONTARIO; TRIAL	Background: Treatment delays of metastatic extradural spinal cord compression (MESCC) sometimes have been reported, but reasons for its delay have remained unclear. The purpose of this study was to assess which clinical factors are associated with treatment delays in neurologically symptomatic MESCC in the hospital settings. Methods: We reviewed medical records of MESCC patients in our institute who had at least one progressive neurological symptom (weakness, sensory changes, urinary retention, or nerve root pain), were diagnosed by magnetic resonance imaging (MRI), and were treated with at least radiotherapy. The number of days prior to treatment initiation were counted and defined as follows: from the patients' first physician visit to our hospital until MRI diagnosis [T1 (days)], from MRI diagnosis to treatment [T2 (days)], and from patients' first visit to treatment [T1+2 (days)]. Nine clinical factors that could potentially delay treatment were analyzed for each period. Results: Forty-three episodes of MESCC met the inclusion criteria. Median days in T1+2 was 3 days (range: 0-22). T1 and T1+2 were significantly higher in patients with normal walking status than in those with deterioration or inabilities to walk (T1+2, 7 days versus 3 days, median, p<0.001). The number of days was higher in all periods when it included weekends (T1+2, 7 days versus 2 days, median, p<0.001). Conclusions: Our findings suggest that normal walking status at the first physician visit and inclusion of weekends during the pretreatment periods were factors that resulted in treatment delays even for MESCC patients with emergency neurological symptoms.	[Tsukada, Yoichiro; Nakamura, Naoki; Akahane, Keiko; Sekiguchi, Kenji] St Lukes Int Hosp, Dept Radiat Oncol, Tokyo, Japan; [Tsukada, Yoichiro; Terahara, Atsuro] Toho Univ, Omori Med Ctr, Dept Radiol, Tokyo 1438541, Japan; [Ohde, Sachiko] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan	Tsukada, Y (reprint author), Toho Univ, Omori Med Ctr, Dept Radiol, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	youichirou.tsukada@med.toho-u.ac.jp					Husband DJ, 1998, BRIT MED J, V317, P18; Rades D, 2007, INT J RADIAT ONCOL, V67, P525, DOI 10.1016/j.ijrobp.2006.09.025; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Loblaw DA, 2012, INT J RADIAT ONCOL, V84, P312, DOI 10.1016/j.ijrobp.2012.01.014; Loblaw DA, 2003, CLIN ONCOL-UK, V15, P211, DOI 10.1016/S0936-6555(03)00400-4; Loblaw DA, 2005, J CLIN ONCOL, V23, P2028, DOI 10.1200/JCO.2005.00.067; Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Lee K, 2007, INT J QUAL HEALTH C, V19, P377, DOI 10.1093/intqhc/mzm043; Bell CM, 2004, AM J MED, V117, P175, DOI 10.1016/j.amjmed.2004.02.047; McLinton A, 2006, BRIT J CANCER, V94, P486, DOI 10.1038/sj.bjc.6602957; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; TURNER S, 1993, INT J RADIAT ONCOL, V26, P141, DOI 10.1016/0360-3016(93)90185-X; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; MARANZANO E, 1995, INT J RADIAT ONCOL, V32, P959, DOI 10.1016/0360-3016(95)00572-G; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Helweg-Larsen S, 2000, INT J RADIAT ONCOL, V46, P1163, DOI 10.1016/S0360-3016(99)00333-8; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; Fitzpatrick D, 2012, INT J RADIAT ONCOL, V84, pE167, DOI 10.1016/j.ijrobp.2012.03.057; Frankel H L, 1969, Paraplegia, V7, P179; LEVIOV M, 1993, INT J RADIAT ONCOL, V27, P231; Lu Charles, 2005, J Support Oncol, V3, P305; Mitera G, 2004, ASCO ANN M; Solberg A, 1999, ANTICANCER RES, V19, P677	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	FEB 1	2015	18	2					107	113		10.1089/jpm.2014.0099		7	Health Care Sciences & Services	Health Care Sciences & Services	AZ9IE	WOS:000348526300006		
J	Tsai, JS; Chen, CH; Wu, CH; Chiu, TY; Morita, T; Chang, CH; Hung, SH; Lee, YP; Chen, CY				Tsai, Jaw-Shiun; Chen, Chao-Hsien; Wu, Chih-Hsun; Chiu, Tai-Yuan; Morita, Tatsuya; Chang, Chin-Hao; Hung, Shou-Hung; Lee, Ya-Ping; Chen, Ching-Yu			Consciousness Levels One Week after Admission to a Palliative Care Unit Improve Survival Prediction in Advanced Cancer Patients	JOURNAL OF PALLIATIVE MEDICINE			English	Article							TERMINALLY-ILL; PROGNOSTIC SCORE; TAIWAN; PREFERENCES; SCALE	Background: Consciousness is an important factor of survival prediction in advanced cancer patients. However, effects on survival of changes over time in consciousness in advanced cancer patients have not been fully explored. Objective: This study evaluated changes in consciousness after admission to a palliative care unit and their correlation with prognosis in terminal cancer patients. Methods: This is a prospective observational study. From a palliative care unit in Taiwan, 531 cancer patients (51.8% male) were recruited. Consciousness status was assessed at admission and one week afterwards and recorded as normal or impaired. Results: The mean age was 65.28 +/- 13.59 years, and the average survival time was 23.41 +/- 37.69 days. Patients with normal consciousness at admission (n=317) had better survival than those with impaired consciousness at admission (n=214): (17.0 days versus 6.0 days, p<0.001). In the analysis on survival within one week after admission, those with normal consciousness at admission had a higher percentage of survival than the impaired (78.9% versus 44.3%, p<0.001). Patients were further classified into four groups according to consciousness levels: (1) normal at admission and one week afterwards, (2) impaired at admission but normal one week afterwards, (3) normal at admission but impaired one week afterwards, and (4) impaired both at admission and one week afterwards. The former two groups had significantly better survival than the latter two groups: (median survival counted from day 7 after admission), 25.5, 27.0, 7.0, and 7.0 days, respectively. Conclusion: Consciousness levels one week after admission should be integrated into survival prediction in advanced cancer patients.	[Tsai, Jaw-Shiun; Chen, Chao-Hsien; Wu, Chih-Hsun; Chiu, Tai-Yuan; Lee, Ya-Ping; Chen, Ching-Yu] Natl Taiwan Univ, Coll Med & Hosp, Dept Family Med, Hosp & Palliat Care Unit, Taipei 10764, Taiwan; [Chang, Chin-Hao] Natl Taiwan Univ, Dept Med Res, Taipei 10764, Taiwan; [Wu, Chih-Hsun] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Morita, Tatsuya] Seirei Mikatahara Hosp, Palliat & Support Care Div, Kita Ku, Hamamatsu, Shizuoka, Japan; [Hung, Shou-Hung] Natl Taiwan Univ Hosp, Dept Community & Family Med, Yun Lin Branch, Yunlin, Taiwan; [Lee, Ya-Ping] Minist Hlth & Welf, Taipei Hosp, Div Family Med, New Taipei City, Taiwan; [Chen, Ching-Yu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Geriatr Res, Ju Nan, Taiwan	Chen, CY (reprint author), Natl Taiwan Univ Hosp, Dept Family Med, 7 Chung Shan South Rd, Taipei 100, Taiwan.	cycchen@ntu.edu.tw		CHEN, CHING-YU/0000-0002-4095-4197; Chen, Chao-Hsien/0000-0002-9798-9825; Wu, Chih-Hsun/0000-0003-4613-5915	Department of Family Medicine at the National Taiwan University Hospital; National Science Council [NSC 91-2314-B-002-224]; Department Of Health [DOH92-HP-1506]; National Health Research Institutes, Executive Yuan, Taipei, Taiwan [NHRI-102A1-PDCO-0100028]	The authors are indebted to the participants and the faculty of the Department of Family Medicine at the National Taiwan University Hospital for their full support of this study. This study was supported by the National Science Council (NSC 91-2314-B-002-224), the Department Of Health (DOH92-HP-1506), and the National Health Research Institutes (NHRI-102A1-PDCO-0100028), Executive Yuan, Taipei, Taiwan.	Hyodo I, 2010, JPN J CLIN ONCOL, V40, P442, DOI 10.1093/jjco/hyp182; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Tang ST, 2005, SOC SCI MED, V61, P1560, DOI 10.1016/j.socscimed.2005.02.006; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Chiu TY, 2000, SUPPORT CARE CANCER, V8, P311, DOI 10.1007/s005209900112; Chan EY, 2013, PALLIATIVE MED, V27, P367, DOI 10.1177/0269216312451613; Tang ST, 2000, CANCER NURS, V23, P367, DOI 10.1097/00002820-200010000-00007; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; Maltoni M, 1999, J PAIN SYMPTOM MANAG, V17, P240, DOI 10.1016/S0885-3924(98)00146-8; Chuang RB, 2004, J PAIN SYMPTOM MANAG, V28, P115, DOI 10.1016/j.jpainsymman.2003.11.008; MALTONI M, 1995, CANCER, V75, P2613, DOI 10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1; Pautex Sophie, 2009, J Pain Symptom Manage, V38, pe1, DOI 10.1016/j.jpainsymman.2009.06.005; Suh Sang-Yeon, 2011, J Oncol Pract, V7, P374, DOI 10.1200/JOP.2011.000434; Tsai JS, 2006, PALLIATIVE MED, V20, P617, DOI 10.1177/0269216306071065	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	FEB 1	2015	18	2					170	175		10.1089/jpm.2014.0220		6	Health Care Sciences & Services	Health Care Sciences & Services	AZ9IE	WOS:000348526300016		
J	Takagi, S; Kadomatsu, K; Kajisa, T; Tokumoto, H; Ishigaki, T; Arimura, K				Takagi, Shinsuke; Kadomatsu, Kouichi; Kajisa, Takuya; Tokumoto, Hideki; Ishigaki, Tatsuya; Arimura, Kazuko			Surgical correction of complex syndactyly with bony fusion using adipofascial flaps for bone and joint surface coverage after finger separation	Journal of Plastic Reconstructive and Aesthetic Surgery			English	Letter									[Takagi, Shinsuke; Kajisa, Takuya; Ishigaki, Tatsuya; Arimura, Kazuko] Imakiire Gen Hosp, Dept Plast & Reconstruct Surg, Kagoshima, Japan; [Kadomatsu, Kouichi] Showa Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 142, Japan; [Tokumoto, Hideki] Chiba Univ, Sch Med, Dept Plast & Reconstruct Surg, Chiba 280, Japan	Takagi, S (reprint author), Imakiire Gen Hosp, Dept Plast & Reconstruct Surg, Kagoshima, Japan.	takagishinsukejapan@yahoo.co.jp					Buck-Gramcko D., 1988, HAND SURG, P22; MARUMO E, 1976, PLAST RECONSTR SURG, V58, P561, DOI 10.1097/00006534-197611000-00005; MORGAN RF, 1985, J HAND SURG-AM, V10A, P754; THOMSON H G, 1971, British Journal of Plastic Surgery, V24, P357, DOI 10.1016/S0007-1226(71)80090-5; VANDERBIEZEN JJ, 1992, J HAND SURG-AM, V17A, P1059	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	FEB	2015	68	2					280	282		10.1016/j.bjps.2014.10.009		4	Surgery	Surgery	AZ9AB	WOS:000348502400033		
J	Kuro, A; Morimoto, N; Ueda, M; Horiuchi, A; Yamauchi, T; Sakamoto, M; Suzuki, K; Kusumoto, K				Kuro, Atsuyuki; Morimoto, Naoki; Ueda, Miyuki; Horiuchi, Ai; Yamauchi, Takashi; Sakamoto, Michiharu; Suzuki, Kenji; Kusumoto, Kenji			Combined use of fenestrated-type artificial dermis and topical negative-pressure wound therapy to treat the complex wound in the lower leg	Journal of Plastic Reconstructive and Aesthetic Surgery			English	Letter									[Kuro, Atsuyuki; Suzuki, Kenji] Kansai Med Univ, Takii Hosp, Dept Plast & Reconstruct Surg, Moriguchi, Osaka, Japan; [Morimoto, Naoki; Ueda, Miyuki; Horiuchi, Ai; Yamauchi, Takashi; Kusumoto, Kenji] Kansai Med Univ, Hirakata Hosp, Dept Plast & Reconstruct Surg, Moriguchi, Osaka, Japan; [Sakamoto, Michiharu] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto 6068501, Japan	Kuro, A (reprint author), Kansai Med Univ, Takii Hosp, Dept Plast & Reconstruct Surg, Moriguchi, Osaka, Japan.	kuroa@takii.kmu.ac.jp; morimotn@hirakata.kmu.ac.jp					Baldwin C, 2009, ANN PLAS SURG, V62, P92, DOI 10.1097/SAP.0b013e31817762fd; Morimoto N, 2013, TISSUE ENG PT A, V19, P1931, DOI [10.1089/ten.TEA.2012.0634, 10.1089/ten.tea.2012.0634]; Moiemen NS, 2010, BURNS, V36, P764, DOI 10.1016/j.burns.2010.04.011; Fraccalvieri M, 2012, INT WOUND J, V9, P214, DOI 10.1111/j.1742-481X.2011.00878.x; Yannas IV, PLAST RECONSTR SU S1, V127, p60S	5	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	FEB	2015	68	2					286	288		10.1016/j.bjps.2014.09.048		4	Surgery	Surgery	AZ9AB	WOS:000348502400036		
J	Sasaki, K; Adachi, K; Aihara, Y; Sekido, M				Sasaki, Kaoru; Adachi, Koji; Aihara, Yukiko; Sekido, Mitsuru			A divided and sliding postauricular myocutaneous flap for anterior auricular reconstruction	Journal of Plastic Reconstructive and Aesthetic Surgery			English	Letter									[Sasaki, Kaoru; Adachi, Koji; Aihara, Yukiko; Sekido, Mitsuru] Univ Tsukuba, Dept Plast & Reconstruct Surg, Tsukuba, Ibaraki, Japan	Sasaki, K (reprint author), Univ Tsukuba, Dept Plast & Reconstruct Surg, Tsukuba, Ibaraki, Japan.	sasakikaoru32@hotmail.com					Dessy LA, 2010, J PLAST RECONSTR AES, V63, P746, DOI 10.1016/j.bjps.2009.01.073; KRESPI YP, 1983, OTOLARYNG HEAD NECK, V91, P193; Masson J K, 1972, Br J Plast Surg, V25, P399, DOI 10.1016/S0007-1226(72)80083-3; Sawaizumi M, 1997, ANN PLAS SURG, V38, P41, DOI 10.1097/00000637-199701000-00008; Talmi YP, 1996, PLAST RECONSTR SURG, V98, P1191, DOI 10.1097/00006534-199612000-00010	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	FEB	2015	68	2					E33	E34		10.1016/j.bjps.2014.09.039		2	Surgery	Surgery	AZ9AB	WOS:000348502400002		
J	Nagatani, H; Suzuki, I; Kita, M; Tanaka, M; Katsuya, Y; Sakata, O; Omata, T				Nagatani, Hiraku; Suzuki, Issei; Kita, Masao; Tanaka, Masahiko; Katsuya, Yoshio; Sakata, Osami; Omata, Takahisa			Structure of beta-AgGaO2; ternary I-III-VI2 oxide semiconductor with a wurtzite-derived structure	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						X-ray diffraction; Crystal structure; Wurtzite structure; I-III-VI2 semiconductors; AgGaO2	PHOTOCATALYTIC PROPERTIES; ELECTRICAL-CONDUCTION; DELAFOSSITE STRUCTURE; ELECTRONIC-STRUCTURES; OPTICAL-PROPERTIES; CRYSTAL-STRUCTURES; THIN-FILMS; TRANSPARENT; GROWTH; CUGAO2	The structure of the wurtzite-derived beta-AgGaO2 was refined by Rietveld analysis of high-resolution powder diffraction data obtained using synchrotron X-ray radiation. The space group of the crystal is Pna2(1) with lattice parameters of a(0) = 5.56175 angstrom, b(0) = 7.14749 angstrom, and c(0) = 5.46875 angstrom. The deviation of O-Ag-O and M-O-M bond angles from the regular tetrahedral angle of 109.5 degrees was very large at similar to 8 degrees and similar to 11 degrees, respectively. The electronic structure of beta-AgGaO2 is discussed based on its structure, and the indirect band gap of beta-AgGaO2 was related to significant tetrahedral distortion. Although beta-AgGaO2 decomposes into metallic silver and Ga2O3 at a high temperature in any atmosphere, beta-AgGaO2 is stable up to 690 degrees C under an O-2 atmosphere. No direct transformation from the wurtzite-derived phase to a delafossite phase occurs in beta-AgGaO2. (C) 2014 Elsevier Inc. All rights reserved.	[Nagatani, Hiraku; Suzuki, Issei; Omata, Takahisa] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Kita, Masao] Toyama Natl Coll Technol, Dept Mech Engn, Toyama 9398630, Japan; [Tanaka, Masahiko; Katsuya, Yoshio; Sakata, Osami] Natl Inst Mat Sci, Synchrotron Xray Stn, SPring 8, Sayo, Hyogo 6795148, Japan	Omata, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	omata@mateng.osaka-u.ac.jp	Omata, Takahisa/C-3946-2009; SAKATA, Osami/H-2621-2011; Suzuki, Issei/F-4675-2015	Omata, Takahisa/0000-0002-6034-4935; Suzuki, Issei/0000-0002-0869-2713	Japan Society for the Promotion of Science [25630283]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported in part by the Grants-in-Aid for Scientific Research of Challenging Exploratory Research (No. 25630283) from the Japan Society for the Promotion of Science and by the NIMS microstructural characterization platform as a program of the "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ouyang SX, 2008, J PHYS CHEM C, V112, P3134, DOI 10.1021/jp077127w; Maruyama Y, 2006, J PHYS CHEM B, V110, P23274, DOI 10.1021/jp063406s; Omata T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903906; ABRAHAMS SC, 1969, ACTA CRYSTALL B-STRU, VB 25, P1233, DOI 10.1107/S0567740869003876; Tanaka M, 2013, J CERAM SOC JPN, V121, P287, DOI 10.2109/jcersj2.121.287; Ouyang SX, 2009, J PHYS CHEM C, V113, P1560, DOI 10.1021/jp806513t; Ouyang SX, 2011, J AM CHEM SOC, V133, P7757, DOI 10.1021/ja110691t; Omata T, 2014, J AM CHEM SOC, V136, P3378, DOI 10.1021/ja501614n; Johnson NW, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/44/445501; Omata T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.031102; Nagarajan R, 2001, INT J INORG MATER, V3, P265, DOI 10.1016/S1466-6049(01)00006-X; Kawazoe H, 1997, NATURE, V389, P939, DOI 10.1038/40087; Ueda K, 2001, J APPL PHYS, V89, P1790, DOI 10.1063/1.1337587; Yanagi H, 2000, J APPL PHYS, V88, P4159, DOI 10.1063/1.1308103; HONLE W, 1986, Z ANORG ALLG CHEM, V543, P161, DOI 10.1002/zaac.19865431220; LEALGONZALEZ J, 1990, ACTA CRYSTALLOGR C, V46, P2017, DOI 10.1107/S0108270190002165; Li J, 2004, J SOLID STATE CHEM, V177, P889, DOI 10.1016/j.jssc.2003.09.036; lzumi F., 2007, SOLID STATE PHENOM, V130, P15; Marezio M., 1965, ACTA CRYSTALLOGR A, V18; MULLER HP, 1992, Z ANORG ALLG CHEM, V611, P73, DOI 10.1002/zaac.19926110512; Nag B.R., 1980, ELECT TRANSPORT COMP, P21; Nicholls JFH, 1996, MATER RES SOC SYMP P, V395, P535; Omata T, 2012, J SOLID STATE CHEM, V188, P92, DOI 10.1016/j.jssc.2012.01.053; Omata T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.061102; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Suzuki I, 2014, THIN SOLID FILMS, V559, P112, DOI 10.1016/j.tsf.2013.10.099; Suzuki I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4836435; Vanaja KA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2204757; Wyckoff R.W.G., 1964, CRYST STRUCT, P291; Wyckoff R.W.G., 1964, CRYST STRUCT, P299; Yanagi H, 2001, APPL PHYS LETT, V78, P1583, DOI 10.1063/1.1355673	31	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	FEB	2015	222						66	70		10.1016/j.jssc.2014.11.012		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	CA0WH	WOS:000348633800010		
J	Tsugawa, Y; Maubuchi, Y; Motohashi, T; Kikkawa, S				Tsugawa, Yuta; Maubuchi, Yuji; Motohashi, Teruki; Kikkawa, Shinichi			Magnetic properties of the ammonolysis product of alpha-Fe powder containing a small amount of aluminum	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Iron nitride; alpha ''-Fe15N2; Magnetic coercivety; Soft magnet	LOW-TEMPERATURE NITRIDATION; FE16N2; FILMS; ALPHA''-FE16N2; MOMENT	Magnetite was prepared containing a small amount of aluminum and its nitride was generated through low temperature ammonolysis following reduction under hydrogen. The nitrided product was determined by XRD to be a mixture of "alpha"-Fe16N2" having a slightly deformed crystal structure from alpha"-Fe16N2 and the residual alpha-Fe. Magnetic coercivity of the mixture was decreased from the value of 150 mT obtained for the nitride product made without aluminum, due to the precipitation of nonmagnetic amorphous alumina in the low temperature nitrided bcc (Fe1-xAlx) with x < 0.03. The aluminum-doped nitride product in which the alpha"-Fe16N2" fraction was 30 at% exhibited magnetization at 1.5 T of approximately 200 Am(2)kg(-1) at room temperature and its magnetic coercivity was 20 mT. 0 2014 Elsevier Inc. All rights reserved.	[Tsugawa, Yuta; Maubuchi, Yuji; Motohashi, Teruki; Kikkawa, Shinichi] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Kikkawa, S (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, N13W8, Sapporo, Hokkaido 0608628, Japan.	kikkawa@eng.hokudai.ac.jp	Motohashi, Teruki/A-5780-2012; Masubuchi, Yuji/A-8434-2012	Motohashi, Teruki/0000-0002-4568-5600; Masubuchi, Yuji/0000-0003-3601-7077			KIM TK, 1972, APPL PHYS LETT, V20, P492, DOI 10.1063/1.1654030; INOUE M, 1988, INORG CHEM, V27, P215, DOI 10.1021/ic00275a001; HILL RJ, 1979, PHYS CHEM MINER, V4, P317, DOI 10.1007/BF00307535; Ohnuma S, 1996, J APPL PHYS, V79, P5130, DOI 10.1063/1.361531; Tessier F, 2000, SOLID STATE SCI, V2, P457, DOI 10.1016/S1293-2558(00)00151-5; JACK KH, 1951, PROC R SOC LON SER-A, V208, P200, DOI 10.1098/rspa.1951.0154; JACK KH, 1994, J APPL PHYS, V76, P6620, DOI 10.1063/1.358482; Kikkawa S, 2008, MATER RES BULL, V43, P3352, DOI 10.1016/j.materresbull.2008.02.008; Masubuchi Y, 2011, J EUR CERAM SOC, V31, P2471, DOI 10.1016/j.jeurceramsoc.2011.02.001; Nagatomi A., 1999, J JPN SOC POWDER POW, V46, P151; NAKAJIMA K, 1990, APPL PHYS LETT, V56, P92, DOI 10.1063/1.102614; Sato H., 2014, J CERAM SOC JPN, V122, P238; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; SUGITA Y, 1994, J APPL PHYS, V76, P6637, DOI 10.1063/1.358157; TAKAHASHI M, 1994, J APPL PHYS, V76, P6642, DOI 10.1063/1.358431; Wiedenmeyer M, 2013, Z ANORG ALLG CHEM, V639, P2851; Yamamoto S, 2013, CHEM COMMUN, V49, P7708, DOI 10.1039/c3cc43590c; Yamanaka K, 2010, J SOLID STATE CHEM, V183, P2236, DOI 10.1016/j.jssc.2010.07.045; Yamashita S, 2012, J SOLID STATE CHEM, V194, P76, DOI 10.1016/j.jssc.2012.07.025	19	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	FEB	2015	222						111	114		10.1016/j.jssc.2014.11.018		4	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	CA0WH	WOS:000348633800017		
J	Yoshihara, H; Yoneoka, D				Yoshihara, Hiroyuki; Yoneoka, Daisuke			Incidental Dural Tear in Cervical Spine Surgery Analysis of a Nationwide Database	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						dural tear; cervical spine surgery; incidence; risk factor; complication; hospital stay; nationwide inpatient sample	CEREBROSPINAL-FLUID LEAKAGE; LUMBAR SPINE; RISK-FACTORS; UNINTENDED DUROTOMY; MANAGEMENT; COMPLICATIONS; SECONDARY	Study Design: This was a retrospective study. Objective: To report the incidence of incidental dural tear (DT) in cervical spine surgery, risk factors, and in-hospital patient outcomes on a national level. Summary of Background Data: DT during cervical spine surgery is not as common as that during lumbar spine surgery; however, DT is still a difficult complication. Methods: Clinical data were obtained from the US Nationwide Inpatient Sample for 2009. Patients who underwent cervical spine surgery were identified and divided into those with and without DT according to the International Classification of Diseases, 9th revision, Clinical Modification codes. The patient and health care system-related demographic data were retrieved. The incidence of DT and patient outcomes were analyzed. A multivariate logistic regression analysis was performed to identify the risk factors for DT. Results: The incidence of DT was 0.45% (855/190,021). The multivariate analysis revealed that a diagnosis of myelopathy and ossification of the posterior longitudinal ligament; posterior approach, anterior and posterior approach; and insurance status were the significant risk factors for DT. Comparison between patients with and without DT showed that those with DT had significantly higher overall in-hospital complications (21.6% vs. 7.3%), longer hospital stays (6.0 vs. 3.2 d), a lower proportion who were discharged home routinely (66.3% vs. 83.9%), increased total hospital costs ($96,424 vs. $62,416), and similar in-hospital mortality (0.6% vs. 0.4%). Conclusions: The incidence of DT in cervical spine surgery was 0.45% in the United States. The risk of DT was highest with a primary diagnosis of the ossification of the posterior longitudinal ligament (58.4 times). DT significantly increased the rate of in-hospital complications and health care burden.	[Yoshihara, Hiroyuki] NYU Hosp Joint Dis, Dept Orthopaed Surg, New York, NY USA; [Yoneoka, Daisuke] Grad Univ Adv Studies, Sch Adv Sci, Dept Stat Sci, Tokyo, Japan	Yoshihara, H (reprint author), 301 East 17th St, New York, NY 10003 USA.	hiroyoshihara55@yahoo.co.jp					Wang JC, 1998, J BONE JOINT SURG AM, V80A, P1728; Cammisa FP, 2000, SPINE, V25, P2663, DOI 10.1097/00007632-200010150-00019; Khan MH, 2006, SPINE, V31, P2609, DOI 10.1097/01.brs.0000241066.55849.41; McMahon P, 2012, J NEUROSURG-SPINE, V17, P30, DOI 10.3171/2012.3.SPINE11939; Jankowitz BT, 2009, EUR SPINE J, V18, P1169, DOI 10.1007/s00586-009-0928-6; Teli M, 2010, EUR SPINE J, V19, P443, DOI 10.1007/s00586-010-1290-4; Narotam PK, 2004, SPINE, V29, P2861, DOI 10.1097/01.brs.0000148049.69541.ad; Espiritu MT, 2010, J AM ACAD ORTHOP SUR, V18, P537; KITCHEL SH, 1989, J BONE JOINT SURG AM, V71A, P984; Tafazal SI, 2005, EUR SPINE J, V14, P287, DOI 10.1007/s00586-004-0821-2; Sin AH, 2006, J NEUROSURG-SPINE, V5, P224, DOI 10.3171/spi.2006.5.3.224; Takahashi Y, 2013, J NEUROSURG-SPINE, V18, P165, DOI 10.3171/2012.10.SPINE12271; Hannallah D, 2008, J BONE JOINT SURG AM, V90A, P1101, DOI 10.2106/JBJS.F.01114; Pechlivanis I, 2009, CENT EUR NEUROSURG, V70, P137, DOI 10.1055/s-0029-1216361; Baker GA, 2012, SPINE J, V12, P121, DOI 10.1016/j.spinee.2012.01.012; Wang MC, 2007, SPINE, V32, P342, DOI 10.1097/01.brs.0000254120.25411.ae; Epstein NE, 2007, J SPINAL DISORD TECH, V20, P380, DOI 10.1097/BSD.0b013e31802dabd2; Guerin P, 2012, INJURY, V43, P397, DOI 10.1016/j.injury.2010.12.014; Fountas KN, 2005, SPINE, V30, pE277, DOI 10.1097/01.brs.0000162399.93992.5c; Ruban D, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11122; STOLKE D, 1989, SPINE, V14, P56, DOI 10.1097/00007632-198901000-00011; Stromqvist F, 2012, EUR SPINE J, V21, P825, DOI 10.1007/s00586-011-2101-2; Stromqvist F, 2010, EUR SPINE J, V19, P439, DOI 10.1007/s00586-009-1236-x; Wiese Matthias, 2004, Spine J, V4, P550, DOI 10.1016/j.spinee.2004.02.007; Williams BJ, 2011, NEUROSURGERY, V68, P117, DOI 10.1227/NEU.0b013e3181fcf14e	25	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	FEB	2015	28	1					19	24				6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AZ5WI	WOS:000348288700013		
J	Oshima, S; Sudo, H; Ito, M; Abumi, K				Oshima, Shigeki; Sudo, Hideki; Ito, Manabu; Abumi, Kuniyoshi			Subaxial Sagittal Alignment After Atlantoaxial Fixation Techniques	JOURNAL OF SPINAL DISORDERS & TECHNIQUES			English	Article						C1 lateral mass screw; Magerl procedure; C1-C2 fixation angle; subaxial sagittal alignment	TRANSARTICULAR SCREW FIXATION; POSTERIOR C1-C2 FUSION; RHEUMATOID-ARTHRITIS; CERVICAL-SPINE; VERTEBRAL ARTERY; POLYAXIAL SCREW; LATERAL MASS; SUBLUXATION; ARTHRODESIS; INSTABILITY	Study Design: A retrospective clinical case series. Objectives: To evaluate the association between C1-C2 fixation angle and postoperative C2-C7 alignment in the sagittal plane after C1 lateral mass screw with C2 pedicle screw fixation (C1-LMS) or Magerl with wiring technique. Summary of Background Data: Various techniques for posterior correction and fusion, such as the Magerl procedure with posterior wiring and C1-LMS procedures, are used for treating atlantoaxial instability. However, only few studies investigating the relationship between postoperative C1-C2 angle and C2-C7 sagittal alignment change after C1-C2 fixation have been reported. Methods: We retrospectively followed up 42 patients who underwent the C1-LMS (22 patients) or Magerl with wiring procedure (20 patients) to treat C1-C2 instability for > 2 years. The atlantodental interval, space available for the spinal cord, and O-C1, C1-C2, C2-C3, and C2-C7 angles were measured. Results: Significant reduction in atlantodental interval and increase in space available for the spinal cord were observed in both groups. Although the preoperative C1-C2 angles were similar, the angle at the final follow-up was higher in the Magerl with wiring group than in the C1-LMS group (P < 0.01). The C1-C2 fixation and postoperative C2-C7 angles were negatively correlated in both groups (C1-LMS group, r = -0.55, P < 0.01; Magerl with wiring, r = -0.62, P < 0.01). Conclusions: Increased lordotic change in the C1-C2 angle was associated with increased kyphotic changes in the C2-C7 angle after both procedures. The C1-LMS procedure effectively controlled C1-C2 sagittal alignment during surgery. To decrease the risk of postoperative subaxial kyphotic changes, the C1-C2 fixation angle should be carefully determined.	[Oshima, Shigeki] Hokkaido Univ, Grad Sch Med, Hokkaido Orthopaed Mem Hosp, Sapporo, Hokkaido 0608638, Japan; [Sudo, Hideki; Ito, Manabu] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido 0608638, Japan; [Abumi, Kuniyoshi] Sapporo Orthopaed Hosp, Sapporo, Hokkaido, Japan	Sudo, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	hidekisudo@yahoo.co.jp					Gluf WM, 2005, J NEUROSURG-SPINE, V2, P155, DOI 10.3171/spi.2005.2.2.0155; Kato Y, 2006, J ORTHOP SCI, V11, P347, DOI 10.1007/s00776-006-1033-x; Nagaria J, 2009, SPINE, V34, P2880, DOI 10.1097/BRS.0b013e3181b4e218; BROOKS AL, 1978, J BONE JOINT SURG AM, V60, P279; Ito H, 2009, EUR SPINE J, V18, P869, DOI 10.1007/s00586-009-0945-5; GOEL A, 1994, ACTA NEUROCHIR, V129, P47, DOI 10.1007/BF01400872; Goel A, 2005, J NEUROSURG-SPINE, V2, P505, DOI 10.3171/spi.2005.2.4.0505; Neo M, 2003, SPINE, V28, P666, DOI 10.1097/00007632-200304010-00009; Tan MS, 2003, SPINE, V28, P888, DOI 10.1097/00007632-200305010-00010; Ishii K, 2010, SPINE, V35, P1551, DOI 10.1097/BRS.0b013e3181af0d85; Yoshimoto H, 2004, SPINE, V29, P175, DOI 10.1097/01.BRS.0000107225.97653.CA; Gunnarsson T, 2007, J SPINAL DISORD TECH, V20, P308, DOI 10.1097/01.bsd.0000211291.21766.4d; Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014; Stulik J, 2007, EUR SPINE J, V16, P479, DOI 10.1007/s00586-006-0241-6; Wright NM, 1998, J NEUROSURG, V88, P634, DOI 10.3171/jns.1998.88.4.0634; Fiore Amory J, 2002, Neurosurg Focus, V12, pE5; Gallie WE, 1939, AM J SURG, V46, P495, DOI 10.1016/S0002-9610(39)90309-0; Haid RW, 2001, NEUROSURGERY, V49, P65, DOI 10.1097/00006123-200107000-00010; Magerl F., 1987, CERVICAL SPINE, V1, P322; Matsumoto M, 2005, J NEUROSURG-SPINE, V2, P23, DOI 10.3171/spi.2005.2.1.0023; Mukai Y, 2007, J SPINAL DISORD TECH, V20, P436, DOI 10.1097/BSD.0b013e318030ca3b; Naderi S, 1998, SPINE, V23, P1946, DOI 10.1097/00007632-199809150-00005; Nojiri K, 2003, J NEUROSURG, V99, P80, DOI 10.3171/spi.2003.99.1.0080; TOYAMA Y, 1994, SPINE, V19, P2565, DOI 10.1097/00007632-199411001-00012	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1536-0652	1539-2465		J SPINAL DISORD TECH	J. Spinal Disord. Tech.	FEB	2015	28	1					E49	E55				7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AZ5WI	WOS:000348288700008		
J	Voigt, JU; Pedrizzetti, G; Lysyansky, P; Marwick, TH; Houle, H; Baumann, R; Pedri, S; Ito, Y; Abe, Y; Metz, S; Song, JH; Hamilton, J; Sengupta, PP; Kolias, TJ; d'Hooge, J; Aurigemma, GP; Thomas, JD; Badano, LP				Voigt, Jens-Uwe; Pedrizzetti, Gianni; Lysyansky, Peter; Marwick, Tom H.; Houle, Helene; Baumann, Rolf; Pedri, Stefano; Ito, Yasuhiro; Abe, Yasuhiko; Metz, Stephen; Song, Joo Hyun; Hamilton, Jamie; Sengupta, Partho P.; Kolias, Theodore J.; d'Hooge, Jan; Aurigemma, Gerard P.; Thomas, James D.; Badano, Luigi Paolo			Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						Echocardiography; Two-dimensional; Deformation imaging; Strain; Strain rate; Speckle tracking; Left ventricle; Myocardial; Standard; Definitions	MYOCARDIAL DEFORMATION; STRAIN; STATEMENT	Recognizing the critical need for standardization in strain imaging, in 2010, the European Association of Echocardiography (now the European Association of Cardiovascular Imaging, EACVI) and the American Society of Echocardiography (ASE) invited technical representatives from all interested vendors to participate in a concerted effort to reduce intervendor variability of strain measurement. As an initial product of the work of the EACVI/ASE/Industry initiative to standardize deformation imaging, we prepared this technical document which is intended to provide definitions, names, abbreviations, formulas, and procedures for calculation of physical quantities derived from speckle tracking echocardiography and thus create a common standard.	[Voigt, Jens-Uwe; d'Hooge, Jan] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Cardiovasc Dis, Leuven, Belgium; [Pedrizzetti, Gianni] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [Pedrizzetti, Gianni; Sengupta, Partho P.] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA; [Lysyansky, Peter] GE Healthcare, Haifa, Israel; [Marwick, Tom H.] Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Houle, Helene] Siemens Med Solut, Ultrasound Div, Mountain View, CA USA; [Baumann, Rolf] Tomtec Imaging Syst, Unterschleissheim, Germany; [Pedri, Stefano] Esaote SpA, Genoa, Italy; [Ito, Yasuhiro] Hitachi Aloka Med Ltd, Mitaka, Tokyo, Japan; [Abe, Yasuhiko] Toshiba Med Syst Corp, Otawara, Tochigi, Japan; [Metz, Stephen] Philips Healthcare, Andover, MA USA; [Song, Joo Hyun] SamsungMedison, Seoul, South Korea; [Hamilton, Jamie] Epsilon Imaging Inc, Ann Arbor, MI USA; [Kolias, Theodore J.] Univ Michigan, Div Cardiol, Ann Arbor, MI 48109 USA; [Aurigemma, Gerard P.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Thomas, James D.] Cleveland Clin Fdn, Dept Cardiol, Cardiovasc Imaging Ctr, Cleveland, OH 44195 USA; [Badano, Luigi Paolo] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Sci, I-35128 Padua, Italy	Voigt, JU (reprint author), Amer Soc Echocardiog, 2100 Gateway Ctr Blvd,Suite 310, Morrisville, NC 27560 USA.	ase@asecho.org		Badano, Luigi/0000-0002-0379-3283			Marwick TH, 2012, J AM SOC ECHOCARDIOG, V25, P1204, DOI 10.1016/j.echo.2012.09.017; Manovel A, 2010, EUR J ECHOCARDIOGR, V11, P417, DOI 10.1093/ejechocard/jep226; Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; Nelson MR, 2012, J AM SOC ECHOCARDIOG, V25, P1189, DOI 10.1016/j.echo.2012.08.006; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Yodwut C, 2012, J AM SOC ECHOCARDIOG, V25, P978, DOI 10.1016/j.echo.2012.06.001; Saito K, 2009, J AM SOC ECHOCARDIOG, V22, P1025, DOI 10.1016/j.echo.2009.05.021; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Mondillo S, 2011, J ULTRAS MED, V30, P71; Negishi K, 2013, ULTRASOUND MED BIOL, V39, P714, DOI 10.1016/j.ultrasmedbio.2012.11.021; Bansal M, 2008, J AM SOC ECHOCARDIOG, V21, P1318, DOI 10.1016/j.echo.2008.09.021; Badano LP, 2013, EUR HEART J-CARD IMG, V14, P285, DOI 10.1093/ehjci/jes184; D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P453; Moen CA, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-32; Takigiku K, 2012, CIRC J, V76, P262; Thomas JD, 2014, EUR HEART J CARDIOVA, V14, P1039; Thomas JD, 2013, J AM SOC ECHOCARDIOG, V26, p21A; Voigt JU, 2010, PRAXIS ECHOKARDIOGRA; Xiao H, 2002, J ELASTICITY, V67, P1, DOI 10.1023/A:1022597823377	21	13	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	FEB	2015	28	2					183	193		10.1016/j.echo.2014.11.003		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AZ8HU	WOS:000348457200003		
J	Takeuchi, Y; Mishima, E; Shima, H; Akiyama, Y; Suzuki, C; Suzuki, T; Kobayashi, T; Suzuki, Y; Nakayama, T; Takeshima, Y; Vazquez, N; Ito, S; Gamba, G; Abe, T				Takeuchi, Yoichi; Mishima, Eikan; Shima, Hisato; Akiyama, Yasutoshi; Suzuki, Chitose; Suzuki, Takehiro; Kobayashi, Takayasu; Suzuki, Yoichi; Nakayama, Tomohiro; Takeshima, Yasuhiro; Vazquez, Norma; Ito, Sadayoshi; Gamba, Gerardo; Abe, Takaaki			Exonic Mutations in the SLC12A3 Gene Cause Exon Skipping and Premature Termination in Gitelman Syndrome	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							NA-CL COTRANSPORTER; SPINAL MUSCULAR-ATROPHY; MISSENSE MUTATIONS; EXPRESSION; NONSENSE; DISEASE; MUTANT	A variety of genetic backgrounds cause the loss of function of thiazide-sensitive sodium chloride co-transporter, encoded by SLC12A3, responsible for the phenotypes in Gitelman syndrome. Recently, the phenomenon of exon skipping, in which exonic mutations result in abnormal splicing, has been associated with various diseases. Specifically, mutations in exonic splicing enhancer (ESE) sequences can promote exon skipping. Here, we used a bioinformatics program to analyze 88 missense mutations in the SLC12A3 gene and identify candidate mutations that may induce exon skipping. The three candidate mutations that reduced ESE scores the most were further investigated by minigene assay, and two (p.A356V and p.M672I) caused abnormal splicing in vitro. Furthermore, we identified the p.M672I (c.2016G>A) mutation in a patient with Gitelman syndrome and found that this single nucleotide mutation causes exclusion of exon 16 in the SLC12A3 mRNA transcript. Functional analyses revealed that the protein encoded by the aberrant SLC12A3 transcript does not transport sodium. These results suggest that aberrant exon skipping is one previously unrecognized mechanism by which missense mutations in SLC12A3 can lead to Gitelman syndrome.	[Takeuchi, Yoichi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi 9808574, Japan; [Takeuchi, Yoichi; Mishima, Eikan; Shima, Hisato; Akiyama, Yasutoshi; Suzuki, Chitose; Suzuki, Takehiro; Ito, Sadayoshi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan; [Kobayashi, Takayasu] Tohoku Univ, Inst Dev Aging & Canc, Dept Biochem, Sendai, Miyagi 9808574, Japan; [Suzuki, Yoichi] Tohoku Univ, Tohoku Med Megabank Org, Dept Educ & Training, Sendai, Miyagi 9808574, Japan; [Nakayama, Tomohiro] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med, Tokyo, Japan; [Takeshima, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 657, Japan; [Vazquez, Norma; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mol Physiol Unit, Mexico City 04510, DF, Mexico; [Vazquez, Norma; Gamba, Gerardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico	Abe, T (reprint author), Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	takaabe@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390033]; Japan Kidney Foundation; S Foundation; Miyagi Kidney Foundation; Conacyt (Mexico) [165815, 180075]	We thank Shoji Tsutaya and Minoru Yasujima (Hirosaki University) for analyzing the genomic data of the patient's family, Toru Kikuchi (Shichinohe Public Hospital) for obtaining the patient's blood, and the patient with GS for her kind participation in this study. This work was supported in part by National grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23390033); the Japan Kidney Foundation the S Foundation and the Miyagi Kidney Foundation; and grants 165815 and 180075 from Conacyt (Mexico) to G.G.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Riveira-Munoz E, 2007, J AM SOC NEPHROL, V18, P1271, DOI 10.1681/ASN.2006101095; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Heintz C, 2012, MOL GENET METAB, V106, P403, DOI 10.1016/j.ymgme.2012.05.013; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Glaudemans B, 2012, EUR J HUM GENET, V20, P263, DOI 10.1038/ejhg.2011.189; Gong QM, 2007, CIRCULATION, V116, P17, DOI 10.1161/CIRCULATIONAHA.107.708818; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Ho PY, 2008, BIOCHEM BIOPH RES CO, V373, P515, DOI 10.1016/j.bbrc.2008.06.072; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643; Liu HX, 2001, NAT GENET, V27, P55; Lo YF, 2011, CLIN J AM SOC NEPHRO, V6, P630, DOI 10.2215/CJN.06730810; Naraba H, 2005, HYPERTENS RES, V28, P805, DOI 10.1291/hypres.28.805; Raponi M, 2011, HUM MUTAT, V32, P436, DOI 10.1002/humu.21458; Reissinger A, 2002, KIDNEY BLOOD PRESS R, V25, P354, DOI 10.1159/000068695; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Santamaria Raül, 2008, BMC Res Notes, V1, P137, DOI 10.1186/1756-0500-1-137; Schmidt H, 2001, HORM METAB RES, V33, P354, DOI 10.1055/s-2001-15417; Tran HTT, 2005, MOL GENET METAB, V85, P213, DOI 10.1016/j.ymgme.2005.03.006; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zucker M, 2011, J THROMB HAEMOST, V9, P1977, DOI 10.1111/j.1538-7836.2011.04426.x	29	0	1	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	FEB	2015	26	2					271	279		10.1681/ASN.2013091013		9	Urology & Nephrology	Urology & Nephrology	CA0RG	WOS:000348623700007		
J	Nordquist, L; Friederich-Persson, M; Fasching, A; Liss, P; Shoji, K; Nangaku, M; Hansell, P; Palm, F				Nordquist, Lina; Friederich-Persson, Malou; Fasching, Angelica; Liss, Per; Shoji, Kumi; Nangaku, Masaomi; Hansell, Peter; Palm, Fredrik			Activation of Hypoxia-Inducible Factors Prevents Diabetic Nephropathy	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							TUBULAR EPITHELIAL-CELLS; OXIDATIVE STRESS; RENAL INJURY; SUPEROXIDE-DISMUTASE; TRANSCRIPTIONAL REGULATION; TUBULOINTERSTITIAL INJURY; UNCOUPLING PROTEIN-2; OXYGEN-CONSUMPTION; GENE-EXPRESSION; NITRIC-OXIDE	Hyperglycemia results in increased oxygen consumption and decreased oxygen tension in the kidney. We tested the hypothesis that activation of hypoxia-inducible factors (HIFs) protects against diabetes-induced alterations in oxygen metabolism and kidney function. Experimental groups consisted of control and streptozotocin-induced diabetic rats treated with or without chronic cobalt chloride to activate HIFs. We elucidated the involvement of oxidative stress by studying the effects of acute administration of the superoxide dismutase mimetic tempol. Compared with controls, diabetic rats displayed tissue hypoxia throughout the kidney, glonnerular hyperfiltration, increased oxygen consumption, increased total mitochondrial leak respiration, and decreased tubular sodium transport efficiency. Diabetic kidneys showed proteinuria and tubulointerstitial damage. Cobalt chloride activated HIFs, prevented the diabetes-induced alterations in oxygen metabolism, mitochondrial leak respiration, and kidney function, and reduced proteinuria and tubulointerstitial damage. The beneficial effects of tempol were less pronounced after activation of HIFs, indicating improved oxidative stress status. In conclusion, activation of HIFs prevents diabetes-induced alteration in kidney oxygen metabolism by normalizing glomerular filtration, which reduces tubular electrolyte load, preventing mitochondrial leak respiration and improving tubular transport efficiency. These improvements could be related to reduced oxidative stress and account for the reduced proteinuria and tubulointerstitial damage. Thus, pharnnacologic activation of the HIF system may prevent development of diabetic nephropathy.	[Nordquist, Lina; Friederich-Persson, Malou; Fasching, Angelica; Hansell, Peter; Palm, Fredrik] Uppsala Univ, Dept Med Cell Biol, Div Integrat Physiol, S-75123 Uppsala, Sweden; [Liss, Per] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, S-75123 Uppsala, Sweden; [Shoji, Kumi; Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Tokyo 113, Japan; [Palm, Fredrik] Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden; [Palm, Fredrik] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden	Palm, F (reprint author), Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Box 571, S-75123 Uppsala, Sweden.	Fredrik.Palm@mcb.uu.se			Swedish Medical Research Council; Swedish Society for Medical Research; Swedish Heart-Lung Foundation; Swedish Diabetes Foundation; Japanese Society for Promotion of Science [24390213]	This study was supported by the Swedish Medical Research Council, the Swedish Society for Medical Research, the Swedish Heart-Lung Foundation, the Swedish Diabetes Foundation, and Japanese Society for Promotion of Science Grant-in-Aid for Scientific Research 24390213 (to M.N.).	Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Eto N, 2007, KIDNEY INT, V72, P455, DOI 10.1038/sj.ki.5002311; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; Palm F, 2004, DIABETOLOGIA, V47, P1223, DOI 10.1007/s00125-004-1434-3; Friederich M, 2008, BBA-BIOENERGETICS, V1777, P935, DOI 10.1016/j.bbabio.2008.03.030; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; DeRubertis FR, 2004, DIABETES, V53, P762, DOI 10.2337/diabetes.53.3.762; Bahlmann FH, 2004, CIRCULATION, V110, P1006, DOI 10.1161/01.CIR.0000139335.04152.F3; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; RISDON RA, 1968, LANCET, V2, P363; Katavetin P, 2007, BIOCHEM BIOPH RES CO, V359, P928, DOI 10.1016/j.bbrc.2007.05.207; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Luan JJ, 2012, J PHARMACOL SCI, V119, P167, DOI 10.1254/jphs.12002FP; Persson MF, 2012, DIABETOLOGIA, V55, P1535, DOI 10.1007/s00125-012-2469-5; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; Palm F, 2011, AM J PHYSIOL-REG I, V301, pR1229, DOI 10.1152/ajpregu.00720.2010; SEMENZA GL, 1994, HUM MUTAT, V3, P180, DOI 10.1002/humu.1380030304; Moreno JM, 2008, AM J PHYSIOL-REG I, V294, pR867, DOI 10.1152/ajpregu.00665.2007; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Chen XG, 2007, AM J PHYSIOL-HEART C, V293, pH3246, DOI 10.1152/ajpheart.00957.2007; Friederich-Persson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039635; Friederich-Persson M, 2013, HYPERTENSION, V62, P914, DOI 10.1161/HYPERTENSIONAHA.113.01425; Guron GS, 2006, J HYPERTENS, V24, P387, DOI 10.1097/01.hjh.0000200511.02700.99; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Masuda Y, 2001, AM J PATHOL, V159, P599, DOI 10.1016/S0002-9440(10)61731-2; Mobasheri A, 2006, ANN NY ACAD SCI, V1091, P83, DOI 10.1196/annals.1378.057; Norman JT, 2006, CLIN EXP PHARMACOL P, V33, P989, DOI 10.1111/j.1440-1681.2006.04476.x; Rodriguez-lturbe B, 2005, KIDNEY INT S, V99, pS82; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Rudnicki M, 2009, LAB INVEST, V89, P337, DOI 10.1038/labinvest.2008.158; Schnackenberg CG, 1998, HYPERTENSION, V32, P59; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447; Son D, 2008, AM J PHYSIOL-RENAL, V294, pF62, DOI 10.1152/ajprenal.00113.2007; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; TELIB M, 1973, ENDOKRINOLOGIE, V61, P395; Vasudevan H, 2007, BIOMETALS, V20, P129, DOI 10.1007/s10534-006-9020-4; Yanes L, 2005, AM J PHYSIOL-REG I, V288, pR903, DOI 10.1152/ajpregu.00530.2004; Yang ZZ, 2003, AM J PHYSIOL-RENAL, V284, pF1207, DOI 10.1152/ajprenal.00017.2002	44	7	8	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	FEB	2015	26	2					328	338		10.1681/ASN.2013090990		11	Urology & Nephrology	Urology & Nephrology	CA0RG	WOS:000348623700012		
J	Sassa, C; Takahashi, M; Tsukamoto, Y				Sassa, Chiyuki; Takahashi, Motomitsu; Tsukamoto, Youichi			Distribution, hatch-date, growth, and mortality of larval Benthosema pterotum (Pisces: Myctophidae) in the shelf region of the East China Sea	JOURNAL OF THE MARINE BIOLOGICAL ASSOCIATION OF THE UNITED KINGDOM			English	Article						Benthosema pterotum; early life history; hatch-date; larval distribution; larval growth; larval mortality; mesopelagic fish; Myctophidae; pseudoceanic species; shelf region of the East China Sea	MESOPELAGIC FISH LARVAE; WESTERN NORTH PACIFIC; MACKEREL TRACHURUS-JAPONICUS; KUROSHIO CURRENT REGION; DIAPHUS SLENDER-TYPE; GULF-OF-MEXICO; VERTICAL-DISTRIBUTION; OTOLITH MICROSTRUCTURE; JACK MACKEREL; TELEOSTEI MYCTOPHIDAE	We examined the distribution, hatch-date, growth, and mortality of larval Benthosema pterotum, a dominant pseudoceanic myctophid in the shelf region of the East China Sea, during early autumn when the main spawning has been predicted. This species is a key species in the food web of this area. Larvae were abundant in the area south of Cheju Island (60-80 m depth), corresponding with the adult habitat. Occurrence of the larvae was restricted to the onshore side of the shelf-break salinity front, indicating that this front acted as a barrier restricting the offshore dispersion of the larvae. In the area where the larvae occurred, a cyclonic eddy is formed, which is considered to limit the dispersal of the larvae, enabling them to recruit into the area of adult habitat. Modes of hatch-date appeared from late August to early September and from mid to late September, suggesting that large-scale spawning events occurred at least twice during the spawning season. Since the modes coincided with the new moon period, B. pterotum is suggested to spawn periodically once a month around the new moon, resulting in efficient mating and fertilization. Mean absolute growth rate (0.26 mm d(-1)) and weight-specific growth rate (18.8% of dry body weight d(-1)) were higher than previously reported values of other subtropical-tropical myc-tophids, which would be related to the high food availability in the study area. Daily instantaneous mortality coefficient during the first two weeks after hatching was estimated to be 0.28 d(-1) (equivalent to 24.7% mortality d(-1)).	[Sassa, Chiyuki; Takahashi, Motomitsu; Tsukamoto, Youichi] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Nagasaki 8512213, Japan	Sassa, C (reprint author), Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, 1551-8 Taira Machi, Nagasaki 8512213, Japan.	csassa@fra.affrc.go.jp			Study of Kuroshio Ecosystem Dynamics for Sustainable Fisheries (SKED) programme of the MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan)	This work was partially supported by grants from the Study of Kuroshio Ecosystem Dynamics for Sustainable Fisheries (SKED) programme of the MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan).	Ahlstrom E. H., 1959, Fishery Bulletin United States, V60, P107; Ahlstrom E. H., 1996, EARLY STAGES FISHES, V33, P387; Tsukamoto K, 2003, ENVIRON BIOL FISH, V66, P221, DOI 10.1023/A:1023926705906; Sassa C, 2004, FISH OCEANOGR, V13, P267, DOI 10.1111/j.1365-2419.2004.00289.x; Okazaki Y, 2007, CONT SHELF RES, V27, P1616, DOI 10.1016/j.csr.2007.01.024; Bartsch J, 2004, FISH OCEANOGR, V13, P365, DOI 10.1111/j.1365-2419.2004.00305.x; Watanabe Hikaru, 2010, Bulletin of the Japanese Society of Fisheries Oceanography, V74, P153; Sassa C, 2010, MAR ECOL PROG SER, V407, P227, DOI 10.3354/meps08526; Sassa C, 2014, J PLANKTON RES, V36, P542, DOI 10.1093/plankt/fbt134; Sassa C, 2006, FISHERIES SCI, V72, P612, DOI 10.1111/j.1444-2906.2006.01191.x; SABATES A, 1990, DEEP-SEA RES, V37, P1085, DOI 10.1016/0198-0149(90)90052-W; Wagner HJ, 2007, DEEP-SEA RES PT I, V54, P1944, DOI 10.1016/j.dsr.2007.08.005; MOSER HG, 1993, B MAR SCI, V53, P283; Conley WJ, 2009, B MAR SCI, V84, P123; Isobe A, 2008, J OCEANOGR, V64, P569, DOI 10.1007/s10872-008-0048-7; REID SB, 1991, MAR BIOL, V109, P427, DOI 10.1007/BF01313508; Sassa C, 2014, J MAR BIOL ASSOC UK, V94, P423, DOI 10.1017/S0025315413001318; Sassa C, 2013, DEEP-SEA RES PT I, V81, P49, DOI 10.1016/j.dsr.2013.07.008; HOUDE ED, 1993, B MAR SCI, V53, P290; Sassa C, 2002, FISH OCEANOGR, V11, P1, DOI 10.1046/j.1365-2419.2002.00182.x; Dypvik E, 2013, DEEP-SEA RES PT I, V72, P9, DOI 10.1016/j.dsr.2012.10.012; Takemura A, 2010, J FISH BIOL, V76, P7, DOI 10.1111/j.1095-8649.2009.02481.x; Nakata H, 2000, J SEA RES, V44, P91, DOI 10.1016/S1385-1101(00)00042-3; YAMASHITA Y, 1989, FISH B-NOAA, V87, P525; LINKOWSKI TB, 1985, J FISH BIOL, V27, P683, DOI 10.1111/j.1095-8649.1985.tb03213.x; BADCOCK J, 1976, Progress in Oceanography, V7, P3, DOI 10.1016/0079-6611(76)90003-3; Brodeur R.D., 2005, 30 PICES; Bystydzienska ZE, 2010, ENVIRON BIOL FISH, V89, P493, DOI 10.1007/s10641-010-9681-2; CLARKE TA, 1973, FISH B-NOAA, V71, P401; GARTNER JV, 1993, B MAR SCI, V52, P721; GARTNER JV, 1991, MAR BIOL, V111, P11, DOI 10.1007/BF01986339; Gartner JV, 2008, MAR BIOL, V153, P825, DOI 10.1007/s00227-007-0855-1; GJOSAETER J, 1984, DEEP-SEA RES, V31, P1019; Gjosaeter J., 1973, Sarsia, VNo. 52, P1; Gjosaeter J., 1981, SERIE HAVUNDERSOKELS, V17, P133; Gjosaeter J, 1980, FAO FISH TECH PAP, V193, P1; GJOSAETER J, 1988, MAR BIOL, V98, P1, DOI 10.1007/BF00392652; HALLIDAY RG, 1970, J FISH RES BOARD CAN, V27, P105; Hayashi A, 2001, FISHERIES SCI, V67, P811, DOI 10.1046/j.1444-2906.2001.00327.x; HEWITT RP, 1985, MAR ECOL PROG SER, V26, P1, DOI 10.3354/meps026001; Houde E.D., 1987, AM FISH SOC S, V2, P17; HULLEY PA, 1992, MAR BIOL, V114, P365, DOI 10.1007/BF00350027; Ishihara Shoko, 1995, Bulletin of Institute of Oceanic Research and Development Tokai University, V16, P1; Ishihara S, 1997, NIPPON SUISAN GAKK, V63, P522; Jiang RiJin, 2012, Journal of Fisheries of China, V36, P216; Jiang Ri-jin, 2013, Yingyong Shengtai Xuebao, V24, P2015; JOHNSON D.L., 1994, NAFO SCI COUNC STUD, V20, P85; Kondo M, 1985, B SEIKAI REG FISH RE, V62, P19; Linkowski TB, 1996, MAR BIOL, V124, P495, DOI 10.1007/BF00351031; Loeb VJ, 1979, FISH B US, V77, P777; Mio S., 1984, B SEIKAI REGIONAL FI, V61, P1; Moku M, 2001, ICHTHYOL RES, V48, P385, DOI 10.1007/s10228-001-8162-1; Moku M, 2005, J FISH BIOL, V67, P1481, DOI 10.1111/j.1095-8649.2005.00824.x; Moku M, 2004, COPEIA, P647, DOI 10.1643/CI-03-113R; MOSER HG, 1993, B MAR SCI, V53, P645; Motoda S, 1971, B FAC FISH HOKKAIDO, V22, P101; Motoda S., 1957, INF B PLANKTOL JAPAN, V4, P13; Nakata H., 1989, TRANSPORT DISTRIBUTI, V191, P153; NAKATA K, 1994, MAR BIOL, V119, P591, DOI 10.1007/BF00354322; Olivar M.P., 2014, J MARINE SY IN PRESS; Omori M, 1965, J OCEANOGR SOC JAPAN, V21, P20; Ozawa T., 1986, STUDIES OCEANIC ICHT; OZAWA T, 1990, NIPPON SUISAN GAKK, V56, P1987; PRESTIDGE MC, 1995, ICES J MAR SCI, V52, P693, DOI 10.1016/1054-3139(95)80082-4; ROPKE A, 1993, MAR ECOL PROG SER, V101, P223, DOI 10.3354/meps101223; Sassa C, 2006, J OCEANOGR, V62, P143, DOI 10.1007/s10872-006-0040-z; SMITH P E, 1977, FAO (Food and Agriculture Organization of the United Nations) Fisheries Technical Paper, V175, P1; Suthers IM, 1996, MAR FRESHWATER RES, V47, P273, DOI 10.1071/MF9960273; Takagi K, 2006, ICHTHYOL RES, V53, P281, DOI 10.1007/s10228-006-0346-2; Thresher RE, 1984, REPROD REEF FISHES; Watanabe Y, 1997, CAN J FISH AQUAT SCI, V54, P1067, DOI 10.1139/cjfas-54-5-1067; Yamada U, 2007, FISHES FISHERIES E C; Yanagi T., 1996, J OCEANOGR, V52, P763, DOI DOI 10.1007/BF02239464; YOUNG JW, 1988, MAR BIOL, V99, P569, DOI 10.1007/BF00392564; YOUNG JW, 1987, MAR BIOL, V95, P323, DOI 10.1007/BF00409562	75	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0025-3154	1469-7769		J MAR BIOL ASSOC UK	J. Mar. Biol. Assoc. U.K.	FEB	2015	95	1					161	174		10.1017/S0025315414001209		14	Marine & Freshwater Biology	Marine & Freshwater Biology	AZ2AR	WOS:000348037500018		
J	Tsushima, Y; Uno, N; Sasaki, D; Morinaga, Y; Hasegawa, H; Yanagihara, K				Tsushima, Yuko; Uno, Naoki; Sasaki, Daisuke; Morinaga, Yoshitomo; Hasegawa, Hiroo; Yanagihara, Katsunori			Quantitative RT-PCR evaluation of a rapid influenza antigen test for efficient diagnosis of influenza virus infection	JOURNAL OF VIROLOGICAL METHODS			English	Article						Influenza virus; Rapid influenza antigen detection test; Quantitative RT-PCR	REAL-TIME PCR; B VIRUSES; PERFORMANCE; COLLECTION	Influenza virus infection is diagnosed in most cases using a rapid influenza antigen diagnostic test (RIOT). However, false-negative results are a major concern. By contrast, the nucleic acid amplification test offers high sensitivity and therefore can aid the interpretation of negative RIDT results. In this study, influenza viral loads were quantified with quantitative reverse transcription-polymerase chain reaction (qRT-PCR) using viral suspensions left over after RIDT, and the performance of both methods was evaluated. qRT-PCR detected as few as 10(3) copies/mL of influenza viruses A and B, whereas RIDT showed negative results for viral loads less than 10(7) and 10(5) copies/mL of influenza viruses A and B, respectively. These results indicate that small quantities of the virus that cause false-negative RIDT results can be detected efficiently with qRT-PCR follow-up. In addition, influenza A virus subtype was determined using qRT-PCR. (C) 2014 Elsevier B.V. All rights reserved.	[Tsushima, Yuko; Uno, Naoki; Sasaki, Daisuke; Morinaga, Yoshitomo; Hasegawa, Hiroo; Yanagihara, Katsunori] Nagasaki Univ Hosp, Clin Lab, Nagasaki 8528501, Japan; [Uno, Naoki; Morinaga, Yoshitomo; Hasegawa, Hiroo; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 8528501, Japan	Uno, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	nuno@nagasaki-u.ac.jp					Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI [10.7326/0003-4819-156-7-201204030-00403, 10.1059/0003-4819-156-7-201204030-00403]; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Wu CL, 2008, J VIROL METHODS, V148, P81, DOI 10.1016/j.jviromet.2007.10.023; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Luinstra K, 2011, J CLIN MICROBIOL, V49, P2138, DOI 10.1128/JCM.00327-11; Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Centers for Disease Control and Prevention, 2013, GUID CLIN US RAP INF; Centre for Health Protection, 2009, CHP MOL DIAGN PROT D; Welch DF, 2010, J CLIN MICROBIOL, V48, P22, DOI 10.1128/JCM.02268-09; Yang YW, 2010, J VIROL METHODS, V167, P37, DOI 10.1016/j.jviromet.2010.03.007	16	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-0934	1879-0984		J VIROL METHODS	J. Virol. Methods	FEB	2015	212						76	79		10.1016/j.jviromet.2014.10.019		4	Biochemical Research Methods; Biotechnology & Applied Microbiology; Virology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Virology	CA0PY	WOS:000348620400014		
J	Kameishi, S; Sugiyama, H; Yamato, M; Sado, Y; Namiki, H; Kato, T; Okano, T				Kameishi, Sumako; Sugiyama, Hiroaki; Yamato, Masayuki; Sado, Yoshikazu; Namiki, Hideo; Kato, Takashi; Okano, Teruo			Remodeling of epithelial cells and basement membranes in a corneal deficiency model with long-term follow-up	LABORATORY INVESTIGATION			English	Article							OCULAR-SURFACE DISORDERS; HUMAN CONJUNCTIVAL EPITHELIUM; STEM-CELLS; AUTOGRAFT TRANSPLANTATION; MESENCHYMAL TRANSITION; MATRIX COMPONENTS; LIMBAL; EXPRESSION; RABBITS; TRANSDIFFERENTIATION	The ocular surface consists of the cornea, conjunctiva, and the limbus that is located in the transitional zone between the cornea and conjunctiva. The corneal epithelial cells are generated through the mitosis of corneal epithelial stem cells in the limbus. This study investigated a rabbit corneal deficiency model prepared by the surgical removal of the corneal and limbal epithelia, which express cytokeratin 12 (K12). After the surgery, K13-expressing conjunctival epithelium migrated onto the corneal surface and completely covered the surface, leading to neovascularization and corneal pacification. However, at 24 and 48 weeks after the surgery, K12-expressing cornea-like cells reappeared on the model ocular surface. These cells formed an island surrounded by invaded conjunctiva and were isolated from the limbus. Interestingly, in the 24-week model surface, alpha 1 (IV) and alpha 2(IV) collagen chains, which are normally found in the basement membrane of the native limbus and conjunctiva, and not in the cornea, were continuously deposited throughout the entire basement membrane, including the basement membrane under cornea-like cells. By contrast, in the 48-week model surface, alpha 1 (IV) and alpha 2(IV) collagen chains were absent from the basement membrane beneath the central part of cornea-like cells and were localized below the invaded conjunctiva and the transitional zone between cornea-like cells and the invaded conjunctiva, which had similar distribution to the native ocular basement membrane. Moreover, K12, K14, p63, vimentin, and alpha 1 (IV) and alpha 2(IV) collagen chains, which are colocalized in the native limbus, were all present at the transitional zone of the 48-week model surface. Therefore, a limbus-like structure appeared to be reconstructed on the surface of the 48-week model as a stem cell niche. This study should aid in the understanding of human corneal deficiency, the correlation between the epithelial cell phenotype and the composition of the basement membrane, and the epithelial stem cell niche.	[Kameishi, Sumako; Namiki, Hideo; Kato, Takashi] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Kameishi, Sumako; Sugiyama, Hiroaki; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; [Sado, Yoshikazu] Shigei Med Res Inst, Div Immunol, Okayama, Japan	Yamato, M (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, TWins 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamato.masayuki@twmu.ac.jp; tkato@waseda.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	We thank Dr Norio Ueno, Dr Ryo Takagi, Mr Daisuke Murakami, and Dr Makoto Kondo (Tokyo Women's Medical University) for their useful comments and technical criticism. This study was partially supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows, Creation of innovation centers for advanced interdisciplinary research areas Program in the Project for Developing Innovation Systems 'Cell Sheet Tissue Engineering Center (CSTEC)' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and the Global COE program, the Multidisciplinary Education and Research Center for Regenerative Medicine (MERCREM) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and Grant-in-Aid for Scientific Research on Innovative Areas 'Hyper Bio Assembler for 3D Cellular Innovation', Japan.	SHAPIRO MS, 1981, INVEST OPHTH VIS SCI, V21, P135; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; KRUSE FE, 1990, INVEST OPHTH VIS SCI, V31, P1903; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Aomatsu K, 2012, INVEST OPHTH VIS SCI, V53, P751, DOI 10.1167/iovs.11-8222; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Dua HS, 1998, BRIT J OPHTHALMOL, V82, P1407, DOI 10.1136/bjo.82.12.1407; Tsubota K, 1999, NEW ENGL J MED, V340, P1697, DOI 10.1056/NEJM199906033402201; Inatomi T, 1996, INVEST OPHTH VIS SCI, V37, P1684; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guerriero E, 2007, INVEST OPHTH VIS SCI, V48, P627, DOI 10.1167/iovs.06-0635; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814; Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293; Ti SE, 2002, INVEST OPHTH VIS SCI, V43, P2584; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Polisetty N, 2008, MOL VIS, V14, P431; MEEK KM, 1993, BIOPHYS J, V64, P273; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446; Espana EM, 2004, INVEST OPHTH VIS SCI, V45, P2961, DOI 10.1167/iovs.03-1397; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002; Wei ZG, 1996, INVEST OPHTH VIS SCI, V37, P523; Barbaro V, 2010, BRIT J OPHTHALMOL, V94, P926, DOI 10.1136/bjo.2009.164152; Boehlke CS, 2004, MOL VIS, V10, P867; BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; Espana EM, 2002, OPHTHALMOLOGY, V109, P2004, DOI 10.1016/S0161-6420(02)01250-2; Katikireddy KR, 2013, STEM CELLS, V32, P717; Kawasaki S, 2006, INVEST OPHTH VIS SCI, V47, P1359, DOI 10.1167/iovs.05-1084; KINOSHITA S, 1981, INVEST OPHTH VIS SCI, V21, P434; KINOSHITA S, 1983, INVEST OPHTH VIS SCI, V24, P1008; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083083; MARSHALL GE, 1993, BRIT J OPHTHALMOL, V77, P515, DOI 10.1136/bjo.77.8.515; Satake Y, 2008, ARCH OPHTHALMOL-CHIC, V126, P23, DOI 10.1001/archopht.126.1.23; Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Sendurai AM, 2008, CELL, V16, P704; Sugiyama H, 2014, MOL THER, V22, P1544, DOI 10.1038/mt.2014.69; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Thoft R., 1983, INVESTIG OPHTHALMOL, V10, P1442; THOFT RA, 1977, INVEST OPHTH VIS SCI, V16, P14; Thorner PS, 1996, J BIOL CHEM, V271, P13821	45	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95	2					168	179		10.1038/labinvest.2014.146		12	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA0XN	WOS:000348636900005		
J	Mizuuchi, Y; Aishima, S; Ohuchida, K; Shindo, K; Fujino, M; Hattori, M; Miyazaki, T; Mizumoto, K; Tanaka, M; Oda, Y				Mizuuchi, Yusuke; Aishima, Shinichi; Ohuchida, Kenoki; Shindo, Koji; Fujino, Minoru; Hattori, Masami; Miyazaki, Tetsuyuki; Mizumoto, Kazuhiro; Tanaka, Masao; Oda, Yoshinao			Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition	LABORATORY INVESTIGATION			English	Article							GROWTH-FACTOR-BETA; PROSTATE-CANCER; BREAST-CANCER; INTRAEPITHELIAL NEOPLASIA; THERAPEUTIC TARGET; XENOPUS-LAEVIS; STELLATE CELLS; GENE XAG-2; EXPRESSION; AGR2	Anterior gradient 2 (AGR2), a member of the protein disulfide isomerase family, has been implicated in various cancers including pancreatic ductal adenocarcinoma (PDAC) and is known to promote cancer progression. However, the prognostic value of AGR2 expression and the interaction with epithelial-mesenchymal transition (EMT) remain unclear. We investigated the clinical significance of AGR2 and EMT markers in PDAC patients by immunohistochemical analyses. Although AGR2 expression was not observed in normal pancreas, all pancreatic precursor neoplastic lesions were positive for AGR2, even at the earliest stages, including pancreatic intraepithelial neoplasia-1A, AGR2 expression was reduced in 27.7% (54/195 cases) of PDAC patients. AGR2 downregulation correlated with EMT markers (vimentin overexpression and reduced membranous E-cadherin expression), high Union for International Cancer Control stage (P< 0.0001), high histological cellular grade (P< 0.0001), and adverse outcome (P<0.0001). In vitro, targeted silencing of AGR2 in cancer cells using siRNA reduced cell proliferation, colony formation, cell invasiveness, and migration, but did not alter EMT markers. To confer a more aggressive phenotype and induce EMT in PDAC cells, we co-cultured PDAC cell lines with primary-cultured pancreatic stellate cells (PSCs) and found that AGR2 was downregulated in co-cultured PDAC cells compared with PDAC monocultures. Treatment with transforming growth factor beta-1 (TGF-beta),secreted from PSCs, decreased AGR2 expression, whereas inhibition of TGF-beta signaling using recombinant soluble human TGF-beta receptor type ll and TGF-beta-neutralizing antibodies restored AGR2 expression. We conclude that AGR2 downregulation is a useful prognostic marker, induced by EMT, and that secreted TGF-beta from PSCs may partially contribute to AGR2 downregulation in PDAC patients. AGR2 downregulation does not induce EMT or a more aggressive phenotype, but is a secondary effect of these processes in advanced PDAC.	[Mizuuchi, Yusuke; Aishima, Shinichi; Shindo, Koji; Fujino, Minoru; Hattori, Masami; Miyazaki, Tetsuyuki; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Mizuuchi, Yusuke; Shindo, Koji] Japan Soc Promot Sci, Tokyo, Japan; [Ohuchida, Kenoki; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka 812, Japan	Oda, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	oda@surgpath.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [13-3401]	We thank N Tateishi (Department of Anatomic Pathology, Kyushu University Hospital) and E Manabe (Department of Surgery and Oncology, Kyushu University Hospital) for their expert technical assistance. This study was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science Fellows (13-3401). We also thank Edanz Group Japan for revising the English used in this article.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Zhang Y, 2007, PROSTATE CANCER P D, V10, P293, DOI 10.1038/sj.pcan.4500960; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ho ME, 2013, MODERN PATHOL, V26, P849, DOI 10.1038/modpathol.2012.238; Prudkin L, 2009, MODERN PATHOL, V22, P668, DOI 10.1038/modpathol.2009.19; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Riener MO, 2014, EUR J CANCER, V50, P1722, DOI 10.1016/j.ejca.2014.04.012; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Shi CJ, 2014, LAB INVEST, V94, P409, DOI 10.1038/labinvest.2014.10; Ellenrieder V, 2001, CANCER RES, V61, P4222; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; van Heek T, 2002, AM J CLIN PATHOL, V117, P755; Schutte M, 1996, CANCER RES, V56, P2527; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; El-Hariry I, 2001, INT J CANCER, V94, P652, DOI 10.1002/ijc.1515; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Norris AM, 2013, ONCOGENE, V32, P3867, DOI 10.1038/onc.2012.394; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; Bender FC, 2000, CANCER RES, V60, P5870; Yang G, 1999, CANCER RES, V59, P5719; Darb-Esfahani S, 2012, VIRCHOWS ARCH, V461, P109, DOI 10.1007/s00428-012-1273-4; Chen R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-149; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Innes HE, 2006, BRIT J CANCER, V94, P1057, DOI 10.1038/sj.bjc.6603065; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Maresh EL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-680; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Odate S, 2013, LUNG CANCER, V79, P205, DOI 10.1016/j.lungcan.2012.12.004; Riener MO, 2009, HISTOL HISTOPATHOL, V24, P1121; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; TSANG MLS, 1995, CYTOKINE, V7, P389, DOI 10.1006/cyto.1995.0054	44	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95	2					193	206		10.1038/labinvest.2014.138		14	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA0XN	WOS:000348636900007		
J	Kang, YA; Zhang, R; Suzuki, R; Li, SQ; Rolfe, D; Truty, MJ; Chatterjees, D; Thomas, RM; Cardwell, J; Wang, Y; Wang, HM; Katz, MH; Fleming, JB				Kang, Ya'an; Zhang, Ran; Suzuki, Rei; Li, Shao-qiang; Rolfe, David; Truty, Mark J.; Chatterjees, Deyali; Thomas, Ryan M.; Cardwell, James; Wang, Yu; Wang, Huamin; Katz, Matthew H.; Fleming, Jason B.			Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype	LABORATORY INVESTIGATION			English	Article							PHASE PROTEIN MICROARRAYS; CANCER; LINES; ESTABLISHMENT; CARCINOMA; DISEASE; MODELS; TUMORS	Many commercially available cell lines have been in culture for ages, acquiring phenotypes that differ from the original cancers from which these cell lines were derived. Therefore, research on new cell lines could improve the success rates of translational research in cancer. We have developed methods for the isolation and culture of human pancreatic ductal adenocarcinoma (PDAC) cells from murine xenografts of human PDAC. We hypothesize that phenotypes of PDAC cells are modified by in vitro culture conditions over time and by in vivo implantation. Patient-derived xenografts were created in immunodeficient mice using surgically resected tumor specimens. These nnurine xenografts were then used to establish human PDAC cell lines in culture. Earlier (<5) passage and later (>20) passage cell lines were evaluated separately regarding proliferation, cell cycle, genetic mutations, invasiveness, chemosensitivity, tumorigenesis, epithelial mesenchymal transition (EMT) status, and proteomics. Later passage cells accelerated their doubling time and colony formation, and were more concentrated in the GO/G1 phase and less in the G2/M checkpoint phase. Later passage cells were more sensitive to gemcitabine and 5-fluorouracil than earlier passage cells, but all four new cell lines were more chemo-resistant compared with commercial ATCC cell lines. EMT induction was observed when establishing and passaging cell lines in vitro and furthermore by growing them as subcutaneous tumors in vivo. This study demonstrates a novel approach to the establishment of PDAC cell lines and observes a process by which newly established cell lines undergo phenotypic changes during in vitro culture and in vivo tumorigenesis. This may help explain differences of treatment effects often observed between experiments conducted in vitro, in vivo, and in human clinical trials.	[Kang, Ya'an; Zhang, Ran; Rolfe, David; Katz, Matthew H.; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Suzuki, Rei] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan; [Li, Shao-qiang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Truty, Mark J.] Mayo Clin, Dept Surg, Rochester, MN USA; [Chatterjees, Deyali] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Thomas, Ryan M.] Univ Florida, Coll Med, Dept Gen Surg, Gainesville, FL USA; [Cardwell, James] Texas Tech Hlth Sci Ctr, Sch Med, Lubbock, TX USA; [Wang, Yu] Univ Texas Med Branch, Neurodiagnost Lab, Galveston, TX 77555 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Fleming, JB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 0107,1515 Holcombe Blvd, Houston, TX 77030 USA.	jbflemin@mdanderson.org			Viragh Family Foundation; Various Donors in Pancreatic Cancer Research; Cancer Center Support Grant (CCSG); Research Animal Support Facility-Houston under NIH/NCI [P30CA016672]; NCI [CA016672]; National Institutes of Health (NIH) [T32CA009599]	This work was funded by Viragh Family Foundation and Various Donors in Pancreatic Cancer Research, and was supported by Cancer Center Support Grant (CCSG) core resources of Flow Cytometry and Cellular Imaging Facility, Functional Proteomics Reverse Phase Protein Array (RPPA) Core, and Research Animal Support Facility-Houston under NIH/NCI award (P30CA016672). STR DNA fingerprinting was done by the Cancer Center Support Grant-funded Characterized Cell Line core is funded by NCI #CA016672. This work was supported in part by National Institutes of Health (NIH) grant T32CA009599 (DR).	Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Besco JA, 2006, BRAIN RES, V1116, P50, DOI 10.1016/j.brainres.2006.07.122; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Larramendy ML, 2000, CANCER GENET CYTOGEN, V119, P132, DOI 10.1016/S0165-4608(99)00226-5; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Li ZK, 2009, CANCER RES, V69, P7851, DOI 10.1158/0008-5472.CAN-08-4002; Chang Z, 2013, CLIN CANCER RES, V19, P549, DOI 10.1158/1078-0432.CCR-12-0032; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; DOBRYNIN YV, 1963, J NATL CANCER I, V31, P1173; Hotz HG, 2000, INT J COLORECTAL DIS, V15, P136, DOI 10.1007/s003840000229; Howlader N, 2013, SEER CANC STAT REV 1; Huntsman DG, 1998, CYTOGENET CELL GENET, V83, P82, DOI 10.1159/000015134; Metildi CA, 2013, J SURG RES, V184, P290, DOI 10.1016/j.jss.2013.03.049; Yachida S, 2011, PANCREAS, V40, P905, DOI 10.1097/MPA.0b013e3182207a58	21	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	FEB	2015	95	2					207	222		10.1038/labinvest.2014.143		16	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CA0XN	WOS:000348636900008		
J	Nunokawa, M; Sokol, J				Nunokawa, Mamoru; Sokol, Janusz			The univalence of alpha-project starlike functions	MATHEMATISCHE NACHRICHTEN			English	Article						Analytic; Bazilevi functions; close-to-convex; convex; starlike; univalent functions; 30C45; 30C55	ANALYTIC-FUNCTIONS	We solve the univalence problem in the class of -project starlike function. The -project close-to-convex function, -project Bazilevi and -project phi-like functions are also considered here. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Nunokawa, Mamoru] Gunma Univ, Chiba 2600808, Japan; [Sokol, Janusz] Rzeszow Univ Technol, Dept Math, PL-35959 Rzeszow, Poland	Sokol, J (reprint author), Rzeszow Univ Technol, Dept Math, Al Powstancow Warszawy 12, PL-35959 Rzeszow, Poland.	mamoru-nuno@doctor.nifty.jp; jsokol@prz.edu.pl					Ali RM, 2012, APPL MATH LETT, V25, P268, DOI 10.1016/j.aml.2011.08.025; BRICKMAN L, 1973, B AM MATH SOC, V79, P555, DOI 10.1090/S0002-9904-1973-13200-8; Bazilevic I. E., 1955, MAT SBORNIK, V37, P471; BRICKMAN L, 1971, ILLINOIS J MATH, V15, P241; Goodman A. W., 1983, UNIVALENT FUNCTIONS, VI; GOODMAN AW, 1979, P AM MATH SOC, V73, P183, DOI 10.2307/2042288; Kobori A., 1932, MEM COLL SCI KYOTO A, V25, P279; Komatsu Y., 1944, CONFORMAL MAPPINGS; Lecko A., 1998, ANN POL MATH, V68, P107; Lecko A., 1997, MATH CLUJ, V39, P107; Liu MS, 2008, COMPLEX VAR ELLIPTIC, V53, P485, DOI 10.1080/17476930701861806; Nunokawa M., 2011, RIMS KOKYUROKU KYOTO, V1772, P91; Sheil-Small T., 1969, J LOND MATH SOC, V2, P483, DOI 10.1112/jlms/s2-1.1.483; Tsuji M., 1968, COMPLEX FUNCTIONS TH; Umezawa T., 1978, THESIS U DELAWARE; Wald J. K., 1955, TOHOKU MATH J, V7, P212	16	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0025-584X	1522-2616		MATH NACHR	Math. Nachr.	FEB	2015	288	2-3					327	333		10.1002/mana.201300017		7	Mathematics	Mathematics	CA2KF	WOS:000348736700013		
J	Okuma, T				Okuma, Tomohiro			The multiplicity of abelian covers of splice quotient singularities	MATHEMATISCHE NACHRICHTEN			English	Article						Splice quotient singularity; abelian cover; multiplicity; Primary: 14B05; Secondary: 14J17; 32S10; 32S25	SURFACE SINGULARITIES; INVARIANT CONJECTURE	From a resolution graph with certain conditions, Neumann and Wahl constructed an equisingular family of surface singularities called splice quotients. For this class some fundamental analytic invariants have been computed from their resolution graph. In this paper we give a method to compute the multiplicity of an abelian covering of a splice quotient from its resolution graph and the Galois group. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	Yamagata Univ, Dept Math Sci, Yamagata 9908560, Japan	Okuma, T (reprint author), Yamagata Univ, Dept Math Sci, Yamagata 9908560, Japan.	okuma@sci.kj.yamagata-u.ac.jp			KAKENHI [20540060]	This work was partly supported by KAKENHI 20540060. The author thanks the referees for their helpful comments and suggestions that greatly improved this paper.	WAGREICH P, 1970, AM J MATH, V92, P419, DOI 10.2307/2373333; Neumann WD, 2002, TRENDS MATH, P181; Okuma T, 2006, MATH ANN, V334, P753, DOI 10.1007/s00208-005-0693-8; Neumann WD, 2005, GEOM TOPOL, V9, P699, DOI 10.2140/gt.2005.9.699; Braun G., ARXIV08124403; Nemethi A, 2008, J LOND MATH SOC, V78, P143, DOI 10.1112/jlms/jdn020; Nemethi A, 1999, INVENT MATH, V137, P145, DOI 10.1007/s002220050327; Nemethi A., ARXIV08104129; Nemethi A, 2009, J ALGEBRAIC GEOM, V18, P135; Neumann WD, 2005, GEOM TOPOL, V9, P757, DOI 10.2140/gt.2005.9.757; Neumann WD, 2010, J EUR MATH SOC, V12, P471, DOI 10.4171/JEMS/206; Okuma T, 2010, J MATH SOC JPN, V62, P1, DOI 10.2969/jmsj/06210001; Okuma T., 2010, DEMONSTRATIO MATH, V43, P325; Okuma T, 2008, T AM MATH SOC, V360, P6643, DOI 10.1090/S0002-9947-08-04559-5; Reid M., 1997, IAS PARK CITY MATH S, V3, P3	15	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0025-584X	1522-2616		MATH NACHR	Math. Nachr.	FEB	2015	288	2-3					343	352		10.1002/mana.201010037		10	Mathematics	Mathematics	CA2KF	WOS:000348736700015		
J	Pugh, CJA; Sprung, VS; Ono, K; Spence, AL; Thijssen, DHJ; Carter, HH; Green, DJ				Pugh, Christopher J. A.; Sprung, Victoria S.; Ono, Kumiko; Spence, Angela L.; Thijssen, Dick H. J.; Carter, Howard H.; Green, Daniel J.			The Effect of Water Immersion during Exercise on Cerebral Blood Flow	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CEREBRAL BLOOD FLOW; WATER IMMERSION; EXERCISE; TRANSCRANIAL DOPPLER	OUT AQUATIC EXERCISES; PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; DYNAMIC EXERCISE; HUMANS; HEAD; RESPONSES; MECHANISMS; STROKE; LAND	Introduction Regular exercise induces recurrent increases in cerebrovascular perfusion. In peripheral arteries, such episodic increases in perfusion are responsible for improvement in arterial function and health. We examined the hypothesis that exercise during immersion augments cerebral blood flow velocity compared with intensity-matched land-based exercise. Methods Fifteen normotensive participants were recruited (26 4 yr, 24.3 1.9 kgm(-2)). We continuously assessed mean arterial blood pressure, HR, stroke volume, oxygen consumption, and blood flow velocities through the middle and posterior cerebral arteries before, during, and after 20-min bouts of water- and land-based stepping exercise of matched intensity. The order in which the exercise conditions were performed was randomized between subjects. Water-based exercise was performed in 30 degrees C water to the level of the right atrium. Results The water- and land-based exercise bouts were closely matched for oxygen consumption (13.3 mLkg(-1)min(-1) (95% confidence interval (CI), 12.2-14.6) vs 13.5 mLkg(-1)min(-1) (95% CI, 12.1-14.8), P = 0.89) and HR (95 bpm (95% CI, 90-101) vs 96 bpm (95% CI, 91-102), P = 0.65). Compared with land-based exercise, water-based exercise induced an increase in middle cerebral artery blood flow velocity (74 cms(-1) (95% CI, 66-81) vs 67 cms(-1) (95% CI, 60-74) P < 0.001), posterior cerebral artery blood flow velocity (47 cms(-1) (95% CI, 40-53) vs 43 cms(-1) (95% CI, 37-49), P < 0.001), mean arterial blood pressure (106 mm Hg (95% CI, 100-111) vs 101 mm Hg (95% CI, 95-106), P < 0.001), and partial pressure of expired CO2 (P 0.001). Conclusions Our findings suggest that water-based exercise augments cerebral blood flow, relative to land-based exercise of similar intensity, in healthy humans.	[Pugh, Christopher J. A.; Sprung, Victoria S.; Spence, Angela L.; Carter, Howard H.; Green, Daniel J.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia; [Sprung, Victoria S.; Thijssen, Dick H. J.; Green, Daniel J.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Ono, Kumiko] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo, Japan; [Thijssen, Dick H. J.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Green, DJ (reprint author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, 35 Stirling Highway, Perth, WA 6009, Australia.	danny.green@uwa.edu.au	Green, Daniel/B-7379-2013; Thijssen, Dick/D-3430-2009		National Health and Medical Research Council of Australia [1045204]	D. J. G. is supported by research funding from the National Health and Medical Research Council of Australia grant (1045204).	Chu KS, 2004, ARCH PHYS MED REHAB, V85, P870, DOI 10.1016/j.apmr.2003.11.001; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Barbosa TM, 2009, J SPORT SCI MED, V8, P179; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Ichinose M, 2008, J PHYSIOL-LONDON, V586, P2753, DOI 10.1113/jphysiol.2007.150060; Carter HH, 2014, AM J PHYSIOL-REG I, V306, pR636, DOI 10.1152/ajpregu.00516.2013; Bocalini DS, 2008, GERIATR GERONTOL INT, V8, P265, DOI 10.1111/j.1447-0594.2008.00485.x; Wilcock IM, 2006, SPORTS MED, V36, P747, DOI 10.2165/00007256-200636090-00003; MCARDLE WD, 1976, J APPL PHYSIOL, V40, P85; Green DJ, 2008, J APPL PHYSIOL, V105, P766, DOI 10.1152/japplphysiol.01028.2007; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Tinken TM, 2009, HYPERTENSION, V54, P278, DOI 10.1161/HYPERTENSIONAHA.109.134361; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Lautenschlager NT, 2010, CURR NEUROL NEUROSCI, V10, P352, DOI 10.1007/s11910-010-0121-7; Williamson JW, 1999, J APPL PHYSIOL, V87, P1213; CHRISTIE JL, 1990, J APPL PHYSIOL, V69, P657; Querido JS, 2007, SPORTS MED, V37, P765, DOI 10.2165/00007256-200737090-00002; Secher NH, 2008, J APPL PHYSIOL, V104, P306, DOI 10.1152/japplphysiol.00853.2007; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; SAITO M, 1993, J APPL PHYSIOL, V75, P663; Willie CK, 2011, J NEUROSCI METH, V198, P270, DOI 10.1016/j.jneumeth.2011.03.017; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; Gappmaier E, 2006, J SPORT MED PHYS FIT, V46, P564; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; ARBORELI.M, 1972, AEROSPACE MED, V43, P592; Barbosa TM, 2007, J STRENGTH COND RES, V21, P1255; BRINKS J, 2009, AM J LIFESTYLE MED, V3, P290; Chu Y, 2010, CIRC RES, V107, P1400, DOI 10.1161/CIRCRESAHA.110.234450; Darby LA, 2000, J SPORT MED PHYS FIT, V40, P303; Frangolias DD, 1996, SPORTS MED, V22, P38, DOI 10.2165/00007256-199622010-00004; GABRIELSEN A, 1993, J APPL PHYSIOL, V75, P581; HOOD WB, 1968, AEROSPACE MED, V39, P579; KOURY JM, 1996, AQUATIC THERAPY PROG; Mayhan WG, 2004, J APPL PHYSIOL, V96, P1730, DOI 10.1152/japplphysiol.01185.2003; Meredith-Jones K, 2011, COMPLEMENT THER MED, V19, P93, DOI 10.1016/j.ctim.2011.02.002; Naylor LH, 2011, AM J PHYSIOL-HEART C, V300, pH664, DOI 10.1152/ajpheart.00985.2010; Perneger TV, 1998, BRIT MED J, V316, P1236; ROWELL LB, 1993, HUMAN CARDIOVASCULAR, P162; Schmid JP, 2007, HEART, V93, P722, DOI 10.1136/hrt.2006.094870; SHELDAHL LM, 1987, J AM COLL CARDIOL, V10, P1254; Volaklis KA, 2007, AM HEART J, V154, p560e1	43	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	FEB	2015	47	2					299	306		10.1249/MSS.0000000000000422		8	Sport Sciences	Sport Sciences	AZ3AS	WOS:000348100800011		
J	Morita, N; Yamauchi, J; Kurihara, T; Fukuoka, R; Otsuka, M; Okuda, T; Ishizawa, N; Nakajima, T; Nakamichi, R; Matsuno, S; Kamiie, S; Shide, N; Kambayashi, I; Shinkaiya, H				Morita, Noriteru; Yamauchi, Junichiro; Kurihara, Toshiyuki; Fukuoka, Ryosuke; Otsuka, Mitsuo; Okuda, Tomoyasu; Ishizawa, Nobuhiro; Nakajima, Toshihiro; Nakamichi, Rio; Matsuno, Syuzo; Kamiie, Suguru; Shide, Noriyuki; Kambayashi, Isao; Shinkaiya, Hisashi			Toe Flexor Strength and Foot Arch Height in Children	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						ISOMETRIC FORCE; TOE GRIP STRENGTH; FLATFOOT; PHYSICAL PERFORMANCE OF THE LOWER LIMBS	VERTICAL JUMP PERFORMANCE; MEDIAL LONGITUDINAL ARCH; MUSCLE STRENGTH; INTRINSIC MUSCLES; BODY-COMPOSITION; SOCCER PLAYERS; MOVEMENT; FORCE; GIRLS; BOYS	Purpose The aim of this study was to investigate the muscle strength and arch height of the foot in the standing position and the relations between these indices and physical performances involving the lower limbs in children. Methods A total of 301 elementary school children (third grade: n = 158, age = 8.6 0.5 yr; fifth grade: n = 143, age = 10.6 0.5 yr; means +/- SD) participated. The maximal isometric toe flexor strength (TFS) in the standing position was measured using a toe flexor dynamometer. Foot arch height was assessed as the distance between the navicular tuberosity of the foot and the floor in the standing position, and foot arch height relative to the foot length was represented by the foot arch index (FAI). For physical performance involving the lower limbs, 50-m sprint, standing broad jump, repeated side step, and rebound jump were measured. Results There were no significant correlations between TFS and FAI and between relative TFS (relative TFS = TFS/body mass) and FAI. Relative TFS was significantly correlated with all physical performance tests. No significant correlations among FAI and physical performances were found, except for rebound jump ability in fifth graders. After multiple regression analyses adjusting for gender and body mass, TFS was the only significant correlating factor for all physical performances involving the lower limbs. Conclusions This study showed that TFS was associated with enhancement of some measures of lower limb physical performance in children. These results suggest that foot function should be evaluated with both the muscle strength and arch height of the foot in children.	[Morita, Noriteru; Okuda, Tomoyasu; Shide, Noriyuki; Shinkaiya, Hisashi] Hokkaido Univ, Dept Sports Educ, Iwamizawa, Hokkaido 0688642, Japan; [Yamauchi, Junichiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo 158, Japan; [Yamauchi, Junichiro] Future Inst Sport Sci, Tokyo, Japan; [Yamauchi, Junichiro] Khon Kaen Univ, Fac Associated Med Sci, Khon Kaen, Thailand; [Kurihara, Toshiyuki; Otsuka, Mitsuo] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Japan; [Fukuoka, Ryosuke; Matsuno, Syuzo; Kamiie, Suguru] Hokkaido Univ, Grad Sch Educ, Sapporo, Hokkaido, Japan; [Ishizawa, Nobuhiro; Nakamichi, Rio; Kambayashi, Isao] Hokkaido Univ, Dept Teacher Training, Sapporo, Hokkaido, Japan; [Nakajima, Toshihiro] Hokkaido Univ Sci, Sapporo, Hokkaido, Japan	Morita, N (reprint author), Hokkaido Univ, Dept Sports Educ, 2-34-1 Midorigaoka, Iwamizawa, Hokkaido 0688642, Japan.	morita.noriteru@i.hokkyodai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22500619, 24700631, 23700688, 23680066, 24650408]	This study was funded by Grant-in-Aid for Scientific Research (C; #22500619 for H. S.), for Young Scientists (B; #24700631 and #23700688 for M. O., and T. K., respectively); for Young Scientists (A; #23680066 for J. Y.); and for Exploratory Research (#24650408 for J. Y.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Markovic G, 2004, EUR J APPL PHYSIOL, V92, P139, DOI 10.1007/s00421-004-1076-7; Wisloff U, 2004, BRIT J SPORT MED, V38, P285, DOI 10.1136/bjsm.2002.002071; Gilmour JC, 2001, FOOT ANKLE INT, V22, P493; Lin CJ, 2001, J PEDIATR ORTHOPED, V21, P378, DOI 10.1097/00004694-200105000-00022; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; ROBBINS SE, 1987, MED SCI SPORT EXER, V19, P148; Kura H, 1997, ANAT REC, V249, P143, DOI 10.1002/(SICI)1097-0185(199709)249:1<143::AID-AR17>3.0.CO;2-P; Quatman CE, 2006, AM J SPORT MED, V34, P806, DOI 10.1177/0363546505281916; Temfemo A, 2009, EUR J PEDIATR, V168, P457, DOI 10.1007/s00431-008-0771-5; Vanttinen T, 2011, J STRENGTH COND RES, V25, P3342, DOI 10.1519/JSC.0b013e318236d0c2; Goldmann JP, 2013, J SPORT SCI, V31, P424, DOI 10.1080/02640414.2012.736627; DOWLING JJ, 1993, J APPL BIOMECH, V9, P95; MANN R, 1964, J BONE JOINT SURG AM, V46, P469; Jaric S, 2002, SPORTS MED, V32, P615, DOI 10.2165/00007256-200232100-00002; Aydog ST, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.011627; Bitar A, 2000, EUR J NUTR, V39, P157, DOI 10.1007/s003940070019; Cappello Teresa, 1998, Current Opinion in Pediatrics, V10, P77, DOI 10.1097/00008480-199802000-00016; Katic R, 2013, COLLEGIUM ANTROPOL, V37, P81; Lizis P, 2010, FOOT ANKLE INT, V31, P815, DOI 10.3113/FAI.2010.0815; Naka H, 2005, J BONE MINER METAB, V23, P463, DOI 10.1007/s00774-005-0629-0; Ortega FB, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7279; Tauchi K, 2008, INT J SPORT HLTH SCI, V6, P78, DOI 10.5432/ijshs.6.78; Tudor A, 2009, PEDIATRICS, V123, pe386, DOI 10.1542/peds.2008-2262; Unger CL, 2000, J STRENGTH COND RES, V14, P373; Wang J, 1999, GROWTH DEVELOP AGING, V63, P99; Yamauchi J, 2007, J STRENGTH COND RES, V21, P703	26	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	FEB	2015	47	2					350	356		10.1249/MSS.0000000000000402		7	Sport Sciences	Sport Sciences	AZ3AS	WOS:000348100800017		
J	Ohashi, Y; Terao, T; Shigeta, Y; Ohsawa, T				Ohashi, Yukitaka; Terao, Toru; Shigeta, Yoshinori; Ohsawa, Teruo			In situ observational research of the gap wind "Hijikawa-Arashi" in Japan	METEOROLOGY AND ATMOSPHERIC PHYSICS			English	Article							WASHINGTON CASCADE MOUNTAINS; MESOSCALE ALPINE PROGRAM; JUAN-DE-FUCA; NUMERICAL SIMULATIONS; TEMPORAL EVOLUTION; SPATIAL STRUCTURE; PART II; IDEALIZED TOPOGRAPHY; KIYOKAWA-DASHI; WESTERN SIDE	The Hijikawa-arashi, a gap wind occurring in Ozu City, Ehime Prefecture, Japan, was investigated through in situ observations of horizontal and vertical directions. Analysis of surface air temperature data revealed that the inland Ozu Basin was radiatively cooled on the days on which the Hijikawa-arashi events occurred. This induced a greater difference in air temperature between the basin and the estuary of the Hijikawa River in comparison to days that no basin cooling occurred. In addition, the wind speeds of the Hijikawa-arashi observed at the estuary of the Hijikawa River were strongly proportional to the sea-level pressure difference between the inland Ozu Basin and the estuary. Theoretical calculations indicated that this pressure gradient force was sufficient for driving the strong wind of the Hijikawa-arashi. Moreover, calculation of the Froude number using vertical meteorological data revealed that the Hijikawa-arashi developed as a supercritical flow. That is, the flow was intensified at the exit of the gap, in accordance with the hydraulic theory. The vertical observations detected the inversion layer over the Hijikawa-arashi and suggested an application of the shallow water theory to this gap wind. The Hijikawa-arashi is an interesting gap flow with a strong wind, despite its small-scale geography relative to other gap winds worldwide. There is an important trigger getting higher basin pressure upstream due to the radiative cooling of the atmosphere and formation of a cold pool at the basin.	[Ohashi, Yukitaka] Okayama Univ Sci, Fac Biosphere Geosphere Sci, Kita Ku, Okayama 7000005, Japan; [Terao, Toru] Kagawa Univ, Fac Educ, Takamatsu, Kagawa 7608522, Japan; [Shigeta, Yoshinori] Rissho Univ, Fac Geoenvironm Sci, Kumagaya, Saitama 3600194, Japan; [Ohsawa, Teruo] Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan	Ohashi, Y (reprint author), Okayama Univ Sci, Fac Biosphere Geosphere Sci, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.	ohashi@big.ous.ac.jp					CLARKE AJ, 1988, J GEOPHYS RES-OCEANS, V93, P15491, DOI 10.1029/JC093iC12p15491; Pan FF, 1999, J ATMOS SCI, V56, P905, DOI 10.1175/1520-0469(1999)056<0905:GWAWSO>2.0.CO;2; GARRATT JR, 1977, MON WEATHER REV, V105, P915, DOI 10.1175/1520-0493(1977)105<0915:RODCOO>2.0.CO;2; Mayr GJ, 2007, Q J ROY METEOR SOC, V133, P881, DOI 10.1002/qj.66; Aoyama T, 1986, J GEOGR, V95, P394; Aoyama T, 1988, B YAMAGATA U NATURE, V12, P105; Arakawa S., 1969, GEOPHYS MAG, V34, P349; ARAKAWA S, 1968, PAP METEOROL GEOPHYS, V19, P69; Bond NA, 1997, B AM METEOROL SOC, V78, P1941, DOI 10.1175/1520-0477(1997)078<1941:TCOASW>2.0.CO;2; Colle BA, 2000, MON WEATHER REV, V128, P2398, DOI 10.1175/1520-0493(2000)128<2398:HROANS>2.0.CO;2; Colle BA, 1998, MON WEATHER REV, V126, P28, DOI 10.1175/1520-0493(1998)126<0028:WATWSO>2.0.CO;2; Colle BA, 1998, MON WEATHER REV, V126, P53, DOI 10.1175/1520-0493(1998)126<0053:WATWSO>2.0.CO;2; Deardorff JW, 1972, MON WEA REV, V113, P89; De Wekker SFJ, 2006, J APPL METEOROL CLIM, V45, P813, DOI 10.1175/JAM2378.1; Gabersek S, 2006, J ATMOS SCI, V63, P2720, DOI 10.1175/JAS3786.1; Gabersek S, 2004, J ATMOS SCI, V61, P2846, DOI 10.1175/JAS-3340.1; Inamura T, 2009, TENKI, V56, P123; Ishii S, 2007, J METEOROL SOC JPN, V85, P797, DOI 10.2151/jmsj.85.797; JACKSON PL, 1994, MON WEATHER REV, V122, P2645, DOI 10.1175/1520-0493(1994)122<2645:GWIAFP>2.0.CO;2; JACKSON PL, 1994, MON WEATHER REV, V122, P2666, DOI 10.1175/1520-0493(1994)122<2666:GWIAFP>2.0.CO;2; Japan Meteorological Agency, 1998, KISH KANS TEB; KONDO J, 1989, J ATMOS SCI, V46, P2917, DOI 10.1175/1520-0469(1989)046<2917:HBAONC>2.0.CO;2; Kurose Yoshitaka, 2002, Journal of Agricultural Meteorology, V58, P103; LACKMANN GM, 1989, MON WEATHER REV, V117, P1817, DOI 10.1175/1520-0493(1989)117<1817:ASAMBD>2.0.CO;2; Liu M, 2000, MON WEATHER REV, V128, P1309, DOI 10.1175/1520-0493(2000)128<1309:NSOALL>2.0.CO;2; Maric T, 2009, J ATMOS SCI, V66, P905; MASS CF, 1985, MON WEATHER REV, V113, P1261, DOI 10.1175/1520-0493(1985)113<1261:ASWITL>2.0.CO;2; MASS CF, 1995, MON WEATHER REV, V123, P315, DOI 10.1175/1520-0493(1995)123<0315:AWITLO>2.0.CO;2; Mayr GJ, 2004, METEOROL ATMOS PHYS, V86, P99, DOI 10.1007/s00703-003-0022-2; Mori Y, 1994, TENKI, V41, P79; Nagoshi T, 2009, ED EARTH SCI, V62, P65; Nagoshi T, 1998, KASHIKA JOHO, V18, P229; Nakata T, 1982, J METEOROL RES, V34, P135; Onodera S, 1975, TENKI, V22, P139; OVERLAND JE, 1981, MON WEATHER REV, V109, P2221, DOI 10.1175/1520-0493(1981)109<2221:GWITSO>2.0.CO;2; PETTRE P, 1982, J ATMOS SCI, V39, P542, DOI 10.1175/1520-0469(1982)039<0542:OTPOVV>2.0.CO;2; Reed RJ, 1981, MON WEATHER REV, V109, P2382; Reed T. R., 1931, MON WEA REV, V59, P373, DOI 10.1175/1520-0493(1931)59373:GWOTSO2.0.CO2; Sasaki K, 2010, J METEOROL SOC JPN, V88, P161, DOI 10.2151/jmsj.2010-204; Sasaki K, 2004, TENKI, V51, P881; SCORER RS, 1952, Q J ROY METEOR SOC, V78, P53, DOI 10.1002/qj.49707833507; Sharp J, 2004, WEATHER FORECAST, V19, P970, DOI 10.1175/826.1; Sharp JM, 2002, B AM METEOROL SOC, V83, P1757, DOI 10.1175/BAMS-83-12-1757; Shigeta Y, 2014, TENKI, V61, P91; Steenburgh JW, 1998, MON WEATHER REV, V126, P2673; Takeuchi M, 1986, TENKI, V33, P219; Weissmann MD, 2004, MON WEATHER REV, V132, P2684, DOI 10.1175/MWR2817.1; WESSEL P, 1998, EOS T AGU, V0079; Yaji M, 1992, P GEN M ASS JPN GEOG, V1992, P100; Zangl G, 2003, METEOROL ATMOS PHYS, V83, P237, DOI 10.1007/s00703-002-0565-7; Zangl G, 2004, MON WEATHER REV, V132, P368, DOI 10.1175/1520-0493(2004)132<0368:NSOTFI>2.0.CO;2; Zangl G, 2002, Q J ROY METEOR SOC, V128, P927, DOI 10.1256/0035900021643755	52	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0177-7971	1436-5065		METEOROL ATMOS PHYS	Meteorol. Atmos. Phys.	FEB	2015	127	1					33	48		10.1007/s00703-014-0345-1		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AZ9WK	WOS:000348564600003		
J	Yanagisawa, A; Ueda, M; Sueyoshi, T; Okada, T; Fujimoto, T; Ogi, Y; Kitagawa, K; Tasaki, M; Misumi, Y; Oshima, T; Jono, H; Obayashi, K; Hirakawa, K; Uchida, H; Westermark, P; Ando, Y; Mizuta, H				Yanagisawa, Akihiro; Ueda, Mitsuharu; Sueyoshi, Takanao; Okada, Tatsuya; Fujimoto, Toru; Ogi, Yasuhiro; Kitagawa, Keisuke; Tasaki, Masayoshi; Misumi, Yohei; Oshima, Toshinori; Jono, Hirofumi; Obayashi, Konen; Hirakawa, Kei; Uchida, Hitoshi; Westermark, Per; Ando, Yukio; Mizuta, Hiroshi			Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis	MODERN PATHOLOGY			English	Article							SENILE SYSTEMIC AMYLOIDOSIS; DIAGNOSIS; FIBRIL; POLYNEUROPATHY; INSTABILITY	Amyloidosis is a protein conformational disorder with the distinctive feature of extracellular accumulation of amyloid fibrils that come from different proteins. In the ligamentum flavum of the lumbar spine, amyloid deposits were frequently found in elderly patients with lumbar spinal canal stenosis and were at least partially formed by wild-type transthyretin. However, how amyloid deposits in the ligamentum flavum affect lumbar spinal canal stenosis has remained unclear. In this study, we analyzed clinical, pathologic, and radiologic findings of patients with lumbar spinal canal stenosis who had amyloid deposits in the ligamentum flavum. We studied 95 ligamentum flavum specimens obtained from 56 patients with lumbar spinal canal stenosis and 21 ligamentum flavum specimens obtained from 19 patients with lumbar disk herniation. We evaluated histopathologic findings and clinicoradiologic manifestations, such as thickness of the ligamentum flavum and lumbar spinal segmental instability. We found that all 95 ligamentum flavum specimens resected from patients with lumbar spinal canal stenosis had amyloid deposits, which we classified into two types, transthyretin-positive and transthyretin-negative, and that transthyretin amyloid formation in the ligamentum flavum of patients with lumbar spinal canal stenosis was an age-associated phenomenon. The amount of amyloid in the ligamentum flavum was related to clinical manifestations of lumbar spinal canal stenosis, such as thickness of the ligamentum flavum and lumbar spinal segmental instability, in the patients with lumbar spinal canal stenosis with transthyretin-positive amyloid deposits. To our knowledge, this report is the first to show clinicopathologic correlations in transthyretin amyloid deposits of the ligamentum flavum. In conclusion, transthyretin amyloid deposits in the ligamentum flavum may be related to the pathogenesis of lumbar spinal canal stenosis in elderly patients.	[Yanagisawa, Akihiro; Sueyoshi, Takanao; Okada, Tatsuya; Fujimoto, Toru; Mizuta, Hiroshi] Kumamoto Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kumamoto 8600811, Japan; [Yanagisawa, Akihiro; Ueda, Mitsuharu; Ogi, Yasuhiro; Kitagawa, Keisuke; Tasaki, Masayoshi; Misumi, Yohei; Oshima, Toshinori; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto 8600811, Japan; [Jono, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut Sci, Kumamoto 8600811, Japan; [Jono, Hirofumi] Kumamoto Univ Hosp, Dept Pharm, Chuo Ku, Kumamoto, Japan; [Obayashi, Konen] Kumamoto Univ, Grad Sch Hlth Sci, Dept Morphol & Physiol Sci, Chuo Ku, Kumamoto 8600811, Japan; [Hirakawa, Kei; Uchida, Hitoshi] Kumamoto Orthopaed Hosp, Chuo Ku, Kumamoto, Japan; [Westermark, Per] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Ueda, M (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8600811, Japan.	mitt@rb3.so-net.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24249036, 25870541]; Swedish Research Council; Selander's Foundation; FAMY; FAMY-Norrbotten; Stiftelsen AMYL	We are indebted to Mrs Hiroko Katsura for excellent technical assistance and Ms Judith B Gandy for providing professional English editing of the manuscript. This research was supported by Grants-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (numbers 24249036, 25870541), the Swedish Research Council, Selander's Foundation, FAMY, FAMY-Norrbotten, and Stiftelsen AMYL.	Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; Ando Y, 2012, CURR MED CHEM, V19, P2312; Merlini G, 2004, J INTERN MED, V255, P159, DOI 10.1046/j.1365-2796.2003.01262.x; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Ihse E, 2011, J MOL MED-JMM, V89, P171, DOI 10.1007/s00109-010-0695-1; Ueda M, 2009, CLIN CHEM, V55, P1223, DOI 10.1373/clinchem.2008.118505; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Ueda M, 2011, MODERN PATHOL, V24, P1533, DOI 10.1038/modpathol.2011.117; Pitkanen MT, 2002, CLIN RADIOL, V57, P632, DOI 10.1053/crad.2001.0899; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; DUPUIS PR, 1985, SPINE, V10, P262, DOI 10.1097/00007632-198504000-00015; Benson MD, 2001, ARTHRITIS ALLIED CON, P1866; DAGOSTINO AN, 1992, CLIN NEUROPATHOL, V11, P147; Gies U, 1996, CLIN NEUROPATHOL, V15, P54; HONIG S, 1992, J RHEUMATOL, V19, P1988; Layfield R, 1997, ANAL BIOCHEM, V253, P142, DOI 10.1006/abio.1997.2370; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; PITKANEN P, 1984, AM J PATHOL, V117, P391; Sueyoshi T, 2011, AMYLOID, V18, P165, DOI 10.3109/13506129.2011.582197; Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017; Westermark P, 2014, UPSALA J MED SCI, V119, P223, DOI 10.3109/03009734.2014.895786; Yamamoto S, 2009, BONE, V45, pS39, DOI 10.1016/j.bone.2009.03.655	24	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28	2					201	207		10.1038/modpathol.2014.102		7	Pathology	Pathology	CA5NY	WOS:000348956300004		
J	Sakamoto, H; Kuboki, Y; Hatori, T; Yamamoto, M; Sugiyama, M; Shibata, N; Shimizu, K; Shiratori, K; Furukawa, T				Sakamoto, Hitomi; Kuboki, Yuko; Hatori, Takashi; Yamamoto, Masakazu; Sugiyama, Masanori; Shibata, Noriyuki; Shimizu, Kyoko; Shiratori, Keiko; Furukawa, Torn			Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas	MODERN PATHOLOGY			English	Article							PATHWAYS; CANCER; TUMOR	Mutations in RNF43, which encodes the ubiquitin E3 ligase ring finger protein 43, were recently found in intraductal papillary mucinous neoplasms of the pancreas. We evaluated somatic mutations of RNF43 and the expression of ring finger protein 43 as well as their associations with the molecular and clinicopathological features in 176 surgically resected intraductal papillary mucinous neoplasms. Frozen tissues were available for 57 cases and were used for next-generation sequencing analysis of the entire coding exons of RNF43. Formalin-fixed and paraffin-embedded tissues from all 176 cases were used for the immunohistochemical analysis of the expression of ring finger protein 43. Mutations detected with the next-generation sequencing analysis were validated by using Sanger sequencing. Statistical analysis was used to evaluate the associations between RNF43 aberrations and molecular and clinicopathological features including GNAS mutations, KRAS mutations, loss of SMA and MAD4 homologue expression, tumor protein 53 overexpression, tumor grade, histological type, mural nodule detection, macroscopic type, stage, recurrence, and survival. Somatic RNF43 mutations were found in 8 (14%) of the 57 examined cases, and included 5 frameshift mutations (p.F69fs, p.S264fs, p.L311fs, p.R363fs, and p.V490fs), 1 non-sense mutation (p.Q153X), and 2 missense mutations (p.I164N and p.P310A). The expression of ring finger protein 43 was downregulated in 52 (29.5%) of the 176 examined cases. RNF43 mutations were significantly associated with the downregulated expression of ring finger protein 43 (P=0.011), GNAS mutation (P=0.020), and mural nodule detection (P=0.038). The expression of ring finger protein 43 was not associated with any clinicopathological features except RNF43 mutation. These results indicate that RNF43 mutation might cause downregulation of the expression of ring finger protein 43 and play a crucial role and associate synergistically with GNAS mutation during development of intraductal papillary mucinous neoplasm of the pancreas.	[Sakamoto, Hitomi; Kuboki, Yuko; Furukawa, Torn] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Sakamoto, Hitomi; Sugiyama, Masanori] Kyorin Univ, Sch Med, Dept Surg, Mitaka, Tokyo 181, Japan; [Hatori, Takashi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Dept Surg Gastroenterol, Tokyo 1628666, Japan; [Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan; [Shimizu, Kyoko; Shiratori, Keiko] Tokyo Womens Med Univ, Dept Gastroenterol, Tokyo 1628666, Japan	Furukawa, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	furukawa.toru@twmu.ac.jp			Program for Promoting the Establishment of Strategic Research Centers, Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank Yasuaki Akazawa, Mitsuhiro Amemiya, and Akira Saito (StaGen Co. Ltd., Tokyo, Japan) for data processing of next-generation sequencing. This study is supported by the Program for Promoting the Establishment of Strategic Research Centers, Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adsay NV, 2010, WHO CLASSIFICATION T, P304; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; FURUKAWA T, 1992, CANCER, V70, P1505, DOI 10.1002/1097-0142(19920915)70:6<1505::AID-CNCR2820700611>3.0.CO;2-D; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Amato E, 2014, J PATHOL, V233, P217, DOI 10.1002/path.4344; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Komatsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087875; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD352; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543	16	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	FEB	2015	28	2					261	267		10.1038/modpathol.2014.98		7	Pathology	Pathology	CA5NY	WOS:000348956300010		
J	Herrera, S; Watanabe, H; Shank, TM				Herrera, Santiago; Watanabe, Hiromi; Shank, Timothy M.			Evolutionary and biogeographical patterns of barnacles from deep-sea hydrothermal vents	MOLECULAR ECOLOGY			English	Article						cenozoic; dispersal; hydrothermal vents; polyphyly; Southern Hemisphere; species delimitation; RAD-seq	OXIDASE SUBUNIT-I; DNA-BARCODES; BIOLOGICAL IDENTIFICATIONS; BAYESIAN PHYLOGENETICS; SPECIES DELIMITATION; POPULATION GENOMICS; MITOCHONDRIAL-DNA; INDIAN OCEANS; PACIFIC; CIRRIPEDIA	The characterization of evolutionary and biogeographical patterns is of fundamental importance to identify factors driving biodiversity. Due to their widespread but discontinuous distribution, deep-sea hydrothermal vent barnacles represent an excellent model for testing biogeographical hypotheses regarding the origin, dispersal and diversity of modern vent fauna. Here, we characterize the global genetic diversity of vent barnacles to infer their time of radiation, place of origin, mode of dispersal and diversification. Our approach was to target a suite of multiple loci in samples representing seven of the eight described genera. We also performed restriction-site associated DNA sequencing on individuals from each species. Phylogenetic inferences and topology hypothesis tests indicate that vent barnacles have colonized deep-sea hydrothermal vents at least twice in history. Consistent with preliminary estimates, we find a likely radiation of barnacles in vent ecosystems during the Cenozoic. Our analyses suggest that the western Pacific was the place of origin of the major vent barnacle lineage, followed by circumglobal colonization eastwards through the Southern Hemisphere during the Neogene. The inferred time of radiation rejects the classic hypotheses of antiquity of vent taxa. The timing and the mode of origin, radiation and dispersal are consistent with recent inferences made for other deep-sea taxa, including nonvent species, and are correlated with the occurrence of major geological events and mass extinctions. Thus, we suggest that the geological processes and dispersal mechanisms discussed here can explain the current distribution patterns of many other marine taxa and have played an important role shaping deep-sea faunal diversity. These results also constitute the critical baseline data with which to assess potential effects of anthropogenic disturbances on deep-sea ecosystems.	[Herrera, Santiago] MIT, Cambridge, MA 02139 USA; [Herrera, Santiago; Shank, Timothy M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Watanabe, Hiromi] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan	Herrera, S (reprint author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sherrera@alum.mit.edu; tshank@whoi.edu			Office of Ocean Exploration and Research of the National Oceanic and Atmospheric Administration [NA09OAR4320129]; Division of Ocean Sciences of the National Science Foundation [OCE-1131620]; Division of Polar Programs of the National Science Foundation [PLR-0739675]; Astrobiology Science and Technology for Exploring Planets program of the National Aeronautics and Space Administration [NNX09AB76G]; Academic Programs Office (Ocean Ventures Fund); Ocean Exploration Institute; Ocean Life Institute of the Woods Hole Oceanographic Institution; Land Information New Zealand; MBIE; Joint New Zealand-USA NOAA Ring of Fire Expedition, part of NIWA's Seamount Program [FRST CO1X0508];  [AT03-28];  [AT07-06];  [JC042];  [JC067];  [KM0417];  [KM0912];  [KOK0505];  [KOK0506];  [NT97-10];  [NT97-14];  [NT99-09];  [RR1211];  [TAN1007];  [TAN1104];  [TAN1206];  [TN234];  [TN236];  [YK06-13];  [YK09-13]	This research was supported by the Office of Ocean Exploration and Research of the National Oceanic and Atmospheric Administration (NA09OAR4320129 to TMS); the Division of Ocean Sciences of the National Science Foundation (OCE-1131620 to TMS); the Division of Polar Programs of the National Science Foundation (PLR-0739675 to TMS); the Astrobiology Science and Technology for Exploring Planets program of the National Aeronautics and Space Administration (NNX09AB76G to TMS); and the Academic Programs Office (Ocean Ventures Fund to SH), the Ocean Exploration Institute (Fellowship support to TMS) and the Ocean Life Institute of the Woods Hole Oceanographic Institution (internal grant to TMS and SH). For enabling access to key specimens, we thank K. Iizasa (U. Tokyo), Y. Suzuki (U. Tokyo), S. Nakagawa (JAMSTEC), P. Tyler (NOCS), J. Copley (NOCS), A. Rogers (Oxford), N. Roterman (Oxford), K. Linse (BAS), M. Clark (NIWA), A. Rowden (NIWA), K. Schnabel (NIWA), S. Mills (NIWA), J. Resing (NOAA-PMEL), R. Embley (NOAA-PMEL), A. Reysenbach (PSU), M. K. Tivey (WHOI), P. Fryer (UH), C. Langmuir (Harvard), K. Von Damm (UNH), M. Lilley (UW), the masters, crew, scientific personnel and funding agencies of expeditions AT03-28, AT07-06, JC042, JC067, KM0417, KM0912, KOK0505, KOK0506, NT97-10, NT97-14, NT99-09, RR1211, TAN1007, TAN1104, TAN1206, TN234, TN236, YK06-13 and YK09-13. Specimens provided by the National Institute of Water and Atmospheric Research (NIWA) were collected under the following research programs: Kermadec Arc Minerals, funded by the New Zealand Ministry of Business, Innovation & Employment (MBIE), Auckland University, Institute of Geological and Nuclear Science (GNS) and WHOI; Ocean Survey 20/20 funded by Land Information New Zealand; Impact of resource use on vulnerable deep-sea communities (CO1X0906), funded by MBIE; and the Joint New Zealand-USA 2005 NOAA Ring of Fire Expedition, part of NIWA's Seamount Program (FRST CO1X0508). We thank A. M. Tarrant, A. M. Reitzel, J.A.H. Benzie and three anonymous reviewers for providing helpful comments that improved this manuscript.	Cairns SD, 2007, B MAR SCI, V81, P311; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Horne DJ, 1999, CRUSTACEANA, V72, P999, DOI 10.1163/156854099503906; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Herrera S, 2012, MOL ECOL, V21, P6053, DOI 10.1111/mec.12074; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Vrijenhoek RC, 2013, DEEP-SEA RES PT II, V92, P189, DOI 10.1016/j.dsr2.2012.12.004; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Tsang LM, 2009, MOL ECOL, V18, P1463, DOI 10.1111/j.1365-294X.2009.04090.x; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Reitzel AM, 2013, MOL ECOL, V22, P2953, DOI 10.1111/mec.12228; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Harnik PG, 2012, TRENDS ECOL EVOL, V27, P608, DOI 10.1016/j.tree.2012.07.010; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Fisher CR, 2007, OCEANOGRAPHY, V20, P14; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Baker ET, 2004, GEOPH MONOG SERIES, V148, P245, DOI 10.1029/148GM10; SHOCK EL, 1995, ORIGINS LIFE EVOL B, V25, P141, DOI 10.1007/BF01581579; Scher HD, 2006, SCIENCE, V312, P428, DOI 10.1126/science.1120044; Buckeridge JS, 2013, ZOOTAXA, V 3745, P551, DOI 10.11646/zootaxa.3745.5.4; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Roterman CN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0718; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Schwaninger HR, 2008, MOL PHYLOGENET EVOL, V49, P893, DOI 10.1016/j.ympev.2008.08.016; Yang JS, 2013, MOL BIOL EVOL, V30, P305, DOI 10.1093/molbev/mss224; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Buckeridge JS, 2000, NEW ZEAL J MAR FRESH, V34, P409; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Verissimo A, 2010, MOL ECOL, V19, P1651, DOI 10.1111/j.1365-294X.2010.04598.x; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Watanabe H, 2005, MAR ECOL PROG SER, V288, P233, DOI 10.3354/meps288233; HESSLER RR, 1991, DEEP-SEA RES, V38, P185, DOI 10.1016/0198-0149(91)90079-U; Fan Y, 2011, MOL BIOL EVOL, V28, P523, DOI 10.1093/molbev/msq224; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Boschen RE, 2013, OCEAN COAST MANAGE, V84, P54, DOI 10.1016/j.ocecoaman.2013.07.005; Atwater T., 1989, E PACIFIC OCEAN HAWA, VN, P21; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BRITO P, 2008, GENETICA, V135, P439, DOI DOI 10.1007/S10709-008-9293-3); Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Cubelio SS, 2007, J CRUSTACEAN BIOL, V27, P513, DOI 10.1651/0278-0372(2007)27[513:VAMDAG]2.0.CO;2; da Silva JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019449; DESBRUYERES D, 1994, MAR GEOL, V116, P227, DOI 10.1016/0025-3227(94)90178-3; Drummond AJ, 2011, GENEIOUS V6 1 6; EDWARDS SV, 2008, EVOLUTION, V63, P1; HERRERA S, 2010, AGU FALL M, V1, P1234; HERRERA S, 2014, BIORXIV, DOI DOI 10.1101/007781; Hipp AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093975; JONES DS, 1993, B MAR SCI, V52, P937; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Linse K, 2013, DEEP-SEA RES PT I, V73, P99, DOI 10.1016/j.dsr.2012.11.006; LIVERMORE R, 2003, GEOL SOC LOND SPEC P, V219, P315, DOI DOI 10.1144/GSL.SP.2003.219.01.15; Marsh L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048348; MOALIC Y, 2011, SYST BIOL, V61, P127, DOI DOI 10.1093/SYSBI0/SYR088); Nakamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032965; NEWMAN W A, 1979, Transactions of the San Diego Society of Natural History, V19, P153; Newman W. A., 1985, B BIOL SOC WASH, V6, P231; NEWMAN WA, 2006, DENISIA, V18, P356; NEWMAN WA, 1995, BULLETIN DU MUSEUM N, V4, P221; Newman W.A., 1989, Transactions of the San Diego Society of Natural History, V21, P259; OHTA S, 1990, P JAMSTEC S DEEP SEA, V6, P145; Ono Taeko, 1996, JAMSTEC Journal of Deep Sea Research, V12, P221; Perez-Losada M, 2014, MOL PHYLOGENET EVOL, V81, P147, DOI 10.1016/j.ympev.2014.09.013; Perez-Losada M, 2008, MOL PHYLOGENET EVOL, V46, P328, DOI 10.1016/j.ympev.2007.10.004; Rambaut A, 2007, TRACER V1 5; Reid WDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065553; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; SHANK T, 2010, AGU FALL M, V1; Smith AB, 2005, P ROY SOC B-BIOL SCI, V272, P865, DOI 10.1098/rspb.2004.2996; Southward Alan J., 2005, Senckenbergiana Maritima, V35, P147; Southward AJ, 1998, CAH BIOL MAR, V39, P259; Strugnell JM, 2008, CLADISTICS, V24, P853, DOI 10.1111/j.1096-0031.2008.00234.x; TAO CH, 2011, GEOLOGY, V40, P47; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; Tufar W., 1990, MITT OSTERR GEOL GES, V82, P183; Tunnicliffe V, 2004, J MAR BIOL ASSOC UK, V84, P121, DOI 10.1017/S0025315404008987h; VANDOVER C, 2000, THE ECOLOGY OF DEEP; VansDover CL, 2002, MAR BIOL, V141, P761; VANSDOVER CL, 2012, MAR POLICY, V36, P378; VANSDOVER CL, 2010, ICES J MAR SCI, V68, P341; VANSDOVER CL, 2001, SCIENCE, V294, P818; WAGNER C, 2012, MOL ECOLOGY, V0022; Yoshida R, 2011, ZOOL SCI, V28, P853, DOI 10.2108/zsj.28.853	111	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	FEB	2015	24	3					673	689		10.1111/mec.13054		17	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AZ9EZ	WOS:000348516900011		
J	Nakao, R; Yamamoto, S; Yasumoto, Y; Kadota, K; Oishi, K				Nakao, Reiko; Yamamoto, Saori; Yasumoto, Yuki; Kadota, Koji; Oishi, Katsutaka			IMPACT OF DENERVATION-INDUCED MUSCLE ATROPHY ON HOUSEKEEPING GENE EXPRESSION IN MICE	MUSCLE & NERVE			English	Article						denervation; housekeeping gene; immobilization; muscle atrophy; real-time RT-PCR	FOXO TRANSCRIPTION FACTORS; REAL-TIME PCR; SKELETAL-MUSCLE; UBIQUITIN LIGASES; GLUCOCORTICOID-RECEPTOR; IDENTIFICATION; NORMALIZATION	Introduction: Immobilization induced by experimental denervation leads to rapid and progressive alterations in structural and biochemical properties of skeletal muscle. Real-time reverse transcription-polymerase chain reaction (RT-PCR) is a popular method of elucidating the molecular mechanisms involved in muscle atrophy. Identification of suitable reference genes that are not affected by experimental conditions is a critical step in accurate normalization of real-time RT-PCR. Methods: We investigated the impact of denervation-induced muscle atrophy for 2 weeks on the expression of common housekeeping genes. Results: Denervation differentially affected the expression levels of these genes. RefFinder software identified TATA box binding protein (Tbp) as the most stable gene and showed that the stability of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and hypoxanthine guanine phosphoribosyl transferase (Hprt) genes was low, even though they are widely used for normalization. Conclusions: The appropriate reference gene for normalization of genes of interest in denervated muscle is Tbp. Muscle Nerve 51: 276-281, 2015	[Nakao, Reiko; Yamamoto, Saori; Yasumoto, Yuki; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Yasumoto, Yuki; Oishi, Katsutaka] Tokyo Univ Sci, Dept Appl Biol Sci, Grad Sch Sci & Technol, Chiba, Japan; [Kadota, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan; [Oishi, Katsutaka] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Oishi, K (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-ooishi@aist.go.jp	Kadota, Koji/C-9168-2011		AIST; KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24620015]	This study was supported by operational subsidies from AIST and KAKENHI [Grant-in-Aid for Scientific Research (C) 24620015 to R.N.] from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	An P, 2007, PLOS PATHOG, V3, P849, DOI 10.1371/journal.ppat.0030088; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Argilés J M, 2006, Adv Gerontol, V18, P39; Batt Jane, 2006, FASEB J, V20, P115; Calura E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-630; Manzano R, 2011, BIOCHEM BIOPH RES CO, V407, P758, DOI 10.1016/j.bbrc.2011.03.096; Nakao R, 2014, CHRONOBIOL INT, V31, P506, DOI 10.3109/07420528.2013.872654; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Vandesompele J., 2002, GENOME BIOL, V18, P3, DOI DOI 10.1186/GB-2002-3-7-RESEARCH0034; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	FEB	2015	51	2					276	281		10.1002/mus.24310		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AZ7WW	WOS:000348426800017		
J	Eguchi, H; Toibana, T; Hotta, F; Miyamoto, T; Mitamura, Y; Yaguchi, T				Eguchi, Hiroshi; Toibana, Toshi; Hotta, Fumika; Miyamoto, Tatsuro; Mitamura, Yoshinori; Yaguchi, Takashi			Severe fungal sclerokeratitis caused by Metarhizium anisopliae: a case report and literature review	MYCOSES			English	Review						Metarhizium anisopliae; sclerokeratitis; ocular infections	SOUTH-INDIA; KERATITIS	To date, there has been only one published report on the infectious sclerokeratitis caused by Metarhizium anisopliae, which is an entomopathogenic fungus. Regarding corneal infection, three reports have been published to date. Although the prognoses of the corneal infections are favourable, prognosis when scleral infection is involved is very poor. A 76-year-old patient presented with foreign body sensation in the left eye. Microscopic examination with Fungi Flora Y staining of the corneal scraping revealed fungal infection. The conjunctiva was melted by the infection over a wide area. Although intensive medications were administered, an emergency surgery was necessary because scleral thinning, corneal perforation and lens prolapse occurred. The fungal isolate was identified as M. anisopliae by sequencing the internal transcribed spacer region. Herein, we report the second known case worldwide of M. anisopliae sclerokeratitis, and we review the literature related to the ocular infections.	[Eguchi, Hiroshi; Hotta, Fumika; Miyamoto, Tatsuro; Mitamura, Yoshinori] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, Tokushima 7708503, Japan; [Toibana, Toshi] Takamatsu Municipal Hosp, Dept Ophthalmol, Takamatsu, Kagawa, Japan; [Yaguchi, Takashi] Chiba Univ, Med Mycol Res Ctr, Dept Mycosis Res, Management Unit,Div Bioresources, Chiba, Japan	Eguchi, H (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	hiroegu0113@gmail.com					Amiel H, 2008, CORNEA, V27, P382, DOI 10.1097/ICO.0b013e31815e9298; Bharathi MJ, 2007, OPHTHAL EPIDEMIOL, V14, P61, DOI 10.1080/09286580601001347; EFRON N, 1989, CURR EYE RES, V8, P901; Jain V, 2009, EYE, V23, P255, DOI 10.1038/sj.eye.6703099; DesGarcia MC, 1997, J MED VET MYCOL, V35, P361; Gopinathan U, 2002, CORNEA, V21, P555, DOI 10.1097/01.ICO.0000022924.90020.30; Jani BR, 2001, CORNEA, V20, P765, DOI 10.1097/00003226-200110000-00020; Motley WW, 2011, J AAPOS, V15, P101, DOI 10.1016/j.jaapos.2010.12.003; ODAY DM, 1985, CURR EYE RES, V4, P243, DOI 10.3109/02713688509000856	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0933-7407	1439-0507		MYCOSES	Mycoses	FEB	2015	58	2					88	92		10.1111/myc.12279		5	Dermatology; Mycology	Dermatology; Mycology	AZ9CL	WOS:000348508800005		
J	Hamamoto, H; Urai, M; Ishii, K; Yasukawa, J; Paudel, A; Murai, M; Kaji, T; Kuranaga, T; Hamase, K; Katsu, T; Su, J; Adachi, T; Uchida, R; Tomoda, H; Yamada, M; Souma, M; Kurihara, H; Inoue, M; Sekimizu, K				Hamamoto, Hiroshi; Urai, Makoto; Ishii, Kenichi; Yasukawa, Jyunichiro; Paudel, Atmika; Murai, Motoki; Kaji, Takuya; Kuranaga, Takefumi; Hamase, Kenji; Katsu, Takashi; Su, Jie; Adachi, Tatsuo; Uchida, Ryuji; Tomoda, Hiroshi; Yamada, Maki; Souma, Manabu; Kurihara, Hiroki; Inoue, Masayuki; Sekimizu, Kazuhisa			Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane	NATURE CHEMICAL BIOLOGY			English	Article							CHROMOSOMAL DNA-REPLICATION; SMALL COLONY VARIANTS; STAPHYLOCOCCUS-AUREUS; INFECTION MODEL; ESCHERICHIA-COLI; MUTANTS; IDENTIFICATION; SILKWORM; RESISTANT; PEPTIDES	To obtain therapeutically effective new antibiotics, we first searched for bacterial culture supernatants with antimicrobial activity in vitro and then performed a secondary screening using the silkworm infection model. Through further purification of the in vivo activity, we obtained a compound with a previously uncharacterized structure and named it 'lysocin E'. Lysocin E interacted with menaquinone in the bacterial membrane to achieve its potent bactericidal activity, a mode of action distinct from that of any other known antibiotic, indicating that lysocin E comprises a new class of antibiotic. This is to our knowledge the first report of a direct interaction between a small chemical compound and menaquinone that leads to bacterial killing. Furthermore, lysocin E decreased the mortality of infected mice. To our knowledge, lysocin E is the first compound identified and purified by quantitative measurement of therapeutic effects in an invertebrate infection model that exhibits robust in vivo effects in mammals.	[Hamamoto, Hiroshi; Urai, Makoto; Ishii, Kenichi; Yasukawa, Jyunichiro; Paudel, Atmika; Su, Jie; Adachi, Tatsuo; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan; [Murai, Motoki; Kaji, Takuya; Kuranaga, Takefumi; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Synthet Med Chem, Tokyo, Japan; [Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Drug Discovery & Evolut, Fukuoka 812, Japan; [Katsu, Takashi] Yasuda Womens Univ, Grad Sch Pharm, Dept Pharm, Hiroshima, Japan; [Uchida, Ryuji; Tomoda, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Microbial Chem, Tokyo, Japan; [Yamada, Maki; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Tokyo, Japan; [Yamada, Maki; Kurihara, Hiroki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Souma, Manabu] MASIS Inc, Aomori, Japan	Sekimizu, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp			Genome Pharmaceuticals Institute Co., Ltd.; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Japan Society for the Promotion of Science (JSPS) [24689008, 25460036]; MEXT [24102510, 26102714]; JSPS [24-11042]; Japan Science and Technology Agency (JST)	This study was supported by a grant from Genome Pharmaceuticals Institute Co., Ltd. for K.S., the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) for K.S., a Grant-in-Aid for Young Scientists (A; 24689008) for H.H., a Grant-in-Aid for Scientific Research (25460036) for T. Katsu from Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research on Innovative Areas-Chemical Biology of Natural Products to K.S. (24102510) and to H.H. (26102714) from MEXT, and it was supported in part by a Grant-in-Aid for JSPS Fellows (24-11042) for K.I. from JSPS and the Japan Science and Technology Agency (JST) A-STEP (High-Risk Challenging Type). We thank A. Noguchi, F. Aihara and S. Nishida (Genome Pharmaceutical Institute, Co., Ltd.) for screening and production of lysocin E. We thank K. Sakamoto (Hirosaki University) for advice regarding the menaquinone analysis. We thank M. Hyodo (Okayama University), K. Kyogoku (University of Tokyo) and Y. Matsuzawa (Genome Pharmaceutical Institute, Co., Ltd.) for technical assistance. We thank Shiseido Co. Ltd. for their technical support in 2D-HPLC analyses.	Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4; Li Y, 2004, MOL GENET GENOMICS, V271, P447, DOI 10.1007/s00438-004-0996-6; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Dartois V, 2005, ANTIMICROB AGENTS CH, V49, P3302, DOI 10.1128/AAC.49.8.3302-3310.2005; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; KREUZER KN, 1979, J BACTERIOL, V140, P424; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Wakeman CA, 2012, MOL MICROBIOL, V86, P1376, DOI 10.1111/mmi.12063; Komagoe K, 2011, PHOTOCH PHOTOBIO SCI, V10, P1181, DOI 10.1039/c0pp00376j; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200; Tamura T, 2001, INT J SYST EVOL MICR, V51, P2119; Hamase K, 2010, J CHROMATOGR A, V1217, P1056, DOI 10.1016/j.chroma.2009.09.002; BENTLEY R, 1982, MICROBIOL REV, V46, P241; Breeuwer P., 2004, ASSESSMENT MEMBRANE; CANEPARI P, 1987, J BACTERIOL, V169, P2432; Clinical and Laboratory Standards Institute, 1997, M27A CLSI; CLSI, 2009, M07A8 CLSI; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Ishibashi M, 2007, FEMS MICROBIOL LETT, V274, P204, DOI 10.1111/j.1574-6968.2007.00829.x; Jukes TH, 1969, MAMMALIAN PROTEIN ME; Kaito C, 2002, FEMS MICROBIOL LETT, V210, P157, DOI 10.1111/j.1574-6968.2002.tb11175.x; KATSU T, 1989, BIOCHIM BIOPHYS ACTA, V983, P135, DOI 10.1016/0005-2736(89)90226-5; KAWAI M, 1976, MOL GEN GENET, V143, P233, DOI 10.1007/BF00269399; Kurokawa K, 2009, ANTIMICROB AGENTS CH, V53, P4025, DOI 10.1128/AAC.00200-09; Maki H, 2001, ANTIMICROB AGENTS CH, V45, P1823, DOI 10.1128/AAC.45.6.1823-1827.2001; Matsuo M, 2003, FEMS MICROBIOL LETT, V222, P107, DOI 10.1016/S0378-1097(03)00260-X; Miyoshi Y., 2014, CHROMATOGRAPHY, V35, P49; Murai N, 2006, FEMS MICROBIOL LETT, V254, P19, DOI 10.1111/j.1574-6968.2005.00012.x; NCCLS-National Committee for Clinical Laboratory Standards, 1999, M26A NCCLS; Nishida S, 2006, J BIOL CHEM, V281, P1714; Paudel A, 2012, J ANTIBIOT, V65, P53, DOI 10.1038/ja.2011.110; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Samuelsen O, 2005, J ANTIMICROB CHEMOTH, V56, P1126, DOI 10.1093/jac/dki385; Uchida R, 2010, J ANTIBIOT, V63, P151, DOI 10.1038/ja.2010.9	44	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2015	11	2					127	U68		10.1038/NCHEMBIO.1710		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ6WN	WOS:000348358800010		
J	Iseki, K				Iseki, Kunitoshi			Control of hypertension and survival in haemodialysis patients	NEPHROLOGY			English	Review						Dry-weight; pre-haemodialysis; salt intake; ultrafiltration; weight	CHRONIC KIDNEY-DISEASE; RANDOMIZED CONTROLLED-TRIALS; BLOOD-PRESSURE CONTROL; RECEPTOR BLOCKADE; MORTALITY; DIALYSIS; OUTCOMES; RISK; METAANALYSIS; HEMOGLOBIN	Hypertension is common in approximately 80% to 90% of patients at the start of dialysis therapy and is an established risk factor for cardiovascular disease. Therefore, it should be controlled, even in the chronic dialysis population. Observational studies indicate a U-shaped phenomenon, as the mortality rate is high among those with hypertension as well as those with hypotension. Among chronic dialysis patients, randomized controlled trials on the effect of anti-hypertensive treatment are not conclusive, at least not as demonstrated by studies with a large sample size. Similar to other potentially effective drug therapies such as erythropoietin stimulating agent, statins, and uraemic toxin adsorbents, the benefit of anti-hypertensive treatment remains to be demonstrated in dialysis patients. The blood pressure target level, however, is difficult to determine as evidence for the level of appropriate target is lacking. Currently, it should be determined individually, as the priority is to perform haemodialysis as prescribed. The target levels of blood pressure for chronic haemodialysis patients are not stated except in the Guidelines in the Japanese Society for Dialysis Therapy. In this guideline, systolic blood pressure between 140 to 159 mmHg is preferable among elderly patients with comorbid conditions. Rapid ultrafiltration, such as >600 mL/h, is to be avoided. Intra-dialysis hypotension, muscle cramps, and other complaints during HD are preventable. Moreover, the nutritional status should be maintained within the normal range with adequate intake of protein and calories, but with salt restriction. Further studies are necessary for better management of hypertension in the dialysis population. Summary at a Glance This review highlights issues specific for the management of haemodialysis patients in Japan with specific regard to control of blood pressure and fluid status. Many of these factors are common to all populations but this review focuses more specifically on this more homogeneous ethic population.	Univ Hosp Ryukyus, Dialysis Unit, Nishihara, Okinawa 9030215, Japan	Iseki, K (reprint author), Univ Hosp Ryukyus, Dialysis Unit, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	chihokun@med.u-ryukyu.ac.jp			Okinawa Dialysis and Transplantation Association (ODTA); Okinawa Dialysis Physicians Association (ODPA); Okinawa Clinical Nephrology Conference (OCNC); Okinawa Heart and Renal Association (OHRA); Kyushu Society for Dialysis Therapy (KSDT); Japanese Society for Dialysis Therapy (JSDT); Japanese Society of Nephrology (JSN); Okinawa Convention & Visitors Bureau (OCVB)	This manuscript is based on the presentation at the 7th Congress of International Society for Hemodialysis (ISHD2014), April 25-27, 2014 in Okinawa, Japan.<SUP>31</SUP> The author expresses his sincere thanks to colleagues in Okinawa and Kyushu for their generous support and encouragement. The author is also very grateful for the generous support from the Okinawa Dialysis and Transplantation Association (ODTA), Okinawa Dialysis Physicians Association (ODPA), Okinawa Clinical Nephrology Conference (OCNC), Okinawa Heart and Renal Association (OHRA), Kyushu Society for Dialysis Therapy (KSDT), Japanese Society for Dialysis Therapy (JSDT), Japanese Society of Nephrology (JSN), and Okinawa Convention & Visitors Bureau (OCVB).	Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Iseki K, 2012, CLIN EXP NEPHROL, V16, P244, DOI 10.1007/s10157-011-0551-9; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Levin NW, 2010, KIDNEY INT, V77, P273, DOI 10.1038/ki.2009.469; Mazzuchi N, 2000, KIDNEY INT, V58, P2147; Peters CD, 2014, KIDNEY INT, V86, P625, DOI 10.1038/ki.2014.69; Charra B, 1998, AM J KIDNEY DIS, V32, P720, DOI 10.1016/S0272-6386(98)70147-7; Robinson BM, 2012, KIDNEY INT, V82, P570, DOI 10.1038/ki.2012.136; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Zoccali C, 2013, J AM SOC NEPHROL, V24, P639, DOI 10.1681/ASN.2012100990; Molnar MZ, 2014, J AM COLL CARDIOL, V63, P650, DOI 10.1016/j.jacc.2013.10.050; Heerspink HL, 2009, LANCET, V373, P1009, DOI 10.1016/S0140-6736(09)60212-9; Iseki K, 2013, NEPHROL DIAL TRANSPL, V28, P1579, DOI 10.1093/ndt/gfs590; Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x; Fujii Y, 2013, EXPERT OPIN PHARMACO, V14, P259, DOI 10.1517/14656566.2013.761690; Iseki K, 1996, KIDNEY INT, V50, P1672, DOI 10.1038/ki.1996.484; Iseki K, 1997, KIDNEY INT, V51, P1212, DOI 10.1038/ki.1997.165; Iseki K, 2011, NEPHROL DIAL TRANSPL, V26, P963, DOI 10.1093/ndt/gfq507; Iseki K, 2009, NEPHRON CLIN PRACT, V113, pC183, DOI 10.1159/000232600; Iseki K, 2007, THER APHER DIAL, V11, P183, DOI 10.1111/j.1744-9987.2007.00479.x; Iseki K, 2014, HEMODIAL IN IN PRESS; Japanese Society for Dialysis Therapy, 2014, CURR STAT DIAL THER; Jun M, 2013, AM J KIDNEY DIS, V61, P247, DOI 10.1053/j.ajkd.2012.08.032; Luther J, 2008, KIDNEY INT, V73, P667, DOI 10.1038/sj.ki.5002799; Moriya H, 2007, NEPHROL DIAL TRANSPL, V22, P1198, DOI 10.1093/ndt/gfl732; NEREM RM, 1980, SCIENCE, V208, P1475, DOI 10.1126/science.7384790; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Twardowski ZJ, 2013, NEPHROL DIAL TRANSPL, V28, P826, DOI 10.1093/ndt/gfs307; Yamada S, 2008, LIFE SCI, V83, P516, DOI 10.1016/j.lfs.2008.08.001; Zagaer PG, 1998, KIDNEY INT, V54, P561	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	FEB	2015	20	2					49	54		10.1111/nep.12358		6	Urology & Nephrology	Urology & Nephrology	AZ9LC	WOS:000348534700001		
J	Sano, N; Yada, K				Sano, Natsuki; Yada, Katsutoshi			The influence of sales areas and bargain sales on customer behavior in a grocery store	NEURAL COMPUTING & APPLICATIONS			English	Article						RFID (radio frequency identification); Customer behavior model; Grocery store shopping; Nonhomogeneous hidden Markov model	HIDDEN MARKOV-MODELS	Developments in radio frequency identification (RFID) technology have resulted in the availability of data on customers' movement paths in various stores. In this paper, we propose a customer behavior model in a grocery store by using RFID and point-of-sales data. This model is based on a nonhomogeneous hidden Markov model with covariates and estimates "Stop" and "Pass by" behaviors. The model introduces sales areas and the number of bargain products as covariates and quantifies the effect of these covariates on each behavior. Thus, we can diagnose sales areas and decide the optimal quantity of bargain products. Further, we can rearrange sales areas and reinforce weak sales areas according to the diagnosis results. In addition, information on the optimal quantity of bargain products allows implementation of an effective bargain sales strategy.		Sano, N (reprint author), 2641 Yamazaki, Noda, Chiba, Japan.	nsano@rs.tus.ac.jp; yada@kansai-u.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology)	This research was supported by the Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy from MEXT (Ministry of Education, Culture, Sports, Science and Technology), 2009-2013.	Montgomery AL, 2004, MARKET SCI, V23, P579, DOI 10.1287/mksc.1040.0073; Larson JS, 2005, INT J RES MARK, V22, P395, DOI 10.1016/j.ijresmar.2005.09.005; Netzer O, 2008, MARKET SCI, V27, P185, DOI 10.1287/mksc.1070.0294; Smith A, 2006, J ECONOMETRICS, V134, P553, DOI 10.1016/j.jeconom.2005.07.005; KAMAKURA WA, 1989, J MARKETING RES, V26, P379, DOI 10.2307/3172759; Visser I, 2010, J STAT SOFTW, V36, P1; HUGHES JP, 1994, WATER RESOUR RES, V30, P1535, DOI 10.1029/93WR02983; FARLEY JU, 1966, OPER RES, V14, P555, DOI 10.1287/opre.14.4.555; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; GUPTA S, 1988, J MARKETING RES, V25, P342, DOI 10.2307/3172945; Chung H, 2007, PSYCHOMETRIKA, V72, P413, DOI 10.1007/s11336-005-1382-y; Baum L. E., 1972, INEQUALITIES, V3, P1; Bengio Y., 1995, Advances in Neural Information Processing Systems 7; Dhar R, 2007, J MARKETING RES, V44, P370, DOI 10.1509/jmkr.44.3.370; Gruber A, 2007, P C ART INT STAT; Guadagni P.M., 1983, MARKET SCI, V2, P203, DOI DOI 10.1287/MKSC.2.3.203; Hu P., 2011, P ICDM DEC, P260; Hui S., 2008, MARKET SCI, V28, P566; Jelinek F., 1997, STAT METHODS SPEECH; McLachlan G., 1997, EM ALGORITHM ITS EXT; SANO N, 2012, P 16 INT C KNOWL BAS, V243, P2104; Yada K, 2012, P SERV RES INNOV I G, V2012, P509	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-0643	1433-3058		NEURAL COMPUT APPL	Neural Comput. Appl.	FEB	2015	26	2			SI		355	361		10.1007/s00521-014-1619-8		7	Computer Science, Artificial Intelligence	Computer Science	AZ8FS	WOS:000348451100010		
J	Borghei-Razavi, H; Shibao, S; Schick, U				Borghei-Razavi, Hamid; Shibao, Shunsuke; Schick, Uta			Anatomical Variations of the Presigmoid Suprabulbar Infralabyrinthine Approach	NEUROSURGERY			English	Letter							JUGULAR FORAMEN		[Borghei-Razavi, Hamid; Schick, Uta] Clemens Hosp, Dept Neurosurg, Munster, Germany; [Shibao, Shunsuke] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 160, Japan	Borghei-Razavi, H (reprint author), Clemens Hosp, Dept Neurosurg, Munster, Germany.						MAZZONI A, 1995, SKULL BASE SURG, V5, P157, DOI 10.1055/s-2008-1058930; Borba Luis A B, 2004, Neurosurg Focus, V17, pE8; Borghei-Razavi H, 2014, ANAT SCI INT, V89, P112, DOI 10.1007/s12565-013-0206-x; Cinibulak Z, 2013, NEUROSURGERY, V73, P3, DOI 10.1227/NEU.0b013e31827fca8c; de Melo José Orlando Junior, 2014, Surg Neurol Int, V5, P131, DOI 10.4103/2152-7806.139819; Memari F, 2009, EUR ARCH OTO-RHINO-L, V266, P1373, DOI 10.1007/s00405-009-0928-5; Ramina R, 2005, NEUROSURGERY, V57, P59, DOI 10.1227/01.NEU.0000163483.44754.47; Ramina Ricardo, 2004, Neurosurg Focus, V17, pE5	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	FEB	2015	76	2					8242	8244		10.1227/NEU.0000000000000630		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AZ3SR	WOS:000348147500007		
J	Aizawa, K; Fujita, K; Kamide, H; Kasahara, N				Aizawa, Kosuke; Fujita, Kaoru; Kamide, Hideki; Kasahara, Naoto			SELECTOR-VALVE FAILED FUEL DETECTION AND LOCATION SYSTEM FOR JAPAN SODIUM-COOLED FAST REACTOR	NUCLEAR TECHNOLOGY			English	Article						Japan Sodium-cooled Fast Reactor; selector-valve FFDL system; upper internal structure with a radial slit	JSFR	The Japan Sodium-cooled Fast Reactor (JSFR) is studied as an advanced loop-type sodium-cooled reactor. A selector-valve (SV) mechanism is adopted in the design of JSFR for its failed fuel detection and location (FFDL) system. JSFR has only two FFDL units for 562 core fuel subassemblies to reduce construction cost by decreasing the reactor vessel diameter. Consequently, one SV-FFDL unit must handle about 300 subassemblies. Because of the large number of subassemblies per unit, it is predicted that the total duration for measuring all the fuel subassemblies becomes long. In addition, JSFR adopts an upper internal structure (UIS) with a slit above the core. In order to detect the fission products from the subassemblies below the slit, additional sampling nozzles for the FFDL are set in the UIS around the slit. In previous water experiments and numerical simulation, the sampling performance for the subassemblies under the UIS slit has been evaluated to be lower than those under the normal UIS position. In this paper, the outline of the FFDL system is shown, which can be applied to a large number of fuel subassemblies in a compact reactor vessel. The detection capability of the FFDL system was studied to achieve the design conditions. Operation modes and procedures of the FFDL system were also investigated.	[Aizawa, Kosuke; Fujita, Kaoru; Kamide, Hideki] Japan Atom Energy Agcy, Oarai, Ibaraki, Japan; [Kasahara, Naoto] Univ Tokyo, Bunkyo Ku, Tokyo 113, Japan	Aizawa, K (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki, Japan.	aizawa.kosuke@jaea.go.jp			Fuji Electric Systems Company, Ltd.	The authors appreciate the support of Fuji Electric Systems Company, Ltd.	AIZAWA K., 2010, P C ADV NUCL POW PLA, P645; Aizawa K, 2012, J NUCL SCI TECHNOL, V49, P47, DOI 10.1080/18811248.2011.636539; Kotake S, 2010, NUCL TECHNOL, V170, P133; [Anonymous], 2006, FEAS STUD COMM FAST; AONO T., 1988, PNCTN942088004 POW R; BANAL M., 1978, NUCL ENG INT, V23, P43; Briesmeister J. F., 2000, LA13709M LOS AL NAT; COULON P., 1991, P INT C FAST REACT R, V1; FIGG JA, 1980, NUCL TECHNOL, V50, P16; GELEE M., 1985, P INT M FAST REACT S, V1, P381; Katoh A, 2010, J NUCL SCI TECHNOL, V47, P642, DOI 10.3327/jnst.47.642; Mizuno T, 2004, NUCL TECHNOL, V146, P155; MIZUNO T., 2005, P 2005 INT C ADV NUC; NAGANUMA M., 2004, TN94002004039 JNC; ODO T., 1988, TN134088004 PNC POW, P45; OHKI S., 2008, P INT C REACT PHYS N; SCOTT RW, 1971, NUCL ENG INT, V16, P646; STRAIN R.V., 1991, P INT C FAST REACT R, V1	18	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	FEB	2015	189	2					111	121				11	Nuclear Science & Technology	Nuclear Science & Technology	CA0WA	WOS:000348633100001		
J	Kinuhata, H; Shirato, Y; Tomiyama, M; Kodama, T; Nakano, M; Yasuda, T; Tsutagi, K; Yoshino, Y; Nakamura, Y; Tamauchi, Y; Matsuoka, S				Kinuhata, Hiroshi; Shirato, Yoji; Tomiyama, Masahiro; Kodama, Takashi; Nakano, Masanao; Yasuda, Takeshi; Tsutagi, Koichi; Yoshino, Yasuyuki; Nakamura, Yoshinobu; Tamauchi, Yoshikazu; Matsuoka, Shingo			THE BEHAVIOR OF RADIOLYTICALLY PRODUCED HYDROGEN IN A HIGH-LEVEL LIQUID WASTE TANK OF A REPROCESSING PLANT: HYDROGEN CONCENTRATION IN THE VENTILATED TANK AIR	NUCLEAR TECHNOLOGY			English	Article						hydrogen; explosion; reprocessing plant	SIMULATED SOLUTION	The H-2 concentration was measured in the ventilated air of actual high-level liquid waste tanks of the Tokai reprocessing plant. It was compared with the value calculated from the parameters that were obtained using the simulated solution. Both values agreed satisfactorily within the limits of uncertainties of the parameters. This agreement showed that the catalytic H-2 consumption reaction caused by Pd ions, which was found previously using the simulated solution, proceeds also in the actual solution. The measured "G(H-2)" for the actual solution and the derived one using the parameters from the simulated solution were between 7 x 10(-6) and 3 x 10(-5).	[Kinuhata, Hiroshi; Kodama, Takashi; Nakano, Masanao; Tamauchi, Yoshikazu; Matsuoka, Shingo] Japan Nucl Fuel Ltd, Safety Technol Off, Rokkasho, Aomori 0393212, Japan; [Shirato, Yoji; Tomiyama, Masahiro; Yasuda, Takeshi; Tsutagi, Koichi; Yoshino, Yasuyuki; Nakamura, Yoshinobu] Japan Atom Energy Agcy, Tokai Reproc Technol Dev Ctr, Reproc Operat Dept, Tokai, Ibaraki 3191194, Japan	Kinuhata, H (reprint author), Japan Nucl Fuel Ltd, Safety Technol Off, Rokkasho, Aomori 0393212, Japan.	hiroshi.Kinuhata@jnfl.co.jp					Kodama T, 2012, NUCL TECHNOL, V180, P103; KUNO Y, 1993, J NUCL SCI TECHNOL, V30, P919; Kodama T, 2010, NUCL TECHNOL, V172, P77; BECKER R., 1979, IAEASM24513; SPECHT S., 1980, KFK2940 NUCL RES CTR, P196; VLADIMIROVA M. B., 1989, RADIOKHIMIYA, V31, P95	6	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	FEB	2015	189	2					122	132				11	Nuclear Science & Technology	Nuclear Science & Technology	CA0WA	WOS:000348633100002		
J	Aizawa, K; Chikazawa, Y				Aizawa, Kosuke; Chikazawa, Yoshitaka			TAGGING-GAS FAILED FUEL DETECTION AND LOCATION SYSTEM FOR SODIUM-COOLED REACTORS	NUCLEAR TECHNOLOGY			English	Article						Japan Sodium-cooled Fast Reactor; tagging-gas FFDL system; isotope ratio change by irradiation	TAG IDENTIFICATION	Failed fuel detection for the Japan Sodium-cooled Fast Reactor (JSFR) has been studied. The present JSFR design adopts a selector-valve (SV) failed fuel detection and location (FFDL) system. In this study, a tagging-gas (Tag) FFDL (Tag-FFDL) system has been investigated as an alternative. Although the identification performance of the Tag-FFDL system has been demonstrated in small and medium-sized reactors, the Tag-FFDL system has not been demonstrated yet in a large reactor like JSFR, which has 1500-MW(electric) power and 562 core fuel sub-assemblies. Major issues of the JSFR Tag-FFDL system are affected by high-burnup fuel and large cover gas volume. High-burnup fuel leads to a large change of the isotope ratio, which is important for the detection performance of the Tag-FFDL system. Since the cover gas volume in JSFR is larger than that in previous reactors, the tagging-gas concentration in the cover gas is lower than that in previous reactors. Thus, a requirement of the background value is more strict in JSFR. This study investigates whether two issues of the Tag-FFDL system for JSFR would be solvable. Tag gas isotope change in a high-burnup condition has been evaluated regarding transmutation and fission gas release. Taking into account tag gas isotope change due to the high-burnup conditions and large cover gas space,JSFR tagging gas has been designed. The investigation results showed that the JSFR FFDL system can provide an identification capability for 672 subassemblies, which is larger than the number of subassemblies in JSFR combining tagging-gas and burnup estimation. In addition, an allowable background concentration of natural Kr and Xe in the cover gas has been evaluated.	[Aizawa, Kosuke; Chikazawa, Yoshitaka] Japan Atom Energy Agcy, Oarai, Ibaraki, Japan	Aizawa, K (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki, Japan.	aizawa.kosuke@jaea.go.jp					A. ENDO, 2002, TN44002002003 JNC DE; AIZAWA K., 2012, P INT C ADV NUCL POW; Kotake S, 2010, NUCL TECHNOL, V170, P133; [Anonymous], 2002, CCC371 RAD SAF INF C; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; CARLSON R. B., 1992, ANLCP74461; ETOH M., 2009, P FAST REACT REL FUE; FIGG JA, 1980, NUCL TECHNOL, V50, P16; FLOWER T. B., 1969, ORNLTM2496; Hazama T, 2006, J NUCL SCI TECHNOL, V43, P908, DOI 10.3327/jnst.43.908; International Atomic Energy Agency, 2006, IAEATECDOC1531; ITO C., 2010, T AM NUCL SOC, V102, P416; ITO C., 2006, P 2006 FALL M AT EN; LAMBERT J. B. D., 1995, P BNES C FUEL MAN FU; SO BYC, 1976, T AM NUCL SOC, V23, P473; LAMBERT JDB, 1978, NUCL TECHNOL, V39, P275; MCCORMIC.NJ, 1974, NUCL TECHNOL, V24, P149; MCCORMIC.NJ, 1974, NUCL TECHNOL, V24, P156; SWAIM D. J., 1991, P FAST REACT REL FUE, VVols. 1; SWAIM D. J., 1991, P FAST REACT REL FUE; SWAIM D. J., 1991, P FAST REACT REL FUE, VVols.2	21	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	FEB	2015	189	2					143	151				9	Nuclear Science & Technology	Nuclear Science & Technology	CA0WA	WOS:000348633100004		
J	Soltanpour, M; Haghshenas, SA; Shibayama, T				Soltanpour, Mohsen; Haghshenas, S. Abbas; Shibayama, Tomoya			A two-dimensional experimental-numerical approach to investigate wave transformation over muddy beds	OCEAN DYNAMICS			English	Article						Fluid mud; Two-dimensional wave transformation; Wave energy dissipation; REF/DIF 1 wave model; Viscoelastic model; Wave basin experiments	SURFACE-WAVES; WATER-WAVES; MODEL; DISSIPATION; ATTENUATION; TRANSPORT; LAYER	The effect of a thin fluid mud layer on nearshore two-dimensional wave transformation is studied through numerical modeling and wave basin experiments. The wave basin experiments were conducted on both muddy and fixed beds. A mixture of commercial kaolinite and tap water was used as fluid mud layer, where its rheological viscoelastic parameters were derived from rheometer cyclic tests. The results can be utilized for better understanding of the complex wave transformation phenomena under real field conditions where the combined effects of shoaling, refraction, and diffraction as well as wave energy dissipation due to existing mud beds and wave breaking jointly occur. A dissipation model was coupled to the combined refraction and diffraction 1 (REF/DIF 1) wave model to develop a numerical wave height transformation model for muddy beaches. The proposed model was utilized to analyze the experimental data on muddy beds. Comparing the computed values of wave heights over mud layer with the corresponding measurements shows a fair agreement.	[Soltanpour, Mohsen] KN Toosi Univ Technol, Dept Civil Engn, Tehran 1996715433, Iran; [Haghshenas, S. Abbas] Univ Tehran, Inst Geophys, Tehran 1439951113, Iran; [Shibayama, Tomoya] Waseda Univ, Tokyo, Japan	Haghshenas, SA (reprint author), Univ Tehran, Inst Geophys, North Kargar Ave,POB 14155-6466, Tehran 1439951113, Iran.	soltanpour@kntu.ac.ir; sahaghshenas@ut.ac.ir; shibayama@waseda.jp		Soltanpour, Mohsen/0000-0003-4297-093X	Japan Society for the Promotion of Science [B-22404011]	The research reported in this paper is supported in part by the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. B-22404011). The authors are grateful to Dr. Hiroshi Takagi and Ms. Megumi Ogawa, former graduates of Yokohama National University, for their valuable collaboration in conducting wave basin experiments and Dr. Farzin Samsami, former graduate of K. N. Toosi University of Technology, for sharing the rheological data. Moreover, we would like to acknowledge two anonymous reviewers for their many useful comments and supervisions.	Jain M, 2009, CONT SHELF RES, V29, P642, DOI 10.1016/j.csr.2008.09.008; Hsu WY, 2013, J GEOPHYS RES-OCEANS, V118, P1126, DOI 10.1002/jgrc.20103; MEI CC, 1987, J GEOPHYS RES-OCEANS, V92, P14581, DOI 10.1029/JC092iC13p14581; Ng CO, 2000, COAST ENG, V40, P221, DOI 10.1016/S0378-3839(00)00012-0; Winterwerp JC, 2007, COAST ENG, V54, P249, DOI 10.1016/j.coastaleng.2006.08.012; DALRYMPLE RA, 1978, J PHYS OCEANOGR, V8, P1121, DOI 10.1175/1520-0485(1978)008<1121:WOSMAT>2.0.CO;2; MACPHERSON H, 1980, J FLUID MECH, V97, P721, DOI 10.1017/S0022112080002777; Sheremet A, 2005, ESTUAR COAST SHELF S, V63, P225, DOI 10.1016/j.ecss.2004.11.017; GADE HG, 1958, J MAR RES, V16, P61; Kaihatu JM, 2007, COAST ENG, V54, P752, DOI 10.1016/j.coastaleng.2007.05.003; DALLY WR, 1985, J GEOPHYS RES-OCEANS, V90, P1917, DOI 10.1029/JC090iC06p11917; DALRYMPLE RA, 1984, J WATERW PORT C-ASCE, V110, P67; de Boer GJ, 2009, WAVE DAMPING FLUID M; De Wit PJ, 1995, THESIS DELFT U TECHN; Goda Y, 2000, RANDOM SEAS DESIGN M, P443; Isobe MTN Huynh, 1992, P 23 INT C COAST ENG, P3093; KIRBY JT, 1986, J WATERW PORT C-ASCE, V112, P78; Kirby J.T., 1983, J FLUID MECH, V136, P543; Kranenburg WM, 2011, J HYDRAUL ENG-ASCE, V137, P959, DOI 10.1061/(ASCE)HY.1943-7900.0000370; MAA JPY, 1988, J WATERW PORT C-ASCE, V114, P765; Maa P-Y, 1986, THESIS U FLORIDA GAI, V32611; Rodriguez HN, 2001, J COASTAL RES, VSI21, P132; Ross MA, 1990, MICROSTRUCTURE FINE, P185; SAKAKIYAMA T, 1989, J WATERW PORT C-ASCE, V115, P614; Samsami F, 2011, 11 INT C COH SED TRA, P195; Shen D, 1993, THESIS U TOKYO; Sheremet A, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001885; Shibayama T, 1993, COASTAL ENG JAPAN, V36, P67; Soltanpour M, 2008, COAST ENG J, V50, P143, DOI 10.1142/S0578563408001806; Soltanpour M, 2003, COAST ENG J, V45, P363, DOI 10.1142/S0578563403000804; Tsuruya H, 1987, REP PORT HARBOR RES, V26, P138; Wells J.T., 1986, ESTUARINE COHESIVE S, V14, P43	32	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1616-7341	1616-7228		OCEAN DYNAM	Ocean Dyn.	FEB	2015	65	2					295	310		10.1007/s10236-014-0797-3		16	Oceanography	Oceanography	AZ7TB	WOS:000348419500010		
J	Nagayoshi, K; Ueki, T; Tashiro, K; Mizuuchi, Y; Manabe, T; Araki, H; Oda, Y; Kuhara, S; Tanaka, M				Nagayoshi, Kinuko; Ueki, Takashi; Tashiro, Kosuke; Mizuuchi, Yusuke; Manabe, Tatsuya; Araki, Hiromitsu; Oda, Yoshinao; Kuhara, Satoru; Tanaka, Masao			Galanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer	ONCOLOGY REPORTS			English	Article						galanin; colorectal cancer; stage II; prognostic factor	EMBRYONIC STEM-CELLS; COLON-CANCER; RECEPTOR SUBTYPES; ADJUVANT THERAPY; EXPRESSION; IDENTIFICATION; PROLIFERATION; APOPTOSIS; DATABASE; NEURONS	Reliable predictors of tumor recurrence for patients with stage II colorectal cancer (CRC) are needed to select patients who should receive adjuvant chemotherapy. Although galanin (GAL) is expressed in several malignant tumors and is associated with cell proliferation and tumor growth, the prognostic value of GAL expression in CRC is poorly understood. We compared GAL expression between 56 patients with stage II and III CRC who developed tumor recurrences and 56 patients who did not. The clinical and prognostic significance of GAL expression was examined using our data and independent public datasets. We also analyzed the influence of GAL expression on the proliferation and invasive activity of CRC cells. Higher expression of GAL was associated with tumor recurrence among the CRC patients (P<0.001). Stage II CRC patients who presented with high expression levels of GAL had significantly poorer prognosis than those with low expression levels of GAL [5-year overall survival: hazard ratio (HR), 7.31; 95% confidence interval (CI), 2.38-24.04; P<0.001; 5-year recurrence-free survival: HR, 3.99; 95% CI, 1.61-9.44; P=0.004], but there was no association between GAL expression and survival in stage III CRC patients. These findings were supported by analysis of two public datasets. Functionally, siRNA-mediated silencing of GAL resulted in a significant decrease in the proliferative and invasive activities of CRC cells. In conclusion, high expression of GAL is associated with poor prognosis of stage II CRC patients and GAL expression may be related to the aggressive behavior of CRC.	[Nagayoshi, Kinuko; Ueki, Takashi; Manabe, Tatsuya; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Tashiro, Kosuke; Araki, Hiromitsu; Kuhara, Satoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Mizuuchi, Yusuke; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan	Ueki, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tueki@surg1.med.kyushu-u.ac.jp					AHREN B, 1988, FEBS LETT, V229, P233, DOI 10.1016/0014-5793(88)81131-1; Anisimov SV, 2002, GENOMICS, V79, P169, DOI 10.1006/geno.2002.6687; Henson BS, 2005, J BIOL CHEM, V280, P22564, DOI 10.1074/jbc.M414589200; Rauch I, 2010, EXPERIENTIA SUPPL, V102, P223, DOI 10.1007/978-3-0346-0228-0_16; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; [Anonymous], 2013, CLIN PRACT GUID COL; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Zhang L, 1999, CANCER LETT, V142, P129, DOI 10.1016/S0304-3835(99)00107-X; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Stevenson L, 2012, CLIN CANCER RES, V18, P5412, DOI 10.1158/1078-0432.CCR-12-1780; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Berger A, 2004, ENDOCRINOLOGY, V145, P500, DOI 10.1210/en.2003-0649; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Floren A, 2000, NEUROPEPTIDES, V34, P331, DOI 10.1054/npep.2000.0808; Berger A, 2005, NEUROPEPTIDES, V39, P353, DOI 10.1016/j.npep.2004.12.016; BURLEIGH DE, 1990, NEUROPEPTIDES, V16, P77, DOI 10.1016/0143-4179(90)90115-F; Edge SB, 2010, AJCC CANC STAGING MA; El-Salhy M, 2005, ONCOL REP, V13, P45; Fujiwara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052682; Gilaberte Y, 2007, Actas Dermosifiliogr, V98, P24; Kask K, 1995, CELL MOL NEUROBIOL, V15, P653, DOI 10.1007/BF02071130; Kim KY, 2007, CANCER EPIDEM BIOMAR, V16, P2373, DOI 10.1158/1055-9965.EPI-06-0740; Misawa Y, 2014, CANCER-AM CANCER SOC, V120, P205, DOI 10.1002/cncr.28411; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Perel Y, 2002, BRIT J CANCER, V86, P117, DOI 10.1038/sj.bjc.6600019; Seufferlein T, 1996, CANCER RES, V56, P5758; Shi Q, 2013, J CLIN ONCOL, V31, P3656, DOI 10.1200/JCO.2013.49.4344; Trejter M, 2002, INT J MOL MED, V10, P183; Xia CY, 2005, NEUROPEPTIDES, V39, P453, DOI 10.1016/j.npep.2005.07.004; Zeng NX, 1998, GASTROENTEROLOGY, V115, P330, DOI 10.1016/S0016-5085(98)70199-4	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					539	546		10.3892/or.2014.3660		8	Oncology	Oncology	AZ6OJ	WOS:000348338500005		
J	Shinbo, T; Fushida, S; Tsukada, T; Harada, S; Kinoshita, J; Oyama, K; Okamoto, K; Ninomiya, I; Takamura, H; Kitagawa, H; Fujimura, T; Yashiro, M; Hirakawa, K; Ohta, T				Shinbo, Toshifumi; Fushida, Sachio; Tsukada, Tomoya; Harada, Shinichi; Kinoshita, Jun; Oyama, Katsunobu; Okamoto, Koichi; Ninomiya, Itasu; Takamura, Hiroyuki; Kitagawa, Hirohisa; Fujimura, Takeshi; Yashiro, Masakazu; Hirakawa, Kousei; Ohta, Tetsuo			Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-beta signaling pathway	ONCOLOGY REPORTS			English	Article						protein-bound polysaccharide; transforming growth factor beta; gastric cancer; cancer-associated fibroblast	GROWTH-FACTOR-BETA; PERITONEAL CARCINOMATOSIS; ORAL FLUOROPYRIMIDINE; PSK; S-1; CELLS; INVASIVENESS; CHEMOTHERAPY; METASTASIS	Peritoneal carcinomatosis (PC) is the most frequent metastatic pattern of gastric cancer and its prognosis is extremely poor. PC is characterized by rich fibrosis and the development of obstructive disorders such as ileus, jaundice and hydronephrosis. Epithelial-mesenchymal transition (EMT) is one of the major causes of tissue fibrosis and transforming growth factor beta (TGF-beta) has a pivotal function in the progression of EMT. Protein-bound polysaccharide K (PSK) is a biological response modifier that can modulate the TGF-beta/Smad signaling pathway in vitro. In the present study, we established a fibrotic tumor model using human peritoneal mesothelial cells (HPMCs) and a human gastric cancer cell line to evaluate whether PSK attenuates tumor fibrosis. HPMCs exposed to PSK did not undergo the morphological change from a cobblestone-like pattern to a spindle-shape pattern normally induced by treatment with TGF-beta. Immunofluorescence further demonstrated that PSK suppressed TGF-beta-induced overexpression of alpha-SMA in the HPMCs. We further showed that HPMCs contributed to the proliferation of tumor fibrosis by using a mouse xenograft model. Additionally, PSK treatment of these mice significantly reduced the area of observable tumor fibrosis. These results suggest that seeded cancer cells transformed HPMCs into myofibroblast-like cells through their release of TGF-beta in the microenvironment, facilitating the development of fibrous tumors in organs covered with HPMCs. Therefore, our study indicates that PSK has potential utility as an anti-fibrotic agent in the treatment of gastric cancer patients with PC.	[Shinbo, Toshifumi; Fushida, Sachio; Tsukada, Tomoya; Kinoshita, Jun; Oyama, Katsunobu; Okamoto, Koichi; Ninomiya, Itasu; Takamura, Hiroyuki; Kitagawa, Hirohisa; Fujimura, Takeshi; Ohta, Tetsuo] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Gastroenterol Surg, Kanazawa, Ishikawa 9208641, Japan; [Harada, Shinichi] Kanazawa Univ, Ctr Biomed Res & Educ, Sch Med, Kanazawa, Ishikawa 9208641, Japan; [Yashiro, Masakazu; Hirakawa, Kousei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan	Fushida, S (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Gastroenterol Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	fushida@staff.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [24791402]	This study was supported in part by Grants-in-Aid for Young Scientists (B; 24791402 to J.K.) from the Japan Society for the Promotion of Science.	Oba K, 2007, CANCER IMMUNOL IMMUN, V56, P905, DOI 10.1007/s00262-006-0248-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ono Y, 2012, CANCER SCI, V103, P317, DOI 10.1111/j.1349-7006.2011.02133.x; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; TSUKAGOSHI S, 1984, CANCER TREAT REV, V11, P131, DOI 10.1016/0305-7372(84)90005-7; Chen CY, 2002, HEPATO-GASTROENTEROL, V49, P874; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fujii M, 2010, SURG TODAY, V40, P295, DOI 10.1007/s00595-009-4148-9; Fushida S, 2013, CANCER CHEMOTH PHARM, V71, P1265, DOI 10.1007/s00280-013-2122-0; Fushida S, 2013, J CANC THER, V4, P6; Ly ZD, 2013, MOL CELL BIOCHEM, V377, P177; Mai M, 1999, Gan To Kagaku Ryoho, V26, P487; Maruyama K, 2006, GASTRIC CANCER, V9, P51, DOI DOI 10.1007/S10120-006-0370-Y; Matsunaga K, 1998, IMMUNOPHARMACOLOGY, V40, P219, DOI 10.1016/S0162-3109(98)00045-9; Naitoh Hiroyuki, 2004, Gan To Kagaku Ryoho, V31, P2031; Ohshima T, 2006, ONCOL REP, V16, P361; Osugi H, 2002, ONCOL REP, V9, P811; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Shinto O, 2010, BRIT J CANCER, V102, P844, DOI 10.1038/sj.bjc.6605561; Terai S, 2014, GASTRIC CANCER, DOI [10.1007/s10120-014-0380-0, DOI 10.1007/S10120-014-0380-0]; Tsukada T, 2012, INT J ONCOL, V41, P476, DOI 10.3892/ijo.2012.1490; Tsukada T, 2013, INT J ONCOL, V42, P1167, DOI 10.3892/ijo.2013.1801; Ueda Y, 2006, JPN J CLIN ONCOL, V36, P519, DOI 10.1093/jjco/hyl048; Yamaguchi Y, 2004, ANTICANCER RES, V24, P639; YAMAZAKI H, 1989, CANCER, V63, P613, DOI 10.1002/1097-0142(19890215)63:4<613::AID-CNCR2820630402>3.0.CO;2-0; Zhang H, 2000, CLIN EXP METASTAS, V18, P343	31	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					553	558		10.3892/or.2014.3636		6	Oncology	Oncology	AZ6OJ	WOS:000348338500007		
J	Ahmed, SMU; Wu, XX; Jin, XH; Zhang, X; Togo, Y; Suzuki, T; Li, YN; Kanematsu, A; Nojima, M; Yamamoto, S; Sugimoto, M; Kakehi, Y				Ahmed, Syed Minhaj Uddin; Wu, Xiuxian; Jin, Xinghua; Zhang, Xia; Togo, Yoshikazu; Suzuki, Toru; Li, Yongnan; Kanematsu, Akihiro; Nojima, Mikio; Yamamoto, Shingo; Sugimoto, Mikio; Kakehi, Yoshiyuki			Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells	ONCOLOGY REPORTS			English	Article						DR4; apoptosis; bladder cancer cells; mapatumumab; anthracyclines	HUMAN MONOCLONAL-ANTIBODY; INHIBITS TUMOR-GROWTH; IN-VIVO; DEATH RECEPTORS; TUMORICIDAL ACTIVITY; CARCINOMA-CELLS; PROSTATE-CANCER; LUNG-CANCER; TRAIL; LIGAND	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in a variety of tumor cells by engaging the death receptors 4 (DR4) and 5 (DR5). We investigated the effect of chemotherapeutic drugs on DR4-mediated apoptosis in human bladder cancer cells, using a human monoclonal agonistic antibody specific for DR4, mapatumumab. Cytotoxicity was determined by 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide assay. Synergy was assessed by isobolographic analysis. Treatment of human bladder cancer T24 cells with mapatumumab in combination with mitomycin C, vinblastine or gemcitabine did not overcome resistance to these agents. However, treatment with mapatumumab in combination with epirubicin (EPI) had a synergistic cytotoxic effect. Synergy was also obtained in KU7 and RT112 human bladder cancer cells. A synergistic effect was also observed with mapatumumab in combination with pirarubicin. The synergy obtained in cytotoxicity with mapatumumab and EPI was also achieved in apoptosis. EPI markedly increased DR4 expression in the bladder cancer cells at both the mRNA and protein levels. Furthermore, the combination-induced cytotoxicity was significantly suppressed by the DR4:Fc chimeric protein. The combination of EPI and mapatumumab significantly activated the caspase cascade, including caspase-8, -9 and -3, which are the downstream molecules of death receptors. These findings indicate that EPI sensitizes bladder cancer cells to DR4 -mediated apoptosis through induction of DR4 and activation of caspases, suggesting that the combination therapy of EPI and mapatumumab may be effective for bladder cancer therapy.	[Ahmed, Syed Minhaj Uddin; Wu, Xiuxian; Zhang, Xia; Sugimoto, Mikio; Kakehi, Yoshiyuki] Kagawa Univ, Fac Med, Dept Urol, Takamatsu, Kagawa 7610793, Japan; [Wu, Xiuxian; Jin, Xinghua; Togo, Yoshikazu; Suzuki, Toru; Li, Yongnan; Kanematsu, Akihiro; Nojima, Mikio; Yamamoto, Shingo] Hyogo Coll Med, Dept Urol, Nishinomiya, Hyogo 6638501, Japan; [Jin, Xinghua] Qiqihar Med Univ, Qiqihar 161006, Heilongjiang, Peoples R China; [Li, Yongnan] Mudanjiang Med Univ, Mudanjiang 157011, Heilongjiang, Peoples R China	Kakehi, Y (reprint author), Kagawa Univ, Fac Med, Dept Urol, 1750-1 Miki Cho, Takamatsu, Kagawa 7610793, Japan.	wuxian@hyo-med.ac.jp; kakehi@med.kagawa-u.ac.jp					Amantana A, 2004, MOL CANCER THER, V3, P699; Gibson SB, 2000, MOL CELL BIOL, V20, P205; Griffiths TRL, 2013, INT J CLIN PRACT, V67, P435, DOI 10.1111/ijcp.12075; Tsai WS, 2006, MOL CANCER THER, V5, P2977, DOI 10.1158/1535-7163.MCT-05-0514; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Pukac L, 2005, BRIT J CANCER, V92, P1430, DOI 10.1038/sj.bjc.6602487; Zeng Y, 2006, INT J ONCOL, V28, P421; Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Chuntharapai A, 2001, J IMMUNOL, V166, P4891; Hotte SJ, 2008, CLIN CANCER RES, V14, P3450, DOI 10.1158/1078-0432.CCR-07-1416; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; von Pawel J, 2014, CLIN LUNG CANCER, V15, P188, DOI 10.1016/j.cllc.2013.12.005; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BERENBAUM MC, 1977, CLIN EXP IMMUNOL, V28, P1; Szliszka E, 2009, FOLIA HISTOCHEM CYTO, V47, P579, DOI 10.2478/v10042-009-0111-2; DeRosier LC, 2007, MOL CANCER THER, V6, P3198, DOI 10.1158/1535-7163.MCT-07-0299; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; BERENBAUM MC, 1978, J INFECT DIS, V137, P122; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; O'Kane HF, 2006, J UROLOGY, V175, P432, DOI 10.1016/S0022-5347(05)00160-6; Walczak H, 1999, NAT MED, V5, P157; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Chen SY, 2010, CHINESE MED J-PEKING, V123, P3422, DOI 10.3760/cma.j.issn.0366-6999.2010.23.009; Hao CH, 2004, CANCER RES, V64, P8502, DOI 10.1158/0008-5472.CAN-04-2599; Jin XH, 2007, J UROLOGY, V177, P1894, DOI 10.1016/j.juro.2007.01.018; Lacour S, 2001, CANCER RES, V61, P1645; Li Y, 2012, UROLOGY, V79; Liu WH, 2001, AM J RESP CELL MOL, V25, P111; Ohtsuka T, 2003, ONCOGENE, V22, P2034, DOI 10.1038/sj.onc.1206290; Shimada O, 2007, UROLOGY, V69, P395, DOI 10.1016/j.urology.2006.12.007; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Wu XX, 2009, CLIN CANCER RES, V15, P2039, DOI 10.1158/1078-0432.CCR-08-2667	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					566	572		10.3892/or.2014.3654		7	Oncology	Oncology	AZ6OJ	WOS:000348338500009		
J	Fukushima, Y; Iinuma, H; Tsukamoto, M; Matsuda, K; Hashiguchi, Y				Fukushima, Yoshihisa; Iinuma, Hisae; Tsukamoto, Mitsuo; Matsuda, Keiji; Hashiguchi, Yojiro			Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer	ONCOLOGY REPORTS			English	Article						microRNA-21; biomarker; prognostic factor; colorectal cancer	CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR GENE; HUMAN BREAST-CANCER; PDCD4 EXPRESSION; MIR-21; PROGNOSIS; CELLS; METASTASIS; INVASION; TARGETS	The potential value of microRNAs (miRNAs) as prognostic biomarkers are of interest. It is known that microRNA-21 (miR-21) is implicated in the promotion, proliferation and progression of several types of human cancers. However, the prognostic significance of miR-21 in each tumor stage of colorectal cancer (CRC) remains elusive. The objective of this study was to clarify the prognostic value of miR-21 for CRC patients at each tumor stage. The expression levels of miR-21 in the tumor tissues and normal adjacent tumor tissues of 306 CRC patients were determined by TaqMan microRNA assays. In order to clarify the miRNA profile in CRC tissues, miRNA arrays were examined. In this analysis, miR-21, miR-224, miR-96, miR-31 and miR-155 showed marked upregulation, and miR-21 showed the highest level. Upon comparison of clinicopathological factors, miR-21 expression showed significant association with depth of invasion, lymphatic and venous invasion, liver metastasis and Dukes' stage. In the Kaplan-Meier survival curve analysis of all patients, overall survival (OS) and disease-free survival (DFS) rates of the patients with high miR-21 expression were significantly worse than these rates in patients with low miR-21 expression. In the Kaplan-Meier analysis of each tumor stage, the DFS of patients with high miR-21 expression was significantly worse than patients with low miR-21 levels in Dukes' stage A tumors. In Dukes' stage B and C, patients with high miR-21 expression showed a significantly worse OS and DFS than patients with low miR-21 expression. In Dukes' stage D, patients with high miR-21 expression showed a significantly worse OS than patients with low miR-21 expression. In the Cox multivariate analysis, it was shown that miR-21 expressions in CRC tissues is an independent prognostic factor in Dukes' stage B, C and D. In conclusion, miR-21 expression may be a valuable biomarker for prediction of poor prognosis in CRC patients with Dukes' stage B, C and D.	[Fukushima, Yoshihisa; Iinuma, Hisae; Tsukamoto, Mitsuo; Matsuda, Keiji; Hashiguchi, Yojiro] Teikyo Univ Sch Med, Dept Surg, Itabashi Ku, Tokyo 1730003, Japan	Iinuma, H (reprint author), Teikyo Univ Sch Med, Dept Surg, Itabashi Ku, 2-11-1 Kaga, Tokyo 1730003, Japan.	iinuma@med.teikyo-u.ac.jp			 [24591984];  [25462070]	We thank Miss J. Tamura for her excellent technical assistance, and all members of the colorectal group for their clinical suggestions. This study was supported by a Grant-in-Aid for Scientific Research (C) (24591984) and (C) (25462070).	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Torres A, 2011, INT J GYNECOL CANCER, V21, P8, DOI 10.1097/IGC.0b013e318200050e; Aslam MI, 2009, BRIT J SURG, V96, P702, DOI 10.1002/bjs.6628; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Gill S, 2003, ALIMENT PHARM THERAP, V18, P683, DOI 10.1046/j.1365-2036.2003.01735.x; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Aggarwal S, 2005, ONCOLOGY-NY, V19, P589; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Wang ZX, 2011, ARCH MED RES, V42, P281, DOI 10.1016/j.arcmed.2011.06.008; Chang KH, 2011, EJSO-EUR J SURG ONC, V37, P597, DOI 10.1016/j.ejso.2011.04.001; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chung Ki-Young Y, 2006, Curr Treat Options Gastroenterol, V9, P272, DOI 10.1007/s11938-006-0046-z; Horiuchi A, 2012, ONCOL REP, V27, P1384, DOI 10.3892/or.2012.1648; Liu M, 2011, FEBS LETT, V585, P2998, DOI 10.1016/j.febslet.2011.08.014; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Ziyan Wu, 2011, Med Oncol, V28, P1469, DOI 10.1007/s12032-010-9563-7	29	4	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					573	582		10.3892/or.2014.3614		10	Oncology	Oncology	AZ6OJ	WOS:000348338500010		
J	Kitagawa, T; Yamamoto, J; Tanaka, T; Nakano, Y; Akiba, D; Ueta, K; Nishizawa, S				Kitagawa, Takehiro; Yamamoto, Junkoh; Tanaka, Tohru; Nakano, Yoshiteru; Akiba, Daisuke; Ueta, Kunihiro; Nishizawa, Shigeru			5-Aminolevulinic acid strongly enhances delayed intracellular production of reactive oxygen species (ROS) generated by ionizing irradiation: Quantitative analyses and visualization of intracellular ROS production in glioma cells in vitro	ONCOLOGY REPORTS			English	Article						5-aminolevulinic acid; radiosensitizer; radiotherapy; glioma; reactive oxygen species; cancer; mitochondria	INDUCED PROTOPORPHYRIN-IX; CYTOCHROME-C RELEASE; MALIGNANT GLIOMA; GLIOBLASTOMA-MULTIFORME; PHOTOFRIN-II; CANCER-CELLS; HL60 CELLS; RADIATION; RADIOTHERAPY; APOPTOSIS	Postoperative adjuvant radiotherapy has important roles in multimodal treatment for highly aggressive malignant gliomas. Previously, we demonstrated that multi-dose ionizing irradiation with repetitive administration of 5-aminolevulinic acid (5-ALA) enhanced the host antitumor response and strongly inhibited tumor growth in experimental glioma. However, the mechanism of the radiosensitizing effect of 5-ALA is not known. Ionizing irradiation not only causes reactive oxygen species (ROS) formation initially by water radiolysis but also induces delayed production of mitochondrial ROS for mediating the long-lasting effects of ionizing irradiation on tumor cells. 5-ALA leads to high accumulation of protoporphyrin IX (PpIX) in the mitochondria of tumor cells, yet can also improve dysfunction of the mitochondrial respiratory chain in tumor cells. Here, we assessed the effect of 5-ALA-induced PpIX synthesis and delayed production of intracellular ROS after ionizing irradiation with 5-ALA in glioma cells in vitro. Temporal changes in intracellular 5-ALA-induced PpIX synthesis after ionizing irradiation in glioma cell lines were evaluated using flow cytometry (FCM). Then, the effect of 5-ALA on delayed production of intracellular ROS 12 h after ionizing irradiation in glioma cells was evaluated by FCM and confocal laser scanning microscopy. Ionizing irradiation had no effect on 5-ALA-induced PpIX synthesis in glioma cells. Delayed intracellular production of ROS was significantly higher than that just after ionizing irradiation, but 5-ALA pretreatment strongly enhanced the delayed intracellular production of ROS, mainly in the cytoplasm of glioma cells. This 5-ALA-induced increase in the delayed production of ROS tended to be higher in the case of 5-ALA treatment before rather than after ionizing irradiation. These results suggest that 5-ALA can affect tumor cells under ionizing irradiation, and greatly increase secondary intracellular production of ROS long after ionizing irradiation, thereby causing a radiosensitizing effect in glioma cells.	[Kitagawa, Takehiro; Yamamoto, Junkoh; Nakano, Yoshiteru; Akiba, Daisuke; Ueta, Kunihiro; Nishizawa, Shigeru] Univ Occupat & Environm Hlth, Dept Neurosurg, Kitakyushu, Fukuoka 8078555, Japan; [Tanaka, Tohru] SBI Pharmaceut Co Ltd, Minato Ku, Tokyo, Japan	Yamamoto, J (reprint author), Univ Occupat & Environm Hlth, Dept Neurosurg, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yama9218@med.uoeh-u.ac.jp			JSPS KAKENHI [25462282]	The present study was supported by JSPS KAKENHI (grant no. 25462282).	Wallace SS, 1998, RADIAT RES, V150, pS60, DOI 10.2307/3579809; Ogura A, 2009, CANCER LETT, V277, P64, DOI 10.1016/j.canlet.2008.11.021; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Westphal M, 2006, ACTA NEUROCHIR, V148, P269, DOI 10.1007/s00701-005-0707-z; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; SHAPIRO WR, 1989, J NEUROSURG, V71, P1, DOI 10.3171/jns.1989.71.1.0001; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; WARBURG O, 1956, SCIENCE, V124, P269; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; BERG K, 1995, RADIAT RES, V142, P340, DOI 10.2307/3579143; Della Puppa A, 2013, ACTA NEUROCHIR, V155, P965, DOI 10.1007/s00701-013-1660-x; Fischer F, 2001, LASER MED SCI, V16, P207, DOI 10.1007/PL00011356; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, P5; Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461; Hosokawa Y, 2005, J RADIAT RES, V46, P293, DOI 10.1269/jrr.46.293; Le Caer S, 2011, WATER-SUI, V3, P235, DOI 10.3390/w3010235; Luksiene Z, 2006, CANCER LETT, V235, P40, DOI 10.1016/j.canlet.2005.03.041; Mimura S, 1996, LASER SURG MED, V19, P168; Mlkvy P, 1996, BRIT J CANCER, V73, P1473, DOI 10.1038/bjc.1996.279; Ogura Shun-Ichiro, 2011, BMC Res Notes, V4, P66, DOI 10.1186/1756-0500-4-66; Saenko Y, 2013, RADIAT RES, V180, P360, DOI 10.1667/RR3247.1; Schaffer M, 2006, ONKOLOGIE, V29, P514, DOI 10.1159/000095979; Sugiyama Y, 2014, ONCOL REP, V31, P1282, DOI 10.3892/or.2013.2945; Tamura Y, 2007, J NEUROSURG, V106, P507, DOI 10.3171/jns.2007.106.3.507; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Yamamoto J, MOL MED REP IN PRESS; Yamamoto J, 2006, CLIN CANCER RES, V12, P7132, DOI 10.1158/1078-0432.CCR-06-0786; Yamamoto J, 2005, INT J ONCOL, V27, P1207; Yamamoto J, 2012, ONCOL REP, V27, P1748, DOI 10.3892/or.2012.1699; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287	38	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					583	590		10.3892/or.2014.3618		8	Oncology	Oncology	AZ6OJ	WOS:000348338500011		
J	Uehara, T; Mitsuhashi, A; Tsuruoka, N; Shozu, M				Uehara, Takashi; Mitsuhashi, Akira; Tsuruoka, Nobuhide; Shozu, Makio			Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro	ONCOLOGY REPORTS			English	Article						cisplatin; combination treatment; endometrial cancer; hypoxia; metformin	ENDOMETRIAL CANCER-CELLS; BREAST-CANCER; DIABETIC-PATIENTS; OVARIAN-CANCER; INSULIN-RESISTANCE; RESPIRATORY-CHAIN; AMPK ACTIVATION; MTT ASSAY; GROWTH; CHEMOTHERAPY	Metformin is a diabetes drug with anticancer properties. Several studies have investigated the effects of metformin combined with chemotherapeutic agents, with controversial results. This study evaluated the efficacy of combined metformin/cisplatin treatment in an endometrial cancer cell line. Ishikawa cells were treated with metformin, cisplatin or both types of treatment. Cell proliferation was evaluated by quantification and colorimetric and thymidine incorporation assays, cell cycle progression was assessed by flow cytometry, and apoptosis by the caspase-3 activity assay. The effects of metformin and cisplatin used in combination were assessed under normoxic (21% O-2) and hypoxic (1% O-2) conditions. Mitochondrial morphology was examined using the MitoTracker dye, while function was assayed by lactate production. Discrepant results were obtained from the different assays of cell proliferation, with the value obtained from the colorimetric assay being higher than that from cell counts after drug treatment. Combined treatment with metformin (>= 2 mM) and cisplatin (1 mu M) had additive anti-proliferative effects on cells under normoxic conditions. However, the additive effect of metformin was attenuated under hypoxia. Metformin caused morphological and functional changes in mitochondria, which appeared shortened after exposure to metformin, while the connections between individual mitochondria appeared weaker. Additionally, decreased MitoTracker staining was observed after an 8-h exposure to metformin. The colorimetric assay did not accurately determine the effects of metformin and cisplatin on cell proliferation. The additive effects of metformin on cisplatin-induced inhibition of cell proliferation were attenuated under hypoxic conditions, while metformin compromised mitochondrial structure and function. Additional studies are needed to determine the efficacy of this drug combination in vivo.	[Uehara, Takashi; Mitsuhashi, Akira; Tsuruoka, Nobuhide; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chuo Ku, Chiba 2608670, Japan; [Tsuruoka, Nobuhide] Chiba Univ, Grad Sch Med, Dept Dev Genet, Chuo Ku, Chiba 2608670, Japan	Uehara, T (reprint author), Chiba Univ, Grad Sch Med, Dept Reprod Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	takuehar@chiba-u.jp			Japan Society for the Promotion of Science KAKENHI [24791686]	This study was supported by the Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Young Scientists (B) (grant no. 24791686).	Janjetovic K, 2011, EUR J PHARMACOL, V651, P41, DOI 10.1016/j.ejphar.2010.11.005; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Liu HY, 2012, ANTICANCER RES, V32, P1627; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Hanna RK, 2012, GYNECOL ONCOL, V125, P458, DOI 10.1016/j.ygyno.2012.01.009; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Ashinuma H, 2012, ONCOL REP, V28, P8, DOI 10.3892/or.2012.1763; Evans JMM, 2005, BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; WILCOCK C, 1994, XENOBIOTICA, V24, P49; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Soliman PT, 2006, CANCER, V106, P2376, DOI 10.1002/cncr.21866; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Collier AC, 2003, BIOCHEM PHARMACOL, V66, P281, DOI 10.1016/S0006-2952(03)00240-5; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363; Dong LL, 2012, J OBSTET GYNAECOL RE, V38, P1077, DOI 10.1111/j.1447-0756.2011.01839.x; LALAU JD, 1995, DIABETES CARE, V18, P779, DOI 10.2337/diacare.18.6.779; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Mu N, 2012, GYNECOL ONCOL, V125, P751, DOI 10.1016/j.ygyno.2012.03.032; Shank JJ, 2012, GYNECOL ONCOL, V127, P390, DOI 10.1016/j.ygyno.2012.07.115; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P172, DOI 10.4161/cc.23058; Martin-Castillo B, 2010, CELL CYCLE, V9, P1057; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Burzawa JK, 2011, AM J OBSTET GYNECOL, V204; Cantrell Lee F, 2012, J Anal Toxicol, V36, P657, DOI 10.1093/jat/bks076; Goodwin PJ, 2008, CLIN BREAST CANCER, V8, P501, DOI 10.3816/CBC.2008.n.060; Harhaji-Trajkovic L, 2009, J CELL MOL MED, V13, P3644, DOI 10.1111/j.1582-4934.2009.00663.x; Johnson N, 2011, COCHRANE DB SYST REV, V10; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Nilsson S, 2011, CANCER LETT, V304, P60, DOI 10.1016/j.canlet.2010.12.022; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; PAGLIACCI MC, 1993, EUR J CANCER, V29A, P1573, DOI 10.1016/0959-8049(93)90297-S; Vale C.L., 2012, COCHRANE DB SYST REV, V8; Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					744	750		10.3892/or.2014.3611		7	Oncology	Oncology	AZ6OJ	WOS:000348338500031		
J	Sonohara, F; Nomoto, S; Inokawa, Y; Hishida, M; Takano, N; Kanda, M; Nishikawa, Y; Fujii, T; Koike, M; Sugimoto, H; Kodera, Y				Sonohara, Fuminori; Nomoto, Shuji; Inokawa, Yoshikuni; Hishida, Mitsuhiro; Takano, Nao; Kanda, Mitsuro; Nishikawa, Yoko; Fujii, Tsutomu; Koike, Masahiko; Sugimoto, Hiroyuki; Kodera, Yasuhiro			High expression of Janus kinase 2 in background normal liver tissue of resected hepatocellular carcinoma is associated with worse prognosis	ONCOLOGY REPORTS			English	Article						hepatocellular carcinoma; background normal liver; Janus kinase 2; prognosis; carcinogenesis; multiarray analysis	INTRAHEPATIC METASTASIS; MULTICENTRIC OCCURRENCE; GENE-TRANSCRIPTION; GROWTH-HORMONE; CLONAL MARKERS; RECURRENCE; MULTIPLE; JAK2; IDENTIFICATION; REGENERATION	When assessing hepatocellular carcinoma (HCC), it is important to examine prognostic factors in the background normal liver tissue and consider malignant aspects of the primary lesion. Candidate genes were extracted from the background normal liver samples via multiarray analysis. Control samples, termed supernormal (SN) liver, were obtained from 11 cases of metastatic liver cancer. Corresponding normal (CN) liver tissue was surgically obtained from a typical HCC patient with chronic hepatitis C background for comparison. Expression profile and methylation array demonstrated that Janus kinase 2 (JAK2) gene expression was increased by 2.378-fold in the CN tissue. Methylation array reported a lower value for CN (0.125) than SN tissues (0.748). We then investigated JAK2 expression by real-time quantitative reverse transcription-polymerase chain reaction in 100 consecutive resected HCC cases. The average expression level of JAK2 (normalized to GAPDH) was significantly lower in CN (9.24 +/- 6.43, n=100) than in SN (35.21 +/- 21.38, n=11) tissues (P<0.001). As such a result was contrary to our expectation, the case used for array analysis seemed to be a rare incidence. One hundred HCC cases were subsequently divided into two groups based on JAK2 expression in the adjacent normal tissue: one consisting of the upper 70% of cases (n=70) and the other of the remaining 30% (n=30). Higher JAK2 expression in the adjacent tissue demonstrated significant correlation with worse survival (P=0.022). Furthermore, multivariate analysis identified higher JAK2 expression in the background normal liver tissue of HCC as an independent prognostic factor (P=0.032). Our findings suggest that higher JAK2 expression in the background normal liver tissue of HCC may be a good prognostic biomarker for resected HCC.	[Sonohara, Fuminori; Nomoto, Shuji; Inokawa, Yoshikuni; Hishida, Mitsuhiro; Takano, Nao; Kanda, Mitsuro; Nishikawa, Yoko; Fujii, Tsutomu; Koike, Masahiko; Sugimoto, Hiroyuki; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Surg Gastroenterol, Nagoya, Aichi 4668550, Japan	Nomoto, S (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Surg, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.	snomoto@dpc.agu.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [22591427]	This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (C) no. 22591427.	Amato D, 2013, BLOOD, V122, P4287, DOI 10.1182/blood-2013-08-524447; Kumada T, 1997, HEPATOLOGY, V25, P87, DOI 10.1002/hep.510250116; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Nomoto S, 2002, CLIN CANCER RES, V8, P481; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; Bibikova Marina, 2009, V507, P149, DOI 10.1007/978-1-59745-522-0_12; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Taura K, 2006, ANN SURG, V244, P265, DOI 10.1097/01.sla.0000217921.28563.55; Morimoto O, 2003, J HEPATOL, V39, P215, DOI 10.1016/S0168-8278(03)00233-2; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Cucchetti A, 2009, ANN SURG ONCOL, V16, P413, DOI 10.1245/s10434-008-0232-4; Nakata T, 2008, HEPATO-GASTROENTEROL, V55, P865; CHEN PJ, 1989, GASTROENTEROLOGY, V96, P527; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; Nomoto S, 2007, BRIT J CANCER, V97, P1260, DOI 10.1038/sj.bjc.6604016; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/ng0501-29; Hellgren G, 1999, GROWTH HORM IGF RES, V9, P212, DOI 10.1054/ghir.1999.0111; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kobayashi A, 2006, HEPATO-GASTROENTEROL, V53, P736; Matsuda M, 2001, J Hepatobiliary Pancreat Surg, V8, P353, DOI 10.1007/s005340170008; Okamura Y, 2011, CANCER LETT, V312, P150, DOI 10.1016/j.canlet.2011.07.028; Ono M, 2007, MOL ENDOCRINOL, V21, P1443, DOI 10.1210/me.2006-0543; Stangegaard Michael, 2009, V529, P133, DOI 10.1007/978-1-59745-538-1_9; Takai Daiya, 2003, In Silico Biology, V3, P235; TAKENAKA K, 1994, HEPATOLOGY, V19, P889, DOI 10.1016/0270-9139(94)90288-7; Wang Zhigang, 2013, Drug Discov Ther, V7, P137; Yeh YT, 2012, WORLD J SURG, V36, P1128, DOI 10.1007/s00268-012-1505-4	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					767	773		10.3892/or.2014.3621		7	Oncology	Oncology	AZ6OJ	WOS:000348338500034		
J	Ando, T; Ito, H; Arioka, Y; Ogiso, H; Seishima, M				Ando, Tatsuya; Ito, Hiroyasu; Arioka, Yuko; Ogiso, Hideyuki; Seishima, Mitsuru			Combination therapy with alpha-galactosylceramide and a Toll-like receptor agonist exerts an augmented suppressive effect on lung tumor metastasis in a mouse model	ONCOLOGY REPORTS			English	Article						alpha-galactosylceramide; lipopolysaccharide; NKT; IFN-gamma; cytotoxic T lymphocytes; lung metastasis	CD8(+) T-CELLS; NITRIC-OXIDE PRODUCTION; V-ALPHA-14 NKT CELLS; IFN-GAMMA; INTERFERON-GAMMA; IMMUNE-RESPONSE; DENDRITIC CELLS; CANCER; CXCR3; RECRUITMENT	alpha-galactosylceramide (GalCer), which is a natural killer T (NKT) cell ligand, has been reported to exert therapeutic effects against cancer in humans and mice. Toll-like receptor (TLR) agonists systemically or locally boost antitumor efficacy in mouse cancer models. In our previous study, the co-administration of GalCer and a TLR agonist synergistically enhanced interferon-gamma (IFN-gamma) production in mouse splenocytes in vitro and in vivo. The increased IFN-gamma production promoted a tumor antigen-specific Th1 response. Therefore, co-treatment with GalCer and a TLR agonist is expected to exert an enhanced antitumor effect. In the present study, we examined the effect of GalCer and lipopolysaccharide (LPS) combination therapy in a mouse lung-metastasis model. GalCer and LPS combination therapy markedly decreased the number of lung metastatic tumor nodes. Co-treatment with GalCer and LPS enhanced the mRNA expression of CXCL9 and CXCL10 in mediastinal lymph nodes (MLNs) and increased the number of CD8(+) cells in the MLNs. Furthermore, the depletion of CD8(+) T cells canceled the antitumor effect of GalCer and LPS combination therapy. Thus, GalCer and LPS combination therapy significantly enhanced tumor antigen-specific immune responses and suppressed tumor growth in a mouse lung-metastasis model.	[Ando, Tatsuya; Ito, Hiroyasu; Arioka, Yuko; Ogiso, Hideyuki; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu 5011194, Japan	Ito, H (reprint author), Gifu Univ, Grad Sch Med, Dept Informat Clin Med, 1-1 Yanagido, Gifu 5011194, Japan.	hito@gifu-u.ac.jp			Ministry for Education, Culture, Sports, Science and Technology of Japan [24890080]	The authors thank Dr H.S. for kindly providing CT26 tumor cell lines in the present study. This study was supported by a Grant-in-Aid for Scientific Research (C) (24890080) from the Ministry for Education, Culture, Sports, Science and Technology of Japan.	Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; Ando T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02559; Ito H, 2005, J ENDOTOXIN RES, V11, P213, DOI 10.1179/096805105X46628; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lim JYH, 2014, CANCER IMMUNOL IMMUN, V63, P259, DOI 10.1007/s00262-013-1506-7; Salaun B, 2006, J IMMUNOL, V176, P4894; Ochi A, 2012, J CLIN INVEST, V122, P4118, DOI 10.1172/JCI63606; Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO;2-U; Ohtaki H, 2009, BIOCHEM BIOPH RES CO, V378, P579, DOI 10.1016/j.bbrc.2008.11.075; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Perret R, 2013, CANCER RES, V73, P6597, DOI 10.1158/0008-5472.CAN-13-0875; Wu L, 2009, CURR MOL MED, V9, P4; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Paget C, 2012, J IMMUNOL, V188, P3928, DOI 10.4049/jimmunol.1103582; Ito H, 2006, LAB INVEST, V86, P254, DOI 10.1038/labinvest.3700388; Wang DQ, 2010, MOL CANCER THER, V9, P1788, DOI 10.1158/1535-7163.MCT-09-1198; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Moreno M, 2008, J IMMUNOL, V181, P2446; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.ummunol.21.120601.141057; Wong JL, 2013, CANCER RES, V73, P4653, DOI 10.1158/0008-5472.CAN-12-4366; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jcm.20042592; Choi DH, 2011, CANCER RES, V71, P7442, DOI 10.1158/0008-5472.CAN-11-1459; Davis MB, 2011, CLIN CANCER RES, V17, P3984, DOI 10.1158/1078-0432.CCR-10-3262; Exley MA, 2011, CLIN IMMUNOL, V140, P184, DOI 10.1016/j.clim.2011.04.017; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Nakagawa Y, 2011, BIOMED RES-TOKYO, V32, P159; Rosenblum JM, 2010, J IMMUNOL, V184, P3450, DOI 10.4049/jimmunol.0903831; Saga K, 2013, CLIN CANCER RES, V19, P668, DOI 10.1158/1078-0432.CCR-12-1947; Smith SM, 2000, IMMUNOL CELL BIOL, V78, P325, DOI 10.1046/j.1440-1711.2000.00936.x; Spaner DE, 2007, LEUKEMIA, V21, P53, DOI 10.1038/sj.leu.2404456; Tessmer MS, 2009, EXPERT OPIN THER TAR, V13, P153, DOI [10.1517/14712590802653601 , 10.1517/14712590802653601]; Wang P, 2010, CANCER IMMUNOL IMMUN, V59, P1715, DOI 10.1007/s00262-010-0901-6	36	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	FEB	2015	33	2					826	832		10.3892/or.2014.3634		7	Oncology	Oncology	AZ6OJ	WOS:000348338500041		
J	Kim, DH; Yoon, KC; Seo, KY; Lee, HS; Yoon, SC; Sotozono, C; Ueta, M; Kim, MK				Kim, Dong Hyun; Yoon, Kyung Chul; Seo, Kyoung Yul; Lee, Hyo Seok; Yoon, Sang Chul; Sotozono, Chie; Ueta, Mayumi; Kim, Mee Kum			The Role of Systemic Immunomodulatory Treatment and Prognostic Factors on Chronic Ocular Complications in Stevens-Johnson Syndrome	OPHTHALMOLOGY			English	Article							TOXIC EPIDERMAL NECROLYSIS; DOSE INTRAVENOUS IMMUNOGLOBULIN; AMNIOTIC MEMBRANE TRANSPLANTATION; ERYTHEMA MULTIFORME; PULSE THERAPY; RISK-FACTORS; MANAGEMENT; MANIFESTATIONS; CORTICOSTEROIDS; EXPERIENCE	Purpose: To compare the effect of early systemic immunomodulatory treatment and to identify prognostic factors of chronic ocular complications in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) patients. Design: Retrospective, comparative, multicenter study. Participants: Forty-three patients admitted to 1 of 3 University Hospitals (Seoul National University Hospital, Chonnam National University Hospital, and Yonsei University Hospital) with a diagnosis of SJS or TEN who were followed up for at least 6 months in Korea. Methods: Patients were divided into 5 groups according to systemic immunomodulatory treatment received: systemic steroids (S), intravenous immunoglobulin (IVIG), combined S plus IVIG, systemic pulse steroids (PS), and supportive care only (C). Best-corrected visual acuity (BCVA) and chronic ocular surface complications score (COCS; range, 0-15) at final follow-up were compared among the 5 groups. Prognostic factors at onset (age, gender, causative drugs, initial visual acuities, acute ocular involvement score [range, 0-3], acute systemic involvement score [range, 0-16], systemic steroid dose, IVIG dose, and amniotic membrane transplantation [AMT]) were analyzed to predict final BCVA or COCS using logistic regression or linear regression analysis. Main Outcome Measures: Best-corrected visual acuity and COCS at final follow-up. Results: The mean age and follow-up period of the patients was 30.5 +/- 21.0 years and 29.1 +/- 30.4 months, respectively. The acute systemic involvement score in the IVIG, S plus IVIG, and PS groups was significantly higher than that in the S and C groups (P < 0.001). However, final BCVA and COCS were not significantly different between groups, even after statistical adjustment. High COCS (>= 8 points) was associated with female gender (P = 0.012) and AMT at the acute stage (P = 0.040). High acute ocular and systemic involvement scores were associated with worse COCS (P < 0.001), and COCS showed good correlation with final BCVA (R-2 = 0.7101; P < 0.0001). Conclusions: There were no therapeutic benefits of systemic immunomodulatory treatments in final visual outcome and COCS in SJS and TEN patients. Female gender and acute ocular and systemic involvement scores may be prognostic factors predicting chronic ocular complications. (C) 2015 by the American Academy of Ophthalmology.	[Kim, Dong Hyun; Kim, Mee Kum] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul 110799, South Korea; [Kim, Dong Hyun; Kim, Mee Kum] Seoul Natl Univ Hosp, Clin Res Inst, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Seoul 110744, South Korea; [Yoon, Kyung Chul; Lee, Hyo Seok] Chonnam Natl Univ, Dept Ophthalmol, Sch Med, Kwangju, South Korea; [Seo, Kyoung Yul; Yoon, Sang Chul] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Sotozono, Chie; Ueta, Mayumi] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Kim, MK (reprint author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, 103 Daehak Ro, Seoul 110799, South Korea.	SEOKY@yuhs.ac; kmk9@snu.ac.kr			Collaborative Research Project of Korea and Japan, Ministry of Science, ICT (Information and Communications Technology); Future Planning, Republic of Korea [2012K2A2A4020148]	Supported by the Collaborative Research Project of Korea and Japan, Ministry of Science, ICT (Information and Communications Technology) and Future Planning, Republic of Korea (grant no.: 2012K2A2A4020148).	TUGALTUTKUN I, 1995, OPHTHALMOLOGY, V102, P576; HALEBIAN PH, 1986, ANN SURG, V204, P503, DOI 10.1097/00000658-198611000-00001; Yip LW, 2005, EYE, V19, P846, DOI 10.1038/sj.eye.6701653; Brown KM, 2004, J BURN CARE REHABIL, V25, P81, DOI 10.1097/01.BCR.0000105096.93526.27; Hirahara K, 2013, J AM ACAD DERMATOL, V69, P496, DOI 10.1016/j.jaad.2013.04.007; Stevens AM, 1922, AM J DIS CHILD, V24, P526; Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Chave TA, 2005, BRIT J DERMATOL, V153, P241, DOI 10.1111/j.1365-2133.2005.06721.x; Hsu M, 2012, CORNEA, V31, P1394, DOI 10.1097/ICO.0b013e31823d02a8; Gueudry J, 2009, ARCH DERMATOL, V145, P157, DOI 10.1001/archdermatol.2009.540; Thong BYH, 2011, BRIT J CLIN PHARMACO, V71, P684, DOI 10.1111/j.1365-2125.2010.03774.x; POWER WJ, 1995, OPHTHALMOLOGY, V102, P1669; Huang YC, 2012, BRIT J DERMATOL, V167, P424, DOI 10.1111/j.1365-2133.2012.10965.x; Kakourou T, 1997, EUR J PEDIATR, V156, P90, DOI 10.1007/s004310050561; John T, 2002, OPHTHALMOLOGY, V109, P351, DOI 10.1016/S0161-6420(01)00900-9; Yang YS, 2009, INT J DERMATOL, V48, P1122, DOI 10.1111/j.1365-4632.2009.04166.x; Al-Mutairi N, 2004, INT J DERMATOL, V43, P847, DOI 10.1111/j.1365-4632.2004.02048.x; Trent JT, 2003, ARCH DERMATOL, V139, P39, DOI 10.1001/archderm.139.1.39; Schneck J, 2008, J AM ACAD DERMATOL, V58, P33, DOI 10.1016/j.jaad.2007.08.039; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Kardaun SH, 2007, ACTA DERM-VENEREOL, V87, P144, DOI 10.2340/00015555-0214; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; Shammas MC, 2010, AM J OPHTHALMOL, V149, P203, DOI 10.1016/j.ajo.2009.08.040; Sotozono C, 2007, OPHTHALMOLOGY, V114, P1294, DOI 10.1016/j.ophtha.2006.10.029; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; Ueta M, 2010, J ALLERGY CLIN IMMUN, V126, P1218, DOI 10.1016/j.jaci.2010.08.007; Shay E, 2009, SURV OPHTHALMOL, V54, P686, DOI 10.1016/j.survophthal.2009.03.004; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; Yip LW, 2007, ALLERGY, V62, P527, DOI 10.1111/j.1398-9995.2006.01295.x; Prins C, 2003, DERMATOLOGY, V207, P96, DOI 10.1159/000070957; Gregory DG, 2011, OPHTHALMOLOGY, V118, P908, DOI 10.1016/j.ophtha.2011.01.046; PATTERSON R, 1994, ANN ALLERGY, V73, P27; Araki Y, 2009, AM J OPHTHALMOL, V147, P1004, DOI 10.1016/j.ajo.2008.12.040; Tseng SCG, 2009, AM J OPHTHALMOL, V147, P949, DOI 10.1016/j.ajo.2009.02.011; Miyata K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1537, DOI 10.1001/archopht.121.11.1537; ARSTIKAI.MJ, 1973, ARCH OPHTHALMOL-CHIC, V90, P376; Campione E, 2003, ACTA DERM-VENEREOL, V83, P430, DOI 10.1080/00015550310005852; Kim HI, 2012, KOREAN J INTERN MED, V27, P203, DOI 10.3904/kjim.2012.27.2.203; Kim Kyeong Hwan, 2013, Korean J Ophthalmol, V27, P331, DOI 10.3341/kjo.2013.27.5.331; Kobayashi A, 2006, OPHTHALMOLOGY, V113, P126, DOI 10.1016/j.ophtha.2005.09.001; Roujeau Jean-Claude, 1997, Journal of Dermatology (Tokyo), V24, P726; Schwartz RA, 2013, J AM ACAD DERMATOL, V69; Ueta M, 2007, AM J OPHTHALMOL, V143, P367, DOI 10.1016/j.ajo.2006.09.029; Yamane Yumiko, 2007, Allergol Int, V56, P419, DOI 10.2332/allergolint.O-07-483	46	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	FEB	2015	122	2					254	264		10.1016/j.ophtha.2014.08.013		11	Ophthalmology	Ophthalmology	AZ5WT	WOS:000348290000016		
J	Fujinami, K; Zernant, J; Chana, RK; Wright, GA; Tsunoda, K; Ozawa, Y; Tsubota, K; Robson, AG; Holder, GE; Allikmets, R; Michaelides, M; Moore, AT				Fujinami, Kaoru; Zernant, Jana; Chana, Ravinder K.; Wright, Genevieve A.; Tsunoda, Kazushige; Ozawa, Yoko; Tsubota, Kazuo; Robson, Anthony G.; Holder, Graham E.; Allikmets, Rando; Michaelides, Michel; Moore, Anthony T.			Clinical and Molecular Characteristics of Childhood-Onset Stargardt Disease	OPHTHALMOLOGY			English	Article							CONE-ROD DYSTROPHY; CASSETTE TRANSPORTER GENE; ABCA4 ABCR GENE; MACULAR DEGENERATION; FUNDUS FLAVIMACULATUS; SEQUENCE VARIATIONS; MUTATIONS; ALLELES; CLASSIFICATION; PROGRESSION	Purpose: To describe the clinical and molecular characteristics of patients with childhood-onset Stargardt disease (STGD). Design: Retrospective case series. Participants: Forty-two patients who were diagnosed with STGD in childhood at a single institution between January 2001 and January 2012. Methods: A detailed history and a comprehensive ophthalmic examination were undertaken, including color fundus photography, autofluorescence imaging, spectral-domain optical coherence tomography (SD-OCT), and pattern and full-field electroretinograms. The entire coding region and splice sites of ABCA4 were screened using a next-generation, sequencing-based strategy. The molecular genetic findings of childhood-onset STGD patients were compared with those of adult-onset patients. Main Outcome Measures: Clinical, imaging, electrophysiologic, and molecular genetic findings. Results: The median ages of onset and the median age at baseline examination were 8.5 (range, 3-16) and 12.0 years (range, 7-16), respectively. The median baseline logarithm of the minimum angle of resolution visual acuity was 0.74. At baseline, 26 of 39 patients (67%) with available photographs had macular atrophy with macular/peripheral flecks; 11 (28%) had macular atrophy without flecks; 1 (2.5%) had numerous flecks without macular atrophy; and 1 (2.5%) had a normal fundus appearance. Flecks were not identified at baseline in 12 patients (31%). SD-OCT detected foveal outer retinal disruption in all 21 patients with available images. Electrophysiologic assessment demonstrated retinal dysfunction confined to the macula in 9 patients (36%), macular and generalized cone dysfunction in 1 subject (4%), and macular and generalized cone and rod dysfunction in 15 individuals (60%). At least 1 disease-causing ABCA4 variant was identified in 38 patients (90%), including 13 novel variants; >= 2 variants were identified in 34 patients (81%). Patients with childhood-onset STGD more frequently harbored 2 deleterious variants (18% vs 5%) compared with patients with adult-onset STGD. Conclusions: Childhood-onset STGD is associated with severe visual loss, early morphologic changes, and often generalized retinal dysfunction, despite often having less severe fundus abnormalities on examination. One third of children do not have flecks at presentation. The relatively high proportion of deleterious ABCA4 variants supports the hypothesis that earlier onset disease is often owing to more severe variants in ABCA4 than those found in adult-onset disease. (C) 2015 by the American Academy of Ophthalmology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).	[Fujinami, Kaoru; Tsunoda, Kazushige] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Lab Visual Physiol, Tokyo, Japan; [Fujinami, Kaoru; Ozawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Fujinami, Kaoru; Chana, Ravinder K.; Wright, Genevieve A.; Robson, Anthony G.; Holder, Graham E.; Michaelides, Michel; Moore, Anthony T.] UCL Inst Ophthalmol, London, England; [Fujinami, Kaoru; Chana, Ravinder K.; Wright, Genevieve A.; Robson, Anthony G.; Holder, Graham E.; Michaelides, Michel; Moore, Anthony T.] Moorfields Eye Hosp, London, England; [Zernant, Jana; Allikmets, Rando] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Moore, AT (reprint author), UCL, Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	michel.michaelides@ucl.ac.uk; tony.moore@ucl.ac.uk			National Institute for Health Research Biomedical Research Center at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology (UK); Foundation Fighting Blindness (USA); Fight for Sight (UK); Moorfields Eye Hospital Special Trustees (UK); Macular Disease Society (UK); National Eye Institute [EY021163, EY019861, EY019007]; Research to Prevent Blindness (New York, NY); Suzuken Memorial Foundation (Japan); Mitsukoshi Health and Welfare Foundation (Japan); Daiwa Anglo-Japanese Foundation (Japan); Ministry of Education, Culture, Sports, Science and Technology (Japan); Foundation Fighting Blindness Career Development Award (USA)	Supported by grants from the National Institute for Health Research Biomedical Research Center at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology (UK), Foundation Fighting Blindness (USA), Fight for Sight (UK), Moorfields Eye Hospital Special Trustees (UK), Macular Disease Society (UK), National Eye Institute EY021163, EY019861, and EY019007 (Core Support for Vision Research), unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, Columbia University, Suzuken Memorial Foundation (Japan), Mitsukoshi Health and Welfare Foundation (Japan), and Daiwa Anglo-Japanese Foundation (Japan), Grant-in-Aid for Young Scientists (B) of the Ministry of Education, Culture, Sports, Science and Technology (Japan). MM is supported by a Foundation Fighting Blindness Career Development Award (USA). ATM is the Chairman of the Data Safety and Management Committee of an Oxford Biomedica sponsored clinical trial of gene replacement therapy for Stargardt disease.	Aguirre-Lamban J, 2011, INVEST OPHTH VIS SCI, V52, P6206, DOI 10.1167/iovs.10-5743; Allikmets R, 1998, GENE, V215, P111, DOI 10.1016/S0378-1119(98)00269-8; McBain VA, 2012, AM J OPHTHALMOL, V154, P146, DOI 10.1016/j.ajo.2012.01.019; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Rotenstreich Y, 2003, OPHTHALMOLOGY, V110, P1151, DOI 10.1016/S0161-6420(03)00333-6; Fujinami K, 2013, AM J OPHTHALMOL, V156, P487, DOI 10.1016/j.ajo.2013.05.003; Fumagalli A, 2001, HUM GENET, V109, P326, DOI 10.1007/s004390100583; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504; Lois N, 2001, ARCH OPHTHALMOL-CHIC, V119, P359; Michaelides M, 2003, J MED GENET, V40, P641, DOI 10.1136/jmg.40.9.641; Fujinami K, 2013, AM J OPHTHALMOL, V155, P1075, DOI 10.1016/j.ajo.2013.01.018; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Sergouniotis PI, 2012, OPHTHALMOLOGY, V119, P596, DOI 10.1016/j.ophtha.2011.09.017; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Zernant J, 2011, INVEST OPHTH VIS SCI, V52, P8479, DOI 10.1167/iovs.11-8182; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Burke TR, 2011, OPHTHALMIC GENET, V32, P165, DOI 10.3109/13816810.2011.565397; Conley SM, 2012, BBA-MOL BASIS DIS, V1822, P1169, DOI 10.1016/j.bbadis.2011.10.007; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061; Fujianami K, 2014, INVEST OPHTH VIS SCI, V54, P8181; Fujinami K, 2013, OPHTHALMOLOGY, V120, P2324, DOI 10.1016/j.ophtha.2013.04.016; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P6662, DOI 10.1167/iovs.13-12570; Fujinami K, 2014, ACTA OPHTHALMOL, V92, pE157, DOI [10.1111/aos.12259, 10.1111/aos.12284]; Fujinami K, 2011, ACTA OPHTHALMOL, V89, pE297, DOI 10.1111/j.1755-3768.2009.01848.x; Jarc-Vidmar M., 2012, Zdravniški Vestnik, V81, P51; Klevering BJ, 2002, INVEST OPHTH VIS SCI, V43, P1980; Michaelides M, 2007, BRIT J OPHTHALMOL, V91, P1650, DOI 10.1136/bjo.2007.118356; Riveiro-Alvarez R, 2013, OPHTHALMOLOGY, V120, P2332, DOI 10.1016/j.ophtha.2013.04.002; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Simonelli F, 2005, OPHTHAL RES, V37, P159, DOI 10.1159/000086073; Wabbels B, 2006, GRAEF ARCH CLIN EXP, V244, P36, DOI 10.1007/s00417-005-0043-2; Westeneng-van Haaften SC, 2012, OPHTHALMOLOGY, V119, P1199, DOI 10.1016/j.ophtha.2012.01.005	41	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	FEB	2015	122	2					326	334		10.1016/j.ophtha.2014.08.012		9	Ophthalmology	Ophthalmology	AZ5WT	WOS:000348290000025		
J	Sapkota, DP; Kayastha, MS; Wakita, K				Sapkota, Durga Prasad; Kayastha, Madhu Sudan; Wakita, Koichi			Electric field effects on exciton in the shape of transmission spectra in high-purity GaAs at room temperature	OPTICAL AND QUANTUM ELECTRONICS			English	Article						Electroabsorption; Exciton; High-purity; Extinction ratio	OPTICAL ABSORPTION; ELECTROABSORPTION; SEMICONDUCTORS; DEPENDENCE; CRYSTALS; EDGE	The electric field effects on the shape of transmission spectra associated with exciton including continuum band transition in ultra-high-purity GaAs have been theoretically studied at room temperature. We have calculated the Stark red shift, linewidth broadening of exciton, height of exciton peak and extinction ratio with applied electric field. The theoretical results are compared with experimental and found the close agreement between them.	[Sapkota, Durga Prasad] Nepal Telecom, Res & Dev Sect, Kathmandu, Nepal; [Kayastha, Madhu Sudan; Wakita, Koichi] Chubu Univ, Dept Elect & Elect Engn, Matsumoto, Aichi, Japan	Sapkota, DP (reprint author), Nepal Telecom, Res & Dev Sect, Kathmandu, Nepal.	durga.sapkota@ntc.net.np					CALLAWAY J, 1963, PHYS REV, V130, P549, DOI 10.1103/PhysRev.130.549; KELDYSH LV, 1958, SOV PHYS JETP-USSR, V7, P788; CASEY HC, 1975, J APPL PHYS, V46, P250, DOI 10.1063/1.321330; Bitou Y, 1998, APPL OPTICS, V37, P1377, DOI 10.1364/AO.37.001377; BOTTKA N, 1975, J APPL PHYS, V46, P2645, DOI 10.1063/1.321897; DOW JD, 1970, PHYS REV B, V1, P3358, DOI 10.1103/PhysRevB.1.3358; Franz W, 1958, NATURFORSCH, V13, P484; Kayastha MS, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.102201; Kayastha MS, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.121102; LEDERMAN FL, 1976, PHYS REV B, V13, P1633, DOI 10.1103/PhysRevB.13.1633; Lin E. Y., 2007, J APPL PHYS, V102; MOSS TS, 1961, J APPL PHYS, V32, P2136, DOI 10.1063/1.1777031; Sapkota D.P., 2012, PHOT GLOB C PGC, P1; SCHULTHEIS L, 1987, PHYS REV B, V36, P6609, DOI 10.1103/PhysRevB.36.6609; SCHULTHEIS L, 1983, PHYS REV B, V28, P2292, DOI 10.1103/PhysRevB.28.2292; Tharmalingam M., 1963, PHYS REV, V130, P2204	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0306-8919	1572-817X		OPT QUANT ELECTRON	Opt. Quantum Electron.	FEB	2015	47	2					203	210		10.1007/s11082-014-9901-7		8	Engineering, Electrical & Electronic; Optics	Engineering; Optics	AZ6UZ	WOS:000348357300010		
J	Shirai, K; Schachern, PA; Schachern, MG; Paparella, MM; Cureoglu, S				Shirai, Kyoko; Schachern, Patricia A.; Schachern, Monika G.; Paparella, Michael M.; Cureoglu, Sebahattin			Volume of the Epitympanum and Blockage of the Tympanic Isthmus in Chronic Otitis Media: A Human Temporal Bone Study	OTOLOGY & NEUROTOLOGY			English	Article						Epitympanum; Tympanic isthmus; Human temporal bone; Chronic otitis media; Volume; 3-D reconstruction	ANTERIOR EPITYMPANUM; MASTOID PROCESS; PNEUMATIZATION; AERATION; ANATOMY; DISEASE	Hypothesis To compare the differences in the epitympanic bony volume and the area of the tympanic isthmus (TI) in human temporal bones (HTBs) with chronic otitis media (COM) having epitympanic involvement and those without COM. Background TI is crucial for mastoid and epitympanic ventilation. Previous studies demonstrated that the area of TI was related to the degree of HTBs pneumatization and that COM caused suppressed pneumatization of the middle ear, decreasing volume. To our knowledge, there have been no studies, however, investigating the correlation between COM and epitympanic volume or between the TI and the epitympanic volume. Methods Eleven HTBs from children with COM and 11 HTBs without COM (control group) were examined. Three-dimensional models were generated from HTB histopathologic slides with reconstruction software (AMIRA), and epitympanic bony volumes were measured and compared between the two groups. The narrowest aerated/bony TI area was also measured and compared to investigate the correlation between the bony epitympanic volume and the TI area within each group. Results There were no significant differences in epitympanic bony volume or bony TI area between the groups. Aerated TI area in the COM group was significantly smaller than that in the control group (p < 0.01). There was no relationship between aerated TI area and bony epitympanic volume in the two groups. In the COM group, there was a negative correlation between bony TI area and epitympanic volume (p < 0.001). Conclusion This study suggests that congenital or developmental stenosis of the TI may not be associated with epitympanic pathology, but blockage of TI with soft tissue pathology may be associated with chronic tissue pathology in COM.	[Shirai, Kyoko; Schachern, Patricia A.; Schachern, Monika G.; Paparella, Michael M.; Cureoglu, Sebahattin] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN 55455 USA; [Shirai, Kyoko] Tokyo Med Univ, Dept Otolaryngol, Tokyo 1608402, Japan; [Paparella, Michael M.] Paparella Ear Head & Neck Inst, Minneapolis, MN USA	Cureoglu, S (reprint author), Univ Minnesota, Dept Otolaryngol, 2001 6th St SE,LRB 210, Minneapolis, MN 55455 USA.	cureo003@umn.edu			National Institutes of Health [NIDCD U24 DC011968-01, R01 DC006452]; International Hearing Foundation; Starkey Foundation; 5 M Lions International	This study was supported by the National Institutes of Health (NIDCD U24 DC011968-01, R01 DC006452), the International Hearing Foundation, the Starkey Foundation, and the 5 M Lions International.	AIMI K, 1978, LARYNGOSCOPE, V88, P1067; TURGUT S, 1992, J LARYNGOL OTOL, V106, P485, DOI 10.1017/S0022215100119942; Ikui A, 2000, ACTA OTO-LARYNGOL, V120, P375; AOKI K, 1990, ACTA OTO-LARYNGOL, V110, P399; COLLINS ME, 1991, AM J OTOL, V12, P11; DIAMANT M, 1958, J Laryngol Otol, V72, P343, DOI 10.1017/S0022215100054049; DIAMANT M, 1965, Acta Otolaryngol, V60, P1, DOI 10.3109/00016486509126982; DIAMANT M, 1955, Arch Ohren Nasen Kehlkopfheilkd, V166, P369, DOI 10.1007/BF02115552; ISHII M, 1987, ARCH OTOLARYNGOL, V113, P401; Marchioni D, 2013, OTOLARYNG CLIN N AM, V46, P165, DOI 10.1016/j.otc.2012.10.002; Miyajima I, 1985, Auris Nasus Larynx, V12, P149; Palva T, 1996, AM J OTOL, V17, P700; Palva T, 1999, AM J OTOL, V20, P145; Palva T, 1966, Acta Otolaryngol, V62, P237, DOI 10.3109/00016486609119570; Palva T, 1997, AM J OTOL, V18, P307; PALVA T, 1995, AM J OTOL, V16, P505; PROCTOR B, 1964, J Laryngol Otol, V78, P631, DOI 10.1017/S002221510006254X; TUMARKIN A, 1959, J Laryngol Otol, V73, P34, DOI 10.1017/S002221510005489X	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	FEB	2015	36	2					254	259		10.1097/MAO.0000000000000623		6	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AZ8IQ	WOS:000348459300021		
J	Honda, K; Noguchi, Y; Kawashima, Y; Takahashi, M; Nishio, A; Kitamura, K				Honda, Keiji; Noguchi, Yoshihiro; Kawashima, Yoshiyuki; Takahashi, Masatoki; Nishio, Ayako; Kitamura, Ken			Ex Vivo Visualization of the Mouse Otoconial Layer Compared With Micro-Computed Tomography	OTOLOGY & NEUROTOLOGY			English	Article						Three-dimensional; Atp2b2; Micro-computed tomography; Wriggle mouse Sagami	CA2+-ATPASE ISOFORM 2; INNER-EAR; POINT MUTATION; MEMBRANE; DEAFNESS; COCHLEA; SAGAMI; BONE	Hypothesis Micro-computed tomography (micro-CT) is useful for assessing the 3-dimensional (3D) morphology and age-related changes of the otoconial layer. Background Wriggle mouse Sagami (WMS) is a mutant of the plasma membrane Ca2+ ATPase type2 gene (Atp2b2) with deficits in the saccular otoconia. We examined the effectiveness of micro-CT in evaluating the otoconial layer of WMS and C57BL/6J mice. Methods Otic capsules of C57BL/6J mice at different fixation time were examined using micro-CT to evaluate the effects of the fixation time on the otoconial layer. Otic capsules of Atp2b2(wri/wri), Atp2b2(wri/+), and Atp2b2(+/+) mice at P14, P21, and the age of 3 months were used to analyze age-related changes in the otoconial layer. A series of cross-section and 3D reconstructed images of the otoconial layer were obtained. The micro-CT findings were compared with the otic capsule findings cleared in methyl salicylate using stereomicroscopy. Results Micro-CT produced high-resolution images of the otoconial layer, thereby providing information regarding the spatial configuration and 3D curvature. There were no changes between the different fixation times. In the Atp2b2(wri/+) and Atp2b2(+/+) mice, the saccular and utricular otoconial layers were normal among all age groups. In the Atp2b2(wri/wri) mice, the saccular otoconial layer decreased on P14 and was absent on P21, whereas the utricular otoconial layer disappeared at 3 months of age. Conclusion We obtained precise information regarding the mouse otoconial layer with minimum artifacts. This method is expected to improve our understanding of the physiologic function and age-related changes in otolith organs.	[Honda, Keiji; Noguchi, Yoshihiro; Kawashima, Yoshiyuki; Takahashi, Masatoki; Nishio, Ayako; Kitamura, Ken] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Otorhinolaryngol, Tokyo 1138519, Japan	Noguchi, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Otorhinolaryngol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	noguchi.oto@gmail.com			JSPS KAKENHI [19591960, 21390459, 22659305, 24791756]; Ministry of Health, Labour and Welfare of Japan [H23-kankaku-005]	This work was supported by JSPS KAKENHI Grant Numbers 19591960, 21390459, 22659305, and 24791756 and by a grand-in-aid for scientific research from the Ministry of Health, Labour and Welfare of Japan (H23-kankaku-005).	Takahashi K, 1999, BIOCHEM BIOPH RES CO, V261, P773, DOI 10.1006/bbrc.1999.1102; Dumont RA, 2001, J NEUROSCI, V21, P5066; Street VA, 1998, NAT GENET, V19, P390; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Shibata T, 2009, AM J OTOLARYNG, V30, P112, DOI 10.1016/j.amjoto.2008.07.012; Buytaert JAN, 2013, J HISTOCHEM CYTOCHEM, V61, P382, DOI 10.1369/0022155413478613; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; LANE J, 1983, CALCIFIED TISSUE INT, V35, P1, DOI 10.1007/BF02404997; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Morsli H, 1998, J NEUROSCI, V18, P3327; Osawa N., 1992, Mouse Genome, V90, P223; Poznyakovskiy AA, 2008, HEARING RES, V243, P95, DOI 10.1016/j.heares.2008.06.008; Rother T, 2003, HEARING RES, V185, P22, DOI 10.1016/S0378-5955(03)00255-7; Takahashi K, 1999, ACTA OTO-LARYNGOL, V119, P767, DOI 10.1080/00016489950180405; Ueno T, 2002, NEUROSCI RES, V42, P287, DOI 10.1016/S0168-0102(02)00008-1; Uzun H, 2007, ACTA OTO-LARYNGOL, V127, P568, DOI 10.1080/00016480600951509; Uzun-Coruhlu H, 2007, HEARING RES, V233, P77, DOI 10.1016/j.heares.2007.07.008	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	FEB	2015	36	2					311	317		10.1097/MAO.0000000000000376		7	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AZ8IQ	WOS:000348459300031		
J	Ohki, M; Baba, Y; Ohata, A				Ohki, Masafumi; Baba, Yuka; Ohata, Atsushi			First Branchial Cleft Anomaly With an Orifice in the Bony External Auditory Canal Accompanied by Contralateral Middle Ear Cholesteatoma	OTOLOGY & NEUROTOLOGY			English	Article									[Ohki, Masafumi; Baba, Yuka; Ohata, Atsushi] Saitama Med Univ, Saitama Med Ctr, Dept Otolaryngol, Saitama, Japan	Ohki, M (reprint author), Saitama Med Ctr, Dept Otolaryngol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	m-ohki@umin.ac.jp					Triglia JM, 1998, ARCH OTOLARYNGOL, V124, P291; OLSEN KD, 1980, LARYNGOSCOPE, V90, P423; CAVO JW, 1976, LARYNGOSCOPE, V86, P739, DOI 10.1288/00005537-197605000-00017; Nicollas R, 2005, INT J PEDIATR OTORHI, V69, P279, DOI 10.1016/j.ijporl.2004.09.009; Schuknecht HF, 1986, ANATOMY TEMPORAL BON, P235	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	FEB	2015	36	2					e70	e72		10.1097/MAO.0000000000000411		3	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AZ8IQ	WOS:000348459300011		
J	Middleton, GD				Middleton, Guy D.			TELLING STORIES: THE MYCENAEAN ORIGINS OF THE PHILISTINES	OXFORD JOURNAL OF ARCHAEOLOGY			English	Review							ANIMAL SACRIFICE; FOOD; INSCRIPTIONS; ARCHAEOLOGY; DIVERSITY; NESTOR; MINOAN; PALACE; EGYPT; DIET	The story of the Philistines as Mycenaean or Aegean migrants, refugees who fled the Aegean after the collapse of the palace societies c.1200 BC, bringing an Aegean culture and practices to the Eastern Mediterranean, is well known. Accepted as essentially true by some, yet rejected as little more than a modern myth by others, the migration narrative retains a central place in the archaeology and historiography of the Eastern Mediterranean in the Late Bronze Age/Early Iron Age (LBA/EIA). In recent years, and despite an increasingly shaky theoretical basis, the migration hypothesis has nevertheless seemed to drown out other interpretations and characterizations of the period, claiming a normative position that is undeserved. In this paper I explore the continuing power of this nineteenth century narrative and seek to show why it is less convincing than its prominent status would suggest.	Univ Tokyo, Meguro Ku, Tokyo 1538902, Japan	Middleton, GD (reprint author), Univ Tokyo, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	gdmiddleton@hotmail.com					Mac Sweeney N, 2009, J MEDITERR ARCHAEOL, V22, P101, DOI 10.1558/jmea.v22i1.101; Norton M, 2006, AM HIST REV, V111, P660, DOI 10.1086/ahr.111.3.660; Faust A, 2011, OXFORD J ARCHAEOL, V30, P13, DOI 10.1111/j.1468-0092.2010.00357.x; Stockhammer P, 2011, CULT HIST ANC, V50, P207; Cross FM, 2006, ISRAEL EXPLOR J, V56, P129; Barako TJ, 2000, AM J ARCHAEOL, V104, P513, DOI 10.2307/507227; Petroutsa EI, 2010, J ARCHAEOL SCI, V37, P614, DOI 10.1016/j.jas.2009.10.026; Wright JC, 2004, HESPERIA, V73, P133, DOI 10.2972/hesp.2004.73.2.133; Twiss K, 2012, J ARCHAEOL RES, V20, P357, DOI 10.1007/s10814-012-9058-5; Jones M, 2011, WORLD ARCHAEOL, V43, P665, DOI 10.1080/00438243.2011.624764; Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294; Astour M. C., 1968, JAOS, V88, P733, DOI 10.2307/598119; Bachhuber C., 2012, ENCY ANCIENT HIST; Barako T. J., 2003, BIBLICAL ARCHAEOLOGY, V29, P24; Barnett R. D., 1975, CAH, V2, P359; Barrett CE, 2009, J MEDITERR ARCHAEOL, V22, P211, DOI 10.1558/jmea.v22i2.211; Beard M., 2008, POMPEII; Ben-Shlomo D., 2009, B AM SCH ORIENT RES, V353, P39; Ben-Shlomo D., 2010, PHILISTINE ICONOGRAP, V241; Ben-Shlomo D, 2011, HOUSEHOLD ARCHAEOLOG, P185; Bombardieri L., 2010, KADMOS, V49, P133; Collard D, 2008, FUNCTION ETHNICITY B; Cross F. M., 1968, BASOR, V190, P41; Cross F. M., 1971, B AM SCH ORIENT RES, V201, P19; Dalglish C., 2005, SCOTTISH ARCHAEOLOGI, V27, P147, DOI 10.3366/saj.2005.27.2.147; Davis B., 2011, KUBABA, V2, P40; Dickinson Oliver, 2006, AEGEAN BRONZE AGE IR; Dothan T., 2004, BASOR, V333, P1; Dothan T., 1982, PHILISTINES THEIR MA; Dothan T, 2003, Symbiosis, Symbolism, and the Power of the Past: Canaan, Ancient Israel, and Their Neighbors - from the Late Bronze Age..., P189; Dothan T., 1992, PEOPLE SEA SEARCH PH; Dothan T, 1997, ARCHAEOLOGY ISRAEL C, P96; Drews R., 1998, JSOT, V81, P39; Drews R, 1993, END BRONZE AGE CHANG; Drews R, 2000, J NEAR EASTERN STUD, V59, P161, DOI 10.1086/468830; Emery K. F, 2002, WORLD ARCHAEOL, V34, P498; Eriksson G, 2008, J ANTHROPOL ARCHAEOL, V27, P520, DOI 10.1016/j.jaa.2008.08.004; Fagan B., 2004, LONG SUMMER CLIMATE; Fantalkin A., 2006, STUDIES E GREEK POTT, P199; French E, 1971, ANNU BRIT SCH ATHENS, V66, P101; Fritz V, 1987, BIBLIC ARCHAEOL, V50, P84, DOI 10.2307/3210090; Goren Y, 2003, AM J ARCHAEOL, V107, P233; Halstead P, 2003, ZOOARCHAEOLOGY GREEC, P257; HAMILAKIS Y., 2004, OJA, V23, P135, DOI DOI 10.1111/J.1468-0092.2004.00206.X; Harl K. W., 2011, OXFORD HDB ANCIENT A, P752; Hirschfeld N., 2010, OXFORD HDB BRONZE AG, P373; Hirschfeld N, 2008, NEAR EAST ARCHAEOL, V71, P120; Hood S., 1978, ARTS PREHISTORIC GRE; Horowitz W, 2002, J AM ORIENTAL SOC, V122, P753, DOI 10.2307/3217614; Iezzi C., 2009, NEW DIRECTIONS SKELE, P175; Isaakidou V, 2002, ANTIQUITY, V76, P86; Janeway B., 2011, COOKING POTS DRINKIN, P167; Janeway B, 2006, SCRIPTA MEDITERRANEA, V27-8, P123; Jones N, 2010, BRITAIN, V78, P80; Kaniewski D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020232; Karageorghis V., 2001, DEFENSIVE SETTLEMENT, P1; Karageorghis V, 1998, MEDITERRANEAN PEOPLES IN TRANSITION: THIRTEENTH TO EARLY TENTH CENTURIES BCE, P276; Karageorghis V., 2000, SEA PEOPLES THEIR WO, P255; Karam VJ, 1998, ADV BOUND ELEM SER, P127; Kilian K., 1988, PROBLEMS GREEK PREHI, P115; Kilian K., 1988, OJA, V7, P291, DOI 10.1111/j.1468-0092.1988.tb00182.x; Killebrew A. E., 1998, AEGEAN ORIENT 2 MILL, V18, P159; Killebrew A. E., 2005, BIBLICAL PEOPLES EHN; Killebrew A. E., 2006, SCRIPTA MEDITERRANEA, V27-8, P244; Knapp A. B., 2009, SCI ANCHITA STORIA A, V15, P219; Knapp A. B., 2013, ARCHAEOLOGY CYPRUS E; KNAPP A.B., 2008, PREHISTORIC PROTOHIS; Kuhrt Amelie, 1995, ANCIENT NEAR E; LaViolette A, 2008, ARCHAEOLOGIES, V4, P24, DOI 10.1007/s11759-008-9064-x; Lederman Z., 2011, B AM SCH ORIENT RES, V364, P37; Lipovitch D. R., 2006, SCRIPTA MEDITERRANEA, V27-8, P147; Lis B., 2006, ARCHEOLOGIA, V57, P7; Longo UG, 2008, J SPORT SCI MED, V7, P565; Mac Sweeney N., 2011, INTERCULTURAL CONTAC, P67; Maran J., 2001, POTNIA DEITIES RELIG, V22, P113; Marshall M., 2012, NEW SCI, P32; Mazar A., 2008, ISRAEL TRANSITION LA, V1, P86; Mazow L. B., 2006, SCRIPTA MEDITERRANEA, V27-8, P291; Middleton G. D., 2010, COLLAPSE PALATIAL SO; Mountjoy P. A., 2000, ANNU BRIT SCH ATHENS, V95, P141; Mountjoy P. A., 2010, B AM SOC ORIENTAL ST, V359, P1; Mountjoy P.A., 1993, MYCENAEAN POTTERY IN; Muhly James D., 1984, CYPRUS CLOSE LATE BR, P39; Nunn N, 2010, J ECON PERSPECT, V24, P163, DOI 10.1257/jep.24.2.163; Palaima TG, 2004, HESPERIA, V73, P217, DOI 10.2972/hesp.2004.73.2.217; Popham M, 1994, OXFORD ILLUSTRATED P, P277; Rosenblum J. D., 2010, JEWISH Q REV, V100, P95; Russell A, 2010, MAT CONNECTIONS ANCI, P106; Rutter J. B., 2007, LH 3 C CHRONOLOGY S, P287; Sagona Antonio, 2009, ANCIENT TURKEY; Sandars N.K., 1978, SEA PEOPLES WARRIORS, V1st; Sherratt E. S., 2004, HESPERIA, V73, P301; Sherratt E. S., 2005, ARCHAEOLOGICAL PERSP, P25; Sherratt E. S., 2003, SYMBIOSIS SYMBOLISM, P37; Sherratt E. S., 2006, I WILL SPEAK RIDDLES, P361; Sherratt E. S., 2012, PARALLEL LIVES ANCIE; Sherratt E. S., 1998, MEDITERRANEAN PEOPLE, P292; Sherratt E. S., 2001, EC POLITICS MYCENAEA, P214; Silberman NA, 1998, MEDITERRANEAN PEOPLES IN TRANSITION: THIRTEENTH TO EARLY TENTH CENTURIES BCE, P268; Stager L. E., 1995, ARCHAEOLOGY SOC HOLY, P332; Steel L., 2004, CYPRUS HIST EARLIEST; Steel L, 2004, HESPERIA, V73, P281, DOI 10.2972/hesp.2004.73.2.281; Stocker SR, 2004, HESPERIA, V73, P179, DOI 10.2972/hesp.2004.73.2.179; Stone B. J., 1995, BASOR, V298, P7, DOI DOI 10.2307/1357082; Thomas HM, 2003, ENGL HIST REV, V118, P303, DOI 10.1093/ehr/118.476.303; Tournavitou I., 1992, ANN BRIT SCH ATHENS, V87, P181; University of Minnesota, EKR SUCC REM FIELD 4; Van Wijngaarden G. J., 2008, IMPORT IMITATION ARC, P125; Van Wijngaarden G. J., 1999, ARCHAEOL DIALOG, V6, P2, DOI 10.1017/S1380203800001306; van Wijngaarden G.J., 2002, USE APPRECIATION MYC; Vanschoonwinkel J., 1999, ANCIENT GREEKS W E, P85; Verstraete J., 2012, 113 ANN M ARCH I AM; Wachsmann S., 2003, BIBLICAL ARCHAEOLOGY, V29, P22; Wachsmann S., 1998, SEAGOING SHIPS SEAMA; Wilkinson T., 2010, RISE FALL ANCIENT EG; WILSON JA, 1956, P AM PHILOS SOC, V100, P439; YASUR- LANDAU A., 2003, BIBLICAL ARCHAEOLOGY, V29, P66; YASUR- LANDAU A., 2003, BIBLICAL ARCHAEOLOGY, V29, P34; Yasur-Landau A., 2006, MEGGIDO, P299; Yasur-Landau A., 2010, PHILISTINES AEGEAN M; Yasur-Landau A., 2001, POTNIA DEITIES RELIG, P329; Zuckerman S., 2007, PALESTINE EXPLORATIO, V139, P186, DOI DOI 10.1179/003103207X227319	122	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0262-5253	1468-0092		OXFORD J ARCHAEOL	Oxf. J. Archaeol.	FEB	2015	34	1					45	65		10.1111/ojoa.12048		21	Archaeology	Archaeology	AZ7AU	WOS:000348371400003		
J	Ito, A				Ito, A.			Basic and applied problems in developmental biology and immunobiology of cestode infections: Hymenolepis, Taenia and Echinococcus	PARASITE IMMUNOLOGY			English	Review						cysticercosis; echinococcoses; Echinococcus; Hymenolepis; Taenia	CONGENITALLY ATHYMIC NUDE; GRANULOSUS SENSU-STRICTO; ISOTHERMAL AMPLIFICATION METHOD; INTESTINAL PARASITIC INFECTIONS; MITOCHONDRIAL-DNA SEQUENCES; DIFFERENT CLINICAL STAGES; LABORATORY-ANIMAL MODELS; RECEPTOR GENES TLR2; MAST-CELL RESPONSES; CYSTIC ECHINOCOCCOSIS	Differentiation and development of parasites, including longevity in host animals, are thought to be governed by host-parasite interactions. In this review, several topics on the developmental biology of cestode infections are discussed from immunobiological perspective with a focus on Hymenolepis, Taenia and Echinococcus infections. The basic premise of this review is that differentiation and development of cestodes' are somehow affected by host immune responses with an evolutionary history.	[Ito, A.] Asahikawa Med Univ, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan; [Ito, A.] Asahikawa Med Univ, NTD Res Lab, Asahikawa, Hokkaido 0788510, Japan	Ito, A (reprint author), Asahikawa Med Univ, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan.	akiraito@asahikawa-med.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS-Asia/Africa Scientific Platform Fund; Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science & Technology, Japan (MEXT); MEXT-Translational Research Fund	I dedicate this article to the late Prof. Kenichi Okamoto (11 Mar 1932-1 Feb 2012) who gave me the opportunity to work on cestode immunology with him at Showa Medical University, Tokyo, from April 1971 to February 1978. I sincerely thank P Deplazes, M Nakao, M Okamoto, T Iwaki, M Lightowlers, D Jenkins, Christine Budke and Agathe Nkouawa for pointing out important literature and suggestions, and K Asano and PS Sahu who permitted me to use their unpublished data and a figure. I sincerely thank for Christine Budke for her amendment of this MS and the anonymous reviewers who gave great suggestions to improve the MS. The studies on cestode infections carried out by Ito have been supported by Grants-in-Aid for international collaboration research funds from the Japan Society for the Promotion of Science (JSPS) (1994-2015), by JSPS-Asia/Africa Scientific Platform Fund (2006-2011), the Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science & Technology, Japan (MEXT) (2003-2005, 2010-2012), and the MEXT-Translational Research Fund (2007-2011).	Abou-Zeid AHA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-133; Adalid-Peralta L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/981468; ANDREASSEN J, 1980, J PARASITOL, V66, P898, DOI 10.2307/3280385; ANDREASSEN J, 1991, Parassitologia (Rome), V33, P45; Andreassen J, 2004, J HELMINTHOL, V78, P1, DOI 10.1079/JOH2003207; ANDREASSEN J, 1978, IMMUNOLOGY, V34, P105; Yanagida T, 2012, PARASITOL INT, V61, P599, DOI 10.1016/j.parint.2012.05.014; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; HARRISON LJS, 1989, PARASITE IMMUNOL, V11, P351, DOI 10.1111/j.1365-3024.1989.tb00673.x; Carmena D, 2013, ACTA TROP, V128, P441, DOI 10.1016/j.actatropica.2013.08.002; Knapp J, 2011, MOL PHYLOGENET EVOL, V61, P628, DOI 10.1016/j.ympev.2011.07.022; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Mbow M, 2013, J INFECT DIS, V207, P186, DOI 10.1093/infdis/jis654; Konyaev SV, 2013, PARASITOLOGY, V140, P1637, DOI 10.1017/S0031182013001340; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Schneider R, 2010, AM J TROP MED HYG, V82, P871, DOI 10.4269/ajtmh.2010.09-0639; Okamoto M, 2010, PARASITOL INT, V59, P70, DOI 10.1016/j.parint.2009.10.007; ITO A, 1984, EXP PARASITOL, V58, P132, DOI 10.1016/0014-4894(84)90028-6; Nakao M, 2010, INT J PARASITOL, V40, P379, DOI 10.1016/j.ijpara.2009.09.006; Casulli A, 2012, INFECT GENET EVOL, V12, P377, DOI 10.1016/j.meegid.2011.12.014; Gauci C, 2008, INT J PARASITOL, V38, P1041, DOI 10.1016/j.ijpara.2007.11.006; Olson PD, 2003, J INFECT DIS, V187, P1962, DOI 10.1086/375357; Garcia HH, 2014, PARASITE IMMUNOL, V36, P388, DOI 10.1111/pim.12126; Nakao M, 2013, PARASITOLOGY, V140, P1625, DOI 10.1017/S0031182013000565; Tappe D, 2010, CLIN VACCINE IMMUNOL, V17, P944, DOI 10.1128/CVI.00026-10; GEMMELL MA, 1986, PARASITOLOGY, V92, P599; Anantaphruti MT, 2007, EMERG INFECT DIS, V13, P1413, DOI 10.3201/eid1309.061148; Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Tappe D, 2009, AM J TROP MED HYG, V80, P792; Flisser A, 2010, PARASITOLOGY, V137, P347, DOI 10.1017/S0031182010000272; Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Rojas CAA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; Michelet L, 2011, J CLIN MICROBIOL, V49, P195, DOI 10.1128/JCM.01554-10; Salant H, 2012, AM J TROP MED HYG, V87, P883, DOI 10.4269/ajtmh.2012.12-0184; Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08; Singh AK, 2013, INT J PARASITOL, V43, P1101, DOI 10.1016/j.ijpara.2013.07.009; Villalobos N, 2007, VET PARASITOL, V147, P185, DOI 10.1016/j.vetpar.2007.03.021; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Lightowlers MW, 2013, PARASITOLOGY, V140, P1566, DOI 10.1017/S0031182013001005; Takayanagui OM, 2006, PARASITOL INT, V55, pS111, DOI 10.1016/j.parint.2005.11.016; Sadjjadi SM, 2013, INT J PARASITOL, V43, P875, DOI 10.1016/j.ijpara.2013.06.008; Nkouawa A, 2012, PARASITOL INT, V61, P723, DOI 10.1016/j.parint.2012.06.001; JOHNSON KS, 1989, NATURE, V338, P585, DOI 10.1038/338585a0; Prasad KN, 2006, PARASITOL INT, V55, P151, DOI 10.1016/j.parint.2006.01.002; Mamuti W, 2004, J CLIN MICROBIOL, V42, P1082, DOI 10.1128/JCM.42.3.1082-1088.2004; Deplazes P, 2001, VET PARASITOL, V98, P65, DOI 10.1016/S0304-4017(01)00424-1; Mogoye BK, 2013, VET PARASITOL, V196, P427, DOI 10.1016/j.vetpar.2013.03.033; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; Okamoto M, 1997, PARASITOLOGY, V115, P661, DOI 10.1017/S0031182097001741; Mamuti W, 2006, EXP PARASITOL, V113, P75, DOI 10.1016/j.exppara.2005.12.007; Johnston CJ, 2014, TRANSPLANTATION, V97, P127, DOI 10.1097/TP.0b013e3182a53f59; Kosik-Bogacka DI, 2012, EXP PARASITOL, V130, P261, DOI 10.1016/j.exppara.2011.12.002; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; SantamariaFries M, 1996, LANCET, V347, P1797, DOI 10.1016/S0140-6736(96)91618-9; Ito A, 2003, TRENDS PARASITOL, V19, P377, DOI 10.1016/S1471-4922(03)00200-9; Addy F, 2012, PARASITOL RES, V111, P2289, DOI 10.1007/s00436-012-3082-8; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Olson PD, 2012, PARASITE IMMUNOL, V34, P130, DOI 10.1111/j.1365-3024.2011.01319.x; Armua-Fernandez MT, 2014, PARASITOL INT, V63, P300, DOI 10.1016/j.parint.2013.11.005; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Dybicz M, 2013, PARASITOL INT, V62, P364, DOI 10.1016/j.parint.2013.03.005; Li TY, 2010, CLIN VACCINE IMMUNOL, V17, P470, DOI 10.1128/CVI.00466-09; Nakao M, 2009, PARASITOL INT, V58, P384, DOI 10.1016/j.parint.2009.07.010; Nkouawa A, 2010, J CLIN MICROBIOL, V48, P3350, DOI 10.1128/JCM.00697-10; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Almeida CR, 2006, EUR ARCH PSY CLIN N, V256, P307, DOI 10.1007/s00406-006-0612-3; Michelet L, 2010, MOL PHYLOGENET EVOL, V55, P744, DOI 10.1016/j.ympev.2010.01.008; Peng SY, 2009, RES VET SCI, V86, P261, DOI 10.1016/j.rvsc.2008.07.009; Nakao M, 2010, INFECT GENET EVOL, V10, P444, DOI 10.1016/j.meegid.2010.01.011; Lightowlers MW, 2006, PARASITOLOGY, V133, pS27, DOI 10.1017/S003118200600179X; Tamarozzi F, 2013, PARASITE IMMUNOL, V35, P433, DOI 10.1111/pim.12050; Asada J, 1963, PROGR PARASITOLOGY R, V3, P251; ASANO K, 1986, EXP PARASITOL, V61, P373, DOI 10.1016/0014-4894(86)90193-1; Avila G, 2006, PARASITOL INT, V55, pS99, DOI 10.1016/j.parint.2005.11.015; Bilqees F M., 1970, Riv. Parassit., V31, P47; BOWTELL DDL, 1983, EXP PARASITOL, V56, P416, DOI 10.1016/0014-4894(83)90087-5; BOWTELL DDL, 1986, PARASITOLOGY, V93, P599; Brunetti E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001146; Burgu A, 2004, VET REC, V155, P711; Campbell DH, 1938, J IMMUNOL, V35, P195; Castillo-Iglesias H, 2006, J Infect, V53, pe35, DOI 10.1016/j.jinf.2005.09.005; Chen Zheng-hong, 2010, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V28, P108; Chinchuluun B, 2014, PARASITOL INT, V63, P324, DOI 10.1016/j.parint.2013.12.002; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; delsBrutto OH, 1999, REV NEUROL, V29, P456; Ebihara Y, 2002, BRIT J HAEMATOL, V119, P525, DOI 10.1046/j.1365-2141.2002.03820.x; Eckert J, 2001, WHO OIE MANUAL ECHIN, P1; Euzeby JA, 1974, PARASITIC ZOONOSES, P151; FAN PC, 1988, PARASITOL TODAY, V4, P86, DOI 10.1016/0169-4758(88)90204-9; FAN P-C, 1990, Yonsei Reports on Tropical Medicine, V21, P39; FAN PC, 1989, ANN TROP MED PARASIT, V83, P395; FEATHERSTON DW, 1992, INT J PARASITOL, V22, P961, DOI 10.1016/0020-7519(92)90054-O; Galan-Puchades MT, 2000, PARASITOL TODAY, V16, P174; Ganaba R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000927; Garcia HH, 2002, CLIN MICROBIOL REV, V15, P747, DOI 10.1128/CMR.15.4.747-756.2002; GEERTS S, 1992, PARASITOL RES, V78, P513, DOI 10.1007/BF00931573; Gelaw A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-304; GEMMELL MA, 1962, IMMUNOLOGY, V5, P496; Gemmell M. A., 1976, Immunology of parasitic infections., P333; GOTTSTEIN B, 1987, TROP MED PARASITOL, V38, P299; Gujdusek DC, 1978, P N G MED J, V21, P329; Hailemariam Z, 2012, PARASITOL INT, V61, P375, DOI 10.1016/j.parint.2012.01.007; Hemer S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-5; Hernandez M, 2008, ANN TROP MED PARASIT, V102, P317, DOI 10.1179/136485908X278856; Hernandez-Gonzalez A, 2008, CLIN VACCINE IMMUNOL, V15, P147, DOI 10.1128/CVI.00363-07; HEYNEMAN D, 1961, J INFECT DIS, V109, P10; HOPKINS CA, 1972, PARASITOLOGY, V65, P111; Hopkins C.A., 1980, P551; HOPKINS CA, 1982, INT J PARASITOL, V12, P327, DOI 10.1016/0020-7519(82)90036-4; HOPKINS CA, 1991, INT J PARASITOL, V21, P47, DOI 10.1016/0020-7519(91)90119-R; Hsu TL, 2013, MOL BIOCHEM PARASIT, V192, P55, DOI 10.1016/j.molbiopara.2013.12.001; ISHIH A, 1994, INT J PARASITOL, V24, P295, DOI 10.1016/0020-7519(94)90042-6; Ishino H, 1941, KACHIKU EISEI KYOUKA, V9, P115; Ito A, 2007, FUTURE MICROBIOL, V2, P439, DOI 10.2217/17460913.2.4.439; ITO A, 1987, J HELMINTHOL, V61, P129; Ito Akira, 1999, Parasitology International, V48, P95, DOI 10.1016/S1383-5769(99)00005-7; Ito A, 2003, PROGR PARASITOLOGY R, V8, P327; Ito A, 1997, PARASITOLOGY, V114, P85, DOI 10.1017/S0031182096008074; Ito A, 1984, J PARASITOL, V70, P170; Ito A., 2007, Flynn's parasites of laboratory animals, P37, DOI 10.1002/9780470344552.ch4; ITO A, 1989, PARASITE IMMUNOL, V11, P453, DOI 10.1111/j.1365-3024.1989.tb00681.x; Ito Akira, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P74; ITO A, 1986, INT J PARASITOL, V16, P623, DOI 10.1016/0020-7519(86)90030-5; Ito A., 1992, PARASITOL TODAY, V8, P181; Ito Akira, 2002, P47, DOI 10.1079/9780851996288.0047; Ito A, 2010, AM J TROP MED HYG, V82, P266, DOI 10.4269/ajtmh.2010.09-0520; Ito A, 1987, IMMUNE RESPONSES PAR, V2, P115; Ito A, 2002, PARASITOL INT, V51, P221, DOI 10.1016/S1383-5769(02)00036-3; Ito A, 1998, AM J TROP MED HYG, V59, P291; ITO A, 1986, INT J PARASITOL, V16, P81, DOI 10.1016/0020-7519(86)90069-X; Ito A, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P79; ITO A, 1980, EXP PARASITOL, V49, P248, DOI 10.1016/0014-4894(80)90121-6; ITO A, 1976, Japanese Journal of Parasitology, V25, P247; Ito A, 1997, INT J PARASITOL, V27, P903, DOI 10.1016/S0020-7519(97)00057-X; ITO A, 1986, INT J PARASITOL, V16, P197, DOI 10.1016/0020-7519(86)90044-5; Ito A, 1999, PARASITOL TODAY, V15, P64, DOI 10.1016/S0169-4758(98)01380-5; Ito A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002937; ITO A, 1988, INT J PARASITOL, V18, P321, DOI 10.1016/0020-7519(88)90140-3; Ito A, 2003, LANCET, V362, P1918, DOI 10.1016/S0140-6736(03)14965-3; Ito A, 1997, INT J PARASITOL, V27, P1203, DOI 10.1016/S0020-7519(97)00118-5; Ito A, 2013, PARASITOLOGY, V140, P1551, DOI 10.1017/S0031182013000966; Ito A, 1997, INT J PARASITOL, V27, P631, DOI 10.1016/S0020-7519(97)00017-9; ITO A, 1987, J HELMINTHOL, V61, P124; Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X; Ito A, 2013, PARASITOLOGY, V140, P1648, DOI 10.1017/S0031182013001030; ITO A, 1985, CLIN EXP IMMUNOL, V60, P87; Ito A, 2010, MOLECULAR DETECTION OF FOODBORNE PATHOGENS, P839; Ito A, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P85; ITO A, 1988, PARASITE IMMUNOL, V10, P265, DOI 10.1111/j.1365-3024.1988.tb00220.x; Ito A, 2014, TRAVEL MED INFECT DI, V12, P582, DOI 10.1016/j.tmaid.2014.06.009; Ito A, 1999, J HELMINTHOL, V73, P363; Ito A, 2002, J HELMINTHOL, V76, P311, DOI 10.1079/JOH2002128; IWAKI T, 1994, J PARASITOL, V80, P461, DOI 10.2307/3283418; Jongwutiwes U, 2011, J TRAVEL MED, V18, P284, DOI 10.1111/j.1708-8305.2011.00535.x; KAMIYA M, 1990, PARASITOLOGY, V100, P125; Kan K., 1934, KEIO IGAKA, V14, P663; KANO S, 1983, Japanese Journal of Parasitology, V32, P183; Kashiide T, 2014, VET PARASITOL, V201, P154, DOI 10.1016/j.vetpar.2014.01.021; Ko RC, 1998, PARASITOL RES, V84, P565, DOI 10.1007/s004360050449; Kobayashi K, 2013, AM J TROP MED HYG, V89, P58, DOI 10.4269/ajtmh.12-0355; Konyaev SV, 2012, J HELMINTHOL, V86, P391, DOI 10.1017/S0022149X1100054X; Kosik-Bogacka DI, 2013, EXP PARASITOL, V135, P437, DOI 10.1016/j.exppara.2013.08.002; Krecek RC, 2008, VET PARASITOL, V154, P38, DOI 10.1016/j.vetpar.2008.03.005; Li T, 2006, ACTA TROP, V100, P223, DOI 10.1016/j.actatropica.2006.11.003; LIGHTOWLERS MW, 1993, IMMUNOL CELL BIOL, V71, P443, DOI 10.1038/icb.1993.50; Lightowlers MW, 2014, PARASITOLOGY, V140, P1566; Lightowlers M. W., 1993, Immunology and molecular biology of parasitic infections., P438; Macnish MG, 2002, J HELMINTHOL, V76, P37, DOI 10.1079/JOH200198; Mamuti W, 2006, PARASITOL INT, V55, pS57, DOI 10.1016/j.parint.2005.11.008; Maravilla P, 2011, PARASITOL INT, V60, P364, DOI 10.1016/j.parint.2011.06.002; Maravilla P, 1998, J PARASITOL, V84, P882, DOI 10.2307/3284613; Maravilla P, 2003, J PARASITOL, V89, P1250, DOI 10.1645/GE-2786RN; Margono SS, 2003, J HELMINTHOL, V77, P39, DOI 10.1079/JOH2002146; Mbae CK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-243; MCDONALD F. E., 1963, New Zealand Veterinary Journal, V11, P131, DOI 10.1080/00480169.1963.33521; McLauchlan PE, 1999, PARASITE IMMUNOL, V21, P151, DOI 10.1046/j.1365-3024.1999.00214.x; Michelet L, 2012, BIOL REV, V87, P731, DOI 10.1111/j.1469-185X.2012.00217.x; Miller HM, 1932, SCIENCE, V75, P270, DOI 10.1126/science.75.1940.270; Mitchell G F, 1979, Adv Immunol, V28, P451; Mohammadzadeh T, 2007, IRAN J VETERINARY RE, V8, P16; Mohan VR, 2013, T ROY SOC TROP MED H, V107, P62, DOI 10.1093/trstmh/trs003; Zain SNM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-47; Morales-Montor J, 2005, PARASITOLOGY, V131, P287, DOI 10.1017/S0031182005007894; Moro PL, 2009, PARASITOL INT, V58, P184, DOI 10.1016/j.parint.2009.01.005; Nakaya K, 2006, PARASITOL INT, V55, pS91, DOI 10.1016/j.parint.2005.11.014; Newport G. R., 1993, Immunology and molecular biology of parasitic infections., P387; Ninomiya M, 2004, LEUKEMIA, V18, P442, DOI 10.1038/sj.leu.2403284; Niwa A, 1998, J HELMINTHOL, V72, P273; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Nono JK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002632; Nono JK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001516; NOVAK M, 1990, PARASITOLOGY, V100, P337; NOVAK M, 1988, J PARASITOL, V74, P81, DOI 10.2307/3282481; Nxasana N, 2013, Ann Med Health Sci Res, V3, P511, DOI 10.4103/2141-9248.122064; Ohbayashi M., 1983, ZOONOTIC PARASITIC D, P211; Okamoto K, 2003, PROGR PARASITOLOGY R, V8, P319; OKAMOTO K, 1970, EXP PARASITOL, V27, P28, DOI 10.1016/S0014-4894(70)80006-6; OKAMOTO K, 1972, EXP PARASITOL, V32, P56, DOI 10.1016/0014-4894(72)90009-4; ONITAKE K, 1990, J HELMINTHOL, V64, P168; Pawlowski Z., 1972, Advances Parasit, V10, P269, DOI 10.1016/S0065-308X(08)60176-1; Peralta RH, 2010, EXP PARASITOL, V124, P295, DOI 10.1016/j.exppara.2009.10.016; Piccoli L, 2013, CLIN MICROBIOL INFEC, V19, P578, DOI 10.1111/j.1469-0691.2012.03993.x; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; Ramahefarisoa RM, 2010, VET PARASITOL, V173, P336, DOI 10.1016/j.vetpar.2010.05.002; Rickard M.D., 1983, P539; Rickard M. D., 1989, New strategies in parasitology. Proceedings of an international symposium sponsored by Glaxo Research, Brocket Hall, Hertfordshire, UK, 22-25 April 1989, P3; Rottbeck R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002558; Sahu PS, 2009, ACTA TROP, V110, P38, DOI 10.1016/j.actatropica.2009.01.002; Sahu PS, 2010, ACTA TROP, V115, P257, DOI 10.1016/j.actatropica.2010.04.006; Sako Y, 2011, CLIN VACCINE IMMUNOL, V18, P1302, DOI 10.1128/CVI.05156-11; Sako Y, 2000, J CLIN MICROBIOL, V38, P4439; Sako Y, 2013, PARASITOLOGY, V140, P1589, DOI 10.1017/S0031182013000978; Sato MO, 2003, VET PARASITOL, V111, P309, DOI 10.1016/S0304-4017(02)00383-7; Sato MO, 2006, J INFECT DIS, V194, P1783, DOI 10.1086/509262; SCHANTZ PM, 1994, CLIN INFECT DIS, V18, P879; Schantz P.M., 1998, EMERG INFECT DIS, V2, P213; SCHILLER EL, 1973, J PARASITOL, V59, P122, DOI 10.2307/3278587; Sikorska Beata, 2012, Subcell Biochem, V65, P457, DOI 10.1007/978-94-007-5416-4_17; Simanjuntak GM, 1997, PARASITOL TODAY, V13, P321, DOI 10.1016/S0169-4758(97)01104-6; Skelding A, 2014, CAN VET J, V55, P551; Terefe Y, 2014, INT J PARASITOL, V44, P533, DOI 10.1016/j.ijpara.2014.03.013; Toral-Bastida E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-147; Torgerson PR, 2009, TRENDS PARASITOL, V25, P57, DOI 10.1016/j.pt.2008.10.003; TSANG VCW, 1989, J INFECT DIS, V159, P50; Wassermann M, 2014, VET PARASITOL, V200, P97, DOI 10.1016/j.vetpar.2013.12.012; WATANABE N, 1994, PARASITE IMMUNOL, V16, P137, DOI 10.1111/j.1365-3024.1994.tb00333.x; WEINMANN C. J., 1966, Biology of parasites. Emphasis on veterinary parasites., P301; Wilkins Patricia P., 2002, P329, DOI 10.1079/9780851996288.0329; Williams J. F., 1982, Immunology of parasitic infections.  2nd edition., P676; Yamane K, 2013, PARASITOLOGY, V140, P1595, DOI 10.1017/S0031182013001273; Yamane K, 2012, PARASITOL INT, V61, P351, DOI 10.1016/j.parint.2012.01.005; Yamashita J, 1961, PROGR PARASITOLOGY R, V1, P385; Yanagida T, 2010, J TRAVEL MED, V17, P206, DOI 10.1111/j.1708-8305.2010.00409.x; Yanagida T, 2014, PLOS ONE, V8; Yang HJ, 1998, PARASITE IMMUNOL, V20, P483; Yoshino K., 1934, Journal of the Medical Association of Formosa, V33, P183; Zhang W, 2009, 23 C MUND HID COL SA, P120; Zhang WB, 2006, J INFECT DIS, V194, P966, DOI 10.1086/506622	239	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-9838	1365-3024		PARASITE IMMUNOL	Parasite Immunol.	FEB	2015	37	2					53	69		10.1111/pim.12167		17	Immunology; Parasitology	Immunology; Parasitology	CA2DC	WOS:000348718100001		
J	Nakada, T				Nakada, Toshimasa			Effects of Anti-Inflammatory Drugs on Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease	PEDIATRIC CARDIOLOGY			English	Article						Kawasaki disease; Intravenous immunoglobulin therapy; Anti-inflammatory drugs; Aspirin; Flurbiprofen; Coronary artery lesions	MODEL	This retrospective study aimed to investigate the effects of anti-inflammatory drugs (ADs) on intravenous immunoglobulin (IVIG) therapy in the acute phase of Kawasaki disease. In total, 182 pediatric patients who received IVIG therapy for Kawasaki disease between 1999 and 2013 at the Department of Pediatrics, Aomori Prefectural Central Hospital were enrolled. Patients were divided into 2 groups: an S group, including 111 patients who received single IVIG therapy with delayed administration of ADs, and a T group, including 71 patients who received concomitant AIDs with IVIG. During the study, the only ADs administered were aspirin (A: 30 mg/kg/day) or flurbiprofen (F: 3-5 mg/kg/day). Steroids were not administered to any patient. The regimen of the S group was partially used after 2004 and was used to all patients after 2009. The following clinical findings were significantly different between the S and T groups: disease onset before 2003 (0 vs. 59 %, P < 0.001) and after 2009 (70 vs. 0 %, P < 0.001), use of 2-g/kg/day IVIG therapy (100 vs. 93 %, P = 0.034), ADs type (A/F: 62/49 vs. 17/54, P < 0.001), and the prevalence of coronary artery lesions (CAL) up to (1/111 vs. 11/71, P < 0.001) and after 30 days of illness (0/111 vs. 4/71, P = 0.022). Logistic regression analysis revealed that IVIG therapy only (S group; P = 0.009) and 2-g/kg/day IVIG therapy (P = 0.015) were significant factors for CAL suppression. The findings revealed a possible negative impact of ADs on initial IVIG therapy in the acute phase of Kawasaki disease. Initial single IVIG therapy with delayed administration of ADs may be useful to suppress CAL caused by Kawasaki disease.	Aomori Prefectural Cent Hosp, Dept Pediat, Aomori 0308553, Japan	Nakada, T (reprint author), Aomori Prefectural Cent Hosp, Dept Pediat, Higashi Tukurimiti 2-1-1, Aomori 0308553, Japan.	toshimasanakada@yahoo.co.jp					Hsieh KS, 2004, PEDIATRICS, V114, pE689, DOI 10.1542/peds.2004-1037; Yamamoto M, 2010, CLIN EXP IMMUNOL, V162, P315, DOI 10.1111/j.1365-2249.2010.04243.x; Lau AC, 2009, ARTHRITIS RHEUM, V60, P2131, DOI 10.1002/art.24660; Huang L, 2011, BRIT J PHARMACOL, V162, P1521, DOI 10.1111/j.1476-5381.2010.01162.x; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; Benammar C, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-54; Buckland M, 2009, HDB EXP PHARM, V188, P197, DOI DOI 10.1007/978-3-540-71029-5_; Inoue Y, 2007, J IMMUNOL, V179, P764; Ito H, 2002, PROG MED, V22, P1640; Lee G, 2013, KOREAN CIRC J, V43, P182, DOI 10.4070/kcj.2013.43.3.182; Nakada T, 2012, MED J AOMORI, V57, P15; Research committee on Kawasaki disease, 1994, REP SUBC STAND DIAGN; The Japan Kawasaki Disease Research Committee, 2002, DIAGN GUID KAW DIS; Yahata T, 2014, CIRC J, V78, P188, DOI 10.1253/circj.CJ-12-1037; Zhang Yi-ying, 2006, Zhonghua Er Ke Za Zhi, V44, P329; Zorzi AD, 1998, J PEDIATR, V133, P254	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	FEB	2015	36	2					335	339		10.1007/s00246-014-1010-7		5	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	AZ9WY	WOS:000348566100014		
J	Hoashi, T; Kagisaki, K; Kurosaki, K; Kitano, M; Shiraishi, I; Ichikawa, H				Hoashi, Takaya; Kagisaki, Koji; Kurosaki, Kenichi; Kitano, Masataka; Shiraishi, Isao; Ichikawa, Hajime			Intrinsic Obstruction in Pulmonary Venous Drainage Pathway is Associated with Poor Surgical Outcomes in Patients with Total Anomalous Pulmonary Venous Connection	PEDIATRIC CARDIOLOGY			English	Article						Total anomalous pulmonary venous connection; Pulmonary vein stenosis; Nitric oxide	PRIMARY SUTURELESS REPAIR; INHALED NITRIC-OXIDE; SINGLE INSTITUTION; HYPERTENSION; RETURN; VEINS; STRATEGIES; CHILDREN; SURGERY	The aim of this study was to review the surgical outcomes of conventional repair in patients with total anomalous pulmonary venous connection (TAPVC). Between 1999 and 2012, 46 patients underwent conventional TAPVC repair; of those, 14 required emergent surgery within the first 24 h after their birth for coexisting intrinsic obstruction in pulmonary venous drainage pathway (Group 1). The remaining 32 were operated on after the first day of life and were divided into two groups: with (Group 2, n = 10) and without (Group 3, n = 22) subsequently progressed pulmonary venous obstruction (PVO) after birth. A follow-up was completed on all patients, and the mean follow-up period was 7 +/- A 4 years (range 0.9-14). Group 1 required a significantly prolonged nitric oxide inhalation (12 +/- A 11 days) and mechanical ventilation support (29 +/- A 36 days) compared to Group 2 and Group 3. The actuarial survival rate at 10 years was 69 % in Group 1, 88 % in Group 2, and 96 % in Group 3 (Group 1 vs. Group 3: p = 0.05). Freedom from postoperative pulmonary vein stenosis at 10 years was 39 % in Group 1, 70 % in Group 2, and 86 % in Group 3 (Group 1 vs. Group 3: p = 0.002). However, all the ten survivors in Group 1 showed an NYHA functional status of I or II, and 60 % of survivors were free from medication. Outcomes of patients with TAPVC requiring surgical repair at the day of birth for coexisting intrinsic PVO were still dismal; however, the acceptable status of current survivors has encouraged us to treat this challenging group surgically.	[Hoashi, Takaya; Kagisaki, Koji; Ichikawa, Hajime] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Kurosaki, Kenichi; Kitano, Masataka; Shiraishi, Isao] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka, Japan	Hoashi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	thoashi@surg1.med.osaka-u.ac.jp					Seale AN, 2013, J THORAC CARDIOV SUR, V145, P1255, DOI 10.1016/j.jtcvs.2012.06.031; Horer J, 2013, EUR J CARDIO-THORAC, V44, P800, DOI 10.1093/ejcts/ezt129; Miller OI, 2000, LANCET, V356, P1464, DOI 10.1016/S0140-6736(00)02869-5; Kelle AM, 2010, J THORAC CARDIOV SUR, V139, P1387, DOI 10.1016/j.jtcvs.2010.02.024; Yong MS, 2011, ANN THORAC SURG, V91, P1921, DOI 10.1016/j.athoracsur.2010.12.069; Gorenflo M, 2010, CARDIOLOGY, V116, P10, DOI 10.1159/000313864; Friesen CLH, 2005, ANN THORAC SURG, V79, P596, DOI 10.1016/j.athoracsur.2004.07.005; Karamlou T, 2007, CIRCULATION, V115, P1591, DOI 10.1161/CIRCULATIONAHA.106.635441; Seale AN, 2010, CIRCULATION, V122, P2718, DOI 10.1161/CIRCULATIONAHA.110.940825; Azakie A, 2011, ANN THORAC SURG, V92, P666, DOI 10.1016/j.athoracsur.2011.04.024; GIRARD C, 1993, J THORAC CARDIOV SUR, V106, P369; Greenway SC, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-72; HAWORTH SG, 1982, BRIT HEART J, V48, P513; Honjo O, 2010, ANN THORAC SURG, V90, P862, DOI 10.1016/j.athoracsur.2010.05.007; LacourGayet F, 1996, ARCH MAL COEUR VAISS, V89, P633; Mueller C, 2013, EUR J CARDIO-THORAC, V43, P635, DOI 10.1093/ejcts/ezs376; St Louis James D, 2012, Ann Thorac Surg, V94, P133, DOI 10.1016/j.athoracsur.2012.03.006; Yanagawa B, 2011, J THORAC CARDIOV SUR, V141, P1346, DOI 10.1016/j.jtcvs.2010.10.056; Yoshimura N, 2010, INTERACT CARDIOV TH, V10, P675, DOI 10.1510/icvts.2009.221440	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	FEB	2015	36	2					432	437		10.1007/s00246-014-1031-2		6	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	AZ9WY	WOS:000348566100028		
J	Takahashi, M; Saito, T; Ito, M; Tsukada, C; Katono, Y; Hosono, H; Maekawa, M; Shimada, M; Mano, N; Oda, A; Hirasawa, N; Hiratsuka, M				Takahashi, M.; Saito, T.; Ito, M.; Tsukada, C.; Katono, Y.; Hosono, H.; Maekawa, M.; Shimada, M.; Mano, N.; Oda, A.; Hirasawa, N.; Hiratsuka, M.			Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation	PHARMACOGENOMICS JOURNAL			English	Article							CURE RATES; CYTOCHROME-P450; POLYMORPHISM; IDENTIFICATION	Genetic variations in cytochrome P450 2C19 (CYP2C19) contribute to interindividual variability in the metabolism of therapeutic agents such as clopidogrel. Polymorphisms in CYP2C19 are associated with large interindividual variations in the therapeutic efficacy of clopidogrel. This study evaluated the in vitro oxidation of clopidogrel by 21 CYP2C19 variants harboring amino acid substitutions. These CYP2C19 variants were heterologously expressed in COS-7 cells, and the kinetic parameters of clopidogrel 2-oxidation were estimated. Among the 21 CYP2C19 variants, 12 (that is, CYP2C19.5A, CYP2C19.5B, CYP2C19.6, CYP2C19.8, CYP2C19.9, CYP2C19.10, CYP2C19.14, CYP2C19.16, CYP2C19.19, CYP2C19.22, CYP2C19.24 and CYP2C19.25) showed no or markedly low activity compared with the wild-type protein CYP2C19.1B. This comprehensive in vitro assessment provided insights into the specific metabolic activities of CYP2C19 proteins encoded by variant alleles, and this may to be valuable when interpreting the results of in vivo studies.	[Takahashi, M.; Saito, T.; Ito, M.; Tsukada, C.; Katono, Y.; Hosono, H.; Hirasawa, N.; Hiratsuka, M.] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 9808578, Japan; [Maekawa, M.; Shimada, M.; Mano, N.] Tohoku Univ Hosp, Dept Pharm, Sendai, Miyagi, Japan; [Oda, A.] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Hiratsuka, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Aoba Ku, 6-3 Aoba Aramaki, Sendai, Miyagi 9808578, Japan.	mhira@m.tohoku.ac.jp	ODA, Akifumi/D-8405-2015		Japan Society for the Promotion of Science (KAKENHI) [23659070]; Smoking Research Foundation; Takeda Science Foundation; Japan Research Foundation for Clinical Pharmacology	This work was supported by the Japan Society for the Promotion of Science (KAKENHI 23659070), Smoking Research Foundation, Takeda Science Foundation and Japan Research Foundation for Clinical Pharmacology. We thank the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support.	Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Hiratsuka M, 2012, DRUG METAB PHARMACOK, V27, P68, DOI 10.2133/dmpk.DMPK-11-RV-090; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; Furuta T, 2002, CLIN PHARMACOL THER, V72, P453, DOI 10.1067/mcp.2002.127637; Lewis DFV, 1998, XENOBIOTICA, V28, P617, DOI 10.1080/004982598239236; Hichiya H, 2005, DRUG METAB DISPOS, V33, P630, DOI 10.1124/dmd.105.003830; Zhou Q, 2009, PHARMACOGENOMICS J, V9, P380, DOI 10.1038/tpj.2009.31; Furuta T, 1998, ANN INTERN MED, V129, P1027; Ibeanu GC, 1998, J PHARMACOL EXP THER, V286, P1490; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Maeda A, 2011, CLIN PHARMACOL THER, V89, P229, DOI 10.1038/clpt.2010.268; Mao Liu, 2013, Arch Cardiovasc Dis, V106, P517, DOI 10.1016/j.acvd.2013.06.055; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Pan Y, 2013, BIOMED CHROMATOGR, V27, P859, DOI 10.1002/bmc.2872; STRAUB P, 1993, BIOCHEM BIOPH RES CO, V197, P433, DOI 10.1006/bbrc.1993.2498; Wang HJ, 2011, DRUG METAB DISPOS, V39, P830, DOI 10.1124/dmd.110.037549	18	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1470-269X	1473-1150		PHARMACOGENOMICS J	Pharmacogenomics J.	FEB	2015	15	1					26	32		10.1038/tpj.2014.30		7	Genetics & Heredity; Pharmacology & Pharmacy	Genetics & Heredity; Pharmacology & Pharmacy	AZ8IT	WOS:000348459700005		
J	Volz, NB; Stintzing, S; Zhang, W; Yang, D; Ning, Y; Wakatsuki, T; El-Khoueiry, RE; Li, JE; Kardosh, A; Loupakis, F; Cremolini, C; Falcone, A; Scherer, SJ; Lenz, HJ				Volz, N. B.; Stintzing, S.; Zhang, W.; Yang, D.; Ning, Y.; Wakatsuki, T.; El-Khoueiry, R. E.; Li, J. E.; Kardosh, A.; Loupakis, F.; Cremolini, C.; Falcone, A.; Scherer, S. J.; Lenz, H-J			Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer	PHARMACOGENOMICS JOURNAL			English	Article							PROTEIN-KINASE; NORMALIZATION; VASCULATURE; EXPRESSION; THERAPY; RAS; NEOVASCULARIZATION; ANGIOGENESIS; FLUOROURACIL; CHEMOTHERAPY	Pericytes are crucial for angiogenesis. The impact of pericyte function to bevacizumab efficacy in mCRC treatment has not been comprehensively examined. This retrospective study investigated germline polymorphisms in genes related to early pericyte maturation to predict bevacizumab efficacy in 424 patients of two clinical trials treated first line with FOLFIRI+bevacizumab. Eight single-nucleotide polymorphisms (SNPs) were tested for potential biomarker value: RGS5 (regulator of G-protein signaling 5; rs1056515, rs2661280), PDGFR-beta (platelet-derived growth factor receptor-beta; rs2229562, rs2302273), CSPG4 (chondroitin sulfate proteoglycan NG2; rs8023621, rs1127648) and RALBP1 (RalA binding protein 1; rs10989, rs329007). For progression-free survival (PFS), PDGFR-beta (rs2302273) was able to define significantly different patient cohorts in uni- and multivariate testing. RALPB1 (rs329007) showed predictive value for tumor response. The C allele in RGS5 (rs2661280) predicted longer overall survival and CSPG4 rs1127648 was associated with differences in PFS, but for both value was lost when multivariate analysis was applied. A comprehensive statistical analysis revealed that the biomarker value of the SNPs was dependent on primary tumor location. This is the first study to identify pericyte germline polymorphisms associated with clinical outcome in mCRC patients treated first line with FOLFIRI+bevacizumab. The differences seen with regard to primary tumor location may lead to further research to understand the clinical outcome differences seen in right-and left-sided colon cancer.	[Volz, N. B.; Stintzing, S.; Zhang, W.; Ning, Y.; Wakatsuki, T.; El-Khoueiry, R. E.; Li, J. E.; Kardosh, A.; Lenz, H-J] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Sharon Carpenter Lab, Los Angeles, CA 90033 USA; [Yang, D.; Lenz, H-J] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Wakatsuki, T.] Canc Inst Hosp, Dept Gastroenterol Ctr, Tokyo, Japan; [Loupakis, F.; Cremolini, C.; Falcone, A.] Aziendo Osped Univ Pisana, UO Oncol Med 2, Pisa, Italy; [Scherer, S. J.] Univ Wurzburg, Bioctr Physiol Chem, D-97070 Wurzburg, Germany	Lenz, HJ (reprint author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Sharon Carpenter Lab, Room 3456,1441 Eastlake Ave, Los Angeles, CA 90033 USA.	lenz@med.usc.edu	Loupakis, Fotios/I-7243-2012		NIH [5 P30CA14089-27S1]; Nancy Bernstein Call to Cure Foundation; German Cancer Aid (Mildred-Scheel-Foundation)	This study was supported by the NIH Grant 5 P30CA14089-27S1 and Nancy Bernstein Call to Cure Foundation. SS is granted a postdoctoral fellowship by the German Cancer Aid (Mildred-Scheel-Foundation).	Sambi BS, 2006, CELL SIGNAL, V18, P971, DOI 10.1016/j.cellsig.2005.08.003; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Lee S, 2012, CANCER RES, V72, P5165, DOI 10.1158/0008-5472.CAN-12-0468; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Boisen MK, 2013, ANN ONCOL, V24, P2554, DOI 10.1093/annonc/mdt253; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Bocci G, 2011, PHARMACOGENOMICS, V12, P1077, DOI [10.2217/pgs.11.75, 10.2217/PGS.11.75]; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Cancer Genome Atlas Research Network, 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gerger A, 2011, CANCER J, V17, P134, DOI 10.1097/PPO.0b013e318212db3c; Harada K, 2007, BRIT J CANCER, V97, P1425, DOI 10.1038/sj.bjc.6604014; Liu PA, 2011, J IMMUNOTHER, V34, P320, DOI 10.1097/CJI.0b013e318213cd12; Loupakis F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066774; Paez D, 2013, PHARMACOGENOMICS J, V14, P142; Stintzing S, 2013, EXPERT OPIN PHARMACO, V14, P2203, DOI 10.1517/14656566.2013.828694; Therneau TM, INTRO RECURSIVE PART; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	37	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1470-269X	1473-1150		PHARMACOGENOMICS J	Pharmacogenomics J.	FEB	2015	15	1					69	76		10.1038/tpj.2014.40		8	Genetics & Heredity; Pharmacology & Pharmacy	Genetics & Heredity; Pharmacology & Pharmacy	AZ8IT	WOS:000348459700011		
J	Kaneyoshi, T				Kaneyoshi, T.			The possibility of re-entrant phenomena induced by a transverse field in ultra-thin transverse Ising films	PHASE TRANSITIONS			English	Article						transverse Ising model; phase diagram; ultra-thin films; magnetizations	PHASE-DIAGRAMS; DILUTED SURFACES; SITE DILUTION; POINTS; BOND; FERRIMAGNETISM; MODEL	The phase diagrams and temperature dependences of magnetizations in ultra-thin transverse Ising thin films are studied by the use of both the effective-field theory with correlations (EFT) and the mean-field theory (MFA). Novel features, such as the possibility of re-entrant phenomena, are obtained for the magnetic properties in such systems with a zero transverse field at the surfaces, when the EFT is applied to them, although such features could not be found from the use of the MFA. When the transverse field at the surfaces takes a finite value, however, the re-entrant phenomena could not be found from the both formulations of the EFT and the MFA. Similar phenomena are then obtained in the phase diagrams by using the MFA and the EFT.	Nagoya Univ, Nagoya, Aichi 4648601, Japan	Kaneyoshi, T (reprint author), Nagoya Univ, Nagoya, Aichi 4648601, Japan.	kaneyosi@is.nagoya-u.ac.jp					Akinci U, 2013, J MAGN MAGN MATER, V329, P178, DOI 10.1016/j.jmmm.2012.10.034; Kaneyoshi T, 2013, PHYSICA E, V53, P14, DOI 10.1016/j.physe.2013.04.004; Kaneyoshi T, 2014, PHYSICA B, V436, P208, DOI 10.1016/j.physb.2013.12.016; Kaneyoshi T, 2012, PHYSICA B, V407, P4358, DOI 10.1016/j.physb.2012.07.034; Zernike F, 1940, PHYSICA, V7, P565, DOI 10.1016/S0031-8914(40)90008-8; HONMURA R, 1979, J PHYS C SOLID STATE, V12, P3979, DOI 10.1088/0022-3719/12/19/016; Kaneyoshi T, 2013, PHYSICA B, V414, P72, DOI 10.1016/j.physb.2013.01.022; Kaneyoshi T, 2013, PHYSICA B, V408, P126, DOI 10.1016/j.physb.2012.09.046; Kaneyoshi T, 1996, PHYSICA A, V229, P166, DOI 10.1016/0378-4371(96)00012-X; FISHMAN S, 1979, J PHYS C SOLID STATE, V12, pL729, DOI 10.1088/0022-3719/12/18/006; Kaneyoshi T, 2014, PHYSICA E, V59, P50; Kaneyoshi T, 1992, INTRO AMORPHOUS MAGN; KANEYOSHI T, 1993, ACTA PHYS POL A, V83, P703; Kaneyoshi T, 2012, PHASE TRANSIT, V85, P264, DOI 10.1080/01411594.2011.604620; Kaneyoshi T, 2014, PHASE TRANSIT, V87, P603, DOI 10.1080/01411594.2013.876023; Liu ZX, 2010, PHYS SCRIPTA, V81; Moorjani K, 1984, MAGNETIC GLASSES; Oitmaa J, 2003, PHYSICA A, V328, P185, DOI 10.1016/S0378-4371(03)00522-3; Polta DL, 1995, MICROELECTRON ENG, V29, P51, DOI 10.1016/0167-9317(95)00114-X; Scott JF, 2000, FERROELECTRIC MAT; Strecka J, 2012, PHYSICA A, V391, P4763, DOI 10.1016/j.physa.2012.05.011	21	7	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0141-1594	1029-0338		PHASE TRANSIT	Phase Transit.	FEB 1	2015	88	2					121	136		10.1080/01411594.2014.961153		16	Crystallography; Physics, Condensed Matter	Crystallography; Physics	CA1KU	WOS:000348672300002		
J	Ifuku, K; Yan, DY; Miyahara, M; Inoue-Kashino, N; Yamamoto, YY; Kashino, Y				Ifuku, Kentaro; Yan, Dongyi; Miyahara, Mado; Inoue-Kashino, Natsuko; Yamamoto, Yoshiharu Y.; Kashino, Yasuhiro			A stable and efficient nuclear transformation system for the diatom Chaetoceros gracilis	PHOTOSYNTHESIS RESEARCH			English	Article						Chaetoceros gracilis; Diatom; Electroporation; Genetic transformation; Green fluorescent protein; Luciferase	MARINE CENTRIC DIATOM; PHAEODACTYLUM-TRICORNUTUM; PHOTOSYSTEM-II; CYLINDROTHECA-FUSIFORMIS; FLUORESCENT PROTEIN; REPORTER GENES; CELL-WALL; BACILLARIOPHYCEAE; BINDING; PROMOTER	Chaetoceros gracilis belongs to the centric diatoms, and has recently been used in basic research on photosynthesis. In addition, it has been commercially used in fisheries and is also attracting interest as a feedstock for biofuels production and biorefinery. In this study, we developed an efficient genetic transformation system for C. gracilis. The diatom cells were transformed via multi-pulse electroporation using plasmids containing various promoters to drive expression of the nourseothricin acetyltransferase gene (nat) as a selectable marker. The transformation efficiency reached similar to 400 positive transgenic clones per 10(8) recipient cells, which is the first example of successful transformation with electroporation in a centric diatom species. We further produced two expression vectors: the vector pCgLhcr5p contains the light-dependent promoter of a fucoxanthin chlorophyll a/c binding protein gene and the vector pCgNRp contains the inducible promoter of a nitrate reductase gene to drive the expression of introduced genes. In both vectors, an acetyl-CoA acetyltransferase promoter drives nat gene expression for antibiotic selection. Stable integration and expression of reporter genes, such as the firefly luciferase and green fluorescent protein Azami-Green genes, were observed in transformed C. gracilis cells. This efficient and stable transformation system for C. gracilis will enable both functional analysis of diatom-specific genes and strain improvement for further biotechnological applications.	[Ifuku, Kentaro; Yan, Dongyi; Miyahara, Mado] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Inoue-Kashino, Natsuko; Kashino, Yasuhiro] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Yamamoto, Yoshiharu Y.] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Ifuku, K (reprint author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan.	ifuku@kais.kyoto-u.ac.jp	Yamamoto, Yoshiharu Y./B-6574-2011	Yamamoto, Yoshiharu Y./0000-0002-9667-0572	Japan Science and Technology Agency, Advanced Low Carbon Technology Research and Development Program	We thank Dr. N. Poulsen and Dr. N. Kroger at the Technical University of Dresden, Germany, for the gift of the vectors pTpNR-GFP/fcpNat, and Dr. J. Hotta, Yamagata Univ. for his help in microscopic analysis of the diatoms. We also appreciate the excellent technical assistance of Ms. N. Inui. This work was supported by the Japan Science and Technology Agency, Advanced Low Carbon Technology Research and Development Program (to K. I., Y. Y., and Y. K.).	Miyahara M, 2013, BIOSCI BIOTECH BIOCH, V77, P874, DOI 10.1271/bbb.120936; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; Ikeda Y, 2008, BBA-BIOENERGETICS, V1777, P351, DOI 10.1016/j.bbabio.2008.01.011; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; BHAYA D, 1993, NUCLEIC ACIDS RES, V21, P4458; Miyagawa A, 2009, PHYCOL RES, V57, P142, DOI 10.1111/j.1440-1835.2009.00531.x; Nagao R, 2010, J BIOL CHEM, V285, P29191, DOI 10.1074/jbc.M110.146092; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Wang Y, 2013, APPL MICROBIOL BIOT, V97, P453, DOI 10.1007/s00253-012-4568-0; Dunahay TG, 1995, J PHYCOL, V31, P1004, DOI 10.1111/j.0022-3646.1995.01004.x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Prihoda J, 2012, J EXP BOT, V63, P1543, DOI 10.1093/jxb/err441; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Ramachandra TV, 2009, IND ENG CHEM RES, V48, P8769, DOI 10.1021/ie900044j; Levitan O, 2014, TRENDS BIOTECHNOL, V32, P117, DOI 10.1016/j.tibtech.2014.01.004; Nagao R, 2007, BBA-BIOENERGETICS, V1767, P1353, DOI 10.1016/j.bbabio.2007.10.007; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Fischer H, 1999, J PHYCOL, V35, P113, DOI 10.1046/j.1529-8817.1999.3510113.x; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Araujo GS, 2011, BIORESOURCE TECHNOL, V102, P5248, DOI 10.1016/j.biortech.2011.01.089; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Hasle G. R., 1997, IDENTIFYING MARINE P, V39, P5; Miyagawa-Yamaguchi A, 2011, PHYCOL RES, V59, P113, DOI 10.1111/j.1440-1835.2011.00607.x; Nagao R, 2014, J PHYS CHEM B, V118, P5093, DOI 10.1021/jp502035y; Niu YF, 2012, BIOTECHNIQUES, V1-3, DOI [10.2144/000113881, DOI 10.2144/000113881]; RUSHFORTH SR, 1986, J PHYCOL, V22, P441, DOI 10.1111/j.1529-8817.1986.tb02487.x; Zhang C, 2013, MAR GENOM, V16, P63	35	5	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0166-8595	1573-5079		PHOTOSYNTH RES	Photosynth. Res.	FEB	2015	123	2					203	211		10.1007/s11120-014-0048-y		9	Plant Sciences	Plant Sciences	AZ7DM	WOS:000348378700008		
J	Wen, ZG; Murata, MS; Xu, ZY; Chen, YH; Nara, K				Wen, Zhugui; Murata, Masao; Xu, Zhangyang; Chen, Yahua; Nara, Kazuhide			Ectomycorrhizal fungal communities on the endangered Chinese Douglas-fir (Pseudotsuga sinensis) indicating regional fungal sharing overrides host conservatism across geographical regions	PLANT AND SOIL			English	Article						Ectomycorrhizal fungi; Pseudotsuga sinensis; Endangered species; Biogeography; Host effect	PINUS-MURICATA; RESISTANT PROPAGULES; PRIMARY SUCCESSION; MOUNT FUJI; DIVERSITY; GRADIENT; PATTERNS; FORESTS; SEEDLINGS; AVAILABILITY	Ectomycorrhizal (ECM) fungal communities are affected by many abiotic and biotic factors, among which host identity is often regarded as the most significant. Although little about ECM fungal communities on endangered tree species is known, knowledge of their ECM associations could be a key to conservation given the functional importance of the symbiosis. We collected 73 soil samples from three relict forests dominated by endangered Chinese Douglas-fir (Pseudotsuga sinensis). Identity of fungal and host species in individual ECM tips was determined by morphotyping and DNA analyses. Of the 86 ECM fungal species identified, 66 were observed on Chinese Douglas-firs. While the fungal composition did not significantly differ between coexisting trees (p = 0.843), the composition was significantly separated based on location (p = 0.021). Moreover, the observed ECM fungal communities were dissimilar to those on the Japanese Douglas-fir (p = 0.001), which is monophyletic to Chinese Douglas-fir. Our results indicate that ECM fungal communities are determined more by geographical location than host monophyly on this spatial (c.770-1,600 km) and geological time scale ( c. 20-25 My). For conservation of endangered trees, it may be important to preserve local ECM fungal pools, irrespective of host species.	[Wen, Zhugui; Xu, Zhangyang; Chen, Yahua] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [Wen, Zhugui; Murata, Masao; Nara, Kazuhide] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan	Chen, YH (reprint author), Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China.	yahuachen@njau.edu.cn; nara@k.u-tokyo.ac.jp			China Scholarship Council; Japan Society for the Promotion of Science KAKENHI [25257411, 25660115, 25304026]; National Natural Science Foundation of China-Guangdong Province Natural Science Foundation [U1133004]	This research was funded by an award from the China Scholarship Council to ZW, by Japan Society for the Promotion of Science KAKENHI Grants to KN (25257411, 25660115, 25304026), and by an award from the National Natural Science Foundation of China-Guangdong Province Natural Science Foundation Joint Research Fund to YC (U1133004). We also thank Liang Shi, Haolin Zhu, and Qizhi Zha for their support in field sampling.	Huang J, 2014, FUNGAL ECOL, V9, P1, DOI 10.1016/j.funeco.2014.01.001; Horton TR, 2005, MYCORRHIZA, V15, P393, DOI 10.1007/s00572-004-0339-9; Peay KG, 2009, J ECOL, V97, P537, DOI 10.1111/j.1365-2745.2009.01489.x; Cox F, 2010, ECOL LETT, V13, P1103, DOI 10.1111/j.1461-0248.2010.01494.x; Nara K, 2006, NEW PHYTOL, V169, P169, DOI 10.1111/j.1469-8137.2005.01545.x; Taylor DL, 1999, MOL ECOL, V8, P1837, DOI 10.1046/j.1365-294x.1999.00773.x; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Koide RT, 2014, NEW PHYTOL, V201, P433, DOI 10.1111/nph.12538; Roy M, 2013, NEW PHYTOL, V198, P1228, DOI 10.1111/nph.12212; Kretzer A, 1996, MYCOLOGIA, V88, P776, DOI 10.2307/3760972; Twieg BD, 2007, NEW PHYTOL, V176, P437, DOI 10.1111/j.1469-8137.2007.02173.x; Tedersoo L, 2007, NEW PHYTOL, V175, P321, DOI 10.1111/j.1469-8137.2007.02104.x; Velmala SM, 2013, MYCORRHIZA, V23, P21, DOI 10.1007/s00572-012-0446-y; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Izzo A, 2006, MYCOL RES, V110, P196, DOI 10.1016/j.mycres.2005.08.010; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Wei XX, 2010, MOL PHYLOGENET EVOL, V55, P776, DOI 10.1016/j.ympev.2010.03.007; Jarvis S, 2013, GLOBAL CHANGE BIOL, V19, P1688, DOI 10.1111/gcb.12178; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; Cline ET, 2005, NEW PHYTOL, V166, P993, DOI 10.1111/j.1469-8137.2005.01387.x; Murata M, 2013, MYCORRHIZA, V23, P641, DOI 10.1007/s00572-013-0504-0; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Hobbie EA, 2006, ECOLOGY, V87, P563, DOI 10.1890/05-0755; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.2307/2680124; Hiramatsu M, 2001, AM J BOT, V88, P1230, DOI 10.2307/3558334; Kinoshita A, 2012, FUNGAL BIOL-UK, V116, P1250, DOI 10.1016/j.funbio.2012.09.006; Nara K, 2003, NEW PHYTOL, V159, P743, DOI 10.1046/j.1469-8137.2003.00844.x; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Eckenwalder JE, 2009, CONIFERS WORLD; ERLAND S, 1992, MYCOL RES, V96, P270; Farjon A, 1990, PINACEAE DRAWINGS DE; Fu LK, 1999, PSEUDOTSUGA, V4, P33; Guo Wei, 2007, Journal of Plant Resources and Environment, V16, P46; Horton TR, 1998, NEW PHYTOL, V139, P331, DOI 10.1046/j.1469-8137.1998.00185.x; Hotta M, 1974, EVOLUTIONARY BIOL PL; Jin J. M., 1992, CHINA PLANT RED DATA, V1; Kasai S, 2009, CHUBU FOR RES, V57, P55; Lande, 1993, AM NAT, V142, P911; Luoma DL, 2006, CAN J FOREST RES, V36, P2561, DOI 10.1139/X06-143; MacArthur RH, 1967, THEORY ISLAND BIOGEO; McCune B., 2011, PC ORD MULTIVARIATE; Mikola P, 1973, ECTOMYCORRHIZAE THEI, P383; Miyamoto Y, 2014, ISME J, V8, P1739, DOI 10.1038/ismej.2014.34; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Ono M, 1989, VEGETATION JAPAN, V10, P127; Polme S, 2013, NEW PHYTOL, V198, P1239, DOI 10.1111/nph.12170; Rineau F, 2011, ANN FOREST SCI, V68, P69, DOI 10.1007/s13595-010-0008-4; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Smith ME, 2009, NEW PHYTOL, V182, P295, DOI 10.1111/j.1469-8137.2009.02801.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; STRAUSS SH, 1990, CAN J BOT, V68, P1502; Tedersoo L, 2010, NEW PHYTOL, V185, P351, DOI 10.1111/j.1469-8137.2009.03134.x; Wu Z, 1999, FLORA CHINA, V4	61	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	FEB	2015	387	1-2					189	199		10.1007/s11104-014-2278-3		11	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	AZ6GT	WOS:000348318100014		
J	Ohashi, M; Kume, T; Yoshifuji, N; Kho, LK; Nakagawa, M; Nakashizuka, T				Ohashi, Mizue; Kume, Tomonori; Yoshifuji, Natsuko; Kho, Lip Khoon; Nakagawa, Michiko; Nakashizuka, Tohru			The effects of an induced short-term drought period on the spatial variations in soil respiration measured around emergent trees in a typical bornean tropical forest, Malaysia	PLANT AND SOIL			English	Article						Drought treatment; Emergent tree; Soil CO2 efflux; Short-term monitoring; Tropical forest	AMAZONIAN RAIN-FOREST; CO2 EFFLUX; CARBON-DIOXIDE; TEMPORAL VARIATION; NITROUS-OXIDE; NITRIC-OXIDE; EL-NINO; EMISSIONS; ECOSYSTEMS; INDONESIA	Our previous studies documented how soil CO2 efflux, one of the main carbon pathways in forest ecosystems, is affected by soil moisture and forest structure in an aseasonal tropical rainforest in Borneo, Malaysia. In this study, we clarify the effect of short-term drought treatment on the spatial variation of soil CO2 efflux in a forest, and to interpret the changes in soil CO2 efflux caused by root activities. Experimental plots (15 m radius) were established around six emergent trees and a drought treatment was conducted for three of the six plots. Soil CO2 efflux was measured along with environmental factors and root biomass, respiration and production in each plot. Soil CO2 efflux at 0.5 m of the emergent trees was nearly three times higher than at 5 and 10 m away from the trees. Root respiration and biomass had no correlation with the spatial variation. Soil water content decreased by nearly 30 % during the drought treatment, although soil CO2 efflux was unchanged between drought and control plots. Our result suggests a strong spatial variation exists in soil CO2 efflux around emergent trees, but short-term severe drought has little effect on it.	[Ohashi, Mizue] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan; [Kume, Tomonori] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10617, Taiwan; [Yoshifuji, Natsuko] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Kho, Lip Khoon] Malaysian Palm Oil Board, Trop Peat Res Inst, Kajang 43000, Selangor, Malaysia; [Nakagawa, Michiko] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nakashizuka, Tohru] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Ohashi, M (reprint author), Univ Hyogo, Sch Human Sci & Environm, 1-1-12 Shinzaike Honcho, Himeji, Hyogo 6700092, Japan.	ohashi@shse.u-hyogo.ac.jp; kumett@ntu.edu.tw; natsuko@kais.kyoto-u.ac.jp; lip.khoon@mpob.gov.my; miko@agr.nagoya-u.ac.jp; toron@m.tohoku.ac.jp			Shikata Memorial Research Grant for the Protection of Global Environment [19,255,006]; CREST program of the Japanese Science and Technology Agency	We thank the staff of the Sarawak Forestry Corporation and the Sarawak Forest Department for help in conducting research at Lambir Hills National Park; S. Sakai, T. Kumagai, T. Ichie, and other researchers who conducted studies at the same site for their assistance in conducting the drought treatment; L. Finer and Y. Kim for field assistance with the root production experiment; M Suzuki for support in obtaining the grant; and H Sakata for comments on the statistical analysis. A Grant-in-Aid for Scientific Research (A) (19,255,006), a Shikata Memorial Research Grant for the Protection of Global Environment in 2008-2009, and the CREST program of the Japanese Science and Technology Agency supported this research.	ABE T, 1979, Japanese Journal of Ecology, V29, P337; Adachi M, 2006, APPL SOIL ECOL, V34, P258, DOI 10.1016/j.apsoil.2006.01.006; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Schwendenmann L, 2003, BIOGEOCHEMISTRY, V64, P111, DOI 10.1023/A:1024941614919; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P2582, DOI 10.1111/j.1365-2486.2008.01694.x; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Kosugi Y, 2007, AGR FOREST METEOROL, V147, P35, DOI 10.1016/j.agrformet.2007.06.005; Malhi Y, 2004, PHILOS T ROY SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Ishizuka S, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001614; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Lukac M, 2010, PLANT SOIL, V331, P505, DOI 10.1007/s11104-009-0271-z; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; Ohashi M, 2008, BIOGEOCHEMISTRY, V90, P275, DOI 10.1007/s10533-008-9253-0; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Sotta ED, 2007, GLOBAL CHANGE BIOL, V13, P2218, DOI 10.1111/j.1365-2486.2007.01416.x; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Timmermann A, 1999, NATURE, V398, P694; Hertel D, 2009, FOREST ECOL MANAG, V258, P1904, DOI 10.1016/j.foreco.2009.07.019; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; Sotta ED, 2006, FOREST ECOL MANAG, V237, P57, DOI 10.1016/j.foreco.2006.09.027; Ashton PS, 2005, ECOL STU AN, V174, P191; Barnes B.V., 1980, FOREST ECOLOGY, V4th; Brechet L, 2011, PLANT SOIL, V347, P293, DOI 10.1007/s11104-011-0848-1; Hirano Y., 2009, Plant Root, V3, P26, DOI 10.3117/plantroot.3.26; Ishizuka S, 1998, TROPICS, V8, P31; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Katayama A, 2013, J PLANT RES, V126, P505, DOI 10.1007/s10265-012-0544-0; Kumagai T, 2012, PLANT CELL ENVIRON, V35, P61, DOI 10.1111/j.1365-3040.2011.02428.x; Kumagai T, 2004, J HYDROL, V287, P237, DOI 10.1016/j.jhydrol.2003.10.002; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Kutsch WL, 2010, SOIL CARBON DYNAMICS; Luo Y., 2006, SOIL RESP ENV; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Nakagawa M, 2012, BIOTROPICA, V44, P715, DOI 10.1111/j.1744-7429.2012.00907.x; Ohashi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029587; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1046/j.1095-8312.2002.00016.x; Song QH, 2013, IFOREST, V6, P65, DOI 10.3832/ifor0681-006; van Straaten O, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00079.1; van Straaten O, 2010, BIOGEOSCIENCES, V7, P1223; Wood TE, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB004014	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	FEB	2015	387	1-2					337	349		10.1007/s11104-014-2303-6		13	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	AZ6GT	WOS:000348318100024		
J	Bohner, A; Kojima, S; Hajirezaei, M; Melzer, M; von Wiren, N				Bohner, Anne; Kojima, Soichi; Hajirezaei, Mohammad; Melzer, Michael; von Wiren, Nicolaus			Urea retranslocation from senescing Arabidopsis leaves is promoted by DUR3-mediated urea retrieval from leaf apoplast	PLANT JOURNAL			English	Article						leaf senescence; urea uptake; urease; phloem transport; nitrogen efficiency; urea metabolism	PLASMA-MEMBRANE; NITROGEN; TRANSPORT; THALIANA; PROTEINS; PLANTS; IDENTIFICATION; REMOBILIZATION; CHLOROPLASTS; ASSIMILATION	In plants, urea derives either from root uptake or protein degradation. Although large quantities of urea are released during senescence, urea is mainly seen as a short-lived nitrogen (N) catabolite serving urease-mediated hydrolysis to ammonium. Here, we investigated the roles of DUR3 and of urea in N remobilization. During natural leaf senescence urea concentrations and DUR3 transcript levels showed a parallel increase with senescence markers like ORE1 in a plant age- and leaf age-dependent manner. Deletion of DUR3 decreased urea accumulation in leaves, whereas the fraction of urea lost to the leaf apoplast was enhanced. Under natural and N deficiency-induced senescence DUR3 promoter activity was highest in the vasculature, but was also found in surrounding bundle sheath and mesophyll cells. An analysis of petiole exudates from wild-type leaves revealed that N from urea accounted for >13% of amino acid N. Urea export from senescent leaves further increased in ureG-2 deletion mutants lacking urease activity. In the dur3ureG double insertion line the absence of DUR3 reduced urea export from leaf petioles. These results indicate that urea can serve as an early metabolic marker for leaf senescence, and that DUR3-mediated urea retrieval contributes to the retranslocation of N from urea during leaf senescence.	[Bohner, Anne; Hajirezaei, Mohammad; Melzer, Michael; von Wiren, Nicolaus] Leibniz Inst Plant Genet & Crop Plant Res, Dept Physiol & Cell Biol, D-06466 Gatersleben, Germany; [Kojima, Soichi] Tohoku Univ, Dept Appl Plant Sci, Sendai, Miyagi 9818555, Japan	von Wiren, N (reprint author), Leibniz Inst Plant Genet & Crop Plant Res, Dept Physiol & Cell Biol, Corrensstr 3, D-06466 Gatersleben, Germany.	vonwiren@ipk-gatersleben.de			Deutsche Forschungsgemeinschaft, Bonn, Germany in frame of the DFG Research Unit FOR948 [WI1728/14]	We thank Bernhard Bauer, Lisa Unrath, Barbara Kettig, Heike Nierig, Susanne Reiner and Twan Rutten (IPK Gatersleben) for excellent technical assistance, Anja Hartmann (IPK Gatersleben) for support in data analysis, and Claus-Peter Witte (Dahlem Center of Plant Sciences, FU Berlin) for providing ureG-2 seeds. We thank the Deutsche Forschungsgemeinschaft, Bonn, Germany, for financial support in frame of the DFG Research Unit FOR948 (WI1728/14).	Soto G, 2010, PLANT J, V64, P1038, DOI 10.1111/j.1365-313X.2010.04395.x; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Witte CP, 2011, PLANT SCI, V180, P431, DOI 10.1016/j.plantsci.2010.11.010; Kojima S, 2006, J MEMBRANE BIOL, V212, P83, DOI 10.1007/s00232-006-0868-6; Lohaus G, 2001, PHYSIOL PLANTARUM, V111, P457, DOI 10.1034/j.1399-3054.2001.1110405.x; Kojima S, 2007, PLANT J, V52, P30, DOI 10.1111/j.1365-313X.2007.03223.x; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Merigout P, 2008, PLANT PHYSIOL, V147, P1225, DOI 10.1104/pp.108.119339; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Gerbeau P, 1999, PLANT J, V18, P577, DOI 10.1046/j.1365-313x.1999.00481.x; Goldraij A, 1999, PLANT PHYSIOL, V119, P297, DOI 10.1104/pp.119.1.297; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Eckert M, 1999, J EXP BOT, V50, P1541, DOI 10.1093/jexbot/50.339.1541; Witte CP, 2005, PLANT PHYSIOL, V139, P1155, DOI 10.1104/pp.105.070292; ZONIA LE, 1995, PLANT PHYSIOL, V107, P1097, DOI 10.1104/pp.107.4.1097; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Liu LH, 2003, PLANT CELL, V15, P790, DOI 10.1105/tpc.007120; Corbesier L, 2001, PLANT CELL ENVIRON, V24, P367, DOI 10.1046/j.1365-3040.2001.00683.x; Wang WH, 2012, NEW PHYTOL, V193, P432, DOI 10.1111/j.1469-8137.2011.03929.x; Cao FQ, 2010, PLANT PHYSIOL, V154, P98, DOI 10.1104/pp.110.160929; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; FAYE L, 1986, PLANTA, V168, P579, DOI 10.1007/BF00392279; HOLLAND MA, 1992, PLANT PHYSIOL, V98, P942, DOI 10.1104/pp.98.3.942; Kokubun N, 2002, PLANT CELL PHYSIOL, V43, P1390, DOI 10.1093/pcp/pcf159; Loque D, 2006, PLANT J, V48, P522, DOI 10.1111/j.1365-313X.2006.02887.x; Masclaux-Daubresse C, 2006, PLANT PHYSIOL, V140, P444, DOI 10.1104/pp.105.071910; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Nielsen KH, 1998, PLANT PHYSIOL, V118, P1361, DOI 10.1104/pp.118.4.1361; Pearson JN, 2002, PLANT MOL BIOL, V49, P483, DOI 10.1023/A:1015549115471; Teige M, 1998, EUR J BIOCHEM, V252, P237, DOI 10.1046/j.1432-1327.1998.2520237.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhang LZ, 2010, PLANT CELL, V22, P3603, DOI 10.1105/tpc.110.073833	32	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	FEB	2015	81	3					377	387		10.1111/tpj.12740		11	Plant Sciences	Plant Sciences	AZ9AC	WOS:000348502500002		
J	Wada, Y; Kusano, H; Tsuge, T; Aoyama, T				Wada, Yukika; Kusano, Hiroaki; Tsuge, Tomohiko; Aoyama, Takashi			Phosphatidylinositol phosphate 5-kinase genes respond to phosphate deficiency for root hair elongation in Arabidopsis thaliana	PLANT JOURNAL			English	Article						phosphate deficiency; root hair elongation; transcriptional regulation; phosphatidylinositol phosphate 5-kinase; cis-element	LOW PHOSPHORUS AVAILABILITY; POLLEN-TUBE GROWTH; SYSTEM ARCHITECTURE; PLASMA-MEMBRANE; LUPINUS-ALBUS; TIP GROWTH; STARVATION; PLANTS; EXPRESSION; ADAPTATION	Plants drastically alter their root system architecture to adapt to different underground growth conditions. During phosphate (Pi) deficiency, most plants including Arabidopsis thaliana enhance the development of lateral roots and root hairs, resulting in bushy and hairy roots. To elucidate the signal pathway specific for the root hair elongation response to Pi deficiency, we investigated the expression of type-B phosphatidylinositol phosphate 5-kinase (PIP5K) genes, as a quantitative factor for root hair elongation in Arabidopsis. At young seedling stages, the PIP5K3 and PIP5K4 genes responded to Pi deficiency in steady-state transcript levels via PHR1-binding sequences (P1BSs) in their upstream regions. Both pip5k3 and pip5k4 single mutants, which exhibit short-root-hair phenotypes, remained responsive to Pi deficiency for root hair elongation; however the pip5k3pip5k4 double mutant exhibited shorter root hairs than the single mutants, and lost responsiveness to Pi deficiency at young seedling stages. In the tactical complementation line in which modified PIP5K3 and PIP5K4 genes with base substitutions in their P1BSs were co-introduced into the double mutant, root hairs of young seedlings had normal lengths under Pi-sufficient conditions, but were not responsive to Pi deficiency. From these results, we conclude that a Pi-deficiency signal is transferred to the pathway for root hair elongation via the PIP5K genes.	[Wada, Yukika; Tsuge, Tomohiko; Aoyama, Takashi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Kusano, Hiroaki] Tokyo Univ Sci, Dept Technol & Sci, Katsushika Ku, Tokyo 2788510, Japan	Aoyama, T (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	aoyama@scl.kyoto-u.ac.jp			Japanese Society of Promotion of Science (JSPS); JSPS [16370023]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [18056012]	We thank K. Yasuda for technical assistance. This work was supported by the Japanese Society of Promotion of Science (JSPS) (Research Fellowships for Young Scientists) to Y.W. and by JSPS (Grants-in-Aid for Scientific Research-B; 16370023) and the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Grants-in-Aid for Scientific Research on Priority Areas; 18056012) to T.A.	Al-Ghazi Y, 2003, PLANT CELL ENVIRON, V26, P1053, DOI 10.1046/j.1365-3040.2003.01030.x; Kusano H, 2008, PLANT CELL, V20, P367, DOI 10.1105/tpc.107.056119; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Munnik T, 2011, CURR OPIN PLANT BIOL, V14, P489, DOI 10.1016/j.pbi.2011.06.007; Kato M, 2013, PLANT J, V74, P690, DOI 10.1111/tpj.12155; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Taniguchi YY, 2010, PLANTA, V231, P491, DOI 10.1007/s00425-009-1052-x; Datta S, 2011, PLANT SOIL, V346, P1, DOI 10.1007/s11104-011-0845-4; Stenzel I, 2008, PLANT CELL, V20, P124, DOI 10.1105/tpc.107.052852; Boss WF, 2012, ANNU REV PLANT BIOL, V63, P409, DOI 10.1146/annurev-arplant-042110-103840; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; FRANCIS R, 1994, PLANT SOIL, V159, P11; Gonzalez-Mendoza V, 2013, PLANT SCI, V205, P2, DOI 10.1016/j.plantsci.2012.12.015; Linkohr BI, 2002, PLANT J, V29, P751, DOI 10.1046/j.1365-313X.2002.01251.x; Miura K, 2011, PLANT PHYSIOL, V155, P1000, DOI 10.1104/pp.110.165191; Ticconi CA, 2004, PLANT J, V37, P801, DOI 10.1111/j.1365-313X.2003.02005.x; Smith LG, 2005, ANNU REV CELL DEV BI, V21, P271, DOI 10.1146/annurev.cellbio.21.122303.114901; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp010934; Puga MI, 2014, P NATL ACAD SCI USA, V111, P14947, DOI 10.1073/pnas.1404654111; Desnos T, 2008, CURR OPIN PLANT BIOL, V11, P82, DOI 10.1016/j.pbi.2007.10.003; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Nacry P, 2005, PLANT PHYSIOL, V138, P2061, DOI 10.1104/pp.105.060061; Doerner P, 2008, CURR OPIN PLANT BIOL, V11, P536, DOI 10.1016/j.pbi.2008.05.006; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Johnson JF, 1996, PLANT PHYSIOL, V112, P31, DOI 10.1104/pp.112.1.31; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Rouached H, 2010, MOL PLANT, V3, P288, DOI 10.1093/mp/ssp120; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Abel S, 2011, CURR OPIN PLANT BIOL, V14, P303, DOI 10.1016/j.pbi.2011.04.007; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Ischebeck T, 2010, PROTOPLASMA, V240, P13, DOI 10.1007/s00709-009-0093-0; Grebe M, 2012, CURR OPIN PLANT BIOL, V15, P31, DOI 10.1016/j.pbi.2011.10.010; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Niu YF, 2013, ANN BOT-LONDON, V112, P391, DOI 10.1093/aob/mcs285; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Tominaga-Wada R, 2011, INT REV CEL MOL BIO, V286, P67, DOI 10.1016/B978-0-12-385859-7.00002-1; Chevalier F, 2003, PLANT CELL ENVIRON, V26, P1839, DOI 10.1046/j.1365-3040.2003.01100.x; Mollier A, 1999, J EXP BOT, V50, P487, DOI 10.1093/jexbot/50.333.487; Zhang YJ, 2003, J EXP BOT, V54, P2351, DOI 10.1093/jxb/erg250; Ischebeck T, 2008, PLANT CELL, V20, P3312, DOI 10.1105/tpc.108.059568; Gu FW, 2013, J INTEGR PLANT BIOL, V55, P835, DOI 10.1111/jipb.12077; Kirk GJD, 1997, NEW PHYTOL, V135, P191, DOI 10.1046/j.1469-8137.1997.00640.x; Xue HW, 2009, BIOCHEM J, V421, P145, DOI 10.1042/BJ20090300; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.050078102; LYNCH J, 1995, PLANT PHYSIOL, V109, P7; Osmont KS, 2007, ANNU REV PLANT BIOL, V58, P93, DOI 10.1146/annurev.arplant.58.032806.104006; Sanchez-Calderon L, 2006, PLANT PHYSIOL, V140, P879, DOI 10.1104/pp.105.073825; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Mayinger P, 2012, BBA-MOL CELL BIOL L, V1821, P1104, DOI 10.1016/j.bbalip.2012.01.002; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Lei MG, 2011, NEW PHYTOL, V189, P1084, DOI 10.1111/j.1469-8137.2010.03555.x; Chandrika NNP, 2013, NEW PHYTOL, V198, P709, DOI 10.1111/nph.12194; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Braun M, 1999, PLANTA, V209, P435, DOI 10.1007/s004250050746; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Kim DW, 2006, PLANT CELL, V18, P2958, DOI 10.1105/tpc.106.045229; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; BUSTOS R, 2010, PLOS GENET, V6, P1; Cárdenas Luis, 2009, Plant Signal Behav, V4, P4; DisPaolo G., 2004, NATURE, V431, P415; He ZX, 2005, ANN BOT-LONDON, V95, P287, DOI 10.1093/aob/mci024; Heilmann M, 2013, PLANT BIOLOGY, V15, P789, DOI 10.1111/plb.12025; Keerthisinghe G, 1998, PLANT CELL ENVIRON, V21, P467, DOI 10.1046/j.1365-3040.1998.00300.x; Lee Y, 2007, PLANT J, V52, P803, DOI 10.1111/j.1365-313X.2007.03277.x; Li ZX, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-89; Lin Qing, 2012, J Integr Plant Biol, V54, P729, DOI 10.1111/j.1744-7909.2012.01159.x; Liu H, 2009, J INTEGR PLANT BIOL, V51, P382, DOI 10.1111/j.1744-7909.2009.00819.x; Peret B, 2014, PLANT PHYSIOL, V166, P1713, DOI 10.1104/pp.114.244541; Saavedra Laura, 2012, Plant Signal Behav, V7, P1302, DOI 10.4161/psb.21547; Shimizu A, 2004, THEOR APPL GENET, V109, P1361, DOI 10.1007/s00122-004-1751-4; vansLeeuwen W., 2007, PLANT J, V52, P1014; Yi K., 2010, NAT GENET, V42, P1	87	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	FEB	2015	81	3					426	437		10.1111/tpj.12741		12	Plant Sciences	Plant Sciences	AZ9AC	WOS:000348502500006		
J	Kidokoro, S; Watanabe, K; Ohori, T; Moriwaki, T; Maruyama, K; Mizoi, J; Htwe, NMPS; Fujita, Y; Sekita, S; Shinozaki, K; Yamaguchi-Shinozaki, K				Kidokoro, Satoshi; Watanabe, Keitaro; Ohori, Teppei; Moriwaki, Takashi; Maruyama, Kyonoshin; Mizoi, Junya; Htwe, Nang Myint Phyu Sin; Fujita, Yasunari; Sekita, Sachiko; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Soybean DREB1/CBF-type transcription factors function in heat and drought as well as cold stress-responsive gene expression	PLANT JOURNAL			English	Article						soybean; abiotic stress; DREB1; CBF-type transcription factors; downstream genes; PYL family gene; translation-related genes	SIGNAL-TRANSDUCTION PATHWAY; 2C PROTEIN PHOSPHATASES; LOW-TEMPERATURE; FREEZING TOLERANCE; MESOPHYLL PROTOPLASTS; ARABIDOPSIS-THALIANA; PLANT DROUGHT; DEHYDRATION; ELEMENT; IDENTIFICATION	Soybean (Glycine max) is a globally important crop, and its growth and yield are severely reduced by abiotic stresses, such as drought, heat, and cold. The cis-acting element DRE (dehydration-responsive element)/CRT plays an important role in activating gene expression in response to these stresses. The Arabidopsis DREB1/CBF genes that encode DRE-binding proteins function as transcriptional activators in the cold stress responsive gene expression. In this study, we identified 14 DREB1-type transcription factors (GmDREB1s) from a soybean genome database. The expression of most GmDREB1 genes in soybean was strongly induced by a variety of abiotic stresses, such as cold, drought, high salt, and heat. The GmDREB1 proteins activated transcription via DREs (dehydration-responsive element) in Arabidopsis and soybean protoplasts. Transcriptome analyses using transgenic Arabidopsis plants overexpressing GmDREB1s indicated that many of the downstream genes are cold-inducible and overlap with those of Arabidopsis DREB1A. We then comprehensively analyzed the downstream genes of GmDREB1B;1, which is closely related to DREB1A, using a transient expression system in soybean protoplasts. The expression of numerous genes induced by various abiotic stresses were increased by overexpressing GmDREB1B;1 in soybean, and DREs were the most conserved element in the promoters of these genes. The downstream genes of GmDREB1B;1 included numerous soybean-specific stress-inducible genes that encode an ABA receptor family protein, GmPYL21, and translation-related genes, such as ribosomal proteins. We confirmed that GmDREB1B;1 directly activates GmPYL21 expression and enhances ABRE-mediated gene expression in an ABA-independent manner. These results suggest that GmDREB1 proteins activate the expression of numerous soybean-specific stress-responsive genes under diverse abiotic stress conditions.	[Kidokoro, Satoshi; Watanabe, Keitaro; Ohori, Teppei; Moriwaki, Takashi; Mizoi, Junya; Sekita, Sachiko; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, Tokyo 1138657, Japan; [Maruyama, Kyonoshin; Htwe, Nang Myint Phyu Sin; Fujita, Yasunari] JIRCAS, Biol Resources Post Harvest Div, Tsukuba, Ibaraki 3058686, Japan; [Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	Yamaguchi-Shinozaki, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Maruyama, Kyonoshin/I-9191-2012; Yamaguchi-Shinozaki, Kazuko/K-9004-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [22119004, 25251031]; Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) of the Japan Science and Technology Agency/Japan International Cooperation Agency	We thank Y. Tanaka, S. Murasaki, and A. Watanabe for providing excellent technical assistance and E. Toma for skillful editorial assistance. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (no. 22119004 and no. 25251031) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan, and the Science and Technology Research Partnership for Sustainable Development (SATREPS) of the Japan Science and Technology Agency/Japan International Cooperation Agency (to K.Y.-S.).	Choi DW, 2002, PLANT PHYSIOL, V129, P1781, DOI 10.1104/pp.003046; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.2307/3870648; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.127.3.910; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; LIN W, 1983, PLANT PHYSIOL, V73, P1067, DOI 10.1104/pp.73.4.1067; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Peng YL, 2013, AQUAT TOXICOL, V140, P68, DOI 10.1016/j.aquatox.2013.05.014; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Tanaka H, 2012, PLANT J, V70, P599, DOI 10.1111/j.1365-313X.2012.04901.x; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Shinwari ZK, 1998, BIOCHEM BIOPH RES CO, V250, P161, DOI 10.1006/bbrc.1998.9267; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Bai G, 2013, PLANT MOL BIOL, V83, P651, DOI 10.1007/s11103-013-0114-4; Hruz T, 2008, ADV BIOINFORMATICS, V2008, DOI [10.1155/2008/420747, DOI 10.1155/2008/420747]; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444	52	8	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	FEB	2015	81	3					505	518		10.1111/tpj.12746		14	Plant Sciences	Plant Sciences	AZ9AC	WOS:000348502500012		
J	Aguilar-Martinez, JA; Uchida, N; Townsley, B; West, DA; Yanez, A; Lynn, N; Kimura, S; Sinha, N				Aguilar-Martinez, Jose Antonio; Uchida, Naoyuki; Townsley, Brad; West, Donnelly Ann; Yanez, Andrea; Lynn, Nafeesa; Kimura, Seisuke; Sinha, Neelima			Transcriptional, Posttranscriptional, and Posttranslational Regulation of SHOOT MERISTEMLESS Gene Expression in Arabidopsis Determines Gene Function in the Shoot Apex	PLANT PHYSIOLOGY			English	Article							KNOTTED1-LIKE HOMEOBOX GENE; CUP-SHAPED-COTYLEDON; STEM-CELL NICHES; APICAL MERISTEM; HOMEODOMAIN PROTEINS; KNOX GENE; LEAF DEVELOPMENT; MESSENGER-RNA; COMPOUND LEAF; SIGNAL-TRANSDUCTION	The activity of SHOOTMERISTEMLESS (STM) is required for the functioning of the shoot apical meristem (SAM). STM is expressed in the SAM but is down-regulated at the site of leaf initiation. STM is also required for the formation of compound leaves. However, how the activity of STM is regulated at the transcriptional, posttranscriptional, and posttranslational levels is poorly understood. We previously found two conserved noncoding sequences in the promoters of STM-like genes across angiosperms, the K-box and the RB-box. Here, we characterize the function of the RB-box in Arabidopsis (Arabidopsis thaliana). The RB-box, along with the K-box, regulates the expression of STM in leaf sinuses, which are areas on the leaf blade with meristematic potential. The RB-box also contributes to restrict STM expression to the SAM. We identified FAR1-RELATED SEQUENCES-RELATED FACTOR1 (FRF1) as a binding factor to the RB-box region. FRF1 is an uncharacterized member of a subfamily of four truncated proteins related to the FAR1-RELATED SEQUENCES factors. Internal deletion analysis of the STM promoter identified a region required to repress the expression of STM in hypocotyls. Expression of STM in leaf primordia under the control of the JAGGED promoter produced plants with partially undifferentiated leaves. We further found that the ELK domain has a role in the posttranslational regulation of STM by affecting the nuclear localization of STM.	[Aguilar-Martinez, Jose Antonio; Uchida, Naoyuki; Townsley, Brad; West, Donnelly Ann; Yanez, Andrea; Lynn, Nafeesa; Kimura, Seisuke; Sinha, Neelima] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Uchida, Naoyuki] Nagoya Univ, World Premier Int Res Ctr Initiat, Inst Transformat Biomol, Nagoya, Aichi 4648602, Japan; [Kimura, Seisuke] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Kyoto 6038555, Japan	Sinha, N (reprint author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	nrsinha@ucdavis.edu			Spanish Ministry of Science; National Science Foundation [1238243]	This work was supported by the Spanish Ministry of Science (postdoctoral fellowship to J.A.A.-M.) and the National Science Foundation (grant no. 1238243 to N.S.).	Aguilar-Martinez JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00406; Hay A, 2006, DEVELOPMENT, V133, P3955, DOI 10.1242/dev.02545; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Cole M, 2006, NUCLEIC ACIDS RES, V34, P1281, DOI 10.1093/nar/gkl016; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Li ZY, 2012, PLANT J, V71, P99, DOI 10.1111/j.1365-313X.2012.04973.x; Smith HMS, 2002, P NATL ACAD SCI USA, V99, P9579, DOI 10.1073/pnas.092271599; Nagasaki H, 2001, PLANT CELL, V13, P2085, DOI 10.1105/tpc.13.9.2085; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Byrne ME, 2002, DEVELOPMENT, V129, P1957; Tsuda K, 2011, PLANT CELL, V23, P4368, DOI 10.1105/tpc.111.090050; Takada S, 2001, DEVELOPMENT, V128, P1127; Groover AT, 2006, PLANT MOL BIOL, V61, P917, DOI 10.1007/s11103-006-0059-y; Kawamura E, 2010, PLANT J, V62, P429, DOI 10.1111/j.1365-313X.2010.04156.x; KERSTETTER R, 1994, PLANT CELL, V6, P1877, DOI 10.1105/tpc.6.12.1877; SMITH LG, 1992, DEVELOPMENT, V116, P21; Hay A, 2002, CURR BIOL, V12, P1557, DOI 10.1016/S0960-9822(02)01125-9; Ori N, 2000, DEVELOPMENT, V127, P5523; Garces HMP, 2007, P NATL ACAD SCI USA, V104, P15578, DOI 10.1073/pnas.0704105104; Smith HMS, 2003, PLANT CELL, V15, P1717, DOI 10.1105/tpc.012856; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; MULLER KJ, 1995, NATURE, V374, P727, DOI 10.1038/374727a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Aida M, 1999, DEVELOPMENT, V126, P1563; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Santi L, 2003, PLANT J, V34, P813, DOI 10.1046/j.1365-313X.2003.01767.x; Gonzalez D, 2007, MOL CELL BIOL, V27, P5306, DOI 10.1128/MCB.01912-06; Rutjens B, 2009, PLANT J, V58, P641, DOI 10.1111/j.1365-313X.2009.03809.x; Gallois JL, 2002, DEVELOPMENT, V129, P3207; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Kimura S, 2008, CURR BIOL, V18, P672, DOI 10.1016/j.cub.2008.04.008; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Testone G, 2012, J EXP BOT, V63, P5417, DOI 10.1093/jxb/ers194; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Rupp HM, 1999, PLANT J, V18, P557, DOI 10.1046/j.1365-313X.1999.00472.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Meisel L, 1996, PLANT MOL BIOL, V30, P1, DOI 10.1007/BF00017799; Laux T, 1996, DEVELOPMENT, V122, P87; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Ichihashi Y, 2014, P NATL ACAD SCI USA, V111, pE2616, DOI 10.1073/pnas.1402835111; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Truernit E, 2006, PLANT MOL BIOL, V60, P1, DOI 10.1007/s11103-005-1673-9; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ohno CK, 2004, DEVELOPMENT, V131, P1111, DOI 10.1242/dev.00991; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Magnani E, 2008, PLANT CELL, V20, P875, DOI 10.1105/tpc.108.058495; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Hofer J, 1997, CURR BIOL, V7, P581, DOI 10.1016/S0960-9822(06)00257-0; Kumaran MK, 2002, PLANT CELL, V14, P2761, DOI 10.1105/tpc.004911; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Autran D, 2002, EMBO J, V21, P6036, DOI 10.1093/emboj/cdf614; Lodha M, 2013, GENE DEV, V27, P596, DOI 10.1101/gad.211425.112; Champagne CEM, 2007, PLANT CELL, V19, P3369, DOI 10.1105/tpc.107.052886; JACKSON D, 1994, DEVELOPMENT, V120, P405; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Depuydt S, 2008, PLANT PHYSIOL, V146, P1267, DOI 10.1104/pp.107.113969; Hay A, 2003, PLANT PHYSIOL, V131, P1671, DOI 10.1104/pp.102.017434; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Bao F, 2010, PLANT PHYSIOL, V152, P821, DOI 10.1104/pp.109.146183; Qi B, 2013, PLANT J, V76, P380, DOI 10.1111/tpj.12295; Osnato M, 2010, PLANT PHYSIOL, V154, P1616, DOI 10.1104/pp.110.161984; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Koenig D, 2009, DEVELOPMENT, V136, P2997, DOI 10.1242/dev.033811; Bhatt AA, 2004, GENE, V328, P103, DOI 10.1016/j.gene.2003.12.033; Hibara K, 2003, PLANT J, V36, P687, DOI 10.1046/j.1365-313X.2003.01911.x; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; Tang WJ, 2012, PLANT CELL, V24, P1984, DOI 10.1105/tpc.112.097022; Atta R, 2009, PLANT J, V57, P626, DOI 10.1111/j.1365-313X.2008.03715.x; Lin RC, 2004, PLANT PHYSIOL, V136, P4010, DOI 10.1104/pp.104.052191; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Scofield S, 2006, PLANT MOL BIOL, V60, P929, DOI 10.1007/s11103-005-4478-y; Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Bauer P, 2004, PLANTA, V219, P359, DOI 10.1007/s00425-004-1233-6; Bellaoui M, 2001, PLANT CELL, V13, P2455, DOI 10.1105/tpc.13.11.2455; Brudno M, 2004, NUCLEIC ACIDS RES, V32, pW41, DOI 10.1093/nar/gkh361; Chuck G, 1996, PLANT CELL, V8, P1277; Dean G, 2004, PLANT MOL BIOL, V54, P71, DOI 10.1023/B:PLAN.0000028772.22892.2d; Fletcher Jennifer C., 1999, Science (Washington D C), V283, P1911, DOI 10.1126/science.283.5409.1911; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GILES J. E., 1998, PLANT PHYSIOL, V117, P1125; GREENE B, 1994, GENETICS, V138, P1275; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hofer J, 2001, PLANT MOL BIOL, V45, P387, DOI 10.1023/A:1010739812836; Hu W, 2011, PLANT MOL BIOL, V76, P57, DOI 10.1007/s11103-011-9768-y; Hudson M, 1999, GENE DEV, V13, P2017, DOI 10.1101/gad.13.15.2017; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Inada DC, 2003, GENOME RES, V13, P2030, DOI 10.1101/gr.1280703; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Ito Y, 2008, PLANT SCI, V174, P357, DOI 10.1016/j.plantsci.2007.12.007; Janssen BJ, 1998, PLANT MOL BIOL, V36, P417, DOI 10.1023/A:1005925508579; Kim JY, 2005, GENE DEV, V19, P788, DOI 10.1101/gad.332805; Koltai H, 2001, MOL PLANT MICROBE IN, V14, P1168, DOI 10.1094/MPMI.2001.14.10.1168; Koltai H, 2000, PLANT J, V22, P455, DOI 10.1046/j.1365-313X.2000.00754.x; Kooiker M, 2005, PLANT CELL, V17, P722, DOI 10.1105/tpc.104.030130; Li JG, 2010, PLANT CELL, V22, P3634, DOI 10.1105/tpc.110.075788; Lin RC, 2008, PLANT PHYSIOL, V148, P981, DOI 10.1104/pp.108.120436; Luo M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003114; Mushegian AR, 1996, GENETICS, V144, P817; Sakamoto T, 1999, PLANT CELL, V11, P1419; Simonini S, 2014, J EXP BOT, V65, P1455, DOI 10.1093/jxb/eru003; Stahle MI, 2009, PLANT CELL, V21, P3105, DOI 10.1105/tpc.109.070458; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tamaoki M, 1997, GENES GENET SYST, V72, P1, DOI 10.1266/ggs.72.1; Townsley BT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00121; Uchida N, 2007, P NATL ACAD SCI USA, V104, P15953, DOI 10.1073/pnas.0707577104; Viola IL, 2009, BIOCHIMIE, V91, P974, DOI 10.1016/j.biochi.2009.04.021; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Williams RW, 1998, BIOESSAYS, V20, P280, DOI 10.1002/(SICI)1521-1878(199804)20:4<280::AID-BIES2>3.0.CO;2-U; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Winter N, 2007, PLANT CELL, V19, P3001, DOI 10.1105/tpc.107.044354	144	2	2	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	FEB	2015	167	2					424	442		10.1104/pp.114.248625		19	Plant Sciences	Plant Sciences	CA1DH	WOS:000348652700010		
J	Shimakawa, G; Shaku, K; Nishi, A; Hayashi, R; Yamamoto, H; Sakamoto, K; Makino, A; Miyake, C				Shimakawa, Ginga; Shaku, Keiichiro; Nishi, Akiko; Hayashi, Ryosuke; Yamamoto, Hiroshi; Sakamoto, Katsuhiko; Makino, Amane; Miyake, Chikahiro			FLAVODIIRON2 and FLAVODIIRON4 Proteins Mediate an Oxygen-Dependent Alternative Electron Flow in Synechocystis sp PCC 6803 under CO2-Limited Conditions	PLANT PHYSIOLOGY			English	Article							SP STRAIN PCC-6803; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; CAROTENOID PROTEIN; EXCITATION-ENERGY; TERMINAL OXIDASES; INORGANIC CARBON; CYANOBACTERIUM; PHOTOSYNTHESIS; LIGHT	This study aims to elucidate the molecular mechanism of an alternative electron flow (AEF) functioning under suppressed (CO2-limited) photosynthesis in the cyanobacterium Synechocystis sp. PCC 6803. Photosynthetic linear electron flow, evaluated as the quantum yield of photosystem II [Y(II)], reaches a maximum shortly after the onset of actinic illumination. Thereafter, Y(II) transiently decreases concomitantly with a decrease in the photosynthetic oxygen evolution rate and then recovers to a rate that is close to the initial maximum. These results show that CO2 limitation suppresses photosynthesis and induces AEF. In contrast to the wild type, Synechocystis sp. PCC 6803 mutants deficient in the genes encoding FLAVODIIRON2 (FLV2) and FLV4 proteins show no recovery of Y(II) after prolonged illumination. However, Synechocystis sp. PCC 6803 mutants deficient in genes encoding proteins functioning in photorespiration show AEF activity similar to the wild type. In contrast to Synechocystis sp. PCC 6803, the cyanobacterium Synechococcus elongatus PCC 7942 has no FLV proteins with high homology to FLV2 and FLV4 in Synechocystis sp. PCC 6803. This lack of FLV2/4 may explain why AEF is not induced under CO2-limited photosynthesis in S. elongatus PCC 7942. As the glutathione S-transferase fusion protein overexpressed in Escherichia coli exhibits NADH-dependent oxygen reduction to water, we suggest that FLV2 and FLV4 mediate oxygen-dependent AEF in Synechocystis sp. PCC 6803 when electron acceptors such as CO2 are not available.	[Shimakawa, Ginga; Shaku, Keiichiro; Nishi, Akiko; Hayashi, Ryosuke; Sakamoto, Katsuhiko; Miyake, Chikahiro] Kobe Univ, Grad Sch Agr Sci, Fac Agr, Dept Biol & Environm Sci,Nada Ku, Kobe, Hyogo 6578501, Japan; [Yamamoto, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; [Makino, Amane] Tohoku Univ, Grad Sch Agr Sci, Dept Agr, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Makino, Amane; Miyake, Chikahiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan	Miyake, C (reprint author), Kobe Univ, Grad Sch Agr Sci, Fac Agr, Dept Biol & Environm Sci,Nada Ku, Kobe, Hyogo 6578501, Japan.	cmiyake@hawk.kobe-u.ac.jp			Japan Society for the Promotion of Science [21570041]; Ministry of Education, Culture, Sports, Science, and Technology in Japan [22114512]	This work was supported by the Japan Society for the Promotion of Science (Scientific Research grant no. 21570041 to C.M.) and the Ministry of Education, Culture, Sports, Science, and Technology in Japan (Scientific Research on Innovative Areas grant no. 22114512 to C.M. and A.M.).	Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; McConnell MD, 2002, PLANT PHYSIOL, V130, P1201, DOI 10.1104/pp.009845; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P11985, DOI 10.1073/pnas.90.24.11985; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Bersanini L, 2014, PLANT PHYSIOL, V164, P805, DOI 10.1104/pp.113.231969; Shirao M, 2013, PLANT CELL PHYSIOL, V54, P1152, DOI 10.1093/pcp/pct066; Driever SM, 2011, PLANT CELL ENVIRON, V34, P837, DOI 10.1111/j.1365-3040.2011.02288.x; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Roberty S, 2014, NEW PHYTOL, V204, P81, DOI 10.1111/nph.12903; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; Eisenhut M, 2012, J BIOL CHEM, V287, P33153, DOI 10.1074/jbc.M112.391755; Lea-Smith DJ, 2013, PLANT PHYSIOL, V162, P484, DOI 10.1104/pp.112.210260; Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; ASADA K, 1984, PLANT CELL PHYSIOL, V25, P1169; Allahverdiyeva Y, 2013, P NATL ACAD SCI USA, V110, P4111, DOI 10.1073/pnas.1221194110; Zhang PP, 2012, PLANT CELL, V24, P1952, DOI 10.1105/tpc.111.094417; Boulay C, 2008, BBA-BIOENERGETICS, V1777, P1344, DOI 10.1016/j.bbabio.2008.07.002; Vicente JB, 2002, BIOCHEM BIOPH RES CO, V294, P82, DOI 10.1016/S0006-291X(02)00434-5; BADGER MR, 1992, PHYSIOL PLANTARUM, V84, P606, DOI 10.1034/j.1399-3054.1992.840416.x; Badger Murray R., 2000, Philosophical Transactions of the Royal Society of London B Biological Sciences, V355, P1433, DOI 10.1098/rstb.2000.0704; Berry S, 2002, BIOCHEMISTRY-US, V41, P3422, DOI 10.1021/bi011683d; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; Hagemann M, 2013, PLANT BIOLOGY, V15, P639, DOI 10.1111/j.1438-8677.2012.00677.x; Hayashi R, 2014, BIOSCI BIOTECH BIOCH, V78, P384, DOI 10.1080/09168451.2014.882745; Lee HM, 1998, FEBS LETT, V427, P291, DOI 10.1016/S0014-5793(98)00451-7; Miller AG, 1996, PHOTOSYNTH RES, V49, P251, DOI 10.1007/BF00034786; Mullineaux CW, 2014, BBA-BIOENERGETICS, V1837, P503, DOI 10.1016/j.bbabio.2013.11.017; Nakahara K, 2003, PLANT CELL PHYSIOL, V44, P326, DOI 10.1093/pcp/pcg044; Nomura CT, 2006, PHOTOSYNTH RES, V87, P215, DOI 10.1007/s11120-005-8533-y; Pils D, 2001, FEMS MICROBIOL LETT, V203, P217, DOI 10.1111/j.1574-6968.2001.tb10844.x; Sato Naoki, 2005, Genome Inform, V16, P56; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331	37	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	FEB	2015	167	2					472	U732		10.1104/pp.114.249987		18	Plant Sciences	Plant Sciences	CA1DH	WOS:000348652700013		
J	Yano, K; Aya, K; Hirano, K; Ordonio, RL; Ueguchi-Tanaka, M; Matsuoka, M				Yano, Kenji; Aya, Koichiro; Hirano, Ko; Ordonio, Reynante Lacsamana; Ueguchi-Tanaka, Miyako; Matsuoka, Makoto			Comprehensive Gene Expression Analysis of Rice Aleurone Cells: Probing the Existence of an Alternative Gibberellin Receptor	PLANT PHYSIOLOGY			English	Article							AVENA-FATUA ALEURONE; DELLA PROTEIN SLR1; ABSCISIC-ACID; INSENSITIVE DWARF1; SIGNALING PATHWAY; PLASMA-MEMBRANE; ARABIDOPSIS; BINDING; PROTOPLASTS; ENCODES	Current gibberellin (GA) research indicates that GA must be perceived in plant nuclei by its cognate receptor, GIBBERELLIN INSENSITIVE DWARF1 (GID1). Recognition of GA by GID1 relieves the repression mediated by the DELLA protein, a model known as the GID1-DELLA GA perception system. There have been reports of potential GA-binding proteins in the plasma membrane that perceive GA and induce alpha-amylase expression in cereal aleurone cells, which is mechanistically different from the GID1-DELLA system. Therefore, we examined the expression of the rice (Oryza sativa) alpha-amylase genes in rice mutants impaired in the GA receptor (gid1) and the DELLA repressor (slender rice1; slr1) and confirmed their lack of response to GA in gid1 mutants and constitutive expression in slr1 mutants. We also examined the expression of GA-regulated genes by genome-wide microarray and quantitative reverse transcription-polymerase chain reaction analyses and confirmed that all GA-regulated genes are modulated by the GID1-DELLA system. Furthermore, we studied the regulatory network involved in GA signaling by using a set of mutants defective in genes involved in GA perception and gene expression, namely gid1, slr1, gid2 (a GA-related F-box protein mutant), and gamyb (a GA-related trans-acting factor mutant). Almost all GA up-regulated genes were regulated by the four named GA-signaling components. On the other hand, GA down-regulated genes showed different expression patterns with respect to GID2 and GAMYB (e.g. a considerable number of genes are not controlled by GAMYB or GID2 and GAMYB). Based on these observations, we present a comprehensive discussion of the intricate network of GA-regulated genes in rice aleurone cells.	[Yano, Kenji; Aya, Koichiro; Hirano, Ko; Ordonio, Reynante Lacsamana; Ueguchi-Tanaka, Miyako; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Matsuoka, M (reprint author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@nuagr1.agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science [23113005, 26.1393]; Ministry of Education, Culture, Sports, Science, and Technology [26252001, 26660278]; Ministry of Education, Culture, Sports, Science, and Technology (Network of Centers of Carbon Dioxide Resource Studies in Plants project)	This work was supported by the Japan Society for the Promotion of Science (grant no. 23113005 and single-year grant nos. 26.1393) and by the Ministry of Education, Culture, Sports, Science, and Technology (grant nos. 26252001 and 26660278 and Grants-in-Aid from the Network of Centers of Carbon Dioxide Resource Studies in Plants project).	de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Thomas SG, 2005, VITAM HORM, V72, P289, DOI 10.1016/S0083-6729(05)72009-4; Chen PW, 2006, PLANT CELL, V18, P2326, DOI 10.1105/tpc.105.038844; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Ueguchi-Tanaka M, 2008, PLANT CELL, V20, P2437, DOI 10.1105/tpc.108.061648; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; HOOLEY R, 1991, PLANTA, V183, P274, DOI 10.1007/BF00197799; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; GILROY S, 1994, PLANT PHYSIOL, V104, P1185; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Hartweck LM, 2006, PLANT CELL, V18, P278, DOI 10.1105/tpc.105.039958; Yoshida H, 2014, P NATL ACAD SCI USA, V111, P7861, DOI 10.1073/pnas.1321669111; Smolkin M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-36; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Sun XL, 2012, BIOCHEM J, V442, P1, DOI 10.1042/BJ20111766; Hirano K, 2012, PLANT J, V71, P443, DOI 10.1111/j.1365-313X.2012.05000.x; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc010827; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Ariizumi T, 2008, PLANT CELL, V20, P2447, DOI 10.1105/tpc.108.058487; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Beale MH, 1992, PHYSIOL PLANTARUM, V85, pA136; Ben-Hur A., 2002, PAC S BIOC, V7, P6; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI DOI 10.1093/NAR/GKQ310; Ho THD, 2003, J PLANT GROWTH REGUL, V22, P185, DOI 10.1007/s00344-003-0026-7; HOOLEY R, 1993, AUST J PLANT PHYSIOL, V20, P573; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; JELSEMA CL, 1977, PLANT CELL PHYSIOL, V18, P1009; Locascio A, 2013, PLANT CELL PHYSIOL, V54, P1229, DOI 10.1093/pcp/pct082; Lovegrove A, 1998, PLANT J, V15, P311, DOI 10.1046/j.1365-313X.1998.00209.x; Sambrook J., 1989, MOL CLONING LAB MANU; Taiz L., 2010, PLANT PHYSL; WALKER RP, 1994, PLANT GROWTH REGUL, V15, P271, DOI 10.1007/BF00029900	46	2	2	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	FEB	2015	167	2					531	U421		10.1104/pp.114.247940		52	Plant Sciences	Plant Sciences	CA1DH	WOS:000348652700018		
J	Takeda, N; Handa, Y; Tsuzuki, S; Kojima, M; Sakakibara, H; Kawaguchi, M				Takeda, Naoya; Handa, Yoshihiro; Tsuzuki, Syusaku; Kojima, Mikiko; Sakakibara, Hitoshi; Kawaguchi, Masayoshi			Gibberellins Interfere with Symbiosis Signaling and Gene Expression and Alter Colonization by Arbuscular Mycorrhizal Fungi in Lotus japonicus	PLANT PHYSIOLOGY			English	Article							MEDICAGO-TRUNCATULA; DIFFERENTIAL EXPRESSION; MOLECULAR-MECHANISM; PLANT HORMONES; PISUM-SATIVUM; ROOT-GROWTH; COUNT DATA; RNA-SEQ; ARABIDOPSIS; PROTEIN	Arbuscular mycorrhiza is a mutualistic plant-fungus interaction that confers great advantages for plant growth. Arbuscular mycorrhizal (AM) fungi enter the host root and form symbiotic structures that facilitate nutrient supplies between the symbionts. The gibberellins (GAs) are phytohormones known to inhibit AM fungal infection. However, our transcriptome analysis and phytohormone quantification revealed GA accumulation in the roots of Lotus japonicus infected with AM fungi, suggesting that de novo GA synthesis plays a role in arbuscular mycorrhiza development. We found pleiotropic effects of GAs on the AM fungal infection. In particular, the morphology of AM fungal colonization was drastically altered by the status of GA signaling in the host root. Exogenous GA treatment inhibited AM hyphal entry into the host root and suppressed the expression of Reduced Arbuscular Mycorrhization1 (RAM1) and RAM2 homologs that function in hyphal entry and arbuscule formation. On the other hand, inhibition of GA biosynthesis or suppression of GA signaling also affected arbuscular mycorrhiza development in the host root. Low-GA conditions suppressed arbuscular mycorrhiza-induced subtilisin-like serine protease1 (SbtM1) expression that is required for AM fungal colonization and reduced hyphal branching in the host root. The reduced hyphal branching and SbtM1 expression caused by the inhibition of GA biosynthesis were recovered by GA treatment, supporting the theory that insufficient GA signaling causes the inhibitory effects on arbuscular mycorrhiza development. Most studies have focused on the negative role of GA signaling, whereas our study demonstrates that GA signaling also positively interacts with symbiotic responses and promotes AM colonization of the host root.	[Takeda, Naoya; Handa, Yoshihiro; Kawaguchi, Masayoshi] Natl Inst Basic Biol, Div Symbiot Syst, Okazaki, Aichi 4448585, Japan; [Takeda, Naoya; Tsuzuki, Syusaku; Kawaguchi, Masayoshi] Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Kojima, Mikiko; Sakakibara, Hitoshi] RIKEN, Ctr Sustainable Resource Sci, Plant Prod Syst Res Grp, Yokohama, Kanagawa 2300045, Japan	Takeda, N (reprint author), Natl Inst Basic Biol, Div Symbiot Syst, Okazaki, Aichi 4448585, Japan.	takedan@nibb.ac.jp	Sakakibara, Hitoshi/A-6040-2010	Sakakibara, Hitoshi/0000-0001-5449-6492	Japan Society for the Promotion of Science [24770050]; Grant for Basic Science Research Projects from Sumitomo Foundation [110044]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry [250023A]	This work was supported by the Japan Society for the Promotion of Science (grant no. 24770050), the Grant for Basic Science Research Projects from the Sumitomo Foundation (grant no. 110044), and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (grant no. 250023A to N.T.).	Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Pumplin N, 2010, PLANT J, V61, P482, DOI 10.1111/j.1365-313X.2009.04072.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Takeda N, 2013, PLANT CELL PHYSIOL, V54, P1711, DOI 10.1093/pcp/pct114; Gobbato E, 2012, CURR BIOL, V22, P2236, DOI 10.1016/j.cub.2012.09.044; Genre A, 2005, PLANT CELL, V17, P3489, DOI 10.1105/tpc.105.035410; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; FLETCHER RA, 1986, PLANT CELL PHYSIOL, V27, P367; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Takezawa D, 1996, J BIOL CHEM, V271, P8126; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Maekawa T, 2009, PLANT J, V58, P183, DOI 10.1111/j.1365-313X.2008.03774.x; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; PATIL S, 1995, P NATL ACAD SCI USA, V92, P4897, DOI 10.1073/pnas.92.11.4897; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Harrison MJ, 2012, CURR OPIN PLANT BIOL, V15, P691, DOI 10.1016/j.pbi.2012.08.010; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; Foo E, 2013, ANN BOT-LONDON, V111, P769, DOI 10.1093/aob/mct041; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Yoshida S, 2012, NEW PHYTOL, V196, P1208, DOI 10.1111/j.1469-8137.2012.04339.x; Yu N, 2014, CELL RES, V24, P130, DOI 10.1038/cr.2013.167; Ubeda-Tomas S, 2008, NAT CELL BIOL, V10, P625, DOI 10.1038/ncb1726; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; ElGhachtouli N, 1996, FEBS LETT, V385, P189, DOI 10.1016/0014-5793(96)00379-1; Penmetsa RV, 1997, SCIENCE, V275, P527, DOI 10.1126/science.275.5299.527; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Yamaguchi N, 2014, SCIENCE, V344, P638, DOI 10.1126/science.1250498; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Ferguson BJ, 2011, NEW PHYTOL, V189, P829, DOI 10.1111/j.1469-8137.2010.03542.x; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; IWASAKI T, 1991, PLANT CELL PHYSIOL, V32, P1007; Achard P, 2003, PLANT CELL, V15, P2816, DOI 10.1105/tpc.015685; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Takeda N, 2012, PLANT CELL, V24, P810, DOI 10.1105/tpc.111.091827; Takeda N, 2009, PLANT J, V58, P766, DOI 10.1111/j.1365-313X.2009.03824.x; Besserer A, 2008, PLANT PHYSIOL, V148, P402, DOI 10.1104/pp.108.121400; Charpentier M, 2014, PLANT PHYSIOL, V166, P2077, DOI 10.1104/pp.114.246371; Demchenko K, 2004, NEW PHYTOL, V163, P381, DOI 10.1111/j.1469-8137.2004.01123.x; Ferguson BJ, 2005, PLANT PHYSIOL, V138, P2396, DOI 10.1104/pp.105.062414; Floss DS, 2013, P NATL ACAD SCI USA, V110, pE5025, DOI 10.1073/pnas.1308973110; Gallego-Bartolome J, 2012, P NATL ACAD SCI USA, V109, P13446, DOI 10.1073/pnas.1119992109; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Kadota K, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-5; Middleton AM, 2012, P NATL ACAD SCI USA, V109, P7571, DOI 10.1073/pnas.1113666109; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Ortu G, 2012, MOL PLANT, V5, P951, DOI 10.1093/mp/sss027; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Song FuQiang, 2012, Journal of Medicinal Plants Research, V6, P3648; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	69	4	4	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	FEB	2015	167	2					545	U442		10.1104/pp.114.247700		21	Plant Sciences	Plant Sciences	CA1DH	WOS:000348652700019		
J	Yagi, I; Ono, R; Oda, T; Takaki, K				Yagi, Ippei; Ono, Ryo; Oda, Tetsuji; Takaki, Koichi			Two-dimensional LIF measurements of humidity and OH density resulting from evaporated water from a wet surface in plasma for medical use	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						plasma medicine; reactive species; humidity; water evaporation; laser-induced fluorescence; nanosecond pulse; streamer discharge	SENSOR; SYSTEM; OZONE	In plasma medicine, plasma is applied to a wet surface and is often accompanied by dry-gas flow. The dry-gas flow affects water evaporation from the wet surface and influences production of reactive species derived from water vapor, such as OH radicals. In this study, the effect of the dry-gas flow on two-dimensional distributions of humidity and OH radical density are examined by measuring them using laser-induced fluorescence (LIF). First, humidity is measured when nitrogen flows from a quartz tube of 4 mm inner diameter onto distilled water and agar media from 5mm distance. NO gas is added to the nitrogen as a tracer and humidity is obtained from the quenching rate of NO molecules measured using LIF. This measurement has a spatial resolution of 0.2 mm(3) and a temporal resolution of less than 220 ns. The two-dimensional humidity distribution shows that the dry-gas flow pushes away water vapor evaporating from the wet surface. As a result, a low-humidity region is formed near the quartz tube nozzle and a high-humidity region is formed near the wet surface. The thickness of the low-humidity region reduces with increasing gas flow rate. It is 0.1-0.5 mm for the flow rate of higher than 0.3 l min(-1). Next, the OH density is measured when a nanosecond pulsed streamer discharge is applied to a distilled water surface with dry-air flow. The OH density decreases with increasing gas flow rate due to decreased humidity. When the flow rate is lower than 0.1 l min(-1), the OH distribution is approximately uniform in the plasma region, while the humidity distribution shows a large gradient. The importance of the thin high-humidity region on the flux of reactive species onto the wet surface is discussed.	[Yagi, Ippei; Ono, Ryo] Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2278568, Japan; [Oda, Tetsuji] Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Takaki, Koichi] Iwate Univ, Dept Elect Engn & Comp Sci, Morioka, Iwate 0208551, Japan	Yagi, I (reprint author), Univ Tokyo, Dept Adv Energy, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2278568, Japan.	ryo-ono@k.u-tokyo.ac.jp	Ono, Ryo/F-5710-2013		Japan Ministry of Education, Culture, Sport, Science and Technology	This work was partially supported by the Grant-in Aid for Scientific Research from the Japan Ministry of Education, Culture, Sport, Science and Technology and by the Grant-in-Aid for Japan Society for the Promotion of Science Fellows.	Takaki K, 2011, IEEE T DIELECT EL IN, V18, P1752, DOI 10.1109/TDEI.2011.6032847; Ikawa S, 2010, PLASMA PROCESS POLYM, V7, P33, DOI 10.1002/ppap.200900090; Tamura M, 1998, COMBUST FLAME, V114, P502, DOI 10.1016/S0010-2180(97)00324-6; Komuro A, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175206; Ono R, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/3/035204; Kronenberg P, 2002, OPT LETT, V27, P1385, DOI 10.1364/OL.27.001385; Tian W, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/16/165201; Yonemori S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/12/125401; Yonemori S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/22/225202; Kalghatgi S, 2012, PLASMA PROCESS POLYM, V9, P726, DOI 10.1002/ppap.201100156; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Nakagawa Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3638457; MITSCHKE F, 1989, OPT LETT, V14, P967, DOI 10.1364/OL.14.000967; Li LQ, 2012, ACTA PHYS SIN-CH ED, V61; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Verreycken T, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/46/464004; Traylor MJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/47/472001; BLACK G, 1976, J PHOTOCHEM, V5, P435, DOI 10.1016/0047-2670(76)85044-7; Braves D B, 2012, J PHYS D, V45; KHARAZ A, 1995, SENSOR ACTUAT A-PHYS, V47, P491, DOI 10.1016/0924-4247(94)00948-H; Luque J, 1999, MP99009 SRI; Marrero T. R., 1972, Journal of Physical and Chemical Reference Data, V1; Michie WC, 1997, CEMENT CONCRETE COMP, V19, P35, DOI 10.1016/S0958-9465(96)00039-X; Schlegel J., 2013, CLIN PLASMA MED, V1, P2; Tsutsui C, 2012, 9 INT BIOEL S KUM JA; WMO (World Meteorological Organization), 2008, GUID MET INSTR METH, V8; ZHOU Q, 1988, ANAL CHEM, V60, P2317, DOI 10.1021/ac00171a035	28	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	FEB	2015	24	1							015002	10.1088/0963-0252/24/1/015002		8	Physics, Fluids & Plasmas	Physics	AZ5ZW	WOS:000348298200003		
J	Kurihara, K; Otomo, A; Yamamoto, K; Takahara, J; Tani, M; Kuwashima, F				Kurihara, Kazuyoshi; Otomo, Akira; Yamamoto, Kazuhiro; Takahara, Junichi; Tani, Masahiko; Kuwashima, Fumiyoshi			Identification of Plasmonic Modes in Parabolic Cylinder Geometry by Quasi-Separation of Variables	PLASMONICS			English	Article						Surface plasmon polaritons; Plasmonics; Quasi-separation of variables; Parabolic cylinder; Nanofocusing; Superfocusing	PLATE WAVE-GUIDE; SURFACE-POLARITONS; FIELD ENHANCEMENT; OPTICAL-FIBER; TIP; LOCALIZATION; EXCITATION	This paper describes the plasmonic modes in the parabolic cylinder geometry as a theoretical complement to the previous paper (J Phys A 42:185401) that considered the modes in the circular paraboloidal geometry. In order to identify the plasmonic modes in the parabolic cylinder geometry, analytic solutions for surface plasmon polaritons are examined by solving the wave equation for the magnetic field in parabolic cylindrical coordinates using quasi-separation of variables in combination with perturbation methods. The examination of the zeroth-order perturbation equations showed that solutions cannot exist for the parabolic metal wedge but can be obtained for the parabolic metal groove as standing wave solutions indicated by the even and odd symmetries.	[Kurihara, Kazuyoshi] Univ Fukui, Fac Educ & Reg Studies, Dept Phys, Fukui 9108507, Japan; [Otomo, Akira] Natl Inst Informat & Commun Technol NICT, Kobe Adv ICT Res Ctr, Kobe, Hyogo 6512492, Japan; [Yamamoto, Kazuhiro] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8168580, Japan; [Takahara, Junichi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Tani, Masahiko] Univ Fukui, Res Ctr Dev Far Infrared Reg, Fukui 9108507, Japan; [Kuwashima, Fumiyoshi] Fukui Univ Technol, Dept Elect Elect & Comp Engn, Fukui 9108505, Japan	Kurihara, K (reprint author), Univ Fukui, Fac Educ & Reg Studies, Dept Phys, Fukui 9108507, Japan.	kuri@u-fukui.ac.jp	Takahara, Junichi/B-2759-2012	Takahara, Junichi/0000-0002-3683-626X	KAKENHI [21560073]	One of the authors (K. Kurihara) is most thankful to Dr. F. Peper of NICT for his useful discussions and comments on calling a Fortran subroutine from Mathematica. This work was supported by KAKENHI (21560073).	Abramowitz M., 1972, HDB MATH FUNCTIONS F; Sadiq D, 2011, NANO LETT, V11, P1609, DOI 10.1021/nl1045457; Takahara J, 1997, OPT LETT, V22, P475, DOI 10.1364/OL.22.000475; Janunts NA, 2005, OPT COMMUN, V253, P118, DOI 10.1016/j.optcom.2005.04.076; Babadjanyan AJ, 2000, J APPL PHYS, V87, P3785, DOI 10.1063/1.372414; Bozhevolnyi SI, 2010, OPT LETT, V35, P541, DOI 10.1364/OL.35.000541; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Zhan H, 2010, OPT EXPRESS, V18, P9643, DOI 10.1364/OE.18.009643; Kurihara K, 2002, SENSOR ACTUAT B-CHEM, V86, P49, DOI 10.1016/S0925-4005(02)00146-6; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; Neacsu CC, 2010, NANO LETT, V10, P592, DOI 10.1021/nl903574a; Vernon KC, 2007, J APPL PHYS, V101, DOI 10.1063/1.2732699; Iwaszczuk K, 2012, OPT EXPRESS, V20, P8344, DOI 10.1364/OE.20.008344; INNES RA, 1987, J PHYS F MET PHYS, V17, P277, DOI 10.1088/0305-4608/17/1/031; Ding W, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.063822; Nerkararyan KV, 1997, PHYS LETT A, V237, P103, DOI 10.1016/S0375-9601(97)00722-6; SAMBLES JR, 1991, CONTEMP PHYS, V32, P173, DOI 10.1080/00107519108211048; Babayan AE, 2007, ULTRAMICROSCOPY, V107, P1136, DOI 10.1016/j.ultramic.2007.01.009; Bahder TB, 1995, MATH SCI ENG; Bozhevolnyi SI, 2009, PLASMONIC NANOGUIDES AND CIRCUITS, P1; Buchholz H., 1969, CONFLUENT HYPERGEOME; Farlow S.J., 1993, PARTIAL DIFFERENTIAL; Gil A., 2007, NUMERICAL METHODS SP; Gil A, 2004, NUMER MATH, V98, P105, DOI 10.1007/s00211-004-0517-x; Gil A, 2006, ACM T MATH SOFTWARE, V32, P70, DOI 10.1145/1132973.1132977; Gramotnev DK, 2005, J APPL PHYS, V98, DOI 10.1063/1.2130520; Gramotnev DK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035431; Gramotnev Dmitri K., 2014, Nature Photonics, V8, DOI 10.1038/nphoton.2013.232; Gramotnev DK, 2007, APPL PHYS B-LASERS O, V86, P7, DOI [10.1007/S00340-006-2387-7, 10.1007/s00340-006-2387-7]; Hagmann MJ, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3560979; Jackson J. D., 1998, CLASSICAL ELECTRODYN; Janunts NA, 2000, PHYS LETT A, V269, P257, DOI 10.1016/S0375-9601(00)00270-X; Kim SH, 2010, OPT EXPRESS, V18, P1289, DOI 10.1364/OE.18.001289; Kurihara K, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/18/185401; Kurihara K, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/29/295401; Kurihara K, 2007, J PHYS A-MATH THEOR, V40, P12479, DOI 10.1088/1751-8113/40/41/015; Lalayan AA, 2002, J APPL PHYS, V91, P2965, DOI 10.1063/1.1428092; Lebedev N. N., 1972, SPECIAL FUNCTIONS TH; Liu W, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.073404; Maier S. A., 2007, PLASMONICS FUNDAMENT; Miller JCP, 1955, TABLES WEBER PARABOL; MILLER JCP, 1952, MATH P CAMBRIDGE PHI, V48, P428, DOI 10.1017/S0305004100027821; Mote RG, 2010, OPTIK, V121, P1962, DOI 10.1016/j.ijleo.2009.05.026; Nerkararyan KV, 2008, PLASMONICS, V3, P27, DOI 10.1007/s11468-007-9050-y; Polyanin A., 2007, HDB MATH ENG SCI; Ruppin R, 2005, PHYS LETT A, V340, P299, DOI 10.1016/j.physleta.2005.03.078; Sarid A, 2010, MODERN INTRO SURFACE; Sommerfeld A, 1949, PARTIAL DIFFERENTIAL; Temme NM, 2000, J COMPUT APPL MATH, V121, P221, DOI 10.1016/S0377-0427(00)00347-2; Vogel MW, 2010, J APPL PHYS, V107, DOI 10.1063/1.3309409; Vogel MW, 2007, PHYS LETT A, V363, P507, DOI 10.1016/j.physleta.2006.11.041; Wang LC, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/1/017303	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1955	1557-1963		PLASMONICS	Plasmonics	FEB	2015	10	1					165	182		10.1007/s11468-014-9791-3		18	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	AZ6RJ	WOS:000348346300023		
J	Mitsushio, M; Nagaura, A; Yoshidome, T; Higo, M				Mitsushio, Masaru; Nagaura, Akimichi; Yoshidome, Toshifumi; Higo, Morihide			Molecular selectivity development of Teflon (R) AF1600-coated gold-deposited surface plasmon resonance-based glass rod sensor	PROGRESS IN ORGANIC COATINGS			English	Article						Au-deposited SPR glass rod sensor; Teflon AF1600 coating; PEG thiol spacer layer; Molecular selectivity; Monohydric alcohol	OPTICAL-FIBER SENSOR; LIGHT-EMITTING-DIODES; ORGANOPHILIC PERVAPORATION; INDIVIDUAL COMPONENTS; VAPOR TRANSPORT; SYSTEM; FILMS; AF; DIFFUSION; MEMBRANE	A gold (Au)-deposited surface plasmon resonance (SPR)-based glass rod sensor coated with an alpha-mercaptoethyl-omega-methoxy polyoxyethylene (PEG thiol) layer and a Teflon AF1600 overlayer with high selectivity for small molecules in aqueous solutions was developed. The PEG thiol layer forms a space (approximately 13 nm thick) for analytes between the Au film (45 nm thick) and the Teflon layer (25 mu m thick). Small molecules in sample solutions pass selectively through the porous Teflon, accumulate in the PEG thiol layer and are detected using the SPR phenomenon. PEG thiol adsorption on the Au films was confirmed by the sensor response and X-ray photoelectron spectroscopy. Teflon overlayer thicknesses on the Au films were measured using cross-sectional scanning electron microscope images of the sensor. The sensor's selectivity was evaluated using aqueous solutions of methanol, ethanol, propanol, ethylene glycol, glycerin, pentaerythritol, and glucose. Only the monohydric alcohols pass through the Teflon overlayer, while the polyhydric alcohols do not pass through the layer. This sensor thus allows us to measure the ethanol concentrations directly in aqueous ethanol solutions mixed with interference compounds. The sensor is unaffected by glucose, tartaric acid, and glutamic acid in the solutions. (C) 2014 Elsevier B.V. All rights reserved.	[Mitsushio, Masaru; Nagaura, Akimichi; Yoshidome, Toshifumi; Higo, Morihide] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan	Mitsushio, M (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, 1-21-40 Korimoto, Kagoshima 8900065, Japan.	mitsushio@cb.kagoshima-u.ac.jp			Iketani Science and Technology Foundation [0191009-A]; Project to Develop "Innovative Seeds" [16-032]; Japan Science and Technology Agency	The authors would like to thank Miss K. Matsuo and Miss K. Anayama for their cooperation in conducting this work. The present study was partially supported by a grant from the Iketani Science and Technology Foundation (No. 0191009-A), and by the Project to Develop "Innovative Seeds" (No. 16-032) and the Technology Transfer and Innovation Program (2007) from the Japan Science and Technology Agency.	Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Cerruti M, 2008, LANGMUIR, V24, P10646, DOI 10.1021/la801357v; Sharma AK, 2007, IEEE SENS J, V7, P1118, DOI 10.1109/JSEN.2007.897946; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Podgorsek RP, 1998, APPL PHYS LETT, V73, P2887, DOI 10.1063/1.122619; Mitsushio M, 2010, SENSOR ACTUAT A-PHYS, V163, P1, DOI 10.1016/j.sna.2010.07.003; Kurihara K, 2002, ANAL CHEM, V74, P6323, DOI 10.1021/ac0203241; Ferrari MC, 2010, IND ENG CHEM RES, V49, P11920, DOI 10.1021/ie100242q; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; O'Brien M, 2010, ORG LETT, V12, P1596, DOI 10.1021/ol100322t; Podgorsek RP, 2002, APPL OPTICS, V41, P601, DOI 10.1364/AO.41.000601; Pinnau I, 1996, J MEMBRANE SCI, V109, P125, DOI 10.1016/0376-7388(95)00193-X; Mitsushio M, 2006, SENSOR ACTUAT A-PHYS, V125, P296, DOI 10.1016/j.sna.2005.08.019; Cacao EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056835; Crist B. V., 1999, HDB MONOCHROMATIC XP, V1; DRAKE PA, 1995, ANAL CHEM, V67, P1766, DOI 10.1021/ac00107a004; Du Pont-Mitsui Fluorochemicals Company, PROD INF TEFL AF; Erickson TA, 2014, TALANTA, V119, P151, DOI 10.1016/j.talanta.2013.10.038; KURAUCHI Y, 1994, ANAL SCI, V10, P213, DOI 10.2116/analsci.10.213; Liu X, 2005, TRAC-TREND ANAL CHEM, V24, P887, DOI 10.1016/j.trac.2005.05.010; Lu HB, 2000, LANGMUIR, V16, P1711, DOI 10.1021/la990221m; Mitsushio M, 2012, OPT COMMUN, V285, P3714, DOI 10.1016/j.optcom.2012.04.043; Mitsushio M, 1999, BUNSEKI KAGAKU, V48, P757; Mitsushio M, 2003, BUNSEKI KAGAKU, V52, P433, DOI 10.2116/bunsekikagaku.52.433; Mitsushio M, 2011, ANAL SCI, V27, P247, DOI 10.2116/analsci.27.247; Mitsushio M, 2014, BUNSEKI KAGAKU, V63, P365, DOI 10.2116/bunsekikagaku.63.365; Mitsushio M, 2012, BUNSEKI KAGAKU, V61, P999; Mitsushio M., 2001, ANAL SCI           S, V17, pi1721; Mitsushio M, 2010, ANAL SCI, V26, P949; Mitsushio M, 2004, SENSOR ACTUAT A-PHYS, V111, P252, DOI 10.1016/j.sna.2003.11.029; Mitsushio M, 2003, ANAL SCI, V19, P1421, DOI 10.2116/analsci.19.1421; Mitsushio M, 2000, BUNSEKI KAGAKU, V49, P307, DOI 10.2116/bunsekikagaku.49.307; Mitsushio M, 2014, PLASMONICS, V9, P451, DOI 10.1007/s11468-013-9643-6; Mitsushio M, 2004, ANAL SCI, V20, P689, DOI 10.2116/analsci.20.689; Montecillo ME, 2010, B CHEM SOC JPN, V83, P1531, DOI 10.1246/bcsj.20100176; Muguruma H., 2003, BUNSEKI, P38; Nishimura S, 2002, ANAL SCI, V18, P261, DOI 10.2116/analsci.18.261; Nishimura S., 2001, ANAL SCI, V17, pi1697; Nishimura S, 2002, ANAL SCI, V18, P267, DOI 10.2116/analsci.18.267; Nishimura S, 2002, BUNSEKI KAGAKU, V51, P163; Nishimura S, 2001, BUNSEKI KAGAKU, V50, P733; Nishimura S, 2001, BUNSEKI KAGAKU, V50, P79, DOI 10.2116/bunsekikagaku.50.79; Podgorsek R.P., 1997, SENSOR ACTUAT B-CHEM, V38-39, P349; Polyakov A, 2006, J MEMBRANE SCI, V277, P108, DOI 10.1016/j.memsci.2005.10.017; Polyakov AM, 2003, J MEMBRANE SCI, V216, P241, DOI 10.1016/S0376-7388(03)00077-2; Polyakov AM, 2004, J MEMBRANE SCI, V238, P21, DOI 10.1016/j.memsci.2004.03.018; TAKAHASH.Y, 1973, MACROMOLECULES, V6, P672, DOI 10.1021/ma60035a005; Wagner C. D., 1979, HDB XRAY PHOTOELECTR; Wei QQ, 2011, CHEM LETT, V40, P132, DOI 10.1246/cl.2011.132; Zhang H, 2010, J AM CHEM SOC, V132, P17867, DOI 10.1021/ja1075647	50	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0300-9440			PROG ORG COAT	Prog. Org. Coat.	FEB	2015	79						62	67		10.1016/j.porgcoat.2014.11.003		6	Chemistry, Applied; Materials Science, Coatings & Films	Chemistry; Materials Science	CA4NE	WOS:000348880500009		
J	Kato, T				Kato, Tadafumi			Whole genome/exome sequencing in mood and psychotic disorders	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Review						bipolar disorder; de novo mutations; depression; next generation sequencing; schizophrenia	DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; BIPOLAR DISORDER; ASSOCIATION ANALYSIS; SUSCEPTIBILITY GENE; MAJOR DEPRESSION; WIDE ASSOCIATION; COMPLEX DISEASE; MOLECULAR-BASIS; RARE VARIANTS	Recent developments in DNA sequencing technologies have allowed for genetic studies using whole genome or exome analysis, and these have been applied in the study of mood and psychotic disorders, including bipolar disorder, depression, schizophrenia, and schizoaffective disorder. In this review, the current situation, recent findings, methodological problems, and future directions of whole genome/exome analysis studies of these disorders are summarized. Whole genome/exome studies of bipolar disorder have included pedigree analysis and case-control studies, demonstrating the role of previously implicated pathways, such as calcium signaling, cyclic adenosine monophosphate response element binding protein (CREB) signaling, and potassium channels. Extensive analysis of trio families and case-control studies showed that de novo mutations play a role in the genetic architecture of schizophrenia and indicated that mutations in several molecular pathways, including chromatin regulation, activity-regulated cytoskeleton, post-synaptic density, N-methyl-D-aspartate receptor, and targets of fragile X mental retardation protein, are associated with this disorder. Depression is a heterogeneous group of diseases and studies using exome analysis have been conducted to identify rare mutations causing Mendelian diseases that accompany depression. In the near future, clarification of the genetic architecture of bipolar disorder and schizophrenia is expected. Identification of causative mutations using these new technologies will facilitate neurobiological studies of these disorders.	RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan	Kato, T (reprint author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kato@brain.riken.jp			Takeda Pharmaceutical Co., Ltd.	The author has received honoraria for lectures, manuscripts, and/or consultancy, from Kyowa Hakko Kirin Co., Ltd, Eli Lilly Japan K.K., Otsuka Pharmaceutical Co., Ltd, GlaxoSmithKline K.K., Taisho Toyama Pharmaceutical Co., Ltd, Dainippon Sumitomo Pharma Co., Ltd, Meiji Seika Pharma Co., Ltd, Pfizer Japan Inc., Mochida Pharmaceutical Co., Ltd, Shionogi & Co., Ltd, Janssen Pharmaceutical K.K., Pfizer, Yoshitomiyakuhin, Agilent Technologies, and Astellas Pharma Inc. within the last 3 years. T.K. also received a research grant from Takeda Pharmaceutical Co., Ltd.	Altamura AC, 2014, PSYCHIAT CLIN NEUROS, V68, P21, DOI 10.1111/pcn.12089; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Timms AE, 2013, JAMA PSYCHIAT, V70, P582, DOI 10.1001/jamapsychiatry.2013.1195; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Fiorentino A, 2014, BIPOLAR DISORD, V16, P583, DOI 10.1111/bdi.12203; Hattori E, 2009, AM J MED GENET B, V150B, P1110, DOI 10.1002/ajmg.b.30941; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Schulze TG, 2004, HUM HERED, V58, P131, DOI 10.1159/000083539; Kato T, 1996, AM J MED GENET, V67, P546, DOI 10.1002/(SICI)1096-8628(19961122)67:6<546::AID-AJMG6>3.0.CO;2-F; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Crowley JJ, 2013, MOL PSYCHIATR, V18, P138, DOI 10.1038/mp.2012.28; Kuo PH, 2014, PROG NEURO-PSYCHOPH, V51, P58, DOI 10.1016/j.pnpbp.2014.01.003; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Myles-Worsley M, 2013, AM J MED GENET B, V162B, P87, DOI 10.1002/ajmg.b.32125; Ionita-Laza I, 2014, P NATL ACAD SCI USA, V111, P343, DOI 10.1073/pnas.1309475110; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Flint J, 2014, NEURON, V81, P484, DOI 10.1016/j.neuron.2014.01.027; Kato T, 2008, TRENDS NEUROSCI, V31, P495, DOI 10.1016/j.tins.2008.07.007; Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001; Kanba S, 2013, PSYCHIAT CLIN NEUROS, V67, P285, DOI 10.1111/pcn.12060; Stahl SM, 2013, CNS SPECTRUMS, V18, P150, DOI 10.1017/S109285291300014X; Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Need AC, 2012, AM J HUM GENET, V91, P303, DOI 10.1016/j.ajhg.2012.06.018; Doyle GA, 2012, BIPOLAR DISORD, V14, P809, DOI 10.1111/bdi.12002; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Tammiste A, 2013, J PSYCHOPHARMACOL, V27, P915, DOI 10.1177/0269881113499829; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Cruceanu C, 2013, GENOME, V56, P634, DOI 10.1139/gen-2013-0081; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Kato T, 2005, MOL PSYCHIATR, V10, P622, DOI 10.1038/sj.mp.4001662; Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Ando S, 2013, PSYCHIAT CLIN NEUROS, V67, P471, DOI 10.1111/pcn.12086; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Takata A, 2013, BIOL PSYCHIAT, V73, P532, DOI 10.1016/j.biopsych.2012.10.024; Balan S, 2014, BRIT J PSYCHIAT, V204, P398, DOI 10.1192/bjp.bp.113.138420; Blumkin Lubov, 2014, JIMD Rep, V12, P103, DOI 10.1007/8904_2013_251; Bundo M, 2014, NEURON, V81, P306, DOI 10.1016/j.neuron.2013.10.053; Chen YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003224; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Drogemoller BI, 2014, PHARMACOGENOMICS, V15, P189, DOI 10.2217/pgs.13.218; Georgi B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004229; Georgieva L, 2014, HUM MOL GEN IN PRESS; Goes F, 2014, 16 ANN C INT SOC BIP; Hodge JC, 2014, MOL PSYCHIATR, V19, P368, DOI 10.1038/mp.2013.42; Hu X, 2014, MOL PSYCHIATR, V19, P857, DOI 10.1038/mp.2013.131; Judy Jennifer Toolan, 2013, Frontiers in Genetics, V4, P87, DOI 10.3389/fgene.2013.00087; Kerner Berit, 2013, Front Psychiatry, V4, P154, DOI 10.3389/fpsyt.2013.00154; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Matoba N, 2013, 21 WORLD C PSYCH GEN; Motomura K, 2013, PSYCHIAT CLIN NEUROS, V67, P1, DOI 10.1111/pcn.12011; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shishido E, 2014, PSYCHIAT CLIN NEUROS, V68, P85, DOI 10.1111/pcn.12128; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Strauss KA, 2014, HUM MOL GEN IN PRESS; Takata A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r92	72	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	2015	69	2					65	76		10.1111/pcn.12247		12	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CA1HU	WOS:000348664200001		
J	Hayashi, T; Legati, A; Nishikawa, T; Coppola, G				Hayashi, Teruo; Legati, Andrea; Nishikawa, Tadashi; Coppola, Giovanni			First Japanese family with primary familial brain calcification due to a mutation in the PDGFB gene: An exome analysis study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						dementia; Fahr's disease; platelet-derived growth factor; primary familial brain calcification; schizophrenia	BASAL GANGLIA CALCIFICATION; FAHRS-SYNDROME; DEMENTIA; SLC20A2; DISEASE; MICE	AimsPrimary familial brain calcification (PFBC) is a rare disorder characterized by abnormal deposits of calcium in the basal ganglia and cerebellum. PFBC can present with a spectrum of neuropsychiatric symptoms resembling those seen in dementia and schizophrenia. Mutations in a few genes have been identified as causing PFBC: namely, the SLC20A2 gene that codes for the sodium-dependent phosphate transporter and the PDGFRB gene that codes for the platelet-derived growth factor receptor (PDGF-R). A recent study identified mutations in PDGFB coding for PDGF-B, the main ligand for PDGF-R, in six families with PFBC. Here we report the first Japanese family with PFBC carrying a mutation in PDGFB, which causes the substitution of an arginine with a stop codon at amino acid 149 of the PDGF-B protein (p. Arg149*). MethodsClinical histories and computed tomography scan images were provided. Sanger sequencing was performed for the exome analysis of SLC20A2 and PDGFB genes. ResultsOne family member began to complain of auditory hallucination at 16 years of age and had been treated for schizophrenia. His father suffered from memory and gait disturbances in his late 60s. A computed tomography scan revealed a symmetrical area of calcification over the basal ganglia in both cases. A known mutation in PDGFB (c.445C>T, p.Arg149*) was consistently detected in both PFBC cases by Sanger sequencing. No mutations in SLC20A2 were detected. ConclusionsOur findings suggest that this mutation in PDGF-B is responsible for PFBC in this Japanese family and that abnormal PDGF signaling may be involved in the pathophysiology of certain psychiatric disorders.	[Hayashi, Teruo; Nishikawa, Tadashi] Seiwakai Nishikawa Hosp, Hamada, Shimane 6970052, Japan; [Legati, Andrea; Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Informat & Personalized Genom, Dept Psychiat, Los Angeles, CA 90024 USA; [Legati, Andrea; Coppola, Giovanni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Hayashi, T (reprint author), Seiwakai Nishikawa Hosp, 293-2 Minato Machi, Hamada, Shimane 6970052, Japan.	thayashi2r@gmail.com		Legati, Andrea/0000-0002-8178-6126			Oliveira JRM, 2004, NEUROLOGY, V63, P2165; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Hsu SC, 2013, NEUROGENETICS, V14, P11, DOI 10.1007/s10048-012-0349-2; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Modrego PJ, 2005, NEUROL SCI, V26, P367, DOI 10.1007/s10072-005-0493-7; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Calabro RS, 2014, BEHAV NEUROL, V2014; Chen WJ, 2013, GENE, V529, P159, DOI 10.1016/j.gene.2013.07.071; Konupcikova K, 2008, NEUROENDOCRINOL LETT, V29, P431; Kostic VS, 2011, J NEUROL, V258, P1637, DOI 10.1007/s00415-011-5985-1; Lemos RR, 2013, INT REV NEUROBIOL, V110, P349, DOI 10.1016/B978-0-12-410502-7.00015-6; Nicolas G, 2013, GEN HOSP PSYCHIAT, V35; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; Schilling D, 1998, BIOCHEM J, V333, P637; Sobrido MJ, 1993, GENEREVIEWS; Yao HH, 2014, J NEUROIMMUNE PHARM, V9, P161, DOI 10.1007/s11481-013-9481-5	19	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	2015	69	2					77	83		10.1111/pcn.12238		7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CA1HU	WOS:000348664200002		
J	Fujii, K; Uchida, H; Suzuki, T; Mimura, M				Fujii, Kazuhito; Uchida, Hiroyuki; Suzuki, Takefumi; Mimura, Masaru			Dependence on benzodiazepines in patients with panic disorder: A cross-sectional study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						benzodiazepines; dependence; panic disorder; severity; treatment	USERS; PERSONALITY; ALPRAZOLAM; SEVERITY; SCALE	AimsThe aim of this cross-sectional study was to examine the prevalence of psychological dependence on benzodiazepines in outpatients with panic disorder and elucidate demographic and clinical characteristics associated with this condition. MethodsSubjects were eligible if they were outpatients in four clinics in Tokyo, Japan, aged 18 years or older and met the diagnostic criteria for panic disorder according to the ICD-10. The subjects received the following assessments: the Severity of Dependence Scale, Japanese Version (SDS), the Self-Report Version of Panic Disorder Severity Scale, Japanese Version (PDSS-SR), and the Quick Inventory of Depressive Symptomatology-Self Report, Japanese Version. The following information was also collected: age, sex, ethnicity, duration of illness, physical and psychiatric comorbidities, and details of prescribed psychotropic medications. ResultsThe data from 51 outpatients showed that 31 patients (60.8%) showed psychological dependence (i.e. a total score of 5 in the SDS). The proportion of patients with dependence was significantly lower in remitted patients (i.e. a total score of 4 in the PDSS) (44.1%, n=15/34) than those who were not (94.1%, n=16/17) (Pearson (2)=11.9, P<0.001). A multiple regression analysis showed that the PDSS scores showed a positive correlation with the SDS total scores (=0.60, 95% confidence interval=0.30-0.90, P=0.0001). ConclusionThese findings emphasize the need for enhanced awareness about benzodiazepine dependence in patients and psychiatrists, as well as especially close attention to patients with panic disorder who present severe symptomatology.	[Fujii, Kazuhito; Uchida, Hiroyuki; Suzuki, Takefumi; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Fujii, Kazuhito] Inokashira Hosp, Azumabashi New Tower Clin, Tokyo, Japan; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan; [Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada	Uchida, H (reprint author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hiroyuki.uchida.hu@gmail.com	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	Inokashira Hospital Research Grant; Pfizer; Astellas Pharmaceutical; Eisai; Otuka Pharmaceutical; GlaxoSmithKline; Shionogi; Dainippon-Sumitomo Pharma; Eli Lilly; Mochida Pharmaceutical; Meiji-Seika Pharma; Janssen Pharmaceutical; Yoshitomi Yakuhin; Astellas; Dainippon Sumitomo; Elsevier Japan; Meiji Seika; Novartis; Otsuka; Weily Japan; Asahi Kasei Pharma; Daiichi Sankyo; MSD; Novartis Pharma; Otsuka Pharmaceutical; Takeda; Tanabe Mitsubishi Pharma	This study was partially funded by an Inokashira Hospital Research Grant. The authors thank Drs Hirano, Mizuno, Sawada, Tsuboi, and Yoshida for their continuous support and Ms Ai Ohtani for her administrative support. Dr Fujii has nothing to disclose. Dr Uchida has received grants from Pfizer, Astellas Pharmaceutical, Eisai, Otuka Pharmaceutical, GlaxoSmithKline, Shionogi, Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, Meiji-Seika Pharma, Janssen Pharmaceutical, and Yoshitomi Yakuhin and speaker's honoraria from Otuka Pharmaceutical, Eli Lilly, Shionogi, GlaxoSmithKline, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, Meiji-Seika Pharma, Abbvie, and Janssen Pharmaceutical within the past 3 years. Dr Suzuki has received manuscript or speaker's fees from Astellas, Dainippon Sumitomo, Eli Lilly, Elsevier Japan, Meiji Seika, Novartis, Otsuka, and Weily Japan within the past 3 years. Dr Mimura has received grants and/or speaker's honoraria from Asahi Kasei Pharma, Astellas Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutical, Meiji-Seika Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi Pharma, and Yoshitomi Yakuhin within the past 3 years.	American Psychiatric Association, 1990, BENZ DEP TOX AB TASK; American Psychiatric Association, 2009, PRACT GUID TREATM PA; Andersch S, 2003, EUR PSYCHIAT, V18, P401, DOI 10.1016/j.eurpsy.2003.03.007; Preville M, 2008, CAN J PSYCHIAT, V53, P822; BUSTO U, 1986, NEW ENGL J MED, V315, P854, DOI 10.1056/NEJM198610023151403; Baldwin DS, 2013, J PSYCHOPHARMACOL, V27, P967, DOI 10.1177/0269881113503509; Houck PR, 2002, DEPRESS ANXIETY, V15, P183, DOI 10.1002/da.10049; Uzun S, 2010, PSYCHIAT DANUB, V22, P90; Moylan S, 2012, AUST NZ J PSYCHIAT, V46, P212, DOI 10.1177/0004867411432074; Bennett JA, 1998, DRUG SAFETY, V18, P419, DOI 10.2165/00002018-199818060-00003; COWLEY DS, 1993, PSYCHIAT RES, V47, P151, DOI 10.1016/0165-1781(93)90045-I; Fiseković Saida, 2005, Bosn J Basic Med Sci, V5, P78; Fujisawa D, 2010, STRESS SCI, V25, P43; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; HOLLISTER LE, 1961, PSYCHOPHARMACOLOGIA, V2, P63, DOI 10.1007/BF00429621; INAGAKI A, 2007, JAPANESE J CLIN PSYC, V10, P2373; Katagami M., 2007, JAPANESE J PSYCHOSOM, V47, P331; Manthey L, 2012, ADDICTION, V107, P2173, DOI 10.1111/j.1360-0443.2012.03975.x; Nardi AE, 2011, BRAZ J MED BIOL RES, V44, P366; Nelson J, 1999, Can J Clin Pharmacol, V6, P69; NOYES R, 1991, COMPR PSYCHIAT, V32, P283, DOI 10.1016/0010-440X(91)90076-O; Ozaki Shigeru, 2005, Nihon Arukoru Yakubutsu Igakkai Zasshi, V40, P126; Rickels K, 1998, J CLIN PSYCHOPHARM, V18, p12S, DOI 10.1097/00004714-199812001-00004; RICKELS K, 1986, PSYCHOPHARMACOL BULL, V22, P407; ROMACH MK, 1992, J CLIN PSYCHOPHARM, V12, P316; Andrews G, 2003, AUST NZ J PSYCHIAT, V37, P641; SCHMIDT LG, 1989, BRIT J PSYCHIAT, V154, P839, DOI 10.1192/bjp.154.6.839; Uchida H, 2009, J ANXIETY DISORD, V23, P477, DOI 10.1016/j.janxdis.2008.10.003; World Health Organization, 1992, F40 F48 NEUR STRESS, P110	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	2015	69	2					93	99		10.1111/pcn.12203		7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CA1HU	WOS:000348664200004		
J	Takeshima, M; Oka, T				Takeshima, Minoru; Oka, Takashi			DSM-5-defined 'mixed features' and Benazzi's mixed depression: Which is practically useful to discriminate bipolar disorder from unipolar depression in patients with depression?	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						bipolar disorder; depression; DSM-5; mixed states; mixed depression	AGITATED DEPRESSION; SUICIDE ATTEMPTS; EPISODES; STATES; DIAGNOSIS; PHENOMENOLOGY; MELANCHOLIA; SYMPTOMS; MANIA	AimsIrritability, psychomotor agitation, and distractibility in a major depressive episode (MDE) should not be counted as manic/hypomanic symptoms of DSM-5-defined mixed features; however, this remains controversial. The practical usefulness of this definition in discriminating bipolar disorder (BP) from major depressive disorder (MDD) in patients with depression was compared with that of Benazzi's mixed depression, which includes these symptoms. MethodsThe prevalence of both definitions of mixed depression in 217 patients with MDE (57 bipolar II disorder, 35 BP not otherwise specified, and 125 MDD cases), and their operating characteristics regarding BP diagnosis were compared. ResultsThe prevalence of both Benazzi's mixed depression and DSM-5-defined mixed features was significantly higher in patients with BP than it was in patients with MDD, with the latter being quite low (62.0% vs 12.8% [P<0.0001], and 7.6% vs 0% [P<0.0021], respectively). The area under the receiver operating curve for BP diagnosis according to the number of all manic/hypomanic symptoms was numerically larger than that according to the number of manic/hypomanic symptoms excluding the above-mentioned three symptoms (0.798; 95% confidence interval, 0.736-0.859 vs 0.722; 95% confidence interval, 0.654-0.790). The sensitivity/specificity of DSM-5-defined mixed features and Benazzi's mixed depression for BP diagnosis were 5.1%/100% and 55.1%/87.2%, respectively. ConclusionsDSM-5-defined mixed features were too restrictive to discriminate BP from MDD in patients with depression compared with Benazzi's definition. To confirm this finding, studies that include patients with BP-I and using tools to assess manic/hypomanic symptoms during MDE are necessary.	[Takeshima, Minoru] Kouseiren Takaoka Hosp, Dept Psychiat, Takaoka, Toyama, Japan; [Takeshima, Minoru; Oka, Takashi] Juzen Hosp, Clin J, Kanazawa, Ishikawa, Japan; [Oka, Takashi] Juzen Hosp, Dept Psychiat, Kanazawa, Ishikawa, Japan	Takeshima, M (reprint author), J Clin, 3-30-10 Sainen, Kanazawa, Ishikawa 9200024, Japan.	min-take@p2.tcnet.ne.jp					American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Swann AC, 2013, AM J PSYCHIAT, V170, P31, DOI 10.1176/appi.ajp.2012.12030301; Koukopoulos A, 1999, PSYCHIAT CLIN N AM, V22, P547, DOI 10.1016/S0193-953X(05)70095-2; Fiedorowicz JG, 2011, AM J PSYCHIAT, V168, P40, DOI 10.1176/appi.ajp.2010.10030328; Malhi GS, 2013, LANCET, V381, P1599, DOI 10.1016/S0140-6736(13)60893-4; Angst J, 2009, EUR ARCH PSY CLIN N, V259, P55, DOI 10.1007/s00406-008-0834-7; Cassidy F, 1998, J AFFECT DISORDERS, V50, P187, DOI 10.1016/S0165-0327(98)00016-0; Bertschy G, 2007, BIPOLAR DISORD, V9, P907; Perlis RH, 2009, ACTA PSYCHIAT SCAND, V119, P282, DOI 10.1111/j.1600-0447.2008.01298.x; Benazzi F, 2001, J AFFECT DISORDERS, V67, P115, DOI 10.1016/S0165-0327(01)00444-X; Goldberg JF, 2009, AM J PSYCHIAT, V166, P173, DOI 10.1176/appi.ajp.2008.08050746; Koukopoulos A, 2007, ACTA PSYCHIAT SCAND, V115, P50, DOI 10.1111/j.1600-0447.2007.00963.x; Sato T, 2005, J AFFECT DISORDERS, V84, P187, DOI 10.1016/S0165-0327(02)00172-6; Balazs J, 2006, J AFFECT DISORDERS, V91, P133, DOI 10.1016/j.jad.2005.12.049; Vieta E, 2013, J AFFECT DISORDERS, V148, P28, DOI 10.1016/j.jad.2013.03.007; Valtonen HM, 2008, BIPOLAR DISORD, V10, P588, DOI 10.1111/j.1399-5618.2007.00553.x; Judd LL, 2013, JAMA PSYCHIAT, V70, P1171, DOI 10.1001/jamapsychiatry.2013.1957; Akiskal HS, 1998, J AFFECT DISORDERS, V50, P175, DOI 10.1016/S0165-0327(98)00113-X; Benazzi F, 2008, PROG NEURO-PSYCHOPH, V32, P932, DOI 10.1016/j.pnpbp.2007.12.019; Benazzi F, 2003, PSYCHOTHER PSYCHOSOM, V72, P300, DOI 10.1159/000073026; Benazzi F, 2002, PROG NEURO-PSYCHOPH, V26, P1105, DOI 10.1016/S0278-5846(02)00244-0; Benazzi F, 2004, PROG NEURO-PSYCHOPH, V28, P1279, DOI 10.1016/j.pnpbp.2004.06.018; Kraepelin E, 1913, PSYCHIAT LEHRBUCH ST; Marneros A, 2001, J AFFECT DISORDERS, V67, P229, DOI 10.1016/S0165-0327(01)00437-2; Pae CU, 2012, J AFFECT DISORDERS, V136, P1059, DOI 10.1016/j.jad.2011.11.024; Takeshima M, 2013, J AFFECT DISORDERS, V147, P150, DOI 10.1016/j.jad.2012.10.026	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	2015	69	2					109	116		10.1111/pcn.12213		8	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CA1HU	WOS:000348664200006		
J	Sugawara, N; Tanaka, O; Yasui-Furukori, N				Sugawara, Norio; Tanaka, Osamu; Yasui-Furukori, Norio			Effects of the 2004 postgraduate training program on the interprefectural distribution of psychiatrists in Japan	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						geographical distribution; Gini coefficient; inequality; Japan; psychiatrist	GEOGRAPHIC-DISTRIBUTION; PHYSICIANS	AimsAfter a new postgraduate training program was launched by the Ministry of Health, Labour, and Welfare in 2004, concern regarding the maldistribution of physicians has increased in Japan. This study aimed to assess the interprefectural distribution of psychiatrists in Japan before and after the start of the new postgraduate training program. MethodsOur data included nine time points: 1996, 1998, 2000, 2002, 2004, 2006, 2008, 2010 and 2012. The Gini coefficient (GC) was calculated using prefectures as the study unit to assess whether the interprefectural distribution of psychiatrists significantly changed in relation to the population and area of prefectures. The effect of the new postgraduate training program on the GC of psychiatrist distribution was assessed by estimating the interaction between year and period (before or after the postgraduate training program) using a general linear model analysis. ResultsThe total number of psychiatrists increased from 10093 to 14733 over the observed period. The general linear model showed a significant interaction between the year and the period for the GC based on the number of psychiatrists per 100km(2), whereas no interaction was found for the GC based on the number of psychiatrists per 100000 population. ConclusionsThe interprefectural distribution of psychiatrists per 100km(2) worsened after the launch of the new training program; this result may reflect the adverse impact of the training program. Further observation is needed to explore how this difference in the interprefectural distribution of psychiatrists affects the mental health status of the population.	[Sugawara, Norio; Tanaka, Osamu] Hirosaki Univ, Sch Med, Aomori Prefectural Ctr Mental Hlth & Welf, Aomori, Japan; [Yasui-Furukori, Norio] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Aomori, Japan	Sugawara, N (reprint author), Aomori Prefectural Ctr Mental Hlth & Welf, 353-92 Sawabe Sannai, Aomori 0380031, Japan.	nsuga3@yahoo.co.jp					KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; Geospatial Information Authority, STAT REP LAND AR PRE; Katsurada E, 2002, SEX ROLES, V47, P249, DOI 10.1023/A:1021334710431; Matsumoto M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-12; Ministry of Health, PAT SURV; Ministry of Health Labour and Welfare, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare, WORK GROUP POSTGR CL; Mori K, REPORT 166; Ono K, 2010, OPHTHAL EPIDEMIOL, V17, P125, DOI 10.3109/09286581003624988; Sakai R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077045; Tanihara S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-260; Toyabe S, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-5; Zurn P, 2004, HUM RESOUR HEALTH, V2, P13, DOI DOI 10.1186/1478-4491-2-13	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	2015	69	2					117	121		10.1111/pcn.12219		5	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CA1HU	WOS:000348664200007		
J	Tei, S; Becker, C; Sugihara, G; Kawada, R; Fujino, J; Sozu, T; Murai, T; Takahashi, H				Tei, Shisei; Becker, Carl; Sugihara, Genichi; Kawada, Ryosaku; Fujino, Junya; Sozu, Takashi; Murai, Toshiya; Takahashi, Hidehiko			Sense of meaning in work and risk of burnout among medical professionals	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Tei, Shisei; Sugihara, Genichi; Kawada, Ryosaku; Fujino, Junya; Murai, Toshiya; Takahashi, Hidehiko] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Sozu, Takashi] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan; [Becker, Carl] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan	Tei, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan.	hidehiko@kuhp.kyoto-u.ac.jp					ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Bellini LM, 2002, JAMA-J AM MED ASSOC, V287, P3143, DOI 10.1001/jama.287.23.3143; Narumoto J, 2008, PSYCHIAT CLIN NEUROS, V62, P174, DOI 10.1111/j.1440-1819.2008.01751.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	2015	69	2					123	124		10.1111/pcn.12217		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CA1HU	WOS:000348664200010		
J	Eguchi, S; Koike, S; Suga, M; Takizawa, R; Kasai, K				Eguchi, Satoshi; Koike, Shinsuke; Suga, Motomu; Takizawa, Ryu; Kasai, Kiyoto			Psychological symptom and social functioning subscales of the modified Global Assessment of Functioning scale: Reliability and validity of the Japanese version	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Letter									[Eguchi, Satoshi; Suga, Motomu] Univ Tokyo, Grad Sch Med, Dept Rehabil, Tokyo, Japan; [Koike, Shinsuke; Takizawa, Ryu; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Koike, Shinsuke] Univ Tokyo, Div Counseling & Support, Off Mental Hlth Support, Tokyo, Japan	Eguchi, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Rehabil, Tokyo, Japan.	skoike-tky@umin.ac.jp					American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; HALL RCW, 1995, PSYCHOSOMATICS, V36, P267	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	2015	69	2					126	127		10.1111/pcn.12250		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CA1HU	WOS:000348664200014		
J	Matsuda, S; Yamamoto, J				Matsuda, Soichiro; Yamamoto, Junichi			Intramodal and cross-modal matching of emotional expression in young children with autism spectrum disorders	RESEARCH IN AUTISM SPECTRUM DISORDERS			English	Article						Affective prosody; Autism; Cross-modal matching; Emotion comprehension; Facial expression	HIGH-FUNCTIONING AUTISM; FACIAL EXPRESSIONS; AFFECTIVE PROSODY; RECOGNITION; PERCEPTION; ABILITY; INTERVENTION; APPRAISAL; ADULTS; SCALE	Children with autism spectrum disorders (ASDs) exhibit difficulties in their comprehension of others' emotions. According to a variety of experimental procedures, many of them can be classified into two types according to the modality of their stimuli and responses. These are intramodal (visual stimulus-visual stimulus) and cross-modal (auditory stimulus-visual stimulus) matching. Previous studies tested both intramodal and cross-modal matching only in adolescents with ASD, although young children with ASD have also been found to have difficulties with cross-modal matching but not intramodal matching. The purpose of this study was to compare the intramodal and cross-modal matching of emotional expression in young children with ASD and typically developing (TD) children. Ten children with ASD aged 4-8 and 22 developmental age (DA)-matched TD children aged 3-6 participated in this study. Pictures of facial expressions were used as visual stimuli, and affective prosodies were used as auditory stimuli. The results showed that the children with ASD were less accurate than the TD children in cross-modal matching but equally accurate on intramodal matching. These findings are discussed along with the modality of stimuli and responses, and the ages of the participants. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsuda, Soichiro; Yamamoto, Junichi] Keio Univ, Dept Psychol, Tokyo, Japan; [Yamamoto, Junichi] Japan Sci & Technol Agcy, CREST, Saitama, Japan	Matsuda, S (reprint author), Keio Univ, Dept Psychol, Minato Ku, 2-15-45 Mita, Tokyo, Japan.	atom.opens.the.stargate@gmail.com					American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Smith MJL, 2010, NEUROPSYCHOLOGIA, V48, P2777, DOI 10.1016/j.neuropsychologia.2010.03.008; Rump KM, 2009, CHILD DEV, V80, P1434, DOI 10.1111/j.1467-8624.2009.01343.x; HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P321, DOI 10.1111/j.1469-7610.1986.tb01836.x; Boucher J, 2000, J CHILD PSYCHOL PSYC, V41, P847, DOI 10.1017/S0021963099006149; Lacroix A, 2009, RES DEV DISABIL, V30, P976, DOI 10.1016/j.ridd.2009.02.002; Humphreys K, 2007, NEUROPSYCHOLOGIA, V45, P685, DOI 10.1016/j.neuropsychologia.2006.08.003; TANTAM D, 1989, J CHILD PSYCHOL PSYC, V30, P623, DOI 10.1111/j.1469-7610.1989.tb00274.x; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Baker KF, 2010, J AUTISM DEV DISORD, V40, P123, DOI 10.1007/s10803-009-0841-1; Gepner B, 2001, J AUTISM DEV DISORD, V31, P37, DOI 10.1023/A:1005609629218; Castelli F, 2005, AUTISM, V9, P428, DOI 10.1177/1362361305056082; Rosset DB, 2008, J AUTISM DEV DISORD, V38, P919, DOI 10.1007/s10803-007-0465-2; Jones CRG, 2011, J CHILD PSYCHOL PSYC, V52, P275, DOI 10.1111/j.1469-7610.2010.02328.x; Peppe S, 2007, J SPEECH LANG HEAR R, V50, P1015, DOI 10.1044/1092-4388(2007/071); Grossman JB, 2000, J CHILD PSYCHOL PSYC, V41, P369, DOI 10.1017/S0021963099005466; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Loveland KA, 1997, DEV PSYCHOPATHOL, V9, P579; DAVIES S, 1994, J CHILD PSYCHOL PSYC, V35, P1033, DOI 10.1111/j.1469-7610.1994.tb01808.x; Koyama T, 2009, PSYCHIAT CLIN NEUROS, V63, P241, DOI 10.1111/j.1440-1819.2009.01931.x; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; PRIOR M, 1990, J CHILD PSYCHOL PSYC, V31, P587, DOI 10.1111/j.1469-7610.1990.tb00799.x; BORMANNKISCHKEL C, 1995, J CHILD PSYCHOL PSYC, V36, P1243, DOI 10.1111/j.1469-7610.1995.tb01368.x; Braverman A., 1989, JOURNAL OF AUTISM AN, V19, P301; CAPPS L, 1992, J CHILD PSYCHOL PSYC, V33, P1169, DOI 10.1111/j.1469-7610.1992.tb00936.x; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Evers K, 2011, RES AUTISM SPECT DIS, V5, P1327, DOI 10.1016/j.rasd.2011.01.004; Fink EJ, 2014, DRAMATIC STORY STRUCTURE: A PRIMER FOR SCREENWRITERS, P44; Grossman RB, 2010, J SPEECH LANG HEAR R, V53, P778, DOI 10.1044/1092-4388(2009/08-0127); HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P671, DOI 10.1111/j.1469-7610.1986.tb00191.x; Ikuzawa M., 2002, KYOTO SCALE OF PSYCH; MACDONALD H, 1989, J CHILD PSYCHOL PSYC, V30, P865, DOI 10.1111/j.1469-7610.1989.tb00288.x; Matsuda S, 2014, RES AUTISM SPECT DIS, V8, P944, DOI 10.1016/j.rasd.2014.04.010; Matsuda S, 2013, RES AUTISM SPECT DIS, V7, P938, DOI 10.1016/j.rasd.2013.04.001; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-005-1999-9	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-9467	1878-0237		RES AUTISM SPECT DIS	Res. Autism Spectr. Disord.	FEB	2015	10						109	115		10.1016/j.rasd.2014.11.010		7	Education, Special; Psychology, Developmental; Psychiatry; Rehabilitation	Education & Educational Research; Psychology; Psychiatry; Rehabilitation	AZ5NE	WOS:000348266700013		
J	Yamamoto, T; Masaoka, N				Yamamoto, Takehiro; Masaoka, Norichika			Numerical simulation of star polymers under shear flow using a coupling method of multi-particle collision dynamics and molecular dynamics	RHEOLOGICA ACTA			English	Article						Multi-particle collision dynamics; MPCD; Flow-induced structures; Star polymers; Shear flows	DILUTE SOLUTION; CYLINDER; COLLOIDS; MODELS; FLUIDS	The numerical simulation of flow-induced structures is important for the flow analysis of complex fluids. Several schemes have been proposed for coupling the macro-flow computation and the microsimulation of the inner structure of complex fluids. In the present study, the flow-induced structure of star polymers was numerically simulated using a coupling method of multi-particle collision dynamics (MPCD) and coarse-grained molecular dynamics (MD). The polymers were modeled as elastic dumbbells, which consist of finitely extensible nonlinear elastic springs and beads. The motion of the beads was computed by MD. The MPCD was applied to model the effect of Brownian motion and hydrodynamic interactions among the beads. In the present study, the MPC-AT+a algorithm was employed for the collision steps in MPCD computations. The behavior of linear polymers in a shear flow was numerically analyzed to confirm the validity of the present simulation scheme. The numerical results agree well with both experimental results and predictions by other numerical methods. Furthermore, the simulation of star polymers under shear flow was carried out. The present simulation captured characteristic behaviors such as the configuration of the star polymers, which was more compact for polymers with more arms due to extruded volume effects, polymers tumbling at high Weissenberg numbers, and the fluctuation in expansions in the direction of flow decreasing for polymers with more arms.	[Yamamoto, Takehiro; Masaoka, Norichika] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan	Yamamoto, T (reprint author), Osaka Univ, Dept Mech Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	take@mech.eng.osaka-u.ac.jp					Ripoll M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188302; Larson RG, 2005, J RHEOL, V49, P1, DOI 10.1122/1.1835336; Hur JS, 2000, J RHEOL, V44, P713, DOI 10.1122/1.551115; GREST GS, 1987, MACROMOLECULES, V20, P1376, DOI 10.1021/ma00172a035; Nakayama Y, 2008, EUR PHYS J E, V26, P361, DOI 10.1140/epje/i2007-10332-y; Noguchi H, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011901; ZIMM BH, 1956, J CHEM PHYS, V24, P269, DOI 10.1063/1.1742462; Kikuchi N, 2003, J CHEM PHYS, V119, P6388, DOI 10.1063/1.1603721; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; DAOUD M, 1982, J PHYS-PARIS, V43, P531, DOI 10.1051/jphys:01982004303053100; Aust C, 1999, MACROMOLECULES, V32, P5660, DOI 10.1021/ma981683u; Nakayama Y, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036707; ZIMM BH, 1959, J POLYM SCI, V37, P19, DOI 10.1002/pol.1959.1203713102; Gotze IO, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046705; Vlassopoulos D, 2001, J PHYS-CONDENS MAT, V13, pR855, DOI 10.1088/0953-8984/13/41/202; Kroger M, 2004, PHYS REP, V390, P453, DOI 10.1016/j.physrep.2003.10.014; Lamura A, 2001, EUROPHYS LETT, V56, P319, DOI 10.1209/epl/i2001-00522-9; Teixeira RE, 2005, MACROMOLECULES, V38, P581, DOI 10.1021/ma0480771; Noguchi H, 2005, P NATL ACAD SCI USA, V102, P14159, DOI 10.1073/pnas.0504243102; LEES AW, 1972, J PHYS PART C SOLID, V5, P1921, DOI 10.1088/0022-3719/5/15/006; Winkler RG, 2004, J PHYS-CONDENS MAT, V16, pS3941, DOI 10.1088/0953-8984/16/38/012; BARRETT AJ, 1987, MACROMOLECULES, V20, P1687, DOI 10.1021/ma00173a040; BAUER BJ, 1989, MACROMOLECULES, V22, P2337, DOI 10.1021/ma00195a058; Cannavacciuolo L, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/34007; Dhont JKG, 2003, FARADAY DISCUSS, V123, P157, DOI 10.1039/b205039k; Doi M, 1986, THEORY POLYM DYNAMIC; Gompper G, 2009, ADV POLYM SCI, V221, P1, DOI 10.1007/12_2008_5; Heine DR, 2010, J CHEM PHYS, V132; Huang HM, 2005, POLYMER, V46, P955, DOI 10.1016/j.polymer.2004.11.102; Iwashita T, 2008, J PHYS SOC JPN, V77; Ji S, 2011, J CHEM PHYS, V135; Kapral R, 2008, ADV CHEM PHYS, V140, P89, DOI 10.1002/9780470371572.ch2; Lamura A, 2002, EUR PHYS J E, V9, P477, DOI 10.1140/epje/i2002-10107-0; Mussawisade K, 2005, J CHEM PHYS, V123; Nikoubashman A, 2010, J CHEM PHYS, V133; Noguchi H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016706; Ripoll M, 2007, EUR PHYS J E, V23, P349, DOI 10.1140/epje/i2006-10220-0; Sarman SS, 1998, PHYS REP, V305, P1, DOI 10.1016/S0370-1573(98)00018-0; Webster MA, 2005, J CHEM PHYS, V122	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0035-4511	1435-1528		RHEOL ACTA	Rheol. Acta	FEB	2015	54	2					139	147		10.1007/s00397-014-0817-8		9	Mechanics	Mechanics	AZ9XF	WOS:000348566900004		
J	Yasukawa, S; Kano, S				Yasukawa, Satoshi; Kano, Shingo			Comparison of examiners' forward citations in the United States and Japan with pairs of equivalent patent applications	SCIENTOMETRICS			English	Article						Patent citation analysis; Examiners' forward citations; Equivalent patent applications	INDICATORS	In this study, we investigate and compare the number of examiners' forward citations in the United States and Japan. The most effective way to do so is to compare pairs of patent applications that have equivalent content. Therefore, we propose a new method of extracting substantially equivalent pairs of US and Japanese patent applications, focusing on the equivalence of the specifications and the claims. Our results reveal that during the substantive examination, US examiners cite patent application publications (PAPs) as well as granted patent publications (GPPs), whereas Japanese examiners tend to cite PAPs only. We further examine why GPPs are frequently cited by US examiners. The most likely reason seems to be that many US examiners retain the old habit of searching and citing only GPPs, but not PAPs. The insights offered by this study could be significant for future analyses based on the number of citations, particularly in the United States.	[Yasukawa, Satoshi; Kano, Shingo] Univ Tokyo, Grad Sch Frontier Sci, Course Intellectual Property Biosci, Dept Med Genome Sci, Tokyo, Japan	Yasukawa, S (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Course Intellectual Property Biosci, Dept Med Genome Sci, Tokyo, Japan.	yasukawa@k.u-tokyo.ac.jp; kano@k.u-tokyo.ac.jp					Martinez C, 2011, SCIENTOMETRICS, V86, P39, DOI 10.1007/s11192-010-0251-3; Meyer M, 2000, SCIENTOMETRICS, V49, P93, DOI 10.1023/A:1005613325648; Narin F, 1998, SCIENTOMETRICS, V41, P51, DOI 10.1007/BF02457966; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Goto A, 2007, RES POLICY, V36, P1431, DOI 10.1016/j.respol.2007.06.005; Michel J, 2001, SCIENTOMETRICS, V51, P185, DOI 10.1023/A:1010577030871; Lanjouw JO, 2004, ECON J, V114, P441, DOI 10.1111/j.1468-0297.2004.00216.x; Harhoff D, 2003, RES POLICY, V32, P1343, DOI 10.1016/S0048-7333(02)00124-5; Gambardella A, 2008, EUR MANAG REV, V5, P69, DOI 10.1057/emr.2008.10; ALBERT MB, 1991, RES POLICY, V20, P251, DOI 10.1016/0048-7333(91)90055-U; Nagaoka S, 2010, HBK ECON, V2, P1083, DOI 10.1016/S0169-7218(10)02009-5; Alcacer J, 2009, RES POLICY, V38, P415, DOI 10.1016/j.respol.2008.12.001; Carpenter M. P., 1981, WORLD PATENT INFORMA, V3, P160, DOI 10.1016/0172-2190(81)90098-3; Hall B. H., 2001, 8498 NBER; Hegde D, 2009, ECON LETT, V105, P287, DOI 10.1016/j.econlet.2009.08.019; Mogee M. E., 2007, SCI TECHN INN POL 20, DOI [10.1109/ACSTIP.2007.4472902, DOI 10.1109/ACSTIP.2007.4472902]; Nagaoka S., 2009, RIETI DISCUSSION PAP, V09-E-010; OECD, 2009, OECD PAT SAT MAN; Wada T., 2009, RIETI DISCUSSION PAP; WIPO, 2013, IPC TECHN CONC TABL; Yasukawa S., 2013, SCIENTOMETRICS, V99, P895	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0138-9130	1588-2861		SCIENTOMETRICS	Scientometrics	FEB	2015	102	2					1189	1205		10.1007/s11192-014-1466-5		17	Computer Science, Interdisciplinary Applications; Information Science & Library Science	Computer Science; Information Science & Library Science	AZ6IS	WOS:000348324000006		
J	Arjunan, SP; Kumar, DK; Wheeler, K; Shimada, H				Arjunan, Sridhar Poosapadi; Kumar, Dinesh Kant; Wheeler, Katherine; Shimada, Hirokazu			Spectral properties of surface electromyogram signal and change in muscle conduction velocity during isometric muscle contraction	SIGNAL IMAGE AND VIDEO PROCESSING			English	Article						Surface electromyogram (sEMG); Median frequency; Muscle conduction velocity; Fatigue; EMG model	MOTOR UNIT RECRUITMENT; MEAN POWER FREQUENCY; MYOELECTRIC SIGNALS; FIBER TYPE; EMG; FORCE; PARAMETERS; MODEL; BICEPS	It is well known that there is a change in the spectrum of surface electromyogram (sEMG) with the onset of muscle fatigue. This change has largely been attributed to the change in muscle conduction velocity. We have investigated this theory by using our previously developed sEMG model with the various neuromuscular parameters. The change of spectrum of the experimental results has been compared with simulated sEMG in response to the change in muscle conduction velocity using similar conditions. In this study, the designed model implemented the change in the muscle conduction velocity (Delta upsilon) as a parameter to simulate the sEMG. The shift in spectrum was identified by computation of the median frequency (MDF) of the sEMG before and after the implementation of the rate of the slow down (RS or ) parameter in the model. The results based on the simulation of the model show that the rate of change in MDF was consistent in all levels of contractions and it is not same with experimental conditions. The results also suggest that the large change in MDF in the simulated sEMG than in experimental conditions may be attributable to other factors such as change in the recruitment pattern and the level of contraction not only due to the change in the muscle conduction velocity (Delta upsilon).	[Arjunan, Sridhar Poosapadi; Kumar, Dinesh Kant; Wheeler, Katherine] RMIT Univ, Biosignals Lab, Melbourne, Vic 3001, Australia; [Shimada, Hirokazu] Oita Natl Coll Technol, Dept Comp & Control Engn, Maki, Oita, Japan	Arjunan, SP (reprint author), RMIT Univ, Biosignals Lab, GPO Box 2476, Melbourne, Vic 3001, Australia.	sridhar.arjunan@rmit.edu.au					Farina D, 2002, J APPL PHYSIOL, V93, P1753, DOI 10.1152/japplphysiol.00314.2002; De Luca CJ, 2012, J BIOMECH, V45, P555, DOI 10.1016/j.jbiomech.2011.11.010; KUKULKA CG, 1981, BRAIN RES, V219, P45, DOI 10.1016/0006-8993(81)90266-3; BROMAN H, 1985, J APPL PHYSIOL, V58, P1428; Merletti R, 1999, IEEE T BIO-MED ENG, V46, P821, DOI 10.1109/10.771191; SADOYAMA T, 1983, EUR J APPL PHYSIOL O, V51, P247, DOI 10.1007/BF00455188; MORITANI T, 1987, EUR J APPL PHYSIOL O, V56, P260, DOI 10.1007/BF00690890; ARENDTNIELSEN L, 1985, ELECTROEN CLIN NEURO, V60, P130, DOI 10.1016/0013-4694(85)90019-7; VANDERHOEVEN JH, 1993, MUSCLE NERVE, V16, P312, DOI 10.1002/mus.880160312; Basmajian J., 1985, MUSCLES ALIVE; Bernardi M, 1996, EUR J APPL PHYSIOL O, V74, P52, DOI 10.1007/BF00376494; Bernardi M, 1997, Electromyogr Clin Neurophysiol, V37, P3; Dumitru D., 1997, MUSCLE NERVE, V22, P733; Elfving B, 2002, J ELECTROMYOGR KINES, V12, P295, DOI 10.1016/S1050-6411(02)00027-5; Farina D, 2008, J APPL PHYSIOL, V105, P1673, DOI 10.1152/japplphysiol.90598.2008a; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; GYDIKOV A, 1974, PFLUG ARCH EUR J PHY, V347, P75, DOI 10.1007/BF00587056; KROGHLUND C, 1992, EUR J APPL PHYSIOL O, V64, P359, DOI 10.1007/BF00636225; Lee Y.S., 2003, J KOREAN SOC IND APP, V7, P79; LINDSTROM LH, 1977, P IEEE, V65, P653, DOI 10.1109/PROC.1977.10544; Lowery MM, 2000, IEEE T REHABIL ENG, V8, P353, DOI 10.1109/86.867877; Merletti R, 1999, IEEE T BIO-MED ENG, V46, P810, DOI 10.1109/10.771190; Onishi H, 2000, J ELECTROMYOGR KINES, V10, P59, DOI 10.1016/S1050-6411(99)00020-6; Roeleveld K, 1997, J ELECTROMYOGR KINES, V7, P221, DOI 10.1016/S1050-6411(97)00009-6; VANVEEN BK, 1993, BIOPHYS J, V64, P1492; Wheeler K., 2010, J MED BIOL ENG, V34, P101	26	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1863-1703	1863-1711		SIGNAL IMAGE VIDEO P	Signal Image Video Process.	FEB	2015	9	2					261	266		10.1007/s11760-013-0437-2		6	Engineering, Electrical & Electronic; Imaging Science & Photographic Technology	Engineering; Imaging Science & Photographic Technology	AZ3FG	WOS:000348112400002		
J	Matsuzaki, R; Kamai, K; Seki, R				Matsuzaki, Ryosuke; Kamai, Kazuto; Seki, Ryosuke			Intelligent tires for identifying coefficient of friction of tire/road contact surfaces using three-axis accelerometer	Smart Materials and Structures			English	Article						intelligent tires; coefficient of friction; accelerometer; smart tires; monitoring	MONITORING-SYSTEM; AUTOMOBILE TIRES; SENSOR; STRAIN; VEHICLES; MEMS; DEFORMATION	Intelligent tires equipped with sensors as well as the monitoring of the tire/road contact conditions are in demand for improving vehicle control and safety. With the aim of identifying the coefficient of friction of tire/road contact surfaces during driving, including during cornering, we develop an identification scheme for the coefficient of friction that involves estimation of the slip angle and applied force by using a single lightweight three-axis accelerometer attached on the inner surface of the tire. To validate the developed scheme, we conduct tire-rolling tests using an accelerometer-equipped tire with various slip angles on various types of road surfaces, including dry and wet surfaces. The results of these tests confirm that the estimated slip angle and applied force are reasonable. Furthermore, the identified coefficient of friction by the developed scheme agreed with that measured by standardized tests.	[Matsuzaki, Ryosuke; Kamai, Kazuto; Seki, Ryosuke] Tokyo Univ Sci, Dept Mech Engn, Noda, Chiba 2788510, Japan	Matsuzaki, R (reprint author), Tokyo Univ Sci, Dept Mech Engn, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	rmatsuza@rs.tus.ac.jp			Bridgestone Corp. in Japan	We acknowledge the financial support of Bridgestone Corp. in Japan.	Sun ZH, 2006, IEEE T PATTERN ANAL, V28, P694; Dong YC, 2011, IEEE T INTELL TRANSP, V12, P596, DOI 10.1109/TITS.2010.2092770; Erdogan G, 2011, IEEE SENS J, V11, P267, DOI 10.1109/JSEN.2010.2053198; Pohl A, 1999, IEEE T INSTRUM MEAS, V48, P1041, DOI 10.1109/19.816111; Matsuzaki R, 2007, SENSOR ACTUAT A-PHYS, V140, P32, DOI 10.1016/j.sna.2007.06.014; Matsuzaki R, 2008, SENSOR ACTUAT A-PHYS, V148, P1, DOI 10.1016/j.sna.2008.08.001; Baffet G, 2009, CONTROL ENG PRACT, V17, P1255, DOI 10.1016/j.conengprac.2009.05.005; Bevly DM, 2000, P AMER CONTR CONF, P2538, DOI 10.1109/ACC.2000.878665; Braghin F, 2010, VEH SYST DYN INT J V, V44, P3; Cao L, 2000, SENSOR ACTUAT A-PHYS, V80, P273, DOI 10.1016/S0924-4247(99)00343-X; Cellario M., 2001, IEEE Intelligent Systems, V16, DOI 10.1109/5254.941364; CO CG, 1991, ENG COST PROD ECON, V21, P35, DOI 10.1016/0167-188X(91)90016-U; Cullen JD, 2002, MEASUREMENT, V32, P181, DOI 10.1016/S0263-2241(02)00010-6; Halfmann C, 1997, CONTROL ENG PRACT, V5, P1151, DOI 10.1016/S0967-0661(97)00109-3; Hautamaki C, 2000, J REINF PLAST COMP, V19, P268, DOI 10.1106/JFAN-201N-FXL2-R94U; Matsuzaki R, 2006, SENSOR ACTUAT A-PHYS, V126, P277, DOI 10.1016/j.sna.2005.10.029; Matsuzaki R, 2012, J SOLID MECH MAT ENG, V6-9, P935; Matsuzaki R, 2008, SENSORS-BASEL, V8, P8123, DOI 10.3390/s8128123; Miyasaki N, 1990, SAE INT; Morinaga H., 2006, FISITA2006 T; Ohori M, 2006, P 2006 IEEE INT TRAN, P1519; Pacejka H., 2005, TIRE VEHICLE DYNAMIC; Palmer M. E., 2002, P 43 AIAA ASME ASCE; Savaresi SM, 2008, IEEE T CONTR SYST T, V16, P769, DOI 10.1109/TCST.2007.912245; Schimetta G, 2000, P IEEE ULTR S, P445; Sergio M, 2006, SMART MATER STRUCT, V15, P1700, DOI 10.1088/0964-1726/15/6/023; Tung S, 2001, SMART MATER STRUCT, V10, P1230, DOI 10.1088/0964-1726/10/6/312; Zhang X., 2004, Proceedings. The 7th International IEEE Conference on Intelligent Transportation Systems (IEEE Cat. No.04TH8749), DOI 10.1109/ITSC.2004.1399036	28	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	FEB	2015	24	2							025010	10.1088/0964-1726/24/2/025010		9	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	AZ8WW	WOS:000348493300010		
J	Sato, T; Igarashi, H				Sato, Takahiro; Igarashi, Hajime			A chaotic vibration energy harvester using magnetic material	Smart Materials and Structures			English	Article						energy harvesting; electromagnetic harvester; wideband harvester; chaotic oscillation	GENERATOR	This paper presents a new wideband electromagnetic vibration energy harvester (VEH) composed of a magnetic core embedded into the coil axis. The magnetic core generates a nonlinear magnetic force, which gives rise to the nonlinearity in the behavior of the VEH. Moreover, the magnetic core increases the flux linkage with the coil. These features improve the operational bandwidth and output power of the VEH. Numerical analysis and experimental measurements reveal that the operational bandwidth of the proposed VEH is over 30 Hz in which the output power is kept about 0.1 mW. Moreover, the proposed VEH operates by complicated oscillation due to nonlinear forces acting on the oscillator. Evaluation of the Lyapunov exponent for the measured oscillation suggests that the proposed VEH produces chaotic oscillation.	[Sato, Takahiro; Igarashi, Hajime] Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, Sapporo, Hokkaido 0600814, Japan	Sato, T (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, Kita 14,Nishi 9, Sapporo, Hokkaido 0600814, Japan.	tsato@em-si.eng.hokudai.ac.jp			JSPS KAKENHI [24310117]; Japan Power Academy	This study was supported by JSPS KAKENHI Grant Number 24310117, Grant-in-Aid for JSPS Fellows, and research grants from Japan Power Academy. We would like to show our appreciation to Mr Michiaki Suzuki and Dr Kenji Kawano of Taiyo-Yuden Cor. who provided the SMC cores.	Harne RL, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/2/023001; Jang S, 2010, SMART STRUCT SYST, V6, P439; Tvedt LGW, 2010, J MICROELECTROMECH S, V19, P305, DOI 10.1109/JMEMS.2009.2039017; Eichhorn C, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/10/104003; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Yang ZT, 2009, J INTEL MAT SYST STR, V20, P569, DOI 10.1177/1045389X08100042; Sebald G, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/10/102001; Stanton SC, 2010, PHYSICA D, V239, P640, DOI 10.1016/j.physd.2010.01.019; Beeby SP, 2007, J MICROMECH MICROENG, V17, P1257, DOI 10.1088/0960-1317/17/7/007; Shokrollahi H, 2007, J MATER PROCESS TECH, V189, P1, DOI 10.1016/j.jmatprotec.2007.02.034; Mann BP, 2010, J SOUND VIB, V329, P1215, DOI 10.1016/j.jsv.2009.11.034; Mann BP, 2009, J SOUND VIB, V319, P515, DOI 10.1016/j.jsv.2008.06.011; Sazonov E, 2009, IEEE SENS J, V9, P1422, DOI 10.1109/JSEN.2009.2019333; Zhu DB, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/10/105039; Williams CB, 2001, IEE P-CIRC DEV SYST, V148, P337, DOI 10.1049/ip-cds:20010525; Beeby SP, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/7/075022; Challa VR, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/2/025005; Ju S, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/11/115037; Lovatt HC, 1999, IEEE T MAGN, V35, P505, DOI 10.1109/20.737473; Tadesse Y, 2009, J INTEL MAT SYST STR, V20, P625, DOI 10.1177/1045389X08099965; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI DOI 10.1007/BFB0091924; Wischke M, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/8/085014; Zhu D, 2013, J PHYS C SER, V479, P330	23	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	FEB	2015	24	2							025033	10.1088/0964-1726/24/2/025033		8	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	AZ8WW	WOS:000348493300033		
J	Shrestha, KC; Saiidi, MS; Cruz, CA				Shrestha, Kshitij C.; Saiidi, M. Saiid; Cruz, Carlos A.			Advanced materials for control of post-earthquake damage in bridges	Smart Materials and Structures			English	Article						advanced material; analytical model; bridge; earthquake simulation; near-fault earthquakes; shake table; shape memory alloy	REINFORCED-CONCRETE BRIDGE; ALLOY BARS; COLUMNS; BRACES	This paper presents analytical modeling to study the seismic response of bridge systems with conventional and advanced details. For validation, a 33 m quarter-scale model of a four-span bridge incorporating innovative materials and details seismically tested on the shake tables at the University of Nevada, Reno was taken. The bridge specimen involved use of advanced materials and details to reduce damage at plastic hinges and minimize residual displacements. A threedimensional, nonlinear model incorporating the response of the innovative materials was developed to study the bridge response using the finite-element software OpenSees. Existing finite-element formulations were used to capture the response of the advanced materials used in the bridge. The analytical model was found to be able to reproduce comparable bent displacements and bent shear forces within reasonable accuracy. The validated model was further used to study different types of bridges under suite of scaled bi-directional near-fault ground motions. Comparisons were made on behavior of five different bridge types, first conventional reinforced concrete bridge, second post-tensioned column bridge, third bridge with elastomeric rubber elements at the plastic hinge zone, fourth bridge with nickel-titanium superelastic shape memory alloy (SMA) reinforcing bar and fifth bridge with CuAlMn superelastic SMA reinforcing bar. Both the SMA used bridges also utilized engineered cementitious composite element at the plastic hinge zone. The results showed effectiveness of the innovative interventions on the bridges in providing excellent recentering capabilities with minimal damage to the columns.	[Shrestha, Kshitij C.; Saiidi, M. Saiid] Univ Nevada, Dept Civil & Environm Engn, Reno, NV 89557 USA; [Shrestha, Kshitij C.] Kyoto Univ, Dept Architecture & Architectural Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Cruz, Carlos A.] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB T6G 2R3, Canada	Shrestha, KC (reprint author), Univ Nevada, Dept Civil & Environm Engn, Reno, NV 89557 USA.	se.kshitij@archi.kyoto-u.ac.jp	Shrestha, Kshitij/K-3844-2015	Shrestha, Kshitij/0000-0001-9007-852X	Federal Highway Administration (FHWA) [DTFH61-07-C-00031]; Kyoto University Foundation	This research was supported by Federal Highway Administration (FHWA) under Contract No. DTFH61-07-C-00031 with Dr Philip Yen serving as the program director. The first author acknowledges the support provided by The Kyoto University Foundation during his stay at University of Nevada, Reno.	Carreras G, 2011, SMART STRUCT SYST, V7, P41; Araki Y, 2011, EARTHQ ENG STRUCT D, V40, P107, DOI 10.1002/eqe.1029; Yakut A, 2002, J STRUCT ENG-ASCE, V128, P986, DOI 10.1061/(ASCE)0733-9445(2002)128:8(986); Omori T, 2011, SCIENCE, V333, P68, DOI 10.1126/science.1202232; MANDER JB, 1988, J STRUCT ENG-ASCE, V114, P1804; Saiidi MS, 2009, ACI STRUCT J, V106, P69; Motaref S, 2010, TRANSP RES RECORD, P109, DOI 10.3141/2202-14; Choi H, 2010, ACI STRUCT J, V107, P3; Phan V, 2007, J STRUCT ENG-ASCE, V133, P982, DOI 10.1061/(ASCE)0733-9445(2007)133:7(982); Sutou Y, 2009, ACTA MATER, V57, P5759, DOI 10.1016/j.actamat.2009.08.011; Casciati S, 2011, ENG STRUCT, V33, P1232, DOI 10.1016/j.engstruct.2010.12.045; Araki Y, 2014, STRUCT CONTROL HLTH, V21, P1304, DOI 10.1002/stc.1644; Casciati S, 2010, SMART STRUCT SYST, V6, P73; Cruz C A, 2010, CCEER1004 U NEV DEP; Cruz C A, 2013, J STRUCT ENG-ASCE, V139, P144; Cruz C. A., 2012, J STRUCTURAL ENG, V138, P183; Hillis D, 2009, CCEER0901 U NEV DEP; Jeong H I, 2008, 200806 PEER U CAL CO; Johnson N, 2008, J BRIDGE ENG, V13, P173, DOI 10.1061/(ASCE)1084-0702(2008)13:2(173); Kawashima K., 2000, P 12 WORLD C EARTHQ; McKenna F, 2001, OPENSEES MANUAL PEER; Motaref S., 2011, CCEER1101 U NEV DEP; SAC Steel Project, 2000, IMP NEAR FIELD EARTH; Saiidi MS, 2013, J STRUCT ENG, V139, P1352, DOI 10.1061/(ASCE)ST.1943-541X.0000790; Shrestha K C, 2012, EARTHQ ENG STRUCT D, V45, P725; Shrestha KC, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/2/025025; Tazarv M, 2013, INT J BRIDGE ENG, V1, P37; Yakut A, 2002, ASCE J BRIDGE ENG, V7, P50; Zadeh S, 2007, CCEER073 OPENSEES U	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	FEB	2015	24	2							025035	10.1088/0964-1726/24/2/025035		16	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	AZ8WW	WOS:000348493300035		
J	Kawashima, Y; Ichimura, K; Katono, K; Kurosawa, T; Oda, M; Tanda, S; Kamihara, Y; Hosono, H				Kawashima, Yuki; Ichimura, Koichi; Katono, Kazuhiro; Kurosawa, Tohru; Oda, Migaku; Tanda, Satoshi; Kamihara, Yoichi; Hosono, Hideo			STM/STS study of the superconducting gap in SmFeAsO1-xFx	SOLID STATE COMMUNICATIONS			English	Article						Iron-based superconductor; Superconducting gap; STM		We report an electron tunneling study of SmFeAsO1-xFx in the low doping region (x=0, 0.045, 0.046, 0.069) by low temperature UI-IV-STM/STS. Superconducting gaps are observed for each superconducting sample x=0.045 (T-c=12.9 K), x=0.046 (T-c=32.9 K) and x=0.069 (T-c=46.9 K). We obtained corresponding superconducting gap size of Delta(sc) = 9.5 +/- 0.5 meV, 9.75 +/- 0.25 mcV and 11 +/- 1 meV. While T-c increases, Delta(sc) is kept the same. This suggests that the effective attractive interaction is the same and that there is some mechanism that suppresses the superconductivity in the low doping region. On the other hand, similar gap structures were found in a non superconducting sample with x=0 at 7.8 K. The obtained gap size was Delta(N) = 8.5 +/- 1.5 meV, which is almost the same as the superconducting gap in the superconducting samples (x=0.045, 0.046, 0.069). (C) 2014 Published by Elsevier Ltd.	[Kawashima, Yuki; Ichimura, Koichi; Katono, Kazuhiro; Tanda, Satoshi] Hokkaido Univ, Dept Appl Phys, Sapporo, Hokkaido 0608628, Japan; [Ichimura, Koichi; Kurosawa, Tohru; Oda, Migaku; Tanda, Satoshi] Hokkaido Univ, Ctr Educ & Res Topol Sci & Technol, Sapporo, Hokkaido 0608628, Japan; [Kurosawa, Tohru; Oda, Migaku] Hokkaido Univ, Dept Phys, Sapporo, Hokkaido 0600810, Japan; [Kamihara, Yoichi] Keio Univ, Dept Appl Phys & Physicoinformat, Yokohama, Kanagawa 2238522, Japan; [Hosono, Hideo] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan	Kawashima, Y (reprint author), Hokkaido Univ, Dept Appl Phys, Sapporo, Hokkaido 0608628, Japan.	yuki-k@eng.hokudai.ac.jp	Kamihara, Yoichi/C-4471-2008; Hosono, Hideo/J-3489-2013	Hosono, Hideo/0000-0001-9260-6728	21COE program on "Topological Science and Technology" of the Ministry of Education, Culture, Sport, Science and Technology of Japan; Asahi Glass Foundation; Japan Society for Promotion of Science (JSPS) KAKENHI [26400337]	This work was supported by the 21COE program on "Topological Science and Technology" of the Ministry of Education, Culture, Sport, Science and Technology of Japan. This work was partially supported by the Asahi Glass Foundation, and the Japan Society for Promotion of Science (JSPS) KAKENHI Grant no. 26400337.	Fujioka M, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/8/085023; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Tapp JH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.060505; Huang Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.257003; Mertelj T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224504; GIAEVER I, 1961, PHYS REV, V122, P1101, DOI 10.1103/PhysRev.122.1101; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; Kamihara Y, 2006, J AM CHEM SOC, V128, P10012, DOI 10.1021/ja063355c; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Chen TY, 2008, NATURE, V453, P1224, DOI 10.1038/nature07081; Liu RH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087001; Kamihara Y, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033005; Hoffman JE, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124513; DYNES RC, 1978, PHYS REV LETT, V41, P1509, DOI 10.1103/PhysRevLett.41.1509; Chen YL, 2010, PHYSICA C, V470, P989, DOI 10.1016/j.physc.2010.05.017; COX A, 1985, J PHYS C SOLID STATE, V18, P1123; Ichimura K, 2008, J PHYS SOC JPN, V77, P151; Ichimura K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.051012; Iimura S., 2013, NAT COMMUN, V3, P943; Ishida Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.060503; Kawashima Y, 2013, SOLID STATE COMMUN, V167, P10, DOI 10.1016/j.ssc.2013.04.033; Margadonna S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014503; Millo O, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.092505; Rotter M., 2008, PHYS REV LETT, V101, P9691; Sato T, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.063708; Tropeano M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094518	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	FEB	2015	204						33	36		10.1016/j.ssc.2014.12.003		4	Physics, Condensed Matter	Physics	CA3YU	WOS:000348842000008		
J	Nakauchi, M; Wiersema, MF				Nakauchi, Motohiro; Wiersema, Margarethe F.			EXECUTIVE SUCCESSION AND STRATEGIC CHANGE IN JAPAN	STRATEGIC MANAGEMENT JOURNAL			English	Article						corporate governance; strategic change; executive succession; Japan	CORPORATE GOVERNANCE; FIRM PERFORMANCE; TOP-MANAGEMENT; CEO DISMISSAL; INSTITUTIONAL INVESTORS; BOARD COMPOSITION; UNITED-STATES; TURNOVER; POWER; OWNERSHIP	Scholars studying upper echelons have found that executive succession can serve as an important adaptation mechanism. The bulk of these findings, however, derive from market-based governance settings, which raises an issue of contextual robustness. This study examines this issue by investigating the link between executive succession and strategic change in Japan, a context noted for relatively weak market-based corporate governance and lack of board independence. We find a greater likelihood of strategic change after non-routine executive succession, with the extent of change unaffected by firm performance. Routine succession in the case of a powerful prior president leads to less post-succession strategic change. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nakauchi, Motohiro] Toyo Univ, Fac Business Adm, Tokyo, Japan; [Wiersema, Margarethe F.] Univ Calif Irvine, Paul Merage Sch Business, Irvine, CA 92717 USA	Wiersema, MF (reprint author), Univ Calif Irvine, Paul Merage Sch Business, Irvine, CA 92717 USA.	mfwierse@uci.edu					Aguilera V, 2003, ACAD MANAGE REV, V28, P447; Denis DJ, 1997, J FINANC ECON, V45, P193, DOI 10.1016/S0304-405X(97)00016-0; Wiersema MF, 2011, STRATEGIC MANAGE J, V32, P1161, DOI 10.1002/smj.932; Hutzschenreuter T, 2012, LEADERSHIP QUART, V23, P729, DOI 10.1016/j.leaqua.2012.06.005; Denis DJ, 2000, J FINANC ECON, V55, P391, DOI 10.1016/S0304-405X(99)00055-0; Tuggle CS, 2010, STRATEGIC MANAGE J, V31, P946, DOI 10.1002/smj.847; HELMICH DL, 1972, ADMIN SCI QUART, V17, P371, DOI 10.2307/2392150; CANNELLA AA, 1993, ACAD MANAGE J, V36, P763, DOI 10.2307/256758; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Westphal JD, 2001, STRATEGIC MANAGE J, V22, P1113, DOI 10.1002/smj.205; Doidge C, 2007, J FINANC ECON, V86, P1, DOI 10.1016/j.jfineco.2006.09.002; FINKELSTEIN S, 1992, ACAD MANAGE J, V35, P505, DOI 10.2307/256485; La Porta R, 2000, J FINANC ECON, V58, P3, DOI 10.1016/S0304-405X(00)00065-9; KAPLAN SN, 1994, J POLIT ECON, V102, P510, DOI 10.1086/261944; Worrell DL, 1997, STRATEGIC MANAGE J, V18, P499, DOI 10.1002/(SICI)1097-0266(199706)18:6<499::AID-SMJ898>3.0.CO;2-F; KANG JK, 1995, J FINANC ECON, V38, P29, DOI 10.1016/0304-405X(94)00807-D; BOEKER W, 1993, ACAD MANAGE J, V36, P172, DOI 10.2307/256517; Bigley GA, 2002, ADMIN SCI QUART, V47, P707, DOI 10.2307/3094914; Quigley TJ, 2012, STRATEGIC MANAGE J, V33, P834, DOI 10.1002/smj.1945; Zajac EJ, 1996, ACAD MANAGE J, V39, P64, DOI 10.2307/256631; BARR PS, 1992, STRATEGIC MANAGE J, V13, P15, DOI 10.1002/smj.4250131004; Cannella AA, 2001, ACAD MANAGE J, V44, P252; Zhang Y, 2008, STRATEG MANAGE J, V29, P859, DOI 10.1002/smj.689; CHILD J, 1972, SOCIOLOGY, V6, P1, DOI 10.1177/003803857200600101; FINKELSTEIN S, 1990, ADMIN SCI QUART, V35, P484, DOI 10.2307/2393314; Sakano T, 1999, ORGAN SCI, V10, P654, DOI 10.1287/orsc.10.5.654; MORCK R, 1989, AM ECON REV, V79, P842; Zhang Y, 2006, STRATEGIC MANAGE J, V27, P283, DOI 10.1002/smj.517; Kaplan SN, 2012, INT REV FINANC, V12, P57, DOI 10.1111/j.1468-2443.2011.01135.x; GOODSTEIN J, 1991, ACAD MANAGE J, V34, P306, DOI 10.2307/256444; MALLETTE P, 1992, ACAD MANAGE J, V35, P1010, DOI 10.2307/256538; Shen W, 2002, ACAD MANAGE J, V45, P1195, DOI 10.2307/3069434; Arthaud-Day Marne L., 2006, ACAD MANAGE J, V49, P119; Ballon R, 1988, FINANCIAL BEHAV JAPA; Clark R, 1979, JAPANESE CO; DAILY CM, 1994, ACAD MANAGE J, V37, P1603, DOI 10.2307/256801; Davidson WN, 1998, STRATEGIC MANAGE J, V19, P905, DOI 10.1002/(SICI)1097-0266(199809)19:9<905::AID-SMJ3>3.0.CO;2-G; Denis DJ, 1996, J FINANC ECON, V40, P239, DOI 10.1016/0304-405X(95)00846-7; Finkelstein S., 1996, STRATEGIC LEADERSHIP; HAMBRICK DC, 1993, STRATEGIC MANAGE J, V14, P401, DOI 10.1002/smj.4250140602; JENSEN MC, 1986, AM ECON REV, V76, P323; KAPLAN SN, 1994, J FINANC ECON, V36, P225, DOI 10.1016/0304-405X(94)90025-6; Lorsch J. W., 1989, PAWNS POTENTATES REA; Mizuno M, 2010, PAC ECON REV, V15, P653, DOI 10.1111/j.1468-0106.2010.00521.x; Nakamura M, 2006, INT J DISCLOSURE GOV, V3, P233, DOI 10.1057/palgrave.jdg.2040081; OCASIO W, 1994, ADMIN SCI QUART, V39, P285, DOI 10.2307/2393237; PROWSE SD, 1992, J FINANC, V47, P1121, DOI 10.2307/2328979; Quinn JB, 1980, IRWIN SERIES MANAGEM; Schaede U, 1994, IND CORP CHANGE, V3, P285, DOI 10.1093/icc/3.2.285; COUGHLAN AT, 1985, J ACCOUNT ECON, V7, P43, DOI 10.1016/0165-4101(85)90027-8; SCHWENK CR, 1988, J MANAGE STUD, V25, P41, DOI 10.1111/j.1467-6486.1988.tb00021.x; Seki T, 2005, CORP GOV, V13, P377, DOI 10.1111/j.1467-8683.2005.00432.x; Selznick P, 1957, LEADERSHIP ADM SOCIO; Sheard P., 1994, BOJ MONETARY EC STUD, V12, P85; TUSHMAN ML, 1985, TECHNOL SOC, V7, P297, DOI 10.1016/0160-791X(85)90031-4; Useem M, 1993, EUROPEAN MANAGEMENT, V11, P175, DOI 10.1016/0263-2373(93)90041-F; Vancil Richard, 1987, PASSING BATON MANAGI; WALSH JP, 1993, ACAD MANAGE J, V36, P671, DOI 10.2307/256755; WIERSEMA MF, 1992, ACAD MANAGE J, V35, P91, DOI 10.2307/256474	59	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2095	1097-0266		STRATEGIC MANAGE J	Strateg. Manage. J.	FEB	2015	36	2					298	306		10.1002/smj.2255		9	Business; Management	Business & Economics	AY8AX	WOS:000347777900008		
J	Murono, S; Tsuji, A; Endo, K; Kondo, S; Wakisaka, N; Yoshizaki, T				Murono, Shigeyuki; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yoshizaki, Tomokazu			Factors associated with gastrostomy tube dependence after concurrent chemoradiotherapy for hypopharyngeal cancer	SUPPORTIVE CARE IN CANCER			English	Article						Hypopharyngeal cancer; Concurrent chemoradiotherapy; Subsite; Swallowing disturbance; Gastrostomy tube	LOCALLY ADVANCED HEAD; SEVERE LATE TOXICITY; NECK-CANCER; CONCOMITANT RADIATION; RTOG ANALYSIS; CARCINOMA; CHEMORADIATION; CHEMOTHERAPY; CISPLATIN	We aimed to identify tumor- and treatment-related factors predicting gastrostomy tube dependence after concurrent chemoradiotherapy (CCRT) for hypopharyngeal cancer. We performed a retrospective review of all patients with hypopharyngeal cancer treated with CCRT between 2002 and 2012 except for those with residual or recurrent disease at evaluation. The incidence of gastrostomy tube dependence, defined as complete or almost complete dependence on tube feeding, at 6 months after the completion of treatment was the endpoint. A total of 75 patients were analyzed in this study. Twelve patients (16 %) showed gastrostomy tube dependence. Among tumor-related factors, the subsite (posterior wall versus pyriform sinus plus postcricoid) was the most significant factor correlated with gastrostomy tube dependence (p < 0.01 by multivariate analysis). The T category of the primary tumor was also correlated with gastrostomy tube dependence on univariate analysis (p < 0.01). Among treatment-related factors, the radiation dose was not associated with gastrostomy tube dependence. On the other hand, gastrostomy tube dependence was also correlated with the requirement of supportive nutrition with a nasogastric tube at the beginning of and during treatment (both p < 0.01). Risk factors for gastrostomy tube dependence after the completion of CCRT for hypopharyngeal cancer were identified.	[Murono, Shigeyuki; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yoshizaki, Tomokazu] Kanazawa Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan	Murono, S (reprint author), Kanazawa Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	murono@med.kanazawa-u.ac.jp					Agarwal J, 2011, DYSPHAGIA, V26, P399, DOI 10.1007/s00455-011-9326-4; Ames JA, 2011, HEAD NECK-J SCI SPEC, V33, P638, DOI 10.1002/hed.21506; Bradley PT, 2012, CURR OPIN OTOLARYNGO, V20, P89, DOI 10.1097/MOO.0b013e32834fa72c; Lee WT, 2006, HEAD NECK-J SCI SPEC, V28, P808, DOI 10.1002/hed.20427; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Platteaux N, 2010, DYSPHAGIA, V25, P139, DOI 10.1007/s00455-009-9247-7; Machtay M, 2012, INT J RADIAT ONCOL, V84, P983, DOI 10.1016/j.ijrobp.2012.03.005; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Mekhail TM, 2001, CANCER, V91, P1785, DOI 10.1002/1097-0142(20010501)91:9<1785::AID-CNCR1197>3.0.CO;2-1; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Paximadis P, 2012, INT J RADIAT ONCOL, V82, P1515, DOI 10.1016/j.ijrobp.2011.04.064; Bhayani MK, 2013, HEAD NECK-J SCI SPEC, V35, P1641, DOI 10.1002/hed.23199; Henk J M, 1997, Clin Oncol (R Coll Radiol), V9, P308, DOI 10.1016/S0936-6555(05)80064-0; Nomura K, 2013, LARYNGOSCOPE, V123, P916, DOI 10.1002/lary.23870; Robbins KT, 2002, INT J RADIAT ONCOL, V53, P4, DOI 10.1016/S0360-3016(02)02713-X; Samant S, 1999, HEAD NECK-J SCI SPEC, V21, P595, DOI 10.1002/(SICI)1097-0347(199910)21:7<595::AID-HED2>3.0.CO;2-J	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	FEB	2015	23	2					457	462		10.1007/s00520-014-2388-8		6	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AZ6AB	WOS:000348298700022		
J	Yamagishi, A; Morita, T; Kawagoe, S; Shimizu, M; Ozawa, T; An, E; Kobayakawa, M; Tsuneto, S; Shima, Y; Miyashita, M				Yamagishi, Akemi; Morita, Tatsuya; Kawagoe, Shohei; Shimizu, Megumi; Ozawa, Taketoshi; An, Emi; Kobayakawa, Makoto; Tsuneto, Satoru; Shima, Yasuo; Miyashita, Mitsunori			Length of home hospice care, family-perceived timing of referrals, perceived quality of care, and quality of death and dying in terminally ill cancer patients who died at home	SUPPORTIVE CARE IN CANCER			English	Article						Hospice; Referral; Length of stay; Quality of death and dying; Quality of care	EARLY PALLIATIVE CARE; CELL LUNG-CANCER; LIFE CARE; MEMBERS; JAPAN; PERCEPTIONS; PERSPECTIVE; ENROLLMENT; NEEDS; SATISFACTION	This study aims to clarify the length of home hospice care, family-perceived timing of referrals, and their effects on the family-perceived quality of care and quality of death and dying of terminally ill cancer patients who died at home and identify the determinants of perceived late referrals. A multicenter questionnaire survey was conducted involving 1,052 family members of cancer patients who died at home supported by 15 home-based hospice services throughout Japan. A total of 693 responses were analyzed (effective response rate, 66 %). Patients received home-based hospice care for a median of 35.0 days, and 8.0 % received home hospice care for less than 1 week. While 1.5 % of the families reported the timing of referrals as early, 42 % reported the timing as late or too late. The families of patients with a length of care of less than 4 weeks were more likely to regard the timing of referrals as late or too late. The patients of family members who regarded the timing of referrals as late or too late had a significantly lower perceived quality of care (effect size, 0.18; P = 0.039) and lower quality of death and dying (effect size, 0.15, P = 0.063). Independent determinants of higher likelihoods of perceived late referrals included: frequent visits to emergency departments, patient being unprepared for worsening condition, and patient having concerns about relationship with new doctor. Discharge nurse availability was independently associated with lower likelihoods of perceived late referrals. A significant number of bereaved families regarded the timing of referrals to home hospices as late, and the perceived timing was associated with the family-perceived quality of care and quality of death and dying. Systematic strategies to overcome the barriers related to perceived late referrals are necessary.	[Yamagishi, Akemi] Hamamatsu Univ, Dept Community Hlth Care, Sch Med, Higashi Ku, Hamamatsu, Shizuoka 4338558, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, Kita Ku, Hamamatsu, Shizuoka 4338558, Japan; [Kawagoe, Shohei] Aozora Clin, Matsudo, Chiba 2710074, Japan; [Shimizu, Megumi; Miyashita, Mitsunori] Tohoku Univ, Grad Sch Med, Dept Palliat Nursing, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ozawa, Taketoshi] Megumi Zaitaku Clin, Seya Ku, Yokohama, Kanagawa 2460031, Japan; [An, Emi] Hananotani Clin, Minamibouso City, Chiba 2950003, Japan; [Kobayakawa, Makoto] Hiroshima Univ Hosp, Palliat Care Team, Minami Ku, Hiroshima 7348551, Japan; [Tsuneto, Satoru] Osaka Univ, Grad Sch Med, Dept Palliat Med, Suita, Osaka 5650871, Japan; [Shima, Yasuo] Tsukuba Med Ctr Hosp, Dept Palliat Med, Tsukuba, Ibaraki 3058558, Japan	Yamagishi, A (reprint author), Hamamatsu Univ, Dept Community Hlth Care, Sch Med, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4338558, Japan.	ayamagishi-tky@umin.ac.jp			Japan Hospice Palliative Care Foundation in Japan	This study was funded by the Japan Hospice Palliative Care Foundation in Japan. The authors have no conflicts of interest.	Finlay IG, 2002, ANN ONCOL, V13, P257, DOI 10.1093/annonc/mdf668; Stillman MJ, 1999, J PAIN SYMPTOM MANAG, V17, P157, DOI 10.1016/S0885-3924(98)00119-5; Lamont EB, 2002, CANCER, V94, P2733, DOI 10.1002/cncr.10530; [Anonymous], 2000, MED MOR BE US HOSP F; Morita T, 2009, J PAIN SYMPTOM MANAG, V38, P191, DOI 10.1016/j.jpainsymman.2008.09.011; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Morita T, 2005, J CLIN ONCOL, V23, P2637; Yamagishi A, 2012, SUPPORT CARE CANCER, V20, P2575, DOI 10.1007/s00520-011-1373-8; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Morita T, 2004, ANN ONCOL, V15, P1551, DOI 10.1093/annonc/mdh386; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Ashbury FD, 1998, J PAIN SYMPTOM MANAG, V16, P298, DOI 10.1016/S0885-3924(98)00102-X; Morita T, 2004, J PAIN SYMPTOM MANAG, V27, P492, DOI 10.1016/j.jpainsymman.2003.10.014; Morita T, 2013, LANCET ONCOL, V14, P638, DOI 10.1016/S1470-2045(13)70127-X; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Teno JM, 2012, J PAIN SYMPTOM MANAG, V43, P732, DOI 10.1016/j.jpainsymman.2011.05.012; Teno JM, 2007, J PAIN SYMPTOM MANAG, V34, P120, DOI 10.1016/j.jpainsymman.2007.04.014; Bradley EH, 2004, AM J PSYCHIAT, V161, P2257, DOI 10.1176/appi.ajp.161.12.2257; Miyashita M, 2008, J CLIN ONCOL, V26, P3845, DOI 10.1200/JCO.2007.15.8287; Kris AE, 2006, AM J GERIAT PSYCHIAT, V14, P264, DOI 10.1097/01.JGP.0000194642.86116.ce; Schockett ER, 2005, J PAIN SYMPTOM MANAG, V30, P400, DOI 10.1016/j.jpainsymman.2005.04.013; Yamagishi A, 2010, J PAIN SYMPTOM MANAG, V40, P671, DOI 10.1016/j.jpainsymman.2010.02.025; Bowles KH, 2008, ONCOL NURS FORUM, V35, P377, DOI 10.1188/08.ONF.377-383; Casarett D, 2001, J CLIN ONCOL, V19, P2057; Casarett D J, 2001, J Palliat Med, V4, P491, DOI 10.1089/109662101753381638; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Costantini M, 1999, J PAIN SYMPTOM MANAG, V18, P243, DOI 10.1016/S0885-3924(99)00084-6; Drieskens K, 2008, J PALLIAT CARE, V24, P162; DUDGEON DJ, 1995, J PALLIATIVE CARE, V11, P5; Emanuel L L, 2001, J Palliat Med, V4, P465, DOI 10.1089/109662101753381601; Friedman Betsy T, 2002, J Palliat Med, V5, P73, DOI 10.1089/10966210252785033; Hirabayashi Y, 2007, PALLIAT SUPPORT CARE, V5, P19; Miyashita M, 2008, J PAIN SYMPTOM MANAG, V35, P486, DOI [10.1016/j.jpainsymman.2007.07.009, 10.1016/j.jpainsmman.2007.07.009]; Morita T, 2013, CURR OPIN SUPPORT PA, V7, P207, DOI 10.1097/SPC.0b013e3283612241; Morita T, 2002, PALLIATIVE MED, V16, P185, DOI 10.1191/0269216302pm524oa; Ogle Karen S, 2002, J Palliat Med, V5, P85, DOI 10.1089/10966210252785042; Olkin I., 1985, STAT METHODS METAANA; Poulose JV, 2013, J PAIN SYMPTOM MANAG, V46, P173, DOI 10.1016/j.jpainsymman.2012.08.009; Pugh EMG, 1996, PALLIATIVE MED, V10, P251; Shinjo T, 2010, J CLIN ONCOL, V28, P142, DOI 10.1200/JCO.2009.23.2793; Weggel J M, 1999, WMJ, V98, P49; Wilkinson S, 2000, Int J Palliat Nurs, V6, P212; Yamagishi A, GAN TO KAGA IN PRESS	44	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	FEB	2015	23	2					491	499		10.1007/s00520-014-2397-7		9	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	AZ6AB	WOS:000348298700026		
J	Mike, M; Kano, N				Mike, Makio; Kano, Nobuyasu			Laparoscopic surgery for colon cancer: a review of the fascial composition of the abdominal cavity	SURGERY TODAY			English	Review						Colon cancer surgery; Fascial composition; Fusion fascia; Subperitoneal fasciae	COMPLETE MESOCOLIC EXCISION; RANDOMIZED CLINICAL-TRIAL; TOTAL MESORECTAL EXCISION; SPLENIC FLEXURE; RECTAL-CANCER; HIGH LIGATION; CURATIVE RESECTION; SURGICAL TECHNIQUE; SURVIVAL; CARCINOMA	Laparoscopic surgery has generally been performed for digestive diseases. Many patients with colon cancer undergo laparoscopic procedures. The outcomes of laparoscopic colectomy and open colectomy are the same in terms of the long-time survival. It is important to dissect the embryological plane to harvest the lymph nodes and to avoid bleeding during colon cancer surgery. To date, descriptions of the anatomy of the fascial composition have mainly involved observations unrelated to fundamental embryological concepts, causing confusion regarding the explanations of the surgical procedures, with various vocabularies used without definitions. We therefore examined the fascia of the abdominal space using a fascia concept based on clinical anatomy and embryology. Mobilization of the bilateral sides of the colon involves dissection between the fusion fascia of Toldt and the deep subperitoneal fascia. It is important to understand that the right fusion fascia of Toldt is divided into the posterior pancreatic fascia of Treitz dorsally and the anterior pancreatic fascia ventrally at the second portion of the duodenum. A comprehensive understanding of fascia composition between the stomach and transverse colon is necessary for dissecting the splenic flexure of the colon. As a result of these considerations of the fascia, more accurate surgical procedures can be performed for the excision of colon cancer.	[Mike, Makio; Kano, Nobuyasu] Kameda Med Ctr, Dept Surg, Chiba 2988602, Japan	Mike, M (reprint author), Kameda Med Ctr, Dept Surg, 929 Higashicho, Chiba 2988602, Japan.	mmike@ace.ocn.ne.jp					Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; West NP, 2010, DIS COLON RECTUM, V53, P1594, DOI 10.1007/DCR.0b013e3181f433e3; Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Feng B, 2012, SURG ENDOSC, V26, P3669, DOI 10.1007/s00464-012-2435-9; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; West NP, 2010, J CLIN ONCOL, V28, P272, DOI 10.1200/JCO.2009.24.1448; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Bertelsen CA, 2011, COLORECTAL DIS, V13, P1123, DOI 10.1111/j.1463-1318.2010.02474.x; West NP, 2008, LANCET ONCOL, V9, P857, DOI 10.1016/S1470-2045(08)70181-5; Hogan AM, 2009, J GASTROINTEST SURG, V13, P1889, DOI 10.1007/s11605-009-0976-6; Hogan AM, 2009, J SURG ONCOL, V100, P182, DOI 10.1002/jso.21310; Bokey EL, 2003, DIS COLON RECTUM, V46, P860, DOI 10.1097/01.DCR.0000074731.78773.BB; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Pramateftakis MG, 2010, TECH COLOPROCTOL, V14, pS49, DOI 10.1007/s10151-010-0609-9; HEALD RJ, 1986, LANCET, V1, P1479; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; Bagshaw PF, 2012, ANN SURG, V256, P915, DOI 10.1097/SLA.0b013e3182765ff8; Black N, 1997, BRIT MED J, V315, P381; Bonjer HJ, 2009, LANCET ONCOL, V10, P44; Day WD, 2010, WORLD J SURG, V34, P1146, DOI 10.1007/s00268-009-0383-x; Eiholm S, 2010, DAN MED BULL, V57; GILLOT C, 1964, J Int Coll Surg, V41, P339; Gray SW, 1972, EMBRYOLOGY SURG, P129; HEALD RJ, 1988, J ROY SOC MED, V81, P503; Heald RJ, 1999, GEKA, V61, P969; Kanemitsu Y, 2006, BRIT J SURG, V93, P609, DOI 10.1002/bjs.5327; Kawamura YJ, 2000, EUR J SURG, V166, P803, DOI 10.1080/110241500447443; Keighley MRB, 2008, SURGERY ANUS RECTUM, P1047; Kelly M, 2006, COLORECTAL DIS, V9, P337; LEVIEN DH, 1991, DIS COLON RECTUM, V34, P401, DOI 10.1007/BF02053691; Liang KL, 2007, ANN SURG ONCOL, V14, P109; Mike M, 2012, LAPAROSCOPIC COLOREC, P24; Mike M, 2012, OPERATIVE MANEUVERS, P116; Mike M, 2011, INT J COLORECTAL DIS, V26, P405, DOI 10.1007/s00384-010-1107-2; Mike M, 2012, LAPAROSCOPIC COLOREC, P134; Nakagoe T, 2001, SURG TODAY, V31, P204; Nelson H, 2004, NEW ENGL J MED, V350, P2050; ROUFFET F, 1994, DIS COLON RECTUM, V37, P651, DOI 10.1007/BF02054407; Sasaki K, 2006, INTRO LOCAL ANATOMY, P173; SATO T, 1984, Bulletin of Tokyo Medical and Dental University, V31, P21; Sato T, 1980, IGAKUNOAYUMI, V114, pC168; STEFFEN C, 1987, DIS COLON RECTUM, V30, P872, DOI 10.1007/BF02555427; Takahashi T, 2004, SHOUKAKIGEKA, V27, P1967; Takahashi T, 2005, SHOUKAKIGEKA, V28, P115; TOBIN CE, 1946, SURG GYNECOL OBSTET, V83, P575; Tobin CE, 1944, ANAT REC, V89, P295, DOI 10.1002/ar.1090890304; Warsi AA, 2002, EUR J SURG ONCOL, V28, P850, DOI 10.1053/ejso.2002.1283; Woodburne RT, 1994, ESSENTIALS HUMAN ANA, P436	48	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					129	139		10.1007/s00595-014-0857-9		11	Surgery	Surgery	AZ7SJ	WOS:000348417800001		
J	Fujita, H				Fujita, Hiromasa			The history of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery	SURGERY TODAY			English	Review						Esophageal cancer; Lymphadenectomy; Oncological surgery; History	SQUAMOUS-CELL CARCINOMA; LYMPH-NODE DISSECTION; THORACIC ESOPHAGUS; BREAST-CANCER; CHEMORADIOTHERAPY; CHEMORADIATION; CARDIA	I would herein like to look back upon surgery for esophageal cancer, particularly on lymphadenectomy, and to speculate a little on the future prospects for esophageal surgery. There are two schools of thought on lymphadenectomy in esophageal cancer: one believes in en bloc esophagectomy, which is commonly performed in Western countries; the other believes in three-field lymphadenectomy, which is commonly performed in Japan. We esophageal surgeons at Kurume University have contributed to some advances in three-field lymphadenectomy. For example, we initiated functional mediastinal dissection to ensure patient safety, and we proposed the lymph node compartment theory to assess the clinical importance of regional nodes. Oncological surgery has progressed in terms of its safety, radicality and functional preservation, leading to improved quality-of-life for patients after surgery. This then evolved to the current development of multimodal and individualized tailor-made treatments. I believe that surgery for esophageal cancer will become bipolarized in the future. One strand will evolve as salvage surgery for residual or recurrent tumors, which non-surgical therapies have failed to cure, and the other strand will evolve as less invasive surgery, adjuvant surgery, for cancers at the relatively early stage, for which micro-metastasis can be cured by non-surgical therapies.	[Fujita, Hiromasa] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; [Fujita, Hiromasa] Fukuoka Wajiro Hosp, Dept Surg, Fukuoka, Japan	Fujita, H (reprint author), Fukuoka Wajiro Hosp, Dept Surg, Fukuoka, Japan.	fujita@med.kurume-u.ac.jp					Akaishi T, 1996, J THORAC CARDIOV SUR, V112, P1533, DOI 10.1016/S0022-5223(96)70012-0; AKAKURA I, 1970, CHEST, V57, P47, DOI 10.1378/chest.57.1.47; Akiyama H, 1990, SURG CANC ESOPHAGUS; Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; Swisher SG, 2002, J THORAC CARDIOV SUR, V123, P175, DOI 10.1067/mtc.2002.119070; Bodner J, 2004, EUR J CARDIO-THORAC, V25, P844, DOI 10.1016/j.ejcts.2004.02.001; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; Hironaka S, 2003, INT J RADIAT ONCOL, V57, P425, DOI 10.1016/S0360-3016(03)00585-6; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; HELLMAN S, 1994, J CLIN ONCOL, V12, P2229; FUJITA H, 1995, ANN SURG, V222, P654, DOI 10.1097/00000658-199511000-00008; FISHER B, 1980, CANCER RES, V40, P3863; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Fisher B, 1999, EUR J CANCER, V35, P1963, DOI 10.1016/S0959-8049(99)00217-8; AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Suda K, 2012, WORLD J SURG, V36, P1608, DOI 10.1007/s00268-012-1538-8; Ariga H, 2009, INT J RADIAT ONCOL, V75, P348, DOI 10.1016/j.ijrobp.2009.02.086; Cuschieri A, 1992, J R Coll Surg Edinb, V37, P7; Fujita H, 1994, DIS ESOPHAGUS, V7, P169; Fujita H, 1984, Nihon Geka Gakkai Zasshi, V85, P17; FUJITA H, 1994, WORLD J SURG, V18, P266; FUJITA H, 1988, JPN J SURG, V18, P77, DOI 10.1007/BF02470850; Fujita H, 2011, ESOPHAGUS-TOKYO, V8, P233, DOI 10.1007/s10388-011-0292-6; FUJITA H, 1993, RECENT ADVANCES IN DISEASES OF THE ESOPHAGUS, P703; FUJITA H, 1988, JPN J SURG, V18, P31, DOI 10.1007/BF02470843; Fujita H, 2001, RECENT ADVANCES IN DISEASES OF THE ESOPHAGUS, P525; Harrison LE, 2000, J SURG ONCOL, V75, P227, DOI 10.1002/1096-9098(200012)75:4<227::AID-JSO1>3.0.CO;2-2; International Union Against Cancer, 1968, TNM CLASSIFICATION M; Isono K, 1986, GEKA SHINRYO SURG DI, V28, P529; ISONO K, 1991, ONCOLOGY, V48, P411; Jinnai D, 1965, GEN RULES GASTRIC CA; Kakegawa Teruo, 1993, Digestive Surgery, V10, P148, DOI 10.1159/000172164; Kakegawa T, 1986, GEKA SHINRYO SURG DI, V28, P523; KATO H, 1991, ANN THORAC SURG, V51, P931; Katsura S., 1957, NIPPON KYOBU GEKA GA, V6, P600; Kinoshita I, 1976, NIPPON SHYOKAKI GEKA, V9, P424; LEWIS I, 1946, BRIT J SURG, V34, P18, DOI 10.1002/bjs.18003413304; LOGAN A, 1963, J THORAC CARDIOV SUR, V46, P150; Mitomi T, 1989, SHUJUTSU OPER, V43, P1525; Mori S, 1990, SHUJUTSU OPER, V44, P53; Muto T, 1986, GEKA SHINRYO SURG DI, V28, P536; NAKAYAMA K, 1963, ARCH SURG-CHICAGO, V87, P1003; Ohsugi H., 2009, SYUJUTSU OPER, V63, P713; ORRINGER MB, 1984, ANN THORAC SURG, V38, P128; Osawa T, 1933, NIPPON GEKA GAKKAI Z, V34, P1319; SANNOHE Y, 1981, AM J SURG, V141, P216, DOI 10.1016/0002-9610(81)90160-4; Sato H, 1969, ESOPHAGEAL CANC DESC; Scannell JG, 1996, J THORAC CARDIOV SUR, V111, P905, DOI 10.1016/S0022-5223(96)70363-X; Seo S, 1933, NIHON GEKA GAKKAI ZA, V33, P1461; Siewert JR, 1989, BREITNER CHIRURGISCH, P17; SKINNER DB, 1983, J THORAC CARDIOV SUR, V85, P59; Sobin LH, 2009, TNM CLASSIFICATION M; Tachimori Y, 2005, RINSYO GEKA, V60, P193; Torek F., 1913, SURG GYNECOL OBSTET, V16, P614; Tsurumaru H, 2001, GUID LIN CLIN PATH S; Tsurumaru M, 1986, GEKA SHINRYO SURG DI, V28, P555; Yada I, 2004, JPN J THORAC CARDIOV, V52, P491	59	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					140	149		10.1007/s00595-014-0841-4		10	Surgery	Surgery	AZ7SJ	WOS:000348417800002		
J	Tsukushi, S; Nishida, Y; Sugiura, H; Yamada, Y; Kamei, Y; Toriyama, K; Ishiguro, N				Tsukushi, Satoshi; Nishida, Yoshihiro; Sugiura, Hideshi; Yamada, Yoshihisa; Kamei, Yuzuru; Toriyama, Kazuhiro; Ishiguro, Naoki			Non-rigid reconstruction of chest wall defects after resection of musculoskeletal tumors	SURGERY TODAY			English	Article						Chest wall; Reconstruction; Sarcoma; Complication; Flap transfer; Non-rigid	EXPERIENCE; FLAP; MESH	We analyzed the techniques used and the complications occurring in chest wall reconstruction after resection of musculoskeletal tumors to identify the optimal reconstruction method. The medical records of 50 patients with primary or metastatic malignant tumors requiring chest wall full thickness resection were retrospectively reviewed. The surgical technique and rate of postoperative complications were investigated, and the factors influencing complications were identified. Flap transfer was used in 23 cases (46 %). For skeletal reconstruction, a prosthetic mesh was used in 19 cases. In 18 recent cases, no prosthetic mesh was used, and patients were treated using only suture stabilization. Postoperative complications were recognized in 11 cases (22 %). The analysis of factors influencing the development of complications identified the use of preoperative adjuvant chemotherapy (p < 0.05), the bone as the primary site (p < 0.05), an anterolateral location (p = 0.081) and resection of a parts per thousand yen3 ribs (p = 0.077) as significant factors. No significant difference in the rate of complications was noted between the groups divided based on whether mesh was used. We used non-rigid reconstruction for full thickness resection of the chest wall, and achieved good postoperative outcomes with no grade 4 complications or perioperative mortality. Non-rigid reconstruction using flap transfers and careful respiratory management is a useful method for treating patients requiring chest wall full thickness resection.	[Tsukushi, Satoshi; Nishida, Yoshihiro; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Sugiura, Hideshi] Aichi Canc Ctr Hosp, Dept Orthopaed Surg, Nagoya, Aichi 464, Japan; [Yamada, Yoshihisa] Nagoya Mem Hosp, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Kamei, Yuzuru; Toriyama, Kazuhiro] Nagoya Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Nagoya, Aichi 4648601, Japan	Tsukushi, S (reprint author), Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	s-tsuku@med.nagoya-u.ac.jp					Walsh GL, 2001, J THORAC CARDIOV SUR, V121, P48, DOI 10.1067/mtc.2001.111381; Deschamps C, 1999, J THORAC CARDIOV SUR, V117, P588, DOI 10.1016/S0022-5223(99)70339-9; Lans TE, 2009, J THORAC ONCOL, V4, P639, DOI 10.1097/JTO.0b013e31819d18c9; Weyant MJ, 2006, ANN THORAC SURG, V81, P279, DOI 10.1016/j.athoracsur.2005.07.001; Pfannschmidt J, 2005, THORAC CARDIOV SURG, V53, P234, DOI 10.1055/s.-2005-837649; Losken A, 2004, BRIT J PLAST SURG, V57, P295, DOI 10.1016/j.bjps.2004.02.004; Kijima Y, 2013, SURG TODAY, V43, P456, DOI 10.1007/s00595-012-0390-7; Mansour KA, 2002, ANN THORAC SURG, V73, P1720, DOI 10.1016/S0003-4975(02)03527-0; Chang RR, 2004, ANN PLAS SURG, V52, P471, DOI 10.1097/01.sap.0000122653.09641.f8; Lardinois D, 2000, ANN THORAC SURG, V69, P919, DOI 10.1016/S0003-4975(99)01422-8; Bosc R, 2011, ANN PLAS SURG, V67, P263, DOI 10.1097/SAP.0b013e3181f9b292; Gonfiotti A, 2010, EUR J CARDIO-THORAC, V38, P39, DOI 10.1016/j.ejcts.2009.12.046; Granetzny Andreas, 2005, Interact Cardiovasc Thorac Surg, V4, P583, DOI 10.1510/icvts.2005.111807; Hameed A, 2008, J PLAST RECONSTR AES, V61, P628, DOI 10.1016/j.bjps.2007.04.011; KROLL SS, 1993, ANN PLAS SURG, V31, P303, DOI 10.1097/00000637-199310000-00003; Pairolero PC, 1999, EUR J CARDIO-THORAC, V16, P48; Pfannschmidt J, 2006, THORAC CARDIOV SURG, V54, P182, DOI 10.1055/s-2005-872973; Thomas Pascal A, 2010, Thorac Surg Clin, V20, P551, DOI 10.1016/j.thorsurg.2010.06.006	18	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					150	155		10.1007/s00595-014-0871-y		6	Surgery	Surgery	AZ7SJ	WOS:000348417800003		
J	Koami, H; Isa, T; Ishimine, T; Kameyama, S; Matsumura, T; Yamada, KC; Sakamoto, Y				Koami, Hiroyuki; Isa, Tsutomu; Ishimine, Tomonari; Kameyama, Shinichiro; Matsumura, Toshinobu; Yamada, Kosuke Chris; Sakamoto, Yuichiro			Risk factors for bowel necrosis in patients with hepatic portal venous gas	SURGERY TODAY			English	Article						Hepatic portal venous gas; Bowel necrosis; MDCT; Logistic regression analysis; Diagnostic criteria	PNEUMATOSIS-INTESTINALIS; CLINICAL-SIGNIFICANCE; COMPUTED-TOMOGRAPHY; CT; MANAGEMENT; ETIOLOGY; ISCHEMIA; SURGERY; ADULT	To evaluate the risk factors for bowel necrosis in adult patients with hepatic portal venous gas (HPVG). This retrospective study comprised 33 adult patients treated for HPVG between August, 2008 and December, 2011. The patients were divided into a necrotic group (n = 14) and a non-necrotic group (n = 19). We analyzed the clinical demographics, laboratory data, multi-detector computed tomography findings, treatments, and outcomes in each group. Abdominal pain, peritoneal signs, systolic blood pressure, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase (LDH), small intestinal dilatation, poor enhancement of the bowel wall, and intestinal pneumatosis were all significantly associated with bowel necrosis. Moreover, there were significantly more operative cases and deaths in the necrotic group. Multivariate analysis revealed that systolic BP (p = 0.048), LDH (p = 0.022), and intestinal pneumatosis (p = 0.038) were independent risk factors for bowel necrosis. Thus, we created new diagnostic criteria for bowel necrosis based on these three factors, the sensitivity, specificity, and accuracy of which were 100, 78.9, and 87.9 %, respectively. This study demonstrates new and important findings to evaluate the risk factors for bowel necrosis. Using our diagnostic criteria, the indications for emergency laparotomy can be established more accurately.	[Koami, Hiroyuki; Isa, Tsutomu; Ishimine, Tomonari; Kameyama, Shinichiro; Matsumura, Toshinobu] Urasoe Gen Hosp, Dept Surg, Ctr Gastroenterol, Urasoe 9012132, Japan; [Yamada, Kosuke Chris; Sakamoto, Yuichiro] Saga Univ, Dept Emergency & Crit Care Med, Fac Med, Saga 8498501, Japan	Koami, H (reprint author), Urasoe Gen Hosp, Dept Surg, Ctr Gastroenterol, Iso 4-16-1, Urasoe 9012132, Japan.	amicopter@gmail.com		Yamada, Kosuke Chris/0000-0002-0297-1893			Wiesner W, 2003, RADIOLOGY, V226, P635, DOI 10.1148/radiol.2263011540; Wiesner W, 2001, AM J ROENTGENOL, V177, P1319; Abboud B, 2009, WORLD J GASTROENTERO, V15, P3585, DOI 10.3748/wjg.15.3585; Nelson AL, 2009, ARCH SURG-CHICAGO, V144, P575, DOI 10.1001/archsurg.2009.88; Ho LM, 2007, AM J ROENTGENOL, V188, P1604, DOI 10.2214/AJR.06.1309; DuBose JJ, 2013, J TRAUMA ACUTE CARE, V75, P15, DOI 10.1097/TA.0b013e318298486e; Faberman RS, 1997, AM J ROENTGENOL, V169, P1535; Hou SK, 2004, AM J EMERG MED, V22, P214, DOI 10.1016/j.ajem.2004.02.017; Iannitti DA, 2003, DIGEST SURG, V20, P306, DOI 10.1159/000071756; Imai K, 2012, SURG TODAY, V42, P992, DOI 10.1007/s00595-012-0184-y; Kinoshita H, 2001, ARCH SURG-CHICAGO, V136, P1410, DOI 10.1001/archsurg.136.12.1410; LIEBMAN PR, 1978, ANN SURG, V187, P281, DOI 10.1097/00000658-197803000-00012; Little Andrew F, 2003, Australas Radiol, V47, P309, DOI 10.1046/j.1440-1673.2003.01184.x; Miyoshi O, 2009, J JPN ASS ACUTE MED, V20, P823; Shimanuki K, 2001, SURG TODAY, V31, P246; WOLFE JN, 1955, AMER J ROENTGENOL RA, V74, P486; Wu JM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-18	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					156	161		10.1007/s00595-014-0941-1		6	Surgery	Surgery	AZ7SJ	WOS:000348417800004		
J	Miyamoto, N; Kawasaki, R; Fukuda, T; Yamaguchi, M; Sugimura, K; Sugimoto, K				Miyamoto, Naokazu; Kawasaki, Ryota; Fukuda, Tetsuya; Yamaguchi, Masato; Sugimura, Kazuro; Sugimoto, Koji			Endovascular treatment for unilateral chronic total occlusions of the iliac artery categorized as TASC II type D lesions	SURGERY TODAY			English	Article						Peripheral arterial disease; Iliac artery; Occlusion; Percutaneous transluminal angioplasty; Stenting	INTER-SOCIETY-CONSENSUS; DISEASE; ANGIOPLASTY; MANAGEMENT; CORONARY; BYPASS	To compare the results of endovascular treatment for unilateral iliac occlusion in types B and D, and confirm its validity for type D. Between 2000 and 2011, 108 patients underwent endovascular treatment for unilateral iliac occlusion. 77 were categorized as type B for occlusion of common iliac artery (CIA) or external iliac artery (EIA) and 31 were categorized as type D for occlusion of both CIA and EIA. The initial success rates, procedure time, penetration time, amount of contrast media used, complication rates, and cumulative primary patency rates were determined and compared between these groups. Between type D and B groups, the initial success rates were 87.1 % (type D) and 89.6 % (type B) (p = 0.9316). The procedure time was 137.0 +/- A 55.5 and 97.2 +/- A 47.2 min (p < 0.05). The penetration time was 49.1 +/- A 40.6 and 31.6 +/- A 30.1 min (p < 0.05). The amount of contrast agent used was 193.9 +/- A 103.1 and 156.5 +/- A 85.0 ml (p = 0.0722). The complication rates were 6.5 and 3.9 % (p = 0.8491). The cumulative primary patency rates, at 1, 3, and 5 years were 91, 85, and 85 % and 100, 96, and 93 %. Endovascular treatment can be indicated for unilateral occlusion of both CIA and EIA categorized as type D.	[Miyamoto, Naokazu; Kawasaki, Ryota] Hyogo Brain & Heart Ctr, Dept Radiol, Himeji, Hyogo 6700981, Japan; [Fukuda, Tetsuya] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Osaka, Japan; [Yamaguchi, Masato; Sugimura, Kazuro; Sugimoto, Koji] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Yamaguchi, Masato; Sugimura, Kazuro; Sugimoto, Koji] Kobe Univ, Grad Sch Med, Ctr Endovasc Therapy, Kobe, Hyogo 657, Japan	Miyamoto, N (reprint author), Hyogo Brain & Heart Ctr, Dept Radiol, 520 Saishokou, Himeji, Hyogo 6700981, Japan.	naoka_zu@ybb.ne.jp					AbuRahma AF, 2007, J VASC SURG, V46, P965, DOI 10.1016/j.jvs.2007.07.027; Al-Ameri H, 2009, J INVASIVE CARDIOL, V21, P468; Leville CD, 2006, J VASC SURG, V43, P32, DOI 10.1016/j.jvs.2005.09.034; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Ichihashi S, 2011, J VASC SURG, V53, P992, DOI 10.1016/j.jvs.2010.10.069; Rits J, 2008, EUR J VASC ENDOVASC, V36, P339, DOI 10.1016/j.ejvs.2008.05.005; Balzer JO, 2006, EUR RADIOL, V16, P124, DOI 10.1007/s00330-005-2736-7; Carnevale FC, 2004, CARDIOVASC INTER RAD, V27, P447, DOI 10.1007/s00270-004-0086-5; Ozkan U, 2010, CARDIOVASC INTER RAD, V33, P18, DOI 10.1007/s00270-009-9691-7; Ballotta E, 2010, SURGERY, V147, P268, DOI 10.1016/j.surg.2009.08.004; Koizumi A, 2009, CIRC J, V73, P860; Uher P, 2002, J ENDOVASC THER, V9, P67, DOI 10.1583/1545-1550(2002)009<0067:LTROSF>2.0.CO;2; Gandini R, 2008, CARDIOVASC INTER RAD, V31, P1069, DOI 10.1007/s00270-008-9386-5; ARONOW WS, 1994, AM J CARDIOL, V74, P64, DOI 10.1016/0002-9149(94)90493-6; FAHAL AH, 1989, BRIT J SURG, V76, P22, DOI 10.1002/bjs.1800760108; Kaneoka Y, 2013, SURG TODAY, V43, P1254, DOI 10.1007/s00595-012-0406-3; Krishnamurthy VN, 2010, ANN VASC SURG, V24, P487, DOI 10.1016/j.avsg.2009.12.002; LOPEZ JF, 1989, SURG RADIOL ANAT, V11, P275, DOI 10.1007/BF02098696; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Paraskevas KI, 2009, ANN VASC SURG, V23, P690, DOI 10.1016/j.avsg.2009.06.002; Sixt S, 2008, J ENDOVASC THER, V15, P408, DOI 10.1583/08-2359.1; Staniloae CS, 2011, J INVASIVE CARDIOL, V23, P359; VANADRICHEM LNA, 1991, NETH J SURG, V43, P67	23	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					162	167		10.1007/s00595-014-0883-7		6	Surgery	Surgery	AZ7SJ	WOS:000348417800005		
J	Homma, Y; Hamano, T; Otsuki, Y; Shimizu, S; Kobayashi, Y				Homma, Yoichiro; Hamano, Takashi; Otsuki, Yoshiro; Shimizu, Shinichi; Kobayashi, Yasuyuki			The total number of lymph node metastases is a more significant risk factor for poor prognosis than positive lateral lymph node metastasis	SURGERY TODAY			English	Article						Lower rectal cancer; Lateral lymph nodes; Regional lymph nodes	TOTAL MESORECTAL EXCISION; LOW RECTAL-CANCER; PELVIC SIDEWALL DISSECTION; CURATIVE RESECTION; COLORECTAL-CANCER; RANDOMIZED-TRIAL; SURGERY; RECURRENCE; RADIOTHERAPY; MULTICENTER	Lateral lymph nodes (LLNs) along the iliac vessels are an important indicator of local recurrence; however, we are unaware of any study that investigates whether the number of LLN metastases influences the prognosis of patients with lower rectal cancer. We analyzed retrospectively the records of 154 patients who underwent radical resection of T1-4 lower rectal adenocarcinoma at a single institution. Among the 88.3 % of patients who underwent LLN dissection, 13 (8.4 %) had LLN metastasis. The Cox proportional hazard model indicated that sex, histological grade, lymphatic or venous invasion, and LLN metastasis were not significantly associated with tumor recurrence, whereas tumor depth and more than three lymph node metastases were risk factors for recurrence (p = 0.002 and p = 0.02, respectively). Of the 13 patients with LLN metastasis, 6 whose mesenteric lymph nodes (MLNs) had been well dissected and examined did not have MLN metastasis. The presence of one or two LLN metastases in patients who have undergone LLN dissection with surgery for lower rectal cancer is not associated with poor prognosis. The number of LLN metastases is a more significant risk factor for poor prognosis.	[Homma, Yoichiro; Hamano, Takashi; Kobayashi, Yasuyuki] Seirei Hamamatsu Gen Hosp, Dept Colorectal Surg, Naka Ku, Hamamatsu, Shizuoka 4308558, Japan; [Otsuki, Yoshiro; Shimizu, Shinichi] Seirei Hamamatsu Gen Hosp, Dept Pathol, Hamamatsu, Shizuoka 4308558, Japan	Homma, Y (reprint author), Seirei Hamamatsu Gen Hosp, Dept Colorectal Surg, Naka Ku, Sumiyoshi 2-12-12, Hamamatsu, Shizuoka 4308558, Japan.	yoh2007@sis.seirei.or.jp					Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Ueno M, 2005, BRIT J SURG, V92, P756, DOI 10.1002/bjs.4975; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Akagi Y, 2013, SURG TODAY, V43, P838, DOI 10.1007/s00595-012-0394-3; Yano H, 2008, BRIT J SURG, V95, P33, DOI 10.1002/bjs.6061; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Kobayashi H, 2009, DIS COLON RECTUM, V52, P567, DOI 10.1007/DCR.0b013e3181a1d994; Endreseth BH, 2005, DIS COLON RECTUM, V48, P1380, DOI 10.1007/s10350-005-0044-6; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Georgiou P, 2009, LANCET ONCOL, V10, P1053, DOI 10.1016/S1470-2045(09)70224-4; [Anonymous], 1996, LANCET, V348, P1610; [Anonymous], 1990, JAMA, V264, P1444; HEALD RJ, 1995, BRIT J SURG, V82, P1297, DOI 10.1002/bjs.1800821002; HEALD RJ, 1986, LANCET, V1, P1479; Bonadeo FA, 2001, DIS COLON RECTUM, V44, P374, DOI 10.1007/BF02234736; Funahashi K, 2006, DIS COLON RECTUM, V49, pS53, DOI 10.1007/s10350-006-0659-2; Hamano T, 2010, COLORECTAL DIS, V12, pE200, DOI 10.1111/j.1463-1318.2009.02134.x; HOJO K, 1982, AM J SURG, V144, P350, DOI 10.1016/0002-9610(82)90018-6; Homma Y, 2010, J SURG ONCOL, V102, P230, DOI 10.1002/jso.21606; Kato T, 2002, LANGENBECK ARCH SURG, V386, P575, DOI 10.1007/s00423-002-9278-x; Mori T, 2010, CANCER INVEST, V28, P387, DOI 10.3109/07357900903287055; Mori Takeo, 2003, Nihon Rinsho, V61 Suppl 7, P255; Moriya Y, 2009, LANCET ONCOL, V10, P1026, DOI 10.1016/S1470-2045(09)70321-3; Muto Tetsuichiro, 2001, International Journal of Clinical Oncology, V6, P171, DOI 10.1007/PL00012102; Nakfoor BM, 1998, ANN SURG, V228, P194, DOI 10.1097/00000658-199808000-00008; Sterk P, 2002, INT J COLORECTAL DIS, V17, P137, DOI 10.1007/s00384-001-0378-z; Yano H, 2010, LANCET ONCOL, V11, P114, DOI 10.1016/S1470-2045(09)70361-4	28	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					168	174		10.1007/s00595-014-0913-5		7	Surgery	Surgery	AZ7SJ	WOS:000348417800006		
J	Tsunoda, A; Kiyasu, Y; Fujii, W; Kano, N				Tsunoda, Akira; Kiyasu, Yoshiyuki; Fujii, Wataru; Kano, Nobuyasu			Comparison of the early results of transanal hemorrhoidal dearterialization and hemorrhoidectomy using an ultrasonic scalpel	SURGERY TODAY			English	Article						Hemorrhoids; Prolapse; Doppler-guided transanal hemorrhoid dearterialization and mucopexy; Hemorrhoidectomy using an ultrasonic scalpel	ARTERY LIGATION; CONVENTIONAL HEMORRHOIDECTOMY	Doppler-guided transanal hemorrhoidal dearterialization and mucopexy (THD surgery) is a new approach for treating hemorrhoids. The early results of the procedure are presented and compared with those of hemorrhoidectomy using an ultrasonic scalpel (US surgery). Thirty-six patients with grade III hemorrhoids underwent the THD surgery and were compared with a cohort of 30 patients with grade III or IV hemorrhoids who were assigned to US surgery in a previous randomized trial. The pain scores were significantly lower in the THD patients on days 6 and 7 after the operation. The number of analgesic tablets consumed during the first postoperative week in the THD patients was significantly lower than that in the US patients. The blood loss was significantly greater in the THD patients. The hospital stay and length of time until the first defecation after surgery were both significantly shorter in the THD patients. The postoperative complications were comparable between the two groups of patients. The THD surgery was as effective as the US surgery for the treatment of hemorrhoids in the short term. THD surgery might be a preferred treatment because it is associated with a similar complication rate and short-term results, but results in lower postoperative pain and analgesic requirements compared with the US surgery.	[Tsunoda, Akira; Kiyasu, Yoshiyuki; Fujii, Wataru; Kano, Nobuyasu] Kameda Med Ctr, Dept Surg, Chiba 2968602, Japan	Tsunoda, A (reprint author), Kameda Med Ctr, Dept Surg, 929 Higashicho, Chiba 2968602, Japan.	a.tsunoda@kameda.jp					MORINAGA K, 1995, AM J GASTROENTEROL, V90, P610; Ratto C, 2011, TECH COLOPROCTOL, V15, P191, DOI 10.1007/s10151-011-0689-1; Khafagy W, 2009, HEPATO-GASTROENTEROL, V56, P1010; Pescatori M, 2008, TECH COLOPROCTOL, V12, P7, DOI 10.1007/s10151-008-0391-0; Giordano P, 2011, TECH COLOPROCTOL, V15, P67, DOI 10.1007/s10151-010-0667-z; Festen S, 2009, INT J COLORECTAL DIS, V24, P1401, DOI 10.1007/s00384-009-0803-2; Giordano P, 2009, DIS COLON RECTUM, V52, P1665, DOI 10.1007/DCR.0b013e3181af50f4; Tjandra JJ, 2007, DIS COLON RECTUM, V50, P878, DOI 10.1007/s10350-006-0852-3; Armstrong DN, 2001, DIS COLON RECTUM, V44, P558, DOI 10.1007/BF02234329; Infantino A, 2012, COLORECTAL DIS, V14, P205, DOI 10.1111/j.1463-1318.2011.02628.x; Bursics A, 2004, INT J COLORECTAL DIS, V19, P176, DOI 10.1007/s00384-003-0517-9; Dal Monte P P, 2007, Tech Coloproctol, V11, P333; Faucheron JL, 2011, DIS COLON RECTUM, V54, P226, DOI 10.1007/DCR.0b013e318201d31c; LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Ratto C, 2010, DIS COLON RECTUM, V53, P803, DOI 10.1007/DCR.0b013e3181cdafa7; Scheyer M, 2006, AM J SURG, V191, P89, DOI 10.1016/j.amsurg.2005.10.007; Sohn N, 2001, AM J SURG, V182, P515, DOI 10.1016/S0002-9610(01)00759-0; THOMSON WHF, 1975, P ROY SOC MED, V68, P574; Tsunoda Akira, 2011, World J Gastrointest Surg, V3, P147, DOI 10.4240/wjgs.v3.i10.147; Wilkerson PM, 2009, COLORECTAL DIS, V11, P394, DOI 10.1111/j.1463-1318.2008.01602.x	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					175	180		10.1007/s00595-014-0885-5		6	Surgery	Surgery	AZ7SJ	WOS:000348417800007		
J	Asari, S; Matsumoto, I; Ajiki, T; Shinzeki, M; Goto, T; Fukumoto, T; Ku, Y				Asari, Sadaki; Matsumoto, Ippei; Ajiki, Tetsuo; Shinzeki, Makoto; Goto, Tadahiro; Fukumoto, Takumi; Ku, Yonson			Perioperative management for pancreatoduodenectomy following severe acute pancreatitis in patients with periampullary cancer: our experience with six consecutive cases	SURGERY TODAY			English	Article						Severe acute pancreatitis; Pancreatoduodenectomy; ERCP	RISK-FACTORS; COMPLICATIONS; FISTULA; PANCREATICOJEJUNOSTOMY; PANCREATICOGASTROSTOMY; SPHINCTEROTOMY; METAANALYSIS; OUTCOMES; TUMORS; TRIAL	We rarely have an opportunity to perform pancreatoduodenectomy (PD) following the onset of severe acute pancreatitis (SAP) for patients with periampullary cancer. The perioperative risks and optimal timing of subsequent PD have, therefore, remained unclear. Between January 2006 and December 2012, we performed PD in six patients with SAP. We reviewed these six cases, and compared the perioperative risks of morbidity and mortality with those of 81 concurrent PD patients matched for primary cancer without preoperative SAP. The six patients were classified as having SAP based on the Japanese criteria developed in 2008. The SAP in five patients was caused by ERCP procedures. The median interval from SAP onset to the operation was 111 days. The rate of Grade B/C postoperative pancreatic fistula formation in the SAP patients was significantly higher than that of the 81 control patients (83 vs. 26 %, P < 0.001). In addition, the median postoperative hospital stay was significantly longer in the six SAP patients relative to that of the control patients (40 vs. 30 days, P < 0.001). An interval of at least 3 months after surgery may be needed to decrease the inflammation of the peripancreas region after SAP. Therefore, unnecessary and low-yield ERCP procedures should be avoided in these patients.	[Asari, Sadaki; Matsumoto, Ippei; Ajiki, Tetsuo; Shinzeki, Makoto; Goto, Tadahiro; Fukumoto, Takumi; Ku, Yonson] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Chuo Ku, Kobe, Hyogo 6500017, Japan	Asari, S (reprint author), Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	sasari@med.kobe-u.ac.jp					COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Lin JW, 2004, J GASTROINTEST SURG, V8, P951, DOI 10.1016/j.gassur.2004.09.044; Kiriyama S, 2010, J HEPATO-BIL-PAN SCI, V17, P24, DOI 10.1007/s00534-009-0214-3; Shinkawa H, 2013, SURG TODAY, V43, P276, DOI 10.1007/s00595-012-0350-2; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Figueras J, 2013, BRIT J SURG, V100, P1597, DOI 10.1002/bjs.9252; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Diener MK, 2007, ANN SURG, V245, P187, DOI 10.1097/01.sla.0000242711.74502.a9; Arung W, 2011, WORLD J GASTROENTERO, V17, P4545, DOI 10.3748/wjg.v17.i41.4545; Takeda K, 2010, J HEPATO-BIL-PAN SCI, V17, P37, DOI 10.1007/s00534-009-0213-4; Topal B, 2013, LANCET ONCOL, V14, P655, DOI 10.1016/S1470-2045(13)70126-8; Pessaux P, 2011, ANN SURG, V253, P879, DOI 10.1097/SLA.0b013e31821219af; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Takeda K, 2006, J HEPATO-BILIARY-PAN, V13, P42, DOI 10.1007/s00534-005-1050-8; Arata S, 2010, J HEPATO-BIL-PAN SCI, V17, P70, DOI 10.1007/s00534-009-0220-5; BALTHAZAR EJ, 1985, RADIOLOGY, V156, P767; Badalov Nison, 2009, JOP, V10, P88; Elliott-Lewis EW, 2009, NEUROSURGERY, V65, P1182, DOI 10.1227/01.NEU.0000356985.27936.93; Erkan M, 2007, DIGESTION, V75, P165, DOI 10.1159/000106799; Mazaki T, 2010, ENDOSCOPY, V42, P842, DOI 10.1055/s-0030-1255781; Sobin LH, 2002, TNM CLASSIFICATION M, P93; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					181	188		10.1007/s00595-014-0900-x		8	Surgery	Surgery	AZ7SJ	WOS:000348417800008		
J	Hattori, A; Suzuki, K; Takamochi, K; Oh, S				Hattori, Aritoshi; Suzuki, Kenji; Takamochi, Kazuya; Oh, Shiaki			Clinical features of multiple lung cancers based on thin-section computed tomography: What are the appropriate surgical strategies for second lung cancers?	SURGERY TODAY			English	Article						Second lung cancer; Surgery; Prognosis; Thin-section computed tomography	SINGLE-CENTER; EXPERIENCE; MANAGEMENT; RESECTION; ADENOCARCINOMA; SURVIVAL; MUTATION; THERAPY; TUMOR; GENE	We investigated the proper surgical strategies for second lung cancers based on the findings of thin-section CT. We classified 59 patients with second lung cancers into two categories based on the thin-section CT findings. In the ground glass nodule (GGN) group (n = 29), the first and/or the second lung cancers showed a GGN on thin-section CT. In the Solid group (n = 30), both the first and second lung cancers showed a solid appearance. The overall 5-year survival rate after second surgery was 71.7 %. The univariate analyses revealed that the presence of more than three lung tumors was significantly more common in the GGN group. Regarding the surgical strategies, all the patients in the GGN group underwent limited resection for at least one of the operations, whereas 36 % of those in the Solid group underwent bilateral lobectomy. The 5-year survival in the GGN group (89.1 %) was significantly better than that in the Solid group (40.8 %) (p = 0.0305). Limited resection should be performed for GGN patients as much as possible to preserve lung function, due to the possible presence of more than three lung cancers. Despite the higher likelihood of having more tumors, the GGN patients had a better survival. In contrast, lobectomy for second lesions should be aggressively considered for solid tumor patients whenever possible.	[Hattori, Aritoshi; Suzuki, Kenji; Takamochi, Kazuya; Oh, Shiaki] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Bunkyo Ku, Tokyo 1138431, Japan	Suzuki, K (reprint author), Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Bunkyo Ku, 1-3 Hongo 3 Chome, Tokyo 1138431, Japan.	ahattori@juntendo.ac.jp; kjsuzuki@juntendo.ac.jp			Ministry of Health, Labour and Welfare, Japan; Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan and the Smoking Research Foundation.	ANGELETTI CA, 1995, EUR J CARDIO-THORAC, V9, P607, DOI 10.1016/S1010-7940(05)80104-6; Chang YL, 2007, J THORAC CARDIOV SUR, V134, P630, DOI 10.1016/j.jtcvs.2007.06.001; De Leyn P, 2008, EUR J CARDIO-THORAC, V34, P1215, DOI 10.1016/j.ejcts.2008.07.069; Suzuki K, 2006, ANN THORAC SURG, V81, P413, DOI 10.1016/j.athoracsur.2005.07.058; Tsunezuka Y, 2004, EJSO, V30, P781, DOI 10.1016/j.ejso.2004.05.008; Adebonojo SA, 1997, CHEST, V112, P693, DOI 10.1378/chest.112.3.693; Okada M, 1998, J THORAC CARDIOV SUR, V115, P836, DOI 10.1016/S0022-5223(98)70364-2; Shah AA, 2012, ANN THORAC SURG, V93, P1055, DOI 10.1016/j.athoracsur.2011.12.070; Surapaneni R, 2012, J THORAC ONCOL, V7, P1252, DOI 10.1097/JTO.0b013e3182582a79; Nakata M, 2004, ANN THORAC SURG, V78, P1194, DOI 10.1016/j.athoracsur.2004.03.102; Johnson BE, 1998, J NATL CANCER I, V90, P1335, DOI 10.1093/jnci/90.18.1335; ANTAKLI T, 1995, ANN THORAC SURG, V59, P863, DOI 10.1016/0003-4975(95)00067-U; Asamura H, 2010, J THORAC ONCOL, V5, P930, DOI 10.1097/JTO.0b013e3181e15d8c; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Trousse D, 2007, J THORAC CARDIOV SUR, V133, P1193, DOI 10.1016/j.jtcvs.2007.01.012; Rea F, 2001, EUR J CARDIO-THORAC, V20, P489, DOI 10.1016/S1010-7940(01)00858-2; Hattori A, 2012, ANN THORAC SURG, V94, P212, DOI 10.1016/j.athoracsur.2012.03.033; Aziz TM, 2002, EUR J CARDIO-THORAC, V21, P527, DOI 10.1016/S1010-7940(02)00024-6; Bae MK, 2011, ANN THORAC SURG, V92, P256, DOI 10.1016/j.athoracsur.2011.02.034; Deschamps C, 1990, J THORAC CARDIOVASC, V99, P777; DESCHAMPS C, 1990, J THORAC CARDIOV SUR, V99, P769; Fabian T, 2011, J THORAC CARDIOV SUR, V142, P547, DOI 10.1016/j.jtcvs.2011.03.035; Girard N, 2010, CHEST, V137, P46, DOI 10.1378/chest.09-0325; Matsuzoe D, 1999, BRIT J CANCER, V79, P1549, DOI 10.1038/sj.bjc.6690247; Mitsudomi T, 1997, J THORAC CARDIOV SUR, V114, P354, DOI 10.1016/S0022-5223(97)70180-6; Rea F, 2010, J THORAC ONCOL, V5, P197	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					189	196		10.1007/s00595-014-0921-5		8	Surgery	Surgery	AZ7SJ	WOS:000348417800009		
J	Go, T; Misaki, N; Matsuura, N; Chang, SS; Tarumi, S; Yokomise, H				Go, Tetsuhiko; Misaki, Noriyuki; Matsuura, Natsumi; Chang, Sung Soo; Tarumi, Shintarou; Yokomise, Hiroyasu			Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer	SURGERY TODAY			English	Article						Lung cancer; Pleural dissemination; Surgery	PLEURAL LAVAGE CYTOLOGY; PROGNOSTIC-SIGNIFICANCE; DISSEMINATION; THORACOTOMY; EFFUSION; DISEASE	To evaluate the role of surgery in the treatment of the patients with non-small cell lung cancer with pleural dissemination. The clinical records of 25 patients (mean age 69 years) diagnosed with carcinomatous pleuritis during a thoracotomy by pathological examination and followed by surgery between 1994 and 2012 were reviewed. The treatment modality, including surgery, the clinicopathologic characteristics and 5-year survival were analyzed. There were 16 adenocarcinomas, 6 squamous cell carcinomas and 3 large cell carcinomas. Surgery included resection of the main tumor by partial resection in 10 cases, segmentectomy in 2 cases, lobar resection in 12 cases and bilobectomy in 1 case. Intrathoracic irrigation was performed in 20 cases. The pathological N status was N0/N1/N2/Nx: 10/6/7/2. Fifteen patients received adjuvant therapy. The overall 5-year survival rate was 22.2 %. The 5-year survival rates of the N0, N1 and N2 groups were 36.0, 16.7 and 14.3 %, respectively (p = 0.0068). Nine patients lived more than 3 years including 5 in N0, 3 in N1 and 1 in N2. Surgery should not be excluded from the multi-modality treatment of patients with carcinomatous pleuritis because there are some patients who could benefit from surgery especially if they are in N0 status.	[Go, Tetsuhiko; Misaki, Noriyuki; Matsuura, Natsumi; Chang, Sung Soo; Tarumi, Shintarou; Yokomise, Hiroyasu] Kagawa Univ, Dept Gen Thorac Breast & Endocrine Surg, Fac Med, Takamatsu, Kagawa 7610793, Japan	Go, T (reprint author), Kagawa Univ, Dept Gen Thorac Breast & Endocrine Surg, Fac Med, 1750-1 Miki Cho, Takamatsu, Kagawa 7610793, Japan.	tetsu-g@med.kagawa-u.ac.jp					Miura T, 2000, J THORAC CARDIOV SUR, V120, P437, DOI 10.1067/mtc.2000.108906; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Janjigian YY, 2011, J THORAC ONCOL, V6, P569, DOI 10.1097/JTO.0b013e318202bffe; Manac'h D, 2001, ANN THORAC SURG, V71, P1088, DOI 10.1016/S0003-4975(00)02649-7; Aokage K, 2010, J THORAC CARDIOV SUR, V139, P1246, DOI 10.1016/j.jtcvs.2009.07.049; Buhr J, 1997, J THORAC CARDIOV SUR, V113, P683, DOI 10.1016/S0022-5223(97)70225-3; BUHR J, 1990, CANCER, V65, P1801, DOI 10.1002/1097-0142(19900415)65:8<1801::AID-CNCR2820650822>3.0.CO;2-9; Higashiyama M, 2009, EUR J CARDIO-THORAC, V35, P337, DOI 10.1016/j.ejcts.2008.10.013; Ichinose Y, 2001, LUNG CANCER-J IASLC, V32, P55, DOI 10.1016/S0169-5002(00)00206-3; Ichinose Y, 2000, SURG TODAY, V30, P1062; KODAMA K, 1993, CANCER, V72, P426, DOI 10.1002/1097-0142(19930715)72:2<426::AID-CNCR2820720218>3.0.CO;2-S; KONDO H, 1993, J THORAC CARDIOV SUR, V106, P1092; Mordant P, 2011, EUR J CARDIO-THORAC, V40, P1444, DOI 10.1016/j.ejcts.2011.02.076; Ohta Y, 2005, J SURG ONCOL, V91, P237, DOI 10.1002/jso.20333; Okada M, 2003, J THORAC CARDIOV SUR, V126, P1911, DOI 10.1016/S0022-5223(03)00715-3; Pagan Vittore, 2005, Chir Ital, V57, P703; RESHAD K, 1985, CHEST, V88, P393, DOI 10.1378/chest.88.3.393; Riquet M, 2002, ANN THORAC SURG, V74, P1750, DOI 10.1016/S0003-4975(02)03942-5; Satoh Y, 2007, ANN THORAC SURG, V83, P197, DOI 10.1016/j.athoracsur.2006.08.025; Sawabata N, 2002, ANN THORAC SURG, V73, P412, DOI 10.1016/S0003-4975(01)03426-9; The Japan Lung Cancer Society, 2010, GEN RUL CLIN PATH RE, P50; Yokoi K, 2002, J THORAC CARDIOV SUR, V123, P184, DOI 10.1067/mtc.2002.118039	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					197	202		10.1007/s00595-014-0987-0		6	Surgery	Surgery	AZ7SJ	WOS:000348417800010		
J	Kanaji, S; Nakamura, T; Yamamoto, M; Imanishi, T; Suzuki, S; Tanaka, K; Kuroda, D; Kakeji, Y				Kanaji, Shingo; Nakamura, Tetsu; Yamamoto, Masashi; Imanishi, Tatsuya; Suzuki, Satoshi; Tanaka, Kenichi; Kuroda, Daisuke; Kakeji, Yoshihiro			Successful laparoscopic gastric resection and safe introduction of a single-incision technique for gastric submucosal tumors located near the esophagogastric junction	SURGERY TODAY			English	Article						SMT; GIST; Esophagogastric junction; Laparoscopic gastric resection; Single-port laparoscopic surgery	GASTROINTESTINAL STROMAL TUMORS; WEDGE RESECTION; PROGNOSTIC-FACTORS; SURGERY; GIST; GASTRECTOMY; STOMACH	Laparoscopic gastric resection cannot be easily applied for submucosal tumors near the esophagogastric junction (NEJ-SMTs). Furthermore, there have been no reports of single-incision laparoscopic surgery (SILS) for NEJ-SMTs. We evaluated our laparoscopic surgical outcomes for NEJ-SMTs, including a newly introduced phase of SILS. We retrospectively reviewed a total of 18 patients diagnosed with NEJ-SMTs who underwent laparoscopic surgery between April 2002 and September 2013. All patients underwent laparoscopic gastric resection without local complications and with a negative surgical margin, including 12 patients treated with conventional laparoscopic surgery (CLS) and six patients treated with SILS. The mean length of the operation was 184.3 +/- A 52.3 min, and the mean blood loss was 19.2 +/- A 17.7 mL. All patients underwent complete resection. There were no statistically significant differences between the CLS and SILS groups in terms of the surgical outcomes. Despite this challenging location of the tumor, laparoscopic gastric resection for NEJ-SMTs is safe and feasible. Furthermore, SILS can provide a better cosmetic result, which can lead to better global patient satisfaction in carefully selected patients with NEJ-SMTs.	[Kanaji, Shingo; Nakamura, Tetsu; Yamamoto, Masashi; Imanishi, Tatsuya; Suzuki, Satoshi; Tanaka, Kenichi; Kuroda, Daisuke; Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg,Chuo Ku, Kobe, Hyogo 6500017, Japan	Kanaji, S (reprint author), Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kanashin@med.kobe-u.ac.jp					Mochizuki Y, 2006, SURG TODAY, V36, P341, DOI 10.1007/s00595-005-3164-7; De Vogelaere K, 2012, SURG ENDOSC, V26, P2339, DOI 10.1007/s00464-012-2186-7; Song KY, 2007, SURG ENDOSC, V21, P2272, DOI 10.1007/s00464-007-9369-7; Tsujimoto H, 2012, WORLD J SURG, V36, P327, DOI 10.1007/s00268-011-1387-x; Sakamoto Y, 2012, SURG TODAY, V42, P708, DOI 10.1007/s00595-012-0121-0; Lee PC, 2010, BRIT J SURG, V97, P1007, DOI 10.1002/bjs.7087; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; St Peter SD, 2011, ANN SURG, V254, P586, DOI 10.1097/SLA.0b013e31823003b5; Novitsky YW, 2006, ANN SURG, V243, P738, DOI 10.1097/01.sla.0000219739.11758.27; Takahashi T, 2012, AM SURGEON, V78, P447; Privette A, 2008, SURG ENDOSC, V22, P487, DOI 10.1007/s00464-007-9493-4; Pfluke JM, 2011, J AM COLL SURGEONS, V212, P113, DOI 10.1016/j.jamcollsurg.2010.09.008; Tagaya N, 2002, SURG ENDOSC, V16, P177, DOI 10.1007/s004640080158; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Mekky MA, 2010, GASTROINTEST ENDOSC, V71, P913, DOI 10.1016/j.gie.2009.11.044; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Shimizu S, 2002, DIGEST SURG, V19, P169, DOI 10.1159/000064209; Demetri George D, 2007, J Natl Compr Canc Netw, V5 Suppl 2, pS1; Hara J, 2012, SURG LAPARO ENDO PER, V22, P251, DOI 10.1097/SLE.0b013e3182508083; Henckens T, 2010, J LAPAROENDOSC ADV S, V20, P469, DOI 10.1089/lap.2009.0391; Hirano Y, 2010, SURG LAPARO ENDO PER, V20, P262, DOI 10.1097/SLE.0b013e3181e36a5b; Kwon SJ, 2001, WORLD J SURG, V25, P290; Liao YT, 2013, SURG INNOV, V20, P478, DOI 10.1177/1553350612469281; Lukaszczyk J J, 1992, J Laparoendosc Surg, V2, P331, DOI 10.1089/lps.1992.2.331; Nguyen SQ, 2006, SURG ENDOSC, V20, P713, DOI 10.1007/s00464-005-0435-8; Walsh R M, 2001, Semin Laparosc Surg, V8, P189, DOI 10.1053/slas.2001.25372; Xu XW, 2013, J GASTROINTEST SURG, V17, P1570, DOI 10.1007/s11605-013-2241-2	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					209	214		10.1007/s00595-014-0940-2		6	Surgery	Surgery	AZ7SJ	WOS:000348417800012		
J	Seto, A; Sugitani, I; Toda, K; Kawabata, K; Takahashi, S; Saotome, T				Seto, Akira; Sugitani, Iwao; Toda, Kazuhisa; Kawabata, Kazuyoshi; Takahashi, Shunji; Saotome, Takashi			Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases	SURGERY TODAY			English	Article						Anaplastic thyroid carcinoma; Chemotherapy; Docetaxel; Cisplatin	PROGNOSTIC-FACTORS; CARCINOMA; DOXORUBICIN; TRIAL; RADIOTHERAPY; PACLITAXEL; SURGERY; BIOLOGY	Anaplastic thyroid carcinoma has a dismal prognosis and lacks an established therapeutic strategy. We have recently conducted chemotherapy with docetaxel and cisplatin as part of multimodal treatment for eight patients with anaplastic thyroid carcinoma. Docetaxel (75 mg/mA(2)) and cisplatin (75 mg/mA(2)) were administered on day 1 every 4 weeks for six courses. This chemotherapy was used as induction therapy in one patient, as therapy for distant metastases in five patients and as postoperative adjuvant therapy in two patients. Three patients showed partial responses and three patients showed stable disease. After excluding the two patients receiving the treatment as adjuvant therapy the response rate was 50 %. Grade 3 or 4 leukocytopenia occurred in seven patients (88 %), but these adverse events were tolerable. Chemotherapy with docetaxel and cisplatin may thus be feasible for anaplastic thyroid carcinoma.	[Seto, Akira; Sugitani, Iwao; Toda, Kazuhisa; Kawabata, Kazuyoshi] Canc Inst Hosp, Div Head & Neck, Koto Ku, Tokyo 1358550, Japan; [Sugitani, Iwao] Nippon Med Sch, Dept Surg, Div Endocrine Surg, Bunkyo Ku, Tokyo 1138603, Japan; [Takahashi, Shunji] Canc Inst Hosp, Dept Med Oncol, Koto Ku, Tokyo 1358550, Japan; [Saotome, Takashi] Matsudo City Hosp, Dept Med Oncol, Matsudo, Chiba 2718511, Japan	Seto, A (reprint author), Canc Inst Hosp, Div Head & Neck, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	akira.seto@jfcr.or.jp					Ain KB, 1998, THYROID, V8, P715, DOI 10.1089/thy.1998.8.715; Glisson BS, 2002, J CLIN ONCOL, V20, P1593, DOI 10.1200/JCO.20.6.1593; Sugitani I, 2001, WORLD J SURG, V25, P617; Sugitani I, 2012, WORLD J SURG, V36, P1247, DOI 10.1007/s00268-012-1437-z; Higashiyama T, 2010, THYROID, V20, P7, DOI 10.1089/thy.2009.0115; De Crevoisier R, 2004, INT J RADIAT ONCOL, V60, P1137, DOI 10.1016/j.ijrobp.2004.05.032; Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; SHIMAOKA K, 1985, CANCER, V56, P2155, DOI 10.1002/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E; Ain KB, 2000, THYROID, V10, P587, DOI 10.1089/thy.2000.10.587; Swaak-Kragten AT, 2009, RADIOTHER ONCOL, V92, P100, DOI 10.1016/j.radonc.2009.02.016; Kawada K, 2010, JPN J CLIN ONCOL, V40, P596, DOI 10.1093/jjco/hyq025; DEBESI P, 1991, J ENDOCRINOL INVEST, V14, P475; Orita Y, 2011, SURGERY, V150, P1212, DOI 10.1016/j.surg.2011.09.005; Tanaka K, 2011, JPN J CLIN ONCOL, V41, P1074, DOI 10.1093/jjco/hyr095; Tennvall J, 2002, BRIT J CANCER, V86, P1848, DOI 10.1038/sj.bjc.6600361	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					221	226		10.1007/s00595-013-0751-x		6	Surgery	Surgery	AZ7SJ	WOS:000348417800014		
J	Wada, T; Anai, H; Morita, M; Shuto, T; Miyamoto, S				Wada, Tomoyuki; Anai, Hirofumi; Morita, Masato; Shuto, Takashi; Miyamoto, Shinji			Simultaneous inflammatory pseudotumors of the coronary arteries and abdominal aorta	SURGERY TODAY			English	Article						Inflammatory pseudotumor; Plasma cell granuloma; Heart; Abdominal aortic aneurysm	HEART; PERIARTERITIS; PLASMACYTOMA; ANEURYSM; TUMOR; IGG4; CT	We herein report a rare case of cardiac and abdominal aortic inflammatory pseudotumors (IPTs). A 64-year-old male presented with a loss of appetite, abdominal distension and general fatigue. A cardiac tumor was suspected on the basis of computed tomography scans. A needle biopsy was performed, but it did not lead to a definitive diagnosis. At the same time, a 70-mm abdominal aortic aneurysm (AAA) was also detected. A full sternotomy was performed, and a huge, elastic hard tumor was found around the bilateral coronary arteries, anterior side of the right atria, ascending aorta and pulmonary artery. The pathological diagnosis was IPT, which was judged to be inoperable because of its anatomical location and the fact that the patient was a Jehovah's Witness, which precluded the administration of heterologous blood transfusions. The AAA was surgically treated, and the pathological diagnosis of the aneurysmal tissue also revealed IPT. Perioral steroid therapy was initiated, and the size of the tumor did not change for 1-2 years, but then gradually increased. The patient eventually died 8 years later, and the cause of his sudden death was considered to be heart failure caused by the pressure on the right atrium and ventricle due to the enlarged cardiac tumor.	[Wada, Tomoyuki; Anai, Hirofumi; Morita, Masato; Shuto, Takashi; Miyamoto, Shinji] Oita Univ Hosp, Dept Cardiovasc Surg, Yufu City, Oita 8795593, Japan	Wada, T (reprint author), Oita Univ Hosp, Dept Cardiovasc Surg, 1-1-1 Idai Ga Oka, Yufu City, Oita 8795593, Japan.	wada@oita-u.ac.jp					Iino M, 2002, J COMPUT ASSIST TOMO, V26, P1006, DOI 10.1097/00004728-200211000-00026; Inoue D, 2011, RADIOLOGY, V261, P625, DOI 10.1148/radiol.11102250; Kasashima S, 2009, J VASC SURG, V49, P1264, DOI 10.1016/j.jvs.2008.11.072; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Brunn H., 1939, J THORAC SURG, V9, P119; Chim CS, 2005, J CLIN ONCOL, V23, P3140, DOI 10.1200/JCO.2005.05.057; Ferbend P, 2004, PEDIATR CARDIOL, V25, P406, DOI 10.1007/s00246-003-0269-x; GONZALEZCRUSSI F, 1975, CANCER, V36, P2214, DOI 10.1002/cncr.2820360939; IMPERATO JP, 1986, CANCER, V57, P2127, DOI 10.1002/1097-0142(19860601)57:11<2127::AID-CNCR2820571107>3.0.CO;2-O; Krishna L, 2001, ANN THORAC SURG, V71, P1361, DOI 10.1016/S0003-4975(00)01804-X; Li Linxi, 2002, Ann Diagn Pathol, V6, P116, DOI 10.1053/adpa.2002.32380; Matsumoto Y, 2008, HUM PATHOL, V39, P975, DOI 10.1016/j.humpath.2007.10.023; Das Narla L, 2003, RADIOGRAPHICS, V23, P719, DOI 10.1148/rg.233025073; Obikane H, 2010, PATHOL INT, V60, P533, DOI 10.1111/j.1440-1827.2010.02556.x; Rose G. Alan, 1996, Archives of Pathology and Laboratory Medicine, V120, P549; Sakamoto A, 2012, ATHEROSCLEROSIS, V221, P602, DOI 10.1016/j.atherosclerosis.2012.01.038; Wan XY, 2001, CARDIOVASC PATHOL, V10, P137, DOI 10.1016/S1054-8807(01)00066-7	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					227	231		10.1007/s00595-013-0780-5		5	Surgery	Surgery	AZ7SJ	WOS:000348417800015		
J	Ishibashi, H; Takasaki, C; Okubo, K				Ishibashi, Hironori; Takasaki, Chihiro; Okubo, Kenichi			Port-site recurrence after complete resection of stage I thymoma by video-assisted thoracoscopic surgery: report of a case	SURGERY TODAY			English	Article						Thymoma; Port-site recurrence; Video-assisted thoracoscopic surgery		A 62-year-old female with myasthenia gravis and a mediastinal tumor underwent extended thymothymectomy by video-assisted thoracoscopic surgery (VATS). The tumor was diagnosed as a stage I type B2 thymoma. Eight years after the initial surgery, an abnormal shadow was detected on the annual follow-up chest radiograph, and computed tomography showed a homogeneous 35 x 15 mm hemispherical mass under a port-site scar in the right anterior chest wall. The mass was between the second and third ribs and was found to be adherent to the lung during surgery, and was excised via lung and chest wall resection. The pathological examination confirmed that it was a type B2 thymoma invading the third rib, and the tumor was considered to be a port-site recurrence. Care should be taken during VATS to avoid contact between the tumor surface and the port tracts to prevent tumor cell implantation.	[Ishibashi, Hironori; Takasaki, Chihiro; Okubo, Kenichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Thorac Surg, Bunkyo Ku, Tokyo 1138519, Japan	Ishibashi, H (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Thorac Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	hishiba.thsr@tmd.ac.jp					BLUMBERG D, 1995, ANN THORAC SURG, V60, P908, DOI 10.1016/0003-4975(95)00669-C; Johnstone PAS, 1996, J CLIN ONCOL, V14, P1950; Blalock A, 1939, ANN SURG, V110, P544, DOI 10.1097/00000658-193910000-00005; Awad WI, 1998, ANN THORAC SURG, V66, P2106, DOI 10.1016/S0003-4975(98)01077-7; Kattach H, 2005, ANN THORAC SURG, V79, P323, DOI 10.1016/j.athoracsur.2003.08.004; Venuta Federico, 2012, Gen Thorac Cardiovasc Surg, V60, P1, DOI 10.1007/s11748-011-0814-0	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					232	234		10.1007/s00595-013-0781-4		3	Surgery	Surgery	AZ7SJ	WOS:000348417800016		
J	Endo, S; Nishikawa, K; Yamada, T; Nakagawa, T; Fushimi, H; Chihara, T; Yamauchi, A; Nishijima, J				Endo, Shunji; Nishikawa, Kazuhiro; Yamada, Terumasa; Nakagawa, Tomo; Fushimi, Hiroaki; Chihara, Tsuyoshi; Yamauchi, Amane; Nishijima, Junichi			Our experience of treating undifferentiated gastric carcinoma: report of four cases	SURGERY TODAY			English	Article						Stomach neoplasms; Undifferentiated carcinoma; Prognosis		Undifferentiated gastric carcinoma is a rare histopathological type of cancer that does not show any differentiation toward adenocarcinoma or squamous cell carcinoma. It is thought to be highly malignant, and is associated with a poor prognosis. However, its clinical behavior has not yet been fully analyzed because of its rarity. We herein review the clinical characteristics and prognoses of patients with undifferentiated gastric carcinoma treated at our institutions. Among 2,651 gastric cancer patients, four (0.2 %) were histopathologically diagnosed to have undifferentiated carcinoma. These four patients included three males and one female. The median age of the patients was 60-year old (range 47-75). Three cases had distant metastases at diagnosis. One of these three cases was treated with chemotherapy alone, and the other two were treated with palliative gastrectomy and chemotherapy. The patient with no distant metastasis underwent curative gastrectomy and adjuvant chemotherapy. All patients died of cancer at a median of 5.4 (range 3.5-7.1) months after their diagnoses.	[Endo, Shunji; Yamada, Terumasa; Nakagawa, Tomo; Nishijima, Junichi] Higashiosaka City Gen Hosp, Dept Surg Gastroenterol, Higashiosaka, Osaka 5788588, Japan; [Nishikawa, Kazuhiro] Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; [Fushimi, Hiroaki] Osaka Gen Med Ctr, Dept Pathol, Osaka, Japan; [Chihara, Tsuyoshi; Yamauchi, Amane] Higashiosaka City Gen Hosp, Dept Clin Pathol, Higashiosaka, Osaka, Japan	Endo, S (reprint author), Higashiosaka City Gen Hosp, Dept Surg Gastroenterol, 3-4-5 Nishiiwata, Higashiosaka, Osaka 5788588, Japan.	endo-s@higashiosaka-hosp.jp					Baba H, 2008, JPN J CANC CHEMOTHER, V35, P2051; Endo S, 2013, JPN J GASTROENTEROL, V46, P159; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Lauwers GY, 2010, WHO CLASSIFICATION T, V98, P48; Matsuzaka T, 2001, JPN J CLIN EXP MED, V78, P927; Matsuzaki H, 2008, J JPN SURG ASS, V69, P810; Takami K, 2008, JPN J GASTROENTEROL, V41, P52; Takashima T, 2010, SURGERY, V72, P884; Tanaka S, 1990, J HIROSHIMA MED ASS, V43, P1884; Terayama H, 1990, J SAPPORO CITY GEN H, V50, P65; Ueda K, 2010, J ABDOM EMERG MED, V30, P937; Yamamoto M, 2012, J JPN SURG ASS, V73, P2847	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					235	240		10.1007/s00595-013-0793-0		6	Surgery	Surgery	AZ7SJ	WOS:000348417800017		
J	Hibi, Y; Hayakawa, N; Hasegawa, M; Ogawa, K; Shimizu, Y; Shibata, M; Kagawa, C; Mizuno, Y; Yuzawa, Y; Itoh, M; Iwase, K				Hibi, Yatsuka; Hayakawa, Nobuki; Hasegawa, Midori; Ogawa, Kimio; Shimizu, Yoshimi; Shibata, Masahiro; Kagawa, Chikara; Mizuno, Yutaka; Yuzawa, Yukio; Itoh, Mitsuyasu; Iwase, Katsumi			Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case	SURGERY TODAY			English	Article						Primary hyperaldosteronism; Hyperparathyroidism; Kidney impairment	OXIDATIVE STRESS; CALCIUM PARADOX; BLOOD-PRESSURE; HYPERTENSION; ADENOMA; PARATHYROIDECTOMY; INVOLVEMENT	We herein report the case of a patient with critical hyperkalemia after unilateral adrenalectomy (ADX) for aldosterone-producing adenomas, which were coexisting with primary hyperparathyroidism. A right adrenal tumor oversecreting mineral corticoid was identified in a 62-year-old female whose kidney function had been impaired due to primary hyperaldosteronism and hyperparathyroidism. The ADX improved her hypertension with normalization of the plasma aldosterone concentration, but without adequately increasing her plasma renin activity. Her eGFR further decreased postoperatively, hyperkalemia appeared and the serum potassium level rose to 6.3 mEq/L at 3 months after ADX. Then, treatment with calcium polystyrene sulfonate jelly was started. Eight months after ADX, a left lower parathyroidectomy was performed, and the serum calcium and intact parathyroid hormone levels decreased to the normal range. The hyperkalemia was difficult to control within 20 months postoperatively without treatment with calcium polystyrene sulfonate jelly or hydrocortisone. This suggests that unmasking the renal impairment and relative hypoaldosteronism after ADX might induce critical hyperkalemia.	[Hibi, Yatsuka; Ogawa, Kimio; Shimizu, Yoshimi; Shibata, Masahiro; Kagawa, Chikara; Mizuno, Yutaka; Iwase, Katsumi] Fujita Hlth Univ, Sch Med, Dept Endocrine Surg, Toyoake, Aichi 4701192, Japan; [Hayakawa, Nobuki] Meijo Univ, Fac Pharm, Nagoya, Aichi 468, Japan; [Hasegawa, Midori; Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi 4701192, Japan; [Itoh, Mitsuyasu] Fujita Hlth Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Toyoake, Aichi 4701192, Japan	Hibi, Y (reprint author), Fujita Hlth Univ, Sch Med, Dept Endocrine Surg, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	hibichan@fujita-hu.ac.jp					RESNICK LM, 1985, AM J MED, V78, P385, DOI 10.1016/0002-9343(85)90328-6; Mazzocchi G, 2001, AM J PHYSIOL-ENDOC M, V280, pE209; Pilz S, 2012, J CLIN ENDOCR METAB, V97, pE75, DOI 10.1210/jc.2011-2183; Gatta-Cherifi B, 2012, EUR J ENDOCRINOL, V166, P269, DOI 10.1530/EJE-11-0679; [Anonymous], FOLIA ENDOCRINOL S86, V201; Virdis A, 2002, HYPERTENSION, V40, P504, DOI 10.1161/01.HYP.0000034738.79310.06; Reincke M, 2009, J CLIN ENDOCR METAB, V94, P869, DOI 10.1210/jc.2008-1851; Chhokar VS, 2005, CIRCULATION, V111, P871, DOI 10.1161/01.CIR.0000155621.10213.06; Maniero C, 2011, HYPERTENSION, V58, P341, DOI 10.1161/HYPERTENSIONAHA.111.173948; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; FERTIG A, 1980, POSTGRAD MED J, V56, P45; Rocha R, 2001, TRENDS ENDOCRIN MET, V12, P308, DOI 10.1016/S1043-2760(01)00432-5; Sechi LA, 2006, JAMA-J AM MED ASSOC, V295, P2638, DOI 10.1001/jama.295.22.2638; Evenepoel P, 2005, NEPHROL DIAL TRANSPL, V20, P1714, DOI 10.1093/ndt/gfh892; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; Arima S, 2003, J AM SOC NEPHROL, V14, P2255, DOI 10.1097/01.ASN.0000083982.74108.54; Arroyo D, 2012, NEFROLOGIA, V32, P655, DOI 10.3265/Nefrologia.pre2012.Jun.11500; Vidal A, 2006, AM J PHYSIOL-HEART C, V290, pH286, DOI 10.1152/ajpheart.00535.2005; KRISTOFFERSSON A, 1990, J INTERN MED, V227, P317; JONES DB, 1983, POSTGRAD MED J, V59, P350; Honda M, 2004, INTERNAL MED, V43, P310, DOI 10.2169/internalmedicine.43.310; Halimi JM, 1995, J HYPERTENS, V13, P1801; BIGLIERI EG, 1966, J CLIN ENDOCR METAB, V26, P553; Fischer E, 2012, J CLIN ENDOCR METAB, V97, P3965, DOI 10.1210/jc.2012-2234; Gadallah MF, 1998, AM J KIDNEY DIS, V32, P160, DOI 10.1053/ajkd.1998.v32.pm9669438; HELLMAN DE, 1980, JAMA-J AM MED ASSOC, V244, P1351, DOI 10.1001/jama.244.12.1351; Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x; Horita Y, 2001, AM J KIDNEY DIS, V37, P884, DOI 10.1016/S0272-6386(05)80002-2; Huang WT, 2010, CLIN NEPHROL, V73, P392; Kimura G, 1996, J HYPERTENS, V14, P1463, DOI 10.1097/00004872-199612000-00013; Pu Q, 2003, HYPERTENSION, V42, P49, DOI 10.1161/01.HYP.0000078357.92682.EC; Robestein J, 2005, J AM SOC NEPHROL, V16, P1320; Taniguchi R, 1998, TOHOKU J EXP MED, V186, P215, DOI 10.1620/tjem.186.215; Waldmann J, 2007, LANGENBECK ARCH SURG, V392, P437, DOI 10.1007/s00423-006-0124-7	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					241	246		10.1007/s00595-013-0813-0		6	Surgery	Surgery	AZ7SJ	WOS:000348417800018		
J	Nakano, A; Akutsu, Y; Shuto, K; Uesato, M; Kono, T; Hoshino, I; Akanuma, N; Maruyama, T; Isozaki, Y; Matsubara, H				Nakano, Akira; Akutsu, Yasunori; Shuto, Kiyohiko; Uesato, Masaya; Kono, Tsuguaki; Hoshino, Isamu; Akanuma, Naoki; Maruyama, Tetsuro; Isozaki, Yuka; Matsubara, Hisahiro			Giant esophageal gastrointestinal stromal tumor: report of a case	SURGERY TODAY			English	Article						Gastrointestinal stromal tumor; Esophagus; Prognostic factor	PROGNOSTIC-FACTORS; TRACT; PATHOLOGY; DIAGNOSIS	Gastrointestinal stromal tumors (GISTs) rarely arise in the esophagus, where carcinoma is the most common malignant neoplasm and leiomyoma is the most common benign tumor. Because of their rarity, the clinical course and treatment of esophageal GISTs are poorly understood. These lesions are generally thought to carry a poor prognosis, making the differential diagnosis of other common mesenchymal neoplasms essential, for both prognostic and therapeutic reasons. We report a case of successfully resected giant esophageal GIST, thought to be the largest resected GIST reported in Japan. The patient was a 65-year-old woman, in whom upper gastrointestinal endoscopy found a 180-mm submucosal tumor in the lower thoracic esophagus, extending just below the aortic arch. We diagnosed esophageal GIST, and the patient underwent middle and lower esophagectomy via left thoracotomy, followed by gastric tube reconstruction. The tumor was resected completely. Histopathological and immunohistochemical staining confirmed that the tumor was a high-risk lesion, and treatment with imatinib was initiated. Computed tomography showed liver metastasis 5 months later, but the patient is doing well 24 months after surgery.	[Nakano, Akira; Akutsu, Yasunori; Shuto, Kiyohiko; Uesato, Masaya; Kono, Tsuguaki; Hoshino, Isamu; Akanuma, Naoki; Maruyama, Tetsuro; Isozaki, Yuka; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, Chiba 2608670, Japan	Nakano, A (reprint author), Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nakanodylan@yahoo.co.jp; yakutsu@faculty.chiba-u.jp					Ahmet B, 2006, J THORAC CARDIOVASC, V131, P1198; Miettinen M, 2005, AM J SURG PATHOL, V29, P52, DOI 10.1097/01.pas.0000146010.92933.de; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Lee HJ, 2009, ANN THORAC SURG, V87, P1569, DOI 10.1016/j.athoracsur.2009.01.051; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Miettinen M, 2000, AM J SURG PATHOL, V24, P211, DOI 10.1097/00000478-200002000-00007; Miettinen M, 2002, EUR J CANCER, V38, pS39, DOI 10.1016/S0959-8049(02)80602-5; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Nishida T, 2000, HISTOL HISTOPATHOL, V15, P1293; Aparicio T, 2004, EJSO, V30, P1098, DOI 10.1016/j.ejso.2004.06.016; Arantes V, 2004, J ULTRAS MED, V23, P1141; Demetri George D, 2005, J Natl Compr Canc Netw, V3, P158; Matsumoto S, 2010, ESOPHAGUS-TOKYO, V7, P115, DOI 10.1007/s10388-010-0231-y; Miettinen M, 2000, PATHOLOGY GENETICS T, P62; Mittinen M, 1998, ANN CHIR GYNAECOL, V87, P278; Rosai J, 1996, ACKERMANS SURG PATHO, P645; Vander Noot MR, 2004, CANCER CYTOPATHOL, V102, P157, DOI 10.1002/cncr.20360; Yan H, 2003, AM J CLIN ONCOL-CANC, V26, P221, DOI 10.1097/00000421-200306000-00002; Yasunori A, 2011, SURG TODAY, V41, P1190	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					247	252		10.1007/s00595-014-0929-x		6	Surgery	Surgery	AZ7SJ	WOS:000348417800019		
J	Tsuboi, K; Omura, N; Yano, F; Hoshino, M; Yamamoto, SR; Akimoto, S; Kashiwagi, H; Yanaga, K				Tsuboi, Kazuto; Omura, Nobuo; Yano, Fumiaki; Hoshino, Masato; Yamamoto, Se Ryung; Akimoto, Shunsuke; Kashiwagi, Hideyuki; Yanaga, Katsuhiko			A novel laparoscopic approach for severe esophageal stenosis due to reflux esophagitis: how to do it	SURGERY TODAY			English	Article						Collis gastroplasty; Esophageal stenosis; Laparoscopic surgery	COLLIS GASTROPLASTY; SHORTENED ESOPHAGUS; NISSEN FUNDOPLICATION; MANAGEMENT	We herein report our technique for laparoscopic esophageal myotomy combined with Collis gastroplasty and Nissen fundoplication for severe esophageal stenosis. Our patient had experienced vomiting since childhood, and his dysphagia had gradually worsened. He was referred to our department for surgery because of resistance to pneumatic dilation. He was diagnosed with a short esophagus based on the findings of a preoperative upper gastrointestinal series and GI endoscopy. After exposing the abdominal esophagus, esophageal myotomy around the esophago-gastric junction (EGJ) was undertaken to introduce an esophageal bougie into the stomach. Then, stapled wedge gastroplasty was performed, and a short and loose Nissen fundoplication was performed. In addition, the bulging mucosa after myotomy was patched using the Dor method. The patient's postoperative course was uneventful. Most patients with esophageal stricture require subtotal esophagectomy. Laparoscopic surgery for patients with benign esophageal stricture refractory to repeated pneumatic dilation is challenging. However, our current procedure might abrogate the need for invasive esophagectomy for the surgical management of severe esophageal stenosis.	[Tsuboi, Kazuto; Omura, Nobuo; Yano, Fumiaki; Hoshino, Masato; Yamamoto, Se Ryung; Akimoto, Shunsuke; Kashiwagi, Hideyuki; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan	Tsuboi, K (reprint author), Jikei Univ, Sch Med, Dept Surg, Minato Ku, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan.	kazuto@jikei.ac.jp					Watanabe M, 2013, SURG TODAY, V43, P237, DOI 10.1007/s00595-012-0300-z; Awad ZT, 2000, SURG ENDOSC-ULTRAS, V14, P508, DOI 10.1007/s004640000091; COLLIS JL, 1957, J THORAC SURG, V34, P768; Dunn LJ, 2010, ANN THORAC SURG, V89, P604, DOI 10.1016/j.athoracsur.2009.06.078; Garg N, 2009, DIS ESOPHAGUS, V22, P532, DOI 10.1111/j.1442-2050.2009.00943.x; Johnson AB, 1998, SURG ENDOSC-ULTRAS, V12, P1055, DOI 10.1007/s004649900780; PAYNE WS, 1984, BRIT J SURG, V71, P971, DOI 10.1002/bjs.1800711221; Sataloff DM, 1997, AM J SURG, V174, P63, DOI 10.1016/S0002-9610(97)00026-3; Terry ML, 2004, AM J SURG, V188, P195, DOI 10.1016/j.amjsurg.2003.12.069; Tsuboi K, 2006, SURG LAPARO ENDO PER, V16, P401, DOI 10.1097/01.sle.0000213733.10828.29; Urbach DR, 2001, SURG ENDOSC-ULTRAS, V15, P1408; Yano F, 2009, SURG ENDOSC, V23, P1308, DOI 10.1007/s00464-008-0155-y; Young MM, 2000, ANN THORAC SURG, V70, P1651, DOI 10.1016/S0003-4975(00)01916-0; Youssef YK, 2006, SURG ENDOSC, V20, P1702, DOI 10.1007/s00464-006-0048-x	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	FEB	2015	45	2					253	257		10.1007/s00595-014-0884-6		5	Surgery	Surgery	AZ7SJ	WOS:000348417800020		
J	Buresova, V; Kopecky, D; Bartos, J; Martinek, P; Watanabe, N; Vyhnanek, T; Dolezel, J				Buresova, Veronika; Kopecky, David; Bartos, Jan; Martinek, Petr; Watanabe, Nobuyoshi; Vyhnanek, Tomas; Dolezel, Jaroslav			Variation in genome composition of blue-aleurone wheat	THEORETICAL AND APPLIED GENETICS			English	Article							TRITICUM-AESTIVUM L; COMMON WHEAT; THINOPYRUM-PONTICUM; CHALCONE SYNTHASE; OXIDATIVE STRESS; GRAINED GENE(S); DIPLOID WHEAT; ANTHOCYANINS; CHROMOSOME; EXPRESSION	Different blue-aleurone wheats display major differences in chromosome composition, ranging from disomic chromosome additions, substitutions, single chromosome arm introgressions and chromosome translocation of Thinopyrum ponticum. Anthocyanins are of great importance for human health due to their antioxidant, anti-inflammatory, anti-microbial and anti-cancerogenic potential. In common wheat (Triticum aestivum L.) their content is low. However, elite lines with blue aleurone exhibit significantly increased levels of anthocyanins. These lines carry introgressed chromatin from wild relatives of wheat such as Thinopyrum ponticum and Triticum monococcum. The aim of our study was to characterize genomic constitutions of wheat lines with blue aleurone using genomic and fluorescence in situ hybridization. We used total genomic DNA of Th. ponticum and two repetitive DNA sequences (GAA repeat and the Afa family) as probes to identify individual chromosomes. This enabled precise localization of introgressed Th. ponticum chromatin. Our results revealed large variation in chromosome constitutions of the blue-aleurone wheats. Of 26 analyzed lines, 17 carried an introgression from Th. ponticum; the remaining nine lines presumably carry T. monococcum chromatin undetectable by the methods employed. Of the Th. ponticum introgressions, six different types were present, ranging from a ditelosomic addition (cv. Blue Norco) to a disomic substitution (cv. Blue Baart), substitution of complete (homologous) chromosome arms (line UC66049) and various translocations of distal parts of a chromosome arm(s). Different types of introgressions present support a hypothesis that the introgressions activate the blue aleurone trait present, but inactivated, in common wheat germplasm.	[Buresova, Veronika; Kopecky, David; Bartos, Jan; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc 78371, Czech Republic; [Martinek, Petr] Agrotest Fyto Ltd, Kromeriz 76701, Czech Republic; [Watanabe, Nobuyoshi] Ibaraki Univ, Coll Agr, Inashiki, Ibaraki 3000393, Japan; [Vyhnanek, Tomas] Mendel Univ Brno, Brno 61300, Czech Republic	Kopecky, D (reprint author), Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Slechtitelu 31, Olomouc 78371, Czech Republic.	kopecky@ueb.cas.cz	Vyhnanek, Tomas/D-5247-2012; Dolezel, Jaroslav/B-7716-2008; Bartos, Jan/F-6071-2014	Dolezel, Jaroslav/0000-0002-6263-0492; 	Ministry of Agriculture of the Czech Republic [QJ1210257]; National Program of Sustainability I [LO1204]	We are grateful to Prof. Adam J. Lukaszewski for critical reading and valuable comments on the manuscript. We thank Prof. Adam J. Lukaszewski, Prof. C.O. Qualset, Prof. F.J. Zeller, Dr. Robert Metzger, Prof. A. Borner and Genebank of the Crop Research Institute, Prague-Ruzyne., Czech Republic for providing seed samples. This work has been partially supported by the Ministry of Agriculture of the Czech Republic (Project No. QJ1210257) and by the grant LO1204 from the National Program of Sustainability I.	Abrouk M, 2014, PLANT ANIMAL GENOME, VXXII; Anderson JW, 2000, J AM COLL NUTR, V19, P291; Afaq F, 2007, J INVEST DERMATOL, V127, P222, DOI 10.1038/sj.jid.5700510; Youdim KA, 2000, FREE RADICAL BIO MED, V29, P51, DOI 10.1016/S0891-5849(00)00329-4; Trojan V, 2014, J CEREAL SCI, V59, P48, DOI 10.1016/j.jcs.2013.10.008; [Anonymous], 2004, J BIOMED BIOTEC 1201; Clifford MN, 2000, J SCI FOOD AGR, V80, P1063, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.3.CO;2-H; Dubcovsky J, 1996, GENETICS, V143, P983; Harborne JB, 2001, NAT PROD REP, V18, P310, DOI 10.1039/b006257j; Wang J, 2002, J AGR FOOD CHEM, V50, P4183, DOI 10.1021/jf011613d; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Knievel DC, 2009, J CEREAL SCI, V50, P113, DOI 10.1016/j.jcs.2009.03.007; GAO L, 1994, J FOOD SCI, V59, P1057, DOI 10.1111/j.1365-2621.1994.tb08189.x; Hou DX, 2004, J BIOMED BIOTECHNOL, P321; ZEVEN AC, 1991, EUPHYTICA, V56, P243, DOI 10.1007/BF00042371; Escribano-Bailon MT, 2004, J CHROMATOGR A, V1054, P129, DOI 10.1016/j.chroma.2004.08.152; Rechner AR, 2005, THROMB RES, V116, P327, DOI 10.1016/j.thromres.2005.01.002; Lamy S, 2006, CARCINOGENESIS, V27, P989, DOI 10.1093/carcin/bgi279; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Arbuzova VS, 2012, RUSS J GENET+, V48, P785, DOI 10.1134/S102279541205002X; Cermeno MC, 1986, 1 INT S CHROM ENG PL, P123; Gao JW, 2000, ACTA BOT BOREAL OCCI, V20, P936; Giorgi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057994; Himi E, 2004, J EXP BOT, V55, P365, DOI 10.1093/jxb/erh046; Horbowicz M., 2008, Vegetable Crops Research Bulletin, V68, P5, DOI 10.2478/v10032-008-0001-8; JAN CC, 1981, GENETICS, V98, P389; Katsube N, 2003, J AGR FOOD CHEM, V51, P68, DOI 10.1021/jf025781x; KEPPENNE VD, 1990, GENOME, V33, P525; KNOTT D. R., 1958, CANADIAN JOUR BOT, V36, P571; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Masoudi-Nejad A, 2002, CHROMOSOME RES, V10, P349, DOI 10.1023/A:1016845200960; Mazza G., 1993, ANTHOCYANINS FRUITS; Mazza Giuseppe Joe, 2007, Ann Ist Super Sanita, V43, P369; Morrison LA, 2004, CROP SCI, V44, P2063; Pisha E, 1994, EC MED PLANT RES, V6, P189; Qualset CO, 2005, CROP SCI, V45, P432; Sears E. R., 1981, Wheat science - today and tomorrow., P75; Shi F, 1999, GENES GENET SYST, V74, P49, DOI 10.1266/ggs.74.49; Singh K, 2007, THEOR APPL GENET, V115, P301, DOI 10.1007/s00122-007-0543-z; WHELAN EDP, 1989, GENOME, V32, P30; WILLIAM MDHM, 1993, THEOR APPL GENET, V86, P365, DOI 10.1007/BF00222103; Yang GH, 2004, ACTA BOT SIN, V46, P588; Yoshinaga K, 1986, J BREW SOC JPN, V81, P337; ZELLER FJ, 1991, THEOR APPL GENET, V81, P551, DOI 10.1007/BF00219448; Zheng Q, 2006, EUPHYTICA, V152, P51, DOI 10.1007/s10681-006-9176-6; Zheng Q, 2006, GENOME, V49, P1109, DOI 10.1139/G06-073	50	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	FEB	2015	128	2					273	282		10.1007/s00122-014-2427-3		10	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	AZ8EL	WOS:000348447600008		
J	Ui, H; Sameri, M; Pourkheirandish, M; Chang, MC; Shimada, H; Stein, N; Komatsuda, T; Handa, H				Ui, Hajime; Sameri, Mohammad; Pourkheirandish, Mohammad; Chang, Men-Chi; Shimada, Hiroaki; Stein, Nils; Komatsuda, Takao; Handa, Hirokazu			High-resolution genetic mapping and physical map construction for the fertility restorer Rfm1 locus in barley	THEORETICAL AND APPLIED GENETICS			English	Article							CYTOPLASMIC MALE-STERILITY; HORDEUM-VULGARE L.; SINGLE-NUCLEOTIDE POLYMORPHISMS; REPEAT-CONTAINING GENE; RESTORATION LOCUS; RICE; PROTEIN; GENOME; MITOCHONDRIAL; ENCODES	High-resolution genetic linkage mapping and BAC physical mapping narrowed the fertility restorer locus Rfm1 in barley to a sub-centimorgan genetic interval and a 208-kb physical interval. Rfm1 restores the fertility of msm1 and msm2 male-sterile cytoplasms in barley. The fertility restoration gene is located on the short arm of chromosome 6H (6HS), and we pursued a positional cloning of this gene. Starting from a previous result that has delimited Rfm1 within a 10.8 cM region on 6HS, we developed novel CAPS and SSR markers tightly linked to the gene in barley using the sequence information from the syntenic region of rice and barley genome assemblies. Next, we performed fine mapping of the Rfm1 locus. To isolate recombinants, we surveyed 3,638 F-2 plants derived from a cross between the CMS strain and the Rf strain with adjacent markers (NAS2090 and NAS1080). This analysis identified 175 recombinant plants from the F-2 population to build a high-resolution map with nine markers tightly linked to the Rfm1 locus. Rfm1 was located within the 0.14 cM region delimited by two markers (NAS9113 and NAS9200). Using these flanking markers as well as marker cosegregating with Rfm1 (NAS9133), we screened the BAC libraries of the cultivar Morex, an rfm1 carrier. We isolated 11 BAC clones and constructed a BAC physical map using their fingerprints. Finally, we delimited the Rfm1 locus encompassing the rfm1 allele on a 208-kb contig composed of three minimally overlapping BAC clones. This precise localization of the Rfm1 locus in the barley genome is expected to greatly accelerate the future map-based cloning of the Rfm1 gene by sequence analysis and its genetic transformation for the complementation of cytoplasmic male-sterile plants.	[Ui, Hajime; Sameri, Mohammad; Pourkheirandish, Mohammad; Komatsuda, Takao; Handa, Hirokazu] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Ui, Hajime; Shimada, Hiroaki] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 1258585, Japan; [Chang, Men-Chi] Natl Taiwan Univ, Dept Agron, Taipei 106, Taiwan; [Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Seeland, Ot Gatersleben, Germany; [Handa, Hirokazu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Handa, H (reprint author), Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kan Non Dai, Tsukuba, Ibaraki 3058602, Japan.	hirokazu@affrc.go.jp	HANDA, Hirokazu/C-9781-2009	HANDA, Hirokazu/0000-0003-2985-2883	Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [TRS-1002]	This work was supported in part by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, TRS-1002).	AHOKAS H, 1982, GENETICS, V102, P285; AHOKAS H, 1979, ACTA AGR SCAND, V29, P219; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kunzel G, 2000, GENETICS, V154, P397; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Matsuhira H, 2012, GENETICS, V192, P1347, DOI 10.1534/genetics.112.145409; Yu Y, 2000, THEOR APPL GENET, V101, P1093, DOI 10.1007/s001220051584; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Touzet P, 2004, TRENDS PLANT SCI, V9, P568, DOI 10.1016/j.tplants.2004.10.001; Ariyadasa R, 2014, PLANT PHYSIOL, V164, P412, DOI 10.1104/pp.113.228213; Fujii S, 2009, P NATL ACAD SCI USA, V106, P9513, DOI 10.1073/pnas.0901860106; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Desloire S, 2003, EMBO REP, V4, P588, DOI 10.1038/sj.embor.embor848; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Koizuka N, 2003, PLANT J, V34, P407, DOI 10.1046/j.1365-313X.2003.01735.x; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Komori T, 2004, PLANT J, V37, P315, DOI 10.1111/j.1365-313X.2004.01961.x; Itabashi E, 2011, PLANT J, V65, P359, DOI 10.1111/j.1365-313X.2010.04427.x; Akagi H, 2004, THEOR APPL GENET, V108, P1449, DOI 10.1007/s00122-004-1591-2; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; IBGSC, 2012, NATURE, V491, P711; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Kosambi DD, 1943, ANN EUGENIC, V12, P172; Matsui K, 2001, THEOR APPL GENET, V102, P477, DOI 10.1007/s001220051670; Ramage RT, 1983, MONOGR THEOR APPL GE, V6, P71; Schulte D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-247	33	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	FEB	2015	128	2					283	290		10.1007/s00122-014-2428-2		8	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	AZ8EL	WOS:000348447600009		
J	Yamada, T; Morikawa, M; Yamada, T; Akaishi, R; Kojima, T; Minakami, H				Yamada, Takashi; Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Kojima, Takashi; Minakami, Hisanori			Fibrinogen levels in the late stage of twin pregnancy	THROMBOSIS RESEARCH			English	Article						Coagulation-fibrinolysis; Fibrinogen; Twin pregnancy; Postpartum hemorrhage; Venous thromboembolism	ANTITHROMBIN-III ACTIVITY; D-DIMER LEVELS; SINGLETON PREGNANCIES; REFERENCE INTERVALS; WOMEN; DECREASE; ASSAYS	Introduction: Twin pregnancy is a risk factor of complications, such as pregnancy-induced hypertension, venous thromboembolism, and postpartum hemorrhage, the pathogenesis of which may involve aberrations of the coagulation-fibrinolysis system. Materials and Methods: Fibrinogen data for 129 and 1202 blood specimens from 84 and 902 women with twin and singleton pregnancies, respectively, at gestational week (GW) >= 32 were analyzed retrospectively. None of the 986 women developed complications in which blood fibrinogen levels may be altered. Thirty-six and 288 women with twin and singleton pregnancies were examined longitudinally, respectively. Results: The fibrinogen levels of 403 +/- 63 and 403 +/- 77mg/dL at GW32 - 33 and 34 - 35, respectively, decreased significantly to 366 +/- 57 mg/dL at GW 36-37 in women with twins, while corresponding levels (422 +/- 79, 420 +/- 65, and 415 +/- 64, respectively) and that at GW >= 38 (408 +/- 60 mg/dL) did not change significantly in women with singleton pregnancies. The fibrinogen levels determined within 3 weeks before delivery were consistently and significantly lower in women with twin than singleton pregnancies. The fibrinogen levels were significantly inversely correlated with GW in women with twins (R = -0.36, P = 0.002), but not in those with singleton pregnancies. Conclusions: The fibrinogen level of twin pregnancy decreases significantly and is significantly lower than that in singleton pregnancy in the last few weeks of pregnancy. (C) 2014 Published by Elsevier Ltd.	[Yamada, Takashi; Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Kojima, Takashi; Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido, Japan	Yamada, T (reprint author), JCHO Hokkaido Hospital, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan.	yamatakashi@me.com					American College of Obstetrics and Gynecology practice bulletin, 2006, OBSTET GYNECOL, V108, P1039; Szecsi PB, 2010, THROMB HAEMOSTASIS, V103, P718, DOI 10.1160/TH09-10-0704; Knight M, 2008, GUT, V57, P951, DOI 10.1136/gut.2008.148676; Simon L, 1997, BRIT J ANAESTH, V78, P678; Liu JJ, 2012, CLIN CHIM ACTA, V413, P258, DOI 10.1016/j.cca.2011.09.046; Hansen AT, 2011, SCAND J CLIN LAB INV, V71, P173, DOI 10.3109/00365513.2010.545432; Bar J, 2000, THROMB RES, V98, P485, DOI 10.1016/S0049-3848(00)00187-0; Day MC, 2005, OBSTET GYNECOL, V106, P927, DOI 10.1097/01.AOG.0000182578.82926.9c; HENRIKSSON P, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E8632; Hui Chen, 2012, Arch Gynecol Obstet, V285, P1231, DOI 10.1007/s00404-011-2137-x; Jacobsen AF, 2012, BEST PRACT RES CL HA, V25, P319, DOI 10.1016/j.beha.2012.07.006; Khalafallah AA, 2012, THROMB RES, V130, pE171, DOI 10.1016/j.thromres.2012.05.022; Krotz S, 2002, TWIN RES, V5, P8; Lussana F, 2012, THROMB RES, V129, DOI 10.1016/j.thromres.2012.01.017; Minakami H, 1999, J HEPATOL, V30, P603, DOI 10.1016/S0168-8278(99)80190-1; Morikawa M, 2006, J PERINAT MED, V34, P392, DOI 10.1515/JPM.2006.078; Morikawa M, 2011, J PERINAT MED, V40, P115; Nishida R, 2014, J OBSTET GYNAECOL RE; Nishii A, 2009, J OBSTET GYNAECOL RE, V35, P689, DOI 10.1111/j.1447-0756.2008.01007.x; Suzuki S, 2012, ARCH GYNECOL OBSTET, V286, P1363, DOI 10.1007/s00404-012-2461-9; Tsunoda T, 2002, ACTA OBSTET GYN SCAN, V81, P840, DOI 10.1034/j.1600-0412.2002.810907.x; Yamada T, 2014, INT J OBSTET ANESTH, V23, P365, DOI 10.1016/j.ijoa.2014.06.004; Yamada T, 2013, THROMB RES, V131, P493, DOI 10.1016/j.thromres.2013.04.029	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	FEB	2015	135	2					318	321		10.1016/j.thromres.2014.11.030		4	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AZ4MY	WOS:000348196900016		
J	Kovac, M; Elezovic, I; Mikovic, Z; Mandic, V; Djordjevic, V; Radojkovic, D; Lalic-Cosic, S; Murata, M; Takagi, A; Kojima, T				Kovac, Mirjana; Elezovic, Ivo; Mikovic, Zeljko; Mandic, Vesna; Djordjevic, Valentina; Radojkovic, Dragica; Lalic-Cosic, Sanja; Murata, Moe; Takagi, Akira; Kojima, Tetsuhito			High prophylactic LMWH dose successfully suppressed hemostatic activation in pregnant woman with a new prothrombin c.1787G > Amutation	THROMBOSIS RESEARCH			English	Letter							ANTITHROMBIN RESISTANCE; VENOUS THROMBOEMBOLISM; COAGULATION ACTIVATION; THROMBOPHILIA; MUTATION; WOMEN; THROMBOSIS; DALTEPARIN; PLASMA; GENE		[Kovac, Mirjana; Elezovic, Ivo; Mikovic, Zeljko; Mandic, Vesna] Univ Belgrade, Fac Med, Belgrade, Serbia; [Kovac, Mirjana] Blood Transfus Inst Serbia, Hemostasis Dept, Belgrade 11000, Serbia; [Elezovic, Ivo] Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia; [Mikovic, Zeljko; Mandic, Vesna] Gynecol & Obstet Clin Narodni Front, Belgrade, Serbia; [Djordjevic, Valentina; Radojkovic, Dragica] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Lalic-Cosic, Sanja] Univ Belgrade, Pharmaceut Fac, Belgrade, Serbia; [Murata, Moe; Takagi, Akira; Kojima, Tetsuhito] Nagoya Univ, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan	Kovac, M (reprint author), Blood Transfus Inst Serbia, Hemostasis Dept, Sv Save 39, Belgrade 11000, Serbia.	mkovac008@gmail.com	Kojima, Tetsuhito/I-6271-2014	Kojima, Tetsuhito/0000-0002-1905-1065			Abou-Nassar K, 2007, THROMB HAEMOSTASIS, V98, P163, DOI 10.1160/TH06-10-0574; Djordjevic V, 2013, J THROMB HAEMOST, V11, P1936, DOI 10.1111/jth.12367; Kovac M, 2010, GYNECOL OBSTET INVES, V69, P233, DOI 10.1159/000274012; Eichinger S, 2008, CLIN CHEM, V54, P2042, DOI 10.1373/clinchem.2008.112243; Kapur RK, 1997, ARTERIOSCL THROM VAS, V17, P2875; Miyawaki Y, 2012, NEW ENGL J MED, V366, P2390, DOI 10.1056/NEJMoa1201994; Poort SR, 1996, BLOOD, V88, P3698; Hoke M, 2004, THROMB HAEMOSTASIS, V91, P935, DOI 10.1160/TH03-11-0719; HRON G, 2010, AM J OBSTET GYNECOL, V203, pS75; Kovac M, 2014, CLIN APPL THROMB-HEM, V20, P184, DOI 10.1177/1076029612468940; Murata M, 2014, THROMB RES, V133, P293, DOI 10.1016/j.thromres.2013.11.021; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; Schambeck CM, 2001, THROMB HAEMOSTASIS, V85, P782	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	FEB	2015	135	2					420	422		10.1016/j.thromres.2014.12.008		3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AZ4MY	WOS:000348196900034		
J	Terasawa, T; Aso, Y; Omori, K; Fukushima, M; Momobayashi, A; Inukai, T				Terasawa, Tomoko; Aso, Yoshimasa; Omori, Kyoko; Fukushima, Maiko; Momobayashi, Atsushi; Inukai, Toshihiko			Bezafibrate, a peroxisome proliferator-activated receptor alpha agonist, decreases circulating CD14(+) CD16(+) monocytes in patients with type 2 diabetes	Translational Research			English	Article							HUMAN PERIPHERAL-BLOOD; NF-KAPPA-B; CD14+CD16+ MONOCYTES; MACROPHAGES; EXPRESSION; SUBSETS; LIGANDS; DISEASE; AP-1	CD14 CD16 monocytes are proinflammatory cells that produce tumor necrosis factor and interleukin 00-1/3. The number of circulating CD14(+)CD16(+) monocytes is increased in patients with chronic renal failure or coronary artery disease. We investigated the effect of bezafibrate, a peroxisome proliferator-activated receptor a agonist, on circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes. Using cells isolated from type 2 diabetic subjects, we also examined the in vitro expression of CDI 6 messenger RNA (mRNA) by mononuclear cells (MNCs) exposed to bezafibrate. The percentage of CD14 CD16(+) monocytes among all CD14+ monocytes was significantly higher in subjects with impaired glucose tolerance (P < 0.01) or type 2 diabetes (P < 0.05) than in those with normal glucose tolerance. The percentage of CD14 CD16(+) monocytes was significantly lower in patients with type 2 diabetes who were taking bezafibrate (400 mg/d) than in patients not taking it (P < 0.01). Treatment with bezafibrate for 12 weeks significantly reduced the percentage of circulating CD I 4 CD16+ monocytes from 45.4 - 25.2% to 38.3 21.8% (P = 0.0144). In an in vitro study, the expression of CD16 mRNA by MNCs from 6 diabetic subjects was decreased after 24 hours of treatment with 10 yg/mL of bezafibrate (P < 0.05). Expression of IL-1/3 mRNA by MNCs was also decreased after 24 hours of treatment with 10 pg/mL of bezafibrate, whereas the IL-1/3 level in the culture supernatant was significantly decreased after treatment of MNCs with either 1 or 10 Ag/mL of bezafibrate. In conclusion, bezafibrate decreased circulating CD14+CD16+ monocytes in patients with type 2 diabetes, probably by inhibiting the expression of CD16 mRNA.	[Terasawa, Tomoko; Aso, Yoshimasa; Omori, Kyoko; Fukushima, Maiko; Momobayashi, Atsushi; Inukai, Toshihiko] Dokkyo Med Univ, Koshigaya Hosp, Dept Internal Med, Koshigaya, Saitama, Japan; [Terasawa, Tomoko; Aso, Yoshimasa; Omori, Kyoko; Fukushima, Maiko; Momobayashi, Atsushi; Inukai, Toshihiko] Dokkyo Med Univ, Dept Endocrinol & Metab, Mibu, Tochigi, Japan; [Terasawa, Tomoko; Aso, Yoshimasa; Omori, Kyoko; Fukushima, Maiko; Momobayashi, Atsushi; Inukai, Toshihiko] Dokkyo Med Univ, Koshigaya Hosp, Joint Res Ctr, Dept Mol Genet Testing, Koshigaya, Saitama, Japan; [Terasawa, Tomoko; Aso, Yoshimasa; Omori, Kyoko; Fukushima, Maiko; Momobayashi, Atsushi; Inukai, Toshihiko] Mitsubishi Chem Medience Corp, Tokyo, Tokyo, Japan	Aso, Y (reprint author), Dokkyo Med Univ, Dept Endocrinol & Metab, Mibu, Tochigi, Japan.	yaso@dokkyomed.ac.jp					Ancuta P, 2000, EUR J IMMUNOL, V30, P1872, DOI 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Frankenberger M, 1996, BLOOD, V87, P373; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; PASSLICK B, 1989, BLOOD, V74, P2527; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Timmerman KL, 2008, J LEUKOCYTE BIOL, V84, P1271, DOI 10.1189/jlb.0408244; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; FINGERLE G, 1993, BLOOD, V82, P3170; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Beige K.U., 2002, J IMMUNOL, V168, P3536; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Sester U, 2001, NEPHROL DIAL TRANSPL, V16, P1402, DOI 10.1093/ndt/16.7.1402; Zambon A, 2006, ARTERIOSCL THROM VAS, V26, P977, DOI 10.1161/01.ATV.0000204327.96431.9a	19	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	FEB	2015	165	2					336	345		10.1016/j.trsl.2014.07.008		10	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	CA0WB	WOS:000348633200009		
J	Kayama, M; Koike, T				Kayama, Masazumi; Koike, Takayoshi			Differences in growth characteristics and dynamics of elements in seedlings of two birch species grown in serpentine soil in northern Japan	TREES-STRUCTURE AND FUNCTION			English	Article						Birch; Serpentine soil; Photosynthetic capacity; Heavy metal; Nutrient physiology	NICKEL TOXICITY; SCLERODERMA-FLAVIDUM; LACTARIUS-RUFUS; TOLERANCE; MAGNESIUM; NITROGEN; PHOTOSYNTHESIS; PLANTS; PHOSPHORUS; POTASSIUM	Seedlings of two birch species were grown in serpentine soil, with Betula ermanii showing high tolerance. Betula ermanii and Betula platyphylla var. japonica, two typical light-demanding-deciduous trees in northern Japan, usually invade disturbed areas. B. ermanii can invade serpentine soil and grow in it, whereas B. platyphylla var. japonica can hardly regenerate in it. Serpentine soil is distributed throughout Japan and is characterized by excessive Mg and heavy metals (Ni, Cr, and Co) which can lead to suppressed plant growth. We examined the tolerance of the two Betula species by planting seedlings in serpentine and non-serpentine (brown forest) soils. The dry mass of each organ was suppressed in both birches planted in serpentine soil, and the photosynthetic rate was reduced by accumulation of Ni. Also, uptakes of K and Ca were inhibited by accumulation of Mg, Ni, Cr and Co. B. ermanii planted in serpentine soil showed high value of net assimilation rate in the second year and maintained the photosynthetic rate from June to September. The effects of Mg, Ni, Cr and Co accumulation were small on the relative growth rate of B. ermanii. In contrast, B. platyphylla var. japonica planted in serpentine soil showed decreased photosynthetic rate in September and smaller net assimilation rate than B. ermanii at the same time. In addition, B. platyphylla var. japonica showed decreased relative growth rate, induced by accumulation of Mg in leaves and Co in roots. We conclude that B. ermanii has the high advantage of regenerating in serpentine soil.	[Kayama, Masazumi] Hokkaido Univ Forests, FSC, Sapporo, Hokkaido 0600809, Japan; [Koike, Takayoshi] Hokkaido Univ, Sapporo, Hokkaido 0608589, Japan	Kayama, M (reprint author), Japan Int Res Ctr Agr Sci, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan.	kayama@affrc.go.jp			JSPS; Japan Science Society	We thank Prof. K. Sasa, Dr. Y. Akibayashi, and Prof. F. Satoh for their valuable comments on this study. We are grateful to the technical staff of Teshio Experimental Forest of Hokkaido University for their excellent technical assistance. Our thanks are due to Dr. S. Kitaoka and Ms. Y. Yanagihara for preparation of the nurseries. Analyses of plant organs were carried out at the Kyushu Research Center, Forestry and Forest Products Research Institute. We are indebted to Dr. K. Makoto and Ms. N. Aoki of the Kyushu Research Center for the analyses. For the ICP analyses of Ni, Cr, and Co concentrations, we are grateful to Dr. H. Kubotera of the National Agriculture and Food Research Organization. Thanks are also due to Mr. E. Agathokleous, Diploma of AUA, and Dr. Anthony Garrett of SCITEXT in Cambridge, UK, for English proofreading. Financial support to M. K. and T. K. by the JSPS and the Japan Science Society is gratefully acknowledged.	Alexander EB, 2007, SERPENTINE GEOECOLOG; Molas J, 2002, ENVIRON EXP BOT, V47, P115, DOI 10.1016/S0098-8472(01)00116-2; Liu J, 2009, PLANT SOIL, V322, P187, DOI 10.1007/s11104-009-9907-2; PROCTOR J, 1971, J ECOL, V59, P827, DOI 10.2307/2258143; Kayama M, 2007, TREE PHYSIOL, V27, P1585; JONES MD, 1988, NEW PHYTOL, V108, P451, DOI 10.1111/j.1469-8137.1988.tb04186.x; Yang X, 1996, J PLANT NUTR, V19, P265, DOI 10.1080/01904169609365121; PALIT S, 1994, BOT REV, V60, P149, DOI 10.1007/BF02856575; Sinha P, 2012, J PLANT NUTR, V35, P952, DOI 10.1080/01904167.2012.663636; Velikova V, 2011, ENVIRON POLLUT, V159, P1058, DOI 10.1016/j.envpol.2010.10.032; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Singh HP, 2013, ENVIRON CHEM LETT, V11, P229, DOI 10.1007/s10311-013-0407-5; Vernay P, 2008, CHEMOSPHERE, V72, P763, DOI 10.1016/j.chemosphere.2008.03.018; Ali B, 2010, J PLANT INTERACT, V5, P223, DOI 10.1080/17429140903370584; Oze C, 2004, INT GEOL REV, V46, P97, DOI 10.2747/0020-6814.46.2.97; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Takahashi K, 2003, ECOL RES, V18, P549, DOI 10.1046/j.1440-1703.2003.00577.x; Seregin IV, 2006, RUSS J PLANT PHYSL+, V53, P257, DOI 10.1134/S1021443706020178; Pettigrew WT, 2008, PHYSIOL PLANTARUM, V133, P670, DOI 10.1111/j.1399-3054.2008.01073.x; [Anonymous], 1998, STANDARD METHODS EXA; Baccouch S, 1998, J PLANT NUTR, V21, P577, DOI 10.1080/01904169809365425; Bai JH, 2007, PEDOSPHERE, V17, P229, DOI 10.1016/S1002-0160(07)60029-0; Baillon F, 1988, TREES-STRUCT FUNCT, V2, P173; BAKER AJM, 1987, NEW PHYTOL, V106, P93; Blandon D. M. Z., 1994, Research Bulletin of the Hokkaido University Forests, V51, P1; Bown HE, 2007, TREE PHYSIOL, V27, P335; Brooks R.R., 1987, SERPENTINE ITS VEGET; COCUCCI SM, 1986, PHYSIOL PLANTARUM, V68, P497, DOI 10.1111/j.1399-3054.1986.tb03388.x; GABBRIELLI R, 1990, PLANT SOIL, V122, P271; Ishibashi S., 1998, Journal of the Japanese Forestry Society, V80, P74; JONES MD, 1988, NEW PHYTOL, V108, P461, DOI 10.1111/j.1469-8137.1988.tb04187.x; Kanai S, 2011, PLANT SCI, V180, P368, DOI 10.1016/j.plantsci.2010.10.011; Kayama M, 2005, ANN BOT-LONDON, V95, P661, DOI 10.1093/aob/mic063; Kayama M, 2006, TREES-STRUCT FUNCT, V20, P430, DOI 10.1007/s00468-006-0057-3; Kayama M., 2006, Research Bulletin of the Hokkaido University Forests, V63, P33; Kitao M, 1999, PHOTOSYNTHETICA, V36, P31, DOI 10.1023/A:1007058418199; Kobayashi H, 2005, PLANT PROD SCI, V8, P38, DOI 10.1626/pps.8.38; Koike T, 1995, VEGETATION SCI FORES, P409; Koyama H, 1989, T M HOKKAIDO BR JAP, V37, P55; Kubota J., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P485; Lambers H., 1998, PLANT PHYSL ECOLOGY; Lazarus BE, 2011, PLANT SOIL, V342, P327, DOI 10.1007/s11104-010-0698-2; MARSCHNER H., 1995, MINERAL NUTR HIGHER; Matsumura Hideyuki, 2005, Journal of Agricultural Meteorology, V60, P1121; Millard P, 1996, Z PFLANZ BODENKUNDE, V159, P1; Miller SP, 2000, TREE PHYSIOL, V20, P1129; Miyawaki A, 1988, VEGETATION JAPAN; Mizuno N, 1992, ECOLOGY AREAS SERPEN, P271; NAKATA M, 1987, FOREST ECOL MANAG, V20, P265, DOI 10.1016/0378-1127(87)90084-3; Neilsen D, 1997, TREE PHYSIOL, V17, P733; Palm E, 2012, FUNCT PLANT BIOL, V39, P679, DOI 10.1071/FP12059; PANDOLFINI T, 1992, PLANT CELL ENVIRON, V15, P719, DOI 10.1111/j.1365-3040.1992.tb01014.x; RAAIMAKERS D, 1995, OECOLOGIA, V102, P120; Rao M, 1987, PLANT PHYSIOL, V84, P1214; Santana KB, 2012, ENVIRON EXP BOT, V80, P35, DOI 10.1016/j.envexpbot.2012.02.004; Takikawa S, 1994, T M HOKKAIDO BR JAP, V42, P82; Tatewaki M, 1971, RES B COLLEGE EXPT F, V28, P1; Thornley J.H.M, 1976, MATH MODELS PLANT PH; Tilistone GH, 1997, PLANT SOIL, V191, P173; Yamada K, 2001, B HOKKAIDO FOR RES I, V38, P23; Yamada K., 1999, Journal of the Japanese Forestry Society, V81, P291	62	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-1890	1432-2285		TREES-STRUCT FUNCT	Trees-Struct. Funct.	FEB	2015	29	1					171	184		10.1007/s00468-014-1102-2		14	Forestry	Forestry	AZ8FZ	WOS:000348451800016		
J	Tiefenbach, T; Coulmas, F				Tiefenbach, Tim; Coulmas, Florian			Civil Society and Happiness: Japan and Beyond	VOLUNTAS			English	Editorial Material									[Tiefenbach, Tim] German Inst Japanese Studies DIJ, Chiyoda Ku, Tokyo 1020094, Japan; [Coulmas, Florian] Univ Duisburg Essen, Fac Social Sci, Duisburg, Germany	Tiefenbach, T (reprint author), German Inst Japanese Studies DIJ, Chiyoda Ku, Jochi Kioizaka Bldg 2F,7-1 Kioicho, Tokyo 1020094, Japan.	tiefenbach@dijtokyo.org; florian.coulmas@uni-due.de					Lange T., 2010, INT J SOC ECON, V37, P686, DOI [10.1108/03068291011062489, DOI 10.1108/03068291011062489]; Meier S., 2007, ECONOMICA PARIS, V75, P39, DOI [10.1111/j.1468-0335.2007.00597.x, DOI 10.1111/J.1468-0335.2007.00597.X]	2	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0957-8765	1573-7888		VOLUNTAS	Voluntas	FEB	2015	26	1					1	4		10.1007/s11266-014-9547-x		4	Social Issues	Social Issues	AZ6RN	WOS:000348346800001		
J	Hommerich, C				Hommerich, Carola			Feeling Disconnected: Exploring the Relationship Between Different Forms of Social Capital and Civic Engagement in Japan	VOLUNTAS			English	Article						Social capital; Civic engagement; Precarity; Social trust; Disconnectedness; Japan	FIT INDEXES; VOLUNTARY-ASSOCIATIONS; GENERALIZED TRUST; UNITED-STATES; PARTICIPATION; EXCLUSION; MODELS; LIFE	This paper analyzes the role of social connectedness in motivating citizens to take an active interest in society and to engage in communal activities. Japan is used as an example of a society which has been diagnosed with a weakening of social bonds, as well as with an increase in social inequality and precarity in recent years. Structural equation modeling was applied to data of a nationwide survey from 2009, to test the assumption that feelings of disconnectedness from society exert a negative effect on civic engagement that needs to be differentiated from effects of general social trust. Results support this hypothesis and further indicate that it is not socioeconomic precarity per se that lowers chances for civic engagement, but its negative impact on the subjective evaluation of both the quality of social networks and one's belonging to and value for society. As precarity, however, enforces the negative effects of low social capital, this implies that specially the socially disadvantaged are less likely to participate.	German Inst Japanese Studies DIJ, Chiyoda Ku, Tokyo 1020094, Japan	Hommerich, C (reprint author), German Inst Japanese Studies DIJ, Chiyoda Ku, Jochi Kioizaka Bldg 2F,7-1 Kioicho, Tokyo 1020094, Japan.	hommerich@dijtokyo.org					Aldrich D. P., 2012, BUILDING RESILIENCE; ALLISON A, 2013, PRECARIOUS JAPAN; Anheier HK, 1999, LAW CONTEMP PROBL, V62, P43, DOI DOI 10.2307/1192266; Paxton P, 1999, AM J SOCIOL, V105, P88, DOI 10.1086/210268; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Wollebaek D, 2002, NONPROF VOLUNT SEC Q, V31, P32, DOI 10.1177/0899764002311002; Requena F, 2003, SOC INDIC RES, V61, P331, DOI 10.1023/A:1021923520951; Delhey J, 2005, EUR SOCIOL REV, V21, P311, DOI 10.1093/esr/jci022; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Stolle D, 1998, POLIT PSYCHOL, V19, P497, DOI 10.1111/0162-895X.00115; Paxton P, 2007, SOC FORCES, V86, P47, DOI 10.1353/sof.2007.0107; Delhey J, 2003, EUR SOC, V5, P93, DOI 10.1080/1461669032000072256; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Beck U, 2003, THEOR CULT SOC, V20, P1, DOI 10.1177/0263276403020002001; Taniguchi H, 2014, VOLUNTAS, V25, P150, DOI 10.1007/s11266-012-9328-3; Taniguchi H, 2010, NONPROF VOLUNT SEC Q, V39, P161, DOI 10.1177/0899764008326480; Sonderskov KM, 2011, EUR SOCIOL REV, V27, P419, DOI 10.1093/esr/jcq017; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Nakano LY, 2000, ETHNOLOGY, V39, P93, DOI 10.2307/3773837; Bjornskov C, 2013, SOC INDIC RES, V114, P1225, DOI 10.1007/s11205-012-0199-1; Avenell S., 2012, NATURAL DISASTER NUC, P53; Barber B.R., 2003, STRONG DEMOCRACY PAR; Bauman Z., 2006, LIQUID FEAR; Beck U, 1994, REFLEXIVE MODERNIZAT; Beck Urick, 2009, WORLD RISK; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Bjornskov Christian, 2006, EUROPEAN J POLITICAL, V22, P22, DOI DOI 10.1016/J.EJPOLECO.2005.05.006; Bohnke P., 2006, RANDE GESELLSCHAFT R; Bohnke P., 2004, PERCEPTIONS SOCIAL I; Bourdieu P., 1996, WEIGHT WORLD SOCIAL; Bourdieu Pierre, 1980, ACTES RECHERCHE SCI, V31, P2; Brown T. A., 2006, CONFIRMATORY FACTOR; Bude H, 2006, KOLNER Z SOZIOL SOZ, V58, P233, DOI 10.1007/s11575-006-0054-1; Burchardt T., 2002, UNDERSTANDING SOCIAL; Byrne B. M., 2010, STRUCTURAL EQUATION; Cabinet Office, 2007, HEIS 19 NEN HAN KOK; Cabinet Office, 2003, HEIS 15 NEND KOK SEI; Cabinet Office, 2012, HEIS 23 NEND KOK SEI; Cabinet Office, 2013, SHAK ISH NI KAN SUR; Cabinet Office, 2013, HEIS 25 NEN KOK SEIK; Castel R., 2003, MANUAL WORKERS WAGE; CIVICUS, 2013, STAT CIV SOC 2013 CR; Coleman J. S., 1988, AM J SOCIOL, V94, P95, DOI DOI 10.1086/228943; de Tocqueville A., 1832, DEMOCRACY AM; Forster M. F., 2009, MEAS POV INC IN SOC; Foschi R, 2014, J PERS SOC PSYCHOL, V106, P339, DOI 10.1037/a0035331; Genda Y., 2013, KORITSU MUGYO SNEP; Genda Y., 2005, NAGGING SENSE INSECU; Giddens A., 1990, CONSEQUENCES MODERNI; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Han S., 2014, J HAPPINESS STUDIES; Hommerich C., 2012, JAPAN FORUM, V24, P205; Ishida H, 2010, NISSAN I ROUTL JPN S, P1; Ishida M., 2011, KORITSU SHAKAIGAKU M; Japan Productivity Center, 2006, SURV RES ACT MENT HL; Kankonsosaigojokyokai Z., 2012, MUEN SHAKAI KARA YUE; KAWANO S, 2014, CAPTURING CONT JAPAN; Krishna A, 2000, 21 WORLD BANK; Lantermann E.-D., 2009, SELBSTSORGE UNSICHER; Lin N., 2011, SOCIAL CAPITAL CRITI; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; MHLW, 2008, COMP SURV LIV COND; Misztal BA, 2011, CHALLENGES OF VULNERABILITY: IN SEARCH OF STRATEGIES FOR A LESS VULNERABLE SOCIAL LIFE, P1, DOI 10.1057/9780230316690; Mitani H., 2013, VOLUNTAS, V25, P1022; Miyamoto M., 2012, WAKAMONO MUENKA SURU; [NHK NHK ''Muen shakai purojekuto'' shuzaihan], 2010, MUEN SHAK MUENSH 32; NIPSSR, 2012, POP STAT JAP 2012; Nishide Yuko, 2009, SOCIAL CAPITAL CIVIL; OECD, 2008, GROW UN INC DISTR PO; OECD, 2013, HOWS LIF 2013 MEAS W; OECD (Organisation for Economic Cooperation and Development), 2011, HOWS LIF MEAS WELL B; Pekkanen R., 2006, JAPANS DUAL CIVIL SO; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam RD, 1993, MAKING DEMOCRACY WOR; Schumacker R. E., 2010, BEGINNERS GUIDE STRU; Sen A., 2000, SOCIAL EXCLUSION CON; Serageldin I., 2000, SOCIAL CAPITAL MULTI; Shirahase S, 2014, NISSAN I ROUTL JPN S, P1; Soeffner H.-G., 2012, VERH 35 K DTSCH GES; Somusho Tokei Kyoku, 2014, ROD CHOS HEIS 25 NEN; Standing G., 2011, PRECARIAT NEW DANGER; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tabachnick B. G., 2013, USING MULTIVARIATE S; Tachibanaki T., 2011, MUEN SHAKAI SHOTAI K; Tachibanaki T, 2005, CONFRONTING INCOME I; Tsujinaka Y, 2007, PAC AFF, V80, P419; Uslaner E., 2002, MORAL FDN TRUST; Vinken H, 2010, NONPROFIT CIV SOC ST, P1, DOI 10.1007/978-1-4419-1504-7; Whelan Christopher T., 2008, HDB QUALITY LIFE ENL, P201; Wilkinson I, 2009, NEW SOCIOL, P1; Wilkinson RG, 2009, SPIRIT LEVEL WHY MOR; Wilson J, 2000, ANNU REV SOCIOL, V26, P215, DOI 10.1146/annurev.soc.26.1.215; Wissink B, 2012, URBAN STUD, V49, P1527, DOI 10.1177/0042098011415437; Wollebaek D., 2007, J CIVIL SOC, V3, P1, DOI 10.1080/17448680701390638; World Economic Forum, 2013, FUT ROL CIV SOC; Yamada Masahiro, 2004, KIBO KAKUSA SHAKAI M; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamauchi N., 2011, JAPANESE CIVIL SOC C; Zielenziger M., 2006, SHUTTING OUT SUN JAP	100	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0957-8765	1573-7888		VOLUNTAS	Voluntas	FEB	2015	26	1					45	68		10.1007/s11266-014-9525-3		24	Social Issues	Social Issues	AZ6RN	WOS:000348346800004		
J	Tiefenbach, T; Holdgrun, PS				Tiefenbach, Tim; Holdgruen, Phoebe Stella			Happiness Through Participation in Neighborhood Associations in Japan? The Impact of Loneliness and Voluntariness	VOLUNTAS			English	Article						Neighborhood associations; Subjective well-being; Japan; Civil participation; Voluntariness; Loneliness; Gender	LIFE SATISFACTION; PROCEDURAL UTILITY; SOCIAL-PARTICIPATION; COMMUNITY; SENSE; DEMOCRACY; SOCIETY; HAPPY	This article analyzes the relationship between subjective well-being (SWB) and participation in neighborhood associations (NHA) in Japan. While the theoretical and empirical literature suggests a strong positive correlation between participation in NHAs and SWB, recent research on Japan could not validate this result. This study shows how those diverging results can be explained by including two factors in the analysis: the voluntariness of the action as well as loneliness as a mediating variable. Using linear regression models on data from two different studies, we find that-even in the case of Japan-voluntary participation in NHAs is positively associated with SWB in two ways: directly and indirectly mediated by loneliness. This result is robust to differently sampled data and different measures of our key variables.	[Tiefenbach, Tim; Holdgruen, Phoebe Stella] German Inst Japanese Studies DIJ, Chiyoda Ku, Tokyo 1020094, Japan	Tiefenbach, T (reprint author), German Inst Japanese Studies DIJ, Chiyoda Ku, Jochi Kioizaka Bldg 2F,7-1 Kioicho, Tokyo 1020094, Japan.	tiefenbach@dijtokyo.org; holdgruen@dijtokyo.org					Alois Stutzer, 2002, HAPPINESS EC EC I AF; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Diener E, 2009, S AFR J PSYCHOL, V39, P391; Stutzer A, 2006, EUR J POLIT RES, V45, P391, DOI 10.1111/j.1475-6765.2006.00303.x; Dorn D, 2007, SOC INDIC RES, V82, P505, DOI 10.1007/s11205-006-9048-4; Frey BS, 2007, J ECON PSYCHOL, V28, P283, DOI 10.1016/j.joep.2007.02.001; DAVIDSON WB, 1991, J COMMUNITY PSYCHOL, V19, P246, DOI 10.1002/1520-6629(199107)19:3<246::AID-JCOP2290190308>3.0.CO;2-L; Frey BS, 2004, J INST THEOR ECON, V160, P377, DOI 10.1628/0932456041960560; Prezza M, 2001, J COMMUNITY PSYCHOL, V29, P29, DOI 10.1002/1520-6629(200101)29:1<29::AID-JCOP3>3.0.CO;2-C; Leung A, 2011, J HAPPINESS STUD, V12, P443, DOI 10.1007/s10902-010-9208-8; Bjornskov C, 2003, KYKLOS, V56, P3, DOI 10.1111/1467-6435.00207; van Houwelingen P, 2012, URBAN AFF REV, V48, P467, DOI 10.1177/1078087411434906; MCMILLAN DW, 1986, J COMMUNITY PSYCHOL, V14, P6, DOI 10.1002/1520-6629(198601)14:1<6::AID-JCOP2290140103>3.0.CO;2-I; Farrell SJ, 2004, J COMMUNITY PSYCHOL, V32, P9, DOI 10.1002/jcop.10082; Weitz-Shapiro R, 2011, LAT AM POLIT SOC, V53, P101, DOI 10.1111/j.1548-2456.2011.00135.x; Blanchflower DG, 2011, ACAD MANAGE PERSPECT, V25, P6; Taniguchi H, 2014, VOLUNTAS, V25, P150, DOI 10.1007/s11266-012-9328-3; Frey BS, 2005, OXFORD ECON PAP, V57, P90, DOI 10.1093/oep/gpi002; MCCARTHY ME, 1990, J COLL STUDENT DEV, V31, P211; Helliwell JF, 2004, PHILOS T ROY SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Mimura N, 2011, MITIG ADAPT STRAT GL, V16, P803, DOI 10.1007/s11027-011-9297-7; Howard MM, 2008, POLIT STUD-LONDON, V56, P12, DOI 10.1111/j.1467-9248.2007.00715.x; Haddad MA, 2011, VOLUNTAS, V22, P26, DOI 10.1007/s11266-010-9135-7; Goodwin R, 2001, PERS RELATIONSHIP, V8, P225, DOI 10.1111/j.1475-6811.2001.tb00037.x; Cicognani E, 2008, SOC INDIC RES, V89, P97, DOI 10.1007/s11205-007-9222-3; Lewbel A, 2012, J BUS ECON STAT, V30, P67, DOI 10.1080/07350015.2012.643126; Portela M, 2013, SOC INDIC RES, V114, P493, DOI 10.1007/s11205-012-0158-x; Baum C. F., 2012, INSTRUMENTAL VARIABL; Benz M, 2007, EC PSYCHOL PROMISING, P199; Coleman J. S., 1988, AM J SOCIOL, V94, P94, DOI DOI 10.1086/229033; Deci EL, 2004, RICERCHE PSICOLOGIA, V1, P23; Dolan P., 2011, MEASURING SUBJECTIVE; Dorn D, 2008, J HAPPINESS STUD, V9, P227, DOI 10.1007/s10902-007-9050-9; Dreze J., 2002, INDIA DEV PARTICIPAT; Frey BS, 2000, ECON J, V110, P918, DOI 10.1111/1468-0297.00570; Frey BS, 2000, J HAPPINESS STUD, V1, P79, DOI 10.1023/A:1010028211269; GRANEY MJ, 1975, J GERONTOL, V30, P701; Grillo MC, 2010, SOC INDIC RES, V97, P451, DOI 10.1007/s11205-009-9511-0; Guyet D., 2007, HDB COMMUNITY MOVEME, P163; Holdgrun P., 2013, GENDER EQUALITY IMPL, V54; Kanaya N., 2008, NONPROFIT REV, V8, P13; Lange T., 2010, INT J SOC ECON, V37, P686, DOI [10.1108/03068291011062489, DOI 10.1108/03068291011062489]; Meyer M, 2004, NONPROF VOLUNT SEC Q, V33, p77S, DOI 10.1177/0899764004265432; Miller E., 2008, KOTUITUI NZ J SOCIAL, V3, P15, DOI 10.1080/1177083X.2008.9522429; Mori H., 2002, DOSHISHA U POLICY MA, V3, P315; Nishide Yuko, 2009, SOCIAL CAPITAL CIVIL; Pekkanen R., 2006, E W CTR SERIES CONT; Pekkanen R., 2008, DEMOGRAPHIC CHALLENG, P707, DOI 10.1163/ej.9789004154773.i-1199.293; Pekkanen RJ, 2014, NISSAN I ROUTL JPN S, P1; Portney K. E., 2001, TOCQUEVILLE CIVIL SO, P70; Pretty GMH, 1996, J COMMUNITY PSYCHOL, V24, P365, DOI 10.1002/(SICI)1520-6629(199610)24:4<365::AID-JCOP6>3.0.CO;2-T; Putnam R., 2000, BOWLING ALONE COLLAP; Salimi A, 2011, PROCD SOC BEHV, V29, DOI 10.1016/j.sbspro.2011.11.241; Sarason S.B., 1974, PSYCHOL SENSE COMMUN; Thranhardt A. M., 1990, 3 SECTOR COMP STUDIE, V21, P347; Tiefenbach T, 2015, J HAPPINESS STUD, V16, P333, DOI 10.1007/s10902-014-9512-9; Tiefenbach T., 2013, 131 DIJ GERM I JAP S; Tsujinaka Y., 2009, GENDAI NIHON JICHIKA, V1; Wallace C, 2009, SOC INDIC RES, V93, P255, DOI 10.1007/s11205-008-9305-9; Wandersman Abraham, 2000, HDB COMMUNITY PSYCHO, P247; World Economic Forum, 2013, GLOB GEN GAP REP 201; Yasui K., 1985, CHONAIKAI NO KENKYU, P195	62	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0957-8765	1573-7888		VOLUNTAS	Voluntas	FEB	2015	26	1					69	97		10.1007/s11266-014-9520-8		29	Social Issues	Social Issues	AZ6RN	WOS:000348346800005		
J	Yamasaki, M; Miyata, H; Yasuda, T; Shiraishi, O; Takahashi, T; Motoori, M; Yano, M; Shiozaki, H; Mori, M; Doki, Y				Yamasaki, Makoto; Miyata, Hiroshi; Yasuda, Takushi; Shiraishi, Osamu; Takahashi, Tsuyoshi; Motoori, Masaaki; Yano, Masahiko; Shiozaki, Hitoshi; Mori, Masaki; Doki, Yuichiro			Impact of the Route of Reconstruction on Post-operative Morbidity and Malnutrition after Esophagectomy: A Multicenter Cohort Study	WORLD JOURNAL OF SURGERY			English	Article							LYMPH-NODE DISSECTION; QUALITY-OF-LIFE; MINIMALLY INVASIVE ESOPHAGECTOMY; GASTRIC TUBE RECONSTRUCTION; CANCER-SURGERY; NUTRITIONAL-STATUS; CONTROLLED-TRIAL; NERVE CHAIN; CARCINOMA; MICROMETASTASIS	Reconstruction after esophagectomy is mainly performed through the retrosternum (RS) or posterior mediastinum (PM). However, the best approach is not clear. This study aimed to assess the impact of the route of gastric conduit reconstruction, after esophagectomy for esophageal squamous cell carcinoma (ESCC), on post-operative outcomes. We analyzed 298 patients who underwent radical esophagectomy for ESCC at three high volume centers between 2008 and 2009. Among them, the RS was selected in 166 patients and PM in 118; while, the antethoracic route was used in 14 patients. Post-operative morbidity, mortality, and long-term outcome were compared. There were no differences between patients of the two routes with respect to operative blood loss (RS: 753 +/- A 519, PM: 748 +/- A 414 g) and post-operative complications, including pulmonary problems (RS: 15 %, PM: 10.2 %) and anastomotic leakage (RS: 9.0 %, PM: 5.1 %); although, the operating time (RS: 566 +/- A 97, PM: 472 +/- A 79 min; p < 0.0001) was shorter in the PM group than the RS group. The percentage weight loss after surgery was significantly less in the PM group than the RS group at 1 year (8.6 vs. 11.1 %; p = 0.025); although, the percentage at discharge was not different between the groups (PM: 4.9 %, RS: 6.3 %; p = 0.072). Multivariate analysis identified pre-operative body weight and the reconstruction route as significant and independent factors associated with 1-year weight loss. The results indicate gastric tube reconstruction through the posterior mediastinal route after esophagectomy may relieve post-operative 1-year malnutrition without increasing post-operative complications.	[Yamasaki, Makoto; Miyata, Hiroshi; Takahashi, Tsuyoshi; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650879, Japan; [Yasuda, Takushi; Shiraishi, Osamu; Shiozaki, Hitoshi] Kinki Univ, Sch Med, Dept Surg, Osaka 589, Japan; [Motoori, Masaaki; Yano, Masahiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan	Yamasaki, M (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2-E2 Yamadaoka, Suita, Osaka 5650879, Japan.	myamasaki@gesurg.med.osaka-u.ac.jp					Yoshioka S, 2002, SURGERY, V132, P34, DOI 10.1067/msy.2002.125306; Miyata H, 2006, J SURG ONCOL, V93, P477, DOI 10.1002/jso.20453; Gawad KA, 1999, AM J GASTROENTEROL, V94, P1490; Khiria LS, 2009, DIGEST LIVER DIS, V41, P711, DOI 10.1016/j.dld.2009.02.051; Orringer MB, 2007, ANN SURG, V246, P363, DOI 10.1097/SLA.0b013e31814697f2; Djarv T, 2009, J CLIN ONCOL, V27, P1963, DOI 10.1200/JCO.2008.20.5864; Olin AO, 2005, EUR J CLIN NUTR, V59, P263, DOI 10.1038/sj.ejcn.1602067; MANNELL A, 1990, BRIT J SURG, V77, P57, DOI 10.1002/bjs.1800770120; Bozzetti F, 2009, SUPPORT CARE CANCER, V17, P279, DOI 10.1007/s00520-008-0476-3; Schiesser M, 2009, SURGERY, V145, P519, DOI 10.1016/j.surg.2009.02.001; Martin L, 2008, BRIT J SURG, V95, P1362, DOI 10.1002/bjs.6374; McCulloch P, 2003, BMJ-BRIT MED J, V327, P1192, DOI 10.1136/bmj.327.7425.1192; Martin L, 2007, BRIT J SURG, V94, P1496, DOI 10.1002/bjs.5881; Urschel JD, 2001, AM J SURG, V182, P470, DOI 10.1016/S0002-9610(01)00763-2; Blazeby JM, 2000, CANCER, V88, P1781; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Martin L, 2009, BRIT J SURG, V96, P1308, DOI 10.1002/bjs.6723; Shiozaki H, 2001, DIS ESOPHAGUS, V14, P191, DOI 10.1046/j.1442-2050.2001.00206.x; LEE Y, 1994, SURG TODAY, V24, P24; van Lanschot JJB, 1999, BRIT J SURG, V86, P102; BARTELS H, 1993, BRIT J SURG, V80, P1141, DOI 10.1002/bjs.1800800924; NGAN SYK, 1986, J THORAC CARDIOV SUR, V91, P790; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Ozawa S, 2011, ESOPHAGUS-TOKYO, V8, P9, DOI 10.1007/s10388-011-0266-8; PUTNAM JB, 1994, ANN THORAC SURG, V57, P319; Sweed Margot Roberts, 2002, Oncol Nurs Forum, V29, P1127, DOI 10.1188/02.ONF.1127-1131; Wang H, 2011, QUAL LIFE RES, V20, P179, DOI 10.1007/s11136-010-9742-1; Wong ACC, 2003, DIGEST SURG, V20, P209, DOI 10.1159/000070387; Yamasaki M, 2011, J SURG ONCOL, V104, P623, DOI 10.1002/jso.21991; Yamashita Y, 1999, SURG TODAY, V29, P107	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	FEB	2015	39	2					433	440		10.1007/s00268-014-2819-1		8	Surgery	Surgery	AZ4XK	WOS:000348224100021		
J	Kokudo, N				Kokudo, Norihiro			Is It a Time to Modify the BCLC Guidelines in Terms of the Role of Surgery?	WORLD JOURNAL OF SURGERY			English	Article							HEPATOCELLULAR-CARCINOMA; PORTAL-HYPERTENSION; HEPATIC RESECTION; CONTRAINDICATION; CIRRHOSIS		Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan.	kokudo-2su@h.u-tokyo.ac.jp					Cucchetti A, 2009, ANN SURG, V250, P922, DOI 10.1097/SLA.0b013e3181b977a5; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Santambrogio R, 2013, HPB, V15, P78, DOI 10.1111/j.1477-2574.2012.00594.x; Ishizawa T, 2009, ARCH SURG-CHICAGO, V144, P46, DOI 10.1001/archsurg.2008.511; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Kawano Y, 2008, ANN SURG ONCOL, V15, P1670, DOI 10.1245/s10434-008-9880-7; Capussotti L, 2006, WORLD J SURG, V30, P992, DOI 10.1007/s00268-005-0524-9; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Forner A, 2009, LANCET, V379, P1245; Liu HT, 2015, WORLD J SURG, V39, P461, DOI 10.1007/s00268-014-2811-9	10	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	FEB	2015	39	2					469	470		10.1007/s00268-014-2915-2		2	Surgery	Surgery	AZ4XK	WOS:000348224100026		
J	Yoshida, N; Takayama, T; Midorikawa, Y; Higaki, T; Nakayama, H; Moriguchi, M; Tsuji, S				Yoshida, Naoki; Takayama, Tadatoshi; Midorikawa, Yutaka; Higaki, Tokio; Nakayama, Hisashi; Moriguchi, Masamichi; Tsuji, Shingo			Surgical Outcomes in Patients with Hepatocellular Carcinoma Associated with Metabolic Syndrome	WORLD JOURNAL OF SURGERY			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; POSTOPERATIVE COMPLICATIONS; RISK; TRANSPLANTATION; CLASSIFICATION; HEPATECTOMY; INCREASES; RESECTION	Only a few papers have focused on the surgical outcomes of patients with hepatocellular carcinoma (HCC) associated with the metabolic syndrome. We compared the outcomes of patients with metabolic HCC with those of patients with non-B, non-C HCC associated with other etiologies. Metabolic HCC was defined as HCC arising in patients with at least three of the following metabolic disorders: central obesity, dyslipidemia, hypertension, and diabetes mellitus. A total of 246 patients with non-B, non-C HCC were divided into three groups: metabolic HCC (n = 35), alcoholic HCC (n = 114), and cryptogenic HCC (n = 97). Clinical characteristics, surgical data, and survival were compared among the three groups. Metabolic HCC was diagnosed at a significantly higher age than alcoholic (75 vs. 68 years, P = 0.004) and cryptogenic HCCs (75 vs. 71 years, P = 0.027). Postoperative complications occurred significantly higher in patients with metabolic HCC compared with those with cryptogenic HCC (40.0 vs. 22.7 %, P = 0.049). Especially, pulmonary complications were significant in metabolic HCC compared with cryptogenic HCC (22.9 vs. 8.2 %, P = 0.023). The overall survival rates in the metabolic, alcoholic, and cryptogenic HCC groups were 96.7 % (95 % CI, 90.5-100), 96.3 % (95 % CI, 92.8-99.9), and 95.6 % (95 % CI, 91.5-99.9) at 1 year, respectively, and 87.2 % (95 % CI, 74.5-100), 82.9 % (95 % CI, 74.6-92.2), and 84.5 % (95 % CI, 75.7-94.3) at 3 years, respectively (P = 0.84). The disease-free survival rates in each group were 74.4 % (95 % CI, 60.5-91.5), 76.9 % (95 % CI, 69.2-85.5), and 74.3 % (95 % CI, 65.0-84.8) at 1 year, respectively, and 29.3 % (95 % CI, 16.6-51.8), 39.0 % (95 % CI, 29.7-51.2), and 41.1 % (95 % CI, 29.7-56.8) at 3 years, respectively, (P = 0.90). Metabolic HCC patients have specific risks of postoperative complication related to the metabolic syndrome.	[Yoshida, Naoki; Takayama, Tadatoshi; Midorikawa, Yutaka; Higaki, Tokio; Nakayama, Hisashi; Moriguchi, Masamichi] Nihon Univ, Sch Med, Dept Digest Surg, Itabashi Ku, Tokyo 1738610, Japan; [Tsuji, Shingo] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Yoshida, N (reprint author), Nihon Univ, Sch Med, Dept Digest Surg, Itabashi Ku, 30-1 Oyaguchikami Machi, Tokyo 1738610, Japan.	yoshida.naoki@nihon-u.ac.jp; takayama.tadatoshi@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24249068]	We thank Mr. Peter Star of Medical Network K.K. for assistance in writing the manuscript. This work was mainly supported by a Grant-in-Aid for Scientific Research (A) 24249068 (T.T.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Heuer M, 2012, DIGESTION, V86, P107, DOI 10.1159/000339344; Fletcher LM, 2002, GASTROENTEROLOGY, V122, P281, DOI 10.1053/gast.2002.30992; Siegel AB, 2012, TRANSPLANTATION, V94, P539, DOI 10.1097/TP.0b013e31825c58ea; Utsunomiya T, 2014, ANN SURG, V259, P336, DOI 10.1097/SLA.0b013e31829291e9; Kaneda K, 2012, HEPATO-GASTROENTEROL, V59, P1889, DOI 10.5754/hge10778; Reddy SK, 2012, HEPATOLOGY, V55, P1809, DOI 10.1002/hep.25536; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI [10.1002/hep.22734, 10.1002/hep.227.34]; Le Bian AZ, 2012, J GASTROINTEST SURG, V16, P2247, DOI 10.1007/s11605-012-2044-x; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Turati F, 2013, BRIT J CANCER, V108, P222, DOI 10.1038/bjc.2012.492; Takayama T, 2001, ARCH SURG-CHICAGO, V136, P922, DOI 10.1001/archsurg.136.8.922; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; McCormack L, 2007, ANN SURG, V245, P923, DOI 10.1097/01.sla.0000251747.80025.b7; Arcidiacono B, 2012, EXP DIABETES RES, V2012, DOI [DOI 10.1155/2012/789174, 10.1155/2012/789174]; Cauchy F, 2013, BRIT J SURG, V100, P113, DOI 10.1002/bjs.8963; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; Midorikawa Y, 1999, SURGERY, V126, P484, DOI 10.1067/msy.2099.99573; Wakai T, 2011, J GASTROINTEST SURG, V15, P1450, DOI 10.1007/s11605-011-1540-8; Yamato I, 2012, SURG TODAY, V43, P865	25	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	FEB	2015	39	2					471	477		10.1007/s00268-014-2828-0		7	Surgery	Surgery	AZ4XK	WOS:000348224100027		
J	Murakami, Y; Uemura, K; Sudo, T; Hashimoto, Y; Kondo, N; Nakagawa, N; Sasaki, H; Sueda, T				Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto, Yasushi; Kondo, Naru; Nakagawa, Naoya; Sasaki, Hayato; Sueda, Taijiro			Is Pancreatic Fistula Associated with Worse Overall Survival in Patients with Pancreatic Carcinoma?	WORLD JOURNAL OF SURGERY			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; INTERNATIONAL STUDY-GROUP; PLUS S-1 CHEMOTHERAPY; TO-MUCOSA PANCREATICOGASTROSTOMY; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; ADJUVANT CHEMOTHERAPY; DISTAL PANCREATECTOMY; COLORECTAL-CANCER; ANASTOMOTIC LEAKAGE	Pancreatic fistula (PF) is one of the leading complications after pancreatic resection for pancreatic carcinoma. The aim of this study was to determine whether PF was associated with deterioration of long-term outcomes in patients with pancreatic carcinoma after surgical resection. Medical records of 210 patients with pancreatic carcinoma who underwent tumor resection were reviewed retrospectively. PF was defined as grade B or C PF according to the criteria of the International Study Group on Pancreatic Fistula. Clinicopathological factors including overall survival were compared between patients with and without PF by univariate and multivariate analyses. Thirty-one patients (15 %) developed postoperative PF, and 179 (85 %) did not. The 31 cases of PF consisted of 27 grade B PF and 4 grade C PF. There were no differences in the use of adjuvant chemotherapy, tumor differentiation, lymph node status, surgical margin status, or UICC stage between groups. Overall 5-year survival rates for patients with and without PF were 25 and 27 %, respectively. There was no significant difference in overall survival between the two groups (P = 0.743). Multivariate analysis demonstrated that the use of postoperative adjuvant chemotherapy (P < 0.001), tumor differentiation (P = 0.005), and lymph node metastasis (p < 0.001) were factors independently associated with overall survival. These results suggested that PF was not associated with deterioration of long-term outcomes in patients with pancreatic carcinoma. However, further analyses on larger number of patients are needed to determine a negative effect of grade C PF on long-term survival.	[Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto, Yasushi; Kondo, Naru; Nakagawa, Naoya; Sasaki, Hayato; Sueda, Taijiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, Hiroshima 7348551, Japan	Murakami, Y (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	mura777@hiroshima-u.ac.jp					Nagai S, 2011, ANN SURG ONCOL, V18, P2329, DOI 10.1245/s10434-011-1604-8; Kamphues C, 2012, ANN SURG ONCOL, V19, P856, DOI 10.1245/s10434-011-2041-4; Murakami Y, 2008, AM J SURG, V195, P757, DOI 10.1016/j.amjsurg.2007.04.018; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Murakami Y, 2013, J SURG ONCOL, V107, P414, DOI 10.1002/jso.23229; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Reid-Lombardo KM, 2007, J GASTROINTEST SURG, V11, P1451, DOI 10.1007/s11605-007-0270-4; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Frozanpor F, 2012, ANN SURG, V255, P1032, DOI 10.1097/SLA.0b013e318251610f; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; den Dulk M, 2009, BRIT J SURG, V96, P1066, DOI 10.1002/bjs.6694; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Kang CM, 2009, J GASTROINTEST SURG, V13, P907, DOI 10.1007/s11605-009-0823-9; Richards CH, 2010, BRIT J CANCER, V103, P1356, DOI 10.1038/sj.bjc.6605919; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; Rizk NP, 2004, J AM COLL SURGEONS, V198, P42, DOI 10.1016/j.jamcollsurg.2003.08.007; Murakami Y, 2010, WORLD J SURG, V34, P1900, DOI 10.1007/s00268-010-0577-2; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Gebauer F, 2012, ANN SURG, V256, P130, DOI 10.1097/SLA.0b013e31824f24e4; Murakami Y, 2012, J SURG ONCOL, V106, P174, DOI 10.1002/jso.23068; Roxburgh CSD, 2011, ANN SURG ONCOL, V18, P997, DOI 10.1245/s10434-010-1410-8; Montorsi M, 2012, ANN SURG, V256, P853, DOI 10.1097/SLA.0b013e318272dec0; Fuks D, 2009, AM J SURG, V197, P702, DOI 10.1016/j.amjsurg.2008.03.004; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Ausania Fabio, 2010, JOP, V11, P226; Colleoni M, 2000, J CLIN ONCOL, V18, P584; Crumley ABC, 2011, ANN SURG ONCOL, V18, P2604, DOI 10.1245/s10434-011-1658-7; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; Hassenpflug M, 2012, SURGERY, V152, pS164, DOI 10.1016/j.surg.2012.05.026; Kawai M, 2009, WORLD J SURG, V33, P2670, DOI 10.1007/s00268-009-0220-2; Murakami Y, 2006, SURGERY, V140, P443; Murakami Y, 2008, J SURG ONCOL, V97, P205, DOI 10.1002/jso.20903; Murakami Y, 2013, CANCER CHEMOTH PHARM, V71, P419, DOI 10.1007/s00280-012-2029-1; Murakami Y, 2009, J GASTROINTEST SURG, V13, P85, DOI 10.1007/s11605-008-0650-4; Sobin LH, 2010, INT UNION CANC UICC; Sudo T, 2011, AM J SURG, V202, P77, DOI 10.1016/j.amjsurg.2010.04.023	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	FEB	2015	39	2					500	508		10.1007/s00268-014-2823-5		9	Surgery	Surgery	AZ4XK	WOS:000348224100031		
J	Hirono, S; Murakami, Y; Tani, M; Kawai, M; Okada, K; Uemura, K; Sudo, T; Hashimoto, Y; Nakagawa, N; Kondo, N; Yamaue, H				Hirono, Seiko; Murakami, Yoshiaki; Tani, Masaji; Kawai, Manabu; Okada, Ken-ichi; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto, Yasushi; Nakagawa, Naoya; Kondo, Naru; Yamaue, Hiroki			Identification of Risk Factors for Pancreatic Exocrine Insufficiency After Pancreaticoduodenectomy Using a C-13-Labeled Mixed Triglyceride Breath Test	WORLD JOURNAL OF SURGERY			English	Article							PYLORUS-PRESERVING PANCREATICODUODENECTOMY; MORPHOLOGICAL-CHANGES; RANDOMIZED-TRIAL; FECAL ELASTASE-1; PANCREATICOGASTROSTOMY; PANCREATICOJEJUNOSTOMY; PANCREATOGASTROSTOMY; PANCREATOJEJUNOSTOMY; RECONSTRUCTION; CAPACITY	There are only a few reports concerning long-term exocrine function after pancreaticoduodenectomy (PD), although the number of long-term survivors has increased. We assessed pancreatic exocrine function after PD in 189 patients to identify risk factors for pancreatic exocrine insufficiency. We evaluated patients' exocrine function by using the C-13-labeled mixed triglyceride breath test, a noninvasive test feasible in outpatient service units. The present study included 99 patients that underwent pancreaticojejunostomy (PJ) at Wakayama Medical University Hospital and 90 patients that underwent pancreaticogastrostomy (PG) at Hiroshima University Hospital, the standard reconstruction techniques during PD at the respective hospitals. We also analyzed long-term morphological changes of remnant pancreas by computed tomography (main pancreatic duct dilation and parenchymal atrophy), nutritional status, and endocrine function. Independent risk factors for exocrine insufficiency after PD include hard pancreas (P = 0.003, odds ratio; 3.157) and PG reconstruction (P = 0.040, odds ratio; 2.321). Breath test results correlated significantly with post-operative morphological changes, nutritional status, and endocrine function. Atrophic changes of the remnant pancreas in the PG group were more severe than those in the PJ group. Furthermore, for patients with a soft pancreas, postoperative body weight changes, prognostic nutritional index, serum total protein levels as well as exocrine test were worse in the PG group, compared with the PJ group. Our results showed that PJ reconstruction might be superior to PG during PD, from the viewpoint of long-term pancreatic exocrine function, although further prospective studies are needed.	[Hirono, Seiko; Tani, Masaji; Kawai, Manabu; Okada, Ken-ichi; Yamaue, Hiroki] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan; [Murakami, Yoshiaki; Uemura, Kenichiro; Sudo, Takeshi; Hashimoto, Yasushi; Nakagawa, Naoya; Kondo, Naru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, Hiroshima 7348551, Japan	Murakami, Y (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	mura777@hiroshima-u.ac.jp; yamaue-h@wakayama-med.ac.jp					Kawai M, 2011, ANN SURG, V253, P495, DOI 10.1097/SLA.0b013e31820d98f1; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Nakamura H, 2009, J GASTROINTEST SURG, V13, P1321, DOI 10.1007/s11605-009-0896-5; Ishikawa O, 2004, SURGERY, V136, P617, DOI 10.1016/j.surg.2004.01.006; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Bassi C, 2005, ANN SURG, V242, P767, DOI 10.1097/01.sla.0000189124.47589.6d; Nakamura H, 2011, J SURG RES, V171, P473, DOI 10.1016/j.jss.2010.03.052; Murakami Y, 2008, J SURG ONCOL, V97, P519, DOI 10.1002/jso.21004; Hirono S, 2009, J GASTROINTEST SURG, V13, P1659, DOI 10.1007/s11605-009-0934-3; Wellner UF, 2012, J GASTROINTEST SURG, V16, P1686, DOI 10.1007/s11605-012-1940-4; Duffas JP, 2005, AM J SURG, V189, P720, DOI 10.1016/j.amjsurg.2005.03.015; Fernandez-Cruz L, 2008, ANN SURG, V248, P930, DOI 10.1097/SLA.0b013e31818fefc7; Fang WL, 2007, PANCREAS, V35, P361; Schiesser M, 2009, SURGERY, V145, P519, DOI 10.1016/j.surg.2009.02.001; Topal B, 2013, LANCET ONCOL, V14, P655, DOI 10.1016/S1470-2045(13)70126-8; YEO CJ, 1995, ANN SURG, V222, P580; Loser C, 1996, GUT, V39, P580, DOI 10.1136/gut.39.4.580; Armstrong T, 2007, PANCREATOLOGY, V7, P37, DOI 10.1159/000101876; Yu HH, 2011, WORLD J SURG, V35, P2110, DOI 10.1007/s00268-011-1170-z; Rault A, 2005, J AM COLL SURGEONS, V201, P239, DOI 10.1016/j.jamcollsurg.2005.03.026; Matsumoto J, 2006, J GASTROINTEST SURG, V10, P1225, DOI 10.1016/j.gassur.2006.08.001; Park JW, 2013, BRIT J SURG, V100, P1064, DOI 10.1002/bjs.9146; Fischer B, 2001, SCAND J GASTROENTERO, V36, P771, DOI 10.1080/003655201300192058; Hyunh H, 2000, PEDIAT GASTROINTESTI, P1515; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; LANKISCH PG, 1986, DIGESTION, V35, P175; Miyakawa S, 2000, HEPATO-GASTROENTEROL, V47, P264; Nakamura H, 2009, SURGERY, V145, P168, DOI 10.1016/j.surg.2008.08.013; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; SZIEGOLEIT A, 1991, GASTROENTEROLOGY, V100, P768; Tomimaru Y, 2009, PANCREAS, V38, P203, DOI 10.1097/MPA.0b013e31818e1772; WATKINS JB, 1982, GASTROENTEROLOGY, V82, P911	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	FEB	2015	39	2					516	525		10.1007/s00268-014-2832-4		10	Surgery	Surgery	AZ4XK	WOS:000348224100033		
J	Moteki, H; Kitoh, R; Tsukada, K; Iwasaki, S; Nishio, SY; Usami, SI				Moteki, Hideaki; Kitoh, Ryosuke; Tsukada, Keita; Iwasaki, Satoshi; Nishio, Shin-Ya; Usami, Shin-Ichi			The advantages of sound localization and speech perception of bilateral electric acoustic stimulation	ACTA OTO-LARYNGOLOGICA			English	Article						High frequency; hearing loss; residual hearing; cochlear implant	TO-PROFOUND DEAFNESS; COCHLEAR IMPLANTATION; HEARING PRESERVATION; AUDITORY-SYSTEM; OUTCOMES; BENEFIT	Conclusion: Bilateral electric acoustic stimulation (EAS) effectively improved speech perception in noise and sound localization in patients with high-frequency hearing loss. Objective: To evaluate bilateral EAS efficacy of sound localization detection and speech perception in noise in two cases of high-frequency hearing loss. Methods: Two female patients, aged 38 and 45 years, respectively, received bilateral EAS sequentially. Pure-tone audiometry was performed preoperatively and postoperatively to evaluate the hearing preservation in the lower frequencies. Speech perception outcomes in quiet and noise and sound localization were assessed with unilateral and bilateral EAS. Results: Residual hearing in the lower frequencies was well preserved after insertion of a FLEX24 electrode (24 mm) using the round window approach. After bilateral EAS, speech perception improved in quiet and even more so in noise. In addition, the sound localization ability of both cases with bilateral EAS improved remarkably.	[Moteki, Hideaki; Kitoh, Ryosuke; Tsukada, Keita; Nishio, Shin-Ya; Usami, Shin-Ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 3908621, Japan; [Iwasaki, Satoshi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 3908621, Japan	Usami, SI (reprint author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	usami@shinshu-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	We thank A.C. Apple-Mathews and Nora Prachar for help in preparing the manuscript. This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (S.U.), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (S.U.).	Adunka OF, 2010, OTOL NEUROTOL, V31, P1049, DOI 10.1097/MAO.0b013e3181d8d6fe; Lorens A, 2008, LARYNGOSCOPE, V118, P288, DOI 10.1097/MLG.0b013e3181598887; Usami SI, 2014, ACTA OTO-LARYNGOL, V134, P717, DOI 10.3109/00016489.2014.894254; Helbig S, 2011, ACTA OTO-LARYNGOL, V131, P585, DOI 10.3109/00016489.2010.544327; Rajan GP, 2012, LARYNGOSCOPE, V122, P190, DOI 10.1002/lary.22142; Adunka OF, 2013, LARYNGOSCOPE, V123, P2509, DOI 10.1002/lary.23741; Dorman MF, 2010, INT J AUDIOL, V49, P912, DOI 10.3109/14992027.2010.509113; Wagner JH, 2010, EUR ARCH OTO-RHINO-L, V267, P1849, DOI 10.1007/s00405-010-1320-1; Olze H, 2012, OTOL NEUROTOL, V33, P1169, DOI 10.1097/MAO.0b013e31825e799f; von Ilberg C, 1999, ORL J OTO-RHINO-LARY, V61, P334, DOI 10.1159/000027695; Skarzynski H, 2007, ACTA OTO-LARYNGOL, V127, P41, DOI 10.1080/00016480500488917; Gstoettner WK, 2008, ACTA OTO-LARYNGOL, V128, P968, DOI 10.1080/00016480701805471; Gstoettner WG, 2009, ACTA OTO-LARYNGOL, V129, P372, DOI 10.1080/00016480802552568; Nopp P, 2004, EAR HEARING, V25, P205, DOI 10.1097/01.AUD.0000130793.20444.50; Punte AK, 2010, ADV OTO-RHINO-LARYNG, V67, P144, DOI 10.1159/000262606; Skarzynski H, 2006, ACTA OTO-LARYNGOL, V126, P934, DOI 10.1080/00016480600606632; Sparreboom M, 2010, OTOL NEUROTOL, V31, P1062, DOI 10.1097/MAO.0b013e3181e3d62c; Tsukada K, 2013, ACTA OTO-LARYNGOL, V133, P1128, DOI 10.3109/00016489.2013.824110; Usami SI, 2011, ACTA OTO-LARYNGOL, V131, P405, DOI 10.3109/00016489.2010.539266; van Schoonhoven J, 2013, OTOL NEUROTOL, V34, P190, DOI 10.1097/MAO.0b013e318278506d	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	FEB	2015	135	2					147	153		10.3109/00016489.2014.951453		7	Otorhinolaryngology	Otorhinolaryngology	AY6XB	WOS:000347705000007		
J	Tachino, H; Fujisaka, M; Fuchizawa, C; Tsubota, M; Takakura, H; Ishida, M; Hayashi, A; Shojaku, H				Tachino, Hirohiko; Fujisaka, Michiro; Fuchizawa, Chiharu; Tsubota, Masahito; Takakura, Hiromasa; Ishida, Masayuki; Hayashi, Atsushi; Shojaku, Hideo			Endonasal flap suture-dacryocystorhinostomy (eFS-DCR): a new surgical technique for nasolacrimal duct obstruction (NLDO)	ACTA OTO-LARYNGOLOGICA			English	Article						Lacrimal sac; needle holder; knot pusher; Nunchaku-style silicone tubes	POWERED ENDOSCOPIC DACRYOCYSTORHINOSTOMY; EXTERNAL DACRYOCYSTORHINOSTOMY	Conclusion: Endonasal flap suture-dacryocystorhinostomy (eFS-DCR) is a new and valuable technique for the treatment of nasolacrimal duct obstruction (NLDO). This technique could improve the success rate of endonasal DCR in comparison to external DCR. Objective: The standard procedure for NLDO is DCR. DCR can be performed via either an external or endonasal approach. External DCR is now regarded as the gold standard in the treatment of NLDO because of its higher success rate. However, we report a new endonasal surgical technique, eFS-DCR, and assess its efficacy by comparison with the standard endonasal DCR. Methods: We prospectively investigated a series of 62 consecutive patients with NLDO undergoing endonasal DCR. There were two surgical intervention groups: group 1 (24 patients, 28 sites) undergoing endonasal DCR without eFS; and group 2 (38 patients, 47 sites) undergoing eFS-DCR. Study end points were success rate, the ostium diameter (OD) of the lacrimal sac after DCR, and the duration of stent placement. We compared the two groups on these three points. Results: The success rate was 78.6% (22 of 28 sites) for group 1 (DCR without eFS) and 97.9% (46 of 47 sites) for group 2 (eFS-DCR). The ostium size in patients in group 2 was larger than that in group 1. The median time for the duration of stent placement was 42.5 days for group 1 and 31.5 days for group 2. There was a statistical difference (p < 0.01) in all these parameters between the two groups.	[Tachino, Hirohiko; Fujisaka, Michiro; Tsubota, Masahito; Takakura, Hiromasa; Ishida, Masayuki; Shojaku, Hideo] Toyama Univ, Dept Otorhinolaryngol Head & Neck Surg, Toyama 9300194, Japan; [Fuchizawa, Chiharu; Hayashi, Atsushi] Toyama Univ, Dept Ophthalmol, Toyama 9300194, Japan	Fujisaka, M (reprint author), Toyama Univ, Dept Otorhinolaryngol Head & Neck Surg, 2630 Sugitani, Toyama 9300194, Japan.	michiro@med.u-toyama.ac.jp					Leong SC, 2010, AMJ RHINOL ALLERGY, V24, P81, DOI 10.2500/ajra.2010.24.3393; Wormald PJ, 2002, LARYNGOSCOPE, V112, P69, DOI 10.1097/00005537-200201000-00013; Janssen AG, 2001, AM J NEURORADIOL, V22, P845; Caldwell GW, 1893, AM J OPHTHALMOL, V10, P189; Callejas CA, 2010, LARYNGOSCOPE, V120, P1449, DOI 10.1002/lary.20916; Cannon PS, 2013, OPHTHALMOLOGY, V120, P1688, DOI 10.1016/j.ophtha.2013.01.023; Chan WO, 2013, OPHTHALMOLOGY, V120, P1693, DOI 10.1016/j.ophtha.2013.01.024; Toti A., 1904, CLIN MOD FIRENZE, V10, P385; Vagefi MR, 2009, OPHTHALMOLOGY, V116, P585, DOI 10.1016/j.ophtha.2008.09.050; Wormald PJ, 2012, BRAZ J OTORHINOLAR, V78, P2, DOI 10.5935/1808-8694.20120025	10	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	FEB	2015	135	2					162	168		10.3109/00016489.2014.968803		7	Otorhinolaryngology	Otorhinolaryngology	AY6XB	WOS:000347705000009		
J	Shinohara, S; Kikuchi, M; Suehiro, A; Kishimoto, I; Harada, H				Shinohara, Shogo; Kikuchi, Masahiro; Suehiro, Atsushi; Kishimoto, Ippei; Harada, Hiroyuki			Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography helpful in the decision-making process for neck dissection in patients with T1-T2 lingual cancer?	ACTA OTO-LARYNGOLOGICA			English	Article						Tongue; squamous cell carcinoma; elective neck dissection; standardized uptake value	SQUAMOUS-CELL CARCINOMA; FINE-NEEDLE-ASPIRATION; ORAL TONGUE CANCER; FDG-PET; INDETERMINATE BIOPSY; METABOLIC BIOPSY; GUIDED CYTOLOGY; TUMOR THICKNESS; METASTASIS; NODE	Conclusion: The usefulness of addition of positron emission tomography/computed tomography (PET/CT) in decisions as to whether to performneck dissection in patients with T1-T2 lingual squamous cell carcinoma (SCC) might be limited, but adding the condition of lymph nodes with a maximum standardized uptake value (SUVmax) >4.5 to existing criteria would be helpful. Objectives: The purpose of this study was to investigate the usefulness of PET/CT for performing neck dissection in patients with T1-T2 lingual SCC. Methods: This retrospective review surveyed 19 patients with T1-T2 lingual SCC who underwent neck dissection after meeting one or more of the following criteria: (1) clinically positive nodes; (2) >4 mm thickness; (3) >= 3 cm longest diameter of the primary tumor. Focal 18F-fluorodeoxyglucose (FDG) uptake was considered to indicate PET-positive nodes (PET + Ns). The relation between pathologically positive nodes (p + Ns) and PET + Ns was estimated. Results: There were 14 PET + Ns at 12 of 66 levels (18%) in 8 of the 19 (42%) patients. There were also 6 p + Ns (1%) among 412 nodes at 5 cervical lymph node levels (8%) in 5 patients (26%). The sensitivity and specificity for PET/CT were 80% and 64%, respectively. The SUVmax was measured, and receiver operating characteristic (ROC) analysis was undertaken to obtain better accuracy. The sensitivity and specificity were 60% and 100% when the SUVmax cut-off value was set at 4.5.	[Shinohara, Shogo; Kikuchi, Masahiro; Suehiro, Atsushi; Kishimoto, Ippei; Harada, Hiroyuki] Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo 6500047, Japan	Shinohara, S (reprint author), Kobe City Med Ctr Gen Hosp, Dept Otolaryngol Head & Neck Surg, Chuo Ku, Minatojima Minamimachi 2-1-1, Kobe, Hyogo 6500047, Japan.	sinosino@kcho.jp			Kasahara Fund for the Promotion of Cancer Research	This study was financially supported by the Kasahara Fund for the Promotion of Cancer Research.	SPIRO RH, 1986, AM J SURG, V152, P345, DOI 10.1016/0002-9610(86)90302-8; Pentenero M, 2008, HEAD NECK-J SCI SPEC, V30, P1488, DOI 10.1002/hed.20906; LYDIATT DD, 1993, HEAD NECK-J SCI SPEC, V15, P308, DOI 10.1002/hed.2880150407; Takes RP, 1996, RADIOLOGY, V198, P819; van den Brekel MWM, 1999, ARCH OTOLARYNGOL, V125, P153; Schoder H, 2006, J NUCL MED, V47, P755; Ng SH, 2005, J NUCL MED, V46, P1136; Sparano A, 2004, OTOLARYNG HEAD NECK, V131, P472, DOI 10.1016/j.otohns.2004.04.008; Haddadin KJ, 1999, HEAD NECK-J SCI SPEC, V21, P517, DOI 10.1002/(SICI)1097-0347(199909)21:6<517::AID-HED4>3.0.CO;2-C; Nieuwenhuis EJC, 2002, HEAD NECK-J SCI SPEC, V24, P282, DOI 10.1002/hed.10018; Yamazaki Y, 2008, ANN NUCL MED, V22, P177, DOI 10.1007/s12149-007-0097-9; Righi PD, 1997, HEAD NECK-J SCI SPEC, V19, P604, DOI 10.1002/(SICI)1097-0347(199710)19:7<604::AID-HED7>3.3.CO;2-K; Kowalski LP, 2002, ARCH OTOLARYNGOL, V128, P58; Murakami R, 2007, INT J RADIAT ONCOL, V68, P377, DOI 10.1016/j.ijrobp.2006.12.032; Asakage T, 1998, CANCER, V82, P1443, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A; ASAKAGE T, 2005, JPN HEAD NECK CANC, V31, P536; Beenken SW, 1999, HEAD NECK-J SCI SPEC, V21, P124, DOI 10.1002/(SICI)1097-0347(199903)21:2<124::AID-HED5>3.0.CO;2-A; Beggs AD, 2002, EUR J NUCL MED MOL I, V29, P542, DOI 10.1007/s00259-001-0736-7; BENNET JA, 2007, ORAL CANC DIAGNOSIS; Hain SF, 2001, EUR J NUCL MED, V28, P1336, DOI 10.1007/s002590100563; vandenBrekel MWM, 1996, RADIOLOGY, V201, P580	21	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	FEB	2015	135	2					181	186		10.3109/00016489.2014.975894		6	Otorhinolaryngology	Otorhinolaryngology	AY6XB	WOS:000347705000012		
J	Karaho, T; Satoh, T; Nakajima, J; Nakayama, T; Kohno, N				Karaho, Takehiro; Satoh, Tetsuya; Nakajima, Junko; Nakayama, Takeshi; Kohno, Naoyuki			Can mano-videoendoscopy substitute for videofluorography in evaluation of upper esophageal sphincter function?	ACTA OTO-LARYNGOLOGICA			English	Article						swallowing study; fluorography; dysphagia	HIGH-RESOLUTION MANOMETRY; BOLUS VOLUME; PHARYNGEAL; PRESSURE; DYSPHAGIA; SWALLOW	Conclusions: Mano-videoendoscopy (MVE), a manometry technique with endoscopic confirmation of the pressure catheter, can supplement the information on upper esophageal sphincter (UES) function, and overcomes the drawbacks of videoendo-scopic swallowing study (VESS). Objectives: This study aimed to investigate the possibility of replacing videofluorographic swallowing study (VFSS) with MVE, as a test to precisely evaluate UES function. Methods: Data from 52 patients with dysphagia were retrospectively reviewed. All patients underwent both MVE and VFSS for evaluation of dysphagia. The manometry was performed with a transnasally inserted catheter (2.6 mm outer diameter and four pressure sensors) under endoscopic observation. The sensors were kept at the tongue base, upper pyriform sinus, apex of pyriform sinus, and UES. We statistically compared the manometric parameters of UES relaxation with fluorographic UES opening. Results: Fluorographic UES opening was diagnosed as good in 34 patients and poor in 18 patients. The nadir pressure, pressure drop, and pressure rise in the UES had significant correlation on the fluorographic UES opening. Stepwise logistic regression test revealed that pressure drop, the gap between the resting pressure and the nadir of UES pressure, was a robust parameter for predicting fluorographic UES opening, and the cut-off level to anticipate good fluorographic opening was >= 33.5 mmHg (specificity, 0.853; sensitivity, 0.759)	[Karaho, Takehiro; Satoh, Tetsuya; Kohno, Naoyuki] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Mitaka, Tokyo 1818611, Japan; [Karaho, Takehiro; Satoh, Tetsuya; Nakajima, Junko; Nakayama, Takeshi; Kohno, Naoyuki] Kyorin Univ Hosp, Swallowing Ctr, Mitaka, Tokyo, Japan; [Nakajima, Junko] Natl Def Med Coll, Dept Oral & Maxillofacial Surg, Tokorozawa, Saitama 359, Japan; [Nakayama, Takeshi] Japan Welf Educ Coll, Shinjuku Ku, Tokyo, Japan	Karaho, T (reprint author), Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	takekaraho@ks.kyorin-u.ac.jp					LANGMORE SE, 1991, ANN OTO RHINOL LARYN, V100, P678; Matsubara K, 2014, LARYNGOSCOPE, V124, P711, DOI 10.1002/lary.24311; Hoffman MR, 2010, LARYNGOSCOPE, V120, P2367, DOI 10.1002/lary.21150; Aviv JE, 2000, LARYNGOSCOPE, V110, P563, DOI 10.1097/00005537-200004000-00008; KAHRILAS PJ, 1988, GASTROENTEROLOGY, V95, P52; Ghosh SK, 2006, AM J PHYSIOL-GASTR L, V291, pG525, DOI 10.1152/ajpgi.00081.2006; Bastian RW, 1993, DYSPHAGIA, V8, P359; Butler SG, 2007, DYSPHAGIA, V22, P367; Butler SG, 2008, DYSPHAGIA, V23, P446; Dodds WJ, 1987, DYSPHAGIA, V1, P209, DOI 10.1007/BF02406919; Karaho T, 2009, DYSPHAGIA, V24, P458; Langmore SE, 2001, ENDOSCOPIC EVALUATIO, P73; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; Lyndon SB, 1975, AM J DIG DIS, V20, P968; Matsumura Y, 2006, J JPN BRONCHOESOPHA, V57, P351; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P71; Mielens JD, 2012, J SPEECH LANG HEAR R, V55, P892, DOI 10.1044/1092-4388(2011/11-0088)	17	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	FEB	2015	135	2					187	192		10.3109/00016489.2014.969384		6	Otorhinolaryngology	Otorhinolaryngology	AY6XB	WOS:000347705000013		
J	Ohashi, K; Sanghvi, T; El-Khoury, GY; Ahn, JM; Bennett, DL; Geijer, M; Inaoka, T; Berbaum, K				Ohashi, Kenjirou; Sanghvi, Tina; El-Khoury, Georges Y.; Ahn, Joong Mo; Bennett, D. Lee; Geijer, Mats; Inaoka, Tsutomu; Berbaum, Kevin			Diagnostic accuracy of 3D color volume-rendered CT images for peroneal tendon dislocation in patients with acute calcaneal fractures	ACTA RADIOLOGICA			English	Article						CT spiral; tendons; adults and pediatrics; technology assessments	MULTIREADER ROC; SUBLUXATION	Background: Use of three-dimensional (3D) color volume-rendered (VR) images has been reported to be more time-efficient compared to that of cross-sectional computed tomography (CT) images for the diagnosis of peroneal tendon dislocation. However, the diagnostic performance of this technique has not been studied. Purpose: To test diagnostic accuracy of 3D color VR CT images of ankle for peroneal tendon dislocation in patients with acute calcaneal fractures. Material and Methods: The study consisted of 121 ankle CT studies from 105 consecutive patients (85 men, 20 women; mean age, 42 years; age range, 16-75 years) with acute calcaneal fractures. Peroneal tendon dislocation was diagnosed on multiplanar CT images by consensus of two experienced musculoskeletal radiologists, which served as the reference standard. Three other musculoskeletal radiologists independently reviewed 3D images alone on a work-station. The readers determined whether or not there was peroneal tendon dislocation using three degrees of certainty (definite, probable, and possible). Diagnostic performance of 3D images for peroneal tendon dislocation was evaluated by calculating the sensitivities, specificities, and area under the receiver-operating characteristic (ROC) curves. Results: Forty-eight (40%) out of 121 studies showed peroneal tendon dislocation based on the expert readings using multiplanar reformatted images. Sensitivities/specificities of 3D images measured 0.92/0.81, 0.88/0.90, and 0.81/0.92 for three readers, respectively. The area under the proper binormal ROC curve based on all three readers (0.93, 0.94, and 0.92) measured 0.93 with a 95% confidence interval of 0.89-0.98. Conclusion: Diagnostic accuracy of 3D images is comparable to, but not as good as that of MPR images for the diagnosis of peroneal tendon dislocation in patients with acute calcaneal fractures.	[Ohashi, Kenjirou; El-Khoury, Georges Y.; Bennett, D. Lee; Berbaum, Kevin] Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA; [Sanghvi, Tina] Univ Florida, Dept Radiol, Gainesville, FL 32610 USA; [Ahn, Joong Mo] Univ Pittsburgh, Dept Radiol, Med Ctr, Pittsburgh, PA 15260 USA; [Geijer, Mats] Skane Univ Hosp, Ctr Med Imaging & Physiol, Dept Radiol, Lund, Sweden; [Inaoka, Tsutomu] Toho Univ, Sakura Med Ctr, Dept Radiol, Sakura, Chiba, Japan	Ohashi, K (reprint author), Univ Iowa Hosp & Clin, Dept Radiol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	kenjirou-ohashi@uiowa.edu		Berbaum, Kevin/0000-0003-0489-2360			Hillis SL, 2008, ACAD RADIOL, V15, P647, DOI 10.1016/j.acra.2007.12.015; BRADLEY SA, 1992, BRIT J RADIOL, V65, P105; Neustadter J, 2004, AM J ROENTGENOL, V183, P985; Rammelt S, 2004, INJURY, V35, P443, DOI 10.1016/j.injury.2003.10.006; Pesce LL, 2007, ACAD RADIOL, V14, P814, DOI 10.1016/j.acra.2007.03.012; Sanders R, 2000, J BONE JOINT SURG AM, V82A, P225; Ho RT, 2001, AM J ROENTGENOL, V177, P1193; Pickhardt PJ, 2004, AM J ROENTGENOL, V183, P429; Ohashi K, 2007, RADIOLOGY, V242, P252, DOI 10.1148/radiol.2421050921; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; ROSENBERG ZS, 1987, AM J ROENTGENOL, V149, P125; Dhillon Mandeep S, 2011, Musculoskelet Surg, V95, P171, DOI 10.1007/s12306-011-0114-y; Hillis SL, 2011, ACAD RADIOL, V18, P129, DOI 10.1016/j.acra.2010.09.007; Ohashi K, 2004, AM J ROENTGENOL, V182, P161; Pelc JS, 2001, AM J ROENTGENOL, V176, P973; ROSENBERG ZS, 1986, RADIOLOGY, V161, P743; Sanders R, 1992, J Orthop Trauma, V6, P252, DOI 10.1097/00005131-199206000-00022; Shellock FG, 1997, JMRI-J MAGN RESON IM, V7, P451, DOI 10.1002/jmri.1880070235; Wechsler RJ, 1998, SKELETAL RADIOL, V27, P1	19	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	FEB	2015	56	2					190	195		10.1177/0284185114522224		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3QE	WOS:000348141000009		
J	Maruyama, M; Yoshizako, T; Uchida, K; Araki, H; Tamaki, Y; Ishikawa, N; Shiina, H; Kitagaki, H				Maruyama, Mitsunari; Yoshizako, Takeshi; Uchida, Koji; Araki, Hisayoshi; Tamaki, Yukihisa; Ishikawa, Noriyuki; Shiina, Hiroaki; Kitagaki, Hajime			Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma	ACTA RADIOLOGICA			English	Article						Urinary; MR diffusion/perfusion; kidney; adults	WEIGHTED MRI; ADC MEASUREMENT; NUCLEAR GRADE; FUHRMAN; INTEROBSERVER; INTRAOBSERVER; NEPHRECTOMY; VARIABILITY; SURVIVAL; LESIONS	Background: There is a significant correlation between tumor size and tumor grade for clear-cell renal cell carcinoma (RCC) in pathology. Thus, apparent diffusion coefficient (ADC) of clear-cell RCC might be influenced by tumor size. Purpose: To compare the utility of tumor size and ADC for distinguishing low-grade from high-grade clear-cell RCC. Material and Methods: Forty-nine patients undergoing preoperative magnetic resonance imaging were retrospectively assessed. ADC values were calculated using b-value combinations of 0 and 800 s/mm(2) at 1.5 T. Two radiologists in consensus measured ADC values via small region of interest (ROI) (mean ROI area, 88.8 mm(2); range, 80-108 mm(2)) placement on an area of solid tumor on a single slice. Maximum tumor diameter was measured at the maximum tumor area. A single pathologist reviewed all pathological slides to determine the nuclear grade according to the Fuhrman classification. The utility of ADC, tumor size, and ADC/size ratio for distinguishing low-grade from high-grade tumors was assessed. Receiver-operating characteristic (ROC) analysis and regression analysis of the each index were performed. The correlation between ADC and tumor size was also investigated. Results: The 49 clear-cell RCC included 34 low-grade and 15 high-grade tumors. The differences of ADC, tumor size, and ADC/size ratio between high-grade and low-grade tumors were statistically significant (P < 0.05). The area under the ROC curve of ADC, tumor size, and ADC/size ratio were 0.802, 0.763, and 0.804 respectively. However, using regression analysis, only ADC (P < 0.05) was statistically significant index as independent risk factors for high-grade clear-cell RCC. Moreover, weak significant correlation was observed between tumor size and ADC (R-2 = 0.3865, P < 0.01). Conclusion: There was a weak significant correlation between tumor size and ADC value of clear-cell RCC. Using ROC and regression analysis, ADC was statistically significant index for distinguishing low-grade from high-grade clear-cell RCC more than tumor size and ADC/size ratio.	[Maruyama, Mitsunari; Yoshizako, Takeshi; Uchida, Koji; Araki, Hisayoshi; Tamaki, Yukihisa; Kitagaki, Hajime] Shimane Univ, Fac Med, Dept Radiol, Matsue, Shimane, Japan; [Ishikawa, Noriyuki] Shimane Univ, Fac Med, Dept Organ Pathol, Matsue, Shimane, Japan; [Shiina, Hiroaki] Shimane Univ, Fac Med, Dept Urol, Matsue, Shimane, Japan	Yoshizako, T (reprint author), Shimane Univ, Fac Med, Dept Radiol, POB 00693-8501,89-1 Enya Izumo, Matsue, Shimane, Japan.	yosizako@med.shimane-u.ac.jp					Lang H, 2005, CANCER, V103, P625, DOI 10.1002/cncr.20812; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Minardi D, 2005, J UROLOGY, V174, P1208, DOI 10.1097/01.ju.0000173078.57871.2d; Beck SDW, 2004, ANN SURG ONCOL, V11, P71, DOI 10.1245/ASO.2004.06.016; Yoshikawa T, 2006, AM J ROENTGENOL, V187, P1521, DOI 10.2214/AJR.05.0778; Zhang JB, 2008, RADIOLOGY, V247, P458, DOI 10.1148/radiol.2472070823; Goyal A, 2012, ACTA RADIOL, V53, P349, DOI 10.1258/ar.2011.110415; Bektas S, 2009, KAOHSIUNG J MED SCI, V25, P596, DOI 10.1016/S1607-551X(09)70562-5; Yu XD, 2012, EUR J RADIOL, V81, P3061, DOI 10.1016/j.ejrad.2012.04.028; Reuter VE, 2006, SEMIN ONCOL, V33, P534, DOI 10.1053/j.seminoncol.2006.06.009; Zhang CJ, 2012, BJU INT, V110, pE481, DOI 10.1111/j.1464-410X.2012.11173.x; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Al-Aynati M, 2003, ARCH PATHOL LAB MED, V127, P593; Tamada T, 2008, J MAGN RESON IMAGING, V28, P720, DOI 10.1002/jmri.21503; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Cova M, 2004, BRIT J RADIOL, V77, P851, DOI 10.1259/bjr/26525081; Eble JN, 2004, PATHOLOGY GENETICS T; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449; Kunkle DA, 2009, SEMIN ULTRASOUND CT, V30, P352, DOI 10.1053/j.sult.2009.03.002; Lohse CM, 2002, AM J CLIN PATHOL, V118, P877, DOI 10.1092/5PWP08HKHX0LY56L; Rosenkrantz AB, 2010, AM J ROENTGENOL, V195, P344; Sanchez-Martin FM, 2008, ADV UROL, DOI [10.1155/2008/310694, DOI 10.1155/2008/310694]; Squillaci E, 2004, J EXP CLIN CANC RES, V23, P39	25	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	FEB	2015	56	2					250	256		10.1177/0284185114523268		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3QE	WOS:000348141000017		
J	Seto, H; Yoneda, T; Morii, T; Hoshino, Y; Miura, Y; Murakami, T				Seto, Hirokazu; Yoneda, Tamami; Morii, Takato; Hoshino, Yu; Miura, Yoshiko; Murakami, Tatsuya			Membrane Reactor Immobilized with Palladium-Loaded Polymer Nanogel for Continuous-Flow Suzuki Coupling Reaction	AICHE JOURNAL			English	Article						polymer nanogel particles; membrane reactor; continuous-flow system; catalytic reaction; palladium	MIZOROKI-HECK REACTION; INCARCERATED PALLADIUM; ALLYLIC SUBSTITUTION; ORGANIC-SYNTHESIS; PD NANOPARTICLES; AQUEOUS-MEDIA; IONIC LIQUID; CATALYST; WATER; HYDROGENATION	A catalytic membrane reactor, which was immobilized with palladium-loaded nanogel particles (NPs), was developed for continuous-flow Suzuki coupling reaction. Palladium-loaded membranes were prepared by immobilization of NPs, adsorption of palladium ions, and reduction into palladium(0). The presence of palladium in the membrane was confirmed by the scanning electron microscopy; palladium aggregation was not observed. The catalytic activity of the membrane reactor in continuous-flow Suzuki coupling reaction was approximately double that of a comparable reactor in which palladium ions were directly adsorbed onto an aminated membrane. This was attributed to the formation of small palladium particles. The reusability in the continuous-flow system was higher than that in a batch system, and the palladium-loaded membrane reactor had high long-term stability. (c) 2014 American Institute of Chemical Engineers AIChE J, 61: 582-589, 2015	[Seto, Hirokazu; Yoneda, Tamami; Morii, Takato; Hoshino, Yu; Miura, Yoshiko] Kyushu Univ, Grad Sch Engn, Dept Chem Engn, Nishi Ku, Fukuoka 8190395, Japan; [Murakami, Tatsuya] Japan Adv Inst Sci & Technol, Ctr Nano Mat & Technol, Nomi, Ishikawa 9231292, Japan	Miura, Y (reprint author), Kyushu Univ, Grad Sch Engn, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	miuray@chem-eng.kyushu-u.ac.jp			 [25.5206];  [24655157];  [23685027]	This work was supported by a Grant-in-Aid for JSPS Fellows (25.5206), a Grant-in-Aid for Challenging Exploratory Research (24655157), and a Grant-in-Aid for Young Scientists (A) (23685027).	Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368; Balanta A, 2011, CHEM SOC REV, V40, P4973, DOI 10.1039/c1cs15195a; Fujii S, 2010, LANGMUIR, V26, P6230, DOI 10.1021/la9039545; Akiyama R, 2003, J AM CHEM SOC, V125, P3412, DOI 10.1021/ja029146j; Noel T, 2011, CHEM SOC REV, V40, P5010, DOI 10.1039/c1cs15075h; Kidambi S, 2004, J AM CHEM SOC, V126, P2658, DOI 10.1021/ja038804c; Yamada YMA, 2010, CHEM-EUR J, V16, P11311, DOI 10.1002/chem.201000511; Hoshino Y, 2012, J AM CHEM SOC, V134, P15209, DOI 10.1021/ja306053s; Suzuki A, 2011, ANGEW CHEM INT EDIT, V50, P6722, DOI 10.1002/anie.201101379; Crudden CM, 2005, J AM CHEM SOC, V127, P10045, DOI 10.1021/ja0430954; Hagio H, 2006, ORG LETT, V8, P375, DOI 10.1021/ol052310y; THOMMES J, 1995, BIOTECHNOL PROGR, V11, P357; Roucoux A, 2002, CHEM REV, V102, P3757, DOI 10.1021/cr010350j; Jas G, 2003, CHEM-EUR J, V9, P5708, DOI 10.1002/chem.200305212; Hagiwara H, 2004, ORG LETT, V6, P2325, DOI 10.1021/ol049343i; Yamada YMA, 2012, J AM CHEM SOC, V134, P3190, DOI 10.1021/ja210772v; Uozumi Y, 2004, TOP CURR CHEM, V242, P77, DOI 10.1007/b96874; Uozumi Y, 2006, J AM CHEM SOC, V128, P15994, DOI 10.1021/ja066697r; Bhandari R, 2012, LANGMUIR, V28, P8110, DOI 10.1021/la3015404; Danjo H, 1999, TETRAHEDRON, V55, P14341, DOI 10.1016/S0040-4020(99)00883-2; Diederich F., 1998, METAL CATALYZED CROS; Hagiwara H, 2005, CHEM COMMUN, P2942, DOI 10.1039/b502528a; Jia CJ, 2011, PHYS CHEM CHEM PHYS, V13, P2457, DOI 10.1039/c0cp02680h; Kobayashi S, 2013, PURE APPL CHEM, V85, P1089, DOI 10.1351/PAC-CON-12-10-11; Li HL, 2012, MICROFLUID NANOFLUID, V12, P981, DOI 10.1007/s10404-011-0932-0; Nishio R, 2005, ORG LETT, V7, P4831, DOI 10.1021/ol051526x; Ohtaka A, 2011, CATAL LETT, V141, P1097, DOI 10.1007/s10562-011-0630-2; Okamoto K, 2004, ORG LETT, V6, P1987, DOI 10.1021/ol049429b; Okamoto K, 2004, J ORG CHEM, V69, P2871, DOI 10.1021/jo0358527; Park SJ, 2007, LANGMUIR, V23, P10902, DOI 10.1021/la7021903; Seto H, 2013, CHEM LETT, V42, P301, DOI 10.1246/cl.2013.301; Uozumi Y, 1998, TETRAHEDRON LETT, V39, P8303, DOI 10.1016/S0040-4039(98)01812-7; Wei GW, 2008, J PHYS CHEM C, V112, P10827, DOI 10.1021/jp800741t; Wiles C, 2008, EUR J ORG CHEM, P1655, DOI 10.1002/ejoc.200701041	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	FEB	2015	61	2					582	589		10.1002/aic.14653		8	Engineering, Chemical	Engineering	AZ1ZG	WOS:000348033200016		
J	Otsuka, A; Kabashima, K				Otsuka, A.; Kabashima, K.			Mast cells and basophils in cutaneous immune responses	ALLERGY			English	Review						allergic contact dermatitis; atopic dermatitis; basophil; mast cell	DELAYED-TYPE HYPERSENSITIVITY; CHRONIC ALLERGIC INFLAMMATION; CHRONIC IDIOPATHIC URTICARIA; ATOPIC-DERMATITIS; IN-VIVO; T-CELLS; DENDRITIC CELLS; CONTACT HYPERSENSITIVITY; LANGERHANS CELLS; STEADY-STATE	Mast cells and basophils share some functions in common and are generally associated with T helper 2 (Th2) immune responses, but taking basophils as surrogate cells for mast cell research or vice versa for several decades is problematic. Thus far, their in vitro functions have been well studied, but their in vivo functions remained poorly understood. New research tools for their functional analysis in vivo have revealed previously unrecognized roles for mast cells and basophils in several skin disorders. Newly developed mast cell-deficient mice provided evidence that mast cells initiate contact hypersensitivity via activating dendritic cells. In addition, studies using basophil-deficient mice have revealed that basophils were responsible for cutaneous Th2 skewing to haptens and peptide antigens but not to protein antigens. Moreover, human basophils infiltrate different skin lesions and have been implicated in the pathogenesis of skin diseases ranging from atopic dermatitis to autoimmune diseases. In this review, we will discuss the recent advances related to mast cells and basophils in human and murine cutaneous immune responses.	[Otsuka, A.; Kabashima, K.] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Kabashima, K.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Kabashima, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Shogoin Kawara, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare of Japan. Dr Kabashima is the winner of PhARF (Phadia Allergy Research Forum) Award 2013. http://www.phadia.com/en/Allergy-Blood-Testing/Learn-more/PhARF/Award-2013/.	Alenius H, 2002, J ALLERGY CLIN IMMUN, V109, P106, DOI 10.1067/mai.2002.120553; Dudeck A, 2011, EUR J IMMUNOL, V41, P1883, DOI 10.1002/eji.201040994; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; SWOPE VB, 1994, J INVEST DERMATOL, V102, P749, DOI 10.1111/1523-1747.ep12376970; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Abboud G, 2009, J IMMUNOL, V182, P6517, DOI 10.4049/jimmunol.0801055; Ravinal RC, 2005, LUPUS, V14, P814, DOI 10.1191/0961203305lu2188oa; Yukawa S, 2013, MOD RHEUMATOL, V23, P1151, DOI 10.1007/s10165-012-0813-8; Niyonsaba F, 2010, J IMMUNOL, V184, P3526, DOI 10.4049/jimmunol.0900712; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; KATZ SI, 1978, J INVEST DERMATOL, V71, P70, DOI 10.1111/1523-1747.ep12544415; Kolb HJ, 2013, BLOOD, V122, P3556, DOI 10.1182/blood-2013-09-527705; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Suto H, 2006, J IMMUNOL, V176, P4102; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; CRISP AJ, 1984, J ROY SOC MED, V77, P450; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; GALLI SJ, 1984, SCIENCE, V226, P710, DOI 10.1126/science.6494907; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Dawicki W, 2010, J IMMUNOL, V184, P2116, DOI 10.4049/jimmunol.0803894; Kojima T, 2007, J IMMUNOL, V179, P7093; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Gan PY, 2012, J AM SOC NEPHROL, V23, P1955, DOI 10.1681/ASN.2012060572; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Kitawaki T, 2006, INT IMMUNOL, V18, P1789, DOI 10.1093/intimm/dxl113; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Yasnowsky KM, 2006, J ALLERGY CLIN IMMUN, V117, P1430, DOI 10.1016/j.jaci.2006.02.016; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Jawdat DM, 2004, J IMMUNOL, V173, P5275; Musch W, 2008, GENESIS, V46, P163, DOI 10.1002/dvg.20378; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Aroni K, 2008, ARCH DERMATOL RES, V300, P125, DOI 10.1007/s00403-007-0816-z; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Eckman JA, 2008, J INVEST DERMATOL, V128, P1956, DOI 10.1038/jid.2008.55; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; MEKORI YA, 1985, J IMMUNOL, V135, P879; Charlesworth EN, 1997, ALLERGY, V52, P31; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Kneilling M, 2007, ARTHRITIS RHEUM, V56, P1806, DOI 10.1002/art.22602; Otsuka A, 2008, J IMMUNOL, V181, P8528; Hammad H, 2003, J IMMUNOL, V171, P3936; Yu N, 2009, J DERMATOL SCI, V56, P113, DOI 10.1016/j.jdermsci.2009.08.003; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; PUDDINGTON L, 1994, IMMUNITY, V1, P733, DOI 10.1016/S1074-7613(94)80015-4; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Raap U, 2008, J ALLERGY CLIN IMMUN, V122, P421, DOI 10.1016/j.jaci.2008.05.047; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Moniaga CS, 2010, AM J PATHOL, V176, P2385, DOI 10.2353/ajpath.2010.090957; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; ROTHE MJ, 1990, J AM ACAD DERMATOL, V23, P615, DOI 10.1016/0190-9622(90)70264-I; Harvima IT, 2008, ARCH DERMATOL RES, V300, P461, DOI 10.1007/s00403-008-0874-x; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Badertscher K, 2005, ARCH DERMATOL RES, V296, P503, DOI 10.1007/s00403-005-0542-3; BASCOM R, 1988, Journal of Allergy and Clinical Immunology, V81, P580, DOI 10.1016/0091-6749(88)90198-4; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Hennino A, 2006, CLIN REV ALLERG IMMU, V30, P3, DOI 10.1385/CRIAI:30:1:003; Honda T, 2011, J DERMATOL SCI, V61, P144, DOI 10.1016/j.jdermsci.2010.11.001; Jiang WY, 2001, INT J DERMATOL, V40, P699, DOI 10.1046/j.1365-4362.2001.01262.x; Kopfnagel V, 2013, CURR OPIN ALLERGY CL, V13, P531, DOI 10.1097/ACI.0b013e328364ddfd; LICHTENSTEIN LM, 1991, ANN NY ACAD SCI, V629, P48; Migalovich-Sheikhet H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00238; Morshed M, 2014, J IMMUNOL, V192, P5314, DOI 10.4049/jimmunol.1303418; Mukai K, 2012, BLOOD, V120, P76, DOI 10.1182/blood-2011-12-399113; Nakahigashi Kyoko, 2013, Case Rep Dermatol, V5, P48, DOI 10.1159/000348650; Oiwa M, 2008, CLIN EXP ALLERGY, V38, P1357, DOI 10.1111/j.1365-2222.2008.03007.x; Otsuka A, 2013, J ALLERGY CLIN IMMUN, V133, P139; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Otsuka A, 2011, EUR J DERMATOL, V21, P816, DOI 10.1684/ejd.2011.1470; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Otsuka A, 2011, BRIT J DERMATOL, V164, P455, DOI 10.1111/j.1365-2133.2010.10083.x; Otsuka A, 2013, ACTA DERM-VENEREOL, V93, P88, DOI 10.2340/00015555-1329; Otsuka A, 2012, J EUR ACAD DERMATOL, V26, P527, DOI 10.1111/j.1468-3083.2011.04091.x; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Poulsen BC, 2012, J IMMUNOL METHODS, V381, P66, DOI 10.1016/j.jim.2012.04.009; RICHERSO.HB, 1970, J EXP MED, V132, P546, DOI 10.1084/jem.132.3.546; Schneider E, 2010, EUR CYTOKINE NETW, V21, P142, DOI 10.1684/ecn.2010.0197; Urb M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002619; Voehringer D, 2008, J IMMUNOL, V180, P4742; Voskamp AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081777; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; WINTROUB BU, 1978, NEW ENGL J MED, V298, P417, DOI 10.1056/NEJM197802232980803; Ying S, 2002, J ALLERGY CLIN IMMUN, V109, P694, DOI 10.1067/mai.2002.123236	106	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	FEB	2015	70	2					131	140		10.1111/all.12526		10	Allergy; Immunology	Allergy; Immunology	AZ0UM	WOS:000347960300001		
J	Tsuruya, K; Yoshida, H; Kuroki, Y; Nagata, M; Mizumasa, T; Mitsuiki, K; Yoshiura, T; Hirakawa, M; Kanai, H; Hori, K; Hirakata, H; Kitazono, T				Tsuruya, Kazuhiko; Yoshida, Hisako; Kuroki, Yusuke; Nagata, Masaharu; Mizumasa, Tohru; Mitsuiki, Koji; Yoshiura, Takashi; Hirakawa, Makoto; Kanai, Hidetoshi; Hori, Kei; Hirakata, Hideki; Kitazono, Takanari			Brain Atrophy in Peritoneal Dialysis and CKD Stages 3-5: A Cross-sectional and Longitudinal Study	AMERICAN JOURNAL OF KIDNEY DISEASES			English	Article						Chronic kidney disease (CKD); gray matter volume (GMV); white matter volume (WMV); magnetic resonance imaging (MRI); peritoneal dialysis (PD); brain atrophy; brain volume	VOXEL-BASED MORPHOMETRY; CHRONIC-HEMODIALYSIS PATIENTS; AMBULATORY BLOOD-PRESSURE; MILD ALZHEIMERS-DISEASE; CHRONIC KIDNEY-DISEASE; COGNITIVE IMPAIRMENT; NOCTURNAL HYPERTENSION; CEREBRAL ATROPHY; LOBE ATROPHY; RISK-FACTORS	Background: Brain atrophy has been reported in patients with end-stage renal disease receiving hemodialysis, although its mechanism is unknown. However, little is known regarding brain atrophy in patients receiving peritoneal dialysis (PD). Therefore, we examined brain volume and its annual change over 2 years in PD patients compared with patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Study Design: Cross-sectional and longitudinal cohort. Setting & Participants: 62 PD patients and 69 patients with NDD-CKD with no history of cerebrovascular disease who underwent brain magnetic resonance imaging (MRI) were recruited in a cross-sectional study. Among them, 34 PD patients and 61 patients with NDD-CKD, who underwent a second brain MRI after 2 years, were recruited in a longitudinal study. Predictor: PD therapy versus NDD-CKD. Outcomes & Measurements: T1-weighted magnetic resonance images were analyzed. Total gray matter volume (GMV), total white matter volume (WMV), and cerebrospinal fluid space volume were segmented, and each volume was quantified using statistical parametric mapping software. Normalized GMV and WMV values were calculated by division of GMV and WMV by intracranial volume to adjust for variations in head size. We compared normalized GMV and normalized WMV between PD patients and patients with NDD-CKD in the cross-sectional study and the annual change in normalized GMV in the longitudinal study. Results: In the cross-sectional study, normalized GMV, which was correlated inversely with age, was lower in PD patients than in patients with NDD-CKD. However, normalized WMV, which was not correlated with age, was comparable between the groups. Annual change in normalized GMV was significantly higher in PD patients than in patients with NDD-CKD. These differences remained significant even after adjustment for potential confounding factors. Limitations: A short observation period and high dropout rate in the longitudinal study. Conclusions: Decline in normalized GMV is faster in PD patients than in patients with NDD-CKD. (C) 2015 by the National Kidney Foundation, Inc.	[Tsuruya, Kazuhiko; Yoshida, Hisako] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 8128582, Japan; [Tsuruya, Kazuhiko; Nagata, Masaharu; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Kuroki, Yusuke; Mitsuiki, Koji; Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan; [Kuroki, Yusuke; Mitsuiki, Koji; Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Dialysis Ctr, Fukuoka, Japan; [Mizumasa, Tohru] Kyushu Cent Hosp, Dept Internal Med, Div Nephrol, Fukuoka, Japan; [Yoshiura, Takashi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 8128582, Japan; [Hirakawa, Makoto] Harasanshin Hosp, Div Nephrol, Fukuoka, Japan; [Kanai, Hidetoshi] Kokura Mem Hosp, Dept Internal Med, Div Nephrol, Kitakyushu, Fukuoka, Japan; [Hori, Kei] Munakata Med Assoc Hosp, Kidney Ctr, Munakata, Japan	Tsuruya, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp					Hicks J, 2007, DIABETES CARE, V30, P2399, DOI 10.2337/dc07-9925; Mummery CJ, 2000, ANN NEUROL, V47, P36; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7; Nagai M, 2008, J HYPERTENS, V26, P1636, DOI 10.1097/HJH.0b013e3283018333; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143; Hajjar I, 2010, AM J HYPERTENS, V23, P17, DOI 10.1038/ajh.2009.187; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Stebbins GT, 2008, STROKE, V39, P785, DOI 10.1161/STROKEAHA.107.507392; Kim CD, 2007, AM J KIDNEY DIS, V50, P98, DOI 10.1053/j.ajkd.2007.03.019; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Yakushiji Y, 2010, HYPERTENS RES, V33, P1232, DOI 10.1038/hr.2010.171; Christodoulou C, 2003, NEUROLOGY, V60, P1793; Yoshimitsu T, 2000, CLIN NEPHROL, V53, P445; Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Baron JC, 2001, NEUROIMAGE, V14, P298, DOI 10.1006/nimg.2001.0848; Lipsitz LA, 2000, STROKE, V31, P1897; Fujisaki K, 2014, NEPHROL DIAL TRANSPL, V29, P529, DOI 10.1093/ndt/gft327; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Plum J, 2001, NEPHROL DIAL TRANSPL, V16, P2378, DOI 10.1093/ndt/16.12.2378; Kalirao P, 2011, AM J KIDNEY DIS, V57, P612, DOI 10.1053/j.ajkd.2010.11.026; Chen YC, 2009, NEPHRON CLIN PRACT, V113, pC112, DOI 10.1159/000228543; Drew DA, 2013, AM J KIDNEY DIS, V61, P271, DOI 10.1053/j.ajkd.2012.08.035; Goldstein IB, 2002, NEUROLOGY, V59, P713; Heijer Tom den, 2003, Neurobiol Aging, V24, P307, DOI 10.1016/S0197-4580(02)00088-X; HIRAKATA H, 1992, AM J PHYSIOL, V262, pF737; Tamura MK, 2011, CLIN J AM SOC NEPHRO, V6, P248, DOI 10.2215/CJN.02660310; MULEC H, 1995, DIABETOLOGIA, V38, P216, DOI 10.1007/BF00400097; Savazzi GM, 1999, NEPHRON, V81, P17, DOI 10.1159/000045240; Taki Y, 2011, NEUROBIOL AGING, V32, P907, DOI 10.1016/j.neurobiolaging.2009.05.003; Uzu T, 1996, HYPERTENSION, V28, P139; van Biesen W, 2013, NEPHROL DIAL TRANSPL, V28, P2620, DOI 10.1093/ndt/gft296; Yoshida H, 2013, COMPUT MATH METHOD M, V2013	39	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0272-6386	1523-6838		AM J KIDNEY DIS	Am. J. Kidney Dis.	FEB	2015	65	2					312	321		10.1053/j.ajkd.2014.07.011		10	Urology & Nephrology	Urology & Nephrology	AZ4MT	WOS:000348196400018		
J	Nakajima, M; Inoue, T; Kato, H; Nangaku, M				Nakajima, Minami; Inoue, Tsuyoshi; Kato, Hideki; Nangaku, Masaomi			Pseudo-Acute Kidney Injury Secondary to Intravenous Dexamethasone	AMERICAN JOURNAL OF KIDNEY DISEASES			English	Letter									[Nakajima, Minami; Inoue, Tsuyoshi; Kato, Hideki; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Nakajima, M (reprint author), Univ Tokyo, Grad Sch Med, Tokyo, Japan.						Akers MJ, 2002, J PHARM SCI, V91, P2283, DOI 10.1002/jps.10154; Darby D, 2012, ANN CLIN BIOCHEM, V49, P292, DOI 10.1258/acb.2011.011114; Makiishi Tetsuya, 2011, Nihon Jinzo Gakkai Shi, V53, P200; MITCHELL RT, 1985, AM J CLIN PATHOL, V84, P251; SHERMAN RA, 1981, CLIN THER, V4, P114	5	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0272-6386	1523-6838		AM J KIDNEY DIS	Am. J. Kidney Dis.	FEB	2015	65	2					344	344		10.1053/j.ajkd.2014.09.020		1	Urology & Nephrology	Urology & Nephrology	AZ4MT	WOS:000348196400026		
J	Suehiro, K; Tanaka, K; Yamada, T; Matsuura, T; Funao, T; Mori, T; Nishikawa, K				Suehiro, K.; Tanaka, K.; Yamada, T.; Matsuura, T.; Funao, T.; Mori, T.; Nishikawa, K.			The utility of intra-operative three-dimensional transoesophageal echocardiography for dynamic measurement of stroke volume	ANAESTHESIA			English	Article							LEFT-VENTRICULAR VOLUMES; CARDIAC MAGNETIC-RESONANCE; PULMONARY-ARTERY THERMODILUTION; RANDOMIZED CONTROLLED-TRIAL; 2-DIMENSIONAL ECHOCARDIOGRAPHY; EJECTION FRACTION; HOSPITAL STAY; 3D ECHOCARDIOGRAPHY; ESOPHAGEAL DOPPLER; FLUID MANAGEMENT	Measurement of left ventricular stroke volume and cardiac output is very important for managing haemodynamically unstable or critically ill patients. The aims of this study were to compare stroke volume measured by three-dimensional transoesophageal echocardiography with stroke volume measured using a pulmonary artery catheter, and to examine the ability of three-dimensional transoesophageal echocardiography to track stroke volume changes induced by haemodynamic interventions. This study included 40 cardiac surgery patients. Haemodynamic variables were measured before and 2min after haemodynamic interventions, which consisted of phenylephrine 100g or ephedrine 5mg. We used Bland-Altman analysis to assess the agreement between the stroke volume measured by three-dimensional transoesophageal echocardiography and by the pulmonary artery catheter. Polar-plot and 4-quadrant plot analyses were used to assess the trending ability of three-dimensional transoesophageal echocardiography compared with the pulmonary artery catheter. Bias and percentage error were -1.2ml and 20%, respectively. The concordance rate in the 4-quadrant analysis after phenylephrine and ephedrine administration was 75% and 84%, respectively. In the polar-plot analysis, the angular concordance rate was 66% and 73% after phenylephrine and ephedrine administration, respectively. Three-dimensional transoesophageal echocardiography was clinically acceptable for measuring stroke volume; however, it was not sufficiently reliable for tracking stroke volume changes after haemodynamic interventions.	[Suehiro, K.; Tanaka, K.; Yamada, T.; Matsuura, T.; Funao, T.; Mori, T.; Nishikawa, K.] Osaka City Univ, Grad Sch Med, Dept Anaesthesiol, Osaka 558, Japan	Tanaka, K (reprint author), Osaka City Univ, Grad Sch Med, Dept Anaesthesiol, Osaka 558, Japan.	katsuakitanakakatsuaki@gmail.com					American Society of Anesthesiologists Task Force on Pulmonary Artery Catheterization, 2003, ANESTHESIOLOGY, V99, P988; Chukwu EO, 2008, J AM SOC ECHOCARDIOG, V21, P990, DOI 10.1016/j.echo.2008.07.009; Grocott MPW, 2005, ANESTH ANALG, V100, P1093, DOI 10.1213/01.ANE.0000148691.33690.AC; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; Dorosz JL, 2012, J AM COLL CARDIOL, V59, P1799, DOI 10.1016/j.jacc.2012.01.037; Bein B, 2004, J CARDIOTHOR VASC AN, V18, P185, DOI 10.1053/j.jvca.2004.01.025; Venn R, 2002, BRIT J ANAESTH, V88, P65, DOI 10.1093/bja/88.1.65; Chang SA, 2011, J AM SOC ECHOCARDIOG, V24, P853, DOI 10.1016/j.echo.2011.04.015; Critchley LAH, 1999, J CLIN MONITOR COMP, V15, P85, DOI 10.1023/A:1009982611386; Soliman OII, 2007, J AM SOC ECHOCARDIOG, V20, P1042, DOI 10.1016/j.echo.2007.02.011; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Sinclair S, 1997, BRIT MED J, V315, P909; Muraru D, 2010, EUR J ECHOCARDIOGR, V11, P359, DOI 10.1093/ejechocard/jep217; Gutierrez-Chico JL, 2005, AM J CARDIOL, V95, P809, DOI 10.1016/j.amjcard.2004.11.046; Soliman OII, 2007, ECHOCARDIOGR-J CARD, V24, P967, DOI 10.1111/j.1540-8175.2007.00502.x; Hare JL, 2008, HEART, V94, P440, DOI 10.1136/hrt.2007.123570; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Aranda M, 1998, ANESTHESIOLOGY, V89, P1592, DOI 10.1097/00000542-199812000-00047; Bhavsar R, 2012, ACTA ANAESTH SCAND, V56, P730, DOI 10.1111/j.1399-6576.2012.02655.x; Bicudo LS, 2008, ECHOCARDIOGR-J CARD, V25, P717, DOI 10.1111/j.1540-8175.2008.00684.x; BLAND JM, 1986, LANCET, V1, P307; Fleming SM, 2005, AM J CARDIOL, V95, P308, DOI 10.1016/j.amjcard.2004.08.101; Hansegard J, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-18; Macron L, 2010, CIRC-CARDIOVASC IMAG, V3, P450, DOI 10.1161/CIRCIMAGING.109.925966; Meris A, 2014, ANESTH ANALG, V118, P711, DOI 10.1213/ANE.0000000000000093; Moller-Sorensen H, 2014, ACTA ANAESTH SCAND, V58, P80, DOI 10.1111/aas.12227; Siegel LC, 1996, ANESTH ANALG, V83, P1173, DOI 10.1097/00000539-199612000-00007; Skubas NJ, 2014, ANESTH ANALG, V118, P698, DOI 10.1213/ANE.0000000000000135; Wakeling HG, 2005, BRIT J ANAESTH, V95, P634, DOI 10.1093/bja/aei223	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	FEB	2015	70	2					150	159		10.1111/anae.12857		10	Anesthesiology	Anesthesiology	AZ0OH	WOS:000347944100007		
J	Hoshino, H; Obata, H; Nakajima, K; Mieda, R; Saito, S				Hoshino, Hajime; Obata, Hideaki; Nakajima, Kunie; Mieda, Rie; Saito, Shigeru			The Antihyperalgesic Effects of Intrathecal Bupropion, a Dopamine and Noradrenaline Reuptake Inhibitor, in a Rat Model of Neuropathic Pain	ANESTHESIA AND ANALGESIA			English	Article							PERIPHERAL-NERVE INJURY; SPINAL-CORD; NUCLEUS-ACCUMBENS; ANTINOCICEPTIVE ACTIONS; STIMULATION; HYPERALGESIA; NOCICEPTION; RECEPTORS; CLONIDINE; ANALGESIA	BACKGROUND: Antidepressants are often used for the treatment of neuropathic pain, and their analgesic effects rely on increased noradrenaline and serotonin levels in the spinal cord. Clinical studies have also shown that bupropion, a dopamine and noradrenaline reuptake inhibitor, has strong efficacy in neuropathic pain; however, the role of spinal cord dopamine in neuropathic pain is unknown. We hypothesized that bupropion inhibits neuropathic pain by increasing noradrenaline and dopamine in the spinal cord. In the present study, we determined the efficacy and underlying mechanisms of intrathecal administration of bupropion in a rat model of neuropathic pain. METHODS: Male Sprague-Dawley rats were anesthetized, and right L5 spinal nerve ligation (SNL) was performed to produce mechanical hyperalgesia of the hindpaw. Withdrawal threshold to a paw pressure test was measured before and after intrathecal administration of bupropion, without or with intrathecal antagonists for alpha(2)-adrenoceptors and dopamine D-2 receptors. In vivo microdialysis was performed in the dorsal horn of the lumbar spinal cord to measure noradrenaline and dopamine concentrations after intrathecal injection of bupropion. We also measured the noradrenaline and dopamine contents in the ipsilateral dorsal lumbar spinal cord in normal rats and in rats 2, 3, and 4 weeks after SNL. RESULTS: Intrathecal injection of bupropion produced a dose-dependent antihyperalgesic effect (3, 10, 30, and 100 mu g, P < 0.001). The effect (30 mu g) was dose-dependently reversed by intrathecal pretreatment (15 minutes before bupropion injection) with the alpha(2)-adrenoceptor antagonist idazoxan (3, 10, and 30 mu g, P < 0.001) and D2 receptor antagonist sulpiride (3, 10, and 30 mu g, P < 0.001). Microdialysis revealed that noradrenaline and dopamine concentrations in the spinal dorsal horn were increased after intrathecal injection of bupropion (30 mu g, P < 0.001 and P = 0.001, respectively). Furthermore, the noradrenaline and dopamine contents in the spinal dorsal horn were increased 2 weeks after SNL (P < 0.001 and P = 0.044, respectively) and then decreased gradually. CONCLUSIONS: These findings suggest that plasticity of descending inhibitory pathways such as the noradrenaline and dopamine systems contributes to the maintenance of neuropathic pain and that spinal cord noradrenaline and dopamine both play an inhibitory role in neuropathic pain.	[Hoshino, Hajime; Obata, Hideaki; Nakajima, Kunie; Mieda, Rie; Saito, Shigeru] Gunma Univ, Grad Sch Med, Dept Anesthesiol, Maebashi, Gumma 3718511, Japan	Obata, H (reprint author), Gunma Univ, Grad Sch Med, Dept Anesthesiol, 3-39-22 Showa, Maebashi, Gumma 3718511, Japan.	hobata@gunma-u.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology of Japan (Tokyo, Japan) [20591823, 42791578, 24791581]	This work was supported by Grants-in-Aid for Scientific Research (grant number 20591823 to HO, 42791578 to RM, and 24791581 to KN) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (Tokyo, Japan).	AKIL H, 1975, BRAIN RES, V94, P279, DOI 10.1016/0006-8993(75)90062-1; Hughes SW, 2013, PAIN, V154, P1680, DOI 10.1016/j.pain.2013.05.010; Sindrup SH, 2005, BASIC CLIN PHARMACOL, V96, P399, DOI 10.1111/j.1742-7843.2005.pto_96696601.x; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Bantel C, 2005, BRAIN RES, V1038, P76, DOI 10.1016/j.brainres.2005.01.016; FERRIS RM, 1981, DRUG DEVELOP RES, V1, P21, DOI 10.1002/ddr.430010103; BARASI S, 1985, EUR J PHARMACOL, V117, P287, DOI 10.1016/0014-2999(85)90001-9; Ansah OB, 2007, EXP NEUROL, V205, P536, DOI 10.1016/j.expneurol.2007.03.010; Eisenach JC, 2005, NEUROSCIENCE, V131, P189, DOI 10.1016/j.neuroscience.2004.10.017; Hayashida KI, 2008, PAIN, V136, P348, DOI 10.1016/j.pain.2007.07.014; Potvin S, 2009, SYNAPSE, V63, P390, DOI 10.1002/syn.20616; Taylor BK, 2003, BRAIN RES, V987, P135, DOI 10.1016/S0006-8993(03)03318-3; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; COOPER BR, 1994, NEUROPSYCHOPHARMACOL, V11, P133; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; KIM SH, 1992, PAIN, V50, P355; Paqueron X, 2003, ANESTHESIOLOGY, V99, P199, DOI 10.1097/00000542-200307000-00030; Magnusson JE, 2000, BRAIN RES, V855, P260, DOI 10.1016/S0006-8993(99)02396-3; Semenchuk MR, 2001, NEUROLOGY, V57, P1583; Nakajima K, 2012, PAIN, V153, P990, DOI 10.1016/j.pain.2012.01.029; LIN Y, 1989, BRAIN RES, V479, P306, DOI 10.1016/0006-8993(89)91633-8; Kimura M, 2012, NEUROSCI LETT, V529, P70, DOI 10.1016/j.neulet.2012.08.008; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; Gao X, 2000, EUR J PHARMACOL, V406, P53, DOI 10.1016/S0014-2999(00)00649-X; Greco R, 2008, BRAIN RES, V1238, P215, DOI 10.1016/j.brainres.2008.08.022; Hayashida KI, 2008, ANESTHESIOLOGY, V109, P1077, DOI 10.1097/ALN.0b013e31818dac9c; Holstege JC, 1996, J COMP NEUROL, V376, P631, DOI 10.1002/(SICI)1096-9861(19961223)376:4<631::AID-CNE10>3.0.CO;2-P; JENSEN TS, 1984, BRAIN RES, V296, P285, DOI 10.1016/0006-8993(84)90064-7; Jesse CR, 2010, PSYCHOPHARMACOLOGY, V212, P513, DOI 10.1007/s00213-010-1977-6; Koyanagi S, 2008, ANESTH ANALG, V106, P1904, DOI 10.1213/ane.0b013e318172b15b; NOMIKOS GG, 1989, NEUROPSYCHOPHARMACOL, V2, P273, DOI 10.1016/0893-133X(89)90031-6; Obata H, 2005, ANESTHESIOLOGY, V102, P657, DOI 10.1097/00000542-200503000-00027; Obata H, 2010, J PHARMACOL EXP THER, V334, P1059, DOI 10.1124/jpet.110.168336; Pedersen LH, 2005, PSYCHOPHARMACOLOGY, V182, P551, DOI 10.1007/s00213-005-0120-6	37	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	FEB	2015	120	2					460	466		10.1213/ANE.0000000000000540		7	Anesthesiology	Anesthesiology	AZ3PG	WOS:000348138700025		
J	Ikeda, M; Katayama, S; Sunagawa, H				Ikeda, Masahiro; Katayama, Soichiro; Sunagawa, Hideaki			Null Structure in a System of Quadratic Derivative Nonlinear Schrodinger Equations	ANNALES HENRI POINCARE			English	Article							KLEIN-GORDON SYSTEMS; ONE SPACE DIMENSION; SMALL AMPLITUDE SOLUTIONS; GLOBAL EXISTENCE; ELASTIC-WAVES; 2D; REGULARITY	We consider the initial value problem for a three-component system of quadratic derivative nonlinear Schrodinger equations in two space dimensions with the masses satisfying the resonance relation. We present a structural condition on the nonlinearity under which small data global existence holds. It is also shown that the solution is asymptotically free. Our proof is based on the commuting vector field method combined with smoothing effects.	[Ikeda, Masahiro] Tohoku Univ, Math Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Katayama, Soichiro] Wakayama Univ, Dept Math, Wakayama 6408510, Japan; [Sunagawa, Hideaki] Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Ikeda, M (reprint author), Tohoku Univ, Math Inst, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	m-ikeda@math.tohoku.ac.jp; katayama@center.wakayama-u.ac.jp; sunagawa@math.sci.osaka-u.ac.jp			JSPS [23540241, 25400161]	The work of S.K. is partially supported by JSPS, Grant-in-Aid for Scientific Research (C) (No. 23540241). The work of H.S. is partially supported by JSPS, Grant-in-Aid for Scientific Research (C) (No. 25400161).	Colin M, 2009, ANN I H POINCARE-AN, V26, P2211, DOI 10.1016/j.anihpc.2009.01.011; Colin M, 2004, DIFFER INTEGRAL EQU, V17, P297; Sunagawa H, 2003, J DIFFER EQUATIONS, V192, P308, DOI 10.1016/S0022-0396(03)00125-6; Chihara H, 1999, MATH ANN, V315, P529, DOI 10.1007/s002080050328; Hayashi N, 2012, COMMUN PART DIFF EQ, V37, P947, DOI 10.1080/03605302.2012.668256; Ozawa T, 2013, J MATH ANAL APPL, V399, P147, DOI 10.1016/j.jmaa.2012.10.003; Hayashi N, 2011, DIFFER INTEGRAL EQU, V24, P417; Agemi R, 2000, INVENT MATH, V142, P225, DOI 10.1007/s002220000084; Bernal-Vilchis F, 2011, NODEA-NONLINEAR DIFF, V18, P329, DOI 10.1007/s00030-011-0098-1; Chihara H., 1995, MATH JPN, V42, P35; CHIHARA H, 1994, J MATH KYOTO U, V34, P353; CHRISTODOULOU D, 1986, COMMUN PUR APPL MATH, V39, P267, DOI 10.1002/cpa.3160390205; Delort JM, 2004, J FUNCT ANAL, V211, P288, DOI 10.1016/j.jfa.2004.01.008; Delort J.-M., 2002, MEM SOC MATH FR; DOI S, 1994, J MATH KYOTO U, V34, P319; Friedman A, 1969, PARTIAL DIFFERENTIAL; GEORGIEV V, 1990, MATH Z, V203, P683, DOI 10.1007/BF02570764; Germain P, 2012, J MATH PURE APPL, V97, P505, DOI 10.1016/j.matpur.2011.09.008; Hayashi N., 2002, INT J PURE APPL MATH, V3, P255; Hayashi N, 2012, COMMUN PART DIFF EQ, V37, P732, DOI 10.1080/03605302.2011.626099; Hayashi N, 1997, COMMUN PART DIFF EQ, V22, P773, DOI 10.1080/03605309708821283; Hayashi N, 2008, SIAM J MATH ANAL, V40, P278, DOI 10.1137/070689103; Hayashi N., 2011, DIFFER EQU APPL, V3, P415; Hormander L., 1997, LECT NONLINEAR HYPER; John F., 1990, FORMATION SINGULARIT, V2; Katayama S, 2012, COMMUN PUR APPL MATH, V65, P1285, DOI 10.1002/cpa.21392; Katayama S, 2014, DIFFER INTEGRAL EQU, V27, P301; KATAYAMA S, 1994, COMMUN PART DIFF EQ, V19, P1971, DOI 10.1080/03605309408821079; Kawahara Y, 2011, J DIFFER EQUATIONS, V251, P2549, DOI 10.1016/j.jde.2011.04.001; Kawahara Y, 2006, P JPN ACAD A-MATH, V82, P117, DOI 10.3792/pjaa.82.117; KENIG CE, 1993, ANN I H POINCARE-AN, V10, P255; Klainerman S., 1986, LECTURES APPL MATH, V23, P293; Mizohata S, 1973, THEORY PARTIAL DIFFE; Racke R., 1992, ASPECTS MATH E; Sideris TC, 1996, INVENT MATH, V123, P323, DOI 10.1007/s002220050030; Sunagawa H, 2006, OSAKA J MATH, V43, P771; TSUTSUMI Y, 1994, INDIANA U MATH J, V43, P241, DOI 10.1512/iumj.1994.43.43012; Tsutsumi Y., 2003, FUNKC EKVACIOJ-SER I, V46, P41, DOI 10.1619/fesi.46.41	38	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1424-0637	1424-0661		ANN HENRI POINCARE	Ann. Henri Poincare	FEB	2015	16	2					535	567		10.1007/s00023-014-0316-6		33	Physics, Multidisciplinary; Physics, Particles & Fields; Physics, Mathematical	Physics	AZ6BA	WOS:000348301900005		
J	Bischoff, M; Tanimoto, Y				Bischoff, Marcel; Tanimoto, Yoh			Integrable QFT and Longo-Witten Endomorphisms	ANNALES HENRI POINCARE			English	Article							QUANTUM-FIELD-THEORY; SIDED MODULAR INCLUSIONS; VON-NEUMANN-ALGEBRAS; FORMFACTOR PROGRAM; LOCALIZATION; MODEL; OPERATORS; THEOREM	Our previous constructions of Borchers triples are extended to massless scattering with nontrivial left and right components. A massless Borchers triple is constructed from a set of left-left, right-right and left-right scattering functions. We find a correspondence between massless left-right scattering S-matrices and massive block diagonal S-matrices. We point out a simple class of S-matrices with examples. We study also the restriction of two-dimensional models to the lightray. Several arguments for constructing strictly local two-dimensional nets are presented and possible scenarios are discussed.	[Bischoff, Marcel] Univ Gottingen, Inst Theoret Phys, D-37077 Gottingen, Germany; [Tanimoto, Yoh] Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan	Bischoff, M (reprint author), Univ Gottingen, Inst Theoret Phys, Friedrich Hund Pl 1, D-37077 Gottingen, Germany.	bischoff@theorie.physik.uni-goettingen.de; hoyt@ms.u-tokyo.ac.jp			German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) by the DFG Research Training Group 1493 "Mathematical Structures in Modern Quantum Physics"; ERC [227458 OACFT]; Deutscher Akademischer Austauschdienst; Hausdorff Institut fur Mathematik; Alexander von Humboldt Stiftung	Marcel Bischoff supported by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) by the DFG Research Training Group 1493 "Mathematical Structures in Modern Quantum Physics". Supported in part by the ERC Advanced Grant 227458 OACFT "Operator Algebras and Conformal Field Theory".; Yoh Tanimoto supported by Deutscher Akademischer Austauschdienst until August 2012, by Hausdorff Institut fur Mathematik until December 2012, by Alexander von Humboldt Stiftung until March 2013 and by Grant-in-Aid for JSPS fellows 25-205 since April 2013.	Abdalla E., 2001, NONPERTURBATIVE METH; Alday LF, 2010, LETT MATH PHYS, V91, P167, DOI 10.1007/s11005-010-0369-5; Brunetti R, 2002, REV MATH PHYS, V14, P759, DOI 10.1142/S0129055X02001387; Lechner G, 2013, LETT MATH PHYS, V103, P421, DOI 10.1007/s11005-012-0599-9; Dybalski W, 2011, COMMUN MATH PHYS, V305, P427, DOI 10.1007/s00220-010-1173-x; Mackay NJ, 2005, INT J MOD PHYS A, V20, P7189, DOI 10.1142/S0217751X05022317; Estienne B, 2012, NUCL PHYS B, V860, P377, DOI 10.1016/j.nuclphysb.2012.03.007; Lechner G, 2008, COMMUN MATH PHYS, V277, P821, DOI 10.1007/s00220-007-0381-5; Araki H, 2005, REV MATH PHYS, V17, P491, DOI 10.1142/S0129055X05002388; BERNARD D, 1993, NUCL PHYS B, V399, P709, DOI 10.1016/0550-3213(93)90515-Q; BERNARD D, 1992, PHYS LETT B, V279, P78, DOI 10.1016/0370-2693(92)91844-Y; Bischoff M, 2013, COMMUN MATH PHYS, V317, P667, DOI 10.1007/s00220-012-1593-x; Bischoff M., 2012, THESIS U ROMA TOR VE; Borchers HJ, 1997, LETT MATH PHYS, V40, P371, DOI 10.1023/A:1007396816791; BORCHERS HJ, 1992, COMMUN MATH PHYS, V143, P315, DOI 10.1007/BF02099011; Bostelmann H, 2011, REV MATH PHYS, V23, P1115, DOI 10.1142/S0129055X11004539; BUCHHOLZ D, 1975, COMMUN MATH PHYS, V45, P1, DOI 10.1007/BF01609862; Buchholz D, 2004, ANN HENRI POINCARE, V5, P1065, DOI 10.1007/s00023-004-0190-8; CHERNOFF PR, 1970, B AM MATH SOC, V76, P395, DOI 10.1090/S0002-9904-1970-12489-2; Chernoff P.R., 1974, MEMOIRS AM MATH SOC, V140; Chernoff P.R., 1968, J FUNCT ANAL, V2, P238, DOI 10.1016/0022-1236(68)90020-7; DELFINO G, 1995, PHYS REV D, V51, pR6620; DRIESSLER W, 1977, ANN I H POINCARE A, V27, P221; Fendley P., 1994, ICTP SERIES THEORETI, V10, P301; Guido D, 1998, COMMUN MATH PHYS, V192, P217, DOI 10.1007/s002200050297; Haag R., 1996, TEXTS MONOGRAPHS PHY; Lechner G., 2006, ARXIVMATHPH0611050; Lechner G., 2014, ANN HENRI POINCARE, V14, P645; Lechner G, 2003, LETT MATH PHYS, V64, P137, DOI 10.1023/A:1025772304804; Longo R, 2011, COMMUN MATH PHYS, V303, P213, DOI 10.1007/s00220-010-1133-5; Mejean P, 1997, INT J MOD PHYS A, V12, P3383, DOI 10.1142/S0217751X97001778; Nakayashiki A, 2004, COMMUN MATH PHYS, V245, P279, DOI 10.1007/s00220-003-1013-3; Quella T., 1999, THESIS FREIE U BERLI; Reed M., 1980, METHODS MODERN MATH; Reed M., 1975, METHODS MODERN MATH, V2; Schroer B, 1999, ANN PHYS-NEW YORK, V275, P190, DOI 10.1006/aphy.1999.5921; Schroer B, 1997, NUCL PHYS B, V499, P547, DOI 10.1016/S0550-3213(97)00359-3; Schroer B, 2005, ANN PHYS-NEW YORK, V319, P48, DOI 10.1016/j.aop.2005.03.002; Smirnov F.A., 1992, ADV SERIES MATH PHYS, V14; Takesaki M., 2003, ENCYCL MATH SCI, V125; Tanimoto Y., 2014, FORUM MATH IN PRESS; Tanimoto Y, 2012, COMMUN MATH PHYS, V314, P419, DOI 10.1007/s00220-012-1439-6; Tanimoto Y, 2012, COMMUN MATH PHYS, V314, P443, DOI 10.1007/s00220-012-1462-7; WIESBROCK HW, 1993, COMMUN MATH PHYS, V157, P83, DOI 10.1007/BF02098019; Wiesbrock HW, 1998, COMMUN MATH PHYS, V193, P269, DOI 10.1007/s002200050329; ZAMOLODCHIKOV AB, 1992, NUCL PHYS B, V379, P602, DOI 10.1016/0550-3213(92)90136-Y; Zinn-Justin J., 1993, INT SERIES MONOGRAPH, V85	47	3	3	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1424-0637	1424-0661		ANN HENRI POINCARE	Ann. Henri Poincare	FEB	2015	16	2					569	608		10.1007/s00023-014-0337-1		40	Physics, Multidisciplinary; Physics, Particles & Fields; Physics, Mathematical	Physics	AZ6BA	WOS:000348301900006		
J	Zhang, J; Shen, XZ; Fujihara, Y; Sano, T; Yamamoto, T; Nakajima, K				Zhang, Jian; Shen, Xiuzhong; Fujihara, Yasuyuki; Sano, Tadafumi; Yamamoto, Toshihiro; Nakajima, Ken			Experimental study on the safety of Kyoto University Research Reactor at natural circulation cooling mode	ANNALS OF NUCLEAR ENERGY			English	Article						KUR (Kyoto University Research Reactor); Experimental study on research reactor; Natural circulation cooling capacity; Temperature measurements; Conservative safety assessment	CORE	In this study, the natural circulation cooling capacity of Kyoto University Research Reactor (KUR) is experimentally investigated by measuring the inlet and outlet temperatures of the core under natural circulation operation at various thermal powers ranging from 10 kW to 100 kW and the shutdown state. In view of the uneven power distribution and the resultant inconsistent coolant outlet temperature in the core, eight measuring points located separately in the outlet of the fuel elements were chosen to investigate the distribution of the outlet temperature of the core. The natural circulation cooling capacity represented by the average natural circulation flow velocity in the core is calculated from the temperature difference between the outlet and inlet temperature of the core. The measured outlet temperature of the fuel elements shows a cross-sectional distribution agreeing with the distribution of the thermal output of the fuel elements in the core. Since the measured outlet temperatures decrease quickly in the flow direction in a small local region above the outlet of the core, the mixing of the hot water out of the core with the cold water around the core outlet is found to happen in the small region not more than 5 cm far from the core outlet. The natural circulation flow velocity in the core increases non-linearly with the thermal power. The safety of KUR has been analysed by conservatively estimating the highest coolant temperature, the highest fuel cladding temperature, the highest fuel meat temperature and the minimum DNBR under all of the normal operations with natural circulation cooling mode. The natural circulation operation at the thermal power of 100 kW is the most serious operating condition. The average natural circulation flow velocity at the thermal power of 100 kW is 3.13 cm/s. All of these estimated parameters under normal natural circulation operation meet the safety criterion of research reactor. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Jian; Shen, Xiuzhong; Fujihara, Yasuyuki; Sano, Tadafumi; Yamamoto, Toshihiro; Nakajima, Ken] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	Zhang, J (reprint author), Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan.	zhang@rri.kyoto-u.ac.jp					Shibata K, 2002, J NUCL SCI TECHNOL, V39, P1125, DOI 10.3327/jnst.39.1125; Shen XZ, 2013, ANN NUCL ENERGY, V62, P195, DOI 10.1016/j.anucene.2013.06.014; Collier J.G., 1972, CONVECTIVE BOILING C; Glasstone S., 1963, NUCL REACTOR ENG; Kaminaga M, 1996, 08208 JAERI; Kaminaga M, 1994, JAERIM94052; Kyoto University Research Reactor Institute (KURRI), 2008, KUR INST CHANG APPR; Nakajima K., 2010, KURRITR440; Shen X., 2010, KURRITR442; Shen XZ, 2002, NUCL ENG DES, V217, P103, DOI 10.1016/S0029-5493(02)00154-1; Sudo Y., 1984, JAERIM84066; Sugimoto M., 1969, KURRITR72; YU Pingan, 2002, NUCL REACTOR THERMAL	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	FEB	2015	76						410	420		10.1016/j.anucene.2014.10.010		11	Nuclear Science & Technology	Nuclear Science & Technology	AY7QW	WOS:000347755100043		
J	Yamamoto, T				Yamamoto, Toshihiro			Higher harmonic analyses of the Cf-252 source driven noise analysis method	ANNALS OF NUCLEAR ENERGY			English	Article						Noise analysis; Cf-252; Higher harmonics; Monte Carlo; Subcriticality	POWER SPECTRAL DENSITY; SPALLATION NEUTRON SOURCE; FEYNMAN-ALPHA METHOD; ORDER MODE ANALYSES; MONTE-CARLO; SUBCRITICAL MEASUREMENTS; PLUTONIUM SPHERE; PARAMETERS; SYSTEM	A theoretical formula has been derived to reconstruct the ratio of spectral densities in the Cf-252 source driven noise analysis (CSDNA) method from the higher harmonic eigenvalues and eigenfunctions of the alpha-mode neutron transport equations. The formula closely reproduces each power spectral density and the ratio of spectral densities calculated by Monte Carlo simulations, thereby verifying the theoretical formula. The reactivity or k(eff) of a subcritical system is related to the ratio of spectral densities by the fundamental mode approximation in which the higher harmonic modes are neglected. However, the ratio of spectral densities measured in the CSDNA method yields an ambiguous reactivity or k(eff) that depends on the locations of detectors due to the effect of the higher harmonics. A more elaborate method developed by Mihalczo and Valentine et al. infers an "experimental" k(eff) using a measurement and accurate Monte Carlo simulation of CSDNA. This paper discusses the uniqueness of the inferred "experimental" k(eff). (C) 2014 Elsevier Ltd. All rights reserved.	Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	Yamamoto, T (reprint author), Kyoto Univ, Inst Res Reactor, 2 Asashiro Nishi, Osaka 5900494, Japan.	toshihiro.yamamoto223@gmail.com					AKCASU AZ, 1993, NUCL SCI ENG, V113, P31; Blakeman E.D., 2008, INT HDB EVALUATED CR; Blakeman E.D., 2006, INT HDB EVALUATED CR; DIFILIPPO FC, 1990, NUCL SCI ENG, V104, P123; Endo T, 2006, ANN NUCL ENERGY, V33, P521, DOI 10.1016/j.anucene.2006.02.002; FICARO EP, 1994, NUCL SCI ENG, V117, P158; Hutchinson J, 2009, NUCL SCI ENG, V161, P357; Hutchinson JD, 2009, NUCL SCI ENG, V163, P285; Mihalczo JT, 1997, NUCL SAFETY, V38, P10; MIHALCZO JT, 1991, NUCL SCI ENG, V107, P35; MIHALCZO JT, 1978, NUCL SCI ENG, V66, P29; Mihalczo JT, 1995, NUCL SCI ENG, V121, P286; MIHALCZO JT, 1990, NUCL SCI ENG, V104, P314; Pare V.K., 1975, NUCL SCI ENG, V57, P213; Perez R.B., 1997, P JOINT INT C MATH M; Spriggs GD, 1999, ANN NUCL ENERGY, V26, P237, DOI 10.1016/S0306-4549(98)00048-6; SUTTON TM, 1991, ANN NUCL ENERGY, V18, P491, DOI 10.1016/0306-4549(91)90094-E; Uhrig R.E, 1970, RANDOM NOISE TECHNIQ; Valentine T.E, 2000, INT HDB EVALUATED CR; Valentine T.E., 1997, ANN NUCL ENERGY, V24, P78; Valentine TE, 1996, ANN NUCL ENERGY, V23, P1271, DOI 10.1016/0306-4549(96)00004-7; Valentine T.E, 2003, INT HDB EVALUATED CR; Valentine T.E, 1999, ORNLTM199928; Yamamoto T, 2014, ANN NUCL ENERGY, V63, P711, DOI 10.1016/j.anucene.2013.09.024; Yamamoto T., 2011, PROGR NUCL SCI TECHN, V2, P826; Yamamoto T, 2011, ANN NUCL ENERGY, V38, P1231, DOI 10.1016/j.anucene.2011.02.017; Yamamoto T, 2014, ANN NUCL ENERGY, V66, P63, DOI 10.1016/j.anucene.2013.12.002; YAMANE Y, 1986, J ATOM ENERG SOC JPN, V28, P850; Yamane Y., 1987, P INT SEM NUCL CRIT	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	FEB	2015	76						521	529		10.1016/j.anucene.2014.10.034		9	Nuclear Science & Technology	Nuclear Science & Technology	AY7QW	WOS:000347755100055		
J	Nemoto, H; Ito, Y; Kasai, Y; Maruyama, N; Kimura, N; Sumiya, N				Nemoto, Hitoshi; Ito, Yoshinori; Kasai, Yoshiaki; Maruyama, Naoki; Kimura, Naohiro; Sumiya, Noriyoshi			Orbital Floor Reconstruction With Ethyl-2-Cyanoacrylate	ANNALS OF PLASTIC SURGERY			English	Article						orbital floor fracture; blowout fracture; orbital floor reconstruction; cyanoacrylate; glue; ethyl-2-cyanoacrylate; autologous bone graft	CYANOACRYLATE TISSUE ADHESIVE; ETHYL-CYANOACRYLATE; CONTACT-DERMATITIS; BONE-GRAFTS; FRACTURES; FIXATION; SURGERY; GLUE; ANASTOMOSIS; HISTOACRYL	The orbital floor is one of the most frequently broken bones in maxillofacial fracture, and orbital reconstruction is needed in many cases. Various materials are used for orbital floor reconstruction. We report here orbital reconstruction using autologous orbital bone with cyanoacrylate. Entrapped soft tissues were freed and repositioned intraorbitally and bone fragments were gathered with a microscope simultaneously. The bone fragments were fixed to a board of bone with ethyl-2-cyanoacrylate and returned to the orbital fracture site. Of 96 fresh orbital floor fractures, this method was used for 31 (32.3%) patients. Simple reduction was performed in 48 patients. Bone graft with iliac crest was performed in the other 12 patients. Reconstruction with alloplastic materials was performed in 5 patients. Diplopia was corrected in 26 patients on whom this method was performed. The reconstructed bone collapsed into the maxillary sinus in 1 patient who underwent iliac bone graft on reoperation. Another 4 patients did not show diplopia preoperatively. None of the patients showed enophthalmos, foreign body reaction, or infection postoperatively. We were able to perform orbital bone reconstruction with autologous orbital bone without another donor site in 30 (62.5%) of 48 cases that required grafting. The indications for this method are that a sufficient quantity of bone fragments can be obtained and returned on a board of bone which can be stabilized in the orbit without collapsing into the maxillary sinus. Good results were obtained, and we consider this to be a safe and useful method.	[Nemoto, Hitoshi; Ito, Yoshinori; Kasai, Yoshiaki; Maruyama, Naoki; Kimura, Naohiro; Sumiya, Noriyoshi] Showa Univ, Sch Med, Dept Plast & Reconstruct Surg, Fujigaoka Hosp, Yokohama, Kanagawa 2278501, Japan	Nemoto, H (reprint author), Showa Univ, Fujigaoka Hosp, Dept Plast & Reconstruct Surg, Sch Med,Aoba Ku, 1-30 Fujigaoka, Yokohama, Kanagawa 2278501, Japan.	hitoshi_nemo@yahoo.co.jp					AMARANTE MTJ, 1995, PLAST RECONSTR SURG, V95, P639; TRAIL IA, 1992, J HAND SURG-BRIT EUR, V17B, P544, DOI 10.1016/S0266-7681(05)80239-6; Magana FG, 2011, J CRANIOFAC SURG, V22, P1991, DOI 10.1097/SCS.0b013e3182319615; Courtney DJ, 2000, BRIT J ORAL MAX SURG, V38, P496, DOI 10.1054/bjom.2000.0500; TORIUMI DM, 1990, ARCH OTOLARYNGOL, V116, P546; Kontio RK, 2006, PLAST RECONSTR SURG, V118, P1365, DOI 10.1097/01.prs.0000244519.26368.4c; BELSITO DV, 1987, CONTACT DERMATITIS, V17, P234, DOI 10.1111/j.1600-0536.1987.tb02719.x; BOVINO JA, 1990, AM J OPHTHALMOL, V109, P616; BRUZE M, 1995, CONTACT DERMATITIS, V32, P156, DOI 10.1111/j.1600-0536.1995.tb00806.x; Conde-Salazar L, 1998, Am J Contact Dermat, V9, P188, DOI 10.1016/S1046-199X(98)90024-0; Esteves JC, 2011, J APPL ORAL SCI, V19, P529, DOI 10.1590/S1678-77572011000500016; Farion KJ, 2003, ACAD EMERG MED, V10, P110, DOI 10.1111/j.1553-2712.2003.tb00027.x; Gonzalez E, 2000, SURG NEUROL, V53, P288, DOI 10.1016/S0090-3019(00)00180-4; Gul Rehan, 2006, Acta Orthop Belg, V72, P641; HARSHA BC, 1986, J ORAL MAXIL SURG, V44, P11, DOI 10.1016/0278-2391(86)90008-X; Isaksson M, 2007, Contact Dermatitis, V57, P346, DOI 10.1111/j.1600-0536.2007.01133.x; Johnson PE, 1999, PLAST RECONSTR SURG, V103, P1709, DOI 10.1097/00006534-199905060-00023; KAMER FM, 1989, ARCH OTOLARYNGOL, V115, P193; Kaplan M, 2004, EUR J CARDIO-THORAC, V25, P167, DOI 10.1016/j.ejcts.2003.11.016; KOPP SK, 1985, ANN INTERN MED, V102, P613; Manson PN, 2006, MATHES PLASTIC SURG, V3, P77; MEHTA MJ, 1987, J ORAL MAXIL SURG, V45, P393, DOI 10.1016/0278-2391(87)90006-1; Rickett T, 2009, J BIOMED MATER RES A, V90A, P750, DOI 10.1002/jbm.a.32137; ROBICSEK F, 1994, J CARDIAC SURG, V9, P353, DOI 10.1111/j.1540-8191.1994.tb00855.x; SACHS ME, 1985, ARCH OTOLARYNGOL, V111, P389; Saska S, 2009, INT J ORAL MAX SURG, V38, P180, DOI 10.1016/j.ijom.2008.12.004; Shermak MA, 1998, PLAST RECONSTR SURG, V102, P319, DOI 10.1097/00006534-199808000-00004; TAKENAKA H, 1992, SURG TODAY, V22, P46; Thomsen G F, 1994, Ugeskr Laeger, V156, P5131; Wiecko J, 1980, Polim Med, V10, P165; ZALTA AH, 1991, BRIT J OPHTHALMOL, V75, P170, DOI 10.1136/bjo.75.3.170	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	FEB	2015	74	2					195	198		10.1097/SAP.0b013e3182956596		4	Surgery	Surgery	AZ3SD	WOS:000348146100013		
J	Miyamoto, S; Kayano, S; Fujiki, M; Kamizono, K; Fukunaga, Y; Sakuraba, M				Miyamoto, Shimpei; Kayano, Shuji; Fujiki, Masahide; Kamizono, Kenichi; Fukunaga, Yutaka; Sakuraba, Minoru			Flow-Through Divided Latissimus Dorsi Musculocutaneous Flap for Large Extremity Defects	ANNALS OF PLASTIC SURGERY			English	Article						latissimus dorsi; flow-through; divided; sliding; extremity reconstruction	ANTEROLATERAL THIGH FLAP; RECONSTRUCTION; ANATOMY; SYSTEM; PEDICLE	Reconstructing large defects of the extremities is a challenging problem for reconstructive microsurgeons. The latissimus dorsi musculocutaneous flap (LDMCF) is widely used for this purpose, but a skin graft is needed when the defect is wider than available flaps. We used flow-through divided LDMCFs to reconstruct large defects of the extremities in 5 consecutive patients from 2010 through 2012. The semicircular skin island was split longitudinally, and 1 skin island was advanced over the other to close a round or oval defect without a skin graft. Postoperatively, all flaps survived completely, and the mean Enneking score was 90.0%. The flow-through divided LDMCF is a reliable and versatile option for reconstructing large defects of the extremities.	[Miyamoto, Shimpei; Kayano, Shuji] Natl Canc Ctr, Div Plast & Reconstruct Surg, Tokyo 1040045, Japan; [Fujiki, Masahide; Kamizono, Kenichi; Fukunaga, Yutaka; Sakuraba, Minoru] Natl Canc Ctr Hosp East, Div Plast & Reconstruct Surg, Kashiwa, Chiba, Japan	Miyamoto, S (reprint author), Natl Canc Ctr, Div Plast & Reconstruct Surg, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	shimiyam@ncc.go.jp					Sofiadellis F, 2012, J RECONSTR MICROSURG, V28, P333, DOI 10.1055/s-0032-1313764; Seitz A, 1999, CELLS TISSUES ORGANS, V164, P227, DOI 10.1159/000016663; Miyamoto S, 2008, PLAST RECONSTR SURG, V122, P449, DOI 10.1097/PRS.0b013e31817d62c5; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Nasir S, 2010, ANN PLAS SURG, V65, P164, DOI 10.1097/SAP.0b013e3181e57cb3; Demirtas Y, 2010, MICROSURG, V30, P24, DOI 10.1002/micr.20696; Yokota K, 2011, J RECONSTR MICROSURG, V27, P109, DOI 10.1055/s-0030-1268209; Kawamura K, 2005, PLAST RECONSTR SURG, V116, P1082, DOI 10.1097/01.prs.0000178791.85118.ca; Lakhiani C, 2012, PLAST RECONSTR SURG, V130, P1254, DOI 10.1097/PRS.0b013e31826d1662; Arya R, 2012, J PLAST RECONSTR AES, V65, P1660, DOI 10.1016/j.bjps.2012.06.003; Bullocks J, 2006, MICROSURG, V26, P439, DOI 10.1002/micr.20268; Katsuragi Y, 2010, J PLAST RECONSTR AES, V63, pE543, DOI 10.1016/j.bjps.2009.11.017; Lin CH, 2006, PLAST RECONSTR SURG, V117, P2478, DOI 10.1097/01.prs.0000219133.72059.71; Maia M, 2011, PLAST RECONSTR SURG, V127, P1206, DOI 10.1097/PRS.0b013e318205f2f7; Marsh DJ, 2010, J PLAST RECONSTR AES, V63, P120, DOI 10.1016/j.bjps.2008.08.022; Masuoka T, 2007, PLAST RECONSTR SURG, V119, P1136, DOI 10.1097/01.prs.0000253560.32940.28; ROUANET P, 1994, ANN PLAS SURG, V33, P418, DOI 10.1097/00000637-199410000-00011; Sawaizumi M, 1997, ANN PLAS SURG, V38, P41, DOI 10.1097/00000637-199701000-00008; WELLISZ T, 1993, ANN PLAS SURG, V30, P405, DOI 10.1097/00000637-199305000-00003	19	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	FEB	2015	74	2					199	203		10.1097/SAP.0b013e3182996eaa		5	Surgery	Surgery	AZ3SD	WOS:000348146100014		
J	Mitsukawa, N; Saiga, A; Akita, S; Kubota, Y; Kuriyama, M; Satoh, K				Mitsukawa, Nobuyuki; Saiga, Atsuomi; Akita, Shinsuke; Kubota, Yoshitaka; Kuriyama, Motone; Satoh, Kaneshige			Two-Stage Repair for Severe Proximal Hypospadias Using Oral Mucosal Grafts Combination of a Modified Bracka Method and a Modified Byars Flap Method	ANNALS OF PLASTIC SURGERY			English	Article						proximal hypospadias; 2-stage repair; oral mucosal graft; Bracka method; Byars flap method	BUCCAL MUCOSA	One-stage repair is a conventional treatment of hypospadias. If hypospadias is severe as in the scrotal type and perineal type, penile curvature sometimes cannot be corrected by dorsal midline plication alone. In addition to resection of the urethral plate, ventral grafting becomes necessary for insufficient skin and subcutaneous tissue. In recent years, there has been renewed interest in 2-stage repair for such severe cases and salvage of failed cases with scarring. In the present study, novel 2-stage urethroplasty was performed in 6 cases to repair severe proximal hypospadias which required resection of the urethral plate. This novel method consisted of a combination of a modified Bracka method using oral mucosal grafts and a modified Byars flap of the dorsal foreskin. Good results were obtained using this novel method.	[Mitsukawa, Nobuyuki; Akita, Shinsuke; Kubota, Yoshitaka; Satoh, Kaneshige] Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chiba 2608670, Japan; [Saiga, Atsuomi] St Marys Hosp, Dept Plast & Reconstruct Surg, Fukuoka, Japan; [Kuriyama, Motone] Kochi Med Sch Hosp, Dept Plast Surg, Kochi, Japan	Mitsukawa, N (reprint author), Chiba Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nmitsu@air.linkclub.or.jp					Snodgrass W, 2004, J UROLOGY, V172, P1720, DOI 10.1097/01.ju.0000139954.92414.7d; BASKIN LS, 1995, BRIT J UROL, V76, P23; Gill NA, 2011, J PLAST RECONSTR AES, V64, P91, DOI 10.1016/j.bjps.2010.02.033; Zhao MX, 2011, INT J UROL, V18, P155, DOI 10.1111/j.1442-2042.2010.02684.x; Barroso U, 2009, J PEDIATR UROL, V5, P90, DOI 10.1016/j.jpurol.2008.09.005; Macedo A, 2011, J PEDIATR UROL, V7, P76, DOI 10.1016/j.jpurol.2010.10.006	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	FEB	2015	74	2					220	222		10.1097/SAP.0b013e318292099d		3	Surgery	Surgery	AZ3SD	WOS:000348146100018		
J	Osman, K; Faudzi, AAM; Rahmat, MF; Hikmat, OF; Suzumori, K				Osman, Khairuddin; Faudzi, Ahmad 'Athif Mohd; Rahmat, M. F.; Hikmat, Omer Faris; Suzumori, Koichi			Predictive Functional Control with Observer (PFC-O) Design and Loading Effects Performance for a Pneumatic System	ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING			English	Article						Pneumatic; System identification (SI); Predictive functional control (PFC); Observer	PARALLEL ROBOT; ACTUATOR	Demand for higher accuracy and control systems is growing rapidly and becoming more important in high-tech industries. However, precise position control of a pneumatic cylinder is very difficult to achieve due to the compressibility of air, nonlinear behavior of the air flow rate through the valves and the friction force between the cylinder and the piston of the system. The purpose of this paper was to present a model and a novel linear process control strategy to design a position controller for a real-time pneumatic system. This paper mainly analyzes the horizontal and vertical precision positioning control under loading effect for pneumatic system in real-time experiment. System identification approach is selected to obtain the plant model. Predictive Functional Control with observer (PFC-O) design is proposed as control strategy to improve tracking performance of the pneumatic system. Performance assessment of the controller was performed in MATLAB. The effectiveness of the proposed control strategy is verified through real-time experiment with the plant. The simulation and the experimental results confirm that the proposed PFC-O controller shows good control performance with various load configurations.	[Osman, Khairuddin] Univ Tekn Malaysia Melaka, Dept Ind Elect, Fac Elect & Comp Engn, Durian Tunggal 76100, Melaka, Malaysia; [Faudzi, Ahmad 'Athif Mohd] Univ Teknol Malaysia, Ctr Artificial Intelligent & Robot, Skudai 81310, Johor Bahru, Malaysia; [Osman, Khairuddin; Rahmat, M. F.; Hikmat, Omer Faris] Univ Teknol Malaysia, Fac Elect Engn, Dept Control & Mechatron Engn, Skudai 81310, Johor Bahru, Malaysia; [Hikmat, Omer Faris] Univ Zakho, Fac Engn, Kurdistan Region, Iraq; [Suzumori, Koichi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Mech & Aerosp Engn, Tokyo 152, Japan	Faudzi, AAM (reprint author), Univ Teknol Malaysia, Ctr Artificial Intelligent & Robot, Skudai 81310, Johor Bahru, Malaysia.	athif@fke.utm.my			Universiti Teknologi Malaysia (UTM); Ministry of Higher Education (MOHE) Malaysia under Exploratory Research Grant Scheme (ERGS) [R.J130000.7823.4L070]; Universiti Teknikal Malaysia Melaka (UTeM); Okayama University	The authors would like to thank Universiti Teknologi Malaysia (UTM), Ministry of Higher Education (MOHE) Malaysia under Exploratory Research Grant Scheme (ERGS) No. R.J130000.7823.4L070, Universiti Teknikal Malaysia Melaka (UTeM) and Okayama University for their support.	Qin SJ, 2003, CONTROL ENG PRACT, V11, P733, DOI 10.1016/S0967-0661(02)00186-7; Vivas A, 2005, CONTROL ENG PRACT, V13, P863, DOI 10.1016/j.conengprac.2004.10.001; Faudzi AAM, 2010, ADV ROBOTICS, V24, P1503, DOI 10.1163/016918610X505602; CHAEWIEANG P, 2008, IEEE INT C MECH AUT, P788; Faudzi Ahmad Athif Mohd, 2010, Journal of Computer Sciences, V6, DOI 10.3844/jcssp.2010.852.861; Faudzi AAM, 2013, SENSOR REV, V33, P341, DOI 10.1108/SR-09-2012-692; Faudzi AAM, 2009, ADV ROBOTICS, V23, P203, DOI 10.1163/156855308X392744; Faudzi AAM, 2012, 2012 IEEE/ASME INTERNATIONAL CONFERENCE ON ADVANCED INTELLIGENT MECHATRONICS (AIM), P1105, DOI 10.1109/AIM.2012.6266014; FAUDZI AAM, 2010, IEEE ASME INTERNATIO, P1035; FAUDZI AM, 2012, P ENG, V41, P593; Giovanini L, 2004, INT J CONTROL AUTOM, V2, P407; Giovanini L, 2006, INT J CONTROL AUTOM, V4, P669; Huixian Liu, 2012, IEEE Transactions on Industrial Electronics, V59, DOI 10.1109/TIE.2011.2162217; Kasdirin HA, 2009, 2009 INTERNATIONAL CONFERENCE OF SOFT COMPUTING AND PATTERN RECOGNITION, P167, DOI 10.1109/SoCPaR.2009.43; Maalouf AI, 2006, IEEE DECIS CONTR P, P6468, DOI 10.1109/CDC.2006.377557; Osman K, 2012, IEEE INT C INT ROBOT, P628, DOI 10.1109/IROS.2012.6385751; RAAFAT SM, 2010, INT J CONTROL AUTOM, V8, P621; Richalet J., 1993, PRATIQUE COMMANDE PR; Rossiter J. A., 2003, MODEL BASED PREDICTI; Rossiter JA, 2002, P AMER CONTR CONF, P4746, DOI 10.1109/ACC.2002.1025409; SATOH T, 2011, 37 ANN C IEEE IND EL, P669; SHIH MC, 1992, IEEE T IE, V39, P472; VIVAS A, 2003, INT CONF INT ROB SYS, V3, P2785; Wang Liuping, 2009, MODEL PREDICTIVE CON; Zhu GG, 2009, P AMER CONTR CONF, P2684, DOI 10.1109/ACC.2009.5159833	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1319-8025	2191-4281		ARAB J SCI ENG	Arab. J. Sci. Eng.	FEB	2015	40	2					633	643		10.1007/s13369-014-1421-z		11	Multidisciplinary Sciences	Science & Technology - Other Topics	AZ5BX	WOS:000348236300029		
J	Sankoda, K; Murata, K; Tanihata, M; Suzuki, K; Nomiyama, K; Shinohara, R				Sankoda, Kenshi; Murata, Kotaro; Tanihata, Mai; Suzuki, Kengo; Nomiyama, Kei; Shinohara, Ryota			Seasonal and Diurnal Variation of Organic Ultraviolet Filters from Personal Care Products Used Along the Japanese Coast	ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article							BENZOTRIAZOLE UV STABILIZERS; WATER TREATMENT PLANTS; WASTE-WATER; ESTROGENIC ACTIVITY; IN-VITRO; MASS-SPECTROMETRY; STEROID-HORMONES; SURFACE WATERS; SEWAGE-SLUDGE; FISH	This study aimed to investigate the behavior of organic ultraviolet (UV) filters released by recreational activities along the Japanese coastline. Seasonal variations of organic UV filters in seawater were investigated at four different recreational beaches (Mogushi, Wakamiya, Tsurugahama, and Otachimisaki beaches) in both summer (July through August) and winter (December). Moreover, short time scale diurnal changes were monitored at Otachimisaki beach in summer. Of the four sunscreen agents tested in this study, two agents-2-ethylhexyl-4-methoxycinnamate (EHMC) and 2-ethylhexyl salicylate (EHS)-were detected in all samples, whereas octyl-dimethyl-p-aminobenzonic acid and 3-(4-methylbenzylidene)-camphor were lower than detection limits. In particular, EHMC, one of the most popular organic UV filters, was dominant. The highest concentration of EHMC was observed at 1,080 ng L-1, a level that exceeds those of previous studies. Both EHMC and EHS concentrations showed significant (p < 0.05) seasonal variations with advancing summer suggesting direct input from recreational activities. The subsequent examination showed short time scale diurnal changes of organic UV filters on the beach. The results showed that diurnal changes in EHMC concentrations were correlated to the number of bathers. EHMC concentrations increased during the afternoon and decreased during the night, although complete attenuation during the night did not occur. EHMC persists along the coast due to low mobility and may persist the next day. This is the first study to show the natural attenuation behavior of organic UV filters along recreational beaches.	[Sankoda, Kenshi; Murata, Kotaro; Suzuki, Kengo; Shinohara, Ryota] Prefectural Univ Kumamoto, Grad Sch Environm & Symbiot Sci, Higashi Ku, Kumamoto 8628502, Japan; [Tanihata, Mai] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Higashi Ku, Kumamoto 8628502, Japan; [Nomiyama, Kei] Ehime Univ, CMES, Matsuyama, Ehime 7908577, Japan	Sankoda, K (reprint author), Prefectural Univ Kumamoto, Grad Sch Environm & Symbiot Sci, Higashi Ku, 3-1-100 Tsukide, Kumamoto 8628502, Japan.	ksankoda@pu-kumamoto.ac.jp	Nomiyama, Kei/A-4698-2013	Nomiyama, Kei/0000-0002-8012-3806			Amine H, 2012, MAR POLLUT BULL, V64, P2435, DOI 10.1016/j.marpolbul.2012.07.051; Fent K, 2010, ENVIRON POLLUT, V158, P1817, DOI 10.1016/j.envpol.2009.11.005; Wijekoon KC, 2013, BIORESOURCE TECHNOL, V144, P247, DOI 10.1016/j.biortech.2013.06.097; Plagellat C, 2006, CHEMOSPHERE, V62, P915, DOI 10.1016/j.chemosphere.2005.05.024; Schlumpf M, 2001, ENVIRON HEALTH PERSP, V109, P239; Kunz PY, 2006, AQUAT TOXICOL, V79, P305, DOI 10.1016/j.aquatox.2006.06.016; Cuderman P, 2007, ANAL BIOANAL CHEM, V387, P1343, DOI 10.1007/s00216-006-0927-y; Giokas DL, 2005, J CHROMATOGR A, V1077, P19, DOI 10.1016/j.chroma.2005.04.074; Kameda Y, 2011, ENVIRON POLLUT, V159, P1570, DOI 10.1016/j.envpol.2011.02.055; Langford KH, 2008, J ENVIRON MONITOR, V10, P894, DOI 10.1039/b806198j; Danovaro R, 2008, ENVIRON HEALTH PERSP, V116, P441, DOI 10.1289/ehp.10966; Kunz PY, 2006, TOXICOL APPL PHARM, V217, P86, DOI 10.1016/j.taap.2006.07.014; Nakata H, 2009, ENVIRON SCI TECHNOL, V43, P6920, DOI 10.1021/es900939j; Nakata H, 2012, MAR POLLUT BULL, V64, P2211, DOI 10.1016/j.marpolbul.2012.07.049; Bachelot M, 2012, SCI TOTAL ENVIRON, V420, P273, DOI 10.1016/j.scitotenv.2011.12.051; Buser HR, 2006, ENVIRON SCI TECHNOL, V40, P1427, DOI 10.1021/es052088s; Gago-Ferrero P, 2013, ENVIRON SCI TECHNOL, V47, P5619, DOI 10.1021/es400675y; Gago-Ferrero P, 2011, CHEMOSPHERE, V84, P1158, DOI 10.1016/j.chemosphere.2011.04.003; Kunz PY, 2006, TOXICOL SCI, V90, P349, DOI 10.1093/toxsci/kfj082; Li WH, 2007, WATER RES, V41, P3506, DOI 10.1016/j.watres.2007.05.039; Balmer ME, 2005, ENVIRON SCI TECHNOL, V39, P953, DOI 10.1021/es040055r; Inui M, 2003, TOXICOLOGY, V194, P43, DOI 10.1016/S0300-483X(03)00340-8; Nguyen LN, 2014, INT BIODETER BIODEGR, V88, P169, DOI 10.1016/j.ibiod.2013.12.017; Baron E, 2013, CHEMOSPHERE, V92, P309, DOI 10.1016/j.chemosphere.2013.03.032; Goksoyr A, 2009, ENVIRON SCI TECHNOL, V43, P4783, DOI 10.1021/es900154h; Ikarashi Y, 2007, KOKURITSU IYAKUHIN S, V125, P65; Ministry of Health Labour and Welfare, 2000, STAND COSM; Nakata H, 2010, J ENVIRON MONITOR, V12, P2088, DOI 10.1039/c0em00170h; Schwarzenbach R., 2005, ENV ORGANIC CHEM; U.S. EPA, 2011, EST PROGR INT EPI SU; Zhang Z, 2011, ENVIRON SCI TECHNOL, V45, P391	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-4341	1432-0703		ARCH ENVIRON CON TOX	Arch. Environ. Contam. Toxicol.	FEB	2015	68	2					217	224		10.1007/s00244-014-0106-7		8	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	AZ4QG	WOS:000348206800001		
J	Matsubara, S				Matsubara, Shigeki			A stepwise cesarean section for placenta percreta: effective only for "separable" placenta percreta?	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Letter									Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, 3311-1 Shimotsuke, Shimotsuke, Tochigi 3290498, Japan.	matsushi@jichi.ac.jp					Jaraquemada JMP, 2004, ACTA OBSTET GYN SCAN, V83, P738; Cunningham FG, 2014, WILLIAMS OBSTET, V24th, P780; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P372, DOI 10.1111/aogs.12074; Shabana A, 2014, ARCH GYNECOL OBSTET, DOI [10.1007/s00404-014-3496-x, DOI 10.1007/S00404-014-3496-X]; Yano H, 2013, ACTA OBSTET GYN SCAN, V92, P988, DOI 10.1111/aogs.12133	5	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	FEB	2015	291	2					243	244		10.1007/s00404-014-3542-8		2	Obstetrics & Gynecology	Obstetrics & Gynecology	AZ3SB	WOS:000348145800004		
J	Baba, Y; Ohkuchi, A; Usui, R; Suzuki, H; Kuwata, T; Matsubara, S				Baba, Yosuke; Ohkuchi, Akihide; Usui, Rie; Suzuki, Hirotada; Kuwata, Tomoyuki; Matsubara, Shigeki			Calculating probability of requiring allogeneic blood transfusion using three preoperative risk factors on cesarean section for placenta previa	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Article						Blood transfusion; Cesarean section; Placenta accreta; Placental lacunae; Placenta previa	MASSIVE HEMORRHAGE; ACCRETA; PREGNANCY; DIAGNOSIS	To construct a model to calculating probability of requiring allogeneic blood transfusion on cesarean section (CS) for placenta previa (PP). A retrospective cohort study involving all 205 patients with PP who underwent CS in our institute. We determined the relationship between allogeneic blood transfusion and nine preoperative factors: (1) maternal age, (2) parity, (3) uterine myoma, (4) previous CS, (5) the placenta covering the previous CS scar (referred to as "scar covering"), (6) degree of previa, (7) ultrasound finding of lacunae, (8) preoperative anemia, and (9) preparation of autologous blood. Independent risk factors of allogeneic blood transfusion were identified by multivariate logistic regression analysis. These significant factors were included in the final model, and, the probability of allogeneic blood transfusion was calculated. Independent risk factors of allogeneic blood transfusion were scar covering, previous CS without scar covering, and lacunae. These three factors were used to create a predictive model. The model revealed that patients with scar covering and lacunae had the highest probability (0.73), while those with no risk factors had the lowest probability (0.02). This simple model may be useful to calculate probability of requiring allogeneic blood transfusion on CS for placenta previa.	[Baba, Yosuke; Ohkuchi, Akihide; Usui, Rie; Suzuki, Hirotada; Kuwata, Tomoyuki; Matsubara, Shigeki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	matsushi@jichi.ac.jp					FINBERG HJ, 1992, J ULTRAS MED, V11, P333; Comstock CH, 2004, AM J OBSTET GYNECOL, V190, P1135, DOI 10.1016/j.ajog.2003.11.024; Yang JI, 2006, ULTRASOUND OBST GYN, V28, P178, DOI 10.1002/uog.2797; Japaraj RP, 2007, J OBSTET GYNAECOL RE, V33, P431, DOI 10.1111/j.1447-0756.2007.00549.x; Patterson JA, 2014, OBSTET GYNECOL, V123, P126, DOI 10.1097/AOG.0000000000000054; Baba Y, 2014, J OBSTET GYNAECOL RE, V40, P1243, DOI 10.1111/jog.12340; Hasegawa J, 2009, ULTRASOUND OBST GYN, V34, P80, DOI 10.1002/uog.6426; Japan Society of Obstetrics and Gynecology, 2008, GLOSS OBST GYN, P226; Ohkuchi A, 2003, J PERINAT MED, V31, P209, DOI 10.1515/JPM.2003.028	9	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	FEB	2015	291	2					281	285		10.1007/s00404-014-3451-x		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AZ3SB	WOS:000348145800011		
J	Saeki, H; Suzuki, C; Yamasaki, S; Hashizume, A; Izumi, H; Suzuki, F; Ishi, K; Nojima, M; Hino, O				Saeki, Harumi; Suzuki, Chikako; Yamasaki, Shigetaka; Hashizume, Akane; Izumi, Hiroshi; Suzuki, Fujihiko; Ishi, Kazuhisa; Nojima, Michio; Hino, Okio			Cotyledonoid dissecting leiomyoma of the uterus: report of two cases	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Article						Cotyledonoid dissecting leiomyoma; Uterus; Myomectomy; Pregnancy; Case report	TUMOR	Cotyledonoid dissecting leiomyoma (Sternberg tumor) is a rare variant of the uterine smooth muscle tumor. Although this tumor is a benign tumor clinically and pathologically, the appearance and growth pattern is unusual, so it may be misdiagnosed as malignancy. We report two cases of cotyledonoid dissecting leiomyoma of the uterus that occurred in two 44- and 31-year-old women, respectively. Total hysterectomy and bilateral salpingo-oophorectomy were performed in one of the patients, and myomectomy was done in the other one. Macroscopically, both tumors were grape-like exophytic masses resembling placental tissue. The patients were well after surgery, and one patient gave birth. To our knowledge, this is the first case report of a successful delivery after myomectomy of this tumor. To prevent aggressive surgery it is important to recognize that this tumor is a benign and unusual appearing variant of leiomyoma. A fertility-sparing surgical procedure should be considered if the patient wishes to preserve her fertility.	[Saeki, Harumi; Hino, Okio] Juntendo Univ, Dept Pathol & Oncol, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Saeki, Harumi; Hashizume, Akane; Izumi, Hiroshi; Suzuki, Fujihiko; Ishi, Kazuhisa] Juntendo Univ, Dept Diagnost Pathol, Urayasu Hosp, Chiba, Japan; [Saeki, Harumi; Yamasaki, Shigetaka] Tokyo Rinkai Hosp, Dept Diagnost Pathol, Edogawa Ku, Tokyo, Japan; [Suzuki, Chikako; Nojima, Michio] Juntendo Univ, Dept Obstet & Gynecol, Urayasu Hosp, Chiba, Japan	Saeki, H (reprint author), Juntendo Univ, Dept Pathol & Oncol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	haru-s@juntendo.ac.jp					Adedipe TO, 2010, EUR J GYNAECOL ONCOL, V31, P230; Ersöz Safak, 2011, Turk Patoloji Derg, V27, P257, DOI 10.5146/tjpath.2011.01085; Gezginc K, 2011, INT J CLIN ONCOL, V16, P701, DOI 10.1007/s10147-011-0184-8; Jordan LB, 2002, HISTOPATHOLOGY, V40, P245, DOI 10.1046/j.1365-2559.2002.01359.x; Majd HS, 2011, ARCH GYNECOL OBSTET, V283, P771, DOI 10.1007/s00404-010-1716-6; Mathew M, 2007, OBSTET GYNECOL, V109, P509, DOI 10.1097/01.AOG.0000222359.34860.91; Preda L, 2009, TUMORI, V95, P532; Raga F, 2009, FERTIL STERIL, V91, P1269, DOI 10.1016/j.fertnstert.2008.08.131; Roth LM, 1996, AM J SURG PATHOL, V20, P1455, DOI 10.1097/00000478-199612000-00004; Roth LM, 2013, INT J GYNECOL PATHOL, V32, P215, DOI 10.1097/PGP.0b013e318257dff4; Roth LM, 2000, INT J GYNECOL PATHOL, V19, P272, DOI 10.1097/00004347-200007000-00012; Saeed AS, 2006, INT J GYNECOL PATHOL, V25, P262, DOI 10.1097/01.pgp.0000186542.19434.ea; Shelekhova KV, 2007, VIRCHOWS ARCH, V450, P119, DOI 10.1007/s00428-006-0329-8; Weissferdt A, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-18; World health organization classification of tumours, 2003, PATH GEN TUM BREAST, P241	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	FEB	2015	291	2					357	361		10.1007/s00404-014-3406-2		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AZ3SB	WOS:000348145800021		
J	Terada, T				Terada, Tadashi			Decidualization of uterine adenomyoma in a pregnant woman: a case report with immunohistochemical study	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Article						Uterus; Pregnancy; Adenomyoma; Decidualization; Immunohistopathology	C-KIT; OVARIAN ENDOMETRIOSIS; MIMICKING MALIGNANCY; GENETIC ANALYSES; STROMAL TUMOR; PDGFRA GENES; CARCINOMA; ADENOCARCINOMA; MUTATIONS; PANCREAS	Decidualization of uterine adenomyoma has not been reported, to the best of the author's knowledge. To report a case of uterine adenomyoma with decidualization. A 43-year-old pregnant woman with "myoma" underwent cesarean operation and "myomectomy" at 37 gestation weeks. The operation was successful, and the baby and mother were healthy. Grossly, the "myoma" measured 12 x 10 x 10 cm, and the consistency was firm. Microscopically, the tumor was adenomyoma consisting of smooth muscle bundles and endometrial islands. Characteristically, the endometrial stroma showed marked decidualization. An immunohistochemical study showed that the decidual cells were positive for pancytokeratin AE1/3, pancytokeratin CAM5.2, cytokeratin (CK)7, CK18, vimentin, CA125, CD10, estrogen receptor (ER), progesterone receptor (PgR), and Ki-67 (labeling 1 %). They were negative for CK34 beta E12, CK5/6, CK8, CK14, CK19, CK20, EMA, p63, desmin, alpha-smooth muscle actin, S100 protein, CK34, CD68, and p53. These results show that marked decidualization occurs in adenomyoma during pregnancy, and that the decidual cells are positive for pancytokeratin AE1/3, pancytokeratin CAM5.2, CK7, CK18, vimentin, CA125, CD10, ER, and PgR. A rare case of uterine adenomyoma with decidualization is reported.	Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Shizuoka 4248636, Japan	Terada, T (reprint author), Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Miyakami 1231, Shizuoka 4248636, Japan.	piyo0111jp@yahoo.co.jp					O'Leary SM, 2006, OBSTET GYNECOL, V108, P776, DOI 10.1097/01.AOG.0000200596.98039.c5; Sammour RN, 2005, J ULTRAS MED, V24, P1289; Machida S, 2008, GYNECOL OBSTET INVES, V66, P241, DOI 10.1159/000147171; Terada T, 2008, PATHOL INT, V58, P801, DOI 10.1111/j.1440-1827.2008.02315.x; Tahlan A, 2006, INT J GYNECOL PATHOL, V25, P361, DOI 10.1097/01.pgp.0000209570.08716.b3; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; SUSTER S, 1990, AM J GASTROENTEROL, V85, P841; Terada T, 2009, WORLD J GASTROENTERO, V15, P2679, DOI 10.3748/wjg.15.2679; Terada T, 2009, PATHOL INT, V59, P53, DOI 10.1111/j.1440-1827.2008.02325.x; Terada T, 2003, PATHOL INT, V53, P790, DOI 10.1046/j.1440-1827.2003.01559.x; Terada T, 2009, MED ONCOL, V26, P233, DOI 10.1007/s12032-008-9092-9; Terada T, 2004, PATHOL INT, V54, P116, DOI 10.1111/j.1440-1827.2004.01594.x; Terada T, 2005, TOHOKU J EXP MED, V206, P271, DOI 10.1620/tjem.206.271; Terada T, 2009, MED ONCOL, V26, P247, DOI 10.1007/s12032-008-9116-5; Terada T, 2009, INT J GYNECOL PATHOL, V28, P98, DOI 10.1097/PGP.0b013e31817eb796; Terada T, 2008, WORLD J GASTROENTERO, V14, P7256, DOI 10.3748/wjg.14.7256; Terada T, 2009, PATHOL INT, V59, P482, DOI 10.1111/j.1440-1827.2009.02397.x; Terada T, 2009, INT J GYNECOL PATHOL, V28, P29, DOI 10.1097/PGP.0b013e3181808000; Terada T, 2002, PATHOL INT, V52, P740, DOI 10.1046/j.1440-1827.2002.01416.x; Terada T, 2011, ANN DIAGN PATHOL, V15, P338, DOI 10.1016/j.anndiagpath.2011.03.008; Terada T, 2008, PATHOL INT, V58, P806, DOI 10.1111/j.1440-1827.2008.02316.x; Toki T, 2002, INT J GYNECOL PATHOL, V21, P41, DOI 10.1097/00004347-200201000-00008	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	FEB	2015	291	2					399	402		10.1007/s00404-014-3413-3		4	Obstetrics & Gynecology	Obstetrics & Gynecology	AZ3SB	WOS:000348145800027		
J	Adthapanyawanich, K; Kumchantuek, T; Nakata, H; Yamamoto, M; Wakayama, T; Nishiuchi, T; Iseki, S				Adthapanyawanich, Kannika; Kumchantuek, Tewarat; Nakata, Hiroki; Yamamoto, Miyuki; Wakayama, Tomohiko; Nishiuchi, Takumi; Iseki, Shoichi			Morphology and gene expression profile of the submandibular gland of androgen-receptor-deficient mice	ARCHIVES OF ORAL BIOLOGY			English	Article						Submandibular gland; Differentiation; Gene expression; Androgen receptor; Androgens; Thyroid hormone	EPIDERMAL GROWTH-FACTOR; SUB-MANDIBULAR GLANDS; MOUSE SUBMAXILLARY GLAND; TESTICULAR FEMINIZATION; SALIVARY-GLANDS; DUCT SYSTEM; TESTOSTERONE; LOCALIZATION; DIFFERENTIATION; THYROXINE	Objectives: In the submandibular gland (SMG) of mice, the granular convoluted tubule (GCT) develops preferentially in males dependent on androgens. To clarify the molecular mechanism of androgen action in SMG, we examined the SMG of mice deficient for the androgen receptor (ARKO). Design: The morphological features and gene expression in the SMG of control and ARKO mice with or without hormone treatments were analysed by immunohistochemistry, DNA microarray, and RT-PCR. Results: The development of GCT and expression of GCT-specific products such as NGF were even lower in ARKO male SMG than in control female SMG. The administration of androgens to ARKO males had no effect on SMG, whereas the administration of thyroid hormone (T4) caused the extensive conversion of striated duct cells to GCT cells with the increase of NGF mRNA. Gene expression profiles in control and ARKO male SMG were analysed by DNA microarrays, and genes with higher or lower expression in AkKO male SMG were determined. They were then classified into groups according to their responsiveness to the administration of dihydotestosterone (DHT) or T4 to ARK males. RT-PCR revealed that, while no gene was responsive to DHT, expression of many genes was up- or down-regulated by T4. Conclusions: These results confirmed that GCT cell differentiation induced by androgens is dependent on the classical androgen receptor (AR), whereas that by T4 is independent of AR. Differential reactivity of genes to androgens and thyroid hormone in ARK mice may shed light on the mechanism of androgen action in the SMG. (C) 2014 Elsevier Ltd. All rights reserved.	[Adthapanyawanich, Kannika; Kumchantuek, Tewarat; Nakata, Hiroki; Yamamoto, Miyuki; Wakayama, Tomohiko; Iseki, Shoichi] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa 9208640, Japan; [Nishiuchi, Takumi] Kanazawa Univ, Adv Sci Res Ctr, Div Funct Genom, Kanazawa, Ishikawa 9208640, Japan	Iseki, S (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	siseki@med.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20590187, 23590231]	Grant-in-Aid for Scientific Research (Nos. 20590187 and 23590231) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALOE L, 1980, CELL TISSUE RES, V205, P19; ALOE L, 1980, EXP CELL RES, V125, P15, DOI 10.1016/0014-4827(80)90183-4; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; BARKA T, 1980, J HISTOCHEM CYTOCHEM, V28, P836; Shihan M, 2014, BBA-MOL CELL RES, V1843, P1172, DOI 10.1016/j.bbamcr.2014.03.002; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Matsumoto T, 2008, J STEROID BIOCHEM, V109, P236, DOI 10.1016/j.jsbmb.2008.03.023; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Michels G, 2008, FRONT NEUROENDOCRIN, V29, P182, DOI 10.1016/j.yfrne.2007.08.004; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; HE WW, 1991, NUCLEIC ACIDS RES, V19, P2373, DOI 10.1093/nar/19.9.2373; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; BORN IA, 1987, VIRCHOWS ARCH A, V411, P583, DOI 10.1007/BF00713290; CARAMIA F, 1966, J ULTRA MOL STRUCT R, V16, P524, DOI 10.1016/S0022-5320(66)80004-7; CARAMIA F, 1966, J ULTRA MOL STRUCT R, V16, P505, DOI 10.1016/S0022-5320(66)80003-5; CHANG CS, 1995, CRIT REV EUKAR GENE, V5, P97; Chrétien M, 1977, Int Rev Cytol, V50, P333; GRESIK EW, 1994, MICROSC RES TECHNIQ, V27, P1, DOI 10.1002/jemt.1070270102; GRESIK EW, 1975, CELL TISSUE RES, V157, P411; GRESIK EW, 1980, J HISTOCHEM CYTOCHEM, V28, P860; Grosse A, 2012, MOL CELL ENDOCRINOL, V352, P46, DOI 10.1016/j.mce.2011.06.032; GUBITS RM, 1986, ENDOCRINOLOGY, V119, P1382; HE WW, 1994, RECEPTOR, V4, P121; Hipkaeo W, 2004, J HISTOCHEM CYTOCHEM, V52, P479; Hipkaeo W, 2008, TOHOKU J EXP MED, V214, P231, DOI 10.1620/tjem.214.231; HOSOI K, 1981, J BIOCHEM-TOKYO, V90, P267; HOSOI K, 1979, J ENDOCRINOL, V83, P429, DOI 10.1677/joe.0.0830429; Iseki S, 2005, ARCH ORAL BIOL, V50, P653, DOI 10.1016/j.archoralbio.2004.07.015; JACOBY F, 1959, J ANAT, V93, P201; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; KASAYAMA S, 1989, J ENDOCRINOL, V121, P269, DOI 10.1677/joe.0.1210269; Keattikunpairoj S, 2009, HISTOCHEM CELL BIOL, V132, P647, DOI 10.1007/s00418-009-0649-2; MATSUURA S, 1984, CELL TISSUE RES, V235, P295; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; MIZUKI N, 1992, MOL CELL ENDOCRINOL, V89, P25, DOI 10.1016/0303-7207(92)90207-M; Moeller LC, 2011, THYROID RES S1, V4, pS1; MORRELL JI, 1987, J HISTOCHEM CYTOCHEM, V35, P1053; Pinkstaff C A, 1980, Int Rev Cytol, V63, P141, DOI 10.1016/S0074-7696(08)61759-3; SAR M, 1990, ENDOCRINOLOGY, V127, P3180; TRONIK D, 1988, FEBS LETT, V234, P336, DOI 10.1016/0014-5793(88)80111-X; Yamagishi R, 2014, ACTA HISTOCHEM CYTOC, V47, P95, DOI 10.1267/ahc.14005	48	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	FEB	2015	60	2					320	332		10.1016/j.archoralbio.2014.11.007		13	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ2UC	WOS:000348086700012		
J	Meiler, S; Baumer, Y; McCurdy, S; Lee, BH; Kitamoto, S; Boisvert, WA				Meiler, Svenja; Baumer, Yvonne; McCurdy, Sara; Lee, Bog-Hieu; Kitamoto, Shiro; Boisvert, William A.			Cluster of Differentiation 43 Deficiency in Leukocytes Leads to Reduced Atherosclerosis-Brief Report	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						atherosclerosis; macrophages	CD43; MOLECULE; LEUKOSIALIN	Objective-The aim of this study was to investigate the role of cluster of differentiation 43 (CD43), an integral membrane glycoprotein with both proadhesive and antiadhesive activities, in atherosclerosis. Approach and Results-Low-density lipoprotein receptor-deficient mice were lethally irradiated and reconstituted with either bone marrow from CD43(-/-) mice or from wild-type controls. We found that mice lacking the CD43 on their leukocytes had significantly less severe atherosclerosis and that, contrary to our expectation, macrophage infiltration into the vessel wall was not affected by the lack of CD43 in the leukocytes. However, we found that CD43 mediates cholesterol homeostasis in macrophages by facilitating cholesterol efflux. This resulted in a significant reduction in storage of cholesterol in the aorta of mice lacking CD43 in the leukocytes. Conclusions-CD43 may be an important mediator of macrophage lipid homeostasis, thereby affecting macrophage foam cell formation and ultimately atherosclerotic plaque development.	[Meiler, Svenja; Baumer, Yvonne; McCurdy, Sara; Boisvert, William A.] Univ Hawaii, Ctr Cardiovasc Res, John A Burns Sch Med, Honolulu, HI 96813 USA; [Lee, Bog-Hieu] Chung Ang Univ, Sch Food Sci & Technol, Dept Food & Nutr, Seoul 156756, South Korea; [Kitamoto, Shiro] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Kitamoto, Shiro] Kyushu Univ, Grad Sch Med Sci, Dept Adv Therapeut Cardiovasc Dis, Fukuoka 812, Japan; [Boisvert, William A.] Kazan Fed Univ, Kazan, Russia	Boisvert, WA (reprint author), Univ Hawaii, Ctr Cardiovasc Res, John A Burns Sch Med, 651 Ilalo St,BSB 311C, Honolulu, HI 96813 USA.	wab@hawaii.edu			National Institutes of Health (NIH) [R01HL075677, R01HL81863]; Hawaii Community Foundation [10ADVC-47037]; NIH [P20GM103516, P20RR016453, G12RR003061, G12MD007601]	This work was supported by National Institutes of Health (NIH) grants R01HL075677 and R01HL81863 and Hawaii Community Foundation grant 10ADVC-47037 to W.A. Boisvert. Core facilities were supported by NIH grants P20GM103516, P20RR016453, G12RR003061, and G12MD007601.	Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; CYSTER JG, 1991, EMBO J, V10, P893; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Hernandez JD, 2006, J IMMUNOL, V177, P5328; McEvoy LM, 1997, BLOOD, V90, P3587; Rosenstein Y, 1999, IMMUNOL RES, V20, P89, DOI 10.1007/BF02786465; ROSENSTEIN Y, 1991, NATURE, V354, P233, DOI 10.1038/354233a0; Stockl J, 1996, J EXP MED, V184, P1769, DOI 10.1084/jem.184.5.1769	8	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	FEB	2015	35	2					309	311		10.1161/ATVBAHA.114.304513		3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AZ4TE	WOS:000348215100011		
J	Kurano, M; Suzuki, A; Inoue, A; Tokuhara, Y; Kano, K; Matsumoto, H; Igarashi, K; Ohkawa, R; Nakamura, K; Dohi, T; Miyauchi, K; Daida, H; Tsukamoto, K; Ikeda, H; Aoki, J; Yatomi, Y				Kurano, Makoto; Suzuki, Akiko; Inoue, Asuka; Tokuhara, Yasunori; Kano, Kuniyuki; Matsumoto, Hirotaka; Igarashi, Koji; Ohkawa, Ryunosuke; Nakamura, Kazuhiro; Dohi, Tomotaka; Miyauchi, Katsumi; Daida, Hiroyuki; Tsukamoto, Kazuhisa; Ikeda, Hitoshi; Aoki, Junken; Yatomi, Yutaka			Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						autotaxin; coronary disease; lysophosphatidic acids; lysophospholipids; molecular species	PLATELET ACTIVATION; ENDOTHELIAL-CELLS; SPHINGOSINE 1-PHOSPHATE; NEOINTIMA FORMATION; IN-VITRO; AUTOTAXIN; RECEPTORS; BLOOD; LIPOPROTEIN; MIGRATION	Objective-Lysophosphatidic acids (LPA) have important roles in the field of vascular biology and are derived mainly from lysophosphatidylcholine via autotaxin. However, in our previous study, only the plasma LPA levels, and not the serum autotaxin levels, increased in patients with acute coronary syndrome (ACS). The aim of this study was to elucidate the pathway by which LPA is increased in patients with ACS. Approach and Results-We measured the plasma lysophospholipids species in 141 consecutive patients undergoing coronary angiography (ACS, n=38; stable angina pectoris, n=71; angiographically normal coronary arteries, n=32) using a liquid chromatography-tandem mass spectrometry analysis. Among the ACS subjects, notable increases in the 22: 6 LPA, 18: 2 LPA, and 20: 4 LPA levels were observed. The in vitro experiments revealed that serum incubation mainly increased the 18: 2 LPA level, whereas platelet activation increased the 20: 4 LPA level. Minor lysophospholipids other than LPA were also elevated in ACS subjects and were well correlated with the corresponding LPA species, including 22: 6 LPA. A multiple regression analysis also revealed that lysophosphatidylinositol, lysophosphatidylcholine, lysophosphatidylethanolamine, and lysophosphatidylglycerol were independent explanatory variables for several LPA species. Conclusions-Specific LPA species, especially long-chain unsaturated LPA, were elevated in ACS patients, along with the corresponding minor lysophospholipids. The elevation of these LPA species might be mainly caused by presently unidentified LPA-producing pathway(s). Minor lysophospholipids might be involved in the generation of LPA, especially 22: 6 LPA, and in the pathogenesis of ACS.	[Kurano, Makoto; Suzuki, Akiko; Ikeda, Hitoshi; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo 1138655, Japan; [Kurano, Makoto; Ikeda, Hitoshi; Aoki, Junken; Yatomi, Yutaka] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan; [Inoue, Asuka; Kano, Kuniyuki; Matsumoto, Hirotaka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi 980, Japan; [Tokuhara, Yasunori; Ohkawa, Ryunosuke; Nakamura, Kazuhiro; Ikeda, Hitoshi; Yatomi, Yutaka] Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan; [Tokuhara, Yasunori] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Pathol Lab, Kagawa, Japan; [Igarashi, Koji] Tosoh Corp, AIA Res Grp, Reagent Dev Dept, Biosci Div, Ayase, Kanagawa, Japan; [Dohi, Tomotaka; Miyauchi, Katsumi; Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiovasc Med, Tokyo 113, Japan; [Tsukamoto, Kazuhisa] Fukushima Med Univ, Dept Metab Diabet & Nephrol, Preparatory Off Aizu Med Ctr, Fukushima, Japan	Yatomi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yatoyuta-tky@umin.ac.jp			KAKENHI from Japan Society for the Promotion of Science (JSPS) [22249017, 25253040, 25860740]; CREST from JST	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (JSPS) Grant Number 22249017 and 25253040 (Y. Yatomi) and Grant Number 25860740 (M. Kurano), and CREST from JST.	Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Nakamura K, 2007, ANAL BIOCHEM, V367, P20, DOI 10.1016/j.ab.2007.05.004; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; Haseruck N, 2004, BLOOD, V103, P2585, DOI 10.1182/blood-2003-04-1128; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Dohi T, 2012, CLIN CHIM ACTA, V413, P207, DOI 10.1016/j.cca.2011.09.027; Spector AA, 2003, CIRCULATION, V108, P641, DOI 10.1161/01.CIR.0000082307.85449.1D; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Siess W, 2004, J CELL BIOCHEM, V92, P1086, DOI 10.1002/jcb.20108; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Pradere JP, 2008, BBA-MOL CELL BIOL L, V1781, P582, DOI 10.1016/j.bbalip.2008.04.001; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; BILLAH MM, 1982, J BIOL CHEM, V257, P5196; Bolen AL, 2011, J LIPID RES, V52, P958, DOI 10.1194/jlr.M013326; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Kohno M, 1998, CIRCULATION, V98, P353; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Rizza C, 1999, LAB INVEST, V79, P1227; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Hosogaya S, 2008, ANN CLIN BIOCHEM, V45, P364, DOI 10.1258/acb.2008.007242; KIKUCHIYANOSHITA R, 1993, J BIOCHEM-TOKYO, V114, P33; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Park KS, 2007, FEBS LETT, V581, P4411, DOI 10.1016/j.febstet.2007.08.014; Pattanaik D, 2010, DISCOV MED, V51, P161; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Siess W, 2002, BBA-MOL CELL BIOL L, V1582, P204, DOI 10.1016/S1388-1981(02)00173-7; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; Tokumura A, 2002, BIOCHEM J, V365, P617; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	41	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	FEB	2015	35	2					463	470		10.1161/ATVBAHA.114.304748		8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AZ4TE	WOS:000348215100029		
J	Karino, S; Willcox, BJ; Fong, K; Lo, S; Abbott, R; Masaki, KH				Karino, Shigehiko; Willcox, Bradley J.; Fong, Kaon; Lo, Serena; Abbott, Robert; Masaki, Kamal H.			Total and differential white blood cell counts predict eight-year incident coronary heart disease in elderly Japanese-American men: The Honolulu Heart Program	ATHEROSCLEROSIS			English	Article						Aging; Atherosclerosis; Coronary disease; Inflammation; Leukocytes	CAUSE-SPECIFIC MORTALITY; LEUKOCYTE COUNT; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; ARTERY-DISEASE; INFLAMMATION; STROKE; WOMEN; ASSOCIATION; NEUTROPHILS	Background: Previous studies have reported an association between total and differential white blood cell (WBC) counts and incident coronary heart disease (CHD), but data from elderly populations are scarce. The purpose of this study was to examine the association between total and differential WBC counts and incident CHD in an elderly Japanese-American population. Methods: Total and differential WBC counts were examined at a baseline examination from 1991 to 1993 in the Honolulu Heart Program. Subjects were Japanese-American men aged 71-93 years free of CHD at baseline (N = 2879), who were divided into quartiles of total and differential WBC counts for analysis, and were followed for incident CHD for 8 years. Results: During the follow up period, 279 men developed CHD. Hazard ratio for incident CHD for each quartile of total and differential WBC counts were obtained by Cox regression using the lowest quartile as the reference group. After full adjustment including age, cardiovascular risk factors, chronic diseases and medication use, the hazard ratios in the highest quartiles of total WBC, granulocyte and neutrophil counts were 1.75 (95% confidence interval [CI], 1.18-2.62; P = 0.006), 1.66 (95%CI, 1.11-2.48; P = 0.01), and 1.57 (95%CI, 1.06-2.34; P = 0.03), respectively. No significant associations were found between lymphocyte or monocyte counts and incident CHD. Conclusions: Higher total WBC, granulocyte and neutrophil counts were associated with higher risk of incident CHD in a population of elderly Japanese-American men. Further studies are needed to establish cut-points and treatment options with anti-inflammatory medications. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Karino, Shigehiko; Willcox, Bradley J.; Fong, Kaon; Lo, Serena; Abbott, Robert; Masaki, Kamal H.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, John A Hartford Fdn Ctr Excellence Geriatr, Honolulu, HI 96817 USA; [Willcox, Bradley J.; Masaki, Kamal H.] Kuakini Med Ctr, Honolulu, HI 96817 USA; [Abbott, Robert] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 5202153, Japan	Karino, S (reprint author), Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, John A Hartford Fdn Ctr Excellence Geriatr, 347 North Kuakini St,HPM 9, Honolulu, HI 96817 USA.	skarino0526@gmail.com; willcoxbj@gmail.com; K.FONG@kuakini.org; Serena.Hy.Lo@kp.org; rda3e@virginia.edu; km1@hawaii.rr.com			National Heart, Lung, and Blood Institute [N01-HC-05102]; National Institute on Aging, Bethesda, Maryland [N01-AG-4-2149, U01-AG-019349, R01-AG-038707, R01-AG-027060]; Hawaii Community Foundation [2004-0463]	This study was supported by the National Heart, Lung, and Blood Institute (contract N01-HC-05102), the National Institute on Aging (contract N01-AG-4-2149, and grants U01-AG-019349, R01-AG-038707, and R01-AG-027060), Bethesda, Maryland, and Hawaii Community Foundation grant 2004-0463.	Abbott RD, 2012, NEUROBIOL AGING, V33, P914, DOI 10.1016/j.neurobiolaging.2010.06.023; Yano K, 2001, ARTERIOSCL THROM VAS, V21, P1065; Takeda Y, 2003, JPN HEART J, V44, P201, DOI 10.1536/jhj.44.201; Abbott RD, 2002, ANN EPIDEMIOL, V12, P173, DOI 10.1016/S1047-2797(01)00309-X; Lee CD, 2001, AM J EPIDEMIOL, V154, P758; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Mody L, 2008, J AM GERIATR SOC, V56, P2340, DOI 10.1111/j.1532-5415.2008.02015.x; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; Folsom AR, 1997, CIRCULATION, V96, P1102; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; BOLLINGER PB, 1987, AM J CLIN PATHOL, V87, P71; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; PHILLIPS AN, 1992, AM J EPIDEMIOL, V136, P59; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496; Rana JS, 2007, J INTERN MED, V262, P678, DOI 10.1111/j.1365-2796.2007.01864.x; Rana JS, 2009, HEART, V95, P1682, DOI 10.1136/hrt.2009.170134; ROSS DW, 1986, ARCH PATHOL LAB MED, V110, P803; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Weijenberg MP, 1996, ARTERIOSCL THROM VAS, V16, P499; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; YANO K, 1984, AM J EPIDEMIOL, V119, P653	30	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	FEB	2015	238	2					153	158		10.1016/j.atherosclerosis.2014.12.003		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AZ1UL	WOS:000348023000001		
J	Shimizu, M; Furusyo, N; Mitsumoto, F; Takayama, K; Ura, K; Hiramine, S; Ikezaki, H; Ihara, T; Mukae, H; Ogawa, E; Toyoda, K; Kainuma, M; Murata, M; Hayashi, J				Shimizu, Motohiro; Furusyo, Norihiro; Mitsumoto, Fujiko; Takayama, Koji; Ura, Kazuya; Hiramine, Satoshi; Ikezaki, Hiroaki; Ihara, Takeshi; Mukae, Haru; Ogawa, Eiichi; Toyoda, Kazuhiro; Kainuma, Mosaburo; Murata, Masayuki; Hayashi, Jun			Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: Results from the Kyushu and Okinawa Population Study (KOPS)	ATHEROSCLEROSIS			English	Article						Atherosclerosis; Carotid intima-media thickness; Triglycerides; Chronic kidney disease (CKD); Estimated glomerular filtration rate (eGFR)	INTIMA-MEDIA THICKNESS; DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CHINESE POPULATION; RENAL-FUNCTION; UNITED-STATES; ASSOCIATION; HYPERTENSION	Objective: To examine whether or not subclinical atherosclerosis independently predicts the incidence of chronic kidney disease (CKD) in the Japanese general population. Methods: This study is part of the Kyushu and Okinawa Population Study (KOPS), a survey of vascular events associated with lifestyle-related diseases. Participants who attended both baseline (2004-2007) and follow-up (2009-2012) examinations were eligible. The common carotid intima-media thickness (IMT) was assessed for each participant at baseline. The end point was the incidence of CKD, defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) during the follow-up of participants without CKD at baseline. Results: During the five-year follow-up, 224 of the 1824 participants (12.3%) who developed CKD had higher carotid IMT (0.74 +/- 0.22 vs. 0.65 +/- 0.14 mm, P < 0.001), higher triglycerides (1.6 +/- 0.8 vs. 1.3 +/- 0.7 mmol/L, P < 0.001), and lower high density lipoprotein cholesterol (1.5 +/- 0.4 vs. 1.6 +/- 0.4 mmol/L, P < 0.001) at baseline than those who did not. In logistic regression analysis adjusted for significant covariates, eGFR (Odds ratio [OR] 0.83, 95% confidence interval (CI) 0.80-0.85, P < 0.001), carotid IMT (0.10 mm increase: OR 1.17, 95% CI 1.04-1.33, P = 0.010), and triglycerides (OR 1.35, 95% CI 1.06-1.73, P = 0.015) at baseline were independent predictors for the development of CKD. Conclusions: Higher carotid IMT and hypertriglyceridemia were independently associated with the development of CKD in the population studied. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Shimizu, Motohiro; Furusyo, Norihiro; Mitsumoto, Fujiko; Takayama, Koji; Ura, Kazuya; Hiramine, Satoshi; Ikezaki, Hiroaki; Ihara, Takeshi; Mukae, Haru; Ogawa, Eiichi; Toyoda, Kazuhiro; Kainuma, Mosaburo; Murata, Masayuki; Hayashi, Jun] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 8128582, Japan; [Hayashi, Jun] Haradoi Hosp, Kyushu Gen Internal Med Ctr, Fukuoka, Japan	Furusyo, N (reprint author), Kyushu Univ Hosp, Dept Gen Internal Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	smotohir@gim.med.kyushu-u.ac.jp; furusyo@gim.med.kyushu-u.ac.jp			Japan Multi-institutional Collaborative Cohort Study (J-MICC Study); Scientific Support Program for Cancer Research [221S001]; Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by the Japan Multi-institutional Collaborative Cohort Study (J-MICC Study), a Scientific Support Program for Cancer Research Grant-in-Aid for Scientific Research on Innovative Areas (No. 221S001), and a Grant-in-Aid for Comprehensive Research of the 21st Century COE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Han LL, 2010, NEPHROL DIAL TRANSPL, V25, P1859, DOI 10.1093/ndt/gfp718; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Muntner P, 2002, J AM SOC NEPHROL, V13; Meisinger C, 2006, EUR HEART J, V27, P1245, DOI 10.1093/eurheartj/ehi880; Ishizaka N, 2007, HYPERTENS RES, V30, P1035, DOI 10.1291/hypres.30.1035; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Coleman A, 2008, BLOOD PRESS MONIT, V13, P49, DOI 10.1097/MBP.0b013e3282cb57b6; Tonelli M, 2014, ANN INTERN MED, V160, P182, DOI 10.7326/M13-2453; Furusyo N, 2013, INT J CARDIOL, V167, P2066, DOI 10.1016/j.ijcard.2012.05.045; Unno M, 2012, J ATHEROSCLER THROMB, V19, P462; Sacks FM, 2014, CIRCULATION, V129, P999, DOI 10.1161/CIRCULATIONAHA.113.002529; McLaughlin T, 2003, ANN INTERN MED, V139, P802; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Zhang LX, 2007, AM J KIDNEY DIS, V49, P786, DOI 10.1053/j.ajkd.2007.03.011; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Furusyo N, 2013, ATHEROSCLEROSIS, V231, P238, DOI 10.1016/j.atherosclerosis.2013.09.008; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Lisowska A, 2009, ATHEROSCLEROSIS, V202, P470, DOI 10.1016/j.atherosclerosis.2008.05.051; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Ohara T, 2013, STROKE, V44, P3537, DOI 10.1161/STROKEAHA.113.002957; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Cases Aleix, 2005, Kidney Int Suppl, pS87; Choi SW, 2010, ATHEROSCLEROSIS, V212, P661, DOI 10.1016/j.atherosclerosis.2010.06.039; Chonchol M, 2008, NEPHROL DIAL TRANSPL, V23, P2593, DOI 10.1093/ndt/gfn021; Dasmahapatra P, 2011, ANN EPIDEMIOL, V21, P311, DOI 10.1016/j.annepidem.2011.01.007; Dogra G, 2006, AM J KIDNEY DIS, V48, P926, DOI 10.1053/j.ajkd.2006.08.008; Erten S, 2011, NEPHROLOGY, V16, P720, DOI 10.1111/j.1440-1797.2011.01499.x; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Ihara T, 2013, ARCH VIROL, V158, P2465, DOI 10.1007/s00705-013-1746-z; Ikezaki H, 2014, DIABETES RES CLIN PR, V103, P88, DOI 10.1016/j.diabres.2013.11.018; Ito H, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-18; Kong XL, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-37; Ohnishi H, 2010, J ATHEROSCLER THROMB, V17, P751; Shimizu M, 2009, AM J HYPERTENS, V22, P611, DOI 10.1038/ajh.2009.61; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Wang F, 2010, NEPHROL DIAL TRANSPL, V25, P3924, DOI 10.1093/ndt/gfq327	38	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	FEB	2015	238	2					207	212		10.1016/j.atherosclerosis.2014.12.013		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AZ1UL	WOS:000348023000011		
J	Kadoya, M; Koyama, H; Kurajoh, M; Kanzaki, A; Kakutani-Hatayama, M; Okazaki, H; Shoji, T; Moriwaki, Y; Yamamoto, T; Emoto, M; Inaba, M; Namba, M				Kadoya, Manabu; Koyama, Hidenori; Kurajoh, Masafumi; Kanzaki, Akinori; Kakutani-Hatayama, Miki; Okazaki, Hirokazu; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Emoto, Masanori; Inaba, Masaaki; Namba, Mitsuyoshi			Sleep, cardiac autonomic function, and carotid atherosclerosis in patients with cardiovascular risks: HSCAA study	ATHEROSCLEROSIS			English	Article						Cohort study; Sleep efficiency; Actigraph; Heart rate variability; Carotid plaque	HEART-RATE-VARIABILITY; INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; ALL-CAUSE MORTALITY; WALL THICKNESS; MENTAL STRESS; DURATION; INFLAMMATION; METAANALYSIS; ASSOCIATION	Objectives: Behavioral and psychosocial factors have been gaining increased attention in regard to cardiovascular diseases. We evaluated sleep conditions, cardiac autonomic function, and carotid atherosclerosis in subjects who participated in the Hyogo Sleep Cardio-Autonomic Atherosclerosis (HSCAA) Study. Methods: This cross-sectional study included 330 serial patients registered in the HSCAA study who were free from past cardiovascular diseases, and prescribing alpha- or beta-blockers. In addition to clinical background and classical cardiovascular risk factors, sleep efficiency, apnea hypopnea index (AHI), awake physical activity, heart rate variability (HRV), carotid intima-media thickness (IMT), presence of plaque and plaque score were determined. Results: Sleep efficiency (r = -0.183) and all HRV parameters (SDNN: r = -0.202; rMSSD: r = -0.234; pNN50: r = -0.277) were significantly (p < 0.01) and negatively associated with IMT, while AHI (r = 0.220, p < 0.001) was positively associated with IMT. Similarly, sleep efficiency (r = -0.129), HRV parameters (SDNN: r = -0.170; rMSSD: r = -0.217; pNN50: r = -0.260) and AHI (r = 0.184) were also significantly (p < 0.05) associated with plaque scores. Multivariate logistic regression analyses showed that rMSSD, but not sleep efficiency or AHI, was significantly associated with carotid plaque (OR 0.74, 95% CI 0.56-0.98, p = 0.037), independent of classical risk factors. The association of rMSSD with carotid plaque remained significant even after adjustment for sleep efficiency or AHI. A comparison of risk factors in specific subgroups showed that the association of lower HRV with carotid plaque was more prominent in patients with cardiovascular risk factors including male gender, hypertension, dyslipidemia and diabetes mellitus. Conclusion: Cardiac autonomic nervous dysfunction was independently associated with carotid atherosclerosis, independent of sleep condition. Moreover, that association was more prominent in specific subgroups with cardiovascular risk factors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kadoya, Manabu; Koyama, Hidenori; Kurajoh, Masafumi; Kanzaki, Akinori; Kakutani-Hatayama, Miki; Okazaki, Hirokazu; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Namba, Mitsuyoshi] Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan; [Emoto, Masanori; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Endocrinol Metab & Mol Med, Osaka 558, Japan	Koyama, H (reprint author), Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	hkoyama@hyo-med.ac.jp					Abe T, 2011, ATHEROSCLEROSIS, V217, P509, DOI 10.1016/j.atherosclerosis.2011.02.029; Liao DP, 1997, AM J EPIDEMIOL, V145, P696; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Gullette ECD, 1997, JAMA-J AM MED ASSOC, V277, P1521, DOI 10.1001/jama.277.19.1521; Koyama H, 2010, CLIN J AM SOC NEPHRO, V5, P659, DOI 10.2215/CJN.08151109; [Anonymous], 2004, DIABETES CARE S1, V27, pS5; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Jain D, 1998, J AM COLL CARDIOL, V31, P1314, DOI 10.1016/S0735-1097(98)00092-8; Hijmering ML, 2002, J AM COLL CARDIOL, V39, P683, DOI 10.1016/S0735-1097(01)01786-7; Suzuki T, 2004, SLEEP, V27, P129; Tsuji H, 1996, CIRCULATION, V94, P2850; Cappuccio FP, 2010, SLEEP, V33, P585; Gottsater A, 2006, CLIN AUTON RES, V16, P228, DOI 10.1007/s10286-006-0345-4; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483; TESFAMARIAM B, 1992, J VASC RES, V29, P396, DOI 10.1159/000158956; Melillo P, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-105; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Tamakoshi A, 2004, SLEEP, V27, P51; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; HANDA N, 1990, STROKE, V21, P1567; Fujii H, 2013, J RENAL NUTR, V23, P340, DOI 10.1053/j.jrn.2012.12.008; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Koyama H, 2003, CIRCULATION, V108, P524, DOI 10.1161/01.CIR.0000081765.88440.51; Yanase T, 2006, AM J HYPERTENS, V19, P1206, DOI 10.1016/j.amjhyper.2006.05.010; Poliakova N, 2012, METABOLISM, V61, P1270, DOI 10.1016/j.metabol.2012.02.006; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Pizzi C, 2010, ATHEROSCLEROSIS, V212, P292, DOI 10.1016/j.atherosclerosis.2010.04.038; Badimon L, 1999, THROMB HAEMOSTASIS, V82, P1736; DZAU VJ, 1987, J CARDIOVASC PHARM, V10, pS2; Kadoya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105977; Krantz DS, 2000, JAMA-J AM MED ASSOC, V283, P1800, DOI 10.1001/jama.283.14.1800; Liao DP, 1995, DIABETES RES CLIN PR, V30, P211, DOI 10.1016/0168-8227(95)01190-0; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Maeno T, 2002, DIABETES, V51, P1523, DOI 10.2337/diabetes.51.5.1523; Patel SR, 2009, AM J EPIDEMIOL, V170, P814, DOI 10.1093/aje/kwp228; Silvestrini M, 2002, STROKE, V33, P1782, DOI 10.1161/01.STR.0000019123.47840.2D; Teramoto Tamio, 2013, J Atheroscler Thromb, V20, P517	38	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	FEB	2015	238	2					409	414		10.1016/j.atherosclerosis.2014.12.032		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AZ1UL	WOS:000348023000038		
J	Ikeda, H; Adachi, K; Fujita, S; Tomiyama, K; Saigusa, T; Kobayashi, M; Koshikawa, N; Waddington, JL				Ikeda, Hiroko; Adachi, Kazunori; Fujita, Satoshi; Tomiyama, Katsunori; Saigusa, Tadashi; Kobayashi, Masayuki; Koshikawa, Noriaki; Waddington, John L.			Investigating complex basal ganglia circuitry in the regulation of motor behaviour, with particular focus on orofacial movement	BEHAVIOURAL PHARMACOLOGY			English	Review						acetylcholine; gamma-aminobutyric acid; basal ganglia; behaviour; dopamine; efferent systems; glutamate; orofacial movements; spiralling circuitry; turning-pivoting	PEDUNCULOPONTINE TEGMENTAL NUCLEUS; MESENCEPHALIC LOCOMOTOR REGION; SEPARATE NEURONAL POPULATIONS; THALAMIC MEDIODORSAL NUCLEUS; GABA-MEDIATED INHIBITION; PARS RETICULATA NEURONS; RAT PREFRONTAL CORTEX; AMINO-ACID MECHANISMS; FREELY MOVING RATS; JAW MOVEMENTS	Current concepts of basal ganglia function have evolved from the essentially motoric, to include a range of extramotoric functions that involve not only dopaminergic but also cholinergic, gamma-aminobutyric acid (GABA)ergic and glutamatergic mechanisms. We consider these mechanisms and their efferent systems, including spiralling, feed-forward striato-nigro-striatal circuitry, involving the dorsal and ventral striatum and the nucleus accumbens (NAc) core and shell. These processes are illustrated using three behavioural models: turning-pivoting, orofacial movements in rats and orofacial movements in genetically modified mice. Turning-pivoting indicates that dopamine-dependent behaviour elicited from the NAc shell is funnelled through the NAc-nigro-striato-nigro-pedunculopontine pathway, whereas acetylcholine-dependent behaviour elicited from the NAc shell is funnelled through the NAc-ventral pallidum-mediodorsal thalamus pathway. Cooperative/synergistic interactions between striatal D1-like and D2-like dopamine receptors regulate individual topographies of orofacial movements that are funnelled through striatal projection pathways and involve interactions with GABAergic and glutamatergic receptor subtypes. This application of concerted behavioural, neurochemical and neurophysiological techniques implicates a network that is yet broader and interacts with other neurotransmitters and neuropeptides within subcortical, cortical and brainstem regions to 'sculpt' aspects of behaviour into its topographical collective. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Ikeda, Hiroko; Adachi, Kazunori; Fujita, Satoshi; Tomiyama, Katsunori; Saigusa, Tadashi; Kobayashi, Masayuki; Koshikawa, Noriaki] Nihon Univ, Sch Dent, Dept Pharmacol, Tokyo 101, Japan; [Ikeda, Hiroko] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Tokyo 142, Japan; [Adachi, Kazunori] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Saitama, Japan; [Saigusa, Tadashi] Nihon Univ, Sch Dent Matsudo, Dept Pharmacol, Chiba, Japan; [Waddington, John L.] Royal Coll Surgeons Ireland, Dublin 2, Ireland	Waddington, JL (reprint author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	jwadding@rcsi.ie			JSPS KAKENHI [26430024]; Hoshi University Ohtani Research Grants; Sato Fund Nihon University School of Dentistry; MEXT-Supported Program for Strategic Research Foundation at Private Universities; JSPS Invitation Fellowship [S-12209]; Science Foundation Ireland Principal Investigator grant [07/IN.1/B960]; Science Foundation Ireland under the International Strategic Cooperation Award [SFI/13/ISCA/284]	The authors dedicate this article to the life and work of Alexander R. Cools, who for 25 years was an esteemed international visitor and collaborator at the Department of Pharmacology, Nihon University School of Dentistry, Tokyo, in relation to the findings and concepts described herein. These studies were supported by JSPS KAKENHI Grant Number 26430024 (HI), Hoshi University Ohtani Research Grants (HI), Sato Fund Nihon University School of Dentistry (M.K., T.S., and S.F.), MEXT-Supported Program for Strategic Research Foundation at Private Universities, 2013-2017 (M.K.), JSPS Invitation Fellowship S-12209 (N.K., J.L.W.) and Science Foundation Ireland Principal Investigator grant 07/IN.1/B960 (J.L.W.). This publication has emanated from research conducted with the financial support of Science Foundation Ireland under the International Strategic Cooperation Award Grant Number SFI/13/ISCA/284.	Adachi K, 2003, EUR J PHARMACOL, V473, P47, DOI 10.1016/S0014-2999(03)01938-1; Adachi K, 2002, EUR J PHARMACOL, V442, P81; Adachi K, 2003, EUR J PHARMACOL, V464, P147, DOI 10.1016/S0014-2999(03)01428-6; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Sessle BJ, 2007, ARCH ORAL BIOL, V52, P334, DOI 10.1016/j.archoralbio.2006.11.002; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; DEVINE DP, 1993, J PHARMACOL EXP THER, V266, P1236; Taylor JL, 2010, BRAIN RES, V1322, P92, DOI 10.1016/j.brainres.2010.01.052; Waddington JL, 2005, PSYCHOPHARMACOLOGY, V181, P611, DOI 10.1007/s00213-005-0058-8; Ikeda H, 2013, NEUROSCIENCE, V241, P126, DOI 10.1016/j.neuroscience.2013.03.023; Meyer-Luehmann M, 2002, EUR J NEUROSCI, V16, P1599, DOI 10.1046/j.1460-9568.2002.02210.x; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; ZAHM DS, 1990, J COMP NEUROL, V302, P437, DOI 10.1002/cne.903020302; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; SAPER CB, 1982, BRAIN RES, V252, P367, DOI 10.1016/0006-8993(82)90404-8; Bamford NS, 2004, J NEUROSCI, V24, P9541, DOI 10.1523/JNEUROSCI.2891-04.2004; Walls AB, 2010, J NEUROCHEM, V115, P1398, DOI 10.1111/j.1471-4159.2010.07043.x; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Ohtsuka N, 2008, P NATL ACAD SCI USA, V105, P12961, DOI 10.1073/pnas.0806180105; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; Adachi K, 2008, J NEUROPHYSIOL, V100, P1234, DOI 10.1152/jn.90609.2008; LEONE P, 1991, PHARMACOL BIOCHEM BE, V39, P469, DOI 10.1016/0091-3057(91)90210-S; Haber SN, 2000, J NEUROSCI, V20, P2369; Ikeda H, 2012, J PHARMACOL SCI, V120, P152, DOI 10.1254/jphs.12R02CR; Ikeda H, 2013, NEUROSCIENCE, V252, P60, DOI 10.1016/j.neuroscience.2013.07.066; Berridge KC, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-4; SKINNER RD, 1984, BRAIN RES, V323, P385, DOI 10.1016/0006-8993(84)90319-6; LEE HJ, 1988, J COMP NEUROL, V275, P469, DOI 10.1002/cne.902750402; Churchill L, 1996, NEUROSCIENCE, V70, P93, DOI 10.1016/0306-4522(95)00351-I; Xu HY, 2011, NEUROSCI RES, V71, P411, DOI 10.1016/j.neures.2011.08.011; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Rotaru DC, 2005, J COMP NEUROL, V490, P220, DOI 10.1002/cne.20661; BENINATO M, 1986, J COMP NEUROL, V253, P525, DOI 10.1002/cne.902530409; Adachi K, 2007, SOMATOSENS MOT RES, V24, P97, DOI 10.1080/08990220701470451; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; WAYLER AH, 1983, J PROSTHET DENT, V49, P427, DOI 10.1016/0022-3913(83)90289-5; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; GARCIARILL E, 1986, BRAIN RES REV, V11, P47, DOI 10.1016/0165-0173(86)90009-3; DELFS JM, 1990, NEUROSCIENCE, V39, P59, DOI 10.1016/0306-4522(90)90221-O; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; FERRON A, 1984, BRAIN RES, V302, P257, DOI 10.1016/0006-8993(84)90238-5; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Sessle BJ, 2005, CLIN EXP PHARMACOL P, V32, P109, DOI 10.1111/j.1440-1681.2005.04137.x; Saitoh K, 2003, EUR J NEUROSCI, V18, P879, DOI 10.1046/j.1460-9568.2003.02825.x; BRUDZYNSKI SM, 1986, BRAIN RES BULL, V16, P377, DOI 10.1016/0361-9230(86)90059-6; Bursten SN, 2000, J COMP PSYCHOL, V114, P281, DOI 10.1037//0735-7036.114.3.281; Carlsson A, 2001, BIOSCIENCE REP, V21, P691, DOI 10.1023/A:1015556204669; CHILDS JA, 1984, BRAIN RES, V304, P387, DOI 10.1016/0006-8993(84)90345-7; Churchill L, 1996, NEUROSCIENCE, V70, P103, DOI 10.1016/0306-4522(95)00352-J; Churchill L, 1999, BEHAV BRAIN RES, V104, P63, DOI 10.1016/S0166-4328(99)00051-0; COOLS AR, 1991, BRAIN RES BULL, V26, P909, DOI 10.1016/0361-9230(91)90256-J; Cools A.R., 1988, NEUROBIOLOGICAL APPR, V2, P15; COOLS AR, 1975, J NEURAL TRANSM, V36, P91, DOI 10.1007/BF01256757; COOLS AR, 1989, NEUROSCIENCE, V33, P535, DOI 10.1016/0306-4522(89)90405-3; Di Chiara G, 2002, HDB EXPT PHARM DOPAM; DIANA M, 1992, EUR J PHARMACOL, V211, P415, DOI 10.1016/0014-2999(92)90400-X; DICHIARA G, 1979, N-S ARCH PHARMACOL, V306, P153; Dum RP, 2005, MOTOR CORTEX VOLUNTA, P3; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; ELLENBROEK B, 1985, NEUROSCI LETT, V54, P189; ELLISON G, 1987, PSYCHOPHARMACOLOGY, V92, P122, DOI 10.1007/BF00215492; Fujita S, 2004, EUR J PHARMACOL, V484, P75, DOI 10.1016/j.ejphar.2003.10.050; Fujita S, 2010, BRAIN RES, V1322, P30, DOI 10.1016/j.brainres.2010.01.068; Fujita Satoshi, 2008, J Oral Sci, V50, P387; Fujita S, 2010, EUR J PHARMACOL, V632, P39, DOI 10.1016/j.ejphar.2010.01.018; Fujita S, 2013, SYNAPSE, V67, P363, DOI 10.1002/syn.21644; GLENTHOJ B, 1991, LIFE SCI, V48, P2137, DOI 10.1016/0024-3205(91)90146-3; GOLDSMITH M, 1988, BRAIN RES, V445, P386, DOI 10.1016/0006-8993(88)91205-X; GUNNE LM, 1986, PHARMACOL BIOCHEM BE, V25, P897, DOI 10.1016/0091-3057(86)90404-1; Ikeda H, 2004, NEUROSCIENCE, V125, P553, DOI 10.1016/j.neuroscience.2004.02.021; Ikeda H, 1999, J NEURAL TRANSM, V106, P1205, DOI 10.1007/s007020050234; Ikeda H, 2009, NEUROSCIENCE, V159, P1200, DOI 10.1016/j.neuroscience.2009.02.015; Ikeda H, 2010, NEUROSCIENCE, V167, P31, DOI 10.1016/j.neuroscience.2010.01.054; INGLIS WL, 1994, NEUROSCIENCE, V58, P817, DOI 10.1016/0306-4522(94)90459-6; Inglis WL, 2000, BEHAV NEUROSCI, V114, P285, DOI 10.1037//0735-7044.114.2.285; JONES MW, 1988, EXP BRAIN RES, V69, P623; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; KELLEY AE, 1994, NEUROSCIENCE, V60, P85, DOI 10.1016/0306-4522(94)90205-4; Kim HA, 2014, NEUROBIOL DIS, V62, P323, DOI 10.1016/j.nbd.2013.09.015; Kitamura M, 2001, NEUROSCIENCE, V104, P117, DOI 10.1016/S0306-4522(01)00053-7; Kitamura M, 1999, NEUROPHARMACOLOGY, V38, P1397, DOI 10.1016/S0028-3908(99)00046-5; Kobayashi M, 2011, TRANSLATING MECH ORO; Koshikawa N, 2011, INT REV NEUROBIOL, V97, P1, DOI 10.1016/B978-0-12-385198-7.00001-1; KOSHIKAWA N, 1989, EUR J PHARMACOL, V163, P227, DOI 10.1016/0014-2999(89)90191-X; Koshikawa N, 1996, PSYCHOPHARMACOLOGY, V126, P185, DOI 10.1007/BF02246447; Koshikawa N, 1994, Rev Neurosci, V5, P331; KOSHIKAWA N, 1990, EUR J PHARMACOL, V182, P375, DOI 10.1016/0014-2999(90)90297-J; Kubo K, 2009, J PHARMACOL EXP THER, V331, P162, DOI 10.1124/jpet.109.156034; Kubo K, 2009, J PHARMACOL EXP THER, V329, P592, DOI 10.1124/jpet.109.151456; LAMBERT RW, 1986, J NEUROPHYSIOL, V55, P301; Lee J, 2003, METHOD FIND EXP CLIN, V25, P525, DOI 10.1358/mf.2003.25.7.778091; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lund JP, 2008, OROFACIAL PAIN BASIC, P117; Maurice N, 1997, NEUROSCIENCE, V80, P523, DOI 10.1016/S0306-4522(97)00002-X; Maurin Y, 1999, NEUROSCIENCE, V91, P891, DOI 10.1016/S0306-4522(98)00681-2; Mele A, 1998, NEUROSCIENCE, V82, P43; MEREDITH GE, 1992, NEUROSCIENCE, V50, P149, DOI 10.1016/0306-4522(92)90389-J; MOGENSON GJ, 1987, BRAIN RES, V404, P221, DOI 10.1016/0006-8993(87)91373-4; MOGENSON GJ, 1983, BRAIN RES BULL, V11, P309, DOI 10.1016/0361-9230(83)90166-1; MOGENSON GJ, 1988, BRAIN RES BULL, V20, P241, DOI 10.1016/0361-9230(88)90184-0; MORIIZUMI T, 1992, NEUROSCIENCE, V46, P701, DOI 10.1016/0306-4522(92)90156-V; Nakamura Yoshio, 1999, Journal of Medical and Dental Sciences, V46, P63; Romanelli RJ, 2010, RECEPT SER, P137, DOI 10.1007/978-1-60327-333-6_6; RUPNIAK NMJ, 1983, PSYCHOPHARMACOLOGY, V79, P226, DOI 10.1007/BF00427817; SAIGUSA T, 1993, EUR J PHARMACOL, V237, P161, DOI 10.1016/0014-2999(93)90264-I; Satorra-Marin N, 2001, BEHAV BRAIN RES, V118, P1, DOI 10.1016/S0166-4328(00)00306-5; Scheel-Krüger J, 1986, Acta Neurol Scand Suppl, V107, P1; SEE RE, 1990, PSYCHOPHARMACOLOGY, V100, P404, DOI 10.1007/BF02244615; Sessle BJ, 2008, OROFACIAL PAIN BASIC, P109; Skinner R D, 1990, Neuroreport, V1, P207, DOI 10.1097/00001756-199011000-00008; SPANN BM, 1991, J COMP NEUROL, V311, P375, DOI 10.1002/cne.903110308; SUGIMOTO T, 1984, NEUROSCIENCE, V11, P931, DOI 10.1016/0306-4522(84)90204-5; SWANSON LW, 1984, BRAIN RES, V295, P161, DOI 10.1016/0006-8993(84)90827-8; SWERDLOW NR, 1987, BRAIN RES, V412, P233, DOI 10.1016/0006-8993(87)91129-2; TAKADA M, 1988, BRAIN RES, V442, P72, DOI 10.1016/0006-8993(88)91433-3; TAKADA M, 1994, J COMP NEUROL, V342, P409, DOI 10.1002/cne.903420308; Tomiyama K, 2006, NEUROPSYCHOPHARMACOL, V16, P437; Tomiyama K, 2004, SYNAPSE, V51, P71, DOI 10.1002/syn.10284; Tomiyama K, 2002, NEUROPHARMACOLOGY, V42, P644, DOI 10.1016/S0028-3908(02)00023-0; Tomiyama K, 2011, INT REV NEUROBIOL, V97, P61, DOI 10.1016/B978-0-12-385198-7.00003-5; Tomiyama K, 2011, SYNAPSE, V65, P835, DOI 10.1002/syn.20910; Tomiyama K, 2013, NEUROSCIENCE, V250, P743, DOI 10.1016/j.neuroscience.2013.07.038; Tomiyama K, 2006, DISRUPTION OROFACIAL; Tomiyama K, 2010, SYNAPSE, V64, P714, DOI 10.1002/syn.20798; Tomiyama K, 2012, J PHARMACOL SCI, V119, P297, DOI 10.1254/jphs.12R05CP; Tomiyama K, 2001, EUR J PHARMACOL, V418, P47, DOI 10.1016/S0014-2999(01)00908-6; Van den Bos R, 2003, NEUROSCIENCE, V118, P1141, DOI 10.1016/S0306-4522(03)00058-7; Van Dongen YC, 2009, ADV BEHAV BIOL, V58, P119, DOI 10.1007/978-1-4419-0340-2_10; VONKROSIGK M, 1992, NEUROSCIENCE, V50, P531, DOI 10.1016/0306-4522(92)90445-8; WADDINGTON JL, 1990, PSYCHOPHARMACOLOGY, V101, P431, DOI 10.1007/BF02244220; Wakasugi M, 1999, ANESTH ANALG, V88, P676, DOI 10.1097/00000539-199903000-00039; Wang L, 2014, INT J NEUROPSYCHOPH, V17, P753, DOI 10.1017/S1461145713001570; YOUNG WS, 1984, J NEUROSCI, V4, P1626; Zahm DS, 1996, J COMP NEUROL, V364, P340, DOI 10.1002/(SICI)1096-9861(19960108)364:2<340::AID-CNE11>3.0.CO;2-T	140	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	FEB	2015	26	1-2			SI		18	32		10.1097/FBP.0000000000000118		15	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	AZ3QC	WOS:000348140800004		
J	Aono, Y; Taguchi, H; Saigusa, T; Uchida, T; Takada, K; Takiguchi, H; Shirakawa, T; Shimizu, N; Koshikawa, N; Cools, AR				Aono, Yuri; Taguchi, Hiroko; Saigusa, Tadashi; Uchida, Takuya; Takada, Koji; Takiguchi, Hatakazu; Shirakawa, Tetsuo; Shimizu, Noriyoshi; Koshikawa, Noriaki; Cools, Alexander R.			Simultaneous activation of the alpha(1A)-, alpha(1B)- and alpha(1D)-adrenoceptor subtypes in the nucleus accumbens reduces accumbal dopamine efflux in freely moving rats	BEHAVIOURAL PHARMACOLOGY			English	Article						dopamine; microdialysis; nucleus accumbens; rat; alpha(1A)-adrenoceptor; alpha(1B)-adrenoceptor; alpha(1D)-adrenoceptor	ALPHA(1B)-ADRENOCEPTOR ANTAGONIST; LOCUS-COERULEUS; ALPHA(1)-ADRENOCEPTOR SUBTYPES; RECEPTOR SUBTYPES; NEURONS; MICRODIALYSIS; ADRENOCEPTORS; PRAZOSIN; AGONISTS; PROFILE	Intra-accumbal infusion of the alpha(1)-adrenergic agonist methoxamine, which has comparable affinity for alpha(1A)-, alpha(1B)- and alpha(1D)-adrenoceptor subtypes, fails to alter noradrenaline efflux but reduces dopamine efflux in the nucleus accumbens of rats. In-vivo microdialysis experiments were carried out to analyse the putative contribution of alpha(1A)-, alpha(1B)- and alpha(1D)-adrenoceptor subtypes to the methoxamine-induced decrease in accumbal dopamine efflux in freely moving rats. The drugs used were dissolved in the infusion medium and administered locally through a dialysis membrane. Intra-accumbal infusions of the alpha(1A)-adrenoceptor antagonist 5-methylurapidil (6 pmol), the alpha(1B)-adrenoceptor antagonist cyclazosin (0.6 and 6 pmol) and the alpha(1D)-adrenoceptor antagonist BMY 7378 (0.6 pmol) did not alter accumbal efflux of noradrenaline or dopamine: pretreatment with each of these alpha 1-adrenoceptor subtype-selective antagonists counteracted the methoxamine (24 pmol)-induced decrease in accumbal dopamine efflux. Doses indicated are the total amount of drug administered over a 60-min infusion period. These results clearly suggest that the alpha(1A)-, alpha(1B)- and alpha(1D)-adrenoceptor subtypes in the nucleus accumbens mediate the alpha 1-adrenergic agonist methoxamine-induced decrease in accumbal dopamine efflux. The present study also provides in-vivo neurochemical evidence indicating that concomitant, but not separate, activation of the alpha(1A)-, alpha(1B)-and alpha(1D)-adrenoceptors in the nucleus accumbens is required for alpha(1)-adrenergic inhibition of accumbal dopaminergic activity. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Aono, Yuri; Saigusa, Tadashi] Nihon Univ, Sch Dent Matsudo, Dept Pharmacol, Matsudo, Chiba 2718587, Japan; [Aono, Yuri; Koshikawa, Noriaki] Nihon Univ, Sch Dent, Dent Res Ctr, Dept Pharmacol, Tokyo 101, Japan; [Taguchi, Hiroko; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Dent Res Ctr, Dept Orthodont, Tokyo 101, Japan; [Uchida, Takuya; Takada, Koji] Nihon Univ, Sch Dent, Dent Res Ctr, Dept Anaesthesiol, Tokyo 101, Japan; [Takiguchi, Hatakazu; Shirakawa, Tetsuo] Nihon Univ, Sch Dent, Dent Res Ctr, Dept Pediat Dent, Tokyo 101, Japan; [Koshikawa, Noriaki] Nihon Univ, Sch Dent, Dent Res Ctr, Div Oral & Craniomaxillofacial Res, Tokyo 101, Japan; [Cools, Alexander R.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Div Psychoneuropharmacol, Dept Cognit Neurosci,Med Ctr Nijmegen, Nijmegen, Netherlands	Saigusa, T (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Pharmacol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	saigusa.tadashi@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25463100, 24593062, 23593045, 25861763]; grant for the Promotion and Mutual Aid Corporation for Private Schools of Japan; Nihon University Multidisciplinary Research Grant; Sato Fund; Uemura Fund; Dental Research Centre, Nihon University School of Dentistry	This study was supported by a Grant-in-Aid for Scientific Research (C) (#25463100 to T.S.; #24593062 to K.T.; #23593045 to T.S.), a Grant-in-Aid for Young Scientists (B) (#25861763 to Y.A.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a grant for the Promotion and Mutual Aid Corporation for Private Schools of Japan (H.T., T.S., N.S., N.K.), the Nihon University Multidisciplinary Research Grant for 2014-2015 (Y.A., T.S.), and Research Grants from the Sato Fund (T.S., N.K.), Uemura Fund (T.S., T.U., N.S.) and the Dental Research Centre (T.S., N.K.), Nihon University School of Dentistry.	Gotoh Y, 2011, NEUROPHARMACOLOGY, V61, P825, DOI 10.1016/j.neuropharm.2011.05.030; Forget B, 2010, NEUROPSYCHOPHARMACOL, V35, P1751, DOI 10.1038/npp.2010.42; Ma JY, 2006, PROG NEURO-PSYCHOPH, V30, P647, DOI 10.1016/j.pnpbp.2005.11.040; CEDARBAUM JM, 1978, J COMP NEUROL, V178, P1, DOI 10.1002/cne.901780102; GRENHOFF J, 1993, EUR J PHARMACOL, V233, P79, DOI 10.1016/0014-2999(93)90351-H; Mori A, 2011, EUR J PHARMACOL, V673, P65, DOI 10.1016/j.ejphar.2011.10.012; Docherty JR, 1998, EUR J PHARMACOL, V361, P1, DOI 10.1016/S0014-2999(98)00682-7; Delfs JM, 1998, BRAIN RES, V806, P127, DOI 10.1016/S0006-8993(98)00672-6; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; Paschalis A, 2009, NEUROSCI LETT, V458, P84, DOI 10.1016/j.neulet.2009.04.023; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Methven L, 2009, BRIT J PHARMACOL, V158, P1663, DOI 10.1111/j.1476-5381.2009.00462.x; Aono Y, 2013, EUR J PHARMACOL, V715, P363, DOI 10.1016/j.ejphar.2013.04.035; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; Bylund DB, 2007, BRAIN NOREPINEPHRINE, P68, DOI 10.1017/CBO9780511544156.004; Camargo LAD, 2000, BRAIN RES, V881, P176, DOI 10.1016/S0006-8993(00)02840-7; Deighan C, 2004, BRIT J PHARMACOL, V142, P1031, DOI 10.1038/sj.bjp.0705872; Deng XF, 1998, J PHARMACOL EXP THER, V286, P489; Giardina D, 1996, J MED CHEM, V39, P4602, DOI 10.1021/jm960510x; GIARDINA D, 1995, EUR J PHARMACOL, V287, P13, DOI 10.1016/0014-2999(95)00471-7; Giardina Dario, 2003, Farmaco (Lausanne), V58, P477, DOI 10.1016/S0014-827X(02)00025-3; Goyal R, 2010, AM J PHYSIOL-HEART C, V298, pH1797, DOI 10.1152/ajpheart.00112.2010; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; HIGGINS GA, 1991, EUR J PHARMACOL, V193, P351, DOI 10.1016/0014-2999(91)90150-O; Ireland LM, 1997, EUR J PHARMACOL, V327, P79, DOI 10.1016/S0014-2999(97)89681-1; JONES LS, 1985, J COMP NEUROL, V231, P190, DOI 10.1002/cne.902310207; Meitzen J, 2011, J NEUROCHEM, V116, P984, DOI 10.1111/j.1471-4159.2010.07137.x; MINNEMAN KP, 1994, MOL PHARMACOL, V46, P929; Mizoguchi N, 2008, EUR J PHARMACOL, V601, P94, DOI 10.1016/j.ejphar.2008.10.045; NAKAMURA S, 1988, NEUROSCIENCE, V27, P921, DOI 10.1016/0306-4522(88)90195-9; Oades R D, 1987, Brain Res, V434, P117; Paladini CA, 2004, J NEUROSCI, V24, P4568, DOI 10.1523/JNEUROSCI.5735-03.2004; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Pudovkina OL, 2005, BRAIN RES, V1061, P50, DOI 10.1016/j.brainres.2005.08.049; RAINBOW TC, 1983, NEUROSCI LETT, V40, P221, DOI 10.1016/0304-3940(83)90042-3; Ramakrishna D, 2010, J NEURAL TRANSM, V117, P1423, DOI 10.1007/s00702-010-0522-4; Saigusa T, 2012, EUR J PHARMACOL, V688, P35, DOI 10.1016/j.ejphar.2012.05.005; SOMMERMEYER H, 1995, EUR J PHARMACOL, V276, P267, DOI 10.1016/0014-2999(95)00062-P; Stam WB, 1998, EUR J PHARMACOL, V361, P79, DOI 10.1016/S0014-2999(98)00735-3; Stanasila L, 2003, J BIOL CHEM, V278, P40239, DOI 10.1074/jbc.M306085200; Tuinstra T, 2000, NEUROSCIENCE, V99, P55, DOI 10.1016/S0306-4522(00)00139-1; Tuinstra T, 2000, NEUROSCIENCE, V98, P743, DOI 10.1016/S0306-4522(00)00175-5; Verheij MMM, 2008, EUR J PHARMACOL, V585, P228, DOI 10.1016/j.ejphar.2008.02.084; Verheij MMM, 2009, J NEURAL TRANSM, V116, P389, DOI 10.1007/s00702-009-0190-4; Yanai-Inamura H, 2012, EUR J PHARMACOL, V679, P127, DOI 10.1016/j.ejphar.2012.01.019; Yoshio R, 2001, JPN J PHARMACOL, V86, P189, DOI 10.1254/jjp.86.189	47	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	FEB	2015	26	1-2			SI		73	80		10.1097/FBP.0000000000000113		8	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	AZ3QC	WOS:000348140800008		
J	Verheij, MMM; Saigusa, T; Koshikawa, N; Cools, AR				Verheij, Michel M. M.; Saigusa, Tadashi; Koshikawa, Noriaki; Cools, Alexander R.			Accumbal alpha-adrenoceptors, but not beta-adrenoceptors, regulate behaviour that is mediated by reserpine-sensitive storage vesicles	BEHAVIOURAL PHARMACOLOGY			English	Article						locomotor activity; noradrenaline; noradrenaline-dopamine interactions; norepinephrine; norepinephrine-dopamine interactions; nucleus accumbens; reserpine pharmacology; storage vesicles; walking and rearing behaviour; walking and rearing behaviour	RAT NUCLEUS-ACCUMBENS; FREELY MOVING RATS; LOW RESPONDERS; <H-3>DOPAMINE RELEASE; MESOLIMBIC NORADRENALINE; EXTRACELLULAR DOPAMINE; LOCOMOTOR-ACTIVITY; WISTAR RATS; NOVELTY; STIMULATION	It has previously been demonstrated that mesolimbic alpha-adrenoceptors, but not beta-adrenoceptors, control the release of dopamine that is derived from reserpine-sensitive storage vesicles. The aim of the present study was to investigate whether these storage vesicles also regulate alpha-adrenoceptor-mediated or beta-adrenoceptor-mediated changes in behaviour. Accordingly, rats were pretreated with reserpine before the a-adrenoceptor antagonist phentolamine or the alpha-adrenoceptor agonist isoproterenol was locally applied to the nucleus accumbens. Both phentolamine and isoproterenol increased the duration of walking, rearing and grooming and decreased the duration of sitting. Reserpine counteracted the behavioural response elicited by phentolamine but not by isoproterenol. The results of the present study demonstrate that mesolimbic a-adrenoceptors, but not alpha-adrenoceptors, regulate behaviour that is mediated by reserpine-sensitive storage pools. It is hypothesized that the observed alpha-adrenoceptor-mediated increase in locomotor activity is due to the alpha-adrenoceptor-mediated increase in the release of accumbal intravesicular dopamine. Our finding that alpha-adrenoceptors inhibit, whereas beta-adrenoceptors stimulate, locomotor activity may help explain why noradrenaline or environmental stressors have previously been found to have opposing effects on the regulation of behaviour. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Verheij, Michel M. M.; Cools, Alexander R.] Radboud Univ Nijmegen, Div Psychoneuropharmacol, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci CNS,Med Ctr, NL-6525 EZ Nijmegen, Netherlands; [Saigusa, Tadashi] Nihon Univ, Sch Dent Matsudo, Dept Pharmacol, Matsudo, Chiba, Japan; [Koshikawa, Noriaki] Nihon Univ, Sch Dent, Dept Pharmacol, Chiyoda Ku, Tokyo 101, Japan	Verheij, MMM (reprint author), Radboud Univ Nijmegen, Div Psychoneuropharmacol, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci CNS,Med Ctr, Geert Grooteplein 21, NL-6525 EZ Nijmegen, Netherlands.	m.verheij@cns.umcn.nl			Ministry of Education and Science, in the Netherlands	This work was partly financed by a special incentive of the Ministry of Education and Science, in the Netherlands, to promote top research at the former department of Psychoneuropharmacology (PNF). The authors thank Sjef van Hulten for analysis of behaviour and production of Fig. 1, and Alexander (Lex) R. Cools for his excellent scientific input during their careers. He was a dear friend, and his passion and creativity was an inspiration to many of his colleagues.	KALIVAS PW, 1984, NEUROSCIENCE, V11, P919, DOI 10.1016/0306-4522(84)90203-3; Saigusa T, 1999, NEUROSCIENCE, V88, P1153, DOI 10.1016/S0306-4522(98)00275-9; Mitrano DA, 2012, NEUROPSYCHOPHARMACOL, V37, P2161, DOI 10.1038/npp.2012.68; Wee S, 2008, EUR NEUROPSYCHOPHARM, V18, P303, DOI 10.1016/j.euroneuro.2007.08.003; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; RUSSELL VA, 1988, NEUROCHEM RES, V13, P487, DOI 10.1007/BF01268885; Economidou D, 2012, NEUROPSYCHOPHARMACOL, V37, P2057, DOI 10.1038/npp.2012.53; De Leonibus E, 2006, EUR J NEUROSCI, V23, P1332, DOI 10.1111/j.1460-9568.2006.04658.x; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Aono Y, 2013, EUR J PHARMACOL, V715, P363, DOI 10.1016/j.ejphar.2013.04.035; Clifford JJ, 1998, NEUROPHARMACOLOGY, V37, P1595, DOI 10.1016/S0028-3908(98)00116-6; Clifford JJ, 2000, NEUROPSYCHOPHARMACOL, V22, P538, DOI 10.1016/S0893-133X(99)00141-4; Cole B J, 1988, Brain Res, V472, P325, DOI 10.1016/0006-8993(88)91225-5; Compton DM, 1995, NEUROREPORT, V7, P177, DOI 10.1097/00001756-199512000-00043; COOLS AR, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P141; COOLS AR, 1990, BRAIN RES BULL, V24, P49, DOI 10.1016/0361-9230(90)90288-B; COOLS AR, 1988, ANN NY ACAD SCI, V525, P338, DOI 10.1111/j.1749-6632.1988.tb38618.x; COOLS AR, 1987, BEHAV BRAIN RES, V25, P49, DOI 10.1016/0166-4328(87)90044-1; Cools AR, 1996, ADV BEHAV BIOL, V47, P493; COOLS AR, 1978, EUR J PHARMACOL, V50, P265, DOI 10.1016/0014-2999(78)90359-X; COSTALL B, 1976, PSYCHOPHARMACOLOGY, V48, P225, DOI 10.1007/BF00423265; COSTALL B, 1975, EUR J PHARMACOL, V32, P87, DOI 10.1016/0014-2999(75)90326-X; Ellenbroek BA, 2014, PSYCHOPHARMACOLOGY, V231, P2219, DOI 10.1007/s00213-014-3583-5; Haile Colin N, 2012, Brain Sci, V2, P619, DOI 10.3390/brainsci2040619; Hajnal A, 2004, PHYSIOL BEHAV, V82, P43, DOI 10.1016/j.physbeh.2004.04.024; Ikeda H, 2007, EUR J PHARMACOL, V554, P175, DOI 10.1016/j.ejphar.2006.10.007; JACKSON DM, 1975, PSYCHOPHARMACOLOGIA, V45, P139, DOI 10.1007/BF00429052; Meyer F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00243; NURSE B, 1985, BRAIN RES, V334, P235, DOI 10.1016/0006-8993(85)90215-X; NURSE B, 1984, NEUROCHEM RES, V9, P1231, DOI 10.1007/BF00973036; PIJNENBU.AJ, 1973, J PHARM PHARMACOL, V25, P1003; PIJNENBURG AJJ, 1975, PSYCHOPHARMACOLOGIA, V41, P175, DOI 10.1007/BF00421076; REDGRAVE P, 1978, BRAIN RES, V155, P277, DOI 10.1016/0006-8993(78)91023-5; ROOZENDAAL B, 1994, BEHAV NEUROSCI, V108, P1107, DOI 10.1037//0735-7044.108.6.1107; RUSSELL VA, 1989, NEUROCHEM RES, V14, P169, DOI 10.1007/BF00969634; RUSSELL VA, 1993, NEUROCHEM RES, V18, P285, DOI 10.1007/BF00969084; Saigusa T, 2012, EUR J PHARMACOL, V688, P35, DOI 10.1016/j.ejphar.2012.05.005; SELDEN NRW, 1990, BEHAV BRAIN RES, V39, P29, DOI 10.1016/0166-4328(90)90119-Y; SELDEN NRW, 1990, J NEUROSCI, V10, P531; SVENSSON L, 1983, PHARMACOL BIOCHEM BE, V19, P693, DOI 10.1016/0091-3057(83)90347-7; SVENSSON L, 1982, ACTA PHARMACOL TOX, V50, P22; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; Tuinstra T, 2000, BEHAV NEUROSCI, V114, P1088; Tuinstra T, 2000, NEUROSCIENCE, V99, P55, DOI 10.1016/S0306-4522(00)00139-1; Tuinstra T, 2002, BEHAV NEUROSCI, V116, P1084, DOI 10.1037//0735-7044.116.6.1084; Tuinstra T, 2000, NEUROSCIENCE, V98, P743, DOI 10.1016/S0306-4522(00)00175-5; van Oosten RV, 2005, EXP NEUROL, V191, P24, DOI 10.1016/j.expneurol.2004.09.004; Verheij MM, 2009, INDIVIDUAL DIFFERENC, P35; Verheij MMM, 2008, EUR J PHARMACOL, V585, P228, DOI 10.1016/j.ejphar.2008.02.084; Verheij MMM, 2009, PSYCHOPHARMACOLOGY, V205, P441, DOI 10.1007/s00213-009-1552-1; Verheij MMM, 2009, NEUROSCIENCE, V162, P1163, DOI 10.1016/j.neuroscience.2009.05.034; Verheij MMM, 2011, PHARMACOL BIOCHEM BE, V98, P43, DOI 10.1016/j.pbb.2010.11.021; Verheij MMM, 2008, J NEUROCHEM, V105, P2122, DOI 10.1111/j.1471-4159.2008.05323.x; Verheij MMM, 2013, NEUROPSYCHOPHARMACOL, V38, P540, DOI 10.1038/npp.2012.209; Verheij MMM, 2007, J NEUROCHEM, V100, P810, DOI 10.1111/j.1471-4159.2006.04259.x; Verheij MMM, 2009, J NEURAL TRANSM, V116, P389, DOI 10.1007/s00702-009-0190-4; Watson C, 2007, RAT BRAIN STEREOTAXI	57	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	FEB	2015	26	1-2			SI		81	90		10.1097/FBP.0000000000000098		10	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	AZ3QC	WOS:000348140800009		
J	Igari, M; Shen, HW; Hagino, Y; Fukushima, S; Kasahara, Y; Lesch, KP; Murphy, DL; Hall, FS; Uhl, GR; Ikeda, K; Yaegashi, N; Sora, I				Igari, Moe; Shen, Hao-Wei; Hagino, Yoko; Fukushima, Setsu; Kasahara, Yoshiyuki; Lesch, Klaus-Peter; Murphy, Dennis L.; Hall, Frank Scott; Uhl, George R.; Ikeda, Kazutaka; Yaegashi, Nobuo; Sora, Ichiro			Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment	BEHAVIOURAL PHARMACOLOGY			English	Article						5-HT1B receptor; addiction; in-vivo microdialysis; knockout; locomotion; methamphetamine; mouse; SB 216641; sensitization; serotonin transporter	INDUCED BEHAVIORAL SENSITIZATION; ENHANCES COCAINE REINFORCEMENT; CONDITIONED PLACE PREFERENCE; IN-VIVO MICRODIALYSIS; 5-HT1B RECEPTORS; DOPAMINE-TRANSPORTER; SEEKING BEHAVIOR; NEUROTRANSMITTER RELEASE; ACUTE WITHDRAWAL; DEFICIENT MICE	Repeated administration of methamphetamine (METH) enhances acute locomotor responses to METH administered in the same context, a phenomenon termed as 'locomotor sensitization'. Although many of the acute effects of METH are mediated by its influences on the compartmentalization of dopamine, serotonin systems have also been suggested to influence the behavioral effects of METH in ways that are not fully understood. The present experiments examined serotonergic roles in METH-induced locomotor sensitization by assessing: (a) the effect of serotonin transporter (SERT; Slc6A4) knockout (KO) on METH-induced locomotor sensitization; (b) extracellular monoamine levels in METH-treated animals as determined by in-vivo microdialysis; and (c) effects of serotonin (5-HT) receptor antagonists on METH-induced behavioral sensitization, with focus on effects of the 5-HT1B receptor antagonist SB 216641 and a comparison with the 5-HT2 receptor antagonist ketanserin. Repeated METH administration failed to induce behavioral sensitization in homozygous SERT KO (SERT-/-) mice under conditions that produced substantial sensitization in wild-type or heterozygous SERT KO (SERT+/-) mice. The selective 5-HT1B antagonist receptor SB 216641 restored METH-induced locomotor sensitization in SERT-/-mice, whereas ketanserin was ineffective. METH-induced increases in extracellular 5-HT (5-HTex) levels were substantially reduced in SERT-/-mice, although SERT genotype had no effect on METH-induced increases in extracellular dopamine. These experiments demonstrate that 5-HT actions, including those at 5-HT1B receptors, contribute to METH-induced locomotor sensitization. Modulation of 5-HT1B receptors might aid therapeutic approaches to the sequelae of chronic METH use. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Igari, Moe; Fukushima, Setsu; Kasahara, Yoshiyuki; Sora, Ichiro] Tohoku Univ, Grad Sch Med, Dept Biol Psychiat, Sendai, Miyagi 980, Japan; [Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Gynecol & Obstet, Sendai, Miyagi 980, Japan; [Shen, Hao-Wei; Hagino, Yoko; Ikeda, Kazutaka] Tokyo Inst Psychiat, Dept Mol Psychiat, Tokyo, Japan; [Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat & Psychotherapy, D-97070 Wurzburg, Germany; [Murphy, Dennis L.] NIMH, Intramural Res Program, Clin Neuropharmacol Sect, Clin Sci Lab, Bethesda, MD 20892 USA; [Hall, Frank Scott; Uhl, George R.] Natl Inst Drug Abuse, Intramural Res Program, Mol Neurobiol Branch, Baltimore, MD USA	Hall, FS (reprint author), Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol, Mail Stop 1015,3000 Arlington Ave, Toledo, OH 43614 USA.	frank.hall@utoledo.edu	Lesch, Klaus-Peter/J-4906-2013; Hall, Frank/C-3036-2013	Lesch, Klaus-Peter/0000-0001-8348-153X; Shen, Hao-wei/0000-0002-2766-5139; Hall, Frank/0000-0002-0822-4063	Japanese Ministry of Health, Labour and Welfare; Global COE program by the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Intramural Research Program of the National Institute on Drug Abuse (NIH/DHHS, USA); Deutsche Forschungsgemeinschaft [Le 629/4-2, SFB 581]	The present study was supported by the Japanese Ministry of Health, Labour and Welfare; Global COE program by the Japanese Ministry of Education, Culture, Sports, Science, and Technology; the Intramural Research Program of the National Institute on Drug Abuse (NIH/DHHS, USA; F.S.H. and G.R.U.); and a grant from the Deutsche Forschungsgemeinschaft (Le 629/4-2, SFB 581 to K.-P.L.). The authors also thank Professor Yoshitaka Kimura for advice for the statistical analysis and Dr Koh Iwasaki for discussion and advice.	Acosta JI, 2005, PHARMACOL BIOCHEM BE, V80, P297, DOI 10.1016/j.pbb.2004.12.001; Ago Y, 2006, NEUROPHARMACOLOGY, V51, P914, DOI 10.1016/j.neuropharm.2006.06.001; Ago Y, 2006, PHARMACOL BIOCHEM BE, V85, P198, DOI 10.1016/j.pbb.2006.07.036; Ago Y, 2008, J PHARMACOL SCI, V106, P15, DOI 10.1254/jphs.FM0070121; Ago Y, 2007, SYNAPSE, V61, P757, DOI 10.1002/syn.20421; Ago Y, 2006, J PHARMACOL SCI, V101, P109; Ago Y, 2007, J PHARMACOL SCI, V103, p38P; Auclair A, 2004, EUR J NEUROSCI, V20, P3073, DOI 10.1111/j.1460-9568.2004.03805.x; Fleckenstein AE, 1999, EUR J PHARMACOL, V382, P45, DOI 10.1016/S0014-2999(99)00588-9; Parent M, 2011, J CHEM NEUROANAT, V41, P256, DOI 10.1016/j.jchemneu.2011.04.005; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Bengel D, 1998, MOL PHARMACOL, V53, P649; Davidson C, 2002, NEUROPSYCHOPHARMACOL, V27, P542; O'Dell LE, 2006, J NEUROCHEM, V99, P1363, DOI 10.1111/j.1471-4159.2006.04163.x; Rothman RB, 2006, ANN NY ACAD SCI, V1074, P245, DOI 10.1196/annals.1369.064; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Hall FS, 2002, NEUROSCIENCE, V115, P153, DOI 10.1016/S0306-4522(02)00379-2; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Przegalinski E, 2001, EUR J PHARMACOL, V422, P91, DOI 10.1016/S0014-2999(01)01079-2; Rocha BA, 1998, NATURE, V393, P175; Hnasko TS, 2007, J NEUROSCI, V27, P12484, DOI 10.1523/JNEUROSCI.3133-07.2007; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Homberg JR, 2008, PSYCHOPHARMACOLOGY, V200, P367, DOI 10.1007/s00213-008-1212-x; Kaneko Y, 2007, NEUROPSYCHOPHARMACOL, V32, P658, DOI 10.1038/sj.npp.1301111; Kitanaka J, 2009, PSYCHOPHARMACOLOGY, V203, P781, DOI 10.1007/s00213-008-1425-z; Mathews TA, 2004, J NEUROSCI METH, V140, P169, DOI 10.1016/j.jneumeth.2004.05.017; Bankson MG, 2002, NEUROPSYCHOPHARMACOL, V26, P40, DOI 10.1016/S0893-133X(01)00345-1; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Oakly AC, 2014, MOL PSYCHIATR, V19, P534, DOI 10.1038/mp.2013.75; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Rocha BA, 1998, NAT NEUROSCI, V1, P132; Guo JD, 2010, NEUROSCIENCE, V165, P1390, DOI 10.1016/j.neuroscience.2009.11.071; ODELL SJ, 1991, BRAIN RES, V564, P256, DOI 10.1016/0006-8993(91)91461-9; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; Parsons LH, 1998, J NEUROSCI, V18, P10078; Bronsert MR, 2001, BEHAV PHARMACOL, V12, P549; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Di Matteo V, 2008, PROG BRAIN RES, V172, P7, DOI 10.1016/S0079-6123(08)00902-3; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Muramatsu M, 1998, EUR J NEUROSCI, V10, P2371, DOI 10.1046/j.1460-9568.1998.00248.x; Hall FS, 2009, NEUROSCIENCE, V162, P870, DOI 10.1016/j.neuroscience.2009.05.058; Barot SK, 2007, EUR J NEUROSCI, V25, P3125, DOI 10.1111/j.1460-9568.2007.05568.x; Broderick PA, 2004, PROG NEURO-PSYCHOPH, V28, P547, DOI 10.1016/j.pnpbp.2004.01.007; Castanon N, 2000, PHARMACOL BIOCHEM BE, V67, P559, DOI 10.1016/S0091-3057(00)00389-0; Clifton PG, 2003, EUR J NEUROSCI, V17, P185, DOI 10.1046/j.1460-9568.2003.02437.x; COOLS AR, 1974, PSYCHOPHARMACOLOGIA, V36, P17, DOI 10.1007/BF00441378; COOLS AR, 1976, PHARMACOL THER PT B, V2, P129, DOI 10.1016/0306-039X(76)90025-8; Davidson C, 2002, EUR J PHARMACOL, V453, P255, DOI 10.1016/S0014-2999(02)02390-7; Dhonnchadha BAN, 2008, BEHAV BRAIN RES, V195, P39, DOI 10.1016/j.bbr.2008.06.026; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; Fox MA, 2013, PSYCHOPHARMACOLOGY, V227, P685, DOI 10.1007/s00213-013-2988-x; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Fukushima S, 2007, PSYCHOPHARMACOLOGY, V193, P55, DOI 10.1007/s00213-007-0749-4; Gerra G, 2007, AM J MED GENET B, V144B, P52, DOI 10.1002/ajmg.b.30388; Ginawi OT, 2004, J PHYSIOL PHARMACOL, V55, P357; Hall FS, 2010, EXPT MODELS SEROTONI, P244; KALIVAS PW, 1995, DRUG ALCOHOL DEPEN, V37, P95, DOI 10.1016/0376-8716(94)01063-Q; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KALIVAS PW, 1993, BEHAV PHARMACOL, V4, P315; Miller K, 2009, TLS-TIMES LIT SUPPL, P6; Neumaier JF, 2002, J NEUROSCI, V22, P10856; Olivier JDA, 2010, EUR J PHARMACOL, V629, P7, DOI 10.1016/j.ejphar.2009.11.049; Parsons LH, 1996, PSYCHOPHARMACOLOGY, V128, P150, DOI 10.1007/s002130050120; Pentkowski NS, 2009, ADDICT BIOL, V14, P419, DOI 10.1111/j.1369-1600.2009.00162.x; Pentkowski NS, 2012, BIOL PSYCHIAT, V72, P396, DOI 10.1016/j.biopsych.2012.03.024; Price GW, 1997, N-S ARCH PHARMACOL, V356, P312, DOI 10.1007/PL00005056; Przegalinski E, 2007, EUR J PHARMACOL, V559, P165, DOI 10.1016/j.ejphar.2006.12.012; Przegalinski E, 2002, J PHYSIOL PHARMACOL, V53, P383; Przegalinski E, 2004, EUR NEUROPSYCHOPHARM, V14, P217, DOI 10.1016/S0924-977X(03)00106-8; Przegalinski E, 2000, LIFE SCI, V66, P1011, DOI 10.1016/S0024-3205(99)00666-9; Przegalinski E, 2002, EUR NEUROPSYCHOPHARM, V12, P387, DOI 10.1016/S0924-977X(02)00052-4; Przegalinski E, 2001, BEHAV PHARMACOL, V12, P109; Przegalinski E, 2008, PHARMACOL REP, V60, P798; Przegalinski E, 2003, NEUROSCI LETT, V351, P169, DOI 10.1016/S0304-3940(03)00970-0; Roca-Vinardell A, 2003, ANESTHESIOLOGY, V98, P741, DOI 10.1097/00000542-200303000-00025; Ross JD, 2006, DRUG ALCOHOL DEPEN, V81, P117, DOI 10.1016/j.drugalcdep.2005.06.004; Schlicker E, 1997, N-S ARCH PHARMACOL, V356, P321, DOI 10.1007/PL00005057; Sora I, 2010, ANN NY ACAD SCI, V1187, P218, DOI 10.1111/j.1749-6632.2009.05276.x; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Tatarczynska E, 2005, EUR J PHARMACOL, V516, P46, DOI 10.1016/j.ejphar.2005.04.025; Verheij MM, 2014, EUR NEUROPSYCHOPHARM; Wood MD, 2008, PROG BRAIN RES, V172, P213, DOI 10.1016/S0079-6123(08)00911-4	87	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	FEB	2015	26	1-2			SI		167	179		10.1097/FBP.0000000000000120		13	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	AZ3QC	WOS:000348140800018		
J	Sekine, S; Ichijo, H				Sekine, Shiori; Ichijo, Hidenori			Mitochondrial proteolysis: Its emerging roles in stress responses	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Review						Mitochondria; Proteolysis; Stress responses	M-AAA PROTEASE; INTERMEMBRANE SPACE PROTEIN; ALTERNATIVE TOPOGENESIS; SACCHAROMYCES-CEREVISIAE; DAMAGED MITOCHONDRIA; RHOMBOID PROTEASE; QUALITY-CONTROL; FUSION; MEMBRANE; OPA1	Background: Mitochondria are multifunctional organelles that not only serve as cellular energy stores but are also actively involved in several cellular stress responses, including apoptosis. In addition, mitochondria themselves are also continuously challenged by stresses such as reactive oxygen species (ROS), an inevitable by-product of oxidative phosphorylation. To exert various functions against these stresses, mitochondria must be equipped with appropriate stress responses that monitor and maintain their quality. Scope of review: Interestingly, increasing evidence indicates that mitochondrial proteolysis has important roles in mitochondrial and cellular stress responses. In this review, we summarize current advances in mitochondria(proteolysis-mediated stress responses. Major conclusions: Mitochondrial proteases do not only function as surveillance systems of protein quality control by degrading unfolded proteins but also regulate mitochondrial stress responses by processing specific mitochondrial proteins. General significance: Studies on the regulation of mitochondrial proteolysis-mediated stress responses will provide the novel mechanistic insights into the stress response research fields. (C) 2014 Elsevier B.V. All rights reserved.	[Sekine, Shiori; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan	Ichijo, H (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ichijo@mol.f.u-tokyo.ac.jp			KAKENHI from the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Global Center of Excellence Program; Understanding of molecular and environmental bases for brain health under the Strategic Research Program for Brain Sciences by MEXT	This work was supported by KAKENHI from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Global Center of Excellence Program; the "Understanding of molecular and environmental bases for brain health" conducted under the Strategic Research Program for Brain Sciences by MEXT. We thank all of the Laboratory of Cell Signaling members for fruitful discussions.	Amoult D., 2011, EMBO REP, V12, P901; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Bergmann A, 2003, CURR OPIN CELL BIOL, V15, P717, DOI 10.1016/j.ceb.2003.10.002; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.E04-09-0807; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Zhang K, 2014, EMBO REP, V15, P576, DOI 10.1002/embr.201338240; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Zhuang M, 2013, MOL CELL, V49, P273, DOI 10.1016/j.molcel.2012.10.022; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Chan EYL, 2012, J BIOL CHEM, V287, P40131, DOI 10.1074/jbc.M112.399428; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Gottlieb E, 2006, CELL, V126, P27, DOI 10.1016/j.cell.2006.06.030; Lin SC, 2004, TRENDS MOL MED, V10, P434, DOI 10.1016/j.molmed.2004.07.005; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Sadatomi D, 2013, INT J MOL SCI, V14, P4596, DOI 10.3390/ijms14034596; Strisovsky K., 2009, MOL CELL, V36, P1048; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014	65	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	FEB	2015	1850	2					274	280		10.1016/j.bbagen.2014.10.012		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ5JF	WOS:000348256800003		
J	Kishida, R; Saputro, AG; Kasai, H				Kishida, Ryo; Saputro, Adhitya G.; Kasai, Hideaki			Mechanism of dopachrome tautomerization into 5,6-dihydroxyindole-2-carboxylic acid catalyzed by Cu(II) based on quantum chemical calculations	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Dopachrome; DHICA; Melanin; Eumelanin; Copper; Density functional theory	METAL-IONS; RADIATIVE RELAXATION; HYDROGEN-PEROXIDE; HUMAN HAIR; EUMELANIN; MELANIN; MELANOGENESIS; TAUTOMERASE; MELANOCYTES; OXYGEN	Background: Tautomerization of dopachrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA) is a biologically crucial reaction relevant to melanin synthesis, cellular antioxidation, and cross-talk among epidermal cells. Since dopachrome spontaneously converts into 5,6-dihydroxyindole (DHI) via decarboxylation without any enzymes at physiologically usual pH, the mechanism of how tautomerization to DHICA occurs in physiological system is a subject of intense debate. A previous work has found that Cu(II) is an important factor to catalyze the tautomerization of dopachrome to DHICA. However, the effect of Cu(II) on the tautomerization has not been clarified at the atomic level. Methods: We propose the reaction mechanism of the tautomerization to DHICA by Cu(II) from density functional theory-based calculation. Results: We clarified that the activation barriers of alpha-deprotonation, beta-deprotonation, and decarboxylation from dopachrome are significantly reduced by coordination of Cu(II) to quinonoid oxygens (5,6-oxygens) of dopachrome, with the lowest activation barrier of beta-deprotonation among them. In contrast to our previous work, in which beta-deprotonation and quinonoid protonation (O5/O6-protonation) were shown to be important to form DHI, our results show that the Cu(II) coordination to quinonoid oxygens inhibits the quinonoid protonation, leading to the preference of proton rearrangement from beta-carbon to carboxylate group but not to the quinonoid oxygens. Conclusion: Integrating these results, we conclude that dopachrome tautomerization first proceeds via proton rearrangement from beta-carbon to carboxylate group and subsequently undergoes alpha-deprotonation to form DHICA. General significance: This study would provide the biochemical basis of DHICA metabolism and the generalized view of dopachrome conversion which is important to understand melanogenesis. (C) 2014 Elsevier B.V. All rights reserved.	[Kishida, Ryo; Saputro, Adhitya G.; Kasai, Hideaki] Osaka Univ, Dept Appl Phys, Suita, Osaka 565, Japan; [Kasai, Hideaki] Osaka Univ, Ctr Atom & Mol Technol, Suita, Osaka, Japan	Kasai, H (reprint author), Osaka Univ, Dept Appl Phys, Suita, Osaka 565, Japan.	kasai@dyn.ap.eng.osaka-u.ac.jp			MEXT [2203-22104008, 26248006]; JST ALCA Program "Development of Novel Metal-Air Secondary Battery Based on Fast Oxide Ion Conductor Nano Thickness Film"; JSPS Core-to-Core Program "A. Advanced Research Networks: Computational Materials Design on Green Energy"; Osaka University Joining and Welding Research Institute Cooperative Research Program	This work is supported in part by:; MEXT Grant-in-Aid for Scientific Research on Innovative Areas Program (2203-22104008) and Scientific Research (A) (26248006); JST ALCA Program "Development of Novel Metal-Air Secondary Battery Based on Fast Oxide Ion Conductor Nano Thickness Film"; JSPS Core-to-Core Program "A. Advanced Research Networks: Computational Materials Design on Green Energy"; and the Osaka University Joining and Welding Research Institute Cooperative Research Program.	Nofsinger JB, 2001, J PHYS CHEM B, V105, P2864, DOI 10.1021/jp004045y; ITO S, 1986, BIOCHIM BIOPHYS ACTA, V883, P155, DOI 10.1016/0304-4165(86)90146-7; Meredith P, 2004, PHOTOCHEM PHOTOBIOL, V79, P211, DOI 10.1562/0031-8655(2004)079<0211:RCRQYF>2.0.CO;2; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Bryantsev VS, 2008, J PHYS CHEM A, V112, P9104, DOI 10.1021/jp804373p; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Nofsinger JB, 2001, PHOTOCHEM PHOTOBIOL, V74, P31; Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x; Commo S, 2012, INT J COSMETIC SCI, V34, P102, DOI 10.1111/j.1468-2494.2011.00691.x; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Tada M, 2010, J CLIN BIOCHEM NUTR, V46, P224, DOI 10.3164/jcbn.09-84; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Tran ML, 2006, BIOPHYS J, V90, P743, DOI 10.1529/biophysj.105.069096; KORYTOWSKI W, 1990, J BIOL CHEM, V265, P12410; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Jiang S, 2010, FREE RADICAL BIO MED, V48, P1144, DOI 10.1016/j.freeradbiomed.2010.01.033; PASCUALAHUIR JL, 1994, J COMPUT CHEM, V15, P1127, DOI 10.1002/jcc.540151009; MASON HS, 1948, J BIOL CHEM, V172, P83; Meredith P, 2006, SOFT MATTER, V2, P37, DOI 10.1039/b511922g; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Pasquarello A, 2001, SCIENCE, V291, P856, DOI 10.1126/science.291.5505.856; Wakamatsu K, 2006, PIGM CELL RES, V19, P154, DOI 10.1111/j.1600-0749.2006.00293.x; FOSTER JP, 1980, J AM CHEM SOC, V102, P7211, DOI 10.1021/ja00544a007; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; AROCA P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P266, DOI 10.1016/0304-4165(90)90088-E; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; SEIJI M, 1963, NATURE, V197, P1082, DOI 10.1038/1971082a0; Becke AD, 1993, CHEM PHYS, V98, P5648, DOI DOI 10.1063/1.464913; Commo S, 2004, PIGM CELL RES, V17, P488, DOI 10.1111/j.1600-0749.2004.00170.x; DAMATO RJ, 1986, SCIENCE, V231, P987, DOI 10.1126/science.3080808; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Ito Shosuke, 2013, Pigment Cell Melanoma Res, V26, P817, DOI 10.1111/pcmr.12137; Ito S., 2010, PIGM CELL MELANOMA R, V24, P63, DOI DOI 10.1111/J.1755-148X.2010.00755; Kishida R, 2014, PIGM CELL MELANOMA R, V27, P734, DOI 10.1111/pcmr.12256; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; KORNER AM, 1980, J INVEST DERMATOL, V75, P192, DOI 10.1111/1523-1747.ep12522650; Kovacs D, 2012, J INVEST DERMATOL, V132, P1196, DOI 10.1038/jid.2011.457; Nofsinger JB, 2002, FREE RADICAL BIO MED, V32, P720, DOI 10.1016/S0891-5849(02)00763-3; PALUMBO A, 1991, BIOCHIM BIOPHYS ACTA, V1115, P1, DOI 10.1016/0304-4165(91)90003-Y; PALUMBO A, 1987, BIOCHIM BIOPHYS ACTA, V925, P203, DOI 10.1016/0304-4165(87)90110-3; PALUMBO A, 1988, BIOCHIM BIOPHYS ACTA, V964, P193, DOI 10.1016/0304-4165(88)90166-3; Panzella L., 2010, PIGM CELL MELANOMA R, V24, P248; PAWELEK JM, 1991, PIGM CELL RES, V4, P53, DOI 10.1111/j.1600-0749.1991.tb00315.x; SARNA T, 1985, PHOTOCHEM PHOTOBIOL, V42, P529, DOI 10.1111/j.1751-1097.1985.tb01605.x; Solano F, 1996, BIOCHEM J, V313, P447; SUGUMARAN M, 1991, J BIOL CHEM, V266, P6073; Tolleson WH, 2005, J ENVIRON SCI HEAL C, V23, P105, DOI 10.1080/10590500500234970; WAKAMATSU K, 1988, ANAL BIOCHEM, V170, P335, DOI 10.1016/0003-2697(88)90639-2; ZECCA L, 1994, J NEUROCHEM, V62, P1097	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	FEB	2015	1850	2					281	286		10.1016/j.bbagen.2014.10.024		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AZ5JF	WOS:000348256800004		
J	Yamashita, S; Hattori, T; Lee, SS; Okabe, K				Yamashita, Satoshi; Hattori, Tsutomu; Lee, Su See; Okabe, Kimiko			Estimating the diversity of wood-decaying polypores in tropical lowland rain forests in Malaysia: the effect of sampling strategy	BIODIVERSITY AND CONSERVATION			English	Article						Fruiting body; Macrofungi; Sampling area; Sampling effort; Southeast Asia; Species richness	APHYLLOPHORACEOUS FUNGI; COMMUNITY STRUCTURE; DIPTEROCARP FOREST; HOST; SARAWAK; CLIMATE; CANOPY; DEBRIS; PLANTS; PANAMA	Unlike in temperate regions, few studies have examined the effect of sampling effort on the observed number of wood-decaying polypores in the tropics. We conducted field surveys at Pasoh Forest Reserve and Lambir Hills National Park, two primary lowland dipterocarp forests in Malaysia, to compare the numbers of observed and estimated species for each site. Field surveys included five occasions over 4 years on a 2-ha plot in Pasoh, and two occasions in 1 year in 12 0.1-ha transects in Lambir. From Pasoh, 140 polypore species were recorded and 188 species were estimated (using the Chao2 estimator). From Lambir, 90 species were recorded and 149 estimated. Thus, at both sites the number of species observed comprised < 75 % of the estimated number of species. At Pasoh, more than 80 % of the total species were recorded by the end of the third sampling occasion. When sampling effort (area x number of sampling occasions) was constant, more species were recorded by field surveys conducted over larger areas with less frequent sampling than those conducted over smaller areas with more frequent sampling. The numbers of species recorded in the present work were greater than those identified in temperate and boreal regions in previous studies. The species richness of wood-decaying polypores in tropical regions may be largely underestimated without conducting field surveys on at least three occasions. If potential sampling effort is limited, surveying a larger area on fewer occasions is a reasonable compromise to ensure coverage of the majority of polypore species.	[Yamashita, Satoshi; Hattori, Tsutomu; Okabe, Kimiko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Lee, Su See] Forest Res Inst Malaysia, Kepong 52109, Selangor, Malaysia	Yamashita, S (reprint author), Forestry & Forest Prod Res Inst, Matsunosato 1, Tsukuba, Ibaraki 3058687, Japan.	symsht@affrc.go.jp			Research Institute for Humanity and Nature Project [D-01]; Global Environmental Research Fund [E-1]; Japan Environment Agency; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9]	This study was supported by the Forest Research Institute Malaysia (FRIM) with research permission and field assistance in the Pasoh Forest Reserve. We also thank L. Chong (Sarawak Forestry Corporation) and J. Kendawang (Forest Department Sarawak) for the permission to conduct research in Lambir Hills National Park. This study was funded in part by the Research Institute for Humanity and Nature Project D-01, the Global Environmental Research Fund (Grant No. E-1), the Japan Environment Agency, and the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan.	Berglund H, 2005, ECOL APPL, V15, P970, DOI 10.1890/04-0628; Bassler C, 2010, J ECOL, V98, P822, DOI 10.1111/j.1365-2745.2010.01669.x; Gibertoni TB, 2007, FUNGAL DIVERS, V25, P49; Hawksworth DL, 2012, BIODIVERS CONSERV, V21, P2425, DOI 10.1007/s10531-012-0335-x; KATO M, 1995, RES POPUL ECOL, V37, P59, DOI 10.1007/BF02515762; MATTSON KG, 1987, CAN J FOREST RES, V17, P712, DOI 10.1139/x87-114; Halme P, 2009, ECOL INDIC, V9, P256, DOI 10.1016/j.ecolind.2008.04.005; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Unterseher M, 2006, MYCOL RES, V110, P169, DOI 10.1016/j.mycres.2005.08.002; Woodall CW, 2008, ECOL INDIC, V8, P686, DOI 10.1016/j.ecolind.2007.11.002; Ferrer A, 2003, DIVERS DISTRIB, V9, P455, DOI 10.1046/j.1472-4642.2003.00039.x; Piepenbring M, 2012, BIODIVERS CONSERV, V21, P2181, DOI 10.1007/s10531-011-0213-y; Gilbert GS, 2002, BIODIVERS CONSERV, V11, P947, DOI 10.1023/A:1015896204113; Halme P, 2012, BIODIVERS CONSERV, V21, P205, DOI 10.1007/s10531-011-0176-z; Ovaskainen O, 2013, ISME J, V7, P1696, DOI 10.1038/ismej.2013.61; Kubartova A, 2012, MOL ECOL, V21, P4514, DOI 10.1111/j.1365-294X.2012.05723.x; CHAO A, 1984, SCAND J STAT, V11, P265; Colwell R K, 2006, ESTIMATES STAT ESTIM; Corner E. J. H., 1991, NOVA HEDWIGIA S, V101, P1; Corner EJH, 1987, NOVA HEDWIGIA S, V86, P1; Corner EJH, 1983, BEIH NOV HEDW, V75, P1; Corner EJH, 1935, GARDENS B STRAITS SE, V9, P79; Corner EJH, 1989, NOVA HEDWIGIA, V96, P1; Davies SJ, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P35; Davies SJ, 2005, ECOL STU AN, V174, P22; Gilbert GS, 2002, BIOTROPICA, V34, P396; Gilbert GS, 2008, MYCOL RES, V112, P674, DOI 10.1016/j.mycres.2007.11.009; Gilbertson RL, 1986, SYN FUNG, V1, P1; Gilbertson RL, 1987, N AM POLYPORES, V2, P445; Gjerde I, 2005, ECOGRAPHY, V28, P705, DOI 10.1111/j.2005.0906-7590.04249.x; Hattori T., 2007, MALAYSIAN FUNGAL DIV, P55; Hattori T, 2013, MYCOSCIENCE, V54, P297, DOI 10.1016/j.myc.2012.10.008; Hattori T, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P161; Hattori Tsutomu, 2000, Mycoscience, V41, P339, DOI 10.1007/BF02463947; Hattori Tsutomu, 2005, Mycoscience, V46, P303, DOI 10.1007/s10267-005-0250-z; Hattori T, 2012, BIODIVERS CONSERV, V21, P2375, DOI 10.1007/s10531-012-0238-x; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; Lee SS, 2012, CHECKLIST FUNGI MALA, P409; Lindblad I, 2000, MYCOLOGIA, V92, P399, DOI 10.2307/3761497; LODGE DJ, 1995, CAN J BOT, V73, pS1391; Magurran AE, 2003, MEASURING BIOL DIVER, P256; Noguchi S, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P51; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Okuda T, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P15; R Core Team, 2013, R LANG ENV STAT COMP; Ryvarden L., 1980, A preliminary Polypore flora of East Africa.; Stokland JN, 2012, BIODIVERSITY DEAD WO, P509; Whitmore TC, 1988, TROPICAL RAIN FOREST; Yamashita S, 2014, J FOREST RES-JPN, V19, P143, DOI 10.1007/s10310-013-0400-7; Yamashita S, 2009, MYCOL RES, V113, P1200, DOI 10.1016/j.mycres.2009.08.004; Yamashita S, 2008, BIOTROPICA, V40, P354, DOI 10.1111/j.1744-7429.2007.00366.x; Yumoto T, 2005, ECOL STU AN, V174, P13	52	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0960-3115	1572-9710		BIODIVERS CONSERV	Biodivers. Conserv.	FEB	2015	24	2					393	406		10.1007/s10531-014-0815-2		14	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AZ3GE	WOS:000348114700011		
J	Nakano, D; Baba, T; Endo, N; Nagayama, S; Fujinaga, A; Uchida, A; Shiragane, A; Urabe, M; Kobayashi, T				Nakano, Daisuke; Baba, Takashi; Endo, Noriyuki; Nagayama, Shigeya; Fujinaga, Ai; Uchida, Asako; Shiragane, Akiko; Urabe, Misako; Kobayashi, Takuya			Invasion, dispersion, population persistence and ecological impacts of a freshwater mussel (Limnoperna fortunei) in the Honshu Island of Japan	BIOLOGICAL INVASIONS			English	Article						Freshwater mussels; Large rivers; Genetic analysis; Water ways; Headrace channels; Reservoirs; Artificial habitats	LAKE-STREAM SYSTEMS; LARGE-RIVER SYSTEM; ZEBRA MUSSEL; DREISSENA-POLYMORPHA; GOLDEN MUSSEL; AICHI PREFECTURE; IRRIGATION PONDS; TOYOHASHI CITY; SOUTH-AMERICA; BIVALVES	The freshwater mussels Limnoperna and Dreissena require the low advective flow conditions of large continental rivers so their larvae can develop sufficiently to settle before reaching the ocean in order to maintain their populations. However, these species have also invaded some island rivers with high advective flows. We integrated data for the invasion, distribution, genetic composition and ecological impacts of L. fortunei on the Honshu Island of Japan. Invasion route and mechanisms of dispersion and population persistence are detailed in non-continental rivers. The initial invasion and several of the dispersions of L. fortunei were closely related to the food culture of consuming freshwater clams in Japan. Other dispersions were most likely affected by head-race channels. Thus, population persistence depends on anthropogenic lentic environments such as reservoirs and channel networks as a nursing habitat for L. fortunei larvae. L. fortunei was often abundant near artificial habitats and less abundant in the lower segments of rivers. We also contrast the invasion processes of freshwater mussels in continental and non-continental rivers.	[Nakano, Daisuke; Endo, Noriyuki; Fujinaga, Ai; Kobayashi, Takuya] CRIEPI, Environm Sci Res Lab, Chiba 2701194, Japan; [Nakano, Daisuke] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Baba, Takashi; Urabe, Misako] Univ Shiga Prefecture, Sch Environm Sci, Dept Ecosyst Studies, Hikone, Shiga 5228533, Japan; [Nagayama, Shigeya] ARRC, Publ Works Res Inst, Gifu 5016021, Japan; [Uchida, Asako; Shiragane, Akiko] Toyota Yahagi River Inst, Toyota, Aichi 4710025, Japan	Nakano, D (reprint author), CRIEPI, Environm Sci Res Lab, 1646 Abiko, Chiba 2701194, Japan.	d-nakano@criepi.denken.or.jp					Aldridge DC, 2010, ZEBRA MUSSEL EUROPE, P79; Nakano D, 2014, FRONT ECOL ENVIRON, V12, P167, DOI 10.1890/130071; Nakano D, 2010, LANDSC ECOL ENG, V6, P53, DOI 10.1007/s11355-009-0082-7; Havel JE, 2005, BIOSCIENCE, V55, P518, DOI 10.1641/0006-3568(2005)055[0518:DRFIIL]2.0.CO;2; Ito Kenji, 2011, Report of Yahagi River Institute, V15, P91; Stoeckel JA, 2004, FRESHWATER BIOL, V49, P919, DOI 10.1111/j.1365-2427.2004.01237.x; Belz CE, 2012, J SHELLFISH RES, V31, P777, DOI 10.2983/035.031.0322; Nalepa TF, 1998, CAN J FISH AQUAT SCI, V55, P2402, DOI 10.1139/cjfas-55-11-2402; Darrigran G, 2011, ZOOL SCI, V28, P1, DOI 10.2108/zsj.28.1; Tominaga Atsushi, 2009, Biodiversity (Ottawa), V10, P61; Karatayev AY, 2007, BIOL INVASIONS, V9, P161, DOI 10.1007/s10530-006-9013-9; Akamatsu F, 2004, ECOL RES, V19, P655, DOI 10.1111/j.1440-1703.2004.00680.x; Kraft CE, 2002, ECOL APPL, V12, P749; Akehoshi Yukihiro, 2011, Report of Yahagi River Institute, V15, P55; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Rehmann CR, 2003, CAN J ZOOL, V81, P1063, DOI 10.1139/Z03-090; Nakano D, 2012, WATER SCI TECHNOL, V65, P426, DOI 10.2166/wst.2012.866; Kato C, 2003, OIKOS, V103, P113, DOI 10.1034/j.1600-0706.2003.12477.x; Ohtaka A, 2011, LIMNOLOGY, V12, P137, DOI 10.1007/s10201-010-0330-4; Bobeldyk AM, 2005, ECOSCIENCE, V12, P339, DOI 10.2980/i1195-6860-12-3-339.1; Boltovskoy D, 2009, HYDROBIOLOGIA, V636, P271, DOI 10.1007/s10750-009-9956-9; Horvath TG, 1996, J N AM BENTHOL SOC, V15, P564, DOI 10.2307/1467807; Boltovskoy D, 2006, BIOL INVASIONS, V8, P947, DOI 10.1007/s10530-005-5107-z; Caraco NF, 1997, ECOLOGY, V78, P588, DOI 10.1890/0012-9658(1997)078[0588:ZMIIAL]2.0.CO;2; Strayer DL, 2009, FRONT ECOL ENVIRON, V7, P135, DOI 10.1890/080020; Speirs DC, 2001, ECOLOGY, V82, P1219, DOI 10.1890/0012-9658(2001)082[1219:PPIRAE]2.0.CO;2; Magara Y, 2001, J WATER SUPPLY RES T, V50, P113; Endo Noriyuki, 2009, Plankton & Benthos Research, V4, P125; Horvath TG, 1999, FRESHWATER BIOL, V42, P69, DOI 10.1046/j.1365-2427.1999.00462.x; Ricciardi A, 1997, CAN J FISH AQUAT SCI, V54, P2596, DOI 10.1139/cjfas-54-11-2596; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Arianoutsou M, 2010, BIOL INVASIONS, V12, P3525, DOI 10.1007/s10530-010-9749-0; Barnard C, 2003, CAN J FISH AQUAT SCI, V60, P1245, DOI 10.1139/F03-103; Bidwell JR, 2010, ZEBRA MUSSEL EUROPE, P69; Buchan LAJ, 1999, ECOL APPL, V9, P254, DOI 10.2307/2641184; Darrigran Gustavo, 2002, Biological Invasions, V4, P145, DOI 10.1023/A:1020521811416; Fukumoto H, 2010, P 14 JAP SOC EC CIV, P229; Hamada Minoru, 2010, Sessile Organisms, V27, P7; Ito Kenji, 2010, Sessile Organisms, V27, P17; Katayama M, 2005, FIELD BIOL, V14, P35; Kimura Taeko, 1994, Chiribotan, V25, P34; Kimura Taeko, 2011, Sessile Organisms, V28, P9; KINZELBACH R, 1992, LIMNOL AKTUELL, V4, P5; Ling SD, 2012, J APPL ECOL, V49, P733, DOI 10.1111/j.1365-2664.2012.02133.x; Lozano SJ, 2001, CAN J FISH AQUAT SCI, V58, P519; Lucy Frances E., 2008, Aquatic Invasions, V3, P297; Mackie GL, 2010, MONITORING AND CONTROL OF MACROFOULING MOLLUSKS IN FRESH WATER SYSTEMS, 2ND EDITION, P1; Masuda O, 2009, ENCY FRESHWATER MO 2; Matsuda M, 1992, ANN REP BIWAKO BUNKA, V10, P45; Matsuoka Keiji, 2010, Science Report of the Toyohashi Museum of Natural History, V20, P1; MC, 1996, DISTR LIMN FORT XEN; McMahon R. F., 1999, NONINDIGENOUS FRESHW, P315; Minchin Dan, 1998, Irish Naturalists' Journal, V26, P38; MLIT, 2006, INV AL SPEC LIMN FOR, pII; MLIT, 2010, DISTR INV MACR LIMN; MOF (Ministry of Finance), 2012, TRAD STAT JAP; Motoki M, 2007, CHIKYU KANNKYO KENNK, V9, P51; MURAKAMI T, 1992, Japanese Journal of Limnology, V53, P1; Naka S, 2008, NAT HIST MIE, V76, P5; Nakai K, 1995, VENUS, V54, P89; Nakai K, 2001, BLACK INVEDERS, P71; Nakamura M, 2000, FISHERIES CLAM JAPAN; Nakano D, 2013, RIVER ECOLOGY, P288; Nakano D, 2005, FRESHWATER BIOL, V50, P1492, DOI 10.1111/j.1365-2427.2005.01421.x; Nalepa TF, 1993, ZEBRA MUSSEL BIOL IM; Nishimura T., 1987, Chiribotan, V18, P110; Pollux BJ, 2010, ZEBRA MUSSEL EUROPE, P45; SAKAMOTO H, 2013, SCI REP TOYOHASH MAR, P39; SAKAMOTO H, 2014, SCI REP TOYOHASH MAR, P25; Shiragane A, 2005, RIO, V80, P4; Stoeckel JA, 1997, J N AM BENTHOL SOC, V16, P586, DOI 10.2307/1468146; Strayer DL, 2007, J N AM BENTHOL SOC, V26, P111, DOI 10.1899/0887-3593(2007)26[111:EOZMDP]2.0.CO;2; Sugiyama Naoto, 2013, Bulletin of Gunma Museum of Natural History, V17, P151; Sunoh N, 2006, REP IBARAKI PREF INL, V40, P79; Takao A, 2006, J N AM BENTHOL SOC, V25, P545, DOI 10.1899/0887-3593(2006)25[545:PIOANC]2.0.CO;2; Tanida K, 1995, ECOLOGY HABITAT, P95; Uchida S, 2007, REP YAHAGI RIV INS, V11, P35; van der Velde G, 2010, ZEBRA MUSSEL EUROPE, P1; Xu M. Z., 2009, P INT C WAT ENG SUST, P1609	79	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-3547	1573-1464		BIOL INVASIONS	Biol. Invasions	FEB	2015	17	2					743	759		10.1007/s10530-014-0765-3		17	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	AZ3TO	WOS:000348149700018		
J	Sugiyama, T; Uo, M; Wada, T; Omagari, D; Komiyama, K; Noguchi, T; Jinbu, Y; Kusama, M				Sugiyama, Tomoko; Uo, Motohiro; Wada, Takahiro; Omagari, Daisuke; Komiyama, Kazuo; Noguchi, Tadahide; Jinbu, Yoshinori; Kusama, Mikio			Estimation of trace metal elements in oral mucosa specimens by using SR-XRF, PIXE, and XAFS	BIOMETALS			English	Article						Synchrotron radiation X-ray fluorescence analysis; Particle-induced X-ray emission analysis; X-ray absorption fine structure analysis; Trace elemental analysis; Histopathological specimen	RAY-FLUORESCENCE MICROSCOPY; ALZHEIMERS-DISEASE; TISSUE; IRON; COPPER; ZN; CU; XANES; FE	The effects of dissolved elements from metal dental restorations are a major concern in lesions of the oral mucosa, and the evaluation of accumulated metal elements, especially their distribution and chemical state, is essential for determining the precise effects of trace metals. In this study, X-ray fluorescence with synchrotron radiation (SR-XRF) and particle-induced X-ray emission (PIXE) were applied for distribution analysis of the trace metal elements contained in the oral mucosa, and the chemical states of the elements were estimated using X-ray absorption fine structure (XAFS) analysis. Appropriate combination of these analysis techniques, particularly SR-XRF and PIXE, to visualize the distributions of the elements in the oral mucosa allowed for the observation and evaluation of accumulated metal ions and debris. Importantly, the analyses in this study could be carried out using conventional histopathological specimens without damaging the specimens. Therefore, this method would be applicable for the detection of accumulated trace metal elements in biopsy specimens from the oral mucosa.	[Sugiyama, Tomoko; Noguchi, Tadahide; Jinbu, Yoshinori; Kusama, Mikio] Jichi Med Univ, Dept Dent Oral & Maxillofacial Surg, Shimotsuke, Tochigi 3290498, Japan; [Uo, Motohiro; Wada, Takahiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Adv Biomat Dept, Bunkyo Ku, Tokyo 1138549, Japan; [Omagari, Daisuke; Komiyama, Kazuo] Nihon Univ, Dept Pathol, Sch Dent, Chiyoda Ku, Tokyo 1318310, Japan	Uo, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Adv Biomat Dept, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	uo.abm@tmd.ac.jp			Japan Society for the Promotion of Science KAKENHI [23390438]; Japan Society for the Promotion of Science	The SR-XRF and XAFS measurements were performed with the approval of the Photon Factory Program Advisory Committee (Proposal Nos. 2012G011, 2013P002, and 2014G017). This work was financially supported by Japan Society for the Promotion of Science KAKENHI (Grant no. 23390438 to M. Uo). T. Sugiyama is a supported by a research fellowship for young scientists from Japan Society for the Promotion of Science.	Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/jjsb.2005.09.004; Farquharson MJ, 2008, PHYS MED BIOL, V53, P3023, DOI 10.1088/0031-9155/53/11/018; Geraki K, 2002, PHYS MED BIOL, V47, P2327, DOI 10.1088/0031-9155/47/13/310; Uo M, 2007, DENT MATER J, V26, P268; Kubala-Kukus A, 1999, NUCL INSTRUM METH B, V150, P193, DOI 10.1016/S0168-583X(98)01057-X; Collingwood J, 2006, J ALZHEIMERS DIS, V10, P215; Ektessabi A, 2001, X-RAY SPECTROM, V30, P44, DOI 10.1002/xrs.466; Fahrni CJ, 2007, CURR OPIN CHEM BIOL, V11, P121, DOI 10.1016/j.cbpa.2007.02.039; Farquharson MJ, 2007, APPL RADIAT ISOTOPES, V65, P183, DOI 10.1016/j.apradiso.2006.08.013; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Ide-Ektessabi A, 2005, ANAL SCI, V21, P885, DOI 10.2116/analsci.21.885; Kinoshita H, 2010, MED MOL MORPHOL, V43, P19, DOI 10.1007/s00795-009-0474-7; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Preoteasa EA, 2002, NUCL INSTRUM METH B, V189, P426, DOI 10.1016/S0168-583X(01)01119-3; Reddy SB, 2003, NUCL INSTRUM METH B, V207, P345, DOI 10.1016/S0168-583X(03)00463-4; Reddy SB, 2002, NUCL INSTRUM METH B, V196, P333, DOI 10.1016/S0168-583X(02)01292-2; Uo M, 2004, DENT MATER, V20, P611, DOI 10.1016/j.dental.2003.08.002; Uo M, 2008, CHEM LETT, V37, P958, DOI 10.1246/cl.2008.958; Uo M, 2009, NANO BIOMED, V1, P133	19	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0966-0844	1572-8773		BIOMETALS	Biometals	FEB	2015	28	1					11	20		10.1007/s10534-014-9796-6		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AZ4QZ	WOS:000348208900002		
J	Konoura, K; Fujii, H; Imaide, S; Gouda, H; Hirayama, S; Hirono, S; Nagase, H				Konoura, Kazuya; Fujii, Hideaki; Imaide, Satomi; Gouda, Hiroaki; Hirayama, Shigeto; Hirono, Shuichi; Nagase, Hiroshi			Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Mesembrane; Opioid; Sceletium alkaloids; Conformational analysis	MESSAGE ADDRESS CONCEPT; MOLECULAR-DYNAMICS; ANTAGONISTS; DISCOVERY; AGONIST; DESIGN; LIGAND; ALKALOIDS; SYSTEM; POTENT	We transformed naltrexone (5) with the morphinan skeleton into mesembrane (4) belonging to the Sceletium alkaloids via key intermediate 6, characterized by a cis-fused hydroindole skeleton with a suspended phenyl ring fixed by an epoxy bridge. We then investigated the binding affinities of 4 and the key intermediate 6 derivatives to the opioid receptors. Among the tested compounds, 150, with a cis-fused hydroindole core, bound to the three opioid receptor types with strong to moderate affinities. The observed differences of binding affinities among the tested compounds were reasonably explained by the conformational analyses of the compounds. The structure-activity relationship (SAR) of the tested compounds like 15' with the hydroindole structure was completely different from the reported SAR of morphinan derivatives with the hydroisoquinoline skeleton. Compound 15' with a structure that differs from the morphinans represents a useful fundamental skeleton with a novel chemotype that may contribute to the development of new opioid ligands. (C) 2014 Elsevier Ltd. All rights reserved.	[Konoura, Kazuya; Fujii, Hideaki; Imaide, Satomi; Hirayama, Shigeto; Nagase, Hiroshi] Kitasato Univ, Sch Pharm, Dept Med Chem, Minato Ku, Tokyo 1088641, Japan; [Gouda, Hiroaki] Showa Univ, Sch Pharm, Shinagawa Ku, Tokyo 1428555, Japan; [Hirono, Shuichi] Kitasato Univ, Sch Pharm, Dept Phys Chem Drug Design, Minato Ku, Tokyo 1088641, Japan; [Nagase, Hiroshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058577, Japan	Fujii, H (reprint author), Kitasato Univ, Sch Pharm, Dept Med Chem, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	fujiih@pharm.kitasato-u.ac.jp					Furrow ME, 2004, J AM CHEM SOC, V126, P5436, DOI 10.1021/ja049694s; Mori M, 1997, J ORG CHEM, V62, P3263, DOI 10.1021/jo9701187; Mizoguchi H, 2012, CURR OPIN PHARMACOL, V12, P87, DOI 10.1016/j.coph.2011.10.020; Correll CC, 2014, J MED CHEM, V57, P6887, DOI 10.1021/jm401677g; BECKETT AH, 1954, J PHARM PHARMACOL, V6, P986; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Pasternak GW, 2014, NEUROPHARMACOLOGY, V76, P198, DOI 10.1016/j.neuropharm.2013.03.039; Nagase H, 2009, BIOORG MED CHEM LETT, V19, P2792, DOI 10.1016/j.bmcl.2009.03.099; Luttrell LM, 2014, MOL ENDOCRINOL, V28, P281, DOI 10.1210/me.2013-1314; Yekkirala AS, 2011, P NATL ACAD SCI USA, V108, P5098, DOI 10.1073/pnas.1016277108; Nagase H, 1998, CHEM PHARM BULL, V46, P1695; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Chen XT, 2013, J MED CHEM, V56, P8019, DOI [10.1021/jm4010829, 10.1021/jm40108291]; Wu HF, 2005, ORG LETT, V7, P2531, DOI 10.1021/ol050433c; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; BECKETT AH, 1956, J PHARM PHARMACOL, V8, P848; CAPPS TM, 1977, J CHEM SOC PERK T 2, P1098, DOI 10.1039/p29770001098; Chang Y., 1973, BIOCHEM PHARMACOL, V22, P3099; Fries D. S., 2008, FOYES PRINCIPLES MED, P652; Fujii H, 2008, TETRAHEDRON LETT, V49, P6293, DOI 10.1016/j.tetlet.2008.08.037; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Halgren H. J., 1990, J AM CHEM SOC, V112, P4710; Harvey AL, 2011, J ETHNOPHARMACOL, V137, P1124, DOI 10.1016/j.jep.2011.07.035; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Jeffs P. M., 1981, ALKALOIDS, V19, P1; Kenakin Terry, 2009, F1000 Biol Rep, V1, P87, DOI 10.3410/B1-87; Klein J. E. M. N., 2010, CHEM COMMUN, P937; KUGITA H, 1970, J MED CHEM, V13, P973, DOI 10.1021/jm00299a043; Nagase H, 2010, BIOORG MED CHEM LETT, V20, P3801, DOI 10.1016/j.bmcl.2010.04.044; Pan Y.-X., 2010, OPIATE, P121; PEARSON WH, 1992, J AM CHEM SOC, V114, P1329, DOI 10.1021/ja00030a031; PORTOGHESE PS, 1990, J MED CHEM, V33, P1714, DOI 10.1021/jm00168a028; PORTOGHESE PS, 1988, J MED CHEM, V31, P281, DOI 10.1021/jm00397a001; Qi H. A., 2009, [No title captured], Patent No. [WO 2009/132313, 2009132313]; Rozenfeld R., 2010, OPIATE RECEPTORS, P407; Tsujishita H, 1997, J COMPUT AID MOL DES, V11, P305, DOI 10.1023/A:1007964913898; Wentland MP, 2009, BIOORG MED CHEM LETT, V19, P2289, DOI 10.1016/j.bmcl.2009.02.078; Yamamoto N, 2011, J ORG CHEM, V76, P2257, DOI 10.1021/jo1022487; ZIMMERMAN DM, 1988, J MED CHEM, V31, P555, DOI 10.1021/jm00398a011	40	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	FEB 1	2015	23	3					439	448		10.1016/j.bmc.2014.12.032		10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AZ2BO	WOS:000348039700007		
J	Konoki, K; Suga, Y; Fuwa, H; Yotsu-Yamashita, M; Sasaki, M				Konoki, Keiichi; Suga, Yuto; Fuwa, Haruhiko; Yotsu-Yamashita, Mari; Sasaki, Makoto			Evaluation of gambierol and its analogs for their inhibition of human K(v)1.2 and cytotoxicity	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Gambierol; Voltage-gated potassium channels; Cytotoxicity	DINOFLAGELLATE GAMBIERDISCUS-TOXICUS; NONSELECTIVE CATION CHANNEL; POTENT MARINE TOXIN; PARTIAL STEREOCHEMICAL ASSIGNMENTS; GATED POTASSIUM CHANNELS; RED TIDE DINOFLAGELLATE; ALGA PRYMNESIUM-PARVUM; PTYCHODISCUS-BREVIS; SODIUM-CHANNELS; ANTIFUNGAL SUBSTANCES	Gambierol and its heptacyclic and tetracyclic analogs were tested for inhibitory activity against the human voltage-gated potassium channel Kv1.2 (hKv1.2), which was stably expressed in Chinese hamster ovary (CHO) cells. Gambierol, the heptacyclic analog, and the tetracyclic analog inhibited the potassium current evoked by a step pulse from -80 mV to 40 mV. The IC50 values for the three compounds were 0.75 +/- 0.15 nM, 7.6 +/- 1.2 nM, and 28 +/- 4.0 nM (the mean +/- SEM, n = 3), respectively. The cytotoxic activity was examined in order to assess a relationship between cytotoxicity and inhibition of the hKv1.2. The IC50 values for gambierol, the heptacyclic analog, and the tetracyclic analog in the wild-type CHO cells were 95 +/- 7.1 lM, 6.5 +/- 0.8 lM(the mean +/- SEM, n = 3), and > 100 lM (n = 3), respectively, whereas those in the CHO cells stably expressing hKv1.2 were 78 +/- 5.8 lM, 6.0 +/- 1.0 lM (the mean +/- SEM, n = 3), and > 100 lM (n = 3). These results suggested that cytotoxicity is not triggered by inhibition of the human Kv1.2. The electrophysiological recording at the resting potential in the presence of gambierol, the heptacyclic analog, and the tetracyclic analog revealed the dose-dependent leak current, which was largest when the heptacyclic analog was administered to the cells. We thus propose that the leak current induced by these compounds might cause a fatal effect on the cultured cells. (C) 2014 Elsevier Ltd. All rights reserved.	[Konoki, Keiichi; Yotsu-Yamashita, Mari] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Suga, Yuto; Fuwa, Haruhiko; Sasaki, Makoto] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Konoki, K (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	konoki@m.tohoku.ac.jp; masasaki@m.tohoku.ac.jp	Fuwa, Haruhiko/D-1773-2010		ERATO Murata Lipid Active Structure Project	The research studies were funded by the ERATO Murata Lipid Active Structure Project, Japan Science and Technology Agency, a Grant-in-Aid for Scientific Research on Innovative Areas ` Chemical Biology of Natural Products' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan64 (M. S., and K. K.), and the Japan Society for the Promotion of Science for Funding Program for the Next Generation World-Leading Researchers (LS012) (M. Y. Y.). We thank Takayuki Oka and Masato Nishio of Bio Research Center Co. Ltd and Atsushi Otsuki of Nanion Technologies GmbH for providing technical support for the electrophysiological recording with Port-A-Patch ~. We thank RIKEN Bioresource Center through the National Bio-Resource Project of the MEXT, Japan, for providing the human embryonic kidney cell line 293T (RCB2202) and the Chinese hamster ovary cell line CHO-K1 (RCB0285).	NAGAI H, 1992, J ORG CHEM, V57, P5448, DOI 10.1021/jo00046a029; Igarashi T, 1996, J AM CHEM SOC, V118, P479, DOI 10.1021/ja9534112; MURATA M, 1987, TETRAHEDRON LETT, V28, P5869, DOI 10.1016/S0040-4039(01)81076-5; Strachan LC, 1999, J PHARMACOL EXP THER, V288, P379; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Kopljar I, 2009, P NATL ACAD SCI USA, V106, P9896, DOI 10.1073/pnas.0812471106; NAGAI H, 1992, J AM CHEM SOC, V114, P1102, DOI 10.1021/ja00029a057; Fuwa H, 2003, BIOORG MED CHEM LETT, V13, P2519, DOI 10.1016/S0960-894X(03)00467-0; GUSOVSKY F, 1989, FEBS LETT, V243, P307, DOI 10.1016/0014-5793(89)80151-6; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; Inoue M, 2003, TOXICON, V41, P469, DOI 10.1016/S0041-0101(02)00369-0; Johnson HWB, 2005, J AM CHEM SOC, V127, P848, DOI 10.1021/ja043396d; SATAKE M, 1993, J AM CHEM SOC, V115, P361, DOI 10.1021/ja00054a061; Cuypers E, 2008, TOXICON, V51, P974, DOI 10.1016/j.toxicon.2008.01.004; Alfonso A, 2003, BIOCHEM PHARMACOL, V65, P193, DOI 10.1016/S0006-2952(02)01454-5; Konoki K, 1999, CHEM RES TOXICOL, V12, P993, DOI 10.1021/tx990014m; Alonso E, 2012, J AM CHEM SOC, V134, P7467, DOI 10.1021/ja300565t; MURATA M, 1989, J AM CHEM SOC, V111, P8929, DOI 10.1021/ja00206a032; Fuwa H, 2002, J AM CHEM SOC, V124, P14983, DOI 10.1021/ja028167a; MURATA M, 1990, J AM CHEM SOC, V112, P4380, DOI 10.1021/ja00167a040; Yamaoka K, 2009, J BIOL CHEM, V284, P7597, DOI 10.1074/jbc.M806481200; SHIMIZU Y, 1986, J AM CHEM SOC, V108, P514, DOI 10.1021/ja00263a031; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Ueda M, 2012, CHEM LETT, V41, P658, DOI 10.1246/cl.2012.658; Satake M, 2002, TETRAHEDRON LETT, V43, P5829, DOI 10.1016/S0040-4039(02)01171-1; Igarashi T, 1999, J AM CHEM SOC, V121, P8499, DOI 10.1021/ja991740e; Fuwa H, 2004, CHEM-EUR J, V10, P4894, DOI 10.1002/chem.200400355; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Perez S, 2012, CHEM RES TOXICOL, V25, P1929, DOI 10.1021/tx300242m; TRAINER VL, 1994, J BIOL CHEM, V269, P19904; YOKOYAMA A, 1988, J BIOCHEM-TOKYO, V104, P184; TAKAHASHI M, 1982, J BIOL CHEM, V257, P7287; BADEN DG, 1982, TOXICON, V20, P457, DOI 10.1016/0041-0101(82)90009-5; Naar JP, 2007, TOXICON, V50, P707, DOI 10.1016/j.toxicon.2007.06.005; Tsukano C, 2006, TETRAHEDRON LETT, V47, P6803, DOI 10.1016/j.tetlet.2006.07.081; DIETL P, 1994, MOL PHARMACOL, V45, P300; Fuwa H, 2002, ORG LETT, V4, P2981, DOI 10.1021/o1026394b; Ghiaroni V, 2005, TOXICOL SCI, V85, P657, DOI 10.1093/toxsci/kfi097; Jeglitsch G, 1998, J PHARMACOL EXP THER, V284, P516; KOBAYASHI M, 1987, BRIT J PHARMACOL, V92, P665; Kopljar I, 2012, TOXICON, V60, P150, DOI 10.1016/j.toxicon.2012.04.111; Legrand A. M., 1989, J APPL PHYCOL, V1, P183, DOI 10.1007/BF00003882; Matile S, 1996, ANGEW CHEM INT EDIT, V35, P757, DOI 10.1002/anie.199607571; Matile S, 1996, CHEM BIOL, V3, P379, DOI 10.1016/S1074-5521(96)90121-0; MORAN A, 1974, J MEMBRANE BIOL, V16, P237, DOI 10.1007/BF01872417; Mouri R, 2009, BIOORG MED CHEM LETT, V19, P2824, DOI 10.1016/j.bmcl.2009.03.103; MURATA M, 1994, J AM CHEM SOC, V116, P7098, DOI 10.1021/ja00095a013; MURATA M, 1993, J AM CHEM SOC, V115, P2060, DOI 10.1021/ja00058a075; Murata M, 2008, B CHEM SOC JPN, V81, P307, DOI 10.1246/bcsj.81.307; Nishio M, 1996, EUR J PHARMACOL, V297, P293, DOI 10.1016/0014-2999(95)00751-2; OHIZUMI Y, 1983, J PHARMACOL EXP THER, V227, P199; OHIZUMI Y, 1983, J PHYSIOL-LONDON, V337, P711; SATAKE M, 1995, J AM CHEM SOC, V117, P7019, DOI 10.1021/ja00131a032; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC755; Schlumberger S, 2010, TOXICON, V56, P785, DOI 10.1016/j.toxicon.2010.06.001; Sinkins WG, 2009, AM J PHYSIOL-CELL PH, V297, pC1533, DOI 10.1152/ajpcell.00252.2009; TAGLIALATELA M, 1986, BRAIN RES, V381, P356, DOI 10.1016/0006-8993(86)90088-0; TAKAHASHI M, 1983, NEUROCHEM RES, V8, P784; TAKAHASHI M, 1983, J BIOL CHEM, V258, P944; Torikai K, 2008, J AM CHEM SOC, V130, P10217, DOI 10.1021/ja801576v; Ujihara S, 2010, BIOORG MED CHEM LETT, V20, P6443, DOI 10.1016/j.bmcl.2010.09.080; VELDHUIS JD, 1987, AM J PHYSIOL, V252, pE8; WORLEY JF, 1994, J BIOL CHEM, V269, P32055	64	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 1	2015	25	3					514	518		10.1016/j.bmcl.2014.12.022		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AY9XT	WOS:000347901700017		
J	Sogabe, Y; Matsumoto, T; Hashimoto, T; Kirii, Y; Sawa, M; Kinoshita, T				Sogabe, Yuri; Matsumoto, Takashi; Hashimoto, Takuma; Kirii, Yasuyuki; Sawa, Masaaki; Kinoshita, Takayoshi			5Z-7-Oxozeaenol covalently binds to MAP2K7 at Cys218 in an unprecedented manner	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						MAP kinase kinase 7; Covalent bonding inhibitor; Cysteine; Crystal structure	KINASE INHIBITORS; FAMILY	5Z-7-Oxozeaenol (5Z7O) is a covalent bonding inhibitor against the several protein kinases (e. g., ERK2 and TAK1) that possess a free cysteine at the gatekeeper-2 position. In addition to this cysteine, MAP2K7 has three other cysteine residues that are candidate for covalent bonding by the inhibitor 5Z7O. The crystal structure of the MAP2K7/5Z7O complex revealed that the inhibitor binds to MAP2K7 at a cysteine residue located at the end of the hinge region and not at the gatekeeper-2 residue. The structural insights into the interaction of 5Z7O with MAP2K7 should aid the development of 5Z7O derivatives with improved potency and selectivity. (C) 2014 Elsevier Ltd. All rights reserved.	[Sogabe, Yuri; Hashimoto, Takuma; Kinoshita, Takayoshi] Osaka Prefecture Univ, Grad Sch Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Matsumoto, Takashi] Rigaku Corp, Akishima, Tokyo 1968666, Japan; [Kirii, Yasuyuki; Sawa, Masaaki] Carna Biosci Inc, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kinoshita, T (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	kinotk@b.s.osakafu-u.ac.jp					Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Furet P, 2006, J MED CHEM, V49, P4451, DOI 10.1021/jm060368s; Tang B, 2012, ONCOL REP, V27, P1090, DOI 10.3892/or.2011.1580; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Wang JW, 2008, BIOCHEM BIOPH RES CO, V372, P623, DOI 10.1016/j.bbrc.2008.05.122; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Emsley P., 2004, ACTA CRYSTALLOGR D, VD60, P2256; Ikemori-Kawada M, 2009, J CHEM INF MODEL, V49, P2650, DOI 10.1021/ci9003128; Ikemori-Kawada M, 2012, J CHEM INF MODEL, V52, P2059, DOI [10.1021/ci300135g, 10.1021/ci30013591]; Lee SI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3750; Ohori M, 2007, BIOCHEM BIOPH RES CO, V353, P633, DOI 10.1016/j.bbrc.2006.12.083; Otwinoski W., 1997, METHOD IN ENZYMOLOGY, V2, P307; Shen YC, 2010, BIOORG MED CHEM LETT, V20, P3047, DOI 10.1016/j.bmcl.2010.03.119; Wu J., 2013, ACS CHEM BIOL, V8, P613	18	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 1	2015	25	3					593	596		10.1016/j.bmcl.2014.12.011		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AY9XT	WOS:000347901700031		
J	Tominaga, Y; Hirata, A; Nokihara, K				Tominaga, Yuki; Hirata, Akiyoshi; Nokihara, Kiyoshi			Recognition of a monoclonal antibody against a small molecular weight antigen by monitoring the antigen-antibody reaction using fluorescence labeled structured peptides	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Antibody against 5-Fluorouracil; De novo designed peptide; Fluorescent label; Pattern recognition; Structural change	FINGERPRINT PATTERNS; PROTEIN-DETECTION; ARRAYS; SYSTEM	Interaction between proteins (as analytes) and de novo designed structured peptides as capture molecules cause structural changes, which are reflected in fluorescent-intensity changes of labeled peptides in a dose dependent manner. In contrast to conventional detection methods our detection system does not involve the detection of specific molecules themselves in a 1: 1 manner, but uses the principle of the differences in fluorescent intensity changes of capture peptides upon addition of analytes. Instead of the use of secondary antibodies we have attempted monitoring these structural changes by an array of de novo designed synthetic and structured peptides. In the present study we have focused on a recognition system, 5-fluorouracil, as a low molecular antigen and a monoclonal antibody against 5-FU. The fluorescent intensity changes of fluorescent labeled peptides have been measured after incubation with a monoclonal antibody and again after further incubation with the antigen, 5-FU. Unique intensity changes were found for several peptides in the fluorescent peptide library that allowed the visualization as a color-coded protein fingerprint. The peptide screen used in the present study offers a useful detection system as capture molecules for peptide-based microarrays. (C) 2014 Elsevier Ltd. All rights reserved.	[Tominaga, Yuki; Hirata, Akiyoshi; Nokihara, Kiyoshi] HiPep Labs, Kamigyo Ku, Kyoto 6028158, Japan	Nokihara, K (reprint author), HiPep Labs, Kamigyo Ku, Nakatsukasa Cho 486-46, Kyoto 6028158, Japan.	peptenchip@hipep.jp			Kyoto Industry Support Organization [21]	Authors deeply appreciate Y. Takagi, Mabel Inc. (Kyoto, Japan) for providing the monoclonal antibody, specific for 5-FU and Dr. V. Wray (HZI, Braunschweig, Germany) for discussion and linguistic advice. A part of the present work was funded by the Kyoto Industry Support Organization 21.	Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; De M, 2009, NAT CHEM, V1, P461, DOI [10.1038/nchem.334, 10.1038/NCHEM.334]; Usui K, 2006, MOL BIOSYST, V2, P113, DOI 10.1039/b514263r; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; HARTMANN KU, 1961, J BIOL CHEM, V236, P3006; Kasai K, 2012, FEBS LETT, V586, P325, DOI 10.1016/j.febslet.2012.01.012; Kawasaki T, 2010, B CHEM SOC JPN, V83, P799, DOI 10.1246/bcsj.20100009; Kissel J, 1997, CANCER RES, V57, P3415; Nokihara K., 2013, PEPTIDE SCI 2012, P167; Nokihara K, 2004, KOBUNSHI RONBUNSHU, V61, P523; Nokihara K., 2008, PEPTIDE SCI 2007, P106; Pisano R, 2005, J PHARMACEUT BIOMED, V38, P738, DOI 10.1016/j.jpba.2005.01.039; SANTINI J, 1989, BRIT J CANCER, V59, P287, DOI 10.1038/bjc.1989.59; Takahashi M, 2003, CHEM BIOL, V10, P53, DOI 10.1016/S1074-5521(02)00308-3; Usui K., 2005, NANOBIOTECHNOLOGY, V1, P191, DOI 10.1385/NBT:1:2:191; Usui K, 2007, BIOORG MED CHEM LETT, V17, P167, DOI 10.1016/j.bmcl.2006.09.075; Usui K, 2004, BIOPOLYMERS, V76, P129, DOI 10.1002/bip.10568; Usui K, 2004, MOL DIVERS, V8, P209, DOI 10.1023/B:MODI.0000036237.82584.2d; Usui K, 2009, METHODS MOL BIOL, V570, P273, DOI 10.1007/978-1-60327-394-7_13	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 1	2015	25	3					611	615		10.1016/j.bmcl.2014.12.009		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AY9XT	WOS:000347901700035		
J	Kumagai, K; Minamida, M; Akakabe, M; Tsuda, M; Konishi, Y; Tominaga, A; Tsuda, M; Fukushi, E; Kawabata, J				Kumagai, Keiko; Minamida, Mika; Akakabe, Mai; Tsuda, Masayuki; Konishi, Yuko; Tominaga, Akira; Tsuda, Masashi; Fukushi, Eri; Kawabata, Jun			Amphirionin-2, a novel linear polyketide with potent cytotoxic activity from a marine dinoflagellate Amphidinium species	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Polyketide; Dinoflagellate; Amphidinium; Cytotoxic activity; Hexahydrofuro[32-b]furan	POLYHYDROXYL METABOLITE; BIOACTIVE MACROLIDES; AMPHIDINOLIDES; LAURENCIA; ATPASE	A novel linear polyketide, amphirionin-2 (1), with two unique hexahydrofuro[ 3,2-b] furan moieties has been isolated from the cultivated algal cells of a benthic dinoflagellate Amphidinium sp. (strain KCA09051). The structure was elucidated on the basis of detailed analyses of 2D NMR data, and the absolute configuration of C-5 was determined by using modified Mosher's method. Amphirionin-2 (1) exhibited potent cytotoxic activity against human colon carcinoma Caco-2 cells and human lung adenocarcinoma A549 cells. (C) 2014 Elsevier Ltd. All rights reserved.	[Kumagai, Keiko; Akakabe, Mai; Tsuda, Masayuki; Konishi, Yuko] Kochi Univ, Ctr Sci Res, Kochi 7838505, Japan; [Minamida, Mika] Kochi Univ, Dept Appl Sci, Kochi 7838502, Japan; [Tominaga, Akira] Kochi Univ, Grad Sch Kuroshio Sci, Kochi 7838502, Japan; [Tominaga, Akira] Kochi Univ, Kochi Med Sch, Kochi 7838502, Japan; [Tsuda, Masashi] Kochi Univ, Ctr Adv Marine Core Res, Kochi 7838502, Japan; [Fukushi, Eri; Kawabata, Jun] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Tsuda, M (reprint author), Kochi Univ, Ctr Adv Marine Core Res, Kochi 7838502, Japan.	mtsuda@kochi-u.ac.jp	Kawabata, Jun/A-4495-2012		Japan Society for the Promotion of Science [25860079]	We thank S. Oka and A. Tokumitsu of the Equipment Management Center, Hokkaido University, for ESI-MS measurements and Satoru Ibuki, Keita Ikebe, and Takahiro Tsushima, Kochi Prefectural Deep Seawater Laboratory, for the supply of deep seawater and help with dinoflagellate cultivation. This study was partially supported by a Grant-in-aid for Young Scientists (B) (Grant Number 25860079) from Japan Society for the Promotion of Science.	Murray S, 2004, J PHYCOL, V40, P366, DOI 10.1046/j.1529-8817.2004.03132.x; Tsuda M, 2007, J NAT PROD, V70, P1661, DOI 10.1021/np0702537; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; Yong KWL, 2011, J NAT PROD, V74, P194, DOI 10.1021/np100620x; SATAKE M, 1991, J AM CHEM SOC, V113, P9859, DOI 10.1021/ja00026a027; Okamoto Y, 2001, BIOSCI BIOTECH BIOCH, V65, P474, DOI 10.1271/bbb.65.474; SUZUKI M, 1985, PHYTOCHEMISTRY, V24, P1999, DOI 10.1016/S0031-9422(00)83109-X; Patil AD, 1996, TETRAHEDRON, V52, P377, DOI 10.1016/0040-4020(95)00856-X; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; BAUER I, 1995, TETRAHEDRON LETT, V36, P991, DOI 10.1016/0040-4039(94)02423-9; Hoffman R. A., 1966, PROGRESS NUCLEAR MAG, V1, P15, DOI 10.1016/S0079-6565(66)80004-3; Inuzuka T, 2012, TETRAHEDRON LETT, V53, P239, DOI 10.1016/j.tetlet.2011.11.033; Kobayashi J, 2007, J NAT PROD, V70, P451, DOI 10.1021/np0605844; KOBAYASHI J, 1991, J ORG CHEM, V56, P5221, DOI 10.1021/jo00017a044; Kobayashi J, 2004, NAT PROD REP, V21, P77, DOI 10.1039/b310427n; Kobayashi J, 1999, J ORG CHEM, V64, P1478, DOI 10.1021/jo981882b; Kobayashi J, 2000, ORG LETT, V2, P2805, DOI 10.1021/ol006223b; KOBAYASHI J, 1994, TETRAHEDRON LETT, V35, P7049, DOI 10.1016/0040-4039(94)88222-3; Kubota T, 2006, TETRAHEDRON LETT, V47, P4369, DOI 10.1016/j.tetlet.2006.04.094; Kumagai K, 2013, HETEROCYCLES, V87, P2615, DOI 10.3987/COM-13-12841; Oguchi K, 2008, J ORG CHEM, V73, P1567, DOI 10.1021/jo702440s; Sohn JH, 2010, B KOREAN CHEM SOC, V31, P1695, DOI 10.5012/bkcs.2010.31.6.1695; SUZUKI M, 1993, TETRAHEDRON, V49, P2033, DOI 10.1016/S0040-4020(01)86303-1; Tsuda M., 2009, Japanese patent, Patent No. [2009-162977, 2009162977]; Tsuda M, 2007, J ORG CHEM, V72, P4469, DOI 10.1021/jo070414b; Tsuda M., 2010, Japan Patent, Patent No. [2010-029372, 2010029372]; Usui T, 2004, CHEM BIOL, V11, P1269, DOI 10.1016/j.chembiol.2004.07.014	27	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 1	2015	25	3					635	638		10.1016/j.bmcl.2014.12.003		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AY9XT	WOS:000347901700040		
J	Saga, Y; Ishitani, A; Takahashi, N; Kawamura, K				Saga, Yoshitaka; Ishitani, Atsushi; Takahashi, Naoya; Kawamura, Kenji			Production of bacteriopurpurin-18 phytyl ester from bacteriopheophytin a via allomerization by contact with titanium oxides in the presence of molecular oxygen	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Allomerization; Bacteriochlorophyll; Bacteriopheophytin; Near-infrared; Titanium oxide	PHOTODYNAMIC THERAPY PDT; BACTERIOCHLOROPHYLL-A; IN-VIVO; PHOTOSENSITIZERS; EFFICACY; CHLOROPHYLLS; PURPURIN-18; DERIVATIVES; SENSITIZERS; METAL	Incubation of bacteriopheophytin (BPhe) a, which was a demetalated pigment of bacteriochlorophyll a in photosynthetic bacteria, in CH2Cl2 in the presence of TiO2 particles with bubbling O-2 in the dark produced a pigment absorbing 814 nm. Detailed characterization of the novel pigment isolated from the CH2Cl2 suspension revealed that bacteriopurpurin-18 phytyl ester possessing an anhydride-type six-membered exocyclic E-ring was majorly formed by the treatment with TiO2 particles under oxygenic conditions. Oxidation of the bacteriochlorin ring in BPhe a, namely formations of derivatives of 3-acetyl pheophytin a and 3-acetyl protopheophytin a, can barely be detected through the conversion processes. (C) 2014 Elsevier Ltd. All rights reserved.	[Saga, Yoshitaka; Ishitani, Atsushi; Takahashi, Naoya; Kawamura, Kenji] Kinki Univ, Fac Sci & Engn, Dept Chem, Higashiosaka, Osaka 5778502, Japan	Saga, Y (reprint author), Kinki Univ, Fac Sci & Engn, Dept Chem, Higashiosaka, Osaka 5778502, Japan.	saga@chem.kindai.ac.jp	Saga, Yoshitaka/D-7714-2014		Japan Society for the Promotion of Science (JSPS) [25107525]; Tokuyama Science Foundation	We thank Prof. Tomohiro Miyatake, Ryukoku University, and Mr. Keiya Hirota, Kinki University, for HRMS measurements and experimental assistance, respectively. This work was partially supported by Grants-in-Aid for Scientific Research on Innovative Areas 'Artificial Photosynthesis (AnApple)' (No. 25107525) from the Japan Society for the Promotion of Science (JSPS) and from the Tokuyama Science Foundation.	Dandler J, 2010, PHOTOCHEM PHOTOBIOL, V86, P182, DOI 10.1111/j.1751-1097.2009.00621.x; Linnanto J, 2006, PHYS CHEM CHEM PHYS, V8, P663, DOI 10.1039/b513086g; Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q; Connor PA, 1999, LANGMUIR, V15, P2402, DOI 10.1021/la980855d; Hadjiivanov KI, 1996, CHEM SOC REV, V25, P61, DOI 10.1039/cs9962500061; Kozyrev AN, 1998, CHEM COMMUN, P1083, DOI 10.1039/a801367e; Tamiaki H, 2011, HANDB PORPHYR SCI, V11, P223; Vakrat-Haglili Y, 2005, J AM CHEM SOC, V127, P6487, DOI 10.1021/ja046210j; Chen YH, 2004, CURR ORG CHEM, V8, P1105, DOI 10.2174/1385272043370131; Pandey SK, 2009, BIOCONJUGATE CHEM, V20, P274, DOI 10.1021/bc8003638; Wang XF, 2011, J PHYS CHEM C, V115, P24394, DOI 10.1021/jp206206x; HENDERSON BW, 1991, J PHOTOCH PHOTOBIO B, V10, P303, DOI 10.1016/1011-1344(91)80016-B; Kozyrev AN, 1996, TETRAHEDRON LETT, V37, P6431, DOI 10.1016/0040-4039(96)01346-9; Fiedor J, 2002, PHOTOCHEM PHOTOBIOL, V76, P145, DOI 10.1562/0031-8655(2002)076<0145:POTBCS>2.0.CO;2; Nyman ES, 2004, J PHOTOCH PHOTOBIO B, V73, P1, DOI 10.1016/j.jphotobiol.2003.10.002; Sternberg ED, 1998, TETRAHEDRON, V54, P4151, DOI 10.1016/S0040-4020(98)00015-5; Nakajima K, 2013, J PHYS CHEM C, V117, P16028, DOI 10.1021/jp404523r; Kozyrev AN, 2006, J ORG CHEM, V71, P1949, DOI 10.1021/jo052334i; Gryshuk AL, 2006, J MED CHEM, V49, P1874, DOI 10.1021/jm050919z; Wang XF, 2010, ENERG ENVIRON SCI, V3, P94, DOI 10.1039/b918464c; Limantara L, 2006, PHOTOCHEM PHOTOBIOL, V82, P770, DOI 10.1652/2005-09-07-RA-676; KESSEL D, 1993, PHOTOCHEM PHOTOBIOL, V58, P200, DOI 10.1111/j.1751-1097.1993.tb09549.x; Hynninen PH, 2002, J ORG CHEM, V67, P4055, DOI 10.1021/jo010673f; Chen Y, 2007, BIOCONJUGATE CHEM, V18, P1460, DOI 10.1021/bc070092i; Chen YH, 2002, J MED CHEM, V45, P255, DOI 10.1021/jm010400c; Goswami LN, 2007, HETEROCYCLES, V71, P1929; Gryshuk A, 2007, J MED CHEM, V50, P1754, DOI 10.1021/jm061036q; HOOBER JK, 1988, PHOTOCHEM PHOTOBIOL, V48, P579, DOI 10.1111/j.1751-1097.1988.tb02867.x; Hynninen P. H., 1991, CHLOROPHYLLS, P145; Hynninen PH, 2006, TETRAHEDRON LETT, V47, P1663, DOI 10.1016/j.tetlet.2005.12.106; Kozyrev AN, 1997, TETRAHEDRON LETT, V38, P3335, DOI 10.1016/S0040-4039(97)00621-7; LEE SJH, 1993, J CHEM SOC PERK T 1, P2369, DOI 10.1039/p19930002369; Saga Y, 2011, J PHYS CHEM B, V115, P11757, DOI 10.1021/jp206534x; Saga Y, 2012, CHEM LETT, V41, P360, DOI 10.1246/cl.2012.360; Scheer H, 2006, CHLOROPHYLLS BACTERI, P1; Zheng G, 2000, BIOORG MED CHEM LETT, V10, P123, DOI 10.1016/S0960-894X(99)00649-6	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 1	2015	25	3					639	641		10.1016/j.bmcl.2014.12.002		3	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AY9XT	WOS:000347901700041		
J	Endo, Y; Kawai, K; Asano, T; Amano, S; Asanuma, Y; Sawada, K; Ogura, K; Nagata, N; Ueo, N; Takahashi, N; Sonoda, Y; Kamei, N				Endo, Yusuke; Kawai, Kentaro; Asano, Takeshi; Amano, Seiji; Asanuma, Yoshihito; Sawada, Keisuke; Ogura, Keiji; Nagata, Naoya; Ueo, Noriko; Takahashi, Nobuaki; Sonoda, Yo; Kamei, Noriyuki			Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Phosphodiesterase; Thienopyrimidinone; T-cell; Aqueous solubility	STRUCTURAL CLASS; DRUG DISCOVERY; PART 1; EFFICIENCY; DISEASE; ANALOGS; CAMP	The discovery and SAR study of a new series of soluble and highly potent phosphodiesterase (PDE) 7 inhibitors are described herein. We explored a new lead compound with improved solubility, which led to the discovery of a 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-one series. The introduction of 3-piperidines at the 7-position resulted in the significant enhancement of PDE7 activity. In particular, compound 32 also showed strong PDE7 inhibitory activity; good selectivity against PDE3, 4, and 5; and good aqueous solubility. (C) 2014 Elsevier Ltd. All rights reserved.	[Endo, Yusuke; Kawai, Kentaro; Asano, Takeshi; Amano, Seiji; Asanuma, Yoshihito; Sawada, Keisuke; Ogura, Keiji; Nagata, Naoya; Ueo, Noriko; Takahashi, Nobuaki; Sonoda, Yo; Kamei, Noriyuki] Kaken Pharmaceut Co Ltd, Drug Res Ctr, Yamashina, Kyoto 6078042, Japan	Endo, Y (reprint author), Kaken Pharmaceut Co Ltd, Drug Res Ctr, 14 Shinomiya Minamigawara Cho, Yamashina, Kyoto 6078042, Japan.						Allen J., 2011, PCT Int. Appl, Patent No. [WO 143495 A1, 143495]; Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105; Verhoest PR, 2009, J MED CHEM, V52, P5188, DOI [10.1021/jm900521k, 10.1021/jm9015334]; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Fujita Y, 2010, BIOORGAN MED CHEM, V18, P1194, DOI 10.1016/j.bmc.2009.12.036; Gewald R, 2011, BIOORG MED CHEM LETT, V21, P6652, DOI 10.1016/j.bmcl.2011.09.065; Barnes MJ, 2001, BIOORG MED CHEM LETT, V11, P1081, DOI 10.1016/S0960-894X(01)00125-1; Lorthiois E, 2004, BIOORG MED CHEM LETT, V14, P4623, DOI 10.1016/j.bmcl.2004.07.011; Banerjee A, 2012, BIOORG MED CHEM LETT, V22, P6286, DOI 10.1016/j.bmcl.2012.07.077; DeNinno MP, 2012, BIOORG MED CHEM LETT, V22, P6794, DOI 10.1016/j.bmcl.2012.09.028; Kawai K., J MED CHEM IN PRESS; Lee R, 2002, CELL SIGNAL, V14, P277, DOI 10.1016/S0898-6568(01)00250-9; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Miro X, 2001, SYNAPSE, V40, P201, DOI 10.1002/syn.1043; Vergne F, 2004, BIOORG MED CHEM LETT, V14, P4607, DOI 10.1016/j.bmcl.2004.07.008	17	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 1	2015	25	3					649	653		10.1016/j.bmcl.2014.11.090		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AY9XT	WOS:000347901700043		
J	Yamakoshi, H; Palonpon, A; Dodo, K; Ando, J; Kawata, S; Fujita, K; Sodeoka, M				Yamakoshi, Hiroyuki; Palonpon, Almar; Dodo, Kosuke; Ando, Jun; Kawata, Satoshi; Fujita, Katsumasa; Sodeoka, Mikiko			A sensitive and specific Raman probe based on bisarylbutadiyne for live cell imaging of mitochondria	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Raman; Imaging; Mitochondria; Triphenylphosphonium; Live cell	FLUORESCENT-PROBES; MICROSCOPY; CYTOCHROME; SCATTERING; MICROSPECTROSCOPY; BIOMOLECULES; ANTIOXIDANT; APOPTOSIS; MEMBRANE; PROTECTS	We previously showed that bisarylbutadiyne (BADY), which has a conjugated diyne structure, exhibits an intense peak in the cellular Raman-silent region. Here, we synthesized a mitochondria-selective Raman probe by linking bisphenylbutadiyne with triphenylphosphonium, a well-known mitochondrial targeting moiety. This probe, named MitoBADY, has a Raman peak 27 times more intense than that of 5-ethynyl-2'-deoxyuridine. Raman microscopy using submicromolar extracellular probe concentrations successfully visualized mitochondria in living cells. A full Raman spectrum is acquired at each pixel of the scanned sample, and we showed that simultaneous Raman imaging of MitoBADY and endogenous cellular biomolecules can be achieved in a single scan. MitoBADY should be useful for the study of mitochondrial dynamics. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamakoshi, Hiroyuki; Palonpon, Almar; Dodo, Kosuke; Ando, Jun; Fujita, Katsumasa; Sodeoka, Mikiko] Japan Sci & Technol Agcy, ERATO, Sodeoka Live Cell Chem Project, Wako, Saitama 3510198, Japan; [Yamakoshi, Hiroyuki; Dodo, Kosuke; Ando, Jun; Sodeoka, Mikiko] RIKEN, Synthet Organ Chem Lab, Wako, Saitama 3510198, Japan; [Dodo, Kosuke; Ando, Jun; Fujita, Katsumasa; Sodeoka, Mikiko] Japan Sci & Technol Agcy, CREST, Wako, Saitama 3510198, Japan; [Palonpon, Almar; Ando, Jun; Kawata, Satoshi; Fujita, Katsumasa] Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan	Sodeoka, M (reprint author), Japan Sci & Technol Agcy, ERATO, Sodeoka Live Cell Chem Project, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sodeoka@riken.jp	Sodeoka, Mikiko/A-9952-2008; Dodo, Kosuke/G-2264-2012; Fujita, Katsumasa/F-6699-2015	Sodeoka, Mikiko/0000-0002-1344-364X; 	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23710276, 2410267]	The authors thank Dr. Masaya Okada for technical support and helpful discussions. This work was partly supported by a Grant-in-Aid for Young Scientist (B) (23710276 to H.Y. and 2410267 to J.A.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Masanta G, 2011, J AM CHEM SOC, V133, P5698, DOI 10.1021/ja200444t; Chen ZX, 2014, J AM CHEM SOC, V136, P8027, DOI 10.1021/ja502706q; Leung CWT, 2013, J AM CHEM SOC, V135, P62, DOI 10.1021/ja310324q; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Bae SK, 2013, J AM CHEM SOC, V135, P9915, DOI 10.1021/ja404004v; Wei L, 2014, NAT METHODS, V11, P410, DOI [10.1038/nmeth.2878, 10.1038/NMETH.2878]; Murase T, 2012, CHEM LETT, V41, P262, DOI 10.1246/cl.2012.262; Kakita M, 2013, J BIOPHOTONICS, V6, P256, DOI 10.1002/jbio.201200042; Hong SL, 2014, ANGEW CHEM INT EDIT, V53, P5827, DOI 10.1002/anie.201400328; Neto BAD, 2013, RSC ADV, V3, P5291, DOI 10.1039/c2ra21995f; Palonpon AF, 2013, NAT PROTOC, V8, P677, DOI 10.1038/nprot.2013.030; Palonpon AF, 2013, CURR OPIN CHEM BIOL, V17, P708, DOI 10.1016/j.cbpa.2013.05.021; Le Trionnaire S, 2014, MEDCHEMCOMM, V5, P728, DOI 10.1039/c3md00323j; Pathak RK, 2014, ACS CHEM BIOL, V9, P1178, DOI 10.1021/cb400944y; Yang Z, 2013, J AM CHEM SOC, V135, P9181, DOI 10.1021/ja403851p; BURNS RJ, 1995, ARCH BIOCHEM BIOPHYS, V322, P60, DOI 10.1006/abbi.1995.1436; Klein K, 2012, BIOPHYS J, V102, P360, DOI 10.1016/j.bpj.2011.12.027; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kakita M, 2012, J BIOPHOTONICS, V5, P20, DOI 10.1002/jbio.201100087; Yamakoshi H, 2011, J AM CHEM SOC, V133, P6102, DOI 10.1021/ja108404p; Matthaus C, 2007, BIOPHYS J, V93, P668, DOI 10.1529/biophysj.106.102061; Hamada K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2952192; Yin WY, 2009, ORG LETT, V11, P709, DOI 10.1021/ol8027863; Biasutto L, 2008, BIOORG MED CHEM LETT, V18, P5594, DOI 10.1016/j.bmcl.2008.08.100; Krumova K, 2013, J AM CHEM SOC, V135, P17135, DOI 10.1021/ja408227f; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0; Ross MF, 2008, BIOCHEM J, V411, P633, DOI 10.1042/BJ20080063; Atkinson J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1499; Ban S, 2007, BIOORG MED CHEM LETT, V17, P2055, DOI 10.1016/j.bincl.2007.01.011; Berezhna S, 2003, BIOCHEMISTRY-US, V42, P6149, DOI 10.1021/bi027387y; Constant-Urban C, 2013, BIOORG MED CHEM LETT, V23, P5878, DOI 10.1016/j.bmcl.2013.08.091; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; Hardy M, 2007, CHEM COMMUN, P1083, DOI 10.1039/b616076j; Horinouchi T, 2011, BIOORG MED CHEM LETT, V21, P2000, DOI 10.1016/j.bmcl.2011.02.027; Hou J.-T., 2014, CHEM COMMUN, P8640; KELSO GF, 2012, J CHEM BIOL, V19, P1237; Malouitre S, 2010, BIOCHEM J, V425, P137, DOI 10.1042/BJ20090332; SPIRO TG, 1972, P NATL ACAD SCI USA, V69, P2622, DOI 10.1073/pnas.69.9.2622; SRIVASTAVA PC, 1984, J MED CHEM, V27, P978, DOI 10.1021/jm00374a007; Tyurina YY, 2012, FEBS LETT, V586, P235, DOI 10.1016/j.febslet.2011.12.016	46	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 1	2015	25	3					664	667		10.1016/j.bmcl.2014.11.080		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AY9XT	WOS:000347901700046		
J	Kawata, J; Aoki, M; Ishimaru, Y; Ono, T; Sagara, K; Narahara, S; Matsmoto, T; Hirose, E; Yamaguchi, Y				Kawata, Jin; Aoki, Manabu; Ishimaru, Yasuji; Ono, Tomomichi; Sagara, Katsurou; Narahara, Shinji; Matsmoto, Tamami; Hirose, Eiji; Yamaguchi, Yasuo			Mechanism of tissue factor production by monocytes stimulated with neutrophil elastase	BLOOD CELLS MOLECULES AND DISEASES			English	Article						Monocyte; Neutrophil elastase; Protein kinase C; Tissue factor; Disseminated intravascular coagulation	PROTEIN-KINASE-C; DISSEMINATED INTRAVASCULAR COAGULATION; PERIPHERAL-BLOOD MONOCYTES; FACTOR EXPRESSION; PHORBOL ESTER; INHIBITION; CELLS; INDUCTION; ALPHA; ACID	Background: Monocytes and neutrophils are activated during disseminated intravascular coagulation. Tissue factor, the main initiator of coagulation, is expressed by monocytes, while elastase is released by neutrophils. Aims: This study investigated tissue factor production by peripheral monocytes after stimulation with human neutrophil elastase. Methods: Tissue factor mRNA levels were investigated by the reverse transcriptase-polymerase chain reaction and tissue factor protein production was assessed by western blotting when monocytes were exposed to neutrophil elastase with or without preincubation using various inhibitors. Results: Neutrophil elastase upregulated tissue factor mRNA and protein levels in monocytes. Both U73122 (phospholipase C inhibitor) and TMB-8 (intracellular calcium antagonist) prevented the upregulation of tissue factor mRNA. SB203580 (p38 mitogen-activated protein kinase inhibitor) suppressed this response, but PD98059 (extracellular signal-regulated kinase inhibitor) did not. Ro-318425 (ATP-competitive and selective protein kinase C (PKC) inhibitor) and Go 6976 (inhibitor of conventional PKCs and PKC mu) blocked the upregulation of tissue factor mRNA expression. Go 6983 (broad-spectrum PKC inhibitor) and CGP 4125 (staurosporine analog) partially attenuated it, as did a PKC theta/delta inhibitor. Conclusions: Neutrophil elastase mainly enhances tissue factor production by monocytes via the phospholipase C/conventional PKC/p38 MAPK pathway, although a novel PKC is also involved. (C) 2014 Elsevier Inc. All rights reserved.	[Kawata, Jin; Aoki, Manabu; Ishimaru, Yasuji; Ono, Tomomichi; Sagara, Katsurou; Narahara, Shinji; Matsmoto, Tamami; Hirose, Eiji; Yamaguchi, Yasuo] Kumamoto Hlth Sci Univ, Dept Med Technol, Kumamoto 8615598, Japan	Yamaguchi, Y (reprint author), Kumamoto Hlth Sci Univ, Dept Med Technol, Kita Ku, Izumi Machi 325, Kumamoto 8615598, Japan.	yamaguti@kumamoto-hsu.ac.jp					Meyer-Hoffert U, 2009, FRONT BIOSCI, V14, P3409, DOI 10.2741/4062; Xiang BG, 2012, J BIOL CHEM, V287, P41277, DOI 10.1074/jbc.M112.393124; CERMAK J, 1993, BLOOD, V82, P513; Shao MXG, 2005, J IMMUNOL, V175, P4009; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Chakraborti S, 2013, CELL SIGNAL, V25, P512, DOI 10.1016/j.cellsig.2012.11.011; Cole DC, 2008, J MED CHEM, V51, P5958, DOI 10.1021/jm800214a; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; NIXON JS, 1991, DRUG EXP CLIN RES, V17, P389; Osterud B, 2001, SEMIN THROMB HEMOST, V27, P605, DOI 10.1055/s-2001-18866; De Smet P, 1999, CELL CALCIUM, V26, P9; BANCSI MJLMF, 1994, INFECT IMMUN, V62, P5669; Chung S, 2011, THROMB RES, V127, P450, DOI 10.1016/j.thromres.2010.12.021; Hayakawa M., 2011, SHOCK, V33, P14; Ibrahim Ikhlass N, 2005, Am J Ther, V12, P411, DOI 10.1097/01.mjt.0000132255.26146.30; INADA K, 1991, MICROBIOL IMMUNOL, V35, P303; Kaneko T, 2002, ARTERIOSCL THROM VAS, V22, P855, DOI 10.1161/01.ATV.0000014427.80594.8F; KOHNO S, 1993, MICROBIOL IMMUNOL, V37, P207; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; Mattsson E, 2004, INFECT IMMUN, V72, P4322, DOI 10.1128/IAI.72.7.4322-4326.2004; Menne J, 2013, DIABETES, V62, P1167, DOI 10.2337/db12-0534; MESZAROS K, 1994, BLOOD, V83, P2516; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; OSTERUD B, 1992, BLOOD COAGUL FIBRIN, V3, P309; Pal D, 2012, BIOCHEM BIOPH RES CO, V425, P836, DOI 10.1016/j.bbrc.2012.07.163; RANA SV, 1988, BLOOD, V71, P259; SIMPSON AWM, 1984, FEBS LETT, V176, P139, DOI 10.1016/0014-5793(84)80928-X; STRIETER RM, 1989, AM J RESP CELL MOL, V1, P57; Takahashi H, 2000, J TRAUMA, V49, P86, DOI 10.1097/00005373-200007000-00013; Xia JH, 2012, J NUTR BIOCHEM, V23, P1668, DOI 10.1016/j.jnutbio.2011.11.010; YULE DI, 1992, J BIOL CHEM, V267, P13830	33	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1079-9796	1096-0961		BLOOD CELL MOL DIS	Blood Cells Mol. Dis.	FEB	2015	54	2					206	209		10.1016/j.bcmd.2014.10.005		4	Hematology	Hematology	AZ5HH	WOS:000348250300013		
J	Yoshitaka, T; Kittaka, M; Ishida, S; Mizuno, N; Mukai, T; Ueki, Y				Yoshitaka, Teruhito; Kittaka, Mizuho; Ishida, Shu; Mizuno, Noriyoshi; Mukai, Tomoyuki; Ueki, Yasuyoshi			Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice	BONE			English	Article						Autoinflammation; Bone loss; Bone marrow transplantation; Cherubism; SH3BP2	WISKOTT-ALDRICH-SYNDROME; 3BP2 ADAPTER PROTEIN; TERM-FOLLOW-UP; ORBITAL INVOLVEMENT; ANTIGEN RECEPTOR; ACTIVATION; DISEASE; LEUKEMIA; CELLS; GENE	Cherubism (OMIM#118400) is a genetic disorder in children characterized by excessive jawbone destruction with proliferation of fibro-osseous lesions containing a large number of osteoclasts. Mutations in the SH3-domain binding protein 2 (SH3BP2) are responsible for cherubism. Analysis of the knock-in (KI) mouse model of cherubism showed that homozygous cherubism mice (Sh3bp2(KI/KI)) spontaneously develop systemic autoinflammation and inflammatory bone loss and that cherubism is a TNF-alpha-dependent hematopoietic disorder. In this study, we investigated whether bone marrow transplantation (BMT) is effective for the treatment of inflammation and bone loss in Sh3bp2(KI/KI) mice. Bone marrow (BM) cells from wild-type (Sh3bp2(+/+)) mice were transplanted to 6-week-old Sh36p2(KI/KI) mice with developing inflammation and to 10-week-old Sh3bp2(KI/KI) mice with established inflammation. Six-week-old Sh36p2(KI/KI) mice transplanted with Sh3bp2(+/+) BM cells exhibited improved body weight loss, facial swelling, and survival rate. Inflammatory lesions in the liver and lung as well as bone loss in calvaria and mandibula were ameliorated at 10 weeks after BMT compared to Sh36p2(KI/KI) mice transplanted with Sh36p2(KI/KI) BM cells. Elevation of serum TNF-alpha levels was not detected after BMT. BMT was effective for up to 20 weeks in 6-week-old Sh36p2(KI/KI) mice transplanted with Sh36p2(KI/KI) BM cells. BMT also ameliorated the inflammation and bone loss in 10-week-old Sh36p2(KI/KI) mice. Thus our study demonstrates that BMT improves the inflammation and bone loss in cherubism mice. BMT may be effective for the treatment of cherubism patients. (C) 2014 Published by Elsevier Inc.	[Yoshitaka, Teruhito; Kittaka, Mizuho; Ishida, Shu; Mizuno, Noriyoshi; Mukai, Tomoyuki; Ueki, Yasuyoshi] Univ Missouri, Dept Oral & Craniofacial Sci, Sch Dent, Kansas City, MO 64108 USA; [Ishida, Shu; Mizuno, Noriyoshi] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Appl Life Sci, Dept Periodontal Med, Hiroshima 734, Japan; [Ishida, Shu; Mizuno, Noriyoshi] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima 734, Japan	Ueki, Y (reprint author), Univ Missouri, Dept Oral & Craniofacial Sci, Sch Dent, 650 E 25th St, Kansas City, MO 64108 USA.	yoshitakat@umkc.edu; kittakam@umkc.edu; shu1222@hotmail.co.jp; mizuno@hiroshima-u.ac.jp; mukai09@gmail.com; uekiy@umkc.edu			National Institutes of Health [R01DE020835]	We thank members in the Department of Oral and Craniofacial Sciences at the University of Missouri-Kansas City, School of Dentistry for critical discussion and helpful suggestions. We are also grateful to M. Dallas and Y. Xie for their technical assistance and to R. Gallant and S. Masrani for critical reading of the manuscript. This work was supported by a grant from the National Institutes of Health (R01DE020835 to YU).	Ahmadi AJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P570, DOI 10.1001/archopht.121.4.570; Ainsua-Enrich E, 2012, J IMMUNOL, V189, P2727, DOI 10.4049/jimmunol.1200380; HOBBS JR, 1981, LANCET, V2, P709; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Roy V, 2001, BONE MARROW TRANSPL, V27, P641, DOI 10.1038/sj.bmt.1702849; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Hyckel P, 2005, J CRANIO MAXILL SURG, V33, P61, DOI 10.1016/j.jcms.2004.07.006; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; HOLLER E, 1990, BLOOD, V75, P1011; Burnett AK, 1998, LANCET, V351, P700, DOI 10.1016/S0140-6736(97)09214-3; HOROWITZ MM, 1990, BLOOD, V75, P555; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Ozsahin H, 2008, BLOOD, V111, P439, DOI 10.1182/blood-2007-03-076679; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Souillet G, 2003, BONE MARROW TRANSPL, V31, P1105, DOI 10.1038/sj.bmt.1704105; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; BACH FH, 1968, LANCET, V2, P1364; Battaglia A, 2000, OTOLARYNG HEAD NECK, V122, P573, DOI 10.1016/S0194-5998(00)70104-5; Carroll AL, 2001, CLIN EXP OPHTHALMOL, V29, P38, DOI 10.1046/j.1442-9071.2001.00363.x; Carvalho VM, 2008, ORAL ONCOL, V44, P153, DOI 10.1016/j.oraloncology.2007.01.012; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chen G, 2012, J IMMUNOL, V189, P2138, DOI 10.4049/jimmunol.1103184; Colombo F, 2001, OPHTHALMOLOGY, V108, P1884, DOI 10.1016/S0161-6420(01)00757-6; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; de Lange J, 2007, J ORAL MAXIL SURG, V65, P1665, DOI 10.1016/j.joms.2006.06.266; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Etoz Osman A, 2011, Eur J Dent, V5, P486; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Hawes M J, 1989, Ophthal Plast Reconstr Surg, V5, P133, DOI 10.1097/00002341-198906000-00010; Hero M, 2013, BONE, V52, P347, DOI 10.1016/j.bone.2012.10.003; Jevremovic D, 2001, J IMMUNOL, V166, P7219; Motamedi MHK, 1998, J ORAL MAXIL SURG, V56, P1336, DOI 10.1016/S0278-2391(98)90618-8; Krivit W, 1999, Curr Opin Neurol, V12, P167, DOI 10.1097/00019052-199904000-00007; Lannon DA, 2001, BRIT J PLAST SURG, V54, P708, DOI 10.1054/bjps.2001.3701; Meng XM, 2005, INT J ORAL MAX SURG, V34, P350, DOI 10.1016/j.ijom.2004.09.006; Mossad SB, 1996, BONE MARROW TRANSPL, V18, P265; Mukai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105518; Mukai T, 2014, J BONE MINER RES; OHNISHI K, 1995, BLOOD, V86, P906; Pagnini Ilaria, 2011, Clin Exp Rheumatol, V29, P147; Papadaki ME, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-S1-S6; Penarrocha M, 2006, J ORAL MAXIL SURG, V64, P924, DOI 10.1016/j.joms.2006.02.003; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; Pontes FSC, 2007, INT J PEDIATR OTORHI, V71, P831, DOI 10.1016/j.ijport.2007.01.017; Prescott T, 2013, EUR J MED GENET, V56, P131, DOI 10.1016/j.ejmg.2012.12.008; Raposo-Amaral CE, 2007, ANN PLAS SURG, V58, P645, DOI 10.1097/01.sap.0000248141.36904.19; Reddy Gv, 2012, J Clin Imaging Sci, V2, P8, DOI 10.4103/2156-7514.93275; Scheinfeld N, 2004, J Dermatolog Treat, V15, P280; Silva GCC, 2007, BRIT J ORAL MAX SURG, V45, P567, DOI 10.1016/j.bjoms.2006.08.013; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; von Wowern N, 2000, ORAL SURG ORAL MED O, V90, P765, DOI 10.1067/moe.2000.108438; Wang CCJ, 2010, BONE, V46, P1306, DOI 10.1016/j.bone.2010.01.380; Wang CN, 2006, BRIT J ORAL MAX SURG, V44, P322, DOI 10.1016/j.bjoms.2005.10.003; Yilmaz B, 2006, J PROSTHET DENT, V96, P313, DOI 10.1016/j.prosdent.2006.09.014; Yoshitaka T, 2014, CELL REP, V8, P1752, DOI 10.1016/j.celrep.2014.08.023; Yoshitaka T, 2014, J BONE MINER RES, V29, P1170, DOI 10.1002/jbmr.2125; Young Neal S, 2010, Biol Blood Marrow Transplant, V16, pS119, DOI 10.1016/j.bbmt.2009.09.013	63	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	FEB	2015	71						201	209		10.1016/j.bone.2014.10.021		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AY7XU	WOS:000347770000026		
J	Kameda, Y; Takahata, M; Mikuni, S; Shimizu, T; Hamano, H; Angata, T; Hatakeyama, S; Kinjo, M; Iwasaki, N				Kameda, Yusuke; Takahata, Masahiko; Mikuni, Shintaro; Shimizu, Tomohiro; Hamano, Hiroki; Angata, Takashi; Hatakeyama, Shigetsugu; Kinjo, Masataka; Iwasaki, Norimasa			Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis	BONE			English	Article						Siglec-15; Osteoclast; DAP12; Menopause; Osteoporosis; Sialic acid	REGULATES OSTEOCLAST DIFFERENTIATION; DAP12-ASSOCIATING LECTIN (MDL)-1; SIGNALING ADAPTER DAP12; ESTROGEN-DEFICIENCY; BONE LOSS; MYELOID CELLS; CUTTING EDGE; FUNCTIONAL OSTEOCLASTS; RECEPTOR; MICE	Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is an immunoreceptor that regulates osteoclast development and bone resorption in association with an immunoreceptor tyrosine-based activation motif (ITAM) adaptor protein, DNAX-activating protein 12 kDa (DAP12). Although Siglec-15 has an important role in physiologic bone remodeling by modulating RANKL signaling, it is unclear whether it is involved in pathologic bone loss in which multiple osteoclastogenic factors participate in excessive osteoclastogenesis. Here we demonstrated that Siglec-15 is involved in estrogen deficiency-induced bone loss. WT and Siglec-15(-/-) mice were ovariectomized (Ovx) or sham-operated at 14 wk of age and their skeletal phenotype was evaluated at 18 and 22 wk of age. Siglec-15(-/-) mice showed resistance to estrogen deficiency-induced bone loss compared to WT mice. Although the number of tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts increased after ovariectomy in both WT and Siglec-15(-/-) mice, the increase was lower in Siglec-15(-/-) mice than in WT mice. Importantly, osteoclasts in Siglec-15(-/-) mice were small and failed to spread on the bone surface, indicating impaired osteoclast differentiation. Because upregulated production of TNF-alpha as well as RANKL is mainly responsible for estrogen deficiency-induced development of osteoclasts, we examined whether Siglec-15 deficiency affects TNF-alpha-induced osteoclastogenesis in vitro. The TNF-alpha mediated induction of TRAP-positive multinucleated cells was impaired in Siglec-15(-/-) cells, suggesting that Siglec-15 is involved in TNF-alpha induced osteoclastogenesis. We also confirmed that signaling through osteoclast-associated receptor/Fc receptor common gamma chain, which is an alternative ITAM adaptor to DAP12, rescues multinucleation but not cytoskeletal organization of TNF-alpha and RANKL-induced Siglec-15(-/-) osteoclasts, indicating that the Siglec-15/DAP12 pathway is especially important for cytoskeletal organization of osteoclasts in both RANKL and TNF-alpha induced osteoclastogenesis. The present findings indicate that Siglec-15 is involved in estrogen deficiency-induced differentiation of osteoclasts and is thus a potential therapeutic target for postmenopausal osteoporosis. (C) 2014 Elsevier Inc. All rights reserved.	[Kameda, Yusuke; Takahata, Masahiko; Shimizu, Tomohiro; Hamano, Hiroki; Iwasaki, Norimasa] Hokkaido Univ, Dept Orthoped Surg, Sch Med, Sapporo, Hokkaido 0608638, Japan; [Mikuni, Shintaro; Kinjo, Masataka] Hokkaido Univ, Lab Mol Cell Dynam, Fac Adv Life Sci, Sapporo, Hokkaido 0608638, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608638, Japan; [Angata, Takashi] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	Takahata, M (reprint author), Hokkaido Univ, Dept Orthoped Surg, Grad Sch Med, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	takamasa@med.hokudai.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23890008]	We would like to thank Dr. Toshio Kitamura for the plasmids and cell lines, and Dr. Toshiyuki Akazawa for the bovine bone slices. This project was supported in part by a Grant-in-Aid for Research Activity Start-up from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 23890008 (to M. Takahata).	Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Dietrich J, 2000, J IMMUNOL, V164, P9; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Hamerman JA, 2006, J IMMUNOL, V177, P2051; Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Stuible M, 2014, J BIOL CHEM, V289, P6498, DOI 10.1074/jbc.M113.494542; Ishida-Kitagawa N, 2012, J BIOL CHEM, V287, P17493, DOI 10.1074/jbc.M111.324194; Kaneda T, 2000, J IMMUNOL, V165, P4254; Turnbull IR, 2006, J IMMUNOL, V177, P3520; Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Zhao RQ, 2012, INT J MED SCI, V9, P825, DOI 10.7150/ijms.5180; Ammann P, 1997, J CLIN INVEST, V99, P1699, DOI 10.1172/JCI119333; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Hiruma Y., BONE, V53, P87; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Kimble RB, 1997, J BONE MINER RES, V12, P935, DOI 10.1359/jbmr.1997.12.6.935; Takahata M, 2007, BONE, V41, P77, DOI 10.1016/j.bone.2007.03.016; Wu YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000586; Zou W, 2010, J CELL SCI, V123, P2955, DOI 10.1242/jcs.069872	33	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	FEB	2015	71						217	226		10.1016/j.bone.2014.10.027		10	Endocrinology & Metabolism	Endocrinology & Metabolism	AY7XU	WOS:000347770000028		
J	Ishihara, M				Ishihara, Masamichi			Suppression of Growth by Multiplicative White Noise in a Parametric Resonant System	BRAZILIAN JOURNAL OF PHYSICS			English	Article						Suppression of growth; Exponent; Multiplicative White Noise; Parametric Resonance	STOCHASTIC RESONANCE; PHASE-TRANSITIONS; OSCILLATOR; MODEL; AMPLIFICATION; DRIVEN	The growth of the amplitude in a Mathieu-like equation with multiplicative white noise is studied. To obtain an approximate analytical expression for the exponent at the extremum on parametric resonance regions, a time-interval width is introduced. To determine the exponents numerically, the stochastic differential equations are solved by a symplectic numerical method. The Mathieu-like equation contains a parameter alpha determined by the intensity of noise and the strength of the coupling between the variable and noise; without loss of generality, only non-negative alpha can be considered. The exponent is shown to decrease with alpha, reach a minimum and increase after that. The minimum exponent is obtained analytically and numerically. As a function of alpha, the minimum at alpha not equal 0, occurs on the parametric resonance regions of alpha=0. This minimum indicates suppression of growth by multiplicative white noise.	Koriyama Womens Univ, Dept Human Life Studies, Koriyama, Fukushima, Japan	Ishihara, M (reprint author), Koriyama Womens Univ, Dept Human Life Studies, Koriyama, Fukushima, Japan.	m_isihar@koriyama-kgc.ac.jp					ABRAMOWITZ M., 1972, HDB MATH FUNCTIONS; VandenBroeck C, 1997, PHYS REV E, V55, P4084, DOI 10.1103/PhysRevE.55.4084; Zanchin V, 1998, PHYS REV D, V57, P4651, DOI 10.1103/PhysRevD.57.4651; Collins JJ, 1996, PHYS REV E, V54, P5575, DOI 10.1103/PhysRevE.54.5575; Son DT, 1996, PHYS REV D, V54, P3745, DOI 10.1103/PhysRevD.54.3745; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Fukuda H, 2003, J PHYS SOC JPN, V72, P487, DOI 10.1143/JPSJ.72.487; Bassett BA, 1998, PHYS REV LETT, V81, P2630, DOI 10.1103/PhysRevLett.81.2630; Bateman H., 1953, HIGHER TRANSCENDENTA, V2; Berthet R, 2003, PHYSICA D, V174, P84, DOI 10.1016/S0167-2789(02)00684-X; Bobryk RV, 2002, PHYSICA A, V316, P225, DOI 10.1016/S0378-4371(02)01312-2; Chialvo DR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.050902; Gradshteyn S., 2000, TABLE INTEGRALS SERI; Ishihara M, 2006, PROG THEOR PHYS, V116, P37, DOI 10.1143/PTP.116.37; Ishihara M, 2004, PROG THEOR PHYS, V112, P511, DOI 10.1143/PTP.112.511; Ishihara M, 2005, PROG THEOR PHYS, V114, P157, DOI 10.1143/PTP.114.157; Landa PS, 1996, PHYS REV E, V54, P3535, DOI 10.1103/PhysRevE.54.3535; Landau L D, 1976, MECHANICS; Mallick K, 2003, PHYSICA A, V325, P213, DOI 10.1016/S0378-4371(03)00200-0; Mallick K, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041113; Mallick K., ARXIVCONDMAT0501640; Mallick K, 2004, EUR PHYS J B, V38, P99, DOI 10.1140/epjb/e2004-00104-3; Milstein GN, 2002, SIAM J NUMER ANAL, V39, P2066, DOI 10.1137/S0036142901387440; Milstein GN, 2002, SIAM J NUMER ANAL, V40, P1583, DOI 10.1137/S0036142901395588; Miyakawa K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056206; Stratonovich R. L., 1967, TOPICS THEORY RANDOM, VII; TAKIMOTO N, 1990, J PHYS SOC JPN, V59, P3495, DOI 10.1143/JPSJ.59.3495; Tashiro T, 2006, PHYSICA A, V366, P124, DOI 10.1016/j.physa.2005.11.003; Tashiro T, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/16/165002; Tessone CJ, 2005, PHYSICA A, V351, P106, DOI 10.1016/j.physa.2004.12.012; Yang LF, 1999, J CHEM PHYS, V110, P3591, DOI 10.1063/1.478227; Zaikin A. A., 2001, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.010601; ZERBE C, 1994, PHYS REV E, V49, P3626, DOI 10.1103/PhysRevE.49.3626	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0103-9733	1678-4448		BRAZ J PHYS	Braz. J. Phys.	FEB	2015	45	1					112	119		10.1007/s13538-014-0290-y		8	Physics, Multidisciplinary	Physics	AZ5CM	WOS:000348237800016		
J	Takeshima, H; Niwa, T; Takahashi, T; Wakabayashi, M; Yamashita, S; Ando, T; Inagawa, Y; Taniguchi, H; Katai, H; Sugiyama, T; Kiyono, T; Ushijima, T				Takeshima, Hideyuki; Niwa, Tohru; Takahashi, Takamasa; Wakabayashi, Mika; Yamashita, Satoshi; Ando, Takayuki; Inagawa, Yuki; Taniguchi, Hirokazu; Katai, Hitoshi; Sugiyama, Toshiro; Kiyono, Tohru; Ushijima, Toshikazu			Frequent involvement of chromatin remodeler alterations in gastric field cancerization	CANCER LETTERS			English	Article						Epigenetics; Chromatin remodeling; DNA methylation; Field defect	ABERRANT DNA METHYLATION; HELICOBACTER-PYLORI INFECTION; TUMOR-SUPPRESSOR GENES; EPIGENETIC FIELD; EPITHELIAL-CELLS; CANCER-RISK; CPG ISLANDS; MUTATIONS; HYPERMETHYLATION; MUCOSAE	A field for cancerization, or a field defect, is formed by the accumulation of genetic and epigenetic alterations in normal-appearing tissues, and is involved in various cancers, especially multiple cancers. Epigenetic alterations are frequently present in chronic inflammation-exposed tissues, but information on individual genes involved in the formation of a field defect is still fragmental. Here, using non-cancerous gastric tissues of cancer patients, we isolated 16 aberrantly methylated genes, and identified chromatin remodelers ACTL6B and SMARCA1 as novel genes frequently methylated in non-cancerous tissues. SMARCA1 was expressed at high levels in normal gastric tissues, but was frequently silenced by aberrant methylation in gastric cancer cells. Moreover, somatic mutations of additional chromatin remodelers, such as ARID1A, SMARCA2, and SMARCA4, were found in 30% of gastric cancers. Mutant allele frequency suggested that the majority of cancer cells harbored a mutation when present. Depletion of a chromatin remodeler, SMARCA1 or SMARCA2, in cancer cell lines promoted their growth. These results showed that epigenetic and genetic alterations of chromatin remodelers are induced at an early stage of carcinogenesis and are frequently involved in the formation of a field defect. (c) 2014 Elsevier Ireland Ltd. All rights reserved.	[Takeshima, Hideyuki; Niwa, Tohru; Takahashi, Takamasa; Wakabayashi, Mika; Yamashita, Satoshi; Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Chuo Ku, Tokyo 1040045, Japan; [Ando, Takayuki; Sugiyama, Toshiro] Toyama Univ, Dept Internal Med 3, Toyama 9300194, Japan; [Inagawa, Yuki; Kiyono, Tohru] Natl Canc Ctr, Div Carcinogenesis & Canc Prevent, Chuo Ku, Tokyo 1040045, Japan; [Taniguchi, Hirokazu] Natl Canc Ctr, Div Pathol, Chuo Ku, Tokyo 1040045, Japan; [Taniguchi, Hirokazu] Natl Canc Ctr, Clin Lab, Chuo Ku, Tokyo 1040045, Japan; [Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Chuo Ku, Tokyo 1040045, Japan	Ushijima, T (reprint author), Natl Canc Ctr, Div Epigen, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tushijim@ncc.go.jp			Ministry of Health, Labour and Welfare, Japan [H22-002, H26-019]	Grants-in-Aid for the Third-Term Comprehensive Cancer Control Strategy (H22-002) and Applied Research for Innovative Treatment of Cancer (H26-019) from the Ministry of Health, Labour and Welfare, Japan.	Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Issa JPJ, 2001, CANCER RES, V61, P3573; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Kim JG, 2013, CANCER LETT, V330, P33, DOI 10.1016/j.canlet.2012.11.022; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Eads CA, 2000, CANCER RES, V60, P5021; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Asada K., GUT; Asada K, 2013, ONCOGENE, V32, P2140, DOI 10.1038/onc.2012.228; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Dennis Glynn Jr, 2003, Genome Biol, V4, pP3, DOI 10.1186/gb-2003-4-5-p3; Enomoto S, 2007, CANCER SCI, V98, P1853, DOI 10.1111/j.1349-7006.2007.00625.x; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Huang da W., 2009, NAT PROTOC, V4, P44, DOI [DOI 10.1038/NPR0T.2008.211, 10.1038/nprot.2008.211]; Kikuyama M, 2012, CANCER LETT, V322, P204, DOI 10.1016/j.canlet.2012.03.016; Mullighan CG, 2009, NAT GENET, V41, P766, DOI 10.1038/ng0709-766; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Nakajima Takeshi, 2006, Gastric Cancer, V9, P93, DOI 10.1007/s10120-006-0372-9; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082302; Takeshima H, 2011, GENOMICS, V98, P182, DOI 10.1016/j.ygeno.2011.06.003; Takeshima H, 2010, EPIGENETICS-US, V5, P89; Weaver J.M., 2014, NAT GENET IN PRESS; Yamamoto E, 2011, DIGESTION, V83, P241, DOI 10.1159/000320453; Yoda Y., GASTRIC CANC	53	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3835	1872-7980		CANCER LETT	Cancer Lett.	FEB 1	2015	357	1					328	338		10.1016/j.canlet.2014.11.038		11	Oncology	Oncology	AZ2TB	WOS:000348084100032		
J	Miyatake, Y; Sheehy, N; Ikeshita, S; Hall, WW; Kasahara, M				Miyatake, Yukiko; Sheehy, Noreen; Ikeshita, Shunji; Hall, William W.; Kasahara, Masanori			Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like ATL cells in an NF-kappa B- and vimentin-dependent manner	CANCER LETTERS			English	Article						Cancer stem cells; Coculture; CD44; Vimentin, ATL	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; GENE-EXPRESSION; LEUKEMIA-CELLS; LYMPHOMA; CULTURE; LEUKEMIA/LYMPHOMA; PROGRESSION; FIBROBLASTS; LYMPHOCYTES	Adult T-cell leukemia/lymphoma (ATL) is an intractable T-cell malignancy accompanied by massive invasion of lymphoma cells into various tissues. We demonstrate here that ATL cells cultured on a layer of epithelial-like feeder cells form anchorage-dependent multicellular aggregates (Ad-MCAs) and that a fraction of MCA-forming ATL cells acquire CD44 high cancer stem cell-like phenotypes. ATL cells forming Ad-MCAs displayed extracellular microvesicles with enhanced expression of CD44v9 at cell synapses, augmented expression of multidrug resistance protein 1, and increased NF-kappa B activity. Blockade of the NF kappa B pathway dramatically reduced Ad-MCA formation by ATL cells and the emergence of CD44 high ATL cells, but left a considerable number of ATL cells adhering to the feeder layer. Disruption of vimentin cytoskeleton by treatment with withaferin A, a natural steroidal lactone, suppressed not only the adhesion of ATL cells to the feeder layer but also subsequent Ad-MCA formation by ATL cells, suggesting the involvement of vimentin in anchoring ATL cells to the feeder layer. Ad-MCA formation by ATL cells on a layer of epithelial-like feeder cells may mimic critical events that occur in metastatic colonization. (c) 2014 Elsevier Ireland Ltd. All rights reserved.	[Miyatake, Yukiko; Ikeshita, Shunji; Kasahara, Masanori] Hokkaido Univ Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; [Miyatake, Yukiko; Sheehy, Noreen; Hall, William W.] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Ctr Res Infect Dis, Dublin 4, Ireland	Miyatake, Y (reprint author), Hokkaido Univ Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan.	yukimiya@med.hokudai.ac.jp	Kasahara, Masanori/G-7651-2011		JSPS KAKENHI [26460464]; Centre for Research in Infectious Diseases, School of Medicine and Medical Science, University College Dublin, Ireland	This work was supported by JSPS KAKENHI Grant Number 26460464 and the Centre for Research in Infectious Diseases, School of Medicine and Medical Science, University College Dublin, Ireland. We thank Drs. Shuichi Ota and Takanori Teshima for supplying us with samples of blood from an ATL patient.	Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Miyatake Y, 2013, AM J PATHOL, V182, P1832, DOI 10.1016/j.ajpath.2013.01.015; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Mori N, 1999, BLOOD, V93, P2360; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Chagan-Yasutan H, 2011, LEUKEMIA RES, V35, P1484, DOI 10.1016/j.leukres.2011.05.011; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Bittencourt AL, 2010, INT J DERMATOL, V49, P1099, DOI 10.1111/j.1365-4632.2010.04568.x; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Ohshima K, 2007, CANCER SCI, V98, P772, DOI 10.1111/j.1349-7006.2007.00456.x; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Gravelle P, 2014, AM J PATHOL, V184, P282, DOI 10.1016/j.ajpath.2013.09.018; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Havasi P, 2013, MOL BIOL REP, V40, P3023, DOI 10.1007/s11033-012-2376-3; Hironaka N, 2004, NEOPLASIA, V6, P266, DOI 10.1593/neo.03388; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Marks P.A, 2000, JNCI-J NATL CANCER I, V92, P1210; Miyatake Y, 2006, AM J PATHOL, V169, P189, DOI 10.2353/ajpath.2006.051225; Nasr R, 2011, VIRUSES-BASEL, V3, P750, DOI 10.3390/v3060750; Solis MA, 2012, BIOCH RES INT, V2012; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Tsutsumi Y, 2014, LEUKEMIA LYMPHOMA, V55, P457, DOI 10.3109/10428194.2013.807511; Yang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075069	47	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3835	1872-7980		CANCER LETT	Cancer Lett.	FEB 1	2015	357	1					355	363		10.1016/j.canlet.2014.11.055		9	Oncology	Oncology	AZ2TB	WOS:000348084100035		
J	Hamamura, K; Chen, A; Tanjung, N; Takigawa, S; Sudo, A; Yokota, H				Hamamura, Kazunori; Chen, Andy; Tanjung, Nancy; Takigawa, Shinya; Sudo, Akihiro; Yokota, Hiroki			In vitro and in silico analysis of an inhibitory mechanism of osteoclastogenesis by salubrinal and guanabenz	CELLULAR SIGNALLING			English	Article						Osteoclasts; NFATc1; c-Fos; JunB; Salubrinal; Guanabenz	GENOME-WIDE; BONE; DIFFERENTIATION; CELLS; SUPPRESSION; EXPRESSION; OSTEOBLAST; DEFECTS; RANKL	Inactivating bone-resorbing osteoclasts is a prime therapeutic strategy for the prevention of bone loss in patients with osteopenia and osteoporosis. Synthetic agents such as salubrinal and guanabenz, which attenuate stress to the endoplasmic reticulum, are reported to inhibit development of osteoclasts. However, the mechanism of their inhibitory action on osteoclasts is largely unknown. Using genome-wide expression profiles, we predicted key transcription factors that downregulated nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), a master transcription factor for osteoclastogenesis. Principal component analysis (PCA) predicted a list of transcription factors that were potentially responsible for reversing receptor activator of nuclear factor kappa-B ligand (RANKL)-driven stimulation of osteoclastogenesis. A partial silencing of NFATc1 allowed a selection of transcription factors that were likely to be located upstream of NFATc1. We validated the predicted transcription factors by focusing on two AP-1 transcription factors (c-Fos and JunB) using RAW264.7 pre-osteoclasts as well as primary bone marrow cells. As predicted, their mRNA and protein levels were elevated by RANK!, and the elevation was suppressed by salubrinal and guanabenz. A partial silencing of c-Fos or JunB by RNA interference decreased NFATc1 as well as tartrate-resistant acid phosphatase (TRAP) mRNA. Collectively, a systems-biology approach allows the prediction of a RANKL-salubrinaliguanabenz-NFATc1 regulatory axis, and in vitro assays validate an involvement of AP-1 transcription factors in suppression of osteoclastogenesis. (C) 2014 Elsevier Inc All rights reserved.	[Hamamura, Kazunori; Chen, Andy; Tanjung, Nancy; Takigawa, Shinya; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Takigawa, Shinya; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 514, Japan; [Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Hamamura, K (reprint author), Indiana Univ Purdue Univ, Dept Biomed Engn, SL155,723 West Michigan St, Indianapolis, IN 46202 USA.	hamamurk@iupui.edu			DOD [W81XWH-11-1-0716]	The authors appreciate M. Hamamura for technical assistance. All authors state that they have no conflicts of interest. This study was supported by grant DOD W81XWH-11-1-0716.	Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; SHAH RS, 1976, CLIN PHARMACOL THER, V19, P732; Wagner EF, 2003, ANN RHEUM DIS, V62, P83; Yu MJ, 2011, J IMMUNOL, V187, P1797, DOI 10.4049/jimmunol.1002628; Wagner EF, 2002, ANN RHEUM DIS, V61, P40; Xu GS, 2012, BLOOD, V119, P4205, DOI 10.1182/blood-2011-05-353300; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen A, 2010, IET SYST BIOL, V4, P52, DOI 10.1049/iet-syb.2008.0151; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dunning M., ILLUMINAMOUSEV2 DB I; Hamamura K, 2013, J BONE MINER METAB, V31, P618, DOI 10.1007/s00774-013-0450-0; Hamamura K, 2014, CELL SIGNAL, V26, P2358, DOI 10.1016/j.cellsig.2014.07.018; He L, 2013, CELL SIGNAL, V25, P552, DOI 10.1016/j.cellsig.2012.11.015; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Smyth GK, 2004, STAT APPL GENET MOL, V3; Yokota H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-197	21	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	FEB	2015	27	2					353	362		10.1016/j.cellsig.2014.11.020		10	Cell Biology	Cell Biology	AY9JD	WOS:000347865400016		
J	Hayashi, K; Dan, K; Goto, F; Tshuchihashi, N; Nomura, Y; Fujioka, M; Kanzaki, S; Ogawa, K				Hayashi, Ken; Dan, Katsuaki; Goto, Fumiyuki; Tshuchihashi, Nana; Nomura, Yasuyuki; Fujioka, Masato; Kanzaki, Sho; Ogawa, Kaoru			The autophagy pathway maintained signaling crosstalk with the Keap1-Nrf2 system through p62 in auditory cells under oxidative stress	CELLULAR SIGNALLING			English	Article						Autophagy Auditory cell; Oxidative stress; p62; Keap1/Nrf2	TRANSCRIPTION FACTOR NRF2; SELECTIVE AUTOPHAGY; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; HYDROGEN-PEROXIDE; GENE-EXPRESSION; ATP DEPLETION; HEARING-LOSS; APOPTOSIS; NECROSIS	The main purposes of our study were to consider the effect of autophagy on auditory cells under oxidative stress, and the function of possible crosstalk among p62, Keap1 and Nrf2 in autophagy-deficient auditory cells. First we described how cell death was induced in auditory cell line (HEI-OC1) exposed to H2O2. We found that the decision for the cell death of auditory cells under oxidative stress depends on the balance between autophagy and necrosis due to ATP depletion, and autophagy plays a cytoprotective function in oxidative stress-induced necrosis. Our data clearly suggested that autophagy was a cell survival mechanism in H2O2-induced cell death, based on the observation that suppression of autophagy by knockdown of Atg7 sensitized, whereas activation of autophagy by rapamycin protected against H2O2-induced cell death. Next our results regarding the relationship among p62, Nr12 and Keapl by siRNA paradoxically showed that p62 creates a positive feedback loop in the Keapl/Nrf2 pathway. Autophagy impaired by Atg7 knockdown degrades Keapl in a p62-dependent manner, whereas Nrf2 is activated. As a result, the cell death induced by H2O2 was promoted in auditory cells. Taken together, these results suggested that the autophagy pathway maintained signaling crosstalk with the KeaplNrf2 system through p62 in auditory cells under oxidative stress. (C) 2014 Elsevier Inc All rights reserved.	[Hayashi, Ken] Kamio Mem Hosp, Dept Otolaryngol, Tokyo 1010063, Japan; [Dan, Katsuaki] Keio Univ, Core Instrumentat Facil, Tokyo 1608582, Japan; [Hayashi, Ken; Goto, Fumiyuki; Tshuchihashi, Nana; Fujioka, Masato; Kanzaki, Sho; Ogawa, Kaoru] Keio Univ, Sch Med, Dept Otolaryngol, Tokyo 1608582, Japan; [Tshuchihashi, Nana] Kyushu Univ, Sch Med, Dept Otolaryngol, Fukuoka 8128582, Japan; [Nomura, Yasuyuki] Nihon Univ, Sch Med, Dept Otolaryngol, Tokyo 1738610, Japan	Hayashi, K (reprint author), Kamio Mem Hosp, Dept Otolaryngol, Tokyo 1010063, Japan.	ken.hayashi@jcom.home.ne.jp; katsudanmrw@yahoo.co.jp; amifumi@gmail.com; nanaakagi0707@yahoo.co.jp; nomusan@siren.ocn.ne.jp; masato@2002.jukuin.keio.ac.jp; shokanza@gmail.com; ogawak@a5.keio.jp			JSPS KAKENHI [23592494]	This work was supported by JSPS KAKENHI grant number 23592494. We thank Federico Kalinec (House Ear Institute, Los Angeles, CA, USA) for providing the auditory cell line, HEI-0C1 cells, and Toyoharu like for giving the technical support in transmission electron microscopy.	Aito H, 2004, BRAIN RES, V1013, P117, DOI 10.1016/j.brainres.2004.04.014; Andreoli SP, 1997, AM J PHYSIOL-RENAL, V272, pF729; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Chakrabarti S, 2011, AGING DIS, V2, P242; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Eguchi Y, 1997, CANCER RES, V57, P1835; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Huang Q, 2009, CELL DEATH DIFFER, V16, P264, DOI 10.1038/cdd.2008.151; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI 10.1089/ARS.2008.2263; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Mizushima Noboru, 2007, Autophagy, V3, P542; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Stepkowski TM, 2011, FREE RADICAL BIO MED, V50, P1186, DOI 10.1016/j.freeradbiomed.2011.01.033; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Xu YN, 2011, J REPROD DEVELOP, V57, P143, DOI 10.1262/jrd.10-110H; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315; Chen YQ, 2008, AUTOPHAGY, V4, P246; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101; Kim SJ, 2009, HEARING RES, V251, P70, DOI 10.1016/j.heares.2009.03.003; Huang Q, 2009, AUTOPHAGY, V5, P273, DOI 10.1038/cdd.2008.151; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Omotehara Y, 2011, OTOL NEUROTOL, V32, P1422, DOI 10.1097/MAO.0b013e3182355658; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Kashio A, 2012, GENE THER, V19, P1141, DOI 10.1038/gt.2011.204; Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474; Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61; Yamashita D, 2008, NEUROSCI RES, V61, P38, DOI 10.1016/j.neures.2008.01.009	58	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	FEB	2015	27	2					382	393		10.1016/j.cellsig.2014.11.024		12	Cell Biology	Cell Biology	AY9JD	WOS:000347865400019		
J	Mori, IC; Arias-Barreiro, CR; Koutsaftis, A; Ogo, A; Kawano, T; Yoshizuka, K; Inayat-Hussain, SH; Aoyama, I				Mori, Izumi C.; Arias-Barreiro, Carlos R.; Koutsaftis, Apostolos; Ogo, Atsushi; Kawano, Tomonori; Yoshizuka, Kazuharu; Inayat-Hussain, Salmaan H.; Aoyama, Isao			Toxicity of tetramethylammonium hydroxide to aquatic organisms and its synergistic action with potassium iodide	CHEMOSPHERE			English	Article						Tetramethylammonium hydroxide; Potassium iodide; Aquatic toxicity; Synergism; D. magna; Semiconductor wastewater	METHYL AMMONIUM HYDROXIDE; WASTE-WATER; BIOLOGICAL TREATMENT; DERMAL EXPOSURE; ACETYLCHOLINESTERASE; MORTALITY; MIXTURES; SILICON; MODEL	The aquatic ecotoxicity of chemicals involved in the manufacturing process of thin film transistor liquid crystal displays was assessed with a battery of four selected acute toxicity bioassays. We focused on tetramethylammonium hydroxide (TMAH, CAS No. 75-59-2), a widely utilized etchant. The toxicity of TMAH was low when tested in the 72 h-algal growth inhibition test (Pseudokirchneriellia subcapitata, EC50 = 360 mg L-1) and the Microtox (R) test (Vibrio fischeri, IC50 = 6.4 g L-1). In contrast, the 24 h-micro-crustacean immobilization and the 96 h-fish mortality tests showed relatively higher toxicity (Daphnia magna, EC50 = 32 mg L-1 and Oryzias latipes, LC50 = 154 mg L-1). Isobolograrn and mixture toxicity index analyses revealed apparent synergism of the mixture of TMAH and potassium iodide when examined with the D. magna immobilization test. The synergistic action was unique to iodide over other halide salts i.e. fluoride, chloride and bromide. Quaternary ammonium ions with longer alkyl chains such as tetraethylammonium and tetrabutylammonium were more toxic than TMAH in the D. magna immobilization test. (C) 2014 Elsevier Ltd. All rights reserved.	[Mori, Izumi C.; Arias-Barreiro, Carlos R.; Koutsaftis, Apostolos; Ogo, Atsushi; Aoyama, Isao] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Kawano, Tomonori; Yoshizuka, Kazuharu] Univ Kitakyushu, Sch Int Environm Sci, Kitakyushu, Fukuoka 8080135, Japan; [Inayat-Hussain, Salmaan H.] Univ Kebangsaan Malaysia, Fac Hlth Sci, Kuala Lumpur, Malaysia	Mori, IC (reprint author), Okayama Univ, Inst Plant Sci & Resources, 2-20-1 Chuo, Kurashiki, Okayama 7100046, Japan.	imori@okayama-u.acjp			Kurita Water and Environment Foundation (Japan); Okayama Foundation for Science and Technology (Japan); JSPS-VCC Japan-Malaysia core program from Japan Society for Promotion of Science	The authors acknowledge funding sources, Kurita Water and Environment Foundation (Japan), Okayama Foundation for Science and Technology (Japan), and JSPS-VCC Japan-Malaysia core program from Japan Society for Promotion of Science.	Akk G, 2003, J PHYSIOL-LONDON, V551, P155, DOI 10.1113/jphysiol.2003.043885; HALLEK M, 1988, BIOCHEM PHARMACOL, V37, P819, DOI 10.1016/0006-2952(88)90167-0; Wu CL, 2008, J OCCUP HEALTH, V50, P99, DOI 10.1539/joh.X7001; Lei CN, 2010, CHEMOSPHERE, V81, P57, DOI 10.1016/j.chemosphere.2010.07.001; Couling DJ, 2006, GREEN CHEM, V8, P82, DOI 10.1039/b511333d; Lin CC, 2010, CLIN TOXICOL, V48, P213, DOI 10.3109/15563651003627777; CAIRNS J, 1968, PROG FISH CULT, V30, P3, DOI 10.1577/1548-8640(1968)30[3:ACOTTO]2.0.CO;2; Carvalho FD, 2003, ECOTOX ENVIRON SAFE, V54, P43, DOI 10.1016/S0147-6513(02)00018-0; DEBRUIJN J, 1993, AQUAT TOXICOL, V24, P257, DOI 10.1016/0166-445X(93)90075-C; Han JQ, 2009, SENSOR ACTUAT A-PHYS, V152, P75, DOI 10.1016/j.sna.2009.03.008; Hodges G, 2006, CHEMOSPHERE, V64, P17, DOI 10.1016/j.chemosphere.2005.12.021; Hu TH, 2010, WATER SCI TECHNOL, V62, P403, DOI 10.2166/wst.2010.284; Hu TH, 2012, BIORESOURCE TECHNOL, V113, P303, DOI 10.1016/j.biortech.2012.02.070; Katayama K., 1999, THIN SOLID FILMS, V341, P140; Kawabata M., 2002, KOGYO ZAIRYO, V50, P59; KENNEDY RH, 1995, AM J PHYSIOL-CELL PH, V268, pC1414; Koutsaftis A, 2007, SCI TOTAL ENVIRON, V387, P166, DOI 10.1016/j.scitotenv.2007.07.023; Lange JH, 1997, ECOTOX ENVIRON SAFE, V38, P2, DOI 10.1006/eesa.1997.1546; Laverock M.J., 1995, ARCH ENV CONTAM TOXI, V29, P344; Lee CH, 2011, TOXICOL IND HEALTH, V27, P497, DOI 10.1177/0748233710391990; Lee SJ, 2008, WATER SCI TECHNOL, V57, P1191, DOI 10.2166/wst.2008.246; Lei L, 2010, ECOTOXICOLOGY, V19, P1268, DOI 10.1007/s10646-010-0511-2; Muratani T., 1999, SHARP GIHO, V73, P20; Nishihama S., 2010, ION EXCH LETT, V3, P1; OECD, 2012, JOINT M CHEM COMM WO; OECD, 1992, TEST GUID 203 FISH A; Okamura H., 1998, ENVIRON TOXIC WATER, V11, P213; Park SJ, 2001, PROCESS BIOCHEM, V36, P579, DOI 10.1016/S0032-9592(00)00252-1; Schnakenberg U., 1990, SENSOR ACTUAT A-PHYS, V25, P1, DOI 10.1016/0924-4247(90)87001-Y; Service RF, 2001, SCIENCE, V292, P825; TABATA O, 1992, SENSOR ACTUAT A-PHYS, V34, P51, DOI 10.1016/0924-4247(92)80139-T; TAKANO K, 1992, J APPL POLYM SCI, V46, P1137, DOI 10.1002/app.1992.070460702; TSUBAKI H, 1986, J PHARMACOBIO-DYNAM, V9, P737; Wu CL, 2012, RESUSCITATION, V83, P119, DOI 10.1016/j.resuscitation.2011.07.006	34	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	FEB	2015	120						299	304		10.1016/j.chemosphere.2014.07.011		6	Environmental Sciences	Environmental Sciences & Ecology	AZ1MN	WOS:000348003200041		
J	Rahman, M; Al Mamun, A; Karim, MR; Islam, K; Al Amin, H; Hossain, S; Hossain, MI; Saud, ZA; Noman, ASM; Miyataka, H; Himeno, S; Hossain, K				Rahman, Mashiur; Al Mamun, Abdullah; Karim, Md. Rezaul; Islam, Khairul; Al Amin, Hasan; Hossain, Shakhawoat; Hossain, Md. Imam; Saud, Zahangir Alam; Noman, Abu Shadat Mohammod; Miyataka, Hideki; Himeno, Seiichiro; Hossain, Khaled			Associations of total arsenic in drinking water, hair and nails with serum vascular endothelial growth factor in arsenic-endemic individuals in Bangladesh	CHEMOSPHERE			English	Article						Arsenic; Vascular endothelial growth factor; Angiogenesis; Cancer; Bangladesh	OXIDATIVE STRESSOR ARSENITE; DOSE-RESPONSE RELATIONSHIP; FACTOR VEGF; SKIN-LESIONS; CANCER; ANGIOGENESIS; PERMEABILITY; EXPRESSION; HYPOXIA; DISEASE	Arsenic exposure is associated with cancer and vascular diseases. Angiogenesis is an important step for the pathological development of cancer and vascular diseases. Vascular endothelial growth factor (VEGF) is a specific marker for angiogenesis. However, human study showing the association between arsenic exposure and serum VEGF levels has not yet been documented. This study was aimed to investigate the association between arsenic exposure and serum VEGF levels in the arsenic-endemic individuals in Bangladesh. A total of 260 individuals were recruited for this study. Arsenic exposure levels were measured by ICP-MS and VEGF levels were quantified using VEGF immunoassay kit. The study subjects were stratified into tertile (low, medium and high) groups based on the arsenic in water, hair and nails. Serum VEGF levels were correlated with water (r(s) = 0.363, p < 0.001), hair (r(s) = 0.205, p < 0.01) and nail (r(s) = 0.190, p < 0.01) arsenic. Further, VEGF levels showed dose-response relationships with water, hair and nail arsenic. Mean VEGF levels in <= 10 mu g L-1, 10.1-50 mu g L-1 and >50 mu g L-1 groups were 91.84, 129.54, and 169.86 pg mL(-1), respectively, however, significant (p < 0.01) difference in VEGF levels was only found in >50 mu g L-1 versus <= 10 mu g L-1 groups. Significant associations of arsenic exposure with VEGF levels were found even after adjusting with relevant covariates. Therefore, these results provide evidence that arsenic exposure has a pro-angiogenic effect on humans, which may be implicated in arsenic-induced tumorigenesis and vascular diseases. (C) 2014 Elsevier Ltd. All rights reserved.	[Rahman, Mashiur; Al Mamun, Abdullah; Islam, Khairul; Al Amin, Hasan; Hossain, Shakhawoat; Hossain, Md. Imam; Saud, Zahangir Alam; Hossain, Khaled] Rajshahi Univ, Dept Biochem & Mol Biol, Rajshahi 6205, Bangladesh; [Karim, Md. Rezaul; Miyataka, Hideki; Himeno, Seiichiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Mol Nutr & Toxicol, Tokushima 7708514, Japan; [Noman, Abu Shadat Mohammod] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong 4331, Bangladesh	Hossain, K (reprint author), Rajshahi Univ, Dept Biochem & Mol Biol, Rajshahi 6205, Bangladesh.	mashiurru@gmail.com; amamun42@gmail.com; mrkarimanft@gmail.com; drkhairul16@gmail.com; mhasan7988@gmail.com; saka3703@yahoo.com; imubcmb@gmail.com; zasaud@yahoo.com; asmnomancubd@gmail.com; hideki@ph.bunri-u.ac.jp; himenos@ph.bunri-u.ac.jp; khossainbio@gmail.com			World Academy of Sciences (TWAS) Research Grant, Italy [09-153 RG/BIO/AS_I, UNESCO FR: 3240230321]; JSPS KAKENHI, Japan [B24406009]; NST fellowship, Ministry of Science and Technology, Bangladesh [39.012.002.01.03.019.2013-431(17)]	This work was supported by The World Academy of Sciences (TWAS) Research Grant, (Grant No: 09-153 RG/BIO/AS_I; UNESCO FR: 3240230321), Italy; JSPS KAKENHI Grant-in-Aid for Scientific Research (Grant No: B24406009), Japan and NST fellowship, Ministry of Science and Technology [No. 39.012.002.01.03.019.2013-431(17)], Bangladesh.	Ali N., 2006, ENV HLTH, V9, P36; Gunsilius E, 2000, ONCOLOGY-BASEL, V58, P169, DOI 10.1159/000012095; van Geen A, 2008, ENVIRON SCI TECHNOL, V42, P2283, DOI 10.1021/es702316k; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; LAI MS, 1994, AM J EPIDEMIOL, V139, P484; Meng D, 2010, TOXICOL APPL PHARM, V244, P291, DOI 10.1016/j.taap.2010.01.004; Mazumder DNG, 1998, INT J EPIDEMIOL, V27, P871; Duyndam MCA, 2001, J BIOL CHEM, V276, P48066, DOI 10.1074/jbc.M106282200; Sandhofer A, 2009, ATHEROSCLEROSIS, V206, P265, DOI 10.1016/j.atherosclerosis.2009.01.031; Chen CJ, 2007, TOXICOL APPL PHARM, V222, P298, DOI 10.1016/j.taap.2006.12.032; Bao LZ, 2010, CHEM RES TOXICOL, V23, P1726, DOI 10.1021/tx100191t; Takahashi S, 2011, BIOL PHARM BULL, V34, P1785; Neufeld G, 1999, FASEB J, V13, P9; Karim MR, 2013, TOXICOL SCI, V135, P17, DOI 10.1093/toxsci/kft130; Hossain E, 2012, TOXICOL APPL PHARM, V259, P187, DOI 10.1016/j.taap.2011.12.023; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Vahidnia A, 2008, CHEM-BIOL INTERACT, V176, P188, DOI 10.1016/j.cbi.2008.07.001; Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Poon RTP, 2001, J CLIN ONCOL, V19, P1207; Chen Y, 2004, AM J PUBLIC HEALTH, V94, P741, DOI 10.2105/AJPH.94.5.741; Maulik N, 2002, FREE RADICAL BIO MED, V33, P1047, DOI 10.1016/S0891-5849(02)01005-5; Di Raimondo F, 2001, LEUKEMIA, V15, P976; Lokuge KM, 2004, ENVIRON HEALTH PERSP, V112, P1172, DOI 10.1289/ehp.6866; CHIOU HY, 1995, CANCER RES, V55, P1296; Verheul HMW, 1997, CLIN CANCER RES, V3, P2187; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; Chen KLB, 1999, BIOL TRACE ELEM RES, V67, P109, DOI 10.1007/BF02784067; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806; Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297; Smith AH, 2009, J EXPO SCI ENV EPID, V19, P343, DOI 10.1038/jes.2008.73; Roboz GJ, 2000, BLOOD, V96, P1525; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; British Geological Survey, 2001, ARS CONT GROUND WAT; Caldwell B. K., 2003, International Journal of Population Geography, V9, P23, DOI 10.1002/ijpg.271; Carpenter TC, 2005, AM J PHYSIOL-LUNG C, V289, pL1075, DOI 10.1152/ajplung.00251.2005; Chen Y, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2431; Chowdhury AMR, 2004, SCI AM, V291, P86; Gagne D, 2003, HUM REPROD, V18, P1674, DOI 10.1093/humrep/deg326; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; Islam K, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-64; Kimura K, 2007, ATHEROSCLEROSIS, V194, P182, DOI 10.1016/j.atherosclerosis.2006.07.025; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Meliker J.R., 2007, ENV HLTH, V4, P6; Shinkaruk S., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P95, DOI 10.2174/1568011033353452; Soucy NV, 2004, CHEM RES TOXICOL, V17, P555, DOI 10.1021/tx034193q; Xiao YF, 2006, WORLD J GASTROENTERO, V12, P5780; Yu Mei-Jia, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P704	52	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	FEB	2015	120						336	342		10.1016/j.chemosphere.2014.08.003		7	Environmental Sciences	Environmental Sciences & Ecology	AZ1MN	WOS:000348003200046		
J	Kameda, T; Kodama, A; Yoshioka, T				Kameda, Tomohito; Kodama, Aki; Yoshioka, Toshiaki			Effect of H2O2 on the treatment of NO and NO2 using a Mg-Al oxide slurry	CHEMOSPHERE			English	Article						Mg-Al oxide slurry; NO; NO2; Treatment; H2O2; Effect	LAYERED DOUBLE HYDROXIDES; MAGNESIUM-ALUMINUM OXIDE; HYDROCHLORIC-ACID; HYDROGEN-PEROXIDE; REMOVAL	We examined the effect of H2O2 on the removal of NO and NO2 by treatment with a Mg-Al oxide slurry. The removal of NO2 and dissolution of NOx species in an aqueous solution increased with increasing concentrations of H2O2. NO2 was reduced to NO by HOO- derived from H2O2. The contribution of Mg-Al oxide decreased with increasing H2O2 concentration. The addition of H2O2 to the Mg-Al oxide slurry promoted the removal of NO owing to the oxidation of NO to NO I by H2O2. However, the contribution of Mg-Al oxide decreased with increasing H2O2 concentration. (C) 2014 Elsevier Ltd. All rights reserved.	[Kameda, Tomohito; Kodama, Aki; Yoshioka, Toshiaki] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Kameda, T (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.	kameda@env.che.tohoku.ac.jp					Altmann R., 1968, ACTA CRYSTALLOGR, V824, P972; [Anonymous], 2000, CHEM LETT 1005; INGRAM L, 1967, MINERAL MAG J M SOC, V36, P465, DOI 10.1180/minmag.1967.036.280.01; Kameda T, 2003, WATER RES, V37, P1545, DOI 10.1016/S0043-1354(02)00374-3; Kaneda K, 2000, CATAL SURV JPN, V4, P31, DOI 10.1023/A:1019048407764; Wu XL, 2013, WATER RES, V47, P4159, DOI 10.1016/j.watres.2012.11.056; Theiss FL, 2013, J COLLOID INTERF SCI, V402, P114, DOI [10.1016/j.jcis.2013.03.051, 10.1016/j.jcis2013.03.051]; Kameda T, 2006, SEP PURIF TECHNOL, V51, P272, DOI 10.1016/j.seppur.2006.02.008; Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K; Kameda T, 2002, B CHEM SOC JPN, V75, P595, DOI 10.1246/bcsj.75.595; Extremera R, 2012, CHEM ENG J, V213, P392, DOI 10.1016/j.cej.2012.10.042; Kameda T, 2013, J ENVIRON SCI HEAL A, V48, P86, DOI 10.1080/10934529.2012.707853; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Thomas D, 1998, CHEM ENG TECHNOL, V21, P975, DOI 10.1002/(SICI)1521-4125(199812)21:12<975::AID-CEAT975>3.3.CO;2-8; Yamaguchi K, 1999, J ORG CHEM, V64, P2966, DOI 10.1021/jo982347e; Zhao DL, 2013, J RADIOANAL NUCL CH, V295, P1251, DOI 10.1007/s10967-012-1994-5	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	FEB	2015	120						378	382		10.1016/j.chemosphere.2014.08.025		5	Environmental Sciences	Environmental Sciences & Ecology	AZ1MN	WOS:000348003200052		
J	Wakita, M; Oyama, Y; Takase, Y; Akaike, N				Wakita, Masahito; Oyama, Yasuo; Takase, Yuko; Akaike, Norio			Modulation of excitatory synaptic transmission in rat hippocampal CA3 neurons by triphenyltin, an environmental pollutant	CHEMOSPHERE			English	Article						Triphenyltin; Synaptic transmission; Glutamate; Calcium	PRESYNAPTIC NERVE-TERMINALS; INTRACELLULAR CA2+; ORGANOTIN COMPOUNDS; MOUSE THYMOCYTES; INDUCED INCREASE; CALCIUM-RELEASE; ACTIVATION; CHANNELS; ACETATE; BOUTONS	Triphenyltin (TPT) is an organometallic compound that poses a known environmental hazard to some fish and mollusks, as well as mammals. However, its neurotoxic mechanisms in the mammalian brain are still unclear. Thus, we have investigated mechanisms through which TPT modulates glutamatergic synaptic transmission, including spontaneous, miniature, and evoked excitatory postsynaptic currents (sEPSCs, mEPSCs, and eEPSCs respectively), in a rat hippocampal CA3 'synaptic-bouton' preparation. TPT, at environmentally relevant concentrations (30 nM to 1 mu M), significantly increased the frequency of sEPSCs and mEPSCs in a concentration-dependent manner, without affecting the currents' amplitudes. The facilitatory effects of TPT on mEPSC frequency were seen even in a Ca2+-free external solution containing tetrodotoxin. These effects were further prolonged by adding caffeine, which releases Ca2+ from intracellular Ca2+ storage sites. In glutamatergic eEPSCs evoked by paired-pulse stimuli, TPT at concentrations greater than or equal to 100 nM markedly increased the current amplitude by the first pulse and decreased failure rate and pair-pulse ratio. On the other hand, both voltage-dependent Na+ and Ca2+ channels were unaffected by submicromolar concentrations of TPT. Overall, these results suggest that TPT, at environmentally relevant concentrations, affects presynaptic transmitter release machinery by directly modulating Ca2+ storage. Further, findings of this study imply that excitotoxic mechanisms may underlie TPT-induced neuronal damage. (c) 2014 Elsevier Ltd. All rights reserved.	[Wakita, Masahito; Takase, Yuko; Akaike, Norio] Kumamoto Kinoh Hosp, Res Div Clin Pharmacol, Med Corp, Kumamoto 8608518, Japan; [Wakita, Masahito; Akaike, Norio] Kumamoto Hlth Sci Univ, Res Div Life Sci, Kumamoto 8615598, Japan; [Oyama, Yasuo] Univ Tokushima, Lab Cellular Signaling, Fac Integrated Arts & Sci, Tokushima 7708501, Japan	Akaike, N (reprint author), Kumamoto Kinoh Hosp, Res Div Clin Pharmacol, Kita Ku, 6-8-1 Yamamuro, Kumamoto 8608518, Japan.	wakitamasahito@gmail.com; oyama@ias.tokushima-u.ac.jp; akaike.n@juryo.or.jp					Wakita M, 2013, EUR J PHARMACOL, V718, P63, DOI [10.1016/j.ejphar.2013.09.018, 10.1010/j.ejphar.2013.09.018]; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Yamashita M, 2001, EUR J PHARMACOL, V431, P269, DOI 10.1016/S0014-2999(01)01421-2; Rhee JS, 1999, J NEUROCHEM, V72, P800, DOI 10.1046/j.1471-4159.1999.0720800.x; Guerin T, 2007, SCI TOTAL ENVIRON, V388, P66, DOI 10.1016/j.scitotenv.2007.08.027; Oliveira RD, 2010, TALANTA, V82, P9, DOI 10.1016/j.talanta.2010.04.046; Yi AX, 2012, CHEMOSPHERE, V89, P1015, DOI 10.1016/j.chemosphere.2012.05.080; Kim NS, 2011, J HAZARD MATER, V192, P634, DOI 10.1016/j.jhazmat.2011.05.065; Akaike N, 2003, TRENDS PHARMACOL SCI, V24, P44, DOI 10.1016/S0165-6147(02)00010-X; Wakita M, 2012, J PHARMACOL EXP THER, V341, P809, DOI 10.1124/jpet.111.189126; Gipperth L, 2009, J ENVIRON MANAGE, V90, pS86, DOI 10.1016/j.jenvman.2008.08.013; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Akaike N, 2002, NEUROSCI RES, V42, P187, DOI 10.1016/S0168-0102(01)00320-0; Berridge J. M., 1998, NEURON, V21, P13; Bock R, 1981, Residue Rev, V79, P1; COLOSIO C, 1991, BRIT J IND MED, V48, P136; FAO, 1991, 1991 JOINT FAO WHO M; FRIEL DD, 1992, NEURON, V8, P1109, DOI 10.1016/0896-6273(92)90132-W; Giriyan A., 2012, ORGANOTINS HUMANS TR, P164; Hachiya, 2012, CURR TOPICS NEUROTOX, V2, P1; Hu JY, 2009, P NATL ACAD SCI USA, V106, P9339, DOI 10.1073/pnas.0809434106; Jang I.S., 2001, J PHYSL, V536, P505; Juang M.S., 1975, NATURE, V256, P211; Kang JJ, 1997, J BIOCHEM, V122, P173; Kishimoto K, 2001, J PHARMACOL EXP THER, V299, P171; Kono K., 2008, COAST MAT SCI, V32, P102; Kotrikla A, 2009, J ENVIRON MANAGE, V90, pS77, DOI 10.1016/j.jenvman.2008.07.017; KUBA K, 1980, J PHYSIOL-LONDON, V298, P251; Luscher C., 2012, COLD SPRING HARB PER, V1, P4, DOI DOI 10.1101/CSHPERSPECT.A005710; MANZO L, 1981, CLIN TOXICOL, V18, P1343; Matthiessen P, 2013, ENVIRON TOXICOL CHEM, V32, P487, DOI 10.1002/etc.2108; Meng R. I., 2009, J ENVIRON MANAGE, V90, pS8; Mizukawa H., 2009, INTERDISCIP STUD ENV, P153; MURASE K, 1990, BRAIN RES, V525, P84, DOI 10.1016/0006-8993(90)91323-9; OYAMA Y, 1991, JPN J PHARMACOL, V57, P419, DOI 10.1254/jjp.57.419; OYAMA Y, 1992, JPN J PHARMACOL, V60, P159, DOI 10.1254/jjp.60.159; OYAMA Y, 1992, JPN J PHARMACOL, V58, P467, DOI 10.1254/jjp.58.467; Rantakokko P, 2008, SCI TOTAL ENVIRON, V399, P90, DOI 10.1016/j.scitotenv.2008.03.017; WHO, 1999, 13 WHO; Yamamoto Isao, 1994, Hokkaido Journal of Medical Science, V69, P273; Yorifuji T, 2013, ARCH ENVIRON OCCUP H, V68, P22, DOI 10.1080/19338244.2011.627894; ZAZUETA C, 1994, J BIOENERG BIOMEMBR, V26, P457, DOI 10.1007/BF00762786	42	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	FEB	2015	120						598	607		10.1016/j.chemosphere.2014.09.073		10	Environmental Sciences	Environmental Sciences & Ecology	AZ1MN	WOS:000348003200083		
J	Arakawa, A; Kaneko, M; Narukawa, M				Arakawa, Akio; Kaneko, Masayuki; Narukawa, Mamoru			An Investigation of Factors Contributing to Higher Levels of Placebo Response in Clinical Trials in Neuropathic Pain: A Systematic Review and Meta-Analysis	CLINICAL DRUG INVESTIGATION			English	Review							DIABETIC PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED-TRIAL; SPINAL-CORD-INJURY; DOUBLE-BLIND; POSTHERPETIC NEURALGIA; IMMPACT RECOMMENDATIONS; GABAPENTIN ENACARBIL; EXTENDED-RELEASE; PREGABALIN; EFFICACY	Background In new drug development in neuropathic pain (NeP), randomized, double-blind, placebo-controlled trials (PCTs) with long treatment durations in a parallel-group design are recommended for confirmatory trials. Objective This study was conducted to identify potential factors contributing to elevated placebo response in parallel-group PCTs for oral drugs with at least a 4-week treatment duration. Methods A literature search was conducted through MEDLINE and EMBASE, and was supplemented with data from ClinicalTrials.gov and US/Japanese regulatory approval review information. Using the 30 or 50 % responder rate (RR), logistic regression analyses were performed to investigate the relationship between the degree of placebo response and several potential influencing factors. Result The search identified 71 trials (n = 6,126). The estimated 50 % RRs (95 % confidence intervals) in the placebo group were as follows: peripheral neuropathic pain (P-NeP) 23 % (21, 26 %); central neuropathic pain (C-NeP) 14 % (10, 19 %); postherpetic neuralgia (PHN) 19 % (15, 24 %); painful diabetic peripheral neuropathy (pDPN) 26 % (23, 29 %); posttraumatic peripheral neuropathic pain (PT) 15 % (10, 20 %). From the logistic regression analyses, it was found that there was a significant association between placebo response (50 % RR and 30 % RR) and NeP classification (P < 0.05). Associations between placebo response and several factors were seen in univariate logistic regression analyses of 50 % RR. Multivariate analyses showed that age and baseline pain intensity in PHN, and treatment duration, trial design (fixed-dose/flexible-dose) and baseline pain intensity in pDPN, were associated with placebo response, suggesting that a reduced placebo response correlated with increasing age and baseline pain intensity, and a higher placebo response correlated with a longer treatment period and flexible dosing regimen. A similar pattern observed in the analysis of 50 % RR was suggested in the analysis of 30 % RR, with the exception of treatment duration. In addition, investigations of trials with at least a 12-week treatment duration in pDPN found associations with the number of patients per site, patient enrolment rate, proportion of male patients and baseline pain intensity, suggesting that a higher placebo response correlated with an increasing number of patients per site, and a reduced placebo response correlated with increasing patient enrolment rate and proportion of male patients and baseline pain intensity. Conclusion The results of this study suggest that NeP condition, trial design, and demographic and baseline characteristics may contribute to elevated placebo response in clinical trials in patients with NeP. In addition, the magnitude of placebo response and the effect of treatment duration are greater in pDPN than in PHN. These facts should be considered when planning and conducting confirmatory trials in NeP.	[Arakawa, Akio; Kaneko, Masayuki; Narukawa, Mamoru] Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Clin Med Pharmaceut Med, Minato Ku, Tokyo 1088641, Japan	Arakawa, A (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Dept Clin Med Pharmaceut Med, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	akio.arakawa@pfizer.com					Dworkin RH, 2003, NEUROLOGY, V60, P1274; Shaibani A, 2009, J PAIN, V10, P818, DOI 10.1016/j.jpain.2009.01.322; Freeman R, 2007, CURR MED RES OPIN, V23, P147, DOI 10.1185/030079906X162674; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Sabatowski R, 2004, PAIN, V109, P26, DOI 10.1016/j.pain.2004.01.001; Dworkin RH, 2010, PAIN, V150, P12, DOI 10.1016/j.pain.2010.02.002; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Moon DE, 2010, CLIN THER, V32, P2370, DOI 10.1016/j.clinthera.2011.01.014; Serpell MG, 2002, PAIN, V99, P557, DOI 10.1016/S0304-3959(02)00255-5; Wernicke JF, 2006, NEUROLOGY, V67, P1411, DOI 10.1212/01.wnl.0000240225.04000.1a; Siddall PJ, 2006, NEUROLOGY, V67, P1792, DOI 10.1212/01.wnl.0000244422.45278.ff; Vinik AI, 2007, PAIN, V128, P169, DOI 10.1016/j.pain.2006.09.040; van Seventer R, 2010, EUR J NEUROL, V17, P1082, DOI 10.1111/j.1468-1331.2010.02979.x; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Quessy SN, 2008, PAIN, V138, P479, DOI 10.1016/j.pain.2008.06.024; Simpson DM, 2010, NEUROLOGY, V74, P413, DOI 10.1212/WNL.0b013e3181ccc6ef; Rauck RL, 2007, CLIN J PAIN, V23, P150, DOI 10.1097/01.ajp.0000210957.39621.b2; Rice ASC, 2001, PAIN, V94, P215, DOI 10.1016/S0304-3959(01)00407-9; Sandercock D, 2012, DIABETES RES CLIN PR, V97, P438, DOI 10.1016/j.diabres.2012.03.010; Rowbotham M, 1998, JAMA-J AM MED ASSOC, V280, P1837, DOI 10.1001/jama.280.21.1837; Shaibani AI, 2012, PAIN MED, V13, P243, DOI 10.1111/j.1526-4637.2011.01316.x; Cepeda MS, 2012, PAIN MED, V13, P575, DOI 10.1111/j.1526-4637.2012.01340.x; Rowbotham MC, 2012, PAIN, V153, P862, DOI 10.1016/j.pain.2012.01.009; van Seventer R, 2006, CURR MED RES OPIN, V22, P375, DOI 10.1185/030079906X80404; Cardenas DD, 2013, NEUROLOGY, V80, P533, DOI 10.1212/WNL.0b013e318281546b; Rowbotham MC, 2004, PAIN, V110, P697, DOI 10.1016/j.pain.2004.05.010; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Hauser W, 2011, PAIN, V152, P1709, DOI 10.1016/j.pain.2011.01.050; Katz N, 2005, NEUROLOGY, V65, pS32; Tolle T, 2008, EUR J PAIN, V12, P203, DOI 10.1016/j.ejpain.2007.05.003; Vranken JH, 2008, PAIN, V136, P150, DOI 10.1016/j.pain.2007.06.033; Lesser H, 2004, NEUROLOGY, V63, P2104; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Katz J, 2008, NEUROLOGY, V70, P263, DOI 10.1212/01.wnl.0000275528.01263.6c; Wallace MS, 2010, CLIN DRUG INVEST, V30, P765, DOI 10.2165/11539520-000000000-00000; Eisenberg E, 2001, NEUROLOGY, V57, P505; Sang CN, 2013, CLIN J PAIN, V29, P281, DOI 10.1097/AJP.0b013e318258993e; Satoh J, 2011, DIABETIC MED, V28, P109, DOI 10.1111/j.1464-5491.2010.03152.x; [Anonymous], PREG CTD STUD A00810; Gao Y, 2010, CHINESE MED J-PEKING, V123, P3184, DOI 10.3760/cma.j.issn.0366-6999.2010.22.003; Ostenfeld T, 2013, EUR J PAIN, V17, P844, DOI 10.1002/j.1532-2149.2012.00256.x; Rauck R, 2013, PAIN PRACT, V13, P485, DOI 10.1111/papr.12014; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Kim JS, 2011, PAIN, V152, P1018, DOI 10.1016/j.pain.2010.12.023; Kost RG, 1996, NEW ENGL J MED, V335, P32; Rowbotham MC, 2009, PAIN, V146, P245, DOI 10.1016/j.pain.2009.06.013; Richter RW, 2005, J PAIN, V6, P253, DOI 10.1016/j.jpain.2004.12.007; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Dogra S, 2005, EUR J PAIN, V9, P543, DOI 10.1016/j.ejpain.2004.11.006; Yasuda H, 2011, J DIABETES INVEST, V2, P132, DOI 10.1111/j.2040-1124.2010.00073.x; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Maier C, 2003, PAIN, V103, P277, DOI 10.1016/S0304-3959(02)00456-6; Guan YZ, 2011, CLIN THER, V33, P159, DOI 10.1016/j.clinthera.2011.02.007; Kalliomaki J, 2013, PAIN, V154, P761, DOI 10.1016/j.pain.2013.02.003; Smith T, 2014, PAIN PRACT, V14, P332, DOI 10.1111/papr.12080; Irizarry MC, 2009, CLIN J PAIN, V25, P469, DOI 10.1097/AJP.0b013e31819ddded; Raskin J, 2005, PAIN MED, V6, P346, DOI 10.1111/j.1526-4637.2005.00061.x; Stacey BR, 2008, J PAIN, V9, P1006, DOI 10.1016/j.jpain.2008.05.014; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Zhang LX, 2013, J PAIN, V14, P590, DOI 10.1016/j.jpain.2013.01.768; Raskin P, 2004, NEUROLOGY, V63, P865; Arezzo JC, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-33; Atli A, 2005, PAIN MED, V6, P225, DOI 10.1111/j.1526-4637.2005.05035.x; Boureau F, 2003, PAIN, V104, P323, DOI 10.1016/S0304-3959(03)00020-4; Dworkin DH, 2003, ARCH NEUROL-CHICAGO, V60, P1524; Dworkin RH, 2005, NEUROLOGY, V65, pS7; European Medical Agency, 2007, GUID CLIN MED PROD I; Irving G, 2009, CLIN J PAIN, V25, P185, DOI 10.1097/AJP.0b013e3181934276; Kochar DK, 2005, QJM-INT J MED, V98, P29, DOI 10.1093/qjmed/hci005; Ogawa S, 2010, J JAPAN SOC PAIN CLI, V17, P141; Pharmaceutical and Medical Devices Agency, PREG CTD STUD 1008 0; Pharmaceutical and Medical Devices Agency, PREG STD STUD 1008 0; Sakai F, 2004, CURR MED RES OPIN, V20, P269, DOI 10.1185/03007990312502973; Skljarevski V, 2012, PAIN RES TREAT, DOI [10.1155/2012/898347, DOI 10.1155/2012/898347]; U.S. Food and Drug Administration, LYR NDA 021466 STUD; US Food and Drug Administration, 2014, GUID IND AN IND DEV; U.S. Food and Drug Administration, NEUR NDA 021397 STUD; U.S. Food and Drug Administration, LYR NDA 021723 STUD; U.S. Food and Drug Administration, LYR NDA 021446 STUD; Vollmer TL, 2014, PAIN PRACT, V14, P732, DOI 10.1111/papr.12127; Wang Shuu-Jiun, 2007, J Chin Med Assoc, V70, P39; Wymer JP, 2009, CLIN J PAIN, V25, P376, DOI 10.1097/AJP.0b013e318196d2b6; Ziegler D, 2007, DIABETES CARE, V30, P664, DOI 10.2337/dc06-2009; Ziegler D, 2010, DIABETES CARE, V33, P839, DOI 10.2337/dc09-1578	84	4	4	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-2563	1179-1918		CLIN DRUG INVEST	Clin. Drug Invest.	FEB	2015	35	2					67	81		10.1007/s40261-014-0259-1		15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ5CB	WOS:000348236700001		
J	Kishimoto, M; Noda, M				Kishimoto, Miyako; Noda, Mitsuhiko			Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study	CLINICAL DRUG INVESTIGATION			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; GLUCOSE MONITORING-SYSTEM; BETA-CELL FUNCTION; INCRETIN SECRETION; GLYCEMIC CONTROL; RECEPTOR AGONISTS; JAPANESE PATIENTS; PLASMA-GLUCOSE; ALPHA-CELLS	The aim of this case study was to examine the efficacy of a dipeptidyl peptidase-4 inhibitor (anagliptin) and an alpha-glucosidase inhibitor (miglitol) when added to ongoing insulin treatment in patients with type 2 diabetes mellitus. Continuous glucose monitoring was performed in four Japanese insulin-treated inpatients with type 2 diabetes. Baseline data were collected on day 1. Miglitol was administered on days 2 and 3. On day 4, miglitol and anagliptin were coadministered before breakfast. On days 1, 3, and 5, blood was drawn for plasma glucose, serum C-peptide, plasma glucagon, total and active glucagon-like peptide-1 (GLP-1), and total and active glucose-dependent insulinotropic peptide (GIP) measurements. Coadministration of anagliptin with miglitol resulted in additional improvements in glycemic control over the entire day in three of the four patients. The C-peptide, glucagon, and total and active GLP-1 and GIP responded differently to the medications for each patient, suggesting interindividual differences in hormonal responses, which may be complicated by multifactorial effects.	[Kishimoto, Miyako] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Diabet Endocrinol & Metab, Shinjuku Ku, Tokyo 1628655, Japan; [Kishimoto, Miyako; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet & Metab Informat Ctr, Diabet Res Ctr, Res Inst,Shinjuku Ku, Tokyo 1628655, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Res Inst, Diabet Res Ctr,Shinjuku Ku, Tokyo 1628655, Japan	Kishimoto, M (reprint author), Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Diabet Endocrinol & Metab, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	miyakok@fides.dti.ne.jp; mnoda@hosp.ncgm.go.jp			Joint Research Association for Japanese Diabetes; Takeda Pharmaceutical Co. LTD.; Daiichi Sankyo; Mitsubishi Tanabe Pharma; Mochida Pharmaceutical Co. LTD.; Sanwa Kagaku Kenkyusho; Kowa Pharmaceutical Co. LTD.; Sumitomo Dainippon Pharma; Novartis Pharma; Sanofi; Teijin; AstraZeneca	Miyako Kishimoto has received a grant from the Joint Research Association for Japanese Diabetes. Mitsuhiko Noda has received speaker honoraria from Sanofi, Mitsubishi Tanabe Pharma, Daiichi Sankyo, Eli Lilly Japan, MSD, Novo Nordisk Pharma, Novartis Pharma, AstraZeneca, Sanwa Kagaku Kenkyusho, Asahi Kasei Pharma, Ono Pharmaceutical Co. LTD., Takeda Pharmaceutical Co. LTD., Astellas, Kowa Pharmaceutical Co. LTD., Terumo Corporation, Taisho Toyama Pharmaceutical Co. LTD., Kissei Pharmaceutical Co. LTD. and Mochida Pharmaceutical Co. LTD.; and research grants from Takeda Pharmaceutical Co. LTD., Daiichi Sankyo, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co. LTD., Sanwa Kagaku Kenkyusho, Kowa Pharmaceutical Co. LTD., Sumitomo Dainippon Pharma, Novartis Pharma, Sanofi, Teijin and AstraZeneca.	Scott LJ, 2000, DRUGS, V59, P521, DOI 10.2165/00003495-200059030-00012; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; QUALMANN C, 1995, SCAND J GASTROENTERO, V30, P892, DOI 10.3109/00365529509101597; Yabe D, 2012, J DIABETES INVEST, V3, P70, DOI 10.1111/j.2040-1124.2011.00141.x; Brazg R, 2007, DIABETES OBES METAB, V9, P186, DOI 10.1111/j.1463-1326.2006.00691.x; Nomiyama T, 2012, DIABETES RES CLIN PR, V95, pE27, DOI 10.1016/j.diabres.2011.08.016; BISCHOFF H, 1994, EUR J CLIN INVEST, V24, P3; Scheen AJ, 2003, DRUGS, V63, P933, DOI 10.2165/00003495-200363100-00002; Bock G, 2010, CLIN ENDOCRINOL, V73, P189, DOI 10.1111/j.1365-2265.2009.03764.x; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Narita T, 2009, DIABETIC MED, V26, P187, DOI 10.1111/j.1464-5491.2008.02651.x; Kato N, 2011, BIOORGAN MED CHEM, V19, P7221, DOI 10.1016/j.bmc.2011.09.043; Deacon CF, 2002, J ENDOCRINOL, V172, P355, DOI 10.1677/joe.0.1720355; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Narita T, 2012, DIABETES OBES METAB, V14, P283, DOI 10.1111/j.1463-1326.2011.01526.x; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Xu L, 2008, DIABETES OBES METAB, V10, P1212, DOI 10.1111/j.1463-1326.2008.00887.x; Kaufman FR, 2001, DIABETES CARE, V24, P2030, DOI 10.2337/diacare.24.12.2030; De Marinis YZ, 2010, CELL METAB, V11, P543, DOI 10.1016/j.cmet.2010.04.007; Lee A, 2002, DIABETES OBES METAB, V4, P329, DOI 10.1046/j.1463-1326.2002.00219.x; Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; Holst JJ, 2011, DIABETES OBES METAB, V13, P89, DOI 10.1111/j.1463-1326.2011.01452.x; Aoki K, 2010, ENDOCR J, V57, P667; Ranganath L, 1998, DIABETIC MED, V15, P120, DOI 10.1002/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO;2-I; Aoki K, 2012, ACTA DIABETOL, V49, P225, DOI 10.1007/s00592-011-0322-9; Cejvan K, 2003, DIABETES, V52, P1176, DOI 10.2337/diabetes.52.5.1176; Deacon Carolyn F, 2011, Rev Diabet Stud, V8, P293, DOI 10.1900/RDS.2011.8.293; Gotoh K, 2013, J NEUROENDOCRINOL, V25, P302, DOI 10.1111/jne.12003; Gross T M, 2000, Diabetes Technol Ther, V2, P49, DOI 10.1089/152091500316737; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Karasik A, 2008, CURR MED RES OPIN, V24, P489, DOI 10.1185/030079908X261069 ; Kishimoto Miyako, 2013, Diabetes Metab Syndr Obes, V6, P187, DOI 10.2147/DMSO.S35682; Kishimoto M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-115; Kishimoto Miyako, 2012, Diabetes Ther, V3, P11, DOI 10.1007/s13300-012-0011-x; Miyachi A, 2013, J PROTEOME RES, V12, P2690, DOI 10.1021/pr400069f; Nagai E, 2011, ENDOCR J, V58, P869; Yamada Y, 2006, DIABETES, V55, pS86, DOI 10.2337/db06-S011	41	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-2563	1179-1918		CLIN DRUG INVEST	Clin. Drug Invest.	FEB	2015	35	2					141	147		10.1007/s40261-014-0260-8		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ5CB	WOS:000348236700007		
J	Shinoda, K; Taki, H; Hounoki, H; Tsuda, R; Tobe, K				Shinoda, Koichiro; Taki, Hirofumi; Hounoki, Hiroyuki; Tsuda, Reina; Tobe, Kazuyuki			Accidental Cannulation of a Femoral Central Venous Catheter Into the Iliolumbar Vein Incidental Detection by Bone Scintigraphy	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						accidental cannulation; femoral central venous catheterization; ascending lumbar vein; iliolumbar vein; bone scintigraphy	ASCENDING LUMBAR; MALPOSITION; MISPLACEMENT	Central venous catheterization at the femoral site is associated with higher complication rates of infections and thrombosis than at the jugular or subclavian sites. However, the procedure of insertion at the femoral site is considered safer. We present a unique but dangerous positioning of a left femoral central venous catheter into the iliolumbar vein. We were aware of this accidental cannulation by chance when our patient underwent bone scintigraphy. Although a few cases were reported about accidental cannulation into the ascending lumbar vein, this is the first case where a femoral central venous catheter was misplaced into the iliolumbar vein.	[Shinoda, Koichiro; Taki, Hirofumi; Hounoki, Hiroyuki; Tsuda, Reina; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 9300194, Japan	Taki, H (reprint author), Toyama Univ, Dept Internal Med 1, 2630 Sugitani, Toyama 9300194, Japan.	htaki-tym@umin.ac.jp	Taki, Hirofumi/I-6284-2012				Gocze I, 2012, ASAIO J, V58, P435, DOI 10.1097/MAT.0b013e3182578fa6; Lavandosky G, 1996, CRIT CARE MED, V24, P893, DOI 10.1097/00003246-199605000-00030; Chen CC, 2001, PEDIATR NEUROL, V24, P65, DOI 10.1016/S0887-8994(00)00222-8; Clarke P, 2003, J PAEDIATR CHILD H, V39, P386, DOI 10.1046/j.1440-1754.2003.00160.x; Izuishi K, 2005, AM J SURG, V189, P47, DOI 10.1016/j.amjsurg.2004.04.010; Lolis E, 2011, ANN ANAT, V193, P516, DOI 10.1016/j.aanat.2011.09.004; Pichereau C, 2011, INTENS CARE MED, V37, P1714, DOI 10.1007/s00134-011-2283-4; Zenker M, 2000, J PEDIATR-US, V136, P837, DOI 10.1067/mpd.2000.105227	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	FEB	2015	40	2					182	183				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3TE	WOS:000348148700043		
J	Ishimura, M; Yamamoto, Y; Kimura, N; Hoshikawa, H; Nishiyama, Y				Ishimura, Mariko; Yamamoto, Yuka; Kimura, Naruhide; Hoshikawa, Hiroshi; Nishiyama, Yoshihiro			C-11-PiB PET/CT in Nasopharyngeal Amyloidosis Associated with Multiple Myeloma	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						amyloidosis; C-11-PiB; PET		We present an unusual case of nasopharyngeal amyloidosis associated with multiple myeloma. A 63-year-old woman presented with 2 months' history of epistaxis and dentalgia 3 years after being diagnosed with multiple myeloma. CT and C-11-Pittsburgh compound B (PiB) PET images demonstrated that the intense C-11-PiB uptake corresponded to the nasal, paranasal, and palatal area matching the CT mass lesion. Histopathologic examination confirmed amyloidosis.	[Ishimura, Mariko; Yamamoto, Yuka; Kimura, Naruhide; Nishiyama, Yoshihiro] Kagawa Univ, Fac Med, Dept Radiol, Miki, Kagawa 7610793, Japan; [Hoshikawa, Hiroshi] Kagawa Univ, Fac Med, Dept Otolaryngol, Miki, Kagawa 7610793, Japan	Yamamoto, Y (reprint author), Kagawa Univ, Fac Med, Dept Radiol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	yuka@kms.ac.jp					SCOTT PP, 1986, SEMIN ROENTGENOL, V21, P103, DOI 10.1016/0037-198X(86)90027-1; Antoni G, 2013, J NUCL MED, V54, P213, DOI 10.2967/jnumed.111.102053; Yoshida A, 2008, J CLIN ONCOL, V26, P5817, DOI 10.1200/JCO.2008.18.6338; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Vela-Ojeda J, 2009, ANN HEMATOL, V88, P59, DOI 10.1007/s00277-008-0554-0; Panda NK, 2007, AM J OTOLARYNG, V28, P208, DOI 10.1016/j.amjoto.2006.08.009; Sachchithanantham S, 2013, BRIT MED BULL, V107, P41, DOI 10.1093/bmb/ldt021; Son YM, 2011, KOREAN J RADIOL, V12, P634, DOI 10.3348/kjr.2011.12.5.634	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	FEB	2015	40	2					E161	E162				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ3TE	WOS:000348148700018		
J	Saneyoshi, A; Michimata, C				Saneyoshi, Ayako; Michimata, Chikashi			Categorical and coordinate processing in object recognition depends on different spatial frequencies	COGNITIVE PROCESSING			English	Article						Object recognition; Spatial frequency; Categorical and coordinate spatial processing	ATTENTION; IDENTIFICATION	Previous studies have suggested that processing categorical spatial relations requires high spatial frequency (HSF) information, while coordinate spatial relations require low spatial frequency (LSF) information. The aim of the present study was to determine whether spatial frequency influences categorical and coordinate processing in object recognition. Participants performed two object-matching tasks for novel, non-nameable objects consisting of "geons" (c.f. Brain Cogn 71:181-186, 2009). For each original stimulus, categorical and coordinate transformations were applied to create comparison stimuli. These stimuli were high-pass/low-cut-filtered or low-pass/high-cut-filtered by a filter with a 2D Gaussian envelope. The categorical task consisted of the original and categorical-transformed objects. The coordinate task consisted of the original and coordinate-transformed objects. The non-filtered object image was presented on a CRT monitor, followed by a comparison object (non-filtered, high-pass-filtered, and low-pass-filtered stimuli). The results showed that the removal of HSF information from the object image produced longer reaction times (RTs) in the categorical task, while removal of LSF information produced longer RTs in the coordinate task. These results support spatial frequency processing theory, specifically Kosslyn's hypothesis and the double filtering frequency model.	[Saneyoshi, Ayako] Teikyo Univ, Dept Psychol, Hachioji, Tokyo 1920395, Japan; [Michimata, Chikashi] Sophia Univ, Dept Psychol, Chiyoda Ku, Tokyo 1028554, Japan	Saneyoshi, A (reprint author), Teikyo Univ, Dept Psychol, 359 Otsuka, Hachioji, Tokyo 1920395, Japan.	a-sane@main.teikyo-u.ac.jp					Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Jager G, 2003, NEUROPSYCHOLOGIA, V41, P504, DOI 10.1016/S0028-3932(02)00086-6; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037//0033-295X.94.2.148; KOSSLYN SM, 1992, J EXP PSYCHOL HUMAN, V18, P562, DOI 10.1037/0096-1523.18.2.562; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037//0033-295X.94.2.115; Baguley T, 2012, BEHAV RES METHODS, V44, P158, DOI 10.3758/s13428-011-0123-7; Baker DP, 1999, COGNITIVE SCI, V23, P33, DOI 10.1207/s15516709cog2301_2; Borst G, 2010, NEUROPSYCHOLOGIA, V48, P2769, DOI 10.1016/j.neuropsychologia.2010.04.027; Collin CA, 2005, PERCEPT PSYCHOPHYS, V67, P354, DOI 10.3758/BF03206498; Cooper EE, 2000, J EXP PSYCHOL LEARN, V26, P470, DOI 10.1037//0278-7393.26.2.470; COWIN EL, 1994, J COGNITIVE NEUROSCI, V6, P156, DOI 10.1162/jocn.1994.6.2.156; Ivry R.B., 1998, 2 SIDES PERCEPTION; JACOBS RA, 1994, COGNITIVE SCI, V18, P361, DOI 10.1207/s15516709cog1803_1; Kosslyn S. M., 1994, IMAGE BRAIN RESOLUTI; Kosslyn SM, 2006, NEUROPSYCHOLOGIA, V44, P1519, DOI 10.1016/j.neuropsychologia.2006.01.022; Laeng B, 2011, COGNITIVE SCI, V35, P297, DOI 10.1111/j.1551-6709.2010.01139.x; Marr D., 1982, VISION; Michimata C, 2011, BRAIN COGNITION, V77, P292, DOI 10.1016/j.bandc.2011.07.008; Okubo M, 2002, J COGNITIVE NEUROSCI, V14, P291, DOI 10.1162/089892902317236902; Okubo M, 2010, ACTA PSYCHOL, V135, P1, DOI 10.1016/j.actpsy.2010.04.004; Okubo M, 2004, J COGNITIVE NEUROSCI, V16, P1576, DOI 10.1162/0898929042568604; Rumelhart DE, 1986, PARALLEL DISTRIBUTED, VII; Saneyoshi A, 2009, BRAIN COGNITION, V71, P181, DOI 10.1016/j.bandc.2009.09.001; Vannucci M, 2001, COGNITIVE BRAIN RES, V12, P475, DOI 10.1016/S0926-6410(01)00086-6	24	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-4782	1612-4790		COGN PROCESS	Cogn. Process.	FEB	2015	16	1					27	33		10.1007/s10339-014-0635-z		7	Psychology, Experimental	Psychology	AZ3GS	WOS:000348116100003		
J	Lebowitz, AJ				Lebowitz, Adam Jon			Community Collaboration as a Disaster Mental Health Competency: A Systematic Literature Review	COMMUNITY MENTAL HEALTH JOURNAL			English	Article						Community participation; Competency-based education; Disaster medicine; Public health	PUBLIC-HEALTH; CORE COMPETENCES; EMERGENCY PREPAREDNESS; NURSING COMPETENCES; MEDICINE; EDUCATION; DEFINITION; CURRICULUM; READINESS; STUDENTS	Disasters impact the mental health of entire communities through destruction and physical displacement. There is growing recognition of the need for disaster mental health competencies. Professional organizations such as the AAFP and the ASPH recommend engaging with communities in equal partnership for their recovery. This systematic study was undertaken for the purpose of reviewing published disaster medicine competencies to determine if core competencies included community cooperation and collaboration. A search of Internet databases was conducted using major keywords "disaster" and "competencies". Articles eligible contained laundry lists of basic core competency curriculum beyond emergency response. Data were qualitatively analyzed to identify types of competencies, and the degree of community cooperation. A total of 12 studies were reviewed. Only one study listed competencies specifying community cooperation, although others refer indirectly to it. Findings suggest competency-based education programs could do more to educate future disaster health professionals about the importance of community collaboration.	Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan	Lebowitz, AJ (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	ajlebo@gmail.com					Altevogt BM, 2009, GUIDANCE ESTABLISHIN; American Academy of Family Physicians, 2009, AAFP REC CURR GUID F; Markenson D, 2005, ACAD MED, V80, P517, DOI 10.1097/00001888-200506000-00002; Fernandez N, 2012, MED EDUC, V46, P357, DOI 10.1111/j.1365-2923.2011.04183.x; Walsh L, 2012, DISASTER MED PUBLIC, V6, P44, DOI 10.1001/dmp.2012.4; Pang SMC, 2009, NURS HEALTH SCI, V11, P367, DOI 10.1111/j.1442-2018.2009.00499.x; Subbarao I, 2008, DISASTER MED PUBLIC, V2, P57, DOI 10.1097/DMP.0b013e31816564af; Satcher D, 2007, JAMA-J AM MED ASSOC, V298, P2540, DOI 10.1001/jama.298.21.2540; Jakeway CC, 2008, PUBLIC HEALTH NURS, V25, P353, DOI 10.1111/j.1525-1446.2008.00716.x; MCMILLAN DW, 1986, J COMMUNITY PSYCHOL, V14, P6, DOI 10.1002/1520-6629(198601)14:1<6::AID-JCOP2290140103>3.0.CO;2-I; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Huntington MK, 2011, FAM MED, V43, P13; Macy RD, 2004, HARVARD REV PSYCHIAT, V12, P217, DOI 10.1080/1067322049059589; Abramson D, 2008, DISASTER MED PUBLIC, V2, P77, DOI 10.1097/DMP.0b013e318173a8e7; Frank JR, 2010, MED TEACH, V32, P631, DOI 10.3109/0142159X.2010.500898; Savoia E, 2009, AM J PREV MED, V37, P150, DOI 10.1016/j.amepre.2009.03.023; Association of Schools of Public Health, 2012, KNOWL SKILLS ATT KSA; Beaton Randal D, 2009, J Public Health Manag Pract, V15, pE1, DOI 10.1097/PHH.0b013e3181a8c307; Carney JK, 2011, AM J PREV MED, V41, pS193, DOI 10.1016/j.amepre.2011.05.026; Chan SSS, 2010, J NURS SCHOLARSHIP, V42, P405, DOI 10.1111/j.1547-5069.2010.01363.x; Culley JM, 2010, J NURS EDUC, V49, P708, DOI 10.3928/01484834-20100930-04; Daily Elaine, 2010, Prehosp Disaster Med, V25, P387; Disaster Mental Health Subcommittee of the National Biodefense Science Board, 2008, DET DEC 2007 PEAK EC, P1; Emergency Management Australia, 2003, COMM DEV REC DIS; Estioko M., 2005, BLOOMS TAXONOMY; Everly GS, 2008, PUBLIC HEALTH REP, V123, P539; FitzGerald Gerard J, 2010, Prehosp Disaster Med, V25, P4; Flynn B. W., 2007, J RURAL MENTAL HLTH, V31, P12; Gebbie K, 2002, QUAL HEALTH RES, V12, P990, DOI 10.1177/104973202129120403; Hawkins RL, 2011, DISASTERS, V35, P143, DOI [10.1111/j.1467-7717.2010.01197.x, 10.1111/j.0361-3666.2010.01197.x]; Kako M, 2010, COLLEGIAN, V17, P161, DOI 10.1016/j.colegn.2010.09.003; Kimura R., 2010, P REGIONAL SAFETY RE, V13, P175; Olson D, 2008, PUBLIC HEALTH REP, V123, P53; Philips B., 2004, NZ RECOVERY S P, P106; Polivka BJ, 2008, PUBLIC HEALTH NURS, V25, P159, DOI 10.1111/j.1525-1446.2008.00692.x; Raphael Beverley, 1986, DISASTER STRIKES IND; Schultz CH, 2012, ANN EMERG MED, V59, P196, DOI 10.1016/j.annemergmed.2011.09.003; Seynaeve G., 2004, PREHOSPITAL DISASTER, V22, P120; Smith Jared, 2012, Prehosp Disaster Med, V27, P492, DOI 10.1017/S1049023X12001215; Stanley SAR, 2012, ANNU REV NURS RES, V30, P89, DOI 10.1891/0739-6686.30.89; Tatsuki S., 2009, INT C COMM 10 ANN 19; University of Hyogo, 2012, GRAD SCH NURS COR CO; Williams J, 2008, ANN EMERG MED, V52, P211, DOI 10.1016/j.annemergmed.2007.09.030; Wizemann T., 2013, ENGAGING PUBLIC CRIT; Yeager VA, 2010, J PUBLIC HEALTH MAN, V16, P441, DOI 10.1097/PHH.0b013e3181c33de4; Young B. H., 2006, INTERVENTIONS FOLLOW, P54	46	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0010-3853	1573-2789		COMMUNITY MENT HLT J	Community Ment. Health J.	FEB	2015	51	2					125	131		10.1007/s10597-014-9751-6		7	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	AZ3HC	WOS:000348117000001		
J	Kang, Y; Kim, H; Suzuki, H; Han, S				Kang, Yuna; Kim, Hyungki; Suzuki, Hiromasa; Han, Soonhung			Editing 3D models on smart devices	COMPUTER-AIDED DESIGN			English	Article						Smart device; Feature based; Multi-touch; Gesture; 3D modeling	SYSTEMS	This study proposes a 3D CAD system available on smart devices, which are now a part of everyday life and which are widely applied in various domains, such as education and robot industry. If an engineer has a new idea while traveling or on the move, or in the case of collaboration between more than two engineers, this 3D CAD system allows modeling to be performed in a rapid and simple manner on a smart device. This 3D CAD system uses the common multi-touch gestures associated with smart devices to keep the modeling operations simple and easy for users. However, it is difficult to input the precise geometric information to generate 3D CAD models by such gestures. It is also impractical to provide a full set of modeling operations on a smart device due to hardware limitations. For this reason, the system excludes several complicated modeling operations. This work provides a scheme to regenerate a parametric 3D model on a PC-based CAD system via a macro-parametrics approach by transferring the 3D model created on a smart device in an editable form to a PC-based CAD system. If fine editing is needed, the user can perform additional work on a PC after reconstruction. Through the developed system, it is possible to produce a 3D editable model swiftly and simply in the smart device environment, allowing for reduced design time while also facilitating collaboration. This paper discusses the first-ever system design of a 3D CAD system on a smart device, the selection of the modeling operations, the assignment of gestures to these operations, and use of operation modes. This is followed by an introduction of the implementation methods, and finally a demonstration of case studies using a prototype system with examples. (C) 2013 Elsevier Ltd.	[Kang, Yuna; Kim, Hyungki; Han, Soonhung] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea; [Suzuki, Hiromasa] Univ Tokyo, Meguro Ku, Tokyo 1538904, Japan	Kang, Y (reprint author), Korea Adv Inst Sci & Technol, Taejon 305701, South Korea.	balba186@kaist.ac.kr	Han, Soonhung/C-2030-2011	Han, Soonhung/0000-0001-5676-8121	Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant - Korea government Ministry of Knowledge Economy [20114030200040]; WCU (World Class University) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [R31-2008-000-10045-0]; Development of Integration & Automation Technology for Nuclear Plant Life-cycle Management grant - Korea government Ministry of Knowledge Economy [2011T100200145]	This work was supported by the Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant funded by the Korea government Ministry of Knowledge Economy (No. 20114030200040).; This research was supported by WCU (World Class University) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-2008-000-10045-0).; This research was supported by Development of Integration & Automation Technology for Nuclear Plant Life-cycle Management grant funded by the Korea government Ministry of Knowledge Economy (2011T100200145).	Modi S, 2011, COMPUT AIDED DESIGN, V43, P170, DOI 10.1016/j.cad.2010.10.006; Esfahani ET, 2012, COMPUT AIDED DESIGN, V44, P1011, DOI 10.1016/j.cad.2011.04.008; [Anonymous], 2009, EV SMART PHON MARK; Zeng Y, 2012, COMPUT AIDED DESIGN, V44, P875, DOI 10.1016/j.cad.2012.05.005; Saul G, 2011, TEI 2011: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON TANGIBLE EMBEDDED AND EMBODIED INTERACTION, P73; Mun DW, 2003, COMPUT AIDED DESIGN, V35, P1171, DOI 10.1016/S0010-4485(03)00022-8; Fuge M, 2012, COMPUT AIDED DESIGN, V44, P1020, DOI 10.1016/j.cad.2011.05.009; Lin JC, 2012, IEEE T VIS COMPUT GR, V18, P1979, DOI 10.1109/TVCG.2012.61; Cheon SU, 2012, COMPUT AIDED DESIGN, V44, P123, DOI 10.1016/j.cad.2011.10.003; Choi GH, 2002, INT J CAD CAM, V2, P23; Company P, 2004, P EUROGRAPHICS WORKS; Hoang TN, 2012, INT SYM MIX AUGMENT, P287, DOI 10.1109/ISMAR.2012.6402577; Ju T, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.12394593; Kang Y, 2012, P AS C DES DIG ENG; Kim DH, 2006, COMPUT AIDED DESIGN, V38, P210, DOI 10.1016/j.cad.2005.10.007; Kim H, 2012, P AS C DES DIG ENG; Li J, 2010, INT J CAD CAM, V10; Li JT, 2011, VISUAL COMPUT, V27, P585, DOI 10.1007/s00371-011-0585-8; Ranglani S., 2012, THESIS U TOKYO JAPAN; Sharma A., 2011, P 13 INT C MULT INT, P307, DOI DOI 10.1145/2070481.2070538; Shin HJ, 2007, P GRAPH INT C 2007; Vizireanu DN, 2012, J INSTRUM, V44; Zhao SY, 2009, CCDC 2009: 21ST CHINESE CONTROL AND DECISION CONFERENCE, VOLS 1-6, PROCEEDINGS, P5879	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0010-4485	1879-2685		COMPUT AIDED DESIGN	Comput.-Aided Des.	FEB	2015	59						229	238		10.1016/j.cad.2013.08.001		10	Computer Science, Software Engineering	Computer Science	AY7XZ	WOS:000347770400020		
J	Nishimura, Y; Murakami, S; Ashikawa, Y; Sasagawa, S; Umemoto, N; Shimada, Y; Tanaka, T				Nishimura, Yuhei; Murakami, Soichiro; Ashikawa, Yoshifumi; Sasagawa, Shota; Umemoto, Noriko; Shimada, Yasuhito; Tanaka, Toshio			Zebrafish as a systems toxicology model for developmental neurotoxicity testing	CONGENITAL ANOMALIES			English	Review						ADME; autism; developmental neurotoxicity; systems toxicology; zebrafish	CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; AUTISM SPECTRUM DISORDERS; PRENATAL ALCOHOL EXPOSURE; DANIO-RERIO EMBRYOS; LARVAL ZEBRAFISH; IN-VIVO; SEROTONERGIC NEURONS; DOPAMINERGIC-NEURONS; BEHAVIORAL-RESPONSES	The developing brain is extremely sensitive to many chemicals. Exposure to neurotoxicants during development has been implicated in various neuropsychiatric and neurological disorders, including autism spectrum disorder, attention deficit hyperactive disorder, schizophrenia, Parkinson's disease, and Alzheimer's disease. Although rodents have been widely used for developmental neurotoxicity testing, experiments using large numbers of rodents are time-consuming, expensive, and raise ethical concerns. Using alternative non-mammalian animal models may relieve some of these pressures by allowing testing of large numbers of subjects while reducing expenses and minimizing the use of mammalian subjects. In this review, we discuss some of the advantages of using zebrafish in developmental neurotoxicity testing, focusing on central nervous system development, neurobehavior, toxicokinetics, and toxicodynamics in this species. We also describe some important examples of developmental neurotoxicity testing using zebrafish combined with gene expression profiling, neuroimaging, or neurobehavioral assessment. Zebrafish may be a systems toxicology model that has the potential to reveal the pathways of developmental neurotoxicity and to provide a sound basis for human risk assessments.	[Nishimura, Yuhei; Murakami, Soichiro; Ashikawa, Yoshifumi; Sasagawa, Shota; Umemoto, Noriko; Shimada, Yasuhito; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Nishimura, Yuhei; Umemoto, Noriko; Shimada, Yasuhito; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Nishimura, Yuhei; Umemoto, Noriko; Shimada, Yasuhito; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan; [Nishimura, Yuhei; Umemoto, Noriko; Shimada, Yasuhito; Tanaka, Toshio] Mie Univ, Ind Technol Innovat Inst, Dept Om Med, Tsu, Mie 514, Japan; [Nishimura, Yuhei; Umemoto, Noriko; Shimada, Yasuhito; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan	Tanaka, T (reprint author), 2-174 Edobashi, Tsu, Mie 5148507, Japan.	tanaka@doc.medic.mie-u.ac.jp			Long-range Research Initiative of the Japan Chemical Industrial Association; Johns Hopkins Center for Alternatives to Animal Testing; Sumitomo Foundation; New Energy and Industrial Technology Development Organization; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Mie University	This work was supported, in part, by Long-range Research Initiative of the Japan Chemical Industrial Association, The Johns Hopkins Center for Alternatives to Animal Testing, The Sumitomo Foundation, The New Energy and Industrial Technology Development Organization, The Ministry of Education, Culture, Sports, Science and Technology of Japan, The Japan Science and Technology Agency, and Mie University. The authors would like to thank Drs. Tsutomu Ichiki and Kunifumi Inawaka (Japan Chemical Industry Association) for their valuable comments and suggestions. The authors are also grateful to the members of Department of Pharmacogenomics, Mie University Graduate School of Medicine for their expert fish care and secretarial support.	Al-Jaberi N, 2015, CEREB CORTEX, V25, P631, DOI 10.1093/cercor/bht254; ALLENDE ML, 1994, DEV BIOL, V166, P509, DOI 10.1006/dbio.1994.1334; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P545, DOI 10.1016/j.ntt.2012.08.006; Szyf M, 2011, TOXICOL SCI, V120, P235, DOI 10.1093/toxsci/kfr024; Selderslaghs IWT, 2010, NEUROTOXICOL TERATOL, V32, P460, DOI 10.1016/j.ntt.2010.03.002; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; Rawson DM, 2000, AQUAC RES, V31, P325, DOI 10.1046/j.1365-2109.2000.00401.x; Hawkes C, 2003, MOVEMENT DISORD, V18, P364, DOI 10.1002/mds.10379; Drummond I, 2003, TRENDS CELL BIOL, V13, P357, DOI 10.1016/S0962-8924(03)00124-7; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; Bailey J, 2013, BIRTH DEFECTS RES C, V99, P14, DOI 10.1002/bdrc.21027; Nishimura M, 2007, DRUG METAB PHARMACOK, V22, P178, DOI 10.2133/dmpk.22.178; Tierney KB, 2011, BBA-MOL BASIS DIS, V1812, P381, DOI 10.1016/j.bbadis.2010.10.011; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Wiegand C, 2000, ECOTOX ENVIRON SAFE, V45, P122, DOI 10.1006/eesa.1999.1845; Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; Fu C, 2012, CEREB CORTEX, V22, P2111, DOI 10.1093/cercor/bhr300; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Colwill RM, 2011, BEHAV PROCESS, V86, P222, DOI 10.1016/j.beproc.2010.12.003; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564; Herbert MR, 2005, NEUROTOXICOLOGY, V26, P565, DOI 10.1016/j.neuro.2005.01.002; Ou H, 2012, HEARING RES, V288, P58, DOI 10.1016/j.heares.2012.01.009; Yang DR, 2011, TOXICOL SCI, V121, P146, DOI 10.1093/toxsci/kfr028; Zellner D, 2011, NEUROTOXICOL TERATOL, V33, P674, DOI 10.1016/j.ntt.2011.06.007; Gorski JA, 2002, J NEUROSCI, V22, P6309; Rubinstein AL, 2006, EXPERT OPIN DRUG MET, V2, P231, DOI 10.1517/17425255.2.2.231; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Buckley CE, 2010, GLIA, V58, P802, DOI 10.1002/glia.20964; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Polanska K, 2013, INT J OCCUP MED ENV, V26, P16, DOI 10.2478/s13382-013-0073-7; Ho NY, 2013, ENVIRON SCI TECHNOL, V47, P3316, DOI 10.1021/es3050967; Bal-Price AK, 2012, ALTEX-ALTERN ANIM EX, V29, P202; Weigt S, 2011, TOXICOLOGY, V281, P25, DOI 10.1016/j.tox.2011.01.004; Otte JC, 2010, AQUAT TOXICOL, V100, P38, DOI 10.1016/j.aquatox.2010.07.006; Chedotal A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001917; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; NI BH, 1995, J NEUROSCI, V15, P5789; Ali S, 2012, BEHAV BRAIN RES, V228, P272, DOI 10.1016/j.bbr.2011.11.020; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Huang YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1899, DOI 10.2741/2810; Buske C, 2011, PROG NEURO-PSYCHOPH, V35, P1409, DOI 10.1016/j.pnpbp.2010.09.003; Farrell TC, 2011, NEUROBIOL DIS, V44, P9, DOI 10.1016/j.nbd.2011.05.016; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Castillo J, 2009, AM J PHYSIOL-REG I, V297, pR1570, DOI 10.1152/ajpregu.00430.2009; Li H, 1999, NAT GENET, V23, P67; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Hjorth J, 2002, INT J DEV BIOL, V46, P609; Steenbergen PJ, 2011, PROG NEURO-PSYCHOPH, V35, P1432, DOI 10.1016/j.pnpbp.2010.10.010; Perkins EJ, 2013, ENVIRON HEALTH PERSP, V121, P1002, DOI 10.1289/ehp.1306638; Chng HT, 2012, J BIOMOL SCREEN, V17, P974, DOI 10.1177/1087057112447305; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Schnorr SJ, 2012, BEHAV BRAIN RES, V228, P367, DOI 10.1016/j.bbr.2011.12.016; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Miyazaki K, 2005, INT J DEV NEUROSCI, V23, P287, DOI 10.1016/j.ijdevneu.2004.05.004; Lovenberg TW, 2000, J PHARMACOL EXP THER, V293, P771; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Bauer M, 2008, J NEUROCHEM, V104, P1101, DOI 10.1111/j.1471-4159,2007.05037.x; Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P119; Gatzidou ET, 2007, J APPL TOXICOL, V27, P302, DOI 10.1002/jat.1248; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; van Vliet E, 2011, ALTEX-ALTERN ANIM EX, V28, P17; Takada N, 2010, GLIA, V58, P996, DOI 10.1002/glia.20981; Martin SC, 1998, J COMP NEUROL, V396, P253; Kucenas S, 2008, NEURON GLIA BIOL, V4, P71, DOI 10.1017/S1740925X09990123; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Spurgeon DJ, 2010, SCI TOTAL ENVIRON, V408, P3725, DOI 10.1016/j.scitotenv.2010.02.038; Mathias JR, 2012, FUTURE MED CHEM, V4, P1811, DOI [10.4155/fmc.12.115, 10.4155/FMC.12.115]; Raftery TD, 2014, ENVIRON SCI TECHNOL, V48, P804, DOI 10.1021/es404322p; Birnbaum LS, 2012, ENVIRON HEALTH PERSP, V120, pA143, DOI 10.1289/ehp.1205179; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Schweitzer J, 2012, DEV NEUROBIOL, V72, P256, DOI 10.1002/dneu.20911; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Engeszer RE, 2007, ANIM BEHAV, V74, P1269, DOI 10.1016/j.anbehav.2007.01.032; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; DRISCOLL CD, 1990, NEUROTOXICOL TERATOL, V12, P231, DOI 10.1016/0892-0362(90)90094-S; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/nmeth.2374, 10.1038/NMETH.2374]; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; van Thriel C, 2012, NEUROTOXICOLOGY, V33, P911, DOI 10.1016/j.neuro.2011.10.002; Hitchcock SA, 2006, J MED CHEM, V49, P7559, DOI 10.1021/jm060642i; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Guo S, 2009, EXPERT OPIN DRUG DIS, V4, P715, DOI 10.1517/17460440902988464; Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214; Kessaris N, 2008, PHILOS T R SOC B, V363, P71, DOI 10.1098/rstb.2006.2013; Benner MJ, 2010, COMP BIOCHEM PHYS A, V157, P310, DOI [10.1016/j.cbpa.2010.07.016, 10.1016/J.cbpa.2010.07.016]; Ito K, 2008, J CONTROL RELEASE, V131, P198, DOI 10.1016/j.jconrel.2008.08.004; Shelton JF, 2012, ENVIRON HEALTH PERSP, V120, P944, DOI 10.1289/ehp.1104553; Crofton KM, 2012, CONGENIT ANOM, V52, P140, DOI 10.1111/j.1741-4520.2012.00377.x; Norton WH, 2005, DEVELOPMENT, V132, P645, DOI 10.1242/dev.01611; Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528; Rihel J, 2012, DEV NEUROBIOL, V72, P373, DOI 10.1002/dneu.20910; Barlow BK, 2007, REPROD TOXICOL, V23, P457, DOI 10.1016/j.reprotox.2007.01.007; Fox DA, 2012, NEUROTOXICOLOGY, V33, P810, DOI 10.1016/j.neuro.2011.12.016; Winneke G, 2011, J NEUROL SCI, V308, P9, DOI 10.1016/j.jns.2011.05.020; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Cowden J, 2012, REPROD TOXICOL, V33, P165, DOI 10.1016/j.reprotox.2011.11.111; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Kokel David, 2008, Briefings in Functional Genomics & Proteomics, V7, P483, DOI 10.1093/bfgp/eln040; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Braubach OR, 2009, BEHAV BRAIN RES, V198, P190, DOI 10.1016/j.bbr.2008.10.044; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Kalberg WO, 2006, ALCOHOL CLIN EXP RES, V30, P2037, DOI 10.1111/j.1530-0277.2006.00250.x; Rombough P, 2002, J EXP BIOL, V205, P1787; Weigt S, 2010, TOXICOLOGY, V275, P36, DOI 10.1016/j.tox.2010.05.012; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Ota S, 2014, CONGENIT ANOM, V54, P8, DOI 10.1111/cga.12040; Jung KH, 2010, TOXICOL IN VITRO, V24, P1696, DOI 10.1016/j.tiv.2010.05.017; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Mueller T, 2008, J COMP NEUROL, V507, P1245, DOI 10.1002/cne.21604; Gunnarsson L, 2008, ENVIRON SCI TECHNOL, V42, P5807, DOI 10.1021/es8005173; Harper SL, 2011, ACS NANO, V5, P4688, DOI 10.1021/nn200546k; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Oyabu A, 2013, INT J DEV NEUROSCI, V31, P202, DOI 10.1016/j.ijdevneu.2013.01.006; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Tseng HP, 2005, TOXICOL APPL PHARM, V205, P247, DOI 10.1016/j.taap.2004.10.019; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Kuwagata M, 2009, INT J DEV NEUROSCI, V27, P399, DOI 10.1016/j.ijdevneu.2009.01.006; Kanungo J, 2011, NEUROTOXICOL TERATOL, V33, P618, DOI 10.1016/j.ntt.2011.08.013; Mattingly CJ, 2009, ENVIRON HEALTH PERSP, V117, P981, DOI 10.1289/ehp.0900555; Alfonso-Loeches S, 2013, TOXICOLOGY, V311, P27, DOI 10.1016/j.tox.2013.03.001; Nishimura Y, 2013, ACS CHEM NEUROSCI, V4, P1183, DOI 10.1021/cn400010t; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Chen LG, 2012, ENVIRON SCI TECHNOL, V46, P9727, DOI 10.1021/es302119g; Barros TP, 2008, BRIT J PHARMACOL, V154, P1400, DOI 10.1038/bjp.2008.249; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Costa LG, 2004, PHARMACOL REV, V56, P103, DOI 10.1124/pr.56.1.5.; Warp E, 2012, CURR BIOL, V22, P93, DOI 10.1016/j.cub.2011.12.002; Mu Y, 2012, NEURON, V75, P688, DOI 10.1016/j.neuron.2012.05.035; Dougherty KJ, 2010, ANN NY ACAD SCI, V1198, P85, DOI 10.1111/j.1749-6632.2010.05502.x; Wolman M, 2012, DEV NEUROBIOL, V72, P366, DOI 10.1002/dneu.20872; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Danesin C, 2009, DEV CELL, V16, P576, DOI 10.1016/j.devcel.2009.03.007; Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019; Landrigan PJ, 2012, ENVIRON HEALTH PERSP, V120, pA258, DOI 10.1289/ehp.1104285; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Wullimann MF, 2004, J COMP NEUROL, V475, P143, DOI 10.1002/cne.20183; Ek CJ, 2012, NEUROTOXICOLOGY, V33, P586, DOI 10.1016/j.neuro.2011.12.009; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1046/j.1601-183X.2003.00038.x; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/nmeth.2434, 10.1038/NMETH.2434]; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Ronneberger O, 2012, NAT METHODS, V9, P735, DOI [10.1038/nmeth.2076, 10.1038/NMETH.2076]; Martyniuk CJ, 2012, GEN COMP ENDOCR, V176, P314, DOI 10.1016/j.ygcen.2011.12.006; Aoyama H, 2012, CONGENIT ANOM, V52, P119, DOI 10.1111/j.1741-4520.2012.00366.x; Appel B, 2000, DEV DYNAM, V219, P155, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1052>3.3.CO;2-B; Arenzana FJ, 2005, BRAIN RES BULL, V66, P421, DOI 10.1016/j.brainresbull.2005.03.006; Arrenberg AB, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00074; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Barresi MJF, 2010, DEV DYNAM, V239, P2603, DOI 10.1002/dvdy.22393; Blader P, 1997, DEVELOPMENT, V124, P4557; Bogdanovic O, 2014, BRIEF FUNCT GENOMICS, V13, P121, DOI 10.1093/bfgp/elt039; Burgess Harold A., 2008, Briefings in Functional Genomics & Proteomics, V7, P474, DOI 10.1093/bfgp/eln039; Burnison BK, 2006, AQUAT TOXICOL, V79, P185, DOI 10.1016/j.aquatox.2006.06.010; CAMERON IL, 1984, J EXP ZOOL, V231, P447, DOI 10.1002/jez.1402310320; Campagna R, 2011, TOXICOL SCI, V123, P170, DOI 10.1093/toxsci/kfr156; Chapouton P, 2010, METHOD CELL BIOL, V100, P73, DOI 10.1016/B978-0-12-384892-5.00004-9; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Chiu CN, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00058; Cornide-Petronio ME, 2013, DEV NEUROSCI-BASEL, V35, P285, DOI 10.1159/000351023; Danesin C, 2012, CURR OPIN GENET DEV, V22, P323, DOI 10.1016/j.gde.2012.05.001; Davis AP, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat080; Davis AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-48; Delgado L, 2008, CEREBELLUM, V7, P444, DOI 10.1007/s12311-008-0047-7; Diekmann H, 2013, DRUG DISCOV TODAY DI, V10, pe31; Dietert Rodney R, 2011, Emerg Health Threats J, V4, P7111, DOI 10.3402/ehtj.v4i0.7111; EASTER SS, 1994, PROG BRAIN RES, V102, P79; Esbenshade TA, 2007, INFLAMM RES, V56, pS45, DOI 10.1007/s00011-006-0522-x; Esterberg R, 2013, DRUG DISCOV TODAY DI; Estudante M, 2013, ADV DRUG DELIVER REV, V65, P1340, DOI 10.1016/j.addr.2012.09.042; Fan CY, 2010, NEUROTOXICOL TERATOL, V32, P91, DOI 10.1016/j.ntt.2009.04.065; Fay RR, 1999, SPRINGER HDB AUDITOR, P269; Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69; Fleming A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077548; Friedrich RW, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00071; Gahtan E, 2004, J NEUROBIOL, V59, P147, DOI 10.1002/neu.20000; Gerlai R, 2013, EVOL PSYCHOL-US, V11, P591; Goldsmith P, 2003, SEMIN CELL DEV BIOL, V14, P11, DOI 10.1016/S1084-9521(02)00167-2; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Helenius IT, 2012, J CELL BIOCHEM, V113, P2208, DOI 10.1002/jcb.24120; Higashijima S, 2008, DEV GROWTH DIFFER, V50, P407, DOI [10.1111/j.1440-169X.2008.01023.x, 10.1111/j.1440-169x.2008.01023.x]; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Huang SM, 2013, MOL BIOSYST, V9, P1372, DOI 10.1039/c3mb25450j; Ingebretson JJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00109; Irons TD, 2009, NEUROTOXICOL TERATOL, V32, P84; Jacob J, 2014, DIS MODEL MECH, V7, P107, DOI 10.1242/dmm.013219; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Korzh V, 2002, TRENDS NEUROSCI, V25, P603, DOI 10.1016/S0166-2236(02)02275-0; Kullander K, 2005, TRENDS NEUROSCI, V28, P239, DOI 10.1016/j.tins.2005.03.001; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; Kuwagata M, 2012, CONGENIT ANOM, V52, P129, DOI 10.1111/j.1741-4520.2012.00376.x; Kyzar E, 2012, ZEBRAFISH, V9, P8, DOI 10.1089/zeb.2011.0725; Lange M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070172; Lindsay SM, 2004, CHEM SENSES, V29, P93, DOI 10.1093/chemse/bjh009; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P381, DOI 10.1016/j.cbpc.2011.01.002; Lucas ME, 2006, DEVELOPMENT, V133, P4015, DOI 10.1242/dev.02574; Matz CJ, 2007, ECOTOX ENVIRON SAFE, V66, P44, DOI 10.1016/j.ecoenv.2005.11.001; Mazumdar M, 2012, ENVIRON HEALTH PERSP, V120, P702, DOI 10.1289/ehp.1104474; McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210; Mikut R, 2013, ZEBRAFISH, V10, P401, DOI 10.1089/zeb.2013.0886; Miyasaka N, 2013, MECH DEVELOP, V130, P336, DOI 10.1016/j.mod.2012.09.001; Morikawa Y, 2007, DEV BIOL, V307, P114, DOI 10.1016/j.ydbio.2007.04.027; Muth-Kohne E, 2012, NEUROTOXICOL TERATOL, V34, P413, DOI 10.1016/j.ntt.2012.04.006; Muto A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00110; Ndubaku U, 2008, ACTA HISTOCHEM, V110, P182, DOI 10.1016/j.acthis.2007.10.003; Nielsen AL, 2003, GENE, V310, P123, DOI 10.1016/S0378-1119(03)00526-2; Norton WHJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00079; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Oliveira RF, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00131; O'Malley DM, 2004, METHOD CELL BIOL, V76, P261; Oswald M, 2008, CAN J ZOOL, V86, P1085, DOI 10.1139/Z08-085; Park HC, 2000, NEUROSCI LETT, V279, P81, DOI 10.1016/S0304-3940(99)00940-4; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; Prykhozhij SV, 2013, ZEBRAFISH, V10, P303, DOI 10.1089/zeb.2012.0865; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Roberts AC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00126; Roberts AD, 2011, TLS-TIMES LIT SUPPL, P6; Roth FC, 2012, NEURAL PLAST, DOI 10.1155/2012/805830; Sackerman J., 2010, INT J COMP PSYCHOL, V23, P43; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; Schreiber R, 2009, CHEMOSPHERE, V77, P928, DOI 10.1016/j.chemosphere.2009.08.038; Shimada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052549; Smidt MP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00200; Sukardi H, 2010, ZEBRAFISH, V7, P41, DOI 10.1089/zeb.2009.0636; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Tiedeken JA, 2007, ENVIRON HEALTH PERSP, V115, P1547, DOI 10.1289/ehp.10344; TRAMPUS M, 1993, EUR J PHARMACOL, V235, P83, DOI 10.1016/0014-2999(93)90823-Z; Tsuji R, 2012, CONGENIT ANOM, V52, P122, DOI 10.1111/j.1741-4520.2012.00374.x; Umemoto N, 2013, MOL BIOTECHNOL, V55, P131, DOI 10.1007/s12033-013-9664-6; Vignet C, 2013, ZEBRAFISH, V10, P365, DOI 10.1089/zeb.2013.0871; Vitebsky A, 2005, DEV DYNAM, V234, P229, DOI 10.1002/dvdy.20530; Watanabe K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-101; Watanabe K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-116; Wendik B, 2004, DEV BIOL, V268, P372, DOI 10.1016/j.ydbio.2003.12.026; Wullimann MF, 2009, INTEGR ZOOL, V4, P123, DOI 10.1111/j.1749-4877.2008.00140.x; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Zhang BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085439; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055474	260	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	FEB	2015	55	1					1	16		10.1111/cga.12079		16	Pediatrics	Pediatrics	AZ2JG	WOS:000348059400001		
J	Nakajima, Y				Nakajima, Yuji			Signaling regulating inner ear development: Cell fate determination, patterning, morphogenesis, and defects	CONGENITAL ANOMALIES			English	Review						development; growth factors; inner ear; malformations; Notch	SEMICIRCULAR CANAL FORMATION; OTIC PLACODE INDUCTION; TEMPORAL BONE FINDINGS; MAMMALIAN COCHLEA; HAIR-CELLS; BRANCHIOOTORENAL SYNDROME; HEARING-LOSS; SUPPORTING CELLS; PLANAR POLARITY; MUENKE SYNDROME	The membranous labyrinth of the inner ear is a highly complex organ that detects sound and balance. Developmental defects in the inner ear cause congenital hearing loss and balance disorders. The membranous labyrinth consists of three semicircular ducts, the utricle, saccule, and endolymphatic ducts, and the cochlear duct. These complex structures develop from the simple otic placode, which is established in the cranial ectoderm adjacent to the neural crest at the level of the hindbrain at the early neurula stage. During development, the otic placode invaginates to form the otic vesicle, which subsequently gives rise to neurons for the vestibulocochlear ganglion, the non-sensory and sensory epithelia of the membranous labyrinth that includes three ampullary crests, two maculae, and the organ of Corti. Combined paracrine and autocrine signals including fibroblast growth factor, Wnt, retinoic acid, hedgehog, and bone morphogenetic protein regulate fate determination, axis formation, and morphogenesis in the developing inner ear. Juxtacrine signals mediated by Notch pathways play a role in establishing the sensory epithelium, which consists of mechanosensory hair cells and supporting cells. The highly differentiated organ of Corti, which consists of uniformly oriented inner/outer hair cells and specific supporting cells, develops during fetal development. Developmental alterations/arrest causes congenital malformations in the inner ear in a spatiotemporal-restricted manner. A clearer understanding of the mechanisms underlying inner ear development is important not only for the management of patients with congenital inner ear malformations, but also for the development of regenerative therapy for impaired function.	[Nakajima, Yuji] Osaka City Univ, Grad Sch Med, Dept Anat & Cell Biol, Osaka 5458585, Japan	Nakajima, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Anat & Cell Biol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	yuji@med.osaka-cu.ac.jp			JSPS [25460273]	The author thanks S Uoya for technical assistance. This work was supported by a JSPS Grant-in-Aid for Scientific Research (C) 25460273.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Abello G, 2007, INT J DEV BIOL, V51, P483, DOI 10.1387/ijdb.072343ga; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299; Magarinos M, 2012, ANAT REC, V295, P1775, DOI 10.1002/ar.22575; Salminen M, 2000, DEVELOPMENT, V127, P13; Tarchini B, 2013, DEV CELL, V27, P88, DOI 10.1016/j.devcel.2013.09.011; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Neves J, 2013, DEV GROWTH DIFFER, V55, P96, DOI 10.1111/dgd.12016; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Kochhar A, 2007, AM J MED GENET A, V143A, P1671, DOI 10.1002/ajmg.a.31561; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Stone JS, 2003, J COMP NEUROL, V460, P487, DOI 10.1002/cne.10662; Propst EJ, 2005, LARYNGOSCOPE, V115, P1855, DOI 10.1097/01.mlg.0000177032.98386.20; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Radde-Gallwitz K, 2004, J COMP NEUROL, V477, P412, DOI 10.1002/cne.20257; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Driver EC, 2009, BIRTH DEFECTS RES C, V87, P212, DOI 10.1002/bdrc.20154; Mansour SL, 2013, GENE DEV, V27, P2320, DOI 10.1101/gad.228957.113; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Zou D, 2004, DEVELOPMENT, V131, P5561, DOI 10.1242/dev.01437; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Sennaroglu L, 2002, LARYNGOSCOPE, V112, P2230, DOI 10.1097/00005537-200212000-00019; Fritzsch B, 2011, HEARING RES, V276, P16, DOI 10.1016/j.heares.2011.01.007; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Senel E, 2009, LARYNGOSCOPE, V119, P832, DOI 10.1002/lary.20198; Bok J, 2011, P NATL ACAD SCI USA, V108, P161, DOI 10.1073/pnas.1010547108; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev/00555; Mansour SL, 2009, HUM MOL GENET, V18, P43, DOI 10.1093/hmg/ddn311; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Chrysostomou E, 2012, DEVELOPMENT, V139, P3764, DOI 10.1242/dev.074476; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Bok J, 2007, DEVELOPMENT, V134, P1713, DOI 10.1242/dev.000760; Bok JW, 2005, DEVELOPMENT, V132, P2115, DOI 10.1242/dev.01796; Bok JW, 2007, INT J DEV BIOL, V51, P521, DOI 10.1387/ijdb.072381jb; Brenski AC, 2003, PEDIAT OTOLARYNGOLOG, V1, P441; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chang W, 2002, DEV BIOL, V251, P380, DOI 10.1006/dbio.2002.0822; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chang WS, 1999, DEV BIOL, V216, P369, DOI 10.1006/dbio.1999.9457; Cole LK, 2000, J COMP NEUROL, V424, P509, DOI 10.1002/1096-9861(20000828)424:3<509::AID-CNE8>3.0.CO;2-Q; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Evsen L, 2013, J NEUROSCI, V33, P3879, DOI 10.1523/JNEUROSCI.4030-12.2013; Frenz DA, 1996, TERATOLOGY, V53, P292; Gerlach LM, 2000, DEVELOPMENT, V127, P45; Huh SH, 2012, PLOS BIOL, V10; JACKLER RK, 1987, LARYNGOSCOPE, V97, P2; Jacques BE, 2012, HEARING RES, V289, P27, DOI 10.1016/j.heares.2012.04.018; Kobayashi Y, 2008, TOHOKU J EXP MED, V215, P207, DOI 10.1620/tjem.215.207; Komada M, 2012, CONGENIT ANOM, V52, P72, DOI 10.1111/j.1741-4520.2012.00368.x; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Mansour SL, 2005, SPR HDB AUD, V26, P43; MARTIN P, 1993, DEV BIOL, V159, P549, DOI 10.1006/dbio.1993.1263; Masuda S, 2013, INT J PEDIATR OTORHI, V77, P228, DOI 10.1016/j.ijporl.2012.11.001; Morsli H, 1998, J NEUROSCI, V18, P3327; Munnamalai V, 2012, J NEUROSCI, V32, P12876, DOI 10.1523/JNEUROSCI.2250-12.2012; NEVES JTD, 2012, PERSPECT CIENC INF, V17, P1, DOI DOI 10.1371/J0URNAL.P0NE.0030871; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Ono K, 2014, PLOS GENET; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Rakowiecki S, 2013, DEVELOPMENT, V140, P1730, DOI 10.1242/dev.092882; Ramsebner R, 2010, LARYNGOSCOPE, V120, P359, DOI 10.1002/lary.20689; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Steventon B, 2012, DEV BIOL, V367, P55, DOI 10.1016/j.ydbio.2012.04.025; Takemoto T, 2013, CONGENIT ANOM, V53, P61, DOI 10.1111/cga.12017; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718; Yasuda M, 2007, ANAT SCI INT, V82, P156, DOI 10.1111/j.1447-073x.2007.00176.x	88	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	FEB	2015	55	1					17	25		10.1111/cga.12072		9	Pediatrics	Pediatrics	AZ2JG	WOS:000348059400002		
J	Masuda, T; Taniguchi, M				Masuda, Tomoyuki; Taniguchi, Masahiko			Congenital diseases and semaphorin signaling: Overview to date of the evidence linking them	CONGENITAL ANOMALIES			English	Review						congenital heart defects; plexin; retinal degeneration; semaphorin	CARDIAC NEURAL CREST; ENTERIC NERVOUS-SYSTEM; HIRSCHSPRUNG DISEASE; KALLMANN-SYNDROME; CHARGE SYNDROME; RETINAL DEGENERATION; TRUNCUS ARTERIOSUS; HEART-DEFECTS; CELLS; GENE	Semaphorins and their receptors, neuropilins and plexins, were initially characterized as a modulator of axonal guidance during development, but are now recognized as a regulator of a wide range of developmental events including morphogenesis and angiogenesis, and activities of the immune system. Owing to the development of next-generation sequencing technologies together with other useful DNA assays, it has also become clear that semaphorin signaling plays a crucial role in many congenital diseases such as retinal degeneration and congenital heart defects. This review summarizes the recent knowledge about the relationship between a variety of congenital diseases and semaphorin signaling.	[Masuda, Tomoyuki] Univ Tsukuba, Fac Med, Dept Neurobiol, Tsukuba, Ibaraki 3058577, Japan; [Taniguchi, Masahiko] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Cell Sci, Sapporo, Hokkaido, Japan	Masuda, T (reprint author), Univ Tsukuba, Fac Med, Dept Neurobiol, Tsukuba, Ibaraki 3058577, Japan.	tmasu@md.tsukuba.ac.jp			MEXT, Japan [24590256, 24590236]; Naito Foundation, Japan	This work was supported by grants from the program Grants-in-Aid for Scientific Research of the MEXT, Japan to T.M. (no. 24590256) and M.T. (no. 24590236), and by grants from the Naito Foundation, Japan to T.M.	Anderson RB, 2007, DEV BIOL, V305, P287, DOI 10.1016/j.ydbio.2007.02.020; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Schulz Y, 2014, HUM GENET, V133, P997, DOI 10.1007/s00439-014-1444-2; Feiner L, 2001, DEVELOPMENT, V128, P3061; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Brown CB, 2001, DEVELOPMENT, V128, P3071; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Young J, 2012, HUM REPROD, V27, P1460, DOI 10.1093/humrep/des022; Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Taniguchi M, 2003, J NEUROSCI, V23, P1390; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Degenhardt K, 2013, NAT MED, V19, P760, DOI 10.1038/nm.3185; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Maier V, 2011, MOL CELL NEUROSCI, V46, P419, DOI 10.1016/j.mcn.2010.11.005; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Jiang Q, 2012, HUM MUTAT, V33, P281, DOI 10.1002/humu.21602; Cariboni A, 2011, HUM MOL GENET, V20, P336, DOI 10.1093/hmg/ddq468; MacColl G, 2002, NEURON, V34, P675, DOI 10.1016/S0896-6273(02)00720-1; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Abid A, 2006, J MED GENET, V43, P378, DOI 10.1136/jmg.2005.035055; Lalani SR, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.017640; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031; Khoshnood B, 2012, HEART, V98, P1667, DOI 10.1136/heartjnl-2012-302543; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Chung L, 2007, DEVELOPMENT, V134, P2935, DOI 10.1242/dev.005066; CLEMENTI M, 1991, AM J MED GENET, V41, P246, DOI 10.1002/ajmg.1320410223; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hanchate NK, 2012, PLOS GENET, V8; Hofmann K, 2013, AM J MED GENET A, V161, P2880, DOI 10.1002/ajmg.a.36250; Kosaki K, 2011, CONGENIT ANOM, V51, P12, DOI 10.1111/j.1741-4520.2010.00309.x; Luzon-Toro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054800; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Masuda T, 2013, CONGENIT ANOM, V53, P141, DOI 10.1111/cga.12023; Masuda T, 2009, BRAIN RES, V1249, P61, DOI 10.1016/j.brainres.2008.10.028; Masuda T, 2014, CONGENIT ANOM, V54, P63, DOI 10.1111/cga.12022; Masuda T, 2013, CONGENIT ANOM, V53, P122, DOI 10.1111/cga.12019; Nakajima Y, 2010, CONGENIT ANOM, V50, P8, DOI 10.1111/j.1741-4520.2009.00267.x; Nojima S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2420; Rice DS, 2004, INVEST OPHTH VIS SCI, V45, P2767, DOI 10.1167/iovs.04-0020; Sato M, 2006, DEV BIOL, V298, P12, DOI 10.1016/jydbio.2006.05.033; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Ta-Shma A, 2013, AM J MED GENET A, V161, P3115, DOI 10.1002/ajmg.a.36194; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; Toyofuku T, 2012, GENE DEV, V26, P816, DOI 10.1101/gad.184481.111; Valdes-Socin Hernan, 2014, Front Endocrinol (Lausanne), V5, P109, DOI 10.3389/fendo.2014.00109; Wang LL, 2011, BIRTH DEFECTS RES A, V91, P842, DOI 10.1002/bdra.20837; Wang LL, 2012, BIRTH DEFECTS RES A, V94, P91, DOI 10.1002/bdra.22866; WOODGUSH HG, 1989, J ROY SOC MED, V82, P355; Yukawa K, 2010, INT J MOL MED, V25, P225, DOI 10.3892/ijmm_00000334	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	FEB	2015	55	1					26	30		10.1111/cga.12095		5	Pediatrics	Pediatrics	AZ2JG	WOS:000348059400003		
J	Sawamura, H; Ikeda, C; Shimada, R; Yoshii, Y; Watanabe, T				Sawamura, Hiromi; Ikeda, Chieko; Shimada, Ryoko; Yoshii, Yui; Watanabe, Toshiaki			Dietary intake of high-dose biotin inhibits spermatogenesis in young rats	CONGENITAL ANOMALIES			English	Article						biotin; high-dose; dietary intake; spermatogenesis; rat	FEMALE SEX STEROIDS; VITAMIN-A; OXIDATIVE STRESS; RETINOIC ACID; DEFICIENCY; MICE; HISTONES; TISSUE; TESTES; SPERM	To characterize a new function of the water-soluble vitamin, biotin, in reproduction and early growth in mammals, the effects of high dietary doses of biotin on early spermatogenesis were biochemically and histologically investigated in male rats. Weaned rats were fed a CE-2 (control) diet containing 0.00004% biotin, or a control diet supplemented with 0.01%, 0.1%, or 1.0% biotin. Pair-fed rats were fed a control diet that was equal in calories to the amount ingested by the 1.0% biotin group, because food intake was decreased in the 1.0% biotin group. Food intake and body weight gain were lower in the 1.0% biotin group than in the control group. The kidney, brain and testis weights were significantly lower in the 1.0% biotin group than in the pair-fed group after 6 weeks of feeding. The accumulation of biotin in the liver and testis increased in a dose-dependent manner. In the 1.0% biotin group, the number of mature sperm was markedly lower, that of sperm with morphologically abnormal heads, mainly consisting of round heads, had increased. In addition, the development of seminiferous tubules was inhibited, and few spermatogonia and no spermatocytes were histologically observed. These results demonstrated that the long-term intake of high-dose biotin inhibited spermatogenesis in young male rats.	[Sawamura, Hiromi] Univ Hyogo, Sch Human Sci & Environm, Dept Mol Nutr, Himeji, Hyogo 6700092, Japan; [Sawamura, Hiromi; Watanabe, Toshiaki] Univ Hyogo, Res Inst Food & Nutr Sci, Himeji, Hyogo 6700092, Japan; [Ikeda, Chieko; Shimada, Ryoko; Yoshii, Yui; Watanabe, Toshiaki] Univ Hyogo, Sch Human Sci & Environm, Dept Dietary Environm Anal, Himeji, Hyogo 6700092, Japan	Sawamura, H (reprint author), Univ Hyogo, Sch Human Sci & Environm, Dept Mol Nutr, Shinzaike Honcho 1-1-12, Himeji, Hyogo 6700092, Japan.	sawamura@shse.u-hyogo.ac.jp					Angulo C, 2011, BIOL RES, V44, P169, DOI [/S0716-97602011000200009, 10.4067/S0716-97602011000200009]; Baumgartner ER, 1997, INT J VITAM NUTR RES, V67, P377; WATANABE T, 1991, MUTAT RES, V262, P93, DOI 10.1016/0165-7992(91)90113-I; Baez-Saldana A, 2009, STEROIDS, V74, P863, DOI 10.1016/j.steroids.2009.06.004; WYROBEK AJ, 1983, MUTAT RES, V115, P73, DOI 10.1016/0165-1110(83)90015-5; Chew YC, 2008, J NUTR, V138, P2316, DOI 10.3945/jn.108.098673; Kothapalli N, 2005, J NUTR BIOCHEM, V16, P446, DOI 10.1016/j.jnutbio.2005.03.025; KWIECINSKI GG, 1989, J NUTR, V119, P741; Watanabe Toshiaki, 2007, Congenital Anomalies, V47, P9, DOI 10.1111/j.1741-4520.2006.00135.x; Kawata T, 1997, INT J VITAM NUTR RES, V67, P17; Kaur P, 2003, INDIAN J BIOCHEM BIO, V40, P246; VANPELT AMM, 1991, ENDOCRINOLOGY, V128, P697; Sawamura H, 2007, BIOSCI BIOTECH BIOCH, V71, P2977, DOI 10.1271/bbb.70381; APPLING DR, 1981, ENDOCRINOLOGY, V108, P2120; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Veeramachaneni DNR, 2006, REPRODUCTION, V131, P805, DOI 10.1530/rep.1.01048; Bonjour JP, 1991, HDB VITAMINS, P393; BONJOUR JP, 1977, INT J VITAM NUTR RES, V47, P107; BROWN BW, 1994, REPROD NUTR DEV, V34, P89, DOI 10.1051/rnd:19940201; Dakshinamutri K, 1989, BIOTIN VITAM HORM, V45, P337; Informatics Inc, 1974, SCI LIT REV GEN REC; KAWATA T, 1992, J NUTR SCI VITAMINOL, V38, P305; Ministry of Health. Labour and welfare, 2009, DIET REF INT JAP 201; Misro M. M., 1997, Indian Journal of Experimental Biology, V35, P576; MITTELHOLZER E, 1976, INT J VITAM NUTR RES, V46, P33; Mock DM, 2003, J NUTR, V133, P2519; MORI AKIRA, 1961, TOHOKU JOUR AGRIC RES, V12, P107; PAUL PK, 1973, CURR SCI INDIA, V42, P206; PAUL PK, 1976, J NUTR SCI VITAMINOL, V22, P181; PAUL PK, 1975, J NUTR SCI VITAMINOL, V21, P89; PAUL PK, 1973, CURR SCI INDIA, V42, P613; PAULOSE CS, 1989, HORM METAB RES, V21, P661, DOI 10.1055/s-2007-1009314; Song H, 2011, ACTA HISTOCHEM CYTOC, V44, P183; WATANABE T, 1984, TERATOLOGY, V30, P91, DOI 10.1002/tera.1420300112; Watanabe T, 1996, EXPERIENTIA, V52, P149, DOI 10.1007/BF01923361; Watanabe Toshiaki, 2003, Congenital Anomalies, V43, P57, DOI 10.1111/j.1741-4520.2003.tb01027.x; Watanabe T, 1983, TERATOLOGY, V113, P574; WATANABE T, 1989, J NUTR, V119, P255; Webb EC, 2004, S AFR J ANIM SCI, V34, P240; Zempleni J, 2000, P SOC EXP BIOL MED, V223, P14, DOI 10.1046/j.1525-1373.2000.22303.x	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	FEB	2015	55	1					31	36		10.1111/cga.12070		6	Pediatrics	Pediatrics	AZ2JG	WOS:000348059400004		
J	Nakayama, Y; Baba, Y; Tsuji, M; Fukuoka, H; Ogawa, T; Ohkuma, M; Moriyama, K				Nakayama, Yumiko; Baba, Yoshiyuki; Tsuji, Michiko; Fukuoka, Hiroki; Ogawa, Takuya; Ohkuma, Mizue; Moriyama, Keiji			Dentomaxillofacial characteristics of ectodermal dysplasia	CONGENITAL ANOMALIES			English	Article						ectodermal dysplasia; hypodontia; maxillary hypoplasia	MISSING PERMANENT TEETH; SEVERE HYPODONTIA; CLASSIFICATION; INDIVIDUALS	The aim of this retrospective hospital-based study was to elucidate the dentomaxillofacial characteristics of ectodermal dysplasia. Six Japanese individuals (one male and five female; age range, 12.7-27.2 years) underwent comprehensive examinations, including history recording, cephalometric analysis, panoramic radiography, and analysis of dental models. All the subjects had two or more major manifestations for clinical diagnosis of ectodermal dysplasia (e.g., defects of hair, teeth, nails, and sweat glands). They presented hypodontia (mean number of missing teeth, 9.5; range, 5-14), especially in the premolar region, and enamel dysplasia. Five subjects had bilateral molar occlusion, whereas one subject had unilateral molar occlusion. The common skeletal features were small facial height, maxillary hypoplasia, counterclockwise rotation of the mandible, and mandibular protrusion. Interestingly, the maxillary first molars were located in higher positions and the upper anterior facial height was smaller than the Japanese norm. The results suggest that vertical and anteroposterior maxillary growth retardation, rather than lack of occlusal support due to hypodontia, leads to reduced anterior facial height in individuals with ectodermal dysplasia.	[Nakayama, Yumiko; Baba, Yoshiyuki; Tsuji, Michiko; Fukuoka, Hiroki; Ogawa, Takuya; Ohkuma, Mizue; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Reconstruct & Funct, Div Maxillofacial Neck Reconstruct, Tokyo 1138549, Japan; [Baba, Yoshiyuki] Natl Ctr Child Hlth & Dev, Dept Surg Specialties, Div Dent, Tokyo, Japan	Tsuji, M (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Reconstruct & Funct, Div Maxillofacial Neck Reconstruct,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	m-tsuji.mort@tmd.ac.jp			Global Center of Excellence (COE) Program "International Research Center for Molecular Science in Tooth and Bone Diseases"; Japan Society for the Promotion of Science (JSPS)	The authors thank Dr. Tastuo Terasima for his helpful advice on the tooth evaluation. This work was supported in part by the Global Center of Excellence (COE) Program "International Research Center for Molecular Science in Tooth and Bone Diseases" and the Japan Society for the Promotion of Science (JSPS).	Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Itin PH, 2004, AM J MED GENET C, V131C, P45, DOI 10.1002/ajmg.c.30033; Priolo M, 2001, J MED GENET, V38, P579, DOI 10.1136/jmg.38.9.579; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; OGAARD B, 1995, AM J ORTHOD DENTOFAC, V108, P472, DOI 10.1016/S0889-5406(95)70047-1; Endo T, 2006, AM J ORTHOD DENTOFAC, V129, P29, DOI 10.1016/j.ajodo.2004.09.024; Endo Toshiya, 2004, Odontology, V92, P48, DOI 10.1007/s10266-004-0034-5; Epstein CJ, 2004, INBORN ERRORS DEV, P359; Hennekam R, 2010, GORLINS SYNDROMES HE, P451; Iizuka T, 1957, J JPN ORTHOD SOC, V16, P4; Iizuka T., 1958, J STOMATOL SOC JPN, V25, P18; ISHIKAWA T, 1987, ACTA PAEDIATR SCAND, V76, P824, DOI 10.1111/j.1651-2227.1987.tb10571.x; Johnson EL, 2002, AM J MED GENET, V112, P327, DOI 10.1002/ajmg.10654; Kajii T, 1998, NEW ATLAS CONGENTIAL, P326; Komurasaki H, 1997, J CHUGOKU SHIKOKU OR, V9, P85; Lamartine J, 2003, CLIN EXP DERMATOL, V28, P351, DOI 10.1046/j.1365-2230.2003.01319.x; Lexner MO, 2007, INT J PAEDIATR DENT, V17, P10, DOI 10.1111/j.1365-263X.2006.00801.x; Lexner MO, 2007, ORTHOD CRANIOFAC RES, V10, P203, DOI 10.1111/j.1601-6343.2007.00402.x; Masaki F., 1980, J JPN ORTHOD SOC, V39, P436; Ministry of Education Culture Sports Science and Technology, 2002, PHYS DEV STUD; Ministry of Health Labor and Welfare Japan, 2010, NAT GROWTH SURV JAP; MULLER TP, 1970, J AM DENT ASSOC, V81, P101; NODAL M, 1994, EUR J ORTHODONT, V16, P104; Okamura E, 2013, CLEFT PALATE-CRAN J, V50, P192, DOI 10.1597/11-123; Otsubo J, 1957, J JPN ORTHOD SOC, V16, P36; Sakamoto T, 1959, J JAPANESE ORTHODONT, V18, P1; SchalkvanderWeide Y, 1996, ARCH ORAL BIOL, V41, P469, DOI 10.1016/0003-9969(95)00143-3; Tan SPK, 2011, EUR J ORTHODONT, V33, P150, DOI 10.1093/ejo/cjq046; Vahid-Dastjerdi Elaheh, 2010, J Oral Sci, V52, P455; Wright J Timothy, 2009, Am J Med Genet A, V149A, P2062, DOI 10.1002/ajmg.a.32869; Yavuz I, 2006, ARCH MED RES, V37, P403, DOI 10.1016/j.arcmed.2005.06.016	31	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	FEB	2015	55	1					42	48		10.1111/cga.12073		7	Pediatrics	Pediatrics	AZ2JG	WOS:000348059400006		
J	Ihara, N; Akihiro, U; Onami, N; Tsumura, H; Inoue, E; Hayashi, S; Sago, H; Mizutani, S				Ihara, Norimasa; Akihiro, Umezawa; Onami, Naoko; Tsumura, Hideki; Inoue, Eisuke; Hayashi, Satoshi; Sago, Haruhiko; Mizutani, Shuki			Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero	CONGENITAL ANOMALIES			English	Article						chimerism; immunotolerance; In utero hematopoietic cell transplantation; lysosomal storage disease	BONE-MARROW-TRANSPLANTATION; BETA-GLUCURONIDASE DEFICIENCY; LYSOSOMAL STORAGE DISEASE; MURINE MODEL; FETAL; MOUSE; MICROCHIMERISM; CHIMERISM; TISSUES; FETUS	In utero hematopoietic cell transplantation (IUHCT) has been performed in Mucopolysaccharidosis Type VII (MPSVII) mice, but a lifelong engraftment of allogeneic donor cells has not been achieved. In this study, we sought to confirm a lifelong engraftment of allogeneic donor cells immunologically matched to the mother and to achieve partial rescue of phenotypes in the original MPSVII strain through IUHCT by intravenous injection. We performed in vitro fertilization in a MPSVII murine model and transferred affected embryos to ICR/B6-GFP surrogate mothers in cases where fetuses receiving IUHCT were all homozygous. Lineage-depleted cells from ICR/B6-GFP mice were injected intravenously at E14.5. Chimerism was confirmed by flow cytometry at 4 weeks after birth, and -glucuronidase activity in serum and several phenotypes were assessed at 8 weeks of age or later. Donor cells in chimeric mice from ICR/B6-GFP mothers were detected at death, and were confirmed in several tissues including the brains of sacrificed chimeric mice. Although the serum enzyme activity of chimeric mice was extremely low, the engraftment rate of donor cells correlated with enzyme activity. Furthermore, improvement of bone structure and rescue of reproductive ability were confirmed in our limited preclinical study. We confirmed the lifelong engraftment of donor cells in an original immunocompetent MPSVII murine model using intravenous IUHCT with cells immunologically matched to the mother without myeloablation, and the improvement of several phenotypes.	[Ihara, Norimasa; Akihiro, Umezawa] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan; [Onami, Naoko; Tsumura, Hideki] Natl Res Inst Child Hlth & Dev, Div Lab Anim Resources, Tokyo 1578535, Japan; [Inoue, Eisuke] Natl Ctr Child Hlth & Dev, Dept Educ Clin Res, Tokyo, Japan; [Ihara, Norimasa; Hayashi, Satoshi; Sago, Haruhiko] Natl Ctr Child Hlth & Dev Hosp, Ctr Maternal Fetal & Neonatal Med, Tokyo, Japan; [Ihara, Norimasa; Mizutani, Shuki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Pediat & Dev Biol, Tokyo, Japan	Ihara, N (reprint author), Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ihara-n@ncchd.go.jp			Ministry of Education, Culture, Sport, Science, and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare Sciences (MHLW), Japan; National Center for Child Health and Development, Japan	This research was supported by grants from the Ministry of Education, Culture, Sport, Science, and Technology (MEXT) of Japan; the Ministry of Health, Labour and Welfare Sciences (MHLW), Japan; and the National Center for Child Health and Development, Japan. We would like to express our sincere thanks to M. Endo for essential advice and help in establishing the intravenous In utero transplantation technique in our laboratory; to H. Makino, M. Yamazaki-Inoue and T. Uyama for providing expert technical assistance; to M. Kosuga, T. Tanaka and H. Kimura for advice; H. Saito for encouragement; to Y. Kajiyama, Y. Suehiro, K. Saito, and K. Ito for their secretarial work, and to E. Barber for her in-house editorial support.	Abkowitz JL, 2009, TRANSPLANTATION, V88, P323, DOI 10.1097/TP.0b013e3181b0d264; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Alonso-Ferrero ME, 2011, GENE THER, V18, P469, DOI 10.1038/gt.2010.160; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; Durkin ET, 2008, BLOOD, V112, P5245, DOI 10.1182/blood-2007-12-128116; SANDS MS, 1993, LAB INVEST, V68, P676; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Hayashi S, 2002, BLOOD, V100, P804, DOI 10.1182/blood-2002-01-0016; Peranteau WH, 2007, BLOOD, V109, P1331, DOI 10.1182/blood-2006-04-018606; Lyck R, 2012, J VASC RES, V49, P497, DOI 10.1159/000341232; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rio P, 2005, GENE THER, V12, P358, DOI 10.1038/sj.gt.3302419; Kawano N, 2014, P NATL ACAD SCI USA, V111, P4145, DOI 10.1073/pnas.1320715111; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Matsushita T, 2011, NEUROSCI LETT, V502, P41, DOI 10.1016/j.neulet.2011.07.021; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Barker JE, 2001, BLOOD CELL MOL DIS, V27, P861, DOI 10.1006/bcmd.2001.1453; Barker JE, 2003, EXP HEMATOL, V31, P1112, DOI 10.1016/S0301-472X(03)00234-0; Barker JE, 2003, BLOOD CELL MOL DIS, V31, P291, DOI 10.1016/S1079-9796(03)00134-7; Beamer WG, 1982, MOUSE NEWSLETTER, V67, P21; BIRKENMEIER EH, 1991, BLOOD, V78, P3081; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; Casal ML, 2001, BLOOD, V97, P1625, DOI 10.1182/blood.V97.6.1625; Casal ML, 2000, PEDIATR RES, V47, P750, DOI 10.1203/00006450-200006000-00011; Casal ML, 1998, LAB INVEST, V78, P1575; Donsante A, 2007, J INHERIT METAB DIS, V30, P227, DOI 10.1007/s10545-007-0483-4; Dutta P, 2011, CURR OPIN ORGAN TRAN, V16, P359, DOI 10.1097/MOT.0b013e3283484b57; Hofling AA, 2003, BLOOD, V101, P2054, DOI 10.1182/blood-2002-08-2597; HOOGERBRUGGE PM, 1987, TRANSPLANTATION, V43, P609, DOI 10.1097/00007890-198705000-00001; Lissauer DM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001264; Mackenzie TC, 2001, CYTOTHERAPY, V3, P403, DOI 10.1080/146532401753277571; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P683, DOI 10.1016/j.bpobgyn.2012.06.005; Merianos DJ, 2009, J CLIN INVEST, V119, P2590, DOI 10.1172/JCI38979; Nijagal A, 2012, CLIN PERINATOL, V39, P301, DOI 10.1016/j.clp.2012.04.004; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Parolini O, 2011, NEW ENGL J MED, V364, P1174, DOI 10.1056/NEJMcibr1100692; Pearson EG, 2013, SEMIN PEDIATR SURG, V22, P56, DOI 10.1053/j.sempedsurg.2012.10.010; POORTHUIS BJHM, 1994, PEDIATR RES, V36, P187, DOI 10.1203/00006450-199408000-00009; SANDS MS, 1993, P NATL ACAD SCI USA, V90, P6567, DOI 10.1073/pnas.90.14.6567; Scriver CR, 1995, METABOLIC BASIS INHE; Shapira E., 1989, BIOCH GENETICS LAB M; Soper BW, 1999, EXP HEMATOL, V27, P1691, DOI 10.1016/S0301-472X(99)00098-3; Tiblad E, 2008, BEST PRACT RES CL OB, V22, P189, DOI 10.1016/j.bpobgyn.2007.07.007; Troeger C, 2010, STEM CELLS DEV, V19, P1385, DOI 10.1089/scd.2009.0434; VOGLER C, 1990, AM J PATHOL, V136, P207; VOGLER C, 1993, PEDIATR RES, V34, P837, DOI 10.1203/00006450-199312000-00028; Vogler C, 2005, PEDIATR DEVEL PATHOL, V8, P453, DOI 10.1007/s10024-005-0025-8; Wolfe J.H., 1996, GENE TRANSFER NEURON, P263; WOLFE JH, 1992, NATURE, V360, P749, DOI 10.1038/360749a0	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	FEB	2015	55	1					55	64		10.1111/cga.12099		10	Pediatrics	Pediatrics	AZ2JG	WOS:000348059400008		
J	Sawada, K; Saito, S; Horiuchi-Hirose, M; Sato, C; Aoyama, J; Kobayashi, T				Sawada, Kazuhiko; Saito, Shigeyoshi; Horiuchi-Hirose, Miwa; Sato, Chika; Aoyama, Junya; Kobayashi, Tetsuya			Brain volumetry: A quantitative approach for detecting region-specific structural abnormalities	CONGENITAL ANOMALIES			English	Letter							MOUSE		[Sawada, Kazuhiko; Horiuchi-Hirose, Miwa] Tsukuba Int Univ, Fac Med & Hlth Sci, Dept Nutr, Tsuchiura, Ibaraki 3000051, Japan; [Saito, Shigeyoshi] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Engn, Osaka, Japan; [Saito, Shigeyoshi] Osaka Univ, Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Osaka, Japan; [Sato, Chika; Aoyama, Junya; Kobayashi, Tetsuya] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan	Sawada, K (reprint author), Tsukuba Int Univ, Fac Med & Hlth Sci, Dept Phys Therapy, 6-8-33 Manabe, Tsuchiura, Ibaraki 3000051, Japan.	k-sawada@tius.ac.jp					Saito S, 2012, BRIT J RADIOL, V85, pE973, DOI 10.1259/bjr/13040401; Kobayashi K, 2001, ZOOL SCI, V18, P955, DOI 10.2108/zsj.18.955; MADEIRA MD, 1990, J ANAT, V171, P41; Sasaki N, 2007, MOL ENDOCRINOL, V21, P1713, DOI 10.1210/me.2007-0040; Sawada K, 2013, CONGENIT ANOM, V53, P127, DOI 10.1111/cga.12016	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0914-3505	1741-4520		CONGENIT ANOM	Congenit. Anom.	FEB	2015	55	1					71	72		10.1111/cga.12094		2	Pediatrics	Pediatrics	AZ2JG	WOS:000348059400010		
J	Ningshen, S; Sakairi, M; Suzuki, K; Okuno, T				Ningshen, S.; Sakairi, M.; Suzuki, K.; Okuno, T.			Corrosion performance and surface analysis of Ti-Ni-Pd-Ru-Cr alloy in nitric acid solution	CORROSION SCIENCE			English	Article						Titanium; Polarization; XPS; SEM; Passive films; High-temperature corrosion	ANODIC OXIDE-FILMS; STAINLESS-STEEL; TI-6AL-4V ALLOY; TITANIUM; BEHAVIOR; RESISTANCE; PALLADIUM; DISSOLUTION; PROTECTION; ADDITIONS	The corrosion resistance of Ti-0.4Ni-0.015Pd-0.025Ru-0.14Cr (AKOT Ti) and commercially pure titanium (CP Ti) has been studied in different concentrations of 6, 9 and 11.5 M HNO3, and boiling 15.65 M In both CP Ti and AKOT Ti alloy, the open circuit potential and corrosion potential are shifted to more noble potential with increasing concentrations. However, passive current density decreases with increasing concentration. Lower corrosion rate was observed in AKOT Ti (similar to 0.075 mm/y) compared to CP Ti (similar to 0.22 mm/y) in boiling 15.65 M HNO3 after 240 h. The mechanisms by which dissolved titanium ions affect the corrosion are also discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Ningshen, S.] Indira Gandhi Ctr Atom Res, Corros Sci & Technol Grp, Kalpakkam 603102, Tamil Nadu, India; [Sakairi, M.; Suzuki, K.] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0508628, Japan; [Okuno, T.] Kobe Steel Ltd, Kakogawa Works, Kakogawa, Hyogo 6750137, Japan	Ningshen, S (reprint author), Indira Gandhi Ctr Atom Res, Corros Sci & Technol Grp, Kalpakkam 603102, Tamil Nadu, India.	ning@igcar.gov.in			Japan Society for the Promotion of Science, Tokyo, Japan	One author Dr. S.N is grateful to the Japan Society for the Promotion of Science, Tokyo, Japan for the postdoctoral fellowship and financial support.	Ferreira EA, 2010, CORROS SCI, V52, P4058, DOI 10.1016/j.corsci.2010.08.021; Gabasch H, 2006, SURF SCI, V600, P2980, DOI 10.1016/j.susc.2006.05.029; Xing JH, 2013, CORROS SCI, V75, P212, DOI 10.1016/j.corsci.2013.06.004; Ashworth MA, 2010, CORROS SCI, V52, P2413, DOI 10.1016/j.corsci.2010.03.006; Kapoor K, 2003, J NUCL MATER, V322, P36, DOI 10.1016/S0022-3115(03)00302-7; BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8; Ningshen S, 2011, CORROS SCI, V53, P64, DOI 10.1016/j.corsci.2010.09.023; Oliveira VMCA, 2014, CORROS SCI, V88, P317, DOI 10.1016/j.corsci.2014.07.047; EICKMANS J, 1990, SURF INTERFACE ANAL, V16, P265, DOI 10.1002/sia.740160156; Dubuisson P, 2012, J NUCL MATER, V428, P6, DOI 10.1016/j.jnucmat.2011.10.037; Armstrong RD, 1998, J APPL ELECTROCHEM, V28, P1205, DOI 10.1023/A:1003499309590; MUDALI UK, 1993, J NUCL MATER, V203, P73, DOI 10.1016/0022-3115(93)90432-X; Duarte LT, 2013, CORROS SCI, V72, P35, DOI 10.1016/j.corsci.2013.02.007; SHIBATA T, 1995, CORROS SCI, V37, P253, DOI 10.1016/0010-938X(94)00133-Q; Godlewska E, 2014, CORROS SCI, V78, P63, DOI 10.1016/j.corsci.2013.08.032; TOMASHOV ND, 1961, J ELECTROCHEM SOC, V108, P113, DOI 10.1149/1.2428023; Whillock GOH, 2010, SHREIR'S CORROSION, VOL 2: CORROSION IN LIQUIDS, CORROSION EVALUATION, P1250; Raj B, 2006, PROG NUCL ENERG, V48, P283, DOI 10.1016/j.pnucene.2005.07.001; Sunol JJ, 2000, APPL SURF SCI, V158, P252, DOI 10.1016/S0169-4332(00)00019-2; DYER CK, 1978, ELECTROCHIM ACTA, V23, P1387, DOI 10.1016/0013-4686(78)80022-X; Fossati A, 2004, CORROS SCI, V46, P917, DOI 10.1016/S0010-938X(03)00188-4; Ningshen S, 2014, CORROS SCI, V78, P322, DOI 10.1016/j.corsci.2013.10.015; Wang YJ, 2004, APPL SURF SCI, V228, P93, DOI 10.1016/j.apsusc.2003.12.028; ARMSTRON.RD, 1973, CORROS SCI, V13, P409, DOI 10.1016/0010-938X(73)90027-9; Barson SD, 2000, CORROS SCI, V42, P1213, DOI 10.1016/S0010-938X(99)00146-8; BURSTEIN GT, 1989, J ELECTROCHEM SOC, V136, P1313, DOI 10.1149/1.2096913; Cotton F.A., 2007, ADV INORG CHEM, P695; FELSKE A, 1990, J ELECTROCHEM SOC, V137, P1804, DOI 10.1149/1.2086808; FURUYA T, 1991, ISIJ INT, V31, P189, DOI 10.2355/isijinternational.31.189; Grauman J.S., 2007, WORLD C TIT TI 2007, P1213; Higginson A., 1989, British Corrosion Journal, V24; Kato C., 2003, CORROS ENG JPN, V52, P44; KELLY EJ, 1976, J ELECTROCHEM SOC, V123, P162, DOI 10.1149/1.2132778; Kiuchi K., 1991, P 3 INT C NUCL FUEL, V2, P549; Koroleva EV, 2005, CORROS SCI, V47, P2225, DOI 10.1016/j.corsci.2004.09.013; Ningshen S, 2011, J NUCL MATER, V408, P1, DOI 10.1016/j.jnucmat.2010.10.015; Ningshen S, 2013, ADV MATER RES-SWITZ, V794, P575, DOI 10.4028/www.scientific.net/AMR.794.575; Pourbaix M., 1974, ATLAS ELECTROCHEMICA; RAZYGRAEV VP, 1990, PROT MET+, V26, P43; Robin A, 1999, CORROS SCI, V41, P1333, DOI 10.1016/S0010-938X(98)00187-5; Sandenbergh RF, 2005, CORROS SCI, V47, P3300, DOI 10.1016/j.corsci.2005.05.056; Sano Y, 2013, J NUCL MATER, V432, P475, DOI 10.1016/j.jnucmat.2012.08.009; Satoh H., 1982, CORROS ENG JPN, V31, P755; Schutz R. W., 1996, PLATINUM MET REV, V40, P54; Schutz R. W., 1987, METALS HDB, V13, P669; STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493; Vetter K., 1950, Z PHYS CHEM, V194, P199; Yu SY, 2001, J ELECTROCHEM SOC, V148, pB68, DOI 10.1149/1.1337605	48	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	FEB	2015	91						120	128		10.1016/j.corsci.2014.11.010		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AZ5MJ	WOS:000348264700013		
J	Chen, XL; Cao, XQ; Zou, BL; Gong, J; Sun, C				Chen, Xiaolong; Cao, Xueqiang; Zou, Binglin; Gong, Jun; Sun, Chao			Corrosion of lanthanum magnesium hexaaluminate as plasma-sprayed coating and as bulk material when exposed to molten V2O5-containing salt	CORROSION SCIENCE			English	Article						Ceramic; Molten salt; Hot corrosion; Oxide coatings	THERMAL BARRIER COATINGS; SULFATE-VANADATE SALT; HOT CORROSION; CALCIUM HEXALUMINATE; VANADIUM-OXIDE; BEHAVIOR; MAGNETOPLUMBITE; MECHANISM; OXIDATION; ALUMINA	Corrosion of LaMgAl11O19 (LaMA) bulk and plasma sprayed coating was studied in molten V2O5-containing salt at 710-1050 degrees C in air. Results indicate that the well crystallized LaMA bulk exhibited prior corrosion resistance to the plasma sprayed LaMA coating with amorphous phase and reduced chemical bond strength in its crystal structure. La-O chemical bonds with the lowest bond energies were the easiest bonds in the LaMA crystal to be broken by molten V2O5-containing salt attack to form LaVO4 at each temperature level for both LaMA bulk and coating. Corrosion products of the LaMA coating were much different at temperature below 900 degrees C. (C) 2014 Elsevier Ltd. All rights reserved.	[Chen, Xiaolong; Gong, Jun; Sun, Chao] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China; [Chen, Xiaolong] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Cao, Xueqiang; Zou, Binglin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resources Utilizat, Changchun 130022, Peoples R China	Chen, XL (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	xlchen@imr.ac.cn			 [NSFC-51301180];  [NSFC-21171160];  [NSFC-51472235]	This work was financially supported by the projects of NSFC-51301180, NSFC-21171160, NSFC-51472235.	Padture NP, 2002, SCIENCE, V296, P280, DOI 10.1126/science.1068609; Ma W, 2008, J AM CERAM SOC, V91, P2630, DOI 10.1111/j.1551-2916.2008.02472.x; Chen XL, 2011, SURF COAT TECH, V205, P3293, DOI 10.1016/j.surfcoat.2010.11.059; Chen XL, 2010, J EUR CERAM SOC, V30, P1649, DOI 10.1016/j.jeurceramsoc.2010.01.013; Shirvani K, 2013, CORROS SCI, V75, P142, DOI 10.1016/j.corsci.2013.05.025; Cao XQ, 2003, ADV MATER, V15, P1438, DOI 10.1002/adma.200304132; Wu NQ, 2005, J AM CERAM SOC, V88, P675, DOI 10.1111/j.1551-2916.2005.00120.x; Clarke DR, 2003, ANNU REV MATER RES, V33, P383, DOI 10.1146/annurev.matsci.33.011403.113718; Chen Z, 2009, J EUR CERAM SOC, V29, P1647, DOI 10.1016/j.jeurceramsoc.2008.10.003; Vassen R, 2004, INT J APPL CERAM TEC, V1, P351; Vassen R, 2010, SURF COAT TECH, V205, P938, DOI 10.1016/j.surfcoat.2010.08.151; Chen XL, 2015, J EUR CERAM SOC, V35, P227, DOI 10.1016/j.jeurceramsoc.2014.08.035; Zhu LJ, 2014, CORROS SCI, V80, P393, DOI 10.1016/j.corsci.2013.11.052; Vassen R, 2000, J AM CERAM SOC, V83, P2023; Gadow R, 2002, SURF COAT TECH, V151, P392, DOI 10.1016/S0257-8972(01)01642-5; Chen XL, 2011, CORROS SCI, V53, P2335, DOI 10.1016/j.corsci.2011.03.019; Sreedhar G, 2009, SURF COAT TECH, V204, P291, DOI 10.1016/j.surfcoat.2009.07.026; Rahaman MN, 2006, ACTA MATER, V54, P1615, DOI 10.1016/j.actamat.2005.11.033; Friedrich C, 2001, J THERM SPRAY TECHN, V10, P592, DOI 10.1361/105996301770349105; Mallamaci MP, 1998, PHILOS MAG A, V77, P561; Cao XQ, 2004, J EUR CERAM SOC, V24, P1, DOI 10.1016/S0955-2219(03)00129-8; Yao JQ, 2014, CORROS SCI, V80, P37, DOI 10.1016/j.corsci.2013.10.006; Bergant Z, 2014, CORROS SCI, V88, P372, DOI 10.1016/j.corsci.2014.07.057; Liu HF, 2014, CORROS SCI, V85, P87, DOI 10.1016/j.corsci.2014.04.001; Chen XL, 2012, SURF COAT TECH, V206, P2265, DOI 10.1016/j.surfcoat.2011.09.076; Choi SR, 2005, CERAM ENG SCI PROC, V26, P11; Habibi MH, 2013, CORROS SCI, V75, P409, DOI 10.1016/j.corsci.2013.06.025; Jones RL, 1997, J THERM SPRAY TECHN, V6, P77, DOI 10.1007/BF02646315; KAHN A, 1981, J APPL PHYS, V52, P6864, DOI 10.1063/1.328680; Li S, 2010, CORROS SCI, V52, P3568, DOI 10.1016/j.corsci.2010.06.007; Nath S, 2014, CORROS SCI, V88, P10, DOI 10.1016/j.corsci.2014.06.050; Sanchez-Herencia AJ, 2000, J EUR CERAM SOC, V20, P2575, DOI 10.1016/S0955-2219(00)00123-0; XIE LK, 1990, MATER LETT, V9, P474, DOI 10.1016/0167-577X(90)90121-2; XU J, 1993, CRYST RES TECHNOL, V28, P365	34	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	FEB	2015	91						185	194		10.1016/j.corsci.2014.11.016		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AZ5MJ	WOS:000348264700018		
J	Liu, L; Yang, ZG; Zhang, C; Ueda, M; Kawamura, K; Maruyama, T				Liu, Lu; Yang, Zhi-gang; Zhang, Chi; Ueda, Mitsutoshi; Kawamura, Kenichi; Maruyama, Toshio			Effect of grain size on the oxidation of Fe-13Cr-5Ni alloy at 973 K in Ar-21 vol%O-2	CORROSION SCIENCE			English	Article						Alloy; SEM; XRD; Oxidation	HIGH-TEMPERATURE OXIDATION; STAINLESS-STEELS; 304-STAINLESS-STEEL; BEHAVIOR; RESISTANCE; STEAM; AIR	Effect of grain refinement from 370 to 34 mu m on oxidation of transition Fe-13Cr-5Ni alloy at 973 K in Ar-21 vol%O-2 was investigated. The measured weight gains were fitted taking into account a mixed kinetic model with an initial linear and subsequent parabolic growth behaviour. Different scale microstructural evolution was discussed. Contribution of grain refinement to the oxidation is predominantly due to its effect on the inward oxidation process. Decreasing grain size promoted intergranular oxidation, accelerated formation of the Cr-containing inner scale, contributed to the faster transition to the steady state oxidation and correspondingly slightly improved the oxidation resistance. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Lu] State Nucl Power Technol Corp Res & Dev Ctr, Beijing 102209, Peoples R China; [Liu, Lu] State Nucl Power Res Inst, Beijing 102209, Peoples R China; [Liu, Lu] Natl Energy Res & Dev Ctr Nucl Grade Zirconium Ma, Beijing 102209, Peoples R China; [Yang, Zhi-gang; Zhang, Chi] Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Mat, Beijing 100084, Peoples R China; [Ueda, Mitsutoshi; Kawamura, Kenichi; Maruyama, Toshio] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Met & Ceram Sci, Tokyo 1528552, Japan	Liu, L (reprint author), State Nucl Power Res Inst, Future Sci & Technol Pk, Beijing 102209, Peoples R China.	liulu840926@126.com			Staff Independent Innovation Fund of State Nuclear Power Technology Corporation [SNP-KJ-CX-2013-5]	The present work was supported by Staff Independent Innovation Fund of State Nuclear Power Technology Corporation (SNP-KJ-CX-2013-5).	ABE F, 1981, CORROS SCI, V21, P819, DOI 10.1016/0010-938X(81)90024-X; Akgtin O.V., 1995, MAT SCI ENG A-STRUCT, V203, P324; BASU SN, 1991, OXID MET, V36, P281, DOI 10.1007/BF00662967; [Anonymous], 2004, E1129663 ASTM; Peng X, 2005, ACTA MATER, V53, P5079, DOI 10.1016/j.actamat.2005.07.019; Kruska K, 2012, CORROS SCI, V63, P225, DOI 10.1016/j.corsci.2012.06.030; SURYANARAYANA C, 1995, INT MATER REV, V40, P41; OTSUKA N, 1989, OXID MET, V32, P13, DOI 10.1007/BF00665267; FISHER JC, 1951, J APPL PHYS, V22, P74, DOI 10.1063/1.1699825; Yu XL, 2014, CORROS SCI, V85, P115, DOI 10.1016/j.corsci.2014.04.006; BAER DR, 1980, METALL TRANS A, V11, P1973, DOI 10.1007/BF02655116; Bhadeshia H. K. D. H., 2006, STEELS MICROSTRUCTUR; Herzig C., 2005, DIFFUSION CONDENSED, P337, DOI 10.1007/3-540-30970-5_8; Kaur I., 1995, FUNDAMENTALS GRAIN I; Kofstad P., 1988, HIGH TEMPERATURE COR; Krupp U, 2005, DEFECT DIFFUS FORUM, V237-240, P946; Lobb R.C., 1981, MET SCI, P267; Lussana D, 2014, OXID MET, V81, P515, DOI 10.1007/s11085-013-9465-0; Martin G., 1980, GRAIN BOUNDARY STRUC, P239; Mehrer H., 2007, DIFFUSION SOLIDS FUN; RAMAN RKS, 1994, OXID MET, V42, P335; RAMAN RKS, 1992, OXID MET, V37, P1; RAMAN RKS, 1992, OXID MET, V38, P483; Ren X.-W., 2008, THESIS U WISCONSIN M; Trindade V, 2010, OXID MET, V73, P551, DOI 10.1007/s11085-010-9192-8; WAGNER C, 1959, Z ELEKTROCHEM, V63, P772; Wang SG, 2013, CORROS SCI, V72, P64, DOI 10.1016/j.corsci.2013.03.008; Young DJ, 2008, ELSEV CORROS SER, V1, P1	28	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	FEB	2015	91						195	202		10.1016/j.corsci.2014.11.020		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AZ5MJ	WOS:000348264700019		
J	Wan, K; Yabuki, Y; Mizuta, K				Wan, Kun; Yabuki, Yukari; Mizuta, Keiko			Roles of Ebp2 and ribosomal protein L36 in ribosome biogenesis in Saccharomyces cerevisiae	CURRENT GENETICS			English	Article						Ribosome biogenesis; EBP2; Ribosomal protein L36a/b; Ribosomal protein L34a/b; Duplicated genes	ANTIGEN 1-BINDING PROTEIN-2; YEAST HOMOLOG; ASSEMBLY FACTORS; EUKARYOTIC RIBOSOME; GENE-EXPRESSION; RNA; SUBUNITS; INTERACTS; DEPLETION; BINDING	Ebp2 plays an essential role in biogenesis of 60S ribosomal subunits. We determined the genetic interactions between EBP2 and RPL36A/B, which encodes ribosomal protein L36a/b. RPL36A/B was a multicopy suppressor to ebp2 mutants, and the suppression was not common to defects in ribosome biogenesis resulting from other mutations of assembly factors. Disruption of RPL36A or RPL36B caused synthetic enhancement of the growth defect of the ebp2-14 allele at high temperatures. Disruption of RPL36B led to a more severe growth defect than that of RPL36A due to imbalances in the expression levels of the duplicated genes. Primer-extension analysis revealed that L36a/b is required for the processing of 27SA(2), 27SA(3), and 27SB(L) pre-rRNAs. Two-hybrid analysis indicated that Ebp2 interacts with ribosomal proteins L36a/b, L34a/b, and L8, which in mature ribosomes are located adjacent to each other in close proximity to the 3' end of 5.8S rRNA. These results suggest that Ebp2 functions cooperatively with ribosomal proteins L36, L34, and L8 in biogenesis of the 60S ribosomal subunit.	[Wan, Kun; Yabuki, Yukari; Mizuta, Keiko] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, Higashihiroshima 7398528, Japan	Mizuta, K (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, 1-4-4 Kagamiyama, Higashihiroshima 7398528, Japan.	wankun@bio-ribs.com; kei7mizuta@hiroshima-u.ac.jp			JSPS KAKENHI [25450516]	We thank K. Kanda for screening of multicopy suppressors, Dr. E. Tsuchiya for the yeast genomic library, Dr. J. L. Woolford, Jr., Dr. D. Shore, and Dr. K. Tanaka for plasmids, and Dr. K. Funato for helpful discussion. This work was supported by JSPS KAKENHI Grant Number 25450516 (to K.M.).	LUCIOLI A, 1988, MOL CELL BIOL, V8, P4792; Tsujii R, 2000, GENES CELLS, V5, P543, DOI 10.1046/j.1365-2443.2000.00346.x; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Horigome C, 2008, BIOSCI BIOTECH BIOCH, V72, P1080, DOI 10.1271/bbb.70817; Talkish J, 2014, MOL CELL BIOL, V34, P1863, DOI 10.1128/MCB.01322-13; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Wan K, 2013, BIOSCI BIOTECH BIOCH, V77, P631, DOI 10.1271/bbb.120860; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Tsuchiya E, 1996, GENE, V176, P35, DOI 10.1016/0378-1119(96)00204-1; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Jakovljevic J, 2012, RNA, V18, P1805, DOI 10.1261/rna.032540.112; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ni L, 2001, MOL BIOL CELL, V12, P2147; BaudinBaillieu A, 1997, MOL CELL BIOL, V17, P5023; Kaiser C, 1994, METHODS YEAST GENETI; LEE JC, 1983, J BIOL CHEM, V258, P854; Miyoshi K, 2002, J BIOL CHEM, V277, P18334, DOI 10.1074/jbc.M201667200; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493; Morita D, 2002, J BIOL CHEM, V277, P28780, DOI 10.1074/jbc.M203399200; Nariai M, 2005, NUCLEIC ACIDS RES, V33, P4553, DOI 10.1093/nar/gki772; Pratte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082741; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Shimoji K, 2012, NUCLEIC ACIDS RES, V40, P4574, DOI 10.1093/nar/gks057; Shirai C, 2008, BIOSCI BIOTECH BIOCH, V72, P1881, DOI 10.1271/bbb.80131; Shirai C, 2004, J BIOL CHEM, V279, P25353, DOI 10.1074/jbc.M403338200; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-8083	1432-0983		CURR GENET	Curr. Genet.	FEB	2015	61	1					31	41		10.1007/s00294-014-0442-1		11	Genetics & Heredity	Genetics & Heredity	AZ4RM	WOS:000348210400004		
J	Araki, T; Toh-e, A; Kikuchi, Y; Watanabe, CK; Hachiya, T; Noguchi, K; Terashima, I; Uesono, Y				Araki, Tomoyuki; Toh-e, Akio; Kikuchi, Yoshiko; Watanabe, Chihiro K.; Hachiya, Takushi; Noguchi, Ko; Terashima, Ichiro; Uesono, Yukifumi			Tetracaine, a local anesthetic, preferentially induces translational inhibition with processing body formation rather than phosphorylation of eIF2 alpha in yeast	CURRENT GENETICS			English	Article						Local anesthetic; Phenothiazine; Actin; Translation initiation; eIF2 alpha; Processing body	SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; VOLATILE ANESTHETICS; GLUCOSE-TRANSPORTER; IN-VITRO; P-BODIES; RNA; INITIATION; STRESS; MECHANISMS	It is unclear whether local anesthetics, such as tetracaine, and antipsychotics, such as phenothiazines, act on lipids or proteins. In Saccharomyces cerevisiae, these drugs inhibit growth, translation initiation, and actin polarization, and induce cell lysis at high concentrations. These activities are likely due to the cationic amphiphilic structure common to these agents. Although drug-induced translational inhibition is conserved in mammalian cells, other mechanisms, including the phosphorylation of eIF2 alpha, a eukaryotic translational initiation factor, remain poorly understood. At a concentration of 10 mM, tetracaine rapidly inhibited translation initiation and lysed cells, whereas, at 2.5 mM, it slowly induced inhibition without lysis. The pat1 disruptant defective in mRNA decapping and the xrn1 disruptant defective in 5'aEuro"3' exoribonuclease were partially resistant to translational inhibition by tetracaine at each concentration, but the gcn2 disruptant defective in the eIF2 alpha kinase was not. Phosphorylation of eIF2 alpha was induced by 10 mM but not by 2.5 mM tetracaine, whereas processing bodies (P-bodies) were formed at 2.5 mM in Pat1-dependent and -independent manners. Therefore, administration of tetracaine inhibits translation initiation with P-body formation at both concentrations but acts via the Gcn2-eIF2 alpha system only at the higher concentration. Because other local anesthetics and phenothiazines induced Pat1-dependent P-body formation, the mechanisms involved in translational inhibition by these cationic amphiphiles are similar. These results suggest that this dose-dependent biphasic translational inhibition by tetracaine results from an increase in membrane proteins that are indirectly inhibited by nonspecific interactions of cationic amphiphiles with membrane lipids.	[Araki, Tomoyuki] Saitama Med Sch, Dept Mol Biol, Moroyama, Saitama 3500495, Japan; [Toh-e, Akio] Chiba Univ, MMRC, Chuo Ku, Chiba 2608673, Japan; [Kikuchi, Yoshiko] Gakushuin Univ, Dept Life Sci, Toshima Ku, Tokyo 1718588, Japan; [Watanabe, Chihiro K.; Hachiya, Takushi; Noguchi, Ko; Terashima, Ichiro; Uesono, Yukifumi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Uesono, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	uesono@bs.s.u-tokyo.ac.jp	TERASHIMA, ICHIRO/G-4943-2014	TERASHIMA, ICHIRO/0000-0001-7680-9867			Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.019; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; OGATA N, 1989, BRAIN RES, V476, P140, DOI 10.1016/0006-8993(89)91546-1; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; SNYDER SH, 1974, SCIENCE, V184, P1243, DOI 10.1126/science.184.4143.1243; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Uesono Y, 2004, MOL BIOL CELL, V15, P1544, DOI 10.1091/mbc.E03-12-0877; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Wang D, 2011, SPINE J, V11, P139, DOI 10.1016/j.spinee.2010.11.017; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; PRINGLE MJ, 1981, MOL PHARMACOL, V19, P49; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; BANERJEE D, 1977, BIOCHIM BIOPHYS ACTA, V500, P49, DOI 10.1016/0304-4165(77)90045-9; BRUCE DL, 1975, ANESTHESIOLOGY, V42, P11, DOI 10.1097/00000542-197501000-00003; CURTIS BM, 1981, ANESTHESIOLOGY, V54, P270, DOI 10.1097/00000542-198104000-00003; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Deloche O, 2004, MOL CELL, V13, P357, DOI 10.1016/S1097-2765(04)00008-5; FRANKS NP, 1990, ENVIRON HEALTH PERSP, V87, P199, DOI 10.2307/3431025; GHANTOUS HN, 1991, ANESTH ANALG, V72, P796; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Guthrie C, 1991, GUIDE YEAST GENETICS, V194; HEYS SD, 1989, CLIN SCI, V77, P651; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Hong DY, 2011, INT J MOL SCI, V12, P7652, DOI 10.3390/ijms12117652; HORBER FF, 1988, ANESTHESIOLOGY, V69, P319, DOI 10.1097/00000542-198809000-00006; Kilchert C, 2010, MOL BIOL CELL, V21, P2624, DOI 10.1091/mbc.E10-02-0099; KUMAR RV, 1991, EUR J BIOCHEM, V195, P313, DOI 10.1111/j.1432-1033.1991.tb15708.x; Lee IS, 1999, BIOCHEM PHARMACOL, V58, P1017, DOI 10.1016/S0006-2952(99)00181-1; Meyer HH, 1899, ARCH EXP PATHOL PH, V42, P109, DOI 10.1007/BF01834479; Mia M, 1975, B EKSP BIOL MED, V79, P62; Mozrzymas JW, 1999, J NEUROSCI, V19, P2474; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; Palmer LK, 2002, GENETICS, V161, P563; Palmer LK, 2006, AM J PHYSIOL-ENDOC M, V290, P1267; Palmer LK, 2005, MOL BIOL CELL, V16, P3727, DOI 10.1091/mbc.E05-02-0127; PROZIALECK WC, 1982, J PHARMACOL EXP THER, V222, P509; RAGHUPAT.E, 1970, BIOCHEM PHARMACOL, V19, P993, DOI 10.1016/0006-2952(70)90362-X; SMITH ICP, 1991, ANN NY ACAD SCI, V625, P668, DOI 10.1111/j.1749-6632.1991.tb33901.x; Toh-e A, 1976, BIOCHIM BIOPHYS ACTA, V28, P182; Toh-e A, 1998, GENES GENET SYST, V73, P365, DOI 10.1266/ggs.73.365; Uesono Yukifumi, 2009, Commun Integr Biol, V2, P275; Uesono Y, 1997, J BIOL CHEM, V272, P16103, DOI 10.1074/jbc.272.26.16103; Uesono Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2884, DOI 10.1271/bbb.80385; Uesono Y, 2011, YEAST, V28, P391, DOI 10.1002/yea.1846; Urban BW, 2006, PHARMACOL THERAPEUT, V111, P729, DOI 10.1016/j.pharmthera.2005.12.005	55	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-8083	1432-0983		CURR GENET	Curr. Genet.	FEB	2015	61	1					43	53		10.1007/s00294-014-0443-0		11	Genetics & Heredity	Genetics & Heredity	AZ4RM	WOS:000348210400005		
J	Ohtsuka, S; Niwa, H				Ohtsuka, Satoshi; Niwa, Hitoshi			The differential activation of intracellular signaling pathways confers the permissiveness of embryonic stem cell derivation from different mouse strains	DEVELOPMENT			English	Article						LIF signaling; MAP kinase; Stat3; Embryonic stem cell; Signal responsiveness	SELF-RENEWAL; ES CELLS; RAT BLASTOCYSTS; ESTABLISHMENT; STAT3; LINES; PLURIPOTENCY; FGF; CULTURE; PROTEIN	The requirement of leukemia inhibitory factor (LIF) for the establishment and maintenance of mouse embryonic stem cells (ESCs) depends on the genetic background of the ESC origin. To reveal the molecular basis of the strain-dependent function of LIF, we compared the activation of the intracellular signaling pathways downstream of LIF in ESCs with different genetic backgrounds. We found that the JAK-Stat3 pathway was dominantly activated in ESCs derived from 'permissive' mouse strains (129Sv and C57BL6), whereas the MAP kinase pathway was hyperactivated in ESCs from 'non-permissive' strains (NOD, CBA and FVB). Artificial activation of Stat3 supported stable self-renewal of ESCs from non-permissive strains. These data suggest that the difference in the balance between the two intracellular signaling pathways underlies the differential response to LIF.	[Ohtsuka, Satoshi; Niwa, Hitoshi] RIKEN, CDB, Lab Pluripotent Stem Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Niwa, Hitoshi] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan; [Niwa, Hitoshi] Kobe Univ, Grad Sch Med, Lab Dev & Regenerat Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Niwa, H (reprint author), RIKEN, CDB, Lab Pluripotent Stem Cell Studies, Chuo Ku, Minatojima Minamimachi 2-2-3, Kobe, Hyogo 6500047, Japan.	niwa@cdb.riken.jp			Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency (JST) CREST program; RIKEN grant	This work was supported by the Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the Japan Science and Technology Agency (JST) CREST program and a RIKEN grant to H.N. Deposited in PMC for immediate release.	Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Endo TA, 1997, NATURE, V387, P921; Brook FA, 2003, DIABETES, V52, P205, DOI 10.2337/diabetes.52.1.205; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Honda A, 2009, EXP CELL RES, V315, P2033, DOI 10.1016/j.yexcr.2009.01.024; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; KAWASE E, 1994, INT J DEV BIOL, V38, P385; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Baharvand H, 2004, IN VITRO CELL DEV-AN, V40, P76; Cinelli P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-57; Kawai-Kowase K, 1999, CIRC RES, V85, P787; Nagafuchi S, 1999, FEBS LETT, V455, P101, DOI 10.1016/S0014-5793(99)00801-7; Ohtsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045220; Sumi T, 2004, STEM CELLS, V22, P861, DOI 10.1634/stemcells.22-5-861	32	3	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	FEB 1	2015	142	3					431	437		10.1242/dev.112375		7	Developmental Biology	Developmental Biology	AZ5HT	WOS:000348251800004		
J	Kinoshita, A; ten Hove, CA; Tabata, R; Yamada, M; Shimizu, N; Ishida, T; Yamaguchi, K; Shigenobu, S; Takebayashi, Y; Iuchi, S; Kobayashi, M; Kurata, T; Wada, T; Seo, M; Hasebe, M; Blilou, I; Fukuda, H; Scheres, B; Heidstra, R; Kamiya, Y; Sawa, S				Kinoshita, Atsuko; ten Hove, Colette A.; Tabata, Ryo; Yamada, Masashi; Shimizu, Noriko; Ishida, Takashi; Yamaguchi, Katsushi; Shigenobu, Shuji; Takebayashi, Yumiko; Iuchi, Satoshi; Kobayashi, Masatomo; Kurata, Tetsuya; Wada, Takuji; Seo, Mitsunori; Hasebe, Mitsuyasu; Blilou, Ikram; Fukuda, Hiroo; Scheres, Ben; Heidstra, Renze; Kamiya, Yuji; Sawa, Shinichiro			A plant U-box protein, PUB4, regulates asymmetric cell division and cell proliferation in the root meristem	DEVELOPMENT			English	Article						Arabidopsis development; Root meristem; Asymmetric cell division; Cell proliferation	RECEPTOR-LIKE KINASE; ARABIDOPSIS SHOOT MERISTEM; OF-FUNCTION PHENOTYPES; CLE PEPTIDES; GENE-EXPRESSION; REPEAT PROTEIN; DIFFERENTIATION; THALIANA; ORGANIZATION; GROWTH	The root meristem (RM) is a fundamental structure that is responsiblefor postembryonic root growth. The RM contains the quiescent center (QC), stem cells and frequently dividing meristematic cells, in which the timing and the frequency of cell division are tightly regulated. In Arabidopsis thaliana, several gain-of-function analyses have demonstrated that peptide ligands of the CLAVATA3 (CLV3)/EMBRYO SURROUNDING REGION-RELATED (CLE) family are important for maintaining RM size. Here, we demonstrate that a plant U-box E3 ubiquitin ligase, PUB4, is a novel downstream component of CLV3/CLE signaling in the RM. Mutations in PUB4 reduced the inhibitory effect of exogenous CLV3/CLE peptide on root cell proliferation and columella stem cell maintenance. Moreover, pub4 mutants grown without exogenous CLV3/CLE peptide exhibited characteristic phenotypes in the RM, such as enhanced root growth, increased number of cortex/endodermis stem cells and decreased number of columella layers. Our phenotypic and gene expression analyses indicated that PUB4 promotes expression of a cell cycle regulatory gene, CYCD6; 1, and regulates formative periclinal asymmetric cell divisions in endodermis and cortex/endodermis initial daughters. These data suggest that PUB4 functions as a global regulator of cell proliferation and the timing of asymmetric cell division that are important for final root architecture.	[Kinoshita, Atsuko; Takebayashi, Yumiko; Seo, Mitsunori; Kamiya, Yuji] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [ten Hove, Colette A.; Blilou, Ikram; Scheres, Ben; Heidstra, Renze] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [ten Hove, Colette A.; Fukuda, Hiroo] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Tabata, Ryo; Sawa, Shinichiro] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Yamada, Masashi; Shimizu, Noriko; Ishida, Takashi] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Yamada, Masashi; Shimizu, Noriko; Ishida, Takashi] Duke Univ, Ctr Syst Biol, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Yamaguchi, Katsushi; Shigenobu, Shuji] Natl Inst Basic Biol, Funct Genom Facil, Okazaki, Aichi 4448585, Japan; [Shigenobu, Shuji; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Iuchi, Satoshi; Kobayashi, Masatomo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Kurata, Tetsuya] NAIST, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Wada, Takuji] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Hasebe, Mitsuyasu] Natl Inst Basic Biol, Div Evolutionary Biol, Okazaki, Aichi 4448585, Japan; [Blilou, Ikram; Scheres, Ben; Heidstra, Renze] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Fukuda, Hiroo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Sawa, S (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	sawa@sci.kumamoto-u.ac.jp	Kamiya, Yuji/F-9420-2010; Ishida, Takashi/D-1072-2010; Seo, Mitsunori/N-9603-2015	Kamiya, Yuji/0000-0003-4415-520X; 	KAKENHI [23119517, 23012034, 24114001, 24114009, 24370024, 24657035, 24658032, 23870040]; International Research Experience for Students and Young Researchers grant by the Japan Society for the Promotion of Science (JSPS); RIKEN Special Postdoctoral Researchers Program; Centre for BioSystems Genomics (CBSG); Horizon grant; National Institute for Basic Biology (NIBB) [12-103]	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) [23119517, 23012034, 24114001, 24114009, 24370024, 24657035, 24658032 and 23870040 to A.K. and S.S.], an International Research Experience for Students and Young Researchers grant by the Japan Society for the Promotion of Science (JSPS), the RIKEN Special Postdoctoral Researchers Program (to A.K.), and by a Centre for BioSystems Genomics (CBSG) and Horizon grant, originating from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (to C.A.t.H. and R.H.). NGS was performed under the National Institute for Basic Biology (NIBB) cooperative research program [#12-103].	DOLAN L, 1993, DEVELOPMENT, V119, P71; Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Yamada M, 2013, CURR OPIN PLANT BIOL, V16, P56, DOI 10.1016/j.pbi.2012.11.004; Cruz-Ramirez A, 2012, CELL, V150, P1002, DOI 10.1016/j.cell.2012.07.017; Strabala TJ, 2006, PLANT PHYSIOL, V140, P1331, DOI 10.1104/pp.105.075515; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Wang H, 2013, PLANT J, V74, P511, DOI 10.1111/tpj.12146; Stahl Y, 2009, CURR BIOL, V19, P909, DOI 10.1016/j.cub.2009.03.060; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Ichikawa T, 2006, PLANT J, V48, P974, DOI 10.1111/j.1365-313X.2006.02924.x; Ding ZJ, 2010, P NATL ACAD SCI USA, V107, P12046, DOI 10.1073/pnas.1000672107; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Mitchum MG, 2008, CURR OPIN PLANT BIOL, V11, P75, DOI 10.1016/j.pbi.2007.10.010; Replogle A, 2013, MOL PLANT MICROBE IN, V26, P87, DOI 10.1094/MPMI-05-12-0118-FI; Kondo Y, 2011, PLANT CELL PHYSIOL, V52, P37, DOI 10.1093/pcp/pcq129; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; SCHERES B, 1994, DEVELOPMENT, V120, P2475; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Koizumi K, 2013, DEVELOPMENT, V140, P1292, DOI 10.1242/dev.090761; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Stahl Y, 2013, CURR BIOL, V23, P362, DOI 10.1016/j.cub.2013.01.045; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Kinoshita A, 2007, PLANT CELL PHYSIOL, V48, P1821, DOI 10.1093/pcp/pcm154; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Miwa H, 2008, PLANT CELL PHYSIOL, V49, P1752, DOI 10.1093/pcp/pcn148; Stegmann M, 2012, PLANT CELL, V24, P4703, DOI 10.1105/tpc.112.104463; Samuel MA, 2008, PLANT PHYSIOL, V147, P2084, DOI 10.1104/pp.108.123380; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Scheres B, 1999, ANNU REV PLANT PHYS, V50, P505, DOI 10.1146/annurev.arplant.50.1.505; Ten Hove CA, 2010, CURR BIOL, V20, P452, DOI 10.1016/j.cub.2010.01.018; Jun J, 2010, PLANT PHYSIOL, V154, P1721, DOI 10.1104/pp.110.163683; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Baum SF, 1996, PROTOPLASMA, V192, P178, DOI 10.1007/BF01273890; Betsuyaku Shigeyuki, 2011, Arabidopsis Book, V9, pe0149, DOI 10.1199/tab.0149; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Gallagher K, 1997, CURR OPIN CELL BIOL, V9, P842, DOI 10.1016/S0955-0674(97)80086-5; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Hirakawa Y, 2010, J INTEGR PLANT BIOL, V52, P8, DOI 10.1111/j.1744-7909.2010.00904.x; Kim M, 2003, BBA-PROTEINS PROTEOM, V1651, P50, DOI 10.1016/S1570-9639(03)00234-6; Koizumi K, 2012, P NATL ACAD SCI USA, V109, P13010, DOI 10.1073/pnas.1205579109; Kondo Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4504; Tabata R, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.22534, DOI 10.4161/PSB.22534]; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307	62	4	4	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	FEB 1	2015	142	3					444	453		10.1242/dev.113167		10	Developmental Biology	Developmental Biology	AZ5HT	WOS:000348251800006		
J	Horstman, A; Fukuoka, H; Muino, JM; Nitsch, L; Guo, CH; Passarinho, P; Sanchez-Perez, G; Immink, R; Angenent, G; Boutilier, K				Horstman, Anneke; Fukuoka, Hiroyuki; Muino, Jose M.; Nitsch, Lisette; Guo, Changhua; Passarinho, Paul; Sanchez-Perez, Gabino; Immink, Richard; Angenent, Gerco; Boutilier, Kim			AIL and HDG proteins act antagonistically to control cell proliferation	DEVELOPMENT			English	Article						AINTEGUMENTA-LIKE; HOMEODOMAIN GLABROUS; Transcription factor; Cell proliferation; Cell differentiation; Arabidopsis	ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; PLANT TRANSFORMATION; ECTOPIC EXPRESSION; QUANTITATIVE PCR; CHIP-SEQ; DIFFERENTIATION; GENES; PLETHORA; GROWTH	AINTEGUMENTA-LIKE (AIL) transcription factors are key regulators of cell proliferation and meristem identity. Although AIL functions have been well described, the direct signalling components of this pathway are largely unknown. We show that BABY BOOM (BBM) and other AIL proteins physically interact with multiple members of the L1-expressed HOMEODOMAIN GLABROUS (HDG) transcription factor family, including HDG1, HDG11 and HDG12. Overexpression of HDG1, HDG11 and HDG12 restricts growth due to root and shoot meristem arrest, which is associated with reduced expression of genes involved in meristem development and cell proliferation pathways, whereas downregulation of multiple HDG genes promotes cell overproliferation. These results suggest a role for HDG proteins in promoting cell differentiation. We also reveal a transcriptional network in which BBM and HDG1 regulate several common target genes, and where BBM/AIL and HDG regulate the expression of each other. Taken together, these results suggest opposite roles for AIL and HDG proteins, with AILs promoting cell proliferation and HDGs stimulating cell differentiation, and that these functions are mediated at both the protein-protein interaction and transcriptional level.	[Horstman, Anneke; Guo, Changhua; Passarinho, Paul; Sanchez-Perez, Gabino; Immink, Richard; Angenent, Gerco; Boutilier, Kim] Univ Wageningen & Res Ctr, NL-6708 PB Wageningen, Netherlands; [Fukuoka, Hiroyuki] NARO Inst Vegetable & Tea Sci NIVTS, Vegetable Breeding & Genome Res Div, Tsu, Mie 5142392, Japan; [Muino, Jose M.] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Nitsch, Lisette] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Sanchez-Perez, Gabino] Wageningen Univ, Lab Bioinformat, NL-6708 PB Wageningen, Netherlands; [Angenent, Gerco] Wageningen Univ, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands	Boutilier, K (reprint author), Univ Wageningen & Res Ctr, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	kim.boutilier@wur.nl			Technology Top Institute - Green Genetics grant; Science and Technology Agency of Japan fellowship	This project was funded by a Technology Top Institute - Green Genetics grant to K.B. and a Science and Technology Agency of Japan fellowship to H.F.	Agusti J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001312; Ahn JW, 2004, PLANT J, V38, P969, DOI 10.1111/j.1365-313X.2004.02102.x; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1005/tpc.001941; Dewitte W, 2003, PLANT CELL, V15, P79, DOI 10.1105/tpc.004838; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; San-Bento R, 2014, PLANT J, V77, P46, DOI 10.1111/tpj.12360; Mordhorst AP, 1998, GENETICS, V149, P549; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Horstman A, 2014, TRENDS PLANT SCI, V19, P146, DOI 10.1016/j.tplants.2013.10.010; Knauer S, 2013, DEV CELL, V24, P125, DOI [10.1016/j.devcel.2012.12.009, 10.1016/j.devce1.2012.12.009]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Soriano M, 2014, PLANT CELL, V26, P2568, DOI 10.1105/tpc.114.126300; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Passarinho P, 2008, PLANT MOL BIOL, V68, P225, DOI 10.1007/s11103-008-9364-y; Mudunkothge JS, 2012, PLANT J, V71, P108, DOI 10.1111/j.1365-313X.2012.04975.x; Aronheim A, 1997, NUCLEIC ACIDS RES, V25, P3373, DOI 10.1093/nar/25.16.3373; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3<224::AID-DVG5>3.3.CO;2-P; Roeder AHK, 2012, DEVELOPMENT, V139, P4416, DOI 10.1242/dev.082925; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; Whitford R, 2008, P NATL ACAD SCI USA, V105, P18625, DOI 10.1073/pnas.0809395105; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Kaufmann K, 2010, NAT PROTOC, V5, P457, DOI 10.1038/nprot.2009.244; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Peterson KM, 2013, DEVELOPMENT, V140, P1924, DOI 10.1242/dev.090209; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Jin P, 2000, GENESIS, V27, P104, DOI 10.1002/1526-968X(200007)27:3<104::AID-GENE30>3.0.CO;2-I; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; Takada S, 2013, DEVELOPMENT, V140, P1919, DOI 10.1242/dev.094417; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; Zhong SL, 2008, TRANSGENIC RES, V17, P985, DOI 10.1007/s11248-008-9199-y; Yaginuma H, 2011, PLANT CELL PHYSIOL, V52, P1354, DOI 10.1093/pcp/pcr081; Becraft PW, 2002, DEVELOPMENT, V129, P5217; Bucherl CA, 2014, PROTOPLASMA, V251, P383, DOI 10.1007/s00709-013-0595-7; Fatouros N. E., 2012, PLOS ONE, V7; Hofhuis H, 2013, CURR BIOL, V23, P956, DOI 10.1016/j.cub.2013.04.048; Holmes Katherine, 2010, BMC Res Notes, V3, P53, DOI 10.1186/1756-0500-3-53; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Krizek BA, 2012, PLANT MOL BIOL, V78, P199, DOI 10.1007/s11103-011-9844-3; Muino JM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-11; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Nobusawa T, 2013, PLANT SIGNAL BEHAV, V8; Peng Y., 2013, PLANT SIGNAL BEHAV, V8; Shepard AR, 2005, ANAL BIOCHEM, V344, P287, DOI 10.1016/j.ab.2005.06.005; Takada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079312; Tsuwamoto R, 2010, PLANT MOL BIOL, V73, P481, DOI 10.1007/s11103-010-9634-3	56	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	FEB 1	2015	142	3					454	464		10.1242/dev.117168		11	Developmental Biology	Developmental Biology	AZ5HT	WOS:000348251800007		
J	Kashiwada, T; Fukuhara, S; Terai, K; Tanaka, T; Wakayama, Y; Ando, K; Nakajima, H; Fukui, H; Yuge, S; Saito, Y; Gemma, A; Mochizuki, N				Kashiwada, Takeru; Fukuhara, Shigetomo; Terai, Kenta; Tanaka, Toru; Wakayama, Yuki; Ando, Koji; Nakajima, Hiroyuki; Fukui, Hajime; Yuge, Shinya; Saito, Yoshinobu; Gemma, Akihiko; Mochizuki, Naoki			beta-catenin-dependent transcription is central to Bmp-mediated formation of venous vessels	DEVELOPMENT			English	Article						beta-catenin; Venous vessel development; Bmp; Aggf1; Nr2f2; Zebrafish	WNT/BETA-CATENIN; COUP-TFII; ENDOTHELIAL-CELLS; GENE-EXPRESSION; LYMPHATIC DEVELOPMENT; SIGNALING PATHWAY; IN-VIVO; ZEBRAFISH; SPECIFICATION; DIFFERENTIATION	beta-catenin regulates the transcription of genes involved in diverse biological processes, including embryogenesis, tissue homeostasis and regeneration. Endothelial cell (EC)-specific gene-targeting analyses in mice have revealed that Nr2f2-dependent is required for vascular development. However, the precise function of beta-catenin-mediated gene regulation in vascular development is not well understood, since beta-catenin regulates not only gene expression but also the formation of cell-cell junctions. To address this question, we have developed a novel transgenic zebrafish line that allows the visualization of beta-catenin transcriptional activity specifically in ECs and discovered that beta-catenin-dependent transcription is central to the bone morphogenetic protein (Bmp)-mediated formation of venous vessels. During caudal vein (CV) formation, Bmp induces the expression of aggf1, a putative causative gene for Klippel-Trenaunay syndrome, which is characterized by venous malformation and hypertrophy of bones and soft tissues. Subsequently, Aggf1 potentiates beta-catenin transcriptional activity by acting as a transcriptional co-factor, suggesting that Bmp evokes beta-catenin-mediated gene expression through Aggf1 expression. Bmp-mediated activation of beta-catenin induces the expression of Nr2f2 (also known as Coup-TFII), a member of the nuclear receptor superfamily, to promote the differentiation of venous ECs, thereby contributing to CV formation. Furthermore, beta-catenin stimulated by Bmp promotes the survival of venous ECs, but not that of arterial ECs. Collectively, these results indicate that Bmp-induced activation of beta-catenin through Aggf1 regulates CV development by promoting the Nr2f2-dependent differentiation of venous ECs and their survival. This study demonstrates, for the first time, a crucial role of beta-catenin-mediated gene expression in the development of venous vessels.	[Kashiwada, Takeru; Fukuhara, Shigetomo; Tanaka, Toru; Wakayama, Yuki; Ando, Koji; Nakajima, Hiroyuki; Fukui, Hajime; Yuge, Shinya; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Suita, Osaka 5658565, Japan; [Kashiwada, Takeru; Tanaka, Toru; Saito, Yoshinobu; Gemma, Akihiko] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 1138603, Japan; [Terai, Kenta] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Funct & Morphol, Tokyo 1130032, Japan; [Mochizuki, Naoki] JST CREST, Natl Cerebral & Cardiovasc Ctr Res Inst, Suita, Osaka 5658565, Japan	Fukuhara, S (reprint author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Suita, Osaka 5658565, Japan.	fuku@ncvc.go.jp; nmochizu@ncvc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [22113009, 22122003]; Japan Society for the Promotion of Science [24790304, 22390040, 25293050, 24370084, 26670107]; Ministry of Health, Labour, and Welfare of Japan; MEXT, Japan; Japan Science and Technology Agency (JST); Takeda Science Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Cardiovascular Research Foundation; Uehara Memorial Foundation	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas 'Fluorescence Live Imaging' [No. 22113009 to S.F.] and 'Neuro-Vascular Wiring' [No. 22122003 to N.M.] from The Ministry of Education, Culture, Sports, Science, and Technology, Japan; by Grants-in-Aid for Young Scientists (B) [No. 24790304 to K.T.], for Scientific Research (B) [No. 22390040 and No. 25293050 to S.F. and No. 24370084 to N.M.] and for Exploratory Research [No. 26670107 to S.F.] from the Japan Society for the Promotion of Science; by grants from the Ministry of Health, Labour, and Welfare of Japan (to N.M.) and by the Program to Disseminate Tenure Tracking System, MEXT, Japan (to K.T.); the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) (to N.M.); Takeda Science Foundation (to S.F., N.M.); the Naito Foundation (to S.F.); Mochida Memorial Foundation for Medical and Pharmaceutical Research (to S.F.); Japan Cardiovascular Research Foundation (to S.F.); and the Uehara Memorial Foundation (to K.T.).	Ahrens MJ, 2011, DEV DYNAM, V240, P2060, DOI 10.1002/dvdy.22704; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Kwon HB, 2013, DEVELOPMENT, V140, P4081, DOI 10.1242/dev.091702; Fukuhara S, 2014, DEV BIOL, V393, P10, DOI 10.1016/j.ydbio.2014.06.015; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Choi J, 2011, DEVELOPMENT, V138, P1173, DOI 10.1242/dev.054049; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Swift MR, 2014, DEV BIOL, V390, P116, DOI 10.1016/j.ydbio.2014.03.018; Kim JD, 2012, DEV CELL, V23, P441, DOI 10.1016/j.devcel.2012.07.007; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Wythe JD, 2013, DEV CELL, V26, P45, DOI 10.1016/j.devcel.2013.06.007; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Davis RB, 2013, DEVELOPMENT, V140, P1272, DOI 10.1242/dev.087379; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Dunworth WP, 2014, CIRC RES, V114, P56, DOI 10.1161/CIRCRESAHA.114.302452; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Aranguren XL, 2011, BIOCHEM BIOPH RES CO, V410, P121, DOI 10.1016/j.bbrc.2011.05.117; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Shimizu N, 2012, DEV BIOL, V370, P71, DOI 10.1016/j.ydbio.2012.07.016; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232	52	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	FEB 1	2015	142	3					497	509		10.1242/dev.115576		13	Developmental Biology	Developmental Biology	AZ5HT	WOS:000348251800011		
J	Wu, Q; Fukuda, K; Weinstein, M; Graff, JM; Saga, Y				Wu, Quan; Fukuda, Kurumi; Weinstein, Michael; Graff, Jonathan M.; Saga, Yumiko			SMAD2 and p38 signaling pathways act in concert to determine XY primordial germ cell fate in mice	DEVELOPMENT			English	Article						Sex determination; Meiosis; SMAD2 signaling; p38 signaling; Nanos2; Smad2/3 conditional knockout mice	ACTIVATED PROTEIN-KINASE; MALE SEX DETERMINATION; RETINOIC ACID; MEIOTIC INITIATION; MOUSE TESTIS; TRANSCRIPTION FACTORS; CHROMOSOME SYNAPSIS; SUPPRESSES MEIOSIS; GRANULOSA-CELLS; SRY EXPRESSION	The sex of primordial germ cells (PGCs) is determined in developing gonads on the basis of cues from somatic cells. In XY gonads, sex-determining region Y (SRY) triggers fibroblast growth factor 9 (FGF9) expression in somatic cells. FGF signaling, together with downstream nodal/activin signaling, promotes male differentiation in XY germ cells by suppressing retinoic acid (RA)-dependent meiotic entry and inducing male-specific genes. However, the mechanism by which nodal/activin signaling regulates XY PGC fate is unknown. We uncovered the roles of SMAD2/3 and p38 MAPK, the putative downstream factors of nodal/activin signaling, in PGC sexual fate decision. We found that conditional deletion of Smad2, but not Smad3, from XY PGCs led to a loss of male-specific gene expression. Moreover, suppression of RA signaling did not rescue male-specific gene expression in Smad2-mutant testes, indicating that SMAD2 signaling promotes male differentiation in a RA-independent manner. By contrast, we found that p38 signaling has an important role in the suppression of RA signaling. The Smad2 deletion did not disrupt the p38 signaling pathway even though Nodal expression was significantly reduced, suggesting that p38 was not regulated by nodal signaling in XY PGCs. Additionally, the inhibition of p38 signaling in the Smad2-mutant testes severely impeded XY PGC differentiation and induced meiosis. In conclusion, we propose a model in which p38 and SMAD2 signaling coordinate to determine the sexual fate of XY PGCs.	[Wu, Quan; Fukuda, Kurumi; Saga, Yumiko] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Wu, Quan; Fukuda, Kurumi; Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan; [Weinstein, Michael] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Weinstein, Michael] Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA; [Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Saga, Y (reprint author), SOKENDAI, Dept Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan.	ysaga@nig.ac.jp			Genome Network Project of MEXT; Japan Society for the Promotion of Science KAKENHI [21227008, 26251025]; Ministry of Education, Culture, Sports, Science and Technology, Japan [25112002]; Iwatani Naoji Foundation	This work was supported by the Genome Network Project of MEXT; and in part by Japan Society for the Promotion of Science KAKENHI [grant numbers 21227008 and 26251025 to Y.S.]; a Grant-in-Aid for Scientific Research on Innovative Areas ('Epigenome dynamics and regulation in germ cells') [grant number 25112002 to Y.S.] from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and the Iwatani Naoji Foundation (Q.W.).	Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014; Saba R, 2014, DEV BIOL, V385, P32, DOI 10.1016/j.ydbio.2013.10.018; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Archambeault DR, 2011, ENDOCRINOLOGY, V152, P4358, DOI 10.1210/en.2011-1288; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Saba R, 2014, DEV BIOL, V389, P173, DOI 10.1016/j.ydbio.2014.02.013; Sakaki-Yumoto M, 2013, J BIOL CHEM, V288, P18546, DOI 10.1074/jbc.M112.446591; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kent J, 1996, DEVELOPMENT, V122, P2813; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Kashimada K, 2011, ENDOCRINOLOGY, V152, P272, DOI 10.1210/en.2010-0636; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Harikae K, 2013, J CELL SCI, V126, P2834, DOI 10.1242/jcs.122663; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Ewen K, 2010, BIOL REPROD, V83, P1005, DOI 10.1095/biolreprod.110.086801; Moniot B, 2014, DEVELOPMENT, V141, P3561, DOI 10.1242/dev.103408; Zhao M, 1999, MOL CELL BIOL, V19, P21; Tanaka SS, 2010, DEV DYNAM, V239, P2851, DOI 10.1002/dvdy.22417; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Hiramatsu R, 2010, DEVELOPMENT, V137, P303, DOI 10.1242/dev.040519; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Ang SL, 1996, DEVELOPMENT, V122, P243; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Jameson SA, 2012, DEV BIOL, V370, P24, DOI 10.1016/j.ydbio.2012.06.009; Archambeault DR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.111393; Avery S, 2010, STEM CELLS, V28, P863, DOI 10.1002/stem.409; Bernard P, 2007, INT J BIOCHEM CELL B, V39, P31, DOI 10.1016/j.biocel.2006.06.007; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; CLEMENTS M, 2011, TLS TIMES LIT S 0325, P21; Guerquin MJ, 2010, DEV BIOL, V346, P320, DOI 10.1016/j.ydbio.2010.08.002; Hirota T, 2011, BIOL REPROD, V85, P367, DOI 10.1095/biolreprod.110.090662; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; Liu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010382; Liu Y, 2004, GENESIS, V40, P118, DOI 10.1002/gene.20072; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Tsuda M, 2006, MECH DEVELOP, V123, P440, DOI 10.1016/j.mod.2006.04.002; ZERVOS AS, 1995, P NATL ACAD SCI USA, V92, P10531, DOI 10.1073/pnas.92.23.10531	71	4	4	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	FEB 1	2015	142	3					575	586		10.1242/dev.119446		12	Developmental Biology	Developmental Biology	AZ5HT	WOS:000348251800018		
J	Murono, K; Kawai, K; Kazama, S; Ishihara, S; Yamaguchi, H; Sunami, E; Kitayama, J; Watanabe, T				Murono, Koji; Kawai, Kazushige; Kazama, Shinsuke; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki			Anatomy of the Inferior Mesenteric Artery Evaluated Using 3-Dimensional CT Angiography	DISEASES OF THE COLON & RECTUM			English	Article						Anatomy; Inferior mesenteric artery; 3-dimensional computed tomography angiography	RECTAL-CANCER SURGERY; LYMPH-NODE DISSECTION; SHORT-TERM OUTCOMES; LEFT COLIC ARTERY; COLORECTAL-CANCER; SIGMOID COLON; HIGH TIE; HIGH LIGATION; ANTERIOR RESECTION; VASCULAR ANATOMY	BACKGROUND: The branching of the inferior mesenteric artery and vein varies among individuals. Three-dimensional CT angiography is a less invasive modality than traditional angiographic examination to assess the artery and vein. OBJECTIVE: We aimed to demonstrate the clinical applicability of CT angiography by evaluating bifurcations of the inferior mesenteric artery and the positional relationship between the inferior mesenteric artery and vein. DESIGN: This was a prospective observational study of patients undergoing preoperative CT angiography. SETTINGS: This study was conducted at a single tertiary care institution in Japan. PATIENTS: A total of 471 consecutive patients who underwent preoperative CT angiography from April 2012 to December 2013 were prospectively enrolled. MAIN OUTCOME MEASURES: The branching pattern of the inferior mesenteric artery, the positional relationship between the inferior mesenteric artery and vein, and the associations between inferior mesenteric artery length and clinical features were evaluated. RESULTS: The length of the inferior mesenteric artery varied widely, from 10.1 to 82.2 mm. In 41.2% patients, the left colic artery arose independently from the sigmoid artery, and in 44.7% of the patients, the left colic artery and sigmoid artery had a common trunk, whereas the left colic artery did not exist in 5.1%. The left colic artery was located lateral to the inferior mesenteric vein at the level of the origin of the inferior mesenteric artery in 73.0% of the patients. The incidence of a short inferior mesenteric artery was significantly increased in men with high BMIs (75.0%). LIMITATIONS: Three-dimensional reconstruction was performed by the use of a single software, and angiographic examination was not performed. Therefore, accuracy and reliability of the 3-dimensional reconstruction could not be established for each modality. CONCLUSIONS: Using 3-dimensional CT angiography, preoperative understanding of the anatomic vascular variations can be easily obtained, which would help surgeons to safely perform laparoscopic surgery in the left-side colon and rectum.	[Murono, Koji; Kawai, Kazushige; Kazama, Shinsuke; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg Oncol, Tokyo 1130033, Japan	Murono, K (reprint author), Univ Tokyo, Fac Med, Dept Surg, Div Surg Oncol,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kojimurono@h.u-tokyo.ac.jp					Adachi Y, 1998, J CLIN GASTROENTEROL, V26, P179, DOI 10.1097/00004836-199804000-00006; Alici A, 2010, TECH COLOPROCTOL, V14, P1, DOI 10.1007/s10151-009-0547-6; Rutegard M, 2012, BRIT J SURG, V99, P127, DOI 10.1002/bjs.7712; Lee SW, 2003, J AM COLL SURGEONS, V197, P927, DOI 10.1016/j.jamcollsurg.2003.07.021; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Kang J, 2011, ANN SURG ONCOL, V18, P704, DOI 10.1245/s10434-010-1291-x; Lange MM, 2008, DIS COLON RECTUM, V51, P1139, DOI 10.1007/s10350-008-9328-y; MICHELS NA, 1965, DIS COLON RECTUM, V8, P251, DOI 10.1007/BF02617894; Bilhim T, 2013, SURG RADIOL ANAT, V35, P517, DOI 10.1007/s00276-012-1068-y; Bonnet S, 2012, DIS COLON RECTUM, V55, P515, DOI 10.1097/DCR.0b013e318246f1a2; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Chin CC, 2008, INT J COLORECTAL DIS, V23, P783, DOI 10.1007/s00384-008-0465-5; Cirocchi R, 2012, SURG ONCOL, V21, pE111, DOI 10.1016/j.suronc.2012.04.004; CORDER AP, 1992, BRIT J SURG, V79, P680, DOI 10.1002/bjs.1800790730; GRIFFITHS J D, 1956, Ann R Coll Surg Engl, V19, P241; Iezzi R, 2013, J COMPUT ASSIST TOMO, V37, P419, DOI 10.1097/RCT.0b013e31828730ed; KAHN P, 1964, RADIOLOGY, V82, P429; Kanemitsu Y, 2006, BRIT J SURG, V93, P609, DOI 10.1002/bjs.5327; Kobayashi M, 2006, SURG ENDOSC, V20, P563, DOI 10.1007/s00464-005-0160-3; Kotake K, 2014, INT J COLORECTAL DIS, V29, P847, DOI 10.1007/s00384-014-1885-z; Mayo CW, 1955, SURG CLIN N AM; Park MG, 2012, INT J COLORECTAL DIS, V27, P671, DOI 10.1007/s00384-011-1372-8; Predescu D, 2013, CHIRURGIA-BUCHAREST, V108, P161; Sekimoto M, 2011, SURG ENDOSC, V25, P861, DOI 10.1007/s00464-010-1284-7; Spasojevic M, 2011, SURG ENDOSC, V25, P1883, DOI 10.1007/s00464-010-1480-5; Spasojevic M, 2011, DIS COLON RECTUM, V54, P1503, DOI 10.1097/DCR.0b013e318232116b; Tan O, 2014, MICROSURG, V34, P277, DOI 10.1002/micr.22185; Tsujinaka S, 2012, SCAND J SURG, V101, P21; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Yada H, 1997, WORLD J SURG, V21, P109; Yang J, 2014, INT J MED ROBOT COMP, V10, P410, DOI 10.1002/rcs.1590	32	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0012-3706	1530-0358		DIS COLON RECTUM	Dis. Colon Rectum	FEB	2015	58	2					214	219		10.1097/DCR.0000000000000285		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ4IZ	WOS:000348186000014		
J	Kuniyoshi, K; Ikeo, K; Sakuramoto, H; Furuno, M; Yoshitake, K; Hatsukawa, Y; Nakao, A; Tsunoda, K; Kusaka, S; Shimomura, Y; Iwata, T				Kuniyoshi, Kazuki; Ikeo, Kazuho; Sakuramoto, Hiroyuki; Furuno, Masaaki; Yoshitake, Kazutoshi; Hatsukawa, Yoshikazu; Nakao, Akira; Tsunoda, Kazushige; Kusaka, Shunji; Shimomura, Yoshikazu; Iwata, Takeshi			Novel nonsense and splice site mutations in CRB1 gene in two Japanese patients with early-onset retinal dystrophy	DOCUMENTA OPHTHALMOLOGICA			English	Article						Leber congenital amaurosis; Early-onset retinal dystrophy; CRB1; Optical coherence tomography; Electroretinography; Visual fields; Japanese	LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; CRUMBS; HOMOLOG	To report novel mutations in the CRB1 gene in two patients with early-onset retinal dystrophy (EORD) and the longitudinal clinical course of EORD. The patients were two unrelated Japanese children. Standard ophthalmic examinations including perimetry, electroretinography, and optical coherence tomography were performed on both patients. Whole exomes of the patients and their nonsymptomatic parents were analyzed using a next-generation sequence (NGS) technique. Patient 1 was noted to have esotropia and hyperopia at age 3. His decimal best-corrected visual acuity (BCVA) was 0.6 OD and 0.3 OS at age 6 with de-pigmentation of the retinal pigment epithelium (RPE). At age 19, his central vision was still preserved; however, numerous pigment granules were present in the retina. NGS analysis revealed a p.R632X nonsense and c.652 + 1_652 + 4delGTAA splice site mutations in the CRB1 gene. Patient 2 was noted to have hyperopia at age 3. His decimal BCVA at age 6 was 0.3 OD and 0.4 OS with de-pigmented RPE. The degree of retinal pigmentation was increased but his BCVA was good until the age of 14 years. NGS analysis revealed c.652 + 1_652 + 4delGTAA and c.652 + 1_652 + 2insT splice site mutations in the CRB1 gene. The phenotypes of these novel mutations for EORD are typical of CRB1-associated EORD (LCA8). They were slowly progressive until the second decade of life.	[Kuniyoshi, Kazuki; Sakuramoto, Hiroyuki; Nakao, Akira; Shimomura, Yoshikazu] Kinki Univ, Dept Ophthalmol, Fac Med, Osaka Sayama City, Osaka 5898511, Japan; [Ikeo, Kazuho; Yoshitake, Kazutoshi] Natl Inst Genet, Lab DNA Data Anal, Shizuoka, Japan; [Furuno, Masaaki] RIKEN Ctr Life Sci Technol, Div Genom Technol, Life Sci Accelerator Technol Grp, Transcriptome Technol Team, Yokohama, Kanagawa, Japan; [Hatsukawa, Yoshikazu] Osaka Med Ctr, Dept Ophthalmol, Osaka, Japan; [Hatsukawa, Yoshikazu] Res Inst Maternal & Child Hlth, Osaka, Japan; [Tsunoda, Kazushige] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Lab Visual Physiol, Tokyo, Japan; [Kusaka, Shunji] Kinki Univ, Fac Med, Sakai Hosp, Dept Ophthalmol, Osaka, Japan; [Iwata, Takeshi] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan	Kuniyoshi, K (reprint author), Kinki Univ, Dept Ophthalmol, Fac Med, 377-2 Ohno Higashi, Osaka Sayama City, Osaka 5898511, Japan.	kuniyoshi-kazuki@umin.net			Ministry of Health, Labour and Welfare, Japan [13803661, 23164001, 82259921]; Japan Society for the Promotion of Science, Japan [23592597]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This research was supported by the research Grants to T.I., K.T., Y.S., and K.K. from the Ministry of Health, Labour and Welfare, Japan (13803661, 23164001, and 82259921), to S.K. and K.K. from Japan Society for the Promotion of Science, Japan (23592597), and to M.F. from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) for RIKEN Center for Life Science Technologies.	Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Kuniyoshi K, 2014, DOC OPHTHALMOL, V128, P219, DOI 10.1007/s10633-014-9436-z; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Bernal S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e89; Daiger SP, 2014, RETNET; Henderson RH, 2011, BRIT J OPHTHALMOL, V95, P811, DOI 10.1136/bjo.2010.186882; Leber T, 1916, GRAEFES SAEMISCH HDB, P1076; Leber T, 1869, GRAEFES ARCH CLIN EX, V15, P1; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415; Weleber RG, 2013, GENEREVIEWS NCBI BOO; Weleber RG, 2006, RETINA, V1, P455	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	FEB	2015	130	1					49	55		10.1007/s10633-014-9464-8		7	Ophthalmology	Ophthalmology	AZ6PH	WOS:000348340800006		
J	Ueno, S; Nakanishi, A; Nishi, K; Suzuki, S; Terasaki, H				Ueno, Shinji; Nakanishi, Ayami; Nishi, Kayo; Suzuki, Shiro; Terasaki, Hiroko			Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs	DOCUMENTA OPHTHALMOLOGICA			English	Article						Paraneoplastic retinopathy; Retinal ON-bipolar cell; Melanoma-associated retinopathy; ERG; Transient receptor potential melastatin 1 (TRPM1); Cancer-associated retinopathy	MELANOMA-ASSOCIATED RETINOPATHY; CUTANEOUS MALIGNANT-MELANOMA; NIGHT BLINDNESS; PATHWAY DYSFUNCTION; TRPM1; ELECTRORETINOGRAM; AUTOANTIBODIES; SURGERY	To report a patient with cancer-associated retinopathy and retinal ON-bipolar cell dysfunction who had a resolution of the electroretinograms (ERGs) after a resection of an ovarian cancer and chemotherapy. A 71-year-old Japanese female patient visited us complaining of night blindness and photopsia in both eyes for 6 months. Her visual acuity was 20/20 in both eyes, and fundus examination, fluorescence angiography, and optical coherence tomography showed no abnormalities in both eyes. The rod responses of the ERGs were absent and bright-flash ERGs were electronegative. The ON responses of the focal macular ERGs and full-field long-flash ERGs were absent. These ERG findings indicate an ON-bipolar cell dysfunction. A general physical examination revealed the presence of ovarian cancer. After resection of the ovarian cancer and adjuvant chemotherapy, the ERGs of the left eye completely recovered within 2 years and those of right eye recovered subsequently. The autoantibody against transient receptor potential melastatin 1 (TRPM1) was not detected in the serum. Our case demonstrates that retinal ON-bipolar dysfunction can be caused by ovarian cancer. Our case indicates that some autoantibodies against other than TRPM1 might cause transient dysfunction of retinal ON-bipolar cells.	[Ueno, Shinji; Nakanishi, Ayami; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nishi, Kayo] Nishi Eye Hosp, Osaka, Osaka, Japan; [Suzuki, Shiro] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4668550, Japan	Ueno, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	ueno@med.nagoya-u.ac.jp	Ueno, Shinji/M-5063-2014		Ministry of Education, Science, Sports and Culture, Japan [23791977]	We thank Professor Duco Hamasaki of the Bascom Palmer Eye Institute for the discussions and editing the final version of the manuscript. We thank Dr. Takahisa Furukawa of Osaka University for kindly supplying the plasmid of TRPM1. Grant support; 23791977 (SU) from the Ministry of Education, Science, Sports and Culture, Japan.	ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Alexander KR, 2002, INVEST OPHTH VIS SCI, V43, P1189; Anastasakis A, 2011, DOC OPHTHALMOL, V123, P59, DOI 10.1007/s10633-011-9277-y; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Hibi N, 2013, INVEST OPHTH VIS SCI, V54, P7207, DOI 10.1167/iovs.13-12884; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; BERSON EL, 1988, AM J OPHTHALMOL, V106, P307, DOI 10.1016/0002-9394(88)90366-2; Duncan LM, 2001, J CLIN ONCOL, V19, P568; Goetgebuer G, 2008, DOC OPHTHALMOL, V116, P49, DOI 10.1007/s10633-007-9074-9; Keltner JL, 2001, J NEURO-OPHTHALMOL, V21, P173, DOI 10.1097/00041327-200109000-00004; Kim Linda S, 2008, Retin Cases Brief Rep, V2, P166, DOI 10.1097/ICB.0b013e318033a41c; Kondo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019911; MILAM AH, 1993, INVEST OPHTH VIS SCI, V34, P91; MIYAKE Y, 1989, INVEST OPHTH VIS SCI, V30, P1743; Stead RE, 2013, DOC OPHTHALMOL, V127, P165, DOI 10.1007/s10633-013-9398-6; Ueno S, 2013, VISION RES, V91, P118, DOI 10.1016/j.visres.2013.08.006; Ueno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081507; Xiong WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069506; Yamamoto S, 2013, DOC OPHTHALMOL, V126, P259, DOI 10.1007/s10633-013-9376-z; Zimov S, 2004, J NEUROCYTOL, V33, P441, DOI 10.1023/B:NEUR.0000046574.72380.e8	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	FEB	2015	130	1					71	76		10.1007/s10633-014-9470-x		6	Ophthalmology	Ophthalmology	AZ6PH	WOS:000348340800009		
J	Ono, T				Ono, Tetsuo			Public education and social security: a political economy approach	ECONOMICS OF GOVERNANCE			English	Article						Public education; Social security; Intergenerational conflict	WELFARE-STATE; GENERAL EQUILIBRIUM; GOVERNMENT EXPENDITURE; ENDOGENOUS GROWTH; AGING POPULATION; LIFE EXPECTANCY; POLICY; INEQUALITY; PROVISION; DEMOCRACY	This study presents an overlapping-generations model with altruism towards children. We characterize a Markov-perfect political equilibrium of voting over two policy issues, public education for the young and social security for the old. The model potentially generates two types of political equilibria, one favoring public education and the other favoring social security. One equilibrium is selected by the government to maximize its objective. It is shown that (i) longevity affects equilibrium selection and relevant policy choices; and (ii) private education as an alternative to public education and a Markov-perfect political equilibrium can generate the two types of equilibria.	Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan	Ono, T (reprint author), Osaka Univ, Grad Sch Econ, 1-7 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	tono@econ.osaka-u.ac.jp					Acemoglu D., 2005, EC ORIGINS DICTATORS; SAINTPAUL G, 1993, J DEV ECON, V42, P399, DOI 10.1016/0304-3878(93)90027-K; Gradstein M, 2004, J PUBLIC ECON, V88, P2469, DOI 10.1016/S0047-2727(03)00065-3; Song Z, 2012, ECONOMETRICA, V80, P2785, DOI 10.3982/ECTA8910; Gonzalez-Eiras M, 2012, EUR ECON REV, V56, P97, DOI 10.1016/j.euroecorev.2011.05.007; GLOMM G, 1992, J POLIT ECON, V100, P818, DOI 10.1086/261841; LINDBECK A, 1987, PUBLIC CHOICE, V52, P273, DOI 10.1007/BF00116710; Cattaneo MA, 2009, EUR J POLIT ECON, V25, P225, DOI 10.1016/j.ejpoleco.2008.10.002; Krusell P, 1997, J ECON DYN CONTROL, V21, P243, DOI 10.1016/0165-1889(95)00931-0; Cardak BA, 2004, ECONOMICA, V71, P57, DOI 10.1111/j.0013-0427.2004.00357.x; Bassetto M, 2008, REV ECON DYNAM, V11, P18, DOI 10.1016/j.red.2007.06.002; de la Croix D, 2004, J DEV ECON, V73, P607, DOI 10.1016/j.jdeveco.2003.05.005; Gonzalez-Eiras M, 2008, J MONETARY ECON, V55, P197, DOI 10.1016/j.jmoneco.2007.10.005; Creedy J, 2009, EUR J POLIT ECON, V25, P42, DOI 10.1016/j.ejpoleco.2008.07.006; Kunze L, 2014, J MACROECON, V39, P54, DOI 10.1016/j.jmacro.2013.12.004; Creedy J, 2011, ECON INQ, V49, P94, DOI 10.1111/j.1465-7295.2010.00294.x; Bearse P, 2001, J PUBLIC ECON THEORY, V3, P471, DOI 10.1111/1097-3923.00079; Bearse P., 2005, J PUBLIC ECON THEORY, V7, P561, DOI 10.1111/j.1467-9779.2005.00234.x; Bellettini G, 1999, REV ECON DYNAM, V2, P796, DOI 10.1006/redy.1998.0050; Bernasconi M, 2012, EUR ECON REV, V56, P84, DOI 10.1016/j.euroecorev.2011.06.001; Bethencourt C, 2008, J PUBLIC ECON, V92, P609, DOI 10.1016/j.jpubeco.2007.06.005; Boldrin M, 2005, RES EC, V59, P85, DOI 10.1016/j.rie.2005.04.005; Casey B, 2003, OECD EC DEP WORKING, V369, DOI [10.1787/737005512385, DOI 10.1787/737005512385]; Castello-Climent A, 2008, ECON J, V118, P653, DOI 10.1111/j.1468-0297.2008.02136.x; Conde-Ruiz JI, 2005, J PUBLIC ECON, V89, P933, DOI 10.1016/j.jpubeco.2004.06.010; De La Croix D, 2009, REV ECON STUD, V76, P597, DOI 10.1111/j.1467-937X.2008.00529.x; Epple D, 1996, J POLIT ECON, V104, P57, DOI 10.1086/262017; Glomm G, 1998, SOC CHOICE WELFARE, V15, P187, DOI 10.1007/s003550050099; Glomm G, 2004, PAC ECON REV, V9, P93, DOI 10.1111/j.1468-0106.2004.00214.x; Glomm G, 1995, EUROPEAN J POLITICAL, V11, P653; Glomm G, 2001, CAN J ECON, V34, P807, DOI 10.1111/0008-4085.00100; Glomm G, 2003, INT ECON REV, V44, P917, DOI 10.1111/1468-2354.t01-1-00094; Gradstein M, 1997, J ECON GROWTH, V2, P169, DOI 10.1023/A:1009781101707; Gradstein M, 1996, INT TAX PUBLIC FINAN, V3, P297, DOI 10.1007/BF00418946; Harris AR, 2001, J PUBLIC ECON, V81, P449, DOI 10.1016/S0047-2727(00)00133-X; Hassler J, 2003, AM ECON REV, V93, P87, DOI 10.1257/000282803321455179; Hassler J, 2005, J MONETARY ECON, V52, P1331, DOI 10.1016/j.jmoneco.2005.08.012; Hassler J, 2007, J ECON THEORY, V133, P127, DOI 10.1016/j.jet.2005.07.013; Holtz-Eakin D, 2004, J MACROECON, V26, P1, DOI 10.1016/j.jmacro.2002.10.001; Hoyt WH, 1998, J PUBLIC ECON, V69, P211, DOI 10.1016/S0047-2727(98)00023-1; Iturbe-Ormaetxe I, 2012, J POPUL ECON, V25, P609, DOI 10.1007/s00148-010-0338-4; Kaganovich M, 2012, J ECON DYN CONTROL, V36, P455, DOI 10.1016/j.jedc.2011.03.015; Kaganovich M, 2012, J PUBLIC ECON THEORY, V14, P573, DOI 10.1111/j.1467-9779.2012.01553.x; Kemnitz A, 2000, J POPUL ECON, V13, P443, DOI 10.1007/s001480050146; KONRAD KA, 1995, J POPUL ECON, V8, P315; Lancia F, 2013, DYNAMIC POLITICOECON; Levy G, 2005, Q J ECON, V120, P1507, DOI 10.1162/003355305775097489; Naito K, 2012, J ECON DYN CONTROL, V36, P1340, DOI 10.1016/j.jedc.2012.02.008; OECD, 2013, ED GLANC 2013 OECD I; Palivos T, 2013, J PUBLIC ECON THEORY, V15, P249, DOI 10.1111/jpet.12017; Persson T., 2000, POLITICAL EC EXPLAIN; Poterba JM, 1997, J POLICY ANAL MANAG, V16, P48, DOI 10.1002/(SICI)1520-6688(199724)16:1<48::AID-PAM3>3.0.CO;2-I; Poterba JM, 1998, AM ECON REV, V88, P315; Poutvaara P, 2006, J POPUL ECON, V19, P345, DOI 10.1007/s00148-006-0063-1; Rangel A, 2003, AM ECON REV, V93, P813, DOI 10.1257/000282803322157106; Razin A, 2002, J POLIT ECON, V110, P900, DOI 10.1086/340780; Rogerson R., 2001, J ED FINANCE, V27, P567; Soares J, 2006, J POPUL ECON, V19, P367, DOI 10.1007/s00148-005-0034-y; Song Z, 2011, REV ECON DYNAM, V14, P613, DOI 10.1016/j.red.2011.05.001; Song Z, 2012, INT ECON REV, V53, P175, DOI 10.1111/j.1468-2354.2011.00676.x; Tosun MS, 2008, J ECON DYN CONTROL, V32, P2031	61	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-6104			ECON GOV	Econ. Gov.	FEB	2015	16	1					1	25		10.1007/s10101-014-0149-2		25	Economics	Business & Economics	AZ4RP	WOS:000348210700001		
J	Okada, R; Matsuura, N; Kasahara, M; Ichinohe, T				Okada, Reina; Matsuura, Nobuyuki; Kasahara, Masataka; Ichinohe, Tatsuya			Effect of changes in end-tidal carbon dioxide tension on oral tissue blood flow during dexmedetomidine infusion in rabbits	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						blood flow; carbon dioxide; dexmedetomidine; sevoflurane	MANDIBULAR BONE-MARROW; ADENOSINE-TRIPHOSPHATE; SODIUM-NITROPRUSSIDE; PROPOFOL ANESTHESIA; INDUCED HYPOTENSION; SEVOFLURANE; DECREASES; PRESSURE; AGONIST; MAC	A decrease in arterial carbon dioxide tension induces an increase in masseter muscle blood flow and a decrease in mandibular bone marrow blood flow during general anesthesia. In addition, dexmedetomidine infusion reduces oral tissue blood flow. In this study we investigated how end-tidal carbon dioxide tension (ET-CO2) changes influence on oral tissue blood flow during continuous dexmedetomidine infusion in rabbits. Eleven male Japan White rabbits were anesthetized with sevoflurane. Then, ET-CO2 was set at 30mmHg and adjusted to 40 and 60mmHg, and heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, common carotid artery blood flow, mandibular bone marrow blood flow, masseter muscle blood flow, and blood flow in other oral tissues were measured. Following this, the ET-CO2 was returned to 30mmHg and dexmedetomidine was infused over 60min. The measurements were repeated. Most parameters increased, regardless of whether or not dexmedetomidine was present, and heart rate and masseter muscle blood flow decreased in an ET-CO2-dependent manner. Dexmedetomidine infusion suppressed ET-CO2-dependent masseter muscle blood flow change. Masseter muscle blood flow during ET-CO2 at 30mmHg with dexmedetomidine was the same as that during ET-CO2 at 40mmHg without dexmedetomidine. Our findings suggest that dexmedetomidine infusion and slight hypocapnia under general anesthesia suppress an increase in masseter muscle blood flow as well as reducing mandibular bone marrow blood flow. These results may be of significance for decreasing bleeding during oral and maxillofacial surgery.	[Okada, Reina; Matsuura, Nobuyuki; Kasahara, Masataka; Ichinohe, Tatsuya] Tokyo Dent Coll, Dept Dent Anesthesiol, Chiba 2618502, Japan	Okada, R (reprint author), Tokyo Dent Coll, Dept Dent Anesthesiol, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.	okadareina@tdc.ac.jp			JSPS KAKENHI [25463147]	This work was partly supported by JSPS KAKENHI Grant Number 25463147.	KALLIO A, 1989, CLIN PHARMACOL THER, V46, P33; Choi WS, 2008, INT J ORAL MAX SURG, V37, P687, DOI 10.1016/j.ijom.2008.03.011; Kemmochi M, 2009, J ORAL MAXIL SURG, V67, P1245, DOI 10.1016/j.joms.2008.06.008; Koshika K, 2011, J ORAL MAXIL SURG, V69, P2128, DOI 10.1016/j.joms.2010.12.056; Sazuka S, 2012, J ORAL MAXIL SURG, V70, P1808, DOI 10.1016/j.joms.2012.02.022; PASCH T, 1986, EUR J ANAESTH, V3, P299; Fragen RJ, 1999, J CLIN ANESTH, V11, P466, DOI 10.1016/S0952-8180(99)00081-1; Kawaai H, 2013, BRIT J ORAL MAX SURG, V51, P928, DOI 10.1016/j.bjoms.2013.07.007; HAYASHI Y, 1993, BRIT J ANAESTH, V71, P108, DOI 10.1093/bja/71.1.108; Cosar M, 2009, SURG NEUROL, V71, P54, DOI 10.1016/j.surneu.2007.08.020; DOZE VA, 1989, ANESTHESIOLOGY, V71, P75, DOI 10.1097/00000542-198907000-00014; Praveen K, 2001, BRIT J ORAL MAX SURG, V39, P138, DOI 10.1054/bjom.2000.0593; Ichinohe T, 1998, ORAL SURG ORAL MED O, V85, P268, DOI 10.1016/S1079-2104(98)90006-3; FUKUNAGA AF, 1982, ANESTH ANALG, V61, P273; BLOOR BC, 1985, ANESTHESIOLOGY, V63, P517, DOI 10.1097/00000542-198511000-00007; Chang C, 2009, ANESTH ANALG, V109, P84, DOI 10.1213/ane.0b013e3181a2ad5f; FALE A, 1994, ANESTH ANALG, V79, P892; Handa M, 2008, J ORAL MAXIL SURG, V66, P1820, DOI 10.1016/j.joms.2007.09.010; Homma Y, 1998, J JPN DENT SOC ANEST, V26, P219; Hori T, 1993, J OSAKA U DENT SOC, V38, P371; Kamijo Y, 1965, 3 ANGIOLOGY ORAL ANA, P426; KANEKO Y, 1987, Shikwa Gakuho, V87, P1159; Kunisawa T, 2010, J JPN SOC CLIN ANEST, V30, P181; Ogawa Y, 2008, ANESTHESIOLOGY, V109, P642, DOI 10.1097/ALN.0b013e3181862a33; Richa F, 2004, EUR J ANAESTHESI S32, V21, pA242; SCHELLER MS, 1988, CAN J ANAESTH, V35, P153; Terakawa Y, 2010, J ORAL MAXIL SURG, V68, P15, DOI 10.1016/j.joms.2009.04.040; ZORNOW MH, 1990, ANESTH ANALG, V70, P624; ZORNOW MH, 1992, ANESTH ANALG, V75, P232	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	FEB	2015	123	1					24	29		10.1111/eos.12162		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY6XY	WOS:000347707200004		
J	Yokokawa, M; Rikuta, A; Tsujimoto, A; Tsuchiya, K; Shibasaki, S; Matsuyoshi, S; Miyazaki, M				Yokokawa, Miho; Rikuta, Akitomo; Tsujimoto, Akimasa; Tsuchiya, Kenji; Shibasaki, Syo; Matsuyoshi, Saki; Miyazaki, Masashi			Influence of methyl mercaptan on the repair bond strength of composites fabricated using self-etch adhesives	EUROPEAN JOURNAL OF ORAL SCIENCES			English	Article						light-cured composite; methyl mercaptan; repair bond strength; repair restoration; surface free-energy	SURFACE-ENERGY CHARACTERISTICS; FREE-RADICAL POLYMERIZATION; CHAIN TRANSFER; RESTORATIVE MATERIALS; MINIMAL INTERVENTION; RESIN COMPOSITES; CLINICAL-TRIAL; CONTACT-ANGLE; BACTERIA; CEMENTS	The influence of methyl mercaptan on the repair bond strength of composites fabricated using self-etch adhesives was investigated. The surface free-energies were determined by measuring the contact angles of test liquids placed on composites that had been immersed in different concentrations of methyl mercaptan (0.01, 0.1, and 1.0M). To determine the repair bond strength, self-etch adhesives were applied to the aged composite, and then newly added composites were condensed. Ten samples of each specimen were subjected to shear testing at a crosshead speed of 1.0mmmin(-1). Samples were analyzed using two-way anova followed by Tukey's honestly significant difference (HSD) test. Although the dispersion force of the composites remained relatively constant, their polar force increased slightly as the concentration of methyl mercaptan increased. The hydrogen-bonding forces were significantly higher after immersion in 1.0M methyl mercaptan, leading to higher surface-free energies. However, the repair bond strengths for the repair restorations prepared from composites immersed in 1.0M methyl mercaptan were significantly lower than for those immersed in 0.01 and 0.10M methyl mercaptan. Considering the results of this study, it can be concluded that the repair bond strengths of both the aged and newly added composites were affected by immersion in methyl mercaptan solutions.	[Yokokawa, Miho; Rikuta, Akitomo; Tsujimoto, Akimasa; Tsuchiya, Kenji; Shibasaki, Syo; Matsuyoshi, Saki; Miyazaki, Masashi] Nihon Univ, Sch Dent, Dept Operat Dent, Tokyo 1018310, Japan	Miyazaki, M (reprint author), Nihon Univ, Sch Dent, Dept Operat Dent, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	miyazaki-m@dent.nihon-u.ac.jp			Japan Society for the Promotion of Science [23592810, 23792186]; Sato Fund; Dental Research Center of the Nihon University School of Dentistry, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (C) 23592810 and a Grant-in-Aid for Young Scientists (B) 23792186 from the Japan Society for the Promotion of Science. This project was also supported in part by the Sato Fund and by a grant from the Dental Research Center of the Nihon University School of Dentistry, Japan.	Hickel R, 2013, DENT MATER, V29, P28, DOI 10.1016/j.dental.2012.07.006; Papacchini F, 2007, J ADHES DENT, V9, P25; Nakano Y, 2002, MICROBES INFECT, V4, P679, DOI 10.1016/S1286-4579(02)01586-1; HATA T, 1987, J ADHESION, V21, P177, DOI 10.1080/00218468708074968; Combe EC, 2004, DENT MATER, V20, P262, DOI 10.1016/S0109-5641(03)00102-7; Kim MJ, 2011, J DENT, V39, P795, DOI 10.1016/j.jdent.2011.08.012; Long J, 2005, ADV COLLOID INTERFAC, V118, P173, DOI 10.1016/j.cis.2005.07.004; Tsujimoto A, 2010, J DENT, V38, P123, DOI 10.1016/j.jdent.2009.09.011; Teixeira EC, 2005, J ADHES DENT, V7, P159; Moncada G, 2008, OPER DENT, V33, P258, DOI 10.2341/07-113; Moghadam N, 2013, J PHYS CHEM A, V117, P2605, DOI 10.1021/jp3100798; Henriquez C, 2003, POLYMER, V44, P5559, DOI 10.1016/S0032-3861(03)00581-0; Fujimoto Y, 2010, DENT MATER J, V29, P392, DOI 10.4012/dmj.2010-015; Wege HA, 2003, J COLLOID INTERF SCI, V263, P162, DOI 10.1016/S0021-9797(03)00114-0; Moncada G, 2009, J AM DENT ASSOC, V140, P425; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; Asmussen E, 2005, J ADHES DENT, V7, P231; Asmussen E, 2005, DENT MATER, V21, P1039, DOI 10.1016/j.dental.2004.12.004; Barcellos DC, 2008, J ADHES DENT, V10, P351; Dall'oca Susanna, 2008, J Oral Sci, V50, P403; dasCosta TRF, 2010, OPER DENT, V35, P231; dasCosta TRF, 2012, J DENT, V40, P513; Delaviz Y, 2014, DENT MATER, V30, P16, DOI 10.1016/j.dental.2013.08.201; Karasu F, 2007, J APPL POLYM SCI, V103, P3766, DOI 10.1002/app.25467; Momoi Y, 2012, J DENT, V40, P95, DOI 10.1016/j.jdent.2011.10.011; Ohkubo T, 2009, DENT MATER J, V28, P426; Perdigão Jorge, 2007, Dent Clin North Am, V51, P333, DOI 10.1016/j.cden.2007.01.001; Junior SAR, 2009, DENT MATER, V25, P442, DOI 10.1016/j.dental.2008.09.009; Ruttermann S, 2014, DENT MATER, V30, P702, DOI 10.1016/j.dental.2014.03.009; vansLanduyt KL, 2008, J DENT RES, V87, P757; Yamada M, 2004, OPER DENT, V29, P532	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-8836	1600-0722		EUR J ORAL SCI	Eur. J. Oral Sci.	FEB	2015	123	1					46	52		10.1111/eos.12164		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY6XY	WOS:000347707200007		
J	Zhou, YB; Chen, WW; Kaneko, Y; Newman, C; Liao, ZH; Zhu, XQ; Buesching, CD; Xie, ZQ; Macdonald, DW				Zhou, Youbing; Chen, Wenwen; Kaneko, Yayoi; Newman, Chris; Liao, Zhonghua; Zhu, Xiaoqin; Buesching, Christina D.; Xie, Zongqiang; Macdonald, David W.			Seasonal dietary shifts and food resource exploitation by the hog badger (Arctonyx collaris) in a Chinese subtropical forest	EUROPEAN JOURNAL OF WILDLIFE RESEARCH			English	Article						Badger; Dietary shifting; Earthworms; Meles; Optimal foraging; Seasonal dietary specialism	LOCAL FEEDING SPECIALIZATION; MELES-MELES; MEDITERRANEAN ENVIRONMENTS; HABITAT SELECTION; ECOLOGY; CARNIVORE; POPULATIONS; GENERALIST; PARK; AVAILABILITY	Spatial and temporal fluctuations in the availability of food resources can affect adaptive foraging strategies substantially, with the potential to promote temporal dietary switching and specialisation among generalist carnivores. To understand this relationship better at the causal level, we examined spatial and temporal variation in diet composition and diversity in the hitherto little-known hog badger (Arctonyx collaris), in comparison to the environmental abundance of principal food resources, in a subtropical forest of central China. Here, hog badgers fed predominantly on earthworms and fruits, complemented with arthropod imagoes and invertebrate larvae, whereas vertebrate prey categories (mammals, birds and reptiles) were consumed infrequently. We observed strong seasonal variation in the consumption of different food categories. Earthworms predominated during spring, fruits in autumn, and earthworms, complemented by arthropods, in summer, with hog badgers apparently hibernating in winter. Fluctuation in dietary preferences between seasons and habitats correlated only partially with environmental food abundance; in autumn, when fruit abundance peaked, and despite a concomitant peak in earthworm abundance, hog badgers exhibited a dietary shift, indicating a preference for fruit, over earthworms. This resulted in autumnal minima in seasonal food niche breadth and evenness values. We conclude that, in this region, hog badgers exhibited a generalist diet but switched between food categories in response to changes in environmental seasonal abundance.	[Zhou, Youbing; Chen, Wenwen; Xie, Zongqiang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Zhou, Youbing; Newman, Chris; Buesching, Christina D.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Abingdon OX13 5QL, Oxon, England; [Chen, Wenwen] Nanjing Univ, Dept Biol, Nanjing 210093, Jiangsu, Peoples R China; [Kaneko, Yayoi] Tokyo Univ Agr & Technol, Inst Agr, Div Ecosci, Carnivore Ecol & Conservat Res Grp, Fuchu, Tokyo 1838509, Japan; [Liao, Zhonghua; Zhu, Xiaoqin] Houhe Natl Nat Reserve, Management Bur, Wufeng 443400, Peoples R China	Zhou, YB (reprint author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China.	zhouyb@ibcas.ac.cn	Kaneko, Yayoi/G-1162-2013	Kaneko, Yayoi/0000-0002-3688-4309	Japan Society for the Promotion of Science [22405003, 26257404]; Special Fund for Environmental Protection Public Welfare Scientific Research - Ministry of Environmental Protection of the People's Republic of China [201309039]	We thank Z. Zhang, Y. Wang, C.A. Nie, Z.H. Huang, L. van Eeden, Y. Z. Zhang and D.Q. Liu for their assistance during the fieldwork. We are grateful to the State Forestry Administration, China, and the Houhe Nature Reserve Administration Bureau, for granting us permission to conduct this study. This work was supported in part by Grants-in-Aid for Scientific Research "KAKENHI" programme (No. 22405003, 26257404) from the Japan Society for the Promotion of Science, and the Special Fund for Environmental Protection Public Welfare Scientific Research sponsored by Ministry of Environmental Protection of the People's Republic of China (No. 201309039).	Revilla E, 2002, CAN J ZOOL, V80, P83, DOI 10.1139/Z01-208; MCNAB BK, 1980, AM NAT, V116, P106, DOI 10.1086/283614; Lemons PR, 2010, J MAMMAL, V91, P66, DOI 10.1644/07-MAMM-A-291R1.1; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Zhou YB, 2013, ANN BOT-LONDON, V112, P85, DOI 10.1093/aob/mct096; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Green K, 2013, EUR J WILDLIFE RES, V59, P693, DOI 10.1007/s10344-013-0723-x; ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; RAW F, 1959, NATURE, V184, P1661, DOI 10.1038/1841661a0; KRUUK H, 1981, J ANIM ECOL, V50, P773, DOI 10.2307/4136; Newman C, 2011, MAMM STUDY, V36, P169; Zhang L, 2009, ETHOL ECOL EVOL, V21, P89; Harrington LA, 2010, EUR J WILDLIFE RES, V56, P377, DOI 10.1007/s10344-009-0328-6; Magnusdottir R, 2012, EUR J WILDLIFE RES, V58, P669, DOI 10.1007/s10344-012-0615-5; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Merritt JF, 2001, OIKOS, V94, P505, DOI 10.1034/j.1600-0706.2001.940312.x; Bonesi L, 2004, OIKOS, V106, P509, DOI 10.1111/j.0030-1299.2004.13034.x; Feore S, 1999, J ZOOL, V247, P537; Goszczynski J, 2000, J ZOOL, V250, P495, DOI 10.1017/S0952836900004076; Zhou YB, 2011, J MAMMAL, V92, P611, DOI 10.1644/10-MAMM-A-296.1; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143; Virgos E, 2004, CAN J ZOOL, V82, P41, DOI 10.1139/Z03-205; Barea-Azcon JM, 2010, ACTA THERIOL, V55, P45, DOI 10.4098/j.at.0001-7051.048.2008; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; CLARIDGE AW, 1993, WILDLIFE RES, V20, P321, DOI 10.1071/WR9930321; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; Johnson DDP, 2000, MAMMAL REV, V30, P171, DOI 10.1046/j.1365-2907.2000.00066.x; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; CARR GM, 1986, ANIM BEHAV, V34, P1540, DOI 10.1016/S0003-3472(86)80223-8; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Freschi P, 2014, EUR J WILDLIFE RES, V60, P423, DOI 10.1007/s10344-014-0799-y; Hanya G, 2013, PRIMATES, V54, P101, DOI 10.1007/s10329-012-0341-3; Chalukian SC, 2013, INTEGR ZOOL, V8, P48, DOI 10.1111/j.1749-4877.2012.12009.x; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Rosalino LM, 2005, MAMM BIOL, V70, P12, DOI 10.1078/1616-5047-00172; Zhou YB, 2013, GLOBAL CHANGE BIOL, V19, P2867, DOI 10.1111/gcb.12245; Cleary GP, 2009, MAMM BIOL, V74, P438, DOI 10.1016/j.mambio.2009.07.003; Aryal A, 2014, INTEGR ZOOL, V9, P34, DOI 10.1111/1749-4877.12004; Callaham MA, 1997, SOIL BIOL BIOCHEM, V29, P317, DOI 10.1016/S0038-0717(96)00095-8; Crowley S, 2012, J MAMMAL, V93, P170, DOI 10.1644/10-MAMM-A-362.1; Fischer C, 2005, J ZOOL, V266, P121, DOI 10.1017/S0952836905006576; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Kaneko Y, 2006, J ZOOL, V270, P78, DOI 10.1111/j.1469-7998.2006.00063.x; Laake J, 2007, PROGRAM MARK GENTLE; Levins R, 1968, EVOLUTION CHANGING E; Li F, 2013, CHINESE SCI BULL, V58, P2255, DOI 10.1007/s11434-012-5650-9; MARTIN R, 1995, OECOLOGIA, V101, P45, DOI 10.1007/BF00328898; McVey JM, 2013, J MAMMAL, V94, P1141, DOI 10.1644/13-MAMM-A-109.1; Parry GS, 2011, EUR J WILDLIFE RES, V57, P485, DOI 10.1007/s10344-010-0457-y; Pianka ER, 1975, ECOLOGY EVOLUTION CO; Roff D. A., 2002, LIFE HIST EVOLUTION; ROPER TJ, 1994, J ZOOL, V234, P437; Shipley LA, 2009, INTEGR COMP BIOL, V49, P274, DOI 10.1093/icb/icp051; Song CS, 1999, SCI SURVEY HUBEI HOU; Tokeshi M, 2009, SPECIES COEXISTENCE; Wang H, 2003, MAMMALIA, V67, P513; WROOT AJ, 1985, OIKOS, V44, P239, DOI 10.2307/3544695; Zagainova OS, 2011, RUSS J ECOL+, V42, P414, DOI 10.1134/S1067413611050158; Zhang L, 2010, J MAMMAL, V91, P101, DOI 10.1644/09-MAMM-A-049R.1; ZHENG S, 1988, Acta Theriologica Sinica, V8, P65; Zhou YB, 2008, J MAMMAL, V89, P435, DOI 10.1644/07-MAMM-A-048R1.1	63	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1612-4642	1439-0574		EUR J WILDLIFE RES	Eur. J. Wildl. Res.	FEB	2015	61	1					125	133		10.1007/s10344-014-0881-5		9	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	AZ4UX	WOS:000348219700013		
J	Haga, S; Tsuchiya, H; Hirai, T; Hamano, T; Mimori, A; Ishizaka, Y				Haga, Shiori; Tsuchiya, Haruka; Hirai, Toshitake; Hamano, Takaichi; Mimori, Akio; Ishizaka, Yukihito			A novel ACE2 activator reduces monocrotaline-induced pulmonary hypertension by suppressing the JAK/STAT and TGF-beta cascades with restored caveolin-1 expression	EXPERIMENTAL LUNG RESEARCH			English	Article						ACE2 activator; Caveolin-1; monocrotaline; pulmonary hypertension	ANGIOTENSIN-CONVERTING ENZYME; ARTERIAL-HYPERTENSION; LUNG FIBROSIS; MAP KINASE; IN-VITRO; MECHANISMS; DISEASE; MICE; INFLAMMATION; PATHOGENESIS	Introduction: Pulmonary hypertension (PH) is characterized by increased pressure in the pulmonary artery and right ventricular hypertrophy (RVH). Recently, angiotensin-converting enzyme 2 (ACE2), which converts angiotensin (Ang) II into Ang-(1-7), was shown to inhibit experimental PH. Here we identified a novel ACE2 activator and investigated how the compound reduced monocrotaline (MCT)-induced PH. Methods: To induce PH, Sprague-Dawley rats were injected subcutaneously with MCT, followed by the continuous administration of NCP-2454, an ACE2 activator, using osmotic pumps. Pulmonary arterial compliance was monitored every week until 4 weeks post-injection (wpi). RVH and lung remodeling was evaluated using lung tissue at 4 wpi. Results: NCP-2454 upregulated the production of Ang-(1-7) when incubated with ACE2 and Ang II. Notably, a continuous infusion of NCP-2454 significantly improved pulmonary arterial compliance, right ventricular systolic pressure, and RVH in MCT-treated rats. Interestingly, NCP-2454 increased the relative expression of ACE2 and MAS mRNA in lung tissue, especially in MCT-treated rats. In addition, the compound inhibited the MCT-induced overexpression of transforming growth factor beta, phosphorylation of signal transducer and activator of transcription-3 (STAT3), and interleukin-6 production. The compound also restored the expression of caveolin-1 (Cav-1), which negatively regulates the Janus kinase-STAT signaling cascade. Conclusions: NCP-2454 prevented MCT-induced PH by suppressing intracellular inflammatory cascades, an upstream molecular change of which is the disruption of Cav-1 expression.	[Haga, Shiori; Tsuchiya, Haruka; Ishizaka, Yukihito] Inst Natl Ctr Global Hlth & Med, Dept Intractable Dis, Tokyo 1628655, Japan; [Tsuchiya, Haruka; Mimori, Akio] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Tokyo, Japan; [Hirai, Toshitake; Hamano, Takaichi] Nippon Chemiphar Co Ltd, Discovery Res Labs, Saitama, Japan	Ishizaka, Y (reprint author), Inst Natl Ctr Global Hlth & Med, Dept Intractable Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	zakay@ri.ncgm.go.jp			National Center for Global Health and Medicine [25A-105]; Japan Science and Technology Agency [AS2415021Q]; Nippon Chemiphar Co. Ltd.	Shiori Haga, Haruka Tsuchiya, Aki Mimori, and Yukihito Ishizaka were supported by a grant-in-aid for the Adaptable and Seamless Technology Transfer Program through Target-driven R&D from the Japan Science and Technology Agency (AS2415021Q), including one-to-one matching funds from Nippon Chemiphar Co. Ltd. All remaining authors have declared no conflicts of interest. The authors alone are responsible for the content and writing of the article.; This work was supported in part by a grant-in-aid for research from the National Center for Global Health and Medicine (25A-105) and by a grant-in-aid for the Adaptable and Seamless Technology Transfer Program through Target-driven R&D from the Japan Science and Technology Agency (AS2415021Q), including one-to-one matching funds from Nippon Chemiphar Co. Ltd.	Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762; Dias-Peixoto MF, 2008, HYPERTENSION, V52, P542, DOI 10.1161/HYPERTENSIONAHA.108.114280; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Huang J, 2010, EXP LUNG RES, V36, P57, DOI 10.3109/01902140903104793; WILSON DW, 1992, CRIT REV TOXICOL, V22, P307, DOI 10.3109/10408449209146311; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Haber PK, 2014, HYPERTENSION, V63, P774, DOI 10.1161/HYPERTENSIONAHA.113.02856; Mathew R, 2014, AM J PHYSIOL-HEART C, V306, pH15, DOI 10.1152/ajpheart.00266.2013; Kuba K, 2013, CIRC J, V77, P301, DOI 10.1253/circj.CJ-12-1544; Andersen CU, 2009, RESP MED, V103, P1663, DOI 10.1016/j.rmed.2009.05.011; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Li ZD, 2013, AM J PATHOL, V182, P325, DOI 10.1016/j.ajpath.2012.10.022; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Wang H, 2011, AM J PHYSIOL-ENDOC M, V300, pE134, DOI 10.1152/ajpendo.00498.2010; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Shenoy V, 2013, AM J RESP CRIT CARE, V187, P648, DOI 10.1164/rccm.201205-0880OC; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; Yamazato Y, 2009, HYPERTENSION, V54, P365, DOI 10.1161/HYPERTENSIONAHA.108.125468; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI 10.1016/j.jacc.2009.04.012; Ou ZJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1131, DOI 10.1152/ajpendo.00107.2010; Prada JAH, 2008, HYPERTENSION, V51, P1312, DOI 10.1161/HYPERTENSIONAHA.107.108944; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Ferreira AJ, 2009, AM J RESP CRIT CARE, V179, P1048, DOI 10.1164/rccm.200811-1678OC; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Li XP, 2008, AM J PHYSIOL-LUNG C, V295, pL178, DOI 10.1152/ajplung.00009.2008; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Shenoy V, 2010, AM J RESP CRIT CARE, V182, P1065, DOI 10.1164/rccm.200912-1840OC; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Furuya Y, 2010, INT J RHEUMATOL, V2010; Imai Y, 2010, CIRC J, V74, P405, DOI 10.1253/circj.CJ-10-0045; Kasahara Y, 1997, J CARDIOVASC PHARM, V30, P124, DOI 10.1097/00005344-199707000-00018; MEYRICK B, 1978, J ANAT, V125, P209; ROTH RA, 1991, ADV EXP MED BIOL, V283, P477; Takaguri A, 2011, J MOL CELL CARDIOL, V50, P545, DOI 10.1016/j.yjmcc.2010.12.009; Yoshimatsu Y., 2011, INT J INFLAM, V2011, DOI [DOI 10.4061/2011/724080, 10.4061/2011/724080]	44	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0190-2148	1521-0499		EXP LUNG RES	Exp. Lung Res.	FEB	2015	41	1					21	31		10.3109/01902148.2014.959141		11	Respiratory System	Respiratory System	AZ6YA	WOS:000348363400003		
J	Matsushima, S; Huang, Y; Suzuki, H; Nishino, J; Lloyd, P				Matsushima, Soichiro; Huang, Yue; Suzuki, Hikoe; Nishino, Junichi; Lloyd, Peter			Ethnic sensitivity assessment - pharmacokinetic comparability between Japanese and non-Japanese healthy subjects on selected mAbs	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY			English	Review						ethnic sensitivity; immunogenicity; Japan; mAb; pharmacokinetics	THERAPEUTIC MONOCLONAL-ANTIBODIES; CLINICAL-TRIALS; SAFETY; PHARMACODYNAMICS; IMMUNOGENICITY; 1ST-IN-HUMAN; PERSPECTIVE; GOLIMUMAB; ARTHRITIS; SIRUKUMAB	Objective: Ethnic sensitivity studies (ESSs), where safety and pharmacokinetics (PK) are assessed in Japanese subjects, are routinely conducted according to Japanese regulatory requirement before the subsequent clinical studies. The necessity of ESSs is questionable in case of mAbs, where inherent IgG characteristics are considered ethnically insensitive. This report investigated PK profiles and immunogenicity (IG) following a single administration of mAbs in Japanese and non-Japanese healthy subjects. Research design and methods: PK and IG comparison between Japanese and non-Japanese healthy subjects was made on mAbs data available from public domain and unpublished internal reports. PK comparison was made based on statistical approach as well as assumed typical IgG profile using modeling and simulation. Results: When compared directly, most mAbs showed no difference between ethnic groups. When profiles of various mAbs were fit to an assumed typical IgG PK model, the majority of mAbs follow the expected behavior regardless of ethnicities. Deviations from this behavior did not appear to be due to inherent ethnic differences. When the incidence of IG was assessed, only Adalimumab showed apparent ethnic difference. Conclusions: The overall lack of observational difference may facilitate discussion of mAbs' early clinical development in Japan, including the utility of dedicated ESSs.	[Matsushima, Soichiro; Suzuki, Hikoe; Nishino, Junichi] Novartis Pharma KK, Minato Ku, Tokyo 1068618, Japan; [Huang, Yue] Novartis Pharma AG, Novartis Inst Biomed Res, Basel, Switzerland; [Lloyd, Peter] Kindyn Consulting Ltd, Horsham, W Sussex, England	Matsushima, S (reprint author), Novartis Pharma KK, Minato Ku, 4-17-30 Nishi Azabu, Tokyo 1068618, Japan.	soichiro.matsushima@novartis.com			Novartis Pharma	This paper has been supported by Novartis Pharma. S Matsushima, Y Huang, H Suzuki, and J Nishino are all employees of Novartis Pharma group. P Lloyd was an employee of Novartis Pharma group during the development of the manuscript. The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of the manuscript apart from those disclosed.	Ando Y, 2012, J BIOPHARM STAT, V22, P977, DOI 10.1080/10543406.2012.701581; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Muller PY, 2009, CLIN PHARMACOL THER, V85, P247, DOI 10.1038/clpt.2008.273; Asano K, 2013, CLIN PHARMACOL THER, V94, P195, DOI 10.1038/clpt.2013.106; Xu ZH, 2011, BRIT J CLIN PHARMACO, V72, P270, DOI 10.1111/j.1365-2125.2011.03964.x; Zhou HH, 2012, J CLIN PHARMACOL, V52, P1273, DOI 10.1177/0091270011411192; Harding FA, 2010, MABS-AUSTIN, V2, P256; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Dirks NL, 2010, CLIN PHARMACOKINET, V49, P633, DOI 10.2165/11535960-000000000-00000; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Kawasaki E, 2006, DIABETOLOGIA, V49, P828, DOI 10.1007/s00125-006-0213-8; Sutjandra L, 2011, CLIN PHARMACOKINET, V50, P793, DOI 10.2165/11594240-000000000-00000; Chiba K, 2014, J CLIN PHARMACOL, V54, P483, DOI 10.1002/jcph.231; Zhou HH, 2007, J CLIN PHARMACOL, V47, P383, DOI 10.1177/0091270006298188; Zhuang YL, 2013, INT J CLIN PHARM TH, V51, P187, DOI 10.5414/CP201785; International Conference on Harmonisation, 1998, ETHN FACT ACC FOR CL; Kumagai Y, 2011, BONE, V49, P1101, DOI 10.1016/j.bone.2011.08.007; Ling J, 2010, J CLIN PHARMACOL, V50, P792, DOI 10.1177/0091270009355162; Palframan R, 2009, J IMMUNOL METHODS, V348, P36, DOI 10.1016/j.jim.2009.06.009; Pharmaceuticals and Medical Device Agency, 2008, MOD 2 7 2 SUMM CLIN; Waldmann H, 2014, METHODS MOL BIOL, V1060, P1, DOI 10.1007/978-1-62703-586-6_1	22	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1742-5255	1744-7607		EXPERT OPIN DRUG MET	Expert Opin. Drug Metab. Toxicol.	FEB	2015	11	2					179	191		10.1517/17425255.2015.990438		13	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AZ0TA	WOS:000347956300002		
J	Song, SNJ; Yoshizaki, K				Song, Soken-Nakazawa J.; Yoshizaki, Kazuyuki			Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY			English	Review						efficacy; IL-6 receptor; pharmacodynamic; pharmacokinetic; rheumatoid arthritis; tocilizumab	ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; MODIFYING ANTIRHEUMATIC DRUGS; RANDOMIZED CONTROLLED-TRIAL; MULTICENTRIC CASTLEMAN-DISEASE; ENDOTHELIAL GROWTH-FACTOR; PLACEBO-CONTROLLED TRIAL; PHASE-III TRIAL; DOUBLE-BLIND; INADEQUATE RESPONSE; GENE-EXPRESSION	Introduction: Dysregulated overproduction of IL-6 has important roles in the pathogenesis of rheumatoid arthritis (RA). Tocilizumab (TCZ) is the only approved biologic agent inhibiting the IL-6 pathway for RA treatment, and is the focus of this review. Areas covered: This review summarizes the pharmacologic characteristics, clinical efficacy and safety profile of TCZ therapy in RA patients. The data reviewed were based mainly on Phase III randomized clinical trials and the literature until 2014 regarding TCZ in RA treatment. Expert opinion: Being a first-line biologic agent for RA, TCZ is especially suitable for RA patients who have shown an inadequate response to TNF-alpha inhibitors or who cannot tolerate methotrexate. In view of its advantage in suppressing acute-phase reactions and as the only approved inhibitor of IL-6 signaling, TCZ might be particularly effective for RA patients with a high systemic inflammatory response, anemia, AA amyloidosis and other diseases mediated by IL-6. Being able to identify reliable predictors of response to TCZ, and finding more effective new biologic and treatment options, will reduce the number of patients who fail to respond to TCZ.	[Song, Soken-Nakazawa J.] Osaka Univ, Grad Sch Engn, Dept Immunomed Sci, Div Appl Chem, Suita, Osaka 5650874, Japan; [Yoshizaki, Kazuyuki] Osaka Univ, Grad Sch Engn, Open Labs Adv Biosci & Biotechnol, Div Appl Chem,Dept Immunomed Sci, Suita, Osaka 5650874, Japan	Yoshizaki, K (reprint author), Osaka Univ, Grad Sch Engn, Open Labs Adv Biosci & Biotechnol, Div Appl Chem,Dept Immunomed Sci, 313 6-2-3 Furuedai, Suita, Osaka 5650874, Japan.	kyoshi@chem.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21659121]; Chugai Pharmaceutical Co. Ltd	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 21659121). K Yoshizaki has received speaking fees from Chugai Pharmaceutical Co. Ltd, and is the co-inventor of tocilizumab treatment for Still's disease. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Dinarello CA, 2005, ARTHRITIS RHEUM, V52, P1960, DOI 10.1002/art.21107; Hagihara K, 2004, BIOCHEM BIOPH RES CO, V314, P363, DOI 10.1016/j.bbrc.2003.12.096; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; MADHOK R, 1993, ANN RHEUM DIS, V52, P232, DOI 10.1136/ard.52.3.232; Nakashima Y, 2014, DRUG DES DEV THER, V8, P913, DOI 10.2147/DDDT.S52099; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nishimoto N, 2003, J RHEUMATOL, V30, P1426; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Nishimoto N, 2004, ARTHRITIS RHEUM, V50, P1761, DOI 10.1002/art.20303; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Nishimoto N., 2008, V181, P151; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Okuda Y, 2014, MOD RHEUMATOL, V24, P137, DOI 10.3109/14397595.2013.854048; Bannwarth B, 2013, EXPERT OPIN DRUG MET, V9, P753, DOI 10.1517/17425255.2013.789500; Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075; Yazici Y, 2013, CLIN EXP RHEUMATOL, V31, P358; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407; Nakahara H, 2003, ARTHRITIS RHEUM, V48, P1521, DOI 10.1002/art.11143; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Dougados M, 2013, ANN RHEUM DIS, V72, P43, DOI 10.1136/annrheumdis-2011-201282; Maini RN, 2006, ARTHRITIS RHEUM, V54, P2817, DOI 10.1002/art.22033; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Semerano L, 2014, EXPERT OPIN INV DRUG, V23, P979, DOI 10.1517/13543784.2014.912276; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; SACK U, 1993, RHEUMATOL INT, V13, P45, DOI 10.1007/BF00307733; Schmitt C, 2011, CLIN PHARMACOL THER, V89, P735, DOI 10.1038/clpt.2011.35; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Nishikawa T, 2008, J IMMUNOL, V180, P3492; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Genovese MC, 2008, ARTHRITIS RHEUM, V58, P2968, DOI 10.1002/art.23940; Feldmann M, 2001, CURR DIRECT AUTOIMMU, V3, P188; Ogata A, 2014, ARTHRIT CARE RES, V66, P344, DOI 10.1002/acr.22110; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Burmester GR, 2014, ANN RHEUM DIS, V73, P69, DOI 10.1136/annrheumdis-2013-203523; [Anonymous], 2013, ACT PROSCR INF; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Smolen JS, 2013, ANN RHEUM DIS, V72, P482, DOI 10.1136/annrheumdis-2012-202469; Al-Shakarchi I, 2013, PATIENT PREFER ADHER, V7, P653, DOI 10.2147/PPA.S41433; Bannwarth B, 2011, EXPERT OPIN DRUG SAF, V10, P123, DOI 10.1517/14740338.2011.537256; Burmester GR, 2012, ARTHRITIS RHEUM-US, V64, pS1075; Daien Cl, 2014, MEDIAT INFLAMM, V2014; De Vita S, 2013, LANCET, V381, P1515, DOI 10.1016/S0140-6736(13)60634-0; Ding Changhai, 2006, Rev Recent Clin Trials, V1, P193, DOI 10.2174/157488706778250168; Faillace C, 2013, RHEUMATOL INT, V33, P1909, DOI 10.1007/s00296-012-2409-1; Gaffo A, 2006, AM J HEALTH-SYST PH, V63, P2451, DOI 10.2146/aihp050514; GUERNE PA, 1989, J CLIN INVEST, V83, P585, DOI 10.1172/JCI113921; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277; Kojima T, 2013, MOD RHEUMATOL, V23, P977, DOI 10.1007/s10165-012-0782-y; Kotake S, 1996, J BONE MINER RES, V11, P88; Nishimoto N, 2000, ANN RHEUM DIS, V59, P121; Nishina N, 2014, ANN RHEUM DIS, V73, P945, DOI 10.1136/annrheumdis-2013-204137; Ohta S, 2014, J CLIN PHARMACOL, V54, P109, DOI 10.1002/jcph.185; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Shetty A, 2014, DRUG DES DEV THER, V8, P349, DOI 10.2147/DDDT.S41437; Song SNJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4323; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tanaka Toshio, 2014, Biologics, V8, P141, DOI 10.2147/BTT.S37509; Wang JM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003199; Zhang Xiaoping, 2011, Expert Rev Clin Pharmacol, V4, P539, DOI 10.1586/ecp.11.33; Zhang XP, 2013, INT J CLIN PHARM TH, V51, P620, DOI 10.5414/CP201904	73	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1742-5255	1744-7607		EXPERT OPIN DRUG MET	Expert Opin. Drug Metab. Toxicol.	FEB	2015	11	2					307	316		10.1517/17425255.2015.992779		10	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AZ0TA	WOS:000347956300011		
J	Hiraoka, K; Tashiro, M; Grobosch, T; Maurer, M; Oda, K; Toyohara, J; Ishii, K; Ishiwata, K; Yanai, K				Hiraoka, Kotaro; Tashiro, Manabu; Grobosch, Thomas; Maurer, Marcus; Oda, Keiichi; Toyohara, Jun; Ishii, Kenji; Ishiwata, Kiichi; Yanai, Kazuhiko			Brain histamine H-1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine	EXPERT OPINION ON DRUG SAFETY			English	Review						antihistamine; histamine H-1 receptor occupancy; levocetirizine; positron emission tomography; sedating side effect	POSITRON-EMISSION-TOMOGRAPHY; PROPORTIONAL IMPAIRMENT RATIOS; PLACEBO-CONTROLLED TRIAL; P-GLYCOPROTEIN EFFLUX; DOUBLE-BLIND; H-1-RECEPTOR OCCUPANCY; 2ND-GENERATION ANTIHISTAMINE; ADMINISTERED ANTIHISTAMINES; CLASSICAL ANTIHISTAMINE; HEALTHY-VOLUNTEERS	Objective: Histamine H-1 receptor (H1R) antagonists often have sedative side effects, which are caused by the blockade of the neural transmission of the histaminergic neurons. We examined the brain H1R occupancy (H1RO) and the subjective sleepiness of levocetirizine, a new second- generation antihistamine, comparing fexofenadine, another non-sedating antihistamine, as a negative active control. Methods: Eight healthy volunteers underwent positron emission tomography (PET) imaging with [C-11] doxepin, a PET tracer that specifically binds to H(1)Rs, after a single oral administration of levocetirizine (5 mg), fexofenadine (60 mg) or placebo in a double-blind crossover study. Binding potential ratios and H1ROs in the cerebral cortices regions were calculated using placebo. Subjective sleepiness was assessed with the Line Analogue Rating Scale and the Stanford Sleepiness Scale. Results: There was no significant difference between the mean brain H1RO after levocetirizine administration (8.1%; 95% CI: -9.8 to 26.0%) and fexofenadine administration (-8.0%; 95% CI: -26.7 to 10.6%). Similarly, subjective sleepiness was not significantly different between the two antihistamines and placebo. Neither subjective sleepiness nor plasma concentrations was significantly correlated with the brain H1RO of the two antihistamines. Conclusion: At therapeutic dose, levocetirizine does not bind significantly to the brain H(1)Rs and does not induce significant sedation.	[Hiraoka, Kotaro; Tashiro, Manabu; Yanai, Kazuhiko] Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Cyclotron Nucl Med, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Grobosch, Thomas] Labor Berlin Charite Vivantes, Dept Lab Med & Toxicol, D-13353 Berlin, Germany; [Maurer, Marcus] Charite, Allergie Ctr Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany; [Oda, Keiichi; Toyohara, Jun; Ishii, Kenji; Ishiwata, Kiichi] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Tokyo 1730015, Japan; [Yanai, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808578, Japan	Yanai, K (reprint author), Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Cyclotron Nucl Med, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	yanai@cyric.tohoku.ac.jp			GlaxoSmithKline; Japan Society of Technology ('Molecular Imaging')	This study was supported by research funding from GlaxoSmithKline. K Hiraoka did the human PET studies and wrote the manuscript. T Grobosch and M Maurer measured the plasma concentration of levocetirizine and fexofenadine and wrote the manuscript. M Tashiro, K Oda, J Toyohara, K Ishii, and K Ishiwata did the human PET studies. K Yanai designed the study and wrote the manuscript. We appreciate R Boev (Global Medical Affairs, UCB Farchim SA, Switzerland) for discussing the manuscript. The authors also thank Kunpei Hayashi for the radiosynthesis of [<SUP>11</SUP>C] doxepin and Hatsumi Endo for supporting PET imaging. This work was supported in part by Grants- in- Aid for Scientific Research from the Japan Society of Technology ('Molecular Imaging').	Tashiro M, 2008, BRIT J CLIN PHARMACO, V65, P811, DOI 10.1111/j.1365-2125.2008.03143.x; Mochizuki H, 2004, NUCL MED BIOL, V31, P1005, DOI 10.1016/j.nucmedbio.2004.06.009; Grant JA, 2002, ANN ALLERG ASTHMA IM, V88, P190; Gupta A, 2006, BIOPHARM DRUG DISPOS, V27, P291, DOI 10.1002/bdd.509; Tashiro M, 2004, J CLIN PHARMACOL, V44, P890, DOI 10.1177/0091270004267590; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Chen C, 2008, CURR MED CHEM, V15, P2173, DOI 10.2174/092986708785747625; Peters FT, 2007, FORENSIC SCI INT, V165, P216, DOI 10.1016/j.forsciint.2006.05.021; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Gupta A, 2006, DRUG METAB DISPOS, V34, P318, DOI 10.1124/dmd.105.007211; De Vos C, 2008, CLIN DRUG INVEST, V28, P221, DOI 10.2165/00044011-200828040-00003; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Kubo N, 2011, HUM PSYCHOPHARM CLIN, V26, P133, DOI 10.1002/hup.1184; Zuberbier T, 2009, ALLERGY, V64, P1427, DOI 10.1111/j.1398-9995.2009.02178.x; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Tagawa M, 2001, BRIT J CLIN PHARMACO, V52, P501, DOI 10.1046/j.1365-2125.2001.01471.x; Schoepke N, 2013, ACTA DERM-VENEREOL, V93, P286, DOI 10.2340/00015555-1490; Holgate ST, 2003, CLIN EXP ALLERGY, V33, P1305, DOI 10.1046/j.1365-2222.2003.01769.x; McDonald K, 2008, HUM PSYCHOPHARM CLIN, V23, P555, DOI 10.1002/hup.962; Iwata R, 2001, APPL RADIAT ISOTOPES, V55, P17, DOI 10.1016/S0969-8043(00)00368-7; Hindmarch I, 2002, CLIN EXP ALLERGY, V32, P133, DOI 10.1046/j.0022-0477.2001.01245.x; Doan KMM, 2004, PHARMACOLOGY, V72, P92, DOI 10.1159/000079137; Broccatelli F, 2012, ADV DRUG DELIVER REV, V64, P95, DOI 10.1016/j.addr.2011.12.008; Yanai K, 2011, EXPERT OPIN DRUG SAF, V10, P613, DOI 10.1517/14740338.2011.562889; Broccatelli F, 2010, MOL INFORM, V29, P16, DOI 10.1002/minf.200900075; Chishty M, 2001, J DRUG TARGET, V9, P223; Devalia JL, 2001, ALLERGY, V56, P50, DOI 10.1034/j.1398-9995.2001.00726.x; Farre M, 2014, BRIT J CLIN PHARMACO, V78, P970, DOI 10.1111/bcp.12421; Fujiwara T, 1997, Ann Nucl Med, V11, P307; Gillard M, 2002, MOL PHARMACOL, V61, P391, DOI 10.1124/mol.61.2.391; Mochizuki H, 2004, NUCL MED BIOL, V31, P165, DOI 10.1016/j.nucmedbio.2003.08.010; Okamura N, 2000, BRIT J PHARMACOL, V129, P115, DOI 10.1038/sj.bjp.0702994; Peters F.T., 2009, TOXICHEM KRIMTECH, V76, P185; Shamsi Z, 2000, HUM PSYCHOPHARM CLIN, V15, pS3, DOI 10.1002/1099-1077(200010)15:1+<::AID-HUP247>3.0.CO;2-S; Shibuya Katsuhiko, 2012, Front Syst Neurosci, V6, P45, DOI 10.3389/fnsys.2012.00045; Tagawa M, 2002, BRIT J CLIN PHARMACO, V53, P296, DOI 10.1046/j.0306-5251.2001.01183.x; Tashiro M, 2005, HUM PSYCHOPHARM CLIN, V20, P501, DOI 10.1002/hup.713; Tashiro M, 2006, BRIT J CLIN PHARMACO, V61, P16, DOI 10.1111/j.1365-2125.2005.02514.x; Tashiro M, 2009, HUM PSYCHOPHARM CLIN, V24, P540, DOI 10.1002/hup.1051; Tzanetos DB, 2011, ANN ALLERG ASTHMA IM, V107, P517, DOI 10.1016/j.anai.2011.08.012; Uesawa Y, 2014, J PHARMACOL SCI, V124, P160, DOI 10.1254/jphs.13169FP; Verster JC, 2003, PSYCHOPHARMACOLOGY, V169, P84, DOI 10.1007/s00213-003-1462-6; Yanai K, 1995, METHOD FIND EXP CLIN, V17, P64; Yanai K, 2012, CURR MED RES OPIN, V28, P623, DOI 10.1185/03007995.2012.672405; YANAI K, 1995, BRIT J PHARMACOL, V116, P1649; Zhang DY, 2010, J CLIN PSYCHOPHARM, V30, P694, DOI 10.1097/JCP.0b013e3181fa8526	47	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1474-0338	1744-764X		EXPERT OPIN DRUG SAF	Expert Opin. Drug Saf.	FEB	2015	14	2					199	206		10.1517/14740338.2015.989831		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ2DY	WOS:000348046000003		
J	Ito, H; Abe, M; Antoku, S; Omoto, T; Shinozaki, M; Nishio, S; Mifune, M; Togane, M				Ito, Hiroyuki; Abe, Mariko; Antoku, Shinichi; Omoto, Takashi; Shinozaki, Masahiro; Nishio, Shinya; Mifune, Mizuo; Togane, Michiko			Comparison of the antidiabetic effects of linagliptin among groups with a normal renal function and a mild or severe renal impairment - retrospective observation study of Japanese patients with type 2 diabetes mellitus	EXPERT OPINION ON PHARMACOTHERAPY			English	Review						adherence; antiproteinuric effect; dipeptidyl peptidase-4 inhibitor; linagliptin; renal impairment; type 2 diabetes mellitus	CHRONIC KIDNEY-DISEASE; IMPROVES GLYCEMIC CONTROL; EFFICACY; METAANALYSIS; INHIBITORS; PLACEBO; SAFETY; MODERATE; TRIALS	Objective: The clinical course > 6 months after the initiation of linagliptin in patients with type 2 diabetes was compared among the groups divided by their renal function. Methods: Two hundred and sixteen Japanese patients with type 2 diabetes treated with 5 mg once daily linagliptin were studied as the treated set. One hundred and forty-five subjects whose medications were not changed during the observation period were investigated as the full analysis set to assess the effectiveness. The subjects were divided into three groups based on an eGFR: eGFR >= 60, 59 - 45 and < 45 ml/min/1.73 m(2). The parameters were analyzed separately in the patients receiving monotherapy and additional therapy of linagliptin. Results: The HbA1c (NGSP) levels significantly improved in both the patients receiving monotherapy and additional therapy. The changes in the HbA1c levels at 6 months were not significantly different between the groups with an eGFR >= 60, 59 - 45 and < 45 ml/min/1.73 m(2) receiving monotherapy (-1.0, -0.8 and -0.8%, respectively). Similarly, those were not significantly different between the different groups receiving additional therapy (-0.6, -0.5 and -0.7%, respectively). Conclusions: Linagliptin is considered to be effective for patients with type 2 diabetes and renal impairment in the present analysis performed at our institution.	[Ito, Hiroyuki; Abe, Mariko; Antoku, Shinichi; Omoto, Takashi; Shinozaki, Masahiro; Nishio, Shinya; Mifune, Mizuo; Togane, Michiko] Edogawa Hosp, Dept Diabet Metab & Kidney Dis, Edogawa Ku, Tokyo 1330052, Japan	Ito, H (reprint author), Edogawa Hosp, Dept Diabet Metab & Kidney Dis, Tokyo 1330052, Japan.	ito@edogawa.or.jp			Eli Lilly Japan KK; Nippon Boehinger Ingelheim Co Ltd.	H Ito has received lecture fees from Eli Lilly Japan KK, Nippon Boehinger Ingelheim Co Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	DeFronzo RA, 2010, DIABETIC MED, V27, P309, DOI 10.1111/j.1464-5491.2010.02941.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Monami M, 2012, ADV THER, V29, P14, DOI 10.1007/s12325-011-0088-z; Lukashevich V, 2011, DIABETES OBES METAB, V13, P947, DOI 10.1111/j.1463-1326.2011.01467.x; Deacon CF, 2010, EXPERT OPIN INV DRUG, V19, P133, DOI 10.1517/13543780903463862; Elias MF, 2013, CONTRIB NEPHROL, V179, P42, DOI 10.1159/000346722; Ferreira JCA, 2013, DIABETES CARE, V36, P1067, DOI 10.2337/dc12-1365; Groop PH, 2013, DIABETES CARE, V36, P3460, DOI 10.2337/dc13-0323; Ferreira JCA, 2013, AM J KIDNEY DIS, V61, P579, DOI 10.1053/j.ajkd.2012.11.043; [Anonymous], 2013, KIDNEY INT S, V3, P1, DOI DOI 10.1038/KISUP.2012.73; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Graefe-Mody U, 2011, DIABETES OBES METAB, V13, P939, DOI 10.1111/j.1463-1326.2011.01458.x; McGill JB, 2013, DIABETES CARE, V36, P237, DOI 10.2337/dc12-0706; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Fujii Y, 2013, EXPERT OPIN PHARMACO, V14, P259, DOI 10.1517/14656566.2013.761690; Haneda M, 2009, NEPHROL DIAL TRANSPL, V24, P338, DOI 10.1093/ndt/gfn616; Ito H, 2012, J DIABETES COMPLICAT, V26, P286, DOI 10.1016/j.jdiacomp.2012.04.011; Ito Hiroyuki, 2013, Nephron Extra, V3, P66, DOI 10.1159/000353592; Ito Hiroyuki, 2013, Diabetes Ther, V4, P321, DOI 10.1007/s13300-013-0029-8; Tamura MK, 2011, CLIN J AM SOC NEPHRO, V6, P248, DOI 10.2215/CJN.02660310; McGill JB, 2014, DIABETES VASC DIS RE, V11, P34, DOI 10.1177/1479164113507068; Monami M, 2012, ADV THER, V29, P736, DOI 10.1007/s12325-012-0045-5; National Kidney Foundation, 2012, AM J KIDNEY DIS, V60, P850, DOI DOI 10.1053/J.AJKD.2012.07.005; Nowicki M, 2011, DIABETES OBES METAB, V13, P523, DOI 10.1111/j.1463-1326.2011.01382.x; Scheen AJ, 2014, CLIN PHARMACOKINET; Tuttle KR, 2014, DIABETES CARE, V37, P2864, DOI 10.2337/dc14-1296; Wasen E, 2004, DIABETES CARE, V27, P2648, DOI 10.2337/diacare.27.11.2648	27	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-6566	1744-7666		EXPERT OPIN PHARMACO	Expert Opin. Pharmacother.	FEB	2015	16	3					289	296		10.1517/14656566.2015.995091		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ3SO	WOS:000348147200003		
J	Morishita, R; Nakagami, H				Morishita, Ryuichi; Nakagami, Hironori			Teneligliptin: expectations for its pleiotropic action	EXPERT OPINION ON PHARMACOTHERAPY			English	Review						diabetes mellitus; dipeptidyl peptidase-4 inhibitors; glucose fluctuations; glycemic control; teneligliptin; vascular function	DIPEPTIDYL PEPTIDASE-4 INHIBITOR; TYPE-2 DIABETES-MELLITUS; JAPANESE PATIENTS; IV INHIBITOR; GLUCOSE FLUCTUATIONS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SAFETY; EFFICACY; HYPERGLYCEMIA	Introduction: The main aim in the management of diabetes mellitus is to prevent the development of its complications. Large fluctuations in glucose levels may increase the risk of complications, so improved control of glucose fluctuations, in addition to management of chronic hyperglycemia, could represent an important goal in diabetes pharmacotherapy. Areas covered: Pre-clinical and clinical studies suggest that poor control of blood glucose fluctuations contributes to progression of diabetic vascular complications. Dipeptidyl peptidase (DPP)-4 inhibitors are one of several drug classes used to manage diabetes, and the potential vasoprotective effects of DPP-4 inhibition have attracted attention in recent years. The DPP-4 inhibitor teneligliptin was approved in Japan in 2012 and in Korea in 2014. Teneligliptin differs in its structural and pharmacokinetic characteristics compared with other drugs in the same class. It appears to have potent, sustained effects on glycemic control, thereby reducing the complications of hypoglycemia and postprandial hyperglycemia. Because of its effects on vascular function, teneligliptin may be beneficial in patients at high risk of cardiovascular disease. Expert opinion: The possible pleiotropic effects of teneligliptin, such as those on endothelial function and metabolic syndrome, are of great interest. This review examines these effects and their potential clinical relevance.	[Morishita, Ryuichi; Nakagami, Hironori] Osaka Univ, Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan	Morishita, R (reprint author), Osaka Univ, Sch Med, Dept Clin Gene Therapy, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	morishit@cgt.med.osaka-u.ac.jp			Mitsubishi Tanabe Pharma Corp.; AnGes MG, Inc.; Novartis; Shionogi; Boehringer Ingelheim; Rohto; Bayer	The Department of Clinical Gene Therapy is financially supported by Mitsubishi Tanabe Pharma Corp., AnGes MG, Inc., Novartis, Shionogi, Boehringer Ingelheim and Rohto. The Division of Vascular Medicine and Epigenetics (to which Hironori Nakagami belongs) is financially supported by Bayer. Ryuichi Morishita is a founder of AnGes MG, Inc., and holds stock in the company. Editorial support for the preparation of this manuscript was provided by H Roberton. Publication support was funded by Mitsubishi Tanabe Pharma Corp. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Del Prato S, 2002, INT J OBESITY, V26, pS9, DOI 10.1038/sj.ijo.0802172; van Genugten RE, 2013, DIABETES OBES METAB, V15, P593, DOI 10.1111/dom.12050; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Nakagami H, 2014, HYPERTENS RES, V37, P629, DOI 10.1038/hr.2014.53; Kadowaki T, 2013, J DIABETES INVEST, V4, P576, DOI 10.1111/jdi.12092; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Liu WJ, 2012, J PHARMACOL EXP THER, V340, P248, DOI 10.1124/jpet.111.186866; Yoshida T, 2012, BIOORGAN MED CHEM, V20, P5705, DOI 10.1016/j.bmc.2012.08.012; Fukuda-Tsuru S, 2012, EUR J PHARMACOL, V696, P194, DOI 10.1016/j.ejphar.2012.09.024; Nabeno M, 2013, BIOCHEM BIOPH RES CO, V434, P191, DOI 10.1016/j.bbrc.2013.03.010; Fukuda-Tsuru S, 2014, EUR J PHARMACOL, V723, P207, DOI 10.1016/j.ejphar.2013.11.030; Goda M, 2013, DRUG TODAY, V49, P615, DOI 10.1358/dot.2013.49.10.2035882; Kadowaki T, 2013, DIABETES OBES METAB, V15, P810, DOI 10.1111/dom.12092; Piconi L, 2004, J THROMB HAEMOST, V2, P1453, DOI 10.1111/j.1538-7836.2004.00835.x; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Deacon CF, 2013, EXPERT OPIN PHARMACO, V14, P2047, DOI 10.1517/14656566.2013.824966; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; Su G, 2013, DIABETES CARE, V36, P1026, DOI 10.2337/dc12-0925; Eto T, 2012, DIABETES OBES METAB, V14, P1040, DOI 10.1111/j.1463-1326.2012.01662.x; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Kadowaki T, 2014, DIABETES OBES METAB, V16, P418, DOI [10.1111/dom.12235, 10.1111/dom.12233]; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Nakamaru Y, 2014, XENOBIOTICA, V44, P242, DOI 10.3109/00498254.2013.816891; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Aroor AR, 2014, AM J PHYSIOL-HEART C, V307, pH477, DOI 10.1152/ajpheart.00209.2014; Balakumar P, 2013, CELL SIGNAL, V25, P1799, DOI 10.1016/j.cellsig.2013.05.009; Ceriello A, 2008, DIABETES, V57, P1349, DOI [10.2337/db08-0063, 10.2337/dbO8-0063]; Ceriello A, 2000, DIABETES METAB RES, V16, P125, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4; Halabi A, 2014, CLIN PHARM DRUG DEV, V3, P290, DOI 10.1002/cpdd.89; Halabi A, 2013, CLIN PHARM DRUG DEV, V2, P246, DOI 10.1002/cpdd.29; International Diabetes Federation, 2011, GUIDELINE FOR MANAGE; Mita T, 2007, BIOCHEM BIOPH RES CO, V358, P679, DOI 10.1016/j.bbrc.2007.04.118; Otsuki H, 2014, INT UROL NEPHROL, V46, P427, DOI 10.1007/s11255-013-0552-6; Pharmaceuticals and Medical Devices Agency, 2012, TENELIA APPLICATION; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924; Scheen AJ, 2014, EXPERT OPIN PHARMACO, V10, P1; Takase B, 2013, J N REMEDIES CLIN, V50, P698; Tanaka S, 2014, DIABETES TECHNOL THE, V16, P840, DOI 10.1089/dia.2014.0095; Tsuchimochi W, 2015, ENDOCR J, V62, P13, DOI 10.1507/endocrj.EJ14-0393	39	5	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-6566	1744-7666		EXPERT OPIN PHARMACO	Expert Opin. Pharmacother.	FEB	2015	16	3					417	426		10.1517/14656566.2015.1000301		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ3SO	WOS:000348147200015		
J	Ohshiro, T; Tomoda, H				Ohshiro, Taichi; Tomoda, Hiroshi			Acyltransferase inhibitors: a patent review (2010-present)	EXPERT OPINION ON THERAPEUTIC PATENTS			English	Article						acyl-CoA:cholesterol acyltransferase; diacylglycerol acyltransferase; inhibitor; isozyme; monoacylglycerol acyltransferase; neutral lipid metabolism	COA-CHOLESTEROL ACYLTRANSFERASE; GLIOCLADIUM-ROSEUM KF-1040; ISOFORM-SPECIFIC INHIBITOR; GHRELIN O-ACYLTRANSFERASE; HUMICOLA SP FO-2942; HUMAN ACYL-COENZYME; E-DEFICIENT MICE; DIACYLGLYCEROL ACYLTRANSFERASE; MONOACYLGLYCEROL ACYLTRANSFERASE; FAMILIAL HYPERCHOLESTEROLEMIA	Introduction: Acyltransferase (AT) catalyzes the transfer of an acyl moiety from acyl-coenzyme A (acyl-CoA) to an acceptor. ATs play important roles in the maintenance of homeostasis in the human body and have been linked to various diseases; therefore, several ATs have been proposed as potential targets for the treatment or prevention of such diseases. The AT family includes acyl-CoA: cholesterol AT (ACAT), diacylglycerol AT (DGAT), and mono-acylglycerol AT (MGAT) for the metabolism of lipids. Furthermore, recent molecular biological studies revealed the existence of their isozymes with distinct functions in the body. Areas covered: This review summarized patent filings published between 2010 and the present date that claimed isozyme-selective inhibitors of ACAT, DGAT and MGAT, which are involved in neutral lipid metabolism. Expert opinion: Isozymes of ACAT, DGAT and MGAT play distinct functions in neutral lipid metabolism in the human body and have been considered as potential therapeutic targets. Accordingly, isozyme-selective inhibitors that could be used in the treatment or prevention of lipid metabolism disorders were searched for. Of these, pyripyropene A derivatives, ACAT2-selective inhibitors, may be potential therapeutics for the treatment of atherosclerosis, homozygous familial hypercholesterolemia and nonalcoholic fatty liver disease.	[Ohshiro, Taichi; Tomoda, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Ohshiro, Taichi] Wake Forest Sch Med, Dept Internal Med Mol Med, Sect Lipid Sci, Winston Salem, NC 27101 USA	Tomoda, H (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, 5-9-1 Shirokane, Tokyo 1088641, Japan.	tomodah@pharm.kitasato-u.ac.jp					Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Ohshiro T, 2007, J ANTIBIOT, V60, P43; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Endo A, 2010, P JPN ACAD B-PHYS, V86, P484, DOI 10.2183/pjab.86.484; Terasaka N, 2007, ATHEROSCLEROSIS, V190, P239, DOI 10.1016/j.atherosclerosis.2006.03.007; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; OBATA R, 1995, J ANTIBIOT, V48, P749; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Raal FJ, 1997, ATHEROSCLEROSIS, V135, P249, DOI 10.1016/S0021-9150(97)00168-8; Lee RG, 2000, J LIPID RES, V41, P1991; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Obata R, 1997, J ANTIBIOT, V50, P229; Obata R, 1996, J ANTIBIOT, V49, P1133; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; DeVita RJ, 2013, J MED CHEM, V56, P9820, DOI 10.1021/jm4007033; Das A, 2008, J BIOL CHEM, V283, P10453, DOI 10.1074/jbc.M709460200; Fazio S, 2006, NEW ENGL J MED, V354, P1307, DOI 10.1056/NEJMe068012; Buhman KK, 2000, NAT MED, V6, P1341; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; MATTSON FH, 1964, J BIOL CHEM, V239, P2772; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; KIM YK, 1994, J ANTIBIOT, V47, P154; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; TOMODA H, 1994, J ANTIBIOT, V47, P148; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Ohshiro T, 2008, J ANTIBIOT, V61, P503, DOI 10.1038/ja.2008.67; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Ohtawa M, 2013, BIOORG MED CHEM LETT, V23, P2659, DOI 10.1016/j.bmcl.2013.02.088; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Smith SJ, 2000, NAT GENET, V25, P87; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; [Anonymous], 2010, [No title captured], Patent No. 2009126624; Tomoda H, 1999, J ANTIBIOT, V52, P689; Obata R, 1996, J ANTIBIOT, V49, P1149; Ohtawa M, 2013, BIOORG MED CHEM LETT, V23, P3798, DOI 10.1016/j.bmcl.2013.04.075; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Ge J, 2013, J CELL BIOCHEM, V114, P2188, DOI 10.1002/jcb.24568; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; OMURA S, 1993, J ANTIBIOT, V46, P1168; Ohshiro T, 2011, FUTURE MED CHEM, V3, P2039, DOI [10.4155/fmc.11.158, 10.4155/FMC.11.158]; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; Ohtawa M, 2013, BIOORG MED CHEM LETT, V23, P1285, DOI 10.1016/j.bmcl.2012.12.099; BELL RM, 1983, ENZYMES, V16, P87; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI200213880; Cho KH, 2003, BIOCHEM BIOPH RES CO, V309, P864, DOI 10.1016/j.bbrc.2003.08.077; Gao Y, 2013, J LIPID RES, V54, P1644, DOI 10.1194/jlr.M035493; Inokoshi J, 2009, J ANTIBIOT, V62, P51, DOI 10.1038/ja.2008.5; Joyce CW, 2000, MOL BIOL CELL, V11, P3675; KAYDEN HJ, 1967, J CLIN INVEST, V46, P1695, DOI 10.1172/JCI105660; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Lockwood JF, 2003, AM J PHYSIOL-ENDOC M, V285, pE927, DOI 10.1152/ajpendo.00179.2003; Matsuda D, 2007, CURR OPIN INVEST DR, V8, P836; Matsuda D, 2014, J ANTIBIOT IN PRESS; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Obata R, 1997, CHEM LETT, P935, DOI 10.1246/cl.1997.935; Ohgusu H, 2012, METHOD ENZYMOL, V514, P147, DOI 10.1016/B978-0-12-381272-8.00010-6; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Tabata N, 1999, J ANTIBIOT, V52, P815; Tomoda H, 1996, J ANTIBIOT, V49, P929; TOMODA H, 1995, J ANTIBIOT, V48, P937; TOMODA H, 1995, J ANTIBIOT, V48, P942	84	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-3776	1744-7674		EXPERT OPIN THER PAT	Expert Opin. Ther. Patents	FEB	2015	25	2					145	158		10.1517/13543776.2014.989833		14	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ3TB	WOS:000348148400003		
J	Takada, I; Makishima, M				Takada, Ichiro; Makishima, Makoto			PPAR gamma ligands and their therapeutic applications: a patent review (2008-2014)	EXPERT OPINION ON THERAPEUTIC PATENTS			English	Article						adverse effects; bone; combinations; diabetes; inflammation; neurological diseases; nuclear receptors; selective modulators; skin	ACTIVATED-RECEPTOR-GAMMA; PHENYLPROPANOIC ACID-DERIVATIVES; TYPE-2 DIABETES-MELLITUS; NUCLEAR RECEPTORS; NEUROPATHIC PAIN; AGONISTS; CELLS; ROSIGLITAZONE; EFATUTAZONE; METABOLISM	Introduction: PPAR gamma regulates glucose and lipid metabolism, immunity, and cellular growth and differentiation. Thiazolidinediones (TZDs) are synthetic PPAR gamma ligands that are used in the treatment of type 2 diabetes. However, TZDs can cause adverse effects, such as increased risks of heart failure, bone fractures and bladder cancer. PPAR gamma has a large ligand-binding pocket, which makes it possible to develop a variety of PPAR gamma ligands, leading to patents on their therapeutic applications. Areas covered: We summarize recent patent activity regarding PPAR gamma ligands and their therapeutic applications from 2008. Pharmacologic methods to increase PPAR gamma expression and to decrease PPAR gamma adverse effects by combining PPAR gamma ligands with other drugs are also reviewed. Expert opinion: In addition to novel PPAR gamma ligands that exhibit selective therapeutic activity without adverse effects, such as bone loss, fluid retention or weight gain, methods for the combination of PPAR gamma ligands and other compounds have been claimed to decrease adverse effects and/or to enhance targeted effects. Combination therapy is useful but has the potential risk of unexpected adverse effects. Patent applications for expanding clinical application of PPAR gamma ligands to non-metabolic diseases, such as neurological and inflammatory diseases, and to skin whitening have been filed, and future studies are needed to elucidate the underlying mechanisms.	[Takada, Ichiro; Makishima, Makoto] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem,Itabashi Ku, Tokyo 1738610, Japan	Makishima, M (reprint author), Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	makishima.makoto@nihon-u.ac.jp			Nihon University School of Medicine	The authors were supported by Nihon University School of Medicine. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Writing assistance was utilized in the production of this manuscript from AI. Schulman and H Uchida.	Acton JJ, 2009, J MED CHEM, V52, P3846, DOI 10.1021/jm900097m; Aestus Theraoeytucs Inc, 2008, Patent No. [WO063842, 070379]; Aestus Therapeutics Inc, 2014, Methods of treating neuropathic pain with benzimidazole derivative agonists of PPARgamma, Patent No. [US0024692, 0034380]; Akasaki Y, 2006, J BIOL CHEM, V281, P6165, DOI 10.1074/jbc.M505266200; Jang WG, 2011, BONE, V48, P885, DOI 10.1016/j.bone.2010.12.003; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Yamada S, 2014, TRENDS PHARMACOL SCI, V35, P324, DOI 10.1016/j.tips.2014.04.008; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P2604, DOI 10.1001/jama.2013.284788; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; [Anonymous], BUSINESS WIRE; VanderLaan PA, 2005, J LIPID RES, V46, P829, DOI 10.1194/jlr.R500003-JLR200; [Anonymous], 2011, BUSINESS WIRE; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Makishima M, 2005, J PHARMACOL SCI, V97, P177, DOI 10.1254/jphs.FMJ04008X4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Salam NK, 2008, CHEM BIOL DRUG DES, V71, P57, DOI 10.1111/j.1747-0285.2007.00606.x; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; He WM, 2009, PPAR RES, DOI 10.1155/2009/849538; Lee SY, 2006, LUNG CANCER-J IASLC, V51, P297, DOI 10.1016/j.lungcan.2005.10.010; Kim WK, 2007, J BONE MINER RES, V22, P1711, DOI 10.1359/JBMR.070710; Komm BS, 2014, J STEROID BIOCHEM, V143, P207, DOI 10.1016/j.jsbmb.2014.03.003; Raval P, 2011, BIOORG MED CHEM LETT, V21, P3103, DOI 10.1016/j.bmcl.2011.03.020; Cariou B, 2012, TRENDS ENDOCRIN MET, V23, P205, DOI 10.1016/j.tem.2012.03.001; Sauerberg P, 2002, J MED CHEM, V45, P789, DOI 10.1021/jm010964g; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Poirier J, 2014, NEUROBIOL AGING, V35, pS3, DOI 10.1016/j.neurobiolaging.2014.03.037; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Mai QG, 2011, J CELL BIOCHEM, V112, P2902, DOI 10.1002/jcb.23206; Pishvaian MJ, 2012, CANCER-AM CANCER SOC, V118, P5403, DOI 10.1002/cncr.27526; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Choi M, 2009, EXPERT OPIN THER PAT, V19, P593, DOI 10.1517/13543770902877717; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Wohlfert EA, 2007, J IMMUNOL, V178, P4129; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; [Anonymous], INH PPAR GAMM AG; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; [Anonymous], DIAB MELL DEV DRUGS; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Copland JA, 2006, ONCOGENE, V25, P2304, DOI 10.1038/sj.onc.1209267; Kyle KA, 2011, ENDOCRINOLOGY, V152, P457, DOI 10.1210/en.2010-1098; Ellis CN, 2000, ARCH DERMATOL, V136, P609, DOI 10.1001/archderm.136.5.609; Koren N, 2014, J NUTR BIOCHEM, V25, P623, DOI 10.1016/j.jnutbio.2014.01.012; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Smallridge RC, 2013, J CLIN ENDOCR METAB, V98, P2392, DOI 10.1210/jc.2013-1106; Lee DH, 2012, AM J PHYSIOL-ENDOC M, V302, pE552, DOI [10.​1152/​ajpendo.​00569.​2011, 10.1152/ajpendo.00569.2011]; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Stopponi S, 2011, BIOL PSYCHIAT, V69, P642, DOI 10.1016/j.biopsych.2010.12.010; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; [Anonymous], 2009, FDA News Release, Patent No. 0012129; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Avon Products Inc, 2011, Patent No. [WO156136, 157394]; Cardoz AB, 2009, Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a PPAR gamma agonist, Patent No. [WO007673, 008767]; Cedars-Sinai Medical Center, 2008, Patent No. [WO008767, 0144884]; Centre National de la Recherche Scientifique, 2010, Patent No. [WO070379, 076553]; Daiichi Sankyo Co. Ltd., 2011, Patent No. [US0160462, 021476]; Dana-Farber Cancer Institute Inc., 2011, Patent No. [WO091134, 095462]; Dantas AT, 2013, PPAR RES, V2013; Dong-A Pharm. Co. Ltd., 2008, Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same, Patent No. [WO108602, 109334]; European Medicines Agency, 2011, ASS REP AV; Fujimura T, 2005, J PHARMACOL SCI, V99, P342, DOI 10.1254/jphs.FP0050578; Galderma Research & Development, 2010, Novel 3-phenyl acrylic acid compound activators of type PPAR receptors and pharmaceutical/cosmetic compositions comprised thereof, Patent No. [US0144884, 0160462]; Galderma Researh & Development, 2009, Novel biaromatic compounds that modulate PPAR-receptors, Patent No. [US0012129, 0022603]; Giuliani International Ltd, 2008, PPAR-gamma agonists for the induction of ationic antimicrobial peptide expression as immunoprotective stimulants, Patent No. [WO104557, 105103]; Guri AJ, 2011, J NUTR BIOCHEM, V22, P812, DOI 10.1016/j.jnutbio.2010.06.011; Higgins LS, 2008, PPAR RES, V2008; Indiana University Research and Technology Corp, 2010, Patent No. [WO028370, 058649]; InteKrin Therapeutics Inc, 2014, PPAR&gamma; agonists for treatment of multiple sclerosis, Patent No. [WO120538, 124311]; InteKrin Therapeutics Inc., 2009, Combination of PPARg agonist and a dipeptidyl peptidase-inhibitor for the treatment of diabetes and obesity, Patent No. [WO111078, 117013]; Kasuga J, 2008, BIOORG MED CHEM LETT, V18, P1110, DOI 10.1016/j.bmcl.2007.12.001; Keil S, 2011, CHEMMEDCHEM, V6, P633, DOI 10.1002/cmdc.201100047; Kim MK, 2009, ARCH PHARM RES, V32, P721, DOI 10.1007/s12272-009-1511-8; Kindex Therapeutics LLC., 2012, Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods, Patent No. [WO058649, 063842]; Konda VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087848; Kowa Co. Ltd, 2012, Novel phenylpyridine derivative and drug containing same, Patent No. [WO124311, 137105]; Kowa Co. Ltd., 2011, Novel 2-pyridone derivative and pharmaceutical product containing same, Patent No. [WO077711, 091134]; Kowa Co. Ltd., 2010, Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3H)-one structure and drugs that comprise same, Patent No. [WO095462, 096564]; Kowa Co. Ltd, 2011, Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same, Patent No. [WO077712, 077711]; La Jolla Institute for Allergy and Immunology, 2008, Regulatory T cells and methods of making and using same, Patent No. [WO157394, 20090137626]; Lamers C, 2012, EXPERT OPIN THER PAT, V22, P803, DOI 10.1517/13543776.2012.699042; Lanfear D, 2011, Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity, Patent No. [US0034380, 004341]; Lincoff AM, 2014, JAMA-J AM MED ASSOC, V311, P1515, DOI 10.1001/jama.2014.3321; Maeda T, 2008, J PHARMACOL SCI, V108, P341, DOI 10.1254/jphs.08207FP; Merck & Co. Inc., 2008, Patent No. [WO109334, 111078]; Merck & Co. Inc., 2006, Patent No. [WO096564, 098801]; Merck Sharp & Dohme Corp, 2008, Method of treatment using fused aromatic compounds having anti-diabetic activity, Patent No. [WO137105, 141897]; Merz Pharma GmbH & Co. KGaA, 2012, Patent No. [WO117013, 117791]; Metabolic Solutions Development Co, 2012, Patent No. [WO021467, 0216883]; Metabolic Solutions Development Co, 2012, Patent No. [WO021476, 021467]; Miyachi H, 2002, BIOORG MED CHEM LETT, V12, P77, DOI 10.1016/S0960-894X(01)00672-2; Nagao Shizuko, 2012, Curr Mol Pharmacol, V5, P292; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ohashi M, 2012, BIOORGAN MED CHEM, V20, P6375, DOI 10.1016/j.bmc.2012.08.061; Okayama University, 2010, Novel &alpha;-substituted propionic derivatives, Patent No. [JP2012041334, 2301539]; Okuno A, 2009, Pharmaceutical composition containing PPARgamma agonist., Patent No. [US20090137626, 20130344043]; Omeros Corp, 2010, Compositions and methods for prophylaxis and treatment of addictions, Patent No. [WO105103, 107652]; Oton AB, 2014, AM ASS CANC RES ANN; Park MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076820; Patano N, 2008, CALCIFIED TISSUE INT, V82, P221, DOI 10.1007/s00223-008-9109-6; ProMD Biotech Co. Ltd, 2013, Method for enhancing PPARg expression, Patent No. [US20130344043, 2012041334]; Pulmagen Therapeutics (Inflammation) Ltd, 2011, Inflammatory disease treatment, Patent No. [WO098801, 099794]; Pulmagen Therapeutics (Inflammation) Ltd, 2010, Sulfonamide compounds for the treatment of respiratory disorders, Patent No. [WO076553, 077712]; Pusan National University Indusrty University, 2012, Patent No. [WO108677, 108602]; Rheinische Friedrich-Wilhelms Universitat, 2011, PPAR gamma agonists for treating illnesses with pathophysiological participation of TH17 lymphocytes, Patent No. [EP2301539, 2612553]; Sanofi-Aventis, 2010, Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use, Patent No. [US0022603, 0024692]; Santen Pharmaceutical Co. Ltd, 2009, Patent No. [WO107652, 108677]; Serizawa M, 2014, CANCER SCI, V105, P683, DOI 10.1111/cas.12411; Sigma-Tau Industrie Farmaceutiche Riunite S. P. A, 2008, Patent No. [WO141897, 153373]; SmithKline Beecham, 2008, PPAR-gamma agonists for improvement of cognitive function in Apoe4 negative patients, Patent No. [US0262047, 026658]; Takada I, 2010, PPAR RES, DOI 10.1155/2010/341671; Takeda Pharmaceutical Co. Ltd., 2008, Fused ring compounds as partial agonists of PPAR-gamma, Patent No. [WO099794, 104557]; The Regents of the University of California, 2011, Inhibition of PPAR gamma expression in preadipocyte cells by oxysterols, Patent No. [WO006087, 007673]; The University of Sydney, 2009, Patent No. [WO021467, 0262047]; The University of Sydney, 2009, Patent No. [WO026658, 028370]; The University of Tokyo, 2008, alpha;-Substituted phenylpropionic acid derivatives, Patent No. [WO004341, 006087]; Umbert Millet I., 2009, Patent No. [WO153373, 156136]; Virginia Tech Intellectual Properties Inc., 2010, Method of using abscisic acid to treat and prevent diseases and disorders, Patent No. [US0216883, 021467]; Vivacell Biotechnology Espana, 2011, Patent No. [WO117429, 120538]; Wang L, 2011, ACTA PHARMACOL SIN, V32, P991, DOI 10.1038/aps.2011.81; Wellstat Therapeutics Corp, 2007, Combination treatment of metabolic disorders, Patent No. [WO117791, 117429]; Wiechers J. W., 2005, International Journal of Cosmetic Science, V27, P123, DOI 10.1111/j.1467-2494.2004.00256.x; Zhang XQ, 2009, EXPERT OPIN THER PAT, V19, P1239, DOI 10.1517/13543770902994397	129	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-3776	1744-7674		EXPERT OPIN THER PAT	Expert Opin. Ther. Patents	FEB	2015	25	2					175	191		10.1517/13543776.2014.985206		17	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ3TB	WOS:000348148400005		
J	Uraoka, T; Hosoe, N; Yahagi, N				Uraoka, Toshio; Hosoe, Naoki; Yahagi, Naohisa			Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening?	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Editorial Material						adenoma detection rate; colonic polyps; colonoscope; colorectal cancer screening	RANDOMIZED CONTROLLED-TRIAL; ADENOMA DETECTION; COLON CAPSULE; BACK COLONOSCOPIES; MISS RATES; MULTICENTER; ENDOSCOPY; RISK; POLYPECTOMY; PREVENTION	A broad range of modalities for colorectal cancer (CRC) screening are available worldwide. Although recent studies have been demonstrating developments of CRC screening modalities including colonoscopy, computed tomography colonography or colon video capsule colonoscopy remains the gold standard for the early detection of adenoma or CRC. Because patient preferences and availability of resources play an important role in the selection of CRC screening options, further improvement of each screening modality and its associated research is necessary to consider its involvement in clinical practice.	[Uraoka, Toshio] Natl Tokyo Med Ctr, Dept Gastroenterol, Meguro Ku, Tokyo 1528902, Japan; [Uraoka, Toshio; Yahagi, Naohisa] Keio Univ, Sch Med, Ctr Canc, Div Res & Dev Minor Invas Treatment,Shinjuku Ku, Tokyo 1608582, Japan; [Hosoe, Naoki] Keio Univ, Sch Med, Ctr Diagnost & Therapeut Endoscopy, Shinjuku Ku, Tokyo 1608582, Japan	Yahagi, N (reprint author), Keio Univ, Sch Med, Ctr Canc, Div Res & Dev Minor Invas Treatment,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yahagi-tky@umin.ac.jp					Hewett DG, 2011, GASTROINTEST ENDOSC, V74, P246, DOI 10.1016/j.gie.2011.04.005; Van Gossum A, 2009, NEW ENGL J MED, V361, P264, DOI 10.1056/NEJMoa0806347; Rex DK, 2009, AM J GASTROENTEROL, V104, P149, DOI 10.1038/ajg.2008.35; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Eliakim R, 2009, ENDOSCOPY, V41, P1026, DOI 10.1055/s-0029-1215360; Rastogi A, 2012, GUT, V61, P402, DOI 10.1136/gutjnl-2011-300187; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rex DK, 2003, AM J GASTROENTEROL, V98, P2000, DOI 10.1016/S0002-9270(03)00625-7; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Leufkens AM, 2011, GASTROINTEST ENDOSC, V73, P480, DOI 10.1016/j.gie.2010.09.004; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; Spada C, 2011, GASTROINTEST ENDOSC, V74, P581, DOI 10.1016/j.gie.2011.03.1125; Gralnek IM, 2014, LANCET ONCOL, V15, P353, DOI 10.1016/S1470-2045(14)70020-8; O'Connell JB, 2004, J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Dinesen L, 2012, GASTROINTEST ENDOSC, V75, P604, DOI 10.1016/j.gie.2011.10.017; Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; Leung WK, 2014, AM J GASTROENTEROL, V109, P855, DOI 10.1038/ajg.2014.83; Sano Y, 2005, DIGEST ENDOSC, V17, pS43; Uraoka T, 2013, GASTROINTEST ENDOSC, V77, P480, DOI 10.1016/j.gie.2012.08.037; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	23	0	0	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	FEB	2015	9	2					129	132		10.1586/17474124.2015.960397		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ1ZZ	WOS:000348035400002		
J	Shitara, K; Ohtsu, A				Shitara, Kohei; Ohtsu, Atsushi			Ramucirumab for gastric cancer	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY			English	Article						anti-VEGFR monoclonal antibodies; gastric cancer; ramucirumab; vascular endothelial growth factor receptor	RANDOMIZED PHASE-III; CLINICOPATHOLOGICAL SIGNIFICANCE; VEGF EXPRESSION; SUPPORTIVE CARE; DOUBLE-BLIND; OPEN-LABEL; TRIAL; CHEMOTHERAPY; PACLITAXEL; SURVIVAL	In recent years, various molecular target agents have been investigated for gastric cancer. VEGF is one of the most potent angiogenic factors and is a signaling molecule secreted by many solid tumors. High VEGF expression is one of the characteristic features of gastric carcinomas, thus targeting VEGF is considered a promising strategy for gastric cancer. Ramucirumab, an anti-VEGF receptor antibody, has proven to be effective for previously treated advanced gastric cancer. Details of ramucirumab, including two pivotal Phase III studies, will be discussed in this review. Ramucirumab, with or without chemotherapy, improved survival in gastric cancer after previous systemic chemotherapy, thus becoming the standard of care for this patient population. Optimal timing of ramucirumab use and adequate biomarkers for patient selection as well as mechanism of resistance should be explored in future research.	[Shitara, Kohei] Natl Canc Ctr Hosp East, Dept Expt Therapeut, Chiba, Japan; [Shitara, Kohei] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan; [Ohtsu, Atsushi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Chiba, Japan	Shitara, K (reprint author), Natl Canc Ctr Hosp East, Dept Expt Therapeut, Chiba, Japan.	kshitara@east.ncc.go.jp					Al-Batran SD, 2014, J CLIN ONCOL S, V32; Tanigawa N, 1996, CANCER RES, V56, P2671; Bocci G, 2013, ANGIOGENESIS, V16, P481, DOI 10.1007/s10456-013-9334-0; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; Aprile G, 2013, DRUGS, V73, P2003, DOI 10.1007/s40265-013-0154-8; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Bang YJ, 2011, INVEST NEW DRUG, V29, P1449, DOI 10.1007/s10637-010-9438-y; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Clarke JM, 2013, EXPERT OPIN BIOL TH, V13, P1187, DOI 10.1517/14712598.2013.810717; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Chiorean EG, 2007, MOL TARGETS CANC THE; Hironaka S, 2014, J CLIN ONCOL S, V32; Jung YD, 2012, EUR J CANCER, P1133; Karayiannakis AJ, 2002, ANN SURG, V236, P37, DOI 10.1097/01.SLA.0000018567.54479.E6; Muro K, 2010, PHSAE STUDY SUNITINI; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; NCCN, 2014, NCCN CLIN PRACT GUID; Oh SY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-123; Qin SK, 2014, J CLIN ONCOL S, V32, p5s; Suzuki S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-659; Van Cutsem E, 2012, CLIN ONCOL, V2012, P30; Wakatsuki T, 2012, J CLIN ONCOL S, V30; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yamada Y, 2009, MOL CANC THER S, V8, pA260; Yoon HH, 2014, J CLIN ONCOL S, V32	32	1	1	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1747-4124	1747-4132		EXPERT REV GASTROENT	Expert Rev. Gastroenterol. Hepatol.	FEB	2015	9	2					133	139		10.1586/17474124.2015.987754		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ1ZZ	WOS:000348035400003		
J	Tsuchiyama, T; Miyazaki, H; Terada, H; Nakajima, M				Tsuchiyama, Tomoyuki; Miyazaki, Hitoshi; Terada, Hisaya; Nakajima, Masahiro			Observed distribution of radiocaesium contamination in shiitake lots and variability of test results	FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT			English	Article						sampling; shiitake mushroom; Cs-134; Cs-137; uncertainty; radiocaesium	MUSHROOMS; ELEMENTS; CS-137; PART; RADIONUCLIDES; EXPOSURE; JAPAN; K-40	Shiitake mushrooms (Lentinula edodes) cultivated on bed-log are known to accumulate radiocaesium. Since the Fukushima-Diichi nuclear power plant accident (2011), the violation rate has been higher for log-cultivated shiitake than that for agricultural products or other foodstuffs. When testing shiitake mushrooms for radionuclide contamination, the validation of the sampling plan can be severely compromised by the heterogeneous contamination within shiitake lots. Currently, few data are available on the statistical properties of the radiocaesium contamination of log-cultivated shiitake. In this paper, shiitake lots contaminated by radiocaesium were identified and the distribution of the radiocaesium concentration within the lots investigated. The risk of misclassifying shiitake lots was predicted from the operating characteristic curve generated from Monte Carlo simulations and the performance of various sampling plans was evaluated. This study provides useful information for deciding on an acceptable level of misclassification risk.	[Tsuchiyama, Tomoyuki; Miyazaki, Hitoshi; Terada, Hisaya; Nakajima, Masahiro] Nagoya City Publ Hlth Res Inst, Food Dept, Mizuho Ku, Nagoya, Aichi 4678615, Japan	Tsuchiyama, T (reprint author), Nagoya City Publ Hlth Res Inst, Food Dept, Mizuho Ku, Nagoya, Aichi 4678615, Japan.	tomtsuchiyama@gmail.com					Mietelski JW, 2010, J ENVIRON RADIOACTIV, V101, P706, DOI 10.1016/j.jenvrad.2010.04.010; Whitaker TB, 2006, J AOAC INT, V89, P1027; Ferrari P, 2013, FOOD ADDIT CONTAM A, V30, P687, DOI 10.1080/19440049.2013.777161; Guillen J, 2014, FOOD CHEM, V154, P14, DOI 10.1016/j.foodchem.2013.12.083; Whitaker TB, 2006, FOOD ADDIT CONTAM, V23, P50, DOI 10.1080/02652030500241587; Pocas MF, 2010, FOOD ADDIT CONTAM A, V27, P1451, DOI 10.1080/19440049.2010.490790; COOPER JA, 1970, NUCL INSTRUM METHODS, V82, P273, DOI 10.1016/0029-554X(70)90361-7; Falandysz J, 2013, APPL MICROBIOL BIOT, V97, P477, DOI 10.1007/s00253-012-4552-8; Falandysz J, 2008, J ENVIRON SCI HEAL A, V43, P1692, DOI 10.1080/10934520802330206; Baeza A, 2006, SCI TOTAL ENVIRON, V359, P255, DOI 10.1016/j.scitotenv.2005.05.015; Bannai T, 1997, HEALTH PHYS, V72, P384, DOI 10.1097/00004032-199703000-00005; Ban-Nai T, 2004, J RADIAT RES, V45, P325, DOI 10.1269/jrr.45.325; CRAN, 2014, PACK FADIST; Falandysz J, 2007, J ENVIRON SCI HEAL A, V42, P2081, DOI 10.1080/10934520701626993; Falandysz J, 2007, J ENVIRON SCI HEAL A, V42, P1161, DOI 10.1080/1093452071418672; Falandysz J, 2007, J ENV SCI HLTH B, V42, P187; Falandysz J, 2007, J ENVIRON SCI HEAL A, V42, P1615, DOI 10.1080/10934520701517853; Gruter H, 1971, HEALTH PHYS, V20, P655; Horvath Z, 2013, J ENVIRON SCI HEAL B, V48, P615, DOI 10.1080/03601234.2013.777277; Jongenburger I, 2012, INT J FOOD MICROBIOL, V157, P35, DOI 10.1016/j.ijfoodmicro.2012.04.009; Kagawa Y, 2005, STANDARD TABLES FOOD; MHLW, 2012, TEST METH RAD SUBST; MIETELSKI JW, 1994, SCI TOTAL ENVIRON, V157, P217; Ministry of Health Labour and Welfare (MHLW), 2014, LEV RAD CONT FOODS T; Nabeshi H, 2013, FOOD HYG SAFE SCI, V54, P65, DOI 10.3358/shokueishi.54.65; Renaud P, 2013, RADIOPROTECTION, V48, P493, DOI 10.1051/radiopro/2013081; Shimizu Masami, 1997, Radioisotopes, V46, P272; TSVETNOVA OB, 1994, SCI TOTAL ENVIRON, V155, P25, DOI 10.1016/0048-9697(94)90358-1; Watanabe T, 2012, J AGR FOOD CHEM, V60, P10702, DOI [10.1021/jf302727f, 10.1021/jf4302727f]; Whitaker Thomas B, 2007, J AOAC Int, V90, P778	30	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1944-0049	1944-0057		FOOD ADDIT CONTAM A	Food Addit. Contam. Part A-Chem.	FEB 1	2015	32	2					205	213		10.1080/19440049.2014.990996		9	Chemistry, Applied; Food Science & Technology; Toxicology	Chemistry; Food Science & Technology; Toxicology	CA1FN	WOS:000348658300008		
J	Kokawa, M; Yokoya, N; Ashida, H; Sugiyama, J; Tsuta, M; Yoshimura, M; Fujita, K; Shibata, M				Kokawa, Mito; Yokoya, Naoto; Ashida, Hiroko; Sugiyama, Junichi; Tsuta, Mizuki; Yoshimura, Masatoshi; Fujita, Kaori; Shibata, Mario			Visualization of Gluten, Starch, and Butter in Pie Pastry by Fluorescence Fingerprint Imaging	FOOD AND BIOPROCESS TECHNOLOGY			English	Article						Fluorescence fingerprint; Autofluorescence; Hyperspectral imaging; Spectral unmixing; Nonnegativity	SCANNING LASER MICROSCOPY; COMPONENT ANALYSIS; HYPERSPECTRAL DATA; BREAD DOUGH; MICROSTRUCTURE; QUANTIFICATION; DISTRIBUTIONS; PROTEINS; QUALITY; MIXTURE	The distribution of starches, proteins, and fat in baked foods determine their texture and palatability, and there is a great demand for techniques to visualize the distributions of these constituents. In this study, the distributions of gluten, starch, and butter in pie pastry were visualized without any staining, by using the fluorescence fingerprint (FF). The FF, also known as the excitation-emission matrix (EEM), is a set of fluorescence spectra acquired at consecutive excitation wavelengths. Fluorescence images of the sample were acquired with excitation and emission wavelengths in the ranges of 270-320 and 350-420 nm, respectively, at 10-nm increments. The FFs of each pixel were unmixed into the FFs and abundances of five constituents, gluten, starch, butter, ferulic acid, and the microscope slide, by using the least squares method coupled with constraints of non-negativity, full additivity, and quantum restraint on the abundances of the slide glass. The calculated abundances of butter, starch, and gluten at each pixel were converted to shades of red (R), green (G), and blue (B), respectively, and RGB images showing the distribution of these three constituents was composited. The composited images showed high correspondence with the images acquired with the conventional staining method. Furthermore, the ratio of gluten, starch, and butter in short pastry was calculated from the abundance images. The calculated ratio was 16.6:37.6:45.8, which was very close to the actual ratio of 12.7:38.8:48.5, and further proved the accuracy of this imaging method.	[Kokawa, Mito; Shibata, Mario] Japan Soc Promot Sci, Chiyoda Ward, Tokyo 1020083, Japan; [Kokawa, Mito; Yoshimura, Masatoshi] Natl Agr & Food Res Org, Natl Food Res Inst, Analyt Sci Div, Tsukuba, Ibaraki 3058642, Japan; [Yokoya, Naoto] Univ Tokyo, Dept Adv Interdisciplinary Studies, Meguro Ward, Tokyo 1530041, Japan; [Ashida, Hiroko] Fuji Oil Co Ltd, Ctr Res & Dev, Tsukubamirai, Ibaraki 3002497, Japan; [Sugiyama, Junichi; Tsuta, Mizuki; Fujita, Kaori; Shibata, Mario] Natl Agr & Food Res Org, Natl Food Res Inst, Food Engn Div, Tsukuba, Ibaraki 3058642, Japan	Sugiyama, J (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, Food Engn Div, 2-1-12 Kan Nondai, Tsukuba, Ibaraki 3058642, Japan.	sugiyama@affrc.go.jp					Gowen AA, 2007, TRENDS FOOD SCI TECH, V18, P590, DOI 10.1016/j.tifs.2007.06.001; Kokawa M, 2012, J CEREAL SCI, V55, P15, DOI 10.1016/j.jcs.2011.09.002; Keshava N, 2002, IEEE SIGNAL PROC MAG, V19, P44, DOI 10.1109/79.974727; Nascimento JMP, 2005, IEEE T GEOSCI REMOTE, V43, P898, DOI 10.1109/TGRS.2005.844293; Peighambardoust SH, 2006, J CEREAL SCI, V43, P183, DOI 10.1016/j.jcs.2005.10.004; Kokawa M, 2013, FOOD BIOPROCESS TECH, V6, P3113, DOI 10.1007/s11947-012-0982-7; Nascimento JMP, 2005, IEEE T GEOSCI REMOTE, V43, P175, DOI 10.1109/TGRS.2004.839806; Lynch EJ, 2009, FOOD RES INT, V42, P885, DOI 10.1016/j.foodres.2009.03.014; Durrenberger MB, 2001, LEBENSM-WISS TECHNOL, V34, P11, DOI 10.1006/fstl.2000.0739; Nasibov H, 2010, IEEE-ASME T MECH, V15, P527, DOI 10.1109/TMECH.2010.2051678; Moreno MC, 2013, J FOOD ENG, V118, P238, DOI 10.1016/j.jfoodeng.2013.03.007; Kokawa M, 2013, FOOD SCI TECHNOL RES, V19, P933; Ghotra BS, 2002, FOOD RES INT, V35, P1015, DOI 10.1016/S0963-9969(02)00163-1; Autio K, 2006, BIOTECHNOL ADV, V24, P633, DOI 10.1016/j.biotechadv.2006.07.002; Watanabe A, 2002, CEREAL CHEM, V79, P203, DOI 10.1094/CCHEM.2002.79.2.203; Heinz DC, 2001, IEEE T GEOSCI REMOTE, V39, P529, DOI 10.1109/36.911111; Autio K, 2001, LEBENSM-WISS TECHNOL, V34, P18, DOI 10.1006/fstl.2000.0725; Boardman J. W., 1994, INT GEOSC REM SENS S, V4, P2369; Cauvain SP, 2006, BAKED PRODUCTS SCI T; Figoni P., 2008, BAKING WORKS EXPLORI; GILL PE, 1984, ACM T MATH SOFTWARE, V10, P282, DOI 10.1145/1271.1276; Gondzio J., 1997, INFORMS Journal on Computing, V9, DOI 10.1287/ijoc.9.1.73; IRVING DW, 1989, CEREAL CHEM, V66, P471; Jiang JK, 2010, SPECTROSC SPECT ANAL, V30, P1525, DOI 10.3964/j.issn.1000-0593(2010)06-1525-05; Keshava N., 2003, Lincoln Laboratory Journal, V14; Kokawa M, 2011, BIOSCI BIOTECH BIOCH, V75, P2112, DOI 10.1271/bbb.110342; Li W, 2004, J CEREAL SCI, V39, P403, DOI 10.1016/j.jcs.2004.02.004; MACRITCHIE F, 1985, J CEREAL SCI, V3, P221; Schulman S.G., 1985, MOL LUMINESCENCE S 1; Sikorska E, 2008, ANAL CHIM ACTA, V613, P207, DOI 10.1016/j.aca.2008.02.063; Sowmya M, 2009, FOOD HYDROCOLLOID, V23, P1827, DOI 10.1016/j.foodhyd.2009.02.008; Sugiyama J, 1999, J AGR FOOD CHEM, V47, P2715, DOI 10.1021/jf981079i; Tsuta M, 2002, J AGR FOOD CHEM, V50, P48, DOI 10.1021/jf010854i; Upadhyay R, 2012, J FOOD ENG, V109, P104, DOI 10.1016/j.jfoodeng.2011.09.028; Yoshino Y, 2005, CEREAL CHEM, V82, P739, DOI 10.1094/CC-82-0739	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1935-5130	1935-5149		FOOD BIOPROCESS TECH	Food Bioprocess Technol.	FEB	2015	8	2					409	419		10.1007/s11947-014-1410-y		11	Food Science & Technology	Food Science & Technology	AZ3MF	WOS:000348130900013		
J	Fan, XJ; Tao, Y; Wei, DQ; Zhang, XH; Lei, Y; Noguchi, H				Fan, Xiaojiang; Tao, Yi; Wei, Dequan; Zhang, Xihui; Lei, Ying; Noguchi, Hiroshi			Removal of organic matter and disinfection by-products precursors in a hybrid process combining ozonation with ceramic membrane ultrafiltration	FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING			English	Article						ceramic ultrafiltration(UF); ozonation; organic matter; hydrophilic; hydrophobic; disinfection by-products	DRINKING-WATER TREATMENT; CATALYTIC MEMBRANES; NATURAL-WATERS; FILTRATION; CARBON; FRACTIONS; NOM	The performance of an integrated process including coagulation, ozonation, ceramic ultrafiltration (UF) and biologic activated carbon (BAC) filtration was investigated for the removal of organic matter and disinfection by-products (DBPs) precursors from micro-polluted surface water. A pilot scale plant with the capacity of 120 m(3) per day was set up and operated for the treatment of drinking water. Ceramic membranes were used with the filtration area of 50 m(2) and a pore size of 60 nm. Dissolved organic matter was divided into five fractions including hydrophobic acid (HoA), base (HoB) and neutral (HoN), weakly hydrophobic acid (WHoA) and hydrophilic matter (HiM) by DAX-8 and XAD-4 resins. The experiment results showed that the removal of organic matter was significantly improved with ozonation in advance. In sum, the integrated process removed 73% of dissolved organic carbon (DOC), 87% of UV254, 77% of trihalomethane (THMs) precursors, 76% of haloacetic acid (HAAs) precursors, 83%of trichloracetic aldehyde (CH) precursor, 77% of dichloroacetonitrile (DCAN) precursor, 51% of trichloroacetonitrile (TCAN) precursor, 96% of 1,1,1-trichloroacetone (TCP) precursor and 63% of trichloronitromethane (TCNM) precursor. Hydrophobic organic matter was converted into hydrophilic organic matter during ozonation/UF, while the organic matter with molecular weight of 1000-3000 Da was remarkably decreased and converted into lower molecular weight organic matter ranged from 200-500 Da. DOC had a close linear relationship with the formation potential of DBPs.	[Fan, Xiaojiang; Tao, Yi; Wei, Dequan; Zhang, Xihui; Lei, Ying] Tsinghua Univ, Grad Sch Shenzhen, Res Ctr Environm Engn & Management, Shenzhen 518055, Peoples R China; [Noguchi, Hiroshi] Meidensha Corp, Shinagawa Ku, Tokyo 1418616, Japan	Zhang, XH (reprint author), Tsinghua Univ, Grad Sch Shenzhen, Res Ctr Environm Engn & Management, Shenzhen 518055, Peoples R China.	zhangxh@sz.tsinghua.edu.cn			National Grand Project "Water Pollution Control and Treatment Technology" [2008ZX07423-002]; Guangdong Science Foundation [2012B030800001]	This work has been supported by the National Grand Project "Water Pollution Control and Treatment Technology" (No. 2008ZX07423-002) and Guangdong Science Foundation (No. 2012B030800001).	Kim HC, 2013, J MEMBRANE SCI, V428, P190, DOI 10.1016/j.memsci.2012.11.004; Byun S, 2011, WATER RES, V45, P163, DOI 10.1016/j.watres.2010.08.031; Chowdhury S, 2009, SCI TOTAL ENVIRON, V407, P4189, DOI 10.1016/j.scitotenv.2009.04.006; Chen Z, 2008, ENVIRON SCI TECHNOL, V42, P5062, DOI 10.1021/esB006673; Yang JS, 2010, DESALINATION, V263, P271, DOI 10.1016/j.desal.2010.06.069; Huang WJ, 2005, SCI TOTAL ENVIRON, V345, P261, DOI 10.1016/j.scitotenv.2004.10.019; Zhang XH, 2013, DESALINATION, V328, P1, DOI 10.1016/j.desal.2013.08.010; Qiao L, 2008, CHEM-EUR J, V14, P151, DOI 10.1002/chem.200701102; VOLK C, 1993, OZONE-SCI ENG, V15, P389; LEENHEER JA, 1981, ENVIRON SCI TECHNOL, V15, P578, DOI 10.1021/es00087a010; Karnik BS, 2005, WATER RES, V39, P728, DOI 10.1016/j.watres.2004.11.017; Lavonen EE, 2013, ENVIRON SCI TECHNOL, V47, P2264, DOI 10.1021/es304669p; von Gunten U, 2003, WATER RES, V37, P1443, DOI 10.1016/S0043-1354(02)00457-8; Chiang PC, 2002, CHEMOSPHERE, V46, P929, DOI 10.1016/S0045-6535(01)00181-3; Fan XJ, 2014, DESALINATION, V335, P47, DOI 10.1016/j.desal.2013.12.014; Rigobello ES, 2013, CHEMOSPHERE, V92, P184, DOI 10.1016/j.chemosphere.2013.03.010; Sartor M, 2008, DESALINATION, V222, P528, DOI 10.1016/j.desal.2007.03.013; Ma HZ, 2001, WATER RES, V35, P985, DOI 10.1016/S0043-1354(00)00350-X; Monteiro MJ, 2010, MACROMOLECULES, V43, P1159, DOI 10.1021/ma902348r; Chen C, 2011, J ENVIRON SCI-CHINA, V23, P582, DOI 10.1016/S1001-0742(10)60423-8; Clesceri L. S., 1998, STANDARD METHODS EXA; Du H, 2012, AGR FOOD CHEM, V60, P2288; Harman BI, 2010, WATER SCI TECHNOL, V62, P547, DOI 10.2166/wst.2010.260; Karnik BS, 2005, ENVIRON SCI TECHNOL, V39, P7656, DOI 10.1021/es0503938; [雷颖 Lei Ying], 2013, [中国给水排水, China Water & Wastewater], V29, P124; Schlichter B, 2004, DESALINATION, V168, P307, DOI 10.1016/j.desal.2004.07.014; Schlichter B, 2003, DESALINATION, V156, P257, DOI 10.1016/S0011-9164(03)00348-5; Sierka RA, 2010, NATO SCI PEACE SECUR, P193, DOI 10.1007/978-94-007-1805-0_13; Zhou QH, 2000, WATER RES, V34, P3505, DOI 10.1016/S0043-1354(00)00115-9	29	0	0	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	2095-2201	2095-221X		FRONT ENV SCI ENG	Front. Env. Sci. Eng.	FEB	2015	9	1					112	120		10.1007/s11783-014-0745-y		9	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AY6WF	WOS:000347702800013		
J	Ishii, N; Ishida, S; Kagami, M				Ishii, Nobuyoshi; Ishida, Seiji; Kagami, Maiko			PCR primers for assessing community structure of aquatic fungi including Chytridiomycota and Cryptomycota	FUNGAL ECOLOGY			English	Article						18S rDNA; Aquatic fungi; Chytridiomycota; Cryptomycota; DGGE; Primer sets	GRADIENT GEL-ELECTROPHORESIS; FOOD-WEB DYNAMICS; RIBOSOMAL-RNA; PARASITIC CHYTRIDS; SEQUENCE ALIGNMENT; HIGH-THROUGHPUT; LAKE INBA; PHYTOPLANKTON; DIVERSITY; ECOSYSTEMS	Fungi are diverse and have the potential for material cycling in freshwater ecosystems. Species composition of aquatic fungi and their seasonal dynamics are often key to their role in the functioning of the ecosystems. However, community structure of aquatic fungi, especially of Chytridiomycota (Chytrids) and Cryptomycota, is still limited because few primer sets are available to examine species composition. In this study, we validated six primer sets for the detection of aquatic fungi by denaturing gradient gel electrophoresis (DGGE) analysis and found that FF390W/EF3r showed the highest specificity among the primer sets tested. We detected both Chytrids and Cryptomycota from Lake Inba by DGGE analysis using the FF390W/EF3r-GC primer set. Further study with our established analysis revealed community structures of aquatic fungi and their seasonal succession patterns in the lake. Results of our study are useful for selection of the primer set for studying community structures of aquatic fungi and their seasonal succession. (C) 2014 Elsevier Ltd and The British Mycological Society.	[Ishii, Nobuyoshi] Natl Inst Radiol Sci, Environm Radiat Effects Res Grp, Inage Ku, Chiba 2638555, Japan; [Ishida, Seiji; Kagami, Maiko] Toho Univ, Funabashi, Chiba 2758510, Japan	Ishii, N (reprint author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	nobu@nirs.go.jp			Japan Society of Promotion of Science for Young Scientists; Futaba Electronics Memorial Foundation	We are grateful to Mr. Amano and Ms. Sato from Toho University who collected environmental samples from Lake Inba. This study was supported by a research fellowship from the Japan Society of Promotion of Science for Young Scientists, and the Futaba Electronics Memorial Foundation.	Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM/69.5.2548.2554.2003; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Wilen BM, 2008, WATER RES, V42, P2300, DOI 10.1016/j.watres.2007.12.013; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Corsaro D, 2014, PARASITOL RES, V113, P1909, DOI 10.1007/s00436-014-3838-4; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; Evans TN, 2012, MICROB ECOL, V63, P773, DOI 10.1007/s00248-011-9984-7; Rasconi S, 2009, APPL ENVIRON MICROB, V75, P2545, DOI 10.1128/AEM.02211-08; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; van Elsas JD, 2000, J MICROBIOL METH, V43, P133, DOI 10.1016/S0167-7012(00)00212-8; Hoshino YT, 2010, MICROBES ENVIRON, V25, P281, DOI 10.1264/jsme2.ME10136; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Sekiguchi H, 2001, BIOTECHNOL LETT, V23, P1205, DOI 10.1023/A:1010517117046; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Gleason Frank H., 2008, Fungal Biology Reviews, V22, P17, DOI 10.1016/j.fbr.2008.02.001; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Wurzbacher CM, 2010, AQUAT MICROB ECOL, V59, P125, DOI 10.3354/ame01385; Holfeld H, 1998, NEW PHYTOL, V138, P507, DOI 10.1046/j.1469-8137.1998.00126.x; Jobard M, 2012, ENVIRON MICROBIOL, V14, P2480, DOI 10.1111/j.1462-2920.2012.02771.x; Kagami M, 2004, LIMNOL OCEANOGR, V49, P680; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Kagami M, 2012, MICROB ECOL, V63, P358, DOI 10.1007/s00248-011-9913-9; Kagami M, 2013, LIMNOLOGY, V14, P51, DOI 10.1007/s10201-012-0385-5; Klindworth A, 2012, NUCLEIC ACIDS RES, V41, pel, DOI DOI 10.1093/NAR/GKS808; MORTON JB, 1990, MYCOLOGIA, V82, P192, DOI 10.2307/3759848; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Rasconi S, 2012, ENVIRON MICROBIOL, V14, P2151, DOI 10.1111/j.1462-2920.2011.02690.x; Sigler WV, 2004, J MICROBIOL METH, V57, P17, DOI 10.1016/j.mimet.2003.11.011; Sparrow FK, 1960, AQUATIC PHYCOMYCETES; Wurzbacher C., 2014, PLOS ONE, V9	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1754-5048	1878-0083		FUNGAL ECOL	Fungal Ecol.	FEB	2015	13						33	43		10.1016/j.funeco.2014.08.004		11	Ecology; Mycology	Environmental Sciences & Ecology; Mycology	AY7UZ	WOS:000347765400004		
J	Azeem, M; Rajarao, GK; Terenius, O; Nordlander, G; Nordenhem, H; Nagahama, K; Norin, E; Borg-Karlson, AK				Azeem, Muhammad; Kuttuva Rajarao, Gunaratna; Terenius, Olle; Nordlander, Goran; Nordenhem, Henrik; Nagahama, Kazuhiro; Norin, Emil; Karin Borg-Karlson, Anna			A fungal metabolite masks the host plant odor for the pine weevil (Hylobius abietis)	FUNGAL ECOLOGY			English	Article						Antifeedant; Blue stain fungus; Chemical communication; Debaryomyces hansenii; Frass; Hylobius abietis; Methyl salicylate; Ophiostoma; Pine weevil	ANTIBIOTIC-PRODUCING FUNGUS; METHYL SALICYLATE; ENDOPHYTIC FUNGUS; MUSCODOR-ALBUS; SCOTS PINE; VOLATILES; CURCULIONIDAE; OVIPOSITION; COLEOPTERA; ANTIFEEDANTS	The pine weevil is one of the most important pest insects of conifer reforestation areas in Europe. Female pine weevils cover their eggs with chewed bark and feces (frass) resulting in avoidance behavior of feeding conspecifics towards egg laying sites. It has been suggested that microorganisms present in the frass may be responsible for producing deterrent compounds for the pine weevil. The fungi Ophiostoma canum, O. pluriannulatum, and yeast Debaryomyces hansenii were isolated from aseptically collected pine-weevil frass. The isolated fungi were cultured on weevil frass broth and their volatiles were collected by SPME and identified by GC MS. D. hansenii produced methyl salicylate (MeS) as a major compound, whereas, in addition, O. canum and O. pluriannulatum produced 6-protoilludene. In a multi-choice lab bioassay, MeS strongly reduced pine weevil's attraction to the Pinus sylvestris volatiles. Thus, a fungal metabolite was found that strongly affects the pine weevil host-odor search. (C) 2014 Elsevier Ltd and The British Mycological Society. All rights reserved.	[Azeem, Muhammad; Nagahama, Kazuhiro; Norin, Emil; Karin Borg-Karlson, Anna] KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Chem, Ecol Chem Grp, SE-10044 Stockholm, Sweden; [Kuttuva Rajarao, Gunaratna] KTH Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden; [Terenius, Olle; Nordlander, Goran; Nordenhem, Henrik] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden; [Karin Borg-Karlson, Anna] Univ Tartu, Inst Technol, Div Organ Chem, EE-50411 Tartu, Estonia; [Nagahama, Kazuhiro] Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Microbial Technol, Kumamoto, Japan; [Azeem, Muhammad] COMSATS Inst Informat Technol, Dept Chem, Abbottabad 22060, Pakistan	Azeem, M (reprint author), KTH, Dept Chem, Teknikringen 30, SE-10044 Stockholm, Sweden.	muhazeem@kth.se		Terenius, Olle/0000-0002-9909-1859	Swedish Research Council Formas, Sweden; Swedish Foundation for Strategic Research, Sweden (SSF) [RBb08-0003]; Mobilitas Programme Top Researcher Grant [MTT2]; Higher Education Commission, Government of Pakistan	We gratefully acknowledge financial support from the Swedish Research Council Formas, Sweden to AKBK, GN and GKR, from the Swedish Foundation for Strategic Research, Sweden (SSF grant number: RBb08-0003) to GN and AKBK, from the Mobilitas Programme Top Researcher Grant No. MTT2 "Chemical Ecology" to AKBK, and from the Higher Education Commission, Government of Pakistan for the Ph.D. scholarship to MA. We are very grateful to Helena Bylund for her advice on statistical analysis.	Alfonzo A., 2012, CURRENT MICROBIOLOGY, V66, P236; Kobayashi C, 2008, EVOL ECOL, V22, P711, DOI 10.1007/s10682-007-9196-2; NORDLANDER G, 1991, ENTOMOL EXP APPL, V59, P229; Demain AL, 1999, APPL MICROBIOL BIOT, V52, P455; Cardoza YJ, 2006, ECOL ENTOMOL, V31, P636, DOI 10.1111/j.1365-2311.2006.00829.x; Tanahashi M, 2009, J INSECT PHYSIOL, V55, P983, DOI 10.1016/j.jinsphys.2009.07.002; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Kimura H, 2002, MAR ECOL-P S Z N I, V23, P157, DOI 10.1046/j.1439-0485.2002.02778.x; Engels B, 2011, J BIOL CHEM, V286, P6871, DOI 10.1074/jbc.M110.165845; Andersson J, 2000, P ROY SOC B-BIOL SCI, V267, P1271, DOI 10.1098/rspb.2000.1138; Atmosukarto I, 2005, PLANT SCI, V169, P854, DOI 10.1016/j.plantsci.2005.06.002; Blande JD, 2010, TREE PHYSIOL, V30, P404, DOI 10.1093/treephys/tpp124; Abreu IN, 2011, J CHEM ECOL, V37, P857, DOI 10.1007/s10886-011-9991-7; Lam K, 2010, J CHEM ECOL, V36, P141, DOI 10.1007/s10886-010-9741-2; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Azeem M, 2013, J CHEM ECOL, V39, P120, DOI 10.1007/s10886-012-0232-5; Hoyoux C, 2009, MAR BIOL, V156, P2421, DOI 10.1007/s00227-009-1266-2; Faldt J, 1999, J CHEM ECOL, V25, P567, DOI 10.1023/A:1020958005023; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775; Cha DH, 2012, J CHEM ECOL, V38, P1419, DOI 10.1007/s10886-012-0196-5; Kidd SE, 2003, MED MYCOL, V41, P171, DOI 10.1080/714858208; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Bi HH, 2007, J CHEM ECOL, V33, P1089, DOI 10.1007/s10886-007-9286-1; Rayamajhi MB, 2006, BIOL CONTROL, V37, P56, DOI 10.1016/j.biocontrol.2005.10.013; Ulland S, 2008, CHEM SENSES, V33, P35, DOI 10.1093/chemse/bjm061; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737; Gange AC, 2012, OECOLOGIA, V168, P1023, DOI 10.1007/s00442-011-2151-5; Quesada-Moraga E, 2004, MYCOL RES, V108, P441, DOI 10.1017/S0953756204009724; HANSSEN HP, 1986, PHYTOCHEMISTRY, V25, P1979, DOI 10.1016/S0031-9422(00)81188-7; Kannaste A, 2009, J CHEM ECOL, V35, P1262, DOI 10.1007/s10886-009-9708-3; Sunnerheim K, 2007, J AGR FOOD CHEM, V55, P9365, DOI 10.1021/ifO70014p; Macias-Rubalcava ML, 2010, J CHEM ECOL, V36, P1122, DOI 10.1007/s10886-010-9848-5; Azeem M, 2013, BIORESOURCE TECHNOL, V144, P684, DOI 10.1016/j.biortech.2013.07.033; BARRAS SJ, 1970, ANN ENTOMOL SOC AM, V63, P1187; Bohman B, 2008, J CHEM ECOL, V34, P339, DOI 10.1007/s10886-008-9435-1; Borg-Karlson AK, 2006, J CHEM ECOL, V32, P943, DOI 10.1007/s10886-006-9050-y; Bylund H, 2004, B ENTOMOL RES, V94, P307, DOI 10.1079/BER2004304; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Eidmann H, 1974, FORSTSCHADLINGC EURO, P272; El-Hamalawi ZA, 2008, ANN APPL BIOL, V152, P169, DOI 10.1111/j.1744-7348.2007.00191.x; HARDIE J, 1994, J CHEM ECOL, V20, P2847, DOI 10.1007/BF02098393; Jankowiak R., 2013, ANN FOREST SCI, P1; JONSSON S, 1988, J CHEM ECOL, V14, P713, DOI 10.1007/BF01013918; KADLEC Z, 1992, EUR J FOREST PATHOL, V22, P316; Kannaste A, 2008, ARTHROPOD-PLANT INTE, V2, P31, DOI 10.1007/s11829-008-9029-4; KOLMODINHEDMAN B, 1982, ARCH TOXICOL, V50, P27, DOI 10.1007/BF00569234; Krokene P, 1998, PHYTOPATHOLOGY, V88, P39, DOI 10.1094/PHYTO.1998.88.1.39; Lam K, 2009, NATURWISSENSCHAFTEN, V96, P1127, DOI 10.1007/s00114-009-0574-1; Langstrom B, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P415; Legrand S, 2004, Z NATURFORSCH B, V59, P829; LEVIEUX J, 1994, CAN ENTOMOL, V126, P929; Lieutier F., 2004, BARK WOOD BORING INS; MIAN LS, 1992, J AGR ENTOMOL, V9, P73; Nordlander G, 1997, ENTOMOL EXP APPL, V85, P1, DOI 10.1046/j.1570-7458.1997.00229.x; Orlander G, 1999, SCAND J FOREST RES, V14, P341; Orlander G, 1997, SCAND J FOREST RES, V12, P225, DOI 10.1080/02827589709355405; PIOU D, 1993, ANN SCI FOREST, V50, P297, DOI 10.1051/forest:19930306; Roder G, 2007, OIKOS, V116, P1514, DOI 10.1111/j.2007.0030-1299.16057.x; Snoeren TAL, 2010, J CHEM ECOL, V36, P479, DOI 10.1007/s10886-010-9787-1; Thakeow P., 2006, Mitteilungen der Deutschen Gesellschaft für allgemeine und angewandte Entomologie, V15, P157; Trudel R, 2001, CAN ENTOMOL, V133, P333; Unelius CR, 2006, J CHEM ECOL, V32, P2191, DOI 10.1007/s10886-006-9139-3; Wang LD, 2007, PEST MANAG SCI, V63, P381, DOI 10.1002/ps.1359; Wen XS, 2004, J ECON ENTOMOL, V97, P1958; Zhang HR, 2004, CAN ENTOMOL, V136, P719	66	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1754-5048	1878-0083		FUNGAL ECOL	Fungal Ecol.	FEB	2015	13						103	111		10.1016/j.funeco.2014.08.009		9	Ecology; Mycology	Environmental Sciences & Ecology; Mycology	AY7UZ	WOS:000347765400012		
J	Maehara, Y; Fernandez-Checa, JC				Maehara, Yoshihiko; Fernandez-Checa, Jose C.			Augmenter of Liver Regeneration Links Mitochondrial Function to Steatohepatitis and Hepatocellular Carcinoma	GASTROENTEROLOGY			English	Editorial Material							INTERMEMBRANE SPACE; EXPRESSION; GENE; PROTEIN; IMPORT; CELLS; ALR		[Maehara, Yoshihiko] Kyushu Univ Hosp, Dept Surg & Sci, Fukuoka 812, Japan; [Fernandez-Checa, Jose C.] Inst Invest Biomed Barcelona CSIC, Dept Cell Death & Proliferat, Barcelona 08036, Spain; [Fernandez-Checa, Jose C.] Hosp Clin Barcelona, IDIBAPS, Liver Unit, Barcelona, Spain; [Fernandez-Checa, Jose C.] Ctr Invest Biomed Red CIBERehd, Barcelona, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis & Cirrhosis, Los Angeles, CA 90033 USA	Fernandez-Checa, JC (reprint author), Inst Invest Biomed Barcelona CSIC, Dept Cell Death & Proliferat, C Rosello 161, Barcelona 08036, Spain.	checa229@yahoo.com	Fernandez-Checa, Jose Carlos/L-8342-2014	Fernandez-Checa, Jose Carlos/0000-0003-3422-2990			Fischer M, 2013, MOL BIOL CELL, V24, P2160, DOI 10.1091/mbc.E12-12-0862; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Best J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00258; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Dayoub R, 2011, MOL MED, V17, P221, DOI 10.2119/molmed.2010.00117; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; Kleespies A, 2011, BIOCHEM BIOPH RES CO, V404, P148; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Mari M, 2008, GASTROENTEROLOGY, V134, P1507; Polimeno L, 2000, DIGEST LIVER DIS, V32, P510, DOI 10.1016/S1590-8658(00)80009-2; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Zhang J, 2014, AM J PHYSIOL-CELL PH, V306, pC279, DOI 10.1152/ajpcell.00117.2013	18	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	FEB	2015	148	2					285	288		10.1053/j.gastro.2014.12.013		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ2FT	WOS:000348050700012		
J	Abe, K; Koga, I; Hoshimoto, K				Abe, Koichiro; Koga, Ichiro; Hoshimoto, Kazufusa			What Are These Yellow Deposits in the Duodenum?	GASTROENTEROLOGY			English	Editorial Material							PATIENT		[Abe, Koichiro; Koga, Ichiro] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Hoshimoto, Kazufusa] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Abe, K (reprint author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.						Abe K, 2013, ENDOSCOPY, V45, pE27, DOI 10.1055/s-0032-1326105; Sun HY, 2005, GASTROINTEST ENDOSC, V61, P775, DOI 10.1016/S0016-5107(04)02786-5; Wagner D, 2006, EMERG INFECT DIS, V12, P532	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	FEB	2015	148	2					E1	E2		10.1053/j.gastro.2014.07.034		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ2FT	WOS:000348050700001		
J	Takizawa, K; Knipschield, MA; Gostout, CJ				Takizawa, Kohei; Knipschield, Mary A.; Gostout, Christopher J.			Submucosal endoscopy as an aid to full-thickness resection: pilot study in the porcine stomach	GASTROINTESTINAL ENDOSCOPY			English	Article							MUCOSAL RESECTION; HYBRID TECHNIQUE; GASTRIC-CANCER; DISSECTION; COLON; SEMR; FLAP	Background: Endoscopic full-thickness resection (EFTR) is commonly performed with laparoscopic assistance. Submucosal endoscopy with full-thickness resection (SEFTR) is a new technique that combines submucosal endoscopy with the mucosal safety valve flap method to enable EFTR. Objective: Pilot evaluation of the feasibility and safety of SEFTR in an animal model. Design: In vivo animal study. Setting: Developmental endoscopy unit/animal research unit. Intervention: Five domestic pigs, under general anesthesia, were used. A 2-cm gastric target area was marked. A circumferential mucosal incision was made. Two parallel submucosal tunnels on opposite sides of the incision were made. The mucosa at the proximal and distal tunnel ends was cut. A suture was passed through the tunnels encircling the target. T bars with sutures were placed full thickness outside the target and brought out of the mouth. Pulling the oral sutures raised the target while the targeted area was cinched serosa to serosa with the encircling suture. Full-thickness excision was then performed without closure. Main Outcome Measurements: Rate of adverse events, procedure times, adverse events, and difficulty scales were recorded prospectively. Results: Circumferential mucosal incisions, submucosal tunnels, and connections were completed in all. In the first case, looping of the target lesion failed. In the remaining 4 cases, looping, cinching, and lifting were completed. Full-thickness resections were completed in 3 of 4 pigs. There were no procedural adverse events and no damage to adjacent organs. Limitations: Acute animal study. Procedures were performed by an endoscopist skilled in the submucosal endoscopy with the mucosal safety valve flap method. Conclusion: This pilot experience suggests that SEFTR is feasible and could be safe.	[Takizawa, Kohei; Knipschield, Mary A.; Gostout, Christopher J.] Mayo Clin, Div Gastroenterol & Hepatol, Dev Endoscopy Unit, Rochester, MN 55905 USA; [Takizawa, Kohei] Shizuoka Canc Ctr Hosp, Div Endoscopy, Shizuoka, Japan	Gostout, CJ (reprint author), Mayo Clin, Div Gastroenterol & Hepatol, Dev Endoscopy Unit, 200 First St SW, Rochester, MN 55905 USA.	gostout.christopher@mayo.edu			Olympus Japan	Dr Gostout is a medical officer of and an advisor to Apollo Endosurgery and is a consultant for and has received research support from Olympus Japan. All other authors disclosed no financial relationships relevant to this article.	Goto O, 2011, GASTRIC CANCER, V14, P183, DOI 10.1007/s10120-011-0014-8; Nunobe S, 2012, GASTRIC CANCER, V15, P338, DOI 10.1007/s10120-012-0146-5; Takizawa K, 2013, ENDOSCOPY, V45, pE38, DOI [10.1055/s-0032-1325889, 10.1055/s0032-1325889]; Sumiyama K, 2007, GASTROINTEST ENDOSC, V65, P688, DOI 10.1016/j.gie.2006.07.030; Takizawa K, 2013, SURG ENDOSC, V27, P4457, DOI 10.1007/s00464-013-3085-2; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Gostout CJ, 2012, GASTROINTEST ENDOSC, V76, P829, DOI 10.1016/j.gie.2012.05.037; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Zhou PH, 2011, SURG ENDOSC, V25, P2926, DOI 10.1007/s00464-011-1644-y; Inoue H, 2012, SURG ONCOL CLIN N AM, V21, P129, DOI 10.1016/j.soc.2011.09.012; Kaehler GFBA, 2006, SURG ENDOSC, V20, P519, DOI 10.1007/s00464-005-0147-0; Kantsevoy SV, 2006, GASTROINTEST ENDOSC, V64, P90, DOI 10.1016/j.gie.2006.02.013; Kantsevoy S. V., 2008, Gastrointestinal Endoscopy, V68, P11, DOI 10.1016/j.gie.2008.01.037; Renteln VD, 2011, GASTROINTEST ENDOSC, V74, P1108; Takizawa K, 2014, GASTROINTEST ENDOSC, V79, P127, DOI 10.1016/j.gie.2013.06.033	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	FEB	2015	81	2					450	454		10.1016/j.gie.2014.08.041		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4OJ	WOS:000348201600027		
J	Ogura, T; Edogawa, S; Imoto, A; Masuda, D; Yamamoto, K; Takeuchi, T; Inoue, T; Uchiyama, K; Higuchi, K				Ogura, Takeshi; Edogawa, Shoko; Imoto, Akira; Masuda, Daisuke; Yamamoto, Kazuhiro; Takeuchi, Toshihisa; Inoue, Takuya; Uchiyama, Kazuhisa; Higuchi, Kazuhide			EUS-guided hepaticojejunostomy combined with antegrade stent placement	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Edogawa, Shoko; Imoto, Akira; Masuda, Daisuke; Takeuchi, Toshihisa; Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Osaka, Japan; [Yamamoto, Kazuhiro] Osaka Med Coll, Dept Radiol, Osaka, Japan; [Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Osaka, Japan	Ogura, T (reprint author), Osaka Med Coll, Dept Internal Med 2, Osaka, Japan.							0	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	FEB	2015	81	2					462	463		10.1016/j.gie.2014.05.323		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4OJ	WOS:000348201600035		
J	Takahashi, K; Sato, Y; Hayakawa, M; Takamura, M; Aoyagi, Y; Hashimoto, S; Kobayashi, M; Watanabe, G; Ajioka, Y				Takahashi, Kazuya; Sato, Yuichi; Hayakawa, Masato; Takamura, Masaaki; Aoyagi, Yutaka; Hashimoto, Satoru; Kobayashi, Masaaki; Watanabe, Gen; Ajioka, Yoichi			Magnified endoscopic findings with a barnacle-like appearance in enterocolitis associated with sepsis	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Takahashi, Kazuya; Sato, Yuichi; Hayakawa, Masato; Takamura, Masaaki; Aoyagi, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan; [Hashimoto, Satoru; Kobayashi, Masaaki] Niigata Univ, Med & Dent Hosp, Dept Endoscopy, Niigata, Japan; [Watanabe, Gen; Ajioka, Yoichi] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan	Takahashi, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	FEB	2015	81	2					472	473		10.1016/j.gie.2014.09.026		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4OJ	WOS:000348201600045		
J	Ishiwatari, H; Hayashi, T; Yoshida, M; Ono, M; Sato, T; Miyanishi, K; Sato, Y; Takimoto, R; Kobune, M; Masuko, H; Miyamoto, A; Sonoda, T; Kato, J				Ishiwatari, Hirotoshi; Hayashi, Tsuyoshi; Yoshida, Makoto; Ono, Michihiro; Sato, Tsutomu; Miyanishi, Koji; Sato, Yasushi; Takimoto, Rishu; Kobune, Masayoshi; Masuko, Hiroyuki; Miyamoto, Atsushi; Sonoda, Tomoko; Kato, Junji			EUS-guided celiac plexus neurolysis by using highly viscous phenol-glycerol as a neurolytic agent	GASTROINTESTINAL ENDOSCOPY			English	Article							PAIN RELIEF; PANCREATIC-CANCER; BLOCK; INJECTION		[Ishiwatari, Hirotoshi; Hayashi, Tsuyoshi; Yoshida, Makoto; Ono, Michihiro; Sato, Tsutomu; Miyanishi, Koji; Sato, Yasushi; Takimoto, Rishu; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Dept Med Oncol & Hematol, Sapporo, Hokkaido 0608543, Japan; [Masuko, Hiroyuki; Miyamoto, Atsushi] Sapporo Med Univ, Dept Hosp Pharm, Sapporo, Hokkaido 0608543, Japan; [Sonoda, Tomoko] Sapporo Med Univ, Dept Publ Hlth, Sapporo, Hokkaido 0608543, Japan	Ishiwatari, H (reprint author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.						Lopez BC, 2004, NEUROSURGERY, V54, P973, DOI 10.1227/NEU.0000114867.98896.FO; Sahai AV, 2009, AM J GASTROENTEROL, V104, P326, DOI 10.1038/ajg.2008.64; LeBlanc JK, 2011, GASTROINTEST ENDOSC, V74, P1300, DOI 10.1016/j.gie.2011.07.073; Mercadante S, 1998, REGION ANESTH PAIN M, V23, P37, DOI 10.1016/S1098-7339(98)90109-2; Iwata K, 2011, DIGEST ENDOSC, V23, P140, DOI 10.1111/j.1443-1661.2010.01046.x; De Cicco M, 2001, ANESTHESIOLOGY, V94, P561, DOI 10.1097/00000542-200104000-00006; Sakamoto H, 2010, AM J GASTROENTEROL, V105, P2599, DOI 10.1038/ajg.2010.339; Doi S, 2013, ENDOSCOPY, V45, P362, DOI 10.1055/s-0032-1326225; WOOD KM, 1978, PAIN, V5, P205, DOI 10.1016/0304-3959(78)90009-X; Ishiwatari H, 2014, WORLD J GASTROENTERO, V20, P10512, DOI 10.3748/wjg.v20.i30.10512; Obstein KL, 2010, WORLD J GASTROENTERO, V16, P728, DOI 10.3748/wjg.v16.i6.728; Rykowski JJ, 2000, ANESTHESIOLOGY, V92, P347, DOI 10.1097/00000542-200002000-00014; VALLAT JM, 1988, MUSCLE NERVE, V11, P540, DOI 10.1002/mus.880110604; Werner N, 2013, PAIN MED, V14, P1140; Wiersema MJ, 1996, GASTROINTEST ENDOSC, V44, P656, DOI 10.1016/S0016-5107(96)70047-0	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	FEB	2015	81	2					479	483		10.1016/j.gie.2014.10.031		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ4OJ	WOS:000348201600048		
J	Nakatani, Y; Kumagai, K; Minami, K; Nakano, M; Inoue, H; Oshima, S				Nakatani, Yosuke; Kumagai, Koji; Minami, Kentaro; Nakano, Masahiro; Inoue, Hiroshi; Oshima, Shigeru			Location of epicardial adipose tissue affects the efficacy of a combined dominant frequency and complex fractionated atrial electrogram ablation of atrial fibrillation	HEART RHYTHM			English	Article						Atrial fibrillation; Ablation; Dominant frequency	PULMONARY VEIN ISOLATION; CATHETER ABLATION; SITES; SUBSTRATE; HUMANS; RHYTHM; MODEL; FAT	BACKGROUND Epicardial adipose tissue (EAT) is located adjacent to high dominant frequency (OF) sites. OBJECTIVE This study aimed to clarify the relationship between the EAT location and efficacy of a combined high OF site and continuous complex fractionated activation electrogram (CFAE) site ablation. METHODS Fifty-five patients with nonparoxysmal atrial fibrillation (AF) (26 (47%) persistent and 29 (53%) long-standing persistent) underwent pulmonary vein isolation followed by high OF site and continuous CFAE site ablation. High OF sites (OF >= 8 Hz) and continuous CFAE sites (fractionated intervals <= 50 ms) were targeted. The patients were divided into an AF-free group and an AF-recurrent group. RESULTS The AF freedom rate on antiarrhythmic drugs in patients with persistent and Long-standing persistent AF was 88.5% and 75.9% over a 12-month follow-up period, respectively. The total EAT, left atrial (LA)-EAT, and right atrial (RA)-EAT volumes did not indicate significant differences between the AF-free and AF-recurrent groups. In the LA, the overlap between high OF sites and EAT was larger in the AF-free group than in the AF-recurrent group (57.0% +/- 33.3% vs 22.6% +/- 23.3%; P < .01). However, this overlap did not differ between the AF-free and AF-recurrent groups in the RA (20.4% +/- 28.2% vs 19.0% +/- 24.4%; P = .91). The overlap between continuous CFAE sites and EAT did not differ between the 2 groups in both the LA and the RA. CONCLUSION High OF sites that overlap with EAT may be important sources of AF. However, the contribution of EAT to the AF substrate may differ between the LA and the RA.	[Nakatani, Yosuke; Kumagai, Koji; Minami, Kentaro; Nakano, Masahiro; Oshima, Shigeru] Gunma Prefectural Cardiovasc Ctr, Div Cardiol, Maebashi, Gunma 3710004, Japan; [Inoue, Hiroshi] Toyama Univ, Dept Internal Med 2, Toyama 930, Japan	Kumagai, K (reprint author), Gunma Prefectural Cardiovasc Ctr, Div Cardiol, 3-12 Kameizumi Machi Kou, Maebashi, Gunma 3710004, Japan.	kkumagai4917@yahoo.co.jp					Verma A, 2011, J CARDIOVASC ELECTR, V22, P1309, DOI 10.1111/j.1540-8167.2011.02128.x; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Nakatani Y, 2013, J AM COLL CARDIOL, V61, P582, DOI 10.1016/j.jacc.2012.11.014; Tsao HM, 2011, AM J CARDIOL, V107, P1498, DOI 10.1016/j.amjcard.2011.01.027; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Atienza F, 2009, HEART RHYTHM, V6, P33, DOI 10.1016/j.hrthm.2008.10.024; Sanders P, 2005, CIRCULATION, V112, P789, DOI 10.1161/CIRCULATIONAHA.104.517011; Umapathy K, 2008, HEART RHYTHM, V5, P1029, DOI 10.1016/j.hrthm.2008.03.022; Nakagawa H, 2009, HEART RHYTHM, V6, pS26, DOI 10.1016/j.hrthm.2009.07.029; Lin YJ, 2008, HEART RHYTHM, V5, P406, DOI 10.1016/j.hrthm.2007.12.009; Nagashima K, 2012, CIRC-ARRHYTHMIA ELEC, V5, P676, DOI 10.1161/CIRCEP.112.971200; Lin YJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P233, DOI 10.1161/CIRCEP.108.812024; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Kumagai K, 2013, J CARDIOVASC ELECTR, V24, P975, DOI 10.1111/jce.12166; Atienza F, 2011, J AM COLL CARDIOL, V57, P1081, DOI 10.1016/j.jacc.2010.09.066; Higuchi K, 2013, PACE, V36, P467, DOI 10.1111/pace.12084; Lin YJ, 2014, J CARDIOVASC ELECTR, V25, P803, DOI 10.1111/jce.12407; Venteclef N, EUR HEART J; Verma A, 2010, J CARDIOVASC ELECTR, V22, P541	20	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	FEB	2015	12	2					257	265		10.1016/j.hrthm.2014.10.020		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AZ2AP	WOS:000348037300001		
J	Aizawa, Y; Sato, M; Kitazawa, H; Aizawa, Y; Takatsuki, S; Oda, E; Okabe, M; Fukuda, K				Aizawa, Yoshifusa; Sato, Masahito; Kitazawa, Hitoshi; Aizawa, Yoshiyasu; Takatsuki, Seiji; Oda, Eiji; Okabe, Masaaki; Fukuda, Keiichi			Tachycardia-dependent augmentation of "notched J waves" in a general patient population without ventricular fibrillation or cardiac arrest: Not a repolarization but a depolarization abnormality?	HEART RHYTHM			English	Article						J waves; Rate dependency; Early repolarization; Conduction delay	T SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; ST-SEGMENT; BRUGADA-SYNDROME; QT SYNDROME; ELECTROCARDIOGRAM; VARIANT; PREVALENCE	BACKGROUND 3 waves can be observed in individuals of the general population, but electrocardiographic characteristics are poorly understood. OBJECTIVE The purpose of this study was to examine the 3-wave dynamicity in a general patient population. METHODS The responses of 3 waves (>0.1 mV above the isoelectric line in 2 contiguous Leads) to varying RR intervals were analyzed. Patients with aborted sudden cardiac death, documented ventricular fibrillation, or a family history of sudden cardiac death were excluded. The 3-wave amplitude was measured at baseline, in beats with short RR intervals in conducted atrial premature beats (APBs) or atrial stimulation during the electrophysiology study, and in the beats next to APBs with prolonged RR intervals. RESULTS Mainly notched J waves were identified in 94 of 701 (24.5%) general patients (13.4%), and APBs were present in 23 of 94 (24.5%) patients. The mean baseline amplitude of J waves was 0.20 +/- 0.06 mV at the baseline RR interval of 853 +/- 152 ms, 0.25 +/- 0.11 mV at the RR interval in the conducted APB of 545 +/- 133 ms (P = .0018), and 0.19 +/- 0.08 mV at the RR interval of 1146 +/- 314 ms (P = .3102). The clinical characteristics were not different between patients with and without tachycardia-dependent augmentation of J waves. Augmentation of J waves was confirmed by the electrophysiology study: 0.28 +/- 0.12 mV vs 0.42 +/- 0.11 mV at baseline and in the beats of atrial stimulation, respectively (P = .0001). However, no bradycardia-dependent augmentation (>0.05 mV) was observed. Such tachycardia-dependent augmentation can represent depolarization abnormality rather than repolarization abnormality. CONCLUSION 3 waves in a general patient population were augmented at shorter RR intervals, but not at prolonged RR intervals. Mechanistically, conduction delay is most likely responsible for this.	[Aizawa, Yoshifusa] Niigata Univ, Tachikawa Med Ctr, Nagaoka, Niigata, Japan; [Sato, Masahito; Kitazawa, Hitoshi; Oda, Eiji; Okabe, Masaaki] Tachikawa Gen Hosp, Dept Cardiol, Nagaoka, Niigata, Japan; [Aizawa, Yoshiyasu; Takatsuki, Seiji; Fukuda, Keiichi] Keio Univ, Dept Cardiol, Tokyo, Japan	Aizawa, Y (reprint author), Tachikawa Med Ctr, Kandacho 3-2-1, Nagaoka, Niigata 9408621, Japan.	aizaways@med.niigata-u.ac.jp	Fukuda, Keiichi/L-3777-2013		Research Fund of Tachikawa Medical Center; MEXT KAKENHI [26461087]; Ministry of Health. Labor and Welfare of Japan [II26-040]	This work was supported by the Research Fund of Tachikawa Medical Center (to Dr Aizawa), MEXT KAKENHI grant (grant no. 26461087, to Dr Aizawa), and a grant for Clinical Research on Intractable Diseases (grant no. II26-040, to Dr Fukuda) from the Ministry of Health. Labor and Welfare of Japan.	Schwartz PJ, 2013, EUR HEART J, V34, P3109, DOI 10.1093/eurheartj/eht089; Rosso R, 2012, HEART RHYTHM, V9, P225, DOI 10.1016/j.hrthm.2011.09.012; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Shipley RA, 1936, AM HEART J, V11, P325, DOI 10.1016/S0002-8703(36)90417-9; Uberoi A, 2011, CIRCULATION, V124, P2208, DOI 10.1161/CIRCULATIONAHA.111.047191; Yan GX, 1996, CIRCULATION, V93, P372; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Nakayama M, 2013, EUROPACE, V15, P109, DOI 10.1093/europace/eus259; Surawicz B, 2011, J AM COLL CARDIOL, V57, P1584, DOI 10.1016/j.jacc.2010.11.040; Aizawa Y, 2013, HEART RHYTHM, V10, P1028, DOI 10.1016/j.hrthm.2013.03.013; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Aizawa Y, 2012, J AM COLL CARDIOL, V59, P1948, DOI 10.1016/j.jacc.2012.02.028; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391; KAMBARA H, 1976, AM J CARDIOL, V38, P157, DOI 10.1016/0002-9149(76)90142-9; Tikkanen JT, 2011, CIRCULATION, V123, P2666, DOI 10.1161/CIRCULATIONAHA.110.014068; Aizawa Y, 2013, CIRCULATION, V128, P1048, DOI 10.1161/CIRCULATIONAHA.113.003472; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Aizawa Y, 2013, J AM COLL CARDIOL, V62, P1015, DOI 10.1016/j.jacc.2013.05.030; Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010; AIZAWA Y, 1993, AM HEART J, V126, P1473, DOI 10.1016/0002-8703(93)90550-S; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Littman CD, 1946, AM HEART J, V32, P370; Nakagawa K, 2014, HEART RHYTHM, V11, P314, DOI 10.1016/j.hrthm.2013.10.057; Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Terho HK, 2014, AM J CARDIOL, V114, P141, DOI 10.1016/j.amjcard.2014.03.066; Tomaszewski W., 1938, ARCH MAL COEUR, V31, P525; WASSERBU.R, 1961, AM J CARDIOL, V8, P184, DOI 10.1016/0002-9149(61)90204-1; Wilde AAM, 2012, HEART RHYTHM, V9, P556, DOI 10.1016/j.hrthm.2012.01.002	31	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	FEB	2015	12	2					376	383		10.1016/j.hrthm.2014.11.010		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AZ2AP	WOS:000348037300018		
J	Matsuyama, T; Asano, T; Inoue, S; Kobayashi, Y				Matsuyama, Taka-aki; Asano, Taku; Inoue, Shin; Kobayashi, Youichi			Pathology in the late phase after extensive and ostial pulmonary vein ablation for atrial fibrillation: Findings in 2 postmortem cases	HEART RHYTHM			English	Article						Pulmonary vein isolation; Catheter ablation; Pathology; Pulmonary vein stenosis	RADIOFREQUENCY ABLATION; CATHETER ABLATION; PREVALENCE; OCCLUSION; RELEVANCE; LESIONS; SITES		[Matsuyama, Taka-aki] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan; [Asano, Taku; Kobayashi, Youichi] Showa Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo 142, Japan; [Inoue, Shin] Showa Univ, Dent Hosp, Dept Internal Med, Tokyo, Japan	Matsuyama, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pathol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	Matsuyama.takaaki.hp@ncvc.go.jp			Japan Society for the Promotion of Science [25860286]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25860286).	Cabrera JA, 2009, HEART RHYTHM, V6, P1192, DOI 10.1016/j.hrthm.2009.04.016; Prieto LR, 2010, HEART RHYTHM, V7, P1233, DOI 10.1016/j.hrthm.2010.03.003; De Greef Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P52, DOI 10.1161/CIRCEP.111.961888; Ho SY, 2001, HEART, V86, P265, DOI 10.1136/heart.86.3.265; Kowalski M, 2012, J AM COLL CARDIOL, V59, P930, DOI 10.1016/j.jacc.2011.09.076; Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88; Junker JPE, 2008, BURNS, V34, P942, DOI 10.1016/j.burns.2008.01.010; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Lee G, 2011, J CARDIOVASC ELECTR, V22, P163, DOI 10.1111/j.1540-8167.2010.01870.x; Yang HM, 2007, CARDIOVASC PATHOL, V16, P51, DOI 10.1016/j.carpath.2006.07.007; Corradi D, 2013, INT J CARDIOL, V168, P1758, DOI 10.1016/j.ijcard.2013.05.091; Deneke T, 2005, EUR HEART J, V26, P1797, DOI 10.1093/eurheartj/ehi255; Gerstenfeld EP, 2007, J CARDIOVASC ELECTR, V18, P849, DOI 10.1111/j.1540-8167.00869.x; Kistler PM, 2007, J CARDIOVASC ELECTR, V18, P1282, DOI 10.1111/j.1540-8167.2007.00981.x; Nehra D, 2009, ANN THORAC SURG, V87, P292, DOI 10.1016/j.athoracsur.2008.06.060	15	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	FEB	2015	12	2					425	429		10.1016/j.hrthm.2014.10.026		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AZ2AP	WOS:000348037300026		
J	Kirat, D; Kato, S				Kirat, Doaa; Kato, Seiyu			The monocarboxylate transporters exist in the cattle endocrine pancreas	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						SLC16; MCTs; Islets of Langerhans; Short-chain fatty acids; Ruminants; Rat	VOLATILE FATTY-ACIDS; FUNCTIONAL-CHARACTERIZATION; GASTROINTESTINAL-TRACT; CELLULAR-LOCALIZATION; HUMAN INTESTINE; GROWTH-HORMONE; PLASMA-INSULIN; ADULT SHEEP; EXPRESSION; BUTYRATE	Extensive studies are published concerning the distribution of monocarboxylate transporters (MCTs) in various animal issues including ruminants; nonetheless, nothing is known about their cellular expression and localization in the ruminant pancreas. The present study was carried out to examine the expression and cellular localization of all the fourteen MCT isoforms in cattle pancreas. RT-PCR verified the existence of mRNA transcripts for eight MCT isoforms, namely, MCT1, MCT2, MCT3, MCT4, MCT5, MCT8, MCT13, and MCT14 in cattle pancreas. Western blotting analysis confirmed the protein expression of these eight MCTs in the cattle pancreatic tissue. Immunohistochemical study, within the whole pancreas, was conducted to localize the eight MCTs identified, and the results showed strong positive immunoreactive staining for MCT1, MCT2, MCT4, MCT5, MCT13, and MCT14 on nearly all the islet cells of Langerhans, while we could not detect immunopositive signals in the acinar cells with any of MCTs antibodies used. This study, for the first time, showed the cellular localization and expression of MCT1-MCT5, MCT8, MCT13, and MCT14 within the ruminant pancreas. The distribution and expression pattern of MCT1, MCT2, MCT4, and CD147 in the cattle pancreas are different from that previously published on monogastric pancreas. Our study suggested that MCT1, MCT2, MCT4, MCT5, MCT13, and MCT14 may participate in the regulation of the pancreatic endocrine secretions in ruminants.	[Kirat, Doaa] Zagazig Univ, Fac Vet Med, Dept Physiol, Zagazig, Egypt; [Kirat, Doaa; Kato, Seiyu] Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Physiol, Ebetsu, Hokkaido 0698501, Japan	Kirat, D (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Dept Vet Physiol, Ebetsu, Hokkaido 0698501, Japan.	doaakirat@hotmail.com					Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Soret R, 2010, GASTROENTEROLOGY, V138, P1772, DOI 10.1053/j.gastro.2010.01.053; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Kirat D, 2007, GENE, V391, P140, DOI 10.1016/j.gene.2006.12.020; BERGMAN EN, 1990, PHYSIOL REV, V70, P567; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; CROOM WJ, 1992, J NUTR, V122, P191; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; Kirat D, 2009, MOL CELL ENDOCRINOL, V298, P89, DOI 10.1016/j.mce.2008.09.040; Tamai I, 1999, J PHARM PHARMACOL, V51, P1113, DOI 10.1211/0022357991776804; Zhao C, 2001, DIABETES, V50, P361, DOI 10.2337/diabetes.50.2.361; Hadjiagapiou C, 2000, AM J PHYSIOL-GASTR L, V279, pG775; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Wang A, 2009, J DAIRY SCI, V92, P2696, DOI 10.3168/jds.2009-2037; BASSETT JM, 1972, AUST J BIOL SCI, V25, P1277; BASSETT JM, 1974, AUST J BIOL SCI, V27, P157; BROCKMAN RP, 1978, CAN VET J, V19, P55; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1013/jphysiol.2001.014241; DEJONG A, 1982, J ENDOCRINOL, V92, P357, DOI 10.1677/joe.0.0920357; Harada E, 1983, AM J PHYSIOL, V244, P284; HARMON DL, 1992, J ANIM SCI, V70, P1290; Kirat D, 2006, J PHYSIOL-LONDON, V576, P635, DOI 10.1113/jphysiol.2006.115931; Kirat D, 2013, CELL TISSUE RES, V352, P585, DOI 10.1007/s00441-013-1570-5; MANNS JG, 1967, AM J PHYSIOL, V212, P756; MANNS JG, 1967, AM J PHYSIOL, V212, P747; MINEO H, 1990, COMP BIOCHEM PHYS A, V95, P411; Rae C, 2012, NEUROCHEM RES, V37, P2541, DOI 10.1007/s11064-012-0847-5; ROSS JP, 1973, J NUTR, V103, P488; SANO H, 1995, J ANIM SCI, V73, P3038; Wang A, 2012, J DAIRY SCI, V95, P1371, DOI 10.3168/jds.2011-4886	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	FEB	2015	143	2					185	194		10.1007/s00418-014-1271-5		10	Cell Biology; Microscopy	Cell Biology; Microscopy	AZ4TC	WOS:000348214900006		
J	Dai, L; Endo, D; Akiyama, N; Yamamoto-Fukuda, T; Koji, T				Dai, Lei; Endo, Daisuke; Akiyama, Naotaro; Yamamoto-Fukuda, Tomomi; Koji, Takehiko			Aberrant levels of histone H3 acetylation induce spermatid anomaly in mouse testis	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						Histone H3; Acetylation; Abnormal morphology; Apoptosis; Round spermatid; Murine spermatogenesis	PHENYLBUTYRATE-INDUCED APOPTOSIS; BREAST-CANCER CELLS; NF-KAPPA-B; DEACETYLASE INHIBITOR; SODIUM PHENYLBUTYRATE; DNA METHYLATION; GENE-EXPRESSION; GERM-CELLS; IN-SITU; SPERMATOGENESIS	Histone acetylation is involved in the regulation of chromatin structure and gene function. We reported previously that histone H3 acetylation pattern is subject to dynamic changes and limited to certain stages of germ cell differentiation during murine spermatogenesis, suggesting a crucial role for acetylation in the process. In the present study, we investigated the effects of hyper- and hypo-acetylation on spermatogenesis. Changes in acetylation level were induced by either in vivo administration of sodium phenylbutyrate, a histone deacetylase inhibitor, or by knockdown of histone acetyltransferases using short hairpin RNA plasmids transfection. Administration of sodium phenylbutyrate induced accumulation of acetylated histone H3 at lysine 9 and lysine 18 in round spermatids, together with spermatid morphological abnormalities and induction of apoptosis through a Bax-related pathway. Knockdown of steroid receptor coactivator 1, a member of histone acetyltransferases, but not general control of amino acid synthesis 5 nor elongator protein 3 by in vivo electroporation of shRNA plasmids, reduced acetylated histone H3 at lysine 9 in round spermatids, and induced morphological abnormalities. We concluded that the proper regulation of histone H3 acetylation levels is important for spermatid differentiation and complex chromatin remodeling during spermiogenesis.	[Dai, Lei; Endo, Daisuke; Akiyama, Naotaro; Yamamoto-Fukuda, Tomomi; Koji, Takehiko] Nagasaki Univ, Dept Histol & Cell Biol, Grad Sch Biomed Sci, Nagasaki 8528523, Japan	Koji, T (reprint author), Nagasaki Univ, Dept Histol & Cell Biol, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	tkoji@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [18390060]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 18390060 to Koji, T.).	De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Lee B, 2010, MOL GENET METAB, V100, P221, DOI 10.1016/j.ymgme.2010.03.014; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Milkevitch M, 2005, BBA-MOL CELL BIOL L, V1734, P1, DOI 10.1016/j.bbalip.2005.01.008; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; CREASY DM, 1990, EXP MOL PATHOL, V52, P155, DOI 10.1016/0014-4800(90)90001-T; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Kopera IA, 2010, PHILOS T R SOC B, V365, P1593, DOI 10.1098/rstb.2009.0251; Wang RA, 1998, BIOL REPROD, V58, P1250, DOI 10.1095/biolreprod58.5.1250; Natsume-Kitatani Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022281; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Spencer TE, 1997, NATURE, V389, P194; Nair M, 2008, DEV BIOL, V320, P446, DOI 10.1016/j.ydbio.2008.05.553; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Boivin AJ, 2002, ANTI-CANCER DRUG, V13, P869, DOI 10.1097/00001813-200209000-00013; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Munshi A, 2009, J GENET GENOMICS, V36, P75, DOI 10.1016/S1673-8527(08)60094-6; Calvaruso G, 2001, INT J ONCOL, V18, P1233; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Damavandi E, 2002, ACTA HISTOCHEM CYTOC, V35, P449; Delfino F, 1998, MOL ENDOCRINOL, V12, P1696, DOI 10.1210/me.12.11.1696; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; Feinman R, 2002, CANCER CHEMOTH PHARM, V49, P27, DOI 10.1007/s00280-001-0390-6; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Govin J, 2006, E SCHERING RES FDN W, V57, P155; Iannitti Tommaso, 2011, Drugs R D, V11, P227, DOI 10.2165/11591280-000000000-00000; Koji T, 2008, HISTOCHEM CELL BIOL, V130, P917, DOI 10.1007/s00418-008-0487-7; Lin YN, 2005, SEMIN REPROD MED, V23, P201, DOI 10.1055/s-2005-872448; Louis M, 2004, INT J ONCOL, V25, P1701; Neal KC, 2000, BBA-GENE STRUCT EXPR, V1490, P170, DOI 10.1016/S0167-4781(99)00211-0; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; PENTTILA TL, 1995, BIOL REPROD, V53, P499, DOI 10.1095/biolreprod53.3.499; ROOSENRUNGE EC, 1962, BIOL REV, V37, P343, DOI 10.1111/j.1469-185X.1962.tb01616.x; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Saito M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015541; Shah P, 2014, BREAST CANCER RES TR, V143, P99, DOI 10.1007/s10549-013-2784-7; SODERSTROM KO, 1976, MOL CELL ENDOCRINOL, V5, P181, DOI 10.1016/0303-7207(76)90082-4; Yan W, 2010, J BIOL CHEM, V285, P31418, DOI 10.1074/jbc.M110.116418; Yomogida K, 2002, BIOL REPROD, V67, P712, DOI 10.1095/biolreprod.101.001743; Yu KH, 1999, LEUKEMIA, V13, P1258; Zhang Z, 2012, GENOMICS, V99, P209, DOI 10.1016/j.ygeno.2012.01.002; Zheng JK, 2008, DEV DYNAM, V237, P1463, DOI 10.1002/dvdy.21499	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	FEB	2015	143	2					209	224		10.1007/s00418-014-1283-1		16	Cell Biology; Microscopy	Cell Biology; Microscopy	AZ4TC	WOS:000348214900008		
J	Sasaki, M; Nitta, T; Sato, Y; Nakanuma, Y				Sasaki, Motoko; Nitta, Takeo; Sato, Yasunori; Nakanuma, Yasuni			Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia	HUMAN PATHOLOGY			English	Article						Autophagy; Intrahepatic cholangtocarcinoma; Biliary intraepithelial neoplasia (BilIN); KRAS; Microtubule-associated proteins light chain 3 beta (LC3); Beclin-1; p62/sequestosome-1	BILE-DUCT; INTRAHEPATIC CHOLANGIOCARCINOMAS; CELLULAR SENESCENCE; UNITED-STATES; EXPRESSION; CANCER; BECLIN-1; P62; PATHOGENESIS; DISEASE	Similar to the pancreatic carcinoma sequence model, cholangiocarcinoma reportedly follows a stepwise carcinogenesis process via the precursor lesion biliary intraepithelial neoplasia (BilIN). Given that autophagy plays an important role in the occurrence and development of carcinomas, we examined the involvement of autophagy in multistep cholangiocarcinogenesis. Thirty-six patients with hepatolithiasis associated with BilIN and/or cholangiocarcinoma, 7 with intrahepatic cholangiocarcinoma, 8 with intraductal papillary neoplasm of the bile duct (IPNB), and 6 with control livers were surveyed. Their lesions were categorized as follows: invasive carcinoma (n = 16), IPNB (n = 8), BIlN-3 (n = 16), BilIN-1/2 (n = 40), nonneoplastic large bile duct (n = 55), and peribiliary gland (n = 55). We examined the immunohistochemical expression of autophagy-related proteins, microtubule-associated proteins light chain 313 (LC3), beclin-1, and p62/sequestosome-1 (p62), as well as tumor suppressor gene product p53. The extent of expression was semiquantitatively assessed. The status of KRAS mutations at codons 12 and 13 was examined in selected cases of BilIN-1/2. The expression of LC3 (cytoplasmic), beclin-1 (cytoplasmic), and p62 (cytoplasmic and nuclear) was significantly higher in BilIN-1/2, BilIN-3, IPNB, and invasive carcinoma than in large bile duct and peribiliary gland (P < .01). KRAS mutation was detected in 6 (40%) of 15 BilIN-1/2 lesions, and there was no correlation between the status of KRAS mutation and the expression of autophagy-related proteins. In conclusion, this study is the first to disclose that the expression of autophagy-related proteins, LC3, beclin-1, and p62, was increased at an early stage of multistep cholangiocarcinogenesis in hepatolithiasis. Autophagy, probably deregulated autophagy, may be related to the occurrence and development of cholangiocarcinoma. (C) 2015 Elsevier Inc. All rights reserved.	[Sasaki, Motoko; Nitta, Takeo; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan; [Nakanuma, Yasuni] Shizuoka Canc Ctr, Dept Pathol, Shizuoka 4118777, Japan	Sasaki, M (reprint author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.		Sasaki, Motoko/K-5913-2015	Sasaki, Motoko/0000-0003-2514-760X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590409]	This study was supported, in part, by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24590409).	Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Lewis JT, 2010, AM J SURG PATHOL, V34, P27, DOI 10.1097/PAS.0b013e3181bc96f9; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Choi J, 2013, HISTOPATHOLOGY, V62, P275, DOI 10.1111/his.12002; Liang XH, 2001, CANCER RES, V61, P3443; McGlynn KA, 2006, CANCER EPIDEM BIOMAR, V15, P1198, DOI 10.1158/1055-99965-EPI-05-0811; Sasaki M, 1996, HEPATOLOGY, V24, P1074; Martinet W, 2013, AUTOPHAGY, V9, P386, DOI 10.4161/auto.22968; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x; Dong LW, 2011, AUTOPHAGY, V7, P1222, DOI 10.4161/auto.7.10.16610; Zen Y, 2006, J HEPATOL, V44, P350, DOI 10.1016/j.jhep.2005.09.025; Wu TT, 2009, CANCER-AM CANCER SOC, V115, P4564, DOI 10.1002/cncr.24471; Sasaki M, 2008, J PATHOL, V215, P175, DOI 10.1002/path.2345; Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56; Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Miracco C, 2007, INT J ONCOL, V30, P429; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Hsu M, 2013, CANCER-AM CANCER SOC, V119, P1669, DOI 10.1002/cncr.27955; NAKANUMA Y, 1989, HEPATOLOGY, V10, P174, DOI 10.1002/hep.1840100209; NAKANUMA Y, 1994, J GASTROEN HEPATOL, V9, P80, DOI 10.1111/j.1440-1746.1994.tb01221.x; TERADA T, 1992, VIRCHOWS ARCH A, V420, P327, DOI 10.1007/BF01600212; Wang TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080317	36	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	FEB	2015	46	2					202	209		10.1016/j.humpath.2014.09.016		8	Pathology	Pathology	AZ5QI	WOS:000348274600005		
J	Iwasaki, T; Matsushita, M; Nonaka, D; Kuwamoto, S; Kato, M; Murakami, I; Nagata, K; Nakajima, H; Sano, S; Hayashi, K				Iwasaki, Takeshi; Matsushita, Michiko; Nonaka, Daisuke; Kuwamoto, Satoshi; Kato, Masako; Murakami, Ichiro; Nagata, Keiko; Nakajima, Hideki; Sano, Shigetoshi; Hayashi, Kazuhiko			Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas	HUMAN PATHOLOGY			English	Article						Merkel cell carcinoma; Merkel cell polyomavirus; Squamous cell carcinoma; Akt/mTOR/4E-BP1 pathway; PIK3CA	CANCER; TARGET; TUMORS; PI3K/AKT/MTOR; ASSOCIATION; EVEROLIMUS; INFECTION	Merkel cell polyomavirus (MCPyV) integrates monoclonally into the genomes of approximately 80% of Merkel cell carcinomas (MCCs), affecting their clinicopathological features. The molecular mechanisms underlying MCC development after MCPyV infection remain unclear. We investigated the association of MCPyV infection with activation of the Akt/mammalian target of rapamycin (mTOR)/4E-binding protein 1 (4E-BP1) signalirig pathway in MCCs to elucidate the role of these signal transductions and to identify molecular targets for treatment. We analyzed the molecular and pathological characteristics of 41 MCPyV-positive and 27 MCPyV-negative MCCs. Expression of mTOR, TSC1, and TSC2 messenger RNA was significantly higher in MCPyV-negative MCCs, and Akt (T308) phosphorylation also was significantly higher (92% vs 66%; P =.019), whereas 4E-BP1 (S65 and T70) phosphorylation was common in both MCC types (92%-100%). The expression rates of most other tested signals were high (60%-100%) and not significantly correlated with MCPyV large T antigen expression. PIK3CA mutations were observed more frequently in MCPyV-positive MCCs (6/36 [17%] vs 2/20 [10%]). These results suggest that protein expression (activation) of most Akt/mTOR/4E-BP1 pathway signals was not significantly different in MCPyV-positive and MCPyV-negative MCCs, although these 2 types may differ in tumorigenesis, and MCPyV-negative MCCs showed significantly more frequent p-Akt (T308) activation. Therefore, certain Akt/mTOR/4E-BPI pathway signals could be novel therapeutic targets for MCC regardless of MCPyV infection status. (C) 2015 Elsevier Inc. All rights reserved.	[Iwasaki, Takeshi; Matsushita, Michiko; Kuwamoto, Satoshi; Kato, Masako; Murakami, Ichiro; Nagata, Keiko; Hayashi, Kazuhiko] Tottori Univ, Fac Med, Dept Pathol, Div Mol Pathol, Yonago, Tottori 6838503, Japan; [Matsushita, Michiko] Tottori Univ, Fac Med, Sch Hlth Sci, Dept Pathobiol Sci & Technol, Yonago, Tottori 6838503, Japan; [Nonaka, Daisuke] Christie Hosp NHS Trust, Dept Histopathol, Manchester M20 4BX, Lancs, England; [Nakajima, Hideki; Sano, Shigetoshi] Kochi Univ, Fac Med, Sch Med, Dept Dermatol, Nankoku, Kochi 7838505, Japan	Hayashi, K (reprint author), Tottori Univ, Fac Med, Dept Pathol, Div Mol Pathol, Nishi Cho 86, Yonago, Tottori 6838503, Japan.	iwasakit-path@umin.ac.jp; hayashik@med.tottori-u.ac.jp			Japan Society for the Promotion of Science [26460433]	This study was supported, in part, by a grant from the Japan Society for the Promotion of Science (No. 26460433).	Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Nardi V, 2012, CLIN CANCER RES, V18, P1227, DOI 10.1158/1078-0432.CCR-11-2308; Gustin JP, 2008, CURR CANCER DRUG TAR, V8, P733, DOI 10.2174/156800908786733504; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Paik JY, 2011, HUM PATHOL, V42, P1385, DOI 10.1016/j.humpath.2010.12.013; Kuwamoto S, 2011, HUM PATHOL, V42, P632, DOI 10.1016/j.humpath.2010.09.011; Kuwamoto S, 2011, HUM PATHOL, V42, P1063, DOI 10.1016/j.humpath.2011.01.020; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Dobashi Y, 2009, MODERN PATHOL, V22, P1328, DOI 10.1038/modpathol.2009.104; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Buchkovich Nicholas J, 2008, Nat Rev Microbiol, V6, P266, DOI 10.1038/nrmicro1855; Chen SJ, 2009, BRIT J DERMATOL, V160, P442, DOI 10.1111/j.1365-2133.2008.08903.x; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Hafner C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031255; Higaki-Mori H, 2012, HUM PATHOL, V43, P2282, DOI 10.1016/j.humpath.2012.04.002; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Hwang JH, 2013, J BIOL CHEM, V288, P32064, DOI 10.1074/jbc.M113.497644; Iwasaki T, 2013, HUM PATHOL, V44, P1912, DOI 10.1016/j.humpath.2013.01.026; Matsushita M, 2014, VIRUS GENES, V48, P233, DOI 10.1007/s11262-013-1023-y	20	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	FEB	2015	46	2					210	216		10.1016/j.humpath.2014.07.025		7	Pathology	Pathology	AZ5QI	WOS:000348274600006		
J	Kohashi, K; Yamada, Y; Hotokebuchi, Y; Yamamoto, H; Taguchi, T; Iwamoto, Y; Oda, Y				Kohashi, Kenichi; Yamada, Yuichi; Hotokebuchi, Yuka; Yamamoto, Hidetaka; Taguchi, Tomoaki; Iwamoto, Yukihide; Oda, Yoshinao			ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor	HUMAN PATHOLOGY			English	Article						SMARCB1/INI1; Epithelioid sarcoma; Malignant rhabdoid tumor; ERG; SALL4	SOFT-TISSUE; PROTEIN EXPRESSION; TRANSCRIPTION FACTOR; GENE	ERG is immunoexpressed in vascular endothelial tumors, blastic extramedullary myeloid tumors, and tumors with ERG-involved translocation, such as prostate carcinoma or Ewing sarcoma. Recently, ERG immunoexpression was reported in an epithelioid sarcoma, which is a SMARCB1/INI1-deficient tumor, although epithelioid sarcoma is not associated with chromosomal translocations involving ERG and is categorized as a tumor with uncertain differentiation. SALL4 is essential for a proliferation and stabilization of embryonic stem cells. It was reported that SALL4 expression may aid in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. We analyzed the frequency of ERG and SALL4 expressions in 80 SMARCB1/INI1-deficient tumors, including 45 epithelioid sarcomas (conventional-type, 24; proximal-type, 20), 17 malignant rhabdoid tumors, 5 atypical teratoid/rhabdoid tumors, 6 undifferentiated/unclassified sarcomas, 5 myoepithelial tumors, and 4 extraskeletal myxoid chondrosarcomas. We found that ERG expression was present in 18 of the epithelioid sarcomas (41%), including 13 conventional-type (54%) and 5 proximal-type (25%), whereas all 17 of the malignant rhabdoid tumors exhibited negative immunoreactivity. One atypical teratoid/rhabdoid tumor (20%), 1 myoepithelial carcinoma (20%), 1 undifferentiated/unclassified sarcoma (17%), and no extraskeletal myxoid chondrosarcomas (0%) also showed ERG expression. SALL4 expression was recognized in 5 epithelioid sarcomas (11%), 12 malignant rhabdoid tumors (71%), 2 atypical teradoid/rhabdoid tumors (40%), 4 undifferentiated/unclassified sarcomas (67%), 1 myoepithelial tumor (20%), and none of the extraskeletal myxoid chondrosarcomas (0%). Therefore, the evaluation of ERG and SALL4 immunoexpressions may be a useful diagnostic tool to distinguish epithelioid sarcoma, especially proximal type, from malignant rhabdoid tumor. (C) 2015 Elsevier Inc. All rights reserved.	[Kohashi, Kenichi; Yamada, Yuichi; Hotokebuchi, Yuka; Yamamoto, Hidetaka; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan; [Taguchi, Tomoaki] Kyushu Univ, Grad Sch Med Sci, Dept Pediat Surg, Higashi Ku, Fukuoka 8128582, Japan; [Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan	Oda, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	oda@surgpath.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [25293088, 26460435]; Ministry of Health Labour and Welfare, Tokyo, Japan	This study was supported by a Grant-in-Aid for Scientific Research (B) (No. 25293088) and Scientific Research (C) (No. 26460435) from the Japan Society for the Promotion of Science, and for Clinical Research from the Ministry of Health Labour and Welfare, Tokyo, Japan. The English used in this article was revised by KN International (http://www.kninter.com/).	Antonescu CR, 2013, GENE CHROMOSOME CANC, V52, P675, DOI 10.1002/gcc.22063; Miettinen M, 2011, AM J SURG PATHOL, V35, P432, DOI 10.1097/PAS.0b013e318206b67b; Kohashi K, 2009, HUM PATHOL, V40, P349, DOI 10.1016/j.humpath.2008.08.007; Miettinen M, 2014, HISTOPATHOLOGY, V64, P101, DOI 10.1111/his.12298; Hollmann TJ, 2011, AM J SURG PATHOL, V35, pE47, DOI 10.1097/PAS.0b013e31822b325b; Wang WL, 2012, MODERN PATHOL, V25, P1378, DOI 10.1038/modpathol.2012.97; Stockman DL, 2014, MODERN PATHOL, V27, P496, DOI 10.1038/modpathol.2013.161; Billings SD, 2003, AM J SURG PATHOL, V27, P48, DOI 10.1097/00000478-200301000-00006; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Antonescu CR, 2010, GENE CHROMOSOME CANC, V49, P1114, DOI 10.1002/gcc.20819; Kohashi K, 2008, AM J SURG PATHOL, V32, P1168, DOI 10.1097/PAS.0b013e318161781a; Fletcher CDM, 2013, WHO CLASSIFICATION S, P153; Homick JL, 2011, AM J SURG PATHOL, V35, P190; Homick JL, 2003, AM J SURG PATHOL, V27, P1183; Homick JL, 2013, WHO CLASSIFICATION T, P153; Judkins AR, 2007, WHO CLASSIFICATION T, P147; Kohashi K, 2013, HUM PATHOL, V44, P526, DOI 10.1016/j.humpath.2012.06.014; Kohashi K, 2007, J CANCER RES CLIN, V133, P817, DOI 10.1007/s00432-007-0223-z; Lucas DR, 2013, WHO CLASSIFICATION T, P223; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; Miettinen M, 2013, AM J SURG PATHOL, V37, P1580, DOI 10.1097/PAS.0b013e31828de23a; Oda Y, 2013, WHO CLASSIFICATION T, P216; Oda Y, 2013, WHO CLASSIFICATION T, P228; Yoshida A, 2014, HISTOPATHOLOGY	24	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	FEB	2015	46	2					225	230		10.1016/j.humpath.2014.10.010		6	Pathology	Pathology	AZ5QI	WOS:000348274600008		
J	Sugiura, R; Kamamoto, Y; Harada, N; Kameoka, H; Moriya, T				Sugiura, Ryosuke; Kamamoto, Yutaka; Harada, Noboru; Kameoka, Hirokazu; Moriya, Takehiro			Resolution Warped Spectral Representation for Low-Delay and Low-Bit-Rate Audio Coder	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Audio compression; frequency warping; line spectrum pairs; linear predictive coding; low delay; non-negative matrix; transform coding excitation	SPEECH; PREDICTION	We have devised a high-quality frequency-domain audio coder based on the state-of-the-art monaural wide-band coder aiming at its use in low-delay and low-bit-rate conditions. The coder efficiently represents frequency spectral envelopes of the target signals with low computational complexity using optimally prepared non-negative sparse matrices. The experimental results reveal that this representation has positive effects on the objective and subjective quality of the coder resulting in the comparable quality to the same bit rate of 3GPP Extended Adaptive Multi-Rate WideBand (AMR-WB+), a coder which permits more than four times longer delay compared with the proposed coder. Consequently, this coder is suitable for applications in mobile communications, which require low delay and low complexity.	[Sugiura, Ryosuke] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan; [Kamamoto, Yutaka; Harada, Noboru; Kameoka, Hirokazu; Moriya, Takehiro] NTT Corp, NTT, Commun Sci Labs, Atsugi, Kanagawa 2430198, Japan	Sugiura, R (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo 1138656, Japan.	r.sugiura.1990@ieee.org; kamamoto.yutaka@lab.ntt.co.jp; harada.noboru@lab.ntt.co.jp; kameoka@hil.t.u-tokyo.ac.jp; moriya.takehiro@lab.ntt.co.jp					3GPP, 2012, 26290 3GPP TS; 3GPP, 2012, 26071 3GPP TS; [Anonymous], 2012, 230033 ISOIEC; [Anonymous], 1449632009 ISOIEC; [Anonymous], 2014, 26445 3GPP TS; [Anonymous], 2009, ITU T SOFTW TOOL LIB; GOLOMB SW, 1966, IEEE T INFORM THEORY, V12, P399, DOI 10.1109/TIT.1966.1053907; ITAKURA F, 1975, J ACOUST SOC AM, V57, pS35, DOI 10.1121/1.1995189; Koishida K, 1997, INT CONF ACOUST SPEE, P1355, DOI 10.1109/ICASSP.1997.596198; [Anonymous], 1998, ACOUST SPEECH SIG PR; [Anonymous], 2001, METH SUBJ ASS INT QU; [Anonymous], 2014, 26441 3GPP TS; [Anonymous], 2012, 26190 3GPP TS; Hans M, 2001, IEEE SIGNAL PROC MAG, V18, P21, DOI 10.1109/79.939834; [Anonymous], 2012, COD SPEECH 8 KBIT S; [Anonymous], 2009, LOSSL COMPR G 711 PU; Backstrom T., 2014, P INT 14, P2794; Fuchs G., 2009, P EUSIPCO, P1264; Goto M., 2004, P 18 INT C AC; Harada N., 2010, P DAT COMPR C MAR, P532; Harada N, 2010, Proceedings 2010 IEEE International Conference on Acoustics, Speech and Signal Processing, ICASSP 2010, DOI 10.1109/ICASSP.2010.5495200; Harrington J., 1999, TECHNIQUES SPEECH AC, P18; ITAKURA F, 1970, ELECTRON COMMUN JPN, V53, P36; Iwakami N., 1995, P ICASSP 95, P937; Kameoka H., 2006, IPSJSIG TECH REP, P77; Kameoka H., 2008, IEICE T FUND ELECTR, V91, P1017; Lefebvre R., 1993, P ICASSP 93, P612; Liebchen T., 2004, P AES 116 CONV MAY, p#6047; Liebchen T., 2004, Proceedings. DCC 2004. Data Compression Conference; Liebechen T., 2005, P AES 119 CONV OCT; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Nakatoh Y., 1998, P ICSLP; Neuendorf M., 2012, P AES 132 CONV APR, V8654; OHMURO H, 1994, ELECTRON COMM JPN 3, V77, P12, DOI 10.1002/ecjc.4430771002; Quackenbush S, 2013, IEEE MULTIMEDIA, V20, P72, DOI 10.1109/MMUL.2013.24; Raake A., 2006, SPEECH QUALITY VOIP, P61; Reznik Y., 2004, P ICASSP 04; Rice R. F., 1991, SOME PRACTICAL UNIVE; Rice R. F., 1979, SOME PRACTICAL UNIVE; Rice R. F., 1983, SOME PRACTICAL NOISE; Robinson T., 1994, 156 CAMBR U ENG DEP; Salomon S., 2010, HDB DATA COMPRESSION; Sayood K., 2003, LOSSLESS COMPRESSION; STRUBE HW, 1980, J ACOUST SOC AM, V68, P1071, DOI 10.1121/1.384992; Sugiura R., 2014, P EUSIPCO; Sugiura R., 2014, P EUSIPCO SEP, VTU-L03-1; Tokuda K., 1993, ELECTR COMMUN JPN, V3, P30; Wabnik S., 2005, P ICASSP, V3; Weinberger MJ, 1996, DCC '96 - DATA COMPRESSION CONFERENCE, PROCEEDINGS, P140, DOI 10.1109/DCC.1996.488319	49	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	FEB	2015	23	2					288	299		10.1109/TASLP.2014.2384279		12	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	AZ4RL	WOS:000348210300006		
J	Matsuyama, Y; Saito, A; Fujie, S; Kobayashi, T				Matsuyama, Yoichi; Saito, Akihiro; Fujie, Shinya; Kobayashi, Tetsunori			Automatic Expressive Opinion Sentence Generation for Enjoyable Conversational Systems	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Conversational robots; natural sentence generation; opinion generation; question answering		In terms of functional conversations, Grice's Maxim of Quantity suggests that responses should contain no more information than was explicitly asked for. However, in our daily conversations, more informative response skills are usually employed in order to hold enjoyable conversations with interlocutors. These responses are usually produced as forms of one's additional opinions, which usually contain their original viewpoints as well as novel means of expression, rather than simple and common responses characteristic of the general public. In this paper, we propose automatic expressive opinion sentence generation mechanisms for enjoyable conversational systems. The generated opinions are extracted from a large number of reviews on the web, and ranked in terms of contextual relevance, length of sentences, and amount of information represented by the frequency of adjectives. The sentence generator also has an additional phrasing skill. Three controlled lab experiments were conducted, where subjects were requested to read generated sentences and watch videos filmed about conversations between the robot and a person. The results implied that mechanisms effectively promote users' enjoyment and interests.	[Matsuyama, Yoichi; Saito, Akihiro; Kobayashi, Tetsunori] Waseda Univ, Dept Comp Sci, Tokyo 1698555, Japan; [Fujie, Shinya] Chiba Inst Technol, Dept Adv Robot, Chiba 2750016, Japan	Matsuyama, Y (reprint author), Waseda Univ, Dept Comp Sci, Tokyo 1698555, Japan.	matsuyama@pcl.cs.waseda.ac.jp			WAKATE-B [23700239]	This work was supported by the Grant-in-Aid for scientific research WAKATE-B (23700239). The associate editor coordinating the review of this manuscript and approving it for publication was Dr. Bowen Zhou.	Misu T, 2007, INT CONF ACOUST SPEE, P145; GROSZ BJ, 1995, COMPUT LINGUIST, V21, P203; Breck E, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2683; Ferrucci D, 2010, AI MAG, V31, P59; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Murakami T, 2008, LECT NOTES ARTIF INT, V4914, P40; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; AUER S, 2007, SEMANTIC WEB, V4825, P722, DOI 10.1007/978-3-540-76298-0_52; Fellbaum C., 2010, WORDNET ELECT LEXICA; Grice H.P., 1975, SYNTAX SEMANTICS, V3, P41, DOI DOI 10.1017/S0022226700005296; Higashiyama M., 2008, P 14 ANN M ASS NAT L, P584; HOFMANN T, 1999, P 15 C UNC ART INT U, P289; Holmes J., 2000, SMALL TALK, P32; Kamps J., 2004, P 4 INT C LANG RES E; Kobayashi N, 2005, LECT NOTES COMPUT SC, V3248, P596; Kobayashi T., 2013, ACOUST SCI TECHNOL, V34, P64; Malinowski B., 1994, LANGUAGE LIT SOCIAL, P1; Matsuyama Y., 2009, ACM SIGGRAPH ASIA 20, P82, DOI 10.1145/1665137.1665201; McNee SM, 2006, CHI 06 HUM FACT COMP, P1103, DOI 10.1145/1125451.1125660; Nakagawa T, 2008, PROCEEDINGS OF THE SECOND INTERNATIONAL SYMPOSIUM ON UNIVERSAL COMMUNICATION, P251, DOI 10.1109/ISUC.2008.17; Nakagawa T., 2010, P HUM LANG TECHN 11, P786; Nakano T, 2006, IEEE INT CONF ROBOT, P194; Nasukawa T., 2004, P 2 INT C KNOWL CAPT, V2003, P70; Noda Y., 2010, P ICWSM; Pang B., 2008, FOUND TRENDS INF RET, V2, P1, DOI DOI 10.1561/1500000011; Pang B., 2002, P ACL 02 C EMP METH, V10, P79, DOI DOI 10.3115/1118693.1118704; Schneider K. P., 1988, SMALL TALK ANAL PHAT, V1; Sha F., 2003, P 2003 C N AM CHAPT, V1, P134, DOI 10.3115/1073445.1073473; Turney P. D., 2002, P 40 ANN M ASS COMP, P417, DOI DOI 10.3115/1073083.1073153; Walker M. A., 1998, CENTERING THEORY DIS; Ziegler C.-N., 2005, P 14 INT C WORLD WID, P22, DOI DOI 10.1145/1060745.1060754	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	FEB	2015	23	2					313	326		10.1109/TASLP.2014.2363589		14	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	AZ4RL	WOS:000348210300008		
J	Hirayama, N; Yoshino, K; Itoyama, K; Mori, S; Okuno, HG				Hirayama, Naoki; Yoshino, Koichiro; Itoyama, Katsutoshi; Mori, Shinsuke; Okuno, Hiroshi G.			Automatic Speech Recognition for Mixed Dialect Utterances by Mixing Dialect Language Models	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Corpus simulation; mixture of dialects; speech recognition		This paper presents an automatic speech recognition (ASR) system that accepts a mixture of various kinds of dialects. The system recognizes dialect utterances on the basis of the statistical simulation of vocabulary transformation and combinations of several dialect models. Previous dialect ASR systems were based on handcrafted dictionaries for several dialects, which involved costly processes. The proposed system statistically trains transformation rules between a common language and dialects, and simulates a dialect corpus for ASR on the basis of a machine translation technique. The rules are trained with small sets of parallel corpora to make up for the lack of linguistic resources on dialects. The proposed system also accepts mixed dialect utterances that contain a variety of vocabularies. In fact, spoken language is not a single dialect but a mixed dialect that is affected by the circumstances of speakers' backgrounds (e.g., native dialects of their parents or where they live). We addressed two methods to combine several dialects appropriately for each speaker. The first was recognition with language models of mixed dialects with automatically estimated weights that maximized the recognition likelihood. This method performed the best, but calculation was very expensive because it conducted grid searches of combinations of dialect mixing proportions that maximized the recognition likelihood. The second was integration of results of recognition from each single dialect language model. The improvements with this model were slightly smaller than those with the first method. Its calculation cost was, however, inexpensive and it worked in real-time on general workstations. Both methods achieved higher recognition accuracies for all speakers than those with the single dialect models and the common language model, and we could choose a suitable model for use in ASR that took into consideration the computational costs and recognition accuracies.	[Hirayama, Naoki; Yoshino, Koichiro; Itoyama, Katsutoshi; Mori, Shinsuke; Okuno, Hiroshi G.] Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan	Hirayama, N (reprint author), Kyoto Univ, Grad Sch Informat, Kyoto 6068501, Japan.	hirayama@kuis.kyoto-u.ac.jp; yoshino@ar.media.kyoto-u.ac.jp; itoyama@kuis.kyoto-u.ac.jp; forest@i.kyoto-u.ac.jp; okuno@i.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24220006]	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (S) No. 24220006. The associate editor coordinating the review of this manuscript and approving it for publication was Prof. Chung-Hsien Wu.	Akita Y., 2009, P INTERSPEECH2009, P84; [Anonymous], DAT SPOK DIAL ALL JA, V1-20, P2001; KNESER R, 1995, INT CONF ACOUST SPEE, P181, DOI 10.1109/ICASSP.1995.479394; Miller DR, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P2025; Aron J., 2011, NEW SCI, V212, P24; Brinton L. J., 2001, CAMBRIDGE HIST ENGLI, V6; Caballero M., 2006, P ITRW MULT SPEECH L; Ching P. C., 1994, P SPEECH IM PROC NEU, P127, DOI 10.1109/SIPNN.1994.344949; Chitturi R., 2008, P ACL HLT COMP VOL C, P21, DOI 10.3115/1557690.1557697; Cruse DA, 1986, LEXICAL SEMANTICS; Elfardy H., 2013, P ACL 13 AUG, V2, P456; Fiscus J. G., 1997, IEEE WORKSH AUT SPEE, P347, DOI DOI 10.1109/ASRU.1997.659110; Hirayama N., 2012, P COLING 12, P1179; Hirayama N., 2013, P INT 13, P1492; Itou K., 1999, ACOUST SOC JPN E, V20, P199; Lambourne A., 2004, International Journal of Speech Technology, V7, DOI 10.1023/B:IJST.0000037071.39044.cc; Lee A., 2001, P EUR C SPEECH COMM, P1691; Lyu DC, 2006, INT CONF ACOUST SPEE, P1105; Maekawa K., 2003, P ISCA IEEE WORKSH S, P7; Maekawa Kikuo, 2008, P 6 WORKSH AS LANG R, P101; Misu T, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P9; Ramon D., 2006, VIAGRA PROZAC LEECHE, P203; Schuster M, 2010, LECT NOTES ARTIF INT, V6230, P8, DOI 10.1007/978-3-642-15246-7_3; Stolcke A, 2002, P INTERSPEECH; Thomas ER, 2008, VARIETIES OF ENGLISH 2: THE AMERICAS AND THE CARIBBEAN, P87; Wolfram W., 2009, ETHNOLINGUISTIC DIVE, P129; Woods Howard B., 1979, THESIS U BRIT COLUMB	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	FEB	2015	23	2					373	382		10.1109/TASLP.2014.2387414		10	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	AZ4RL	WOS:000348210300013		
J	Caiafa, CF; Cichocki, A				Caiafa, Cesar F.; Cichocki, Andrzej			Stable, Robust, and Super Fast Reconstruction of Tensors Using Multi-Way Projections	IEEE TRANSACTIONS ON SIGNAL PROCESSING			English	Article						Compressed Sensing (CS); Kronecker-CS; low-rank tensor approximation; multi-way analysis; Tucker model	INFORMATION	In the framework of multidimensional Compressed Sensing (CS), we introduce an analytical reconstruction formula that allows one to recover an Nth-order data tensor X is an element of R-I1 x I2 x ... IN from a reduced set of multi-way compressive measurements by exploiting its low multilinear-rank structure. Moreover, we show that, an interesting property of multi-way measurements allows us to build the reconstruction based on compressive linear measurements taken only in two selected modes, independently of the tensor order N. In addition, it is proved that, in the matrix case and in a particular case with 3rd-order tensors where the same 2D sensor operator is applied to all mode-3 slices, the proposed reconstruction X-tau is stable in the sense that the approximation error is comparable to the one provided by the best low-multilinear-rank approximation, where tau is a threshold parameter that controls the approximation error. Through the analysis of the upper bound of the approximation error we show that, in the 2D case, an optimal value for the threshold parameter tau = tau(0) > 0 exists, which is confirmed by our simulation results. On the other hand, our experiments on 3D datasets show that very good reconstructions are obtained using tau = 0, which means that this parameter does not need to be tuned. Our extensive simulation results demonstrate the stability and robustness of the method when it is applied to real-world 2D and 3D signals. A comparison with state-of-the-arts sparsity based CS methods specialized for multidimensional signals is also included. A very attractive characteristic of the proposed method is that it provides a direct computation, i.e., it is non-iterative in contrast to all existing sparsity based CS algorithms, thus providing super fast computations, even for large datasets.	[Caiafa, Cesar F.] Inst Argentino Radioastron IAR CCT, La Plata, Buenos Aires, Argentina; [Caiafa, Cesar F.] Fac Ingn UBA, Buenos Aires, DF, Argentina; [Cichocki, Andrzej] RIKEN, LABSP, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Cichocki, Andrzej] PAS, Syst Res Inst, Warsaw, Poland	Caiafa, CF (reprint author), Inst Argentino Radioastron IAR CCT, La Plata, Buenos Aires, Argentina.	ccaiafa@fi.uba.ar; a.cichocki@riken.jp			ANPCyT, PICT [1519]; CONICET, PIP [114-201101-00021]	This work was supported in part by Grants from ANPCyT, PICT 2012 #1519, and CONICET, PIP #114-201101-00021.	Candes EJ, 2010, P IEEE, V98, P925, DOI 10.1109/JPROC.2009.2035722; Rivenson Y, 2009, IEEE SIGNAL PROC LET, V16, P449, DOI 10.1109/LSP.2009.2017817; Acar E, 2011, CHEMOMETR INTELL LAB, V106, P41, DOI 10.1016/j.chemolab.2010.08.004; De Lathauwer L, 2000, SIAM J MATRIX ANAL A, V21, P1253, DOI 10.1137/S0895479896305696; Willett RM, 2014, IEEE SIGNAL PROC MAG, V31, P116, DOI 10.1109/MSP.2013.2279507; Robucci R, 2010, P IEEE, V98, P1089, DOI 10.1109/JPROC.2010.2041422; Duarte MF, 2012, IEEE T IMAGE PROCESS, V21, P494, DOI 10.1109/TIP.2011.2165289; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Sidiropoulos ND, 2012, IEEE SIGNAL PROC LET, V19, P757, DOI 10.1109/LSP.2012.2210872; Golbabaee M, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P2741; Duarte MF, 2008, IEEE SIGNAL PROC MAG, V25, P83, DOI 10.1109/MSP.2007.914730; Oseledets IV, 2009, SIAM J SCI COMPUT, V31, P3744, DOI 10.1137/090748330; August Y, 2013, APPL OPTICS, V52, pD46, DOI 10.1364/AO.52.000D46; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Auria A, 2014, MON NOT R ASTRON SOC, V437, P2083, DOI 10.1093/mnras/stt1994; Bader B. W., 2012, MATLAB TENSOR TOOLBO; Caiafa C. F., 2014, IEEE INT C AC SPEECH; Caiafa C. F., 2012, NEURAL COMPUT, P186; Caiafa CF, 2013, WIRES DATA MIN KNOWL, V3, P355, DOI 10.1002/widm.1108; Caiafa CF, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P2709; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Cichocki A., 2015, IEEE SI IN PRESS MAR, P1; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Eldar Y., 2012, COMPRESSED SENSING T, V20, P12; Foster DH, 2004, VISUAL NEUROSCI, V21, P331, DOI 10.1017/S0952523804043330; Hansen P. C., 1998, NUMERICAL ASPECTS LI; Li Q., 2013, MULT EXP ICME; Liu J, 2012, IEEE T PATTERN ANAL, V35, P208; Marvasti F, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-44; Nico V., 2013, INTERNAL REP ESAT ST, V13, P1; Rauhut H., 2013, P SAMPTA 2013 JUN; Wetzstein G, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185576; Yu YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098441	33	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1053-587X	1941-0476		IEEE T SIGNAL PROCES	IEEE Trans. Signal Process.	FEB 1	2015	63	3					780	793		10.1109/TSP.2014.2385040		14	Engineering, Electrical & Electronic	Engineering	AZ7BT	WOS:000348374000019		
J	Wang, YF; Vasilakos, AV; Ma, JH; Xiong, NX				Wang, Yufeng; Vasilakos, Athanasios V.; Ma, Jianhua; Xiong, Naixue			On Studying the Impact of Uncertainty on Behavior Diffusion in Social Networks	IEEE TRANSACTIONS ON SYSTEMS MAN CYBERNETICS-SYSTEMS			English	Article						Behavior diffusion; random utility theory; social networks; uncertainty	MODELS; DYNAMICS; CHOICE	Unlike traditional epidemic virus spreading, behavior diffusion in social networks is conducted by rational users, who would make strategic choices instead of being randomly infected with some probability. Specifically, individuals always try to maximize their utilities through rationally selecting specific behaviors (adopting a new product, or spreading a rumor, etc.). However, utility obtained by an individual, naturally contains uncertainty, and it may stem from two sources: users' imperfect and incomplete knowledge about others, and the inherently stochastic property in human behavior. Thus, it is imperative to model and analyze the diffusion pattern under the resulting uncertainty in social networks, which, however, has not yet been deeply examined by the existing works. This paper deeply explores the pattern of gossip diffusion in social networks when uncertainty exists in users' decision making. In detail, the innovative results provided in this paper are: first, inspired by random utility theory, we formulate the diffusion model based on mixed logit model that allows for user's uncertainty in determining whether to adopt a specific strategy; second, the formal analysis framework characterizing the diffusion process is derived through the approximation method of mean field theory; finally, we explore the extensive applicability of our proposed analysis framework through modeling rumor diffusion in social networks as a coordination game. Our findings are, for various structural characteristics, small uncertainty can significantly speed up the diffusion of gossip; furthermore, social networks with scale-free property can facilitate the gossip diffusion in the easiest way, but, the range of uncertainty factor that can maximize gossip diffusion is the smallest. The obtained results perfectly comply with the philosophical saying about rumor diffusion in real social life: easy come, easy go.	[Wang, Yufeng] Nanjing Univ Posts & Telecommun, Nanjing 210003, Peoples R China; [Vasilakos, Athanasios V.] Kuwait Univ, Kuwait 13060, Kuwait; [Ma, Jianhua] Hosei Univ, Tokyo 1028160, Japan; [Xiong, Naixue] Colorado Tech Univ, Sch Comp Sci, Colorado Springs, CO 80907 USA	Wang, YF (reprint author), Nanjing Univ Posts & Telecommun, Nanjing 210003, Peoples R China.	wfwang@njupt.edu.cn; th.vasilakos@gmail.com; jianhua@hosei.ac.jp; nxiong@coloradotech.edu			National Natural Science Foundation of China [61171092]; JiangSu Educational Bureau [14KJA510004]; JiangSu 973 Program [BK2011027]; Huawei Innovation Research Program	This work was supported in part by the National Natural Science Foundation of China under Grant 61171092, in part by the JiangSu Educational Bureau Project under Grant 14KJA510004, in part by the JiangSu 973 Program under Grant BK2011027, and in part by the Huawei Innovation Research Program. This paper was recommended by Associate Editor J. Lu.	Klass OS, 2006, ECON LETT, V90, P290, DOI 10.1016/j.econlet.2005.08.020; McFadden D, 2000, J APPL ECONOM, V15, P447, DOI 10.1002/1099-1255(200009/10)15:5<447::AID-JAE570>3.0.CO;2-1; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Lim SH, 2011, IEEE T SYST MAN CY A, V41, P853, DOI 10.1109/TSMCA.2011.2157130; Lelarge M, 2012, GAME ECON BEHAV, V75, P752, DOI 10.1016/j.geb.2012.03.009; [Anonymous], 2013, ASTRO PHYS COLLABORA; Lopez-Pintado D, 2008, GAME ECON BEHAV, V62, P573, DOI 10.1016/j.geb.2007.08.001; Sen S, 2010, IEEE ACM T NETWORK, V18, P1793, DOI 10.1109/TNET.2010.2048923; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Young HP, 2011, P NATL ACAD SCI USA, V108, P21285, DOI 10.1073/pnas.1100973108; Jackson MO, 2007, AM ECON REV, V97, P92, DOI 10.1257/aer.97.2.92; Chen W, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P199, DOI 10.1145/1557019.1557047; Burda M, 2008, J ECONOMETRICS, V147, P232, DOI 10.1016/j.jeconom.2008.09.029; BLUME LE, 1995, GAME ECON BEHAV, V11, P111, DOI 10.1006/game.1995.1046; Chakrabarti Deepayan, 2008, ACM Transactions on Information and Systems Security, V10, DOI 10.1145/1284680.1284681; Doer B, 2012, COMMUN ACM, V55, P70, DOI 10.1145/2184319.2184338; Gonalves B., 2011, PLOS ONE, V6, DOI [DOI 10.1371/JOURNAL.PONE.0022656, 10.1371/journal.pone.0022656]; Hernando A, 2010, EUR PHYS J B, V76, P87, DOI 10.1140/epjb/e2010-00216-1; Athey S, 2007, INT ECON REV, V48, P1159; Keane M., 2012, J APPL EC, V28, P1018; Lopez-Pintado D., 2008, E ECON J, V34, P464; Lopez-Pintado D, 2006, INT J GAME THEORY, V34, P371, DOI 10.1007/s00182-006-0026-5; McFadden D, 1973, FRONTIERS ECONOMETRI; Namatame A., 2009, P SPRING SIM SPRINGS; Nevo A, 2011, ANNU REV ECON, V3, P51, DOI 10.1146/annurev-economics-061109-080402; Simon S., 2012, P 8 WORKSH INT NETW, P100; Sundsoy P. R., 2013, LECT NOTES SOCIAL NE, V6, P201; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Wang YL, 2011, PROCEEDINGS OF THE 2011 INTERNATIONAL CONFERENCE ON ENGINEERING AND RISK MANAGEMENT, P188; Wasserkrug S, 2012, IEEE T KNOWL DATA EN, V24, P45, DOI 10.1109/TKDE.2010.204; Young H. P., 2002, EC COMPLEX EVOLVING, V3	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2216			IEEE T SYST MAN CY-S	IEEE Trans. Syst. Man Cybern. -Syst.	FEB	2015	45	2					185	197		10.1109/TSMC.2014.2359857		13	Automation & Control Systems; Computer Science, Cybernetics	Automation & Control Systems; Computer Science	AZ3KM	WOS:000348126100001		
J	Nakamura, Y; Sato, K; Yamamoto, H; Matsumura, K; Matsumoto, I; Nomura, T; Miyasaka, T; Ishii, K; Kanno, E; Tachi, M; Yamasaki, S; Saijo, S; Iwakura, Y; Kawakami, K				Nakamura, Yuri; Sato, Ko; Yamamoto, Hideki; Matsumura, Kana; Matsumoto, Ikumi; Nomura, Toshiki; Miyasaka, Tomomitsu; Ishii, Keiko; Kanno, Emi; Tachi, Masahiro; Yamasaki, Sho; Saijo, Shinobu; Iwakura, Yoichiro; Kawakami, Kazuyoshi			Dectin-2 Deficiency Promotes Th2 Response and Mucin Production in the Lungs after Pulmonary Infection with Cryptococcus neoformans	INFECTION AND IMMUNITY			English	Article							C-TYPE LECTIN; HOST-DEFENSE; CANDIDA-ALBICANS; INNATE IMMUNITY; T-CELLS; ANTIMICROBIAL PEPTIDES; ANTIFUNGAL IMMUNITY; DENDRITIC CELLS; MICE; RECOGNITION	Dectin-2 is a C-type lectin receptor that recognizes high mannose polysaccharides. Cryptococcus neoformans, a yeast-form fungal pathogen, is rich in polysaccharides in its cell wall and capsule. In the present study, we analyzed the role of Dectin-2 in the host defense against C. neoformans infection. In Dectin-2 gene-disrupted (knockout) (Dectin-2KO) mice, the clearance of this fungus and the inflammatory response, as shown by histological analysis and accumulation of leukocytes in infected lungs, were comparable to those in wild-type (WT) mice. The production of type 2 helper T (Th2) cytokines in lungs was higher in Dectin-2KO mice than in WT mice after infection, whereas there was no difference in the levels of production of Th1, Th17, and proinflammatory cytokines between these mice. Mucin production was significantly increased in Dectin-2KO mice, and this increase was reversed by administration of anti-interleukin 4 (IL-4) monoclonal antibody (MAb). The levels of expression of beta 1-defensin, cathelicidin, surfactant protein A (Sp-A), and Sp-D in infected lungs were comparable between these mice. In in vitro experiments, IL-12p40 and tumor necrosis factor alpha (TNF-alpha) production and expression of CD86 and major histocompatibility complex (MHC) class II by bone marrow-derived dendritic cells and alveolar macrophages were completely abrogated in Dectin-2KO mice. Finally, the disrupted lysates of C. neoformans, but not of whole yeast cells, activated Dectin-2-triggered signaling in an assay with nuclear factor of activated T cells (NFAT)-green fluorescent protein (GFP) reporter cells expressing this receptor. These results suggest that Dectin-2 may oppose the Th2 response and IL-4-dependent mucin production in the lungs after infection with C. neoformans, and it may not be required for the production of Th1, Th17, and proinflammatory cytokines or for clearance of this fungal pathogen.	[Nakamura, Yuri; Sato, Ko; Yamamoto, Hideki; Matsumoto, Ikumi; Nomura, Toshiki; Miyasaka, Tomomitsu; Ishii, Keiko; Kawakami, Kazuyoshi] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan; [Matsumura, Kana; Tachi, Masahiro] Tohoku Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sendai, Miyagi 980, Japan; [Kanno, Emi] Tohoku Univ, Grad Sch Med, Dept Sci Nursing Practice, Sendai, Miyagi 980, Japan; [Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 812, Japan; [Saijo, Shinobu] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Ctr Anim Dis Models, Res Inst Biol Sci, Chiba, Japan	Kawakami, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 980, Japan.	kawakami@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23390263, 24659477]; Ministry of Health, Labor and Welfare of Japan [H22-SHINKOU-IPPAN-008, H25-SHINKOU-IPPAN-006]	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (23390263) and a Grant-in-Aid for Challenging Exploratory Research (24659477) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by grants (Research on Emerging and Re-emerging Infectious Diseases [H22-SHINKOU-IPPAN-008 and H25-SHINKOU-IPPAN-006]) from the Ministry of Health, Labor and Welfare of Japan.	Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Decken K, 1998, INFECT IMMUN, V66, P4994; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Cunha BA, 2001, INFECT DIS CLIN N AM, V15, P567, DOI 10.1016/S0891-5520(05)70160-4; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Jarvis JN, 2007, AIDS, V21, P2119; Kullberg BJ, 1999, FEMS IMMUNOL MED MIC, V26, P299, DOI 10.1016/S0928-8244(99)00150-9; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507; Geunes-Boyer S, 2009, INFECT IMMUN, V77, P2783, DOI 10.1128/IAI.00088-09; LIM TS, 1980, INFECT IMMUN, V30, P5; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Kawakami K, 2000, J IMMUNOL, V165, P941; Walenkamp AME, 1999, EUR J CLIN INVEST, V29, P83; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Muller U, 2007, J IMMUNOL, V179, P5367; KAWAKAMI K, 1994, CLIN EXP IMMUNOL, V96, P230; [Anonymous], P NATL ACAD SCI US, V101, P8126; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Risso A, 2000, J LEUKOCYTE BIOL, V68, P785; Yamamoto H, 2014, INFECT IMMUN, V82, P1606, DOI 10.1128/IAI.01089-13; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Hardison SE, 2010, INFECT IMMUN, V78, P5341, DOI 10.1128/IAI.00845-10; Yuan RR, 1997, P NATL ACAD SCI USA, V94, P2483, DOI 10.1073/pnas.94.6.2483; Barrett NA, 2009, J IMMUNOL, V182, P1119; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00036-3; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Viriyakosol S, 2014, INFECT IMMUN, V82, P1147, DOI 10.1128/IAI.01355-13; Blackstock R, 1999, INFECT IMMUN, V67, P3601; Blackstock R, 2004, AM J RESP CELL MOL, V30, P109, DOI 10.1165/rcmb.2003-0156OC; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Grahnert A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087341; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Rossi GR, 1999, CLIN IMMUNOL, V90, P256, DOI 10.1006/clim.1998.4639; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; Zuyderduyn S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-59	47	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	FEB	2015	83	2					671	681		10.1128/IAI.02835-14		11	Immunology; Infectious Diseases	Immunology; Infectious Diseases	AZ0ST	WOS:000347955700022		
J	Imai, Y				Imai, Yasuo			Poorly differentiated adenocarcinoma of the colon: subsite location and clinicopathologic features	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Poorly differentiated adenocarcinoma; Colon; Subsite; Microsatellite instability; Clinicopathologic features	DNA-REPLICATION ERRORS; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; ABERRANT EXPRESSION; MUCIN GENES; CARCINOMAS; P53; MUC5AC; PHENOTYPE; MUTATION	Colorectal cancers of the proximal colon are characterized by good prognosis, microsatellite instability (MSI), and poor differentiation. MSI is associated with a favorable prognosis, but poorly differentiated adenocarcinomas (PDAs) have a poor prognosis. In this study, we aimed to investigate this inconsistency by analyzing the heterogeneity of PDAs. A total of 156 surgically resected PDAs were analyzed according to tumor subsite by morphological and immunohistochemical analyses. Proximal PDAs (n = 86) were significantly associated with females, older age, cytokeratin (CK) 20 downregulation, aberrant MUC5AC expression, and MSI compared with distal PDAs (n = 70). Proximal PDAs tended to show a better overall survival rate than distal PDAs. PDAs with microsatellite stability (MSS) were suggested to progress from well- and moderately differentiated adenocarcinomas (WMDAs), but MSI PDAs typically not. MSI PDAs demonstrated a prognosis marginally better than MSS PDAs, but significantly worse than WMDAs (n = 170). Proximal MSS PDAs had a similar unfavorable prognosis but were significantly associated with females and aberrant MUC5AC expression compared with distal MSS PDAs. MSI may be predictive of prognosis only in proximal PDAs, because nearly all distal PDAs were MSS. In contrast, CK20 downregulation was significantly associated with better prognosis in both subsites. Proximal PDAs had a better prognosis than distal PDAs due to a higher incidence of MSI PDAs, whose prognosis was significantly worse than WMDAs. Female and MUC5AC expression were characteristic of proximal PDAs independent of MSI. Subsite-specific features of PDAs may serve for subclassification and predicting prognosis.	Fuji Heavy Ind Hlth Insurance Soc, Ota Mem Hosp, Dept Diagnost Pathol, Ota, Gunma 3738585, Japan	Imai, Y (reprint author), Fuji Heavy Ind Hlth Insurance Soc, Ota Mem Hosp, Dept Diagnost Pathol, 455-1 Oshima, Ota, Gunma 3738585, Japan.	yimai@s3.dion.ne.jp					American Joint Committee on Cancer, 2009, COL RECT CANC STAG; Ookawa K, 2002, J BIOL CHEM, V277, P48270, DOI 10.1074/jbc.M207986200; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Jass JR, 1998, GUT, V42, P673; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064; BLANK M, 1994, INT J CANCER, V59, P301, DOI 10.1002/ijc.2910590302; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Hirano K, 2012, PATHOL INT, V62, P600, DOI 10.1111/j.1440-1827.2012.02850.x; Yamagishi H, 2013, J GASTROEN HEPATOL, V28, P1815, DOI 10.1111/jgh.12319; BUFILL JA, 1990, ANN INTERN MED, V113, P779; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Bartman AE, 1999, INT J CANCER, V80, P210; Marcus VA, 1999, AM J SURG PATHOL, V23, P1248, DOI 10.1097/00000478-199910000-00010; Losi L, 2004, PATHOL RES PRACT, V200, P371, DOI 10.1016/j.prp.2004.01.008; McGregor DK, 2004, AM J SURG PATHOL, V28, P712, DOI 10.1097/01.pas.0000126757.58474.12; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; GREENBLATT MS, 1994, CANCER RES, V54, P4855; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Sinicrope FA, 2006, AM J GASTROENTEROL, V101, P2818, DOI 10.1111/j.1572-0241.2006.00845.x; KIM HG, 1994, AM J PATHOL, V145, P148; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; STARZYNSKA T, 1992, BRIT J CANCER, V66, P558, DOI 10.1038/bjc.1992.314; Guastadisegni C, 2010, EUR J CANCER, V46, P2788, DOI 10.1016/j.ejca.2010.05.009; GOH HS, 1995, CANCER RES, V55, P5217; Hanski C, 1997, LAB INVEST, V77, P685; Wray CM, 2009, DIS COLON RECTUM, V52, P1359, DOI 10.1007/DCR.0b013e3181a7b7de; BARA J, 1983, CANCER RES, V43, P3885; BARA J, 1980, BRIT J CANCER, V41, P209, DOI 10.1038/bjc.1980.32; Biemer-Huttmann AE, 2000, CLIN CANCER RES, V6, P1909; Biemer-Huttmann AE, 1999, J HISTOCHEM CYTOCHEM, V47, P1039; Buisine MP, 1996, GASTROENTEROLOGY, V110, P84, DOI 10.1053/gast.1996.v110.pm8536891; Cottu PH, 1996, ONCOGENE, V13, P2727; Gervaz P, 2004, J SURG ONCOL, V88, P261, DOI 10.1002/jso.20156; Hamilton SR, 2013, WHO CLASSIFICATION T, P134; Haydon AMM, 2002, LANCET ONCOL, V3, P83, DOI 10.1016/S1470-2045(02)00649-6; Imai Y, 2013, WORLD J GASTROENTERO, V19, P3957, DOI 10.3748/wjg.v19.i25.3957; Imai Y, 2014, ANTICANCER RES, V34, P159; Ishihara S, 2012, INT J COLORECTAL DIS, V27, P371, DOI 10.1007/s00384-011-1343-0; Kim JH, 2013, AM J SURG PATHOL, V37, P1532, DOI 10.1097/PAS.0b013e31829ab1c1; Kim YH, 2010, ANN SURG ONCOL, V17, P1435, DOI 10.1245/s10434-009-0888-4; Mizoshita T, 2007, HISTOL HISTOPATHOL, V22, P251; Smith Martin L., 1995, Current Opinion in Oncology, V7, P69; The Japanese Society for Cancer of the Colon and Rectum, 2013, GEN RUL JAP CLASS CO	45	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	FEB	2015	30	2					187	196		10.1007/s00384-014-2070-0		10	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ4WX	WOS:000348222400005		
J	Nagata, N; Niikura, R; Aoki, T; Shimbo, T; Kishida, Y; Sekine, K; Tanaka, S; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Akiyama, J; Yanase, M; Mizokami, M; Uemura, N				Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Shimbo, Takuro; Kishida, Yoshihiro; Sekine, Katsunori; Tanaka, Shohei; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio; Mizokami, Masashi; Uemura, Naomi			Natural history of outpatient-onset ischemic colitis compared with other lower gastrointestinal bleeding: a long-term cohort study	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Acute large bowel ischemia (ALBI); Blood transfusion requirement; Length of hospital stay; Recurrence; Prognosis	RISK-FACTORS; EPIDEMIOLOGY; MANAGEMENT; HEMORRHAGE; COLON; PROGNOSIS; PATTERNS; OUTCOMES	The long-term clinical course of outpatient-onset ischemic colitis remains unknown. Our aims are to elucidate the in- and out-of-hospital clinical outcomes of ischemic colitis and compare them with those of lower gastrointestinal bleeding (LGIB). A cohort of 370 outpatients was hospitalized for ischemic colitis (n = 57) or other LGIB (n = 313). All patients had undergone colonoscopy. During hospitalization, the need for transfusion or interventions, further bleeding, mortality, and length of hospital stay were measured. After discharge, long-term recurrence and mortality were analyzed by the Kaplan-Meier method. Colonoscopy revealed that 88 % of ischemic colitis cases were left sided. Compared with other LGIB, ischemic colitis cases had significantly lower transfusion requirements (p < 0.01), further bleeding (p = 0.02), endoscopic intervention (p < 0.01), and shorter hospital stay (p = 0.03). No significant differences between the groups were noted in the need for surgery, angiographic procedures, or mortality during hospitalization. During a mean follow-up of 22 months, rebleeding was significantly lower (log-rank test; p < 0.01) in ischemic colitis cases (5.3 %) than in other LGIB cases (19.4 %) after discharge. During the mean follow-up period of 29 months, 1 patient (1.8 %) with ischemic colitis and 18 patients (5.8 %) with other LGIB died (log-rank test; p = 0.41). Outpatient-onset ischemic colitis patients usually had left-sided colitis, recovered with conservative short-term treatment and had lower transfusion requirements and further bleeding compared with other LGIB patients. After discharge, patients with outpatient-onset ischemic colitis had lower recurrence over the long term than other LGIB patients.	[Nagata, Naoyoshi; Niikura, Ryota; Aoki, Tomonori; Kishida, Yoshihiro; Sekine, Katsunori; Tanaka, Shohei; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio] Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1628655, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Res Inst, Dept Clin Res & Informat, Tokyo, Japan; [Mizokami, Masashi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	The authors declare no conflict of interest. This study was supported in part by the National Center for Global Health and Medicine (26A-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Niikura R, 2012, COLORECTAL DIS, V14, P302, DOI 10.1111/j.1463-1318.2011.02611.x; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; Sotiriadis J, 2007, AM J GASTROENTEROL, V102, P2247, DOI 10.1111/j.1572-0241.2007.01341.x; Longstreth GF, 2010, CLIN GASTROENTEROL H, V8, P49, DOI 10.1016/j.cgh.2009.09.006; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Strate LL, 2005, GASTROENTEROL CLIN N, V34, P643, DOI 10.1016/j.gtc.2005.08.007; O'Neill S, 2012, COLORECTAL DIS, V14, pE751, DOI 10.1111/j.1463-1318.2012.03171.x; Medina C, 2004, DIS COLON RECTUM, V47, P180, DOI 10.1007/s10350-003-0033-6; LONGO WE, 1992, DIS COLON RECTUM, V35, P726, DOI 10.1007/BF02050319; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; LONGSTRETH GF, 1995, AM J GASTROENTEROL, V90, P206; Brandt LJ, 2010, AM J GASTROENTEROL, V105, P2245, DOI 10.1038/ajg.2010.217; Nagata N, 2013, CLIN GASTROENTEROL H, V11, P673, DOI 10.1016/j.cgh.2012.12.034; Brandt LJ, 2010, AM J GASTROENTEROL, V105, P2253; Chavalitdhamrong D, 2011, GASTROINTEST ENDOSC, V74, P852, DOI 10.1016/j.gie.2011.05.039; Huguier M, 2006, AM J SURG, V192, P679, DOI 10.1016/j.amjsurg.2005.09.018; Koutroubakis IE, 2001, GASTROENTEROLOGY, V121, P561, DOI 10.1053/gast.2001.27227; Longstreth GF, 2009, CLIN GASTROENTEROL H, V7, P1075, DOI 10.1016/j.cgh.2009.05.026; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; Zou XP, 2009, DIGEST DIS SCI, V54, P2009, DOI 10.1007/s10620-008-0579-1	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	FEB	2015	30	2					243	249		10.1007/s00384-014-2079-4		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AZ4WX	WOS:000348222400013		
J	Katayama, T; Yoshioka, H; Muramoto, Y; Usami, J; Fujiwara, K; Yoshida, S; Kamagata, Y; Sakata, S				Katayama, Taiki; Yoshioka, Hideyoshi; Muramoto, Yoshiyuki; Usami, Jun; Fujiwara, Kazuhiro; Yoshida, Satoshi; Kamagata, Yoichi; Sakata, Susumu			Physicochemical impacts associated with natural gas development on methanogenesis in deep sand aquifers	ISME JOURNAL			English	Article							EASTERN NANKAI TROUGH; IN-WATER TYPE; MICROBIAL COMMUNITIES; ISOTOPIC COMPOSITIONS; METHANE PRODUCTION; SUBSURFACE; SEDIMENTS; JAPAN; DIVERSITY; FIELD	The Minami-Kanto gas field, where gases are dissolved in formation water, is a potential analogue for a marine gas hydrate area because both areas are characterized by the accumulation of microbial methane in marine turbidite sand layers interbedded with mud layers. This study examined the physicochemical impacts associated with natural gas production and well drilling on the methanogenic activity and composition in this gas field. Twenty-four gas-associated formation water samples were collected from confined sand aquifers through production wells. The stable isotopic compositions of methane in the gases indicated their origin to be biogenic via the carbonate reduction pathway. Consistent with this classification, methanogenic activity measurements using radiotracers, culturing experiments and molecular analysis of formation water samples indicated the predominance of hydrogenotrophic methanogenesis. The cultivation of water samples amended only with methanogenic substrates resulted in significant increases in microbial cells along with high-yield methane production, indicating the restricted availability of substrates in the aquifers. Hydrogenotrophic methanogenic activity increased with increasing natural gas production from the corresponding wells, suggesting that the flux of substrates from organic-rich mudstones to adjacent sand aquifers is enhanced by the decrease in fluid pressure in sand layers associated with natural gas/water production. The transient predominance of methylotrophic methanogens, observed for a few years after well drilling, also suggested the stimulation of the methanogens by the exposure of unutilized organic matter through well drilling. These results provide an insight into the physicochemical impacts on the methanogenic activity in biogenic gas deposits including marine gas hydrates.	[Katayama, Taiki; Yoshioka, Hideyoshi; Sakata, Susumu] Natl Inst Adv Ind Sci & Technol, AIST, Inst Georesources & Environm, Tsukuba, Ibaraki 3058567, Japan; [Muramoto, Yoshiyuki; Usami, Jun] Kanto Nat Gas Dev Co Ltd, Mobara, Japan; [Fujiwara, Kazuhiro] Japan Oil Gas & Met Natl Corp, Minato Ku, Tokyo, Japan; [Yoshida, Satoshi] Natl Inst Radiol Sci, Fukushima Project Headquarters, Inage Ku, Fukushima, Japan; [Kamagata, Yoichi] AIST, Bioprod Res Inst, Toyohira, Japan	Yoshioka, H (reprint author), Natl Inst Adv Ind Sci & Technol, AIST, Inst Georesources & Environm, 1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	hi-yoshioka@aist.go.jp			Japan Oil, Gas and Metals National Corporation (JOGMEC)	We thank Y Suzuki and T Tonooka for the acetate quantification and Y Togo for the iodine quantification. This work was supported by a grant from the Japan Oil, Gas and Metals National Corporation (JOGMEC).	Pohlman JW, 2009, EARTH PLANET SC LETT, V287, P504, DOI 10.1016/j.epsl.2009.08.037; Vandenbroucke M, 2007, ORG GEOCHEM, V38, P719, DOI 10.1016/j.orggeochem.2007.01.001; Yoshioka H, 2009, GEOCHEM J, V43, P315, DOI 10.2343/geochemj.1.0028; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Gray ND, 2009, EXTREMOPHILES, V13, P511, DOI 10.1007/s00792-009-0237-3; Grabowski A, 2005, FEMS MICROBIOL ECOL, V54, P427, DOI 10.1016/j.femsec.2005.05.007; PEDERSEN K, 1993, EARTH-SCI REV, V34, P243, DOI 10.1016/0012-8252(93)90058-F; Kirk MF, 2012, CHEM GEOL, V332, P15, DOI 10.1016/j.chemgeo.2012.08.032; Wawrik B, 2012, FEMS MICROBIOL ECOL, V81, P26, DOI 10.1111/j.1574-6941.2011.01272.x; Dawson KS, 2012, APPL ENVIRON MICROB, V78, P3599, DOI 10.1128/AEM.07122-11; Krumholz LR, 1997, NATURE, V386, P64, DOI 10.1038/386064a0; Kotelnikova S, 2002, EARTH-SCI REV, V58, P367, DOI 10.1016/S0012-8252(01)00082-4; Milkov AV, 2005, ORG GEOCHEM, V36, P681, DOI 10.1016/j.orggeochem.2005.01.010; Kvenvolden KA, 1995, ORG GEOCHEM, V23, P997, DOI 10.1016/0146-6380(96)00002-2; Shimizu S, 2007, GEOBIOLOGY, V5, P423, DOI 10.1111/j.1472-4669.2007.00123.x; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Guo HG, 2012, APPL MICROBIOL BIOT, V96, P1587, DOI 10.1007/s00253-012-3889-3; Waseda A, 2004, RESOUR GEOL, V54, P69, DOI 10.1111/j.1751-3928.2004.tb00188.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Newberry CJ, 2004, ENVIRON MICROBIOL, V6, P274, DOI 10.1111/j.1462-2920.2004.00568.x; IGARI SI, 1989, GEOCHEM J, V23, P139; Mesle M, 2013, RES MICROBIOL, V164, P959, DOI 10.1016/j.resmic.2013.07.004; Mochimaru H, 2007, GEOMICROBIOL J, V24, P93, DOI 10.1080/01490450701266571; ADAMS J, 1990, TECTONICS, V9, P569, DOI 10.1029/TC009i004p00569; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; MCMAHON PB, 1991, NATURE, V349, P233, DOI 10.1038/349233a0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Yoshioka H, 2010, GEOBIOLOGY, V8, P223, DOI 10.1111/j.1472-4669.2009.00231.x; Fujii T., 2009, AAPG MEMOIR, V89, P385; Kimura K, 1993, J JPN ASS PETROL TEC, V58, P447; Maekawa T, 2006, GEOCHEM J, V40, P475, DOI 10.2343/geochemj.40.475; Strapoc D, 2010, APPL MICROBIOLOGY MO, P211, DOI 10.1007/978-90-481-9252-6_25; Ueno M., 1964, J JPN ASS PETROLEUM, V29, P39; Uyeda S., 1972, CRUST UPPER MANTLE 1	36	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	FEB	2015	9	2					436	446		10.1038/ismej.2014.140		11	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	AZ4SQ	WOS:000348213600014		
J	Sato, N; Nunome, H; Ikegami, Y				Sato, Nahoko; Nunome, Hiroyuki; Ikegami, Yasuo			Kinematic Analysis of Basic Rhythmic Movements of Hip-hop Dance: Motion Characteristics Common to Expert Dancers	JOURNAL OF APPLIED BIOMECHANICS			English	Article						phase delay of motion; rhythmic movement; evaluation of performance		In hip-hop dance contests, a procedure for evaluating performances has not been clearly defined, and objective criteria for evaluation are necessary. It is assumed that most hip-hop dance techniques have common motion characteristics by which judges determine the dancer's skill level. This study aimed to extract motion characteristics that may be linked to higher evaluations by judges. Ten expert and 12 nonexpert dancers performed basic rhythmic movements at a rate of 100 beats per minute. Their movements were captured using a motion capture system, and eight judges evaluated the performances. Four kinematic parameters, including the amplitude of the body motions and the phase delay, which indicates the phase difference between two joint angles, were calculated. The two groups showed no significant differences in terms of the amplitudes of the body motions. In contrast, the phase delay between the head motion and the other body parts' motions of expert dancers who received higher scores from the judges, which was approximately a quarter cycle, produced a loop-shaped motion of the head. It is suggested that this slight phase delay was related to the judges' evaluations and that these findings may help in constructing an objective evaluation system.	[Sato, Nahoko] Nagoya Gakuin Univ, Fac Rehabil Sci, Dept Phys Therapy, Seto, Aichi, Japan; [Nunome, Hiroyuki] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 81401, Japan; [Ikegami, Yasuo] Aichi Shukutoku Univ, Fac Hlth & Med Sci, Nagakute, Aichi, Japan	Sato, N (reprint author), Nagoya Gakuin Univ, Fac Rehabil Sci, Dept Phys Therapy, Seto, Aichi, Japan.	nsato@ngu.ac.jp					Ae M, 1992, BIOMECHANISMS, V11, P23; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Orishimo KF, 2009, AM J SPORT MED, V37, P2187, DOI 10.1177/0363546509339365; Sato N, 2014, J APPL BIOMECH, V30, P439, DOI 10.1123/jab.2013-0190; Bronner Shaw, 2011, J Dance Med Sci, V15, P23; Chatfield Steven J, 2009, J Dance Med Sci, V13, P108; Imura A, 2010, J APPL BIOMECH, V26, P484; Imura A, 2010, HUM MOVEMENT SCI, V29, P947, DOI 10.1016/j.humov.2010.08.002; Jaspers E, 2011, GAIT POSTURE, V33, P279, DOI 10.1016/j.gaitpost.2010.11.021; Krasnow Donna, 2009, J Dance Med Sci, V13, P101; Kuno-Mizumura M, 2005, JPN J BIOMECH SPORTS, V9, P120; Lockwood KL, 2006, SPORT BIOMECH, V5, P231, DOI 10.1080/14763140608522876; Miura A, 2011, HUM MOVEMENT SCI, V30, P1260, DOI 10.1016/j.humov.2010.08.006	13	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	FEB	2015	31	1					1	7		10.1123/JAB.2014-0027		7	Engineering, Biomedical; Sport Sciences	Engineering; Sport Sciences	AZ5HF	WOS:000348250100001		
J	Pei, XY; Ouyang, XY; He, L; Cao, CF; Luan, QX; Suda, R				Pei, Xiyan; Ouyang, Xiangying; He, Lu; Cao, Caifang; Luan, Qingxian; Suda, Reiko			A 4-year prospective study of the progression of periodontal disease in a rural Chinese population	JOURNAL OF DENTISTRY			English	Article						Periodontal disease; Longitudinal study; Natural progression	ORAL-HEALTH-CARE; ATTACHMENT LOSS; NATURAL-HISTORY; TOOTH LOSS; CLINICAL-COURSE; SOUTH BRAZIL; GINGIVAL RECESSION; ELDERLY CHINESE; RISK INDICATORS; UNITED-STATES	Objectives: The natural progression of periodontitis in the Chinese population is not well researched. We investigated the progression of periodontal disease over 4 years in 15-44-year-old Chinese villagers with no access to regular dental care. Methods: In 1992, 486 villagers were enrolled, and in 1996, 413 villagers were re-examined. Probing depth (PD) and clinical attachment level (CAL) were examined at six sites per tooth. Sites with Delta CAL >= 3 mm were defined as active sites. Cross-sectional and longitudinal analyses were performed using means and percentile plots. Results: The mean CAL increased by 0.26 mm over 4 years. The incidence of periodontitis (at least one site with CAL >= 3 mm) was 8%. The incidence of periodontitis among those with no periodontal disease at baseline was 44.9%. Seventy-eight percent of the subjects had at least one active site. In the 15-24-year group, 244 of 401 active sites had gingival recession, while only 51 active sites had both gingival recession and deeper pockets. In the 25-34-year and 35-44-year groups, almost one-third of the active sites (329/1087) and more than one-third of the active sites (580/1312) respectively had a combination of gingival recession and deeper pockets. Conclusions: In this study, we demonstrated that in Chinese population without regular dental care, both the initiation of periodontitis and progression of previously existed periodontitis contributed to the natural progression of periodontitis and periodontal pocketing played a greater role with age increasing. Clinical significance: This rare study reports the natural progression of periodontal disease in a group of Chinese villagers (15-44 years) with virtually no access to regular dental care. (C) 2014 Elsevier Ltd. All rights reserved.	[Pei, Xiyan; Ouyang, Xiangying; He, Lu; Cao, Caifang; Luan, Qingxian] Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing 100081, Peoples R China; [Pei, Xiyan] Peking Univ, Sch & Hosp Stomatol, Outpatient Dept, Beijing 100081, Peoples R China; [Suda, Reiko] Showa Univ, Sch Dent, Dept Periodont, Tokyo 142, Japan	Ouyang, XY (reprint author), Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, 22 Zhonggguancun South Ave, Beijing 100081, Peoples R China.	kqouyangxy@bjmu.edu.cn					LINDHE J, 1983, J CLIN PERIODONTOL, V10, P433, DOI 10.1111/j.1600-051X.1983.tb01292.x; Neely AL, 2005, J CLIN PERIODONTOL, V32, P984, DOI 10.1111/j.1600-051X.2005.00797.x; Buchwald S, 2013, J CLIN PERIODONTOL, V40, P203, DOI 10.1111/jcpe.12056; ALBANDAR JM, 1990, J CLIN PERIODONTOL, V17, P467, DOI 10.1111/j.1600-051X.1990.tb02346.x; ALBANDAR JM, 1986, J CLIN PERIODONTOL, V13, P195, DOI 10.1111/j.1600-051X.1986.tb01459.x; Dye BA, 2012, PERIODONTOL 2000, V58, P10, DOI 10.1111/j.1600-0757.2011.00413.x; Susin C, 2011, J CLIN PERIODONTOL, V38, P326, DOI 10.1111/j.1600-051X.2011.01699.x; Schatzle M, 2009, J CLIN PERIODONTOL, V36, P365, DOI 10.1111/j.1600-051X.2009.01391.x; YONEYAMA T, 1988, J CLIN PERIODONTOL, V15, P581, DOI 10.1111/j.1600-051X.1988.tb02133.x; Beck JD, 1997, J PERIODONTAL RES, V32, P516, DOI 10.1111/j.1600-0765.1997.tb00567.x; HAFFAJEE AD, 1991, J CLIN PERIODONTOL, V18, P117, DOI 10.1111/j.1600-051X.1991.tb01700.x; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Schatzle M, 2003, J CLIN PERIODONTOL, V30, P909, DOI 10.1034/j.1600-051X.2003.00401.x; Heitz-Mayfield LJA, 2003, J CLIN PERIODONTOL, V30, P902, DOI 10.1034/j.1600-051X.2003.00399.x; Thomson WM, 2006, J PERIODONTOL, V77, P947, DOI 10.1902/jop.2006.050319; Ship JA, 1996, ORAL SURG ORAL MED O, V81, P281, DOI 10.1016/S1079-2104(96)80327-1; Baelum V, 1997, COMMUNITY DENT ORAL, V25, P265, DOI 10.1111/j.1600-0528.1997.tb00938.x; Baelum V, 1997, J PERIODONTOL, V68, P1033; Borrell LN, 2012, PUBLIC HEALTH REP, V127, P497; Cao CF, 1998, CHINESE J DENT RES, V1, P7; Chen X, 2001, J CLIN PERIODONTOL, V28, P331, DOI 10.1034/j.1600-051x.2001.028004331.x; Craig RG, 2003, J CLIN PERIODONTOL, V30, P1075, DOI 10.1046/j.0303-6979.2003.00421.x; Eliasson S, 1997, J CLIN PERIODONTOL, V24, P34, DOI 10.1111/j.1600-051X.1997.tb01181.x; Gaio EJ, 2012, GERODONTOLOGY, V29, P214, DOI 10.1111/j.1741-2358.2011.00617.x; Gatke D, 2012, J CLIN PERIODONTOL, V39, P357, DOI 10.1111/j.1600-051X.2011.01849.x; Gilbert GH, 2005, J PERIODONTOL, V76, P1161, DOI 10.1902/jop.2005.76.7.1161; Haas AN, 2012, J CLIN PERIODONTOL, V39, P1, DOI 10.1111/j.1600-051X.2011.01818.x; Holtfreter B, 2012, J CLIN PERIODONTOL, V39, P1115, DOI 10.1111/jcpe.12018; ISMAIL AI, 1990, J DENT RES, V69, P430, DOI 10.1177/00220345900690020201; LINDHE J, 1989, J CLIN PERIODONTOL, V16, P662, DOI 10.1111/j.1600-051X.1989.tb01037.x; LOE H, 1978, J PERIODONTOL, V49, P607, DOI 10.1902/jop.1978.49.12.607; LOE H, 1986, J CLIN PERIODONTOL, V13, P431, DOI 10.1111/j.1600-051X.1986.tb01487.x; LOE H, 1992, J PERIODONTOL, V63, P489; Murray H, 1997, Int Dent J, V47, P3; Neely AL, 2001, J PERIODONTOL, V72, P1006, DOI 10.1902/jop.2001.72.8.1006; OKAMOTO H, 1988, J CLIN PERIODONTOL, V15, P430, DOI 10.1111/j.1600-051X.1988.tb01597.x; Ong G, 1996, J CLIN PERIODONTOL, V23, P307, DOI 10.1111/j.1600-051X.1996.tb00550.x; Ouyang Xiang-ying, 2004, Zhonghua Kou Qiang Yi Xue Za Zhi, V39, P193; Owens JD, 2003, J PERIODONTOL, V74, P1206, DOI 10.1902/jop.2003.74.8.1206; PAPAPANOU PN, 1990, J CLIN PERIODONTOL, V17, P78, DOI 10.1111/j.1600-051X.1990.tb01066.x; PREUS HR, 1995, J CLIN PERIODONTOL, V22, P674, DOI 10.1111/j.1600-051X.1995.tb00825.x; Suda R, 1999, COMMUNITY DENT ORAL, V27, P216, DOI 10.1111/j.1600-0528.1999.tb02013.x; Suda R, 2000, J PERIODONTOL, V71, P1067, DOI 10.1902/jop.2000.71.7.1067; Susin C, 2005, J PERIODONTOL, V76, P262, DOI 10.1902/jop.2005.76.2.262; Thomson WM, 2004, J CLIN PERIODONTOL, V31, P119, DOI 10.1111/j.0303-6979.2004.00460.x; Timmerman MF, 2000, J CLIN PERIODONTOL, V27, P932, DOI 10.1034/j.1600-051x.2000.027012932.x	46	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	FEB	2015	43	2					192	200		10.1016/j.jdent.2014.12.008		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ2DT	WOS:000348045600004		
J	Tanaka, A; Nakajima, M; Seki, N; Foxton, RM; Tagami, J				Tanaka, A.; Nakajima, M.; Seki, N.; Foxton, R. M.; Tagami, J.			The effect of tooth age on colour adjustment potential of resin composite restorations	JOURNAL OF DENTISTRY			English	Article						Tooth age; Colour shifting; Colour adjustment; Colour of resin composite; Light transmission characteristics	LIGHT TRANSMITTANCE CHARACTERISTICS; DENTAL MATERIALS; ENAMEL; TRANSLUCENCY; REFLECTANCE	Objectives: The purpose of this study was to investigate the effect of tooth age on colour adjustment potential of resin composite restorations in human teeth. Methods: Twenty extracted human premolars with an A2 shade, extracted for orthodontic reasons from younger patients (20-28 yrs) (younger teeth) and periodontal reasons from older patients (45-69 yrs) (older teeth), were used in this study. Cylindrical shaped cavities (3.0 mm depth; 2.0 mm diameter) were prepared in the centre of the crowns on the buccal surface. One of four resin composites of A2 shade (Kalore, KA; Solare, SO; Clearfil Majesty, MJ; Beautifil II, BF) was placed in the cavity, and the colour was measured at four areas (0.4 mm x 0.4 mm) on the restored teeth (area 1; tooth area 1.0 mm away from the border of resin composite restoration: area 2; tooth border area 0.3 mm away from margin of resin composite restoration: area 3; resin composite border area 0.3 mm away from margin of resin composite restoration: area 4; resin composite area at the centre of resin composite restoration) using a spectrophotometer (Crystaleye). The colour of each area was determined according to the CIELAB colour scale. Colour differences (Delta E*) between the areas of 1 and 2, 2 and 3, 3 and 4 and 1 and 4 were calculated, and also the ratio of Delta E*(area 2-3) to Delta E*(area 1-4) (Delta E*(area 2-3/1-4)), Delta E*(area 3-4) to Delta E*(area 1-4) (Delta E*(area 3-4/1-4)) and Delta E*(area 1-2) to Delta E*(area 1-4) (Delta E*(area 1-/1-4)) as a parameter of the colour shift in resin composite restoration, were determined. Moreover, the light transmission characteristics of the resin materials and dentine discs from the younger and older teeth were measured using a goniophotometer. The data were statistically analyzed using two-way ANOVA, and Dunnett's T3 and t-test for the post hoc test. Results: Delta E*(area 2-3) (colour difference between resin composite and tooth at the border) and Delta E*(area 1-4) (colour difference between resin composite and tooth) of the older teeth groups were significantly larger than those of younger teeth groups (p < 0.05). The Delta E*(area 2-3/1-4) (mis-match rate in colour shifting at the border) of the older teeth groups was larger than that of the younger teeth groups (p < 0.05). Delta E*(area 3-4/1-4) (colour shifting rate of resin composite side) was significantly larger in older teeth than younger teeth (p < 0.05), while Delta E*(area 1-/1-4) (colour shifting rate of tooth side), was significantly smaller in older teeth than younger teeth (p < 0.05). In each tooth group, there were no significant differences in Delta E*(area 2-3), Delta E*(area 1-4), Delta E*(area 2-3/1-4), Delta E*(area 3-4/1-4) and Delta E*(area 1-2/1-4) between the materials (p > 0.05). Analysis of the light transmission properties indicated that older dentine transmitted more light, while younger dentine exhibited greater light diffusion and transmitted less light. Conclusions: The colour shifting effects at the border of the resin composite restorations were influenced by the age of the tooth. This behaviour might be influenced by the light transmission characteristics of dentine in restored teeth. Clinical significance: The potential for colour adjustment of resin composite restorations may be less in older teeth than younger teeth. (C) 2014 Elsevier Ltd. All rights reserved.	[Tanaka, A.; Nakajima, M.; Tagami, J.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Oral Restitut Dept, Bunkyo Ku, Tokyo 1138549, Japan; [Seki, N.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dent Educ Dev Sect, Bunkyo Ku, Tokyo 1138549, Japan; [Foxton, R. M.] Kings Coll London, Guys Hosp, Inst Dent, Div Conservat Dent, London SE1 9RT, England; [Foxton, R. M.] Kings Coll London, Kings Hosp, London SE1 9RT, England; [Foxton, R. M.] Kings Coll London, St Thomas Hosp, London SE1 9RT, England; [Tagami, J.] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Tokyo 1138549, Japan; [Tagami, J.] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1138549, Japan	Nakajima, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Oral Restitut Dept, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	nakajima.ope@tmd.ac.jp			Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, "International Research Center for Molecular Science in Tooth and Bone Diseases''	This work was supported by the grant from the Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, "International Research Center for Molecular Science in Tooth and Bone Diseases''.	OBRIEN WJ, 1990, J DENT RES, V69, P1762, DOI 10.1177/00220345900690111001; WATTS DC, 1994, J DENT, V22, P112, DOI 10.1016/0300-5712(94)90014-0; Joiner A, 2004, J DENT, V32, P3, DOI 10.1016/j.jdent.2003.10.013; Arikawa H, 2007, DENT MATER J, V26, P38; Yu B, 2009, ACTA ODONTOL SCAND, V67, P57, DOI 10.1080/00016350802577818; Paul S, 2002, J DENT RES, V81, P578; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; LOMBARDI RE, 1973, J PROSTHET DENT, V29, P358, DOI 10.1016/S0022-3913(73)80013-7; Ishikawa-Nagai S, 2010, J ESTHET RESTOR DENT, V22, P42, DOI 10.1111/j.1708-8240.2009.00311.x; Arikawa H, 1998, DENT MATER, V14, P405, DOI 10.1016/S0300-5712(99)00014-7; Ragain JC, 2001, J DENT RES, V80, P449; Eimar H, 2011, J DENT, V39, P3; Gawriolek M, 2012, J PROSTHODONT, V21, P112, DOI 10.1111/j.1532-849X.2011.00808.x; Goodking RJ, 1987, J PROSTHET DENT, V58, P6; Hall N R, 1991, Aust Prosthodont J, V5, P47; HASSAN R, 1981, J DENT RES, V60, P820, DOI 10.1177/00220345810600040901; Lee YK, 2005, DENT MATER, V21, P971, DOI 10.1016/j.dental.2005.04.033; Lee YK, 2005, OPER DENT, V30, P436; Marshall G W Jr, 1993, Quintessence Int, V24, P606; Nagai S, 2009, J DENT, V37, P57; Nagai S, 2005, J PROSTHET DENT, V93, P129; Nakajima M, 2012, J DENT, V40, P77; O'Keefe KL, 1991, J PROSTHETIC DENT, V66; Paravina RD, 2006, DENT MATER, V22, P299, DOI 10.1016/j.dental.2005.04.022; Paravina RD, 2008, J DENT RES, V87, P499; Paravina RD, 2006, DENT MATER, V22, P903, DOI 10.1016/j.dental.2005.11.018; Sptoull RC., 1974, J PROSTHET DENT, V31, P146; Swift E J Jr, 1994, Int J Prosthodont, V7, P356; TENBOSCH JJ, 1995, J DENT RES, V74, P374; Tsubone M, 2012, DENT MATER, V28, P811, DOI 10.1016/j.dental.2012.04.032	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	FEB	2015	43	2					253	260		10.1016/j.jdent.2014.09.007		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ2DT	WOS:000348045600012		
J	Ogihara, T; Fukushima, T				Ogihara, Toshiyuki; Fukushima, Takenobu			Semantic properties of the so-called past tense morpheme in Late Late Middle Japanese	JOURNAL OF EAST ASIAN LINGUISTICS			English	Article						Tense-aspect; Late Late Middle Japanese; Resultatives; Unaccusative verbs; Target states; Historical change		This article, which provides the very first formal semantic analysis of Late Late Middle Japanese (LLMJ) data, discusses adjectival (non-preterit) interpretations of the so-called past tense morpheme -ta in LLMJ and contemporary New Japanese (cNJ), accounting for their similarities and differences. We explain the historical semantic change of -ta and its predecessors as a gradual change from a resultative to a perfect and then to a preterit, in compliance with Maslov's (in: Nedjalkov (ed.) Typology of resultative constructions, 1988) hypothesis. Adjectival -ta is restricted to prenominal modifier cases in cNJ, but is found in both prenominal and matrix clause cases in LLMJ. Assuming that a matrix clause must be tensed, we argue that -ta is used as an aspect morpheme -ta (state) , and that a verbal complex V-ta (state) could in principle be suffixed by a tense morpheme. This analysis is needed for LLMJ and constitutes a major departure from the previous works dealing with adjectival -ta in cNJ such as Kusumoto (in: Cuervo et al. (eds.) Formal approaches to Japanese Linguistics 3, 2001) and Ogihara (Linguist Philos 27: 557-608, 2004). According to our account, V-ta (state) -ta (past) is illicit in both LLMJ and cNJ. The form V-ta (state) -a... (present) is licit in LLMJ, whereas cNJ only accepts the tenseless form V-ta (state) , which reflects the gradual marginalization of this construction over the course of Japanese language history. This accounts for the distributional constraint on adjectival -ta in cNJ. Regarding semantic interpretation, V-ta (state) asserts in both LLMJ and cNJ that a target state (Parsons, Events in the semantics of English: A study in subatomic semantics, 1990) of V-ing holds now without entailing that V actually occurred in the past. This semantic proposal is couched in an intensional analysis of -ta (state) .	[Ogihara, Toshiyuki] Univ Washington, Dept Linguist, Seattle, WA 98195 USA; [Fukushima, Takenobu] Jissen Womens Univ, Dept Japanese Literature, Shibuya Ku, Tokyo 1508538, Japan	Ogihara, T (reprint author), Univ Washington, Dept Linguist, Box 352425, Seattle, WA 98195 USA.	ogihara@uw.edu; fukushima-takenobu@jissen.ac.jp					Abe Yasuaki, 1993, P 1992 AS C LANG INF, P132; Amakusa-Esopo, 1963, AMAKUSABAN ESOPO MON; Amakusa-Feiqe, 1986, AMAKUSABAN HEIKE MON; Bybee Joan, 1994, EVOLUTION GRAMMAR TE; Chomsky Noam, 1982, SOME CONCEPTS CONSEQ; Dowty D., 1979, WORD MEANING MONTAGU; Frellesvig Bjarke, 2010, HIST JAPANESE LANGUA; Fukushima Takenobu, 2005, NIHONGO NO KENKYUU, V1-3, P139; Fukushima Takenobu, 2002, KOKUGO KOKUBUN, V71-8, P33; Fukushima Takenobu, 2011, NIHONGO BUNPOO NO RE, P119; Harasawa Itsuo, 1999, GEKKAN GENGO, V28-9, P114; Hasegawa Nobuko, 2011, 70NENDAI SEISEI BUNP, P85; Heim I., 1998, SEMANTICS GENERATIVE; Inoue Masaru, 2001, TA GENGOGAKU, P97; Iwasaki Takashi, 2000, NIHONGOGAKU, V19-5, P28; Kageyama Taro, 1996, DOOSHI IMIRON; Kindaichi Haruhiko, 1950, GENGO KENKYU, V15, P48; Kinsui Satoshi, 1995, TUKISIMA HIROSI HAKA, P169; Kinsui Satoshi, 1994, NIHONGO NO MEISHI SH, P29; Kratzer A., 2000, P BERKELEY LINGUISTI, V26, P385; KRATZER ANGELIKA, 1996, PHRASE STRUCTURE LEX, P109; Kudo Mayumi, 1995, ASUPEKUTO TENSU TAIK; Kusumoto Kiyomi, 2001, FORMAL APPROACHES JA, V3, P163; Maslov Jurij S, 1988, TYPOLOGY RESULTATIVE, P63; McCoard Robert, 1978, ENGLISH PERFECT TENS; Mihara Ken-ichi, 2011, NIHONGO BUNPOO, V11-1, P71; Minami F, 1993, GENDAI NIHONGO BUNPO; Minami Fujio, 1974, GENDAI NIHONGO NO KO; Nomura Takashi, 2004, GEKKAN GENGO, V33-4, P50; Nomura Takashi, 2011, HANASHI KOTABA NO NI; Ogihara T, 2004, LINGUIST PHILOS, V27, P557, DOI 10.1023/B:LING.0000033856.09799.c5; Parsons T., 1990, EVENTS SEMANTICS ENG; Rizzi Luigi, 1997, ELEMENTS GRAMMAR, P281; Shirane Haruo, 2002, EARLY MODERN JAPANES; Shirane Haruo, 2007, TRADITIONAL JAPANESE; Suzuki Tai, 1992, KODAI NIHONGO DOOSHI; Suzuki Tai, 1993, GEKKAN GENGO, V22-2, P60; Takayama Yuriko, 1995, CHIKUSHI KOKUBUN, V18, P1; Takezawa Koichi, 1991, NIHONGO VOISU TADOOS, P59; Takezawa Koichi, 1987, THESIS U WASHINGTON; Takubo Yukinori, 1987, NIHONGOGAKU, V6-5, P37; Teramura Hideo, 1984, NIHONSO NO SHINTAKKU; Tora, 1972, OOKURA TORA AKIRABON; Yamada Yoshio, 1922, NIHON BUNPOO KOOGI; Yanagida Seiji, 1987, EHIME KOKUBUN TO KYO, V19, P1; Yazawa Makoto, 1990, KOKUGO KOKUBUN RONSH, V19, P94; Yoshikawa Taketoki, 1973, LINGUISTIC COMMUNICA, V10, P1; Yuzawa Kokichiro, 1929, MUROMACHI JIDAL NO G	48	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-8558	1572-8560		J EAST ASIAN LINGUIS	J. East Asian Linguist.	FEB	2015	24	1					75	112		10.1007/s10831-014-9124-8		38	Linguistics; Language & Linguistics	Linguistics	AZ3HZ	WOS:000348119400003		
J	Kikunaga, K; Hoshi, T; Yamashita, H; Egashira, M; Nonaka, K				Kikunaga, K.; Hoshi, T.; Yamashita, H.; Egashira, M.; Nonaka, K.			Development of a technique for measuring static electricity distribution using focused ultrasound waves and an induced electric field	JOURNAL OF ELECTROSTATICS			English	Article						Static electricity; Electric field; Focused ultrasound; Measuring technology; Distribution	ACOUSTIC RADIATION PRESSURE	A novel method is proposed for non-contact measurement of static electricity distribution on a surface using focused ultrasound to excite movement of the charge. The focused ultrasound is generated by controlling individually the phases of 285 airborne ultrasound transducers, and it was demonstrated local excitation could be measured. An electric field is induced by local excitation of a charged object. The electric field intensity and phase are related to the surface potential and electrical polarity of the object, respectively. It is possible to measure static electricity distribution over an entire object surface by scanning the position of the focused ultrasound. (C) 2014 Elsevier B.V. All rights reserved.	[Kikunaga, K.; Yamashita, H.; Egashira, M.; Nonaka, K.] Natl Inst Adv Ind Sci & Technol, Tosu, Saga 8410052, Japan; [Hoshi, T.] Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan	Kikunaga, K (reprint author), Natl Inst Adv Ind Sci & Technol, 807-1 Shuku Machi, Tosu, Saga 8410052, Japan.	k-kikunaga@aist.go.jp			Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan	This study was supported by an Industrial Technology Research Grant Program in 2011 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	ANDERSON RA, 1984, J APPL PHYS, V56, P2856, DOI 10.1063/1.333821; Sowinski A, 2009, J ELECTROSTAT, V67, P568, DOI 10.1016/j.elstat.2008.11.005; AWATANI J, 1955, J ACOUST SOC AM, V27, P278, DOI 10.1121/1.1907514; Hoshi T, 2010, IEEE T HAPTICS, V3, P155, DOI [10.1109/TOH.2010.4, 10.1109/ToH.2010.4]; CHU BT, 1982, J ACOUST SOC AM, V72, P1673, DOI 10.1121/1.388660; Eisenmenger E., 1982, SOLID STATE COMMUN, V41, P917; Hasegawa T., 2000, ACOUST SCI TECHNOL, V21, P145; Hoshi T., 2012, P JSME C ROB MECH; Kikunaga K., 2013, JPN J APPL PHYS, V52; Kikunaga K., 2014, P INT S EL COMP, P41; Kikunaga K., 2012, J ELECTROSTAT, V71, P554; Matsui M., 1986, J I ELECTROSTAT JPN, V10, P217; Secker P. E., 1975, Journal of Electrostatics, V1, DOI 10.1016/0304-3886(75)90005-4; Taylor D.M., 1994, IND ELECT FUNDAMENTA; Vosteen R.E., 1982, INT C CHARG PART MAN; Yamada H., 1986, J I ELECTROSTAT JPN, V10, P213	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	FEB	2015	73						6	11		10.1016/j.elstat.2014.10.016		6	Engineering, Electrical & Electronic	Engineering	AZ2TY	WOS:000348086300002		
J	Kawamoto, H; Shibata, T				Kawamoto, Hiroyuki; Shibata, Takuya			Electrostatic cleaning system for removal of sand from solar panels	JOURNAL OF ELECTROSTATICS			English	Article						Cleaner; Electrostatic force; Mega solar; Sand; Solar panel	TRAVELING-WAVE TRANSPORT; PARTICLE-TRANSPORT; DUST REMOVAL; LUNAR DUST; PERFORMANCE; FIELD; LIQUID; CELLS; MITIGATION; SEPARATION	An improved cleaning system has been developed that uses electrostatic force to remove sand from the surface of solar panels. A single-phase high voltage is applied to parallel wire electrodes embedded in the cover glass plate of a solar panel. It has been demonstrated that more than 90% of the adhering sand is repelled from the surface of the slightly inclined panel after the cleaning operation. The performance of the system was further improved by improving the electrode configuration and introducing natural wind on the surface of the panel, even when the deposition of sand on the panel is extremely high. The power consumption of this system is virtually zero. This technology is expected to increase the effective efficiency of mega solar power plants constructed in deserts at low latitudes. (C) 2014 Elsevier B.V. All rights reserved.	[Kawamoto, Hiroyuki; Shibata, Takuya] Waseda Univ, Dept Appl Mech & Aerosp Engn, Shinjuku Ku, Tokyo 1698555, Japan	Kawamoto, H (reprint author), Waseda Univ, Dept Appl Mech & Aerosp Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	kawa@waseda.jp			JSPS KAKENHI [23360116]	The author would like to express his gratitude to Haruna Takahashi and Shogo Shibata (Waseda University) who helped to carry out the experiments. This work was supported by JSPS KAKENHI Grant Number 23360116.	Mani M, 2010, RENEW SUST ENERG REV, V14, P3124, DOI 10.1016/j.rser.2010.07.065; Calle CI, 2009, J ELECTROSTAT, V67, P89, DOI 10.1016/j.elstat.2009.02.012; Kawamoto H, 2011, J ELECTROSTAT, V69, P370, DOI 10.1016/j.elstat.2011.04.016; Mazumder M, 2013, IEEE T IND APPL, V49, P1793, DOI 10.1109/TIA.2013.2258391; AOYAMA M, 1993, J ELECTROSTAT, V30, P247, DOI 10.1016/0304-3886(93)90079-M; Benatiallah A, 2012, INT J MULTIDISCIP SC, V3, P3; Calle C.I., 2008, P ESA ANN M EL; ELSHOBOKSHY MS, 1985, IEE PROC-I, V132, P5; Goossens D, 1999, SOL ENERGY, V66, P277, DOI 10.1016/S0038-092X(99)00028-6; Kawamoto H, 2006, J PHYS D APPL PHYS, V39, P1249, DOI 10.1088/0022-3727/39/6/036; Kawamoto H, 2011, J ELECTROSTAT, V69, P365, DOI 10.1016/j.elstat.2011.04.015; Kawamoto H, 2004, J IMAGING SCI TECHN, V48, P404; Kawamoto H., 2013, 39 IEEE PHOT SPEC C, P39; Kawamoto H, 2011, J AEROSPACE ENG, V24, P442, DOI 10.1061/(ASCE)AS.1943-5525.0000084; Kawamoto H, 2006, J PHYS D APPL PHYS, V39, P418, DOI 10.1088/0022-3727/39/2/026; Kawamoto H, 2008, J ELECTROSTAT, V66, P220, DOI 10.1016/j.elstat.2008.01.002; Kazem H.A., 2013, INT J RENEW ENERGY R, V3, P850; Kober K, 2000, P NPI16 INT C DIG PR, P736; Kober R., 2002, P IS TS NIP18 IS T, P453; KOMOTO K, 2012, 38 IEEE PHOT SPEC PV, P1778; Liu G, 2010, J ELECTROSTAT, V68, P289, DOI 10.1016/j.elstat.2010.02.004; Liu GQ, 2010, J ELECTROSTAT, V68, P179, DOI 10.1016/j.elstat.2009.12.007; Masuda S., 1972, T IEE JAPAN B, V92, P9; MASUDA S, 1988, IEEE T IND APPL, V24, P217, DOI 10.1109/28.2859; MELCHER JR, 1989, IEEE T IND APPL, V25, P949, DOI 10.1109/28.41263; MELCHER JR, 1989, IEEE T IND APPL, V25, P956, DOI 10.1109/28.41264; Mohamed A.O., 2012, J BASIC APPL SCI RES, V2, P11030; Ndiaye Ababacar, 2013, INT J PHYS SCI, V8, P1166; Onozuka M, 1997, J NUCL SCI TECHNOL, V34, P1031, DOI 10.3327/jnst.34.1031; Qasem H, 2011, 26 EUR PHOT SOL EN C; Rajput D. S., 2013, INT J CHEM TECHNOL R, V5, P1083; Robison J.R., 2008, P ESA ANN M EL; Schmidlin F, 1999, P NIP15 INT C DIG PR, P302; SCHMIDLIN FW, 1995, J ELECTROSTAT, V34, P225, DOI 10.1016/0304-3886(94)00035-U; SCHMIDLIN FW, 1991, IEEE T IND APPL, V27, P480, DOI 10.1109/28.81831; Taniguchi K., 2000, P NIP16 INT C DIG PR, P740; Taniguchi K, 2003, J IMAGING SCI TECHN, V47, P224; Thompson M.D., 1999, P NIP15 INT C DIG PR, P262; WEISS LC, 1984, J AM OIL CHEM SOC, V61, P886, DOI 10.1007/BF02542157	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	FEB	2015	73						65	70		10.1016/j.elstat.2014.10.011		6	Engineering, Electrical & Electronic	Engineering	AZ2TY	WOS:000348086300010		
J	Kudo, K; Ito, H; Ihara, S; Terato, H				Kudo, Ken-ichi; Ito, Hironori; Ihara, Satoshi; Terato, Hiroaki			Quantitative analysis of oxidative DNA damage induced by high-voltage pulsed discharge with cavitation	JOURNAL OF ELECTROSTATICS			English	Article						Pulsed discharge; Cavitation; Reactive oxygen species; DNA damage; 8-Hydroxyguanine	APURINIC APYRIMIDINIC SITES; COLI FPG PROTEIN; CENTER-DOT-DG; ESCHERICHIA-COLI; HYDRODYNAMIC CAVITATION; SUBSTRATE-SPECIFICITY; ORGANIC-COMPOUNDS; GAMMA-RAYS; GLYCOSYLASE; WATER	Pulsed discharge is used for sterilization and disinfection, but the details of the molecular mechanisms remain largely unknown. Since pulsed discharge generates reactive oxygen species (ROS), we analyzed the oxidative DNA damages after pulsed discharge treatment to consider the involvement of ROS in the damaging process. We applied pulsed discharge with cavitation to plasmid DNA molecules and estimated the yields of the damages by agarose gel electrophoresis. The treated DNA contained various oxidative DNA damages, including single and double strand breaks and base lesions. The yields of the damages increased in response to the energy used for pulsed discharge. We also measured the yield of 8hydroxyguanine (8-OH-G), one of the major oxidative base lesions, in the treated plasmid DNA by mass spectrometry quantitatively and found that the yield of the oxidative base lesion corresponded to the increment of the applied energy. In addition, we observed the involvement of mutM gene, which is responsible for repair of 8-OH-G, in the increased sensitivity of Estherichia coil to pulsed discharge. Therefore, ROS seem to mediate the sterilization ability of pulsed discharge. (C) 2014 Published by Elsevier B.V.	[Kudo, Ken-ichi; Terato, Hiroaki] Saga Univ, Analyt Res Ctr Expt Sci, Saga 8498501, Japan; [Ito, Hironori; Ihara, Satoshi] Saga Univ, Grad Sch Sci & Engn, Saga 8408502, Japan	Terato, H (reprint author), Saga Univ, Analyt Res Ctr Expt Sci, 5-1-1 Nabeshima, Saga 8498501, Japan.	terato@cc.saga-u.ac.jp	Kudo, Ken-ichi/M-8437-2015		JSPS KAKENHI [22510062, 25340034]	We thank Mr. Noriki Kobayashi and Mrs. Yuka Ikeda from Saga University for their technical assistance. This work was partly supported by JSPS KAKENHI Grant Number 22510062 and 25340034 (H.T.).	Ali MM, 2004, J RADIAT RES, V45, P229; Sato M, 1996, IEEE T IND APPL, V32, P106, DOI 10.1109/28.485820; Dev SB, 2000, IEEE T PLASMA SCI, V28, P206, DOI 10.1109/27.842905; Preis S, 2013, J ENVIRON MANAGE, V114, P125, DOI 10.1016/j.jenvman.2012.10.042; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Wiederholt CJ, 2003, BIOCHEMISTRY-US, V42, P9755, DOI 10.1021/bi034844h; Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2; CHETSANGA CJ, 1979, NUCLEIC ACIDS RES, V6, P3673, DOI 10.1093/nar/6.11.3673; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; Terato H, 2008, J RADIAT RES, V49, P133, DOI 10.1269/jrr.07089; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; Gogate PR, 2000, AICHE J, V46, P1641, DOI 10.1002/aic.690460815; Jyoti KK, 2001, BIOCHEM ENG J, V7, P201, DOI 10.1016/S1369-703X(00)00128-5; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Gulston M, 2002, NUCLEIC ACIDS RES, V30, P3464, DOI 10.1093/nar/gkf467; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; Sun B, 1999, J PHYS D APPL PHYS, V32, P1908, DOI 10.1088/0022-3727/32/15/319; MICHAELS ML, 1991, NUCLEIC ACIDS RES, V19, P3629, DOI 10.1093/nar/19.13.3629; APPLEBY A, 1969, J PHYS CHEM-US, V73, P1937, DOI 10.1021/j100726a048; Asagoshi K, 2000, J BIOL CHEM, V275, P4956, DOI 10.1074/jbc.275.7.4956; Asagoshi K, 2000, J BIOL CHEM, V275, P24781, DOI 10.1074/jbc.M000576200; BENZ R, 1980, BIOCHIM BIOPHYS ACTA, V597, P637, DOI 10.1016/0005-2736(80)90236-9; Chen CW, 2008, IEEE T PLASMA SCI, V36, P215, DOI 10.1109/TPS.2007.913928; CHETSANGA CJ, 1981, BIOCHEMISTRY-US, V20, P5201, DOI 10.1021/bi00521a016; GORMAN AA, 1976, PHOTOCHEM PHOTOBIOL, V23, P399, DOI 10.1111/j.1751-1097.1976.tb07272.x; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Haraguchi K, 2001, J AM CHEM SOC, V123, P8636, DOI 10.1021/ja0160952; Ihara S., 2011, Japan Patent, Patent No. [4813443 B2, 4813443]; Kadowaki K, 2009, BIOSCI BIOTECH BIOCH, V73, P1978, DOI 10.1271/bbb.90153; Kuda T, 2004, FOOD CONTROL, V15, P421, DOI 10.1016/S0956-7135(03)00116-6; Leverone MR, 1996, J MICROBIOL METH, V25, P49, DOI 10.1016/0167-7012(95)00084-4; Miichi T, 2002, OZONE-SCI ENG, V24, P471, DOI 10.1080/01919510208901636; OBRIEN PJ, 1969, CAN J BIOCHEM CELL B, V47, P493; OCONNOR TR, 1989, P NATL ACAD SCI USA, V86, P5222, DOI 10.1073/pnas.86.14.5222; Sahni M, 2006, PLASMA PROCESS POLYM, V3, P668, DOI 10.1002/ppap.200600020; SANTOS ME, 1994, GENETICS, V138, P553; Soyama H., 2010, 20 INT C WAT JETT CU, P259; Su X, 2011, RADIAT PHYS CHEM, V80, P1343, DOI 10.1016/j.radphyschem.2011.06.017; Sun B, 1997, J ELECTROSTAT, V39, P189, DOI 10.1016/S0304-3886(97)00002-8; TEST ST, 1984, J BIOL CHEM, V259, P399; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; WEISS SJ, 1982, J BIOL CHEM, V257, P2947; Yasuoka K., 2009, INT J PLASMA ENV SCI, V3, P22; YUKAWA O, 1980, INT J RADIAT BIOL, V37, P621, DOI 10.1080/713857573	47	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	FEB	2015	73						131	139		10.1016/j.elstat.2014.10.010		9	Engineering, Electrical & Electronic	Engineering	AZ2TY	WOS:000348086300019		
J	Tanino, T; Yoshida, T; Sakai, K; Bing, S; Ohshima, T				Tanino, Takanori; Yoshida, Tomoki; Sakai, Kazuki; Bing, Sun; Ohshima, Takayuki			Inactivation of Escherichia coli phages by PEF treatment and analysis of inactivation mechanism	JOURNAL OF ELECTROSTATICS			English	Article						Pulsed electric field; Phage; Inactivation	BACTERIOPHAGES; LAMBDA; M13	Inactivation of phage by pulsed electric field (PEF) treatment using Escherichia coli phages (M13mp18 and lambda phage) as the phage particle model was studied. E. coli phages were successfully inactivated, and the absence of degradation of biological molecules was confirmed by electrophoretic analysis of these molecules from the inactivated phages. The comparison of sensitivity to PEF treatment between the E. coli phage and the E. coli cells was also carried out. The E. coli phages were more sensitive to the PEF treatment than the E. coli cells, and this difference allowed the preferential inactivation of E. coli phages. (C) 2014 Elsevier B.V. All rights reserved.	[Tanino, Takanori; Yoshida, Tomoki; Sakai, Kazuki; Ohshima, Takayuki] Gunma Univ, Grad Sch Engn, Dept Chem & Environm Engn, Kiryu, Gunma 3768515, Japan; [Bing, Sun] Dalian Maritime Univ, Coll Environm Sci & Engn, Dalian 116023, Peoples R China	Ohshima, T (reprint author), Gunma Univ, Grad Sch Engn, Dept Chem & Environm Engn, 1-5-1 Tenjincho, Kiryu, Gunma 3768515, Japan.	tohshima@gunma-u.ac.jp			Japan Society for the Promotion of Science [22510082]	This research was supported by a Grand-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (22510082).	Muller-Merbach M, 2005, INT DAIRY J, V15, P777, DOI 10.1016/j.idairyj.2004.08.019; MARVIN DA, 1994, J MOL BIOL, V235, P260, DOI 10.1016/S0022-2836(05)80032-4; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Lee C, 2011, CHEMOSPHERE, V82, P1135, DOI 10.1016/j.chemosphere.2010.11.036; Aksyuk AA, 2011, VIRUSES-BASEL, V3, P172, DOI 10.3390/v3030172; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; Locke BR, 2006, IND ENG CHEM RES, V45, P882, DOI 10.1021/ie050981u; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; Capra ML, 2009, INT DAIRY J, V19, P336, DOI 10.1016/j.idairyj.2008.11.002; Castro AJ, 2001, FOOD PRESERV TECHNOL, P83; Chen HQ, 2004, J FOOD PROTECT, V67, P505; HOHN T, 1977, CURR TOP MICROBIOL, P69; Ohshima T., 1999, J ELECTROSTAT, V46, P163; Ohshima T, 1997, J ELECTROSTAT, V42, P159, DOI 10.1016/S0304-3886(97)00152-6; Vega-Mercado H, 2001, FOOD PRESERV TECHNOL, P121	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3886	1873-5738		J ELECTROSTAT	J. Electrost.	FEB	2015	73						151	155		10.1016/j.elstat.2014.11.004		5	Engineering, Electrical & Electronic	Engineering	AZ2TY	WOS:000348086300021		
J	Baba, S; Kobayashi, N; Takahashi, S; Hirano, S				Baba, Soumei; Kobayashi, Nariyoshi; Takahashi, Sanyo; Hirano, Satoshi			Development of Anode Gas Recycle System Using Ejector for 1 kW Solid Oxide Fuel Cell	JOURNAL OF ENGINEERING FOR GAS TURBINES AND POWER-TRANSACTIONS OF THE ASME			English	Article							MICRO-COMBINED HEAT; RESIDENTIAL APPLICATIONS; RECIRCULATION BEHAVIOR; PERFORMANCE EVALUATION; DESIGN; CONFIGURATIONS	An anode gas recycle (AGR) system using an ejector for 1 kW solid oxide fuel cells (SOFCs) was developed to increase the electrical efficiency of combined power generation. We call this an AGR-SOFC. The effects of recirculation ratio, externally steam feed rate, and fuel utilization were determined experimentally on the AGR-SOFC performance (i.e., output power, stack temperature, and gas composition) using a variable flow ejector and a recirculation ratio of 0.55-0.62, overall fuel utilization of 0.720-84, and steam feed rate of 0-1.5 g/min. A quadrupole mass spectrometer was used to identify the recirculation ratio, the gas composition of reformed gas at the AGR-SOFC inlet, and that of the recycle gas at the outlet. Compared to one-path SOFC systems, i.e., without an AGR, the AGR-SOFC was stable and generated about 15 W more electricity when the overall fuel utilization was 0.84 and the recirculation ratio was 0.622 with no steam supply. This improved performance was due to the reduced H2O concentration in the anodic gas. In addition, although the recirculation ratio did not affect the AGR-SOFC performance, a high recirculation ratio can provide steam produced via the electrochemical reaction to the injected fuel for the steam reforming process.	[Baba, Soumei; Kobayashi, Nariyoshi; Takahashi, Sanyo] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Thermal & Fluid Syst Grp, Tsukuba, Ibaraki 3058564, Japan; [Hirano, Satoshi] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Thermal & Fluid Syst Grp, Tsukuba, Ibaraki 3058569, Japan	Baba, S (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Thermal & Fluid Syst Grp, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	soumei.baba@aist.go.jp; nariyoshi-kobayashi@aist.go.jp; takahashi.sanyo@aist.go.jp; hirano.s@aist.go.jp					Powell M, 2012, J POWER SOURCES, V205, P377, DOI 10.1016/j.jpowsour.2012.01.098; Santarelli MG, 2007, J FUEL CELL SCI TECH, V4, P143, DOI 10.1115/1.2713772; Brunner DA, 2012, INT J HYDROGEN ENERG, V37, P4457, DOI 10.1016/j.ijhydene.2011.11.116; Liso V, 2011, ENERGY, V36, P4216, DOI 10.1016/j.energy.2011.04.022; Traverso A, 2008, Journal of Engineering for Gas Turbines and Power, V130, DOI 10.1115/1.2772638; Zhu YH, 2007, J POWER SOURCES, V173, P437, DOI 10.1016/j.jpowsour.2007.08.036; Dietrich RU, 2011, J POWER SOURCES, V196, P7152, DOI 10.1016/j.jpowsour.2010.09.016; Braun RJ, 2006, J POWER SOURCES, V158, P1290, DOI 10.1016/j.jpowsour.2005.10.064; Zhu YH, 2011, ENERG CONVERS MANAGE, V52, P1881, DOI 10.1016/j.enconman.2010.11.012; Farhad S, 2010, INT J HYDROGEN ENERG, V35, P3758, DOI 10.1016/j.ijhydene.2010.01.052; Liu M, 2013, INT J HYDROGEN ENERG, V38, P2868, DOI 10.1016/j.ijhydene.2012.12.070; Ferrari ML, 2013, APPL ENERG, V105, P369, DOI 10.1016/j.apenergy.2013.01.029; Zhu YH, 2008, J POWER SOURCES, V185, P1122, DOI 10.1016/j.jpowsour.2008.07.027; Ferrari ML, 2010, J FUEL CELL SCI TECH, V7, DOI 10.1115/1.3176663; Zhu YH, 2009, APPL THERM ENG, V29, P898, DOI 10.1016/j.applthermaleng.2008.04.025; Saebea D, 2012, J POWER SOURCES, V208, P120, DOI 10.1016/j.jpowsour.2012.02.023; Peters R, 2013, INT J HYDROGEN ENERG, V38, P6809, DOI 10.1016/j.ijhydene.2013.03.110; Marsano F, 2004, J POWER SOURCES, V129, P216, DOI 10.1016/j.jpowsour.2003.11.034; Ferrari ML, 2011, J POWER SOURCES, V196, P2682, DOI 10.1016/j.jpowsour.2010.11.029; Liso V., 2013, APPL THERM ENG, V54, P26; Ray E. R., 1993, JOINT CONTR M FE EE, P304; Takahashi S., 2004, T JPN SOC MECH ENG-B, V70, P192	22	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0742-4795	1528-8919		J ENG GAS TURB POWER	J. Eng. Gas. Turbines Power-Trans. ASME	FEB	2015	137	2							021504	10.1115/1.4028361		9	Engineering, Mechanical	Engineering	AZ2FU	WOS:000348050800004		
